PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Provenzano, L; Ryan, Y; Hilton, DA; Lyons-Rimmer, J; Dave, F; Maze, EA; Adams, CL; Rigby-Jones, R; Ammoun, S; Hanemann, CO				Provenzano, L.; Ryan, Y.; Hilton, D. A.; Lyons-Rimmer, J.; Dave, F.; Maze, E. A.; Adams, C. L.; Rigby-Jones, R.; Ammoun, S.; Hanemann, C. O.			Cellular prion protein (PrPC) in the development of Merlin-deficient tumours	ONCOGENE			English	Article							UBIQUITIN LIGASE CRL4(DCAF1); LAMININ RECEPTOR; HUMAN SCHWANNOMA; C-JUN; GENE-EXPRESSION; AMYLOID-BETA; CANCER-CELLS; ACTIVATION; PROLIFERATION; MENINGIOMAS	Loss of function mutations in the neurofibromatosis Type 2 (NF2) gene, coding for a tumour suppressor, Merlin, cause multiple tumours of the nervous system such as schwannomas, meningiomas and ependymomas. These tumours may occur sporadically or as part of the hereditary condition neurofibromatosis Type 2 (NF2). Current treatment is confined to (radio) surgery and no targeted drug therapies exist. NF2 mutations and/or Merlin inactivation are also seen in other cancers including some mesothelioma, breast cancer, colorectal carcinoma, melanoma and glioblastoma. To study the relationship between Merlin deficiency and tumourigenesis, we have developed an in vitro model comprising human primary schwannoma cells, the most common Merlin-deficient tumour and the hallmark for NF2. Using this model, we show increased expression of cellular prion protein (PrPC) in schwannoma cells and tissues. In addition, a strong overexpression of PrPC is observed in human Merlin-deficient mesothelioma cell line TRA and in human Merlin-deficient meningiomas. PrPC contributes to increased proliferation, cell-matrix adhesion and survival in schwannoma cells acting via 37/67 kDa non-integrin laminin receptor (LR/37/67 kDa) and downstream ERK1/2, PI3K/AKT and FAK signalling pathways. PrPC protein is also strongly released from schwannoma cells via exosomes and as a free peptide suggesting that it may act in an autocrine and/or paracrine manner. We suggest that PrPC and its interactor, LR/37/67 kDa, could be potential therapeutic targets for schwannomas and other Merlin-deficient tumours.	[Provenzano, L.; Ryan, Y.; Lyons-Rimmer, J.; Dave, F.; Maze, E. A.; Adams, C. L.; Ammoun, S.; Hanemann, C. O.] Plymouth Univ, Inst Translat & Stratified Med, Peninsula Sch Med, John Bull Bldg,Tamar Sci Pk,Res Way, Plymouth PL6 8BU, Devon, England; [Provenzano, L.; Ryan, Y.; Lyons-Rimmer, J.; Dave, F.; Maze, E. A.; Adams, C. L.; Ammoun, S.; Hanemann, C. O.] Plymouth Univ, Inst Translat & Stratified Med, Peninsula Sch Dent, John Bull Bldg,Tamar Sci Pk,Res Way, Plymouth PL6 8BU, Devon, England; [Hilton, D. A.; Rigby-Jones, R.] Derriford Hosp, Dept Cellular & Anat Pathol, Plymouth, Devon, England	University of Plymouth; University of Plymouth; Derriford Hospital	Ammoun, S (corresponding author), Plymouth Univ, Inst Translat & Stratified Med, Peninsula Sch Med, John Bull Bldg,Tamar Sci Pk,Res Way, Plymouth PL6 8BU, Devon, England.; Ammoun, S (corresponding author), Plymouth Univ, Inst Translat & Stratified Med, Peninsula Sch Dent, John Bull Bldg,Tamar Sci Pk,Res Way, Plymouth PL6 8BU, Devon, England.	sylwia.ammoun@plymouth.ac.uk	Atangana Maze, Emmanuel/HHC-2713-2022; Hanemann, C Oliver/AAV-6257-2020	Atangana Maze, Emmanuel/0000-0003-4632-6324; Hanemann, C Oliver/0000-0002-1951-1025; Adams, Claire/0000-0003-3871-9267; Ryan, Yan/0000-0002-4708-5350; Provenzano, Lucy/0000-0002-2922-0109	Laura Crane Youth Cancer Trust; Brain Tumour Research	Laura Crane Youth Cancer Trust; Brain Tumour Research	We thank Mario Salmona for mock PrP peptide and Joseph Testa for Merlin adenovirus. This work was supported by The Laura Crane Youth Cancer Trust and Brain Tumour Research.	Alais S, 2008, BIOL CELL, V100, P603, DOI 10.1042/BC20080025; Altmeppen HC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-36; Ammoun S, 2014, ONCOGENE, V33, P336, DOI 10.1038/onc.2012.587; Ammoun S, 2012, ONCOGENE, V31, P1710, DOI 10.1038/onc.2011.357; Ammoun S, 2015, MOL ONCOL, V9, P236, DOI 10.1016/j.molonc.2014.08.005; Ammoun S, 2008, CANCER RES, V68, P5236, DOI 10.1158/0008-5472.CAN-07-5849; Ammoun S, 2010, NEUROBIOL DIS, V37, P141, DOI 10.1016/j.nbd.2009.09.017; Arsenault RJ, 2012, PRION, V6, DOI 10.4161/pri.21914; Bacot SM, 2003, J LEUKOCYTE BIOL, V74, P118, DOI 10.1189/jlb.1102521; Blakeley Jaishri O, 2012, Am J Med Genet A, V158A, P24, DOI 10.1002/ajmg.a.34359; Bourteele S, 2007, CELL MICROBIOL, V9, P2202, DOI 10.1111/j.1462-5822.2007.00950.x; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Carimalo J, 2005, EUR J NEUROSCI, V21, P2311, DOI 10.1111/j.1460-9568.2005.04080.x; Clark VE, 2013, SCIENCE, V339, P1077, DOI 10.1126/science.1233009; Deguen B, 1998, INT J CANCER, V77, P554, DOI 10.1002/(SICI)1097-0215(19980812)77:4<554::AID-IJC14>3.0.CO;2-6; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Flaiz C, 2009, BRAIN PATHOL, V19, P27, DOI 10.1111/j.1750-3639.2008.00165.x; Ford MJ, 2002, NEUROSCIENCE, V113, P177, DOI 10.1016/S0306-4522(02)00155-0; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Gerber MA, 2006, CANCER RES, V66, P5295, DOI 10.1158/0008-5472.CAN-05-1628; Godsave SF, 2015, VIRUS RES, V207, P136, DOI 10.1016/j.virusres.2015.02.004; Gu YP, 2002, J BIOL CHEM, V277, P2275, DOI 10.1074/jbc.M104345200; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; Guo BB, 2016, J BIOL CHEM, V291, P5128, DOI 10.1074/jbc.M115.684258; Hanemann CO, 2008, BRAIN, V131, P606, DOI 10.1093/brain/awm249; Hanemann CO, 2006, NEUROPATH APPL NEURO, V32, P605, DOI 10.1111/j.1365-2990.2006.00769.x; Hilton DA, 2016, NEUROPATHOLOGY, V36, P250, DOI 10.1111/neup.12266; Kimata A, 2007, J MED CHEM, V50, P5053, DOI 10.1021/jm070688r; Klyubin I, 2014, J NEUROSCI, V34, P6140, DOI 10.1523/JNEUROSCI.3526-13.2014; Li W, 2010, CELL CYCLE, V9, P4433, DOI 10.4161/cc.9.22.13838; Li W, 2010, CELL, V140, P477, DOI 10.1016/j.cell.2010.01.029; Liang J, 2007, FASEB J, V21, P2247, DOI 10.1096/fj.06-7799com; Lin Y, 2010, EXPERT OPIN THER TAR, V14, P45, DOI 10.1517/14728220903431069; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Lopes JP, 2009, CELL CYCLE, V8, P97, DOI 10.4161/cc.8.1.7506; Loubet D, 2012, FASEB J, V26, P678, DOI 10.1096/fj.11-185579; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Nunes F, 2005, CANCER GENET CYTOGEN, V162, P135, DOI 10.1016/j.cancergencyto.2005.04.003; Parkin ET, 2004, J BIOL CHEM, V279, P11170, DOI 10.1074/jbc.M312105200; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Parkinson DB, 2004, J CELL BIOL, V164, P385, DOI 10.1083/jcb.200307132; Petrilli AM, 2016, ONCOGENE, V35, P537, DOI 10.1038/onc.2015.125; Pflanzner T, 2012, J CEREBR BLOOD F MET, V32, P628, DOI 10.1038/jcbfm.2012.7; Robb VA, 2005, ONCOGENE, V24, P1946, DOI 10.1038/sj.onc.1208335; Robertson C, 2006, BLOOD, V107, P3907, DOI 10.1182/blood-2005-02-0802; Rosenbaum C, 1998, NEUROBIOL DIS, V5, P55, DOI 10.1006/nbdi.1998.0179; Santos TG, 2015, PRION, V9, P165, DOI 10.1080/19336896.2015.1027855; Sarnataro D, 2016, SCI REP-UK, V6, DOI 10.1038/srep24457; Satoh J, 2000, AM J PATHOL, V157, P59, DOI 10.1016/S0002-9440(10)64517-8; Shivane A, 2013, HISTOPATHOLOGY, V62, P651, DOI 10.1111/his.12062; Singh N, 2010, ANTIOXID REDOX SIGN, V12, P1271, DOI 10.1089/ars.2009.2628; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; Stella R, 2010, MOL CELL BIOL, V30, P4864, DOI 10.1128/MCB.01040-09; Utermark T, 2003, BRAIN PATHOL, V13, P352; van den Munckhof P, 2012, NEUROGENETICS, V13, P1, DOI 10.1007/s10048-011-0300-y; Watts JC, 2007, BBA-MOL BASIS DIS, V1772, P654, DOI 10.1016/j.bbadis.2007.05.001; Weise J, 2008, RESTOR NEUROL NEUROS, V26, P57; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Wozniak K, 2008, CANCER GENET CYTOGEN, V183, P14, DOI 10.1016/j.cancergencyto.2008.01.020; Xiao GH, 2005, MOL CELL BIOL, V25, P2384, DOI 10.1128/MCB.25.6.2384-2394.2005; Yap YHY, 2011, CANCER LETT, V306, P111, DOI 10.1016/j.canlet.2011.02.040; Yuzawa S, 2016, BRAIN TUMOR PATHOL, V33, P237, DOI 10.1007/s10014-016-0271-7; Zeng L, 2015, INT J CLIN EXP MED, V8, P8042; Zhou L, 2012, FEBS LETT, V586, P1403, DOI 10.1016/j.febslet.2012.03.016; Zhou L, 2011, NEOPLASIA, V13, P1101, DOI 10.1593/neo.111060; Zhou XM, 2008, MICROB PATHOGENESIS, V44, P129, DOI 10.1016/j.micpath.2007.08.014; Zuber C, 2008, MOL IMMUNOL, V45, P144, DOI 10.1016/j.molimm.2007.04.030	69	20	20	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 2	2017	36	44					6132	6142		10.1038/onc.2017.200	http://dx.doi.org/10.1038/onc.2017.200			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FL5CU	28692055	Green Submitted			2022-12-26	WOS:000414249800007
J	Butcher, BG; Bao, ZM; Wilson, J; Stodghill, P; Swingle, B; Filiatrault, M; Schneider, D; Cartinhour, S				Butcher, Bronwyn G.; Bao, Zhongmeng; Wilson, Janet; Stodghill, Paul; Swingle, Bryan; Filiatrault, Melanie; Schneider, David; Cartinhour, Samuel			The ECF sigma factor, PSPTO_1043, in Pseudomonas syringae pv. tomato DC3000 is induced by oxidative stress and regulates genes involved in oxidative stress response	PLOS ONE			English	Article							SINGLET OXYGEN; ESCHERICHIA-COLI; HRPL REGULON; EXPRESSION; PATHOGEN; SYSTEM; ARABIDOPSIS; VIRULENCE; PLASMIDS; SEQUENCE	The bacterial plant pathogen Pseudomonas syringae adapts to changes in the environment by modifying its gene expression profile. In many cases, the response is mediated by the activation of extracytoplasmic function (ECF) sigma factors that direct RNA polymerase to transcribe specific sets of genes. In this study we focus on PSPTO_1043, one of ten ECF sigma factors in P. syringae pv. tomato DC3000 (DC3000). PSPTO_1043, together with PSPTO_1042, encode an RpoERsp/ChrR-like sigma/anti-sigma factor pair. Although this gene pair is unique to the P. syringae group among the pseudomonads, homologous genes can be found in photosynthetic genera such as Rhodospirillum, Thalassospira, Phaeospirillum and Parvibaculum. Using ChIP-Seq, we detected 137 putative PSPTO_1043 binding sites and identified a likely promoter motif. We characterized 13 promoter candidates, six of which regulate genes that appear to be found only in P. syringae. PSPTO_1043 responds to the presence of singlet oxygen (O-1(2)) and tert-butyl hydroperoxide (tBOOH) and several of the genes regulated by PSPTO_1043 appear to be involved in response to oxidative stress.	[Butcher, Bronwyn G.; Bao, Zhongmeng; Swingle, Bryan; Filiatrault, Melanie; Schneider, David; Cartinhour, Samuel] Cornell Univ, Sch Integrat Plant Sci, Sect Plant Pathol & Plant Microbe Biol, Ithaca, NY 14853 USA; [Wilson, Janet; Stodghill, Paul; Swingle, Bryan; Filiatrault, Melanie; Schneider, David; Cartinhour, Samuel] USDA ARS, Robert W Holley Ctr, 583 Tower Rd, Ithaca, NY 14853 USA; [Butcher, Bronwyn G.] Cornell Univ, Cornell Lab Ornithol, 159 Sapsucker Woods Rd, Ithaca, NY 14850 USA; [Wilson, Janet] Ctr Dis Control & Prevent, Div Select Agents & Toxins, 1600 Clifton Rd,NE MS A46, Atlanta, GA 30333 USA; [Schneider, David] Univ Saskatchewan, Global Inst Food Secur, 110 Gymnasium Pl, Saskatoon, SK S7N 4J8, Canada	Cornell University; United States Department of Agriculture (USDA); Cornell University; Centers for Disease Control & Prevention - USA; University of Saskatchewan	Stodghill, P (corresponding author), USDA ARS, Robert W Holley Ctr, 583 Tower Rd, Ithaca, NY 14853 USA.	paul.stodghill@ars.usda.gov	Swingle, Bryan/AAX-6102-2021; Schneider, David J/H-2236-2012	Schneider, David J/0000-0002-2124-8385; Stodghill, Paul/0000-0003-3875-8450				Anthony JR, 2004, J MOL BIOL, V341, P345, DOI 10.1016/j.jmb.2004.06.018; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Berghoff BA, 2011, ENVIRON MICROBIOL, V13, P775, DOI 10.1111/j.1462-2920.2010.02381.x; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Butcher BG, 2011, J BACTERIOL, V193, P4598, DOI 10.1128/JB.00340-11; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Dufour YS, 2008, J MOL BIOL, V383, P713, DOI 10.1016/j.jmb.2008.08.017; Ferreira AO, 2006, MOL PLANT MICROBE IN, V19, P1167, DOI 10.1094/MPMI-19-1167; Filiatrault MJ, 2010, J BACTERIOL, V192, P2359, DOI 10.1128/JB.01445-09; Flors C, 2006, ACCOUNTS CHEM RES, V39, P293, DOI 10.1021/ar0402863; Guo M, 2012, J BACTERIOL, V194, P5054, DOI 10.1128/JB.00999-12; Gupta N, 2013, MICROBIOL-SGM, V159, P205, DOI 10.1099/mic.0.061937-0; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Ishiga Y, 2016, MOL PLANT MICROBE IN, V29, P119, DOI 10.1094/MPMI-09-15-0204-R; Keith LMW, 1999, J BACTERIOL, V181, P7176, DOI 10.1128/JB.181.23.7176-7184.1999; Kim JJ, 2011, APPL ENVIRON MICROB, V67, P1405; King E, 1954, J LAB CLIN MED, V44; Lam HN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106115; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lourenco RF, 2009, MOL MICROBIOL, V72, P1159, DOI 10.1111/j.1365-2958.2009.06714.x; Lun DS, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r142; Marchler-Bauer A, 2016, NUCLEIC ACIDS RES, V45, pD200; Markel E, 2016, J BACTERIOL, V198, P2330, DOI 10.1128/JB.00276-16; Markel E, 2013, APPL ENVIRON MICROB, V79, P725, DOI 10.1128/AEM.02801-12; Markel E, 2011, J BACTERIOL, V193, P5775, DOI 10.1128/JB.05114-11; Mishra MN, 2011, MICROBIOL-SGM, V157, P988, DOI 10.1099/mic.0.046672-0; Oguiza JA, 2005, TRENDS MICROBIOL, V13, P565, DOI 10.1016/j.tim.2005.10.005; Park SH, 2014, MICROBIOL-SGM, V160, P941, DOI 10.1099/mic.0.076497-0; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schindler D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-638; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Swingle B, 2008, MOL MICROBIOL, V68, P871, DOI 10.1111/j.1365-2958.2008.06209.x; Tamir-Ariel D, 2011, MOL PLANT PATHOL, V12, P57, DOI 10.1111/j.1364-3703.2010.00652.x; Tarkowski P, 2014, BIOTECHNOL ADV, V32, P215, DOI 10.1016/j.biotechadv.2013.11.001; Thakur PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058846; Triantaphylides C, 2009, TRENDS PLANT SCI, V14, P219, DOI 10.1016/j.tplants.2009.01.008; Vencato M, 2006, MOL PLANT MICROBE IN, V19, P1193, DOI 10.1094/MPMI-19-1193; Wei CF, 2007, PLANT J, V51, P32, DOI 10.1111/j.1365-313X.2007.03126.x; Wei Q, 2012, NUCLEIC ACIDS RES, V40, P4320, DOI 10.1093/nar/gks017; Xin XF, 2013, ANNU REV PHYTOPATHOL, V51, P473, DOI 10.1146/annurev-phyto-082712-102321	44	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180340	10.1371/journal.pone.0180340	http://dx.doi.org/10.1371/journal.pone.0180340			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700608	gold, Green Submitted, Green Published			2022-12-26	WOS:000405649600028
J	Fan, WT; Zhong, YS; Qin, MY; Lin, BM; Chen, FY; Yan, HC; Li, WC; Lin, JR				Fan, Wentao; Zhong, Yangsheng; Qin, Mingyue; Lin, Bimin; Chen, Fangyan; Yan, Huichao; Li, Wenchu; Lin, Jianrong			Differentially expressed microRNAs in diapausing versus HCl-treated Bombyx embryos	PLOS ONE			English	Article							SORBITOL DEHYDROGENASE; GENE-EXPRESSION; SILKWORM; EGGS; MORI; DROSOPHILA; REDUCTASE; HORMONE; CLONING	Differentially expressed microRNAs were detected to explore the molecular mechanisms of diapause termination. The total small RNA of diapause-destined silkworm eggs and HCl-treated eggs was extracted and then sequenced using HiSeq high-throughput method. 44 novel miRNAs were discovered. Compared to those in the diapause-destined eggs, 61 miRNAs showed significant changes in the acid-treated eggs, with 23 being up-regulated and 38 being down-regulated. The potential target genes of differentially expressed miRNAs were predicted by miRanda. Gene Ontology and KEGG pathway enrichment analysis of these potential target genes revealed that they were mainly located within cells and organelles, involved in cellular and metabolic processes, and participated in protein production, processing and transportation. Two differentially expressed genes, Bombyx mori SDH and Bmo-miR-2761-3p, were further analyzed with qRT-PCR. BmSDH was significantly up-regulated in the HCl-treated eggs, while Bmo-miR-2761-3p was down-regulated. These results suggested that these two genes were well coordinated in silkworm eggs. Dual luciferase reporter assay demonstrated that Bmo-miR-2761-3p inhibited the expression of BmSDH.	[Fan, Wentao; Zhong, Yangsheng; Qin, Mingyue; Lin, Bimin; Chen, Fangyan; Yan, Huichao; Li, Wenchu; Lin, Jianrong] South China Agr Univ, Coll Anim Sci, Dept Sericulture, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Lin, JR (corresponding author), South China Agr Univ, Coll Anim Sci, Dept Sericulture, Guangzhou, Guangdong, Peoples R China.	jianronglinscau@hotmail.com	æ, ææ/ABE-2840-2020		National Natural Science Foundation of China [31272368]; National Modern Agricultural Industrial Technological System construction projects of China [CARS-22]; special Public Welfare Industry (agriculture) Research [201403064]; Science and Technology Project of Guangdong Province, China [2014A020208120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Modern Agricultural Industrial Technological System construction projects of China; special Public Welfare Industry (agriculture) Research; Science and Technology Project of Guangdong Province, China	This project was supported by grants from the National Natural Science Foundation of China (31272368), National Modern Agricultural Industrial Technological System construction projects of China (CARS-22), the special Public Welfare Industry (agriculture) Research (201403064) and Science and Technology Project of Guangdong Province, China (2014A020208120).	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Andronescu MS, 2010, RNA, V16, P26, DOI 10.1261/rna.1689910; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Enright AJ, 2004, GENOME BIOL, V5; Fan LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060386; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Iwasaki H, 1997, INSECT MOL BIOL, V6, P131, DOI 10.1111/j.1365-2583.1997.tb00081.x; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; NAKAGAKI M, 1991, ROUX ARCH DEV BIOL, V200, P223, DOI 10.1007/BF00361341; NIIMI T, 1992, COMP BIOCHEM PHYS B, V102, P169, DOI 10.1016/0305-0491(92)90291-X; NIIMI T, 1993, EUR J BIOCHEM, V213, P1125, DOI 10.1111/j.1432-1033.1993.tb17862.x; Pan MH, 2013, SCI CHINA LIFE SCI, V56, P360, DOI 10.1007/s11427-013-4459-3; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rubio RO, 2011, INSECT BIOCHEM MOLEC, V41, P378, DOI 10.1016/j.ibmb.2011.02.007; Sasibhushan S, 2013, GENOMICS, V102, P379, DOI 10.1016/j.ygeno.2013.07.007; Sasibhushan S, 2013, BRAZ ARCH BIOL TECHN, V56, P1, DOI 10.1590/S1516-89132013000100001; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; SOHAL RS, 1990, MECH AGEING DEV, V56, P223, DOI 10.1016/0047-6374(90)90084-S; Varghese J, 2007, GENE DEV, V21, P2277, DOI 10.1101/gad.439807; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wen M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-140; Xu YM, 2011, INSECT BIOCHEM MOLEC, V41, P572, DOI 10.1016/j.ibmb.2011.03.009; YAGINUMA T, 1979, INSECT BIOCHEM, V9, P547, DOI 10.1016/0020-1790(79)90075-1; Yamashita O, 1996, J INSECT PHYSIOL, V42, P669, DOI 10.1016/0022-1910(96)00003-0; YASUKOCHI Y, 1979, J BIOL CHEM, V254, P7097; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004677; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224	32	6	8	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180085	10.1371/journal.pone.0180085	http://dx.doi.org/10.1371/journal.pone.0180085			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700597	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649400007
J	Winger, EE; Reed, JL; Ji, XH				Winger, Edward E.; Reed, Jane L.; Ji, Xuhuai			Early first trimester peripheral blood cell microRNA predicts risk of preterm delivery in pregnant women: Proof of concept	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; DECIDUA; BIRTH; EXPRESSION; MORTALITY; OUTCOMES	Objective We investigated the capacity of first trimester peripheral blood mononuclear cell (PBMC) microRNA to determine risk of spontaneous preterm birth among pregnant women. Study design The study included 39 pregnant women with the following delivery outcomes: 25 with a full term delivery (38-42 weeks gestation) 14 with spontaneous preterm birth (< 38 weeks gestation). Of the 14 women experiencing spontaneous preterm birth, 7 delivered at 34-< 38 weeks gestation (late preterm) and 7 delivered at < 34 weeks gestation (early preterm). Samples were collected at a mean of 7.9 +/- 3.0 weeks gestation. Quantitative rtPCR was performed on 30 selected microRNAs. MicroRNA Risk Scores were calculated and Area-Under the Curve-Receiver-Operational-Characteristic (AUC-ROC) curves derived. Results The AUC-ROC for the group delivering preterm (< 38 weeks) was 0.95 (p> 0.0001). The AUC-ROC for early preterm group (< 34 weeks) was 0.98 (p< 0.0001) and the AUC-ROC for the late preterm group (34-< 38 weeks) was 0.92 (p< 0.0001). Conclusion Quantification of first trimester peripheral blood PBMC MicroRNA may provide sensitive and specific prediction of spontaneous preterm birth in pregnant women. Larger studies are needed for confirmation.	[Winger, Edward E.; Reed, Jane L.] Lab Reprod Med & Immunol, San Francisco, CA USA; [Ji, Xuhuai] Stanford Univ, Human Immune Monitoring Ctr, Stanford, CA 94305 USA	Stanford University	Winger, EE (corresponding author), Lab Reprod Med & Immunol, San Francisco, CA USA.	ewinger@sbcglobal.net		Reed, Jane/0000-0002-2565-951X				[Anonymous], 2013, Obstet Gynecol, V122, P1139, DOI 10.1097/01.AOG.0000437385.88715.4a; Behrma RE, 2007, NATL RES COUNCIL PRE, P400; Beta J, 2008, PRENAT DIAGN, V31, P75; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Cantonwine DE, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2016.02.005; Chen CP, 2015, REPROD SCI, V22, P1461, DOI 10.1177/1933719115585148; Conde-Agudelo A, 2011, BJOG-INT J OBSTET GY, V118, P1042, DOI 10.1111/j.1471-0528.2011.02923.x; Corn PG, 2008, CANCER BIOL THER, V7, P265, DOI 10.4161/cbt.7.2.5745; de Planell-Saguer M, 2011, ANAL CHIM ACTA, V699, P134, DOI 10.1016/j.aca.2011.05.025; Elovitz MA, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.023; Enquobahrie DA, 2016, REPROD SCI, V23, P731, DOI 10.1177/1933719115612925; Escudero CA, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00098; Foxman B, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.003; Fulci V, 2010, HUM IMMUNOL, V71, P206, DOI 10.1016/j.humimm.2009.11.008; Haneklaus M, 2013, J INTERN MED, V274, P215, DOI 10.1111/joim.12099; He C, 2016, GUT, V65, P1938, DOI 10.1136/gutjnl-2015-309389; Huang TH, 2010, PRENATAL DIAG, V30, P471, DOI 10.1002/pd.2505; Jelliffe-Pawlowski LL, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.02.012; Kanai T, 2001, AM J REPROD IMMUNOL, V45, P94, DOI 10.1111/j.8755-8920.2001.450205.x; Kramer MR, 2009, EPIDEMIOL REV, V31, P84, DOI 10.1093/ajerev/mxp003; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Luque A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04882; Manaster I, 2010, AM J REPROD IMMUNOL, V63, P434, DOI 10.1111/j.1600-0897.2009.00794.x; McIntire DD, 2008, OBSTET GYNECOL, V111, P35, DOI 10.1097/01.AOG.0000297311.33046.73; Moffett A, 2004, BMJ-BRIT MED J, V329, P1283, DOI 10.1136/bmj.329.7477.1283; Moffett A, 2014, J CLIN INVEST, V124, P1872, DOI 10.1172/JCI68107; Mori M, 2016, SEMIN IMMUNOPATHOL, V38, P635, DOI 10.1007/s00281-016-0574-0; Norwitz Errol R, 2007, Reprod Biomed Online, V14 Spec No 1, P101, DOI 10.1016/S1472-6483(10)61464-2; Ratsep MT, 2015, REPRODUCTION, V149, pR91, DOI 10.1530/REP-14-0271; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Romero R, 2011, BEST PRACT RES CL OB, V25, P313, DOI 10.1016/j.bpobgyn.2011.02.006; Saade GR, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2016.02.001; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Schjenken JE, 2016, AM J REPROD IMMUNOL, V75, P272, DOI 10.1111/aji.12490; Sheikh AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160808; Smith GCS, 2001, BRIT MED J, V323, P476, DOI 10.1136/bmj.323.7311.476; Sweeting A, 2015, BEST PRACT RES CL OB, V29, P183, DOI 10.1016/j.bpobgyn.2014.09.006; To MS, 2006, ULTRASOUND OBST GYN, V27, P362, DOI 10.1002/uog.2773; Vacca P, 2011, P NATL ACAD SCI USA, V108, P2402, DOI 10.1073/pnas.1016257108; Wang WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09571; Winger EE, 2015, J REPROD IMMUNOL, V110, P22, DOI 10.1016/j.jri.2015.03.005; Winger EE, 2014, AM J REPROD IMMUNOL, V72, P515, DOI 10.1111/aji.12287	43	21	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180124	10.1371/journal.pone.0180124	http://dx.doi.org/10.1371/journal.pone.0180124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692679	gold, Green Published, Green Submitted			2022-12-26	WOS:000405544800025
J	Ciarlillo, D; Celeste, C; Carmeliet, P; Boerboom, D; Theoret, C				Ciarlillo, Domenic; Celeste, Christophe; Carmeliet, Peter; Boerboom, Derek; Theoret, Christine			A hypoxia response element in the Vegfa promoter is required for basal Vegfa expression in skin and for optimal granulation tissue formation during wound healing in mice	PLOS ONE			English	Article							GROWTH-FACTOR VEGF; INDUCIBLE FACTOR-1-ALPHA; CONSTITUTIVE EXPRESSION; KERATINOCYTE PROLIFERATION; OXYGEN; HIF-1; ANGIOGENESIS; HIF-1-ALPHA; MEDIATOR; PATHWAY	Hypoxia in skin wounds is thought to contribute to healing through the induction of hypoxia inducible factor-1 (HIF-1). Although HIF-1 can regulate the expression of vascular endothelial growth factor A (Vegfa), whether hypoxia and HIF-1 are required to induce Vegfa expression in the context of wound healing is unknown. To test this hypothesis, we evaluated Vegfa expression and wound healing in mutant mice that lack a functional HIF-1 binding site in the Vegfa promoter. Full-thickness excisional wounds were made using a biopsy punch, left to heal by second intention, and granulation tissue isolated on a time course during healing. mRNA levels of Vegfa and its target genes platelet-derived growth factors B (Pdgfb) and stromal cell-derived factor-1 (Sdf1) were measured by RT-qPCR, and HIF-1alpha and VEGFA protein levels measured by immunoblotting. Lower levels of Vegfa, Pdgf1 and Sdf1 mRNA were found in intact skin of mutant mice relative to wild-type controls (n = 6 mice / genotype), whereas levels in granulation tissue during wound healing were unaltered. VEGFA protein levels were also lower in intact skin of the mutant versus the wild-type mice. Decreased Vegfa mRNA levels in skin of mutant mice could not be attributed to decreased HIF-1alpha protein expression, and were therefore a consequence of the loss of HIF-1 responsiveness of the Vegfa promoter. Comparative histologic analyses of healing wounds in mutant and wild-type mice (n = 8 mice / genotype) revealed significant defects in granulation tissue in the mutant mice, both in terms of quantity and capillary density, although epithelialization and healing rates were unaltered. We conclude that HIF-1 is not a major regulator of Vegfa expression during wound healing; rather, it serves to maintain basal levels of expression of Vegfa and its target genes in intact skin, which are required for optimal granulation tissue formation in response to wounding.	[Ciarlillo, Domenic; Celeste, Christophe; Boerboom, Derek; Theoret, Christine] Univ Montreal, Fac Med Vet, Dept Biomed Vet, St Hyacinthe, PQ, Canada; [Carmeliet, Peter] Univ Leuven, Vesalius Res Ctr, Lab Angiogenesis & Vasc Metab, Leuven, Belgium	Universite de Montreal; KU Leuven	Theoret, C (corresponding author), Univ Montreal, Fac Med Vet, Dept Biomed Vet, St Hyacinthe, PQ, Canada.	christine.theoret@umontreal.ca	Carmeliet, Peter/AAQ-5140-2020; Theoret, Christine/C-7320-2015	Carmeliet, Peter/0000-0001-7961-1821; Theoret, Christine/0000-0002-7893-2495	Natural Sciences and Engineering Research Council of Canada [250231]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (CT), grant #250231 (http://www.nserc-crsng.gc.ca). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akakura N, 2001, CANCER RES, V61, P6548; Ben-Shoshan J, 2008, STEM CELLS, V26, P2634, DOI 10.1634/stemcells.2008-0369; Berra E, 2000, CANCER METAST REV, V19, P139, DOI 10.1023/A:1026506011458; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Ceradini DJ, 2005, TRENDS CARDIOVAS MED, V15, P57, DOI 10.1016/j.tcm.2005.02.002; Cho YS, 2008, BBA-MOL CELL RES, V1783, P323, DOI 10.1016/j.bbamcr.2007.11.017; Cowburn AS, 2013, P NATL ACAD SCI USA, V110, P17570, DOI 10.1073/pnas.1306942110; Curry JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003405; Davidson JM, 2013, ADV WOUND CARE, V2, P142, DOI 10.1089/wound.2012.0424; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Deschene K, 2011, WOUND REPAIR REGEN, V19, P250, DOI 10.1111/j.1524-475X.2010.00663.x; Eichmann A, 2012, CURR OPIN CELL BIOL, V24, P188, DOI 10.1016/j.ceb.2012.02.002; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Maharaj ASR, 2007, MICROVASC RES, V74, P100, DOI 10.1016/j.mvr.2007.03.004; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Michaels J, 2007, WOUND REPAIR REGEN, V15, P665, DOI 10.1111/j.1524-475X.2007.00273.x; Milanini J, 1998, J BIOL CHEM; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Ripple MO, 2013, J BIOL CHEM, V288, P2933, DOI 10.1074/jbc.M112.430082; Rodriguez PG, 2008, DERMATOL SURG, V34, P1159, DOI 10.1111/j.1524-4725.2008.34254.x; Romagnani P, 2004, TRENDS IMMUNOL, V25, P201, DOI 10.1016/j.it.2004.02.006; Rousseau S, 2000, TRENDS CARDIOVAS MED, V10, P321, DOI 10.1016/S1050-1738(01)00072-X; Schreml S, 2010, BRIT J DERMATOL, V163, P257, DOI 10.1111/j.1365-2133.2010.09804.x; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Sen CK, 2009, WOUND REPAIR REGEN, V17, P1, DOI 10.1111/j.1524-475X.2008.00436.x; Sen CK, 2002, J BIOL CHEM, V277, P33284, DOI 10.1074/jbc.M203391200; Shih SC, 2001, GROWTH FACTORS, V19, P19, DOI 10.3109/08977190109001073; Stadelmann WK, 1998, AM J SURG, V176, p39S, DOI 10.1016/S0002-9610(98)00184-6; Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2; Tsuzuki Y, 2000, CANCER RES, V60, P6248; Wilgus TA, 2008, LAB INVEST, V88, P579, DOI 10.1038/labinvest.2008.36; Wise LM, 2012, CELL MICROBIOL, V14, P1376, DOI 10.1111/j.1462-5822.2012.01802.x	38	17	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180586	10.1371/journal.pone.0180586	http://dx.doi.org/10.1371/journal.pone.0180586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686658	Green Published, gold, Green Submitted			2022-12-26	WOS:000405464100078
J	Ellis, CK; Rice, S; Maurer, D; Stahl, R; Waters, WR; Palmer, MV; Nol, P; Rhyan, JC; VerCauteren, KC; Koziel, JA				Ellis, Christine K.; Rice, Somchai; Maurer, Devin; Stahl, Randal; Waters, W. Ray; Palmer, Mitchell V.; Nol, Pauline; Rhyan, Jack C.; VerCauteren, Kurt C.; Koziel, Jacek A.			Use of fecal volatile organic compound analysis to discriminate between nonvaccinated and BCG-Vaccinated cattle prior to and after Mycobacterium bovis challenge	PLOS ONE			English	Article							WHITE-TAILED DEER; TUBERCULOSIS; INFECTION; BREATH; BIOMARKERS; DISEASE; METABOLOMICS; METABOLISM; DIAGNOSIS; SYNTHASE	Bovine tuberculosis is a zoonotic disease of global public health concern. Development of diagnostic tools to improve test accuracy and efficiency in domestic livestock and enable surveillance of wildlife reservoirs would improve disease management and eradication efforts. Use of volatile organic compound analysis in breath and fecal samples is being developed and optimized as a means to detect disease in humans and animals. In this study we demonstrate that VOCs present in fecal samples can be used to discriminate between non-vaccinated and BCG-vaccinated cattle prior to and after Mycobacterium bovis challenge.	[Ellis, Christine K.; Stahl, Randal; VerCauteren, Kurt C.] USDA, Natl Wildlife Res Ctr, Anim Plant & Hlth Inspect Serv, Wildlife Serv, Ft Collins, CO 80524 USA; [Rice, Somchai; Maurer, Devin; Koziel, Jacek A.] Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA USA; [Waters, W. Ray; Palmer, Mitchell V.] USDA ARS, Natl Anim Dis Ctr, POB 70, Ames, IA 50010 USA; [Nol, Pauline; Rhyan, Jack C.] USDA, Anim Plant & Hlth Inspect Serv, Vet Serv, Wildlife Livestock Dis Invest Team, Ft Collins, CO USA	United States Department of Agriculture (USDA); Iowa State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Ellis, CK (corresponding author), USDA, Natl Wildlife Res Ctr, Anim Plant & Hlth Inspect Serv, Wildlife Serv, Ft Collins, CO 80524 USA.	Christine.K.Ellis@aphis.usda.gov	Palmer, Mitchell/R-7091-2018; Rice, Somchai/AAG-8148-2019; Maurer, Devin L/B-6633-2014; Stahl, Randal/AAC-6492-2021; Koziel, Jacek A./B-5483-2014; Rice, Somchai/O-1426-2015	Palmer, Mitchell/0000-0002-5902-3333; Rice, Somchai/0000-0001-8868-3202; Maurer, Devin L/0000-0002-4605-1263; Koziel, Jacek A./0000-0002-2387-0354; Rice, Somchai/0000-0001-8868-3202				Anchana Devi C., 2012, IOSR JPBS, V4, P01; Aoki KF, 2002, USING KEGG DATABASE; AVIGAN J, 1967, BIOCHIM BIOPHYS ACTA, V144, P127, DOI 10.1016/0005-2760(67)90084-7; Bass KE, 2013, CLIN VACCINE IMMUNOL, V20, P1827, DOI 10.1128/CVI.00519-13; Bayn A, 2013, ANAL CHEM, V85, P11146, DOI 10.1021/ac403134f; Bergmann A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123980; Biet F, 2005, VET RES, V36, P411, DOI 10.1051/vetres:2005001; Briere JJ, 2005, CELL MOL LIFE SCI, V62, P2317, DOI 10.1007/s00018-005-5237-6; Burciaga-Robles LO, 2009, AM J VET RES, V70, P1291, DOI 10.2460/ajvr.70.10.1291; Cai LS, 2006, ANAL BIOANAL CHEM, V386, P1791, DOI 10.1007/s00216-006-0799-1; Carrion O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7579; CHEN S, 1970, J LAB CLIN MED, V75, P628; Cleaveland S, 2007, TUBERCULOSIS, V87, P30, DOI 10.1016/j.tube.2006.03.001; Cosgrove MK, 2012, WILDLIFE RES, V39, P104, DOI 10.1071/WR11147; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; ElliottMartin RJ, 1997, J AGR ENG RES, V67, P267, DOI 10.1006/jaer.1997.0168; Ellis CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089280; Engelke UFH, 2005, NMR BIOMED, V18, P331, DOI 10.1002/nbm.966; Eoh HJ, 2013, P NATL ACAD SCI USA, V110, P6554, DOI 10.1073/pnas.1219375110; Filzmoser P., 2009, MULTIVARIATE STAT AN, V66, P112; Fletcher W. H., 2012, KFNGRAM; Garner CE, 2009, T ROY SOC TROP MED H, V103, P1171, DOI 10.1016/j.trstmh.2009.02.004; Grange JM, 2001, TUBERCULOSIS, V81, P71, DOI 10.1054/tube.2000.0263; Hung AW, 2016, CHEMMEDCHEM, V11, P38, DOI 10.1002/cmdc.201500414; Johnston JB, 2009, P NATL ACAD SCI USA, V106, P20687, DOI 10.1073/pnas.0907398106; KAJI H, 1978, J CHROMATOGR, V145, P464, DOI 10.1016/S0378-4347(00)81377-8; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaufman L., 2009, FINDING GROUPS DATA; Knobloch H, 2009, OLFACTION ELECT NOS; Knobloch H, 2009, AIP C SER; LACHMANN PJ, 1968, J IMMUNOL, V100, P691; Larsen MH, 2005, CURRENT PROTOCOLS MI; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; LEE YM, 1991, J BIOL CHEM, V266, P2715; LEOPOLD DA, 1990, ARCH OTOLARYNGOL, V116, P354; LIDDELL K, 1976, POSTGRAD MED J, V52, P136, DOI 10.1136/pgmj.52.605.136; Ma WD, 1995, J CHEM ECOL, V21, P1895, DOI 10.1007/BF02033850; Madigan CA, 2012, P NATL ACAD SCI USA, V109, P1257, DOI 10.1073/pnas.1109958109; McNerney R, 2012, FEMS MICROBIOL LETT, V328, P150, DOI 10.1111/j.1574-6968.2011.02493.x; Miller RS, 2013, EPIDEMIOL INFECT, V141, P1357, DOI 10.1017/S0950268813000976; Mottram TT, 1999, LIVEST PROD SCI, V61, P7, DOI 10.1016/S0301-6226(99)00045-7; Muller B, 2013, EMERG INFECT DIS, V19, P899, DOI 10.3201/eid1906.120543; Nakajima K, 2014, AMELIORATION EFFECT; Nawrath T, 2012, BEILSTEIN J ORG CHEM, V8, P290, DOI 10.3762/bjoc.8.31; O'Brien DJ, 2002, PREV VET MED, V54, P47, DOI 10.1016/S0167-5877(02)00010-7; Oyarzun MP, 2009, J MED ENTOMOL, V46, P1320, DOI 10.1603/033.046.0610; Palmer MV, 2007, CURR TOP MICROBIOL, V315, P195; Palmer MV, 2010, ZOONOSES PUBLIC HLTH, V57, pE206, DOI 10.1111/j.1863-2378.2010.01329.x; Palmer MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097031; Palmer MV, 2002, TUBERCULOSIS, V82, P275, DOI 10.1054/tube.2002.0341; Palmer MV, 2001, J VET DIAGN INVEST, V13, P530, DOI 10.1177/104063870101300614; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Peled N, 2012, SENSOR ACTUAT B-CHEM, V171, P588, DOI 10.1016/j.snb.2012.05.038; Phillips M, 1999, LANCET, V353, P1930, DOI 10.1016/S0140-6736(98)07552-7; Phillips M, 2004, J HEART LUNG TRANSPL, V23, P701, DOI 10.1016/j.healun.2003.07.017; Phillips M, 2007, TUBERCULOSIS, V87, P44, DOI 10.1016/j.tube.2006.03.004; Phillips M, 2006, BREAST CANCER RES TR, V99, P19, DOI 10.1007/s10549-006-9176-1; Phillips M, 2010, TUBERCULOSIS, V90, P145, DOI 10.1016/j.tube.2010.01.003; Probert CSJ, 2009, J GASTROINTEST LIVER, V18, P337; Purkhart R, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/2/027103; Qualls JE, 2012, CELL HOST MICROBE, V12, P313, DOI 10.1016/j.chom.2012.07.012; Raja S., 2011, International Journal of ChemTech Research, V3, P1926; Rinehart D, 2014, NAT BIOTECHNOL, V32, P524, DOI 10.1038/nbt.2927; Schiller I, 2010, TRANSBOUND EMERG DIS, V57, P205, DOI 10.1111/j.1865-1682.2010.01148.x; Schmitt SM, 2002, ANN NY ACAD SCI, V969, P262, DOI 10.1111/j.1749-6632.2002.tb04390.x; Scott-Thomas A, 2013, TUBERCULOSIS, V93, P312, DOI 10.1016/j.tube.2013.01.005; Shaw SL, 2007, ENVIRON SCI TECHNOL, V41, P1310, DOI 10.1021/es061475e; Shen HB, 2009, FEBS J, V276, P144, DOI 10.1111/j.1742-4658.2008.06763.x; Shirasu M, 2011, J BIOCHEM, V150, P257, DOI 10.1093/jb/mvr090; Stahl R, 2014, HEAD SPACE ANAL NONI; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Thacker TC, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-50; Tsugawa H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-131; Turner C, 2012, BIOSYST ENG, V112, P75, DOI 10.1016/j.biosystemseng.2012.03.001; USDA, 2005, BOV TUB ER UN METH R, V603, P1; Venables W., 2002, MODERN APPL STAT USI; Verhoeven NM, 1998, J INHERIT METAB DIS, V21, P697, DOI 10.1023/A:1005476631419; Waters W, 2011, VET MED INT, V2011; Waters WR, 2016, CLIN VACCINE IMMUNOL, V23, P168, DOI 10.1128/CVI.00637-15; Waters WR, 2009, VACCINE, V27, P1201, DOI 10.1016/j.vaccine.2008.12.018; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; World Health Organization, 2015, GLOB TUB REP 2015	84	14	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179914	10.1371/journal.pone.0179914	http://dx.doi.org/10.1371/journal.pone.0179914			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686691	Green Published, gold			2022-12-26	WOS:000405464100026
J	Locke, B; Semberg, E; Forsgren, E; de Miranda, JR				Locke, Barbara; Semberg, Emilia; Forsgren, Eva; de Miranda, Joachim R.			Persistence of subclinical deformed wing virus infections in honeybees following Varroa mite removal and a bee population turnover	PLOS ONE			English	Article							APIS-MELLIFERA; VERTICAL-TRANSMISSION; COLONIES; REPLICATION; PHYSIOLOGY; LIFE; DWV	Deformed wing virus (DWV) is a lethal virus of honeybees (Apis mellifera) implicated in elevated colony mortality rates worldwide and facilitated through vector transmission by the ectoparasitic mite Varroa destructor. Clinical, symptomatic DWV infections are almost exclusively associated with high virus titres during pupal development, usually acquired through feeding by Varroa mites when reproducing on bee pupae. Control of the mite population, generally through acaricide treatment, is essential for breaking the DWV epidemic and minimizing colony losses. In this study, we evaluated the effectiveness of remedial mite control on clearing DWV from a colony. DWV titres in adult bees and pupae were monitored at 2 week intervals through summer and autumn in acaricide-treated and untreated colonies. The DWV titres in Apistan treated colonies was reduced 1000-fold relative to untreated colonies, which coincided with both the removal of mites and also a turnover of the bee population in the colony. This adult bee population turnover is probably more critical than previously realized for effective clearing of DWV infections. After this initial reduction, subclinical DWV titres persisted and even increased again gradually during autumn, demonstrating that alternative non-Varroa transmission routes can maintain the DWV titres at significant subclinical levels even after mite removal. The implications of these results for practical recommendations to mitigate deleterious subclinical DWV infections and improving honeybee health management are discussed.	[Locke, Barbara; Semberg, Emilia; Forsgren, Eva; de Miranda, Joachim R.] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden	Swedish University of Agricultural Sciences	Locke, B (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	barbara.locke@slu.se	locke, barbara/X-1857-2019	locke, barbara/0000-0001-6083-9981; Rodrigues de Miranda, Joachim/0000-0002-0335-0386	Swedish Board of Agriculture (Nationella Honungsprogrammet, Jordbruksverket; Swedish Research Council, Formas	Swedish Board of Agriculture (Nationella Honungsprogrammet, Jordbruksverket; Swedish Research Council, Formas(Swedish Research CouncilSwedish Research Council Formas)	Financial support was provided to BL by the Swedish Board of Agriculture (Nationella Honungsprogrammet, Jordbruksverket) and The Swedish Research Council, Formas (diarienr. 20121060). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2009, EXP GERONTOL, V44, P467, DOI 10.1016/j.exger.2009.02.013; Amdam GV, 2005, INSECT SOC, V52, P316, DOI 10.1007/s00040-005-0812-2; Bailey L., 1991, HONEY BEE PATHOLOGY; Benaets K, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2149; Berthoud H, 2010, J APICULT RES, V49, P60, DOI 10.3896/IBRA.1.49.1.08; Boecking O, 2008, J APICULT RES, V49, P60; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; Chen YP, 2006, J INVERTEBR PATHOL, V92, P152, DOI 10.1016/j.jip.2006.03.010; CRAILSHEIM K, 1990, APIDOLOGIE, V21, P417, DOI 10.1051/apido:19900504; Dainat B, 2013, J INVERTEBR PATHOL, V112, P278, DOI 10.1016/j.jip.2012.12.009; Dainat B, 2012, APPL ENVIRON MICROB, V78, P981, DOI 10.1128/AEM.06537-11; de Miranda JR, 2008, J INVERTEBR PATHOL, V98, P184, DOI 10.1016/j.jip.2008.02.004; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.09; Doke MA, 2015, CURR OPIN INSECT SCI, V10, P185, DOI 10.1016/j.cois.2015.05.014; Evans JD, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.11; Fievet J, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-16; Flottum K., 1997, HONEY BEE PESTS PRED, P11; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; Frey E, 2011, J APICULT RES, V50, P138, DOI 10.3896/IBRA.1.50.2.05; Fujiyuki T, 2009, J VIROL, V83, P11560, DOI 10.1128/JVI.00519-09; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Hansson A, 1980, BIN OCH BIODLING; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Locke B, 2012, APPL ENVIRON MICROB, V78, P227, DOI 10.1128/AEM.06094-11; Martin SJ, 2001, J APICULT RES, V49, P72; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Martin SJ, 2010, J APICULT RES, V49, P72, DOI 10.3896/IBRA.1.49.1.10; Mockel N, 2011, J GEN VIROL, V92, P370, DOI 10.1099/vir.0.025940-0; Ribiere M., 2008, VIROLOGY HONEY BEE, P15, DOI DOI 10.1016/J.JVIROMET.2019.04.020; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Santillan-Galicia MT, 2008, J GEN VIROL, V89, P1685, DOI 10.1099/vir.0.83223-0; Seehuus SC, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.5201; Smedal B, 2009, J EXP BIOL, V212, P3795, DOI 10.1242/jeb.035063; Tentcheva D, 2006, APIDOLOGIE, V37, P41, DOI 10.1051/apido:2005057; Wells T, 2016, ENV MICROBIOL REP, V8, P728, DOI 10.1111/1758-2229.12434; Wilfert L, 2016, SCIENCE, V351, P594, DOI 10.1126/science.aac9976; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Yue C, 2007, J GEN VIROL, V88, P2329, DOI 10.1099/vir.0.83101-0; Zioni N, 2011, VIROLOGY, V417, P106, DOI 10.1016/j.virol.2011.05.009	42	22	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180910	10.1371/journal.pone.0180910	http://dx.doi.org/10.1371/journal.pone.0180910			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686725	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000405464100121
J	Bautista-Caro, MB; de Miguel, E; Peiteado, D; Plasencia-Rodriguez, C; Villalba, A; Monjo-Henry, I; Puig-Kroger, A; Sanchez-Mateos, P; Martin-Mola, E; Miranda-Carus, ME				Bautista-Caro, Maria-Belen; de Miguel, Eugenio; Peiteado, Diana; Plasencia-Rodriguez, Chamaida; Villalba, Alejandro; Monjo-Henry, Irene; Puig-Kroger, Amaya; Sanchez-Mateos, Paloma; Martin-Mola, Emilio; Miranda-Carus, Maria-Eugenia			Increased frequency of circulating CD19+CD24(hi) CD38(hi) B cells with regulatory capacity in patients with Ankylosing spondylitis (AS) naive for biological agents	PLOS ONE			English	Article							GUT INFLAMMATION; MICROBIOTA; DISEASE; SPONDYLOARTHRITIS; PERMEABILITY; EXPRESSION; BARRIER; TNF	Our objective was to study the frequency of circulating CD19+CD24(hi) CD38(hi) B cells (Breg) in AS patients. To this end, peripheral blood was drawn from AS patients naive for TNF blockers (AS/nb) (n = 42) and healthy controls (HC) (n = 42). Six patients donated blood for a second time, 6 months after initiating treatment with anti-TNF alpha drugs. After isolation by Ficoll-Hypaque, PBMCs were stained with antibodies to CD3, CD4, CD19, CD24, and CD38, and examined by cytometry. For functional studies, total CD19+ B cells were isolated from PBMCs of 3 HC by magnetical sorting. Breg-depleted CD19+ B cells were obtained after CD19+ CD24(hi)CD38(hi) B cells were removed from total CD19+ cells by cytometry. Total CD19+ B cells or Breg-depleted CD19+ B cells were established in culture and stimulated through their BCR. Secretion of IFN. was determined by ELISA in culture supernatants. When compared with HC, AS/nb patients demonstrated a significantly increased frequency of Breg cells, which was independent of disease activity. Anti-TNF alpha drugs induced a significant reduction of circulating Breg numbers, which were no longer elevated after six months of treatment. Functional in vitro studies showed that the secretion of IFN. was significantly higher in Breg-depleted as compared with total CD19+ B cells, indicating that Breg can downmodulate B cell pro-inflammatory cytokine secretion. In summary, an increased frequency of circulating CD19+ CD24 hi CD38 hi B cells is observed in AS/nb patients, that is not related with disease activity; anti-TNF alpha drugs are able to downmodulate circulating Breg numbers in AS.	[Bautista-Caro, Maria-Belen; de Miguel, Eugenio; Peiteado, Diana; Plasencia-Rodriguez, Chamaida; Villalba, Alejandro; Monjo-Henry, Irene; Martin-Mola, Emilio; Miranda-Carus, Maria-Eugenia] Hosp Univ La Paz IdiPAZ, Dept Rheumatol, Madrid, Spain; [Puig-Kroger, Amaya; Sanchez-Mateos, Paloma] Hosp Gen Univ Gregorio Maranon, Lab Inmunooncol, Madrid, Spain	Hospital Universitario La Paz; General University Gregorio Maranon Hospital	Miranda-Carus, ME (corresponding author), Hosp Univ La Paz IdiPAZ, Dept Rheumatol, Madrid, Spain.	mariaeugenia.miranda@salud.madrid.org	Puig, Amaya/B-6164-2015; Sanchez-Mateos, Paloma/E-8931-2013; Miranda-Carus, Maria-Eugenia/S-7403-2019	Puig, Amaya/0000-0003-2943-9757; Monjo Henry, Irene/0000-0002-3252-8016	Ministerio de Economia y Competitividad/Instituto de Salud Carlos III (MINECO/ISCIII) [FIS PI-16/01189, RD12/0009/0012, RD16/0012/0012]; COnsejeria de Educacion de la Comunidad de Madrid/Fondo Europeo de Desarrollo Regional RAPHYME [S2010/BMD-2350]; Roche Pharmaceuticals	Ministerio de Economia y Competitividad/Instituto de Salud Carlos III (MINECO/ISCIII); COnsejeria de Educacion de la Comunidad de Madrid/Fondo Europeo de Desarrollo Regional RAPHYME; Roche Pharmaceuticals(Roche Holding)	This work was supported by Ministerio de Economia y Competitividad/Instituto de Salud Carlos III (MINECO/ISCIII) grant numbers FIS PI-16/01189, RD12/0009/0012 and RD16/0012/0012 (RIER, RETICS Program) (http://www.idi.mineco.gob.es/portal/site/MICINN, http://www.isciii.es), by COnsejeria de Educacion de la Comunidad de Madrid/Fondo Europeo de Desarrollo Regional RAPHYME, grant number S2010/BMD-2350 (www.madrimasd.org) and by an unrestricted research grant from Roche Pharmaceuticals (www.roche.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambarus C, 2012, CURR OPIN RHEUMATOL, V24, P351, DOI 10.1097/BOR.0b013e3283534df4; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Cantaert T, 2012, ARTHRITIS RHEUM-US, V64, P1859, DOI 10.1002/art.34364; Chen M, 2016, DNA CELL BIOL, V35, P88, DOI 10.1089/dna.2015.3046; Cypers H, 2016, ANN RHEUM DIS, V75, P1357, DOI 10.1136/annrheumdis-2015-208025; Demetter P, 2002, J PATHOL, V198, P517, DOI 10.1002/path.1235; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; Fonseca-Camarillo G, 2015, CYTOKINE, V75, P389, DOI 10.1016/j.cyto.2015.04.009; Furuzawa-Carballeda J, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4245; Gibson PR, 2004, GUT, V53, P1724, DOI 10.1136/gut.2004.047092; Gill T, 2015, CURR OPIN RHEUMATOL, V27, P319, DOI 10.1097/BOR.0000000000000187; Hindryckx P, 2011, ANN RHEUM DIS, V70, P2044, DOI 10.1136/ard.2010.149229; Jones-Hall YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119441; Jones-Hall YL, 2016, INTERSECTION TNF IBD, V7, P58; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Machado P, 2011, ANN RHEUM DIS, V70, P47, DOI 10.1136/ard.2010.138594; MARTINEZGONZALEZ O, 1994, BRIT J RHEUMATOL, V33, P644; Matsushita T, 2016, RHEUMATOLOGY, V55, P263, DOI 10.1093/rheumatology/kev331; Mauri C, 2015, INT IMMUNOL, V27, P479, DOI 10.1093/intimm/dxv038; Mavropoulos A, 2016, ARTHRITIS RHEUMATOL, V68, P494, DOI 10.1002/art.39437; MIELANTS H, 1991, J RHEUMATOL, V18, P1542; Nova-Lamperti E, 2016, SCI REP-UK, V6, DOI 10.1038/srep20044; Ochoa-Reparaz J, 2010, GUT MICROBES, V1, P103, DOI 10.4161/gmic.1.2.11515; Rigoni R, 2016, J EXP MED, V213, P355, DOI 10.1084/jem.20151116; Rosenbaum JT, 2011, ARTHRITIS RHEUM-US, V63, P3195, DOI 10.1002/art.30558; Rosser EC, 2014, NAT MED, V20, P1334, DOI 10.1038/nm.3680; Rosser EC, 2014, MOL IMMUNOL, V62, P296, DOI 10.1016/j.molimm.2014.01.014; Schroeder B, 2016, NAT MED, V22, P1079, DOI 10.1038/nm.4185; Silverman GJ, 2003, ARTHRITIS RES THER, V5, pS1, DOI 10.1186/ar1010; Suenaert P, 2002, AM J GASTROENTEROL, V97, P2000; Todd SK, 2014, RHEUMATOLOGY, V53, P1693, DOI 10.1093/rheumatology/keu136; Turina MC, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0413-4; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Watson AJM, 2012, ANN NY ACAD SCI, V1258, P1, DOI 10.1111/j.1749-6632.2012.06523.x	34	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180726	10.1371/journal.pone.0180726	http://dx.doi.org/10.1371/journal.pone.0180726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683133	Green Published, gold, Green Submitted			2022-12-26	WOS:000405335200062
J	Molaei, A; Lakzian, A; Haghnia, G; Astaraei, A; Rasouii-Sadaghiani, M; Ceccherini, MT; Datta, R				Molaei, Ali; Lakzian, Amir; Haghnia, Gholamhosain; Astaraei, Alireza; Rasouii-Sadaghiani, MirHassan; Ceccherini, Maria Teresa; Datta, Rahul			Assessment of some cultural experimental methods to study the effects of antibiotics on microbial activities in a soil: An incubation study	PLOS ONE			English	Article							COMMUNITY STRUCTURE; SULFONAMIDE ANTIBIOTICS; VETERINARY ANTIBIOTICS; EXTRACTION METHOD; ACTIVATED-SLUDGE; RESISTANCE GENES; ORGANIC-MATTER; SULFADIAZINE; MANURE; DIVERSITY	Oxytetracycline (OTC) and sulfamethoxazole (SMX) are two of most widely used antibiotics in livestock and poultry industry. After consumption of antibiotics, a major portion of these compounds is excreted through the feces and urine of animals. Land application of anti-biotictreated animal wastes has caused increasing concern about their adverse effects on ecosystem health. In this regard, inconsistent results have been reported regarding the effects of antibiotics on soil microbial activities. This study was conducted based on the completely randomized design to the measure microbial biomass carbon, cumulative respiration and iron (III) reduction bioassays. Concentrations of OTC and SMX including 0, 1, 10, 25, 50, and 100 mg./kg were spiked in triplicate to a sandy loam soil and incubated for 21 days at 25 degrees C. Results showed that the effects of OTC and SMX antibiotics on cumulative respiration and microbial biomass carbon were different. SMX antibiotic significantly affected soil microbial biomass carbon and cumulative respiration at different treatments compared to control with increasing incubation time. OTC antibiotic, on the other hand, negatively affected cumulative respiration compared to control treatment throughout the incubation period. Although OTC antibiotic positively affected microbial biomass carbon at day one of incubation, there was no clear trend in microbial biomass carbon between different treatments of this antibiotic after that time period. Nevertheless, sulfamethoxazole and oxytetracycline antibiotics had similar effects on iron (III) reduction such that they considerably affected iron (III) reduction at 1 and 10 mg./kg, and iron (III) reduction was completely inhibited at concentrations above 10 mg./kg. Hence, according to our results, microbial biomass carbon and cumulative respiration experiments are not able alone to exhibit the effect of antibiotics on soil microbial activity, but combination of these two experiments with iron (III) reduction test could well display the effects of sulfamethoxazole (SMX) and oxytetracycline (OTC) antibiotics on soil biochemical activities.	[Molaei, Ali; Lakzian, Amir; Haghnia, Gholamhosain; Astaraei, Alireza] Ferdowsi Univ Mashhad, Fac Agr, Dept Soil Sci, Mashhad, Iran; [Rasouii-Sadaghiani, MirHassan] Urmia Univ, Fac Agr, Dept Soil Sci, Orumiyeh, Iran; [Ceccherini, Maria Teresa] Univ Florence, Dept Agrifood & Environm Sci, Florence, Italy; [Datta, Rahul] Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Geol & Soil Sci, Brno, Czech Republic	Ferdowsi University Mashhad; Urmia University; University of Florence; Mendel University in Brno	Lakzian, A (corresponding author), Ferdowsi Univ Mashhad, Fac Agr, Dept Soil Sci, Mashhad, Iran.	lakzian@um.ac.ir	Ceccherini, Maria Teresa/J-7847-2019; ASTARAEI, ALI REZA/AAF-6672-2022; Lakzian, Amir/AAH-2645-2021; Datta, Rahul/J-9495-2014; ASTARAEI, ALI REZA/AFJ-9621-2022	Ceccherini, Maria Teresa/0000-0002-4261-7514; ASTARAEI, ALI REZA/0000-0001-6156-8570; Lakzian, Amir/0000-0003-3972-5802; Datta, Rahul/0000-0001-9001-2555; ASTARAEI, ALI REZA/0000-0001-6156-8570; Rasouli-Sadaghiani, MirHassan/0000-0001-9804-4076	Ferdowsi University of Mashhad, Department Of Soil Science, Iran; Mendel University in Brno, Department of Geology and Soil Science, Zemidilska, Brno, Czech Republic	Ferdowsi University of Mashhad, Department Of Soil Science, Iran; Mendel University in Brno, Department of Geology and Soil Science, Zemidilska, Brno, Czech Republic	This work was supported by the Ferdowsi University of Mashhad, Department Of Soil Science, Iran and the Mendel University in Brno, Department of Geology and Soil Science, Zemidilska 3, 613 00 Brno, Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black C.A., 1965, METHODS SOIL ANAL, P653; BOUYOUCOS GJ, 1962, AGRON J, V54, P464, DOI 10.2134/agronj1962.00021962005400050028x; Chander Y, 2005, J ENVIRON QUAL, V34, P1952, DOI 10.2134/jeq2005.0017; Chee-Sanford JC, 2009, J ENVIRON QUAL, V38, P1086, DOI 10.2134/jeq2008.0128; Drillia P, 2005, J HAZARD MATER, V122, P259, DOI 10.1016/j.jhazmat.2005.03.009; Elsgaard L, 2001, ENVIRON TOXICOL CHEM, V20, P1656, DOI [10.1897/1551-5028(2001)020&lt;1656:EARAOL&gt;2.0.CO;2, 10.1002/etc.5620200806]; Fang H, 2016, SCI TOTAL ENVIRON, V572, P1203, DOI 10.1016/j.scitotenv.2016.08.038; Gutierrez IR, 2010, J SOIL SEDIMENT, V10, P537, DOI 10.1007/s11368-009-0168-8; Haluschak P, 2006, CANADA MANITOBA SOIL, P3; Hammesfahr U, 2011, J PLANT NUTR SOIL SC, V174, P614, DOI 10.1002/jpln.201000322; Hammesfahr U, 2011, EUR J SOIL BIOL, V47, P61, DOI 10.1016/j.ejsobi.2010.10.004; Imfeld G, 2012, EUR J SOIL BIOL, V49, P22, DOI 10.1016/j.ejsobi.2011.11.010; ISERMEYER H., 1952, Zeitschrift fur Pflanzenernahrung, Dungung und Bodenkunde, V56, P26, DOI 10.1002/jpln.19520560107; Kahle M, 2007, CHEMOSPHERE, V68, P1224, DOI 10.1016/j.chemosphere.2007.01.061; Kotzerke A, 2008, ENVIRON POLLUT, V153, P315, DOI 10.1016/j.envpol.2007.08.020; Kreuzig R, 2003, FRESEN ENVIRON BULL, V12, P550; Kumar K, 2004, J ENVIRON QUAL, V33, P250, DOI 10.2134/jeq2004.0250; Liu B, 2015, EUR J SOIL BIOL, V68, P69, DOI 10.1016/j.ejsobi.2015.01.002; Liu W, 2012, PLANT SOIL ENVIRON, V58, P295, DOI 10.17221/430/2011-PSE; Ma TT, 2016, EUR J SOIL BIOL, V76, P53, DOI 10.1016/j.ejsobi.2016.07.004; Mojica ERE, 2011, ENCY ENV HLTH, P97, DOI DOI 10.1016/B978-0-444-52272-6.00338-X; Nelson KL, 2011, WORLD J MICROB BIOT, V27, P659, DOI 10.1007/s11274-010-0504-6; Park JY, 2016, ENVIRON POLLUT, V213, P561, DOI 10.1016/j.envpol.2016.01.089; Pfeiffer C., 1998, Umweltwissenschaften und Schadstoff-Forschung, V10, P147; Reichel R, 2013, SOIL BIOL BIOCHEM, V62, P82, DOI 10.1016/j.soilbio.2013.03.007; Schmitt H, 2004, ENVIRON SCI TECHNOL, V38, P1148, DOI 10.1021/es034685p; SPARLING GP, 1990, SOIL BIOL BIOCHEM, V22, P301, DOI 10.1016/0038-0717(90)90104-8; SPARLING GP, 1988, SOIL BIOL BIOCHEM, V20, P337, DOI 10.1016/0038-0717(88)90014-4; [汤玮婧 TANG Wei-jing], 2009, [湖北农业科学, Hubei Agricultural Sciences], V48, P70; Thiele-Bruhn S, 2005, CHEMOSPHERE, V59, P457, DOI 10.1016/j.chemosphere.2005.01.023; Thiele-Bruhn S, 2005, ENVIRON TOXICOL CHEM, V24, P869, DOI 10.1897/04-166R.1; Thiele-Bruhn S, 2003, J PLANT NUTR SOIL SC, V166, P145, DOI 10.1002/jpln.200390023; Toth JD, 2011, SOIL BIOL BIOCHEM, V43, P2470, DOI 10.1016/j.soilbio.2011.09.004; Vaclavik E, 2004, CHEMOSPHERE, V56, P667, DOI 10.1016/j.chemosphere.2004.02.018; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Welp G, 1995, IRON, P296; Westergaard K, 2001, SOIL BIOL BIOCHEM, V33, P2061, DOI 10.1016/S0038-0717(01)00134-1; Widenfalk A, 2008, ENVIRON POLLUT, V152, P576, DOI 10.1016/j.envpol.2007.07.003; ZELLES L, 1986, ECOTOX ENVIRON SAFE, V12, P53, DOI 10.1016/0147-6513(86)90006-0; Zhang YY, 2016, SCI TOTAL ENVIRON, V571, P479, DOI 10.1016/j.scitotenv.2016.07.014; Zielezny Y, 2006, SOIL BIOL BIOCHEM, V38, P2372, DOI 10.1016/j.soilbio.2006.01.031	41	27	29	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180663	10.1371/journal.pone.0180663	http://dx.doi.org/10.1371/journal.pone.0180663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683144	Green Published, gold, Green Submitted			2022-12-26	WOS:000405335200057
J	Roberts, JJ; Fausch, KD; Schmidt, TS; Walters, DM				Roberts, James J.; Fausch, Kurt D.; Schmidt, Travis S.; Walters, David M.			Thermal regimes of Rocky Mountain lakes warm with climate change	PLOS ONE			English	Article							UNITED-STATES; ICE COVER; NUTRIENT LIMITATION; NATIONAL-PARK; COLORADO; TRENDS; TEMPERATURES; SENSITIVITY; SENTINELS; PHENOLOGY	Anthropogenic climate change is causing a wide range of stresses in aquatic ecosystems, primarily through warming thermal conditions. Lakes, in response to these changes, are experiencing increases in both summer temperatures and ice-free days. We used continuous records of lake surface temperature and air temperature to create statistical models of daily mean lake surface temperature to assess thermal changes in mountain lakes. These models were combined with downscaled climate projections to predict future thermal conditions for 27 high-elevation lakes in the southern Rocky Mountains. The models predict a 0.25 degrees C.decade(-1) increase in mean annual lake surface temperature through the 2080s, which is greater than warming rates of streams in this region. Most striking is that on average, ice-free days are predicted to increase by 5.9 days.decade(-1), and summer mean lake surface temperature is predicted to increase by 0.47 degrees C.decade(-1). Both could profoundly alter the length of the growing season and potentially change the structure and function of mountain lake ecosystems. These results highlight the changes expected of mountain lakes and stress the importance of incorporating climate- related adaptive strategies in the development of resource management plans.	[Roberts, James J.; Schmidt, Travis S.] US Geol Survey, Colorado Water Sci Ctr, Ft Collins, CO 80526 USA; [Roberts, James J.; Walters, David M.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA; [Fausch, Kurt D.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; Colorado State University	Roberts, JJ (corresponding author), US Geol Survey, Colorado Water Sci Ctr, Ft Collins, CO 80526 USA.; Roberts, JJ (corresponding author), US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA.	jroberts@usgs.gov	Schmidt, Travis S/I-3416-2018	Schmidt, Travis S/0000-0003-1400-0637	United States Geological Survey; Mendenhall Postdoctoral Fellowship Program	United States Geological Survey(United States Geological Survey); Mendenhall Postdoctoral Fellowship Program	This work was funded by the United States Geological Survey, who provided JJR funding through the Mendenhall Postdoctoral Fellowship Program. Colorado Parksand Wildlife also provided funding to KDF. The funder provided support in the form of salaries for authors JJR, DMW, TSS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adrian R, 2009, LIMNOL OCEANOGR, V54, P2283, DOI 10.4319/lo.2009.54.6_part_2.2283; Alder JR, 2011, GEOSCI MODEL DEV, V4, P69, DOI 10.5194/gmd-4-69-2011; Austin JA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029021; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Baron JS, 2009, GLOBAL CHANGE BIOL, V15, P1777, DOI 10.1111/j.1365-2486.2009.01847.x; Baron JS, 2000, FRESHWATER BIOL, V43, P463, DOI 10.1046/j.1365-2427.2000.00517.x; Bergstrom AK, 2005, LIMNOL OCEANOGR, V50, P987, DOI 10.4319/lo.2005.50.3.0987; Campbell DH, 2000, WATER RESOUR RES, V36, P37, DOI 10.1029/1999WR900283; Clow DW, 2010, J CLIMATE, V23, P2293, DOI 10.1175/2009JCLI2951.1; Doak DF, 2008, ECOLOGY, V89, P952, DOI 10.1890/07-0965.1; Domis LND, 2013, FRESHWATER BIOL, V58, P463, DOI 10.1111/fwb.12053; Dunham J, 2005, RMRSGTR150WWW USDA F; Edenhofer O., 2014, CONTRIBUTION WORKING; Einum S, 2000, EVOLUTION, V54, P628, DOI 10.1111/j.0014-3820.2000.tb00064.x; Elser JJ, 2009, SCIENCE, V326, P835, DOI 10.1126/science.1176199; Fang X, 2004, ECOL MODEL, V172, P39, DOI 10.1016/S0304-3800(03)00285-0; Fang X, 2012, WATER QUAL RES J CAN, V47, P375, DOI 10.2166/wqrjc.2012.031; Fang X, 2009, LIMNOL OCEANOGR, V54, P2359, DOI 10.4319/lo.2009.54.6_part_2.2359; Gauthier J, 2014, FRESHWATER BIOL, V59, P998, DOI 10.1111/fwb.12322; Giorgetta M.E.M., 2003, REPORTMAX PLANCK INS, DOI DOI 10.17617/2.995269; Granados Ignacio, 2000, Journal of Limnology, V59, P109; Hampton SE, 2017, ECOL LETT, V20, P98, DOI 10.1111/ele.12699; Hartman MD, 2014, BIOGEOCHEMISTRY, V119, P85, DOI 10.1007/s10533-014-9950-9; Heino J, 2009, BIOL REV, V84, P39, DOI 10.1111/j.1469-185X.2008.00060.x; HOSTETLER S.W., 2011, 20111238 US GEOL SUR; Hostetler SW, 1999, J AM WATER RESOUR AS, V35, P1625, DOI 10.1111/j.1752-1688.1999.tb04241.x; Isaak DJ, 2012, CLIMATIC CHANGE, V113, P499, DOI 10.1007/s10584-011-0326-z; Isaak DJ, 2016, P NATL ACAD SCI USA, V113, P4374, DOI 10.1073/pnas.1522429113; Isaak DJ, 2015, GLOBAL CHANGE BIOL, V21, P2540, DOI 10.1111/gcb.12879; Jankowski T, 2006, LIMNOL OCEANOGR, V51, P815, DOI 10.4319/lo.2006.51.2.0815; Kao YC, 2015, J GREAT LAKES RES, V41, P423, DOI 10.1016/j.jglr.2015.03.012; Lapierre JF, 2015, GLOBAL CHANGE BIOL, V21, P4425, DOI 10.1111/gcb.13031; Leppi JC, 2012, CLIMATIC CHANGE, V112, P997, DOI 10.1007/s10584-011-0235-1; Letcher BH, 2004, CAN J FISH AQUAT SCI, V61, P2288, DOI [10.1139/f04-214, 10.1139/F04-214]; Lindenmayer DB, 2010, P NATL ACAD SCI USA, V107, P21957, DOI 10.1073/pnas.1015696107; Magnuson JJ, 2000, SCIENCE, V289, P1743, DOI 10.1126/science.289.5485.1743; MAGNUSON JJ, 1979, AM ZOOL, V19, P331; Markensten H, 2010, ECOL APPL, V20, P752, DOI 10.1890/08-2109.1; Mast MA, 2014, ENVIRON SCI TECHNOL, V48, P14258, DOI 10.1021/es502461k; McGuire CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044370; Metcalf JL, 2012, MOL ECOL, V21, P5194, DOI 10.1111/mec.12028; Michalak AM, 2013, P NATL ACAD SCI USA, V110, P6448, DOI 10.1073/pnas.1216006110; Mohseni O, 1998, WATER RESOUR RES, V34, P2685, DOI 10.1029/98WR01877; Mohseni O, 1999, WATER RESOUR RES, V35, P3723, DOI 10.1029/1999WR900193; Muths E, 2014, BIOL CONSERV, V172, P200, DOI 10.1016/j.biocon.2014.02.034; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Nijssen B, 2001, CLIMATIC CHANGE, V50, P143, DOI 10.1023/A:1010616428763; O'Reilly CM, 2015, GEOPHYS RES LETT, V42, P10773, DOI 10.1002/2015GL066235; Oyler JW, 2015, GEOPHYS RES LETT, V42, P153, DOI 10.1002/2014GL062803; Parker BR, 2008, P NATL ACAD SCI USA, V105, P12927, DOI 10.1073/pnas.0806481105; Peeters F, 2007, GLOBAL CHANGE BIOL, V13, P1898, DOI 10.1111/j.1365-2486.2007.01412.x; Penaluna BE, 2015, PLOS ONE, P10; Preston DL, 2016, GEOPHYS RES LETT, V43, P5553, DOI 10.1002/2016GL069036; Read JS, 2014, ECOL MODEL, V291, P142, DOI 10.1016/j.ecolmodel.2014.07.029; Roberts JJ, 2013, GLOBAL CHANGE BIOL, V19, P1383, DOI 10.1111/gcb.12136; Sadro S, 2012, ECOSYSTEMS, V15, P363, DOI 10.1007/s10021-011-9515-x; Scavia D, 2014, J GREAT LAKES RES, V40, P226, DOI 10.1016/j.jglr.2014.02.004; Schmid M, 2014, CLIMATIC CHANGE, V124, P301, DOI 10.1007/s10584-014-1087-2; Schneider P, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040846; SCHNEIDER P, 1985, GEOPHYS RES LETT, V2010, P37, DOI DOI 10.1029/2010GL045059; Serreze MC, 1999, WATER RESOUR RES, V35, P2145, DOI 10.1029/1999WR900090; Sharma S, 2011, PLOS ONE, V6; Sharma S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25061; Shuter BJ, 2013, CAN J FISH AQUAT SCI, V70, P982, DOI 10.1139/cjfas-2012-0437; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stowell SML, 2015, CAN J FISH AQUAT SCI, V72, P1565, DOI 10.1139/cjfas-2015-0009; Straile D, 2015, ECOLOGY, V96, P2794, DOI 10.1890/14-0839.1.sm; Warren DR, 2012, GLOBAL CHANGE BIOL, V18, P1804, DOI 10.1111/j.1365-2486.2012.02670.x; Wedekind C, 2010, CONSERV BIOL, V24, P1418, DOI 10.1111/j.1523-1739.2010.01534.x; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER; Williamson CE, 2010, HYDROBIOLOGIA, V648, P73, DOI 10.1007/s10750-010-0147-5; Williamson CE, 2009, LIMNOL OCEANOGR, V54, P2273, DOI 10.4319/lo.2009.54.6_part_2.2273; Williamson CE, 2009, SCIENCE, V323, P887, DOI 10.1126/science.1169443; Winslow LA, 2015, GEOPHYS RES LETT, V42, P355, DOI 10.1002/2014GL062325; Wolfe AP, 2003, GEOBIOLOGY, V1, P153, DOI 10.1046/j.1472-4669.2003.00012.x	75	26	26	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0179498	10.1371/journal.pone.0179498	http://dx.doi.org/10.1371/journal.pone.0179498			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683083	Green Published, gold, Green Submitted			2022-12-26	WOS:000405335200006
J	Hu, JL; Li, ZF; Hong, L; Bao, CJ; Zhang, Z; Zhang, HY; He, H; Wang, XC; Liu, WD; Peng, ZH; Shi, LM; Zhu, FC				Hu, Jianli; Li, Zhifeng; Hong, Lei; Bao, Changjun; Zhang, Zhong; Zhang, Hongying; He, Hao; Wang, Xiaochen; Liu, Wendong; Peng, Zhihang; Shi, Limin; Zhu, Fengcai			Preliminary fast diagnosis of severe fever with thrombocytopenia syndrome with clinical and epidemiological parameters	PLOS ONE			English	Article							SYNDROME VIRUS; SFTS VIRUS; SHANDONG PROVINCE; BUNYAVIRUS; TICKS; TRANSMISSION; ANIMALS	Objectives To identify specific clinical and epidemiological parameters for clinical diagnosis of SFTSV infection with relatively higher accuracy. Methods 231 suspected cases of SFTS were reported by various medical institutions from 2011 to 2013 in Jiangsu Province, China. They were followed with SFTSV diagnosis tests and interview-administered questionnaires about demographic characteristics, clinical symptoms and epidemiological exposure factors. Univariate and multivariable logistic regression analysis were used to examine the diagnostic value of these parameters. Results SFTSV infection occurred only from April to October annually and usually in hilly areas of specific regions. Three prediction models of SFTSV infection were constructed. Model 3 with clinical and epidemiological parameters combined the benefits of both Model 1and Model 2, which was optimal and had an overall accuracy of 80.2%. Independent indicators for clinical diagnosis of SFTSV infection in Model 3 were as follows: lymphadenopathy (P = 0.01), leucopenia (P<0.01), age >50 years (P = 0.01), tick bites (P<0.01), raising domestic animals in the residential areas (P<0.01) and farming (P = 0.03). Conclusions Our results show that using a combination of clinical and epidemiological parameters may be a feasible strategy to provide preliminary fast diagnosis as differentiating SFTSV infection from SFTS-like diseases, thus reducing the risk of misdiagnosis.	[Hu, Jianli; Li, Zhifeng; Bao, Changjun; Wang, Xiaochen; Liu, Wendong; Zhu, Fengcai] Jiangsu Prov Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Li, Zhifeng] Nanjing Univ, Sch Med, Nanjing, Jiangsu, Peoples R China; [Hong, Lei; Zhang, Zhong; Zhang, Hongying; Shi, Limin] Nanjing Municipal Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [He, Hao] Gulou Dist Ctr Dis Control & Prevent, Dept Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Peng, Zhihang] Nanjing Med Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention; Nanjing University; Nanjing Medical University	Bao, CJ (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China.	bao2000_cn@163.com			Natural Science Foundation of China [81373055, 81601794]; Jiangsu Province Science & Technology Demonstration Project for Major Emerging Infectious Diseases Control and Prevention [BE2015714]; Jiangsu Provincial Nature Science Foundation [BK20161584]; Jiangsu Provincial Key Medical Discipline of Epidemiology [ZDXKA2016008]; 10th Summit of Six Top Talents of Jiangsu Province [2013-WSN-061]; Jiangsu Provincial Medical Youth Talent [ZDRCA2016032, QNRC2016545]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Science & Technology Demonstration Project for Major Emerging Infectious Diseases Control and Prevention; Jiangsu Provincial Nature Science Foundation; Jiangsu Provincial Key Medical Discipline of Epidemiology; 10th Summit of Six Top Talents of Jiangsu Province; Jiangsu Provincial Medical Youth Talent	Our research was supported by Natural Science Foundation of China (No. 81373055 and No. 81601794), Jiangsu Province Science & Technology Demonstration Project for Major Emerging Infectious Diseases Control and Prevention (No.BE2015714), Jiangsu Provincial Nature Science Foundation (No. BK20161584), Jiangsu Provincial Key Medical Discipline of Epidemiology (ZDXKA2016008), the 10th Summit of Six Top Talents of Jiangsu Province (No. 2013-WSN-061) and Jiangsu Provincial Medical & Youth Talent (No. ZDRCA2016032 & QNRC2016545). All of the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao CJ, 2011, CLIN INFECT DIS, V53, P1208, DOI 10.1093/cid/cir732; Cui F, 2013, AM J TROP MED HYG, V88, P510, DOI 10.4269/ajtmh.11-0760; Ding F, 2013, CLIN INFECT DIS, V56, P1682, DOI 10.1093/cid/cit100; Ding SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111736; Gai ZT, 2012, J INFECT DIS, V206, P1095, DOI 10.1093/infdis/jis472; Jiang Xiao-lin, 2012, Chinese Journal of Virology, V28, P252; Jiao YJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004092; Jiao YJ, 2012, J CLIN MICROBIOL, V50, P372, DOI 10.1128/JCM.01319-11; Jin C, 2012, P NATL ACAD SCI USA, V109, P10053, DOI 10.1073/pnas.1120246109; Kang Kai, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P106; Li DX, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.1; Li Yi-fan, 2011, Journal of Traffic and Transportation Engineering, V11, P36; Li ZF, 2014, J CLIN VIROL, V60, P185, DOI 10.1016/j.jcv.2014.03.020; Liu K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09679; Liu Li, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P168; Liu Y., 2012, CHIN J PREMED, V46, P500; Liu Y, 2012, VECTOR-BORNE ZOONOT, V12, P156, DOI 10.1089/vbz.2011.0758; Lu QB, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.07.012; Luo LM, 2015, EMERG INFECT DIS, V21, P1770, DOI 10.3201/eid2110.150126; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; Niu GY, 2013, EMERG INFECT DIS, V19, P756, DOI 10.3201/eid1905.120245; Park S.U., 2013, INT J CHEM, V2, P10, DOI DOI 10.3201/EID2011.140888; Shimada S, 2015, VIROLOGY, V482, P19, DOI 10.1016/j.virol.2015.03.010; Shimojima M, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0412-3; Sun Y, 2012, AASRI PROC, V3, P694, DOI 10.1016/j.aasri.2012.11.110; Takahashi T, 2014, J INFECT DIS, V209, P816, DOI 10.1093/infdis/jit603; Tang XY, 2013, J INFECT DIS, V207, P736, DOI 10.1093/infdis/jis748; Vynograd N, 2014, ARCH IMMUNOL THER EX, V62, P445, DOI 10.1007/s00005-014-0316-8; Wang SW, 2015, AM J TROP MED HYG, V92, P684, DOI 10.4269/ajtmh.14-0008; Xie YT, 2015, LANCET INFECT DIS, V15, P145, DOI 10.1016/S1473-3099(14)70891-6; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang Yong-Zhen, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P209; Zhao L, 2012, EMERG INFECT DIS, V18, P963, DOI 10.3201/eid1806.111345	34	9	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180256	10.1371/journal.pone.0180256	http://dx.doi.org/10.1371/journal.pone.0180256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678811	gold, Green Published, Green Submitted			2022-12-26	WOS:000405272200043
J	Perez, LG; Martinez, DR; Decamp, AC; Pinter, A; Berman, PW; Francis, D; Sinangil, F; Lees, C; Greene, K; Gao, HM; Nitayaphan, S; Rerks-Ngarm, S; Kaewkungwal, J; Pitisuttithum, P; Tartaglia, J; O'Connell, RJ; Robb, ML; Michael, NL; Kim, JH; Gilbert, P; Montefiori, DC				Perez, Lautaro G.; Martinez, David R.; Decamp, Allan C.; Pinter, Abraham; Berman, Phillip W.; Francis, Donald; Sinangil, Faruk; Lees, Carter; Greene, Kelli; Gao, Hongmei; Nitayaphan, Sorachai; Rerks-Ngarm, Supachai; Kaewkungwal, Jaranit; Pitisuttithum, Punnee; Tartaglia, James; O'Connell, Robert J.; Robb, Merlin L.; Michael, Nelson L.; Kim, Jerome H.; Gilbert, Peter; Montefiori, David C.			V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIBODY-DEPENDENT ENHANCEMENT; VACCINE EFFICACY; IN-VITRO; TYPE-1 INFECTION; PLASMA VIRUS; FACTOR-H; BINDING; CELLS; CD55	Non-neutralizing IgG to the V1V2 loop of HIV-1 gp120 correlates with a decreased risk of HIV-1 infection but the mechanism of protection remains unknown. This V1V2 IgG correlate was identified in RV144 Thai trial vaccine recipients, who were primed with a canarypox vector expressing membrane-bound gp120 (vCP1521) and boosted with vCP1521 plus a mixture gp120 proteins from clade B and clade CRF01_AE (B/E gp120). We sought to determine whether the mechanism of vaccine protection might involve antibody-dependent complement activation. Complement activation was measured as a function of complement component C3d deposition on V1V2-coated beads in the presence of RV144 sera. Variable levels of complement activation were detected two weeks post final boosting in RV144, which is when the V1V2 IgG correlate was identified. The magnitude of complement activation correlated with V1V2-specific serum IgG and was stronger and more common in RV144 than in HIV-1 infected individuals and two related HIV-1 vaccine trials, VAX003 and VAX004, where no protection was seen. After adjusting for gp120 IgA, V1V2 IgG, gender, and risk score, complement activation by case-control plasmas from RV144 correlated inversely with a reduced risk of HIV-1 infection, with odds ratio for positive versus negative response to TH023-V1V2 0.42 (95% CI 0.18 to 0.99, p = 0.048) and to A244-V1V2 0.49 (95% CI 0.21 to 1.10, p = 0.085). These results suggest that complement activity may have contributed in part to modest protection against the acquisition of HIV-1 infection seen in the RV144 trial.	[Perez, Lautaro G.; Martinez, David R.; Greene, Kelli; Gao, Hongmei; Montefiori, David C.] Duke Univ, Med Ctr, Durham, NC 27708 USA; [Decamp, Allan C.; Gilbert, Peter] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Pinter, Abraham] Publ Hlth Res Inst, Newark, NJ USA; [Berman, Phillip W.] Univ Calif Santa Cruz, Baskin Sch Engn, Santa Cruz, CA 95064 USA; [Francis, Donald; Sinangil, Faruk; Lees, Carter] Global Solut Infect Dis, San Francisco, CA USA; [Nitayaphan, Sorachai; O'Connell, Robert J.] Armed Forces Res Inst Med Sci, Bangkok, Thailand; [Rerks-Ngarm, Supachai] Minist Publ Hlth, Bangkok, Thailand; [Kaewkungwal, Jaranit; Pitisuttithum, Punnee] Fac Trop Med, Mahidol, Thailand; [Tartaglia, James] Sanofi Pasteur, Dept Res & Dev, Swiftwater, PA USA; [O'Connell, Robert J.; Robb, Merlin L.; Michael, Nelson L.] Walter Reed Army Inst Res, Mil HIV Res Program, Silver Spring, MD USA; [Kim, Jerome H.] Int Vaccine Inst, Seoul, South Korea	Duke University; Fred Hutchinson Cancer Center; University of California System; University of California Santa Cruz; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Ministry of Public Health - Thailand; Sanofi-Aventis; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); International Vaccine Institute	Montefiori, DC (corresponding author), Duke Univ, Med Ctr, Durham, NC 27708 USA.	david.montefiori@duke.edu	martinez, david/GQI-0849-2022		Bill & Melinda Gates Foundation [1032144]; National Institutes of Health, USA [Y1-AI2 642-12]; U.S. Department of Defense [W81XWH-07-2-0067]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068635, R01AI046283, P01AI088610] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Bill & Melinda Gates Foundation, Grant #1032144; the National Institutes of Health, USA, Grant #Y1-AI2 642-12 and the U.S. Department of Defense, Grant #W81XWH-07-2-0067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. James Tartagliais employed by Sanofi Pasteur. Dr. Tartaglia was involved in providing RV144 plasmas for our study. We received no funding from Sanofi Pasteur for the work described in our manuscript.	Aasa-Chapman MMI, 2005, J VIROL, V79, P2823, DOI 10.1128/JVI.79.5.2823-2830.2005; Bonsignori M, 2012, J VIROL, V86, P11521, DOI 10.1128/JVI.01023-12; Chung AW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007736; deCamp A, 2014, J VIROL, V88, P2489, DOI 10.1128/JVI.02853-13; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Edlefsen PT, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1003973; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gottardo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075665; GRAS G, 1993, BLOOD, V81, P1808; HEYMAN B, 1990, J EXP MED, V172, P665, DOI 10.1084/jem.172.2.665; Huber M, 2006, PLOS MED, V3, P2078, DOI 10.1371/journal.pmed.0030441; JUNE RA, 1991, AIDS, V5, P269, DOI 10.1097/00002030-199103000-00004; Karasavvas N, 2012, AIDS RES HUM RETROV, V28, P1444, DOI 10.1089/aid.2012.0103; KAYMAN SC, 1994, J VIROL, V68, P400, DOI 10.1128/JVI.68.1.400-410.1994; Li SYS, 2014, J CLIN INVEST, V124, P3879, DOI 10.1172/JCI75539; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; McMichael AJ, 2012, NAT IMMUNOL, V13, P423, DOI 10.1038/ni.2264; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; MONTEFIORI DC, 1993, J VIROL, V67, P2699, DOI 10.1128/JVI.67.5.2699-2706.1993; Montefiori DC, 1996, J INFECT DIS, V173, P60, DOI 10.1093/infdis/173.1.60; MONTEFIORI DC, 1992, CLIN EXP IMMUNOL, V90, P383; MONTEFIORI DC, 1994, J INFECT DIS, V170, P429, DOI 10.1093/infdis/170.2.429; MONTEFIORI DC, 1994, VIROLOGY, V205, P82, DOI 10.1006/viro.1994.1622; Montefiori DC, 1996, SYMPOSIUM IN IMMUNOLOGY V, P31; Nesargikar PN, 2012, EUR J MICROBIOL IMMU, V2, P103, DOI 10.1556/EuJMI.2.2012.2.2; PINTER C, 1995, AIDS RES HUM RETROV, V11, P577, DOI 10.1089/aid.1995.11.577; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Pollara J, 2014, J VIROL, V88, P7715, DOI 10.1128/JVI.00156-14; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; ROBINSON WE, 1990, VIROLOGY, V175, P600, DOI 10.1016/0042-6822(90)90449-2; ROBINSON WE, 1990, J VIROL, V64, P5301, DOI 10.1128/JVI.64.11.5301-5305.1990; ROBINSON WE, 1991, J VIROL, V65, P4169, DOI 10.1128/JVI.65.8.4169-4176.1991; ROBINSON WE, 1988, LANCET, V1, P790; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Saifuddin M, 1997, J GEN VIROL, V78, P1907, DOI 10.1099/0022-1317-78-8-1907; Stoiber H, 1996, J EXP MED, V183, P307, DOI 10.1084/jem.183.1.307; Stoiber H, 2008, VACCINE, V26, P3046, DOI 10.1016/j.vaccine.2007.12.003; Sullivan BL, 1996, J IMMUNOL, V157, P1791; Sullivan BL, 1998, VIROLOGY, V248, P173, DOI 10.1006/viro.1998.9289; Thurman JM, 2013, J CLIN INVEST, V123, P2218, DOI 10.1172/JCI65861; Tomaras GD, 2014, VACCINES, V2, P15, DOI 10.3390/vaccines2010015; Tomaras GD, 2013, P NATL ACAD SCI USA, V110, P9019, DOI 10.1073/pnas.1301456110; TOTH FD, 1994, CLIN EXP IMMUNOL, V96, P389, DOI 10.1111/j.1365-2249.1994.tb06040.x; TREMBLAY M, 1990, J EXP MED, V171, P1791, DOI 10.1084/jem.171.5.1791; Willey S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-16; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730; Yu QG, 2010, CELL MOL IMMUNOL, V7, P334, DOI 10.1038/cmi.2010.8; Zhou JT, 1996, VIROLOGY, V226, P13, DOI 10.1006/viro.1996.0623; Zolla-Pazner S, 2010, PLOS ONE, V9; Zolla-Pazner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053629	51	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180720	10.1371/journal.pone.0180720	http://dx.doi.org/10.1371/journal.pone.0180720			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678869	Green Published, Green Submitted, gold			2022-12-26	WOS:000405272200085
J	Woywod, C; Gruber, FX; Engh, RA; Fla, T				Woywod, Clemens; Gruber, Franz X.; Engh, Richard A.; Fla, Tor			Dynamical models of mutated chronic myelogenous leukemia cells for a post-imatinib treatment scenario: Response to dasatinib or nilotinib therapy	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; BLAST CRISIS; CML PATIENTS; MATHEMATICAL-MODELS; DRUG-RESISTANCE; TYROSINE KINASE; STEM-CELLS; CANCER; EMERGENCE; MESYLATE	Targeted inhibition of the oncogenic BCR-ABL1 fusion protein using the ABL1 tyrosine kinase inhibitor imatinib has become standard therapy for chronic myelogenous leukemia (CML), with most patients reaching total and durable remission. However, a significant fraction of patients develop resistance, commonly due to mutated ABL1 kinase domains. This motivated development of second-generation drugs with broadened or altered protein kinase selectivity profiles, including dasatinib and nilotinib. Imatinib-resistant patients undergoing treatment with second-line drugs typically develop resistance to them, but dynamic and clonal properties of this response differ. Shared, however, is the observation of clonal competition, reflected in patterns of successive dominance of individual clones. We present three deterministic mathematical models to study the origins of clinically observed dynamics. Each model is a system of coupled first-order differential equations, considering populations of three mutated active stem cell strains and three associated pools of differentiated cells; two models allow for activation of quiescent stem cells. Each approach is distinguished by the way proliferation rates of the primary stem cell reservoir are modulated. Previous studies have concentrated on simulating the response of wild-type leukemic cells to imatinib administration; our focus is on modelling the time dependence of imatinib-resistant clones upon subsequent exposure to dasatinib or nilotinib. Performance of the three computational schemes to reproduce selected CML patient profiles is assessed. While some simple cases can be approximated by a basic design that does not invoke quiescence, others are more complex and require involvement of non-cycling stem cells for reproduction. We implement a new feedback mechanism for regulation of coupling between cycling and noncycling stem cell reservoirs that depends on total cell populations. A bifurcation landscape analysis is also performed for solutions to the basic ansatz. Computational models reproducing patient data illustrate potential dynamic mechanisms that may guide optimization of therapy of drug resistant CML.	[Woywod, Clemens; Fla, Tor] Univ Tromso, Dept Chem, Ctr Theoret & Computat Chem, N-9037 Tromso, Norway; [Gruber, Franz X.; Engh, Richard A.] Univ Tromso, Dept Chem, NORSTRUCT, N-9037 Tromso, Norway; [Fla, Tor] Univ Tromso, Dept Math, N-9037 Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso	Woywod, C (corresponding author), Univ Tromso, Dept Chem, Ctr Theoret & Computat Chem, N-9037 Tromso, Norway.	clemens.woywod@ch.tum.de	woywod, clemens/Q-2939-2017	woywod, clemens/0000-0002-3407-1486; Engh, Richard/0000-0002-6207-0560	Research Council of Norway [179568/V30]; Tromso Research Foundation [A32542]; Kreftforeningen [PK01-2009-0541]; Publication Fund of UiT The Arctic University of Norway	Research Council of Norway(Research Council of Norway); Tromso Research Foundation; Kreftforeningen; Publication Fund of UiT The Arctic University of Norway	This work was supported by Research Council of Norway (Grant Nr 179568/V30), URL: http://www.forskningsradet.no/en/Home_page/ 1177315753906, Received Funding: CW, Role: Funding position; Tromso Research Foundation (supported by Trond Mohn, Grant Nr. A32542), URL:http://www.tfstiftelse.no, Received funding: CW, Role: Funding position; and Kreftforeningen (Grant Nr. PK01-2009-0541), URL:http://kreftforeningen.no, Received funding: RAE, FXG, Role: Funding position (FXG). The publication charges for this article have been funded by a grant from the Publication Fund of UiT The Arctic University of Norway.	Abbott LH, 2006, BRIT J CANCER, V95, P1136, DOI 10.1038/sj.bjc.6603310; [Anonymous], 2010, MATL VERS 7 11 0; Apperley JF, 2007, LANCET ONCOL, V8, P1018, DOI 10.1016/S1470-2045(07)70342-X; Berezansky L, 2005, COMPUT MATH APPL, V49, P549, DOI 10.1016/j.camwa.2004.07.015; Brown G, 2012, LEUKEMIA RES, V36, P14, DOI 10.1016/j.leukres.2011.10.010; Catlin SN, 2005, BLOOD, V106, P2688, DOI 10.1182/blood-2005-03-1240; Chereda B, 2015, ANN HEMATOL, V94, pS107, DOI 10.1007/s00277-015-2325-z; Clapp GD, 2015, CANCER RES, V75, P4053, DOI 10.1158/0008-5472.CAN-15-0611; Cortes J, 2004, BLOOD, V104, P2204, DOI 10.1182/blood-2004-04-1335; Dingli D, 2007, PLOS COMPUT BIOL, V3, P482, DOI 10.1371/journal.pcbi.0030053; Dingli D, 2006, STEM CELLS, V24, P2603, DOI 10.1634/stemcells.2006-0136; Dormand J.R., 1980, J COMPUT APPL MATH, V6, P19, DOI [10.1016/0771-050X(80)90013-3, DOI 10.1016/0771-050X(80)90013-3]; Doumic-Jauffret M, 2010, B MATH BIOL, V72, P1732, DOI 10.1007/s11538-009-9500-0; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Drummond MW, 2009, LEUKEMIA, V23, P1199, DOI 10.1038/leu.2009.43; Ernst T, 2008, HAEMATOLOGICA, V93, P186, DOI 10.3324/haematol.11993; Fla T, 2013, SPRINGER P MATH STAT, V35, P221; Fla T, 2015, MATH METHOD APPL SCI, V38, P3392, DOI 10.1002/mma.3345; Foo J, 2010, J THEOR BIOL, V263, P179, DOI 10.1016/j.jtbi.2009.11.022; Foo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000557; Foo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000503; Gambacorti-Passerini C, 2011, JNCI-J NATL CANCER I, V103, P553, DOI 10.1093/jnci/djr060; Ghanima W, 2004, EUR J HAEMATOL, V72, P441, DOI 10.1111/j.1600-0609.2004.00257.x; Glauche I, 2007, BRIT J CANCER, V96, P677, DOI 10.1038/sj.bjc.6603603; Glauche I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000447; Gruber FX, 2006, LEUKEMIA, V20, P2057, DOI 10.1038/sj.leu.2404400; Gruber FX, 2012, LEUKEMIA, V26, P172, DOI 10.1038/leu.2011.187; Gruber FX, 2009, QUANTITATIVE UNDERST; Gruber FXE, 2005, LEUKEMIA, V19, P2159, DOI 10.1038/sj.leu.2403983; Ha KJ, 2007, ATMOS RES, V86, P330, DOI 10.1016/j.atmosres.2007.07.002; Haeno H, 2009, P NATL ACAD SCI USA, V106, P16616, DOI 10.1073/pnas.0908107106; Han L, 2010, ANN HEMATOL, V89, P861, DOI 10.1007/s00277-010-0948-7; Higashi T, 2004, AM J HEMATOL, V76, P275, DOI 10.1002/ajh.20096; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Hochhaus A, 2007, SEMIN HEMATOL, V44, pS15, DOI 10.1053/j.seminhematol.2006.12.002; Horn M, 2008, CELLS TISSUES ORGANS, V188, P236, DOI 10.1159/000118786; Ito T, 2013, INT J HEMATOL, V98, P641, DOI 10.1007/s12185-013-1318-8; Jackson RC, 2014, CANCER CHEMOTH PHARM, V74, P765, DOI 10.1007/s00280-014-2556-z; Kantarjian HM, 2006, ANN INTERN MED, V145, P913, DOI 10.7326/0003-4819-145-12-200612190-00008; Kim PS, 2008, B MATH BIOL, V70, P1994, DOI 10.1007/s11538-008-9336-z; Kim PS, 2008, B MATH BIOL, V70, P728, DOI 10.1007/s11538-007-9276-z; Kim PS, 2007, J THEOR BIOL, V246, P33, DOI 10.1016/j.jtbi.2006.12.012; Kim PS, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000095; Komarova NL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000990; Komarova NL, 2007, THEOR POPUL BIOL, V72, P523, DOI 10.1016/j.tpb.2007.08.003; Komarova NL, 2009, CANCER RES, V69, P4904, DOI 10.1158/0008-5472.CAN-08-1959; Komarova NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004423; Komarova NL, 2005, P NATL ACAD SCI USA, V102, P9714, DOI 10.1073/pnas.0501870102; Korfi K, 2015, ANN ONCOL, V26, P1180, DOI 10.1093/annonc/mdv110; Leder K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027682; Lenaerts T, 2010, HAEMATOL-HEMATOL J, V95, P900, DOI 10.3324/haematol.2009.015271; MacLean AL, 2014, P NATL ACAD SCI USA, V111, P3883, DOI 10.1073/pnas.1317072111; Mauro MJ, 2004, LEUKEMIA RES, V28, pS71, DOI 10.1016/j.leukres.2003.10.017; Merante S, 2005, HAEMATOLOGICA, V90, P979; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Michor F, 2008, J CLIN ONCOL, V26, P2854, DOI 10.1200/JCO.2007.15.2421; Michor F, 2007, TRENDS PHARMACOL SCI, V28, P197, DOI 10.1016/j.tips.2007.03.003; Michor F, 2007, STEM CELLS, V25, P1114, DOI 10.1634/stemcells.2006-0638; Mustjoki S, 2013, LEUKEMIA, V27, P1520, DOI 10.1038/leu.2013.19; Olshen A, 2014, HAEMATOLOGICA, V99, P1701, DOI 10.3324/haematol.2013.085977; Paquin D, 2011, B MATH BIOL, V73, P1082, DOI 10.1007/s11538-010-9553-0; Roeder I, 2008, J MOL MED, V86, P17, DOI 10.1007/s00109-007-0241-y; Roeder I, 2006, NAT MED, V12, P1181, DOI 10.1038/nm1487; Roeder I, 2006, CURR OPIN HEMATOL, V13, P222, DOI 10.1097/01.moh.0000231418.08031.48; Roeder I, 2009, B MATH BIOL, V71, P602, DOI 10.1007/s11538-008-9373-7; Rousselot P, 2007, BLOOD, V109, P58, DOI 10.1182/blood-2006-03-011239; Shampine LF, 1997, SIAM J SCI COMPUT, V18, P1, DOI 10.1137/S1064827594276424; Shieh MP, 2011, CLIN MED INSIGHTS-ON, V5, P185, DOI 10.4137/CMO.S6416; SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313; Tang M, 2011, BLOOD, V118, P1622, DOI 10.1182/blood-2011-02-339267; Tomasetti C, 2010, P NATL ACAD SCI USA, V107, P16766, DOI 10.1073/pnas.1007726107; Ursan LD, 2015, J MANAG CARE SPEC PH, V21, P114; Weissman I., 2015, PHILOS T R SOC LON B, V370, P1680, DOI DOI 10.1098/RSTB.2014.0364; Wodarz D, 2005, SEMIN CANCER BIOL, V15, P506, DOI 10.1016/j.semcancer.2005.07.002; Wodarz D, 2008, MED HYPOTHESES, V70, P128, DOI 10.1016/j.mehy.2007.03.040	75	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179700	10.1371/journal.pone.0179700	http://dx.doi.org/10.1371/journal.pone.0179700			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678800	Green Submitted, Green Published, gold			2022-12-26	WOS:000405272200023
J	Spaans, F; Kao, CK; Morton, JS; Quon, AL; Sawamura, T; Tannetta, DS; Sargent, IL; Davidge, ST				Spaans, Floor; Kao, Cindy K.; Morton, Jude S.; Quon, Anita L.; Sawamura, Tatsuya; Tannetta, Dionne S.; Sargent, Ian L.; Davidge, Sandra T.			Syncytiotrophoblast extracellular vesicles impair rat uterine vascular function via the lectin-like oxidized LDL receptor-1	PLOS ONE			English	Article							MULTICOLOR FLOW-CYTOMETRY; NITRIC-OXIDE; ENDOTHELIAL-CELLS; RESISTANCE ARTERIES; OXIDATIVE STRESS; OX-LDL; LOX-1; MICROPARTICLES; DYSFUNCTION; PLASMA	Syncytiotrophoblast extracellular vesicles (STBEVs) are placenta derived particles that are released into the maternal circulation during pregnancy. Abnormal levels of STBEVs have been proposed to affect maternal vascular function. The lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is a multi-ligand scavenger receptor. Increased LOX-1 expression and activation has been proposed to contribute to endothelial dysfunction. As LOX-1 has various ligands, we hypothesized that, being essentially packages of lipoproteins, STBEVs are able to activate the LOX-1 receptor thereby impairing vascular function via the production of superoxide and decreased nitric oxide bioavailability. Uterine arteries were obtained in late gestation from Sprague-Dawley rats and incubated for 24h with or without human STBEVs (derived from a normal pregnant placenta) in the absence or presence of a LOX-1 blocking antibody. Vascular function was assessed using wire myography. Endothelium-dependent maximal vasodilation to methylcholine was impaired by STBEVs (MCh E-max: 57.7 +/- 5.9% in STBEV-incubated arteries vs. 77.8 +/- 2.9% in controls, p< 0.05). This was prevented by co-incubation of STBEV-incubated arteries with LOX-1 blocking antibodies (MCh E-max: 78.8 +/- 4.3%, p<0.05). Pre-incubation of the vessels with a nitric oxide synthase inhibitor (L-NAME) demonstrated that the STBEV-induced impairment in vasodilation was due to decreased nitric oxide contribution (Delta AUC 12.2 +/- 11.7 in STBEV-arteries vs. 86.5 +/- 20 in controls, p<0.05), which was abolished by LOX-1 blocking antibody (Delta AUC 98.9 +/- 17, p<0.05). In STBEV-incubated vessels, LOX-1 inhibition resulted in an increased endothelial nitric oxide synthase expression (p<0.05), to a level similar to control vessels. The oxidant scavenger, superoxide dismutase, did not improve this impairment, nor were vascular superoxide levels altered. Our data support an important role for STBEVs in impairment of vascular function via activation of LOX-1 and reduced nitric oxide mediated vasodilation. Moreover, we postulate that the LOX-1 pathway could be a potential therapeutic target in pathologies associated with vascular dysfunction during pregnancy.	[Spaans, Floor; Kao, Cindy K.; Morton, Jude S.; Quon, Anita L.; Davidge, Sandra T.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada; [Spaans, Floor; Kao, Cindy K.; Morton, Jude S.; Quon, Anita L.; Davidge, Sandra T.] Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Sawamura, Tatsuya] Shinshu Univ, Sch Med, Dept Physiol, Asahi Ku, Matsumoto, Nagano, Japan; [Tannetta, Dionne S.; Sargent, Ian L.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford, England; [Davidge, Sandra T.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada	University of Alberta; University of Alberta; Shinshu University; University of Oxford; University of Alberta	Davidge, ST (corresponding author), Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada.; Davidge, ST (corresponding author), Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada.; Davidge, ST (corresponding author), Univ Alberta, Dept Physiol, Edmonton, AB, Canada.	sandra.davidge@ualberta.ca		Davidge, Sandra/0000-0002-5559-4905	Canadian Institutes of Health Research (CIHR) [MOP142320]; Women and Children's Health Research Institute (WCHRI) through generosity of the Stollery Children's Hospital Foundation; Lois Hole Hospital for Women; Medical Research Council Programme [MR/J003360/1]; Post graduate Fellowship award from Alberta Innovates-Health Solutions (AIHS) [PF 201400457]; Dr. Kaobya Clinical Investigator Program of Alberta Health Services (AHS); MRC [MR/J003360/1] Funding Source: UKRI; Medical Research Council [MR/J003360/1] Funding Source: researchfish; Alberta Innovates [201400457] Funding Source: researchfish	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Women and Children's Health Research Institute (WCHRI) through generosity of the Stollery Children's Hospital Foundation; Lois Hole Hospital for Women; Medical Research Council Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Post graduate Fellowship award from Alberta Innovates-Health Solutions (AIHS); Dr. Kaobya Clinical Investigator Program of Alberta Health Services (AHS); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Alberta Innovates	This study was funded by grants from Canadian Institutes of Health Research (CIHR; MOP142320), by the Women and Children's Health Research Institute (WCHRI) through the generosity of the Stollery Children's Hospital Foundation and supporters of the Lois Hole Hospital for Women, and by the Medical Research Council Programme grant MR/J003360/1. Dr. Spaans was funded by a Post graduate Fellowship award from Alberta Innovates-Health Solutions (AIHS; PF 201400457), and Dr. Kaobya Clinical Investigator Program of Alberta Health Services (AHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106540; Buchwalow IB, 2002, FASEB J, V16, P500, DOI 10.1096/fj.01-0842com; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Chen MJ, 2002, PHARMACOL THERAPEUT, V95, P89, DOI 10.1016/S0163-7258(02)00236-X; Chen XP, 2007, VASC PHARMACOL, V47, P1, DOI 10.1016/j.vph.2007.01.004; Chen Y, 2012, INT J GYNECOL OBSTET, V119, P234, DOI 10.1016/j.ijgo.2012.07.010; Cockell AP, 1997, BRIT J OBSTET GYNAEC, V104, P235, DOI 10.1111/j.1471-0528.1997.tb11052.x; Cominacini L, 2001, J BIOL CHEM, V276, P13750, DOI 10.1074/jbc.M010612200; Dragovic RA, 2015, METHODS, V87, P64, DOI 10.1016/j.ymeth.2015.03.028; Dragovic RA, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.113266; Eichhorn B, 2009, CARDIOVASC RES, V82, P493, DOI 10.1093/cvr/cvp089; English FA, 2013, AM J HYPERTENS, V26, P279, DOI 10.1093/ajh/hps035; Forstermann U, 2010, PFLUG ARCH EUR J PHY, V459, P923, DOI 10.1007/s00424-010-0808-2; Germain SJ, 2007, J IMMUNOL, V178, P5949, DOI 10.4049/jimmunol.178.9.5949; Gohner C, 2015, AM J REPROD IMMUNOL, V73, P582, DOI 10.1111/aji.12367; Goulopoulou S, 2015, TRENDS MOL MED, V21, P88, DOI 10.1016/j.molmed.2014.11.009; Ho E, 2013, REDOX BIOL, V1, P483, DOI 10.1016/j.redox.2013.07.006; Kertesz Z, 2000, PLACENTA, V21, P150, DOI 10.1053/plac.1999.0476; Knight M, 1998, BRIT J OBSTET GYNAEC, V105, P632, DOI 10.1111/j.1471-0528.1998.tb10178.x; Lok CAR, 2008, HYPERTENS PREGNANCY, V27, P344, DOI 10.1080/10641950801955733; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Messerli M, 2010, PLACENTA, V31, P106, DOI 10.1016/j.placenta.2009.11.011; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; MICHEL T, 1993, P NATL ACAD SCI USA, V90, P6252, DOI 10.1073/pnas.90.13.6252; Morton JS, 2012, HYPERTENSION, V59, P1014, DOI 10.1161/HYPERTENSIONAHA.112.191825; Oka K, 1998, P NATL ACAD SCI USA, V95, P9535, DOI 10.1073/pnas.95.16.9535; Pirillo A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/152786; Redman CWG, 2012, PLACENTA, V33, pS48, DOI 10.1016/j.placenta.2011.12.006; Ryoo S, 2011, ATHEROSCLEROSIS, V214, P279, DOI 10.1016/j.atherosclerosis.2010.10.044; Sakamoto N, 2009, J CELL PHYSIOL, V220, P706, DOI 10.1002/jcp.21818; Sankaralingam S, 2009, HYPERTENSION, V53, P270, DOI 10.1161/HYPERTENSIONAHA.108.122630; Sawamura T, 2012, CURR OPIN LIPIDOL, V23, P439, DOI 10.1097/MOL.0b013e32835688e4; Shin HK, 2004, CIRCULATION, V109, P1022, DOI 10.1161/01.CIR.0000117403.64398.53; van der Post JAM, 2011, SEMIN THROMB HEMOST, V37, P146, DOI 10.1055/s-0030-1270342; Van Wijk MJ, 2001, BRIT J OBSTET GYNAEC, V108, P967; VanWijk MJ, 2002, AM J OBSTET GYNECOL, V187, P1686, DOI 10.1067/mob.2002.127905; Welter H, 2004, REPROD FERT DEVELOP, V16, P689, DOI 10.1071/RD03103; Xu L, 2015, J CELL MOL MED, V19, P92, DOI 10.1111/jcmm.12463; Xu X, 2007, THROMB VASC BIOL, V27, P871, DOI DOI 10.1161/01.ATV.0000259358.31234.37; Zhou J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003179	40	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180364	10.1371/journal.pone.0180364	http://dx.doi.org/10.1371/journal.pone.0180364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672042	Green Submitted, gold, Green Published			2022-12-26	WOS:000405268500047
J	Zhou, SD; Du, XX; Xie, JX; Wang, J				Zhou, Shida; Du, Xinxing; Xie, Junxia; Wang, Jun			Interleukin-6 regulates iron-related proteins through c-Jun N-terminal kinase activation in BV2 microglial cell lines	PLOS ONE			English	Article							PARKINSONS-DISEASE; INTRACEREBRAL HEMORRHAGE; SIGNALING PATHWAYS; FACTOR-ALPHA; EXPRESSION; MODEL; INFLAMMATION; NEURONS; STRESS; NEURODEGENERATION	Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the loss of dopaminergic (DA) neurons in the substantia nigra (SN) and subsequent DA depletion in the striatum. Microglia activation and nigral iron accumulation play important roles in the pathogenesis of PD. Activated microglia show increased iron deposits. However, the relationship between microglia activation and iron accumulation remains unclear. In the present study, we aimed to determine how iron levels affect interleukin-6 (IL-6) synthesis, and the effect of IL-6 on cellular iron metabolism in BV2 microglial cells. IL-6 mRNA was up-regulated after FAC treatment for 12 h in BV2 cells. Iron regulatory protein 1 (IRP1) and divalent metal transporter 1 (DMT1) were up-regulated and iron exporter ferroportin 1 (FPN1) was down-regulated in BV2 cells after 24 h of IL-6 treatment. Phosphorylated JNK increased significantly compared to the control after BV2 cells were treated with IL-6 for 1 h. Pretreatment with SP600125 attenuated the up-regulation of IRP1 and DMT1 and down-regulation of FPN1 (compared to IL-6-treated group). These results suggest that iron load could increase IL-6 mRNA expression in BV2 cells. Further, IL-6 likely up-regulates IRP1 and DMT1 expression and down-regulates FPN1 expression in BV2 microglial cells through JNK signaling pathways.	[Zhou, Shida; Xie, Junxia; Wang, Jun] Qingdao Univ, Coll Med, Dept Physiol, Shandong Prov Key Lab Pathogenesis & Prevent Neur, Qingdao, Peoples R China; [Zhou, Shida; Xie, Junxia; Wang, Jun] Qingdao Univ, Coll Med, State Key Disciplines Physiol, Qingdao, Peoples R China; [Du, Xinxing] Qingdao Univ, Coll Med, Qingdao, Peoples R China	Qingdao University; Qingdao University; Qingdao University	Xie, JX; Wang, J (corresponding author), Qingdao Univ, Coll Med, Dept Physiol, Shandong Prov Key Lab Pathogenesis & Prevent Neur, Qingdao, Peoples R China.; Xie, JX; Wang, J (corresponding author), Qingdao Univ, Coll Med, State Key Disciplines Physiol, Qingdao, Peoples R China.	jxiaxie@public.qd.sd.cn; junwangqdu@163.com		Zhou, Shida/0000-0002-9493-9072	National Natural Science Foundation of China [31571054, 81430024]; Excellent InnovativeTeam of Shandong Province; Taishan Scholars Construction Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent InnovativeTeam of Shandong Province; Taishan Scholars Construction Project	z This work was supported by the National Natural Science Foundation of China (31571054, 81430024), Excellent InnovativeTeam of Shandong Province and Taishan Scholars Construction Project to JW and JX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2016, NATURE, V539, P207, DOI 10.1038/nature20414; Chuang JY, 2014, INT J MOL SCI, V15, P545, DOI 10.3390/ijms15010545; Coffey ET, 2014, NAT REV NEUROSCI, V15, P285, DOI 10.1038/nrn3729; Du F, 2011, GLIA, V59, P936, DOI 10.1002/glia.21166; Ferrer I, 2001, J NEURAL TRANSM, V108, P1383, DOI 10.1007/s007020100015; Ferrer I, 2001, J NEURAL TRANSM, V108, P1397, DOI 10.1007/s007020100016; Gayle DA, 2002, DEV BRAIN RES, V133, P27, DOI 10.1016/S0165-3806(01)00315-7; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; GOOSSEN B, 1990, EMBO J, V9, P4127, DOI 10.1002/j.1460-2075.1990.tb07635.x; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gozzelino R, 2012, CELL HOST MICROBE, V12, P693, DOI 10.1016/j.chom.2012.10.011; Hare DJ, 2016, BRAIN, V139, P1026, DOI 10.1093/brain/aww022; Hua Y., 2017, INT J HEMATOL, P1; Jiang H, 2010, CELL RES, V20, P345, DOI 10.1038/cr.2010.20; Jomova K, 2011, CURR PHARM DESIGN, V17, P3460, DOI 10.2174/138161211798072463; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Kannarkat GT, 2013, J PARKINSON DIS, V3, P493, DOI 10.3233/JPD-130250; Kaushal V, 2008, J NEUROSCI, V28, P2221, DOI 10.1523/JNEUROSCI.5643-07.2008; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Lee YJ, 2010, ARCH PHARM RES, V33, P1539, DOI 10.1007/s12272-010-1006-7; Lee Y, 2015, BRAIN RES, V1627, P233, DOI 10.1016/j.brainres.2015.09.029; Maria Erta AQ, 2011, INT J BIOL SCI, V8, P1254; Mogi M, 1996, NEUROSCI LETT, V211, P13, DOI 10.1016/0304-3940(96)12706-3; Nagatsu T, 2000, CHANGES CYTOKINES NE, P265; Ni W, 2015, EXP NEUROL, V272, P128, DOI 10.1016/j.expneurol.2015.02.035; Nunez MT, 2012, BIOMETALS, V25, P761, DOI 10.1007/s10534-012-9523-0; Oh ES, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.5.051207; Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048, DOI 10.1523/JNEUROSCI.20-16-06048.2000; Qin XY, 2016, JAMA NEUROLOGY, V73; Smith JA, 2012, BRAIN RES BULL, V87, P10, DOI 10.1016/j.brainresbull.2011.10.004; Song N, 2010, FREE RADICAL BIO MED, V48, P332, DOI 10.1016/j.freeradbiomed.2009.11.004; Wang G, 2012, PROG NEUROBIOL, V98, P207, DOI 10.1016/j.pneurobio.2012.06.003; Wang J, 2013, BBA-MOL BASIS DIS, V1832, P618, DOI 10.1016/j.bbadis.2013.01.021; Xiong XY, 2016, CIRCULATION, V134, P1025, DOI 10.1161/CIRCULATIONAHA.116.021881; Yao L, 2016, J CELLULAR BIOCH, V118; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhang K, 2011, NEUROPHARMACOLOGY, V61, P329, DOI 10.1016/j.neuropharm.2011.04.021; Zhang W, 2014, MOL NEUROBIOL, V49, P1153, DOI 10.1007/s12035-013-8586-4	38	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180464	10.1371/journal.pone.0180464	http://dx.doi.org/10.1371/journal.pone.0180464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672025	Green Published, Green Submitted, gold			2022-12-26	WOS:000405268500055
J	Silvander, JSG; Kvarnstrom, SM; Kumari-Ilieva, A; Shrestha, A; Alam, CM; Toivola, DM				Silvander, Jonas S. G.; Kvarnstrom, Sofie M.; Kumari-Ilieva, Angeli; Shrestha, Anup; Alam, Catharina M.; Toivola, Diana M.			Keratins regulate beta-cell mitochondrial morphology, motility, and homeostasis	FASEB JOURNAL			English	Article						TEM; insulin secretion; islets; K8-null mice; fusion	SIMPLE EPITHELIAL KERATINS; INTERMEDIATE-FILAMENTS; ENDOPLASMIC-RETICULUM; CYTOCHROME-C; MITOFUSIN 2; DYSFUNCTION; DIFFERENTIATION; CYTOKERATINS; DISRUPTION; METABOLISM	Loss of the epithelial intermediate filament protein keratin 8 (K8) in murine beta cells leads to irregular insulin vesicles and decreased insulin levels. Because mitochondria are central in glucose-stimulated insulin secretion, the relationship between keratins and beta-cell mitochondrial function and morphology was investigated. beta cells in murine K8-knockout (K8(-/-)) islets of Langerhans have increased numbers of mitochondria, which are rounder and have diffuse cristae, as seen by electron microscopy. The mitochondrial network in primary cultured K8(-/-) beta cells is more fragmented compared with K8(+/+) mitochondria, correlating with decreased levels of mitofusin 2 and the mitofusin 2- and keratin-binding protein trichoplein. K8(-/-) beta-cell mitochondria have decreased levels of total and mitochondrial cytochrome c, which correlates with a reduction in electron transport complexes I and IV. This provokes loss of mitochondrial membrane potential and reduction of ATP and insulin amount, as seen in K8(-/-) beta cells. Mitochondria in K8 wild-type cells and MIN6 insulinoma cells overexpressing K8 and 18 are more stationary compared with mitochondria in keratin-deficient cells. In conclusion, keratins, likely through trichoplein-mitofusin interactions, regulate both structural and dynamic functions of -cell mitochondria, which could have implications for downstream insulin secretion.-Silvander, J. S. G., Kvarnstrom, S. M., Kumari-Ilieva, A., Shrestha, A., Alam, C. M., Toivola, D. M. Keratins regulate beta-cell mitochondrial morphology, motility, and homeostasis.	[Silvander, Jonas S. G.; Kvarnstrom, Sofie M.; Kumari-Ilieva, Angeli; Shrestha, Anup; Alam, Catharina M.; Toivola, Diana M.] Abo Akad Univ, Fac Sci & Engn, Cell Biol, Tykistokatu 6A, FIN-20520 Turku, Finland	Abo Akademi University	Toivola, DM (corresponding author), Abo Akad Univ, Fac Sci & Engn, Cell Biol, Tykistokatu 6A, FIN-20520 Turku, Finland.	dtoivola@abo.fi		Toivola, Diana M./0000-0001-7165-9839	Swedish Cultural Foundation and Doctoral Network in Molecular Biosciences at AAU; Novo Nordisk Foundation; Finnish Diabetes Research Foundation; Diabetes Wellness; Sigrid Juselius Foundation; Academy of Finland; Novo Nordisk Fonden [NNF15OC0016524, NNF16OC0021344] Funding Source: researchfish	Swedish Cultural Foundation and Doctoral Network in Molecular Biosciences at AAU; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Finnish Diabetes Research Foundation; Diabetes Wellness; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors thank Helena Saarento, Terhi Helenius, Aruna Ghimire, Carl-Gustaf Stenvall [Abo Akademi University (AAU)], and the personnel at the Cell Imaging Core (Turku Centre for Biotechnology) and the Central Animal Laboratory (University of Turku, UTU) for skillful technical assistance; the D.M.T. laboratory members for joint maintenance of the mouse colony; and Helen Cooper, John Eriksson (AAU), Rudolf Leube [Rheinisch-Westfalische Technische Hochschule (RWTH) Aachen University, Aachen, Germany), M. Bishr Omary (University of Michigan, Ann Arbor, MI, USA), and Kid Tornqvist (AAU) for providing reagents and for fruitful discussions. This work was funded by the Swedish Cultural Foundation and Doctoral Network in Molecular Biosciences at AAU (to J.S.G.S.) and The Novo Nordisk Foundation, The Finnish Diabetes Research Foundation, Diabetes Wellness, The Sigrid Juselius Foundation, and The Academy of Finland (to D.M.T.). The authors declare no conflicts of interest.	Ahmed M, 2005, DIABETOLOGIA, V48, P477, DOI 10.1007/s00125-004-1661-7; Alam CM, 2013, J CELL SCI, V126, P5635, DOI 10.1242/jcs.132795; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964; BLESSING M, 1993, J CELL BIOL, V120, P743, DOI 10.1083/jcb.120.3.743; Bouwens L, 1998, J PATHOL, V184, P234; Cerqua C, 2010, EMBO REP, V11, P854, DOI 10.1038/embor.2010.151; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chernoivanenko IS, 2015, FASEB J, V29, P820, DOI 10.1096/fj.14-259903; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Gentil BJ, 2012, FASEB J, V26, P1194, DOI 10.1096/fj.11-196345; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Hoppins S, 2014, CURR OPIN CELL BIOL, V29, P46, DOI 10.1016/j.ceb.2014.03.005; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Ku NO, 2004, METHOD CELL BIOL, V78, P489; Kumemura H, 2008, BIOCHEM BIOPH RES CO, V367, P33, DOI 10.1016/j.bbrc.2007.12.116; Lahdeniemi IA, 2017, CELL DEATH DIFFER, V24, P984, DOI 10.1038/cdd.2017.28; Liew CW, 2010, J CLIN INVEST, V120, P2876, DOI 10.1172/JCI36849; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103; Maechler P, 2013, MOL CELL ENDOCRINOL, V379, P12, DOI 10.1016/j.mce.2013.06.019; Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315; Mourier A, 2015, J CELL BIOL, V208, P429, DOI 10.1083/jcb.201411100; Nekrasova OE, 2011, MOL BIOL CELL, V22, P2282, DOI 10.1091/mbc.E10-09-0766; Nishizawa M, 2005, J CELL SCI, V118, P1081, DOI 10.1242/jcs.01667; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Oriolo AS, 2007, EXP CELL RES, V313, P2255, DOI 10.1016/j.yexcr.2007.02.030; Overly CC, 1996, J CELL SCI, V109, P971; Pan XO, 2013, CURR OPIN CELL BIOL, V25, P47, DOI 10.1016/j.ceb.2012.10.018; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Schwarz N, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5030030; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sheng ZH, 2014, J CELL BIOL, V204, P1087, DOI 10.1083/jcb.201312123; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; StoneO MR, 2007, J CELL SCI, V120, P3999, DOI 10.1242/jcs.009241; Supale S, 2012, TRENDS ENDOCRIN MET, V23, P477, DOI 10.1016/j.tem.2012.06.002; Tao GZ, 2009, J CELL SCI, V122, P3851, DOI 10.1242/jcs.051862; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Toivola DM, 2015, CURR OPIN CELL BIOL, V32, P73, DOI 10.1016/j.ceb.2014.12.008; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Vecchione A, 2009, ONCOGENE, V28, P257, DOI 10.1038/onc.2008.381; Vempati UD, 2009, J BIOL CHEM, V284, P4383, DOI 10.1074/jbc.M805972200; Winter L, 2008, J CELL BIOL, V181, P903, DOI 10.1083/jcb.200710151; Zmuda EJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2096	51	10	10	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4578	4587		10.1096/fj.201700095R	http://dx.doi.org/10.1096/fj.201700095R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28666985				2022-12-26	WOS:000413397400033
J	Han, GS; Carman, GM				Han, Gil-Soo; Carman, George M.			Yeast PAH1-encoded phosphatidate phosphatase controls the expression of CHO1-encoded phosphatidylserine synthase for membrane phospholipid synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE-GEL-ELECTROPHORESIS; PATCH PROTEIN APP1P; SACCHAROMYCES-CEREVISIAE; LIPID-SYNTHESIS; COORDINATE REGULATION; PHOSPHATIDYLINOSITOL SYNTHASE; DIACYLGLYCEROL KINASE; MEDIATED REGULATION; ESCHERICHIA-COLI; ORTHOLOGUE PAH1P	The PAH1-encoded phosphatidate phosphatase (PAP), which catalyzes the committed step for the synthesis of triacylglycerol in Saccharomyces cerevisiae, exerts a negative regulatory effect on the level of phosphatidate used for the de novo synthesis of membrane phospholipids. This raises the question whether PAP thereby affects the expression and activity of enzymes involved in phospholipid synthesis. Here, we examined the PAP-mediated regulation of CHO1-encoded phosphatidylserine synthase (PSS), which catalyzes the committed step for the synthesis of major phospholipids via the CDP-diacylglycerol pathway. The lack of PAP in the pah1 Delta mutant highly elevated PSS activity, exhibiting a growth-dependent up-regulation from the exponential to the stationary phase of growth. Immunoblot analysis showed that the elevation of PSS activity results from an increase in the level of the enzyme encoded by CHO1. Truncation analysis and site-directed mutagenesis of the CHO1 promoter indicated that Cho1 expression in the pah1 Delta mutant is induced through the inositol-sensitive upstream activation sequence (UAS(INO)), a cis-acting element for the phosphatidate-controlled Henry (Ino2-Ino4/Opi1) regulatory circuit. The abrogation of Cho1 induction and PSS activity by a CHO1 UAS(INO) mutation suppressed pah1 Delta effects on lipid synthesis, nuclear/endoplasmic reticulum membrane morphology, and lipid droplet formation, but not on growth at elevated temperature. Loss of the DGK1-encoded diacylglycerol kinase, which converts diacylglycerol to phosphatidate, partially suppressed the pah1 Delta-mediated induction of Cho1 and PSS activity. Collectively, these data showed that PAP activity controls the expression of PSS for membrane phospholipid synthesis.	Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Dept Food Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 61 Dudley Rd, Brunswick, NJ 08901 USA.	gcarman@rutgers.edu			National Institutes of Health [GM028140]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140, R01GM028140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM028140. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Anderson MS, 1996, J BIOL CHEM, V271, P26596, DOI 10.1074/jbc.271.43.26596; ATKINSON K, 1980, J BIOL CHEM, V255, P6653; ATKINSON KD, 1980, J BACTERIOL, V141, P558, DOI 10.1128/JB.141.2.558-564.1980; BAELEE M, 1990, J BIOL CHEM, V265, P7221; BAELEE MS, 1984, J BIOL CHEM, V259, P857; BAILIS AM, 1992, NUCLEIC ACIDS RES, V20, P1411, DOI 10.1093/nar/20.6.1411; BAILIS AM, 1987, MOL CELL BIOL, V7, P167, DOI 10.1128/MCB.7.1.167; Barbosa AD, 2015, MOL BIOL CELL, V26, P3641, DOI 10.1091/mbc.E15-03-0173; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; CARMAN GM, 1992, METHOD ENZYMOL, V209, P298; CARMAN GM, 1981, CAN J MICROBIOL, V27, P1140, DOI 10.1139/m81-179; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Chae M, 2013, J BIOL CHEM, V288, P6427, DOI 10.1074/jbc.M112.449629; Chae M, 2012, J BIOL CHEM, V287, P40186, DOI 10.1074/jbc.M112.421776; Chang YF, 2008, PROG LIPID RES, V47, P333, DOI 10.1016/j.plipres.2008.03.004; Choi HS, 2004, J BIOL CHEM, V279, P12081, DOI 10.1074/jbc.M400297200; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Choi HS, 2010, J BIOL CHEM, V285, P11526, DOI 10.1074/jbc.M110.100727; Dey P, 2017, J LIPID RES, V58, P742, DOI 10.1194/jlr.M075036; DONAHUE TF, 1981, J BIOL CHEM, V256, P7077; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Fei WH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002201; Greenberg ML, 1996, MICROBIOL REV, V60, P1; GUENGERICH FP, 1982, BIOCHEMISTRY-US, V21, P1698, DOI 10.1021/bi00536a035; Habeler G, 2002, NUCLEIC ACIDS RES, V30, P80, DOI 10.1093/nar/30.1.80; HAID A, 1983, METHOD ENZYMOL, V96, P192; HAMAMATSU S, 1994, FEBS LETT, V348, P33, DOI 10.1016/0014-5793(94)00576-1; Han GS, 2008, J BIOL CHEM, V283, P20443, DOI 10.1074/jbc.M802866200; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hassaninasab A, 2017, ANAL BIOCHEM, V526, P69, DOI 10.1016/j.ab.2017.03.020; HASSLACHER M, 1993, J BIOL CHEM, V268, P10946; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; HOMANN MJ, 1987, J BACTERIOL, V169, P533, DOI 10.1128/jb.169.2.533-539.1987; HOMANN MJ, 1987, J BACTERIOL, V169, P3276, DOI 10.1128/jb.169.7.3276-3280.1987; HOSAKA K, 1990, J BACTERIOL, V172, P2005, DOI 10.1128/jb.172.4.2005-2012.1990; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; Iwanyshyn WM, 2004, J BIOL CHEM, V279, P21976, DOI 10.1074/jbc.M402047200; Karanasios E, 2013, MOL BIOL CELL, V24, P2124, DOI 10.1091/mbc.E13-01-0021; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; Kersting MC, 2004, J BIOL CHEM, V279, P35353, DOI 10.1074/jbc.M405704200; KINNEY AJ, 1988, P NATL ACAD SCI USA, V85, P7962, DOI 10.1073/pnas.85.21.7962; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPING E, 1994, GENETICS, V137, P55; LARSON TJ, 1976, BIOCHEMISTRY-US, V15, P5212, DOI 10.1021/bi00669a003; LEE KS, 1993, MOL CELL BIOL, V13, P3067, DOI 10.1128/MCB.13.5.3067; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Lussier M, 1997, GENETICS, V147, P435; MCMASTER CR, 1994, J BIOL CHEM, V269, P14776; Miner GE, 2017, TRAFFIC, V18, P315, DOI 10.1111/tra.12479; MORASH SC, 1994, J BIOL CHEM, V269, P28769; Morita S, 2009, J LIPID RES, V50, P1945, DOI 10.1194/jlr.D900014-JLR200; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; Nakamura H, 2000, BIOSCI BIOTECH BIOCH, V64, P167, DOI 10.1271/bbb.64.167; Natter K, 2005, MOL CELL PROTEOMICS, V4, P662, DOI 10.1074/mcp.M400123-MCP200; Nomura W, 2017, CELL SIGNAL, V31, P146, DOI 10.1016/j.cellsig.2017.01.002; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; Park Y, 2015, J BIOL CHEM, V290, P25382, DOI 10.1074/jbc.M115.680314; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; POOLE MA, 1986, J BACTERIOL, V168, P668, DOI 10.1128/jb.168.2.668-672.1986; Rose MD., 1990, METHODS YEAST GENETI; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Ruiz C, 1999, YEAST, V15, P1001; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; SCHULLER HJ, 1992, EMBO J, V11, P107, DOI 10.1002/j.1460-2075.1992.tb05033.x; SIKORSKI RS, 1989, GENETICS, V122, P19; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; Sun YD, 2012, J CELL SCI, V125, P6157, DOI 10.1242/jcs.115741; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; Vance JE, 1998, TRENDS BIOCHEM SCI, V23, P423, DOI 10.1016/S0968-0004(98)01297-3; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f	93	25	27	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13230	13242		10.1074/jbc.M117.801720	http://dx.doi.org/10.1074/jbc.M117.801720			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28673963	Green Published, hybrid			2022-12-26	WOS:000407465300013
J	Dembia, CL; Silder, A; Uchida, TK; Hicks, JL; Delp, SL				Dembia, Christopher L.; Silder, Amy; Uchida, Thomas K.; Hicks, Jennifer L.; Delp, Scott L.			Simulating ideal assistive devices to reduce the metabolic cost of walking with heavy loads	PLOS ONE			English	Article							MUSCLE-TENDON MECHANICS; ENERGY-COST; ENERGETICS; EXOSKELETON; CARRIAGE; HIP; ASSISTANCE; BIOMECHANICS; MODELS; MASS	Wearable robotic devices can restore and enhance mobility. There is growing interest in designing devices that reduce the metabolic cost of walking; however, designers lack guidelines for which joints to assist and when to provide the assistance. To help address this problem, we used musculoskeletal simulation to predict how hypothetical devices affect muscle activity and metabolic cost when walking with heavy loads. We explored 7 massless devices, each providing unrestricted torque at one degree of freedom in one direction (hip abduction, hip flexion, hip extension, knee flexion, knee extension, ankle plantarflexion, or ankle dorsiflexion). We used the Computed Muscle Control algorithm in OpenSim to find device torque profiles that minimized the sum of squared muscle activations while tracking measured kinematics of loaded walking without assistance. We then examined the metabolic savings provided by each device, the corresponding device torque profiles, and the resulting changes in muscle activity. We found that the hip flexion, knee flexion, and hip abduction devices provided greater metabolic savings than the ankle plantarflexion device. The hip abduction device had the greatest ratio of metabolic savings to peak instantaneous positive device power, suggesting that frontal-plane hip assistance may be an efficient way to reduce metabolic cost. Overall, the device torque profiles generally differed from the corresponding net joint moment generated by muscles without assistance, and occasionally exceeded the net joint moment to reduce muscle activity at other degrees of freedom. Many devices affected the activity of muscles elsewhere in the limb; for example, the hip flexion device affected muscles that span the ankle joint. Our results may help experimentalists decide which joint motions to target when building devices and can provide intuition for how devices may interact with the musculoskeletal system. The simulations are freely available online, allowing others to reproduce and extend our work.	[Dembia, Christopher L.; Delp, Scott L.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Silder, Amy; Uchida, Thomas K.; Hicks, Jennifer L.; Delp, Scott L.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Delp, Scott L.] Stanford Univ, Dept Orthopaed Surg, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Dembia, CL (corresponding author), Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.	dembia@stanford.edu		Uchida, Thomas/0000-0002-7700-7476; Delp, Scott/0000-0002-9643-7551; Hicks, Jennifer/0000-0002-2516-9334	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD065690] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Afschrift M, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-111; Alexander RM, 2005, J EXP BIOL, V208, P1645, DOI 10.1242/jeb.01484; Arch ES, 2016, PROSTHET ORTHOT INT, V40, P606, DOI 10.1177/0309364615592693; Au SK, 2008, IEEE ROBOT AUTOM MAG, V15, P52, DOI 10.1109/MRA.2008.927697; BARATTA R, 1988, AM J SPORT MED, V16, P113, DOI 10.1177/036354658801600205; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bretz F., 2011, MULTIPLE COMPARISONS; Browning RC, 2007, MED SCI SPORT EXER, V39, P515, DOI 10.1249/mss.0b013e31802b3562; Collins SH, 2015, NATURE, V522, P212, DOI 10.1038/nature14288; Ding Y, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0196-8; Dollar AM, 2008, IEEE T ROBOT, V24, P144, DOI 10.1109/TRO.2008.915453; Dorn TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121407; Farris DJ, 2014, J EXP BIOL, V217, P4018, DOI 10.1242/jeb.107656; Farris DJ, 2012, J R SOC INTERFACE, V9, P110, DOI 10.1098/rsif.2011.0182; Ferris DP, 2007, INT J HUM ROBOT, V4, P507, DOI 10.1142/S0219843607001138; Ferris DP, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-17; Galle S, 2015, GAIT POSTURE, V41, P246, DOI 10.1016/j.gaitpost.2014.10.015; Galle S, 2013, GAIT POSTURE, V38, P495, DOI 10.1016/j.gaitpost.2013.01.029; Gordon KE, 2007, J BIOMECH, V40, P2636, DOI 10.1016/j.jbiomech.2006.12.006; Gregorczyk KN, 2010, ERGONOMICS, V53, P1263, DOI 10.1080/00140139.2010.512982; Handford ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep19983; Handsfield GG, 2014, J BIOMECH, V47, P631, DOI 10.1016/j.jbiomech.2013.12.002; Hicks JL, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029304; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Huang TWP, 2014, J EXP BIOL, V217, P605, DOI 10.1242/jeb.091587; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jackson RW, 2017, J EXP BIOL, V220, P2082, DOI 10.1242/jeb.150011; Jackson RW, 2015, J APPL PHYSIOL, V119, P541, DOI 10.1152/japplphysiol.01133.2014; Kao PC, 2010, J BIOMECH, V43, P203, DOI 10.1016/j.jbiomech.2009.09.030; Knapik JJ, 2004, MIL MED, V169, P45, DOI 10.7205/MILMED.169.1.45; Koller JR, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0086-5; Lenzi T, 2013, IEEE T NEUR SYS REH, V21, P938, DOI 10.1109/TNSRE.2013.2248749; Lewis CL, 2011, J BIOMECH, V44, P789, DOI 10.1016/j.jbiomech.2011.01.030; Lusk G, 1924, J BIOL CHEM, V59, P41; Malcolm P, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0014-8; Malcolm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056137; Markowitz J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004912; Millard M, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023390; Miller RH, 2014, J BIOMECH, V47, P1373, DOI 10.1016/j.jbiomech.2014.01.049; Mooney LM, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0111-3; Mooney LM, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-151; Mooney LM, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-80; NEUMANN DA, 1994, J ORTHOP SPORT PHYS, V19, P296, DOI 10.2519/jospt.1994.19.5.296; NEWHAM DJ, 1983, CLIN SCI, V64, P55, DOI 10.1042/cs0640055; Panizzolo FA, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0150-9; Quinlivan BT, 2017, SCI ROBOT, V2, DOI 10.1126/scirobotics.aah4416; Rajagopal A, 2016, IEEE T BIO-MED ENG, V63, P2068, DOI 10.1109/TBME.2016.2586891; RCore Team, 2020, R LANG ENV STAT COMP; Riener R, 2010, J HEALTHC ENG, V1, P197, DOI 10.1260/2040-2295.1.2.197; Ruby BC, 2003, INT J WILDLAND FIRE, V12, P111, DOI 10.1071/WF02025; Samuels ML, 1999, STATISTICS FOR THE L; Sawicki GS, 2008, J EXP BIOL, V211, P1402, DOI 10.1242/jeb.009241; Sawicki GS, 2016, IEEE T BIO-MED ENG, V63, P914, DOI 10.1109/TBME.2015.2491224; Selinger JC, 2016, IEEE T NEUR SYS REH, V24, P364, DOI 10.1109/TNSRE.2015.2510546; Selinger JC, 2015, CURR BIOL, V25, P2452, DOI 10.1016/j.cub.2015.08.016; Seo K, 2016, IEEE INT CONF ROBOT, P4628, DOI 10.1109/ICRA.2016.7487663; Silder A, 2013, J BIOMECH, V46, P2522, DOI 10.1016/j.jbiomech.2013.06.020; Slider A, 2012, J BIOMECH, V45, P1842, DOI 10.1016/j.jbiomech.2012.03.032; Steele KM, 2012, J BIOMECH, V45, P2564, DOI 10.1016/j.jbiomech.2012.07.028; Strickland E, 2012, IEEE SPECTRUM, V49, P30, DOI 10.1109/MSPEC.2012.6117830; Thelen DG, 2003, J BIOMECH, V36, P321, DOI 10.1016/S0021-9290(02)00432-3; Uchida TK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163417; Uchida TK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150378; Umberger Brian R., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P99, DOI 10.1080/1025584031000091678; Umberger BR, 2010, J R SOC INTERFACE, V7, P1329, DOI 10.1098/rsif.2010.0084; van Vuuren BJ, 2005, AM J IND MED, V47, P451, DOI 10.1002/ajim.20164; WINTER DA, 1983, CLIN ORTHOP RELAT R, P147; Yagn N., 1890, US Patents, Patent No. 440684	69	63	64	7	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180320	10.1371/journal.pone.0180320	http://dx.doi.org/10.1371/journal.pone.0180320			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700630	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649600026
J	Garabedian, C; Champion, C; Servan-Schreiber, E; Butruille, L; Aubry, E; Sharma, D; Logier, R; Deruelle, P; Storme, L; Houfflin-Debarge, V; De Jonckheere, J				Garabedian, C.; Champion, C.; Servan-Schreiber, E.; Butruille, L.; Aubry, E.; Sharma, D.; Logier, R.; Deruelle, P.; Storme, L.; Houfflin-Debarge, V.; De Jonckheere, J.			A new analysis of heart rate variability in the assessment of fetal parasympathetic activity: An experimental study in a fetal sheep model	PLOS ONE			English	Article							SPECTRAL-ANALYSIS	Analysis of heart rate variability (HRV) is a recognized tool in the assessment of autonomic nervous system (ANS) activity. Indeed, both time and spectral analysis techniques enable us to obtain indexes that are related to the way the ANS regulates the heart rate. However, these techniques are limited in terms of the lack of thresholds of the numerical indexes, which is primarily due to high inter-subject variability. We proposed a new fetal HRV analysis method related to the parasympathetic activity of the ANS. The aim of this study was to evaluate the performance of our method compared to commonly used HRV analysis, with regard to i) the ability to detect changes in ANS activity and ii) inter-subject variability. This study was performed in seven sheep fetuses. In order to evaluate the sensitivity and specificity of our index in evaluating parasympathetic activity, we directly administered 2.5 mg intravenous atropine, to inhibit parasympathetic tone, and 5 mg propranolol to block sympathetic activity. Our index, as well as time analysis (root mean square of the successive differences; RMSSD) and spectral analysis (high frequency (HF) and low frequency (LF) spectral components obtained via fast Fourier transform), were measured before and after injection. Inter-subject variability was estimated by the coefficient of variance (% CV). In order to evaluate the ability of HRV parameters to detect fetal parasympathetic decrease, we also estimated the effect size for each HRV parameter before and after injections. As expected, our index, the HF spectral component, and the RMSSD were reduced after the atropine injection. Moreover, our index presented a higher effect size. The % CV was far lower for our index than for RMSSD, HF, and LF. Although LF decreased after propranolol administration, fetal stress index, RMSSD, and HF were not significantly different, confirming the fact that those indexes are specific to the parasympathetic nervous system. In conclusion, our method appeared to be effective in detecting parasympathetic inhibition. Moreover, inter-subject variability was much lower, and effect size higher, with our method compared to other HRV analysis methods.	[Garabedian, C.; Champion, C.; Servan-Schreiber, E.; Butruille, L.; Aubry, E.; Sharma, D.; Deruelle, P.; Storme, L.; Houfflin-Debarge, V.; De Jonckheere, J.] Univ Lille, EA Perinatal Environm & Hlth 4489, Lille, France; [Garabedian, C.; Servan-Schreiber, E.; Deruelle, P.; Houfflin-Debarge, V.] CHU Lille, Dept Obstet, Lille, France; [Champion, C.; Aubry, E.; Sharma, D.] CHU Lille, Dept Pediat Surg, Lille, France; [Logier, R.; De Jonckheere, J.] CHU Lille, CIC IT 1403, MRRC, Lille, France; [Storme, L.] CHU Lille, Dept Neonatol, Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille	Garabedian, C (corresponding author), Univ Lille, EA Perinatal Environm & Hlth 4489, Lille, France.; Garabedian, C (corresponding author), CHU Lille, Dept Obstet, Lille, France.	charles.garabedian@chru-lille.fr		Garabedian, Charles/0000-0003-2105-9784; BUTRUILLE, Laura/0000-0001-5760-1489				Akselrod S, 2000, PHYSIOL MEAS, V21, P319, DOI 10.1088/0967-3334/21/2/311; Aubry E, 2013, J PEDIATR SURG, V48, P481, DOI 10.1016/j.jpedsurg.2012.08.024; Camm AJ, 1996, EUR HEART J, V17, P354; Chung DY, 2001, INT J GYNECOL OBSTET, V73, P109, DOI 10.1016/S0020-7292(01)00348-4; De Jonckheere J, 2005, P ANN INT IEEE EMBS, P6739, DOI 10.1109/IEMBS.2005.1616051; Frasch MG, 2009, REPROD SCI, V16, P509, DOI 10.1177/1933719108327597; Frasch MG, 2009, AM J PHYSIOL-REG I, V296, pR702, DOI 10.1152/ajpregu.90474.2008; Houfflin-Debarge V, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.049; Jeanne M, 2009, IEEE ENG MED BIO, P1840, DOI 10.1109/IEMBS.2009.5332598; Logier R, 2004, P ANN INT IEEE EMBS, V26, P3937; Siira SM, 2013, EARLY HUM DEV, V89, P739, DOI 10.1016/j.earlhumdev.2013.05.007; Siira SM, 2005, BJOG-INT J OBSTET GY, V112, P418, DOI 10.1111/j.1471-0528.2004.00454.x; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Ugwumadu A, 2013, BEST PRACT RES CL OB, V27, P509, DOI 10.1016/j.bpobgyn.2013.04.002; Van Laar JOEH, 2008, ACTA OBSTET GYN SCAN, V87, P300, DOI 10.1080/00016340801898950; van Laar JOEH, 2010, BJOG-INT J OBSTET GY, V117, P429, DOI 10.1111/j.1471-0528.2009.02456.x	16	21	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180653	10.1371/journal.pone.0180653	http://dx.doi.org/10.1371/journal.pone.0180653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700617	Green Published, gold, Green Submitted			2022-12-26	WOS:000405544800063
J	Ackerman, JE; Geary, MB; Orner, CA; Bawany, F; Loiselle, AE				Ackerman, Jessica E.; Geary, Michael B.; Orner, Caitlin A.; Bawany, Fatima; Loiselle, Alayna E.			Obesity/Type II diabetes alters macrophage polarization resulting in a fibrotic tendon healing response	PLOS ONE			English	Article							INJURY; ACTIVATION; ADHESIONS; REPAIR; TISSUE; STAGE	Type II Diabetes (T2DM) dramatically impairs the tendon healing response, resulting in decreased collagen organization and mechanics relative to non-diabetic tendons. Despite this burden, there remains a paucity of information regarding the mechanisms that govern impaired healing of diabetic tendons. Mice were placed on either a high fat diet (T2DM) or low fat diet (lean) and underwent flexor tendon transection and repair surgery. Healing was assessed via mechanical testing, histology and changes in gene expression associated with collagen synthesis, matrix remodeling, and macrophage polarization. Obese/diabetic tendons healed with increased scar formation and impaired mechanical properties. Consistent with this, prolonged and excess expression of extracellular matrix (ECM) components were observed in obese/T2DM tendons. Macrophages are involved in both inflammatory and matrix deposition processes during healing. Obese/T2DM tendons healed with increased expression of markers of pro- inflammatory M1 macrophages, and elevated and prolonged expression of M2 macrophages markers that are involved in ECM deposition. Here we demonstrate that tendons from obese/diabetic mice heal with increased scar formation and increased M2 polarization, identifying excess M2 macrophage activity and matrix synthesis as a potential mechanism of the fibrotic healing phenotype observed in T2DM tendons, and as such a potential target to improve tendon healing in T2DM.	[Ackerman, Jessica E.; Geary, Michael B.; Orner, Caitlin A.; Bawany, Fatima; Loiselle, Alayna E.] Univ Rochester, Med Ctr, Dept Orthopaed & Rehabil, Ctr Musculoskeletal Res, Rochester, NY 14642 USA	University of Rochester	Loiselle, AE (corresponding author), Univ Rochester, Med Ctr, Dept Orthopaed & Rehabil, Ctr Musculoskeletal Res, Rochester, NY 14642 USA.	Alayna_Loiselle@urmc.rochester.edu		Loiselle, Alayna/0000-0002-7548-6653	NIAMS/NIH [K01AR068386, P30 AR061307]; University of Rochester CTSA from the National Center for Advancing Translational Sciences of the National Institutes of Health [TL1 TR000096]; University of Rochester School of Medicine Office for Medical Education Year-out Research Fellowship;  [R01 AR056696];  [P30 AR069655]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR069655, K01AR068386, P30AR061307] Funding Source: NIH RePORTER	NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Rochester CTSA from the National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); University of Rochester School of Medicine Office for Medical Education Year-out Research Fellowship; ; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIAMS/NIH grants K01AR068386 and P30 AR061307 Pilot (to AEL), as well as R01 AR056696, and P30 AR069655. MBG was supported by the University of Rochester CTSA award number TL1 TR000096 from the National Center for Advancing Translational Sciences of the National Institutes of Health. CAO was supported by the University of Rochester School of Medicine Office for Medical Education Year-out Research Fellowship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate M, 2013, RHEUMATOLOGY, V52, P599, DOI 10.1093/rheumatology/kes395; Abdgawad M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032439, 10.1371/journal.pone.0046057]; Ackerman JE, 2016, JOVE-J VIS EXP, DOI 10.3791/54433; Ahmed AS, 2014, CELL TISSUE RES, V357, P109, DOI 10.1007/s00441-014-1871-3; Ahmed AS, 2012, J APPL PHYSIOL, V113, P1784, DOI 10.1152/japplphysiol.00767.2012; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Aydin Atakan, 2004, Acta Orthop Traumatol Turc, V38, P54; Ban CR, 2008, VASC HEALTH RISK MAN, V4, P575; Bedi A, 2010, J SHOULDER ELB SURG, V19, P978, DOI 10.1016/j.jse.2009.11.045; Bellon T, 2011, NEPHROL DIAL TRANSPL, V26, P2995, DOI 10.1093/ndt/gfq771; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Connizzo BK, 2014, ANN BIOMED ENG, V42, P1880, DOI 10.1007/s10439-014-1031-7; David MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091234; Derosa G, 2008, ENDOTHELIUM-J ENDOTH, V15, P219, DOI 10.1080/10623320802228815; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Dong L, 2008, J ASTHMA, V45, P648, DOI 10.1080/02770900802126941; Fitzgibbons PG, 2008, J HAND SURG-AM, V33A, P771, DOI 10.1016/j.jhsa.2008.01.038; Geary MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136351; Glasner MF, 2017, BIORXIV; Hasslund S, 2008, J ORTHOP RES, V26, P824, DOI 10.1002/jor.20531; Kang L, 2011, DIABETES, V60, P416, DOI 10.2337/db10-1116; Lin TW, 2004, J BIOMECH, V37, P865, DOI 10.1016/j.jbiomech.2003.11.005; Liu T., 2014, COMP MATH MATH PHYS, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0088362; Locati M, 2013, ADV IMMUNOL, V120, P163, DOI 10.1016/B978-0-12-417028-5.00006-5; Loiselle AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040602; Loiselle AE, 2009, J ORTHOP RES, V27, P833, DOI 10.1002/jor.20769; Marsolais D, 2001, J ORTHOPAED RES, V19, P1203, DOI 10.1016/S0736-0266(01)00031-6; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Moreira AP, 2011, J INTERF CYTOK RES, V31, P485, DOI 10.1089/jir.2011.0027; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Novak ML, 2013, AM J PATHOL, V183, P1352, DOI 10.1016/j.ajpath.2013.06.034; Prevention CfDCa, 2014, NAT DIAB STAT REP; Romanic AM, 2001, AM J PHYSIOL-RENAL, V281, pF309, DOI 10.1152/ajprenal.2001.281.2.F309; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Shen H, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0406-0; Strickland JW, 2000, J HAND SURG-AM, V25A, P214; Sugg KB, 2014, J ORTHOP RES, V32, P944, DOI 10.1002/jor.22624; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	39	31	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0181127	10.1371/journal.pone.0181127	http://dx.doi.org/10.1371/journal.pone.0181127			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686669	Green Published, Green Submitted, gold			2022-12-26	WOS:000405464100134
J	Hennenberg, EM; Eyking, A; Reis, H; Cario, E				Hennenberg, Eva Maria; Eyking, Annette; Reis, Henning; Cario, Elke			MDR1A deficiency restrains tumor growth in murine colitis-associated carcinogenesis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; PLATELET-ACTIVATING-FACTOR; P-GLYCOPROTEIN EXPRESSION; COLORECTAL-CANCER RISK; ULCERATIVE-COLITIS; INTESTINAL INFLAMMATION; NEOPLASTIC PROGRESSION; MULTIDRUG TRANSPORTER; GENE POLYMORPHISM; RESISTANCE GENE	Patients with Ulcerative Colitis (UC) have an increased risk to develop colitis-associated colorectal cancer (CAC). Here, we found that protein expression of ABCB1 (ATP Binding Cassette Subfamily B Member 1) /MDR1 (multidrug resistance 1) was diminished in the intestinal mucosa of patients with active UC with or without CAC, but not in non-UC patients with sporadic colon cancer. We investigated the consequences of ABCB1/MDR1 loss-offunction in a common murine model for CAC (AOM/DSS). Mice deficient in MDR1A (MDR1A KO) showed enhanced intratumoral inflammation and cellular damage, which were associated with reduced colonic tumor size and decreased degree of dysplasia, when compared to wild-type (WT). Increased cell injury correlated with reduced capacity for growth of MDR1A KO tumor spheroids cultured ex-vivo. Gene expression analysis by microarray demonstrated that MDR1A deficiency shaped the inflammatory response towards an anti-tumorigenic microenvironment by downregulating genes known to be important mediators of cancer progression (PTGS2 (COX2), EREG, IL-11). MDR1A KO tumors showed increased gene expression of TNFSF10 (TRAIL), a known inducer of cancer cell death, and CCL12, a strong trigger of B cell chemotaxis. Abundant B220+ B lymphocyte infiltrates with interspersed CD138+ plasma cells were recruited to the MDR1A KO tumor microenvironment, concomitant with high levels of immunoglobulin light chain genes. In contrast, MDR1A deficiency in RAG2 KO mice that lack both B and T cells aggravated colonic tumor progression. MDR1A KO CD19+ B cells, but not WT CD19+ B cells, suppressed growth of colonic tumor-derived spheroids from AOM/DSS-WT mice in an ex-vivo co-culture system, implying that B-cell regulated immune responses contributed to delayed tumor development in MDR1A deficiency. In conclusion, we provide first evidence that loss of ABCB1/MDR1 function may represent an essential tumor-suppressive host defense mechanism in CAC.	[Hennenberg, Eva Maria; Eyking, Annette; Cario, Elke] Univ Hosp Essen, Dept Gastroenterol & Hepatol, Expt Gastroenterol, Essen, Germany; [Hennenberg, Eva Maria; Eyking, Annette; Reis, Henning; Cario, Elke] Univ Duisburg Essen, Med Sch, Essen, Germany; [Reis, Henning] Univ Hosp Essen, Inst Pathol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Cario, E (corresponding author), Univ Hosp Essen, Dept Gastroenterol & Hepatol, Expt Gastroenterol, Essen, Germany.; Cario, E (corresponding author), Univ Duisburg Essen, Med Sch, Essen, Germany.	elke.cario@uni-due.de	Reis, Henning/AAX-9545-2020	Reis, Henning/0000-0003-1373-5295	Deutsche Forschungsgemeinschaft [CA226/4-3]; Interne Forschungsforderung Essen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interne Forschungsforderung Essen	This study was supported by the Deutsche Forschungsgemeinschaft (Grant CA226/4-3 to E.C.) and intramural funding (Interne Forschungsforderung Essen to E.C.). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Andersen V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072119; Andersen V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-407; Aponte M, 2008, CANCER RES, V68, P5839, DOI 10.1158/0008-5472.CAN-07-5771; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Balcerczak E, 2010, INT J COLORECTAL DIS, V25, P1167, DOI 10.1007/s00384-010-0961-2; Belliard AM, 2004, J PHARM SCI-US, V93, P1524, DOI 10.1002/jps.20072; Bosman FT, 2010, WHO CLASSIFICATION T, DOI [10.4049/jimmunol.1402481, DOI 10.4049/jimmunol.1402481]; Brandl K, 2010, P NATL ACAD SCI USA, V107, P19967, DOI 10.1073/pnas.1014669107; Brandtzaeg P, 2006, ADV EXP MED BIOL, V579, P149; BRENTNALL TA, 1994, GASTROENTEROLOGY, V107, P369, DOI 10.1016/0016-5085(94)90161-9; Bushey RT, 2016, CELL REP, V15, P1505, DOI 10.1016/j.celrep.2016.04.038; Campa D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032784; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Cario E, 2017, WORLD J GASTROENTERO, V23, P1513, DOI 10.3748/wjg.v23.i9.1513; Cario E, 2013, CURR OPIN GASTROEN, V29, P85, DOI 10.1097/MOG.0b013e32835a670e; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chen JQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085161, 10.1371/journal.pone.0101277]; CHIN KV, 1992, SCIENCE, V255, P459, DOI 10.1126/science.1346476; Cleynen I, 2014, GUT, V63, P1265, DOI 10.1136/gutjnl-2012-303205; Cupi ML, 2014, J IMMUNOL, V192, P6083, DOI 10.4049/jimmunol.1302238; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Ernest S, 1999, J AM SOC NEPHROL, V10, P2306; Ey B, 2013, J IMMUNOL, V190, P5676, DOI 10.4049/jimmunol.1201592; Ey B, 2009, J BIOL CHEM, V284, P22332, DOI 10.1074/jbc.M901619200; Eyking A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156871; Eyking A, 2011, GASTROENTEROLOGY, V141, P2154, DOI 10.1053/j.gastro.2011.08.043; Fernandez C, 2004, J PHARM PHARM SCI, V7, P359; Fooksman DR, 2010, IMMUNITY, V33, P118, DOI 10.1016/j.immuni.2010.06.015; Frank M, 2015, J IMMUNOL, V194, P1983, DOI 10.4049/jimmunol.1402481; Georgopoulos NT, 2014, J CELL SCI, V127, P2967, DOI 10.1242/jcs.150888; Gutmann H, 2008, DIGESTION, V78, P154, DOI 10.1159/000179361; He T, 2013, COLORECTAL DIS, V15, P12, DOI 10.1111/j.1463-1318.2012.02919.x; Ho GT, 2005, GASTROENTEROLOGY, V128, P288, DOI 10.1053/j.gastro.2004.11.019; Ho GT, 2006, HUM MOL GENET, V15, P797, DOI 10.1093/hmg/ddi494; Hopper-Borge EA, 2009, EXPERT OPIN THER TAR, V13, P339, DOI [10.1517/14712590902735795 , 10.1517/14712590902735795]; Hu Y, 2005, INT J CANCER, V115, P561, DOI 10.1002/ijc.20876; Iijima N, 2011, P NATL ACAD SCI USA, V108, P284, DOI 10.1073/pnas.1005201108; Jia GQ, 1996, J EXP MED, V184, P1939, DOI 10.1084/jem.184.5.1939; Katayama K., 2014, NEW J SCI, V2014, P1, DOI [DOI 10.1155/2014/476974, 10.1155/2014/476974]; Katayama K, 2013, CANCER SCI, V104, P694, DOI 10.1111/cas.12145; Kemp TJ, 2004, J IMMUNOL, V173, P892, DOI 10.4049/jimmunol.173.2.892; KUBBEN FJGM, 1994, GUT, V35, P530, DOI 10.1136/gut.35.4.530; Kurzawski M, 2005, EUR J CLIN PHARMACOL, V61, P389, DOI 10.1007/s00228-005-0926-5; LANGHOLZ E, 1992, GASTROENTEROLOGY, V103, P1444, DOI 10.1016/0016-5085(92)91163-X; Langmann T, 2004, GASTROENTEROLOGY, V127, P26, DOI 10.1053/j.gastro.2004.04.019; Maggio-Price L, 2005, AM J PATHOL, V166, P1793, DOI 10.1016/S0002-9440(10)62489-3; Marrache AM, 2002, J IMMUNOL, V169, P6474, DOI 10.4049/jimmunol.169.11.6474; Miyoshi H, 2017, EMBO J, V36, P5, DOI 10.15252/embj.201694660; Miyoshi H, 2013, NAT PROTOC, V8, P2471, DOI 10.1038/nprot.2013.153; MULLER C, 1995, J CELL PHYSIOL, V163, P538, DOI 10.1002/jcp.1041630314; Murphy JE, 2003, J IMMUNOL, V170, P5697, DOI 10.4049/jimmunol.170.11.5697; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Panwala CM, 1998, J IMMUNOL, V161, P5733; Park CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044307; Park EJ, 2017, INT IMMUNOLOGY; Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463; Patel VA, 2002, J BIOL CHEM, V277, P38915, DOI 10.1074/jbc.M206855200; Putoczki TL, 2013, CANCER CELL, V24, P257, DOI 10.1016/j.ccr.2013.06.017; Resta-Lenert S, 2005, AM J PHYSIOL-GASTR L, V289, pG153, DOI 10.1152/ajpgi.00395.2004; Reuter BK, 1996, J CLIN INVEST, V98, P2076, DOI 10.1172/JCI119013; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Sarafi MN, 1997, J EXP MED, V185, P99, DOI 10.1084/jem.185.1.99; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Schwab M, 2003, GASTROENTEROLOGY, V124, P26, DOI 10.1053/gast.2003.50010; Shimabukuro-Vornhagen A, 2014, ONCOTARGET, V5, P4651, DOI 10.18632/oncotarget.1701; Singh B, 2006, J SURG RES, V131, P267, DOI 10.1016/j.jss.2005.11.582; Souza PS, 2015, EXP CELL RES, V336, P318, DOI 10.1016/j.yexcr.2015.06.005; Stanko G, 2016, GASTROENTEROL REV, V11, P35, DOI 10.5114/pg.2015.51185; Thaker AI, 2012, JOVE-J VIS EXP, DOI 10.3791/4100; Totzke G, 2003, ONCOGENE, V22, P8021, DOI 10.1038/sj.onc.1206837; Triantafillidis JK, 2009, ANTICANCER RES, V29, P2727; Tung JW, 2006, P NATL ACAD SCI USA, V103, P6293, DOI 10.1073/pnas.0511305103; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wirths S, 2005, EUR J IMMUNOL, V35, P3433, DOI 10.1002/eji.200535364; Xia ZX, 2015, CURR CANCER DRUG TAR, V15, P519, DOI 10.2174/1568009615666150506093643; Yaeger R, 2016, GASTROENTEROLOGY, V151, P278, DOI 10.1053/j.gastro.2016.04.001; Yamada T, 2003, CANCER RES, V63, P895; Yamada T, 2000, CANCER RES, V60, P4761; Zhang WD, 2000, J CELL PHYSIOL, V184, P17, DOI 10.1002/(SICI)1097-4652(200007)184:1<17::AID-JCP2>3.0.CO;2-U	84	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180834	10.1371/journal.pone.0180834	http://dx.doi.org/10.1371/journal.pone.0180834			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686677	Green Published, Green Submitted, gold			2022-12-26	WOS:000405464100113
J	Clark, DP; Badea, CT				Clark, Darin P.; Badea, Cristian T.			Hybrid spectral CT reconstruction	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; IMAGE-RECONSTRUCTION; MATERIAL DECOMPOSITION; TUMOR VASCULATURE; NOISE-REDUCTION; MOUSE MODEL; MICRO-CT; ALGORITHM; IODINE; ACQUISITION	Current photon counting x-ray detector (PCD) technology faces limitations associated with spectral fidelity and photon starvation. One strategy for addressing these limitations is to supplement PCD data with high-resolution, low-noise data acquired with an energy-integrating detector (EID). In this work, we propose an iterative, hybrid reconstruction technique which combines the spectral properties of PCD data with the resolution and signal-to-noise characteristics of EID data. Our hybrid reconstruction technique is based on an algebraic model of data fidelity which substitutes the EID data into the data fidelity term associated with the PCD reconstruction, resulting in a joint reconstruction problem. Within the split Bregman framework, these data fidelity constraints are minimized subject to additional constraints on spectral rank and on joint intensity-gradient sparsity measured between the reconstructions of the EID and PCD data. Following a derivation of the proposed technique, we apply it to the reconstruction of a digital phantom which contains realistic concentrations of iodine, barium, and calcium encountered in small-animal micro-CT. The results of this experiment suggest reliable separation and detection of iodine at concentrations >= 5 mg/ml and barium at concentrations >= 10 mg/ml in 2-mm features for EID and PCD data reconstructed with inherent spatial resolutions of 176 mu m and 254 mu m, respectively (point spread function, FWHM). Furthermore, hybrid reconstruction is demonstrated to enhance spatial resolution within material decomposition results and to improve low-contrast detectability by as much as 2.6 times relative to reconstruction with PCD data only. The parameters of the simulation experiment are based on an in vivo micro-CT experiment conducted in a mouse model of soft-tissue sarcoma. Material decomposition results produced from this in vivo data demonstrate the feasibility of distinguishing two K-edge contrast agents with a spectral separation on the order of the energy resolution of the PCD hardware.	[Clark, Darin P.; Badea, Cristian T.] Duke Univ, Med Ctr, Dept Radiol, Ctr In Vivo Microscopy, Durham, NC 27710 USA	Duke University	Badea, CT (corresponding author), Duke Univ, Med Ctr, Dept Radiol, Ctr In Vivo Microscopy, Durham, NC 27710 USA.	cristian.badea@duke.edu	Badea, Cristian T/M-3323-2019; Badea, Cristian/B-6681-2011	Badea, Cristian T/0000-0002-1850-2522; Badea, Cristian/0000-0002-1850-2522	National Institutes of Health, National Cancer Institute [R01CA196667]; NATIONAL CANCER INSTITUTE [R01CA196667] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	All work was performed at Duke University Medical Center's Center for In Vivo Microscopy (http://www.civm.duhs.duke.edu/), a National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering national Biomedical Technology Resource Center (P4 EB015897; https://www.nibib.nih.gov/; CTB). The work was also supported by the National Institutes of Health, National Cancer Institute (R01CA196667; https://www.cancer.gov/; CTB). These funding sources had no direct role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.This work was made possible by the loan of a PILATUS3 CdTe 300K photon counting x-ray detector from Dectris AG of Baden-Dattwil, Switzerland (https://www.dectris.com/). Dectris AG reviewed this manuscript prior to its initial submission to PLOSONE, but had no direct role in the study design or the analysis methods employed.	Aharon M, 2006, IEEE T SIGNAL PROCES, V54, P4311, DOI 10.1109/TSP.2006.881199; ALVAREZ RE, 1976, PHYS MED BIOL, V21, P733, DOI 10.1088/0031-9155/21/5/002; Aly HA, 2014, IEEE T IMAGE PROCESS, V23, P2596, DOI 10.1109/TIP.2014.2316641; Anderson NG, 2010, EUR RADIOL, V20, P2126, DOI 10.1007/s00330-010-1768-9; Ashton JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088129; Ashton JR, 2014, CONTRAST MEDIA MOL I, V9, P161, DOI 10.1002/cmmi.1557; Badea C, 2008, MED IMAGING; Ballabriga R, 2006, 2006 IEEE NUCL SCI S; Bennett JR, 2014, IEEE T BIO-MED ENG, V61, P246, DOI 10.1109/TBME.2013.2279673; Bhavane R, 2013, CIRC-CARDIOVASC IMAG, V6, P285, DOI 10.1161/CIRCIMAGING.112.000119; Boll H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025692; Broennimann C, 2006, J SYNCHROTRON RADIAT, V13, P120, DOI 10.1107/S0909049505038665; Cai JF, 2010, SIAM J OPTIMIZ, V20, P1956, DOI 10.1137/080738970; Candes EJ, 2011, J ACM, V58, DOI 10.1145/1970392.1970395; Chen Y, 2017, PHYS MED BIOL, V62, P2103, DOI 10.1088/1361-6560/aa5c24; Chen Y, 2014, IEEE T MED IMAGING, V33, P2271, DOI 10.1109/TMI.2014.2336860; Chen Y, 2011, EUR J RADIOL, V80, pE42, DOI 10.1016/j.ejrad.2010.07.003; Clark D, 2016, SPIE MED IMAGING; Clark D, 2016, SPIE MED IMAGING; Clark DP, 2015, PROC SPIE, V9412, DOI 10.1117/12.2081249; Clark DP, 2015, MED PHYS, V42, P6317, DOI 10.1118/1.4931407; Clark DP, 2014, PHYS MED BIOL, V59, P6445, DOI 10.1088/0031-9155/59/21/6445; Clark DP, 2013, PHYS MED BIOL, V58, P1683, DOI 10.1088/0031-9155/58/6/1683; Cormode DP, 2010, RADIOLOGY, V256, P774, DOI 10.1148/radiol.10092473; Donath T, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/6/062001; Donoho DL, 1995, J AM STAT ASSOC, V90, P1200, DOI 10.1080/01621459.1995.10476626; Elad M, 2002, IEEE T IMAGE PROCESS, V11, P1141, DOI 10.1109/TIP.2002.801126; Elbakri IA, 2002, IEEE T MED IMAGING, V21, P89, DOI 10.1109/42.993128; Farsiu S, 2004, IEEE T IMAGE PROCESS, V13, P1327, DOI 10.1109/TIP.2004.834669; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Galigekere RR, 2003, IEEE T MED IMAGING, V22, P1202, DOI 10.1109/TMI.2003.817787; Gang GJ, 2016, PROC SPIE, V9783, DOI 10.1117/12.2216387; Gao H, 2011, INVERSE PROBL, V27, DOI 10.1088/0266-5611/27/11/115012; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Gutjahr R, 2016, INVEST RADIOL, V51, P421, DOI 10.1097/RLI.0000000000000251; Hansen N, 2004, INT C PAR PROBL SOLV; Hermosillo G, 2002, INT J COMPUT VISION, V50, P329, DOI 10.1023/A:1020830525823; Jawak SD, 2013, ADV REMOTE SENSING, V2013; Johnson T, 2011, DUAL ENERGY CT CLINI; Kim K, 2015, IEEE T MED IMAGING, V34, P748, DOI 10.1109/TMI.2014.2380993; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Kraft P, 2009, IEEE T NUCL SCI, V56, P758, DOI 10.1109/TNS.2008.2009448; Kraft P, 2009, J SYNCHROTRON RADIAT, V16, P368, DOI 10.1107/S0909049509009911; Lai RJ, 2014, J SCI COMPUT, V58, P431, DOI 10.1007/s10915-013-9740-x; Lawson CL., 1995, SOLVING LEAST SQUARE; Leng SA, 2011, MED PHYS, V38, P4946, DOI 10.1118/1.3609097; Loeliger T, 2012, NUCL SCI S MED IM C; Long Y, 2010, IEEE T MED IMAGING, V29, P1839, DOI 10.1109/TMI.2010.2050898; Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3; McCollough CH, 2004, MED PHYS, V31, P2423, DOI 10.1118/1.1769632; Moding EJ, 2013, INT J RADIAT ONCOL, V85, P1353, DOI 10.1016/j.ijrobp.2012.09.027; Mukundan S, 2006, AM J ROENTGENOL, V186, P300, DOI 10.2214/AJR.05.0523; Ouadah S, 2015, SPIE MED IMAGING; Radicci V, INT WORKSH RAD IM DE; Rigie DS, 2015, PHYS MED BIOL, V60, P1741, DOI 10.1088/0031-9155/60/5/1741; Rubinstein R, 2008, EFFICIENT IMPLEMENTA; Schlifske D, 2016, SPIE MED IMAGING; Schlomka JP, 2008, PHYS MED BIOL, V53, P4031, DOI 10.1088/0031-9155/53/15/002; Schmidt TG, 2011, MED PHYS, V38, P5657, DOI 10.1118/1.3641749; Schmidt TG, 2009, MED PHYS, V36, P3018, DOI 10.1118/1.3148535; Shaw C, 2014, CONE BEAM COMPUTED T, DOI DOI 10.1201/B16465; Sidky EY, 2008, PHYS MED BIOL, V53, P4777, DOI 10.1088/0031-9155/53/17/021; Siewerdsen JH, 2004, MED PHYS, V31, P3057, DOI 10.1118/1.1758350; Szczykutowicz TP, 2010, PHYS MED BIOL, V55, P6411, DOI 10.1088/0031-9155/55/21/005; Taguchi K, 2013, MED PHYS, V40, DOI 10.1118/1.4820371; Touch M, 2016, PHYS MED BIOL, V61, P6132, DOI 10.1088/0031-9155/61/16/6132; VANDERVORST HA, 1992, SIAM J SCI STAT COMP, V13, P631, DOI 10.1137/0913035; Vivone G, 2015, IEEE T GEOSCI REMOTE, V53, P2565, DOI 10.1109/TGRS.2014.2361734; Wang AS, 2015, MED PHYS, V42, P2699, DOI 10.1118/1.4914378; Wang J, 2006, IEEE T MED IMAGING, V25, P1272, DOI 10.1109/TMI.2006.882141; Xu Q, 2012, IEEE T MED IMAGING, V31, P1682, DOI 10.1109/TMI.2012.2195669; Xu Q, 2012, IEEE T BIO-MED ENG, V59, P1711, DOI 10.1109/TBME.2012.2192119; Zeng D, 2016, IEEE T BIO-MED ENG, V63, P1044, DOI 10.1109/TBME.2015.2476371; Zhang YB, 2017, IEEE T MED IMAGING, V36, P142, DOI 10.1109/TMI.2016.2600249; Zhang Y, 2016, IEEE T COMPUT IMAG, V2, P510, DOI 10.1109/TCI.2016.2609414	75	30	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180324	10.1371/journal.pone.0180324	http://dx.doi.org/10.1371/journal.pone.0180324			52	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683124	Green Submitted, Green Published, gold			2022-12-26	WOS:000405335200023
J	Deng, PY; Li, X; Wei, Y; Liu, J; Chen, M; Xu, YM; Dong, B; Zhu, LQ; Cheri, LM				Deng, Peiying; Li, Xue; Wei, Yi; Liu, Juan; Chen, Meng; Xu, Yamei; Dong, Bin; Zhu, Lingqun; Chai, Limin			The herbal decoction modified Danggui Buxue Tang attenuates immune-mediated bone marrow failure by regulating the differentiation of T lymphocytes in an immune-induced aplastic anemia mouse model	PLOS ONE			English	Article							RADIX-ASTRAGALI; NITRIC-OXIDE; CELLS; PATHOPHYSIOLOGY; MECHANISMS; EXPRESSION; RESPONSES; GAMMA; HETEROGENEITY; RHIZOMA	Angelicae Sinensis, Radix Astragali and Rhizoma Coptidis are all herbs of modified Danggui Buxue Tang (DGBX) and are extensively applied herbs in traditional Chinese medicine for the treatment of anemia and inflammation. In this study, immune-induced AA mice were used as an animal model, and the immunosuppressive agent, Ciclosporin A (CsA), was used as a positive control. Multiple pro-inflammatory cytokines were examined by bead based multiplex flow cytometry. The T-cell subsets were assessed using a fluorescence activated cell sorter (FACS). Western blot analysis was used to estimate the protein expression levels of specific transcription factors for T helper cells (Th1, Th2 and Th17) and key molecules of the Janus-activated kinase (Jak)/signal transducer and activator of transcription (Stat3) signaling pathway. DGBX treatment could significantly increase the production of whole blood cells in peripheral blood (PB); inhibit the expansion of Th1 and Th17 cells; increase the differentiation of Th2 and Tregs cells; regulate the expression levels of T-bet, GATA-3, RORy and proinflammatory cytokines; and decrease the expression levels of key molecules in the Jak/Stat signaling pathway. These results indicate that DGBX can regulate the differentiation of T lymphocytes, resulting in immunosuppressive and hematogenic functions on AA mice. DGBX might be a good candidate for inclusion in a randomized study for AA with more data on the possible side effects and doses used in humans. Ultimately, it may be used for applications of traditional medicine against AA in modern complementary and alternative immunosuppressive therapeutics.	[Deng, Peiying; Li, Xue; Wei, Yi; Dong, Bin; Zhu, Lingqun; Chai, Limin] Beijing Univ Chinese Med, Minist Educ, Key Lab Chinese Internal Med, Beijing, Peoples R China; [Deng, Peiying; Li, Xue; Wei, Yi; Dong, Bin; Zhu, Lingqun; Chai, Limin] Beijing Univ Chinese Med, Dongzhimen Hosp, Beijing, Peoples R China; [Liu, Juan; Xu, Yamei] Beijing Univ Chinese Med, Dongzhimen Hosp, Dept Hematol & Oncol, Beijing, Peoples R China; [Chen, Meng] Beijing Univ Chinese Med, Sch Preclin Med, Beijing, Peoples R China	Beijing University of Chinese Medicine; Beijing University of Chinese Medicine; Beijing University of Chinese Medicine; Beijing University of Chinese Medicine	Cheri, LM (corresponding author), Beijing Univ Chinese Med, Minist Educ, Key Lab Chinese Internal Med, Beijing, Peoples R China.; Cheri, LM (corresponding author), Beijing Univ Chinese Med, Dongzhimen Hosp, Beijing, Peoples R China.	liminchai@hotmail.com			National Natural Science Foundation of China [81373583]; Fundamental Research Funds for Beijing University of Chinese medicine [2015-JYB-XJQ002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Beijing University of Chinese medicine	This work was supported by National Natural Science Foundation of China 81373583 (http://wwtiv.nsfc.gov.cri), Fundamental Research Funds for Beijing University of Chinese medicine 2015-JYB-XJQ002 (http./Armwbum.eduLn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad W, 2016, FOOD FUNCT, V7, P1380, DOI [10.1039/c5fo01531f, 10.1039/C5FO01531F]; [Anonymous], 2006, [No title captured]; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Bin Dong JL, 2014, J BEIJING U TRADITIO, V37; Bloom ML, 2004, EXP HEMATOL, V32, P1163, DOI 10.1016/j.exphem.2004.08.006; Brodsky RA, 2005, LANCET, V365, P1647, DOI 10.1016/S0140-6736(05)66515-4; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chen Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep11638; Choi YY, 2013, J ETHNOPHARMACOL, V149, P506, DOI 10.1016/j.jep.2013.07.008; de Latour RP, 2010, BLOOD, V116, P4175, DOI 10.1182/blood-2010-01-266098; Fagerlie SR, 2004, J IMMUNOL, V173, P3863, DOI 10.4049/jimmunol.173.6.3863; Gao QT, 2006, PLANTA MED, V72, P1227, DOI 10.1055/s-2006-947186; Giannakoulas NC, 2004, BRIT J HAEMATOL, V124, P97, DOI 10.1046/j.1365-2141.2003.04729.x; Gong AGW, 2016, PLANTA MED, V82, P418, DOI 10.1055/s-0035-1558332; Hoyer KK, 2009, BLOOD, V113, P389, DOI 10.1182/blood-2008-04-153346; Iizuka N, 2000, CANCER LETT, V158, P35, DOI 10.1016/S0304-3835(00)00496-1; Ishikawa S, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/7262054; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Juan Liu CZ, 2013, J BEIJING U TRADITIO, V36; Kordasti S, 2012, BLOOD, V119, P2033, DOI 10.1182/blood-2011-08-368308; Kotsianidis I, 2009, LEUKEMIA, V23, P510, DOI 10.1038/leu.2008.333; Li J., 2016, STEM CELLS INT, V2016, P6, DOI DOI 10.1016/J.ENGGE0.2016.03.006; Liu TT, 2015, SCI REP-UK, V5, DOI 10.1038/srep13982; Miyara M, 2011, IMMUNOL CELL BIOL, V89, P346, DOI 10.1038/icb.2010.137; Munoz J, 2014, ONCOLOGIST, V19, P536, DOI 10.1634/theoncologist.2013-0407; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; NISTICO A, 1994, ANN INTERN MED, V120, P463, DOI 10.7326/0003-4819-120-6-199403150-00003; Perez-Diez A, 2007, BLOOD, V109, P5346, DOI 10.1182/blood-2006-10-051318; Qiu CL, 2014, CELL PHYSIOL BIOCHEM, V33, P784, DOI 10.1159/000358652; Quan GH, 2015, INT J MOL SCI, V16, P29496, DOI 10.3390/ijms161226179; Remppis A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/194896; Shi J, 2012, BLOOD, V120, P1624, DOI 10.1182/blood-2011-11-390708; Shin JS, 2016, J PHARMACOL EXP THER, V358, P20, DOI 10.1124/jpet.115.231043; Solomou EE, 2007, BLOOD, V110, P1603, DOI 10.1182/blood-2007-01-066258; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Yan Y, 2013, J PHARMACEUT BIOMED, V80, P192, DOI 10.1016/j.jpba.2013.03.008; Yang M, 2009, J ETHNOPHARMACOL, V124, P87, DOI 10.1016/j.jep.2009.04.007; Young NS, 2008, CURR OPIN HEMATOL, V15, P162, DOI 10.1097/MOH.0b013e3282fa7470; Young NS, 2010, BIOL BLOOD MARROW TR, V16, pS119, DOI 10.1016/j.bbmt.2009.09.013; Young NS, 1997, NEW ENGL J MED, V336, P1365, DOI 10.1056/NEJM199705083361906; Zeng WH, 2001, J CLIN INVEST, V108, P765, DOI 10.1172/JCI12687; Zeng Y, 2015, CLIN EXP IMMUNOL, V180, P361, DOI 10.1111/cei.12605; Zhang B, 2016, J CLIN INVEST, V126, P975, DOI 10.1172/JCI79196; Zhou B, 2014, J CLIN INVEST, V124, P553, DOI 10.1172/JCI69804; Zhou K, 2016, INFLAMMATION, V39, P1558, DOI 10.1007/s10753-016-0391-6; Zierau O, 2014, EVID-BASED COMPL ALT, V2014, DOI DOI 10.1155/2014/	49	15	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180417	10.1371/journal.pone.0180417	http://dx.doi.org/10.1371/journal.pone.0180417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683082	Green Published, Green Submitted, gold			2022-12-26	WOS:000405335200033
J	Hata, T; Asano, Y; Yoshihara, K; Kimura-Todani, T; Miyata, N; Zhang, XT; Takakura, S; Aiba, Y; Koga, Y; Sudo, N				Hata, Tomokazu; Asano, Yasunari; Yoshihara, Kazufumi; Kimura-Todani, Tae; Miyata, Noriyuki; Zhang, Xue-Ting; Takakura, Shu; Aiba, Yuji; Koga, Yasuhiro; Sudo, Nobuyuki			Regulation of gut luminal serotonin by commensal microbiota in mice	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; CENTRAL-NERVOUS-SYSTEM; ENTEROCHROMAFFIN CELLS; INTESTINAL MICROBIOTA; INTRALUMINAL PRESSURE; VISCERAL SENSITIVITY; RELEASE; 5-HYDROXYTRYPTAMINE; MUCOSA; BRAIN	Gut lumen serotonin (5-hydroxytryptamine: 5-HT) contributes to several gastrointestinal functions such as peristaltic reflexes. 5-HT is released from enterochromaffin (EC) cells in response to a number of stimuli, including signals from the gut microbiota. However, the specific mechanism by which the gut microbiota regulates 5-HT levels in the gut lumen has not yet been clarified. Our previous work with gnotobiotic mice showed that free catecholamines can be produced by the deconjugation of conjugated catecholamines; hence, we speculated that deconjugation by bacterial enzymes may be one of the mechanisms whereby gut microbes can produce free 5-HT in the gut lumen. In this study, we tested this hypothesis using germ-free (GF) mice and gnotobiotic mice recolonized with specific pathogen-free (SPF) fecal flora (EX-GF). The 5-HT levels in the lumens of the cecum and colon were significantly lower in the GF mice than in the EX-GF mice. Moreover, these levels were rapidly increased, within only 3 days after exposure to SPF microbiota. The majority of 5-HT was in an unconjugated, free form in the EX-GF mice, whereas approximately 50% of the 5-HT was found in the conjugated form in the GF mice. These results further support the current view that the gut microbiota plays a crucial role in promoting the production of biologically active, free 5-HT. The deconjugation of glucuronide-conjugated 5-HT by bacterial enzymes is likely one of the mechanisms contributing to free 5-HT production in the gut lumen.	[Hata, Tomokazu; Asano, Yasunari; Yoshihara, Kazufumi; Kimura-Todani, Tae; Miyata, Noriyuki; Zhang, Xue-Ting; Takakura, Shu; Sudo, Nobuyuki] Kyushu Univ, Grad Sch Med Sci, Dept Psychosomat Med, Fukuoka, Japan; [Aiba, Yuji; Koga, Yasuhiro] Tokai Univ Med, Dept Infect Dis, Isehara, Kanagawa, Japan	Kyushu University; Tokai University	Sudo, N (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Psychosomat Med, Fukuoka, Japan.	nobuyuki@med.kyushu-u.ac.jp		Sudo, Nobuyuki/0000-0002-7935-878X; Asano, Yasunari/0000-0002-6180-3494	Ministry of Education, Culture, Sports, Science, and Technology in Japan [25293054, 25293167, 16H05278, 16K15413, 16H06404]	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was totally supported by Grants-in-Aid for General Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (25293054, https://kaken. nii.ac.ip/d/p/25293054.ja.html; 25293167, https:// kaken.ni.acdpid/p/25293167.1a.html; 16H05278, https://kaken.nii.ac.jd/p/16H05278.ja.html; 16K15413, https://kaken.nii.ac.jp/d/p/16K15413.ja. htm;; 16H06404, https://kaken.nii.ac.jp/d/p/16H06404.ja.html: NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano Y, 2012, AM J PHYSIOL-GASTR L, V303, pG1288, DOI 10.1152/ajpgi.00341.2012; Bertrand PP, 2010, AUTON NEUROSCI-BASIC, V153, P47, DOI 10.1016/j.autneu.2009.08.002; Bertrand PP, 2004, NEUROGASTROENT MOTIL, V16, P511, DOI 10.1111/j.1365-2982.2004.00572.x; Braun T, 2007, GASTROENTEROLOGY, V132, P1890, DOI 10.1053/j.gastro.2007.02.036; BULBRING E, 1959, J PHYSIOL-LONDON, V146, P18; BULBRING E, 1958, J PHYSIOL-LONDON, V140, P381; Coates MD, 2004, GASTROENTEROLOGY, V126, P1657, DOI 10.1053/j.gastro.2004.03.013; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Collins SM, 2009, GASTROENTEROLOGY, V136, P2003, DOI 10.1053/j.gastro.2009.01.075; Forsythe P, 2010, BRAIN BEHAV IMMUN, V24, P9, DOI 10.1016/j.bbi.2009.05.058; Fujimiya M, 1997, HISTOCHEM CELL BIOL, V108, P105, DOI 10.1007/s004180050151; Gershon MD, 2004, ALIMENT PHARM THER, V20, P3, DOI 10.1111/j.1365-2036.2004.02180.x; Gershon MD, 2013, CURR OPIN ENDOCRINOL, V20, P14, DOI 10.1097/MED.0b013e32835bc703; Grundy D, 2008, EUR REV MED PHARMACO, V12, P63; HAZENBERG MP, 1988, FEMS MICROBIOL LETT, V54, P9; ILETT KF, 1990, PHARMACOL THERAPEUT, V46, P67, DOI 10.1016/0163-7258(90)90036-2; Kerckhoffs APM, 2012, AM J PHYSIOL-GASTR L, V302, pG1053, DOI 10.1152/ajpgi.00153.2011; Kirkup AJ, 2001, AM J PHYSIOL-GASTR L, V280, pG787, DOI 10.1152/ajpgi.2001.280.5.G787; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Murakami T, 2010, AMINO ACIDS, V39, P427, DOI 10.1007/s00726-009-0458-x; Nishino R, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12110; O'Hara JR, 2004, AM J PHYSIOL-GASTR L, V287, pG998, DOI 10.1152/ajpgi.00090.2004; O'Mahony SM, 2015, BEHAV BRAIN RES, V277, P32, DOI 10.1016/j.bbr.2014.07.027; Reigstad CS, 2015, FASEB J, V29, P1395, DOI 10.1096/fj.14-259598; Rhee SH, 2009, NAT REV GASTRO HEPAT, V6, P306, DOI 10.1038/nrgastro.2009.35; Rodriguez MJ, 2001, CELL TISSUE RES, V304, P215, DOI 10.1007/s004410100361; Selwyn FP, 2016, DRUG METAB DISPOS, V44, P262, DOI 10.1124/dmd.115.067504; Shibata O, 1988, Masui, V37, P428; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Sudo N, 1997, J IMMUNOL, V159, P1739; Toda T, 2009, XENOBIOTICA, V39, P323, DOI 10.1080/00498250802651984; Tsukamoto K, 2007, AM J PHYSIOL-REG I, V293, pR64, DOI 10.1152/ajpregu.00856.2006; URIBE A, 1994, GASTROENTEROLOGY, V107, P1259, DOI 10.1016/0016-5085(94)90526-6; Verbeuren TJ, 1989, PERIPHERAL ACTIONS 5, P1; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; YONEDA S, 1983, LIFE SCI, V33, P935, DOI 10.1016/0024-3205(83)90749-X; Zeng FN, 2010, GASTROENTEROLOGY, V138, P1491, DOI 10.1053/j.gastro.2009.11.048	38	101	103	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180745	10.1371/journal.pone.0180745	http://dx.doi.org/10.1371/journal.pone.0180745			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683093	Green Submitted, Green Published, gold			2022-12-26	WOS:000405335200065
J	Kessel, KA; Hesse, J; Straube, C; Zimmer, C; Schmidt-Graf, F; Schlegel, J; Meyer, B; Combs, SE				Kessel, Kerstin A.; Hesse, Josefine; Straube, Christoph; Zimmer, Claus; Schmidt-Graf, Friederike; Schlegel, Juergen; Meyer, Bernhard; Combs, Stephanie E.			Modification and optimization of an established prognostic score after re-irradiation of recurrent glioma	PLOS ONE			English	Article							STEREOTAXIC RADIOTHERAPY; GRADE GLIOMAS; GLIOBLASTOMA; VALIDATION; RESECTION; MANAGEMENT; OUTCOMES; SURGERY; THERAPY	Introduction For about 30 years, researchers developed prognostic scores and searched for prognostic factors to predict outcomes for cancer patients. The Combs Prognostic Score for re-irradiation in recurrent glioma was recently validated and results showed that the score is a significant (p < .001) and reliable predictor for patients undergoing re-irradiation (re-RT). We sought to enhance the score and generated a novel scoring approach, taking into account the information on resection of recurrent tumors, KPS, and tumor volume. Patients and methods The prognostic score was generated based on 209 patients treated between 2002 and 2016 for recurrent glioma at the department of radiation oncology at the Klinikum rechts der Isar, Munich. To further enhance the previously validated Combs Prognostic Score, which uses the prognostic factors primary histology, time between primary RT and re-RT, and age, we added KPS, tumor volume (PTV) and re-resection into the scoring scheme. Results The median follow-up time was 3.5 months. 67.5% were WHO IV gliomas with a median OS after re-RT of 7.9 months, 17.7% were WHO III gliomas with an OS of 11.3 months and 14.8% were WHO I/II gliomas with an OS of 14.7 months. Multivariate analyses confirmed the prognostic factors KPS (p < .001) and showed a tendency to significance for tumor volume (p = .067) and re-resection (p = .064). The new prognostic score demonstrated a high significance (p < .001). Conclusion The New Combs Prognostics Score is a significant and useful tool to predict the overall effect of re-RT in patients with recurrence gliomas. This modified score offers an even better way to classify patients in clinical routine and prospective clinical trials investigating re-irradiation.	[Kessel, Kerstin A.; Hesse, Josefine; Straube, Christoph; Combs, Stephanie E.] TUM, Dept Radiat Oncol, Munich, Germany; [Kessel, Kerstin A.; Combs, Stephanie E.] Helmholtz Zentrum Munchen, Inst Innovat Radiotherapy iRT, Neuherberg, Germany; [Zimmer, Claus] TUM, Dept roradiol, Munich, Germany; [Schmidt-Graf, Friederike] TUM, Dept Neurol, Munich, Germany; [Schlegel, Juergen] TUM, Dept Neuropathol, Munich, Germany; [Meyer, Bernhard] TUM, Dept Neurosurg, Munich, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich	Kessel, KA (corresponding author), TUM, Dept Radiat Oncol, Munich, Germany.; Kessel, KA (corresponding author), Helmholtz Zentrum Munchen, Inst Innovat Radiotherapy iRT, Neuherberg, Germany.	Kerstin.Kessel@tum.de		Eitz, Kerstin A./0000-0002-6544-8151; Schlegel, Jurgen/0000-0002-5544-2717				Adeberg S, 2015, IMPACT DELAYS INITIA, V15, P987; Amichetti Maurizio, 2011, Cancers (Basel), V3, P4061, DOI 10.3390/cancers3044061; Brandes AA, 2010, NEURO-ONCOLOGY, V12, P283, DOI 10.1093/neuonc/nop050; Combs SE, 2005, J NEURO-ONCOL, V74, P167, DOI 10.1007/s11060-004-2463-y; Combs SE, 2013, ACTA ONCOL, V52, P147, DOI 10.3109/0284186X.2012.692882; Combs SE, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-167; Fogh SE, 2010, J CLIN ONCOL, V28, P3048, DOI 10.1200/JCO.2009.25.6941; Hayes J, 2016, MOL ONCOL, V10, P1296, DOI 10.1016/j.molonc.2016.06.004; Hayes J, 2015, MOL ONCOL, V9, P704, DOI 10.1016/j.molonc.2014.11.004; Kessel KA, 2017, ACTA ONCOL, V56, P422, DOI 10.1080/0284186X.2016.1276621; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; LAING RW, 1993, RADIOTHER ONCOL, V27, P22, DOI 10.1016/0167-8140(93)90040-F; Lee J, 2016, YONSEI MED J, V57, P824, DOI 10.3349/ymj.2016.57.4.824; Mallick S, 2016, J EGYPT NATL CANCER, V28, P199, DOI 10.1016/j.jnci.2016.07.001; Nieder C, 2016, ANTICANCER RES; Niyazi M, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-128; Palmer JD, 2015, J NEURO-ONCOL, V124, P215, DOI 10.1007/s11060-015-1825-y; Reifenberger G, 2016, NAT REV CLIN ONCOL; Ringel F, 2016, NEURO-ONCOLOGY, V18, P96, DOI 10.1093/neuonc/nov145; Sana J, 2014, CARCINOGENESIS, V35, P2756, DOI 10.1093/carcin/bgu212; Scholtyssek F, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-161; Shepherd SF, 1997, INT J RADIAT ONCOL, V37, P393, DOI 10.1016/S0360-3016(96)00455-5; Taunk NK, 2016, EXPERT REV ANTICANC, V16, P347, DOI 10.1586/14737140.2016.1143364; Thon N, 2016, J NEUROL; Torcuator RG, 2010, J NEURO-ONCOL, V97, P401, DOI 10.1007/s11060-009-0034-y; Uppstrom TJ, 2016, CLIN NEUROL NEUROSUR, V151, P18, DOI 10.1016/j.clineuro.2016.09.013; Wong ET, 1999, J CLIN ONCOL, V17, P2572, DOI 10.1200/JCO.1999.17.8.2572	27	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180457	10.1371/journal.pone.0180457	http://dx.doi.org/10.1371/journal.pone.0180457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678889	Green Published, gold, Green Submitted			2022-12-26	WOS:000405272200065
J	Bae, JH; Hwang, AR; Kim, CY; Yu, HG; Koh, HJ; Yang, WI; Chang, HR; Lee, SC				Bae, Jeong Hun; Hwang, Ah Reum; Kim, Chan Yun; Yu, Hyeong Gon; Koh, Hyoung Jun; Yang, Woo Ick; Chang, Hae Ran; Lee, Sung Chul			Intravitreal itraconazole inhibits laser-induced choroidal neovascularization in rats	PLOS ONE			English	Article							MACULAR DEGENERATION; GROWTH; VEGF; ANTIFUNGAL; ANGIOGENESIS; EXPRESSION; CANCER; TRIAMCINOLONE; TRAFFICKING; ACTIVATION	Choroidal neovascularization (CNV) is a major cause of severe visual loss in patients with age-related macular degeneration (AMD). Recently, itraconazole has shown potent and dose-dependent inhibition of tumor-associated angiogenesis. We evaluated the anti-angiogenic effect of itraconazole in a rat model of laser-induced CNV. After laser photocoagulation in each eye to cause CNV, right eyes were administered intravitreal injections of itraconazole; left eyes received balanced salt solution (BSS) as controls. On day 14 after laser induction, fluorescein angiography (FA) was used to assess abnormal vascular leakage. Flattened retinal pigment epithelium (RPE)-choroid tissue complex was stained with Alexa Fluor 594-conjugated isolectin B4 to measure the CNV area and volume. Vascular endothelial growth factor receptor 2 (VEGFR2) mRNA and protein expression was determined 1, 4, 7, and 14 days after intravitreal injection by quantitative RT-PCR or Western blot. VEGF levels were analyzed by enzyme-linked immunosorbent assay (ELISA). Intravitreal itraconazole significantly reduced leakage from CNV as assessed by FA and CNV area and volume on flat mounts compared with intravitreal BSS (p = 0.002 for CNV leakage, p< 0.001 for CNV area and volume). Quantitative RT-PCR showed significantly lower expression of VEGFR2 mRNA in the RPE-choroid complexes of itraconazole-injected eyes than those of BSS-injected eyes on days 7 and 14 (p = 0.003 and p = 0.006). Western blots indicated that VEGFR2 was downregulated after itraconazole treatment. ELISA showed a significant difference in VEGF level between itraconazole-injected and BSS-injected eyes on days 7 and 14 (p = 0.04 and p = 0.001). Our study demonstrated that intravitreal itraconazole significantly inhibited the development of laser-induced CNV in rats. Itraconazole had anti-angiogenic activity along with the reduction of VEGFR2 and VEGF levels. Itraconazole may prove beneficial for treating CNV as an alternative or adjunct to other therapies.	[Bae, Jeong Hun; Chang, Hae Ran] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Med Res Inst,Dept Ophthalmol, Seoul, South Korea; [Bae, Jeong Hun; Hwang, Ah Reum; Kim, Chan Yun; Koh, Hyoung Jun; Lee, Sung Chul] Yonsei Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Yu, Hyeong Gon] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Yang, Woo Ick] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Yonsei University; Yonsei University Health System	Lee, SC (corresponding author), Yonsei Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	sunglee@yuhs.ac		Koh, Hyoung Jun/0000-0002-5932-8516; , Sung Chul/0000-0001-9438-2385; Kim, Chan Yun/0000-0002-8373-9999	Medical Research Funds from Kangbuk Samsung Hospital; Samsung Biomedical Research Institute [SMX1132251]	Medical Research Funds from Kangbuk Samsung Hospital(Samsung); Samsung Biomedical Research Institute(Samsung)	This work was supported by Medical Research Funds from Kangbuk Samsung Hospital (https://www.kbsmc.co.kr/) and Samsung Biomedical Research Institute grant #SMX1132251 (http://www.smc.or.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftab BT, 2011, CANCER RES, V71, P6764, DOI 10.1158/0008-5472.CAN-11-0691; Antonarakis ES, 2013, ONCOLOGIST, V18, P163, DOI 10.1634/theoncologist.2012-314; Barouch Fina C., 2004, International Ophthalmology Clinics, V44, P23, DOI 10.1097/00004397-200404430-00005; Blinder KJ, 2003, AM J OPHTHALMOL, V136, P407, DOI 10.1016/S0002-9394(03)00223-X; Campochiaro PA, 2015, PROG RETIN EYE RES, V49, P67, DOI 10.1016/j.preteyeres.2015.06.002; Chong CR, 2007, ACS CHEM BIOL, V2, P263, DOI 10.1021/cb600362d; Del Carratore R, 2012, BIOMED PHARMACOTHER, V66, P312, DOI 10.1016/j.biopha.2011.11.004; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Frey T, 2009, J BIOL CHEM, V284, P16882, DOI 10.1074/jbc.M109.007609; Fu YL, 2007, INVEST OPHTH VIS SCI, V48, P5184, DOI 10.1167/iovs.07-0469; Goktas S, 2014, OPHTHALMIC RES, V52, P170, DOI 10.1159/000366283; Grunewald FS, 2010, BBA-PROTEINS PROTEOM, V1804, P567, DOI 10.1016/j.bbapap.2009.09.002; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Kelly BD, 2003, CIRC RES, V93, P1074, DOI 10.1161/01.RES.0000102937.50486.1B; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kim J, 2010, CANCER CELL, V17, P388, DOI 10.1016/j.ccr.2010.02.027; Kim SJ, 2010, ARCH OPHTHALMOL-CHIC, V128, P596, DOI 10.1001/archophthalmol.2010.69; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338; Lambert V, 2013, NAT PROTOC, V8, P2197, DOI 10.1038/nprot.2013.135; Lin CH, 2013, BRIT J PHARMACOL, V168, P920, DOI 10.1111/j.1476-5381.2012.02227.x; Liu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057473, 10.1371/journal.pone.0050719, 10.1371/journal.pone.0064143]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyzogubov VV, 2012, BBA-MOL CELL RES, V1823, P1264, DOI 10.1016/j.bbamcr.2012.05.017; Nacev BA, 2011, J BIOL CHEM, V286, P44045, DOI 10.1074/jbc.M111.278754; Nagy JA, 2007, ANNU REV PATHOL-MECH, V2, P251, DOI 10.1146/annurev.pathol.2.010506.134925; Oshima Y, 2004, J CELL PHYSIOL, V201, P393, DOI 10.1002/jcp.20110; Ozaki H, 1999, INVEST OPHTH VIS SCI, V40, P182; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Saishin Y, 2003, J CELL PHYSIOL, V195, P241, DOI 10.1002/jcp.10246; SCHULMAN JA, 1991, INT OPHTHALMOL, V15, P21, DOI 10.1007/BF00150975; Shi W, 2010, ACS MED CHEM LETT, V1, P155, DOI 10.1021/ml1000068; Shi YY, 2011, GRAEF ARCH CLIN EXP, V249, P1667, DOI 10.1007/s00417-011-1699-4; Surace EM, 2006, MOL THER, V13, P573, DOI 10.1016/j.ymthe.2005.10.010; Takahashi H, 2006, J OCUL PHARMACOL TH, V22, P213, DOI 10.1089/jop.2006.22.213; Takata S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09898; Thompson JT, 2006, AM J OPHTHALMOL, V141, P629, DOI 10.1016/j.ajo.2005.11.050; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu J, 2010, P NATL ACAD SCI USA, V107, P4764, DOI 10.1073/pnas.0910872107; Yamada K, 2007, INVEST OPHTH VIS SCI, V48, P1839, DOI 10.1167/iovs.06-1085	40	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180482	10.1371/journal.pone.0180482	http://dx.doi.org/10.1371/journal.pone.0180482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666022	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608700011
J	Madejon, P; Maranon, T; Navarro-Fernandez, CM; Dominguez, MT; Alegre, JM; Robinson, B; Murillo, JM				Madejon, Paula; Maranon, Teodoro; Navarro-Fernandez, Carmen M.; Dominguez, Maria T.; Alegre, Jose M.; Robinson, Brett; Murillo, Jose M.			Potential of Eucalyptus camaldulensis for phytostabilization and biomonitoring of traceelement contaminated soils	PLOS ONE			English	Article							TRACE-ELEMENTS; HEAVY-METALS; DEGRADED SOILS; MINE TAILINGS; POPULUS-ALBA; ACCUMULATION; PHYTOREMEDIATION; POLLUTION; CADMIUM; PLANTS	Soil pollution by trace elements (TEs) from mining and industrial activity is widespread and presents a risk to humans and ecosystems. The use of trees to immobilize TEs (phytostabilization) is a low-cost and effective method of soil remediation. We aimed to determine the chemical composition of leaves and flower buds of Eucalyptus camaldulensis in seven sites along the Guadiamar River valley (SW Spain), an area contaminated by a mine-spill in 1998. E. camaldulensis trees in the spill-affected area and adjacent non affected areas were growing on a variety of soils with pH from 5.6 to 8.1 with low concentration of plant nutrients. The spill affected soils contained up to 1069 mg kg(-1) of As and 4086 mg kg(-1) of Pb. E. camaldulensis tolerated elevated TE concentrations in soil and, compared to other species growing in the same environment, had low TE concentrations in the aerial portions. Besides tolerance to soil contamination, E. camaldulensis had low bioaccumulation coefficients for soil contaminants. TE concentrations in the aboveground portions were below levels reported to be toxic to plants or ecosystems. Flower buds had even lower TE concentrations than leaves. Despite the relatively low concentration of TEs in leaves they were significantly correlated with the soil extractable (0.01 M CaCl2) Cd, Mn and Zn (but not Cu and Pb). The general features of this tree species: tolerance to impoverished and contaminated soils, fast growth and deep root system, and low transfer of TEs from soil to aboveground organs makes it suitable for phytostabilization of soils contaminated by TEs. In addition, eucalyptus leaves could be used for biomonitoring the soil extractability of Cd, Mn and Zn but not Cu or Pb.	[Madejon, Paula; Maranon, Teodoro; Navarro-Fernandez, Carmen M.; Dominguez, Maria T.; Alegre, Jose M.; Murillo, Jose M.] IRNAS, Seville, Spain; [Robinson, Brett] Lincoln Univ, Dept Soil & Phys Sci, Canterbury, New Zealand	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); Lincoln University - New Zealand	Madejon, P (corresponding author), IRNAS, Seville, Spain.	pmadejon@irnase.csic.es	Domínguez, María T./K-6081-2014; Dominguez, Maria T./AAV-4787-2020; Maranon, Teodoro/K-6648-2014; MADEJON, PAULA/K-1237-2014; Robinson, Brett/F-1208-2010	Domínguez, María T./0000-0002-7348-9543; Dominguez, Maria T./0000-0002-7348-9543; Maranon, Teodoro/0000-0002-7751-9316; MADEJON, PAULA/0000-0002-8641-8293; Robinson, Brett/0000-0003-0322-0255	European Union Seventh Framework Programme (FP7) [603498]; Spanish Ministry of Economy and Competitiveness project RESTECO [CGL-2014-52858-R]	European Union Seventh Framework Programme (FP7); Spanish Ministry of Economy and Competitiveness project RESTECO	This work has been funded by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement n 603498 (RECARE), and by the Spanish Ministry of Economy and Competitiveness, project RESTECO (CGL-2014-52858-R).	Adriano D.C., 2001, TRACE ELEMENTS TERRE, VSecond; Aguilar J, 2004, ENVIRON POLLUT, V132, P395, DOI 10.1016/j.envpol.2004.05.028; Aguilar J, 1999, CRITERIOS ESTA NDARE; Ali H, 2013, CHEMOSPHERE, V91, P869, DOI 10.1016/j.chemosphere.2013.01.075; [Anonymous], 2013, INT J FORESTRY RES, DOI DOI 10.1155/2013/463030; Arenas J. M, 2003, GUADIAMAR GREEN CORR; Arriagada CA, 2007, J ENVIRON MANAGE, V84, P93, DOI 10.1016/j.jenvman.2006.05.005; Baker AJM, 2000, PHYTOREMEDIATION OF, P85; Baoeva K, 2014, INT J PHYTOREMEDIAT, V16, P347; BARGAGLI R, 1998, TRACE ELEMENTS TERRE; Bolan NS, 2011, ADV AGRON, V112, P145, DOI 10.1016/B978-0-12-385538-1.00004-4; Bowen H. J. M., 1979, Environmental chemistry of the elements.; Bren L. J., 1991, Australian Forestry, V54, P9; Cabrera F, 1999, SCI TOTAL ENVIRON, V242, P117, DOI 10.1016/S0048-9697(99)00379-4; CAC (Consejeria de Agricultura y Comercio), 1992, JUNT EXTR; Carbonell AA, 1998, SCI TOTAL ENVIRON, V217, P189, DOI 10.1016/S0048-9697(98)00195-8; Chaney RL, 2017, ADV BOT RES, V83, P189, DOI 10.1016/bs.abr.2016.12.006; Ciadamidaro L, 2014, J ENVIRON MANAGE, V132, P329, DOI 10.1016/j.jenvman.2013.11.010; Coleman CM, 2005, J CHEM ECOL, V31, P1669, DOI 10.1007/s10886-005-5919-4; Das P, 1997, ENVIRON POLLUT, V98, P29, DOI 10.1016/S0269-7491(97)00110-3; Davidson J., 1993, P REG EXP CONS EUC O, V1, P35; Demolon A., 1952, GUIDE ETUDE EXPT SOL; Deng THB, 2016, PLANT SOIL, V404, P35, DOI 10.1007/s11104-016-2825-1; Dominguez MT, 2016, GEODERMA, V261, P133, DOI 10.1016/j.geoderma.2015.07.008; Dominguez MT, 2008, ENVIRON POLLUT, V152, P50, DOI 10.1016/j.envpol.2007.05.021; Dominguez MT, 2012, PLANT SOIL, V357, P407, DOI 10.1007/s11104-012-1214-7; Dominguez MT, 2010, WATER AIR SOIL POLL, V205, P305, DOI 10.1007/s11270-009-0075-z; Doumas P, 2016, REGIONAL ENV CHANGE, P1; ERNST WHO, 1992, ACTA BOT NEERL, V41, P229, DOI 10.1111/j.1438-8677.1992.tb01332.x; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; Fine P, 2013, INT J PHYTOREMEDIAT, V15, P585, DOI 10.1080/15226514.2012.723061; Flege A, 2000, LAND RECONS, V1, P291; Freitas P, 1970, PHYS CHEM METHODS SO; GEE GW, 1979, SOIL SCI SOC AM J, V43, P1004, DOI 10.2136/sssaj1979.03615995004300050038x; Grimalt JO, 1999, SCI TOTAL ENVIRON, V242, P3, DOI 10.1016/S0048-9697(99)00372-1; Hazelton P., 2007, Interpreting soil test results: what do all the numbers mean?; Heckenroth A, 2016, J ENVIRON MANAGE, V183, P850, DOI 10.1016/j.jenvman.2016.09.029; Hesse P. R., 1971, TXB SOIL CHEM ANAL; Houba VJG, 2000, COMMUN SOIL SCI PLAN, V31, P1299, DOI 10.1080/00103620009370514; Kabata-Pendias A., 1992, Trace elements in soils and plants.; King DJ, 2008, SCI TOTAL ENVIRON, V406, P35, DOI 10.1016/j.scitotenv.2008.07.054; Lambers H, 2015, TRENDS PLANT SCI, V20, P83, DOI 10.1016/j.tplants.2014.10.007; Lepp NW, 2007, J ENVIRON QUAL, V36, P1123, DOI 10.2134/jeq2006.0218; Macklin MG, 2006, GEOMORPHOLOGY, V79, P423, DOI 10.1016/j.geomorph.2006.06.024; Madejon P, 2007, CHEMOSPHERE, V67, P20, DOI 10.1016/j.chemosphere.2006.10.008; Madejon P, 2004, ENVIRON POLLUT, V132, P145, DOI 10.1016/j.envpol.2004.03.015; Madejon P, 2013, INT J PHYTOREMEDIAT, V15, P602, DOI 10.1080/15226514.2012.723062; Madejon P, 2003, SCI TOTAL ENVIRON, V307, P239, DOI 10.1016/S0048-9697(02)00609-5; Madejon P, 2009, INT J PHYTOREMEDIAT, V11, P542, DOI 10.1080/15226510902717572; Madejon P, 2006, ENVIRON POLLUT, V143, P1, DOI 10.1016/j.envpol.2005.11.008; Madejon P, 2016, J ENVIRON MANAGE, V169, P18, DOI 10.1016/j.jenvman.2015.11.050; Markert BA, 2003, TRACE METALS OTHER, V6, P3; Meeinkuirt W, 2016, SCIENCEASIA, V42, P83, DOI 10.2306/scienceasia1513-1874.2016.42.083; Meeinkuirt W, 2012, INT J PHYTOREMEDIAT, V14, P925, DOI 10.1080/15226514.2011.636403; Meers E, 2007, ENVIRON EXP BOT, V60, P57, DOI 10.1016/j.envexpbot.2006.06.008; Meindl GA, 2013, ENVIRON POLLUT, V177, P78, DOI 10.1016/j.envpol.2013.02.017; Mendez Monica O., 2008, Reviews in Environmental Science and Bio/Technology, V7, P47, DOI 10.1007/s11157-007-9125-4; Mengel K, 1987, PRINCIPLES PLANT NUT, V4th, DOI DOI 10.1093/AOB/MCH063; Mleczek M, 2009, ENVIRON EXP BOT, V66, P289, DOI 10.1016/j.envexpbot.2009.02.010; Mok HF, 2013, INT J PHYTOREMEDIAT, V15, P615, DOI 10.1080/15226514.2012.723063; Moreno-Jimenez E, 2012, J HAZARD MATER, V201, P52, DOI 10.1016/j.jhazmat.2011.11.013; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; Navarro A, 2016, BIOENERG RES, V9, P208, DOI 10.1007/s12155-015-9677-z; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Panagos P, 2013, J ENVIRON PUBLIC HEA, V2013, DOI 10.1155/2013/158764; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Pietrini F, 2015, J ENVIRON MANAGE, V162, P221, DOI 10.1016/j.jenvman.2015.07.053; Pilon-Smits E, 2005, ANNU REV PLANT BIOL, V56, P15, DOI 10.1146/annurev.arplant.56.032604.144214; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Pulford ID, 2003, ENVIRON INT, V29, P529, DOI 10.1016/S0160-4120(02)00152-6; Reichman SM, 2004, PLANT SOIL, V258, P341, DOI 10.1023/B:PLSO.0000016564.14512.eb; Reimann C, 1998, CHEM ELEMENTS ENV FA, DOI DOI 10.1017/S0016756800264613; Reuter D.J., 1997, PLANT ANAL INTERPRET, P83; Robinson BH, 2000, PLANT SOIL, V227, P301, DOI 10.1023/A:1026515007319; SECF, 2010, SIT BOSQ SECT FOR ES; STONE C, 1994, J APPL ECOL, V31, P604, DOI 10.2307/2404151; Teh T, 2016, PEDOSPHERE, V26, P431, DOI 10.1016/S1002-0160(15)60055-8; Dominguez MT, 2010, EUR J FOREST RES, V129, P47, DOI 10.1007/s10342-008-0253-3; Terrab A, 2004, J AGR FOOD CHEM, V52, P3441, DOI 10.1021/jf035352e; Terrab A, 2003, J SCI FOOD AGR, V83, P637, DOI 10.1002/jsfa.1341; TOMLINSON DL, 1980, HELGOLANDER MEERESUN, V33, P566, DOI 10.1007/BF02414780; Turnbull J.W., 2002, EUCALYPTUS GENUS EUC, P52; Wahsha M, 2012, J GEOCHEM EXPLOR, V123, P19, DOI 10.1016/j.gexplo.2012.07.004; Wolterbeek B, 2002, ENVIRON POLLUT, V120, P11, DOI 10.1016/S0269-7491(02)00124-0; Wong MH, 2003, CHEMOSPHERE, V50, P775, DOI 10.1016/S0045-6535(02)00232-1; Wu G, 2010, J HAZARD MATER, V174, P1, DOI 10.1016/j.jhazmat.2009.09.113; Xie QQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136606; Zuur A, 2009, MIXED EFFECTS MODELS	88	22	24	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180240	10.1371/journal.pone.0180240	http://dx.doi.org/10.1371/journal.pone.0180240			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666017	gold, Green Submitted, Green Published			2022-12-26	WOS:000404608700075
J	Foley, MM; Magilligan, FJ; Torgersen, CE; Major, JJ; Anderson, CW; Connolly, PJ; Wieferich, D; Shafroth, PB; Evans, JE; Infante, D; Craig, LS				Foley, Melissa M.; Magilligan, Francis J.; Torgersen, Christian E.; Major, Jon J.; Anderson, Chauncey W.; Connolly, Patrick J.; Wieferich, Daniel; Shafroth, Patrick B.; Evans, James E.; Infante, Dana; Craig, Laura S.			Landscape context and the biophysical response of rivers to dam removal in the United States	PLOS ONE			English	Article							ECOLOGICAL RESEARCH; FISH; RESTORATION; MACROINVERTEBRATE; LESSONS; ASSEMBLAGES; WASHINGTON; CHANNEL; TIME	Dams have been a fundamental part of the U. S. national agenda over the past two hundred years. Recently, however, dam removal has emerged as a strategy for addressing aging, obsolete infrastructure and more than 1,100 dams have been removed since the 1970s. However, only 130 of these removals had any ecological or geomorphic assessments, and fewer than half of those included before-and after-removal (BAR) studies. In addition, this growing, but limited collection of dam-removal studies is limited to distinct landscape settings. We conducted a meta-analysis to compare the landscape context of existing and removed dams and assessed the biophysical responses to dam removal for 63 BAR studies. The highest concentration of removed dams was in the Northeast and Upper Midwest, and most have been removed from 3 rd and 4 th order streams, in low-elevation (< 500 m) and low-slope (< 5%) watersheds that have small to moderate upstream watershed areas (10-1000 km 2) with a low risk of habitat degradation. Many of the BAR-studied removals also have these characteristics, suggesting that our understanding of responses to dam removals is based on a limited range of landscape settings, which limits predictive capacity in other environmental settings. Biophysical responses to dam removal varied by landscape cluster, indicating that landscape features are likely to affect biophysical responses to dam removal. However, biophysical data were not equally distributed across variables or clusters, making it difficult to determine which landscape features have the strongest effect on dam-removal response. To address the inconsistencies across dam-removal studies, we provide suggestions for prioritizing and standardizing data collection associated with dam removal activities.	[Foley, Melissa M.] US Geol Survey, Pacific Coastal & Marine Sci Ctr, Santa Cruz, CA 95060 USA; [Magilligan, Francis J.] Dartmouth Coll, Dept Geog, Hanover, NH 03755 USA; [Torgersen, Christian E.] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Seattle, WA USA; [Major, Jon J.] US Geol Survey, Volcano Sci Ctr, Cascades Volcano Observ, Vancouver, WA USA; [Anderson, Chauncey W.] US Geol Survey Portland, Oregon Water Sci Ctr, Portland, OR USA; [Connolly, Patrick J.] US Geol Survey, Columbia River Res Lab, Western Fisheries Res Ctr, Cook, WA USA; [Wieferich, Daniel] US Geol Survey, Denver Fed Ctr, Lakewood, CO 80225 USA; [Shafroth, Patrick B.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA; [Evans, James E.] Bowling Green State Univ, Dept Geol, Bowling Green, OH 43403 USA; [Infante, Dana] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Craig, Laura S.] Amer Rivers, Washington, DC USA; [Foley, Melissa M.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA	United States Department of the Interior; United States Geological Survey; Dartmouth College; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University System of Ohio; Bowling Green State University; Michigan State University; University of California System; University of California Santa Cruz	Foley, MM (corresponding author), US Geol Survey, Pacific Coastal & Marine Sci Ctr, Santa Cruz, CA 95060 USA.; Foley, MM (corresponding author), Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA.	mfoley@ucsc.edu	Van Cleave, Keith/AAN-2338-2021; Evans, James/U-7695-2019	Evans, James/0000-0002-9382-1910; Magilligan, Francis/0000-0002-0082-5526; Anderson, Chauncey/0000-0002-1016-3781; Foley, Melissa/0000-0002-5832-6404; Wieferich, Daniel/0000-0003-1554-7992	US Geological Survey John Wesley Powell Center for Analysis and Synthesis	US Geological Survey John Wesley Powell Center for Analysis and Synthesis	This work was supported by the US Geological Survey John Wesley Powell Center for Analysis and Synthesis (https://powellcenter.usgs.gov/). The funders had no role in study design, data collection and anlysis, decision to publish, or preparation of the manuscript	Ahearn DS, 2005, LIMNOL OCEANOGR, V50, P1752, DOI 10.4319/lo.2005.50.6.1752; Bednarek AT, 2001, ENVIRON MANAGE, V27, P803, DOI 10.1007/s002670010189; Bernhardt ES, 2007, RESTOR ECOL, V15, P482, DOI 10.1111/j.1526-100X.2007.00244.x; Bernhardt ES, 2005, SCIENCE, V308, P636, DOI 10.1126/science.1109769; Bulak J, 2011, TWELVEMILE CREEK DAM; Burdick SM, 2006, T AM FISH SOC, V135, P1290, DOI 10.1577/T05-190.1; Burroughs BA, 2010, T AM FISH SOC, V139, P1595, DOI 10.1577/T09-056.1; Catalano MJ, 2002, EVALUATING FISH HABI; Chaplin JJ, EFFECTS REMOVING GOO; CHURCH M, 1995, REGUL RIVER, V11, P3, DOI 10.1002/rrr.3450110103; Claeson SM, 2016, RIVER RES APPL, V32, P1143, DOI 10.1002/rra.2935; Clarke KR, 2015, PRIMER V7 USER MANUA; Crawford S., 2016, FISHS EYE STATUS FIS; Daniel WM, 2015, NATL FISH HABITAT PA; Doyle MW, 2005, GEOMORPHOLOGY, V71, P227, DOI 10.1016/j.geomorph.2004.04.011; Doyle MW, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001714; East AE, 2015, GEOMORPHOLOGY, V228, P765, DOI 10.1016/j.geomorph.2014.08.028; Foley MM, COASTAL HAB IN PRESS; Foley MM, WATER RESOU IN PRESS; Gibson AM, 2011, ECOSYSTEM RESPONSES; Grant GE, 2015, ENGINEERING GEOLOGY FOR SOCIETY AND TERRITORY, VOL 3: RIVER BASINS, RESERVOIR SEDIMENTATION AND WATER RESOURCES, P31, DOI 10.1007/978-3-319-09054-2_7; Hansen JF, 2012, RIVER RES APPL, V28, P1540, DOI 10.1002/rra.1540; Harbold W, 2013, PATAPSCO RIVER DAM R; Hart DD, 2002, BIOSCIENCE, V52, P669, DOI 10.1641/0006-3568(2002)052[0669:DRCAOF]2.0.CO;2; Herreman K, 2015, NATL FISH HABITAT PA; Hitt NP, 2012, T AM FISH SOC, V141, P1171, DOI 10.1080/00028487.2012.675918; Hoenke KM, 2014, ECOL ENG, V64, P27, DOI 10.1016/j.ecoleng.2013.12.009; Hogg RS, 2015, T AM FISH SOC, V144, P467, DOI 10.1080/00028487.2015.1007164; Howard G, 2007, CARBONTON DAM DEEP R; Hutchison B., 2008, FISH MACROINVERTEBRA; Jolley JC, 2013, OCCURRENCE DETECTION; Kemp PS, 2010, FISHERIES MANAG ECOL, V17, P297, DOI 10.1111/j.1365-2400.2010.00751.x; Knittel MJ, 2010, IMPACT SMALL DAM REM; Kornis MS, 2015, AQUAT SCI, V77, P465, DOI 10.1007/s00027-014-0391-2; Magilligan F, 2016, ELEMENTA, V4; Major J. J., 2017, GRAVELBED RIVERS PRO, P355; Major JJ, 2012, GEOMORPHIC RESPONSE; Maloney KO, 2008, FRESHWATER BIOL, V53, P1055, DOI 10.1111/j.1365-2427.2008.01956.x; Marks JC, 2010, RESTOR ECOL, V18, P934, DOI 10.1111/j.1526-100X.2009.00574.x; McHenry M., 2015, SPAWNING DISTRIBUTIO; McKay SK, 2013, ECOL APPL, V23, P1396, DOI 10.1890/12-1564.1; Neeson TM, 2015, P NATL ACAD SCI USA, V112, P6236, DOI 10.1073/pnas.1423812112; O'Connor JE, 2015, SCIENCE, V348, P496, DOI 10.1126/science.aaa9204; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; Orr CH, 2006, J N AM BENTHOL SOC, V25, P556, DOI 10.1899/0887-3593(2006)25[556:CMAPUF]2.0.CO;2; Ostroff S, 2013, 2012 NATL ANTHROPOGE; Palmer MA, 2005, J APPL ECOL, V42, P208, DOI 10.1111/j.1365-2664.2005.01004.x; Palmer MA, 2009, ESTUAR COAST, V32, P1, DOI 10.1007/s12237-008-9129-5; Pess G, ECOSYSTEM R IN PRESS; Pohl MM, 2002, J AM WATER RESOUR AS, V38, P1511, DOI 10.1111/j.1752-1688.2002.tb04361.x; Pollard AI, 2004, HYDROBIOLOGIA, V513, P51, DOI 10.1023/B:hydr.0000018164.17234.4f; QGIS, 2016, QGIS GEOGR INF SYST; Sawaske SR, 2012, GEOMORPHOLOGY, V151, P50, DOI 10.1016/j.geomorph.2012.01.013; Shafroth PB, 2002, BIOSCIENCE, V52, P703, DOI 10.1641/0006-3568(2002)052[0703:PRORVT]2.0.CO;2; Sherman M., 2013, POTENTIAL IMPACTS SM; Somerfield PJ, 2014, MAR ENVIRON RES, V102, P51, DOI 10.1016/j.marenvres.2014.06.004; Stanley EH, 2003, FRONT ECOL ENVIRON, V1, P15, DOI 10.1890/1540-9295(2003)001[0015:TOTEEO]2.0.CO;2; Stanley EH, 2002, BIOSCIENCE, V52, P693, DOI 10.1641/0006-3568(2002)052[0693:AGPONR]2.0.CO;2; Stewart GB, 2006, PATTERNS PROCESSES S; SWANSON FJ, 1990, BIOSCIENCE, V40, P502, DOI 10.2307/1311318; Thomson JR, 2005, J N AM BENTHOL SOC, V24, P192, DOI 10.1899/0887-3593(2005)024<0192:EOROAS>2.0.CO;2; Tonitto C, 2016, SUST WAT RESOUR MAN, V2, P489, DOI 10.1007/s40899-016-0062-7; Tullos DD, 2016, J AM WATER RESOUR AS, V52, P1179, DOI 10.1111/1752-1688.12450; Tullos DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108091; Ward J., 1983, DYNAMICS LOTIC ECOSY, P29, DOI 10.2307/2259560; Whitener P., 2013, 12 MILE CREEK CHANNE; Wieferich DJ, NATL DAM REMOVAL SCI	67	29	30	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180107	10.1371/journal.pone.0180107	http://dx.doi.org/10.1371/journal.pone.0180107			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692693	Green Published, gold			2022-12-26	WOS:000405544800024
J	Hudak, R; Szekely, EG; Kovacs, KR; Nagy, A; Hofgart, G; Berenyi, E; Csiba, L; Kappelmayer, J; Bagoly, Z				Hudak, Renata; Szekely, Edina G.; Kovacs, Katalin R.; Nagy, Attila; Hofgart, Gergely; Berenyi, Ervin; Csiba, Laslo; Kappelmayer, Janos; Bagoly, Zsuzsa			Low thrombin generation predicts poor prognosis in ischemic stroke patients after thrombolysis	PLOS ONE			English	Article							ASSAYS; HEMOPHILIA; HEMORRHAGE; MANAGEMENT; RISK	Thrombolysis by intravenous recombinant tissue plasminogen activator (rt-PA) is an effective therapy in acute ischemic stroke (AIS). Thrombin generation test (TGT) is a global hemostasis test providing information about the speed and amount of generated thrombin in plasma. Here we aimed to find out whether results of this test before the initiation of thrombolysis might predict outcomes. Study population included 120 consecutive AIS patients, all within 4.5 hours of their symptom onset, who underwent thrombolysis by rt-PA. Blood samples were collected from all patients upon admission and TGT was performed using platelet poor plasma. Clinical data of patients including the NIHSS were registered at admission, day 1 and 7 after therapy. The ASPECT score was assessed using CT images taken before and 24 hours after thrombolysis. Long-term functional outcome was defined 3 months after the event by the modified Rankin Scale. Endogenous Thrombin Potential (ETP) and Peak Thrombin were significantly lower in patients with cardioembolic IS. Symptomatic intracranial hemorrhage (SICH) was found in 6 patients and was significantly associated with low ETP and Peak Thrombin levels. A multiple logistic regression model revealed that an ETP result in the lower quartile is an independent predictor of mortality within the first two weeks (OR: 6.03; 95% CI: 1.2-30.16, p< 0.05) and three months after the event (OR: 5.28; 95% CI: 1.27-21.86, p< 0.05). Low levels of ETP and Peak Thrombin parameters increase the risk of therapy associated SICH. A low ETP result is an independent predictor of short-and longterm mortality following thrombolysis.	[Hudak, Renata; Kappelmayer, Janos] Univ Debrecen, Fac Med, Dept Lab Med, Debrecen, Hungary; [Szekely, Edina G.; Bagoly, Zsuzsa] Univ Debrecen, Fac Med, Dept Lab Med, Div Clin Lab Sci, Debrecen, Hungary; [Kovacs, Katalin R.; Hofgart, Gergely; Csiba, Laslo] Univ Debrecen, Fac Med, Dept Neurol, Debrecen, Hungary; [Nagy, Attila] Univ Debrecen, Fac Publ Hlth, Dept Prevent Med, Debrecen, Hungary; [Berenyi, Ervin] Univ Debrecen, Fac Med, Dept Radiol, Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen	Bagoly, Z (corresponding author), Univ Debrecen, Fac Med, Dept Lab Med, Div Clin Lab Sci, Debrecen, Hungary.	bagoly@med.unideb.hu	Bagoly, Zsuzsa/AAB-3553-2020; Bagoly, Zsolt/K-6365-2018	Bagoly, Zsolt/0000-0002-2679-7594; Bagoly, Zsuzsa/0000-0001-5314-5607; Nagy, Attila/0000-0002-0554-7350	National Research, Development and Innovation Fund (OTKA) [K109712, PD111929]; National Development Agency [TAMOP 4.2.2.A-11/1/KONV-2012-0045]; European Union; European Regional Development Fund [GINOP-2.3.2-15-2016-00043]; Janos Bolyai fellowship; European Social Fund [TAMOP -4.2.4.A/2-11/1-2012-0001]	National Research, Development and Innovation Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Development Agency; European Union(European Commission); European Regional Development Fund(European Commission); Janos Bolyai fellowship(Hungarian Academy of Sciences); European Social Fund(European Social Fund (ESF))	This work was supported by grants from the National Research, Development and Innovation Fund (OTKA K109712, PD111929), the National Development Agency (TAMOP 4.2.2.A-11/1/KONV-2012-0045) and by the European Union and the European Regional Development Fund, GINOP-2.3.2-15-2016-00043. ZB is the recipient of Janos Bolyai fellowship and Lajos Szodoray Prize. RH was supported by the European Social Fund in the frame of TAMOP -4.2.4.A/2-11/1-2012-0001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Aviv RI, 2007, AM J NEURORADIOL, V28, P1975, DOI 10.3174/ajnr.A0689; Ay Y, 2013, CLIN APPL THROMB-HEM, V19, P389, DOI 10.1177/1076029612438611; Bosch Y, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-154; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Brummel-Ziedins KE, 2014, CURR OPIN HEMATOL, V21, P395, DOI 10.1097/MOH.0000000000000074; Carcaillon L, 2011, ARTERIOSCL THROM VAS, V31, P1445, DOI 10.1161/ATVBAHA.111.223453; Castoldi E, 2011, THROMB RES, V127, pS21, DOI 10.1016/S0049-3848(11)70007-X; Cocho D, 2006, STROKE, V37, P996, DOI 10.1161/01.STR.0000206461.71624.50; Fugate Jennifer E, 2010, Front Neurol, V1, P139, DOI 10.3389/fneur.2010.00139; Gerotziafas GT, 2005, THROMB J, V3, DOI 10.1186/1477-9560-3-16; Gissel M, 2010, THROMB RES, V126, P262, DOI 10.1016/j.thromres.2010.07.002; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Haidl H, 2006, THROMB HAEMOSTASIS, V95, P772, DOI 10.1160/TH05-10-0685; Hemker HC, 2006, THROMB HAEMOSTASIS, V96, P553, DOI 10.1160/TH06-07-0408; Hemker HC, 2013, THROMB RES, V131, P3, DOI 10.1016/j.thromres.2012.10.011; Lance MD, 2015, THROMB J, V13, DOI 10.1186/1477-9560-13-1; Larrue V, 2001, STROKE, V32, P438, DOI 10.1161/01.STR.32.2.438; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Perrin J, 2015, THROMB RES, V136, P125, DOI 10.1016/j.thromres.2014.12.015; Rooth E, 2013, SCAND J CLIN LAB INV, V73, P576, DOI 10.3109/00365513.2013.826817; Seet RCS, 2012, CEREBROVASC DIS, V34, P106, DOI 10.1159/000339675; Smid M, 2011, J THROMB HAEMOST, V9, P450, DOI 10.1111/j.1538-7836.2010.04162.x; Young G, 2013, BLOOD, V121, P1944, DOI 10.1182/blood-2012-08-378935	25	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180477	10.1371/journal.pone.0180477	http://dx.doi.org/10.1371/journal.pone.0180477			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692682	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000405544800045
J	Kim, JH; Choi, SH; Jang, JH; Lee, DH; Lee, KJ; Lee, WJ; Moon, JY; Kim, YC; Kang, DH				Kim, Jae-Hun; Choi, Soo-Hee; Jang, Joon Hwan; Lee, Do-Hyeong; Lee, Kyung-Jun; Lee, Won Joon; Moon, Jee Youn; Kim, Yong Chul; Kang, Do-Hyung			Impaired insula functional connectivity associated with persistent pain perception in patients with complex regional pain syndrome	PLOS ONE			English	Article							OLD-WORLD MONKEY; CORTEX FUNCTION; BRAIN; DYSFUNCTION; ABNORMALITIES; ACTIVATION; ALLODYNIA; INVENTORY; GRAY	Given that the insula plays a contributory role in the perception of chronic pain, we examined the resting-state functional connectivity between the insular cortex and other brain regions to investigate neural underpinnings of persisting perception of background pain in patients with complex regional pain syndrome (CRPS). A total of 25 patients with CRPS and 25 matched healthy controls underwent functional magnetic resonance imaging at rest. With the anterior and posterior insular cortices as seed regions, we compared the strength of the= resting-state functional connectivity between the two groups. Functional connectivity between the anterior and posterior insular cortices and the postcentral and inferior frontal gyri, cingulate cortices was reduced in patients with CRPS compared with controls. Additionally, greater reductions in functional connectivity between the anterior insula and right postcentral gyrus were associated with more severe sensory pain in patients with CRPS (short-form McGill Pain Questionnaire sensory subscores, r = -. 517, P =.023). The present results imply a possible role of the insula in aberrant processing of pain information in patients with CRPS. The findings suggest that a functional derangement of the connection between one of the somatosensory cortical functions of perception and one of the insular functions of awareness can play a significant role in the persistent experience of regional pain that is not confined to a specific nerve territory.	[Kim, Jae-Hun] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Radiol, Seoul, South Korea; [Choi, Soo-Hee; Lee, Do-Hyeong; Lee, Kyung-Jun; Lee, Won Joon; Kang, Do-Hyung] Seoul Natl Univ Hosp, Dept Psychiat, Seoul, South Korea; [Choi, Soo-Hee; Kang, Do-Hyung] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Choi, Soo-Hee; Kang, Do-Hyung] Seoul Natl Univ, Coll Med, Inst Human Behav Sci, Seoul, South Korea; [Jang, Joon Hwan] Seoul Natl Univ, Coll Med, Dept Med, Seoul, South Korea; [Moon, Jee Youn; Kim, Yong Chul] Seoul Natl Univ Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kang, DH (corresponding author), Seoul Natl Univ Hosp, Dept Psychiat, Seoul, South Korea.; Kang, DH (corresponding author), Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea.; Kang, DH (corresponding author), Seoul Natl Univ, Coll Med, Inst Human Behav Sci, Seoul, South Korea.	basuare@hanmail.net		Kim, Jae-Hun/0000-0003-3064-6948	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Science, ICT FuturePlanning [2014R1A1A1004553]; Aspiring Researcher Program through Seoul National University (SNU)	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Science, ICT FuturePlanning; Aspiring Researcher Program through Seoul National University (SNU)	This study was funded by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & FuturePlanning (2014R1A1A1004553) and Aspiring Researcher Program through Seoul National University (SNU) in 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Bar KJ, 2013, ACTA PSYCHIAT SCAND, V127, P269, DOI 10.1111/j.1600-0447.2012.01896.x; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Baliki MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106133; Baliki MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026010; Barad MJ, 2014, J PAIN, V15, P197, DOI 10.1016/j.jpain.2013.10.011; Becerra L, 2014, NEUROIMAGE-CLIN, V6, P347, DOI 10.1016/j.nicl.2014.07.012; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bentley WJ, 2016, CEREB CORTEX, V26, P346, DOI 10.1093/cercor/bhu260; Berryman C, 2013, PAIN, V154, P1181, DOI 10.1016/j.pain.2013.03.002; Birklein F, 2015, NEUROLOGY, V84, P89, DOI 10.1212/WNL.0000000000001095; Birklein F, 2014, J PAIN, V15, P485, DOI 10.1016/j.jpain.2014.01.490; Bolwerk A, 2013, J PAIN, V14, P1107, DOI 10.1016/j.jpain.2013.04.007; Brass M, 2007, J NEUROSCI, V27, P9141, DOI 10.1523/JNEUROSCI.0924-07.2007; BRUEHL S, 1992, CLIN J PAIN, V8, P287, DOI 10.1097/00002508-199212000-00003; Bruehl S, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h2730; Bussa M, 2015, ACTA ANAESTH SCAND, V59, P685, DOI 10.1111/aas.12489; Choi SH, 2012, AM J PSYCHIAT, V169, P498, DOI 10.1176/appi.ajp.2012.11060976; Cohen H, 2013, EUR J PAIN, V17, P527, DOI 10.1002/j.1532-2149.2012.00213.x; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Craig AD, 2009, NATURE REVIEWS NEURO, P10; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Damasio A, 2013, CEREB CORTEX, V23, P833, DOI 10.1093/cercor/bhs077; de Mos M, 2007, PAIN, V129, P12, DOI 10.1016/j.pain.2006.09.008; de Mos M, 2009, CLIN J PAIN, V25, P590, DOI 10.1097/AJP.0b013e3181a11623; Di Pietro F, 2015, HUM BRAIN MAPP, V36, P508, DOI 10.1002/hbm.22643; Di Pietro F, 2013, J PAIN, V14, P1270, DOI 10.1016/j.jpain.2013.07.004; Di Pietro F, 2013, J PAIN, V14, P1001, DOI 10.1016/j.jpain.2013.04.001; Erpelding N, 2016, BRAIN STRUCT FUNCT, V221, P1095, DOI 10.1007/s00429-014-0957-8; Erpelding N, 2014, J NEUROPHYSIOL, V111, P239, DOI 10.1152/jn.00405.2013; First M. B, 1996, STRUCTURED CLINICAL; Freund W, 2011, CLIN J PAIN, V27, P796, DOI 10.1097/AJP.0b013e31821d9063; Galer BS, 1998, CLIN J PAIN, V14, P48, DOI 10.1097/00002508-199803000-00007; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; Hahn HM, 1986, J KOREAN NEUROPSYCHI, V25, P487; Head H, 1911, BRAIN, V34, P102, DOI 10.1093/brain/34.2-3.102; HSIEH JC, 1995, PAIN, V63, P225, DOI 10.1016/0304-3959(95)00048-W; Kim ZS., 1997, KOREAN J CLIN PSYCHO, V16, P185; Landro NI, 2013, PAIN, V154, P972, DOI 10.1016/j.pain.2013.01.013; Lee DH, 2015, J PAIN, V16, P580, DOI 10.1016/j.jpain.2015.03.006; Lee DH, 2014, PSYCHIAT INVEST, V11, P32, DOI 10.4306/pi.2014.11.1.32; Maihofner C, 2006, NEUROLOGY, V66, P711, DOI 10.1212/01.wnl.0000200961.49114.39; Marinus J, 2011, LANCET NEUROL, V10, P637, DOI 10.1016/S1474-4422(11)70106-5; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; Monti DA, 1998, CLIN J PAIN, V14, P295, DOI 10.1097/00002508-199812000-00005; MUFSON EJ, 1982, J COMP NEUROL, V212, P23, DOI 10.1002/cne.902120103; Mutso AA, 2012, J NEUROSCI, V32, P5747, DOI 10.1523/JNEUROSCI.0587-12.2012; Pleger B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085372; Ploner M, 2000, J NEUROPHYSIOL, V83, P1770, DOI 10.1152/jn.2000.83.3.1770; Simons LE, 2014, PAIN, V155, P1727, DOI 10.1016/j.pain.2014.05.023; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Uddin LQ, 2015, NAT REV NEUROSCI, V16, P55, DOI 10.1038/nrn3857	57	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180479	10.1371/journal.pone.0180479	http://dx.doi.org/10.1371/journal.pone.0180479			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692702	Green Published, Green Submitted, gold			2022-12-26	WOS:000405544800046
J	Barinov, A; Galgano, A; Krenn, G; Tanchot, C; Vasseur, F; Rocha, B				Barinov, Aleksandr; Galgano, Alessia; Krenn, Gerald; Tanchot, Corinne; Vasseur, Florence; Rocha, Benedita			CD4/CD8/Dendritic cell complexes in the spleen: CD8 T+ cells can directly bind CD4(+) T cells and modulate their response	PLOS ONE			English	Article							DENDRITIC CELLS; TRANSGENIC MICE; IN-VIVO; ANTIGEN; MEMORY; NAIVE; EXPRESSION; LYMPHOCYTES; HELP; REPERTOIRE	CD4(+) T cell help to CD8(+) T cell responses requires that CD4(+) and CD8(+) T cells interact with the same antigen presenting dendritic cell (Ag + DC), but it remains controversial whether helper signals are delivered indirectly through a licensed DC and/or involve direct CD4(+) CD8(+) T cell contacts and/or the formation of ternary complexes. We here describe the first in vivo imaging of the intact spleen, aiming to evaluate the first interactions between antigen-specific CD4(+), CD8(+) T cells and Ag+ DCs. We show that in contrast to CD4(+) T cells which form transient contacts with Ag+ DC, CD8(+) T cells form immediate stable contacts and activate the Ag + DC, acquire fragments of the DC membranes by trogocytosis, leading to their acquisition of some of the DC properties. They express MHC class II, and become able to present the specific Marilyn peptide to naive Marilyn CD4 (+) T cells, inducing their extensive division. In vivo, these CD8 (+) T cells form direct stable contacts with motile naive CD4 + T cells, recruiting them to Ag + DC binding and to the formation of ternary complexes, where CD4 (+) and CD8 (+) T cells interact with the DC and with one another. The presence of CD8 (+) T cells during in vivo immune responses leads to the early activation and up-regulation of multiple functions by CD4 (+) T lymphocytes. Thus, while CD4(+) T cell help is important to CD8 (+) T cell responses, CD8 (+) T cells can interact directly with naive CD4 (+) T cells impacting their recruitment and differentiation.	[Barinov, Aleksandr; Galgano, Alessia; Krenn, Gerald; Vasseur, Florence; Rocha, Benedita] Fac Med Rene Descartes, INSERM, U1020, Paris, France; [Tanchot, Corinne] Univ Paris 05, INSERM, U970, Ctr Rech Cardiovasc HEGP, Paris, France; [Barinov, Aleksandr; Vasseur, Florence; Rocha, Benedita] Inst Pasteur, Immunol Dept, Paris, France; [Galgano, Alessia] Inst Pasteur, Dept Infect & Epidemiol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Rocha, B (corresponding author), Fac Med Rene Descartes, INSERM, U1020, Paris, France.; Rocha, B (corresponding author), Inst Pasteur, Immunol Dept, Paris, France.	benedita.rocha@pasteur.fr		BARINOV, Aleksandr/0000-0003-2530-5081; Tanchot, Corinne/0000-0002-2913-1755	European Research Council [ERC-2008-AdG]	European Research Council(European Research Council (ERC)European Commission)	The European Research Council supported this work (Grant Nr. ERC-2008-AdG).	Ahmed KA, 2012, J LEUKOCYTE BIOL, V92, P289, DOI 10.1189/jlb.1211631; Aoshi T, 2008, IMMUNITY, V29, P476, DOI 10.1016/j.immuni.2008.06.013; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Baptista AP, 2014, ELIFE, V3, DOI 10.7554/eLife.04433; Berard M, 2002, IMMUNOLOGY, V106, P127, DOI 10.1046/j.1365-2567.2002.01447.x; Beuneu H, 2006, J IMMUNOL, V177, P1406, DOI 10.4049/jimmunol.177.3.1406; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; CAHILL RNP, 1976, J EXP MED, V143, P870, DOI 10.1084/jem.143.4.870; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Crowley MT, 1999, J IMMUNOL, V163, P4894; D'Souza WN, 2003, J IMMUNOL, V171, P5727, DOI 10.4049/jimmunol.171.11.5727; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; de Sousa M, 1979, Adv Exp Med Biol, V114, P51; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; Eickhoff S, 2015, CELL, V162, P1322, DOI 10.1016/j.cell.2015.08.004; Faure M, 2004, CELL IMMUNOL, V228, P8, DOI 10.1016/j.cellimm.2004.04.002; Filipe-Santos O, 2009, CELL HOST MICROBE, V6, P23, DOI 10.1016/j.chom.2009.04.014; Goncalves P, 2017, MOL IMMUNOL, V85, P66, DOI 10.1016/j.molimm.2017.01.026; Hao Y, 2006, J EXP MED, V203, P1643, DOI 10.1084/jem.20052174; HASTON WS, 1982, J CELL BIOL, V92, P747, DOI 10.1083/jcb.92.3.747; Hor JL, 2015, IMMUNITY, V43, P554, DOI 10.1016/j.immuni.2015.07.020; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hugues S, 2007, NAT IMMUNOL, V8, P921, DOI 10.1038/ni1495; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; Legrand N, 2001, J IMMUNOL, V167, P6150, DOI 10.4049/jimmunol.167.11.6150; MacInnes H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024448; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Rapetti L, 2008, J IMMUNOL, V181, P299, DOI 10.4049/jimmunol.181.1.299; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Romagnoli PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056999; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sung HC, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00452; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Zehn D, 2004, EUR J IMMUNOL, V34, P1551, DOI 10.1002/eji.200324355; Zinselmeyer BH, 2013, J EXP MED, V210, P757, DOI 10.1084/jem.20121416	44	18	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180644	10.1371/journal.pone.0180644	http://dx.doi.org/10.1371/journal.pone.0180644			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686740	Green Submitted, gold, Green Published			2022-12-26	WOS:000405464100084
J	Brown, KR; Krouse, RZ; Calatroni, A; Visness, CM; Sivaprasad, U; Kercsmar, CM; Matsui, EC; West, JB; Makhija, MM; Gill, MA; Kim, H; Kattan, M; Pillai, D; Gern, JE; Busse, WW; Togias, A; Liu, AH; Hershey, GKK				Brown, K. R.; Krouse, R. Z.; Calatroni, A.; Visness, C. M.; Sivaprasad, U.; Kercsmar, C. M.; Matsui, E. C.; West, J. B.; Makhija, M. M.; Gill, M. A.; Kim, H.; Kattan, M.; Pillai, D.; Gern, J. E.; Busse, W. W.; Togias, A.; Liu, A. H.; Hershey, G. K. Khurana			Endotypes of difficult-to-control asthma in inner-city African American children	PLOS ONE			English	Article							CLUSTER-ANALYSIS; NEUTROPHILIC INFLAMMATION; NATIONAL INSTITUTES; UNITED-STATES; IL-17A; PHENOTYPE; CELLS; HYPERRESPONSIVENESS; IDENTIFICATION; POPULATION	African Americans have higher rates of asthma prevalence, morbidity, and mortality in comparison with other racial groups. We sought to characterize endotypes of childhood asthma severity in African American patients in an inner-city pediatric asthma population. Baseline blood neutrophils, blood eosinophils, and 38 serum cytokine levels were measured in a sample of 235 asthmatic children (6-17 years) enrolled in the NIAID (National Institute of Allergy and Infectious Diseases)-sponsored Asthma Phenotypes in the Inner City (APIC) study (ICAC (Inner City Asthma Consortium)-19). Cytokines were quantified using a MILLIPLEX panel and analyzed on a Luminex analyzer. Patients were classified as Easy-to-Control or Difficult-to-Control based on the required dose of controller medications over one year of prospective management. A multivariate variable selection procedure was used to select cytokines associated with Difficult-to-Control versus Easy-to-Control asthma, adjusting for age, sex, blood eosinophils, and blood neutrophils. In inner-city African American children, 12 cytokines were significant predictors of Difficult-to-Control asthma (n = 235). CXCL-1, IL-5, IL-8, and IL-17A were positively associated with Difficult-to-Control asthma, while IL-4 and IL-13 were positively associated with Easy-to-Control asthma. Using likelihood ratio testing, it was observed that in addition to blood eosinophils and neutrophils, serum cytokines improved the fit of the model. In an inner-city pediatric population, serum cytokines significantly contributed to the definition of Difficult-to-Control asthma endotypes in African American children. Mixed responses characterized by T(H)2 (IL-5) and T(H)17-associated cytokines were associated with Difficult-to-Control asthma. Collectively, these data may contribute to risk stratification of Difficult-to-Control asthma in the African American population.	[Brown, K. R.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Allergy & Immunol, Cincinnati, OH USA; [Krouse, R. Z.; Calatroni, A.; Visness, C. M.] Rho Fed Syst Div Inc, Chapel Hill, NC USA; [Sivaprasad, U.; Hershey, G. K. Khurana] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Dept Pediat, Cincinnati, OH 45220 USA; [Kercsmar, C. M.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Pulm Med, Cincinnati, OH USA; [Matsui, E. C.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [West, J. B.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Makhija, M. M.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Gill, M. A.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Kim, H.] Henry Ford Hlth Syst, Detroit, MI USA; [Kattan, M.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Pillai, D.] Childrens Natl Hlth Syst, Washington, DC USA; [Gern, J. E.; Busse, W. W.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Togias, A.] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Liu, A. H.] Natl Jewish Hlth, Denver, CO USA; [Liu, A. H.] Childrens Hosp Colorado, Aurora, CO USA; [Liu, A. H.] Univ Colorado, Sch Med, Aurora, CO USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Johns Hopkins University; Boston University; Ann & Robert H. Lurie Children's Hospital of Chicago; University of Texas System; University of Texas Southwestern Medical Center Dallas; Henry Ford Health System; Henry Ford Hospital; Columbia University; Children's National Health System; University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Hershey, GKK (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Dept Pediat, Cincinnati, OH 45220 USA.	gurjit.hershey@cchmc.org		Matsui, Elizabeth/0000-0001-8134-5593	Russian Foundation for Basic Research [15-51-15008, 17-04-01309]; Russian Academy of Sciences; Grant of President of Russian Federation [MK-9245.2016.4, MD-229.2017.4]; Russian Science Foundation [16-14-00-224]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000451, UL1TR001105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM2AI117870] Funding Source: NIH RePORTER	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); Grant of President of Russian Federation; Russian Science Foundation(Russian Science Foundation (RSF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was supported by Russian Foundation for Basic Research grants 15-51-15008 and 17-04-01309 to MAP; by Russian Academy of Sciences grants to FIA (Molecular and Cellular Biology, Basic Research for Development of Biomedical Technologies, Molecular Mechanisms of Physiologic Functions) and to MAP (Basic Science for Medicine); by Grant of President of Russian Federation MK-9245.2016.4 to AMS and MD-229.2017.4 to MAP. Theoretical modelling was supported by grant from Russian Science Foundation 16-14-00-224 to FIA (sections Computational model of fibrin clot growth and lysis and Computer simulation of spatial clot growth and lysis; Figures 6 and 7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agache I, 2016, ALLERGY, V71, P1192, DOI 10.1111/all.12906; Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Bourdin A, 2014, J ALLERGY CLIN IMMUN, V134, P1043, DOI 10.1016/j.jaci.2014.04.038; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Brandt EB, 2015, J ALLERGY CLIN IMMUN, V136, P295, DOI 10.1016/j.jaci.2014.11.043; Brandt EB, 2013, J ALLERGY CLIN IMMUN, V132, P1194, DOI 10.1016/j.jaci.2013.06.048; Busse WW, 2013, AM J RESP CRIT CARE, V188, P1294, DOI 10.1164/rccm.201212-2318OC; Busse WW, 2010, J ALLERGY CLIN IMMUN, V125, P529, DOI 10.1016/j.jaci.2010.01.036; Chambers ES, 2015, J ALLERGY CLIN IMMUN, V136, P628, DOI 10.1016/j.jaci.2015.01.026; Chien JW, 2013, CLIN EXP ALLERGY, V43, P1018, DOI 10.1111/cea.12119; Choy DF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3142; Endo Y, 2014, TRENDS IMMUNOL, V35, P69, DOI 10.1016/j.it.2013.11.003; Fitzpatrick AM, 2011, J ALLERGY CLIN IMMUN, V127, P382, DOI 10.1016/j.jaci.2010.11.015; Fitzpatrick AM, 2010, J ALLERGY CLIN IMMUN, V125, P851, DOI 10.1016/j.jaci.2010.01.048; Gelfand EW, 2015, J ALLERGY CLIN IMMUN, V135, P1196, DOI 10.1016/j.jaci.2015.01.032; Green RH, 2002, THORAX, V57, P875, DOI 10.1136/thorax.57.10.875; Hastie AT, 2010, J ALLERGY CLIN IMMUN, V125, P1028, DOI 10.1016/j.jaci.2010.02.008; Hastie T., 2009, UNSUPERVISED LEARNIN; Hill TD, 2011, CURR ALLERGY ASTHM R, V11, P85, DOI 10.1007/s11882-010-0159-2; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Hosoki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126035; Irvin C, 2014, J ALLERGY CLIN IMMUN, V134, P1175, DOI 10.1016/j.jaci.2014.05.038; Jatakanon A, 1999, AM J RESP CRIT CARE, V160, P1532, DOI 10.1164/ajrccm.160.5.9806170; Just J, 2012, EUR RESPIR J, V40, P55, DOI 10.1183/09031936.00123411; Keet CA, 2015, J ALLERGY CLIN IMMUN, V135, P655, DOI 10.1016/j.jaci.2014.11.022; Lenoir Michael, 2008, J Natl Med Assoc, V100, P1; Levy BD, 2015, AM J RESP CRITICAL C; Mizutani N, 2014, J IMMUNOL, V192, P1372, DOI 10.4049/jimmunol.1301538; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Moorman JE., 2011, MMWR SURVEILL SUMM S, V60, P84; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Newcomb DC, 2012, J IMMUNOL, V188, P1027, DOI 10.4049/jimmunol.1102216; Noda S, 2015, J ALLERGY CLIN IMMUN, V136, P1254, DOI 10.1016/j.jaci.2015.08.015; Ownby DR, 2015, J ALLERGY CLIN IMMUN, V136, P595, DOI 10.1016/j.jaci.2015.02.007; Parkitny L, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/890706; Pino-Yanes M, 2015, J ALLERGY CLIN IMMUN, V135, P228, DOI 10.1016/j.jaci.2014.07.053; Pongracic JA, 2016, J ALLERGY C IN PRESS; Ray NF, 1998, CHEST, V113, P1277, DOI 10.1378/chest.113.5.1277; Redd SC, 2002, ENVIRON HEALTH PERSP, V110, P557, DOI 10.1289/ehp.02110s4557; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Schramm A, 2016, ALLERGY ASTHMA CL IM, V12, DOI 10.1186/s13223-016-0157-6; Sheehan WJ, 2015, CURR OPIN ALLERGY CL, V15, P397, DOI 10.1097/ACI.0000000000000195; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Woodruff PG, 2001, J ALLERGY CLIN IMMUN, V108, P753, DOI 10.1067/mai.2001.119411; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	46	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180778	10.1371/journal.pone.0180778	http://dx.doi.org/10.1371/journal.pone.0180778			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686637	gold, Green Published, Green Submitted			2022-12-26	WOS:000405464100101
J	Buschiazzo, J; Rios, GL; Canizo, JR; Antollini, SS; Alberio, RH				Buschiazzo, Jorgelina; Rios, Glenda L.; Canizo, Jesica R.; Antollini, Silvia S.; Alberio, Ricardo H.			Free cholesterol and cholesterol esters in bovine oocytes: Implications in survival and membrane raft organization after cryopreservation	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; EPIDERMAL-GROWTH-FACTOR; LIPID RAFTS; DEVELOPMENTAL COMPETENCE; PREIMPLANTATION EMBRYOS; ADDING CHOLESTEROL; MASS-SPECTROMETRY; CYCLODEXTRINS; VITRIFICATION; MATURATION	Part of the damage caused by cryopreservation of mammalian oocytes occurs at the plasma membrane. The addition of cholesterol to cell membranes as a strategy to make it more tolerant to cryopreservation has been little addressed in oocytes. In order to increase the survival of bovine oocytes after cryopreservation, we proposed not only to increase cholesterol level of oocyte membranes before vitrification but also to remove the added cholesterol after warming, thus recovering its original level. Results from our study showed that modulation of membrane cholesterol by methyl-beta-cyclodextrin (M beta CD) did not affect the apoptotic status of oocytes and improved viability after vitrification yielding levels of apoptosis closer to those of fresh oocytes. Fluorometric measurements based on an enzyme-coupled reaction that detects both free cholesterol (membrane) and cholesteryl esters (stored in lipid droplets), revealed that oocytes and cumulus cells present different levels of cholesterol depending on the seasonal period. Variations at membrane cholesterol level of oocytes were enough to account for the differences found in total cholesterol. Differences found in total cholesterol of cumulus cells were explained by the differences found in both the content of membrane cholesterol and of cholesterol esters. Cholesterol was incorporated into the oocyte plasma membrane as evidenced by comparative labeling of a fluorescent cholesterol. Oocytes and cumulus cells increased membrane cholesterol after incubation with M beta CD/cholesterol and recovered their original level after cholesterol removal, regardless of the season. Finally, we evaluated the effect of vitrification on the putative raft molecule GM1. Cholesterol modulation also preserved membrane organization by maintaining ganglioside level at the plasma membrane. Results suggest a distinctive cholesterol metabolic status of cumulus-oocyte complexes (COCs) among seasons and a dynamic organizational structure of cholesterol homeostasis within the COC. Modulation of membrane cholesterol by M beta CD improved survival of bovine oocytes and preserved integrity of GM1-related rafts after vitrification.	[Buschiazzo, Jorgelina; Rios, Glenda L.; Canizo, Jesica R.; Alberio, Ricardo H.] EEA Balcarce, INTA, Dept Prod Anim, Biotecnol Reprod, Balcarce, Argentina; [Antollini, Silvia S.] CONICET UNS, Inst Invest Bioquim Bahia Blanca, Camino Carringanda, Bahia Blanca, Buenos Aires, Argentina; [Antollini, Silvia S.] UNS, Dept Biol Bioquim & Farm, Bahia Blanca, Buenos Aires, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South; National University of the South	Buschiazzo, J (corresponding author), EEA Balcarce, INTA, Dept Prod Anim, Biotecnol Reprod, Balcarce, Argentina.	buschiazzo.jorgelina@inta.gob.ar		Alberio, Ricardo Horacio/0000-0003-2760-8932; Canizo, Jesica Romina/0000-0003-2559-5867	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-0534, PICT-2746]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP-0273, PIP-00239]; Universidad Nacional del Sur [PGI 24/B217]; Comision de Investigaciones Cientificas [CIC-832]; Instituto Nacional de Tecnologia Agropecuaria [PNSA-1115033]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional del Sur; Comision de Investigaciones Cientificas; Instituto Nacional de Tecnologia Agropecuaria	This work was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica (PICT-0534) and Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP-0273) to JB; Agencia Nacional de Promocion Cientifica y Tecnologica (PICT-2746), Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP-00239), and Universidad Nacional del Sur (PGI 24/B217) to SSA; and Comision de Investigaciones Cientificas (CIC-832) and Instituto Nacional de Tecnologia Agropecuaria (PNSA-1115033) to RHA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim EAM, 2009, CRYOBIOLOGY, V58, P210, DOI 10.1016/j.cryobiol.2008.12.007; Arav A, 1996, CRYOBIOLOGY, V33, P589, DOI 10.1006/cryo.1996.0062; Arav A, 2014, THERIOGENOLOGY, V81, P96, DOI 10.1016/j.theriogenology.2013.09.011; Barcelo-Fimbres M, 2011, THERIOGENOLOGY, V75, P434, DOI 10.1016/j.theriogenology.2010.09.007; Behrman EJ, 2005, J CHEM EDUC, V82, P1791, DOI 10.1021/ed082p1791; Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; Bromfield EG, 2013, REPRODUCTION, V145, pR31, DOI 10.1530/REP-12-0316; Buschiazzo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062919; Cerri RLA, 2009, J DAIRY SCI, V92, P1520, DOI 10.3168/jds.2008-1614; Checura CM, 2007, THERIOGENOLOGY, V67, P919, DOI 10.1016/j.theriogenology.2006.09.044; Christian AE, 1997, J LIPID RES, V38, P2264; Comiskey M, 2007, DEV BIOL, V303, P727, DOI 10.1016/j.ydbio.2006.12.009; DELOOS F, 1989, GAMETE RES, V24, P197, DOI 10.1002/mrd.1120240207; Di Rienzo J. A., 2016, INFOSTAT VERSION 201; Dunning KR, 2014, REPRODUCTION, V148, pR15, DOI 10.1530/REP-13-0251; Dupont J, 2014, ANIMAL, V8, P1031, DOI 10.1017/S1751731114000937; Ferguson EM, 1999, J REPROD FERTIL, V116, P373, DOI 10.1530/jrf.0.1160373; Ferreira CR, 2015, REPROD FERT DEVELOP, V27, P621, DOI 10.1071/RD14310; Fouladi-Nashta AA, 2007, BIOL REPROD, V77, P9, DOI 10.1095/biolreprod.106.058578; Fujimoto T., 2011, COLD SPRING HARB PER, V3; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; Fujita A, 2009, BBA-MOL CELL BIOL L, V1791, P388, DOI 10.1016/j.bbalip.2009.01.008; Gonzalez-Serrano AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074981; Horvath G, 2006, THERIOGENOLOGY, V66, P1026, DOI 10.1016/j.theriogenology.2006.03.004; Hwang IS, 2014, BIOMED RES INT; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Ivankin A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.238103; Kim JY, 2001, REPRODUCTION, V122, P131, DOI 10.1530/rep.0.1220131; Lapa M, 2011, REPROD DOMEST ANIM, V46, P904, DOI 10.1111/j.1439-0531.2011.01762.x; Leao BC, 2016, REPROD FERTIL DEV; Leao BCS, 2015, ZYGOTE, V23, P732, DOI 10.1017/S0967199414000380; Leroy JL, REPROD DOMEST ANIM, V43, P623; Leroy JLMR, 2015, REPROD FERT DEVELOP, V27, P693, DOI 10.1071/RD14363; Lonergan P, 1996, BIOL REPROD, V54, P1420, DOI 10.1095/biolreprod54.6.1420; Marco-Jimenez F, 2014, CRYOLETTERS, V35, P320; Marquardt D, 2016, CHEM PHYS LIPIDS, V199, P17, DOI 10.1016/j.chemphyslip.2016.04.001; Marquez YC, 2005, REPROD DOMEST ANIM, V40, P553, DOI 10.1111/j.1439-0531.2005.00632.x; McEvoy TG, 2000, J REPROD FERTIL, V118, P163, DOI 10.1530/reprod/118.1.163; Moce E, 2010, REPROD DOMEST ANIM, V45, P57, DOI 10.1111/j.1439-0531.2010.01635.x; Moore AI, 2005, CRYOBIOLOGY, V51, P241, DOI 10.1016/j.cryobiol.2005.07.004; Moraes EA, 2010, ANIM REPROD SCI, V118, P148, DOI 10.1016/j.anireprosci.2009.08.002; Nixon B, 2011, J CELL PHYSIOL, V226, P2651, DOI 10.1002/jcp.22615; Ortiz-Escribano N, 2016, THERIOGENOLOGY, V86, P635, DOI 10.1016/j.theriogenology.2016.02.015; PARASASSI T, 1995, FREE RADICAL BIO MED, V19, P511, DOI 10.1016/0891-5849(95)00038-Y; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Purdy PH, 2004, BIOL REPROD, V71, P522, DOI 10.1095/biolreprod.103.025577; Rios GL, 2015, THERIOGENOLOGY, V83, P874, DOI 10.1016/j.theriogenology.2014.11.022; Santos JEP, 2008, REPROD DOMEST ANIM, V43, P23, DOI 10.1111/j.1439-0531.2008.01139.x; Saragusty J, 2011, REPRODUCTION, V141, P1, DOI 10.1530/REP-10-0236; Sato B, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-22; Sekhavati MH, 2012, CELL REPROGRAM, V14, P295, DOI 10.1089/cell.2012.0014; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Spizziri BE, 2010, ANIM REPROD SCI, V118, P255, DOI 10.1016/j.anireprosci.2009.08.001; Spricigo JFW, 2012, CRYOBIOLOGY, V65, P319, DOI 10.1016/j.cryobiol.2012.09.001; Sturmey RG, 2009, REPROD DOMEST ANIM, V44, P50, DOI 10.1111/j.1439-0531.2009.01402.x; Suzuki M, 2011, J ELECTRON MICROSC, V60, pS101, DOI 10.1093/jmicro/dfr016; Van Blerkom J, 2016, REPROD BIOMED ONLINE, V33, P458, DOI 10.1016/j.rbmo.2016.06.029; van der Valk J, 2010, TOXICOL IN VITRO, V24, P1053, DOI 10.1016/j.tiv.2010.03.016; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Van Soom A, 2002, REPROD DOMEST ANIM, V37, P144, DOI 10.1046/j.1439-0531.2002.00345.x; Yesilaltay A, 2014, P NATL ACAD SCI USA, V111, pE4972, DOI 10.1073/pnas.1418954111; Zachut M, 2010, J DAIRY SCI, V93, P529, DOI 10.3168/jds.2009-2167; Zeron Y, 2002, CRYOBIOLOGY, V45, P143, DOI 10.1016/S0011-2240(02)00123-2; Zeron Y, 2001, REPRODUCTION, V121, P447, DOI 10.1530/rep.0.1210447; Zhou XL, 2010, CRYOBIOLOGY, V61, P66, DOI 10.1016/j.cryobiol.2010.05.002; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	66	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180451	10.1371/journal.pone.0180451	http://dx.doi.org/10.1371/journal.pone.0180451			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686720	Green Submitted, Green Published, gold			2022-12-26	WOS:000405464100065
J	Densten, IL; Borrowman, L				Densten, Iain L.; Borrowman, Luc			Does the implicit models of leadership influence the scanning of other-race faces in adults?	PLOS ONE			English	Article							EYE-TRACKING; INFORMATION; ATTRACTIVENESS; CATEGORIZATION; INTEGRATION; ACCURACY; EMOTION; PREDICT; MEMORY; VIDEO	The current study aims to identify the relationships between implicit leadership theoretical (ILT) prototypes/anti-prototype and five facial features (i.e., nasion, upper nose, lower nose, and upper lip) of a leader from a different race than respondents. A sample of 81 Asian respondents viewed a 30-second video of a Caucasian female who in a non-engaging manner talked about her career achievements. As participants watch the video, their eye movements were recorded via an eye tracking devise. While previous research has identified that ILT influences perceptional and attitudinal ratings of leaders, the current study extends these findings by confirming the impact of ILT on the gaze patterns of other race participants, who appear to adopt system one type thinking. This study advances our understanding in how cognitive categories or schemas influence the physicality of individuals (i.e., eye gaze or movements). Finally, this study confirms that individual ILT factors have a relationship with the eye movements of participants and suggests future research directions.	[Densten, Iain L.] Monash Univ Australia Alumni, Melbourne, Vic, Australia; [Borrowman, Luc] Monash Univ Malaysia, Sch Business, Dept Econ, Sunway, Malaysia; [Densten, Iain L.] 59 Golflinks Rd, Frankston, Vic, Australia	Monash University; Monash University; Monash University Sunway	Densten, IL (corresponding author), Monash Univ Australia Alumni, Melbourne, Vic, Australia.; Densten, IL (corresponding author), 59 Golflinks Rd, Frankston, Vic, Australia.	itangodeno@gmail.com	Densten, Iain L./AAE-7342-2021; Densten, Iain/AAF-3901-2021	Borrowman, Luc/0000-0002-1581-9962	Social & Economic Transformation in Asia (SETA)	Social & Economic Transformation in Asia (SETA)	Funded by Social & Economic Transformation in Asia (SETA).	Antonakis J. E, 2004, NATURE LEADERSHIP; Attard J, 2014, APPL COGNITIVE PSYCH, V28, P215, DOI 10.1002/acp.2986; Basil M, 2011, QUAL MARK RES, V14, P246, DOI 10.1108/13522751111137488; Baumeister RF, 2010, PSYCHOL REV, V117, P945, DOI 10.1037/a0019393; Boyce MA, 2008, LAW HUMAN BEHAV, V32, P439, DOI 10.1007/s10979-007-9125-5; Brown DJ, 2012, OXFORD HDB LEADERSHI; Cain J, 2013, CURR PHARM TEACH LEA, V5, P620, DOI 10.1016/j.cptl.2013.07.009; Campbell D, 1991, CAMPBELL LEADERSHIP; Caza A, 2015, LEADERSHIP QUART, V26, P518, DOI 10.1016/j.leaqua.2015.05.008; Chan E.K.H., 2014, VALIDITY VALIDATION; Cote S, 2011, PSYCHOL SCI, V22, P1073, DOI 10.1177/0956797611416251; Crehan ET, 2015, BEHAV RES METHODS, V47, P994, DOI 10.3758/s13428-014-0514-7; CRONSHAW SF, 1987, J APPL PSYCHOL, V72, P97, DOI 10.1037/0021-9010.72.1.97; Currie TE, 2009, EVOL HUM BEHAV, V30, P409, DOI 10.1016/j.evolhumbehav.2009.06.005; Dang JH, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00933; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Duchowski A., 2007, EYE TRACKING METHODO; Duchowski A.T., 2003, EYE TRACKING METHODO; EDEN D, 1975, J APPL PSYCHOL, V60, P736, DOI 10.1037/0021-9010.60.6.736; Elfenbein HA, 2007, ACAD MANAG ANN, V1, P315, DOI 10.1080/078559812; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Epitropaki O, 2004, J APPL PSYCHOL, V89, P293, DOI 10.1037/0021-9010.89.2.293; Fernald RD, 1997, BRAIN BEHAV EVOLUT, V50, P253, DOI 10.1159/000113339; Fiedler S, 2013, ORGAN BEHAV HUM DEC, V120, P272, DOI 10.1016/j.obhdp.2012.07.002; FOSTER RA, 1994, APPL COGNITIVE PSYCH, V8, P107, DOI 10.1002/acp.2350080203; Foti RJ, 2007, J APPL PSYCHOL, V92, P347, DOI 10.1037/0021-9010.92.2.347; Fruhen LS, 2015, LEADERSHIP QUART, V26, P1005, DOI 10.1016/j.leaqua.2015.07.001; Fu G, 2012, PLOS ONE, V7, P1, DOI DOI 10.1371/J0URNAL.P0NE; Furnham A, 2001, PERS INDIV DIFFER, V30, P491, DOI 10.1016/S0191-8869(00)00040-4; George JM, 2000, HUM RELAT, V53, P1027, DOI 10.1177/0018726700538001; GIOIA DA, 1985, EDUC PSYCHOL MEAS, V45, P217, DOI 10.1177/001316448504500204; Hansbrough TK, 2015, LEADERSHIP QUART, V26, P220, DOI 10.1016/j.leaqua.2014.11.006; Hareli S, 2010, COGNITION EMOTION, V24, P128, DOI 10.1080/02699930802613828; Hartmann M, 2016, PSYCHOL RES-PSYCH FO, V80, P325, DOI 10.1007/s00426-016-0759-0; Heck A, 2016, J EXP CHILD PSYCHOL, V147, P100, DOI 10.1016/j.jecp.2016.03.005; Helminen TM, 2016, PSYCHOL RES-PSYCH FO, V80, P159, DOI 10.1007/s00426-015-0649-x; House R. J., 1999, ADV GLOBAL LEADERSHI, P171; Hu C. S., 2015, COGNITION EMOTION, P1; Hu C, 2014, VISION RES, V102, P1, DOI 10.1016/j.visres.2014.05.010; Junker NM, 2014, LEADERSHIP QUART, V25, P1154, DOI 10.1016/j.leaqua.2014.09.002; Juslin P, 2007, PSYCHOL REV, V114, P678, DOI 10.1037/0033-295X.114.3.678; JUST MA, 1976, COGNITIVE PSYCHOL, V8, P441, DOI 10.1016/0010-0285(76)90015-3; Keltner D, 1999, COGNITION EMOTION, V13, P505, DOI 10.1080/026999399379168; Kenney RA, 1996, PERS SOC PSYCHOL B, V22, P1128, DOI 10.1177/01461672962211004; Krumhuber EG, 2013, EMOT REV, V5, P41, DOI 10.1177/1754073912451349; Ladkin D, 2014, MONOGR LEAD MANAGE, V6, P1, DOI 10.1108/S1479-357120140000006001; Little AC, 2012, Q J EXP PSYCHOL, V65, P2018, DOI 10.1080/17470218.2012.677048; Lord R.G., 1991, EXECUTIVE LEADERSHIP; LORD RG, 1985, HUM RELAT, V38, P47, DOI 10.1177/001872678503800103; LORD RG, 1984, ORGAN BEHAV HUM PERF, V34, P343, DOI 10.1016/0030-5073(84)90043-6; Lord RG, 1993, LEADERSHIP INFORM PR, Vxi; Macrae CN, 2000, ANNU REV PSYCHOL, V51, P93, DOI 10.1146/annurev.psych.51.1.93; Martell RF, 2005, J APPL PSYCHOL, V90, P956, DOI 10.1037/0021-9010.90.5.956; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Memon A, 2003, J APPL PSYCHOL, V88, P341, DOI 10.1037/0021-9010.88.2.341; Morewedge CK, 2010, TRENDS COGN SCI, V14, P435, DOI 10.1016/j.tics.2010.07.004; Nusseck M, 2008, J VISION, V8, DOI 10.1167/8.8.1; Offermann L. R., 1994, LEADERSHIP QUART, V5, P43, DOI DOI 10.1016/1048-9843(94)90005-1; Ohlsen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059471; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Perez WF, 2015, PSYCHOL REC, V65, P83, DOI 10.1007/s40732-014-0092-1; Pernice K, 2016, CONDUCT EYE TRACKING; PHILLIPS JS, 1984, ORGAN BEHAV HUM PERF, V33, P125, DOI 10.1016/0030-5073(84)90015-1; Podsakoff NP, 2013, J APPL PSYCHOL, V98, P99, DOI 10.1037/a0029570; Rayner K, 2015, CURR OPIN BEHAV SCI, V1, P107, DOI 10.1016/j.cobeha.2014.10.008; Rensink RA, 2003, ENCY COGNITIVE SCI, P509; Rosch E, 1978, COGNITION CATEGORIZA, P328; Rule NO, 2008, PSYCHOL SCI, V19, P109, DOI 10.1111/j.1467-9280.2008.02054.x; Rule NO, 2011, LEADERSHIP QUART, V22, P690, DOI 10.1016/j.leaqua.2011.05.009; RUSH MC, 1988, J EXP SOC PSYCHOL, V24, P88, DOI 10.1016/0022-1031(88)90045-5; Schall A., 2014, EYE TRACKING USER EX, P3; SCHEIN VE, 1973, J APPL PSYCHOL, V57, P95, DOI 10.1037/h0037128; Schurgin MW, 2014, J VISION, V14, DOI 10.1167/14.13.14; Schyns PG, CURRENT BIOL, V17, P1580; Schyns PG, 2007, CURR BIOL, V17, P1580, DOI 10.1016/j.cub.2007.08.048; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Shondrick SJ, 2010, LEADERSHIP QUART, V21, P959, DOI 10.1016/j.leaqua.2010.10.004; Smith ER, 2000, PERS SOC PSYCHOL REV, V4, P108, DOI 10.1207/S15327957PSPR0402_01; Smith JA, 1998, LEADERSHIP QUART, V9, P147, DOI 10.1016/S1048-9843(98)90002-9; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; Tanaka JW, 2016, Q J EXP PSYCHOL, V69, P1876, DOI 10.1080/17470218.2016.1146780; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Todorov A, 2015, ANNU REV PSYCHOL, V66, P519, DOI 10.1146/annurev-psych-113011-143831; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Van Kleef GA, 2011, EUR REV SOC PSYCHOL, V22, P114, DOI 10.1080/10463283.2011.627192; Weick K.E., 1995, SENSEMAKING ORG; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	88	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179058	10.1371/journal.pone.0179058	http://dx.doi.org/10.1371/journal.pone.0179058			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686605	gold, Green Published, Green Submitted			2022-12-26	WOS:000405464100008
J	Kaleita, AL; Schott, LR; Hargreaves, SK; Hofmockel, KS				Kaleita, Amy L.; Schott, Linda R.; Hargreaves, Sarah K.; Hofmockel, Kirsten S.			Differences in soil biological activity by terrain types at the sub-field scale in central Iowa US	PLOS ONE			English	Article							MICROBIAL BIOMASS CALIBRATION; FUMIGATION-EXTRACTION METHOD; SPATIAL VARIABILITY; NITROGEN; CARBON; RESOURCES; COMMUNITIES	Soil microbial communities are structured by biogeochemical processes that occur at many different spatial scales, which makes soil sampling difficult. Because soil microbial communities are important in nutrient cycling and soil fertility, it is important to understand how microbial communities function within the heterogeneous soil landscape. In this study, a self-organizing map was used to determine whether landscape data can be used to characterize the distribution of microbial biomass and activity in order to provide an improved understanding of soil microbial community function. Points within a row crop field in southcentral Iowa were clustered via a self-organizing map using six landscape properties into three separate landscape clusters. Twelve sampling locations per cluster were chosen for a total of 36 locations. After the soil samples were collected, the samples were then analysed for various metabolic indicators, such as nitrogen and carbon mineralization, extractable organic carbon, microbial biomass, etc. It was found that sampling locations located in the potholes and toe slope positions had significantly greater microbial biomass nitrogen and carbon, total carbon, total nitrogen and extractable organic carbon than the other two landscape position clusters, while locations located on the upslope did not differ significantly from the other landscape clusters. However, factors such as nitrate, ammonia, and nitrogen and carbon mineralization did not differ significantly across the landscape. Overall, this research demonstrates the effectiveness of a terrain-based clustering method for guiding soil sampling of microbial communities.	[Kaleita, Amy L.] Iowa State Univ, Agr & Biosyst Engn, Ames, IA 50011 USA; [Schott, Linda R.] Univ Nebraska, Biol Syst Engn, Lincoln, NE USA; [Hargreaves, Sarah K.] Ecol Farmers Assoc Ontario, Guelph, ON, Canada; [Hargreaves, Sarah K.; Hofmockel, Kirsten S.] Iowa State Univ, Ecol Evolutionary & Organismal Biol, Ames, IA USA; [Hofmockel, Kirsten S.] Pacific Northwest Natl Lab, Environm Mol Sci Lab, Richland, WA USA	Iowa State University; University of Nebraska System; University of Nebraska Lincoln; Iowa State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Kaleita, AL (corresponding author), Iowa State Univ, Agr & Biosyst Engn, Ames, IA 50011 USA.	kaleita@iastate.edu	Kaleita, Amy/O-5105-2019	Kaleita, Amy/0000-0002-8906-3408; Hofmockel, Kirsten/0000-0003-1586-2167; Schott, Linda/0000-0001-8600-0535				Adamchuk VI, 2004, COMPUT ELECTRON AGR, V44, P71, DOI 10.1016/j.compag.2004.03.002; ANDERSON TH, 1989, SOIL BIOL BIOCHEM, V21, P471, DOI 10.1016/0038-0717(89)90117-X; Brevik E, 2003, PRECIS AGRIC, V4, P71; Cavigelli MA, 2005, APPL SOIL ECOL, V29, P99, DOI 10.1016/j.apsoil.2004.12.007; Corre MD, 2002, SOIL BIOL BIOCHEM, V34, P445, DOI 10.1016/S0038-0717(01)00198-5; Dupuis EM, 2007, CAN J SOIL SCI, V87, P479, DOI 10.4141/CJSS07001; Enwall K, 2010, APPL ENVIRON MICROB, V76, P2243, DOI 10.1128/AEM.02197-09; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Fierer N, 2002, SOIL BIOL BIOCHEM, V34, P777, DOI 10.1016/S0038-0717(02)00007-X; Florinsky IV, 2004, GEODERMA, V119, P33, DOI 10.1016/S0016-7061(03)00224-6; Franklin RB, 2003, FEMS MICROBIOL ECOL, V44, P335, DOI 10.1016/S0168-6496(03)00074-6; Fromin N, 2013, GEODERMA, V197, P98, DOI 10.1016/j.geoderma.2012.12.009; Giraudel JL, 2001, ECOL MODEL, V146, P329, DOI 10.1016/S0304-3800(01)00324-6; Girvan MS, 2004, APPL ENVIRON MICROB, V70, P2692, DOI 10.1128/AEM.70.5.2692-2701.2004; Hargreaves SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134345; Hedley CB, 2013, GEODERMA, V199, P22, DOI 10.1016/j.geoderma.2012.07.018; Hood-Nowotny R, 2010, SOIL SCI SOC AM J, V74, P1018, DOI 10.2136/sssaj2009.0389; Joergensen RG, 1996, SOIL BIOL BIOCHEM, V28, P25, DOI 10.1016/0038-0717(95)00102-6; Joergensen RG, 1996, SOIL BIOL BIOCHEM, V28, P33, DOI 10.1016/0038-0717(95)00101-8; Kalteh AM, 2008, ENVIRON MODELL SOFTW, V23, P835, DOI 10.1016/j.envsoft.2007.10.001; Katsalirou E, 2010, EUR J SOIL BIOL, V46, P181, DOI 10.1016/j.ejsobi.2010.04.005; Kiang MY, 2001, COMPUT STAT DATA AN, V38, P161, DOI 10.1016/S0167-9473(01)00040-8; Kohonen T., 2001, SELF ORG MAPS; Landesman WJ, 2011, MICROB ECOL, V62, P228, DOI 10.1007/s00248-011-9811-1; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Mele PM, 2008, AGR ECOSYST ENVIRON, V126, P139, DOI 10.1016/j.agee.2007.12.008; MOORE ID, 1991, HYDROL PROCESS, V5, P3, DOI 10.1002/hyp.3360050103; Peigne J, 2009, EUR J SOIL BIOL, V45, P488, DOI 10.1016/j.ejsobi.2009.09.002; Pennock DJ, 2005, J SOIL WATER CONSERV, V60, P396; Robertson G, 2011, P AM MATH SOC, V139, P2705, DOI 10.1090/S0002-9939-2011-10808-6; Shennan C, 2008, PHILOS T R SOC B, V363, P717, DOI 10.1098/rstb.2007.2180; Simfukwe P, 2011, SOIL BIOL BIOCHEM, V43, P1688, DOI 10.1016/j.soilbio.2011.04.014; Stenrod M, 2006, SOIL BIOL BIOCHEM, V38, P962, DOI 10.1016/j.soilbio.2005.08.014; Tajik S, 2012, ENVIRON ENG SCI, V29, P798, DOI 10.1089/ees.2011.0313; Van Arkel Z, 2014, WATER RESOUR RES, V50, P7050, DOI 10.1002/2013WR015015; Vesanto J., 2000, A57 HELS U TECHN, P60; Welbaum GE, 2004, CRIT REV PLANT SCI, V23, P175, DOI 10.1080/07352680490433295; Yang L.Y., 2010, THESIS	38	1	1	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180596	10.1371/journal.pone.0180596	http://dx.doi.org/10.1371/journal.pone.0180596			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686652	Green Published, gold, Green Submitted			2022-12-26	WOS:000405464100081
J	Mao, B; Mao, R; Zeng, DH				Mao, Bing; Mao, Rong; Zeng, De-Hui			Species diversity and chemical properties of litter influence non-additive effects of litter mixtures on soil carbon and nitrogen cycling	PLOS ONE			English	Article							LEAF-LITTER; DECOMPOSITION DYNAMICS; FUNCTIONAL DIVERSITY; MICROBIAL COMMUNITIES; ORGANIC-CARBON; MASS-LOSS; FOREST; MINERALIZATION; MANIPULATION; CHEMISTRY	Decomposition of litter mixtures generally cannot be predicted from the component species incubated in isolation. Therefore, such non-additive effects of litter mixing on soil C and N dynamics remain poorly understood in terrestrial ecosystems. In this study, litters of Mongolian pine and three dominant understory species and soil were collected from a Mongolian pine plantation in Northeast China. In order to examine the effects of mixed-species litter on soil microbial biomass N, soil net N mineralization and soil respiration, four single litter species and their mixtures consisting of all possible 2-, 3-and 4-species combinations were added to soils, respectively. In most instances, species mixing produced synergistic nonadditive effects on soil microbial biomass N and soil respiration, but antagonistic non-additive effects on net N mineralization. Species composition rather than species richness explained the non-additive effects of species mixing on soil microbial biomass N and net N mineralization, due to the interspecific differences in litter chemical composition. Both litter species composition and richness explained non-additive soil respiration responses to mixed-species litter, while litter chemical diversity and chemical composition did not. Our study indicated that litter mixtures promoted soil microbial biomass N and soil respiration, and inhibited net N mineralization. Soil N related processes rather than soil respiration were partly explained by litter chemical composition and chemical diversity, highlighting the importance of functional diversity of litter on soil N cycling.	[Mao, Bing; Zeng, De-Hui] Chinese Acad Sci, Inst Appl Ecol, Key Lab Forest Ecol & Management, Shenyang, Peoples R China; [Mao, Bing; Zeng, De-Hui] Chinese Acad Sci, Inst Appl Ecol, Daqinggou Ecol Stn, Shenyang, Peoples R China; [Mao, Rong] Chinese Acad Sci, Chongqing Inst Green & Intelligent Technol, Chongqing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; Chongqing Institute of Green & Intelligent Technology, CAS	Zeng, DH (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Key Lab Forest Ecol & Management, Shenyang, Peoples R China.; Zeng, DH (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Daqinggou Ecol Stn, Shenyang, Peoples R China.	zengdh@iae.ac.cn	Mao, Rong/Q-2595-2019	Mao, Rong/0000-0002-0469-2281	National Natural Science Foundation of China [31270668]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31270668).	Aka H, 2005, EUR J SOIL BIOL, V41, P31, DOI 10.1016/j.ejsobi.2005.05.001; Ball BA, 2008, J ECOL, V96, P303, DOI 10.1111/j.1365-2745.2007.01346.x; Ball BA, 2014, SOIL BIOL BIOCHEM, V69, P71, DOI 10.1016/j.soilbio.2013.10.048; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bottollier-Curtet M, 2015, PLANT SOIL, V390, P265, DOI 10.1007/s11104-015-2394-8; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; CABRERA ML, 1993, SOIL SCI SOC AM J, V57, P1007, DOI 10.2136/sssaj1993.03615995005700040021x; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chen YC, 2015, BIOL FERT SOILS, V51, P791, DOI 10.1007/s00374-015-1025-0; Cong WF, 2014, J ECOL, V102, P1163, DOI 10.1111/1365-2745.12280; Duan JC, 2013, SOIL BIOL BIOCHEM, V57, P841, DOI 10.1016/j.soilbio.2012.08.009; Fang X, 2015, PLANT SOIL, V392, P139, DOI 10.1007/s11104-015-2450-4; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Giesselmann UC, 2010, APPL SOIL ECOL, V46, P283, DOI 10.1016/j.apsoil.2010.07.006; Gogo S, 2016, J SOIL SEDIMENT, V16, P13, DOI 10.1007/s11368-015-1178-3; Hattenschwiler S, 2008, NEW PHYTOL, V179, P165, DOI 10.1111/j.1469-8137.2008.02438.x; Han TF, 2015, SCI REP-UK, V5, DOI 10.1038/srep18166; Hattenschwiler S, 2000, TRENDS ECOL EVOL, V15, P238, DOI 10.1016/S0169-5347(00)01861-9; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; HELBERT JR, 1957, ANAL CHEM, V29, P1464, DOI 10.1021/ac60130a020; Hobbie SE, 2015, TRENDS ECOL EVOL, V30, P357, DOI 10.1016/j.tree.2015.03.015; Hoorens B, 2003, OECOLOGIA, V137, P578, DOI 10.1007/s00442-003-1365-6; Hu YL, 2006, PLANT SOIL, V282, P379, DOI 10.1007/s11104-006-0004-5; IIYAMA K, 1990, J SCI FOOD AGR, V51, P145, DOI 10.1002/jsfa.2740510202; Jiang J, 2013, PLANT SOIL, V373, P931, DOI 10.1007/s11104-013-1859-x; Kominoski JS, 2007, ECOLOGY, V88, P1167, DOI 10.1890/06-0674; Kraus TEC, 2004, SOIL BIOL BIOCHEM, V36, P309, DOI 10.1016/j.soilbio.2003.10.006; Kraus TEC, 2003, PLANT SOIL, V256, P41, DOI 10.1023/A:1026206511084; Leff JW, 2012, GLOBAL CHANGE BIOL, V18, P2969, DOI 10.1111/j.1365-2486.2012.02749.x; Li W, 2009, ECOL RES, V24, P761, DOI 10.1007/s11284-008-0546-5; Loreau M, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P79; Lummer D, 2012, OIKOS, V121, P1649, DOI 10.1111/j.1600-0706.2011.20073.x; Ma L, 2013, BIOGEOSCIENCES, V10, P7361, DOI 10.5194/bg-10-7361-2013; Mao B, 2015, PLANT SOIL, V396, P339, DOI 10.1007/s11104-015-2593-3; McIntyre RES, 2009, SOIL BIOL BIOCHEM, V41, P92, DOI 10.1016/j.soilbio.2008.09.021; Meier CL, 2010, SOIL BIOL BIOCHEM, V42, P1447, DOI 10.1016/j.soilbio.2010.05.005; Meier CL, 2008, P NATL ACAD SCI USA, V105, P19780, DOI 10.1073/pnas.0805600105; Muller Robert N., 2003, P15; Mulvaney R. L., 1996, Methods of soil analysis. Part 3 - chemical methods., P1123; Naeem S, 2003, ECOL LETT, V6, P567, DOI 10.1046/j.1461-0248.2003.00471.x; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Nilsson MC, 2005, FRONT ECOL ENVIRON, V3, P421, DOI 10.2307/3868658; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; PORTER L J, 1986, Phytochemistry (Oxford), V25, P223; Redin M, 2014, SOIL BIOL BIOCHEM, V78, P65, DOI 10.1016/j.soilbio.2014.07.014; Rinnan R, 2008, APPL SOIL ECOL, V39, P271, DOI 10.1016/j.apsoil.2007.12.014; Rudolf VHW, 2013, ECOLOGY, V94, P1046, DOI 10.1890/12-0378.1; Salamanca EF, 1998, ECOL ENG, V10, P53, DOI 10.1016/S0925-8574(97)10020-9; Sayer EJ, 2006, BIOL REV, V81, P1, DOI 10.1017/S1464793105006846; Schadler M, 2005, SOIL BIOL BIOCHEM, V37, P329, DOI 10.1016/j.soilbio.2004.07.042; Scheibe A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114040; Smolander A, 2012, PLANT SOIL, V350, P1, DOI 10.1007/s11104-011-0895-7; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Talbot JM, 2012, ECOLOGY, V93, P345, DOI 10.1890/11-0843.1; Townsend AR, 2007, ECOLOGY, V88, P107, DOI 10.1890/0012-9658(2007)88[107:COFNRI]2.0.CO;2; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Wang QK, 2014, SOIL BIOL BIOCHEM, V71, P13, DOI 10.1016/j.soilbio.2014.01.004; Wardle DA, 2003, SOIL BIOL BIOCHEM, V35, P827, DOI 10.1016/S0038-0717(03)00118-4; Wardle DA, 2006, SOIL BIOL BIOCHEM, V38, P1052, DOI 10.1016/j.soilbio.2005.09.003; Waterman PG, 1994, BLACKWELL SCI PUBLIC, V38, P1064, DOI DOI 10.1007/BF03028669; Xu S, 2013, BIOGEOSCIENCES, V10, P7423, DOI 10.5194/bg-10-7423-2013; Zeng DH, 2009, PLANT SOIL, V317, P121, DOI 10.1007/s11104-008-9793-z	63	5	7	16	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180422	10.1371/journal.pone.0180422	http://dx.doi.org/10.1371/journal.pone.0180422			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686660	Green Published, gold			2022-12-26	WOS:000405464100062
J	Zhou, P; Hu, J; Xi, P; Zhang, N; Yang, B; Zheng, J; Wang, XQ				Zhou, Ping; Hu, Jian; Xi, Ping; Zhang, Ning; Yang, Bo; Zheng, Jie; Wang, Xiaoqin			Survey on the levels of 25-hydroxy vitamin D and bone metabolic markers and evaluation of their correlations with osteoporosis in perimenopausal woman in Xi'an region	PLOS ONE			English	Article							D DEFICIENCY; POSTMENOPAUSAL WOMEN; MINERAL DENSITY; HIGH PREVALENCE; D INSUFFICIENCY; PREGNANT-WOMEN; TURNOVER MARKERS; FRACTURE RISK; SERUM; CALCIUM	It has been accepted that vitamin D (VD) plays an important role in bone metabolism. However, the levels of VD in people of different regions are quite different and there is still no final conclusion on the significant correlation between VD and osteoporosis. 245 cases of peri-menopausal women were collected to study the relationship between VD and osteoporosis in western China. The mean value of 25-hydroxyvitamin D for the participants was 14.39 ng/mL. The average values of parathyroid hormone (PTH), calcium (Ca) and phosphorus (P) were 47.62 pg/mL, 2.26 mmol/L and 1.18 mmol/L, respectively. The average value of bone mineral density (BMD) in lumbar vertebrae was -1.20 SD and that in femoral neck was -0.04 SD. Compared with normal group, PTH of VD deficiency group was significantly increased (P < 0.05), Ca was remarkably decreased (P < 0.01) while the BMD between these two groups showed no significant difference (P > 0.05). VD was in positive correlation with the age (P < 0.01) and Ca (< 0.01) of the participants, negative correlation with PTH (P < 0.01) while no significant correlation with the BMD of lumbar vertebrae and femoral neck (P > 0.05). The risk factors resulting in the occurrence of osteoporosis in the lumbar vertebrae of the participants covered Ca increase (OR = 66.247, P < 0.05), age growth (OR = 1.194, P < 0.01) and menopause (OR = 2.285, P < 0.05). This study has found that the status of VD deficiency showed no significant correlation with the level of BMD, which hinted that independent measurement of the bone metabolic markers, including Ca, P, VD and PTH, was difficult to accurately reflect the status of BMD in peri-menopausal women of this region. It's necessary to combine multi-site bone scanning to diagnose the patients' status of osteoporosis so as to provide reasonable guidance for early clinical prevention and treatment.	[Zhou, Ping; Hu, Jian; Zhang, Ning; Yang, Bo; Wang, Xiaoqin] Xi An Jiao Tong Univ, Lab Dept, Med Coll, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China; [Xi, Ping] Xi An Jiao Tong Univ, Endocrinol Dept, Med Coll, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China; [Zheng, Jie] Xi An Jiao Tong Univ, Affiliated Hosp 1, Med Coll, Clin Res Ctr, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Wang, XQ (corresponding author), Xi An Jiao Tong Univ, Lab Dept, Med Coll, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China.	21107028@zju.edu.cn						Ardawi MSM, 2011, OSTEOPOROSIS INT, V22, P463, DOI 10.1007/s00198-010-1249-7; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Casado-Diaz A, 2013, J STEROID BIOCHEM, V136, P187, DOI 10.1016/j.jsbmb.2012.09.026; Chapuy MC, 1997, OSTEOPOROSIS INT, V7, P439, DOI 10.1007/s001980050030; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hwang YC, 2013, CALCIFIED TISSUE INT, V92, P68, DOI 10.1007/s00223-012-9669-3; Kuchuk NO, 2009, J BONE MINER RES, V24, P693, DOI 10.1359/JBMR.081209; Li S, 2014, ANN NUTR METAB, V64, P13, DOI 10.1159/000358340; Lim JS, 2012, J CLIN ENDOCR METAB, V97, P1995, DOI 10.1210/jc.2011-3098; Mata G, 2013, ARCH OSTEOPOROS, V8, P124, DOI DOI 10.1007/S11657-013-0124-5; Need AG, 2008, BONE, V42, P1021, DOI 10.1016/j.bone.2008.01.012; Nguyen HTT, 2012, BONE, V51, P1029, DOI 10.1016/j.bone.2012.07.023; Reid IR, 2014, LANCET, V383, P146, DOI 10.1016/S0140-6736(13)61647-5; Rizzoli R, 2013, CURR MED RES OPIN, V29, P305, DOI 10.1185/03007995.2013.766162; Robinson PJ, 2013, AUSTRALAS J AGEING, V32, P177, DOI 10.1111/j.1741-6612.2011.00553.x; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Ross AC, 2011, PUBLIC HEALTH NUTR, V14, P938, DOI 10.1017/S1368980011000565; Sadat-Ali M, 2011, ANN SAUDI MED, V31, P602, DOI 10.4103/0256-4947.87097; Slominski AT, 2016, EXP DERMATOL, V25, P231, DOI 10.1111/exd.12872; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Tao MF, 2012, J MATERN-FETAL NEO M, V25, P237, DOI 10.3109/14767058.2011.569613; Wang J, 2010, WORLD J PEDIATR, V6, P265, DOI 10.1007/s12519-010-0224-x; Wang XY, 2012, CHINESE J WOMAN CHIL, V23, P20; Xiang F, 2013, J ENDOCRINOL INVEST, V36, P503, DOI 10.3275/8814; Zhao J, 2011, MENOPAUSE, V18, P1237, DOI 10.1097/gme.0b013e31821d7ff7; Zhen DH, 2015, BONE, V71, P1, DOI 10.1016/j.bone.2014.09.024; 中国老年学学会骨质疏松委员会维生素D学科组专家委员会, 2014, [中国骨质疏松杂志, Chinese Journal of Osteoporosis], V20, P1011	29	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180366	10.1371/journal.pone.0180366	http://dx.doi.org/10.1371/journal.pone.0180366			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686649	Green Submitted, Green Published, gold			2022-12-26	WOS:000405464100055
J	Stuhr, M; Reymond, CE; Rieder, V; Hallock, P; Rahnenfuhrer, J; Westphal, H; Kucera, M				Stuhr, Marleen; Reymond, Claire E.; Rieder, Vera; Hallock, Pamela; Rahnenfuehrer, Joerg; Westphal, Hildegard; Kucera, Michel			Reef calcifiers are adapted to episodic heat stress but vulnerable to sustained warming	PLOS ONE			English	Article							LARGE BENTHIC FORAMINIFERA; GREAT-BARRIER-REEF; MARGINOPORA-VERTEBRALIS; OCEAN ACIDIFICATION; FLORIDA-KEYS; CORAL-REEFS; TEMPERATURE; RESPONSES; GROWTH; ENVIRONMENTS	Shallow marine ecosystems naturally experience fluctuating physicochemical conditions across spatial and temporal scales. Widespread coral-bleaching events, induced by prolonged heat stress, highlight the importance of how the duration and frequency of thermal stress influence the adaptive physiology of photosymbiotic calcifiers. Large benthic foraminifera harboring algal endosymbionts are major tropical carbonate producers and bioindicators of ecosystem health. Like corals, they are sensitive to thermal stress and bleach at temperatures temporarily occurring in their natural habitat and projected to happen more frequently. However, their thermal tolerance has been studied so far only by chronic exposure, so how they respond under more realistic episodic heat-event scenarios remains unknown. Here, we determined the physiological responses of Amphistegina gibbosa, an abundant western Atlantic foraminifera, to four different treatments control, single, episodic, and chronic exposure to the same thermal stress (32 degrees C) in controlled laboratory cultures. Exposure to chronic thermal stress reduced motility and growth, while antioxidant capacity was elevated, and photosymbiont variables (coloration, oxygen-production rates, chlorophyll a concentration) indicated extensive bleaching. In contrast, single- and episodic-stress treatments were associated with higher motility and growth, while photosymbiont variables remained stable. The effects of single and episodic heat events were similar, except for the presumable occurrence of reproduction, which seemed to be suppressed by both episodic and chronic stress. The otherwise different responses between treatments with thermal fluctuations and chronic stress indicate adaptation to thermal peaks, but not to chronic exposure expected to ensue when baseline temperatures are elevated by climate change. This firstly implies that marine habitats with a history of fluctuating thermal stress potentially support resilient physiological mechanisms among photosymbiotic organisms. Secondly, there seem to be temporal constraints related to heat events among coral reef environments and reinforces the importance of temporal fluctuations in stress exposure in global-change studies and projections.	[Stuhr, Marleen; Reymond, Claire E.; Westphal, Hildegard] Leibniz Ctr Trop Marine Res ZMT, Dept Biogeochem & Geol, Bremen, Germany; [Rieder, Vera; Rahnenfuehrer, Joerg] TU Dortmund Univ, Dept Stat, Dortmund, Germany; [Hallock, Pamela] Univ S Florida, Coll Marine Sci, St Petersburg, FL USA; [Westphal, Hildegard] Univ Bremen, Dept Geosci, Bremen, Germany; [Kucera, Michel] Univ Bremen, MARUM, Ctr Marine Environm Sci, Bremen, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Dortmund University of Technology; State University System of Florida; University of South Florida; University of Bremen; University of Bremen	Stuhr, M (corresponding author), Leibniz Ctr Trop Marine Res ZMT, Dept Biogeochem & Geol, Bremen, Germany.	marleen.stuhr@lebniz-zmt.de	Kucera, Michal/ABH-6065-2020; Stuhr, Marleen/T-9771-2019; Westphal, Hildegard/ACQ-0391-2022; Kucera, Michal/B-9277-2009; Kucera, Michal/AAE-8115-2020	Kucera, Michal/0000-0002-7817-9018; Kucera, Michal/0000-0002-7817-9018; Baumeister, Vera/0000-0002-8706-1492; Westphal, Hildegard/0000-0001-7324-6122; Hallock, Pamela/0000-0002-1813-0482; Rahnenfuhrer, Jorg/0000-0002-8947-440X	Leibniz Association [SAW-2014-ISAS-2]	Leibniz Association	This study was funded by the Leibniz Association (SAW-2014-ISAS-2, www.leibnizgemeinschaft.de) awarded to HW and JR. The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado LL, 2009, SCI TOTAL ENVIRON, V407, P2115, DOI 10.1016/j.scitotenv.2008.11.038; Anderson J, FLORIDA KEYS NATL MA; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bernhard JM, 2000, MICROPALEONTOLOGY, V46, P38; Boyd PW, 2016, GLOBAL CHANGE BIOL, V22, P2633, DOI 10.1111/gcb.13287; Buerger P, 2015, J EXP MAR BIOL ECOL, V471, P232, DOI 10.1016/j.jembe.2015.06.014; Doo SS, 2012, ZOOL STUD, V51, P1298; Doo SS, 2012, J EXP MAR BIOL ECOL, V430, P63, DOI 10.1016/j.jembe.2012.06.025; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Faraway J.J., 2006, MIXED EFFECTS NONPAR, DOI 10.1201/b21296; Fujita K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090304; Genolini C., 2016, LONGITUDINALDATA LON; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; HALLOCK P, 1986, J FORAMIN RES, V16, P224, DOI 10.2113/gsjfr.16.3.224; HALLOCK P, 1981, Journal of Foraminiferal Research, V11, P40; Hallock P, 2003, ENVIRON MONIT ASSESS, V81, P221, DOI 10.1023/A:1021337310386; HALLOCK P, 1995, J FORAMIN RES, V25, P280, DOI 10.2113/gsjfr.25.3.280; Hallock P., 1993, P 7 INT COR REEF S G, V1, P44; Harper D, 2001, PAST PALEONTOLOGICAL; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; JAAP WC, 1979, B MAR SCI, V29, P414; Langer MR, 2008, J EUKARYOT MICROBIOL, V55, P163, DOI 10.1111/j.1550-7408.2008.00321.x; Leichter JJ, 2006, J MAR RES, V64, P563, DOI 10.1357/002224006778715711; Leichter JJ, 1996, LIMNOL OCEANOGR, V41, P1490, DOI 10.4319/lo.1996.41.7.1490; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Manzello DP, 2015, SCI REP-UK, V5, DOI 10.1038/srep16762; Mayfield AB, 2012, J EXP BIOL, V215, P4183, DOI 10.1242/jeb.071688; Middlebrook R, 2008, J EXP BIOL, V211, P1050, DOI 10.1242/jeb.013284; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Prazeres M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45227; Prazeres M, 2016, SCI REP-UK, V6, DOI 10.1038/srep21936; Putnam HM, 2011, J EXP MAR BIOL ECOL, V396, P216, DOI 10.1016/j.jembe.2010.10.026; Putnam HM, 2010, INVERTEBR BIOL, V129, P199, DOI 10.1111/j.1744-7410.2010.00199.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reymond CE, 2013, GLOBAL CHANGE BIOL, V19, P291, DOI 10.1111/gcb.12035; Reymond CE, 2011, MAR ECOL PROG SER, V435, P97, DOI 10.3354/meps09172; Rodolfo-Metalpa R, 2014, GLOBAL CHANGE BIOL, V20, P3036, DOI 10.1111/gcb.12571; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidt C, 2016, SCI REP-UK, V6, DOI 10.1038/srep30930; Schmidt C, 2014, CORAL REEFS, V33, P805, DOI 10.1007/s00338-014-1151-4; Schmidt C, 2011, LIMNOL OCEANOGR, V56, P1587, DOI 10.4319/lo.2011.56.5.1587; Schwartzwald D., 2012, COLOR SPACE CONVERTE; Sinutok S, 2011, LIMNOL OCEANOGR, V56, P1200, DOI 10.4319/lo.2011.56.4.1200; Soto I.M., 2011, Journal of Marine Biology, V2011, P1; Talge HK, 2003, J EUKARYOT MICROBIOL, V50, P324, DOI 10.1111/j.1550-7408.2003.tb00143.x; TERKUILE B, 1984, J FORAMIN RES, V14, P262, DOI 10.2113/gsjfr.14.4.262; Uthicke S, 2012, CORAL REEFS, V31, P401, DOI 10.1007/s00338-011-0851-2; Vasseur DA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2612; Vega-Rodriguez M, 2015, MAR ECOL PROG SER, V528, P173, DOI 10.3354/meps11268; Waters H, 2017, J FORAMINIF IN PRESS, V47; Williams DE, 2004, MAR BIOL, V145, P641, DOI 10.1007/s00227-004-1351-5	53	22	23	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0179753	10.1371/journal.pone.0179753	http://dx.doi.org/10.1371/journal.pone.0179753			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683118	Green Published, Green Submitted, gold			2022-12-26	WOS:000405335200014
J	Buhmann, C; Huckhagel, T; Engel, K; Gulberti, A; Hidding, U; Poetter-Nerger, M; Goerendt, I; Ludewig, P; Braass, H; Choe, CU; Krajewski, K; Oehlwein, C; Mittmann, K; Engel, AK; Gerloff, C; Westphal, M; Koppen, JA; Moll, CKE; Hamel, W				Buhmann, Carsten; Huckhagel, Torge; Engel, Katja; Gulberti, Alessandro; Hidding, Ute; Poetter-Nerger, Monika; Goerendt, Ines; Ludewig, Peter; Braass, Hanna; Choe, Chi-un; Krajewski, Kara; Oehlwein, Christian; Mittmann, Katrin; Engel, Andreas K.; Gerloff, Christian; Westphal, Manfred; Koeppen, Johannes A.; Moll, Christian K. E.; Hamel, Wolfgang			Adverse events in deep brain stimulation: A retrospective long-term analysis of neurological, psychiatric and other occurrences	PLOS ONE			English	Article							SUBTHALAMIC NUCLEUS STIMULATION; ADVANCED PARKINSONS-DISEASE; 5-YEAR FOLLOW-UP; QUALITY-OF-LIFE; ESSENTIAL TREMOR; THALAMIC-STIMULATION; COGNITIVE FUNCTION; BILATERAL STIMULATION; GENERALIZED DYSTONIA; URINARY-BLADDER	Background and objective The extent to which deep brain stimulation (DBS) can improve quality of life may be perceived as a permanent trade-off between neurological improvements and complications of therapy, comorbidities, and disease progression. Patients and methods We retrospectively investigated 123 consecutive and non-preselected patients. Indications for DBS surgery were Parkinson's disease (82), dystonia (18), tremor of different etiology (21), Huntington's disease (1) and Gilles de la Tourette syndrome (1). AEs were defined as any untoward clinical occurrence, sign or patient complaint or unintended disease if related or unrelated to the surgical procedures, implanted devices or ongoing DBS therapy. Results Over a mean/median follow-up period of 4.7 years (578 patient-years) 433 AEs were recorded in 106 of 123 patients (86.2%). There was no mortality or persistent morbidity from the surgical procedure. All serious adverse events (SAEs) that occurred within 4 weeks of surgery were reversible. Neurological AEs (193 in 85 patients) and psychiatric AEs (78 in 48 patients) were documented most frequently. AEs in 4 patients (suicide under GPI stimulation, weight gain >20 kg, impairment of gait and speech, cognitive decline >2 years following surgery) were severe or worse, at least possibly related to DBS and non reversible. In PD 23.1% of the STN-stimulated patients experienced non-reversible (or unknown reversibility) AEs that were at least possibly related to DBS in the form of impaired speech or gait, depression, weight gain, cognitive disturbances or urinary incontinence (severity was mild or moderate in 15 of 18 patients). Age and Hoehn&Yahr stage of STN-simulated PD patients, but not preoperative motor impairment or response to levodopa, showed a weak correlation (r = 0.24 and 0.22, respectively) with the number of AEs. Conclusions DBS-related AEs that were severe or worse and non-reversible were only observed in PD (4 of 82 patients; 4.9%), but not in other diseases. PD patients exhibited a significant risk for non-severe AEs most of which also represented preexisting and progressive axial and non-motor symptoms of PD. Mild gait and/or speech disturbances were rather frequent complaints under VIM stimulation. GPI stimulation for dystonia could be applied with negligible DBS-related side effects.	[Buhmann, Carsten; Hidding, Ute; Poetter-Nerger, Monika; Goerendt, Ines; Ludewig, Peter; Braass, Hanna; Choe, Chi-un; Gerloff, Christian] Univ Klinikum Hamburg Eppendorf, Klin Neurol, Hamburg, Germany; [Huckhagel, Torge; Engel, Katja; Krajewski, Kara; Westphal, Manfred; Koeppen, Johannes A.; Hamel, Wolfgang] Univ Klinikum Hamburg Eppendorf, Klin Neurochirurg, Hamburg, Germany; [Gulberti, Alessandro; Engel, Andreas K.; Moll, Christian K. E.] Univ Klinikum Hamburg Eppendorf, Inst Neurophysiol & Pathophysiol, Hamburg, Germany; [Oehlwein, Christian; Mittmann, Katrin] Praxis Neurol, Gera, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Hamel, W (corresponding author), Univ Klinikum Hamburg Eppendorf, Klin Neurochirurg, Hamburg, Germany.	whamel@uke.de	Krajewski, Kara/ABH-2587-2020; Engel, Andreas K/C-7781-2012; Engel, Andreas K./AAH-6384-2019	Engel, Andreas K/0000-0003-4899-8466; Engel, Andreas K./0000-0003-4899-8466; Gerloff, Christian/0000-0002-6484-8882; Gulberti, Alessandro/0000-0003-0538-5109; Huckhagel, Torge/0000-0003-1183-2630				Alegret M, 2001, ARCH NEUROL-CHICAGO, V58, P1223, DOI 10.1001/archneur.58.8.1223; Blomstedt P, 2007, BRIT J NEUROSURG, V21, P504, DOI 10.1080/02688690701552278; Blomstedt P, 2006, STEREOT FUNCT NEUROS, V84, P72, DOI 10.1159/000094035; Castelli L, 2006, EUR NEUROL, V55, P136, DOI 10.1159/000093213; Combs HL, 2015, NEUROPSYCHOL REV, V25, P439, DOI 10.1007/s11065-015-9302-0; Contarino MF, 2007, J NEUROL NEUROSUR PS, V78, P248, DOI 10.1136/jnnp.2005.086660; Daniele A, 2003, J NEUROL NEUROSUR PS, V74, P175, DOI 10.1136/jnnp.74.2.175; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Dujardin K, 2001, J NEUROL, V248, P603, DOI 10.1007/s004150170139; Faist M, 2001, BRAIN, V124, P1590, DOI 10.1093/brain/124.8.1590; Fasano A, 2010, BRAIN, V133, P2664, DOI 10.1093/brain/awq221; Favilla CG, 2012, BRAIN, V135, P1455, DOI 10.1093/brain/aws026; Ferraye MU, 2008, NEUROLOGY, V70, P1431, DOI 10.1212/01.wnl.0000310416.90757.85; Follett KA, 2010, NEW ENGL J MED, V362, P2077, DOI 10.1056/NEJMoa0907083; Frost E, 2010, INT J SPEECH-LANG PA, V12, P399, DOI 10.3109/17549507.2010.497560; Funkiewiez A, 2004, J NEUROL NEUROSUR PS, V75, P834, DOI 10.1136/jnnp.2002.009803; Funkiewiez A, 2003, MOVEMENT DISORD, V18, P524, DOI 10.1002/mds.10441; Funkiewiez A, 2006, MOVEMENT DISORD, V21, P1656, DOI 10.1002/mds.21029; Gervais-Bernard H, 2009, J NEUROL, V256, P225, DOI 10.1007/s00415-009-0076-2; Gironell A, 2003, J NEUROL, V250, P917, DOI 10.1007/s00415-003-1109-x; Guehl D, 2006, EXP BRAIN RES, V170, P206, DOI 10.1007/s00221-005-0202-z; Hammer MJ, 2010, J NEUROL, V257, P1692, DOI 10.1007/s00415-010-5605-5; Hariz GM, 2002, J NEUROL NEUROSUR PS, V72, P47, DOI 10.1136/jnnp.72.1.47; Hariz MI, 2008, MOVEMENT DISORD, V23, P416, DOI 10.1002/mds.21888; Hariz MI, 1999, STEREOT FUNCT NEUROS, V72, P208, DOI 10.1159/000029728; Herzog J, 2008, BRAIN, V131, P132, DOI 10.1093/brain/awm254; Herzog J, 2006, BRAIN, V129, P3366, DOI 10.1093/brain/awl302; Kim HJ, 2014, J NEUROL, V261, P1090, DOI 10.1007/s00415-014-7321-z; Kim HJ, 2013, J NEUROL, V260, P2130, DOI 10.1007/s00415-013-6959-2; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Kronenbuerger M, 2009, CEREBELLUM, V8, P389, DOI 10.1007/s12311-009-0111-y; Krystkowiak P, 2003, ARCH NEUROL-CHICAGO, V60, P80, DOI 10.1001/archneur.60.1.80; Kumar R, 2003, NEUROLOGY, V61, P1601, DOI 10.1212/01.WNL.0000096012.07360.1C; Kupsch A, 2006, NEW ENGL J MED, V355, P1978, DOI 10.1056/NEJMoa063618; Louis ED, 2013, PARKINSONISM RELAT D, V19, P363, DOI 10.1016/j.parkreldis.2012.10.005; Louis ED, 2009, MOVEMENT DISORD, V24, P1606, DOI 10.1002/mds.22570; Maurer C, 2003, BRAIN, V126, P1146, DOI 10.1093/brain/awg100; McNeely ME, 2013, PARKINSONISM RELAT D, V19, P86, DOI 10.1016/j.parkreldis.2012.07.013; Merola A, 2014, J NEUROL, V261, P1745, DOI 10.1007/s00415-014-7414-8; Moll Christian K E, 2013, Acta Neurochir Suppl, V117, P19, DOI 10.1007/978-3-7091-1482-7_4; Mueller J, 2008, MOVEMENT DISORD, V23, P131, DOI 10.1002/mds.21783; Obeso JA, 2001, NEW ENGL J MED, V345, P956, DOI 10.1056/nejmoa000827; Odekerken VJJ, 2013, LANCET NEUROL, V12, P37, DOI 10.1016/S1474-4422(12)70264-8; Okun MS, 2012, LANCET NEUROL, V11, P140, DOI 10.1016/S1474-4422(11)70308-8; Okun MS, 2009, ANN NEUROL, V65, P586, DOI 10.1002/ana.21596; Papavassiliou E, 2004, NEUROSURGERY, V54, P1120, DOI 10.1227/01.NEU.0000119329.66931.9E; Parsons TD, 2006, LANCET NEUROL, V5, P578, DOI 10.1016/S1474-4422(06)70475-6; Pilitsis JG, 2008, J NEUROSURG, V109, P640, DOI 10.3171/JNS/2008/109/10/0640; Pinto S, 2005, MOVEMENT DISORD, V20, P1507, DOI 10.1002/mds.20601; Putzke JD, 2006, J NEUROL NEUROSUR PS, V77, P1235, DOI 10.1136/jnnp.2006.086579; Rehncrona S, 2003, MOVEMENT DISORD, V18, P163, DOI 10.1002/mds.10309; Rousseaux M, 2004, J NEUROL, V251, P327, DOI 10.1007/s00415-004-0327-1; Saez-Zea C, 2012, EUR NEUROL, V68, P361, DOI 10.1159/000341380; Schuepbach WMM, 2013, NEW ENGL J MED, V368, P610, DOI 10.1056/NEJMoa1205158; Schulz GM, 2012, J PARKINSON DIS, V2, P29, DOI 10.3233/JPD-2012-11049; Schupbach WMM, 2005, J NEUROL NEUROSUR PS, V76, P1640, DOI 10.1136/jnnp.2005.063206; Schuurman PR, 2008, MOVEMENT DISORD, V23, P1146, DOI 10.1002/mds.22059; Schuurman PR, 2000, NEW ENGL J MED, V342, P461, DOI 10.1056/NEJM200002173420703; Shih LC, 2013, PARKINSONISM RELAT D, V19, P676, DOI 10.1016/j.parkreldis.2013.03.006; Skodda S, 2014, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00218; St George RJ, 2012, J NEUROSURG, V116, P1347, DOI 10.3171/2012.2.JNS11847; Stolze H, 2001, BRAIN, V124, P2278, DOI 10.1093/brain/124.11.2278; Stolze H, 2001, NEUROLOGY, V57, P144, DOI 10.1212/WNL.57.1.144; Sydow O, 2003, J NEUROL NEUROSUR PS, V74, P1387, DOI 10.1136/jnnp.74.10.1387; Timmermann L, 2015, LANCET NEUROL, V14, P693, DOI 10.1016/S1474-4422(15)00087-3; Tripoliti E, 2011, NEUROLOGY, V76, P80, DOI 10.1212/WNL.0b013e318203e7d0; Tripoliti E, 2014, MOVEMENT DISORD, V29, P532, DOI 10.1002/mds.25816; Tsuboi T, 2015, J NEUROL NEUROSUR PS, V86, P856, DOI 10.1136/jnnp-2014-308043; van Nuenen BFL, 2008, MOVEMENT DISORD, V23, P2404, DOI 10.1002/mds.21986; Vercruysse S, 2014, J NEUROL NEUROSUR PS, V85, P872, DOI 10.1136/jnnp-2013-306336; Vesper J, 2002, J NEUROL NEUROSUR PS, V73, P275, DOI 10.1136/jnnp.73.3.275; Vidailhet M, 2007, LANCET NEUROL, V6, P223, DOI 10.1016/S1474-4422(07)70035-2; Visser JE, 2008, J NEUROL, V255, P205, DOI 10.1007/s00415-008-0636-x; Volkmann J, 2014, LANCET NEUROL, V13, P875, DOI 10.1016/S1474-4422(14)70143-7; Volkmann J, 2012, LANCET NEUROL, V11, P1029, DOI 10.1016/S1474-4422(12)70257-0; Voon V, 2008, BRAIN, V131, P2720, DOI 10.1093/brain/awn214; Weaver FM, 2009, JAMA-J AM MED ASSOC, V301, P63, DOI 10.1001/jama.2008.929; Weintraub D, 2013, J NEUROL NEUROSUR PS, V84, P1113, DOI 10.1136/jnnp-2012-304396; Wertheimer J, 2014, PARKINSONISM RELAT D, V20, P1065, DOI 10.1016/j.parkreldis.2014.06.010; Williams A, 2010, LANCET NEUROL, V9, P581, DOI 10.1016/S1474-4422(10)70093-4; Winge K, 2007, MOVEMENT DISORD, V22, P220, DOI 10.1002/mds.21253; Witt K, 2004, ARCH NEUROL-CHICAGO, V61, P697, DOI 10.1001/archneur.61.5.697; Witt K, 2006, J NEUROPSYCH CLIN N, V18, P397, DOI 10.1176/appi.neuropsych.18.3.397; Xie J, 2001, J NEUROL, V248, P1068, DOI 10.1007/s004150170027; Yaguez L, 2014, J CLIN NEUROSCI, V21, P445, DOI 10.1016/j.jocn.2013.06.005; York MK, 2008, J NEUROL NEUROSUR PS, V79, P789, DOI 10.1136/jnnp.2007.118786; Zhang K, 2010, J NEUROSURG, V112, P1271, DOI 10.3171/2009.10.JNS09371	87	68	68	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0178984	10.1371/journal.pone.0178984	http://dx.doi.org/10.1371/journal.pone.0178984			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2LF	28678830	Green Published, gold, Green Submitted			2022-12-26	WOS:000405272200007
J	Wang, HL; Tang, XY; Su, YC; Chen, JB; Yan, JB				Wang, Hongling; Tang, Xiaoyang; Su, Yi-Cheng; Chen, Jiabei; Yan, Jianbo			Characterization of clinical Vibrio parahaemolyticus strains in Zhoushan, China, from 2013 to 2014	PLOS ONE			English	Article							RISK-ASSESSMENT; SEAFOOD; TEMPERATURE; VIRULENCE; PROVINCE; MODEL	Vibrio parahaemolyticus is recognized as major cause of foodborne illness of global public health concern. This study collected 107 strains of V. parahaemolyticus during active surveillance of diarrheal diseases in hospitals in Zhoushan during 2013 to 2014 and investigated their serotypes, virulence genes (tdh, trh, and orf8), antimicrobial resistance, and genotypes. The dominant serotypes of the 107 clinical strains were O3: K6, O4: K8, and O4: KUT with 87.9% and 3.7% of the strains carrying the virulence genes tdh and trh, respectively. Molecular typing by pulsed-field gel electrophoresis indicated divergence among the clinical strains. Most isolates were sensitive to the common antimicrobial agents used against the Vibrio species except ampicillin. We conclude that continuous surveillance of V. parahaemolyticus in diarrhea patients is a public health priority and is useful for conducting risk assessment of foodborne illnesses caused by V. parahaemolyticus.	[Wang, Hongling; Chen, Jiabei; Yan, Jianbo] Key Lab Hlth Risk Factors Seafood Zhejiang Prov, Zhoushan, Zhejiang, Peoples R China; [Wang, Hongling; Chen, Jiabei; Yan, Jianbo] Zhoushan Municipal Ctr Dis Control & Prevent, Zhoushan, Zhejiang, Peoples R China; [Tang, Xiaoyang] MasterKong Holding, Cent Res Inst, Food Safety Res Ctr, Shanghai, Peoples R China; [Su, Yi-Cheng] Oregon State Univ, Seafood Res & Educ Ctr, Astoria, OR USA	Oregon State University	Wang, HL (corresponding author), Key Lab Hlth Risk Factors Seafood Zhejiang Prov, Zhoushan, Zhejiang, Peoples R China.; Wang, HL (corresponding author), Zhoushan Municipal Ctr Dis Control & Prevent, Zhoushan, Zhejiang, Peoples R China.	whlwillia@163.com			Bureau of Science and Technology of Zhoushan [2014C31073]	Bureau of Science and Technology of Zhoushan	This research was supported by the grants from Bureau of Science and Technology of Zhoushan (Project NO.2014C31073).	Broberg CA, 2011, MICROBES INFECT, V13, P992, DOI 10.1016/j.micinf.2011.06.013; Chao GX, 2009, FOODBORNE PATHOG DIS, V6, P1021, DOI 10.1089/fpd.2009.0295; Chen Y, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.11.003; Hernandez-Diaz LD, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00221; Han HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130302; Iwahori J, 2010, RISK ANAL, V30, P1817, DOI 10.1111/j.1539-6924.2010.01444.x; Li BS, 2015, INT J FOOD MICROBIOL, V200, P13, DOI 10.1016/j.ijfoodmicro.2014.12.009; Liao YX, 2015, FOODBORNE PATHOG DIS, V12, P881, DOI 10.1089/fpd.2015.1988; Ludeke CHM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00564; Mahoney JC, 2010, APPL ENVIRON MICROB, V76, P7459, DOI 10.1128/AEM.01450-10; Pazhani GP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002815; Shinoda S, 2011, BIOCONTROL SCI, V16, P129, DOI 10.4265/bio.16.129; Su YC, 2007, FOOD MICROBIOL, V24, P549, DOI 10.1016/j.fm.2007.01.005; Tsai SE, 2013, INT J FOOD MICROBIOL, V165, P18, DOI 10.1016/j.ijfoodmicro.2013.04.017; Vongxay K, 2008, FOODBORNE PATHOG DIS, V5, P127, DOI 10.1089/fpd.2007.0045; Wang RZ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00144; Wang XY, 2015, CHEMOSPHERE, V118, P163, DOI 10.1016/j.chemosphere.2014.07.057; Ward LN, 2006, APPL ENVIRON MICROB, V72, P2031, DOI 10.1128/AEM.72.3.2031-2042.2006; Wu YC, 2014, ACTA PSYCHOL, V153, P39, DOI 10.1016/j.actpsy.2014.09.002; Xie J, 2012, FOOD CONTROL, V23, P320, DOI 10.1016/j.foodcont.2011.07.019; Xue ChaoBo, 2008, Disease Surveillance, V23, P424; Yamamoto A, 2008, INT J FOOD MICROBIOL, V124, P70, DOI 10.1016/j.ijfoodmicro.2008.02.021; Yoon KS, 2008, FOOD MICROBIOL, V25, P635, DOI 10.1016/j.fm.2008.04.007; Zarei M, 2012, FOODBORNE PATHOG DIS, V9, P108, DOI 10.1089/fpd.2011.0989; Zhang HZ, 2013, FOODBORNE PATHOG DIS, V10, P796, DOI 10.1089/fpd.2012.1378	25	17	19	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180335	10.1371/journal.pone.0180335	http://dx.doi.org/10.1371/journal.pone.0180335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678810	gold, Green Submitted, Green Published			2022-12-26	WOS:000405272200055
J	Bighiu, MA; Gorokhova, E; Almroth, BC; Wiklund, AKE				Bighiu, Maria Alexandra; Gorokhova, Elena; Almroth, Bethanie Carney; Wiklund, Ann-Kristin Eriksson			Metal contamination in harbours impacts life-history traits and metallothionein levels in snails	PLOS ONE			English	Article							FRESH-WATER PULMONATE; ANTI-FOULING PAINTS; SPECTROPHOTOMETRIC METHOD; THEODOXUS-FLUVIATILIS; COPPER CONTAMINATION; AQUATIC ENVIRONMENT; ZINC CONCENTRATIONS; REPRODUCTIVE-CYCLE; BRACKISH-WATER; WEST-COAST	Harbours with limited water exchange are hotspots of contaminant accumulation. Antifouling paints (AF) contribute to this accumulation by leaching biocides that may affect non-target species. In several leisure boat harbours and reference areas in the Baltic Sea, chronic exposure effects were evaluated using caging experiments with the snail Theodoxus fluviatilis. We analysed variations in ecologically relevant endpoints (mortality, growth and reproduction) in concert with variation in metallothionein-like proteins (MTLP) levels. The latter is a biomarker of exposure to metals, such as copper (Cu) and zinc (Zn), which are used in AF paints as active ingredient and stabilizer, respectively. In addition, environmental samples (water, sediment) were analysed for metal (Cu and Zn) and nutrient (total phosphorous and nitrogen) concentrations. All life-history endpoints were negatively affected by the exposure, with higher mortality, reduced growth and lower fecundity in the harbours compared to the reference sites. Metal concentrations were the key explanatory variables for all observed adverse effects, suggesting that metal-driven toxicity, which is likely to stem from AF paints, is a source of anthropogenic stress for biota in the harbours.	[Bighiu, Maria Alexandra; Gorokhova, Elena; Wiklund, Ann-Kristin Eriksson] Stockholm Univ, Dept Environm Sci & Analyt Chem, Stockholm, Sweden; [Almroth, Bethanie Carney] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden	Stockholm University; University of Gothenburg	Bighiu, MA (corresponding author), Stockholm Univ, Dept Environm Sci & Analyt Chem, Stockholm, Sweden.	maria.bighiu@aces.su.se	Bighiu, Maria/ABA-9079-2020; Gorokhova, Elena/E-7105-2018; Almroth, Bethanie Carney/Q-6411-2019	Gorokhova, Elena/0000-0002-4192-6956; Almroth, Bethanie Carney/0000-0002-5037-4612; Bighiu, Maria/0000-0001-8478-0144	BONUS (CHANGE-project) - European Community's Seventh Framework Programme [2012-90]; BONUS (CHANGE-project) - Baltic Seanational funding institutions [2012-90]	BONUS (CHANGE-project) - European Community's Seventh Framework Programme; BONUS (CHANGE-project) - Baltic Seanational funding institutions	This study was funded by BONUS (CHANGE-project) financed jointly by the European Community's Seventh Framework Programme (grant agreement 2012-90) and Baltic Seanational funding institutions, www.bonusportal.org; AKEW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiard JC, 2006, AQUAT TOXICOL, V76, P160, DOI 10.1016/j.aquatox.2005.08.015; Ancion PY, 2013, ENVIRON POLLUT, V173, P117, DOI 10.1016/j.envpol.2012.10.012; Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Barranguet C, 2000, EUR J PHYCOL, V35, P397, DOI 10.1080/09670260010001736001; Berthelin C, 2000, COMP BIOCHEM PHYS B, V125, P359, DOI 10.1016/S0305-0491(99)00187-X; Besser JM, 2016, ARCH ENVIRON CON TOX, V70, P321, DOI 10.1007/s00244-015-0255-3; Biggs TW, 2012, MAR POLLUT BULL, V64, P627, DOI 10.1016/j.marpolbul.2011.12.006; Bighiu MA, 2016, ENV SCI POLLUT RES; Brix KV, 2011, COMP BIOCHEM PHYS C, V154, P261, DOI 10.1016/j.cbpc.2011.06.004; Connon RE, 2012, SENSORS-BASEL, V12, P12741, DOI 10.3390/s120912741; Cooper NL, 2009, ECOTOX ENVIRON SAFE, V72, P1523, DOI 10.1016/j.ecoenv.2009.03.002; Daka ER, 2006, WATER AIR SOIL POLL, V171, P19, DOI 10.1007/s11270-005-9009-6; DALLINGER R, 1993, EUR J BIOCHEM, V216, P739, DOI 10.1111/j.1432-1033.1993.tb18193.x; Das S, 2011, J HAZARD MATER, V185, P295, DOI 10.1016/j.jhazmat.2010.09.033; Dillon R. T., 2000, ECOLOGY FRESHWATER M, DOI 10.1017/CBO9780511542008; Ejhed H, 2011, FEASIBILITY STUDY NE; Eklund B., 2008, Open Environmental Sciences, V2, P124, DOI 10.2174/1876325100802010124; Eklund B., 2013, DISPOSAL PLASTIC END; Eklund B, 2016, ARCH ENVIRON CON TOX, V70, P583, DOI 10.1007/s00244-016-0262-z; Eklund B, 2014, ENVIRON MANAGE, V53, P930, DOI 10.1007/s00267-014-0249-3; Eklund B, 2010, J SOIL SEDIMENT, V10, P127, DOI 10.1007/s11368-009-0149-y; Ferrer LD, 2003, CHEM SPEC BIOAVAILAB, V15, P7, DOI 10.3184/095422903782775271; FLEMMING CA, 1989, WATER AIR SOIL POLL, V44, P143, DOI 10.1007/BF00228784; Costa LDF, 2013, ENVIRON MONIT ASSESS, V185, P6767, DOI 10.1007/s10661-013-3063-0; Galloway TS, 2004, ENVIRON SCI TECHNOL, V38, P1723, DOI 10.1021/es030570+; Galloway TS, 2001, ECOTOXICOLOGY, V10, P5, DOI 10.1023/A:1008939520263; Hagger JA, 2009, ENVIRON POLLUT, V157, P2003, DOI 10.1016/j.envpol.2009.02.038; Hamer B, 2008, AQUAT TOXICOL, V89, P137, DOI 10.1016/j.aquatox.2008.06.015; Helsinki Commission, 2012, BALT SEA ENV P; Holding KL, 2003, ENVIRON GEOCHEM HLTH, V25, P87, DOI 10.1023/A:1021205101133; Karlsson J, 2004, MAR POLLUT BULL, V49, P456, DOI 10.1016/j.marpolbul.2004.02.034; Karlsson J, 2010, ENVIRON POLLUT, V158, P681, DOI 10.1016/j.envpol.2009.10.024; Kirkegaard J, 2006, LIMNOLOGICA, V36, P26, DOI 10.1016/j.limno.2005.11.002; Konstantinou IK, 2004, ENVIRON INT, V30, P235, DOI 10.1016/S0160-4120(03)00176-4; Lawes JC, 2016, MAR POLLUT BULL, V102, P148, DOI 10.1016/j.marpolbul.2015.11.040; Legras S, 2000, J EXP MAR BIOL ECOL, V246, P259, DOI 10.1016/S0022-0981(99)00187-2; Leung KMY, 2001, MAR ENVIRON RES, V52, P173, DOI 10.1016/S0141-1136(00)00271-3; Machreki-Ajmi M, 2011, MAR BIOL RES, V7, P261, DOI 10.1080/17451000.2010.497187; Marigomez I, 2002, MICROSC RES TECHNIQ, V56, P358, DOI 10.1002/jemt.10040; MUNZINGER A, 1988, AQUAT TOXICOL, V12, P51, DOI 10.1016/0166-445X(88)90019-7; Neira C, 2014, MAR ECOL-EVOL PERSP, V35, P46, DOI 10.1111/maec.12054; Oaten JFP, 2015, SCI TOTAL ENVIRON, V518, P238, DOI 10.1016/j.scitotenv.2015.03.003; Obiakor MO, 2015, ECOTOX ENVIRON SAFE, V117, P149, DOI 10.1016/j.ecoenv.2015.03.035; Oehlmann J, 2007, ECOTOXICOLOGY, V16, P29, DOI 10.1007/s10646-006-0109-x; Palacios O, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-4; Perceval O, 2002, ENVIRON POLLUT, V118, P5, DOI 10.1016/S0269-7491(01)00282-2; Peters A, 2014, ENVIRON SCI POLLUT R, V21, P193, DOI 10.1007/s11356-013-1851-2; Real M, 2003, AQUAT TOXICOL, V63, P283, DOI 10.1016/S0166-445X(02)00187-X; Sapozhnikova Y, 2013, MAR POLLUT BULL, V69, P189, DOI 10.1016/j.marpolbul.2013.01.039; Schettino T., 2012, Open Environmental Sciences, V6, P20, DOI 10.2174/1876325101206010020; Schiedek D, 2006, MAR POLLUT BULL, V53, P387, DOI 10.1016/j.marpolbul.2005.11.013; Schiff K, 2007, MAR POLLUT BULL, V54, P322, DOI 10.1016/j.marpolbul.2006.10.013; Schmera D, 2015, CAN J ZOOL, V93, P403, DOI 10.1139/cjz-2014-0307; Serafim A, 2010, AQUAT TOXICOL, V99, P370, DOI 10.1016/j.aquatox.2010.05.016; Sim VXY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130537; Skoog G., 1978, ASPECTS BIOL ECOLOGY; Swedish Agency for Marine and Water Management, 2013, 201319 HVMFS; Swedish Chemicals Agency, 1993, 293 SWED CHEM AG; Swedish Environmental Protection Agency Swedish Chemicals Agency, 2008, FORSL TILL GRANSV SA; Turner A, 2010, MAR POLLUT BULL, V60, P159, DOI 10.1016/j.marpolbul.2009.12.004; Viarengo A, 1997, MAR ENVIRON RES, V44, P69, DOI 10.1016/S0141-1136(96)00103-1; Vijver MG, 2011, ENVIRON TOXICOL CHEM, V30, P1482, DOI 10.1002/etc.499; Wang WX, 2002, MAR ECOL PROG SER, V243, P295, DOI 10.3354/meps243295; Warnken J, 2004, MAR POLLUT BULL, V49, P833, DOI 10.1016/j.marpolbul.2004.06.012; Welsh AH, 1996, ECOL MODEL, V88, P297, DOI 10.1016/0304-3800(95)00113-1; Wiklund AKE, 2002, ENVIRON TOXICOL CHEM, V21, P1219, DOI 10.1002/etc.5620210615; Xie LT, 2011, AQUAT TOXICOL, V105, P199, DOI 10.1016/j.aquatox.2011.06.009; Zettler ML, 2004, J CONCHOL, V38, P305; Zorita I, 2005, BIOMARKERS, V10, P342, DOI 10.1080/13547500500264645	69	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180157	10.1371/journal.pone.0180157	http://dx.doi.org/10.1371/journal.pone.0180157			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671998	Green Submitted, Green Published, gold			2022-12-26	WOS:000405268500019
J	Lajko, M; Cardona, HJ; Taylor, JM; Farrow, KN; Fawzi, AA				Lajko, Michelle; Cardona, Herminio J.; Taylor, Joann M.; Farrow, Kathryn N.; Fawzi, Amani A.			Photoreceptor oxidative stress in hyperoxiainduced proliferative retinopathy accelerates rd8 degeneration	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; MULLER GLIAL-CELLS; RETINITIS-PIGMENTOSA; NADPH OXIDASE; CRB1 GENE; RETINAL DYSTROPHIES; CRUMBS HOMOLOG-1; RHO GTPASES; MOUSE MODEL; MUTATION	To investigate the impact of photoreceptor oxidative stress on photoreceptor degeneration in mice carrying the rd8 mutation (C57BL/6N). We compared the hyperoxia-induced proliferative retinopathy (HIPR) model in two mouse strains (C57BL/6J and C57BL/6N). Pups were exposed to 75% oxygen, starting at birth and continuing for 14 days (P14). Mice were euthanized at P14, or allowed to recover in room air for one day (P15), seven days (P21), or 14 days (P28). We quantified retinal thickness and the length of residual photoreceptors not affected by rosette formation. In addition we explored differences in retinal immunostaining for NADPH oxidase 4 (NOX4), Rac1, vascular endothelium, and activated Muller cells. We analyzed photoreceptor oxidative stress using DCF staining in cross sections and quantified NOX4 protein levels using western blotting. C57BL/6N mice in HIPR showed increased oxidative stress, NOX4, and Rac1 in the photoreceptors at P14 and P15 compared to C57BL/6J. In addition, we observed significant progression of photoreceptor degeneration, with significantly accelerated rosette formation in C57BL/6N under HIPR, compared to their room air counterparts. Furthermore, C57BL/6N under HIPR had significantly thinner central retinas than C57BL/6J in HIPR. We did not find a difference in vascular disruption or Mu E ller cell activation comparing the two strains in hyperoxia. In HIPR, the C57BL/6N strain carrying the rd8 mutation showed significantly accelerated photoreceptor degeneration, mediated via exacerbated photoreceptor oxidative stress, which we believe relates to Rac1-NOX dysregulation in the setting of Crb1 loss-of-function.	[Lajko, Michelle; Fawzi, Amani A.] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA; [Cardona, Herminio J.; Taylor, Joann M.; Farrow, Kathryn N.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Fawzi, AA (corresponding author), Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA.	afawzimd@gmail.com	fawzi, amani/AAA-9199-2021	fawzi, amani/0000-0002-9568-3558	North western University Mouse Histology and Phenotyping Laboratory; Cancer Center Support Grant [NCI CA060553]; NCI CCSG [P30 CA060553]; National Institutes of Health [R21HD077336]; Friends of Prentice Grants Initiative of the North western Memorial Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD077336] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109478] Funding Source: NIH RePORTER	North western University Mouse Histology and Phenotyping Laboratory; Cancer Center Support Grant; NCI CCSG; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Friends of Prentice Grants Initiative of the North western Memorial Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the North western University Mouse Histology and Phenotyping Laboratory and a Cancer Center Support Grant (NCI CA060553). Imaging work was performed at the North western University Center for Advanced Microscopy generously supported by NCI CCSG P30 CA060553 awarded to the Robert H Lurie Comprehensive Cancer Center. Supported by grants from the National Institutes of Health (R21HD077336, A.A.F. and K.N.F.) and The Friends of Prentice Grants Initiative of the North western Memorial Foundation (K.N.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman TS, 2011, INVEST OPHTH VIS SCI, V52, P6898, DOI 10.1167/iovs.11-7701; Alves CH, 2012, MOL SYNDROMOL; Aslam M, 2009, AM J RESP CRIT CARE, V180, P1122, DOI 10.1164/rccm.200902-0242OC; Banfi B, 2004, J BIOL CHEM, V279, P46065, DOI 10.1074/jbc.M403046200; Belmonte MA, 2006, INVEST OPHTH VIS SCI, V47, P1193, DOI 10.1167/iovs.05-0446; Berkelhamer SK, 2013, FREE RADICAL BIO MED, V61, P51, DOI 10.1016/j.freeradbiomed.2013.03.003; Bernal S, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.7.e89; Bhatt L, 2010, MOL VIS, V16, P283; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAITIN MH, 1994, EXP EYE RES, V58, P359, DOI 10.1006/exer.1994.1026; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chang B, 2013, INVEST OPHTH VIS SCI, V54, P4974, DOI 10.1167/iovs.13-12289; Chang HY, 2000, SCIENCE, V290, P1978, DOI 10.1126/science.290.5498.1978; Chartier FJM, 2012, J CELL BIOL, V198, P991, DOI 10.1083/jcb.201203083; Chartier FJM, 2011, J CELL SCI, V124, P3393, DOI 10.1242/jcs.092601; Chou JC, 2014, INVEST OPHTH VIS SCI, V55, P2516, DOI 10.1167/iovs.13-13676; Datta A, 2015, AM J PHYSIOL-LUNG C, V309, pL369, DOI 10.1152/ajplung.00176.2014; den Hollander AI, 2004, HUM MUTAT, V24, P355, DOI 10.1002/humu.20093; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; den Hollander AI, 2001, AM J HUM GENET, V69, P198; Du Y, 2013, P NATL ACAD SCI USA, V110, P16586, DOI 10.1073/pnas.1314575110; Dworakowski R, 2008, PHARMACOL REP, V60, P21; Fawzi AA, 2014, INVEST OPHTH VIS SCI, V55, P1493, DOI 10.1167/iovs.13-13207; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Gerber Sylvie, 2002, Ophthalmic Genet, V23, P225, DOI 10.1076/opge.23.4.225.13879; Gorin Y, 2003, AM J PHYSIOL-RENAL, V285, pF219, DOI 10.1152/ajprenal.00414.2002; Hanein S, 2004, HUM MUTAT, V23, P306, DOI 10.1002/humu.20010; Haruta M, 2009, P NATL ACAD SCI USA, V106, P9397, DOI 10.1073/pnas.0808940106; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Henderson RH, 2011, BRIT J OPHTHALMOL, V95, P811, DOI 10.1136/bjo.2010.186882; Heynen SR, 2011, MOL VIS, V17, P2934; Heynen SR, 2013, PROG RETIN EYE RES, V8; Ildefonso CJ, 2016, INVEST OPHTH VIS SCI, V57, P372, DOI 10.1167/iovs.15-17703; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jeanes A, 2009, J MOL HISTOL, V40, P395, DOI 10.1007/s10735-010-9253-y; Khaliq S, 2003, EXP EYE RES, V76, P343, DOI 10.1016/S0014-4835(02)00304-4; Korystov YN, 2007, RADIAT RES, V168, P226, DOI 10.1667/RR0925.1; Lajko M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166886; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Lamont RE, 2016, EUR J HUM GENET, V24, P1436, DOI 10.1038/ejhg.2016.24; Laprise P, 2002, J BIOL CHEM, V277, P8226, DOI 10.1074/jbc.M110235200; Lee KJ, 2014, AM J RESP CELL MOL, V50, P369, DOI 10.1165/rcmb.2013-0118OC; Lotery AJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P415, DOI 10.1001/archopht.119.3.415; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mehalow AK, 2003, HUM MOL GEN, V12; Mekada K, 2009, EXP ANIM, P58; Mekada K, 2009, EXP ANIM, V58; Roehlecke C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071570; Ronchi JA, 2013, FREE RADICAL BIO MED, V63, P446, DOI 10.1016/j.freeradbiomed.2013.05.049; Schnabolk G, 2014, EXP EYE RES, V129, P18, DOI 10.1016/j.exer.2014.10.005; Simon MM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r82; Slavotinek AM, 2016, MOL SYNDROMOL, V7, P274, DOI 10.1159/000448109; Soetikno BT, 2015, SCI REP-UK, V5, DOI 10.1038/srep16752; Song HM, 2016, INVEST OPHTH VIS SCI, V57, P2864, DOI 10.1167/iovs.15-18974; Usui S, 2009, J NEUROCHEM, V110, P1028, DOI 10.1111/j.1471-4159.2009.06195.x; van de Pavert SA, 2004, J CELL SCI, V117, P4169, DOI 10.1242/jcs.01301; Wang JF, 2016, INVEST OPHTH VIS SCI, V57, P3892, DOI 10.1167/iovs.16-19447; Wang J, 2015, FREE RADICAL BIO MED, V86, P25, DOI 10.1016/j.freeradbiomed.2015.04.009; Yu DY, 2001, PROG RETIN EYE RES, V20, P175, DOI 10.1016/S1350-9462(00)00027-6; Zhao M, 2015, J NEUROSCI, V35, P6093, DOI 10.1523/JNEUROSCI.3412-14.2015	61	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180384	10.1371/journal.pone.0180384	http://dx.doi.org/10.1371/journal.pone.0180384			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671996	Green Published, gold, Green Submitted			2022-12-26	WOS:000405268500048
J	Liguori, R; Incensi, A; de Pasqua, S; Mignani, R; Fileccia, E; Santostefano, M; Biagini, E; Rapezzi, C; Palmieri, S; Romani, I; Borsini, W; Burlina, A; Bombardi, R; Caprini, M; Avoni, P; Donadio, V				Liguori, Rocco; Incensi, Alex; de Pasqua, Silvia; Mignani, Renzo; Fileccia, Enrico; Santostefano, Marisa; Biagini, Elena; Rapezzi, Claudio; Palmieri, Silvia; Romani, Ilaria; Borsini, Walter; Burlina, Alessandro; Bombardi, Roberto; Caprini, Marco; Avoni, Patrizia; Donadio, Vincenzo			Skin globotriaosylceramide 3 deposits are specific to Fabry disease with classical mutations and associated with small fibre neuropathy	PLOS ONE			English	Article							GALACTOSIDASE-A-GENE; ALPHA-GALACTOSIDASE; REPLACEMENT THERAPY; INVOLVEMENT; NERVE	Background Fabry Disease (FD) is characterized by globotriaosylceramide-3 (Gb3) accumulation in several tissues and a small fibre neuropathy (SFN), however the underlying mechanisms are poorly known. This study aimed to: 1) ascertain the presence of Gb3 deposits in skin samples, by an immunofluorescence method collected from FD patients with classical GLA mutations or late-onset FD variants or GLA polymorphisms; 2) correlate skin GB3 deposits with skin innervation. Methods we studied 52 genetically-defined FD patients (32 with classical GLA mutations and 20 with late-onset variants or GLA polymorphisms), 15 patients with SFN associated with a specific cause and 22 healthy controls. Subjects underwent skin biopsy to evaluate Gb3 deposits and epi-dermal innervation. Results Skin Gb3 deposits were found in all FD patients with classical GLA mutations but never in FD patients with late-onset variants or GLA polymorphisms or in patients with SFN and healthy controls. Abnormal deposits were found inside different skin structures but never inside axons. FD patients with GB3 deposits showed lower skin innervation than FD patients with late-onset variants or polymorphisms. Conclusions 1) Skin Gb3 deposits are specific to FD patients with classical GLA mutations; 2) Gb3 deposits were associated with lower skin innervation but they were not found inside axons, suggesting an indirect damage on peripheral small fibre innervation.	[Liguori, Rocco; Incensi, Alex; Avoni, Patrizia; Donadio, Vincenzo] IRCCS Inst Neurol Sci, Bologna, Italy; [Liguori, Rocco; de Pasqua, Silvia; Fileccia, Enrico; Avoni, Patrizia] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Mignani, Renzo] Infermi Hosp, Dept Nephrol, Rimini, Italy; [Santostefano, Marisa] St Orsola Marcello Malpighi Hosp, Div Nephrol, Bologna, Italy; [Biagini, Elena; Rapezzi, Claudio; Palmieri, Silvia] St Orsola Marcello Malpighi Hosp, Dept Cardiol, Bologna, Italy; [Romani, Ilaria; Borsini, Walter] Univ Florence, Neurosci Sect, NEUROFARBA Dept, Florence, Italy; [Burlina, Alessandro; Bombardi, Roberto] S Bassiano Hosp, Dept Neurol, Bassano Del Grappa, VI, Italy; [Caprini, Marco] Univ Bologna, Lab Human & Gen Physiol, FaBiT, Bologna, Italy	IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; Hospital of Rimini; IRCCS Azienda Ospedaliero-Universitaria di Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Florence; ULSS 7 Pedemontana; Ospedale San Bassiano; University of Bologna	Liguori, R (corresponding author), IRCCS Inst Neurol Sci, Bologna, Italy.; Liguori, R (corresponding author), Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy.	rocco.liguori@unibo.it	Liguori, Rocco/AAB-7860-2020; Incensi, Alex/AAB-6092-2020; Donadio, Vincenzo/AAB-9165-2020; Avoni, Patrizia/AAC-1879-2020	Incensi, Alex/0000-0003-2163-5403; de Pasqua, Silvia/0000-0003-0457-9366; Liguori, Rocco/0000-0002-1815-1013; Romani, Ilaria/0000-0001-7966-3525	Ricerca Finalizzata Ministerodella Salute [RF-20102 313899]	Ricerca Finalizzata Ministerodella Salute(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF))	This work was supported by Ricerca Finalizzata Ministerodella Salute Grant RF-20102 313899 to R.L.,M.C. and V.D; Wethank Dr. Francesco Formaggio for technical assistance and Fondazione Del Montedi Bolognae Ravenna, Italy, for providing the F.F. Ph Dfellowship. The funders had no role instudy design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlercreutz D, 2010, CARBOHYD RES, V345, P1384, DOI 10.1016/j.carres.2010.02.006; BISHOP DF, 1988, P NATL ACAD SCI USA, V85, P3903, DOI 10.1073/pnas.85.11.3903; BRADY RO, 1967, NEW ENGL J MED, V276, P1163, DOI 10.1056/NEJM196705252762101; Chevrier M, 2010, AUTOPHAGY, V6, P589, DOI 10.4161/auto.6.5.11943; Desnick R., 2001, METABOLIC MOL BASES, P3733, DOI DOI 10.1036/OMMBID.181; Dobrovolny R, 2005, J MOL MED, V83, P647, DOI 10.1007/s00109-005-0656-2; Dutsch M, 2002, J CLIN NEUROPHYSIOL, V19, P575; El-Abassi R, 2014, J NEUROL SCI, V344, P5, DOI 10.1016/j.jns.2014.06.029; Elleder M, 2003, ACTA PAEDIATR, V92, P46, DOI 10.1080/08035320310000465; Froissart R, 2003, MOL GENET METAB, V80, P307, DOI 10.1016/S1096-7192(03)00136-7; GADOTH N, 1983, J MED GENET, V20, P309, DOI 10.1136/jmg.20.4.309; KAYE EM, 1988, ANN NEUROL, V23, P505, DOI 10.1002/ana.410230513; KINT J A, 1970, Science (Washington D C), V167, P1268, DOI 10.1126/science.167.3922.1268; Lacomis D, 2005, MUSCLE NERVE, V31, P102, DOI 10.1002/mus.20130; Lakoma J, 2016, MOL PAIN, V12, DOI 10.1177/1744806916663729; Lakoma J, 2016, J CELL PHYSIOL, V231, P192, DOI 10.1002/jcp.25072; Lakoma J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108641; Lenders M, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0441-z; Liguori R, 2010, MUSCLE NERVE, V41, P409, DOI 10.1002/mus.21606; Lukas J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003632; Mignani R, 2008, NEPHROL DIAL TRANSPL, V23, P1628, DOI 10.1093/ndt/gfm813; Navarro C, 2006, ACTA NEUROPATHOL, V111, P178, DOI 10.1007/s00401-005-0026-8; PELLISSIER JF, 1981, MUSCLE NERVE, V4, P381, DOI 10.1002/mus.880040506; Provitera V, 2016, EUR J NEUROL, V23, P333, DOI 10.1111/ene.12842; Rigoldi M, 2014, CLIN GENET, V86, P258, DOI 10.1111/cge.12261; Rodrigues LG, 2009, NEUROBIOL DIS, V33, P48, DOI 10.1016/j.nbd.2008.09.001; Rombach SM, 2010, BBA-MOL BASIS DIS, V1802, P741, DOI 10.1016/j.bbadis.2010.05.003; SAKURABA H, 1990, AM J HUM GENET, V47, P784; Schiffmann R, 2002, ACTA PAEDIATR, V91, P48, DOI 10.1080/080352502762457923; Schiffmann R, 2006, ACTA NEUROL BELG, V106, P61; Schiffmann R, 2009, NEPHROL DIAL TRANSPL, V24, P2102, DOI 10.1093/ndt/gfp031; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; Thurberg BL, 2004, J INVEST DERMATOL, V122, P900, DOI 10.1111/j.0022-202X.2004.22425.x; Toyooka K, 1997, J NEUROL, V244, P464, DOI 10.1007/s004150050125; Uceyler N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166484; Wijburg FA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124987	36	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180581	10.1371/journal.pone.0180581	http://dx.doi.org/10.1371/journal.pone.0180581			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672034	Green Published, Green Submitted, gold			2022-12-26	WOS:000405268500073
J	Zelik, KE; Franz, JR				Zelik, Karl E.; Franz, Jason R.			It's positive to be negative: Achilles tendon work loops during human locomotion	PLOS ONE			English	Article							MUSCLE-TENDON; IN-VIVO; GASTROCNEMIUS-MUSCLE; MECHANICAL-PROPERTIES; STRAIN PATTERNS; ANKLE; BEHAVIOR; WALKING; PERFORMANCE; DYNAMICS	Ultrasound imaging is increasingly used with motion and force data to quantify tendon dynamics during human movement. Frequently, tendon dynamics are estimated indirectly from muscle fascicle kinematics (by subtracting muscle from muscle-tendon unit length), but there is mounting evidence that this Indirect approach yields implausible tendon work loops. Since tendons are passive viscoelastic structures, when they undergo a loading-unloading cycle they must exhibit a negative work loop (i.e., perform net negative work). However, prior studies using this Indirect approach report large positive work loops, often estimating that tendons return 2-5 J of elastic energy for every 1 J of energy stored. More direct ultrasound estimates of tendon kinematics have emerged that quantify tendon elongations by tracking either the muscle-tendon junction or localized tendon tissue. However, it is unclear if these yield more plausible estimates of tendon dynamics. Our objective was to compute tendon work loops and hysteresis losses using these two Direct tendon kinematics estimates during human walking. We found that Direct estimates generally resulted in negative work loops, with average tendon hysteresis losses of 2-11% at 1.25 m/s and 33-49% at 0.75 m/s (N = 8), alluding to 0.51-0.98 J of tendon energy returned for every 1 J stored. We interpret this finding to suggest that Direct approaches provide more plausible estimates than the Indirect approach, and may be preferable for understanding tendon energy storage and return. However, the Direct approaches did exhibit speed-dependent trends that are not consistent with isolated, in vitro tendon hysteresis losses of about 5-10%. These trends suggest that Direct estimates also contain some level of error, albeit much smaller than Indirect estimates. Overall, this study serves to highlight the complexity and difficulty of estimating tendon dynamics non-invasively, and the care that must be taken to interpret biological function from current ultrasound-based estimates.	[Zelik, Karl E.] Vanderbilt Univ, Dept Mech Engn, Nashville, TN 37235 USA; [Zelik, Karl E.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Zelik, Karl E.] Vanderbilt Univ, Dept Phys Med & Rehabil, 221 Kirkland Hall, Nashville, TN 37235 USA; [Franz, Jason R.] Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC 27599 USA; [Franz, Jason R.] North Carolina State Univ, Chapel Hill, NC 27599 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University	Zelik, KE (corresponding author), Vanderbilt Univ, Dept Mech Engn, Nashville, TN 37235 USA.; Zelik, KE (corresponding author), Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.; Zelik, KE (corresponding author), Vanderbilt Univ, Dept Phys Med & Rehabil, 221 Kirkland Hall, Nashville, TN 37235 USA.; Franz, JR (corresponding author), Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC 27599 USA.; Franz, JR (corresponding author), North Carolina State Univ, Chapel Hill, NC 27599 USA.	karl.zelik@vanderbilt.edu; jrfranz@email.unc.edu		Zelik, Karl/0000-0002-5054-2479	National Institutes of Health [K12HD073945, F32AG044904, R01AG051748]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD073945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG051748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by funding from the National Institutes of Health: K12HD073945 (awarded to KEZ), F32AG044904 and R01AG051748 (awarded to JRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Alexander RM, 2002, COMP BIOCHEM PHYS A, V133, P1001; ALEXANDER RM, 1991, J EXP BIOL, V160, P55; Arellano CJ, 2016, J BIOMECH, V49, P1812, DOI 10.1016/j.jbiomech.2016.04.022; Arndt A, 2012, KNEE SURG SPORT TR A, V20, P1868, DOI 10.1007/s00167-011-1801-9; Azizi E, 2009, J PHYSIOL-LONDON, V587, P4309, DOI 10.1113/jphysiol.2009.173690; Bennett MB, 1986, J ZOOL, V209, P548, DOI DOI 10.1111/J.1469-7998.1986.TB03609.X; Chernak LA, 2012, J BIOMECH, V45, P2618, DOI 10.1016/j.jbiomech.2012.08.001; Cronin NJ, 2013, GAIT POSTURE, V37, P305, DOI 10.1016/j.gaitpost.2012.07.024; Csapo R, 2013, J APPL PHYSIOL, V115, P468, DOI 10.1152/japplphysiol.00395.2013; DeVita P, 2007, J EXP BIOL, V210, P3361, DOI 10.1242/jeb.003970; Epstein M, 2006, J BIOMECH, V39, P2020, DOI 10.1016/j.jbiomech.2005.06.011; Farris DJ, 2016, COMPUT METH PROG BIO, V128, P111, DOI 10.1016/j.cmpb.2016.02.016; Farris DJ, 2016, J EXP BIOL, V219, P528, DOI 10.1242/jeb.126854; Farris DJ, 2013, J EXP BIOL, V216, P594, DOI 10.1242/jeb.077131; Farris DJ, 2012, P NATL ACAD SCI USA, V109, P977, DOI 10.1073/pnas.1107972109; Finni T, 2016, SCAND J MED SCI SPOR, V26, P992, DOI 10.1111/sms.12731; Finni T, 2013, J APPL PHYSIOL, V114, P515, DOI 10.1152/japplphysiol.01005.2012; Franz JR, 2016, J BIOMECH, V49, P1403, DOI 10.1016/j.jbiomech.2016.04.032; Franz JR, 2015, J APPL PHYSIOL, V119, P242, DOI 10.1152/japplphysiol.00114.2015; Franz JR, 2015, GAIT POSTURE, V41, P192, DOI 10.1016/j.gaitpost.2014.10.001; Franz JR, 2012, GAIT POSTURE, V35, P143, DOI 10.1016/j.gaitpost.2011.08.025; Fukunaga T, 2001, P ROY SOC B-BIOL SCI, V268, P229, DOI 10.1098/rspb.2000.1361; Grieve D. W., 1978, INT SERIES BIOMECH A, V4, P405; Hall GW, 1999, J BIOMECH, V32, P203, DOI 10.1016/S0021-9290(98)00167-5; HAWKINS D, 1990, J BIOMECH, V23, P487, DOI 10.1016/0021-9290(90)90304-L; Henry HT, 2005, J EXP BIOL, V208, P3293, DOI 10.1242/jeb.01764; Honert EC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163169; Ishikawa M, 2005, J APPL PHYSIOL, V99, P603, DOI 10.1152/japplphysiol.00189.2005; KER RF, 1981, J EXP BIOL, V93, P283; Konow N, 2012, P ROY SOC B-BIOL SCI, V279, P1108, DOI 10.1098/rspb.2011.1435; Korstanje JWH, 2010, J BIOMECH, V43, P1373, DOI 10.1016/j.jbiomech.2010.01.001; Kubo K, 2000, ACTA PHYSIOL SCAND, V170, P127, DOI 10.1046/j.1365-201x.2000.00768.x; Lichtwark GA, 2007, J BIOMECH, V40, P1768, DOI 10.1016/j.jbiomech.2006.07.025; Lichtwark GA, 2006, J EXP BIOL, V209, P4379, DOI 10.1242/jeb.02434; Lichtwark GA, 2005, J EXP BIOL, V208, P4715, DOI 10.1242/jeb.01950; Maganaris CN, 2000, J BIOMECH, V33, P1723, DOI 10.1016/S0021-9290(00)00130-5; Mian OS, 2007, ACTA PHYSIOL, V189, P57, DOI 10.1111/j.1748-1716.2006.01634.x; Nigg BM, 2007, BIOMECHANICS MUSCULO, P162; Peltonen J, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-212; Riemer R, 2008, GAIT POSTURE, V27, P578, DOI 10.1016/j.gaitpost.2007.07.012; Roberts TJ, 2011, J EXP BIOL, V214, P353, DOI 10.1242/jeb.038588; Roberts TJ, 2010, J APPL PHYSIOL, V109, P396, DOI 10.1152/japplphysiol.01272.2009; Roberts TJ, 2003, J EXP BIOL, V206, P2567, DOI 10.1242/jeb.00452; Sakuma J, 2012, EUR J APPL PHYSIOL, V112, P887, DOI 10.1007/s00421-011-2032-y; Sawicki GS, 2009, EXERC SPORT SCI REV, V37, P130, DOI 10.1097/JES.0b013e31819c2df6; Seynnes OR, 2015, J APPL PHYSIOL, V118, P133, DOI 10.1152/japplphysiol.00849.2014; Slane LC, 2014, J BIOMECH, V47, P750, DOI 10.1016/j.jbiomech.2013.11.023; Sugisaki N, 2005, INT J SPORT HLTH SCI, V3, P100; Sugisaki N, 2010, J BIOMECH, V43, P2844, DOI 10.1016/j.jbiomech.2010.06.013; Zelik KE, 2015, J EXP BIOL, V218, P876, DOI 10.1242/jeb.115451; Zelik KE, 2010, J EXP BIOL, V213, P4257, DOI 10.1242/jeb.044297; Zelik KE, 2014, J THEOR BIOL	52	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0179976	10.1371/journal.pone.0179976	http://dx.doi.org/10.1371/journal.pone.0179976			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671955	Green Published, gold, Green Submitted			2022-12-26	WOS:000405268500011
J	Katschnig, AM; Kauer, MO; Schwentner, R; Tomazou, EM; Mutz, CN; Linder, M; Sibilia, M; Alonso, J; Aryee, DNT; Kovar, H				Katschnig, A. M.; Kauer, M. O.; Schwentner, R.; Tomazou, E. M.; Mutz, C. N.; Linder, M.; Sibilia, M.; Alonso, J.; Aryee, D. N. T.; Kovar, H.			EWS-FLI1 perturbs MRTFB/YAP-1/TEAD target gene regulation inhibiting cytoskeletal autoregulatory feedback in Ewing sarcoma	ONCOGENE			English	Article							SERUM RESPONSE FACTOR; PROTEIN-COUPLED RECEPTOR; ACTIN CYTOSKELETON; BREAST-CANCER; TRANSCRIPTIONAL REGULATION; CELL-PROLIFERATION; DNA-BINDING; EXPRESSION; MRTF; METASTASIS	Ewing sarcoma (EWS) is a paediatric bone cancer with high metastatic potential. Cellular plasticity resulting from dynamic cytoskeletal reorganization, typically regulated via the Rho pathway, is a prerequisite for metastasis initiation. Here, we interrogated the role of the Ewing sarcoma driver oncogene EWS-FLI1 in cytoskeletal reprogramming. We report that EWS-FLI1 strongly represses the activity of the Rho-F-actin signal pathway transcriptional effector MRTFB, affecting the expression of a large number of EWS-FLI1-anticorrelated genes including structural and regulatory cytoskeletal genes. Consistent with this finding, chromatin immunoprecipitation sequencing (ChIP-seq) revealed strong overlaps in myocardin-related transcription factor B (MRTFB) and EWS-FLI1 chromatin occupation, especially for EWS-FLI1-anticorrelated genes. Binding of the transcriptional co-activator Yes-associated protein (YAP)-1, enrichment of TEAD-binding motifs in these shared genomic binding regions and overlapping transcriptional footprints of MRTFB and TEAD factors led us to propose synergy between MRTFB and the YAP/TEAD complex in the regulation of EWS-FLI1-anticorrelated genes. We propose that EWS-FLI1 suppresses the Rho-actin pathway by perturbation of a MRTFB/YAP-1/TEAD transcriptional module, which directly affects the actin-autoregulatory feedback loop. As spontaneous fluctuations in EWS-FLI1 levels of Ewing sarcoma cells in vitro and in vivo, associated with a switch between a proliferative, non-migratory EWS-FLI1-high and a non-proliferative highly migratory EWS-FLI1-low state, were recently described, our data provide a mechanistic basis for the underlying EWS-FLI1-dependent reversible cytoskeletal reprogramming of Ewing sarcoma cells.	[Katschnig, A. M.; Kauer, M. O.; Schwentner, R.; Tomazou, E. M.; Mutz, C. N.; Aryee, D. N. T.; Kovar, H.] St Anna Kinderkrebsforsch, Childrens Canc Res Inst, Zimmermannpl 10, A-1090 Vienna, Austria; [Linder, M.; Sibilia, M.] Med Univ Vienna, Inst Canc Res, Vienna, Austria; [Alonso, J.] Inst Invest Enfermedades Raras, Unidad Tumores Solidos Infantiles, Madrid, Spain; [Aryee, D. N. T.; Kovar, H.] Med Univ Vienna, Dept Paediat, Vienna, Austria	Saint Anna Children's Hospital; Medical University of Vienna; Instituto de Salud Carlos III; Instituto de Investigacion de Enfermedades Raras (IIER); Medical University of Vienna	Kovar, H (corresponding author), St Anna Kinderkrebsforsch, Childrens Canc Res Inst, Zimmermannpl 10, A-1090 Vienna, Austria.	heinrich.kovar@ccri.at	Tomazou, Eleni M/J-1475-2014; Alonso, Javier/B-6012-2013	Alonso, Javier/0000-0002-6287-8391; Tomazou, Eleni Marina/0000-0002-7497-4567; Schwentner, Raphaela/0000-0001-6839-0322; Sibilia, Maria/0000-0001-6129-5613	Austrian Science Fund [I1125-B19]; Liddy Shriver Initiative; European Commission [259348]	Austrian Science Fund(Austrian Science Fund (FWF)); Liddy Shriver Initiative; European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by the Austrian Science Fund grant I1125-B19, the Liddy Shriver Initiative and by the European Commission Framework Program 7 grant 259348 ('ASSET').	Amsellem V, 2005, EXP CELL RES, V304, P443, DOI 10.1016/j.yexcr.2004.10.035; Asparuhova MB, 2009, SCAND J MED SCI SPOR, V19, P490, DOI 10.1111/j.1600-0838.2009.00928.x; Ban J, 2008, CANCER RES, V68, P7100, DOI 10.1158/0008-5472.CAN-07-6145; Bernstein M, 2006, ONCOLOGIST, V11, P503, DOI 10.1634/theoncologist.11-5-503; Bilke S, 2013, GENOME RES, V23, P1797, DOI 10.1101/gr.151340.112; Carrillo J, 2007, CLIN CANCER RES, V13, P2429, DOI 10.1158/1078-0432.CCR-06-1762; Chaturvedi A, 2014, MOL BIOL CELL, V25, P2695, DOI 10.1091/mbc.E14-01-0007; Chaturvedi Aashi, 2012, Genes Cancer, V3, P102, DOI 10.1177/1947601912457024; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; Franzetti GA, 2017, ONCOGENE, V36, P3505, DOI 10.1038/onc.2016.498; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hu QD, 2011, MOL CELL BIOL, V31, P3223, DOI 10.1128/MCB.01365-10; Kauer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005415; Kim S, 2006, MOL CELL BIOL, V26, P2467, DOI 10.1128/MCB.26.7.2467-2478.2006; Kim T, 2017, EMBO J, V36, P520, DOI 10.15252/embj.201695137; Kovar H, 2010, GENOME MED, V2, DOI 10.1186/gm129; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lawlor Elizabeth R., 2015, Critical Reviews in Oncogenesis, V20, P155, DOI 10.1615/CritRevOncog.2015013553; Lee SM, 2010, J BIOL CHEM, V285, P22036, DOI 10.1074/jbc.M110.108878; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liu CY, 2016, ONCOTARGET, V7, P13706, DOI 10.18632/oncotarget.7333; Liu XF, 2016, CELL REP, V14, P1169, DOI 10.1016/j.celrep.2015.12.104; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Postel-Vinay S, 2012, NAT GENET, V44, P323, DOI 10.1038/ng.1085; Riggi N, 2014, CANCER CELL, V26, P668, DOI 10.1016/j.ccell.2014.10.004; Riggi N, 2010, GENE DEV, V24, P916, DOI 10.1101/gad.1899710; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodenberg JM, 2010, AM J PHYSIOL-CELL PH, V299, pC1058, DOI 10.1152/ajpcell.00080.2010; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Schwentner R, 2015, NUCLEIC ACIDS RES, V43, P2780, DOI 10.1093/nar/gkv123; Selvaraj A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-13; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Speight P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11642; Spraker HL, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00002; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan AL, 2011, MOL CELL BIOL, V31, P861, DOI 10.1128/MCB.00836-10; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Tomazou EM, 2015, CELL REP, V10, P1082, DOI 10.1016/j.celrep.2015.01.042; Toomey EC, 2010, ONCOGENE, V29, P4504, DOI 10.1038/onc.2010.205; Yu OM, 2016, MOL CELL BIOL, V36, P39, DOI 10.1128/MCB.00772-15; Yu OM, 2015, MOL PHARMACOL, V88, P171, DOI 10.1124/mol.115.097857; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	52	29	32	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 26	2017	36	43					5995	6005		10.1038/onc.2017.202	http://dx.doi.org/10.1038/onc.2017.202			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FK9OT	28671673	hybrid, Green Published			2022-12-26	WOS:000413841400008
J	Preston, S; Korhonen, PK; Mouchiroud, L; Cornaglia, M; McGee, SL; Young, ND; Davis, RA; Crawford, S; Nowell, C; Ansell, BRE; Fisher, GM; Andrews, KT; Chang, BCH; Gijs, MAM; Sternberg, PW; Auwerx, J; Baell, J; Hofmann, A; Jabbar, A; Gasser, RB				Preston, Sarah; Korhonen, Pasi K.; Mouchiroud, Laurent; Cornaglia, Matteo; McGee, Sean L.; Young, Neil D.; Davis, Rohan A.; Crawford, Simon; Nowell, Cameron; Ansell, Brendan R. E.; Fisher, Gillian M.; Andrews, Katherine T.; Chang, Bill C. H.; Gijs, Martin A. M.; Sternberg, Paul W.; Auwerx, Johan; Baell, Jonathan; Hofmann, Andreas; Jabbar, Abdul; Gasser, Robin B.			Deguelin exerts potent nematocidal activity via the mitochondrial respiratory chain	FASEB JOURNAL			English	Article						natural product; anthelmintic activity; transcriptomics; oxidative phosphorylation; nematode	NATURAL-PRODUCTS; COMPLEX-I; CYSTEINE PROTEINASES; HAEMONCHUS-CONTORTUS; FUMARATE REDUCTASE; CATHEPSIN-L; INHIBITORS; NEMATODE; ELEGANS; PATHWAY	As a result of limited classes of anthelmintics and an over-reliance on chemical control, there is a great need to discover new compounds to combat drug resistance in parasitic nematodes. Here, we show that deguelin, a plant-derived rotenoid, selectively and potently inhibits the motility and development of nematodes, which supports its potential as a lead candidate for drug development. Furthermore, we demonstrate that deguelin treatment significantly increases gene transcription that is associated with energy metabolism, particularly oxidative phosphorylation and mitoribosomal protein production before inhibiting motility. Mitochondrial tracking confirmed enhanced oxidative phosphorylation. In accordance, real-time measurements of oxidative phosphorylation in response to deguelin treatment demonstrated an immediate decrease in oxygen consumption in both parasitic (Haemonchus contortus) and free-living (Caenorhabditis elegans) nematodes. Consequently, we hypothesize that deguelin is exerting its toxic effect on nematodes as a modulator of oxidative phosphorylation. This study highlights the dynamic biologic response of multicellular organisms to deguelin perturbation.-Preston, S., Korhonen, P. K., Mouchiroud, L., Cornaglia, M., McGee, S. L., Young, N. D., Davis, R. A., Crawford, S., Nowell, C., Ansell, B. R. E., Fisher, G. M., Andrews, K. T., Chang, B. C. H., Gijs, M. A. M., Sternberg, P. W., Auwerx, J., Baell, J., Hofmann, A., Jabbar, A., Gasser, R. B. Deguelin exerts potent nematocidal activity via the mitochondrial respiratory chain.	[Preston, Sarah; Korhonen, Pasi K.; Young, Neil D.; Ansell, Brendan R. E.; Chang, Bill C. H.; Hofmann, Andreas; Jabbar, Abdul; Gasser, Robin B.] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic 3010, Australia; [Preston, Sarah] Federat Univ, Fac Sci & Technol, Ballarat, Vic, Australia; [Mouchiroud, Laurent; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, Lausanne, Switzerland; [Cornaglia, Matteo; Gijs, Martin A. M.] Ecole Polytech Fed Lausanne, Lab Microsyst, Lausanne, Switzerland; [McGee, Sean L.] Deakin Univ, Sch Med, Fac Hlth, Metab Res Unit,Metab Reprogramming Lab, Waurn Ponds, Vic, Australia; [Davis, Rohan A.; Fisher, Gillian M.; Andrews, Katherine T.; Hofmann, Andreas] Griffith Univ, Griffith Inst Drug Discovery, Nathan, Qld, Australia; [Crawford, Simon] Univ Melbourne, Sch Biosci, Parkville, Vic, Australia; [Nowell, Cameron] Monash Univ, Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic, Australia; [Baell, Jonathan] Monash Univ, Inst Pharmaceut Sci, Med Chem, Parkville, Vic, Australia; [Chang, Bill C. H.] Yourgene Biosci, Taipei, Taiwan; [Sternberg, Paul W.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	University of Melbourne; Federation University Australia; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Deakin University; Griffith University; University of Melbourne; Monash University; Monash University; California Institute of Technology	Gasser, RB (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic 3010, Australia.	robinbg@unimelb.edu.au	Ansell, Brendan/O-4150-2014; Young, Neil David/AAU-4572-2020; Fisher, Gillian M/B-7539-2017; Auwerx, Johan/ABE-9307-2021; Gasser, Robin/ABH-6185-2020; Andrews, Katherine/F-9586-2011; Hofmann, Andreas/M-9870-2019; Davis, Rohan A/B-1689-2008; Jabbar, Abdul/F-8584-2013	Ansell, Brendan/0000-0003-0297-897X; Young, Neil David/0000-0001-8756-229X; Fisher, Gillian M/0000-0001-8560-3406; Gasser, Robin/0000-0002-4423-1690; Andrews, Katherine/0000-0002-1591-8979; Hofmann, Andreas/0000-0003-4408-5467; Davis, Rohan A/0000-0003-4291-7573; Jabbar, Abdul/0000-0001-8888-0046; Auwerx, Johan/0000-0002-5065-5393; Chang, Bill Chia-Han/0000-0001-5313-4852; Preston, Sarah/0000-0002-4227-1664; Korhonen, Pasi/0000-0002-9957-4674	Australian Research Council; National Health and Medical Research Council (NHMRC) of Australia; Medicines for Malaria Venture, Yourgene Bioscience, the University of Melbourne; Ecole Polytechnique Federale de Lausanne; Gebert Ruf Stiftung [GRS-025/16]; AgingX program of the Swiss Initiative for Systems Biology; EU Ideas Program [ERC-2012-AdG-320404]; Griffith University; NHMRC	Australian Research Council(Australian Research Council); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Medicines for Malaria Venture, Yourgene Bioscience, the University of Melbourne; Ecole Polytechnique Federale de Lausanne; Gebert Ruf Stiftung; AgingX program of the Swiss Initiative for Systems Biology; EU Ideas Program; Griffith University(Griffith University); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the Australian Research Council and the National Health and Medical Research Council (NHMRC) of Australia, as well as by the Medicines for Malaria Venture, Yourgene Bioscience, the University of Melbourne (to R.B.G. S.P., A.J., J.B., B.C.H.C., and A.H.), the Ecole Polytechnique Federale de Lausanne, and the Gebert Ruf Stiftung (GRS-025/16) and the AgingX program of the Swiss Initiative for Systems Biology (to J.A. and L.M.). Some work was supported by the EU Ideas Program (ERC-2012-AdG-320404; to M.A.M.G and M.C.). G.M.F. was supported by a postdoctoral fellowship and a new researcher grant from Griffith University. P.K.K. was supported by an early career research fellowship, and N.D.Y. by a career development fellowship (CDF1) from NHMRC. Funding bodies played no role in the design of the study or collection, analysis, or interpretation of data, or in the writing of the manuscript. The authors thank Compounds Australia (http://www.griffith.edu.au/science-aviation/compounds-australia) for access to the Davis open-access natural product library, which forms part of the Open Access Compound Collection. The authors declare no conflicts of interest.	Agrawal RK, 2012, CURR OPIN STRUC BIOL, V22, P797, DOI 10.1016/j.sbi.2012.08.003; Andreux PA, 2014, SCI REP-UK, V4, DOI 10.1038/srep05285; Andreux PA, 2013, NAT REV DRUG DISCOV, V12, P465, DOI 10.1038/nrd4023; Arulampalam V, 2011, EXP CELL RES, V317, P9, DOI 10.1016/j.yexcr.2010.10.002; ASHACK RJ, 1980, J MED CHEM, V23, P1022, DOI 10.1021/jm00183a011; Atanasov AG, 2015, BIOTECHNOL ADV, V33, P1582, DOI 10.1016/j.biotechadv.2015.08.001; Baell JB, 2016, J NAT PROD, V79, P616, DOI 10.1021/acs.jnatprod.5b00947; Barnes EC, 2016, NAT PROD REP, V33, P372, DOI 10.1039/c5np00121h; Barnes EC, 2010, TETRAHEDRON, V66, P283, DOI 10.1016/j.tet.2009.10.109; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boreddy SR, 2013, ONCOGENE, V32, P3980, DOI 10.1038/onc.2012.413; Bortul R, 2005, BRIT J HAEMATOL, V129, P677, DOI 10.1111/j.1365-2141.2005.05504.x; Cabizza M, 2004, J AGR FOOD CHEM, V52, P288, DOI 10.1021/jf034987a; Caboni P, 2004, CHEM RES TOXICOL, V17, P1540, DOI 10.1021/tx049867r; Cerniglia GJ, 2015, MOL CANCER THER, V14, P1928, DOI 10.1158/1535-7163.MCT-14-0888; Chang DJ, 2012, J MED CHEM, V55, P10863, DOI 10.1021/jm301488q; Chen CS, 2014, ONCOTARGET, V5, P693, DOI 10.18632/oncotarget.1328; Chen JM, 1998, FEBS LETT, V441, P361, DOI 10.1016/S0014-5793(98)01574-9; Cornaglia M, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0083-6; COX GN, 1981, J CELL BIOL, V90, P7, DOI 10.1083/jcb.90.1.7; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Dalton JP, 1995, PARASITOLOGY, V111, P575, DOI 10.1017/S0031182000077052; Dalton JP, 1996, PARASITOL TODAY, V12, P125, DOI 10.1016/0169-4758(96)80676-4; Davis RA, 2005, J NAT PROD, V68, P769, DOI 10.1021/np050025h; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Eder J, 2014, NAT REV DRUG DISCOV, V13, P577, DOI 10.1038/nrd4336; Embeya VO, 2014, J ETHNOPHARMACOL, V153, P686, DOI 10.1016/j.jep.2014.03.027; Epe C, 2013, TRENDS PARASITOL, V29, P129, DOI 10.1016/j.pt.2013.01.001; Fang NB, 1998, P NATL ACAD SCI USA, V95, P3380, DOI 10.1073/pnas.95.7.3380; Farmer RL, 2013, CHEM SCI, V4, P3304, DOI 10.1039/c3sc50424g; Fisher GM, 2014, CHEM BIOL DRUG DES, V84, P462, DOI 10.1111/cbdd.12335; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Fritz JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005117; Garcia J, 2012, BIOORGAN MED CHEM, V20, P672, DOI 10.1016/j.bmc.2011.09.064; Gerhauser C, 1997, CANCER RES, V57, P3429; Guiliano DB, 2004, MOL BIOCHEM PARASIT, V136, P227, DOI 10.1016/j.molbiopara.2004.03.015; Harder A, 2016, ADV PARASIT, V93, P69, DOI 10.1016/bs.apar.2016.02.010; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; HOLLINGWORTH RM, 1994, BIOCHEM SOC T, V22, P230, DOI 10.1042/bst0220230; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jian Wenjie, 2009, International Journal of Agricultural and Biological Engineering, V2, P98, DOI 10.3965/j.issn.1934-6344.2009.04.098-103; Jovaisaite V, 2014, J EXP BIOL, V217, P137, DOI 10.1242/jeb.090738; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim WY, 2008, CANCER PREV RES, V1, P577, DOI 10.1158/1940-6207.CAPR-08-0184; Kita K, 2003, CURR MED CHEM, V10, P2535, DOI 10.2174/0929867033456549; Kita K, 2002, ADV PARASIT, V51, P95, DOI 10.1016/S0065-308X(02)51004-6; Knox DP, 2007, PARASITE IMMUNOL, V29, P57, DOI 10.1111/j.1365-3024.2006.00913.x; Korhonen PK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10513; Lee HY, 2005, J NATL CANCER I, V97, P1695, DOI 10.1093/jnci/dji377; Lee HY, 2004, BIOCHEM PHARMACOL, V68, P1119, DOI 10.1016/j.bcp.2004.05.033; Lee SC, 2016, CANCER RES, V76, P686, DOI 10.1158/0008-5472.CAN-15-1492; Lee SC, 2015, MOL PHARMACOL, V88, P245, DOI 10.1124/mol.114.096883; Leon-Felix J, 2004, GENE, V335, P25, DOI 10.1016/j.gene.2004.03.002; Levrier C, 2013, PHYTOCHEMISTRY, V86, P121, DOI 10.1016/j.phytochem.2012.09.019; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu YP, 2016, HEAD NECK-J SCI SPEC, V38, pE524, DOI 10.1002/hed.24034; Lummen P, 1998, BBA-BIOENERGETICS, V1364, P287, DOI 10.1016/S0005-2728(98)00034-6; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Lustigmana S, 2004, MOL BIOCHEM PARASIT, V138, P165, DOI 10.1016/j.molbiopara.2004.08.003; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Matsumoto J, 2008, ANTIMICROB AGENTS CH, V52, P164, DOI 10.1128/AAC.00378-07; Mehta R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065113; Mouchiroud L., 2016, CURR PROTOC NEUROSCI, V77; Mount David W, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.top17; Murillo G, 2002, EUR J CANCER, V38, P2446, DOI 10.1016/S0959-8049(02)00192-2; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oliver EM, 2006, PARASITOLOGY, V133, P237, DOI 10.1017/S0031182006000229; Omura S, 2001, P NATL ACAD SCI USA, V98, P60, DOI 10.1073/pnas.011524698; Ondrovics M, 2016, ADV PARASIT, V91, P233, DOI 10.1016/bs.apar.2015.09.001; Page AP, 2007, WORMBOOK, P1, DOI DOI 10.1895/WORMBOOK.1.138.1; Paulus P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039265; Preston S, 2016, INT J PARASITOL-DRUG, V6, P329, DOI 10.1016/j.ijpddr.2016.07.004; Preston S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1612-4; Preston S, 2016, MOL CELL PROBE, V30, P13, DOI 10.1016/j.mcp.2015.08.005; Preston S, 2015, INT J PARASITOL, V45, P333, DOI 10.1016/j.ijpara.2015.01.007; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rascon AA, 2013, CURR MED CHEM, V20, P3078; Redmond DL, 2006, PARASITE IMMUNOL, V28, P213, DOI 10.1111/j.1365-3024.2006.00823.x; Rhoads ML, 1998, J PARASITOL, V84, P686, DOI 10.2307/3284570; Rhoads ML, 2001, J PARASITOL, V87, P1144, DOI 10.1645/0022-3395(2001)087[1144:CCSBAS]2.0.CO;2; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sakai C, 2012, BBA-GEN SUBJECTS, V1820, P643, DOI 10.1016/j.bbagen.2011.12.013; Sankowsky N. A., 1936, Patent, Patent No. [US2058832, 2058832]; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Schwarz EM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r89; Shang HS, 2014, MOLECULES, V19, P16588, DOI 10.3390/molecules191016588; Shen B, 2015, CELL, V163, P1297, DOI 10.1016/j.cell.2015.11.031; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Skinner-Adams TS, 2016, DRUG DISCOV TODAY, V21, P725, DOI 10.1016/j.drudis.2016.01.002; Skuce PJ, 1999, PARASITOLOGY, V119, P405, DOI 10.1017/S0031182099004813; Sojka D, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-7; Suh YA, 2013, CANCER LETT, V332, P102, DOI 10.1016/j.canlet.2013.01.022; Thamilselvan V, 2011, INT J CANCER, V129, P2916, DOI 10.1002/ijc.25949; Tort J, 1999, ADV PARASIT, V43, P161, DOI 10.1016/S0065-308X(08)60243-2; Tsang WY, 2002, BIOCHEM BIOPH RES CO, V291, P8, DOI 10.1006/bbrc.2002.6394; Udeani GO, 1997, CANCER RES, V57, P3424; Udeani GO, 2001, CANCER CHEMOTH PHARM, V47, P263, DOI 10.1007/s002800000187; Vats S, 2014, PLANT CELL TISS ORG, V116, P403, DOI 10.1007/s11240-013-0409-9; Vrana JA, 2013, TOXICON, V74, P83, DOI 10.1016/j.toxicon.2013.07.028; Wu W, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.212; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	104	15	15	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4515	4532		10.1096/fj.201700288R	http://dx.doi.org/10.1096/fj.201700288R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28687609				2022-12-26	WOS:000413397400028
J	Iannuzzi, A; Pereira, J; Iannuzzi, C; Fu, BY; Ferguson-Smith, M				Iannuzzi, Alessandra; Pereira, Jorge; Iannuzzi, Clara; Fu, Beiyuan; Ferguson-Smith, Malcolm			Pooling strategy and chromosome painting characterize a living zebroid for the first time	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; SHEEP-GOAT HYBRID; MAMMALIAN CHROMOSOMES; HIGH-RESOLUTION; G-BAND; KARYOTYPE; DONKEY; REARRANGEMENTS; FISH; CYTOGENETICS	We have investigated the complex karyotype of a living zebra-donkey hybrid for the first time using chromosome-specific painting probes produced from flow-sorted chromosomes from a zebra (Equus burchelli) and horse (Equus caballus). As the chromosomes proved difficult to distinguish from one another, a successful new strategy was devised to resolve the difficulty and characterize each chromosome. This was based on selecting five panels of whole chromosome painting probes that could differentiate zebra and donkey chromosomes by labelling the probes with either FITC or Cy3 fluorochromes. Each panel was hybridized sequentially to the same G-Q-banded metaphases and the results combined so that every zebra and donkey chromosome in each suitable metaphase could be identified. A diploid number of 2n = 53, XY was found, containing haploid sets of 22 chromosomes from the zebra and 31 chromosomes from the donkey, without evidence of chromosome rearrangement. This new strategy, developed for the first time, may have several applications in the resolution of other complex hybrid karyotypes and chromosomal aberrations.	[Iannuzzi, Alessandra] ISPAAM, Natl Res Council Italy, Lab Anim Cytogenet & Genom, Naples, Italy; [Pereira, Jorge] Cytocell Ltd, Cambridge, England; [Iannuzzi, Clara] Univ Campania Luigi Vanvitelli, Dept Biochem Biophys & Gen Pathol, Naples, Italy; [Fu, Beiyuan] Wellcome Trust Sanger Inst, Cytogenet Facil, Hinxton, England; [Ferguson-Smith, Malcolm] Univ Cambridge, Cambridge Resource Ctr Comparat Genom, Dept Vet Med, Cambridge, England	Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Sistema Produzione Animale In Ambiente Mediterraneo (ISPAAM-CNR); Universita della Campania Vanvitelli; Wellcome Trust Sanger Institute; University of Cambridge	Iannuzzi, A (corresponding author), ISPAAM, Natl Res Council Italy, Lab Anim Cytogenet & Genom, Naples, Italy.	alessandra.iannuzzi@ispaam.cnr.it	Iannuzzi, Alessandra/B-8085-2015; Pereira, Jorge C/T-1822-2017	Pereira, Jorge C/0000-0002-1472-1613; IANNUZZI, Clara/0000-0003-0092-5997	MIUR (Finanziamento per Rientro dei Cervelli "Rita Levi Montalcini")	MIUR (Finanziamento per Rientro dei Cervelli "Rita Levi Montalcini")(Ministry of Education, Universities and Research (MIUR))	This work was supported by a grant from MIUR (Finanziamento per Rientro dei Cervelli Rita Levi Montalcini). Cytocell Ltd provided support in the form of a salary for one of the authors (JP). The funders had no role in study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	BENIRSCHKE K, 1964, CHROMOSOMA, V15, P1, DOI 10.1007/BF00326911; Chudoba I, 1999, CYTOGENET CELL GENET, V84, P156, DOI 10.1159/000015245; Di Meo GP, 2009, CYTOGENET GENOME RES, V125, P266, DOI 10.1159/000235932; Eils R, 1998, CYTOGENET CELL GENET, V82, P160, DOI 10.1159/000015092; Gray AP, 1972, MAMMALIAN HYBRIDS CH, P115; Halbert ND, 2007, J HERED, V98, P1, DOI 10.1093/jhered/esl051; HANSEN KM, 1975, HEREDITAS, V81, P133; Hito I, 2015, SCI REP, V5, P13171; IANNUZZI L, 1985, HEREDITAS, V103, P153, DOI 10.1111/j.1601-5223.1985.tb00495.x; IANNUZZI L, 1989, HEREDITAS, V110, P43, DOI 10.1111/j.1601-5223.1989.tb00415.x; Iannuzzi L, 2008, J APPL GENET, V49, P357, DOI 10.1007/BF03195634; KING M, 1987, HEREDITY, V59, P1, DOI 10.1038/hdy.1987.90; MCGOVERN PT, 1975, BRIT VET J, V131, P691, DOI 10.1016/S0007-1935(17)35141-2; Megersa B., 2006, ANIM PROD RES ADV, V2, P148, DOI DOI 10.4314/APRA.V2I3.36328; Mine OM, 2000, SMALL RUMINANT RES, V37, P141, DOI 10.1016/S0921-4488(99)00146-7; Muller S, 1997, HUM GENET, V100, P271, DOI 10.1007/s004390050504; Musilova P, 2013, CHROMOSOME RES, V21, P175, DOI 10.1007/s10577-013-9346-z; Pauciullo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep34781; Pauciullo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110297; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Roberts I, 1999, GENE CHROMOSOME CANC, V25, P241, DOI 10.1002/(SICI)1098-2264(199907)25:3<241::AID-GCC6>3.0.CO;2-7; RYDER OA, 1985, J HERED, V76, P379; Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368; STEBBINS GL, 1958, ADV GENET, V9, P147, DOI 10.1016/S0065-2660(08)60162-5; STEWARTSCOTT IA, 1990, NEW ZEAL VET J, V38, P7, DOI 10.1080/00480169.1990.35605; Tumennasan K, 1997, CYTOGENET CELL GENET, V78, P69, DOI 10.1159/000134633; Yang F, 2003, CYTOGENET GENOME RES, V102, P235, DOI 10.1159/000075755; Yang FT, 2004, CHROMOSOME RES, V12, P65, DOI 10.1023/B:CHRO.0000009298.02689.8a	28	8	8	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180158	10.1371/journal.pone.0180158	http://dx.doi.org/10.1371/journal.pone.0180158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700625	gold, Green Submitted, Green Published			2022-12-26	WOS:000405649600018
J	Jie, ZW; Zhang, Y; Wang, C; Shen, B; Guan, X; Ren, ZH; Ding, XX; Dai, W; Jiang, YP				Jie, Zhenwang; Zhang, Yu; Wang, Chen; Shen, Bin; Guan, Xin; Ren, Zhihua; Ding, Xinxin; Dai, Wei; Jiang, Yongping			Large-scale ex vivo generation of human neutrophils from cord blood CD34(+) cells	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; STEM-CELLS; HEMATOPOIETIC DIFFERENTIATION; EXPANSION; TRANSPLANTATION; KINETICS; RECONSTITUTION; TRANSFUSIONS; EXPRESSION; PHENOTYPE	Conventional high-dose chemotherapy frequently leads to severe neutropenia, during which patients experience a high risk of infection. Although support care with donor's neutrophils is possible this choice is largely hampered by the limited availability of matched donors. To overcome this problem, we explored a large-scale ex vivo production of neutrophils from hematopoietic stem cells (HSCs) using a four-stage culture approach in a roller-bottle production platform. We expanded CD34(+) HSCs isolated from umbilical cord blood (UCB) using our in-house special medium supplemented with cytokine cocktails and achieved about 49000-fold expansion of cells, among which about 61% were differentiated mature neutrophils. Ex vivo differentiated neutrophils exhibited a chemotactic activity similar to those from healthy donors and were capable of killing E. coli in vitro. The expansion yield as reported herein was at least 5 times higher than any other methods reported in the literature. Moreover, the cost of our modified medium was only a small fraction (<1/60) of the StemSpan (TM) SFEM. Therefore, our ex vivo expansion platform, coupled with a low cost of stem cell culture due to the use of a modified medium, makes large-scale manufacturing neutrophils possible, which should be able to greatly ameliorate neutrophil shortage for transfusion in the clinic.	[Jie, Zhenwang; Zhang, Yu; Shen, Bin; Guan, Xin; Ren, Zhihua; Ding, Xinxin; Dai, Wei; Jiang, Yongping] Tsinghua Univ, Peking Union Med Coll, Biopharmaceut R&D Ctr, Suzhou, Peoples R China; [Wang, Chen; Ren, Zhihua; Jiang, Yongping] Biopharmagen Corp, Suzhou, Peoples R China; [Ding, Xinxin] SUNY Polytech Inst, Coll Nanoscale Sci & Engn, Albany, NY USA; [Dai, Wei] NYU Langone Med Ctr, Environm Med, New York, NY USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tsinghua University; SUNY Polytechnic Institute; NYU Langone Medical Center	Jiang, YP (corresponding author), Tsinghua Univ, Peking Union Med Coll, Biopharmaceut R&D Ctr, Suzhou, Peoples R China.; Jiang, YP (corresponding author), Biopharmagen Corp, Suzhou, Peoples R China.	yjiang@biopharmagen.com		Dai, Wei/0000-0003-0169-8327	State Scientific Key Projects for New Drug Research and Development [2014ZX09101042-004, 2011ZX09401-027]; International Cooperation and Exchange Program, China [2013DFA30830]; Biopharmagen Corp	State Scientific Key Projects for New Drug Research and Development; International Cooperation and Exchange Program, China; Biopharmagen Corp	This work was funded by the State Scientific Key Projects for New Drug Research and Development (2014ZX09101042-004 and 2011ZX09401-027) and the International Cooperation and Exchange Program (2013DFA30830), China. Biopharmagen Corp provided support in the form of salaries for authors [C.W. and Z.R.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	ATHENS JW, 1961, J CLIN INVEST, V40, P989, DOI 10.1172/JCI104338; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828; Buono KD, 2015, J NEUROSCI, V35, P8855, DOI 10.1523/JNEUROSCI.2868-12.2015; Chaiworapongsa T, 2011, J PERINAT MED, V39, P653, DOI [10.1515/JPM.2011.072, 10.1515/jpm.2011.072]; Chaurasia P, J CLIN INVESTIGATION, V124, P2378; Choi KD, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.184; Covey MV, 2007, NEUROSCIENCE, V148, P501, DOI 10.1016/j.neuroscience.2007.06.015; DANCEY JT, 1976, J CLIN INVEST, V58, P705, DOI 10.1172/JCI108517; De Bruyn C, 2003, CYTOTHERAPY, V5, P87, DOI 10.1080/14653240310000119; De Larco JE, 2004, CLIN CANCER RES, V10, P4895, DOI 10.1158/1078-0432.CCR-03-0760; Decleva E, 2006, J LEUKOCYTE BIOL, V79, P87, DOI 10.1189/jlb.0605338; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Dick EP, 2008, STEM CELLS, V26, P2552, DOI 10.1634/stemcells.2008-0328; Doshi M, 2006, INT J HEMATOL, V84, P231, DOI 10.1532/IJH97.06040; Edvardsson L, 2004, BRIT J HAEMATOL, V127, P451, DOI 10.1111/j.1365-2141.2004.05227.x; Engels EA, 1999, CLIN INFECT DIS, V28, P256, DOI 10.1086/515103; Evans CA, 1999, BLOOD, V94, P1504, DOI 10.1182/blood.V94.5.1504.417a27_1504_1514; Gorczyca W., 2010, FLOW CYTOMETRY NEOPL; Guan X, 2016, SAFETY EFFICACY MEGA; HAM RG, 1963, EXP CELL RES, V29, P515, DOI 10.1016/S0014-4827(63)80014-2; HARVATH L, 1980, J IMMUNOL METHODS, V37, P39, DOI 10.1016/0022-1759(80)90179-9; HAYLOCK DN, 1992, BLOOD, V80, P1405; Hino M, 2000, BRIT J HAEMATOL, V109, P314, DOI 10.1046/j.1365-2141.2000.02054.x; Hsu KC, 2005, BLOOD, V105, P4878, DOI 10.1182/blood-2004-12-4825; Hughes WT AD, 2002, CLIN INFECT DIS, V15, P730; Jacobs L, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-64; Jiang YP, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-28; Keohane E, 1993, RODAKS HEMATOLOGY CL; Lachmann N, 2015, STEM CELL REP, V4, P282, DOI 10.1016/j.stemcr.2015.01.005; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; McNiece I, 2000, EXP HEMATOL, V28, P1181, DOI 10.1016/S0301-472X(00)00520-8; Morishima T, 2011, J CELL PHYSIOL, V226, P1283, DOI 10.1002/jcp.22456; Morris J, 2010, LAB EQUIPMENT; Muguruma Y, 2006, BLOOD, V107, P1878, DOI 10.1182/blood-2005-06-2211; Oza A, 2006, TRANSFUSION, V46, P14, DOI 10.1111/j.1537-2995.2005.00665.x; PIZZO PA, 1993, NEW ENGL J MED, V328, P1323; Posadas I, 2000, N-S ARCH PHARMACOL, V361, P98, DOI 10.1007/s002109900150; Price TH, 2006, TRANSFUSION, V46, P1, DOI 10.1111/j.1537-2995.2006.00693.x; Price TH, 1996, BLOOD, V88, P335; Price TH, 2000, BLOOD, V95, P3302, DOI 10.1182/blood.V95.11.3302.010k35_3302_3309; Qin M, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0482-9; Ren Z, 2016, STEM CELL INVESTIGAT, V3; Rodak B. F., 2013, HEMATOLOGY CLIN PRIN; Saeki K, 2009, STEM CELLS, V27, P59, DOI 10.1634/stemcells.2007-0980; Scheding S, 2000, EXP HEMATOL, V28, P460, DOI 10.1016/S0301-472X(00)00133-8; Shen B, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0413-1; Shen B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141485; SKUBITZ KM, 1995, J IMMUNOL, V155, P5382; Stevens A, 2002, WHEATERS BASIC HISTO; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Sweeney CL, 2016, STEM CELLS, V34, P1513, DOI 10.1002/stem.2332; Timmins NE, 2009, BIOTECHNOL BIOENG, V104, P832, DOI 10.1002/bit.22433; Timmins NE, 2009, TRENDS BIOTECHNOL, V27, P415, DOI 10.1016/j.tibtech.2009.03.008; TO LB, 1990, BONE MARROW TRANSPL, V6, P109; Tura Olga RB G, 2007, J TRANSL MED, V5, P1; van Raam BJ, 2008, BLOOD, V112, P2046, DOI 10.1182/blood-2008-04-149575; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Zimmerman TM, 2000, BONE MARROW TRANSPL, V26, P505, DOI 10.1038/sj.bmt.1702543	59	10	10	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180832	10.1371/journal.pone.0180832	http://dx.doi.org/10.1371/journal.pone.0180832			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700636	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649400019
J	Sui, S; Yang, Y; Sun, Y; Wang, XM; Wang, GL; Shan, GL; Wang, JC; Yu, J				Sui, Shuo; Yang, Yu; Sun, Yi; Wang, Xumin; Wang, Guoliang; Shan, Guangle; Wang, Jiancheng; Yu, Jun			On the core bacterial flora of Ixodes persulcatus (Taiga tick)	PLOS ONE			English	Article							METAGENOMICS; MICROBIOME; METATRANSCRIPTOMICS; ENDOSYMBIONTS; COMMUNITIES; DIVERSITY; PROVINCE	Ixodes persulcatus is a predominant hard tick species that transmits a wide range of human and animal pathogens. Since bacterial flora of the tick dwelling in the wild always vary according to their hosts and the environment, it is highly desirable that species-associated microbiomes are fully determined by using next-generation sequencing and based on comparative metagenomics. Here, we examine such metagenomic changes of I. persulcatus starting with samples collected from the wild ticks and followed by the reared animals under pathogen-free laboratory conditions over multiple generations. Based on high-coverage genomic sequences from three experimental groups-wild, reared for a single generation or R1, and reared for eight generations or R8-we identify the core bacterial flora of I. persulcatus, which contains 70 species that belong to 69 genera of 8 phyla; such a core is from the R8 group, which is reduced from 4625 species belonging to 1153 genera of 29 phyla in the wild group. Our study provides a novel example of tick core bacterial flora acquired based on wild-to-reared comparison, which paves a way for future research on tick metagenomics and tick-borne disease pandemics.	[Sui, Shuo; Wang, Xumin; Wang, Guoliang; Shan, Guangle; Yu, Jun] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Sui, Shuo; Wang, Xumin; Yu, Jun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Yang, Yu; Wang, Jiancheng] Chinese Acad Inspect & Quarantine, Beijing, Peoples R China; [Sun, Yi] Beijing Inst Microbiol & Epidemiol, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Inspection & Quarantine; Beijing Institute of Microbiology & Epidemiology	Yu, J (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.; Yu, J (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	junyu@big.ac.cn	wang, xumin/HII-8627-2022		Quality Inspection Public Welfare Program of China [201410020]; National key R D plan [2016YFC1202700]; CAIQ project [2016JK031]	Quality Inspection Public Welfare Program of China; National key R D plan; CAIQ project	This work was supported by Quality Inspection Public Welfare Program of China [201410020] (http://www.aqsiq.gov.cn/) YY, National key R & D plan [2016YFC1202700] (http://www.most.gov.cn/) YY,CAIQ project [2016JK031] (http://www.caiq.org.cn/) YY. The funders paid all the fee in the study design,data collection and analysis,decision to publish the manuscript.	Aguiar-Pulido V, 2016, EVOL BIOINFORM, V12, P5, DOI 10.4137/EBO.S36436; Bikel S, 2015, COMPUT STRUCT BIOTEC, V13, P390, DOI 10.1016/j.csbj.2015.06.001; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Cao WC, 2003, AM J TROP MED HYG, V68, P547, DOI 10.4269/ajtmh.2003.68.547; Cao WC, 2000, J CLIN MICROBIOL, V38, P4208, DOI 10.1128/JCM.38.11.4208-4210.2000; Chengxu AI, 1991, EPIDEMIOLOGICAL AETI, V19, P1061; de la Fuente J, 2003, CLIN DIAGN LAB IMMUN, V10, P182, DOI 10.1128/CDLI.10.1.182-184.2003; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Faust K, 2015, CURR OPIN MICROBIOL, V25, P56, DOI 10.1016/j.mib.2015.04.004; Huson DH, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004957; Igolkina Y, 2016, TICKS TICK-BORNE DIS, V7, P1284, DOI 10.1016/j.ttbdis.2016.06.005; Jaaskelainen AE, 2011, EMERG INFECT DIS, V17, P323, DOI 10.3201/eid1702.101487; Jia N, 2013, NEW ENGL J MED, V369, P1176, DOI 10.1056/NEJMc1303625; Kageyama Daisuke, 2012, Insects, V3, P161, DOI 10.3390/insects3010161; Kurilshikov A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131413; Narasimhan S, 2015, TRENDS PARASITOL, V31, P315, DOI 10.1016/j.pt.2015.03.010; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Niu QL, 2016, INFECT GENET EVOL, V41, P8, DOI 10.1016/j.meegid.2016.03.007; Ottman N, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00104; Oulas A, 2015, BIOINFORM BIOL INSIG, V9, P75, DOI 10.4137/BBI.S12462; Papa A, 2017, TICKS TICK-BORNE DIS, V8, P31, DOI 10.1016/j.ttbdis.2016.09.011; Ponnusamy Loganathan AG, 2013, APPL ENV MICROBIOLOG, V80; Porter L, 2015, TICKS TICK-BORNE DIS, V6, P16, DOI 10.1016/j.ttbdis.2014.08.002; Sun JM, 2015, EXP APPL ACAROL, V65, P403, DOI 10.1007/s10493-015-9880-9; Sun Y, 2008, VET PARASITOL, V156, P333, DOI 10.1016/j.vetpar.2008.05.026; Turaev D, 2016, CURR OPIN BIOTECH, V39, P174, DOI 10.1016/j.copbio.2016.04.011; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V66, P72, DOI 10.1111/j.1574-6941.2008.00468.x; Williams-Newkirk AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102130; Zhang XC, 2014, TICKS TICK-BORNE DIS, V5, P864, DOI 10.1016/j.ttbdis.2014.07.009	29	3	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180150	10.1371/journal.pone.0180150	http://dx.doi.org/10.1371/journal.pone.0180150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692666	Green Published, gold, Green Submitted			2022-12-26	WOS:000405544800026
J	Landman, J; Brewster, RC; Weinert, FM; Phillips, R; Kegel, WK				Landman, Jasper; Brewster, Robert C.; Weinert, Franz M.; Phillips, Rob; Kegel, Willem K.			Self-consistent theory of transcriptional control in complex regulatory architectures	PLOS ONE			English	Article							REPRESSOR CAP INTERACTION; ESCHERICHIA-COLI; GENE-EXPRESSION; LAC REPRESSOR; DNA; SEQUENCE; PROTEIN; OPERON; KINETICS; MODEL	Individual regulatory proteins are typically charged with the simultaneous regulation of a battery of different genes. As a result, when one of these proteins is limiting, competitive effects have a significant impact on the transcriptional response of the regulated genes. Here we present a general framework for the analysis of any generic regulatory architecture that accounts for the competitive effects of the regulatory environment by isolating these effects into an effective concentration parameter. These predictions are formulated using the grand-canonical ensemble of statistical mechanics and the fold-change in gene expression is predicted as a function of the number of transcription factors, the strength of interactions between the transcription factors and their DNA binding sites, and the effective concentration of the transcription factor. The effective concentration is set by the transcription factor interactions with competing binding sites within the cell and is determined self-consistently. Using this approach, we analyze regulatory architectures in the grand-canonical ensemble ranging from simple repression and simple activation to scenarios that include repression mediated by DNA looping of distal regulatory sites. It is demonstrated that all the canonical expressions previously derived in the case of an isolated, non-competing gene, can be generalised by a simple substitution to their grand canonical counterpart, which allows for simple intuitive incorporation of the influence of multiple competing transcription factor binding sites. As an example of the strength of this approach, we build on these results to present an analytical description of transcriptional regulation of the lac operon.	[Landman, Jasper; Kegel, Willem K.] Univ Utrecht, Vant Hoff Lab Phys & Colloid Chem, Utrecht, Netherlands; [Landman, Jasper] European Synchrotron Radiat Facil, Grenoble, France; [Brewster, Robert C.] Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01605 USA; [Weinert, Franz M.; Phillips, Rob] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [Phillips, Rob] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	Utrecht University; European Synchrotron Radiation Facility (ESRF); University of Massachusetts System; University of Massachusetts Worcester; California Institute of Technology; California Institute of Technology	Kegel, WK (corresponding author), Univ Utrecht, Vant Hoff Lab Phys & Colloid Chem, Utrecht, Netherlands.; Phillips, R (corresponding author), CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA.; Phillips, R (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	phillips@pboc.caltech.edu; w.k.kegel@uu.nl	Kegel, Willem K/H-4084-2016	Brewster, Robert/0000-0002-7656-4086	Netherlands Organisation for Scientific Research [022.004.016]; European Synchrotron Radiation Facility; La Fondation Pierre Gilles de Gennes; National Institutes of Health through the Directors Pioneer Award [DP1OD000217, R01GM085286]; John Templeton Foundation	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Synchrotron Radiation Facility; La Fondation Pierre Gilles de Gennes; National Institutes of Health through the Directors Pioneer Award; John Templeton Foundation	This work was supported by the Netherlands Organisation for Scientific Research grant 022.004.016 (JL), by the European Synchrotron Radiation Facility (JL), by La Fondation Pierre Gilles de Gennes (RP), by the National Institutes of Health through the Directors Pioneer Award DP1OD000217 (RP) and through R01GM085286 (RP), and by the John Templeton Foundation (RP and FMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Alberts B, 2008, MOL BIOL CELL; Biggin MD, 2011, DEV CELL, V21, P611, DOI 10.1016/j.devcel.2011.09.008; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Boedicker JQ, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.018101; Brewster RC, 2014, CELL, V156, P1312, DOI 10.1016/j.cell.2014.02.022; BUC H, 1985, BIOCHEMISTRY-US, V24, P2712, DOI 10.1021/bi00332a018; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Burger A, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.041920; Burger A, 2010, P NATL ACAD SCI USA, V107, P4016, DOI 10.1073/pnas.0915138107; CARRA JH, 1993, EMBO J, V12, P35, DOI 10.1002/j.1460-2075.1993.tb05629.x; Einav T, 2016, J PHYS CHEM B, V120, P6021, DOI 10.1021/acs.jpcb.6b01911; Fried MG, 1996, SCIENCE, V274, P1930, DOI 10.1126/science.274.5294.1930; Garcia HG, 2011, P NATL ACAD SCI USA, V108, P12173, DOI 10.1073/pnas.1015616108; Geertz M, 2012, P NATL ACAD SCI USA, V109, P16540, DOI 10.1073/pnas.1206011109; Gibbs JW, 1928, COLLECTED WORKS, VII; Gowetski DB, 2013, NUCLEIC ACIDS RES, V41, P8253, DOI 10.1093/nar/gkt553; Hammar P, 2014, NAT GENET, V46, P405, DOI 10.1038/ng.2905; HAWLEY DK, 1982, J MOL BIOL, V157, P493, DOI 10.1016/0022-2836(82)90473-9; Hill TL, 1994, THERMODYNAMICS SMA 1; Hill TL, 1994, THERMODYNAMICS SMA 2; HUDSON JM, 1990, J MOL BIOL, V214, P381, DOI 10.1016/0022-2836(90)90188-R; Karapetyan S, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.062712; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Keren L, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.59; Kinney JB, 2010, P NATL ACAD SCI USA, V107, P9158, DOI 10.1073/pnas.1004290107; KO MSH, 1991, J THEOR BIOL, V153, P181, DOI 10.1016/S0022-5193(05)80421-7; KRAMER H, 1987, EMBO J, V6, P1481, DOI 10.1002/j.1460-2075.1987.tb02390.x; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; Kwon H, 2001, EUR J BIOCHEM, V268, P565, DOI 10.1046/j.1432-1327.2001.01897.x; Kyo M, 2004, GENES CELLS, V9, P153, DOI 10.1111/j.1356-9597.2004.00711.x; Lengyel IM, 2014, PAPERS IN PHYS, V6, P1; Michel D, 2010, PROG BIOPHYS MOL BIO, V102, P16, DOI 10.1016/j.pbiomolbio.2009.12.007; Mitarai N, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.022710; Mitarai N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000109; Narang A, 2007, J THEOR BIOL, V247, P695, DOI 10.1016/j.jtbi.2007.03.030; OEHLER S, 1994, EMBO J, V13, P3348, DOI 10.1002/j.1460-2075.1994.tb06637.x; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; Okahata Y, 1998, BIOCHEMISTRY-US, V37, P5666, DOI 10.1021/bi980037k; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Perros M, 1996, SCIENCE, V274, P1929, DOI 10.1126/science.274.5294.1929; Phillips R., 2012, PHYS BIOL CELL; Phillips R, 2015, ANNU REV CONDEN MA P, V6, P85, DOI 10.1146/annurev-conmatphys-031214-014558; Razo-Mejia M, 2014, PHYS BIOL, V11, DOI 10.1088/1478-3975/11/2/026005; Record Jr MT, 1996, ESCHERICHIA COLI SAL, P792; Rydenfelt M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114347; Rydenfelt M, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012702; Saiz L, 2008, IET SYST BIOL, V2, P247, DOI 10.1049/iet-syb:20080091; Saiz L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000355; Saiz L, 2008, NUCLEIC ACIDS RES, V36, P726, DOI 10.1093/nar/gkm1034; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Sanchez A, 2008, P NATL ACAD SCI USA, V105, P5081, DOI 10.1073/pnas.0707904105; Schleif R, 2000, TRENDS GENET, V16, P559, DOI 10.1016/S0168-9525(00)02153-3; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Segal E, 2009, NAT REV GENET, V10, P443, DOI 10.1038/nrg2591; SHEA MA, 1985, J MOL BIOL, V181, P211, DOI 10.1016/0022-2836(85)90086-5; Slutsky M, 2004, BIOPHYS J, V87, P4021, DOI 10.1529/biophysj.104.050765; Vilar JMG, 2005, CURR OPIN GENET DEV, V15, P136, DOI 10.1016/j.gde.2005.02.005; Vilar JMG, 2003, J MOL BIOL, V331, P981, DOI 10.1016/S0022-2836(03)00764-2; Vilar JMG, 2013, ACS SYNTH BIOL, V2, P576, DOI 10.1021/sb400013w; Vilar JMG, 2011, NUCLEIC ACIDS RES, V39, P6854, DOI 10.1093/nar/gkr272; Vilar JMG, 2010, BIOINFORMATICS, V26, P2060, DOI 10.1093/bioinformatics/btq328; Weinert FM, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.258101; Zhang YL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000136	66	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179235	10.1371/journal.pone.0179235	http://dx.doi.org/10.1371/journal.pone.0179235			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686609	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000405464100011
J	Ohsugi, H; Ikuno, Y; Shoujou, T; Oshima, K; Ohsugi, E; Tabuchi, H				Ohsugi, Hideharu; Ikuno, Yasushi; Shoujou, Tomohiro; Oshima, Kanako; Ohsugi, Eiko; Tabuchi, Hitoshi			Axial length changes in highly myopic eyes and influence of myopic macular complications in Japanese adults	PLOS ONE			English	Article							TRACTION MACULOPATHY; PATHOLOGICAL MYOPIA; FOLLOW-UP; FOVEOSCHISIS; POPULATION	Purpose To investigate changes of the axial length in normal eyes and highly myopic eyes and influence of myopic macular complications in Japanese adults. Study design Retrospective longitudinal case series. Methods The changes in the axial length of 316 eyes from 316 patients (mean age, 63.8 +/- 9.0 years; range, 34-82; 240 females) examined using IOLMaster with a follow-up period of at least 1 year were studied. This study included 85 non-highly myopic eyes (| refractive error| <= 5 diopters; 63 females; non-highly myopic group), 165 highly myopic eyes (refractive error <=-6 diopters or axial length >= 26 mm; 124 females) without macular complications (no complications group), 32 eyes (25 females) with myopic traction maculopathy (MTM group), and 34 eyes (28 females) with myopic choroidal neovascularization (CNV group). All groups showed a significant increase in the axial length during the follow-up period (mean follow-up, 28.7 +/- 16.8 months; range, 12-78) (P < 0.01). Changes in the axial length/year in the no complications group (0.041 +/- 0.05 mm) were significantly greater than those in the non-highly myopic group (0.007 +/- 0.02 mm) (P < 0.0001). Furthermore, changes in the CNV group (0.081 +/- 0.04 mm) were significantly greater than those in the no complications (P < 0.0001) and MTM (0.040 +/- 0.05 mm) (P = 0.0059) groups, whereas no significant difference was found between the changes in the MTM and no complications groups (P = 0.91). Multiple regression analyses indicated that CNV eyes (P < 0.0001) and female patients' eyes (P = 0.04) showed greater changes in the axial length/year. Conclusions All groups showed an increase in the axial length, which was greater for highly myopic eyes. In particular, CNV eyes showed greater increases, indicating that larger changes in the axial length may require careful follow-up.	[Ohsugi, Hideharu; Shoujou, Tomohiro; Oshima, Kanako; Ohsugi, Eiko; Tabuchi, Hitoshi] Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo, Japan; [Ikuno, Yasushi] Ikuno Eye Ctr, Osaka, Japan		Ohsugi, H (corresponding author), Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo, Japan.	h.ohsugi@tsukazaki-eye.net						Bando H, 2005, AM J OPHTHALMOL, V139, P197, DOI 10.1016/j.ajo.2004.07.027; CURTIN BJ, 1971, AM J OPHTHALMOL, V71, P42, DOI 10.1016/0002-9394(71)91092-0; Fledelius HC, 2010, ACTA OPHTHALMOL, V88, P472, DOI 10.1111/j.1755-3768.2008.01472.x; Fotedar R, 2008, OPHTHALMOLOGY, V115, P1273, DOI 10.1016/j.ophtha.2007.11.003; Gaucher D, 2007, AM J OPHTHALMOL, V143, P455, DOI 10.1016/j.ajo.2006.10.053; Gudmundsdottir E, 2005, OPHTHALMOLOGY, V112, P672, DOI 10.1016/j.ophtha.2004.11.039; Hayashi K, 2010, OPHTHALMOLOGY, V117, P1595, DOI 10.1016/j.ophtha.2009.11.003; He MG, 2014, JAMA OPHTHALMOL, V132, P978, DOI 10.1001/jamaophthalmol.2014.1011; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P3721, DOI 10.1167/iovs.09-3493; LARSEN JS, 1971, ACTA OPHTHALMOL, V49, P873; Miyake M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107923; Panozzo G, 2004, ARCH OPHTHALMOL-CHIC, V122, P1455, DOI 10.1001/archopht.122.10.1455; Saka N, 2013, GRAEF ARCH CLIN EXP, V251, P495, DOI 10.1007/s00417-012-2066-9; Saka N, 2010, AM J OPHTHALMOL, V150, P562, DOI 10.1016/j.ajo.2010.05.009; Takano M, 1999, AM J OPHTHALMOL, V128, P472, DOI 10.1016/S0002-9394(99)00186-5; Wakazono T, 2016, OPHTHALMOLOGY, V123, P919, DOI 10.1016/j.ophtha.2015.10.031	16	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180851	10.1371/journal.pone.0180851	http://dx.doi.org/10.1371/journal.pone.0180851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686709	gold, Green Published, Green Submitted			2022-12-26	WOS:000405464100114
J	Suzuki, T; Espana, MU; Nunes, MA; Zhurov, V; Dermauw, W; Osakabe, M; Van Leeuwen, T; Grbic, M; Grbic, V				Suzuki, Takeshi; Espana, Maria Urizarna; Nunes, Maria Andreia; Zhurov, Vladimir; Dermauw, Wannes; Osakabe, Masahiro; Van Leeuwen, Thomas; Grbic, Miodrag; Grbic, Vojislava			Protocols for the delivery of small molecules to the two-spotted spider mite, Tetranychus urticae	PLOS ONE			English	Article							GREEN PEACH APHID; RNA INTERFERENCE; INDOLE GLUCOSINOLATE; BEMISIA-TABACI; HONEY-BEE; GENE; DSRNA; DIET; IMPROVEMENT; ELEGANS	The two-spotted spider mite, Tetranychus urticae, is a chelicerate herbivore with an extremely wide host range and an extraordinary ability to develop pesticide resistance. Due to its responsiveness to natural and synthetic xenobiotics, the spider mite is becoming a prime pest herbivore model for studies of the evolution of host range, plant-herbivore interactions and mechanisms of xenobiotic resistance. The spider mite genome has been sequenced and its transcriptional responses to developmental and various biotic and abiotic cues have been documented. However, to identify biological and evolutionary roles of T. urticae genes and proteins, it is necessary to develop methods for the efficient manipulation of mite gene function or protein activity. Here, we describe protocols developed for the delivery of small molecules into spider mites. Starting with mite maintenance and the preparation of the experimental mite populations of developmentally synchronized larvae and adults, we describe 3 methods for delivery of small molecules including artificial diet, leaf coating, and soaking. The presented results define critical steps in these methods and demonstrate that they can successfully deliver tracer dyes into mites. Described protocols provide guidelines for high-throughput setups for delivery of experimental compounds that could be used in reverse genetics platforms to modulate gene expression or protein activity, or for screens focused on discovery of new molecules for mite control. In addition, described protocols could be adapted for other Tetranychidae and related species of economic importance such as Varroa, dust and poultry mites.	[Suzuki, Takeshi; Espana, Maria Urizarna; Nunes, Maria Andreia; Zhurov, Vladimir; Grbic, Miodrag; Grbic, Vojislava] Univ Western Ontario, Dept Biol, London, ON, Canada; [Dermauw, Wannes; Van Leeuwen, Thomas] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Lab Agrozool, Ghent, Belgium; [Osakabe, Masahiro] Kyoto Univ, Grad Sch Agr, Lab Ecol Informat, Kyoto, Japan; [Van Leeuwen, Thomas] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Evolutionary Biol, Amsterdam, Netherlands; [Grbic, Miodrag] Univ La Rioja, Logrono, Spain; [Suzuki, Takeshi] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Koganei, Tokyo, Japan; [Nunes, Maria Andreia] Inst Agron Campinas, Ctr Citricultura Sylvio Moreira, Cordeiropolis, SP, Brazil	Western University (University of Western Ontario); Ghent University; Kyoto University; University of Amsterdam; Universidad de La Rioja; Tokyo University of Agriculture & Technology; Instituto Agronomico de Campinas (IAC)	Grbic, M; Grbic, V (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.; Grbic, M (corresponding author), Univ La Rioja, Logrono, Spain.	mgrbic@uwo.ca; vgrbic@uwo.ca	Dermauw, Wannes/H-1583-2015; Suzuki, Takeshi/F-7548-2012; Grbic, Miodrag/AID-4825-2022; Osakabe, Masahiro/H-8587-2019	Dermauw, Wannes/0000-0003-4612-8969; Suzuki, Takeshi/0000-0002-7930-1425; Osakabe, Masahiro/0000-0002-2246-3431; Grbic, Vojislava/0000-0001-6570-8796; Zhurov, Vladimir/0000-0002-7120-4655; Van Leeuwen, Thomas/0000-0003-4651-830X	Ontario Research FundResearch Excellence Round 8 [RE08-067]; Postdoctoral Fellowship for Research Abroad - Japan Society for the Promotion of Science (JSPS); National Counsel of Technological and Scientific Development (CNPq/Brazil); Grants-in-Aid for Scientific Research [16K18661] Funding Source: KAKEN	Ontario Research FundResearch Excellence Round 8; Postdoctoral Fellowship for Research Abroad - Japan Society for the Promotion of Science (JSPS); National Counsel of Technological and Scientific Development (CNPq/Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Development of described protocols was supported by the Ontario Research Fund Research Excellence Round 8 (RE08-067) (to MG and VG). TS has been supported by the Postdoctoral Fellowship for Research Abroad funded by the Japan Society for the Promotion of Science (JSPS) and MAN by the National Counsel of Technological and Scientific Development (CNPq/Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronstein K, 2006, J APICULT RES, V45, P20, DOI 10.1080/00218839.2006.11101307; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bensoussan N, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01105; Bosse TC, 1996, PHYSIOL ENTOMOL, V21, P188, DOI 10.1111/j.1365-3032.1996.tb00854.x; Campbell EM, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-73; Caplen NJ, 2000, GENE, V252, P95, DOI 10.1016/S0378-1119(00)00224-9; Cazaux M, 2014, JOVE-J VIS EXP, DOI 10.3791/51738; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Conte D, 2015, CURR PROTOC MOL BIOL, V109; EKKA I, 1971, J INSECT PHYSIOL, V17, P1393, DOI 10.1016/0022-1910(71)90148-X; Ekka I., 1969, REARING 2 SPOTTED SP; FEBVAY G, 1988, CAN J ZOOL, V66, P2449, DOI 10.1139/z88-362; Ghanim M, 2007, INSECT BIOCHEM MOLEC, V37, P732, DOI 10.1016/j.ibmb.2007.04.006; Gotoh T, 2008, INT J ACAROL, V34, P393, DOI 10.1080/17088180809434783; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; HARE JD, 1988, ENTOMOL EXP APPL, V47, P137, DOI 10.1007/BF00367479; Ikegami Y, 2000, APPL ENTOMOL ZOOL, V35, P339, DOI 10.1303/aez.2000.339; Jonckheere W, 2016, MOL CELL PROTEOMICS, V15, P3594, DOI 10.1074/mcp.M116.058081; Khila A, 2007, DEV GENES EVOL, V217, P241, DOI 10.1007/s00427-007-0132-9; Kim JH, 2008, PLANT J, V54, P1015, DOI 10.1111/j.1365-313X.2008.03476.x; Kim JH, 2007, PLANT J, V49, P1008, DOI 10.1111/j.1365-313X.2006.03019.x; Kim YH, 2015, PESTIC BIOCHEM PHYS, V120, P109, DOI 10.1016/j.pestbp.2015.01.002; Kola VSR, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00119; Kranthi K.R., 2005, INSECTICIDE RESISTAN; Kwon DH, 2016, PESTIC BIOCHEM PHYS, V130, P1, DOI 10.1016/j.pestbp.2015.11.005; Kwon DH, 2013, PESTIC BIOCHEM PHYS, V105, P69, DOI 10.1016/j.pestbp.2012.12.001; Li JJ, 2015, PEST MANAG SCI, V71, P1175, DOI 10.1002/ps.3903; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Migeon A., 2006, SPIDER MITES WEB COM; PROSSER WA, 1992, J INSECT PHYSIOL, V38, P93, DOI 10.1016/0022-1910(92)90037-E; Protocols CSH, 2006, COLD SPRING HARBOR P, V2006; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sterck L, 2012, NAT METHODS, V9, P1041, DOI 10.1038/nmeth.2242; Tabara H, 1998, SCIENCE, V282, P430, DOI 10.1126/science.282.5388.430; Ubara M, 2015, ENVIRON ENTOMOL, V44, P1210, DOI 10.1093/ee/nvv080; Van Leeuwen T, 2015, PESTIC BIOCHEM PHYS, V121, P12, DOI 10.1016/j.pestbp.2014.12.009; Van Leeuwen T, 2012, P NATL ACAD SCI USA, V109, P4407, DOI 10.1073/pnas.1200068109; VANDERGEEST LPS, 1983, ENTOMOL EXP APPL, V33, P297, DOI 10.1111/j.1570-7458.1983.tb03272.x; Wang YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018644; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Wuriyanghan H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027736; Yu N, 2013, INSECT SCI, V20, P4, DOI 10.1111/j.1744-7917.2012.01534.x	43	25	25	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180658	10.1371/journal.pone.0180658	http://dx.doi.org/10.1371/journal.pone.0180658			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686745	Green Published, Green Submitted, gold			2022-12-26	WOS:000405464100088
J	Belfry, KD; Trueman, C; Vyn, RJ; Loewen, SA; Van Eerd, LL				Belfry, Kimberly D.; Trueman, Cheryl; Vyn, Richard J.; Loewen, Steven A.; Van Eerd, Laura L.			Winter cover crops on processing tomato yield, quality, pest pressure, nitrogen availability, and profit margins	PLOS ONE			English	Article							SWEET CORN YIELD; SOIL; FERTILIZATION; TILLAGE; GROWTH; CARBON; ACCUMULATION; ATTRIBUTES; MANAGEMENT; DISEASE	Much of cover crop research to date focuses on key indicators of impact without considering the implications over multiple years, in the absence of a systems-based approach. To evaluate the effect of three years of autumn cover crops on subsequent processing tomato (Solanum lycopersicum L.) production in 2010 and 2011, a field split-split-plot factorial design trial with effects of cover crop type, urea ammonium nitrate fertilizer rate (0 or 140 kg N ha(-1) pre-plant broadcast incorporated) and tomato cultivar (early vs. late) was conducted. The main plot factor, cover crop, included a no cover crop control, oat (Avena sativa L.), winter cereal rye (hereafter referred to as rye) (Secale cereale L.), oilseed radish (OSR) (Raphanus sativus L. var. oleiferus Metzg Stokes), and mix of OSR and rye (OSR + rye) treatments. Cover crop biomass of 0.5 to 2.8 and 1.7 to 3.1 Mg ha-1 was attained in early Oct. and the following early May, respectively. In general, OSR increased soil mineral N during cover crop growth and into the succeeding summer tomato growing season, while the remaining cover crops did not differ from the no cover crop control. The lack of a cover crop by N rate interaction in soil and plant N analyses at harvest suggests that growers may not need to modify N fertilizer rates to tomatoes based on cover crop type. Processing tomato fruit quality at harvest (rots, insect or disease damage, Agtron colour, pH, or natural tomato soluble solids (NTSS)) was not affected by cover crop type. In both years, marketable yield in the no cover crop treatment was lower or not statistically different than all planted cover crops. Partial profit margins over both years were 1320 $ ha(-1) higher with OSR and $ 960 higher with oat compared to the no cover crop control. Thus, results from a systems-based approach suggest that the cover crops tested had no observed negative impact on processing tomato production and have the potential to increase marketable yield and profit margins.	[Belfry, Kimberly D.; Trueman, Cheryl; Loewen, Steven A.] Univ Guelph Ridgetown Campus, Ridgetown, ON, Canada; [Vyn, Richard J.] Univ Guelph Ridgetown Campus, Dept Food Agr & Resource Econ, Ridgetown, ON, Canada; [Van Eerd, Laura L.] Univ Guelph Ridgetown Campus, Sch Environm Sci, Ridgetown, ON, Canada	University of Guelph; University of Guelph; University of Guelph	Van Eerd, LL (corresponding author), Univ Guelph Ridgetown Campus, Sch Environm Sci, Ridgetown, ON, Canada.	Ivaneerd@uoguelph.ca			Ontario Tomato Research Institute (OTRI); Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA) through the OMAFRA-University of Guelph; Conagra Foods Canada Inc	Ontario Tomato Research Institute (OTRI); Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA) through the OMAFRA-University of Guelph; Conagra Foods Canada Inc	The authors grate fully acknowledgethe contributions of J.Leboeuf, M.Zink, P.May, R.Wright, J.Newport, B.Eagen. LVE, CT and SAL received funding from Ontario Tomato Research Institute (OTRI). LVE received funding from Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA) through the OMAFRA-University of Guelph Partnership. Conagra Foods Canada Inc.	[Anonymous], OPVG INF HDB, P84; Baysal F, 2009, ACTA HORTIC, V808, P117, DOI 10.17660/ActaHortic.2009.808.16; Bjorkman T, 2013, HORTTECHNOLOGY, V23, P575, DOI 10.21273/HORTTECH.23.5.575; Blanco-Canqui H, 2015, AGRON J, V107, P2449, DOI 10.2134/agronj15.0086; Bowley SR, 2008, HITCHHIKERS GUIDE ST, P97; BrandiDohrn FM, 1997, J ENVIRON QUAL, V26, P181, DOI 10.2134/jeq1997.00472425002600010026x; Carrera LM, 2007, APPL SOIL ECOL, V37, P247, DOI 10.1016/j.apsoil.2007.08.003; Creamer NG, 1996, J AM SOC HORTIC SCI, V121, P559, DOI 10.21273/JASHS.121.3.559; Dabney SM, 2001, COMMUN SOIL SCI PLAN, V32, P1221, DOI 10.1081/CSS-100104110; Ding GW, 2006, GEODERMA, V130, P229, DOI 10.1016/j.geoderma.2005.01.019; Feyereisen GW, 2006, AGRON J, V98, P1416, DOI 10.2134/agronj2005.0134; Galvao AG, 2013, HORTIC BRAS, V31, P68, DOI 10.1590/S0102-05362013000100011; Garcia E, 2006, J FOOD PROCESS PRES, V30, P20, DOI 10.1111/j.1745-4549.2005.00044.x; Gleason ML, 2014, COMPENDIUM TOMATO DI, P50; Gould W.A., 1992, TOMATO PRODUCTION PR, V3rd, P201; HARCOURT D. G., 1963, CANADIAN ENTOMOL, V95, P813; Hartz TK, 2005, HORTSCIENCE, V40, P2016, DOI 10.21273/HORTSCI.40.7.2016; Hendershot W. H., 1993, SOIL SAMPLING METHOD, P141; Hermawan B, 1997, SOIL TILL RES, V44, P109, DOI 10.1016/S0167-1987(97)00043-3; Hively WD, 2009, J SOIL WATER CONSERV, V64, P303, DOI 10.2489/jswc.64.5.303; Hu S, 1997, SOIL SCI SOC AM J, V61, P901, DOI 10.2136/sssaj1997.03615995006100030027x; Jones J.P., 2014, COMPENDIUM TOMATO DI, P23; Kaspar TC, 2012, AGR WATER MANAGE, V110, P25, DOI 10.1016/j.agwat.2012.03.010; Lenzi A, 2009, RENEW AGR FOOD SYST, V24, P92, DOI 10.1017/S1742170508002445; Loewen SA, 2007, ANN REPORT ONTARIO P; Lu YC, 2000, FOOD REV INT, V16, P121, DOI 10.1081/FRI-100100285; Maynard D, 1993, SOIL SAMPLING METHOD, P71; McKeown AW, 1998, CAN J PLANT SCI, V78, P341, DOI 10.4141/P97-090; MILLER MH, 1994, J ENVIRON QUAL, V23, P267, DOI 10.2134/jeq1994.00472425002300020007x; MILLER STEVEN P., 2014, COMPENDIUM TOMATO DI, P54; O'Reilly KA, 2012, CAN J SOIL SCI, V92, P353, DOI 10.4141/CJSS2011-065; O'Reilly KA, 2011, WEED TECHNOL, V25, P374, DOI 10.1614/WT-D-10-00051.1; OMAFRA, 2014, VEG CROP PROT GUID; OMAFRA, 2009, USITC PUBL, V363; Ouellette L, 2016, SOIL SCI SOC AM J, V80, P284, DOI 10.2136/sssaj2015.10.0371; PATRICK W. H. JR, 1957, Soil Science Society of America. Proceedings, V21, P366; Ranells NN, 1996, AGRON J, V88, P777, DOI 10.2134/agronj1996.00021962008800050015x; Rutherford P.M., 2008, SOIL SAMPLING METHOD, P239; Sainju UM, 2001, SCI HORTIC-AMSTERDAM, V91, P201, DOI 10.1016/S0304-4238(01)00264-3; Sainju UM, 2002, SOIL TILL RES, V63, P167, DOI 10.1016/S0167-1987(01)00244-6; Schomberg HH, 2006, BIOL FERT SOILS, V42, P299, DOI 10.1007/s00374-005-0027-8; Seliga JP, 1995, SCI HORTIC-AMSTERDAM, V64, P159, DOI 10.1016/0304-4238(95)00837-3; Snapp SS, 2005, AGRON J, V97, P322; Statistics Canada, 2012, FRUIT VEG PROD; Sterrett SB, 2005, HORTSCIENCE, V40, P602, DOI 10.21273/HORTSCI.40.3.602; Stevenson WR, 2014, COMPENDIUM TOMATO DI, P16; Stivers-Young L, 1998, HORTSCIENCE, V33, P60; Summers CF, 2014, APPL SOIL ECOL, V77, P51, DOI 10.1016/j.apsoil.2014.01.010; Thorup-Kristensen K, 2003, ADV AGRON, V79, P227, DOI 10.1016/S0065-2113(02)79005-6; Tomatoes Mailvaganam S., 1979, HORTICULTURAL CROPS; USDA Natural Resources Conservation Service, 2011, CARB NITR RAT CROPP; Vyn TJ, 2000, AGRON J, V92, P915, DOI 10.2134/agronj2000.925915x; Vyn TJ, 1999, AGRON J, V91, P17, DOI 10.2134/agronj1999.00021962009100010004x; Wagger MG, 1998, J SOIL WATER CONSERV, V53, P214; Wang QR, 2005, HORTSCIENCE, V40, P2125, DOI 10.21273/HORTSCI.40.7.2125; Weinert TL, 2000, NITROGEN RECYCLING N, V94, P365; Yu L, 2015, CROP PROT, V75, P11, DOI 10.1016/j.cropro.2015.05.005	57	16	16	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180500	10.1371/journal.pone.0180500	http://dx.doi.org/10.1371/journal.pone.0180500			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683080	Green Published, gold, Green Submitted			2022-12-26	WOS:000405335200041
J	Chang, YC; Ching, YH; Chiu, CC; Liu, JY; Hung, SW; Huang, WC; Huang, YT; Chuang, HL				Chang, Yi-Chih; Ching, Yung-Hao; Chiu, Chien-Chao; Liu, Ju-Yun; Hung, Shao-Wen; Huang, Wen-Ching; Huang, Yen-Te; Chuang, Hsiao-Li			TLR2 and interleukin-1 0 are involved in Bacteroides fragilis-mediated prevention of DSS-induced colitis in gnotobiotic mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTORS; INTESTINAL INFLAMMATION; ULCERATIVE-COLITIS; COMMENSAL; DISEASE; PATHOGENESIS; EXPRESSION; ATTENUATE; MUCOSA	Background and aims Bacteroides fragilis (BF) are Gram-negative anaerobe symbionts present in the colon. Recent studies have reported the beneficial role of BF in maintaining intestinal homeostasis, stimulating host immunologic development, and preventing infectious colitis caused by pathogenic bacteria. Our previous studies showed that monocolonization of germ-free mice with BFsignificantly reduced colon inflammations and damage. Methods In order to investigate the Toll-like receptor-2 (TLR2), TLR4, and interleukin 10 (IL-10) molecular signaling pathways involved in BF -mediated prevention of dextran sulfate sodium (DSS)-induced colitis. The wild -type (WT), TLR4, TLR2, and IL -10 knockout (-/-) germ -free mice grown were with or without BFcolonization for 28 days, and then administered 1% DSS in drinking water for 7 day to induce acute ulcerative colitis. Results We compared phenotypes such as weight loss, disease activity, intestinal histological scores, and immunohistochemistry for inflammatory cells. Unlike WT and TLR4(-/-) mice, the severity of DSS-colitis did not improve in TLR2(-/-) animals after BFcolonization. The BF enhanced anti-inflammatory cytokines IL -10 expression and inhibited pro -inflammatory related tumor necrosis factor (TNF-alpha) and IL-6 mRNA expression in both WT and TLR4(-/-) mice. In contrast, the failed to up-regulated IL -10 and down -regulated the TNF-a and IL-6 in BFcolonization TLR2-/- mice. In addition, we further perform IL -104- mice to clarify whether the BF through TLR2/IL -10 pathway to alleviate DSS-colitis. There were no significant differences in colitis severity and pro -inflammatory related genes expression in the IL -10-/mice with or without BFcolonization. Conclusions These results indicate the disease-preventing effects of BF in acute DSS-induced colitis may occur through the TLR2/IL-10 signal pathway.	[Chang, Yi-Chih] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Ching, Yung-Hao] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Chiu, Chien-Chao; Hung, Shao-Wen] Agr Technol Res Inst, Div Anim Resources, Anim Technol Labs, Hsinchu, Taiwan; [Liu, Ju-Yun; Huang, Yen-Te; Chuang, Hsiao-Li] Natl Lab Anim Ctr, Natl Appl Res Labs, Taipei, Taiwan; [Huang, Wen-Ching] Natl Taipei Univ Nursing & Hlth Sci, Dept Exercise & Hlth Sci, Taipei, Taiwan	China Medical University Taiwan; Tzu Chi University; Agricultural Technology Research Institute; National Applied Research Laboratories - Taiwan; National Taipei University of Nursing & Health Science (NTUNHS)	Chuang, HL (corresponding author), Natl Lab Anim Ctr, Natl Appl Res Labs, Taipei, Taiwan.	p650214@nlac.narl.org.tw		Chuang, Hsiao Li/0000-0002-3718-9076	Ministry of Science and Technology of Taiwan [NSC 101-2320-B-492-001-MY3]; National Laboratory Animal Center of Taiwan [104-1-3-1-2]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); National Laboratory Animal Center of Taiwan	This study was supported by a Grant from Ministry of Science and Technology (NSC 101-2320-B-492-001-MY3) of Taiwan and 104-1-3-1-2 from National Laboratory Animal Center of Taiwan. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Baroja ML, 2007, CLIN EXP IMMUNOL, V149, P470, DOI 10.1111/j.1365-2249.2007.03434.x; Basso PJ, 2014, BRAZ J MED BIOL RES, V47, P727, DOI 10.1590/1414-431X20143932; Borruel N, 2002, GUT, V51, P659, DOI 10.1136/gut.51.5.659; Brun P, 2013, GASTROENTEROLOGY, V145, P1323, DOI 10.1053/j.gastro.2013.08.047; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Chiu CC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/675786; Dong L, 2012, J GASTROEN HEPATOL, V27, P110, DOI 10.1111/j.1440-1746.2011.06839.x; Fan YJ, 2015, EXP THER MED, V9, P1455, DOI 10.3892/etm.2015.2258; Farrell RJ, 2002, GASTROENTEROL CLIN N, V31, P41, DOI 10.1016/S0889-8553(01)00004-8; Frolova L, 2008, J HISTOCHEM CYTOCHEM, V56, P267, DOI 10.1369/jhc.7A7303.2007; Hakansson A, 2015, CLIN EXP MED, V15, P107, DOI 10.1007/s10238-013-0270-5; Karrasch T, 2007, J IMMUNOL, V178, P6522, DOI 10.4049/jimmunol.178.10.6522; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kitajima S, 2001, EXP ANIM TOKYO, V50, P387, DOI 10.1538/expanim.50.387; Komatsu M, 2001, CLIN CHEM, V47, P1297; Kumar NSN, 2008, J GASTROEN HEPATOL, V23, P1834, DOI 10.1111/j.1440-1746.2008.05723.x; Lowe EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013027; Luongo D, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-298; MAHIDA YR, 1989, GUT, V30, P835, DOI 10.1136/gut.30.6.835; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Osman N, 2008, DIGEST DIS SCI, V53, P2464, DOI 10.1007/s10620-007-0174-x; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P1008, DOI 10.1056/NEJM199110033251406; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sales-Campos H, 2015, BRAZ J MED BIOL RES, V48, P96, DOI [10.1590/1414-431X20143774, 10.1590/1414-431x20143774]; Shah R, 2016, GUT MICROBES, V23, P1; So JS, 2008, MOL IMMUNOL, V45, P2690, DOI 10.1016/j.molimm.2007.12.010; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Taghipour Niloofar, 2016, Gastroenterol Hepatol Bed Bench, V9, P45; Takeda K, 2003, CELL MICROBIOL, V5, P143, DOI 10.1046/j.1462-5822.2003.00264.x; Toiyama Y, 2006, SURG TODAY, V36, P287, DOI 10.1007/s00595-005-3144-y; Whittem C.G., 2010, JOVE-J VIS EXP, V35, DOI [10.3791/1652, DOI 10.3791/1652]; Xu XR, 2014, WORLD J GASTROENTERO, V20, P3255, DOI 10.3748/wjg.v20.i12.3255	37	47	49	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180025	10.1371/journal.pone.0180025	http://dx.doi.org/10.1371/journal.pone.0180025			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683149	Green Published, gold, Green Submitted			2022-12-26	WOS:000405335200017
J	Nacheva, E; Mokretar, K; Soenmez, A; Pittman, AM; Grace, C; Valli, R; Ejaz, A; Vattathil, S; Maserati, E; Houlden, H; Taanman, JW; Schapira, AH; Proukakis, C				Nacheva, Elizabeth; Mokretar, Katya; Soenmez, Aynur; Pittman, Alan M.; Grace, Colin; Valli, Roberto; Ejaz, Ayesha; Vattathil, Selina; Maserati, Emanuela; Houlden, Henry; Taanman, Jan-Willem; Schapira, Anthony H.; Proukakis, Christos			DNA isolation protocol effects on nuclear DNA analysis by microarrays, droplet digital PCR, and whole genome sequencing, and on mitochondrial DNA copy number estimation	PLOS ONE			English	Article							HUMAN BRAIN; GENETIC-VARIATION; WAVES; CELL; MOSAICISM; DELETIONS; TISSUES	Potential bias introduced during DNA isolation is inadequately explored, although it could have significant impact on downstream analysis. To investigate this in human brain, we isolated DNA from cerebellum and frontal cortex using spin columns under different conditions, and salting-out. We first analysed DNA using array CGH, which revealed a striking wave pattern suggesting primarily GC-rich cerebellar losses, even against matched frontal cortex DNA, with a similar pattern on a SNP array. The aCGH changes varied with the isolation protocol. Droplet digital PCR of two genes also showed protocol-dependent losses. Whole genome sequencing showed GC-dependent variation in coverage with spin column isolation from cerebellum. We also extracted and sequenced DNA from substantia nigra using salting-out and phenol / chloroform. The mtDNA copy number, assessed by reads mapping to the mitochondrial genome, was higher in substantia nigra when using phenol /chloroform. We thus provide evidence for significant method-dependent bias in DNA isolation from human brain, as reported in rat tissues. This may contribute to array "waves", and could affect copy number determination, particularly if mosaicism is being sought, and sequencing coverage. Variations in isolation protocol may also affect apparent mtDNA abundance.	[Nacheva, Elizabeth; Mokretar, Katya; Grace, Colin] UCL, Acad Haematol, Royal Free Campus, London, England; [Mokretar, Katya; Soenmez, Aynur; Ejaz, Ayesha; Taanman, Jan-Willem; Schapira, Anthony H.; Proukakis, Christos] UCL, Inst Neurol, Clin Neurosci, London, England; [Pittman, Alan M.; Houlden, Henry] UCL, Inst Neurol, Mol Neurosci, London, England; [Valli, Roberto; Maserati, Emanuela] Univ Insubria, Dipartimento Med & Chirurg, Varese, Italy; [Vattathil, Selina] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	University of London; University College London; University of London; University College London; University of London; University College London; University of Insubria; University of Texas System; UTMD Anderson Cancer Center	Proukakis, C (corresponding author), UCL, Inst Neurol, Clin Neurosci, London, England.	c.proukakis@ucl.ac.uk	Pittman, Alan M/D-6231-2012; Schapira, Anthony H V/A-1245-2010; Taanman, Jan W/A-5379-2011; Houlden, Henry J/C-1532-2008; Pittman, Alan/AAP-2534-2020; proukakis, christos/ABE-3447-2020; Valli, Roberto/ABF-2985-2021	Pittman, Alan M/0000-0002-8112-2987; Schapira, Anthony H V/0000-0002-3018-3966; Taanman, Jan W/0000-0002-5476-9785; Houlden, Henry J/0000-0002-2866-7777; Pittman, Alan/0000-0002-8112-2987; proukakis, christos/0000-0001-6423-6539; VALLI, ROBERTO/0000-0002-3209-8917	Michael J Fox Foundation Rapid Response Innovation Award; Wellcome Trust [WT089698]; NIHR [RCF103/AS/2014, RCF73TS2045989]; Isaac Shapera Trust for medical research; Parkinson's UK in England [258197]; Parkinson's UK in Wales [258197]; Parkinson's UK in Scotland [SC037554]; MRC [G108/638, MR/J004758/1, G1001253, G0802760] Funding Source: UKRI; Medical Research Council [G108/638, MR/J004758/1, G0802760, G1001253] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10082] Funding Source: researchfish; Muscular Dystrophy UK [16GRO-PS36-0055] Funding Source: researchfish	Michael J Fox Foundation Rapid Response Innovation Award; Wellcome Trust(Wellcome TrustEuropean Commission); NIHR(National Institute for Health Research (NIHR)); Isaac Shapera Trust for medical research; Parkinson's UK in England; Parkinson's UK in Wales; Parkinson's UK in Scotland; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Muscular Dystrophy UK	This work was supported by a Michael J Fox Foundation Rapid Response Innovation Award https://www.rnichaelifokerg, the Wellcome Trust https://wellcomeac.uk /MRC https://www.mrc.ac.uk Joint Call in Neurodegeneration award (WT089698), NIHR http://wmnihrac.uk, Awards RCF103/AS/2014 and RCF73TS2045989, and the Isaac Shapera Trust for medical research. Tissue samples and associated anonymized data were supplied by the Parkinson's UK Tissue Bank, funded by Parkinson's UK, a charity registered in England and Wales (258197) and in Scotland (SC037554). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghili L, 2014, CELL REP, V7, P1310, DOI 10.1016/j.celrep.2014.03.071; Aplenc R, 2002, LEUKEMIA, V16, P1865, DOI 10.1038/sj.leu.2402681; Atanesyan L, 2017, AM J CLIN PATHOL, V14; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; BENDICH A, 1958, J AM CHEM SOC, V80, P3949, DOI 10.1021/ja01548a038; Cai XY, 2014, CELL REP, V8, P1280, DOI 10.1016/j.celrep.2014.07.043; Costantini M, 2006, GENOME RES, V16, P536, DOI 10.1101/gr.4910606; Cozzi P, 2015, EVOL BIOINFORM, V11, P253, DOI 10.4137/EBO.S27693; D'Erchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005; Devall M., COMPARISON MITOCHOND; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Evrony GD, 2015, NEURON, V85, P49, DOI 10.1016/j.neuron.2014.12.028; Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003; Huggett JF, 2014, CLIN CHEM; Jacobs K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5227; Kasak L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08342; Kluwe L, 2016, EUR J HUM GENET, V24, P1644, DOI 10.1038/ejhg.2016.56; Koren A, 2014, CELL, V159, P1015, DOI 10.1016/j.cell.2014.10.025; Leo A, 2012, J MOL DIAGN, V14, P550, DOI 10.1016/j.jmoldx.2012.06.002; Lindgren D, 2011, ADV CANCER RES, V112, P151, DOI 10.1016/B978-0-12-387688-1.00006-5; Marioni JC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r228; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; Miotke L, 2014, ANAL CHEM, V86, P2618, DOI 10.1021/ac403843j; O'Huallachain M, 2012, P NATL ACAD SCI USA, V109, P18018, DOI 10.1073/pnas.1213736109; Pyle A, 2015, NEUROBIOL AGING ELSE; Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Sakai M, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0144-5; Scheinin I, 2014, GENOME RES, V24, P2022, DOI 10.1101/gr.175141.114; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Speicher MR, 2010, VOGEL AND MOTULSKY'S HUMAN GENETICS, FOURTH EDITION, P1, DOI 10.1007/978-3-540-37654-5; Valli R, 2011, MOL CYTOGENET, V4, DOI 10.1186/1755-8166-4-13; van de Wiel MA, 2009, BIOINFORMATICS, V25, P1099, DOI 10.1093/bioinformatics/btp132; van Heesch S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r33; Vattathil S, 2016, AM J HUM GENET, V98, P571, DOI 10.1016/j.ajhg.2016.02.003; Vattathil S, 2013, GENOME RES, V23, P152, DOI 10.1101/gr.141374.112; Ye F, 2014, MITOCHONDRION, V17, P157, DOI 10.1016/j.mito.2014.05.004	37	22	22	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180467	10.1371/journal.pone.0180467	http://dx.doi.org/10.1371/journal.pone.0180467			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683077	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000405335200040
J	Gu, RX; Wei, H; Wang, Y; Lin, D; Liu, BC; Zhou, CL; Liu, KQ; Gong, BF; Wei, SN; Zhang, GJ; Gong, XY; Liu, YT; Li, Y; Zhao, XL; Qiu, SW; Wang, HJ; Wang, M; Mi, YC; Wang, JX				Gu, Runxia; Wei, Hui; Wang, Ying; Lin, Dong; Liu, Bingcheng; Zhou, Chunlin; Liu, Kaiqi; Gong, Benfa; Wei, Shuning; Zhang, Guangji; Gong, Xiaoyuan; Liu, Yuntao; Li, Yan; Zhao, Xingli; Qiu, Shaowei; Wang, Huijun; Wang, Min; Mi, Yingchang; Wang, Jianxiang			The number of CD34+CD38+CD117+HLA-DR+CD13+CD33+cells indicates post-chemotherapy hematopoietic recovery in patients with acute myeloid leukemia	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; UMBILICAL-CORD BLOOD; PHASE-III; CD34(+); NICHES	Hematopoietic recovery is considered to be associated with the number of multipotent hematopoietic stem cells in the bone marrow, as observed in functional assays involving stem cell transplantation. However, there is little evidence related to hematopoietic recovery in non-transplantation settings, which is accomplished by endogenous hematopoietic cells. A recent study suggested that progenitors are the main contributors during this steady-state hematopoiesis, which differs from exogenous transplantation. We hypothesized that endogenous progenitor support post-chemotherapy hematopoietic recovery. To investigate the potential impact of these progenitor cell percentage on hematopoietic recovery, we retrospectively analyzed the percentage of CD34+CD38+CD117+HLA-DR+CD13+CD33+ cells (P cells) and hematopoietic recovery in 223 newly diagnosed acute myeloid leukemia patients during two courses of consolidation chemotherapy after complete remission. We found that a lower P cell percentage was significantly associated with prolonged neutropenia recovery time after the first and second courses of consolidation chemotherapy (p = 0.001; p = 0.045, respectively). We also observed similar results with regard to platelet recovery time after the first course of consolidation chemotherapy (p = 0.000). Univariate analysis showed that P cell percentage and consolidation chemotherapy regimens, and not gender, age, induction chemotherapy regimens, infection grade, WHO classification and NCCN risk category, were associated with neutrophil recovery after chemotherapy. Multivariate analysis demonstrated that P cell percentage is an independent factor affecting neutrophil recovery capacity for both the first and second courses (p = 0.008; p = 0.032, respectively). Our results indicate that CD34+CD38+CD117+HLA-DR+CD13+CD33+ cells before each course of chemotherapy is independently associated with chemotherapy-related hematopoietic reconstitution capacity. These findings may help modify future chemotherapy regimens based on progenitor cell percentages.	[Gu, Runxia; Wei, Hui; Wang, Ying; Lin, Dong; Liu, Bingcheng; Zhou, Chunlin; Liu, Kaiqi; Gong, Benfa; Wei, Shuning; Zhang, Guangji; Gong, Xiaoyuan; Liu, Yuntao; Li, Yan; Zhao, Xingli; Qiu, Shaowei] Chinese Acad Med Sci, Hosp Blood Dis, Dept Leukemia, Inst Hematol, Tianjin, Peoples R China; [Wang, Huijun] Chinese Acad Med Sci, Dept Pathol & Lab Med, Inst Hematol, Hosp Blood Dis, Tianjin, Peoples R China; [Wang, Min; Mi, Yingchang; Wang, Jianxiang] Chinese Acad Med Sci, State Key Lab Expt Hematol, Inst Hematol, Tianjin, Peoples R China; [Wang, Min; Mi, Yingchang; Wang, Jianxiang] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China; [Wang, Min; Mi, Yingchang; Wang, Jianxiang] Peking Union Med Coll, Tianjin, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, JX (corresponding author), Chinese Acad Med Sci, State Key Lab Expt Hematol, Inst Hematol, Tianjin, Peoples R China.; Wang, JX (corresponding author), Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China.; Wang, JX (corresponding author), Peking Union Med Coll, Tianjin, Peoples R China.	wangjx@ihcams.ac.cn	刘, 云涛/GQQ-5223-2022; wang, hui/GRS-4730-2022; wang, huimin/HDM-8421-2022		State Key Program of the National Natural Science of China [81430004]; Foundation for Innovative Research Groups of the Natural Science Foundation of China [81421002]; National Natural Science Foundation [81400136, 81570147]; National Science & Technology Pillar Program during the Twelfth Five year Plan Period [2014BAI09B12]	State Key Program of the National Natural Science of China(National Natural Science Foundation of China (NSFC)); Foundation for Innovative Research Groups of the Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program during the Twelfth Five year Plan Period	This study was supported, inpart, by the State Key Program of the National Natural Science of China (81430004), the Foundation for Innovative Research Groups of the Natural Science Foundation of China (81421002), the National Natural Science Foundation (81400136 and 81570147),and the National Science & Technology Pillar Program during the Twelfth Five year Plan Period (2014BAI09B12)	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Aksentijevich I, 2002, CANCER BIOTHER RADIO, V17, P399, DOI 10.1089/108497802760363196; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; De Los Angeles A, 2015, NATURE, V525, P469, DOI 10.1038/nature15515; Ginestier C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1741; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Heil G, 1997, BLOOD, V90, P4710, DOI 10.1182/blood.V90.12.4710.4710_4710_4718; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Remberger M, 2015, BIOL BLOOD MARROW TR, V21, P889, DOI 10.1016/j.bbmt.2015.01.025; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; ROWE JM, 1995, BLOOD, V86, P457, DOI 10.1182/blood.V86.2.457.bloodjournal862457; Savarese TM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1674; Sieburg HB, 2006, BLOOD, V107, P2311, DOI 10.1182/blood-2005-07-2970; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Terakura S, 2007, BIOL BLOOD MARROW TR, V13, P822, DOI 10.1016/j.bbmt.2007.03.006; Trounson A, 2015, CELL STEM CELL, V17, P11, DOI 10.1016/j.stem.2015.06.007; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Zoller M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00235	20	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180624	10.1371/journal.pone.0180624	http://dx.doi.org/10.1371/journal.pone.0180624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678809	Green Submitted, Green Published, gold			2022-12-26	WOS:000405272200078
J	Schoemaker, MH; Kleemann, R; Morrison, MC; Verheij, J; Salic, K; van Tol, EAF; Kooistra, T; Wielinga, PY				Schoemaker, Marieke H.; Kleemann, Robert; Morrison, Martine C.; Verheij, Joanne; Salic, Kanita; van Tol, Eric A. F.; Kooistra, Teake; Wielinga, Peter Y.			A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice	PLOS ONE			English	Article							WHITE ADIPOSE-TISSUE; DIET-INDUCED OBESITY; INSULIN-RESISTANCE; BODY-WEIGHT; DEVELOPMENTAL ORIGINS; INFANT FORMULAS; INFLAMMATION; ACIDS; SUPPLEMENTATION; STEATOHEPATITIS	Background Obesity frequently associates with the development of non-alcoholic fatty liver disease (NAFLD) and atherosclerosis. Chronic inflammation in white adipose tissue (WAT) seems to be an important driver of these manifestations. Objective This study investigated a combination of an extensively hydrolyzed casein (eHC), docosahexaenoic acid (DHA), arachidonic acid (ARA), and Lactobacillus Rhamnosus GG (LGG) (together referred to as nutritional ingredients, NI) on the development of obesity, metabolic risk factors, WAT inflammation, NAFLD and atherosclerosis in high-fat diet-fed LDLr-/-.Leiden mice, a model that mimics disease development in humans. Methods LDLr-/-.Leiden male mice (n = 15/group) received a high-fat diet (HFD, 45 Kcal%) for 21 weeks with or without the NI (23.7% eHC, 0.083% DHA, 0.166% ARA; all w/w and 1x10(9) CFU LGG gavage 3 times/week). HFD and HFD+NI diets were isocaloric. A low fat diet (LFD, 10 Kcal%) was used for reference. Body weight, food intake and metabolic risk factors were assessed over time. At week 21, tissues were analyzed for WAT inflammation (crown-like structures), NAFLD and atherosclerosis. Effects of the individual NI components were explored in a follow-up experiment (n = 7/group). Results When compared to HFD control, treatment with the NI strongly reduced body weight to levels of the LFD group, and significantly lowered (P<0.01) plasma insulin, cholesterol, triglycerides, leptin and serum amyloid A (P<0.01). NI also reduced WAT mass and inflammation. Strikingly, NI treatment significantly reduced macrovesicular steatosis, lobular inflammation and liver collagen (P<0.05), and attenuated atherosclerosis development (P<0.01). Of the individual components, the effects of eHC were most pronounced but could not explain the entire effects of the NI formulation. Conclusions A combination of eHC, ARA, DHA and LGG attenuates obesity and associated cardiometabolic diseases (NAFLD, atherosclerosis) in LDLr-/-.Leiden mice. The observed reduction of inflammation in adipose tissue and in the liver provides a rationale for these comprehensive health effects.	[Schoemaker, Marieke H.; van Tol, Eric A. F.] Global R&D, Mead Johnson Pediat Nutr Inst, Nijmegen, Netherlands; [Kleemann, Robert; Morrison, Martine C.; Salic, Kanita; Kooistra, Teake; Wielinga, Peter Y.] TNO, Netherlands Org Sci Res, Metab Hlth Res, Leiden, Netherlands; [Verheij, Joanne] Univ Amsterdam, Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands	Netherlands Organization Applied Science Research; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Schoemaker, MH (corresponding author), Global R&D, Mead Johnson Pediat Nutr Inst, Nijmegen, Netherlands.	marieke.schoemaker@mjn.com	Morrison, Martine C./C-3168-2014	Morrison, Martine C./0000-0003-4996-943X; Verheij, Joanne/0000-0003-1283-630X	Mead Johnson Nutrition	Mead Johnson Nutrition	This study received unconditional funding support from Mead Johnson Nutrition. MH Schoemaker and EAF vanTolare employees of Mead Johnson Nutrition and contributed to the design of the study and manuscript preparation. Mead Johnson Nutrition employees were not involved in the execution of the study, the consequent data collection and analysis. No other authors declare a conflict of interest. The specific roles of these authors are articulated in the 'author contributions' section.	Arnoldussen IA, 2017, INT J OBES LOND; Astrup A, 2012, LANCET, V379, P1100, DOI 10.1016/S0140-6736(12)60456-5; Berni Canani R, 2015, ISME J; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brumbaugh DE, 2014, PEDIATR RES, V75, P140, DOI 10.1038/pr.2013.193; Calder PC, 2013, BRIT J NUTR, V109, pS1, DOI 10.1017/S0007114512005119; Canani RB, 2012, J ALLERGY CLIN IMMUN, V129, P580, DOI 10.1016/j.jaci.2011.10.004; Canfora EE, 2015, NAT REV ENDOCRINOL, V11, P577, DOI 10.1038/nrendo.2015.128; Clausen MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118895; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Drover J, 2009, CHILD DEV, V80, P1376, DOI 10.1111/j.1467-8624.2009.01339.x; Flachs P, 2009, CLIN SCI, V116, P1, DOI 10.1042/CS20070456; Fuijkschot WW, 2016, ATHEROSCLEROSIS, V255, P164, DOI 10.1016/j.atherosclerosis.2016.07.909; Godfrey KM, 2010, TRENDS ENDOCRIN MET, V21, P199, DOI 10.1016/j.tem.2009.12.008; Gray B, 2013, EUR J CLIN NUTR, V67, P1234, DOI 10.1038/ejcn.2013.197; Hojsak I, 2010, CLIN NUTR, V29, P312, DOI 10.1016/j.clnu.2009.09.008; Hu FB, 2001, J AM COLL NUTR, V20, P5, DOI 10.1080/07315724.2001.10719008; Juarez-Hernandez E, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0191-8; Kleemann R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r200; Kooistra T, 2006, ARTERIOSCL THROM VAS, V26, P2322, DOI 10.1161/01.ATV.0000238348.05028.14; Krishack PA, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001858; Lambers TT, 2015, FOOD SCI NUTR, V3, P81, DOI 10.1002/fsn3.196; Lapillonne A, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-168; Liang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115922; Lillefosse HH, 2013, J NUTR, V143, P1367, DOI 10.3945/jn.112.170415; Lopez-Alarcon M, 2011, ARCH MED RES, V42, P502, DOI 10.1016/j.arcmed.2011.06.010; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luke A, 2013, INT J EPIDEMIOL, V42, P1831, DOI 10.1093/ije/dyt159; Monteiro R, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/289645; Morrison MC, 2016, INT J OBESITY, V40, P1416, DOI 10.1038/ijo.2016.74; Morrison MC, 2015, J HEPATOL, V62, P1180, DOI 10.1016/j.jhep.2014.12.011; Mulder P., 2015, INT J OBES LOND; Mulder P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169740; Mulder P, 2016, SCI REP-UK, V6, DOI 10.1038/srep31542; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nobili V, 2013, J HEPATOL, V58, P1218, DOI 10.1016/j.jhep.2012.12.003; Poitou C, 2006, OBESITY, V14, P309, DOI 10.1038/oby.2006.40; Prentice A, 2004, NUTR REV, V62, pS98, DOI 10.1111/j.1753-4887.2004.tb00095.x; Radonjic M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056122; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Ritze Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0101702, 10.1371/journal.pone.0080169]; Romacho T, 2014, ACTA PHYSIOL, V210, P733, DOI 10.1111/apha.12246; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Thibault R, 2010, INFLAMM BOWEL DIS, V16, P684, DOI 10.1002/ibd.21108; van der Heijden RA, 2015, AGING-US, V7, P256, DOI 10.18632/aging.100738; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; von Berg A, 2008, J ALLERGY CLIN IMMUN, V121, P1442, DOI 10.1016/j.jaci.2008.04.021; Wielinga PY, 2012, MOL NUTR FOOD RES, V56, P1081, DOI 10.1002/mnfr.201100762; Yates T, 2012, BRIT J GEN PRACT, V62, P4, DOI 10.3399/bjgp12X616201; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570	51	27	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180648	10.1371/journal.pone.0180648	http://dx.doi.org/10.1371/journal.pone.0180648			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678821	Green Submitted, Green Published, gold			2022-12-26	WOS:000405272200083
J	Cortinez-O'Ryan, A; Albagli, A; Sadarangani, KP; Aguilar-Farias, N				Cortinez-O'Ryan, Andrea; Albagli, Andrea; Sadarangani, Kabir P.; Aguilar-Farias, Nicolas			Reclaiming streets for outdoor play: A process and impact evaluation of ''Juega en tu Barrio'' (Play in your Neighborhood), an intervention to increase physical activity and opportunities for play	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ACTIVITY PROGRAM; CHILDRENS; HEALTH; TIME; AGE; ENVIRONMENT; CHILDHOOD; YOUTH; LIFE	Background New strategies are required to create supportive physical and social environments for children and promote active free-play. Juega en tu Barrio (JETB; Play in your Neighborhood) was designed and implemented to explore the effectiveness of closing a street in a low-tomiddle income neighborhood in order to increase children's outside play and physical activity. Methods A pretest-posttest design with control group was employed to investigate the intervention effects in a subsample of 100 children, 51 from the intervention neighborhood and 49 from the control neighborhood. The children wore pedometers for one week, and their parents completed questionnaires at two time points: before the intervention began and during the last two weeks of the intervention. JETB was conducted in the intervention neighborhood from 17: 30 to 20: 30, twice a week, from September to December 2014. Stewards ensured that the children were safe. Children and adults were assessed using systematic observation. Results The intervention and control neighborhoods included 177 and 116 children respectively. The average attendance per event was 60 children (SD = 22, reach 34%). In the intervention neighborhood, a significant increase between baseline and final assessment was observed in afterschool outdoor playtime (p = 0.02), steps during the 3-hour intervention (p = 0.004), and daily steps Monday to Sunday (p = 0.006). Meanwhile, no changes were observed in the control neighborhood for the same variables. The proportion of children who met recommended daily step counts increased from 27.5% to 53.0% in the intervention neighborhood (p = 0.007), while for control neighborhood no difference was observed (49.0% to 53.0% p = 0.804). Conclusions JETB showed high community engagement while offering opportunities for increased outdoor play in children. The intervention showed a significant effect on the number of children meeting the daily pedometer-derived physical activity recommendations.	[Cortinez-O'Ryan, Andrea; Aguilar-Farias, Nicolas] Univ La Frontera, Dept Phys Educ Sports & Recreat, Temuco, Chile; [Albagli, Andrea] Minist Hlth Santiago, Div Hlth Planning, Santiago, Chile; [Sadarangani, Kabir P.] Univ San Sebastian, Fac Hlth Sci, Sch Kinesiol, Santiago, Chile; [Sadarangani, Kabir P.] Autonomous Univ Madrid, Dept Phys Educ Sport & Human Movement, Madrid, Spain	Universidad de La Frontera; Universidad San Sebastian; Autonomous University of Madrid	Cortinez-O'Ryan, A (corresponding author), Univ La Frontera, Dept Phys Educ Sports & Recreat, Temuco, Chile.	andrea.cortinez@ufrontera.cl	Aguilar-Farias, Nicolas/AAF-5136-2019; Aguilar-Farias, Nicolas/V-2742-2018	Aguilar-Farias, Nicolas/0000-0002-6974-1312; Aguilar-Farias, Nicolas/0000-0002-6974-1312; Cortinez-O'Ryan, Andrea/0000-0001-6207-3377	National Fund for research and development in health, FONIS [EVS-13I0052]	National Fund for research and development in health, FONIS	This research was funded by the National Fund for research and development in health, FONIS, http://www.conicyt.cl/fonis/, Grantnumber: EVS-13I0052(AC).	Ajja R, 2014, PREV MED, V69, pS49, DOI 10.1016/j.ypmed.2014.09.010; Alexander SA, 2014, HEALTH PROMOT INT, V29, P155, DOI 10.1093/heapro/das042; Rivera JA, 2014, LANCET DIABETES ENDO, V2, P321, DOI 10.1016/S2213-8587(13)70173-6; [Anonymous], 2014, MED SCI SPORT EXER; Arundell L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140132; Ball K., 2007, CHILDRENS GEOGRAPHIE, V5, P409, DOI [10.1080/14733280701631874, DOI 10.1080/14733280701631874]; BARANOWSKI T, 1993, RES Q EXERCISE SPORT, V64, P127, DOI 10.1080/02701367.1993.10608789; Beaulac J, 2011, J YOUTH STUD, V14, P961, DOI 10.1080/13676261.2011.616488; Beets MW, 2012, AM J PREV MED, V42, P180, DOI 10.1016/j.amepre.2011.10.007; Brockman R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-461; Brussoni M, 2015, INT J ENV RES PUB HE, V12, P6423, DOI 10.3390/ijerph120606423; Burdette HL, 2005, ARCH PEDIAT ADOL MED, V159, P46, DOI 10.1001/archpedi.159.1.46; Burdette HL, 2004, ARCH PEDIAT ADOL MED, V158, P353, DOI 10.1001/archpedi.158.4.353; Burrows R, 2008, REV MED CHILE, V136, P53, DOI /S0034-98872008000100007; Cleland V, 2008, INT J OBESITY, V32, P1685, DOI 10.1038/ijo.2008.171; Coombes E, 2013, HEALTH PLACE, V20, P62, DOI 10.1016/j.healthplace.2012.11.008; Cooper AR, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0274-5; Cooper AR, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-31; D'Haese S, 2015, INT J BEHAV NUTR PHY, V12, P171, DOI DOI 10.1186/S12966-015-0171-Y; Direccion Meteorologica de Chile, 2008, GUIA CLIM PRACT; Espinoza A., 2012, Californian Journal of Health Promotion, V10, P13; Fadel AC, 2015, RES Q EXERCISE SPORT, V86, pA13; Farley TA, 2007, AM J PUBLIC HEALTH, V97, P1625, DOI 10.2105/AJPH.2006.092692; Faulkner G., 2015, INT J PLAY, V4, P84, DOI [DOI 10.1080/21594937.2015.1017303, 10.1080/21594937.2015.1017303]; Fisher A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010110; Gomersall SR, 2013, SPORTS MED, V43, P135, DOI 10.1007/s40279-012-0008-7; Green J., 2018, QUALITATIVE METHODS, VFourth; Hewes J, 2014, CHILDREN-BASEL, V1, P280, DOI 10.3390/children1030280; Holt NL, 2015, CHILD GEOGR, V13, P73, DOI 10.1080/14733285.2013.828449; Hyndman BP, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-164; Isenberg J. P., 2002, PLAY ESSENTIAL ALL C, V79, P33, DOI DOI 10.1080/00094056.2002.10522763; Jago R, 2009, J PUBLIC HEALTH-UK, V31, P472, DOI 10.1093/pubmed/fdp053; Jago R, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-4; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Karsten L, 2003, CHILDHOOD, V10, P457, DOI 10.1177/0907568203104005; Lawlor DA, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-181; Martinez-Lopez EJ, 2012, J SPORT SCI MED, V11, P312; McKenzie Thomas L, 2006, J Phys Act Health, V3 Suppl 1, pS208, DOI 10.1123/jpah.3.s1.s208; Ngo CS, 2014, OPHTHAL PHYSL OPT, V34, P362, DOI 10.1111/opo.12112; Okely AD, 2012, SYSTEMATIC REV UPDAT, V1246, P1; Remmers T, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-76; Rowlands AV, 2005, RES Q EXERCISE SPORT, V76, P251; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sandseter EBH, 2011, EVOL PSYCHOL-US, V9, P257, DOI 10.1177/147470491100900212; Sarmiento O, 2010, J PHYS ACT HEALTH, V7, pS163, DOI 10.1123/jpah.7.s2.s163; Singer DG, 2009, AM J PLAY, V1, P283; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tremblay MS, 2016, J PHYS ACT HEALTH, V13, pS343, DOI 10.1123/jpah.2016-0594; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; Tudor-Locke C, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0172-x; Veitch J, 2006, HEALTH PLACE, V12, P383, DOI 10.1016/j.healthplace.2005.02.009; World Health Organization, 1986, OTT CHART GES; Zieff SG, 2016, CHILD YOUTH SERV REV, V70, P95, DOI 10.1016/j.childyouth.2016.09.014	53	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180172	10.1371/journal.pone.0180172	http://dx.doi.org/10.1371/journal.pone.0180172			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2JX	28671984	gold, Green Published, Green Submitted			2022-12-26	WOS:000405268500021
J	Du, XK; Jiang, CL; Lv, Y; Dull, RO; Zhao, YY; Schwartz, DE; Hu, GC				Du, Xueke; Jiang, Chunling; Lv, Yang; Dull, Randal O.; Zhao, You-Yang; Schwartz, David E.; Hu, Guochang			Isoflurane promotes phagocytosis of apoptotic neutrophils through AMPK-mediated ADAM17/Mer signaling	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ACUTE LUNG INJURY; ACUTE-INFLAMMATION; CELLS; MACROPHAGES; CLEARANCE; RESOLUTION; RECEPTOR; EFFEROCYTOSIS; TACE	A patient's recovery from lung inflammatory injury or development of multi-system organ failure is determined by the host's ability to resolve inflammation and repair tissue damage, both of which require the clearance of apoptotic neutrophils by macrophages (efferocytosis). Here, we investigated the effects of isoflurane on macrophage efferocytosis and resolution of lung inflammatory injury. Treatment of murine bone marrow-derived macrophages (BMDMs) or alveolar macrophages with isoflurane dramatically enhanced phagocytosis of apoptotic neutrophils. Isoflurane significantly increased the surface expression of the receptor tyrosine kinase Mer in macrophages, but markedly decreased the levels of a soluble form of Mer protein in the medium. Isoflurane treatment also caused a decrease in a disintegrin and metalloproteinase 17 (ADAM17) on the cell surface and a concomitant increase in its cytoplasmic fraction. These responses induced by isoflurane were completely reversed by a pharmacological inhibitor or genetic deletion of AMP-activated protein kinase (AMPK). In a mouse model of lipopolysaccharide-induced lung injury, isoflurane accelerated the recovery of lung inflammation and injury that was coupled with an increase in the number of alveolar macrophages containing apoptotic bodies. In alveolar macrophage-depleted mice, administration of isoflurane-pretreated BMDMs facilitated resolution of lung inflammation following lipopolysaccharide challenge. Thus, isoflurane promoted resolution of lipopolysaccharide-induced lung inflammatory injury via enhancement of macrophage efferocytosis. Increased macrophage efferocytosis following isoflurane treatment correlates with upregulation of Mer surface expression through AMPK-mediated blockade of ADAM17 trafficking to the cell membrane.	[Du, Xueke; Jiang, Chunling; Lv, Yang; Dull, Randal O.; Schwartz, David E.; Hu, Guochang] Univ Illinois, Coll Med, Dept Anesthesiol, Chicago, IL 60680 USA; [Du, Xueke] Guangxi Med Univ, Affiliated Tumor Hosp, Nanning, Guangxi, Peoples R China; [Zhao, You-Yang; Hu, Guochang] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60680 USA; [Zhao, You-Yang] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL USA; [Hu, Guochang] Xuzhou Med Univ, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Guangxi Medical University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Xuzhou Medical University	Hu, GC (corresponding author), Univ Illinois, Coll Med, Dept Anesthesiol, Chicago, IL 60680 USA.; Hu, GC (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60680 USA.; Hu, GC (corresponding author), Xuzhou Med Univ, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China.	gchu@uic.edu		Hu, Guochang/0000-0002-7054-7867; ZHAO, YOU-YANG/0000-0002-0041-0339	National Institutes of Health [HL104092]; Natural Science Foundation of China [81470259]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104092, R01HL125350, P01HL077806, R01HL123957, R01HL133951] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a National Institutes of Health Grant HL104092 (to Guochang Hu), https://www.nih.gov/, and the Natural Science Foundation of China 81470259 (Guochang Hu),	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Aggarwal NR, 2014, J IMMUNOL, V192, P4453, DOI 10.4049/jimmunol.1400146; Akalu YT, 2017, IMMUNOL REV, V276, P165, DOI 10.1111/imr.12522; Bae HB, 2011, FASEB J, V25, P4358, DOI 10.1096/fj.11-190587; Cai BS, 2016, P NATL ACAD SCI USA, V113, P6526, DOI 10.1073/pnas.1524292113; Chiang N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001879; Chung IS, 2013, ANESTH ANALG, V116, P327, DOI 10.1213/ANE.0b013e31827aec06; D'Alessio FR, 2012, J IMMUNOL, V189, P2234, DOI 10.4049/jimmunol.1102606; Driscoll WS, 2013, CIRC RES, V113, P52, DOI 10.1161/CIRCRESAHA.112.300683; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Flondor M, 2008, EUR SURG RES, V40, P1, DOI 10.1159/000107614; Goetzenich A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092827; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Hu GC, 2006, ANESTHESIOLOGY, V104, P777, DOI 10.1097/00000542-200604000-00023; Hu GC, 2008, AM J PHYSIOL-LUNG C, V294, pL178, DOI 10.1152/ajplung.00263.2007; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Jiang CL, 2017, J IMMUNOL, V198, P1660, DOI 10.4049/jimmunol.1601495; Korns D, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00057; Lemke G, 2010, ANN NY ACAD SCI, V1209, P23, DOI 10.1111/j.1749-6632.2010.05744.x; Levy BD, 2014, ANNU REV PHYSIOL, V76, P467, DOI 10.1146/annurev-physiol-021113-170408; Li QF, 2009, ANESTH ANALG, V109, P1591, DOI 10.1213/ANE.0b013e3181baf506; Liu C, 2009, MOL CELL, V35, P26, DOI 10.1016/j.molcel.2009.06.018; Maiti G, 2012, P NATL ACAD SCI USA, V109, P16600, DOI 10.1073/pnas.1207789109; McCubbrey AL, 2013, CHEST, V143, P1750, DOI 10.1378/chest.12-2413; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Michlewska S, 2009, FASEB J, V23, P844, DOI 10.1096/fj.08-121228; Miksa M, 2009, J IMMUNOL METHODS, V342, P71, DOI 10.1016/j.jim.2008.11.019; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Patel BV, 2012, EUR RESPIR J, V39, P1162, DOI 10.1183/09031936.00093911; Plachinta RV, 2003, ANESTHESIOLOGY, V98, P89, DOI 10.1097/00000542-200301000-00017; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Reutershan J, 2006, ANESTHESIOLOGY, V104, P511, DOI 10.1097/00000542-200603000-00019; Ross E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128013; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; Sonner JM, 2000, ANESTH ANALG, V91, P720, DOI 10.1213/00000539-200009000-00042; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; Thorp E, 2011, J BIOL CHEM, V286, P33335, DOI 10.1074/jbc.M111.263020; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Vandivier RW, 2002, CHEST, V121, p89S, DOI 10.1378/chest.121.3_suppl.89S; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Wang YL, 2011, J IMMUNOL, V186, P3180, DOI 10.4049/jimmunol.1001252; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wu JB, 2013, J IMMUNOL, V190, P3590, DOI 10.4049/jimmunol.1200860; YAMAMOTO K, 1984, J EXP MED, V159, P405, DOI 10.1084/jem.159.2.405; Yang ZY, 2014, J IMMUNOL, V193, P1931, DOI 10.4049/jimmunol.1302863; Zaynagetdinov R, 2013, AM J RESP CELL MOL, V49, P180, DOI 10.1165/rcmb.2012-0366MA; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	51	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180213	10.1371/journal.pone.0180213	http://dx.doi.org/10.1371/journal.pone.0180213			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671983	Green Published, Green Submitted, gold			2022-12-26	WOS:000405268500029
J	Senturk, JC; Bohlman, S; Manfredi, JJ				Senturk, J. C.; Bohlman, S.; Manfredi, J. J.			Mdm2 selectively suppresses DNA damage arising from inhibition of topoisomerase II independent of p53	ONCOGENE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; GENE AMPLIFICATION; CATALYTIC-ACTIVITY; P-GLYCOPROTEIN; CELL-LINES; CANCER; OVEREXPRESSION; ALPHA; MANAGEMENT; LEUKEMIA	Mdm2 is often overexpressed in tumors that retain wild-type TP53 but may affect therapeutic response independently of p53. Herein is shown that tumor cells with MDM2 amplification are selectively resistant to treatment with topoisomerase II poisons but not other DNA damaging agents. Tumor cells that overexpress Mdm2 have reduced DNA double-strand breaks in response to doxorubicin or etoposide. This latter result is not due to altered drug uptake. The selective attenuation of DNA damage in response to these agents is dependent on both Mdm2 levels and an intact ubiquitin ligase function. These findings reveal a novel, p53-independent activity of Mdm2 and have important implications for the choice of chemotherapeutic agents in the treatment of Mdm2-overexpressing tumors.	[Manfredi, J. J.] Icahn Sch Med Mt Sinai, Dept Oncol Sci, One Gustave L Levy Pl,Box 1130, New York, NY 10021 USA; Icahn Sch Med Mt Sinai, Grad Sch Biol Sci, New York, NY 10021 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Manfredi, JJ (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, One Gustave L Levy Pl,Box 1130, New York, NY 10021 USA.	james.manfredi@mssm.edu			National Cancer Institute [T32CA078207, R03CA216466, P30CA196521]; NATIONAL CANCER INSTITUTE [R03CA216466, T32CA078207, P30CA196521] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We wish to thank the members of the Manfredi laboratory-Lois Resnick-Silverman, Luis Carvajal, Pierre-Jacques Hamard, Crystal Tonnessen and Nicolas Bartelery-as well as Matthew O'Connell, Miguel Gama-Sosa, Stuart Aaronson and Robert Maki for helpful discussions. We also wish to thank Jonathan Fletcher (Brigham and Women's Hospital) for the LS141 liposarcoma cell line, Ze'ev Ronai (Sanford-Burnham Medical Research Institute) for the expression vector for Flag-tagged Mdm2WT and Shohreh Varmeh for the recombinant Adeno-Mdm2-GFP adenovirus. We wish to thank Carol Prives (Columbia University) for Trp53<SUP>-/-</SUP> MDM2<SUP>+/+</SUP> and Trp53<SUP>-/-</SUP>Mdm2<SUP>-/-</SUP> MEFs. Joseph Tripodi and Vesna Najfeld are gratefully thanked for performing the FISH analysis. These studies were supported by National Cancer Institute grants T32CA078207 to JCS and R03CA216466 to JJM and developmental support from P30CA196521.	Alt JR, 2005, J BIOL CHEM, V280, P18771, DOI 10.1074/jbc.M413387200; Ambrosini G, 2007, ONCOGENE, V26, P3473, DOI 10.1038/sj.onc.1210136; Binaschi M, 1998, CANCER RES, V58, P1886; Bond GL, 2005, CANCER RES, V65, P5481, DOI 10.1158/0008-5472.CAN-05-0825; Bouska A, 2008, MOL CELL BIOL, V28, P4862, DOI 10.1128/MCB.01584-07; Bouska A, 2009, TRENDS BIOCHEM SCI, V34, P279, DOI 10.1016/j.tibs.2009.02.006; Chen W, 2012, DRUG DISCOV THER, V6, P230, DOI 10.5582/ddt.2012.v6.5.230; Cheng QA, 2011, CELL CYCLE, V10, P1162, DOI 10.4161/cc.10.7.15249; Chikamori K, 2003, J BIOL CHEM, V278, P12696, DOI 10.1074/jbc.M300837200; Chikamori K, 2010, CURR CANCER DRUG TAR, V10, P758, DOI 10.2174/156800910793605785; Conradt L, 2013, INT J CANCER, V132, P2248, DOI 10.1002/ijc.27916; CORDONCARDO C, 1994, CANCER RES, V54, P794; DAVIES SM, 1988, J BIOL CHEM, V263, P17724; Dimitriadi M, 2008, BRIT J CANCER, V99, P1144, DOI 10.1038/sj.bjc.6604643; Duhamel LAE, 2012, HISTOPATHOLOGY, V60, P357, DOI 10.1111/j.1365-2559.2011.04023.x; DURAND RE, 1981, CANCER RES, V41, P3489; FRICHE E, 1991, CANCER RES, V51, P4213; Geller David S, 2010, Clin Adv Hematol Oncol, V8, P705; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Gomez-Herreros F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003226; Grozav AG, 2009, NUCLEIC ACIDS RES, V37, P382, DOI 10.1093/nar/gkn934; Hamard PJ, 2012, J BIOL CHEM, V287, P22397, DOI 10.1074/jbc.M111.331298; HE J, 1994, GENE CHROMOSOME CANC, V11, P91, DOI 10.1002/gcc.2870110205; ISHIDA R, 1995, CANCER RES, V55, P2299; ISSELL BF, 1979, CANCER TREAT REV, V6, P239, DOI 10.1016/S0305-7372(79)80040-7; Ivashkevich A, 2012, CANCER LETT, V327, P123, DOI 10.1016/j.canlet.2011.12.025; Khasraw M, 2012, BREAST, V21, P142, DOI 10.1016/j.breast.2011.12.012; Kondo S, 1996, BRIT J CANCER, V74, P1263, DOI 10.1038/bjc.1996.527; LADANYI M, 1993, CANCER RES, V53, P16; Lamoureux F, 2007, EXPERT REV ANTICANC, V7, P169, DOI 10.1586/14737140.7.2.169; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; LUK CK, 1989, JNCI-J NATL CANCER I, V81, P55, DOI 10.1093/jnci/81.1.55; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Michaelis M, 2009, CANCER RES, V69, P416, DOI 10.1158/0008-5472.CAN-08-1856; Miller CW, 1996, J CANCER RES CLIN, V122, P559, DOI 10.1007/BF01213553; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Movva S, 2011, DRUGS, V71, P2115, DOI 10.2165/11594500-000000000-00000; Nayak MS, 2007, CANCER RES, V67, P5831, DOI 10.1158/0008-5472.CAN-06-4533; Neal JW, 2011, CLIN CHEST MED, V32, P853, DOI 10.1016/j.ccm.2011.07.002; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Ohnstad HO, 2013, CANCER-AM CANCER SOC, V119, P1013, DOI 10.1002/cncr.27837; Onel K, 2004, MOL CANCER RES, V2, P1; Ottaviano L, 2010, GENE CHROMOSOME CANC, V49, P40, DOI 10.1002/gcc.20717; Plo I, 2002, J BIOL CHEM, V277, P31407, DOI 10.1074/jbc.M204654200; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Rayburn E, 2005, CURR CANCER DRUG TAR, V5, P27, DOI 10.2174/1568009053332636; Reis C, 2005, MOL CANCER THER, V4, P1457, DOI 10.1158/1535-7163.MCT-05-0156; RITKE MK, 1995, MOL PHARMACOL, V48, P798; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; WATANABE T, 1994, BLOOD, V84, P3158; Wunder JS, 1999, ONCOGENE, V18, P783, DOI 10.1038/sj.onc.1202346; Yamazaki K, 1997, CANCER CHEMOTH PHARM, V39, P192; Yeo CQX, 2016, CELL REP, V15, P132, DOI 10.1016/j.celrep.2016.03.011; Zeng ZH, 2011, J BIOL CHEM, V286, P403, DOI 10.1074/jbc.M110.181016	60	8	8	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 2	2017	36	44					6085	6096		10.1038/onc.2017.229	http://dx.doi.org/10.1038/onc.2017.229			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FL5CU	28692049	Green Accepted			2022-12-26	WOS:000414249800003
J	Sorenson, KS; Mahaney, BL; Lees-Miller, SP; Cobb, JA				Sorenson, Kyle S.; Mahaney, Brandi L.; Lees-Miller, Susan P.; Cobb, Jennifer A.			The non-homologous end-joining factor Nej1 inhibits resection mediated by Dna2-Sgs1 nuclease-helicase at DNA double strand breaks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; HOMOLOGOUS RECOMBINATION; CHECKPOINT ACTIVATION; CHROMOSOMAL REARRANGEMENTS; REPAIR; PROTEINS; YEAST; SGS1; EXO1	Double strand breaks (DSBs) represent highly deleterious DNA damage and need to be accurately repaired. Homology-directed repair and non-homologous end joining (NHEJ) are the two major DSB repair pathways that are highly conserved from yeast to mammals. The choice between these pathways is largely based on 5' to 3' DNA resection, and NHEJ proceeds only if resection has not been initiated. In yeast, yKu70/80 rapidly localizes to the break, protecting DNA ends from nuclease accessibility, and recruits additional NHEJ factors, including Nej1 and Lif1. Cells harboring the nej1-V338A mutant exhibit NHEJ-mediated repair deficiencies and hyper-resection 0.15 kb from the DSB that was dependent on the nuclease activity of Dna2-Sgs1. The integrity of Nej1 is also important for inhibiting long-range resection, 4.8 kb from the break, and for preventing the formation of large genomic deletions at sizes >700 bp around the break. Nej1(V338A) localized to a DSB similarly to WT Nej1, indicating that the Nej1-Lif1 interaction becomes critical for blocking hyper-resection mainly after their recruitment to the DSB. This work highlights that Nej1 inhibits 5' DNA hyperresection mediated by Dna2-Sgs1, a function distinct from its previously reported role in supporting Dnl4 ligase activity, and has implications for repair pathway choice and resection regulation upon DSB formation.	[Cobb, Jennifer A.] Univ Calgary, Cumming Sch Med, Arnie Charbonneau Canc Inst, Dept Biochem & Mol Biol,Robson DNA Sci Ctr, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada; Univ Calgary, Cumming Sch Med, Arnie Charbonneau Canc Inst, Dept Oncol,Robson DNA Sci Ctr, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Cobb, JA (corresponding author), Univ Calgary, Cumming Sch Med, Arnie Charbonneau Canc Inst, Dept Biochem & Mol Biol,Robson DNA Sci Ctr, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	jcobb@ucalgary.ca		Lees-Miller, Susan/0000-0001-5809-2516	Canadian Institutes of Health Research (CIHR) [MOP-82736, MOP-137062]; Natural Sciences and Engineering Research Council of Canada [418122]; CIHR Grant [MOP-13639]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); CIHR Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by operating grants from Canadian Institutes of Health Research (CIHR) Grants MOP-82736 and MOP-137062 and Natural Sciences and Engineering Research Council of Canada Grant 418122 (to J. A. C.) and CIHR Grant MOP-13639 (to S. P. L.-M.). The authors declare that they have no conflicts of interest with the contents of this article.	Balestrini A, 2013, CELL REP, V3, P2033, DOI 10.1016/j.celrep.2013.05.026; Bressan DA, 1998, GENETICS, V150, P591; Cannavo E, 2014, NATURE, V514, P122, DOI 10.1038/nature13771; Cejka P, 2015, J BIOL CHEM, V290, P22931, DOI 10.1074/jbc.R115.675942; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Chen X, 2011, J BIOL CHEM, V286, P4931, DOI 10.1074/jbc.M110.195024; Chen XF, 2016, NUCLEIC ACIDS RES, V44, P2742, DOI 10.1093/nar/gkv1544; Chen XF, 2011, NAT STRUCT MOL BIOL, V18, P1015, DOI 10.1038/nsmb.2105; Chiolo I, 2005, MOL CELL BIOL, V25, P5738, DOI 10.1128/MCB.25.13.5738-5751.2005; Chung WH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000948; Clerici M, 2008, EMBO REP, V9, P810, DOI 10.1038/embor.2008.121; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Deshpande RA, 2007, DNA REPAIR, V6, P1507, DOI 10.1016/j.dnarep.2007.04.014; Ferrari M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004928; Foster SS, 2011, MOL CELL BIOL, V31, P4379, DOI 10.1128/MCB.05854-11; Frank-Vaillant M, 2001, GENE DEV, V15, P3005, DOI 10.1101/gad.206801; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Herrmann G, 1998, EMBO J, V17, P4188, DOI 10.1093/emboj/17.14.4188; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Horigome C, 2016, GENE DEV, V30, P931, DOI 10.1101/gad.277665.116; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jain S, 2016, GENETICS, V203, P667, DOI 10.1534/genetics.115.184317; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Mahaney BL, 2014, DNA REPAIR, V14, P9, DOI 10.1016/j.dnarep.2013.12.002; Matsuzaki K, 2008, GENETICS, V179, P213, DOI 10.1534/genetics.107.079236; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Ooi SL, 2001, SCIENCE, V294, P2552, DOI 10.1126/science.1065672; Oza P, 2009, GENE DEV, V23, P912, DOI 10.1101/gad.1782209; Palmbos PL, 2008, GENETICS, V180, P1809, DOI 10.1534/genetics.108.095539; Schar P., 1997, GENE DEV, V11, P1912; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Symington LS, 2016, CRIT REV BIOCHEM MOL, V51, P195, DOI 10.3109/10409238.2016.1172552; Teo SH, 1997, EMBO J, V16, P4788, DOI 10.1093/emboj/16.15.4788; Valencia M, 2001, NATURE, V414, P666, DOI 10.1038/414666a; Wasko BM, 2009, DNA REPAIR, V8, P162, DOI 10.1016/j.dnarep.2008.09.010; Wilson TE, 1997, NATURE, V388, P495, DOI 10.1038/41365; Wu DL, 2008, GENETICS, V178, P1237, DOI 10.1534/genetics.107.083535; Yu X, 2003, GENETICS, V163, P843; Zakharyevich K, 2010, MOL CELL, V40, P1001, DOI 10.1016/j.molcel.2010.11.032; Zhang Y, 2007, NAT STRUCT MOL BIOL, V14, P639, DOI 10.1038/nsmb1261; Zhang Y, 2009, DNA REPAIR, V8, P1235, DOI 10.1016/j.dnarep.2009.07.007; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zierhut C, 2008, EMBO J, V27, P1875, DOI 10.1038/emboj.2008.111	51	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14576	14586		10.1074/jbc.M117.796011	http://dx.doi.org/10.1074/jbc.M117.796011			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28679532	Green Published, hybrid			2022-12-26	WOS:000408747500023
J	Lynch, ZR; Schlenke, TA; Morran, LT; de Roode, JC				Lynch, Zachary R.; Schlenke, Todd A.; Morran, Levi T.; de Roode, Jacobus C.			Ethanol confers differential protection against generalist and specialist parasitoids of Drosophila melanogaster	PLOS ONE			English	Article							OVIPOSITION-SITE PREFERENCE; ANTIMICROBIAL PEPTIDE GENES; ALCOHOL-DEHYDROGENASE; SELF-MEDICATION; LEPTOPILINA-HETEROTOMA; RESOURCE UTILIZATION; ASOBARA-TABIDA; HOST-DEFENSE; RESISTANCE; EVOLUTION	As parasites coevolve with their hosts, they can evolve counter-defenses that render host immune responses ineffective. These counter-defenses are more likely to evolve in specialist parasites than generalist parasites; the latter face variable selection pressures between the different hosts they infect. Natural populations of the fruit fly Drosophila melanogaster are commonly threatened by endoparasitoid wasps in the genus Leptopilina, including the specialist L. boulardi and the generalist L. heterotoma, and both wasp species can incapacitate the cellular immune response of D. melanogaster larvae. Given that ethanol tolerance is high in D. melanogaster and stronger in the specialist wasp than the generalist, we tested whether fly larvae could use ethanol as an anti-parasite defense and whether its effectiveness would differ against the two wasp species. We found that fly larvae benefited from eating ethanol-containing food during exposure to L. heterotoma; we observed a two-fold decrease in parasitization intensity and a 24-fold increase in fly survival to adulthood. Although host ethanol consumption did not affect L. boulardi parasitization rates or intensities, it led to a modest increase in fly survival. Thus, ethanol conferred stronger protection against the generalist wasp than the specialist. We tested whether fly larvae can self-medicate by seeking ethanol-containing food after being attacked by wasps, but found no support for this hypothesis. We also allowed female flies to choose between control and ethanol-containing oviposition sites in the presence vs. absence of wasps and generally found significant preferences for ethanol regardless of wasp presence. Overall, our results suggest that D. melanogaster larvae obtain protection from certain parasitoid wasp species through their mothers' innate oviposition preferences for ethanol-containing food sources.	[Lynch, Zachary R.; Schlenke, Todd A.; Morran, Levi T.; de Roode, Jacobus C.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Schlenke, Todd A.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	Emory University; University of Arizona	Lynch, ZR (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	zach.lynch1@gmail.com		Schlenke, Todd/0000-0003-3091-3057				Agrawal AA, 2012, SCIENCE, V338, P113, DOI 10.1126/science.1225977; Allemand R, 2002, ANN SOC ENTOMOL FR, V38, P319, DOI 10.1080/00379271.2002.10697346; Anagnostou C, 2010, OIKOS, V119, P533, DOI 10.1111/j.1600-0706.2009.18001.x; Azanchi R, 2013, P NATL ACAD SCI USA, V110, P21153, DOI 10.1073/pnas.1320208110; Becher PG, 2012, FUNCT ECOL, V26, P822, DOI 10.1111/j.1365-2435.2012.02006.x; BOULETREAU M, 1981, EVOLUTION, V35, P395, DOI 10.2307/2407848; CARTON Y, 1981, BIOL J LINN SOC, V16, P227, DOI 10.1111/j.1095-8312.1981.tb01849.x; Carton Y., 1986, P347; CAVENER D, 1979, BEHAV GENET, V9, P359, DOI 10.1007/BF01066974; DAVID JR, 1983, COMP BIOCHEM PHYS A, V74, P283, DOI 10.1016/0300-9629(83)90601-1; de Roode JC, 2013, SCIENCE, V340, P150, DOI 10.1126/science.1235824; de Roode Jacobus C., 2012, Insects, V3, P789, DOI 10.3390/insects3030789; Dweck HKM, 2013, CURR BIOL, V23, P2472, DOI 10.1016/j.cub.2013.10.047; Eslin P, 2000, J INSECT PHYSIOL, V46, P1161, DOI 10.1016/S0022-1910(99)00227-9; Eslin P, 1998, J INSECT PHYSIOL, V44, P807, DOI 10.1016/S0022-1910(98)00013-4; Fleury F, 2004, GENETICA, V120, P181, DOI 10.1023/B:GENE.0000017640.78087.9e; Fleury F, 2009, ADV PARASIT, V70, P3, DOI 10.1016/S0065-308X(09)70001-6; GIBSON JB, 1981, OECOLOGIA, V51, P191, DOI 10.1007/BF00540600; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Goddard MR, 2008, ECOLOGY, V89, P2077, DOI 10.1890/07-2060.1; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Hoang D, 2015, PEERJ, V3, P16; Jaenike J, 2010, SCIENCE, V329, P212, DOI 10.1126/science.1188235; Kacsoh BZ, 2015, GENETICS, V199, P1143, DOI 10.1534/genetics.114.172221; Kacsoh BZ, 2013, SCIENCE, V339, P947, DOI 10.1126/science.1229625; Kawecki TJ, 1998, AM NAT, V152, P635, DOI 10.1086/286195; Labrosse C, 2003, J INSECT PHYSIOL, V49, P513, DOI 10.1016/S0022-1910(03)00054-4; Lefevre T, 2012, BIOL LETTERS, V8, P230, DOI 10.1098/rsbl.2011.0725; Lefevre T, 2012, J ANIM ECOL, V81, P70, DOI 10.1111/j.1365-2656.2011.01901.x; Lefevre T, 2010, ECOL LETT, V13, P1485, DOI 10.1111/j.1461-0248.2010.01537.x; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lynch ZR, 2016, J EVOLUTION BIOL, V29, P1016, DOI 10.1111/jeb.12842; Mauricio R, 1997, EVOLUTION, V51, P1435, DOI [10.2307/2411196, 10.1111/j.1558-5646.1997.tb01467.x]; MCKECHNIE SW, 1984, INSECT BIOCHEM, V14, P231, DOI 10.1016/0020-1790(84)90034-9; MCKENZIE JA, 1979, OECOLOGIA, V40, P299, DOI 10.1007/BF00345326; MCKENZIE JA, 1972, OECOLOGIA, V10, P373, DOI 10.1007/BF00345738; MERCOT H, 1994, EVOLUTION, V48, P746, DOI 10.1111/j.1558-5646.1994.tb01358.x; Milan NF, 2012, CURR BIOL, V22, P488, DOI 10.1016/j.cub.2012.01.045; Palanca L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075332; Parker BJ, 2011, TRENDS ECOL EVOL, V26, P242, DOI 10.1016/j.tree.2011.02.005; PARSONS PA, 1977, OECOLOGIA, V30, P141, DOI 10.1007/BF00345417; PARSONS PA, 1977, EXPERIENTIA, V33, P898, DOI 10.1007/BF01951269; Poyet M, 2013, PHYSIOL ENTOMOL, V38, P45, DOI 10.1111/phen.12002; R Development Core team, 2014, R A LANGUAGE AND ENV; RICHMOND RC, 1979, BEHAV GENET, V9, P233, DOI 10.1007/BF01071304; RIZKI RM, 1984, P NATL ACAD SCI-BIOL, V81, P6154, DOI 10.1073/pnas.81.19.6154; RIZKI TM, 1990, EXP PARASITOL, V70, P466, DOI 10.1016/0014-4894(90)90131-U; Schlenke TA, 2007, PLOS PATHOG, V3, P1486, DOI 10.1371/journal.ppat.0030158; Siegal ML, 1999, BEHAV GENET, V29, P199, DOI 10.1023/A:1021648103496; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; Stamps JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042238; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Sumethasorn M, 2016, BIOL OPEN, V5, P1642, DOI 10.1242/bio.019380; Thompson JN, 1999, AM NAT, V153, pS1, DOI 10.1086/303208; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Zhu J, 2015, ENTOMOL EXP APPL, V155, P64, DOI 10.1111/eea.12285	57	10	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180182	10.1371/journal.pone.0180182	http://dx.doi.org/10.1371/journal.pone.0180182			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700600	Green Submitted, Green Published, gold			2022-12-26	WOS:000405649600022
J	Dobrovolny, HM; Beauchemin, CAA				Dobrovolny, Hana M.; Beauchemin, Catherine A. A.			Modelling the emergence of influenza drug resistance: The roles of surface proteins, the immune response and antiviral mechanisms	PLOS ONE			English	Article							NEURAMINIDASE INHIBITOR RESISTANCE; 2009 PANDEMIC INFLUENZA; VIRUS IN-VITRO; A VIRUS; VIRAL FITNESS; INTRACELLULAR-TRANSPORT; AMANTADINE-RESISTANT; REPLICATION FITNESS; APICAL SURFACE; UNITED-STATES	The emergence of influenza drug resistance has become of particular interest as current planning for an influenza pandemic involves using massive amounts of antiviral drugs. We use semi-stochastic simulations to examine the emergence of drug resistant mutants during the course of a single infection within a patient in the presence and absence of antiviral therapy. We specifically examine three factors and their effect on the emergence of drugresistant mutants: antiviral mechanism, the immune response, and surface proteins. We find that adamantanes, because they act at the start of the replication cycle to prevent infection, are less likely to produce drug-resistant mutants than NAIs, which act at the end of the replication cycle. A mismatch between surface proteins and internal RNA results in drugresistant mutants being less likely to emerge, and emerging later in the infection because the mismatch gives antivirals a second chance to prevent propagation of the mutation. The immune response subdues slow growing infections, further reducing the probability that a drug resistant mutant will emerge and yield a drug-resistant infection. These findings improve our understanding of the factors that contribute to the emergence of drug resistance during the course of a single influenza infection.	[Dobrovolny, Hana M.] Texas Christian Univ, Dept Phys & Astron, Ft Worth, TX 76129 USA; [Dobrovolny, Hana M.; Beauchemin, Catherine A. A.] Ryerson Univ, Dept Phys, Toronto, ON, Canada; [Beauchemin, Catherine A. A.] RIKEN, Interdisciplinary Theoret Sci iTHES Res Grp, Wako, Saitama, Japan	Texas Christian University; Toronto Metropolitan University; RIKEN	Dobrovolny, HM (corresponding author), Texas Christian Univ, Dept Phys & Astron, Ft Worth, TX 76129 USA.; Dobrovolny, HM (corresponding author), Ryerson Univ, Dept Phys, Toronto, ON, Canada.	h.dobrovolny@tcu.edu	Beauchemin, Catherine AA/G-4619-2011; Dobrovolny, Hana M./A-2447-2013	Beauchemin, Catherine AA/0000-0003-0599-0069; Dobrovolny, Hana M./0000-0003-3592-6770	Natural Sciences and Engineering Research Council of Canada [355837-2013]; Ministry of Research and Innovation of the Government of Ontario [ER13-09-040]; iTHES research programme at RIKEN	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ministry of Research and Innovation of the Government of Ontario; iTHES research programme at RIKEN	This research was supported in part by Discovery Grant 355837-2013 from the Natural Sciences and Engineering Research Council of Canada (to C.A.A.B.), Early Researcher Award ER13-09-040 (to C.A.A.B) from the Ministry of Research and Innovation of the Government of Ontario, with additional support through the iTHES research programme at RIKEN (to C.A.A.B.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2005, ANTIMICROB AGENTS CH, V49, P556, DOI 10.1128/AAC.49.2.556-559.2005; Abed Y, 2002, J INFECT DIS, V186, P1074, DOI 10.1086/344237; Abed Y, 2006, ANTIVIR THER, V11, P971; Abed Y, 2014, J VIROL, V88, P1652, DOI 10.1128/JVI.02681-13; Alexander ME, 2007, P R SOC B, V274, P1675, DOI 10.1098/rspb.2007.0422; Althouse BM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002912; Atkinson K., 2004, ELEMENTARY NUMERICAL, V3rd; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Baranovich T, 2011, CURR OPIN VIROL, V1, P574, DOI 10.1016/j.coviro.2011.08.006; Baz M, 2006, CLIN INFECT DIS, V43, P1555, DOI 10.1086/508777; Beauchemin CAA, 2008, J THEOR BIOL, V254, P439, DOI 10.1016/j.jtbi.2008.05.031; BELSHE RB, 1988, J VIROL, V62, P1508, DOI 10.1128/JVI.62.5.1508-1512.1988; Boianelli A, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00060; Bourret V, 2015, INFECT GENET EVOL, V33, P47, DOI 10.1016/j.meegid.2015.04.009; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Brookes DW, 2011, J ANTIMICROB CHEMOTH, V66, P466, DOI 10.1093/jac/dkq486; Brown AN, 2010, ANTIMICROB AGENTS CH, V54, P3442, DOI 10.1128/AAC.01385-09; Butler J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004065; Canini L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003568; Chao DL, 2012, J R SOC INTERFACE, V9, P648, DOI 10.1098/rsif.2011.0427; Cheng PKC, 2009, EMERG INFECT DIS, V15, P966, DOI 10.3201/eid1506.081357; COPELAND CS, 1986, J CELL BIOL, V103, P1179, DOI 10.1083/jcb.103.4.1179; Crystal RG, 1991, THE LUNG SCIENTIFIC; DANIELS PU, 1989, FEBS LETT, V244, P57, DOI 10.1016/0014-5793(89)81161-5; Debarre F, 2007, J R SOC INTERFACE, V4, P893, DOI 10.1098/rsif.2007.1126; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Dobrovolny HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057088; Dobrovolny HM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013811; DRAKE JW, 1993, P NATL ACAD SCI USA, V90, P4171, DOI 10.1073/pnas.90.9.4171; ENAMI M, 1985, VIROLOGY, V142, P68, DOI 10.1016/0042-6822(85)90423-4; Ferguson NM, 2003, J ANTIMICROB CHEMOTH, V51, P977, DOI 10.1093/jac/dkg136; Govorkova EA, 2010, J VIROL, V84, P8042, DOI 10.1128/JVI.00689-10; Gubareva LV, 1996, J VIROL, V70, P1818, DOI 10.1128/JVI.70.3.1818-1827.1996; Gubareva LV, 2001, J INFECT DIS, V183, P523, DOI 10.1086/318537; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Hamelin ME, 2011, ANTIVIR THER, V16, P775, DOI 10.3851/IMP1794; Handel A, 2007, PLOS COMPUT BIOL, V3, P2456, DOI 10.1371/journal.pcbi.0030240; Handel A, 2009, J THEOR BIOL, V256, P117, DOI 10.1016/j.jtbi.2008.09.021; HAY AJ, 1996, ANTIVIRAL DRUG RESIS, P43; Hayden FG, 1996, JAMA-J AM MED ASSOC, V275, P295, DOI 10.1001/jama.275.4.295; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Hayden FG, 1996, ANTIVIRAL DRUG RESIS, P59; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Holder BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014767; HUGHEY PG, 1992, J VIROL, V66, P5542, DOI 10.1128/JVI.66.9.5542-5552.1992; Hur KY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068235; Hurt AC, 2010, J VIROL, V84, P9427, DOI 10.1128/JVI.00373-10; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; KUNDU A, 1994, J VIROL, V68, P1812, DOI 10.1128/JVI.68.3.1812-1818.1994; Li TCM, 2015, VIRUSES-BASEL, V7, P4929, DOI 10.3390/v7092850; Loverdo C, 2013, EVOLUTION, V67, P1815, DOI 10.1111/evo.12048; Loverdo C, 2012, EVOLUTION, V66, P3462, DOI 10.1111/j.1558-5646.2012.01687.x; Moghadas SM, 2008, P ROY SOC B-BIOL SCI, V275, P1163, DOI 10.1098/rspb.2008.0016; Morrison D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001305; Nayak DP, 2009, VIRUS RES, V143, P147, DOI 10.1016/j.virusres.2009.05.010; Palmer J, 2017, SCI REP-UK, V7, DOI 10.1038/srep40210; Paradis EG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126115; Pawelek KA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002588; Perelson AS, 2012, J INFECT DIS, V205, P1642, DOI 10.1093/infdis/jis265; Petrie SM, 2015, J THEOR BIOL, V382, P259, DOI 10.1016/j.jtbi.2015.07.003; Pinilla LT, 2012, J VIROL, V86, P10651, DOI 10.1128/JVI.07244-11; Pizzorno A, 2012, ANTIMICROB AGENTS CH, V56, P1208, DOI 10.1128/AAC.05994-11; Robinson M, 2013, MATH BIOSCI, V243, P163, DOI 10.1016/j.mbs.2013.03.003; RODRIGUEZBOULAN E, 1984, J CELL BIOL, V98, P308, DOI 10.1083/jcb.98.1.308; Samji Tasleem, 2009, Yale Journal of Biology and Medicine, V82, P153; Schunemann HJ, 2007, LANCET INFECT DIS, V7, P21, DOI 10.1016/S1473-3099(06)70684-3; Seibert CW, 2010, J VIROL, V84, P11219, DOI 10.1128/JVI.01424-10; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Simon P, 2011, J CLIN MICROBIOL, V49, P715, DOI 10.1128/JCM.01732-10; Tamura SI, 2004, JPN J INFECT DIS, V57, P236; Vester D, 2010, J VIROL METHODS, V168, P63, DOI 10.1016/j.jviromet.2010.04.017; Wang MZ, 2002, ANTIMICROB AGENTS CH, V46, P3809, DOI 10.1128/AAC.46.12.3809-3816.2002; Wargo AR, 2012, CURR OPIN VIROL, V2, P538, DOI 10.1016/j.coviro.2012.07.007; Wong DDY, 2012, J VIROL, V86, P10558, DOI 10.1128/JVI.00985-12; Wu HL, 2006, J VIROL, V80, P2380, DOI 10.1128/JVI.80.5.2380-2389.2006; Wutzler P, 2004, J CLIN VIROL, V31, P84, DOI 10.1016/j.jcv.2004.05.009; Xiao YY, 2016, J MATH BIOL, V72, P343, DOI 10.1007/s00285-015-0887-y; Xu Y, 2007, J THEOR BIOL, V248, P179, DOI 10.1016/j.jtbi.2007.05.009; Yen HL, 2005, ANTIMICROB AGENTS CH, V49, P4075, DOI 10.1128/AAC.49.10.4075-4084.2005; Zaraket H, 2010, J CLIN MICROBIOL, V48, P1085, DOI 10.1128/JCM.01532-09; Zhao X, 2012, ANTIVIR RES, V96, P91, DOI 10.1016/j.antiviral.2012.09.001	83	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180582	10.1371/journal.pone.0180582	http://dx.doi.org/10.1371/journal.pone.0180582			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700622	Green Published, gold			2022-12-26	WOS:000405544800057
J	Neerland, BE; Krogseth, M; Juliebo, V; Ranhoff, AH; Engedal, K; Frihagen, F; Raeder, J; Wyller, TB; Watne, LO				Neerland, Bjorn Erik; Krogseth, Maria; Juliebo, Vibeke; Ranhoff, Anette Hylen; Engedal, Knut; Frihagen, Frede; Raeder, Johan; Wyller, Torgeir Bruun; Watne, Leiv Otto			Perioperative hemodynamics and risk for delirium and new onset dementia in hip fracture patients; A prospective follow-up study	PLOS ONE			English	Article							POSTOPERATIVE DELIRIUM; ELDERLY-PATIENTS; INTRAOPERATIVE HYPOTENSION; COGNITIVE DECLINE; AUTOREGULATION; PRESSURE; REPAIR; TRIAL; OSLO	Background Delirium is common in hip fracture patients and many risk factors have been identified. Controversy exists regarding the possible impact of intraoperative control of blood pressure upon acute (delirium) and long term (dementia) cognitive decline. We explored possible associations between perioperative hemodynamic changes, use of vasopressor drugs, risk of delirium and risk of new-onset dementia. Methods Prospective follow-up study of 696 hip fracture patients, assessed for delirium pre- and post-operatively, using the Confusion Assessment Method. Pre-fracture cognitive function was assessed using the Informant Questionnaire of Cognitive Decline in the Elderly and by consensus diagnosis. The presence of new-onset dementia was determined at follow-up evaluation at six or twelve months after surgery. Blood pressure was recorded at admission, perioperatively and postoperatively. Results Preoperative delirium was present in 149 of 536 (28%) assessable patients, and 124 of 387 (32%) developed delirium postoperatively (incident delirium). The following risk factors for incident delirium in patients without pre-fracture cognitive impairment were identified: low body mass index, low level of functioning, severity of physical illness, and receipt of >= 2 blood transfusions. New-onset dementia was diagnosed at follow-up in 26 of 213 (12%) patients, associated with severity of physical illness, delirium, receipt of vasopressor drugs perioperatively and high mean arterial pressure postoperatively. Conclusion Risk factors for incident delirium seem to differ according to pre-fracture cognitive status. The use of vasopressors during surgery and/or postoperative hypertension is associated with new-onset dementia after hip fracture.	[Neerland, Bjorn Erik; Krogseth, Maria; Juliebo, Vibeke; Engedal, Knut; Wyller, Torgeir Bruun; Watne, Leiv Otto] Oslo Univ Hosp, Dept Geriatr Med, Oslo Delirium Res Grp, Oslo, Norway; [Neerland, Bjorn Erik; Engedal, Knut; Raeder, Johan; Wyller, Torgeir Bruun] Univ Oslo, Inst Clin Med, Oslo, Norway; [Krogseth, Maria] Telemark Hosp Trust, Old Age Psychiat Res Network, Tonsberg, Norway; [Krogseth, Maria] Vestfold Hosp Trust, Tonsberg, Norway; [Krogseth, Maria] Univ Coll Southeast Norway, Fac Hlth Sci, Drammen, Norway; [Ranhoff, Anette Hylen] Diakonhjemmet Hosp, Oslo, Norway; [Ranhoff, Anette Hylen] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Engedal, Knut] Vestfold Hlth Trust, Norwegian Natl Advisory Unit Ageing & Hlth, Tonsberg, Norway; [Frihagen, Frede] Oslo Univ Hosp, Dept Orthopaed Surg, Oslo, Norway; [Raeder, Johan] Oslo Univ Hosp, Dept Anaesthesiol, Oslo, Norway; [Watne, Leiv Otto] Univ Oslo, Inst Basic Med Sci, Oslo, Norway	University of Oslo; University of Oslo; Telemark Hospital Trust; University College of Southeast Norway; Diakonhjemmet Hospital; University of Bergen; University of Oslo; University of Oslo; University of Oslo	Neerland, BE (corresponding author), Oslo Univ Hosp, Dept Geriatr Med, Oslo Delirium Res Grp, Oslo, Norway.; Neerland, BE (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	bjorn.erik@neerland.net		Frihagen, Frede/0000-0002-4811-669X; Neerland, Bjorn Erik/0000-0001-5335-9146	Research Council of Norway; The University of Oslo; Research into Ageing; Norwegian Health Association	Research Council of Norway(Research Council of Norway); The University of Oslo; Research into Ageing; Norwegian Health Association	This study was funded by the Research Council of Norway; The University of Oslo; Research into Ageing; Norwegian Health Association. The sponsors had no role in the design, methods, subject recruitment, data collection, analysis or preparation of the manuscript	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Anesthesiologists ASo, 1963, ANESTHESIOLOGY, V24; Bentler SE, 2009, AM J EPIDEMIOL, V170, P1290, DOI 10.1093/aje/kwp266; Bickel H, 2008, DEMENT GERIATR COGN, V26, P26, DOI 10.1159/000140804; Brady K, 2013, ANESTHESIOLOGY, V119, P495, DOI 10.1097/ALN.0b013e3182a10cce; Breitbart W, 1997, J PAIN SYMPTOM MANAG, V13, P128, DOI 10.1016/S0885-3924(96)00316-8; Burkhart CS, 2011, BRIT J ANAESTH, V107, P742, DOI 10.1093/bja/aer252; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clegg A, 2011, AGE AGEING, V40, P23, DOI 10.1093/ageing/afq140; Deckers K, 2015, INT J GERIATR PSYCH, V30, P234, DOI 10.1002/gps.4245; Edlund A, 2001, J AM GERIATR SOC, V49, P1335, DOI 10.1046/j.1532-5415.2001.49261.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GUSTAFSON Y, 1988, J AM GERIATR SOC, V36, P525, DOI 10.1111/j.1532-5415.1988.tb04023.x; Harrison JK, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010772.pub2; Hirsch J, 2015, BRIT J ANAESTH, V115, P418, DOI 10.1093/bja/aeu458; Hori D, 2014, BRIT J ANAESTH, V113, P1009, DOI 10.1093/bja/aeu319; Iadecola C, 2008, CELL METAB, V7, P476, DOI 10.1016/j.cmet.2008.03.010; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Jackson TA, 2016, AGE AGEING; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Juliebo V, 2009, J AM GERIATR SOC, V57, P1354, DOI 10.1111/j.1532-5415.2009.02377.x; Lee HB, 2011, J AM GERIATR SOC, V59, P2306, DOI 10.1111/j.1532-5415.2011.03725.x; Lincoln N B, 1992, Disabil Rehabil, V14, P41; MAHONEY F I, 1965, Md State Med J, V14, P61; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V272, P1518, DOI 10.1001/jama.272.19.1518; Marcantonio ER, 1998, AM J MED, V105, P380, DOI 10.1016/S0002-9343(98)00292-7; Meng L, 2011, BRIT J ANAESTH, V107, P209, DOI 10.1093/bja/aer150; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; O'Callaghan Susan, 2016, Yale Journal of Biology and Medicine, V89, P59; Oh ES, 2015, INT J GERIATR PSYCH, V30, P900, DOI 10.1002/gps.4233; Patti R, 2011, EUR J ONCOL NURS, V15, P519, DOI 10.1016/j.ejon.2011.01.004; Saczynski JS, 2012, NEW ENGL J MED, V367, P30, DOI 10.1056/NEJMoa1112923; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; Slater JP, 2009, ANN THORAC SURG, V87, P36, DOI 10.1016/j.athoracsur.2008.08.070; Stoen RO, 2012, OSTEOPOROSIS INT, V23, P2527, DOI 10.1007/s00198-011-1888-3; Tognoni P, 2011, ARCH GERONTOL GERIAT, V52, pE166, DOI 10.1016/j.archger.2010.10.021; Wang NY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123892; Watne LO, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-63; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Williams-Russo P, 1999, ANESTHESIOLOGY, V91, P926, DOI 10.1097/00000542-199910000-00011; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; World Health Organization, ICD 10 CLASS MENT BE; World Health Organization, 1992, INT STAT CLASS DIS R	45	30	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180641	10.1371/journal.pone.0180641	http://dx.doi.org/10.1371/journal.pone.0180641			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700610	Green Submitted, Green Published, gold			2022-12-26	WOS:000405544800061
J	Reichert, JL; Chocholous, M; Leiss, U; Pletschko, T; Kasprian, G; Furtner, J; Kollndorfer, K; Krajnik, J; Slavc, I; Prayer, D; Czech, T; Schopf, V; Dorfer, C				Reichert, Johanna L.; Chocholous, Monika; Leiss, Ulrike; Pletschko, Thomas; Kasprian, Gregor; Furtner, Julia; Kollndorfer, Kathrin; Krajnik, Jacqueline; Slavc, Irene; Prayer, Daniela; Czech, Thomas; Schoepf, Veronika; Dorfer, Christian			Neuronal correlates of cognitive function in patients with childhood cerebellar tumor lesions	PLOS ONE			English	Article							VERBAL WORKING-MEMORY; INDEPENDENT COMPONENT ANALYSIS; PEDIATRIC BRAIN-TUMORS; POSTERIOR-FOSSA TUMORS; MRI DATA; CHILDREN; CONNECTIVITY; TOPOGRAPHY; SURVIVORS; NETWORKS	While it has been shown that cerebellar tumor lesions have an impact on cognitive functions, the extent to which they shape distant neuronal pathways is still largely undescribed. Thus, the present neuroimaging study was designed to investigate different aspects of cognitive function and their neuronal correlates in patients after childhood cerebellar tumor surgery. An alertness task, a working memory task and an incompatibility task were performed by 11 patients after childhood cerebellar tumor surgery and 17 healthy controls. Neuronal correlates as reflected by alterations in functional networks during tasks were assessed using group independent component analysis. We were able to identify eight networks involved during task performance: default mode network, precuneus, anterior salience network, executive control network, visual network, auditory and sensorimotor network and a cerebellar network. For the most 'basic' cognitive tasks, a weaker task-modulation of default mode network, left executive control network and the cerebellar network was observed in patients compared to controls. Results for higher-order tasks are in line with a partial restoration of networks responsible for higher-order task execution. Our results provide tentative evidence that the synchronicity of brain activity in patients was at least partially restored in the course of neuroplastic reorganization, particularly for networks related to higher-order cognitive processes. The complex activation patterns underline the importance of testing several cognitive functions to assess the specificity of cognitive deficits and neuronal reorganization processes after brain lesions.	[Reichert, Johanna L.; Schoepf, Veronika] Karl Franzens Univ Graz, Inst Psychol, Graz, Austria; [Reichert, Johanna L.; Schoepf, Veronika] BioTechMed, Graz, Austria; [Chocholous, Monika; Leiss, Ulrike; Pletschko, Thomas; Slavc, Irene] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Chocholous, Monika; Leiss, Ulrike; Pletschko, Thomas; Furtner, Julia; Slavc, Irene; Czech, Thomas; Dorfer, Christian] Med Univ Vienna, Comprehens Canc Ctr, CNS Tumors Unit CCC CNS, Vienna, Austria; [Kasprian, Gregor; Furtner, Julia; Kollndorfer, Kathrin; Krajnik, Jacqueline; Prayer, Daniela; Schoepf, Veronika] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Krajnik, Jacqueline; Czech, Thomas; Dorfer, Christian] Med Univ Vienna, Dept Neurosurg, Vienna, Austria	University of Graz; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Dorfer, C (corresponding author), Med Univ Vienna, Comprehens Canc Ctr, CNS Tumors Unit CCC CNS, Vienna, Austria.; Dorfer, C (corresponding author), Med Univ Vienna, Dept Neurosurg, Vienna, Austria.	christian.dorfer@meduniwien.ac.at	Kasprian, Gregor/AAJ-5052-2020; Dorfer, Christian/AAP-1990-2020	Kasprian, Gregor/0000-0003-3858-3347; Pletschko, Thomas/0000-0002-7865-0164; Furtner, Julia/0000-0001-8258-3681; Leiss, Ulrike/0000-0003-2605-8334; Schopf, Veronika/0000-0003-1937-4216; Dorfer, Christian/0000-0002-1843-7732	Austrian Science Fund (FWF) [KLI 252]; FWF [KLI252, P23205-B09]; BioTechMed Graz	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); FWF(Austrian Science Fund (FWF)); BioTechMed Graz	This study was part of a project (KLI 252) funded by the Austrian Science Fund (FWF) dedicated to CD. JK, TP and KK were supported by the FWF (JK: KLI252 to CD, P23205-B09 to VS, TP: KLI252 to CD, KK: P23205-B09 to VS). JR is supported by BioTechMed Graz.	Aarsen FK, 2004, NEUROLOGY, V62, P1311, DOI 10.1212/01.WNL.0000120549.77188.36; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Baillieux H, 2008, CLIN NEUROL NEUROSUR, V110, P763, DOI 10.1016/j.clineuro.2008.05.013; Bellebaum C, 2007, CEREBELLUM, V6, P184, DOI 10.1080/14734220601169707; Bleyer A, 1998, P ANN M AM SOC CLINC, P1498; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2013, NEURON, V80, P807, DOI 10.1016/j.neuron.2013.10.044; Calhoun VD, 2001, HUM BRAIN MAPP, V13, P43, DOI 10.1002/hbm.1024; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chen HB, 2016, NEUROIMAGE-CLIN, V11, P339, DOI 10.1016/j.nicl.2016.02.010; Chen SHA, 2005, NEUROIMAGE, V24, P332, DOI 10.1016/j.neuroimage.2004.08.032; Chiricozzi FR, 2008, NEUROPSYCHOLOGIA, V46, P1940, DOI 10.1016/j.neuropsychologia.2008.01.024; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Hoang DH, 2014, J NEUROSURG-PEDIATR, V14, P136, DOI 10.3171/2014.5.PEDS13571; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Gottwald B, 2004, J NEUROL NEUROSUR PS, V75, P1524, DOI 10.1136/jnnp.2003.018093; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Haarmeier T, 2007, CEREBELLUM, V6, P177, DOI 10.1080/14734220701286187; Justus T, 2005, BRAIN LANG, V95, P304, DOI 10.1016/j.bandl.2005.02.001; Keren-Happuch E, 2014, HUM BRAIN MAPP, V35, P593, DOI 10.1002/hbm.22194; Kim DI, 2009, SCHIZOPHRENIA BULL, V35, P67, DOI 10.1093/schbul/sbn133; King TZ, 2015, J INT NEUROPSYCH SOC, V21, P494, DOI 10.1017/S135561771500051X; Kirschen MP, 2008, BEHAV NEUROL, V20, P39, DOI [10.1155/2008/817253, 10.3233/BEN-2008-0216]; Levisohn L, 2000, BRAIN, V123, P1041, DOI 10.1093/brain/123.5.1041; Marvel CL, 2010, NEUROPSYCHOL REV, V20, P271, DOI 10.1007/s11065-010-9137-7; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Palmer SL, 2013, J CLIN ONCOL, V31, P3494, DOI 10.1200/JCO.2012.47.4775; Peterburs J, 2016, CURR OPIN NEUROBIOL, V40, P38, DOI 10.1016/j.conb.2016.06.011; Peterburs J, 2015, NEUROPSYCHOLOGIA, V68, P139, DOI 10.1016/j.neuropsychologia.2015.01.017; Peterburs J, 2013, CEREBELLUM, V12, P1, DOI 10.1007/s12311-012-0386-2; Peterburs J, 2012, NEUROPSYCHOLOGIA, V50, P379, DOI 10.1016/j.neuropsychologia.2011.12.009; Peterburs J, 2010, CEREBELLUM, V9, P375, DOI 10.1007/s12311-010-0171-z; Piscione PJ, 2014, NEURO-ONCOLOGY, V16, P147, DOI 10.1093/neuonc/not138; Poldrack RA, 2008, NEUROIMAGE, V40, P409, DOI 10.1016/j.neuroimage.2007.11.048; POLLACK IF, 1994, NEW ENGL J MED, V331, P1500, DOI 10.1056/NEJM199412013312207; Ravizza SM, 2006, BRAIN, V129, P306, DOI 10.1093/brain/awh685; Riva D, 2000, BRAIN, V123, P1051, DOI 10.1093/brain/123.5.1051; Robinson KE, 2015, CHILD NEUROPSYCHOL, V21, P779, DOI 10.1080/09297049.2014.924492; Robinson KE, 2014, NEUROPSYCHOLOGY, V28, P791, DOI 10.1037/neu0000077; Robinson KE, 2013, J INT NEUROPSYCH SOC, V19, P44, DOI 10.1017/S1355617712000987; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Silveri MC, 1998, BRAIN, V121, P2175, DOI 10.1093/brain/121.11.2175; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Timmann D, 2007, CEREBELLUM, V6, P159, DOI 10.1080/14734220701496448; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Bosch GE, 2014, HUM BRAIN MAPP, V35, P698, DOI 10.1002/hbm.22193; Von Aster M, 2006, DEUTSCHSPRACHIGE BEA; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Zakrzewski K, 2003, FOLIA NEUROPATHOL, V41, P251; Zimmermann P, 2007, TESTBATTERIE AUFMERK	55	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180200	10.1371/journal.pone.0180200	http://dx.doi.org/10.1371/journal.pone.0180200			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692686	Green Submitted, gold, Green Published			2022-12-26	WOS:000405544800030
J	Xu, EG; Mager, EM; Grosell, M; Stieglitz, JD; Hazard, ES; Hardiman, G; Schlenk, D				Xu, Elvis Genbo; Mager, Edward M.; Grosell, Martin; Stieglitz, John D.; Hazard, E. Starr; Hardiman, Gary; Schlenk, Daniel			Developmental transcriptomic analyses for mechanistic insights into critical pathways involved in embryogenesis of pelagic mahimahi (Coryphaena hippurus)	PLOS ONE			English	Article							ATLANTIC BLUEFIN TUNA; NITRIC-OXIDE; CRUDE-OIL; GENE-EXPRESSION; AROMATIC-HYDROCARBONS; LARVAL DEVELOPMENT; SKELETAL-MUSCLE; NMDA RECEPTORS; IN-VIVO; CALCIUM	Mahi-mahi (Coryphaena hippurus) is a commercially and ecologically important species of fish occurring in tropical and temperate waters worldwide. Understanding early life events is crucial for predicting effects of environmental stress, which is largely restricted by a lack of genetic resources regarding expression of early developmental genes and regulation of pathways. The need for anchoring developmental stages to transcriptional activities is highlighted by increasing evidence on the impacts of recurrent worldwide oil spills in this sensitive species during early development. By means of high throughput sequencing, we characterized the developmental transcriptome of mahi-mahi at three critical developmental stages, from pharyngula embryonic stage (24 hpf) to 48 hpf yolk-sac larva (transition 1), and to 96 hpf free-swimming larva (transition 2). With comparative analysis by multiple bioinformatic tools, a larger number of significantly altered genes and more diverse gene ontology terms were observed during transition 2 than transition 1. Cellular and tissue development terms were more significantly enriched in transition 1, while metabolism related terms were more enriched in transition 2, indicating a switch progressing from general embryonic development to metabolism during the two transitions. Special focus was given on the most significant common canonical pathways (e.g. calcium signaling, glutamate receptor signaling, cAMP response element-binding protein signaling, cardiac beta-adrenergic signaling, etc.) and expression of developmental genes (e.g. collagens, myosin, notch, glutamate metabotropic receptor etc.), which were associated with morphological changes of nervous, muscular, and cardiovascular system. These data will provide an important basis for understanding embryonic development and identifying molecular mechanisms of abnormal development in fish species.	[Xu, Elvis Genbo; Schlenk, Daniel] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA; [Mager, Edward M.] Univ North Texas, Dept Biol Sci, Denton, TX USA; [Grosell, Martin; Stieglitz, John D.] Univ Miami, Dept Marine Biol & Ecol, Miami, FL USA; [Hazard, E. Starr; Hardiman, Gary] Med Univ South Carolina, Ctr Genom Med, Charleston, SC USA; [Hazard, E. Starr] Med Univ South Carolina, Computat Biol Resource Ctr, Charleston, SC USA; [Hardiman, Gary] Med Univ South Carolina, Dept Med, Charleston, SC USA; [Hardiman, Gary] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC USA; [Hardiman, Gary] Hollings Marine Lab, Lab Marine Syst Biol, Charleston, SC USA	University of California System; University of California Riverside; University of North Texas System; University of North Texas Denton; University of Miami; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Xu, EG; Schlenk, D (corresponding author), Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA.	genboxu@ucr.edu; daniel.schlenk@ucr.edu	Xu, Elvis Genbo/AAA-9267-2020	Xu, Elvis Genbo/0000-0002-4414-1978; Hardiman, Gary/0000-0003-4558-0400	Gulf of Mexico Research Initiative [SA-1520]; Relationship of Effects of Cardiac Outcomes in fish for Validation of Ecological Risk (RECOVER); Medical University of South Carolina College of Medicine for start-up funds; Genomics Shared Resource, Hollings Cancer Center	Gulf of Mexico Research Initiative; Relationship of Effects of Cardiac Outcomes in fish for Validation of Ecological Risk (RECOVER); Medical University of South Carolina College of Medicine for start-up funds; Genomics Shared Resource, Hollings Cancer Center	This research was made possible by a grant from The Gulf of Mexico Research Initiative, Grant No: SA-1520; Name: Relationship of Effects of Cardiac Outcomes in fish for Validation of Ecological Risk (RECOVER). The authors are grateful to the Gulf of Mexico Research Initiative Information and Data Cooperative (GRIIDC) for supporting data management system to store the data generated. GRIIDC doi:10.7266/N7GX48ND. GH acknowledges the Medical University of South Carolina College of Medicine for start-up funds. This research was supported in part by the Genomics Shared Resource, Hollings Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker ME, 2009, ENVIRON HEALTH PERSP, V117, P223, DOI 10.1289/ehp.11627; Bannai H, 2015, CELL REP, V13, P2768, DOI 10.1016/j.celrep.2015.12.002; Berman N, 2001, J NEUROPHYSIOL, V86, P1612, DOI 10.1152/jn.2001.86.4.1612; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bleckmann SC, 2002, MOL CELL BIOL, V22, P1919, DOI 10.1128/MCB.22.6.1919-1925.2002; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Brusle J., 1996, FISH MORPHOLOGY, P77, DOI DOI 10.1201/9780203755990-6; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chu J, 2009, HEPATOLOGY, V50, P1656, DOI 10.1002/hep.23157; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Darias MJ, 2008, MAR BIOTECHNOL, V10, P416, DOI 10.1007/s10126-007-9078-1; Davidson E. H., 2001, DEV EVOLUTION; Davis-Turak J, 2017, EXPERT REV MOL DIAGN, V17, P225, DOI 10.1080/14737159.2017.1282822; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Esbaugh AJ, 2016, SCI TOTAL ENVIRON, V543, P644, DOI 10.1016/j.scitotenv.2015.11.068; Evsikov AV, 2009, MOL REPROD DEV, V76, P805, DOI 10.1002/mrd.21038; Ferraresso S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-315; FRASER IDC, 1995, J BIOL CHEM, V270, P7836, DOI 10.1074/jbc.270.14.7836; Heintz RA, 2007, INTEGR ENVIRON ASSES, V3, P351, DOI 10.1002/ieam.5630030306; Holmqvist B, 2004, J EXP BIOL, V207, P923, DOI 10.1242/jeb.00845; HOUDE ED, 1994, ICES J MAR SCI, V51, P91, DOI 10.1006/jmsc.1994.1008; Incardona JP, 2004, TOXICOL APPL PHARM, V196, P191, DOI 10.1016/j.taap.2003.11.026; Irie N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1248; Jung JH, 2015, ENVIRON SCI TECHNOL, V49, P13639, DOI 10.1021/acs.est.5b03729; Khursigara AJ, 2016, SCIENCE OF THE TOTAL; KOBZIK L, 1994, NATURE, V372, P546, DOI 10.1038/372546a0; Krol E, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2473-0; Laine R, 1998, MOL PHARMACOL, V54, P305, DOI 10.1124/mol.54.2.305; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Mager EM, 2014, ENVIRON SCI TECHNOL, V48, P7053, DOI 10.1021/es501628k; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; MAREN S, 1993, P NATL ACAD SCI USA, V90, P9654, DOI 10.1073/pnas.90.20.9654; Mazurais D, 2011, CAN J ZOOL, V89, P599, DOI [10.1139/z11-036, 10.1139/Z11-036]; MITO SATOSHI, 1960, BULL JAPANESE SOC SCI FISH, V26, P223; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Muhling BA, 2012, MAR POLLUT BULL, V64, P679, DOI 10.1016/j.marpolbul.2012.01.034; Mungrue IN, 2004, J CELL SCI, V117, P2627, DOI 10.1242/jcs.01187; Pasparakis C, 2016, AQUAT TOXICOL, V181, P113, DOI 10.1016/j.aquatox.2016.10.022; Rodriguez-Zas SL, 2008, REPRODUCTION, V135, P129, DOI 10.1530/REP-07-0426; Rooker JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076080; Sarropoulou E, 2005, PHYSIOL GENOMICS, V23, P182, DOI 10.1152/physiolgenomics.00139.2005; Sears CE, 2003, CIRC RES, V92, pE52, DOI 10.1161/01.RES.0000064585.95749.6D; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; SIVILOTTI L, 1991, PROG NEUROBIOL, V36, P35, DOI 10.1016/0301-0082(91)90036-Z; Sorhus E, 2016, DEV BIOL, V411, P301, DOI 10.1016/j.ydbio.2016.02.012; Stieglitz JD, 2017, AQUACULTURE, V479, P1, DOI 10.1016/j.aquaculture.2017.05.006; Stieglitz JD, 2012, AQUAC RES, V43, P1557, DOI 10.1111/j.1365-2109.2011.02961.x; Sweet LE, 2016, ENVIRONMENTAL TOXICO; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vesterlund L, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-30; Willard SS, 2013, INT J BIOL SCI, V9, P948, DOI 10.7150/ijbs.6426; Xu EG, 2016, ENVIRON SCI TECHNOL, V50, P7842, DOI 10.1021/acs.est.6b02205; Xu P, 2011, MAR BIOTECHNOL, V13, P215, DOI 10.1007/s10126-010-9283-1; Yadetie F, 2013, AQUAT TOXICOL, V126, P314, DOI 10.1016/j.aquatox.2012.09.013	56	13	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180454	10.1371/journal.pone.0180454	http://dx.doi.org/10.1371/journal.pone.0180454			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692652	Green Published, gold, Green Submitted			2022-12-26	WOS:000405544800042
J	Yoon, H; Walters, G; Paulsen, AR; Scarisbrick, IA				Yoon, Hyesook; Walters, Grant; Paulsen, Alex R.; Scarisbrick, Isobel A.			Astrocyte heterogeneity across the brain and spinal cord occurs developmentally, in adulthood and in response to demyelination	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; REACTIVE ASTROCYTES; DIFFERENTIAL EXPRESSION; THROMBIN RECEPTOR; GFAP; OLIGODENDROCYTES; ASTROGLIOSIS; RECOVERY; MICE; GLIA	Astrocytes have emerged as essential regulators of function and response to injury in the brain and spinal cord, yet very little is known about regional differences that exist. Here we compare the expression of key astroglial markers (glial fibrillary acidic protein (GFAP) and Aldehyde Dehydrogenase-1 Family Member L1 (ALDH1L1)) across these disparate poles of the neuraxis, tracking their expression developmentally and in the context of demyelination. In addition, we document changes in the astrocyte regulatory cytokine interleukin 6 (IL-6), and its signaling partner signal transducer and activator of transcription 3 (STAT3), in vivo and in vitro. Results demonstrate that GFAP expression is higher in the developing and adult spinal cord relative to brain. Comparisons between GFAP and ALDH1L1 expression suggest elevations in spinal cord GFAP during the early postnatal period reflect an accelerated appearance of astrocytes, while elevations in adulthood reflect higher expression by individual astrocytes. Notably, increases in spinal cord compared to whole brain GFAP were paralleled by higher levels of IL-6 and STAT3. Equivalent elevations in GFAP, GFAP/ALDH1L1 ratios, and in IL-6, were observed in primary astrocyte cultures derived from spinal cord compared to cortex. Also, higher levels of GFAP were observed in the spinal cord compared to the brain after focal demyelinating injury. Altogether, these studies point to key differences in astrocyte abundance and the expression of GFAP and IL-6 across the brain and spinal cord that are positioned to influence regional specialization developmentally and responses occurring in the context of injury and disease.	[Yoon, Hyesook; Walters, Grant; Paulsen, Alex R.; Scarisbrick, Isobel A.] Mayo Clin, Dept Phys Med & Rehabil, Rehabil Med Res Ctr, Rochester, MN 55905 USA; [Yoon, Hyesook; Walters, Grant; Paulsen, Alex R.; Scarisbrick, Isobel A.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Scarisbrick, Isobel A.] Mayo Clin, Neurobiol Dis Program, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Scarisbrick, IA (corresponding author), Mayo Clin, Dept Phys Med & Rehabil, Rehabil Med Res Ctr, Rochester, MN 55905 USA.; Scarisbrick, IA (corresponding author), Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA.; Scarisbrick, IA (corresponding author), Mayo Clin, Neurobiol Dis Program, Rochester, MN 55905 USA.	Scarisbrick.Isobel@mayo.edu		Walters, Grant/0000-0001-5081-3104	National Institutes of Health, National Multiple Sclerosis Society [R01NS052741, RG4958]; Mayo Clinic Rehabilitation Medicine Research Center (IAS); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052741] Funding Source: NIH RePORTER	National Institutes of Health, National Multiple Sclerosis Society; Mayo Clinic Rehabilitation Medicine Research Center (IAS); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Studies were supported by the National Institutes of Health (https://www.nih.gov) R01NS052741 (IAS), RG4958 (IAS) from the National Multiple Sclerosis Society (http://www. nationalmssociety.org), and the Mayo Clinic Rehabilitation Medicine Research Center (IAS)	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Bachoo RM, 2004, P NATL ACAD SCI USA, V101, P8384, DOI 10.1073/pnas.0402140101; Bayraktar OA, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020362; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Brunello AG, 2000, AM J PATHOL, V157, P1485, DOI 10.1016/S0002-9440(10)64787-6; Bugiani M, 2011, J NEUROPATH EXP NEUR, V70, P69, DOI 10.1097/NEN.0b013e318203ae74; Burda JE, 2013, GLIA, V61, P1456, DOI 10.1002/glia.22534; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Butt AM, 2006, J CELL MOL MED, V10, P33, DOI 10.1111/j.1582-4934.2006.tb00289.x; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Constantinescu CS, 2005, J NEUROCHEM, V95, P331, DOI 10.1111/j.1471-4159.2005.03368.x; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Drogemuller K, 2008, J IMMUNOL, V181, P2683, DOI 10.4049/jimmunol.181.4.2683; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Fulmer CG, 2014, J NEUROSCI, V34, P8186, DOI 10.1523/JNEUROSCI.4267-13.2014; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; Haas B, 2006, CEREB CORTEX, V16, P237, DOI 10.1093/cercor/bhi101; Hammond TR, 2014, NEURON, V81, P588, DOI 10.1016/j.neuron.2013.11.015; HARIRI RJ, 1994, BRAIN RES, V636, P139, DOI 10.1016/0006-8993(94)90188-0; Haroon F, 2011, J IMMUNOL, V186, P6521, DOI 10.4049/jimmunol.1001135; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hochstim C, 2008, CELL, V133, P510, DOI 10.1016/j.cell.2008.02.046; Iwama S, 2011, GLIA, V59, P452, DOI 10.1002/glia.21114; Kim S, 2012, BRAIN PATHOL, V22, P41, DOI 10.1111/j.1750-3639.2011.00501.x; Klein MA, 1997, GLIA, V19, P227, DOI 10.1002/(SICI)1098-1136(199703)19:3<227::AID-GLIA5>3.0.CO;2-W; LeComte MD, 2015, P NATL ACAD SCI USA, V112, P8726, DOI 10.1073/pnas.1501029112; Levine J, 2016, GLIA, V64, P668, DOI 10.1002/glia.22953; Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4; Liu ZW, 2014, GLIA, V62, P2022, DOI 10.1002/glia.22723; Lundgaard I, 2014, NEUROSCIENCE, V276, P161, DOI 10.1016/j.neuroscience.2013.10.050; Marshall CAG, 2003, GLIA, V43, P52, DOI 10.1002/glia.10213; Masahira N, 2006, DEV BIOL, V293, P358, DOI 10.1016/j.ydbio.2006.02.029; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; Messing A, 1998, AM J PATHOL, V152, P391; Messing A, 2012, J NEUROSCI, V32, P5017, DOI 10.1523/JNEUROSCI.5384-11.2012; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Ming XT, 2013, J NEUROSCI, V33, P12528, DOI 10.1523/JNEUROSCI.0536-13.2013; Molofsky AV, 2013, GLIA, V61, P1518, DOI 10.1002/glia.22538; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nagy JI, 2000, BRAIN RES REV, V32, P29, DOI 10.1016/S0165-0173(99)00066-1; Nash B, 2011, J NEUROSCI, V31, P13028, DOI 10.1523/JNEUROSCI.1449-11.2011; Nawashiro H, 1998, NEUROREPORT, V9, P1691, DOI 10.1097/00001756-199806010-00004; Neymeyer V, 1997, BRAIN RES, V766, P195, DOI 10.1016/S0006-8993(97)00528-3; Oberheim NA, 2006, TRENDS NEUROSCI, V29, P547, DOI 10.1016/j.tins.2006.08.004; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Ogata K, 2002, NEUROSCIENCE, V113, P221, DOI 10.1016/S0306-4522(02)00041-6; Okada S, 2004, J NEUROSCI RES, V76, P265, DOI 10.1002/jnr.20044; Olsen JV, 2007, BRAIN RES, V1134, P95, DOI 10.1016/j.brainres.2006.11.082; Ono K, 2008, DEV BIOL, V320, P456, DOI 10.1016/j.ydbio.2008.06.001; Orthmann-Murphy JL, 2007, MOL CELL NEUROSCI, V34, P629, DOI 10.1016/j.mcn.2007.01.010; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Petzold GC, 2011, NEURON, V71, P782, DOI 10.1016/j.neuron.2011.08.009; Poopalasundaram S, 2000, GLIA, V30, P362, DOI 10.1002/(SICI)1098-1136(200006)30:4<362::AID-GLIA50>3.0.CO;2-4; Radulovic M, 2016, NEUROBIOL DIS, V93, P226, DOI 10.1016/j.nbd.2016.04.010; Radulovic M, 2015, NEUROBIOL DIS, V83, P75, DOI 10.1016/j.nbd.2015.08.021; Regan MR, 2007, J NEUROSCI, V27, P6607, DOI 10.1523/JNEUROSCI.0790-07.2007; Ridder MC, 2011, BRAIN, V134, P3342, DOI 10.1093/brain/awr255; Scarisbrick IA, 1999, J NEUROSCI, V19, P7757; Scarisbrick IA, 2012, BIOL CHEM, V393, P355, DOI 10.1515/hsz-2011-0241; Skripuletz T, 2013, BRAIN, V136, P147, DOI 10.1093/brain/aws262; Sofroniew MV, 2014, NEUROSCIENTIST, V20, P160, DOI 10.1177/1073858413504466; Su ZD, 2011, J NEUROTRAUM, V28, P1089, DOI 10.1089/neu.2010.1597; Sullivan SM, 2007, J BIOL CHEM, V282, P29414, DOI 10.1074/jbc.M704152200; Thrane VR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02582; Tong XP, 2014, NAT NEUROSCI, V17, P694, DOI 10.1038/nn.3691; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Verkhratsky A, 2014, BIOCHEM SOC T, V42, P1291, DOI 10.1042/BST20140107; Wang N, 2014, NEUROPHARMACOLOGY, V79, P282, DOI 10.1016/j.neuropharm.2013.12.004; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Wasseff SK, 2011, NEUROBIOL DIS, V42, P506, DOI 10.1016/j.nbd.2011.03.003; WU E, 1992, LAB INVEST, V67, P88; Yeh TH, 2009, MICROARRAY ANAL REVE, P57; Yoon H, 2015, GLIA, V63, P846, DOI 10.1002/glia.22788; Yoon H, 2013, J NEUROCHEM, V127, P283, DOI 10.1111/jnc.12293; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005; Zhou M, 2000, MOL BRAIN RES, V76, P121, DOI 10.1016/S0169-328X(99)00341-1; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	83	49	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180697	10.1371/journal.pone.0180697	http://dx.doi.org/10.1371/journal.pone.0180697			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700615	gold, Green Published, Green Submitted			2022-12-26	WOS:000405544800067
J	Chen, YZ; Li, JL; Ju, WM; Ruan, HH; Qin, ZH; Huang, YY; Jeelani, N; Padarian, JA; Propastin, P				Chen, Yizhao; Li, Jianlong; Ju, Weimin; Ruan, Honghua; Qin, Zhihao; Huang, Yiye; Jeelani, Nasreen; Padarian, Jose A.; Propastin, Pavel			Quantitative assessments of water-use efficiency in Temperate Eurasian Steppe along an aridity gradient	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; CLIMATE-CHANGE; CARBON SEQUESTRATION; TERRESTRIAL ECOSYSTEMS; GRASSLAND ECOSYSTEMS; VEGETATION GROWTH; INNER-MONGOLIA; PROCESS MODEL; LAND-SURFACE; SOIL CARBON	Water-use efficiency (WUE), defined as the ratio of net primary productivity (NPP) to evapotranspiration (ET), is an important indicator to represent the trade-off pattern between vegetation productivity and water consumption. Its dynamics under climate change are important to ecohydrology and ecosystem management, especially in the drylands. In this study, we modified and used a late version of Boreal Ecosystem Productivity Simulator (BEPS), to quantify the WUE in the typical dryland ecosystems, Temperate Eurasian Steppe (TES). The Aridity Index (AI) was used to specify the terrestrial water availability condition. The regional results showed that during the period of 1999-2008, the WUE has a clear decreasing trend in the spatial distribution from arid to humid areas. The highest annual average WUE was in dry and semi-humid sub-region (DSH) with 0.88 gC mm (-1) and the lowest was in arid sub-region (AR) with 0.22 gC mm (-1). A two-stage pattern of WUE was found in TES. That is, WUE would enhance with lower aridity stress, but decline under the humid environment. Over 65% of the region exhibited increasing WUE. This enhancement, however, could not indicate that the grasslands were getting better because the NPP even slightly decreased. It was mainly attributed to the reduction of ET over 70% of the region, which is closely related to the rainfall decrease. The results also suggested a similar negative spatial correlation between the WUE and the mean annual precipitation (MAP) at the driest and the most humid ends. This regional pattern reflected the different roles of water in regulating the terrestrial ecosystems under different aridity levels. This study could facilitate the understanding of the interactions between terrestrial carbon and water cycles, and thus contribute to a sustainable management of nature resources in the dryland ecosystems.	[Chen, Yizhao; Ruan, Honghua] Nanjing Forestry Univ, Coll Biol & Environm, Joint Innovat Ctr Modern Forestry Studies, Nanjing, Jiangsu, Peoples R China; [Chen, Yizhao; Li, Jianlong] Nanjing Univ, Sch Life Sci, Nanjing, Jiangsu, Peoples R China; [Ju, Weimin] Nanjing Univ, Int Inst Earth Syst Sci, Nanjing, Jiangsu, Peoples R China; [Qin, Zhihao] Chinese Acad Agr Sci, Inst Agroresources & Reg Planning, Beijing, Peoples R China; [Huang, Yiye] Nanjing Univ, Sch Atmospher Sci, Nanjing, Jiangsu, Peoples R China; [Jeelani, Nasreen] Nanjing Univ, Dept Ecol, Nanjing, Jiangsu, Peoples R China; [Padarian, Jose A.] Univ Sydney, Fac Agr & Environm, Sydney, NSW, Australia; [Propastin, Pavel] Georg August Univ Gottingen, Inst Geog, Gottingen, Germany; [Propastin, Pavel] Georg August Univ Gottingen, Busgen Inst, Dept Bioclimatol, Gottingen, Germany	Nanjing Forestry University; Nanjing University; Nanjing University; Chinese Academy of Agricultural Sciences; Nanjing University; Nanjing University; University of Sydney; University of Gottingen; University of Gottingen	Li, JL (corresponding author), Nanjing Univ, Sch Life Sci, Nanjing, Jiangsu, Peoples R China.	jianlongli@gmail.com	Padarian, José/AAZ-4340-2020	Jeelani, Nasreen/0000-0002-3887-7321	National Key Research and Development Program of China for Ecological Restoration and Conservation in Typical Ecosystems [2016YFC0500202]; National Key Research and Development Program of China for Global Change and Adaptation [2016YFA0600202]; APN Global Change Fund Project [ARCP2013-16NMY-Li]; National Natural Science Foundation of China [41271361]; National Key Research Program of China [2016YFC0500202]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Key Research and Development Program of China for Ecological Restoration and Conservation in Typical Ecosystems; National Key Research and Development Program of China for Global Change and Adaptation; APN Global Change Fund Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research Program of China; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Key Research and Development Program of China for Ecological Restoration and Conservation in Typical Ecosystems (2016YFC0500202); National Key Research and Development Program of China for Global Change and Adaptation (2016YFA0600202); APN Global Change Fund Project (No. ARCP2013-16NMY-Li); the National Natural Science Foundation of China (No. 41271361); the National Key Research Program of China (2016YFC0500202); and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULLA S., 2012, J ARID LAND, V1; Arora VK, 2003, AGR FOREST METEOROL, V118, P21, DOI 10.1016/S0168-1923(03)00073-X; Austin AT, 1998, OECOLOGIA, V113, P519, DOI 10.1007/s004420050405; Bai YY, 2010, ACTA OECOL, V36, P393, DOI 10.1016/j.actao.2010.03.007; Barger NN, 2004, J RANGE MANAGE, V57, P613, DOI 10.2307/4004017; Beer C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003233; Belelli Marchesini L, 2007, BIOGEOSCI DISCUSS, V4, P165; BJORKMAN O, 1984, PLANTA, V161, P490, DOI 10.1007/BF00407081; BONAN GB, 1995, J GEOPHYS RES-ATMOS, V100, P2817, DOI 10.1029/94JD02961; Campos GEP, 2013, NATURE, V494, P349, DOI 10.1038/nature11836; Chen BZ, 2007, J HYDROMETEOROL, V8, P123, DOI 10.1175/JHM566.1; Chen FH, 2011, SCI CHINA EARTH SCI, V54, P1812, DOI 10.1007/s11430-011-4333-8; Chen JM, 1999, ECOL MODEL, V124, P99, DOI 10.1016/S0304-3800(99)00156-8; Chen YZ, 2016, RANGELAND ECOL MANAG, V69, P84, DOI 10.1016/j.rama.2015.09.003; Craine JM, 2013, NAT CLIM CHANGE, V3, P63, DOI [10.1038/NCLIMATE1634, 10.1038/nclimate1634]; Dai AG, 2011, WIRES CLIM CHANGE, V2, P45, DOI 10.1002/wcc.81; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; Deng XP, 2006, AGR WATER MANAGE, V80, P23, DOI 10.1016/j.agwat.2005.07.021; Donohue RJ, 2013, GEOPHYS RES LETT, V40, P3031, DOI 10.1002/grl.50563; Fahu Chen, 2009, Frontiers of Earth Science in China, V3, P42, DOI 10.1007/s11707-009-0013-9; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Feng X, 2007, J ENVIRON MANAGE, V85, P563, DOI 10.1016/j.jenvman.2006.09.021; Flexas J, 2006, PHYSIOL PLANTARUM, V127, P343, DOI 10.1111/j.1399-3054.2006.00621.x; Gao ZQ, 2008, CHINESE SCI BULL, V53, P434, DOI 10.1007/s11434-008-0097-8; He C, 2005, J ARID ENVIRON, V63, P814, DOI 10.1016/j.jaridenv.2005.03.028; Holzel N., 2002, Journal for Nature Conservation, V10, P75, DOI 10.1078/1617-1381-00009; Hu ZM, 2008, GLOBAL CHANGE BIOL, V14, P1609, DOI 10.1111/j.1365-2486.2008.01582.x; Hulme M, 1996, GEOPHYS RES LETT, V23, P61, DOI 10.1029/95GL03586; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Jassal RS, 2009, AGR FOREST METEOROL, V149, P1168, DOI 10.1016/j.agrformet.2009.02.004; Ju WM, 2007, J ENVIRON MANAGE, V85, P538, DOI 10.1016/j.jenvman.2006.04.028; Ju WM, 2006, AGR FOREST METEOROL, V140, P136, DOI 10.1016/j.agrformet.2006.08.008; Le Houerou HN, 2001, J ARID ENVIRON, V48, P103, DOI 10.1006/jare.2000.0679; LEHOUEROU HN, 1984, J ARID ENVIRON, V7, P213; LEHOUEROU HN, 1977, J RANGE MANAGE, V30, P181; Li CF, 2015, GLOBAL CHANGE BIOL, V21, P1951, DOI 10.1111/gcb.12846; Li CF, 2013, ECOL MODEL, V267, P148, DOI 10.1016/j.ecolmodel.2013.06.007; Li SY, 2012, REG ENVIRON CHANGE, V12, P461, DOI 10.1007/s10113-011-0264-3; LIANG YM, 1989, OECOLOGIA, V80, P148, DOI 10.1007/BF00380143; Lioubimtseva E, 2005, J ARID ENVIRON, V62, P285, DOI 10.1016/j.jaridenv.2004.11.005; Lioubimtseva E, 2009, J ARID ENVIRON, V73, P963, DOI 10.1016/j.jaridenv.2009.04.022; Liu J, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001680; Liu J, 1997, REMOTE SENS ENVIRON, V62, P158, DOI 10.1016/S0034-4257(97)00089-8; Liu Y, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002084; Liu Y, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/258514; Lu XL, 2010, REMOTE SENS ENVIRON, V114, P1924, DOI 10.1016/j.rse.2010.04.001; Ma ZG, 2007, SCI CHINA SER D, V50, P776, DOI 10.1007/s11430-007-0036-6; Maestre FT, 2012, PHILOS T R SOC B, V367, P3062, DOI 10.1098/rstb.2011.0323; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Matsushita B, 2002, REMOTE SENS ENVIRON, V81, P58, DOI 10.1016/S0034-4257(01)00331-5; McDowell NG, 2011, TRENDS ECOL EVOL, V26, P523, DOI 10.1016/j.tree.2011.06.003; [孟祥新 MENG Xiangxin], 2009, [气候与环境研究, Climatic and Environmental Research], V14, P352; Mitchell SW, 2001, ECOL MODEL, V139, P101, DOI 10.1016/S0304-3800(01)00229-0; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Mohammat A, 2013, AGR FOREST METEOROL, V178, P21, DOI 10.1016/j.agrformet.2012.09.014; MONTEITH JL, 1981, Q J ROY METEOR SOC, V107, P1, DOI 10.1256/smsqj.45101; Mu Q, 2005, J GEOPHYS RES BIOGEO, V113; Mu SJ, 2013, GLOBAL PLANET CHANGE, V108, P29, DOI 10.1016/j.gloplacha.2013.06.007; Niu SL, 2008, NEW PHYTOL, V177, P209, DOI 10.1111/j.1469-8137.2007.02237.x; Niu SL, 2011, GLOBAL CHANGE BIOL, V17, P1073, DOI 10.1111/j.1365-2486.2010.02280.x; Oki T, 2006, SCIENCE, V313, P1068, DOI 10.1126/science.1128845; Partel M, 2007, J ECOL, V95, P574, DOI 10.1111/j.1365-2745.2007.01230.x; Peng SS, 2009, SOIL BIOL BIOCHEM, V41, P1008, DOI 10.1016/j.soilbio.2008.10.023; Piao SL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028205; Pomfret R, 2006, CENT ASIA RES FORUM, P77; POST WM, 1990, AM SCI, V78, P310; Prieto Calvo P, 2008, PHENOLOGY BIOMASS CO; Propastin P, 2012, GISCI REMOTE SENS, V49, P538, DOI 10.2747/1548-1603.49.4.538; Propastin PA, 2012, INT J REMOTE SENS, V33, P1465, DOI 10.1080/01431161.2011.577105; Qi JG, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/015202; RIND D, 1990, J GEOPHYS RES-ATMOS, V95, P9983, DOI 10.1029/JD095iD07p09983; Saunders IR, 1997, CAG CAN G, P222; Schaffrath D, 2013, J ARID ENVIRON, V88, P184, DOI 10.1016/j.jaridenv.2012.07.021; Schulze E-D, 1982, PHYSL PLANT ECOLOGY, P615; Schwalm CR, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001229; Sitch S, 2015, BIOGEOSCIENCES, V12, P653, DOI 10.5194/bg-12-653-2015; Sui XH, 2013, CLIMATIC CHANGE, V117, P259, DOI 10.1007/s10584-012-0533-2; Suzuki Yukio, 2013, MONGOLIAN ECOSYSTEM, P269, DOI DOI 10.1007/978-4-431-54052-6_20; Tian YH, 2002, REMOTE SENS ENVIRON, V83, P414, DOI 10.1016/S0034-4257(02)00047-0; Trenberth KE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022760; Tsialtas JT, 2001, FUNCT ECOL, V15, P605, DOI 10.1046/j.0269-8463.2001.00555.x; Wang XH, 2007, LAND USE POLICY, V24, P417, DOI 10.1016/j.landusepol.2006.05.005; Wesche K., 2012, EURASIAN STEPPES ECO, P3, DOI [10.1007/978-94-007-3886-7_1, DOI 10.1007/978-94-007-3886-7_]; Wesche K, 2005, ERFORSCH BIOL RESS M, V9, P133; Whitehead D. C., 2000, Nutrient elements in grassland: soil-plant-animal relationships, DOI 10.1079/9780851994376.0000; XING Xianxu, 2010, GEOGR SCI, V20, P193; Xu ZZ, 2006, PLANTA, V224, P1080, DOI 10.1007/s00425-006-0281-5; Yang YT, 2016, J GEOPHYS RES-BIOGEO, V121, P2125, DOI 10.1002/2016JG003475; Yang YT, 2016, SCI REP-UK, V6, DOI 10.1038/srep23284; Yang YT, 2015, GEOPHYS RES LETT, V42, P9825, DOI 10.1002/2015GL066835; Yu GR, 2008, NEW PHYTOL, V177, P927, DOI 10.1111/j.1469-8137.2007.02316.x; Yusupov SU, 2003, INTERACTION LIVESTOC; Zhang C, 2013, ECOL MODEL, V267, P158, DOI 10.1016/j.ecolmodel.2013.06.008; Zhang FM, 2014, THEOR APPL CLIMATOL, V116, P359, DOI 10.1007/s00704-013-0949-2; Zhang GG, 2011, GLOBAL CHANGE BIOL, V17, P377, DOI 10.1111/j.1365-2486.2010.02237.x; Zhang SW Q., 2013, AGR SCI TECHNOLOGY, V14, P7; Zhang Y., 2012, CHINESE SCI BULL, V57, P11, DOI DOI 10.1360/972011-; [张彦敏 Zhang Yanmin], 2012, [生态学报, Acta Ecologica Sinica], V32, P5907; Zhou Y, 2007, J ENVIRON MANAGE, V85, P574, DOI 10.1016/j.jenvman.2006.04.024	99	19	25	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179875	10.1371/journal.pone.0179875	http://dx.doi.org/10.1371/journal.pone.0179875			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686667	Green Submitted, Green Published, gold			2022-12-26	WOS:000405464100025
J	Hammer, MF; Ishii, A; Johnstone, L; Tchourbanov, A; Lau, B; Sprissler, R; Hallmark, B; Zhang, M; Zhou, J; Watkins, J; Hirose, S				Hammer, Michael F.; Ishii, Atsushi; Johnstone, Laurel; Tchourbanov, Alexander; Lau, Branden; Sprissler, Ryan; Hallmark, Brian; Zhang, Miao; Zhou, Jin; Watkins, Joseph; Hirose, Shinichi			Rare variants of small effect size in neuronal excitability genes influence clinical outcome in Japanese cases of SCN1A truncation-positive Dravet syndrome	PLOS ONE			English	Article							FEBRILE SEIZURES PLUS; SODIUM-CHANNEL; GLUCOCORTICOID-RECEPTOR; GENERALIZED EPILEPSY; MOUSE MODEL; MODIFIER; STRESS; MUTATION; POLYMORPHISMS; LOCUS	Dravet syndrome (DS) is a rare, devastating form of childhood epilepsy that is often associated with mutations in the voltage-gated sodium channel gene, SCN1A. There is considerable variability in expressivity within families, as well as among individuals carrying the same primary mutation, suggesting that clinical outcome is modulated by variants at other genes. To identify modifier gene variants that contribute to clinical outcome, we sequenced the exomes of 22 individuals at both ends of a phenotype distribution (i. e., mild and severe cognitive condition). We controlled for variation associated with different mutation types by limiting inclusion to individuals with a de novo truncation mutation resulting in SCN1A haploinsufficiency. We performed tests aimed at identifying 1) single common variants that are enriched in either phenotypic group, 2) sets of common or rare variants aggregated in and around genes associated with clinical outcome, and 3) rare variants in 237 candidate genes associated with neuronal excitability. While our power to identify enrichment of a common variant in either phenotypic group is limited as a result of the rarity of mild phenotypes in individuals with SCN1A truncation variants, our top candidates did not map to functional regions of genes, or in genes that are known to be associated with neurological pathways. In contrast, we found a statistically-significant excess of rare variants predicted to be damaging and of small effect size in genes associated with neuronal excitability in severely affected individuals. A KCNQ2 variant previously associated with benign neonatal seizures is present in 3 of 12 individuals in the severe category. To compare our results with the healthy population, we performed a similar analysis on whole exome sequencing data from 70 Japanese individuals in the 1000 genomes project. Interestingly, the frequency of rare damaging variants in the same set of neuronal excitability genes in healthy individuals is nearly as high as in severely affected individuals. Rather than a single common gene/variant modifying clinical outcome in SCN1A-related epilepsies, our results point to the cumulative effect of rare variants with little to no measurable phenotypic effect (i.e., typical genetic background) unless present in combination with a disease-causing truncation mutation in SCN1A.	[Hammer, Michael F.; Ishii, Atsushi; Johnstone, Laurel; Tchourbanov, Alexander; Lau, Branden; Sprissler, Ryan] Univ Arizona, ARL Div Biotechnol, Tucson, AZ 85721 USA; [Hammer, Michael F.] Univ Arizona, Neurol Dept, Tucson, AZ 85721 USA; [Ishii, Atsushi; Hirose, Shinichi] Fukuoka Univ, Dept Pediat, Sch Med, Fukuoka, Japan; [Ishii, Atsushi; Hirose, Shinichi] Fukuoka Univ, Cent Res Inst Mol Pathogeneses Epilepsy, Fukuoka, Japan; [Hallmark, Brian; Zhang, Miao] Univ Arizona, Interdisciplinary Program Stat, Tucson, AZ USA; [Zhou, Jin] Univ Arizona, Coll Publ Hlth, Tucson, AZ USA; [Watkins, Joseph] Univ Arizona, Dept Math, Tucson, AZ 85721 USA	University of Arizona; University of Arizona; Fukuoka University; Fukuoka University; University of Arizona; University of Arizona; University of Arizona	Hammer, MF (corresponding author), Univ Arizona, ARL Div Biotechnol, Tucson, AZ 85721 USA.; Hammer, MF (corresponding author), Univ Arizona, Neurol Dept, Tucson, AZ 85721 USA.; Hirose, S (corresponding author), Fukuoka Univ, Dept Pediat, Sch Med, Fukuoka, Japan.; Hirose, S (corresponding author), Fukuoka Univ, Cent Res Inst Mol Pathogeneses Epilepsy, Fukuoka, Japan.	mfh@email.arizona.edu; hirose@fukuoka-u.ac.jp		HIROSE, Shinichi/0000-0001-6796-3790; Johnstone, Laurel/0000-0001-7335-3972; Hammer, Michael/0000-0003-0172-429X	Dravet Syndrome Foundation; Grants-in-Aid for Scientific Research [15H02548] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK106116] Funding Source: NIH RePORTER	Dravet Syndrome Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Dravet Syndrome Foundation (www.dravetfoundation. org).	Abou-Khalil B, 2001, NEUROLOGY, V57, P2265, DOI 10.1212/WNL.57.12.2265; Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Aschard H, 2015, AM J HUM GENET, V96, P329, DOI 10.1016/j.ajhg.2014.12.021; Bechi G, 2012, EPILEPSIA, V53, P87, DOI 10.1111/j.1528-1167.2011.03346.x; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Bortsov AV, 2013, PAIN, V154, P1419, DOI 10.1016/j.pain.2013.04.037; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Emond MJ, 2012, NAT GENET, V44, P886, DOI 10.1038/ng.2344; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Gaily E, 2013, EPILEPSIA, V54, P1577, DOI 10.1111/epi.12256; Genin E, 2008, HUM GENET, V124, P357, DOI 10.1007/s00439-008-0560-2; Goldberg-Stern H, 2014, J CHILD NEUROL, V29, P221, DOI 10.1177/0883073813509016; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Guerrini R, 2010, EPILEPSIA, V51, P2474, DOI 10.1111/j.1528-1167.2010.02790.x; Hawkins NA, 2012, GENES BRAIN BEHAV, V11, P452, DOI 10.1111/j.1601-183X.2012.00790.x; Hawkins NA, 2016, EPILEPSY RES, V119, P20, DOI 10.1016/j.eplepsyres.2015.11.016; Hawkins NA, 2011, NEUROBIOL DIS, V41, P655, DOI 10.1016/j.nbd.2010.11.016; Henn BM, 2015, NAT REV GENET, V16, P333, DOI 10.1038/nrg3931; Ishii A, 2016, EPILEPSIA; Kearney JA, 2006, HUM MOL GENET, V15, P1043, DOI 10.1093/hmg/ddl019; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Klassen T, 2011, CELL, V145, P1036, DOI 10.1016/j.cell.2011.05.025; Lee IC, 2016, J FORMOS MED ASS; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Maguire J, 2013, EPILEPSY BEHAV, V26, P352, DOI 10.1016/j.yebeh.2012.09.040; Maiaru M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aab3376; Martin MS, 2007, HUM MOL GENET, V16, P2892, DOI 10.1093/hmg/ddm248; Meng H. B., 2015, J HARBIN ENG U, V36, P1, DOI DOI 10.1002/HUMU.22782; Miller AR, 2014, GENES BRAIN BEHAV, V13, P163, DOI 10.1111/gbb.12099; Moulard B, 1999, AM J HUM GENET, V65, P1396, DOI 10.1086/302621; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ohmori I, 2013, NEUROBIOL DIS, V50, P209, DOI 10.1016/j.nbd.2012.10.016; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rubinstein M, 2015, NEUROBIOL DIS, V73, P106, DOI 10.1016/j.nbd.2014.09.017; Sawyer NT, 2014, PSYCHONEUROENDOCRINO, V39, P225, DOI 10.1016/j.psyneuen.2013.09.018; Sharma S, 2016, ANNU REV PSYCHOL, V67, P239, DOI 10.1146/annurev-psych-122414-033408; Singh NA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000649; Stephens MAC, 2016, PSYCHONEUROENDOCRINO, V66, P47, DOI 10.1016/j.psyneuen.2015.12.021; Suls A, 2010, NEUROLOGY, V75, P72, DOI 10.1212/WNL.0b013e3181e62088; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029	44	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180485	10.1371/journal.pone.0180485	http://dx.doi.org/10.1371/journal.pone.0180485			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686619	Green Published, Green Submitted, gold			2022-12-26	WOS:000405464100067
J	Hollmann, AK; Dammann, I; Wemheuer, WM; Wemheuer, WE; Chilla, A; Tipold, A; Schulz-Schaeffer, WJ; Beck, J; Schutz, E; Brenig, B				Hollmann, Anne K.; Dammann, Insa; Wemheuer, Wiebke M.; Wemheuer, Wilhelm E.; Chilla, Almuth; Tipold, Andrea; Schulz-Schaeffer, Walter J.; Beck, Julia; Schuetz, Ekkehard; Brenig, Bertram			Morgagnian cataract resulting from a naturally occurring nonsense mutation elucidates a role of CPAMD8 in mammalian lens development	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PROTEOMIC ANALYSIS; AQUEOUS-HUMOR; CONGENITAL CATARACTS; HUMAN IRIS; GENOME; ASSOCIATION; EXPRESSION; HYBRIDIZATION; PREDICTION	To investigate the genetic basis of hereditary lens opacities we analyzed 31 cases of bilateral congenital cataract in Red Holstein Friesian cattle. A genome-wide association study revealed a significant association on bovine chromosome 7 at positions 6,166,179 and 12,429,691. Whole genome re-sequencing of one case and four relatives showed a nonsense mutation (g.5995966C>T) in the PZP-like, alpha-2-macroglobulin domain containing 8 (CPAMD8) gene leading to a premature stop codon (CPAMD8 p. Gln74*) associated with cataract development in cattle. With immunohistochemistry we confirmed a physiological expression of CPAMD8 in the ciliary body epithelium of the eye in unaffected cattle, while the protein was not detectable in the ciliary body of cattle with cataracts. RNA expression of CPAMD8 was detected in healthy adult, fetal and cataractous lenses.	[Hollmann, Anne K.; Wemheuer, Wilhelm E.; Chilla, Almuth; Schuetz, Ekkehard; Brenig, Bertram] Univ Goettingen, Inst Vet Med, Gottingen, Germany; [Dammann, Insa] Univ Med Ctr Goettingen, Dept Neuropathol, Prion & Dementia Res Unit, Gottingen, Germany; [Wemheuer, Wiebke M.; Schulz-Schaeffer, Walter J.] Univ Saarland, Inst Neuropathol, Homburg, Germany; [Tipold, Andrea] Univ Vet Med Hannover, Dept Small Anim Med & Surg, Hannover, Germany; [Beck, Julia] Chronix Biomed, Gottingen, Germany	University of Gottingen; University of Gottingen; Saarland University; University of Veterinary Medicine Hannover, Foundation	Brenig, B (corresponding author), Univ Goettingen, Inst Vet Med, Gottingen, Germany.	bbrenig@gwdg.de		Brenig, Bertram/0000-0002-7635-9656; Jurgens-Wemheuer, Wiebke/0000-0002-1234-3321	German Research Foundation; Open Access Publication Funds of the University of Goettingen	German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the University of Goettingen	We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the University of Goettingen. The German Research Foundation and the Open Access Publication Funds of the University of Goettingen only cover the publication costs and did not have any additional role in the study design, data collection and analysis,decision to publish, or preparation of the manuscript.	Armstrong PB, 1999, DEV COMP IMMUNOL, V23, P375, DOI 10.1016/S0145-305X(99)00018-X; ASHTON N, 1977, VET REC, V100, P505, DOI 10.1136/vr.100.24.505; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bennett KL, 2011, J PROTEOMICS, V74, P151, DOI 10.1016/j.jprot.2010.10.002; BISTNER SI, 1970, PATHOL VET, V7, P275, DOI 10.1177/030098587000700306; BRUBAKER RF, 1991, INVEST OPHTH VIS SCI, V32, P3145; CARTER A. H., 1960, PROC NEW ZEALAND SOC ANIMAL PROD, V20, P108; Cheong SS, 2016, AM J HUM GENET, V99, P1338, DOI 10.1016/j.ajhg.2016.09.022; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chowdhury UR, 2010, INVEST OPHTH VIS SCI, V51, P4921, DOI 10.1167/iovs.10-5531; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; COGAN DG, 1962, EXP EYE RES, V1, P291, DOI 10.1016/S0014-4835(62)80013-X; CROOKSTON KP, 1994, J BIOL CHEM, V269, P1533; De Iongh RU, 2001, EXP EYE RES, V72, P649, DOI 10.1006/exer.2001.1001; de Longh RU, 2001, DEVELOPMENT, V128, P3995; De Maria A, 2017, INVEST OPHTH VIS SCI, V58, P573, DOI 10.1167/iovs.16-20866; Detlefson JA, 1920, AM NAT, V54, P277, DOI 10.1086/279759; Duckman R. H., 2006, VISUAL DEV DIAGNOSIS, P124; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; FREDDO TF, 1990, INVEST OPHTH VIS SCI, V31, P125; Garbe J., 2008, PEDIGRAPH SOFTWARE T; GELATT KN, 1971, J AM VET MED ASSOC, V159, P195; Goel R, 2013, CLIN PROTEOM, V10, DOI 10.1186/1559-0275-10-9; Graw J, 2003, NAT REV GENET, V4, P876, DOI 10.1038/nrg1202; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Gregory PW, 1943, J HERED, V34, P125, DOI 10.1093/oxfordjournals.jhered.a105263; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Hurley S, 2008, VET REC, V163, P579, DOI 10.1136/vr.163.19.579-b; Ji YH, 2015, CLIN BIOCHEM, V48, P1304, DOI 10.1016/j.clinbiochem.2015.08.006; Kenny EE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002559; Krump L, 2014, IRISH VET J, V67, DOI 10.1186/2046-0481-67-2; Kurien BT, 2011, METHODS MOL BIOL, V717, P55, DOI 10.1007/978-1-61779-024-9_3; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li ZF, 2004, GENOMICS, V83, P1083, DOI 10.1016/j.ygeno.2003.12.005; Lovicu FJ, 2002, BRIT J OPHTHALMOL, V86, P220, DOI 10.1136/bjo.86.2.220; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Murgiano L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110628; Murthy KR, 2016, OMICS, V20, P510, DOI 10.1089/omi.2016.0100; Murthy KR, 2015, OMICS, V19, P283, DOI 10.1089/omi.2015.0029; Murthy KR, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-29; Pascolini D, 2010, BR J OPHTHALMOL, V96, P614, DOI DOI 10.1136/BJ0PHTHALM0L-2011-300539; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; POTTS JD, 1995, DEV DYNAM, V203, P317, DOI 10.1002/aja.1002030304; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; SAUNDERS LZ, 1951, CORNELL VET, V41, P351; Schulz MW, 1996, INVEST OPHTH VIS SCI, V37, P1509; Schutz E, 1999, BIOTECHNIQUES, V27, P1218, DOI 10.2144/99276bc04; Skeie JM, 2014, JAMA OPHTHALMOL, V132, P1271, DOI 10.1001/jamaophthalmol.2014.2065; Sousounis K, 2014, REGENERATION, V1, P47, DOI 10.1002/reg2.25; To Chi-ho, 2002, Clin Exp Optom, V85, P335; von Ahsen N, 1999, CLIN CHEM, V45, P2094; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang PB, 2016, PROTEOMICS, V16, P1146, DOI 10.1002/pmic.201500188	56	12	12	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180665	10.1371/journal.pone.0180665	http://dx.doi.org/10.1371/journal.pone.0180665			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683140	Green Published, gold			2022-12-26	WOS:000405335200058
J	Langford, ST; Wiggins, CS; Santos, R; Hauser, M; Becker, JM; Ruggles, AE				Langford, Seth T.; Wiggins, Cody S.; Santos, Roque; Hauser, Melinda; Becker, Jeffrey M.; Ruggles, Arthur E.			Three-dimensional spatiotemporal tracking of fluorine-18 radiolabeled yeast cells via positron emission particle tracking	PLOS ONE			English	Article							PROGENITOR CELLS; PET	A method for Positron Emission Particle Tracking (PEPT) based on optical feature point identification techniques is demonstrated for use in low activity tracking experiments. A population of yeast cells of approximately 125,000 members is activated to roughly 55 Bq/cell by F-18 uptake. An in vitro particle tracking experiment is performed with nearly 20 of these cells after decay to 32 Bq/cell. These cells are successfully identified and tracked simultaneously in this experiment. This work extends the applicability of PEPT as a cell tracking method by allowing a number of cells to be tracked together, and demonstrating tracking for very low activity tracers.	[Langford, Seth T.; Santos, Roque; Ruggles, Arthur E.] Univ Tennessee, Dept Nucl Engn, Knoxville, TN 37996 USA; [Wiggins, Cody S.] Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA; [Santos, Roque] Escuela Politec Nacl, Dept Ciencias Nucl, Quito, Ecuador; [Hauser, Melinda; Becker, Jeffrey M.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; Escuela Politecnica Nacional Ecuador; University of Tennessee System; University of Tennessee Knoxville	Wiggins, CS (corresponding author), Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA.	cwiggin2@vols.utk.edu		Wiggins, Cody/0000-0001-8767-8866	National Nuclear Security Administration under Stewardship Science Academic Alliances [DE-NA0001983]; National Institutes of Health [GM112496]; Nuclear Energy University Programs; Integrated University Programs fellowship	National Nuclear Security Administration under Stewardship Science Academic Alliances(National Nuclear Security Administration); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nuclear Energy University Programs; Integrated University Programs fellowship	This work was supported by the National Nuclear Security Administration (https://nnsa.energy.gov/)under the Stewardship Science Academic Alliances award DE-NA0001983, awarded to AER, and National Institutes of Health (https://www.nih.gov/) grant GM112496, awarded to JMB. This materialis based on work supported under a Nuclear Energy University Programs (https://neup.inl.gov/) Integrated University Programs fellowship awarded to CSW. The National Nuclear Security Administration assisted in the data collection and analysis in that they provided funding explicitly for the acquisition of the PET scanner used in this research	Adonai N, 2002, P NATL ACAD SCI USA, V99, P3030, DOI 10.1073/pnas.052709599; Aicher A, 2003, CIRCULATION, V107, P2134, DOI 10.1161/01.CIR.0000062649.63838.C9; Bao Q, 2009, J NUCL MED, V50, P401, DOI 10.2967/jnumed.108.056374; Bickell M, 2012, NUCL INSTRUM METH A, V682, P36, DOI 10.1016/j.nima.2012.04.037; Chang YF, 2015, EXP FLUIDS, V56, DOI 10.1007/s00348-014-1875-5; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Doherty P W, 1978, Clin Nucl Med, V3, P108; Game JC, 2005, GENETICS, V169, P51, DOI 10.1534/genetics.104.028613; Goertzen AL, 2006, P IEEE NUCL SCI S 20; Hamerly G, 2003, P NEUR INF PROC SYST, V16; Heyn C, 2006, MAGN RESON MED, V56, P1001, DOI 10.1002/mrm.21029; Jan S, 2004, PHYS MED BIOL, V49, P4543, DOI 10.1088/0031-9155/49/19/007; Kircher MF, 2011, NAT REV CLIN ONCOL, V8, P677, DOI 10.1038/nrclinonc.2011.141; Langford S, 2016, P INT C NUCL ENG 24, P24; Langford S, 2016, NUCL ENG DES, V302, P81, DOI 10.1016/j.nucengdes.2016.01.017; Lee KS, 2015, IEEE T MED IMAGING, V34, P994, DOI 10.1109/TMI.2014.2373351; Lee S, 2013, MOL IMAGING, V12, DOI 10.2310/7290.2013.00058; Li SS, 2013, P NATL ACAD SCI USA, V110, P19018, DOI 10.1073/pnas.1310439110; Lu L, 2013, P IEEE NUCL SCI S ME; Ma B, 2005, NUCL MED BIOL, V32, P701, DOI 10.1016/j.nucmedbio.2005.04.018; MELDER RJ, 1994, J IMMUNOL METHODS, V175, P79, DOI 10.1016/0022-1759(94)90333-6; Morrison AJ, 2016, CHEM ENG SCI, V152, P186, DOI 10.1016/j.ces.2016.06.022; Ouyang Y, 2016, MOL IMAGING, V15, DOI 10.1177/1536012116646489; PARKER DJ, 1993, NUCL INSTRUM METH A, V326, P592, DOI 10.1016/0168-9002(93)90864-E; Patel N, 2017, EXP FLUIDS  IN PRESS; Perez-Mohedano R, 2015, CHEM ENG J, V259, P724, DOI 10.1016/j.cej.2014.08.033; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Shaw RF, 1978, United States patent, Patent No. [US 4224303 A, 4224303]; Tong Shan, 2010, Imaging Med, V2, P529, DOI 10.2217/iim.10.49; Wiggins C, 2017, FEATURE POINT IDENTI, V843, P22; Wiggins C, 2016, NUCL INSTRUM METH A, V811, P18, DOI 10.1016/j.nima.2015.11.136; Yang Z, 2006, NUCL INSTRUM METH A, V564, P332, DOI 10.1016/j.nima.2006.04.054; Zhang Y, 2012, CELL TRANSPLANT, V21, P1821, DOI 10.3727/096368911X637416	33	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180503	10.1371/journal.pone.0180503	http://dx.doi.org/10.1371/journal.pone.0180503			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683074	Green Published, gold, Green Submitted			2022-12-26	WOS:000405335200043
J	Tominami, K; Kanetaka, H; Sasaki, S; Mokudai, T; Kaneko, T; Niwano, Y				Tominami, Kanako; Kanetaka, Hiroyasu; Sasaki, Shota; Mokudai, Takayuki; Kaneko, Toshiro; Niwano, Yoshimi			Cold atmospheric plasma enhances osteoblast differentiation	PLOS ONE			English	Article							MC3T3-E1 CELLS; PROLIFERATION; RESPONSES; PRODUCTS; PATHWAY; ROS	This study was designed to assess the effects of cold atmospheric plasma on osteoblastic differentiation in pre-osteoblastic MC3T3-E1 cells. Plasma was irradiated directly to a culture medium containing plated cells for 5 s or 10 s. Alkaline phosphatase (ALP) activity assay and alizarin red staining were applied to assess osteoblastic differentiation. The plasma-generated radicals were detected directly using an electron spin resonance-spin trapping technique. Results show that plasma irradiation under specific conditions increased ALP activity and enhanced mineralization, and demonstrated that the yield of radicals was increased in an irradiation-time-dependent manner. Appropriate plasma irradiation stimulated the osteoblastic differentiation of the cells. This process offers the potential of promoting bone regeneration.	[Tominami, Kanako; Kanetaka, Hiroyasu] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi, Japan; [Kanetaka, Hiroyasu; Mokudai, Takayuki; Niwano, Yoshimi] Tohoku Univ, Grad Sch Dent, Sendai, Miyagi, Japan; [Sasaki, Shota; Kaneko, Toshiro] Tohoku Univ, Dept Elect Engn, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University	Kanetaka, H (corresponding author), Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi, Japan.; Kanetaka, H (corresponding author), Tohoku Univ, Grad Sch Dent, Sendai, Miyagi, Japan.	kanetaka@dent.tohoku.ac.jp	MOKUDAI, TAKAYUKI/AAK-1541-2020; Mokudai, Takayuki/M-1029-2018; Niwnao, Yoshimi/Z-3593-2019	MOKUDAI, TAKAYUKI/0000-0003-4628-6908; Mokudai, Takayuki/0000-0003-4628-6908; Sasaki, Shota/0000-0002-1478-7700; Tominami, Kanako/0000-0003-4342-6979; Kanetaka, Hiroyasu/0000-0001-7744-3879	JSPS KAKENHI [JP25293390, JP16H05520]; Grants-in-Aid for Scientific Research [16K13708] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers JP25293390, JP16H05520 (https://www.jsps.go.jp/english/index.html).The funder had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript	Arai M, 2007, IUBMB LIFE, V59, P27, DOI 10.1080/15216540601156188; Bou R, 2008, ANAL BIOCHEM, V377, P1, DOI 10.1016/j.ab.2008.02.029; Chen LL, 2011, ARCH ORAL BIOL, V56, P1655, DOI 10.1016/j.archoralbio.2011.06.008; Fatokun AA, 2008, EUR J PHARMACOL, V587, P35, DOI 10.1016/j.ejphar.2008.03.024; He WW, 2014, J FOOD DRUG ANAL, V22, P49, DOI 10.1016/j.jfda.2014.01.004; Hirose Y, 1995, NIHON HOTETSU SHIKA, V39, P159; Houghton EA, 2009, J BIOL INORG CHEM, V14, P243, DOI 10.1007/s00775-008-0444-x; Ishaq M, 2014, MOL BIOL CELL, V25, P1523, DOI 10.1091/mbc.E13-10-0590; Jadlowiec J, 2004, J BIOL CHEM, V279, P53323, DOI 10.1074/jbc.M404934200; Joshi SG, 2011, ANTIMICROB AGENTS CH, V55, P1053, DOI 10.1128/AAC.01002-10; Kalghatgi S, 2010, ANN BIOMED ENG, V38, P748, DOI 10.1007/s10439-009-9868-x; Karkonen A, 2006, J EXP BOT, V57, P1633, DOI 10.1093/jxb/erj197; Kono R, 2011, BIOSCI BIOTECH BIOCH, V75, P1907, DOI 10.1271/bbb.110264; Ma YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091947; Mukohda M, 2010, J VET MED SCI, V72, P1547, DOI 10.1292/jvms.10-0232; NOUROOZZADEH J, 1994, ANAL BIOCHEM, V220, P403, DOI 10.1006/abio.1994.1357; Saito K, 2009, FREE RADICAL RES, V43, P668, DOI 10.1080/10715760902988850; Sasaki S, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.026202; Takamatsu T, 2014, RSC ADV, V4, P39901, DOI 10.1039/c4ra05936k; Takenaka K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.11NE04; Toda M, 2014, BONE, V67, P237, DOI 10.1016/j.bone.2014.07.018; Tominami K, 2016, JPN J APPL PHYS, V55, DOI 10.7567/JJAP.55.01AF03; Wu AS, 2013, J SURG RES, V179, pE1, DOI 10.1016/j.jss.2012.02.039; Yumoto H, 2015, CELL PHYSIOL BIOCHEM, V35, P601, DOI 10.1159/000369722; Zhou YH, 2012, ACTA BIOMATER, V8, P2307, DOI 10.1016/j.actbio.2012.03.012	25	23	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180507	10.1371/journal.pone.0180507	http://dx.doi.org/10.1371/journal.pone.0180507			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683076	gold, Green Published, Green Submitted			2022-12-26	WOS:000405335200044
J	Willems, MGM; Kemp, MW; Fast, LA; Wagemaker, NMM; Janssen, LEW; Newnham, JP; Payne, MS; Spiller, OB; Kallapur, SG; Jobe, AH; Delhaas, T; Kramer, BW; Wolfs, TGAM				Willems, Monique G. M.; Kemp, Matthew W.; Fast, Laura A.; Wagemaker, Nick M. M.; Janssen, Leon E. W.; Newnham, John P.; Payne, Matt S.; Spiller, Owen B.; Kallapur, Suhas G.; Jobe, Alan H.; Delhaas, Tammo; Kramer, Boris W.; Wolfs, Tim G. A. M.			Pulmonary vascular changes in extremely preterm sheep after intra-amniotic exposure to Ureaplasma parvum and lipopolysaccharide	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BRONCHOPULMONARY DYSPLASIA; TRAINED IMMUNITY; FETAL SHEEP; OVINE MODEL; LUNG; CHORIOAMNIONITIS; ENDOTOXIN; HYPERTENSION; INFLAMMATION	Background Chorioamnionitis can induce pulmonary inflammation and promote bronchopulmonary dysplasia development, distinguished by alveolar simplification and impaired vascular growth. Chorioamnionitis is more common during the extremely preterm canalicular lung stage (crucial for vascular development); and increases the risk for subsequent sepsis. We hypothesized that single/combined exposure to chronic and/or acute inflammation induces pulmonary inflammatory responses and vascular changes. Methods Ovine fetuses were intra-amniotically exposed to chronic Ureaplasma parvum (UP) at 24 days (d) before extreme preterm delivery at 94d (term 147d) and/or to lipopolysaccharide (LPS) 7 or 2d before delivery. Pulmonary inflammation, vascular remodeling and angiogenic factors were assessed. Results LPS exposure increased CD3-positive and myeloperoxidase-positive cells. Combined UP-LPS exposure increased pulmonary inflammation compared with 2d LPS or UP groups. The UP+2d LPS group had an increased adventitial fibrosis score when compared with UP-treated animals. A reduced wall-to-lumen ratio was found in the 7d LPS animals when compared to the 2d LPS-treated animals. Exposure to UP+2d LPS reduced VEGF and VEGFR2 levels compared with 2d LPS-treated animals. Angiopoietin-1 (Ang1) and tunica interna endothelial cell kinase 2 (Tie-2) levels were decreased after UP+7d LPS as well as after 7d LPS, but not with UP alone. Conclusion Chronic UP and subsequent LPS exposure increased pulmonary inflammation and decreased expression of angiogenic growth factors and receptors when compared to single	[Willems, Monique G. M.; Fast, Laura A.; Wagemaker, Nick M. M.; Janssen, Leon E. W.; Kramer, Boris W.; Wolfs, Tim G. A. M.] Maastricht Univ, Med Ctr, Dept Pediat, Maastricht, Netherlands; [Willems, Monique G. M.; Delhaas, Tammo; Wolfs, Tim G. A. M.] Maastricht Univ, Med Ctr, Dept Biomed Engn, Maastricht, Netherlands; [Willems, Monique G. M.; Kramer, Boris W.; Wolfs, Tim G. A. M.] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands; [Kemp, Matthew W.; Newnham, John P.; Payne, Matt S.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA, Australia; [Spiller, Owen B.] Cardiff Univ, Univ Wales Hosp, Sch Med, Cardiff, S Glam, Wales; [Kallapur, Suhas G.; Jobe, Alan H.] Cincinnati Childrens Hosp Med Ctr, Div Neonatol, Cincinnati, OH 45229 USA; [Delhaas, Tammo] Maastricht Univ, Med Ctr, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands; [Kramer, Boris W.] Maastricht Univ, Sch Mental Hlth & Neurosci, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; University of Western Australia; Cardiff University; Cincinnati Children's Hospital Medical Center; Maastricht University; Maastricht University	Wolfs, TGAM (corresponding author), Maastricht Univ, Med Ctr, Dept Pediat, Maastricht, Netherlands.; Wolfs, TGAM (corresponding author), Maastricht Univ, Med Ctr, Dept Biomed Engn, Maastricht, Netherlands.; Wolfs, TGAM (corresponding author), Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands.	tim.wolfs@maastrichtuniversity.nl	Spiller, Owen Brad/AAC-2474-2020; Kramer, Boris/AAO-3183-2021	Spiller, Owen Brad/0000-0002-9117-6911; Wolfs, Tim/0000-0003-4417-4144				Baker CD, 2014, PEDIAT ALLER IMM PUL, V27, P8, DOI 10.1089/ped.2013.0323; Bhatt AJ, 2001, AM J RESP CRIT CARE, V164, P1971, DOI 10.1164/ajrccm.164.10.2101140; BUSH A, 1990, ARCH DIS CHILD, V65, P739, DOI 10.1136/adc.65.7.739; Cardenas I, 2011, AM J REPROD IMMUNOL, V65, P110, DOI 10.1111/j.1600-0897.2010.00908.x; Coalson JJ, 2006, SEMIN PERINATOL, V30, P179, DOI 10.1053/j.semperi.2006.05.004; Collins JJP, 2010, AM J PHYSIOL-LUNG C, V299, pL852, DOI 10.1152/ajplung.00183.2010; Correa-Rocha R, 2012, PEDIATR RES, V71, P590, DOI 10.1038/pr.2012.6; Dempsey E, 2005, AM J PERINAT, V22, P155, DOI 10.1055/s-2005-865020; Dowling DJ, 2014, TRENDS IMMUNOL, V35, P299, DOI 10.1016/j.it.2014.04.007; Galinsky R, 2013, J PREGNANCY, V2013, DOI 10.1155/2013/412831; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Hagen ASE, 2005, PEDIATR RES, V58, P1228, DOI 10.1203/01.pdr.0000185266.23265.87; Jobe AH, 2012, CLIN PERINATOL, V39, P441, DOI 10.1016/j.clp.2012.06.010; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kallapur SG, 2004, AM J PHYSIOL-LUNG C, V287, pL1178, DOI 10.1152/ajplung.00049.2004; Kallapur SG, 2005, AM J PHYSIOL-LUNG C, V288, pL966, DOI 10.1152/ajplung.00389.2004; Kallapur SG, 2011, J IMMUNOL, V187, P2688, DOI 10.4049/jimmunol.1100779; Kemp MW, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.09.076; Kramer BW, 2011, NEONATOLOGY, V99, P320, DOI 10.1159/000326620; Lahra MM, 2004, AM J OBSTET GYNECOL, V190, P147, DOI 10.1016/j.ajog.2003.07.012; Le Cras TD, 2002, AM J PHYSIOL-LUNG C, V283, pL555, DOI 10.1152/ajplung.00408.2001; Levy O, 2014, NEONATOLOGY, V105, P136, DOI 10.1159/000356035; Levy O, 2014, PEDIATR RES, V75, P184, DOI 10.1038/pr.2013.214; Lowe J, 2014, PEDIATR INFECT DIS J, V33, P697, DOI 10.1097/INF.0000000000000239; Melville JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00079; Moss TJM, 2002, AM J OBSTET GYNECOL, V187, P1059, DOI 10.1067/mob.2002.126296; Mulvany MJ, 1999, CARDIOVASC RES, V41, P9, DOI 10.1016/S0008-6363(98)00289-2; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Nikiforou M, 2015, INFLAMM BOWEL DIS, V21, P2026, DOI 10.1097/MIB.0000000000000455; Romero R, 2014, J MATERN-FETAL NEO M, V27, P1397, DOI 10.3109/14767058.2013.860963; Speer CP, 2006, J PERINATOL, V26, pS57, DOI 10.1038/sj.jp.7211476; Stenmark KR, 2005, ANNU REV PHYSIOL, V67, P623, DOI 10.1146/annurev.physiol.67.040403.102229; Sung TJ, 2011, PEDIATR INFECT DIS J, V30, P379, DOI 10.1097/INF.0b013e318202ac3a; Tang JR, 2010, AM J PHYSIOL-LUNG C, V299, pL735, DOI 10.1152/ajplung.00153.2010; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; Thebaud B, 2007, AM J RESP CRIT CARE, V175, P978, DOI 10.1164/rccm.200611-1660PP; Van Rheen Z, 2011, AM J RESP CELL MOL, V44, P500, DOI 10.1165/rcmb.2010-0065OC; van Varik Bernard J., 2012, Frontiers in Genetics, V3, P290, DOI 10.3389/fgene.2012.00290; Willems MGM, 2016, AM J PHYSIOL-LUNG C, V310, pL1, DOI 10.1152/ajplung.00289.2015; Xiao L, 2014, INFECT IMMUN, V82, P1657, DOI 10.1128/IAI.01231-13	40	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180114	10.1371/journal.pone.0180114	http://dx.doi.org/10.1371/journal.pone.0180114			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666032	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000404608700062
J	Kishor, A; White, EJF; Matsangos, AE; Yan, ZS; Tandukar, B; Wilson, GM				Kishor, Aparna; White, Elizabeth J. F.; Matsangos, Aerielle E.; Yan, Zisui; Tandukar, Bishal; Wilson, Gerald M.			Hsp70's RNA-binding and mRNA-stabilizing activities are independent of its protein chaperone functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; chaperone; heat shock protein (HSP); mRNA decay; RNA-binding protein	AU-RICH ELEMENTS; MOLECULAR CHAPERONES; GENE-EXPRESSION; POSTTRANSCRIPTIONAL CONTROL; DESTABILIZING SEQUENCES; INTERDOMAIN LINKER; DECAY; STRESS; TRISTETRAPROLIN; DOMAIN	Hsp70 is a protein chaperone that prevents protein aggregation and aids protein folding by binding to hydrophobic peptide domains through a reversible mechanism directed by an ATPase cycle. However, Hsp70 also binds U-rich RNA including some AU-rich elements (AREs) that regulate the decay kinetics of select mRNAs and has recently been shown to bind and stabilize some ARE-containing transcripts in cells. Previous studies indicated that both the ATP- and peptide-binding domains of Hsp70 contributed to the stability of Hsp70-RNA complexes and that ATP might inhibit RNA recruitment. This suggested the possibility that RNA binding by Hsp70 might mimic features of its peptide-directed chaperone activities. Here, using purified, cofactor-free preparations of recombinant human Hsp70 and quantitative biochemical approaches, we found that high-affinity RNA binding requires at least 30 nucleotides of RNA sequence but is independent of Hsp70's nucleotide-bound status, ATPase activity, or peptide-binding roles. Furthermore, although both the ATP- and peptide-binding domains of Hsp70 could form complexes with an ARE sequence from VEGFA mRNA in vitro, only the peptide-binding domain could recover cellular VEGFA mRNA in ribonucleoprotein immunoprecipitations. Finally, Hsp70-directed stabilization of VEGFA mRNA in cells was mediated exclusively by the protein's peptide-binding domain. Together, these findings indicate that the RNA-binding and mRNA-stabilizing functions of Hsp70 are independent of its protein chaperone cycle but also provide potential mechanical explanations for several well-established and recently discovered cytoprotective and RNA-based Hsp70 functions.	[Wilson, Gerald M.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Wilson, GM (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	gwilson@som.umaryland.edu	Wilson, Gerald/AAF-3874-2019	Wilson, Gerald/0000-0002-1273-7507; Tandukar, Bishal/0000-0002-9650-1664	National Institutes of Health [R01 CA102428]; University of Maryland Greenebaum Comprehensive Cancer Center; UMGCCC Nathan Schnaper Intern Program in Translational Cancer Research through NCI Grant [R25 CA186872]; NATIONAL CANCER INSTITUTE [R25CA186872, R01CA102428] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland Greenebaum Comprehensive Cancer Center; UMGCCC Nathan Schnaper Intern Program in Translational Cancer Research through NCI Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01 CA102428. This work was also supported by a pilot grant from the University of Maryland Greenebaum Comprehensive Cancer Center (to G.M.W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the UMGCCC Nathan Schnaper Intern Program in Translational Cancer Research through NCI Grant R25 CA186872 (to Bret A. Hassel).	Assimon VA, 2015, BIOCHEMISTRY-US, V54, P7120, DOI 10.1021/acs.biochem.5b00801; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Briata P, 2013, BBA-GENE REGUL MECH, V1829, P689, DOI 10.1016/j.bbagrm.2012.11.003; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Chang L, 2010, J BIOL CHEM, V285, P21282, DOI 10.1074/jbc.M110.124149; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Fialcowitz EJ, 2005, J BIOL CHEM, V280, P22406, DOI 10.1074/jbc.M500618200; Fialcowitz-White EJ, 2007, J BIOL CHEM, V282, P20948, DOI 10.1074/jbc.M701751200; Ganassi M, 2016, MOL CELL, V63, P796, DOI 10.1016/j.molcel.2016.07.021; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; GRAGEROV A, 1994, J MOL BIOL, V235, P848, DOI 10.1006/jmbi.1994.1043; Gratacos FM, 2010, WIRES RNA, V1, P457, DOI 10.1002/wrna.26; Griseri P, 2014, J INTERF CYTOK RES, V34, P242, DOI 10.1089/jir.2013.0140; Halees AS, 2008, NUCLEIC ACIDS RES, V36, pD137, DOI 10.1093/nar/gkm959; HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Henics T, 1999, J BIOL CHEM, V274, P17318, DOI 10.1074/jbc.274.24.17318; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; Kishor A., 2012, BIOPHYSICAL APPROACH, P173; Kishor A, 2013, MOL CELL BIOL, V33, P71, DOI 10.1128/MCB.01275-12; Kityk R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9308; Kumar DP, 2011, J MOL BIOL, V411, P1099, DOI 10.1016/j.jmb.2011.07.001; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; LI GC, 1992, P NATL ACAD SCI USA, V89, P2036, DOI 10.1073/pnas.89.6.2036; Majorek KA, 2014, PROTEIN SCI, V23, P1359, DOI 10.1002/pro.2520; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Moore AE, 2014, WIRES RNA, V5, P549, DOI 10.1002/wrna.1230; Muller P, 2013, ONCOGENE, V32, P3101, DOI 10.1038/onc.2012.314; Nicolai A, 2010, J CHEM THEORY COMPUT, V6, P2501, DOI 10.1021/ct1002169; Ozgur S, 2015, FEBS J, V282, P850, DOI 10.1111/febs.13198; Pan C, 2010, RNA BIOL, V7, P667, DOI 10.4161/rna.7.6.13571; Patury S., 2012, THESIS; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Ross CR, 2012, AGEING RES REV, V11, P473, DOI 10.1016/j.arr.2012.02.005; Schlecht R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078443; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; SMITH JS, 1994, J VIROL, V68, P5721, DOI 10.1128/JVI.68.9.5721-5729.1994; Suzuki A, 1998, ONCOGENE, V17, P931, DOI 10.1038/sj.onc.1202021; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Truman AW, 2012, CELL, V151, P1308, DOI 10.1016/j.cell.2012.10.051; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; von Roretz C, 2011, WIRES RNA, V2, P336, DOI 10.1002/wrna.55; Waris S, 2014, INT J MOL SCI, V15, P23377, DOI 10.3390/ijms151223377; White EJF, 2013, BBA-GENE REGUL MECH, V1829, P680, DOI 10.1016/j.bbagrm.2012.12.002; Willmund F, 2013, CELL, V152, P196, DOI 10.1016/j.cell.2012.12.001; Wilson GM, 2001, J BIOL CHEM, V276, P38400, DOI 10.1074/jbc.M106509200; Wilson GM, 2001, J BIOL CHEM, V276, P44450, DOI 10.1074/jbc.M108521200; Wisniewska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008625; Wu XY, 2012, GENE, V500, P10, DOI 10.1016/j.gene.2012.03.021; Yoon JH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6248; Ysla RM, 2008, METHOD ENZYMOL, V449, P47, DOI 10.1016/S0076-6879(08)02403-8; Zhang PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103518; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002; Zimmer C, 2001, RNA, V7, P1628; Zucconi BE, 2013, J BIOL CHEM, V288, P28034, DOI 10.1074/jbc.M113.489559; Zucconi BE, 2010, J BIOL CHEM, V285, P39127, DOI 10.1074/jbc.M110.180182; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	72	12	12	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14122	14133		10.1074/jbc.M117.785394	http://dx.doi.org/10.1074/jbc.M117.785394			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28679534	Green Published, hybrid			2022-12-26	WOS:000408439800018
J	Maheshwari, S; Miller, MS; O'Meally, R; Cole, RN; Amzel, LM; Gabelli, SB				Maheshwari, Sweta; Miller, Michelle S.; O'Meally, Robert; Cole, Robert N.; Amzel, L. Mario; Gabelli, Sandra B.			Kinetic and structural analyses reveal residues in phosphoinositide 3-kinase alpha that are critical for catalysis and substrate recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; PIK3CA GENE; PHOSPHATIDYLINOSITOL 3-KINASE; LIPID KINASE; BREAST CANCERS; HIGH-FREQUENCY; ATP-BINDING; P-LOOP; MUTATIONS; SUBUNIT	Phosphoinositide 3-kinases (PI3Ks) are ubiquitous lipid kinases that activate signaling cascades controlling cell survival, proliferation, protein synthesis, and vesicle trafficking. PI3Ks have dual kinase specificity: a lipid kinase activity that phosphorylates the 3'-hydroxyl of phosphoinositides and a protein-kinase activity that includes autophosphorylation. Despite the wealth of biochemical and structural information on PI3K alpha, little is known about the identity and roles of individual active-site residues in catalysis. To close this gap, we explored the roles of residues of the catalytic domain and the regulatory subunit of human PI3K alpha in lipid and protein phosphorylation. Using site-directed mutagenesis, kinetic assays, and quantitative mass spectrometry, we precisely mapped key residues involved in substrate recognition and catalysis by PI3K alpha. Our results revealed that Lys-776, located in the P-loop of PI3K alpha, is essential for the recognition of lipid and ATP substrates and also plays an important role in PI3K alpha autophosphorylation. Replacement of the residues His-936 and His-917 in the activation and catalytic loops, respectively, with alanine dramatically changed PI3K alpha kinetics. Although H936A inactivated the lipid kinase activity without affecting autophosphorylation, H917A abolished both the lipid and protein kinase activities of PI3K alpha. On the basis of these kinetic and structural analyses, we propose possible mechanistic roles of these critical residues in PI3K alpha catalysis.	[Maheshwari, Sweta; Amzel, L. Mario; Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Miller, Michelle S.; Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21287 USA; [O'Meally, Robert; Cole, Robert N.] Johns Hopkins Univ, Sch Med, Mass Spectrometry & Prote Facil, Baltimore, MD 21205 USA; [Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Amzel, LM; Gabelli, SB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.; Gabelli, SB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21287 USA.	mamzel@jhmi.edu; gabelli@jhmi.edu	Gabelli, Sandra/A-3705-2008	Gabelli, Sandra/0000-0003-1205-5204; Miller, Michelle/0000-0003-1972-4503	Johns Hopkins University; Sidney Kimmel Comprehensive Cancer Center (NCI) [2P30 CA006973]; NATIONAL CANCER INSTITUTE [R37CA043460, P30CA006973, P50CA062924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER	Johns Hopkins University(Johns Hopkins University); Sidney Kimmel Comprehensive Cancer Center (NCI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Cole laboratory for the gift of CK2 kinase, Dr. Valerie O'Shea for help with the radioactive experiments, and Dr. B. Vogelstein and Dr. K. Kinzler for helpful discussions. Part of this research was undertaken in the Eukaryotic Tissue Culture Facility, which is supported by The Johns Hopkins University. We thank Dr. Li, manager of the facility, for help and suggestions on insect cell protein expression. We acknowledge the use and service of the Johns Hopkins University School of Medicine Mass Spectrometry and Proteomics Core supported by the Sidney Kimmel Comprehensive Cancer Center (NCI Grant 2P30 CA006973).	Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Buchanan CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071337; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; CARPENTER CL, 1993, MOL CELL BIOL, V13, P1657, DOI 10.1128/MCB.13.3.1657; Carson JD, 2008, BIOCHEM J, V409, P519, DOI 10.1042/BJ20070681; Chang HW, 1997, SCIENCE, V276, P1848, DOI 10.1126/science.276.5320.1848; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Deyrup AT, 1998, J BIOL CHEM, V273, P9450, DOI 10.1074/jbc.273.16.9450; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; Domin J, 1997, FEBS LETT, V410, P91, DOI 10.1016/S0014-5793(97)00617-0; ESCOBEDO JA, 1991, CELL, V65, P75, DOI 10.1016/0092-8674(91)90409-R; Foukas LC, 2004, MOL CELL BIOL, V24, P966, DOI 10.1128/MCB.24.3.966-975.2004; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HILES ID, 1992, CELL, V70, P419, DOI 10.1016/0092-8674(92)90166-A; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; HUNTER T, 1995, CELL, V83, P1, DOI 10.1016/0092-8674(95)90225-2; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ikenoue T, 2005, CANCER RES, V65, P4562, DOI 10.1158/0008-5472.CAN-04-4114; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; KNIGHTON DR, 1993, P NATL ACAD SCI USA, V90, P5001, DOI 10.1073/pnas.90.11.5001; Koorella C, 2014, J BIOL CHEM, V289, P7747, DOI 10.1074/jbc.M113.519686; Layton MJ, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-30; Levine DA, 2005, CLIN CANCER RES, V11, P2875, DOI 10.1158/1078-0432.CCR-04-2142; MADHUSUDAN, 1994, PROTEIN SCI, V3, P176; Maira SM, 2011, CURR TOP MICROBIOL, V347, P209, DOI 10.1007/82_2010_60; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Miller MS, 2014, ONCOTARGET, V5, P5198, DOI 10.18632/oncotarget.2263; Miyaki M, 2007, INT J CANCER, V121, P1627, DOI 10.1002/ijc.22829; Pedrero JMG, 2005, INT J CANCER, V114, P242, DOI 10.1002/ijc.20711; Pirola L, 2001, J BIOL CHEM, V276, P21544, DOI 10.1074/jbc.M011330200; Samuels Y, 2004, CELL CYCLE, V3, P1221, DOI 10.4161/cc.3.10.1164; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schwartz PA, 2011, BIOORG CHEM, V39, P192, DOI 10.1016/j.bioorg.2011.07.004; Segel I. H., 1975, ENZYME KINETICS, P320; SigmaPlot, 2015, SIGMAPLOT VERS 13; STACK JH, 1994, J BIOL CHEM, V269, P31552; Strong TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028100; Taylor SS, 1999, PHARMACOL THERAPEUT, V82, P133, DOI 10.1016/S0163-7258(99)00007-8; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Thomas D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001515; Velho S, 2005, EUR J CANCER, V41, P1649, DOI 10.1016/j.ejca.2005.04.022; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Wymann MP, 1996, MOL CELL BIOL, V16, P1722; Zhang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10115; Zhao L, 2008, P NATL ACAD SCI USA, V105, P2652, DOI 10.1073/pnas.0712169105; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005	49	26	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13541	13550		10.1074/jbc.M116.772426	http://dx.doi.org/10.1074/jbc.M116.772426			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28676499	hybrid, Green Published			2022-12-26	WOS:000407942400016
J	Zhang, XJ; Liu, XY; Zhang, DF; Tang, HJ; Sun, BC; Li, CH; Hao, LY; Liu, C; Li, YX; Shi, YS; Xie, XQ; Song, YC; Wang, TY; Li, Y				Zhang, Xiaojing; Liu, Xuyang; Zhang, Dengfeng; Tang, Huaijun; Sun, Baocheng; Li, Chunhui; Hao, Luyang; Liu, Cheng; Li, Yongxiang; Shi, Yunsu; Xie, Xiaoqing; Song, Yanchun; Wang, Tianyu; Li, Yu			Genome-wide identification of gene expression in contrasting maize inbred lines under field drought conditions reveals the significance of transcription factors in drought tolerance	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; ORYZA-SATIVA L.; STRESS RESPONSES; WATER-DEFICIT; TRANSGENIC ARABIDOPSIS; MOLECULAR CHAPERONES; PRIMARY ROOTS; ZEA-MAYS; RNA-SEQ; PHYSIOLOGICAL-RESPONSES	Drought is a major threat to maize growth and production. Understanding the molecular regulation network of drought tolerance in maize is of great importance. In this study, two maize inbred lines with contrasting drought tolerance were tested in the field under natural soil drought and well-watered conditions. In addition, the transcriptomes of their leaves was analyzed by RNA-Seq. In total, 555 and 2,558 genes were detected to specifically respond to drought in the tolerant and the sensitive line, respectively, with a more positive regulation tendency in the tolerant genotype. Furthermore, 4,700, 4,748, 4,403 and 4,288 genes showed differential expression between the two lines under moderate drought, severe drought and their well-watered controls, respectively. Transcription factors were enriched in both genotypic differentially expressed genes and specifically responsive genes of the tolerant line. It was speculated that the genotype`-specific response of 20 transcription factors in the tolerance line and the sustained genotypically differential expression of 22 transcription factors might enhance tolerance to drought in maize. Our results provide new insight into maize drought tolerance-related regulation systems and provide gene resources for subsequent studies and drought tolerance improvement.	[Zhang, Xiaojing; Liu, Xuyang; Zhang, Dengfeng; Li, Chunhui; Hao, Luyang; Li, Yongxiang; Shi, Yunsu; Song, Yanchun; Wang, Tianyu; Li, Yu] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China; [Tang, Huaijun; Sun, Baocheng; Liu, Cheng; Xie, Xiaoqing] Xinjiang Acad Agr Sci, Inst Grain Crops, Urumqi, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Wang, TY; Li, Y (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China.	wangtianyu@263.net; liyu03@caas.cn	li, yong/HDN-3885-2022; li, yongxiang/GPW-6930-2022		Chinese Academy of Agricultural Sciences [1610092016208]	Chinese Academy of Agricultural Sciences	This work was supported by Chinese Academy of Agricultural Sciences (the Innovation Program, 1610092016208).	Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Baldoni E, 2015, INT J MOL SCI, V16, P15811, DOI 10.3390/ijms160715811; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Blum A, 2014, FUNCT PLANT BIOL, V41, P1191, DOI 10.1071/FP14018; Boston RS, 1996, PLANT MOL BIOL, V32, P191, DOI 10.1007/BF00039383; Chen W, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01044; Chen WQJ, 2004, TRENDS PLANT SCI, V9, P591, DOI 10.1016/j.tplants.2004.10.007; D'Angelo C, 2006, PLANT J, V48, P857, DOI 10.1111/j.1365-313X.2006.02921.x; Dai XY, 2007, PLANT PHYSIOL, V143, P1739, DOI 10.1104/pp.106.094532; Dey S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00640; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fracasso A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0800-x; Gahlaut V, 2016, THEOR APPL GENET, V129, P2019, DOI 10.1007/s00122-016-2794-z; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Harrison MT, 2014, GLOBAL CHANGE BIOL, V20, P867, DOI 10.1111/gcb.12381; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hayano-Kanashiro C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007531; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Humbert S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-3; Jeong JS, 2010, PLANT PHYSIOL, V153, P185, DOI 10.1104/pp.110.154773; Jia JP, 2006, PLANT J, V48, P710, DOI 10.1111/j.1365-313X.2006.02905.x; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Joshi R, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01029; Jung H, 2015, PLANT SCI, V236, P304, DOI 10.1016/j.plantsci.2015.04.018; Kakumanu A, 2012, PLANT PHYSIOL, V160, P846, DOI 10.1104/pp.112.200444; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kizis D, 2002, PLANT J, V30, P679, DOI 10.1046/j.1365-313X.2002.01325.x; Kohli A, 2013, PLANT CELL REP, V32, P945, DOI 10.1007/s00299-013-1461-y; Li CH, 2013, EUPHYTICA, V193, P303, DOI 10.1007/s10681-013-0901-7; Li HY, 2007, DNA SEQUENCE, V18, P443, DOI 10.1080/10425170701292051; Li MJ, 2016, J PLANT RES, V129, P1097, DOI 10.1007/s10265-016-0857-5; Li SB, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00047; Li YZ, 2009, PLANT CELL PHYSIOL, V50, P2092, DOI 10.1093/pcp/pcp145; Liu SX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003790; Lobell DB, 2014, SCIENCE, V344, P516, DOI 10.1126/science.1251423; Lu HF, 2011, THEOR APPL GENET, V123, P943, DOI 10.1007/s00122-011-1638-0; Lu M, 2013, PLANT CELL TISS ORG, V115, P443, DOI 10.1007/s11240-013-0375-2; Lu M, 2012, PLANT CELL REP, V31, P1701, DOI 10.1007/s00299-012-1284-2; Luo M, 2010, J INTEGR PLANT BIOL, V52, P1059, DOI 10.1111/j.1744-7909.2010.01000.x; Mallikarjuna G, 2011, BIOTECHNOL LETT, V33, P1689, DOI 10.1007/s10529-011-0620-x; Mao HD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9326; Marcolino-Gomes J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139051; Murakami T, 2004, MOL BREEDING, V13, P165, DOI 10.1023/B:MOLB.0000018764.30795.c1; Okay S, 2014, MOL GENET GENOMICS, V289, P765, DOI 10.1007/s00438-014-0849-x; Oono Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096946; Opitz N, 2016, J EXP BOT, V67, P1095, DOI 10.1093/jxb/erv453; Opitz N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-741; Poroyko V, 2007, J EXP BOT, V58, P279, DOI 10.1093/jxb/erl119; Qin F, 2007, PLANT J, V50, P54, DOI 10.1111/j.1365-313X.2007.03034.x; Qin YZ, 2008, SCI CHINA SER C, V51, P391, DOI 10.1007/s11427-008-0059-z; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Sato Y, 2008, PLANT CELL REP, V27, P329, DOI 10.1007/s00299-007-0470-0; Shan XH, 2013, PLANT MOL BIOL REP, V31, P1485, DOI 10.1007/s11105-013-0622-z; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Silveira RDD, 2015, GENET MOL RES, V14, P8181, DOI 10.4238/2015.July.27.6; Singh KL, 2015, PLANTA, V242, P997, DOI 10.1007/s00425-015-2338-9; Song HM, 2009, PLANTA, V229, P955, DOI 10.1007/s00425-008-0886-y; Song L, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2378-y; Sun WN, 2001, PLANT J, V27, P407, DOI 10.1046/j.1365-313X.2001.01107.x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Verma V, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0771-y; Wang CT, 2011, ACTA PHYSIOL PLANT, V33, P575, DOI 10.1007/s11738-010-0582-y; Wang HY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00067; Wang YJ, 2012, MOL BIOL REP, V39, P2401, DOI 10.1007/s11033-011-0991-z; Wu G, 2007, J PLANT INTERACT, V2, P135, DOI 10.1080/17429140701586357; Xiang Y, 2007, PLANT PHYSIOL, V144, P1416, DOI 10.1104/pp.107.101295; Yang WQ, 2008, J GENET GENOMICS, V35, P531, DOI 10.1016/S1673-8527(08)60073-9; Yu LX, 2003, PLANT PHYSIOL, V131, P1921; Zhao JF, 2009, PLANT MOL BIOL, V69, P661, DOI 10.1007/s11103-008-9445-y; Zheng J, 2004, PLANT MOL BIOL, V55, P807, DOI 10.1007/s11103-005-1969-9; Zheng J, 2010, PLANT MOL BIOL, V72, P407, DOI 10.1007/s11103-009-9579-6; Zhuang Y, 2007, PLANT CELL REP, V26, P2137, DOI 10.1007/s00299-007-0419-3; Zinselmeier C, 2002, FIELD CROP RES, V75, P111, DOI 10.1016/S0378-4290(02)00021-7; Zou J, 2012, J PLANT PHYSIOL, V169, P628, DOI 10.1016/j.jplph.2011.12.014; Zou J, 2009, J PLANT PHYSIOL, V166, P851, DOI 10.1016/j.jplph.2008.11.007	82	35	39	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e179477	10.1371/journal.pone.0179477	http://dx.doi.org/10.1371/journal.pone.0179477			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700592	Green Submitted, Green Published, gold			2022-12-26	WOS:000405649600008
J	Greco, N; Cluigt, N; Cline, A; Liljesthrom, G				Greco, Nancy; Cluigt, Nicolas; Cline, Andrew; Liljesthroem, Gerardo			Life history traits and life table analysis of Lobiopa insularis (Coleoptera: Nitidulidae) fed on strawberry	PLOS ONE			English	Article							SAP BEETLE COLEOPTERA; SPECIES COLEOPTERA; ENVIRONMENTS	Lobiopa insularis is a newly reported pest of strawberry in Argentina. We investigated characteristics of its biology in the laboratory, including survivorship and reproduction. We also estimated population growth for L. insularis fed ripe strawberry fruits. Lobiopa insularis was not observed ovipositing on strawberry fruits. A higher proportion of egg masses were recorded from a depth of 1 cm within the soil than on either the soil surface or deeper than 1cm (i.e. between 1and 2 cm) within the soil. The duration of preimaginal developmental stages represented similar to 18.5% of the total life cycle, while the adult stage represented 81.5%. Survival from egg to adult was 64.20% and mean longevity of females and males adults was 121.84, (SE = 8.86) and 118.58 (SE = 5.90) days, respectively. Females laid eggs only when they were with a male, so reproductive period was dependent on male presence. The number of eggs/female/day was 18.01 (SE = 1.71); and total fecundity was 1655 (ES = 249.53) eggs/female. The long life span of adults and high reproductive output, i.e high fecundity and long reproductive period, indicate that availability and concentration of suitable developmental resources are important factors in the population dynamics of Lobiopa insularis associated with strawberry crops.	[Greco, Nancy; Cluigt, Nicolas; Liljesthroem, Gerardo] UNLP, CONICET, Fac Ciencias Nat & Museo, Ctr Estudios Parasitol & Vectores CEPAVE, La Plata, Buenos Aires, Argentina; [Greco, Nancy] Comis Invest Cient Prov Buenos Aires, La Plata, Buenos Aires, Argentina; [Cline, Andrew] Calif Dept Food & Agr, Plant Pest Diagnost Branch, Sacramento, CA 95814 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; Comision de Investigaciones Cientificas; California Department of Food & Agriculture	Greco, N (corresponding author), UNLP, CONICET, Fac Ciencias Nat & Museo, Ctr Estudios Parasitol & Vectores CEPAVE, La Plata, Buenos Aires, Argentina.; Greco, N (corresponding author), Comis Invest Cient Prov Buenos Aires, La Plata, Buenos Aires, Argentina.	ngreco@cepave.edu.ar			BID FONCyT, PICT [2012-1624]; Programa de Incentivos UNLP [N712]	BID FONCyT, PICT; Programa de Incentivos UNLP	This research was partially supported by grants from BID FONCyT, PICT 2012-1624, and Programa de Incentivos UNLP, N712. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	BEGON M, 2006, ECOLOGY FROM INDIVID; Berryman AA, 2008, POPULATION SYSTEMS A; Bortli LC, 2014, PESQUI AGROPECU BRAS, V49, P144, DOI [10.1590/S0100-204X2013000200009, 10.1590/S0100-204X2014000200009]; Bortolozzo AR, 2007, PRODUCE AO DE MORANG; Carey JR, 2001, ANNU REV ENTOMOL, V46, P79, DOI 10.1146/annurev.ento.46.1.79; Carey JR, 1993, APPLIED DEMOGRAPHY F; Cline AR, 2008, ZOOTAXA, P1; Cline AR, 2012, PAN-PAC ENTOMOL, V88, P202, DOI 10.3956/2012-25.1; Cline AR, 2009, ZOOTAXA, P34, DOI 10.11646/zootaxa.2237.1.2; Cline AR, 2004, COLEOPTS BULL, V58, P355, DOI 10.1649/630; Cline AR, 2005, THESIS; Cluigt N, 30 E CONGRESO ARGENT; Denno RF, 1983, VARIABLE PLANTS AND; DESANTIS L, 1964, ANALES COMISION INVE, V4, P9; Dowd PF, 1994, J ECON ENTOMOL, V93, P1714; Ebert TA, 1999, PLANT AND ANIMAL POP; Ellis JD, 2008, J APICULT RES, V47, P188, DOI 10.1080/00218839.2008.11101456; Galford JR, 1991, RES PAP NE 654; Galford JR, 1991, RES PAP NE 644; GEHAN EA, 1969, BIOMETRIKA, V56, P127, DOI 10.2307/2334697; Guimaraes JA, COMUNICADO TECNICO 7; Hayashi C., 1978, MATH SCI, V3, P117; Hunter MD, 1992, EFFECTS OF RESOURCE; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kennedy GG, 2000, ANNU REV ENTOMOL, V45, P467, DOI 10.1146/annurev.ento.45.1.467; Loughner RL, 2007, ENVIRON ENTOMOL, V36, P1059, DOI 10.1603/0046-225X(2007)36[1059:EOSSBC]2.0.CO;2; Majka CG, 2006, CAN ENTOMOL, V138, P314; Majka CG, 2008, ZOOKEYS, P337, DOI 10.3897/zookeys.2.23; Myers L., 2004, NITIDULIDAE; Parsons Carl T., 1943, BULL MUS COMP ZOOL HARVARD UNIV, V92, P121; PIMM SL, 1982, FOOD WEBS; Price JF, 2001, BERRY TIMES, V1; Price Michele B., 2006, Insecta Mundi, V20, P69; Price PW, 2011, INSECT ECOLOGY; Rabb R.L., 1978, Bulletin of the Entomological Society of America, V24, P55; Rondon SI, 2011, MANAGEMENT IN STRAWB, P1; Salles LAB., 2005, SISTEMA DE PRODUCE D; SANFORD J. W., 1963, P N CENTRAL BRANCH E, V18, P39; Schowalter T.D., 2006, INSECT ECOLOGY, Vsecond; Stearns SC, 1992, THE EVOLUTION OF LIF; Stinner R.E., 1979, P199; Sunderland KD, 2002, AGROECOLOGY OF CARABID BEETLES, P165; TINKLE DW, 1969, AM NAT, V103, P501, DOI 10.1086/282617; TULJAPURKAR S, 1990, P NATL ACAD SCI USA, V87, P1139, DOI 10.1073/pnas.87.3.1139; TULJAPURKAR S, 1989, THEOR POPUL BIOL, V35, P227, DOI 10.1016/0040-5809(89)90001-4; WILLIAMS RN, 1986, FLA ENTOMOL, V69, P298, DOI 10.2307/3494932; Williams RN, 1984, SUMMARY EXPT CONTROL, V283, P66	47	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180093	10.1371/journal.pone.0180093	http://dx.doi.org/10.1371/journal.pone.0180093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700607	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649400008
J	Bastias, JM; Balladares, P; Acuna, S; Quevedo, R; Munoz, O				Bastias, Jose M.; Balladares, Pamela; Acuna, Sergio; Quevedo, Roberto; Munoz, Ociel			Determining the effect of different cooking methods on the nutritional composition of salmon (Salmo salar) and chilean jack mackerel (Trachurus murphyi) fillets	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; MUSCLE-TISSUE; CONSUMPTION; OXIDATION; FISH; TEXTURE	The effect of four cooking methods was evaluated for proximate composition, fatty acid, calcium, iron, and zinc content in salmon and Chilean jack mackerel. The moisture content of steamed salmon decreased (64.94%) compared to the control (68.05%); a significant decrease was observed in Chilean jack mackerel in all the treatments when compared to the control (75.37%). Protein content in both salmon and Chilean jack mackerel significantly increased under the different treatments while the most significant decrease in lipids was found in oven cooking and canning for salmon and microwaving for Chilean jack mackerel. Ash concentration in both salmon and Chilean jack mackerel did not reveal any significant differences. Iron and calcium content only had significant changes in steaming while zinc did not undergo any significant changes in the different treatments. Finally, no drastic changes were observed in the fatty acid profile in both salmon and Chilean jack mackerel.	[Bastias, Jose M.; Balladares, Pamela; Acuna, Sergio] Univ Bio Bio, Dept Food Engn, Chillan, Chile; [Quevedo, Roberto] Univ Los Lagos, Dept Aquaculture & Agrifood Resources, Osorno, Chile; [Munoz, Ociel] Univ Austral Chile, Inst Food Sci & Technol, Valdivia, Chile	Universidad del Bio-Bio; Universidad de Los Lagos; Universidad Austral de Chile	Bastias, JM (corresponding author), Univ Bio Bio, Dept Food Engn, Chillan, Chile.	jobastias@ubiobio.cl	Bastias, Jose/AGI-3305-2022; Acuña, Sergio M./N-3875-2019; Acuña, Sergio M./D-4071-2016	Acuña, Sergio M./0000-0003-1365-9851; Acuña, Sergio M./0000-0003-1365-9851; Quevedo, Roberto/0000-0001-8132-838X; Bastias, Jose/0000-0003-3387-6917	Universidad del Bio-Bio [GI 152322/EF]; Center CRHIAM-FONDAP-CONICYT [15130015]; Direction of research and development of University Austral de Chile [DID S-2015-11]	Universidad del Bio-Bio; Center CRHIAM-FONDAP-CONICYT; Direction of research and development of University Austral de Chile	We gratefully acknowledge the Universidad del Bio-Bio through Project GI 152322/EF, Center CRHIAM-FONDAP-CONICYT through Project 15130015, and to the Direction of research and development of University Austral de Chile (DID S-2015-11).	AOAC, 1996, OFFICIAL METHODS ANA, V16th; AOAC. Association of Official Analitical Chemistry, 1996, OFF METH AN, P3; Arab-Tehrany E, 2012, TRENDS FOOD SCI TECH, V25, P24, DOI 10.1016/j.tifs.2011.12.002; Bastias JM, 2015, INNOV FOOD SCI EMERG, V30, P98, DOI 10.1016/j.ifset.2015.05.011; Belitz H. D., 2009, QUIMICA ALIMENTOS; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Campo MM, 2013, J FOOD COMPOS ANAL, V31, P185, DOI 10.1016/j.jfca.2013.05.010; Castro-Gonzalez M, 2010, ALAN, V60; Colli C, 2008, MINERALES ALIMENTOS, P43; de Castro FAF, 2007, FOOD CHEM, V103, P1080, DOI 10.1016/j.foodchem.2006.10.002; Delgado-Andrade C, 2008, FOOD CHEM, V107, P631, DOI 10.1016/j.foodchem.2007.08.055; Dominguez R, 2014, MEAT SCI, V97, P223, DOI 10.1016/j.meatsci.2014.01.023; Ersoy B, 2006, FOOD CHEM, V99, P748, DOI 10.1016/j.foodchem.2005.08.055; Ersoy B, 2009, FOOD CHEM, V115, P419, DOI 10.1016/j.foodchem.2008.12.018; Gebauer SK, 2006, AM J CLIN NUTR, V83, p1526S, DOI 10.1093/ajcn/83.6.1526S; Gladyshev MI, 2006, FOOD CHEM, V96, P446, DOI 10.1016/j.foodchem.2005.02.034; Gladyshev MI, 2007, FOOD CHEM, V101, P1694, DOI 10.1016/j.foodchem.2006.04.029; Gladyshev MI, 2009, FOOD CHEM, V115, P545, DOI 10.1016/j.foodchem.2008.12.062; Candela CG, 2011, NUTR HOSP, V26, P323, DOI [10.1590/S0212-16112011000200013, 10.3305/nh.2011.26.2.5117]; Hartman L, 1973, Lab Pract, V22, P475; Hosseini H, 2014, FOOD CHEM, V148, P86, DOI 10.1016/j.foodchem.2013.10.012; Huynh MD, 2009, FOOD CHEM, V114, P912, DOI 10.1016/j.foodchem.2008.10.038; Castro-Gonzalez MI, 2013, ARCH LATINOAM NUTR, V63, P74; Kong FB, 2007, J FOOD ENG, V83, P510, DOI 10.1016/j.jfoodeng.2007.04.002; Loughrill E, 2016, FOOD CHEM, V197, P783, DOI 10.1016/j.foodchem.2015.10.141; Márquez Figueroa Yunilde del Valle, 2006, Zootecnia Trop., V24, P17; Mendil D, 2010, FOOD CHEM TOXICOL, V48, P865, DOI 10.1016/j.fct.2009.12.023; Perea A, 2008, ARCH LATINOAM NUTR, V58, P91; Quitral V, 2006, ARCH LATINOAM NUTR, V56, P69; Rincon L, 2016, AQUACULTURE, V451, P195, DOI 10.1016/j.aquaculture.2015.09.016; Saldanha T, 2008, FOOD CHEM, V106, P619, DOI 10.1016/j.foodchem.2007.06.021; Schuchardt JP, 2010, EUR J PEDIATR, V169, P149, DOI 10.1007/s00431-009-1035-8; Teague H, 2016, J NUTR BIOCHEM, V28, P30, DOI 10.1016/j.jnutbio.2015.09.012; Toppe J, 2007, COMP BIOCHEM PHYS B, V146, P395, DOI 10.1016/j.cbpb.2006.11.020; Un H, 2007, MONATSSCHR PHARM, V30, P138; Valenzuela A, 2009, REV CHIL NUTR, V36, P246; Weber J, 2008, FOOD CHEM, V106, P140, DOI 10.1016/j.foodchem.2007.05.052	37	32	32	5	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180993	10.1371/journal.pone.0180993	http://dx.doi.org/10.1371/journal.pone.0180993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686742	gold, Green Published, Green Submitted			2022-12-26	WOS:000405464100129
J	Chang, JC; Morton, DB				Chang, Jer-Cherng; Morton, David B.			Drosophila lines with mutant and wild type human TDP-43 replacing the endogenous gene reveals phosphorylation and ubiquitination in mutant lines in the absence of viability or lifespan defects	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; ALS-LINKED TDP-43; IN MOUSE MODEL; MOTOR-NEURONS; TARDBP MUTATIONS; ANIMAL-MODELS; MITOCHONDRIAL DYSFUNCTION; LOCOMOTION DEFECTS; PROGRESSIVE MOTOR	Mutations in TDP-43 are associated with proteinaceous inclusions in neurons and are believed to be causative in neurodegenerative diseases such as frontotemporal dementia or amyotrophic lateral sclerosis. Here we describe a Drosophila system where we have engineered the genome to replace the endogenous TDP-43 orthologue with wild type or mutant human TDP-43(hTDP-43). In contrast to other models, these flies express both mutant and wild type hTDP-43 at similar levels to those of the endogenous gene and importantly, no age-related TDP-43 accumulation observed among all the transgenic fly lines. Immunoprecipitation of TDP-43 showed that flies with hTDP-43 mutations had increased levels of ubiquitination and phosphorylation of the hTDP-43 protein. Furthermore, histologically, flies expressing hTDP-43 M337V showed global, robust neuronal staining for phospho-TDP. All three lines: wild type hTDP-43, -G294A and -M337V were homozygous viable, with no defects in development, life span or behaviors observed. The primary behavioral defect was that flies expressing either hTDP-43 G294A or M337V showed a faster decline with age in negative geotaxis. Together, these observations implied that neurons could handle these TDP-43 mutations by phosphorylation-and ubiquitin-dependent proteasome systems, even in a background without the wild type TDP-43. Our findings suggest that these two specific TDP-43 mutations are not inherently toxic, but may require additional environmental or genetic factors to affect longevity or survival.	[Chang, Jer-Cherng; Morton, David B.] Oregon Hlth & Sci Univ, Dept Integrat Biosci, Portland, OR 97201 USA	Oregon Health & Science University	Morton, DB (corresponding author), Oregon Hlth & Sci Univ, Dept Integrat Biosci, Portland, OR 97201 USA.	mortonda@ohsu.edu			National Institutes of Health [NS071186]; Amyotrophic Lateral Sclerosis Association [23VU14]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amyotrophic Lateral Sclerosis Association; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health [grant number NS071186] and the Amyotrophic Lateral Sclerosis Association [grant number 23VU14]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Armstrong GAB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150188; Arnold ES, 2013, P NATL ACAD SCI USA, V110, pE736, DOI 10.1073/pnas.1222809110; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Banks GT, 2008, MAMM GENOME, V19, P299, DOI 10.1007/s00335-008-9117-x; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Caroppo P, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000080; Chang JC, 2014, BRAIN RES, V1584, P39, DOI 10.1016/j.brainres.2013.11.019; Cheng CW, 2015, J NEUROGENET, V29, P59, DOI 10.3109/01677063.2015.1077832; Chiang PM, 2010, P NATL ACAD SCI USA, V107, P16320, DOI 10.1073/pnas.1002176107; Corrado L, 2009, HUM MUTAT, V30, P688, DOI 10.1002/humu.20950; Coulom H, 2004, J NEUROSCI, V24, P10993, DOI 10.1523/JNEUROSCI.2993-04.2004; Cragnaz L, 2015, NEUROSCIENCE, V311, P415, DOI 10.1016/j.neuroscience.2015.10.037; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; Diaper DC, 2013, HUM MOL GENET, V22, P3883, DOI 10.1093/hmg/ddt243; Diaper DC, 2013, HUM MOL GENET, V22, P1539, DOI 10.1093/hmg/ddt005; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Estes PS, 2011, HUM MOL GENET, V20, P2308, DOI 10.1093/hmg/ddr124; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Fujita Y, 2011, NEUROLOGY, V77, P1427, DOI 10.1212/WNL.0b013e318232ab87; Gareau C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055342; Gareau C, 2013, BIOL OPEN, V2, P68, DOI 10.1242/bio.20123012; Geser F, 2009, ARCH NEUROL-CHICAGO, V66, P180, DOI 10.1001/archneurol.2008.558; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Greenspan RJ, 2004, FLY PUSHING; Hanson KA, 2010, J BIOL CHEM, V285, P11068, DOI 10.1074/jbc.C109.078527; Hazelett DJ, 2012, G3-GENES GENOM GENET, V2, P789, DOI 10.1534/g3.112.002998; Heemels MT, 2016, NATURE, V539, P179, DOI 10.1038/539179a; Huang C, 2012, J CLIN INVEST, V122, P107, DOI 10.1172/JCI59130; Huang C, 2010, INT J BIOL SCI, V6, P396; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Janssens J, 2013, MOL NEUROBIOL, V48, P22, DOI 10.1007/s12035-013-8427-5; Jawaid A, 2014, J BIOL CHEM, V289, P18593, DOI 10.1074/jbc.L114.572651; Josephs KA, 2014, ACTA NEUROPATHOL, V127, P441, DOI 10.1007/s00401-013-1211-9; Joyce PI, 2011, MAMM GENOME, V22, P420, DOI 10.1007/s00335-011-9339-1; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Koyama A, 2016, NUCLEIC ACIDS RES, V44, P5820, DOI 10.1093/nar/gkw499; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Kuehnlein P, 2008, ARCH NEUROL-CHICAGO, V65, P1185, DOI 10.1001/archneur.65.9.1185; Lee CM, 2016, MOL THER, V24, P475, DOI 10.1038/mt.2016.1; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Liachko NF, 2010, J NEUROSCI, V30, P16208, DOI 10.1523/JNEUROSCI.2911-10.2010; Lin MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020371; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Liu YC, 2013, INT J MOL SCI, V14, P20079, DOI 10.3390/ijms141020079; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; McGoldrick P, 2013, BBA-MOL BASIS DIS, V1832, P1421, DOI 10.1016/j.bbadis.2013.03.012; McGurk L, 2015, GENETICS, V201, P377, DOI 10.1534/genetics.115.179457; Mitchell JC, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0212-4; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Origone P, 2010, AMYOTROPH LATERAL SC, V11, P223, DOI 10.3109/17482960903165039; Pamphlett R, 2009, NEUROPATH APPL NEURO, V35, P222, DOI 10.1111/j.1365-2990.2008.00982.x; Picher-Martel V, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0340-5; Rabin SJ, 2010, HUM MOL GENET, V19, P313, DOI 10.1093/hmg/ddp498; Ratti A, 2016, J NEUROCHEM, V138, P95, DOI 10.1111/jnc.13625; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Scotter EL, 2014, J CELL SCI, V127, P1263, DOI 10.1242/jcs.140087; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Shan X, 2010, P NATL ACAD SCI USA, V107, P16325, DOI 10.1073/pnas.1003459107; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stallings NR, 2010, NEUROBIOL DIS, V40, P404, DOI 10.1016/j.nbd.2010.06.017; Stribl C, 2014, J BIOL CHEM, V289, P10769, DOI 10.1074/jbc.M113.515940; Swarup V, 2011, BRAIN, V134, P2610, DOI 10.1093/brain/awr159; Tamaoka A, 2010, INTERNAL MED, V49, P331, DOI 10.2169/internalmedicine.49.2915; Tian TA, 2011, INT J BIOL SCI, V7, P234, DOI 10.7150/ijbs.7.234; Tong JB, 2013, EMBO J, V32, P1917, DOI 10.1038/emboj.2013.122; Tsai KJ, 2010, J EXP MED, V207, P1661, DOI 10.1084/jem.20092164; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Van Langenhove T, 2012, ANN MED, V44, P817, DOI 10.3109/07853890.2012.665471; Vanderwerf SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136167; Voigt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012247; Wegorzewska I, 2011, NEURODEGENER DIS, V8, P262, DOI 10.1159/000321547; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Xiong HL, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-8; Xu YF, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-73; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Zhou HX, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000887	86	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180828	10.1371/journal.pone.0180828	http://dx.doi.org/10.1371/journal.pone.0180828			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686708	Green Submitted, Green Published, gold			2022-12-26	WOS:000405464100111
J	Chen, L; Zhao, L; Samanta, A; Mahmoudi, SM; Buehler, T; Cantilena, A; Vincent, RJ; Girgis, M; Breeden, J; Asante, S; Xuan, YT; Dawn, B				Chen, Lei; Zhao, Lin; Samanta, Anweshan; Mahmoudi, Seyed Morteza; Buehler, Tanner; Cantilena, Amy; Vincent, Robert J.; Girgis, Magdy; Breeden, Joshua; Asante, Samuel; Xuan, Yu-Ting; Dawn, Buddhadeb			STAT3 balances myocyte hypertrophy vis-a-vis autophagy in response to Angiotensin II by modulating the AMPKa/ mTOR axis	PLOS ONE			English	Article							PROTEIN-KINASE REGULATION; JAK/STAT PATHWAY; MYOCARDIAL-INFARCTION; SIGNAL TRANSDUCER; MAMMALIAN TARGET; AT(1) RECEPTOR; HEART-FAILURE; ACTIVATION; CARDIOMYOCYTES; EXPRESSION	Signal transducers and activators of transcription 3 (STAT3) is known to participate in various cardiovascular signal transduction pathways, including those responsible for cardiac hypertrophy and cytoprotection. However, the role of STAT3 signaling in cardiomyocyte autophagy remains unclear. We tested the hypothesis that Angiotensin II (Ang II)-induced cardiomyocyte hypertrophy is effected, at least in part, through STAT3-mediated inhibition of cellular autophagy. In H9c2 cells, Ang II treatment resulted in STAT3 activation and cellular hypertrophy in a dose-dependent manner. Ang II enhanced autophagy, albeit without impacting AMPK alpha/mTOR signaling or cellular ADP/ATP ratio. Pharmacologic inhibition of STAT3 with WP1066 suppressed Ang II-induced myocyte hypertrophy and mRNA expression of hypertrophy-related genes ANP and beta-MHC. These molecular events were recapitulated in cells with STAT3 knockdown. Genetic or pharmacologic inhibition of STAT3 significantly increased myocyte ADP/ATP ratio and enhanced autophagy through AMPK alpha/mTOR signaling. Pharmacologic activation and inhibition of AMPK alpha attenuated and exaggerated, respectively, the effects of Ang II on ANP and beta-MHC gene expression, while concomitant inhibition of STAT3 accentuated the inhibition of hypertrophy. Together, these data indicate that novel nongenomic effects of STAT3 influence myocyte energy status and modulate AMPK alpha/mTOR signaling and autophagy to balance the transcriptional hypertrophic response to Ang II stimulation. These findings may have significant relevance for various cardiovascular pathological processes mediated by Ang II signaling.	[Chen, Lei; Zhao, Lin; Samanta, Anweshan; Mahmoudi, Seyed Morteza; Buehler, Tanner; Cantilena, Amy; Vincent, Robert J.; Girgis, Magdy; Breeden, Joshua; Asante, Samuel; Xuan, Yu-Ting; Dawn, Buddhadeb] Univ Kansas, Med Ctr, Cardiovasc Res Inst, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Dawn, B (corresponding author), Univ Kansas, Med Ctr, Cardiovasc Res Inst, Kansas City, KS 66103 USA.	bdawn@kumc.edu	Zhao, Lin/T-3047-2019		National Institutes of Health [R01 HL-117730]; National Institutes of Health COBRE grant [P20GM104936]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health COBRE grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by the National Institutes of Health grant R01 HL-117730. We wish to acknowledge the Electron Microscopy Research Laboratory (EMRL) at the University of Kansas Medical Center for assistance with scanning electron microscopic studies. The EMRL is supported in part by the National Institutes of Health COBRE grant P20GM104936	Bairwa SC, 2016, BBA-MOL BASIS DIS, V1862, P2199, DOI 10.1016/j.bbadis.2016.07.001; Balakumar P, 2014, CELL SIGNAL, V26, P2147, DOI 10.1016/j.cellsig.2014.06.011; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Bhuiyan MS, 2013, J CLIN INVEST, V123, P5284, DOI 10.1172/JCI70877; Boengler K, 2008, PHARMACOL THERAPEUT, V120, P172, DOI 10.1016/j.pharmthera.2008.08.002; Bolli R, 2003, TRENDS CARDIOVAS MED, V13, P72, DOI 10.1016/S1050-1738(02)00230-X; Braunwald E, 2013, JACC-HEART FAIL, V1, P1, DOI 10.1016/j.jchf.2012.10.002; BURNETT JC, 1986, SCIENCE, V231, P1145, DOI 10.1126/science.2935937; Fujita K, 2008, ARTERIOSCL THROM VAS, V28, P863, DOI 10.1161/ATVBAHA.107.156687; Hariharan N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051632; Hernandez JS, 2014, J CELL MOL MED, V18, P709, DOI 10.1111/jcmm.12220; Hilfiker-Kleiner D, 2010, CIRCULATION, V122, P145, DOI 10.1161/CIRCULATIONAHA.109.933127; Hopkins TA, 2003, BIOCHEM SOC T, V31, P207, DOI 10.1042/bst0310207; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kodama H, 1998, CIRC RES, V82, P244; Kunisada K, 2000, P NATL ACAD SCI USA, V97, P315, DOI 10.1073/pnas.97.1.315; Kunisada K, 1998, CIRCULATION, V98, P346, DOI 10.1161/01.CIR.98.4.346; Li Y., 2014, INT J ANTENN PROPAG, V2014, P1, DOI DOI 10.1101/GR.181990.114; Ma JH, 2010, J CLIN INVEST, V120, P103, DOI 10.1172/JCI37964; MARRERO MB, 1995, NATURE, V375, P247, DOI 10.1038/375247a0; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Nagata D, 2004, CIRCULATION, V110, P444, DOI 10.1161/01.CIR.0000136025.96811.76; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Negoro S, 2000, CARDIOVASC RES, V47, P797, DOI 10.1016/S0008-6363(00)00138-3; Porrello ER, 2009, HYPERTENSION, V53, P1032, DOI 10.1161/HYPERTENSIONAHA.108.128488; Sciarretta S, 2014, CIRC RES, V114, P549, DOI 10.1161/CIRCRESAHA.114.302022; Tian YK, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-53; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Willis MS, 2013, NEW ENGL J MED, V368, P455, DOI 10.1056/NEJMra1106180; Xuan YT, 2001, P NATL ACAD SCI USA, V98, P9050, DOI 10.1073/pnas.161283798; Yan CH, 2015, BBA-MOL BASIS DIS, V1852, P353, DOI 10.1016/j.bbadis.2014.05.027; Yu XW, 2003, J BIOL CHEM, V278, P16304, DOI 10.1074/jbc.M212321200; Zaha VG, 2012, CIRC RES, V111, P800, DOI 10.1161/CIRCRESAHA.111.255505; Zou YZ, 1998, CIRC RES, V82, P337, DOI 10.1161/01.RES.82.3.337	36	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179835	10.1371/journal.pone.0179835	http://dx.doi.org/10.1371/journal.pone.0179835			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686615	Green Published, gold, Green Submitted			2022-12-26	WOS:000405464100021
J	Gong, XX; Shi, ZJ; Wang, Y; Tian, YM; Li, WJ; Liu, L				Gong, Xiaoxing; Shi, Zejin; Wang, Yong; Tian, Yaming; Li, Wenjie; Liu, Lei			Characteristics and origin of the relatively high-quality tight reservoir in the Silurian Xiaoheba Formation in the southeastern Sichuan Basin	PLOS ONE			English	Article							SECONDARY POROSITY; GAS-RESERVOIRS; SANDSTONE	A mature understanding of the sandstone gas reservoir in the Xiaoheba Formation in the southeastern Sichuan Basin remains lacking. To assess the reservoir characteristics and the origin of the high-quality reservoir in the Xiaoheba Formation, this paper uses systematic field investigations, physical property analysis, thin section identification, scanning electron microscopy and electron microprobe methods. The results indicate that the Xiaoheba sandstone is an ultra-tight and ultra-low permeability reservoir, with an average porosity of 2.97% and an average permeability of 0.56x10(-3) mu m(2). This promising reservoir is mainly distributed in the Lengshuixi and Shuangliuba regions and the latter has a relatively high-quality reservoir with an average porosity of 5.28% and average permeability of 0.53x10(-3) mu m(2). The reservoir space comprises secondary intergranular dissolved pores, moldic pores and fractures. Microfacies, feldspar dissolution and fracture connectivity control the quality of this reservoir. The relatively weak compaction and cementation in the interbedded delta front distal bar and interdistributary bay microfacies indirectly protected the primary intergranular pores and enhanced late-stage dissolution. Late-stage potassium feldspar dissolution was controlled by the earlystage organic acid dissolution intensity and the distance from the hydrocarbon generation center. Early-stage fractures acted as pathways for organic acid migration and were therefore important factors in the formation of the reservoir. Based on these observations, the area to the west of the Shuangliuba and Lengshuixi regions has potential for gas exploration.	[Gong, Xiaoxing; Shi, Zejin; Li, Wenjie] Chengdu Univ Technol, Coll Energy Resources, Chengdu, Peoples R China; [Shi, Zejin] Chengdu Univ Technol, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China; [Wang, Yong; Tian, Yaming; Liu, Lei] Chengdu Univ Technol, Coll Earth Sci, Chengdu, Peoples R China	Chengdu University of Technology; Chengdu University of Technology; Chengdu University of Technology	Shi, ZJ (corresponding author), Chengdu Univ Technol, Coll Energy Resources, Chengdu, Peoples R China.; Shi, ZJ (corresponding author), Chengdu Univ Technol, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China.	zejin_shi@126.com		Gong, Xiaoxing/0000-0002-1471-1888; Li, Wenjie/0000-0001-6463-4131	National Natural Science Foundation of China [40739903]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant number 40739903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BJORLYKKE K, 1993, SEDIMENT GEOL, V86, P137, DOI 10.1016/0037-0738(93)90137-T; Bruce S.H., 2006, AAPG BULL, V90, P1519; Cao Q., 2013, THESIS; Castle JW, 2005, AAPG BULL, V89, P41, DOI 10.1306/08170404028; [陈洪德 Chen Hongde], 2007, [石油实验地质, Petroleum Geology & Experiment], V29, P13; [戴少武 Dai Shaowu], 2002, [石油与天然气地质, Oil & Gas Geology], V23, P229; [丁晓琪 Ding Xiaoqi], 2014, [地质论评, Geological Review], V60, P145; El-ghali MAK, 2006, SEDIMENT GEOL, V190, P299, DOI 10.1016/j.sedgeo.2006.05.021; EMERY D, 1990, GEOLOGY, V18, P1178, DOI 10.1130/0091-7613(1990)018<1178:ASEAFL>2.3.CO;2; Folk RL, 1974, PETROLOGY SEDIMENTAR; Franca AB, 2003, AAPG BULL, V87, P1073, DOI 10.1306/02260301071; Franks SG, 2010, AAPG BULL, V94, P1133, DOI 10.1306/04211009142; [郭英海 Guo Yinghai], 2004, [古地理学报, Journal of palaeogeography], V6, P20; Huang Jie, 2007, Geological Science and Technology Information, V26, P76; [黄金亮 Huang Jinliang], 2012, [煤炭学报, Journal of China Coal Society], V37, P782; [黄可可 HUANG Ke-ke], 2009, [地质通报, Geological Bulletin of China], V28, P474; Huang SF, 2009, J MED BIOL ENG, V29, P25; [黄思静 HUANG Si-jing], 2009, [地球化学, Geochimica], V38, P498; Jin C., 2010, THESIS; Jin ZJ, 2012, SCI CHINA EARTH SCI, V12, P1791; LAUBACH SE, 1988, TECTONOPHYSICS, V156, P37, DOI 10.1016/0040-1951(88)90281-8; Law B. E., 1986, GEOLOGY TIGHT GAS RE, V24, P253; Liu S.F., 2014, FORMATION PROCESS ME; Lu ZX, 2009, ACTA PETROL SIN, V25, P2373; Ma DF, 2011, MARINE ORIGIN PETROL, V1, P14; Meng WB, 2011, ACTA PETROL SIN, V27, P2371; Norbert C, 1999, AAPG BULL, V83, P62; [邱隆伟 Qiu Longwei], 2002, [沉积学报, Acta Sedimentologica Sinica], V20, P621; [任拥军 REN Yongjun], 2010, [地质学报, Acta Geologica Sinica], V84, P257; Ronald CS, 1993, AAPG BULL, V77, P1509; ROSSO KM, 1995, GEOCHIM COSMOCHIM AC, V59, P3961, DOI 10.1016/0016-7037(95)94441-H; Salem AM, 2005, J SEDIMENT RES, V75, P572, DOI 10.2110/jsr.2005.047; Schegg R, 1997, OIL GAS J, V95, P102; SPENCER CW, 1985, J PETROL TECHNOL, V37, P1308, DOI 10.2118/11647-PA; Surdam R.C, 1989, AAPG BULL, V73, P23; Surdam R.C., 1984, AAPG MEM, V37, P127; SURDAM RC, 1987, ANNU REV EARTH PL SC, V15, P141; Tan XF, 2014, OIL GAS GEOLOGY, V1, P56; [万友利 Wan Youli], 2014, [沉积学报, Acta Sedimentologica Sinica], V32, P138; Wang G, 2011, EVID-BASED COMPL ALT, V2011, P7, DOI DOI 10.1016/J.F0REC0.2011.04.007; Wang Y, 2010, J CHENGDU U TECHNOLO, V3, P244; Wang Y., 2010, THESIS; [王勇 Wang Yong], 2011, [石油与天然气地质, Oil & Gas Geology], V32, P75; [王正和 Wang Zhenghe], 2013, [石油与天然气地质, Oil & Gas Geology], V34, P499; [魏国齐 Wei Guoqi], 2016, [天然气地球科学, Natural Gas Geoscience], V27, P199; [文玲 Wen Ling], 2002, [石油勘探与开发, Petroleum Exploration and Development], V29, P11; Xie T, 2011, NATURAL GAS EXPLORAT, V3, P16; [徐二社 Xu Ershe], 2015, [石油实验地质, Petroleum Geology & Experiment], V37, P494; Yan DP, 2003, TECTONOPHYSICS, V361, P239, DOI 10.1016/S0040-1951(02)00646-7; [杨志安 YANG ZhiAn], 2009, [机械强度, Journal of Mechanical Strength], V31, P166; [张林 Zhang Lin], 2005, [天然气工业, Natural Gas Industry], V25, P6; [张哨楠 Zhang Shaonan], 2008, [石油与天然气地质, Oil & Gas Geology], V29, P1; [周恳恳 Zhou Kenken], 2014, [石油勘探与开发, Petroleum Exploration and Development], V41, P623; Zhu GY, 2012, J ASIAN EARTH SCI, V50, P88, DOI 10.1016/j.jseaes.2012.01.008; [朱志军 ZHU Zhi-jun], 2010, [沉积学报, Acta Sedimentologica Sinica], V28, P243; [朱志军 Zhu Zhijun], 2012, [吉林大学学报. 地球科学版, Journal of Jilin University. Earth Science Edition], V42, P1590; [朱志军 Zhu Zhijun], 2012, [中国地质, Geology of China], V39, P64; [卓皆文 ZHUO Jie-wen], 2009, [沉积与特提斯地质, Sedimentary Geology and Tethyan Geology], V29, P1	58	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180980	10.1371/journal.pone.0180980	http://dx.doi.org/10.1371/journal.pone.0180980			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686735	Green Submitted, Green Published, gold			2022-12-26	WOS:000405464100125
J	Littera, R; Piredda, G; Argiolas, D; Lai, S; Congeddu, E; Ragatzu, P; Melis, M; Carta, E; Michittu, MB; Valentini, D; Cappai, L; Porcella, R; Alba, F; Serra, M; Loi, V; Maddi, R; Orru, S; La Nasa, G; Caocci, G; Cusano, R; Arras, M; Frongia, M; Pani, A; Carcassi, C				Littera, Roberto; Piredda, Gianbenedetto; Argiolas, Davide; Lai, Sara; Congeddu, Elena; Ragatzu, Paola; Melis, Maurizio; Carta, Elisabetta; Michittu, Maria Benigna; Valentini, Donatella; Cappai, Luisella; Porcella, Rita; Alba, Francesco; Serra, Maria; Loi, Valentina; Maddi, Roberta; Orru, Sandro; La Nasa, Giorgio; Caocci, Giovanni; Cusano, Roberto; Arras, Marcella; Frongia, Mauro; Pani, Antonello; Carcassi, Carlo			KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE RECEPTORS; RENAL-ALLOGRAFT REJECTION; MYELOID-LEUKEMIA PATIENTS; NK-CELL-RECEPTOR; T-CELLS; MOLECULES; DISEASE; SPECIFICITY; RECOGNITION; ACTIVATION	Background Kidney transplantation is a life-saving treatment for patients with end-stage renal disease. However, despite progress in surgical techniques and patient management, immunological rejection continues to have a negative impact on graft function and overall survival. Incompatibility between donors and recipients for human leukocyte antigens (HLA) of the major histocompatibility complex (MHC) generates a series of complex cellular and humoral immune response mechanisms that are largely responsible for rejection and loss of graft function. Within this context, a growing amount of evidence shows that alloreactive natural killer (NK) cells play a critical role in the immune response mechanisms elicited by the allograft. Killer immunoglobulin-like receptors (KIRs) are prominent mediators of NK cell alloreactivity. Methods and findings A cohort of 174 first cadaveric kidney allograft recipients and their donors were selected from a total cohort of 657 transplanted patients for retrospective immunogenetic analyses. Patients with HLA Class II mismatches were excluded. HLA Class I allele frequencies were compared among patients with chronic rejection, patients with stable graft function and a group of 2388 healthy controls. Activating and inhibitory KIR gene frequencies, KIR haplotypes, KIR-HLA ligand matches/mismatches and combinations of recipient KIRs and donor HLA Class I ligands were compared among patients with and without chronic rejection and a group of 221 healthy controls. Patients transplanted from donors homozygous for HLA-C1 antigens had a significantly higher risk for chronic rejection than patients transplanted from donors homozygous or heterozygous for HLA-C2 antigens or with epitopes belonging to the HLA-Bw4 ligand group. The Kaplan-Meier curves obtained by dividing the patients into 3 groups according to the presence or absence of one or both of the combinations of recipient KIRs and donor HLA ligands (rKIR2DL1/dHLA-C2 and rKIR3DL1/dHLA-Bw4) showed a significantly higher cumulative incidence of chronic rejection in the group of patients completely lacking these functional units. These patients showed a progressively stronger decline in modification of diet in renal disease-estimated glomerular filtration rate. Conclusions KIR genotyping should be performed at the time of enrolment of patients on the waiting list for organ transplantation. In our study, a significantly higher risk of chronic rejection after kidney transplantation was observed when recipient (r) and donor (d) pairs completely lacked the two functional rKIR-dHLA ligand combinations rKIR2DL1/dHLA-C2 and rKIR3DL1/dHLA-Bw4. This immunogenetic profile corresponds to low levels of NK cell inhibition. Therefore, patients with this high risk profile could benefit from immunosuppressive therapy aimed at reducing NK-cell cytotoxicity.	[Littera, Roberto; Melis, Maurizio] ATS Sardegna, ASSL Cagliari, R Binaghi Hosp, Reg Transplant Ctr, Cagliari, Italy; [Piredda, Gianbenedetto; Argiolas, Davide; Congeddu, Elena; Ragatzu, Paola; Carta, Elisabetta; Michittu, Maria Benigna] G Brotzu Hosp, Dept Renal Dieases, Kidney Transplant Unit, Cagliari, Italy; [Lai, Sara; Valentini, Donatella; Cappai, Luisella; Porcella, Rita; Alba, Francesco; Serra, Maria; Loi, Valentina; Maddi, Roberta; Orru, Sandro; Carcassi, Carlo] ATS Sardegna, ASSL Cagliari, R Binaghi Hosp, Med Genet, Cagliari, Italy; [Orru, Sandro; Carcassi, Carlo] Univ Cagliari, Dept Med Sci & Publ Hlth, Med Genet, Cagliari, Italy; [La Nasa, Giorgio; Caocci, Giovanni; Arras, Marcella] ATS Sardegna, Bone Marrow Transplant Ctr, R Binaghi Hosp, ASSL Cagliari, Cagliari, Italy; [La Nasa, Giorgio; Caocci, Giovanni] Univ Cagliari, Dept Med Sci & Publ Hlth, Hematol Unit, Cagliari, Italy; [Cusano, Roberto] Ctr Adv Studies Res & Dev CRS4, Biomed Sect, Polaris Technol Pk, Cagliari, Italy; [Frongia, Mauro] G Brotzu Hosp, Complex Struct Urol Kidney Transplantat & Robot S, Cagliari, Italy; [Pani, Antonello] G Brotzu Hosp, Complex Struct Nephrol & Dialysis, Dept Renal Dis, Cagliari, Italy	University of Cagliari; University of Cagliari	Littera, R (corresponding author), ATS Sardegna, ASSL Cagliari, R Binaghi Hosp, Reg Transplant Ctr, Cagliari, Italy.	roby.litter@gmail.com	LAI, SARA/GXV-2963-2022; Pani, Antonello/HDN-3366-2022; Littera, Roberto/N-9759-2016; Caocci, Giovanni/AAM-6674-2020	Littera, Roberto/0000-0003-3143-3792; Caocci, Giovanni/0000-0002-6585-5187; Lai, Sara/0000-0002-8040-0631; Melis, Maurizio/0000-0002-5857-781X; ORRU, SANDRO/0000-0001-5085-7975; Cusano, Roberto/0000-0001-5543-7881	"Fondazione Sardegna" [2014-1861]	"Fondazione Sardegna"(Fondazione Banco di Sardegna)	The research performed in this report falls within the institutional responsibilities of the investigators of the participating centers, all of which pertain to the Italian National Public Health Service. The authors received no specific funding for this work. Grant funding (2014-1861) for part of the reagents was received from the Fondazione Sardegna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN CB, 1994, APMIS, V102, P23, DOI 10.1111/j.1699-0463.1994.tb04841.x; Bashirova AA, 2006, ANNU REV GENOM HUM G, V7, P277, DOI 10.1146/annurev.genom.7.080505.115726; Bontadini A, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-44; Bostom AG, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022011.35035.F3; Boucherma R, 2013, J IMMUNOL, V191, P583, DOI 10.4049/jimmunol.1300483; Broeders N, 2015, TRANSPL P, V47, P267, DOI 10.1016/j.transproceed.2014.12.018; Caocci G, 2015, EXP HEMATOL, V43, P1015, DOI 10.1016/j.exphem.2015.08.004; Cerwenka A, 2001, IMMUNOL REV, V181, P158, DOI 10.1034/j.1600-065X.2001.1810113.x; COOKSEY G, 1984, BRIT J SURG, V71, P874, DOI 10.1002/bjs.1800711124; Cornell LD, 2008, ANNU REV PATHOL-MECH, V3, P189, DOI 10.1146/annurev.pathmechdis.3.121806.151508; David G, 2013, J IMMUNOL, V191, P4778, DOI 10.4049/jimmunol.1301580; Eissens DN, 2010, AM J TRANSPLANT, V10, P1981, DOI 10.1111/j.1600-6143.2010.03242.x; Garcia-Beltran WF, 2016, NAT IMMUNOL, V17, P1067, DOI 10.1038/ni.3513; HANCOCK WW, 1985, TRANSPLANTATION, V39, P430, DOI 10.1097/00007890-198504000-00018; Kikuchi-Maki A, 2003, J IMMUNOL, V171, P3415, DOI 10.4049/jimmunol.171.7.3415; Kim S, 2008, P NATL ACAD SCI USA, V105, P3053, DOI 10.1073/pnas.0712229105; Kuzushima K, 2003, BLOOD, V101, P1460, DOI 10.1182/blood-2002-04-1240; La Nasa G, 2007, BIOL BLOOD MARROW TR, V13, P1358, DOI 10.1016/j.bbmt.2007.07.011; La Nasa G, 2013, EXP HEMATOL, V41, P424, DOI 10.1016/j.exphem.2013.01.008; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Liu J, 2012, J VIROL, V86, P13281, DOI 10.1128/JVI.01841-12; Moesta AK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00336; Nankivell BJ, 2010, NEW ENGL J MED, V363, P1451, DOI 10.1056/NEJMra0902927; Nowak I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044718; Opelz G, 1999, COLLABORATIVE TRANSP, p1334 ; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Parham P, 2012, PHILOS T R SOC B, V367, P800, DOI 10.1098/rstb.2011.0266; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Ruggeri L, 2007, BLOOD, V110, P433, DOI 10.1182/blood-2006-07-038687; Thewissen M, 2007, J IMMUNOL, V179, P6514, DOI 10.4049/jimmunol.179.10.6514; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; van Bergen J, 2011, AM J TRANSPLANT, V11, P1959, DOI 10.1111/j.1600-6143.2011.03621.x; Womer KL, 2009, AM J TRANSPLANT, V9, P1265, DOI 10.1111/j.1600-6143.2009.02639.x; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884	34	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180831	10.1371/journal.pone.0180831	http://dx.doi.org/10.1371/journal.pone.0180831			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686681	gold, Green Published			2022-12-26	WOS:000405464100112
J	Machado, CEP; Flores, MRP; Lima, LNC; Tinoco, RLR; Franco, A; Bezerra, ACB; Evison, MP; Guimaraes, MA				Palhares Machado, Carlos Eduardo; Pinheiro Flores, Marta Regina; Correia Lima, Laise Nascimento; Ribeiro Tinoco, Rachel Lima; Franco, Ademir; Barreto Bezerra, Ana Cristina; Evison, Martin Paul; Guimaraes, Marco Aureilio			A new approach for the analysis of facial growth and age estimation: Iris ratio	PLOS ONE			English	Article								The study of facial growth is explored in many fields of science, including anatomy, genetics, and forensics. In the field of forensics, it acts as a valuable tool for combating child pornography. The present research proposes a new method, based on relative measurements and fixed references of the human face-specifically considering measurements of the diameter of the iris (iris ratio)-for the analysis of facial growth in association with age in children and sub-adults. The experimental sample consisted of digital photographs of 1000 Brazilian subjects, aged between 6 and 22 years, distributed equally by sex and divided into five specific age groups (6, 10, 14, 18, and 22 year olds +/- one month). The software package SAFF-2D (R) (Forensic Facial Analysis System, Brazilian Federal Police, Brazil) was used for positioning 11 landmarks on the images. Ten measurements were calculated and used as fixed references to evaluate the growth of the other measurements for each age group, as well the accumulated growth (6-22 years old). The Intraclass Correlation Coefficient (ICC) was applied for the evaluation of intra-examiner and inter-examiner reliability within a specific set of images. Pearson's Correlation Coefficient was used to assess the association between each measurement taken and the respective age groups. ANOVA and Post-hoc Tukey tests were used to search for statistical differences between the age groups. The outcomes indicated that facial structures grow with different timing in children and adolescents. Moreover, the growth allometry expressed in this study may be used to understand what structures have more or less proportional variation in function for the age ranges studied. The diameter of the iris was found to be the most stable measurement compared to the others and represented the best cephalometric measurement as a fixed reference for facial growth ratios (or indices). The method described shows promising potential for forensic applications, especially as part of the armamentarium against crimes involving child pornography and child abuse.	[Palhares Machado, Carlos Eduardo] Minist Justice, Brazilian Fed Police, Natl Inst Criminalist, Brasilia, DF, Brazil; [Palhares Machado, Carlos Eduardo; Barreto Bezerra, Ana Cristina] Univ Brasilia, Hlth Sci Coll, Brasilia, DF, Brazil; [Palhares Machado, Carlos Eduardo; Guimaraes, Marco Aureilio] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pathol & Legal Med, Medico Legal Ctr, Ribeirao Preto, SP, Brazil; [Pinheiro Flores, Marta Regina] Univ Sao Paulo, Sch Dent, Sao Paulo, SP, Brazil; [Correia Lima, Laise Nascimento] Univ Fed Maranhao, Sch Dent, Sao Luis, Maranhao, Brazil; [Correia Lima, Laise Nascimento] Univ Estadual Campinas, Piracicaba Dent Sch, Piracicaba, SP, Brazil; [Ribeiro Tinoco, Rachel Lima] Univ Salgado de Oliveira, Sch Dent, Niteroi, RJ, Brazil; [Ribeiro Tinoco, Rachel Lima] Univ Fed Rio de Janeiro, Natl Museum, Dept Anthropol, Rio De Janeiro, RJ, Brazil; [Franco, Ademir] Katholieke Univ Leuven, Dept Oral Hlth Sci, Leuven, Belgium; [Evison, Martin Paul] Northumbria Univ, Ctr Forens Sci, Dept Appl Sci, Newcastle, England	Universidade de Brasilia; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Maranhao; Universidade Estadual de Campinas; Universidade Salgado de Oliveira; Universidade Federal do Rio de Janeiro; KU Leuven; Northumbria University	Machado, CEP (corresponding author), Minist Justice, Brazilian Fed Police, Natl Inst Criminalist, Brasilia, DF, Brazil.; Machado, CEP (corresponding author), Univ Brasilia, Hlth Sci Coll, Brasilia, DF, Brazil.; Machado, CEP (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pathol & Legal Med, Medico Legal Ctr, Ribeirao Preto, SP, Brazil.	palhares.cepm@dpf.gov.br	Evison, Martin P/L-5112-2014; Franco, Ademir/D-6665-2017	Evison, Martin P/0000-0002-4405-4751; Franco, Ademir/0000-0002-1417-2781				Ackermann Rebecca Rogers, 2002, Anatomical Record, V269, P142, DOI 10.1002/ar.10119; Augusteyn RC, 2012, EXP EYE RES, V102, P70, DOI 10.1016/j.exer.2012.06.009; Bergman RT, 2014, ANGLE ORTHOD, V84, P48, DOI 10.2319/041513-291.1; Byers S., 2004, INTRO FORENSIC ANTHR, P254, DOI 10.4324/9781315642031; Cattaneo C, 2012, INT J LEGAL MED, V126, P139, DOI 10.1007/s00414-011-0564-7; Cattaneo C, 2009, FORENSIC SCI INT, V183, pE21, DOI 10.1016/j.forsciint.2008.09.005; Chakravarty MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020241; Cunha E, 2009, FORENSIC SCI INT, V193, P1, DOI 10.1016/j.forsciint.2009.09.008; Driessen JP, 2011, INT J PEDIATR OTORHI, V75, P579, DOI 10.1016/j.ijporl.2011.01.023; Enlow D. H., 1990, FACIAL GROWTH; Evison MP, 2010, COMPUTER-AIDED FORENSIC FACIAL COMPARISON, P1, DOI 10.1201/9781439811344; Farkas L G, 1987, ANTHROPOMETRIC FACIA; Ferrario VF, 1999, PLAST RECONSTR SURG, V103, P768, DOI 10.1097/00006534-199903000-00002; FISHMAN LS, 1979, ANGLE ORTHOD, V49, P181; Flores-Mir C, 2004, ANGLE ORTHOD, V74, P118; Garamendi PM, 2005, FORENSIC SCI INT, V154, P3, DOI 10.1016/j.forsciint.2004.08.018; Gayon J, 2000, AM ZOOL, V40, P748, DOI 10.1668/0003-1569(2000)040[0748:HOTCOA]2.0.CO;2; George R, 2007, FACIAL GEOMETRY GRAP; Goldstein MS, 1936, AM J PHYS ANTHROPOL, V22, P37, DOI 10.1002/ajpa.1330220104; Huxley J. S., 1936, Nature London, V137, P780, DOI 10.1038/137780b0; Iscan M.Y., 1993, FORENSIC ANAL SKULL; Kolar JC., 1997, CRANIOFACIAL ANTHROP; Kramer RSS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042705; Kuc-Michalska M, 2010, ANGLE ORTHOD, V80, P54, DOI 10.2319/020309-69.1; Olze A, 2008, J FORENSIC LEG MED, V15, P426, DOI 10.1016/j.jflm.2008.02.008; Olze A, 2007, J FORENSIC SCI, V52, P1161, DOI 10.1111/j.1556-4029.2007.00534.x; Santoro V, 2009, FORENSIC SCI INT, V193, DOI 10.1016/j.forsciint.2009.09.014; Schmeling A, 2008, INT J LEGAL MED, V122, P457, DOI 10.1007/s00414-008-0254-2; Schmeling A, 2004, FORENSIC SCI INT, V144, P243, DOI 10.1016/j.forsciint.2004.04.059; Stanford C, 2005, BIOL ANTHR NATURAL H; Stavrianos C., 2012, Research Journal of Medical Sciences, V6, P77; Wilkinson C, 2012, CRANIOFACIAL IDENTIFICATION, P1, DOI 10.1017/CBO9781139049566; Zebrick B, 2014, AM J ORTHOD DENTOFAC, V146, P603, DOI 10.1016/j.ajodo.2014.07.021	33	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180330	10.1371/journal.pone.0180330	http://dx.doi.org/10.1371/journal.pone.0180330			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686631	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000405464100051
J	Sharpe, AL; Varela, E; Beckstead, MJ				Sharpe, Amanda L.; Varela, Erika; Beckstead, Michael J.			Systemic PD149163, a neurotensin receptor 1 agonist, decreases methamphetamine self-administration in DBA/2J mice without causing excessive sedation	PLOS ONE			English	Article							DOPAMINE; PSYCHOSTIMULANT; ACTIVATION; STRIATUM; RAT	Methamphetamine (METH) is a psychostimulant that exhibits significant abuse potential. Although METH addiction is a major health and societal concern, no drug is currently approved for its therapeutic management. METH activates the central dopaminergic "reward" circuitry, and with repeated use increases levels of the neuromodulatory peptide neurotensin in the nucleus accumbens and ventral tegmental area. Previous studies in rats suggest that neurotensin agonism decreases METH self-administration, but these studies did not examine the effect of neurotensin agonism on the pattern of self-administration or open field locomotion. In our studies, we established intravenous METH self-administration in male, DBA/2J mice (fixed ratio 3, 2 hr sessions) and examined the effect of pretreatment with the NTS1 receptor agonist PD149163 on METH self-administration behavior. Locomotion following PD149163 was also measured up to 2 hours after injection on a rotarod and in an open field. Pretreatment with PD149163 (0.05 and 0.10 mg/kg, s.c.) significantly decreased METH self-administration. The pattern of responding suggested that PD149163 decreased motivation to self-administer METH initially in the session with more normal intake in the second hour of access. Voluntary movement in the open-field was significantly decreased by both 0.05 and 0.10 mg/kg (s.c.) PD149163 from 10-120 minutes after injection, but rotarod performance suggested that PD149163 did not cause frank sedation. These results suggest that a systemically delivered NTS1 receptor agonist decreases METH self-administration in mice. The pattern of self-administration suggests that PD149163 may acutely decrease motivation to self-administer METH before the drug is experienced, but cannot rule out that depression of voluntary movement plays a role in the decreased self-administration.	[Sharpe, Amanda L.] Univ Incarnate Word, Feik Sch Pharm, Dept Pharmaceut Sci, San Antonio, TX 78209 USA; [Sharpe, Amanda L.; Varela, Erika; Beckstead, Michael J.] UT Hlth, Dept Cellular & Integrat Physiol, San Antonio, TX 78229 USA; [Beckstead, Michael J.] UT Hlth, Ctr Biomed Neurosci, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Sharpe, AL (corresponding author), Univ Incarnate Word, Feik Sch Pharm, Dept Pharmaceut Sci, San Antonio, TX 78209 USA.; Sharpe, AL (corresponding author), UT Hlth, Dept Cellular & Integrat Physiol, San Antonio, TX 78229 USA.	sharpe@uiwtx.edu		Sharpe, Amanda/0000-0003-3971-5946	National Institutes of Health [K01 DA21699, R01 DA32701]; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA021699, R01DA032701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	These studies were funded by National Institutes of Health grants K01 DA21699 and R01 DA32701 to MJB. The funder had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Binder EB, 2001, PHARMACOL REV, V53, P453; Boules Mona, 2013, Front Endocrinol (Lausanne), V4, P36, DOI 10.3389/fendo.2013.00036; Boules M, 2011, NEUROPEPTIDES, V45, P9, DOI 10.1016/j.npep.2010.09.003; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; CASTEL MN, 1994, EUR J NEUROSCI, V6, P646, DOI 10.1111/j.1460-9568.1994.tb00310.x; Cooke JH, 2009, OBESITY, V17, P1135, DOI 10.1038/oby.2008.652; DEUTCH AY, 1992, ANN NY ACAD SCI, V668, P232, DOI 10.1111/j.1749-6632.1992.tb27353.x; Feifel D, 2008, PSYCHOPHARMACOLOGY, V200, P197, DOI 10.1007/s00213-008-1197-5; Frankel PS, 2011, J PHARMACOL EXP THER, V336, P809, DOI 10.1124/jpet.110.176610; Fuxe K, 2014, PROG BRAIN RES, V211, P113, DOI 10.1016/B978-0-444-63425-2.00005-2; Geisler S, 2006, EUR J NEUROSCI, V24, P116, DOI 10.1111/j.1460-9568.2006.04928.x; Grimond-Billa SK, 2007, PSYCHOPHARMACOLOGIA, V22, P290; Hanson GR, 2012, NEUROSCIENCE, V203, P99, DOI 10.1016/j.neuroscience.2011.12.037; Hanson GR, 2013, J PHARMACOL EXP THER, V346, P173, DOI 10.1124/jpet.113.205310; HAWKINS MF, 1986, PHYSIOL BEHAV, V36, P1, DOI 10.1016/0031-9384(86)90064-8; HAWKINS MF, 1986, PHARMACOL BIOCHEM BE, V24, P1195, DOI 10.1016/0091-3057(86)90170-X; Holly EN, 2011, EUR NEUROPSYCHOPHARM, V21, P526, DOI 10.1016/j.euroneuro.2010.12.004; LEE TF, 1987, AM J PHYSIOL, V252, pE102, DOI 10.1152/ajpendo.1987.252.1.E102; LEVINE AS, 1983, PHARMACOL BIOCHEM BE, V19, P23, DOI 10.1016/0091-3057(83)90305-2; LUTTINGER D, 1982, EUR J PHARMACOL, V81, P499, DOI 10.1016/0014-2999(82)90116-9; MEISENBERG G, 1985, PHARMACOL BIOCHEM BE, V22, P189, DOI 10.1016/0091-3057(85)90376-4; Prus AJ, 2014, DRUG DEVELOP RES, V75, P47, DOI 10.1002/ddr.21171; Richelson E, 2003, LIFE SCI, V73, P679, DOI 10.1016/S0024-3205(03)00388-6; Sharpe AL, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu073; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Vadnie CA, 2014, NEUROPHARMACOLOGY, V85, P482, DOI 10.1016/j.neuropharm.2014.05.046; Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022	27	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180710	10.1371/journal.pone.0180710	http://dx.doi.org/10.1371/journal.pone.0180710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686721	gold, Green Submitted, Green Published			2022-12-26	WOS:000405464100093
J	Ezura, K; Ji-Seong, K; Mori, K; Suzuki, Y; Kuhara, S; Ariizumi, T; Ezura, H				Ezura, Kentaro; Ji-Seong, Kim; Mori, Kazuki; Suzuki, Yutaka; Kuhara, Satoru; Ariizumi, Tohru; Ezura, Hiroshi			Genome-wide identification of pistil-specific genes expressed during fruit set initiation in tomato (Solanum lycopersicum)	PLOS ONE			English	Article							CELL-WALL INVERTASE; MADS-BOX GENE; MOSAIC VIRUS-35S PROMOTER; PEAR PYRUS-SEROTINA; PLANT DEVELOPMENT; TRANSCRIPTOME ANALYSIS; PECTIN METHYLESTERASE; ARABIDOPSIS-THALIANA; RECEPTOR KINASE; RNA-SEQ	Fruit set involves the developmental transition of an unfertilized quiescent ovary in the pistil into a fruit. While fruit set is known to involve the activation of signals (including various plant hormones) in the ovary, many biological aspects of this process remain elusive. To further expand our understanding of this process, we identified genes that are specifically expressed in tomato (Solanum lycopersicum L.) pistils during fruit set through comprehensive RNA-seq-based transcriptome analysis using 17 different tissues including pistils at six different developmental stages. First, we identified 532 candidate genes that are preferentially expressed in the pistil based on their tissue-specific expression profiles. Next, we compared our RNA-seq data with publically available transcriptome data, further refining the candidate genes that are specifically expressed within the pistil. As a result, 108 pistil-specific genes were identified, including several transcription factor genes that function in reproductive development. We also identified genes encoding hormone -like peptides with a secretion signal and cysteine-rich residues that are conserved among some Solanaceae species, suggesting that peptide hormones may function as signaling molecules during fruit set initiation. This study provides important information about pistil -specific genes, which may play specific roles in regulating pistil development in relation to fruit set.	[Ezura, Kentaro; Ariizumi, Tohru; Ezura, Hiroshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Ji-Seong, Kim; Ariizumi, Tohru; Ezura, Hiroshi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Mori, Kazuki; Kuhara, Satoru] Kyushu Univ, Fac Agr, Higashi Ku, Fukuoka, Japan; [Suzuki, Yutaka] Univ Tokyo, Dept Computat Biol, Grad Sch Frontier Sci, Chiba, Japan	University of Tsukuba; University of Tsukuba; Kyushu University; University of Tokyo	Ariizumi, T; Ezura, H (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.; Ariizumi, T; Ezura, H (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.	arriizumi.toru.ge@u.tsukuba.ac.jp; ezura.hiroshi.fa@u.tsukuba.ac.jp	Ezura, Kentaro/AAK-4519-2020; Mori, Kazuki/M-2670-2018; Ezura, H/AAO-8184-2021	Mori, Kazuki/0000-0003-3238-2472; Ezura, Kentaro/0000-0002-2303-3396	Program to Disseminate Tenure Tracking System; JSPS Kakenhi [23780001, 221S0002]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry, Japan	Program to Disseminate Tenure Tracking System; JSPS Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry, Japan	This work was funded by Program to Disseminate Tenure Tracking System, http//www.jst.go_jp/tenure/, Receipt: TA; JSPS Kakenhi, https://www.jsps.go.jp/english/e-grants/, grant no. 23780001 and 221S0002 to TA; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry, Japan, http//www.affrc.maff.go.jp/index.htm, grant	Alvarez J, 1999, DEVELOPMENT, V126, P2377; Ampomah-Dwamena C, 2002, PLANT PHYSIOL, V130, P605, DOI 10.1104/pp.005223; Appelhagen I, 2011, PLANT J, V67, P406, DOI 10.1111/j.1365-313X.2011.04603.x; Ariel FD, 2007, TRENDS PLANT SCI, V12, P419, DOI 10.1016/j.tplants.2007.08.003; Ariizumi T, 2002, PLANT CELL REP, V21, P90, DOI 10.1007/s00299-002-0487-3; Ariizumi T, 2013, BREEDING SCI, V63, P3, DOI 10.1270/jsbbs.63.3; Azzi L, 2015, J EXP BOT, V66, P1075, DOI 10.1093/jxb/eru527; Balasubramanian S, 2000, DEVELOPMENT, V127, P4227; Belkhadir Y, 2015, NEW PHYTOL, V206, P522, DOI 10.1111/nph.13269; Bemer M, 2008, PLANT CELL, V20, P2088, DOI 10.1105/tpc.108.058958; Bemer M, 2010, PLANT PHYSIOL, V154, P287, DOI 10.1104/pp.110.160770; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brambilla V, 2007, PLANT CELL, V19, P2544, DOI 10.1105/tpc.107.051797; Breiden M, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0280-3; Canales C, 2002, CURR BIOL, V12, P1718, DOI 10.1016/S0960-9822(02)01151-X; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Clouse SD, 2011, PLANT CELL, V23, P1219, DOI 10.1105/tpc.111.084475; Colombo M, 2008, PLANT J, V54, P1037, DOI 10.1111/j.1365-313X.2008.03485.x; Costa LM, 2014, SCIENCE, V344, P168, DOI 10.1126/science.1243005; Daher FB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00523; Daminato M, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0319-y; de Graaf BHJ, 2003, J EXP BOT, V54, P55, DOI 10.1093/jxb/54.380.55; de Martino G, 2006, PLANT CELL, V18, P1833, DOI 10.1105/tpc.106.042978; Debeaujon I, 2001, PLANT CELL, V13, P853, DOI 10.1105/tpc.13.4.853; DEIKMAN J, 1992, PLANT PHYSIOL, V100, P2013, DOI 10.1104/pp.100.4.2013; Di C, 2014, PLANT J, V80, P848, DOI 10.1111/tpj.12679; Gomez MD, 2014, J EXP BOT, V65, P4515, DOI 10.1093/jxb/eru093; Dreni L, 2014, NEW PHYTOL, V201, P717, DOI 10.1111/nph.12555; Dutt M, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.47; Eberle CA, 2013, PLANT J, V74, P805, DOI 10.1111/tpj.12163; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Fasoli M, 2012, PLANT CELL, V24, P3489, DOI 10.1105/tpc.112.100230; Ficker M, 1997, PLANT MOL BIOL, V35, P425, DOI 10.1023/A:1005898624425; FIEDLER U, 1993, PLANT MOL BIOL, V22, P669, DOI 10.1007/BF00047407; Fiers M, 2005, PLANT CELL, V17, P2542, DOI 10.1105/tpc.105.034009; Figueiredo DD, 2016, ELIFE, V5, DOI 10.7554/eLife.20542; Figueiredo DD, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2015.184, 10.1038/NPLANTS.2015.184]; Gaffe J, 1997, PLANT PHYSIOL, V114, P1547, DOI 10.1104/pp.114.4.1547; GILLASPY G, 1993, PLANT CELL, V5, P1439, DOI 10.1105/tpc.5.10.1439; GOLDMAN MHD, 1992, PLANT CELL, V4, P1041, DOI 10.1105/tpc.4.9.1041; Golz JF, 1999, CURR BIOL, V9, pR861, DOI 10.1016/S0960-9822(00)80047-0; Gomez M, 2004, PLANTA, V219, P967, DOI 10.1007/s00425-004-1300-z; Guo YF, 2010, PLANT J, V63, P889, DOI 10.1111/j.1365-313X.2010.04295.x; Gupta V, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0046-9; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Hazak O, 2016, J EXP BOT, V67, P4827, DOI 10.1093/jxb/erw247; Hiwasa-Tanase K, 2012, PLANT CELL REP, V31, P1415, DOI 10.1007/s00299-012-1257-5; Hong SB, 2000, PLANT CELL REP, V19, P680, DOI 10.1007/s002999900175; Hong YF, 2008, PLANT MOL BIOL, V67, P347, DOI 10.1007/s11103-008-9324-6; Hothorn M, 2004, PLANT CELL, V16, P3437, DOI 10.1105/tpc.104.025684; Hothorn M, 2010, P NATL ACAD SCI USA, V107, P17427, DOI 10.1073/pnas.1004481107; Hu T, 2015, PLANT, V85, P16; Huang J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006147; Huang ZJ, 2013, MOL GENET GENOMICS, V288, P111, DOI 10.1007/s00438-013-0733-0; Ingrosso I, 2011, PLANT PHYSIOL BIOCH, V49, P1092, DOI 10.1016/j.plaphy.2011.07.012; Jeong HJ, 2014, GENE, V553, P17, DOI 10.1016/j.gene.2014.09.051; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Jia GX, 2008, P NATL ACAD SCI USA, V105, P2220, DOI 10.1073/pnas.0708795105; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Jin Y, 2009, PLANT CELL, V21, P2072, DOI 10.1105/tpc.108.063719; Jolie RP, 2010, CARBOHYD RES, V345, P2583, DOI 10.1016/j.carres.2010.10.002; Jones MO, 2008, FUNCT PLANT BIOL, V35, P1224, DOI 10.1071/FP08139; Ju CL, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2014.4, 10.1038/nplants.2014.4]; Kato H, 2010, PLANT MOL BIOL REP, V28, P381, DOI 10.1007/s11105-009-0162-8; Katsir L, 2011, CURR BIOL, V21, pR356, DOI 10.1016/j.cub.2011.03.012; KAUSS H, 1967, BIOCHEM BIOPH RES CO, V26, P234, DOI 10.1016/0006-291X(67)90240-9; Kesanakurti D, 2012, PHYSIOL PLANTARUM, V146, P136, DOI 10.1111/j.1399-3054.2012.01626.x; Kim G, 2014, SCIENCE, V345, P808, DOI 10.1126/science.1253122; Klap C, 2016, PLANT BIOTECHNOL J; Koenig D, 2013, P NATL ACAD SCI USA, V110, pE2655, DOI 10.1073/pnas.1309606110; Kuboyama T, 1998, SEX PLANT REPROD, V11, P251, DOI 10.1007/s004970050150; Lee J S, 2012, Cold Spring Harb Symp Quant Biol, V77, P83, DOI 10.1101/sqb.2012.77.014886; Li ZM, 2012, J EXP BOT, V63, P1155, DOI 10.1093/jxb/err329; Li ZJT, 2005, GENOME, V48, P312, DOI [10.1139/g04-110, 10.1139/G04-110]; Lin ZF, 2008, PLANT J, V55, P301, DOI 10.1111/j.1365-313X.2008.03505.x; LINERS F, 1992, PLANT PHYSIOL, V99, P1099, DOI 10.1104/pp.99.3.1099; Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803; Mao YF, 2016, PLANT BIOTECHNOL J, V14, P519, DOI 10.1111/pbi.12468; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Marshall E, 2011, J EXP BOT, V62, P1677, DOI 10.1093/jxb/err002; Martinelli F, 2009, J EXP BOT, V60, P3873, DOI 10.1093/jxb/erp227; Masiero S, 2011, PLANT CELL, V23, P865, DOI 10.1105/tpc.110.081737; Matsubayashi Y, 2011, PLANT CELL PHYSIOL, V52, P5, DOI 10.1093/pcp/pcq169; Mazzucato A, 2013, PLANT PHYSIOL BIOCH, V72, P125, DOI 10.1016/j.plaphy.2013.05.012; Mergaert P, 2003, PLANT PHYSIOL, V132, P161, DOI 10.1104/pp.102.018192; Mezzetti B, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-4; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; MIYOSHI H, 1995, SEX PLANT REPROD, V8, P205, DOI 10.1007/BF00228938; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mutz KO, 2013, CURR OPIN BIOTECH, V24, P22, DOI 10.1016/j.copbio.2012.09.004; Nibau C, 2011, J EXP BOT, V62, P949, DOI 10.1093/jxb/erq325; O'Rourke JA, 2013, PLANT PHYSIOL, V161, P705, DOI 10.1104/pp.112.209254; Ocarez N, 2016, PLANT CELL REP, V35, P239, DOI 10.1007/s00299-015-1882-x; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; Osakabe Y, 2013, J EXP BOT, V64, P445, DOI 10.1093/jxb/ers354; Palmer WM, 2015, MOL PLANT, V8, P315, DOI 10.1016/j.molp.2014.12.019; Pan LX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01573; Pattison RJ, 2015, PLANT PHYSIOL, V168, P1684, DOI 10.1104/pp.15.00287; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Pesaresi P, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00124; Quinet M, 2014, J EXP BOT, V65, P2243, DOI 10.1093/jxb/eru089; Rhee SJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2186-9; Ribone PA, 2015, J EXP BOT, V66, P5929, DOI 10.1093/jxb/erv302; Richardson LGL, 2013, J EXP BOT, V64, P5243, DOI 10.1093/jxb/ert246; Royo C, 2016, J EXP BOT, V67, P259, DOI 10.1093/jxb/erv452; Ruan YL, 2012, TRENDS PLANT SCI, V17, P656, DOI 10.1016/j.tplants.2012.06.005; Ruiu F, 2015, PLANT MOL BIOL, V89, P263, DOI 10.1007/s11103-015-0367-1; Sagasser M, 2002, GENE DEV, V16, P138, DOI 10.1101/gad.212702; Sassa H, 1998, PLANTA, V205, P514, DOI 10.1007/s004250050350; Sassa H, 2002, PLANT MOL BIOL, V50, P371, DOI 10.1023/A:1019866029629; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schijlen EGWM, 2007, PLANT PHYSIOL, V144, P1520, DOI 10.1104/pp.107.100305; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Shen XY, 2014, PLANT MOL BIOL, V86, P303, DOI 10.1007/s11103-014-0230-9; Silverstein KAT, 2005, PLANT PHYSIOL, V138, P600, DOI 10.1104/pp.105.060079; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Smaczniak C, 2012, DEVELOPMENT, V139, P3081, DOI 10.1242/dev.074674; Smaczniak C, 2012, P NATL ACAD SCI USA, V109, P1560, DOI 10.1073/pnas.1112871109; Sotelo-Silveira M, 2014, PLANTA, V239, P1147, DOI 10.1007/s00425-014-2057-7; Sprunck S, 2012, SCIENCE, V338, P1093, DOI 10.1126/science.1223944; Sweetman C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-691; Tang N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125355; Tavormina P, 2015, PLANT CELL, V27, P2095, DOI 10.1105/tpc.15.00440; Terao A, 2013, J PLANT RES, V126, P719, DOI 10.1007/s10265-013-0555-5; Tesfaye M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058992; VANNIER MP, 1992, BIOCHEM J, V286, P863, DOI 10.1042/bj2860863; Vaughan SP, 2006, J EXP BOT, V57, P3901, DOI 10.1093/jxb/erl185; Villanneva JM, 1999, GENE DEV, V13, P3160, DOI 10.1101/gad.13.23.3160; Voss U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8641; Vriezen WH, 2008, NEW PHYTOL, V177, P60, DOI 10.1111/j.1469-8137.2007.02254.x; Wang H, 2009, PLANT CELL, V21, P1428, DOI 10.1105/tpc.108.060830; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Wang ZY, 2012, ANNU REV GENET, V46, P701, DOI 10.1146/annurev-genet-102209-163450; Wei ZR, 2015, GENOME, V58, P121, DOI 10.1139/gen-2015-0035; Yamaguchi YL, 2016, J EXP BOT, V67, P4813, DOI 10.1093/jxb/erw208; Yang SL, 2003, PLANT CELL, V15, P2792, DOI 10.1105/tpc.016618; Yang XH, 2011, GENOME RES, V21, P634, DOI 10.1101/gr.109280.110; Ye J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130885; Yung MH, 1999, PLANT J, V17, P203, DOI 10.1046/j.1365-313X.1999.00359.x; Zhang SB, 2016, SCI REP-UK, V6, DOI 10.1038/srep23173; Zhu BZ, 2015, J EXP BOT, V66, P4483, DOI 10.1093/jxb/erv203	144	21	22	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180003	10.1371/journal.pone.0180003	http://dx.doi.org/10.1371/journal.pone.0180003			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683065	Green Published, Green Submitted, gold			2022-12-26	WOS:000405335200016
J	Li, TB; Lu, G; Chiang, EY; Chernov-Rogan, T; Grogan, JL; Chen, J				Li, Tianbo; Lu, Gang; Chiang, Eugene Y.; Chernov-Rogan, Tania; Grogan, Jane L.; Chen, Jun			High-throughput electrophysiological assays for voltage gated ion channels using SyncroPatch 768PE	PLOS ONE			English	Article							EXTREME PAIN DISORDER; PATCH-CLAMP; KV1.3; MODULATORS; MUTATIONS; NA(V)1.7; TARGET; DYE	Ion channels regulate a variety of physiological processes and represent an important class of drug target. Among the many methods of studying ion channel function, patch clamp electrophysiology is considered the gold standard by providing the ultimate precision and flexibility. However, its utility in ion channel drug discovery is impeded by low throughput. Additionally, characterization of endogenous ion channels in primary cells remains technical challenging. In recent years, many automated patch clamp (APC) platforms have been developed to overcome these challenges, albeit with varying throughput, data quality and success rate. In this study, we utilized SyncroPatch 768PE, one of the latest generation APC platforms which conducts parallel recording from two -384 modules with giga-seal data quality, to push these 2 boundaries. By optimizing various cell patching parameters and a two-step voltage protocol, we developed a high throughput APC assay for the voltage-gated sodium channel Nav1.7. By testing a group of Nav1.7 reference compounds' IC50, this assay was proved to be highly consistent with manual patch clamp (R > 0.9). In a pilot screening of 10,000 compounds, the success rate, defined by > 500 MCI seal resistance and >500 pA peak current, was 79%. The assay was robust with daily throughput - 6,000 data points and Z' factor 0.72. Using the same platform, we also successfully recorded endogenous voltage -gated potassium channel Kv1.3 in primary T cells. Together, our data suggest that SyncroPatch 768PE provides a powerful platform for ion channel research and drug discovery.	[Li, Tianbo; Lu, Gang; Chernov-Rogan, Tania; Chen, Jun] Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA; [Chiang, Eugene Y.; Grogan, Jane L.] Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Li, TB; Chen, J (corresponding author), Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA.	li.tianbo@gene.com; chen.jun@gene.com		Li, Tianbo/0000-0002-2386-910X	Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	The studies in this manuscript were fully funded by Genentech, Inc. The funder, Genentech, Inc., approved the manuscript for public disclosure, and provided support in the form of salaries for authors [TL, GL, EC, TC, JG, JC], but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahuja S, 2015, SCIENCE, V350, DOI 10.1126/science.aac5464; Baxter DF, 2002, J BIOMOL SCREEN, V7, P79, DOI 10.1177/108705710200700110; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Benjamin ER, 2006, J BIOMOL SCREEN, V11, P29, DOI 10.1177/1087057105280918; Castle N, 2009, COMB CHEM HIGH T SCR, V12, P107, DOI 10.2174/138620709787047993; Cerne R, 2016, ASSAY DRUG DEV TECHN, V14, P75, DOI 10.1089/adt.2015.678; Cerne R, 2016, ASSAY DRUG DEV TECHN, V14, P84, DOI 10.1089/adt.2015.677; Chambers C, 2016, ASSAY DRUG DEV TECHN, V14, P93, DOI 10.1089/adt.2016.700; Chiang EY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14644; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Ehling P, 2016, J THEOR BIOL, V404, P236, DOI 10.1016/j.jtbi.2016.06.001; Estacion M, 2009, ANN NEUROL, V66, P862, DOI 10.1002/ana.21895; Felix JP, 2004, ASSAY DRUG DEV TECHN, V2, P260, DOI 10.1089/1540658041410696; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Hou P, 2014, PLOS ONE, V9; John Comley, 2014, DRUG DISCOV WORLD, P45; Li TB, 2012, J BIOL CHEM, V287, P40680, DOI 10.1074/jbc.M112.418400; Liu CJ, 2003, J BIOL CHEM, V278, P1029, DOI 10.1074/jbc.M207074200; Liu JX, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-129; Mannikko R, 2015, BRIT J PHARMACOL, V172, P3112, DOI 10.1111/bph.13115; Milligan CJ, 2009, NAT PROTOC, V4, P244, DOI 10.1038/nprot.2008.230; Nicolaou SA, 2007, J IMMUNOL, V179, P346, DOI 10.4049/jimmunol.179.1.346; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Parihar AS, 2003, ASSAY DRUG DEV TECHN, V1, P647, DOI 10.1089/154065803770381002; Theile JW, 2011, J PHYSIOL-LONDON, V589, P597, DOI 10.1113/jphysiol.2010.200915; Vijayaragavan K, 2001, J NEUROSCI, V21, P7909, DOI 10.1523/JNEUROSCI.21-20-07909.2001; Wang DW, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00144; Wolff C, 2003, J BIOMOL SCREEN, V8, P533, DOI 10.1177/1087057103257806; Zakrzewska JM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-402; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	31	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180154	10.1371/journal.pone.0180154	http://dx.doi.org/10.1371/journal.pone.0180154			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683073	Green Published, gold, Green Submitted			2022-12-26	WOS:000405335200018
J	Soares, MC; Cardoso, SC; Mazzei, R; Andre, GI; Morais, M; Gozdowska, M; Kalamarz-Kubiak, H; Kulczykowska, E				Soares, Marta C.; Cardoso, Sonia C.; Mazzei, Renata; Andre, Goncalo I.; Morais, Marta; Gozdowska, Magdalena; Kalamarz-Kubiak, Hanna; Kulczykowska, Ewa			Region specific changes in nonapeptide levels during client fish interactions with allopatric and sympatric cleaner fish	PLOS ONE			English	Article							ARGININE-VASOTOCIN; TELENCEPHALIC ABLATION; SOCIAL-BEHAVIOR; LABROIDES-DIMIDIATUS; AGGRESSIVE-BEHAVIOR; NEUROPEPTIDE REGULATION; PARTNER CONTROL; BRAIN LEVELS; REEF FISH; EVOLUTION	Social relationships are crucially dependent on individual ability to learn and remember ecologically relevant cues. However, the way animals recognize cues before engaging in any social interaction and how their response is regulated by brain neuromodulators remains unclear. We examined the putative involvement of arginine vasotocin (AVT) and isotocin (IT), acting at different brain regions, during fish decision-making in the context of cooperation, by trying to identify how fish distinguish and recognize the value of other social partners or species. We hypothesized that the behavioural responses of cleaner fish clients to different social contexts would be underlain by changes in brain AVT and IT levels. We have found that changes in AVT at the level of forebrain and optic tectum are linked with a response to allopatric cleaners (novel or unfamiliar stimuli) while those at cerebellum are associated with the willingness to be cleaned (in response to sympatric cleaners). On the other hand, higher brain IT levels that were solely found in the diencephalon, also in response to allopatric cleaners. Our results are the first to implicate these nonapeptides, AVT in particular, in the assessment of social cues which enable fish to engage in mutualistic activities.	[Soares, Marta C.; Cardoso, Sonia C.; Mazzei, Renata; Andre, Goncalo I.; Morais, Marta] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO, Campus Agr Vairao, Vairao, Portugal; [Mazzei, Renata] Univ Neuchatel, Inst Biol, Ecoethol, Rue Emilie Argand 11, Neuchatel, Switzerland; [Gozdowska, Magdalena; Kalamarz-Kubiak, Hanna; Kulczykowska, Ewa] Polish Acad Sci, Inst Oceanol, Genet & Marine Biotechnol Dept, Sopot, Poland	Universidade do Porto; University of Neuchatel; Polish Academy of Sciences; Institute of Oceanology of the Polish Academy of Sciences	Soares, MC (corresponding author), Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO, Campus Agr Vairao, Vairao, Portugal.	marta.soares@cibio.up.pt	Kulczykowska, Ewa/X-2879-2019; Gozdowska, Magdalena/A-4169-2018; Kalamarz-Kubiak, Hanna/AAL-6172-2020; Soares, Marta C/J-4448-2013; Soares, Marta/GSM-7143-2022	Kulczykowska, Ewa/0000-0002-3979-9310; Gozdowska, Magdalena/0000-0002-7927-2230; Kalamarz-Kubiak, Hanna/0000-0002-1904-7146; Soares, Marta C/0000-0002-5213-2377; Soares, Marta/0000-0002-5213-2377; Andre, Goncalo/0000-0002-1513-4832; Cardoso, Sonia/0000-0002-5985-7792	Portuguese Foundation for Science and Technology-FCT [PTDC/MAR/105276/2008]; National Science Center [2012/05/B/NZ4/02410]; Institute of Oceanology of the Polish Academy of Sciences;  [SFRH/BPD/109433/2015]	Portuguese Foundation for Science and Technology-FCT(Portuguese Foundation for Science and Technology); National Science Center(National Science Centre, Poland); Institute of Oceanology of the Polish Academy of Sciences; 	This study was supported by the Portuguese Foundation for Science and Technology-FCT (grant PTDC/MAR/105276/2008 given to MCS). MSC is currently supported by SFRH/BPD/109433/2015. HPLC analyses of AVT and IT, and E2 analyses were partially financed by the National Science Center grant 2012/05/B/NZ4/02410 and by Institute of Oceanology of the Polish Academy of Sciences statutory research task IV.2.2 (giventoEK).	ACHER R, 1995, FRONT NEUROENDOCRIN, V16, P237, DOI 10.1006/frne.1995.1009; Almeida O, 2012, HORM BEHAV, V61, P212, DOI 10.1016/j.yhbeh.2011.12.008; [Anonymous], 2014, R LANG ENV STAT COMP; Backstrom T, 2009, PHYSIOL BEHAV, V96, P470, DOI 10.1016/j.physbeh.2008.11.013; Bangasser DA, 2006, J NEUROSCI, V26, P8702, DOI 10.1523/JNEUROSCI.1742-06.2006; Bshary R, 2002, ANIM BEHAV, V63, P547, DOI 10.1006/anbe.2001.1937; Bshary R, 2001, P ROY SOC B-BIOL SCI, V268, P1495, DOI 10.1098/rspb.2001.1495; Bshary R., 2011, FISH COGNITION BEHAV, P277; Bshary R, 2006, NATURE, V441, P975, DOI 10.1038/nature04755; Bshary R, 2011, ETHOLOGY, V117, P271, DOI 10.1111/j.1439-0310.2011.01882.x; Bshary Redouan, 2008, P563; Cardoso SC, 2015, BEHAV ECOL SOCIOBIOL, V69, P1173, DOI 10.1007/s00265-015-1931-z; Cardoso SC, 2015, PHYSIOL BEHAV, V145, P1, DOI 10.1016/j.physbeh.2015.03.024; Cardoso SC, 2015, PHYSIOL BEHAV, V139, P314, DOI 10.1016/j.physbeh.2014.11.052; Carneiro LA, 2003, FISH PHYSIOL BIOCHEM, V28, P241, DOI 10.1023/B:FISH.0000030542.31395.8a; Cheney KL, 2008, BEHAV ECOL, V19, P583, DOI 10.1093/beheco/arn001; Cheney KL, 2012, BIOL LETTERS, V8, P10, DOI 10.1098/rsbl.2011.0687; Cheney KL, 2009, BEHAV ECOL, V20, P459, DOI 10.1093/beheco/arp017; Cheney KL, 2009, CURR BIOL, V19, P1283, DOI 10.1016/j.cub.2009.06.028; Cho MM, 1999, BEHAV NEUROSCI, V113, P1071, DOI 10.1037/0735-7044.113.5.1071; Cote IM, 2000, OCEANOGR MAR BIOL, V38, P311; Dugatkin L.A., 1997, COOPERATION ANIMALS; Feder HM., 1966, SYMBIOSIS, V1, P327; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; Godwin J, 2012, HORM BEHAV, V61, P230, DOI 10.1016/j.yhbeh.2011.12.016; Goodson JL, 2001, BRAIN RES REV, V35, P246, DOI 10.1016/S0165-0173(01)00043-1; GORLICK DL, 1987, COPEIA, P41, DOI 10.2307/1446035; Gozdowska M, 2013, FISH PHYSIOL BIOCHEM, V39, P863, DOI 10.1007/s10695-012-9746-6; Groppe SE, 2013, BIOL PSYCHIAT, V74, P172, DOI 10.1016/j.biopsych.2012.12.023; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Herberstein ME, 2014, BEHAV ECOL, V25, P12, DOI 10.1093/beheco/art105; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Huffman LS, 2012, J CHEM NEUROANAT, V44, P86, DOI 10.1016/j.jchemneu.2012.05.002; Kline RJ, 2011, J CHEM NEUROANAT, V42, P72, DOI 10.1016/j.jchemneu.2011.06.005; Kulczykowska E, 2015, GEN COMP ENDOCR, V222, P99, DOI 10.1016/j.ygcen.2015.06.005; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Lema SC, 2004, HORM BEHAV, V46, P628, DOI 10.1016/j.yhbeh.2004.07.003; Lema SC, 2012, GEN COMP ENDOCR, V179, P451, DOI 10.1016/j.ygcen.2012.10.001; Lettieri L, 2010, J EVOLUTION BIOL, V23, P2289, DOI 10.1111/j.1420-9101.2010.02098.x; LIMBAUGH C, 1961, SCI AM, V205, P42, DOI 10.1038/scientificamerican0861-42; Lopez JC, 2000, BEHAV BRAIN RES, V109, P91, DOI 10.1016/S0166-4328(99)00167-9; Lopez JC, 2000, BEHAV NEUROSCI, V114, P687, DOI 10.1037/0735-7044.114.4.687; Losey GC, 1999, BEHAV CONSERVATION L, P379; Loveland JL, 2017, BEHAV BRAIN RES, V317, P188, DOI 10.1016/j.bbr.2016.09.008; McNamara JM, 2010, PHILOS T R SOC B, V365, P2627, DOI 10.1098/rstb.2010.0159; Modi ME, 2012, HORM BEHAV, V61, P340, DOI 10.1016/j.yhbeh.2011.12.010; O'Connell LA, 2012, HORM BEHAV, V61, P725, DOI 10.1016/j.yhbeh.2012.03.009; Oldfield RG, 2011, PHYSIOL BEHAV, V102, P296, DOI 10.1016/j.physbeh.2010.11.022; Pinto A, 2011, CURR BIOL, V21, P1140, DOI 10.1016/j.cub.2011.05.021; Rink E, 2001, BRAIN RES, V889, P316, DOI 10.1016/S0006-8993(00)03174-7; Rodriguez F, 2005, BRAIN RES BULL, V66, P365, DOI 10.1016/j.brainresbull.2004.11.026; Ros AFH, 2011, HORM BEHAV, V59, P151, DOI 10.1016/j.yhbeh.2010.11.006; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Saito D, 2004, NEUROSCIENCE, V124, P973, DOI 10.1016/j.neuroscience.2003.12.038; Salas C, 1996, BEHAV NEUROSCI, V110, P965, DOI 10.1037/0735-7044.110.5.965; Salas C, 1996, BEHAV BRAIN RES, V79, P193, DOI 10.1016/0166-4328(96)00014-9; Santangelo N, 2006, P ROY SOC B-BIOL SCI, V273, P3085, DOI 10.1098/rspb.2006.3683; Santangelo N, 2010, BRAIN BEHAV EVOLUT, V75, P282, DOI 10.1159/000316867; Semsar K, 2001, HORM BEHAV, V40, P21, DOI 10.1006/hbeh.2001.1663; Soares MC, 2008, ETHOLOGY, V114, P209, DOI 10.1111/j.1439-0310.2007.01471.x; Soares MC, 2008, ANIM BEHAV, V76, P123, DOI 10.1016/j.anbehav.2008.01.015; Soares MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039583; Soares MC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1547; Teles MC, 2016, HORM BEHAV, V84, P57, DOI 10.1016/j.yhbeh.2016.05.020; Yaeger C, 2014, NEUROSCIENCE, V267, P205, DOI 10.1016/j.neuroscience.2014.02.045	65	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180290	10.1371/journal.pone.0180290	http://dx.doi.org/10.1371/journal.pone.0180290			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683143	Green Published, gold, Green Submitted			2022-12-26	WOS:000405335200022
J	Takahashi, H; Nishimura, R; Onda, Y; Ando, K; Tsujino, D; Utsunomiya, K				Takahashi, Hiroshi; Nishimura, Rimei; Onda, Yoshiko; Ando, Kiyotaka; Tsujino, Daisuke; Utsunomiya, Kazunori			Prediction of nocturnal hypoglycemia unawareness by fasting glucose levels or post-breakfast glucose fluctuations in patients with type 1 diabetes receiving insulin degludec: A pilot study	PLOS ONE			English	Article							GLYCEMIC VARIABILITY; MONITORING-SYSTEM; JAPANESE PATIENTS; CROSS-OVER; MORTALITY; GLARGINE; FREQUENCY; MELLITUS; RISK	Objective To evaluate whether nocturnal asymptomatic hypoglycemia (NAH) can be predicted by fasting glucose levels or post-breakfast glucose fluctuations in patients with type 1 diabetes (T1D) receiving insulin degludec. Methods Patients with T1D receiving insulin degludec underwent at-home CGM assessments. Indices for glycemic variability before and after breakfast included fasting glucose levels and the range of post-breakfast glucose elevation. For comparison, the patients were classified into those with NAH and those without. The optimal cut-off values for the relevant parameters were determined to predict NAH using ROC analysis. Results The study included a total of 31 patients (mean HbA1c values, 7.8 +/- 0.7%), and 16 patients (52%) had NAH. Those with NAH had significantly lower fasting glucose levels than did those without (82 +/- 48 mg/dL vs. 144 +/- 69 mg/dL; P = 0.009). The change from pre-to postbreakfast glucose levels was significantly greater among those with NAH (postprandial 1-h, P = 0.028; postprandial 2-h, P = 0.028). The cut-off values for prediction of NAH were as follows: fasting glucose level <84 mg/dL (sensitivity 0.80/specificity 0.75/AUC 0.80; P = 0.004), 1-h postprandial elevation >69 mg/dL (0.75/0.67/0.73; P = 0.033), and 2-h postprandial elevation > 99 mg/dL (0.69/0.67/0.71; P = 0.044). Conclusions The results suggest that fasting glucose level of <84 mg/dL had approximately 80% probability of predicting the occurrence of NAH in T1D receiving insulin degludec. It was also shown that the occurrence of hypoglycemia led to greater post-breakfast glucose fluctuations and steeper post-breakfast glucose gradients.	[Takahashi, Hiroshi; Nishimura, Rimei; Onda, Yoshiko; Ando, Kiyotaka; Tsujino, Daisuke; Utsunomiya, Kazunori] Jikei Univ, Sch Med, Div Diabet Metab & Endocrinol, Dept Internal Med, Tokyo, Japan	Jikei University	Nishimura, R (corresponding author), Jikei Univ, Sch Med, Div Diabet Metab & Endocrinol, Dept Internal Med, Tokyo, Japan.	rimei@jikei.ac.jp			Boehringer Ingelheim; Takeda; Kowa; Kyowa Kirin; MSD; Onoand Tanabe-Mitsubishi	Boehringer Ingelheim(Boehringer Ingelheim); Takeda(Takeda Pharmaceutical Company Ltd); Kowa; Kyowa Kirin; MSD; Onoand Tanabe-Mitsubishi	Dr. Rimei Nishimura has participated in speaker's bureau/advisorypanels for Astellas, AstraZeneca, Boehringer Ingelheim, Daiichi-Sankyo, EliLilly, Johnson&JohnsonKssei, Kowa, Medtronic, NovoNordisk, Ono, Sanofi, Taisho, Takedaand Tanabe Mitsubishi, and served as a consultant for Abbott, Boehringer Ingelheim, EliLilly, and Taisho. Dr.Kiyotaka Ando has participate dinspeaker's bureau/advisory panels for Novo Nordiskand Sanofi. Dr.Daisuke Tsujino has participated in speaker's bureau/ advisory panels for Novo Nordisk, and has received research support from Boehringer Ingelheim, and Takeda. Dr. Kazunori Utsunomiya has received research support from Kowa, Kyowa Kirin, MSD, Onoand Tanabe-Mitsubishi, and has participate din speaker's bureau/advisory panels for Astellas, Astra Zeneca, Kowa, MSD, Novo Nordisk and Sanofi. All other authors declare to have no conflict ofinterest. However, these does not alter our adherence to PLOSONE policies on sharingdata and materials	Asao K, 2003, DIABETES CARE, V26, P2037, DOI 10.2337/diacare.26.7.2037; Banarer S, 2003, DIABETES, V52, P1195, DOI 10.2337/diabetes.52.5.1195; Birkeland KI, 2011, DIABETES CARE, V34, P661, DOI 10.2337/dc10-1925; Choudhary P, 2013, DIABETIC MED, V30, P914, DOI 10.1111/dme.12175; Chow E, 2014, DIABETES, V63, P1738, DOI 10.2337/db13-0468; Cryer PE, 2009, J CLIN ENDOCR METAB, V94, P709, DOI 10.1210/jc.2008-1410; DCCT Res Grp, 1991, AM J MED, V90, P450, DOI 10.1016/0002-9343(91)80085-Z; Diabet Control Complications Trial Res Grp, 1995, DIABETES CARE, V18, P1415; Diabetes C, 2016, DIABETES CARE, V39, P686, DOI DOI 10.2337/DC15-1990; Genuth S, 2002, JAMA-J AM MED ASSOC, V287, P2563; Gough SCL, 2013, DIABETES OBES METAB, V15, P301, DOI 10.1111/dom.12052; Harjutsalo V, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5364; Heise T, 2012, DIABETES OBES METAB, V14, P859, DOI 10.1111/j.1463-1326.2012.01627.x; Heller S, 2012, LANCET, V379, P1489, DOI 10.1016/S0140-6736(12)60204-9; Hoi-Hansen T, 2005, DIABETOLOGIA, V48, P2437, DOI 10.1007/s00125-005-1946-5; Jones TW, 1998, NEW ENGL J MED, V338, P1657, DOI 10.1056/NEJM199806043382303; Kaufman FR, 2002, J PEDIATR-US, V141, P625, DOI 10.1067/mpd.2002.129175; Khunti K, 2015, DIABETES CARE, V38, P316, DOI 10.2337/dc14-0920; Lind M, 2014, NEW ENGL J MED, V371, P1972, DOI 10.1056/NEJMoa1408214; Lung TWC, 2014, DIABETES CARE, V37, P2974, DOI 10.2337/dc14-0405; Mauras N, 2007, PEDIATR DIABETES, V8, P199; Miller CD, 2001, ARCH INTERN MED, V161, P1653, DOI 10.1001/archinte.161.13.1653; Mitsuishi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144041; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Onda Y, 2016, DIABETES RES CLIN PR, V120, P149, DOI 10.1016/j.diabres.2016.07.019; REICHARD P, 1991, J INTERN MED, V230, P101, DOI 10.1111/j.1365-2796.1991.tb00415.x; REICHARD P, 1994, DIABETES, V43, P313, DOI 10.2337/diabetes.43.2.313; Robinson RTCE, 2004, DIABETOLOGIA, V47, P312, DOI 10.1007/s00125-003-1292-4; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shannon H, 2000, NEW ENGL J MED, V342, P381; Suys B, 2006, DIABETES CARE, V29, P427, DOI 10.2337/diacare.29.02.06.dc05-1450; Takahashi H, 2017, EXPERT OPIN PHARMACO, V18, P335, DOI 10.1080/14656566.2017.1293652; TATTERSALL RB, 1991, DIABETIC MED, V8, P49, DOI 10.1111/j.1464-5491.1991.tb01516.x; Tsujimoto T, 2014, DIABETES CARE, V37, P217, DOI 10.2337/dc13-0701; Wentholt IME, 2007, DIABETIC MED, V24, P527, DOI 10.1111/j.1464-5491.2007.02107.x; Weston PJ, 1999, DIABETIC MED, V16, P626, DOI 10.1046/j.1464-5491.1999.00121.x; Wiltshire EJ, 2006, J PAEDIATR CHILD H, V42, P758, DOI 10.1111/j.1440-1754.2006.00973.x; Woodward A, 2009, QJM-INT J MED, V102, P603, DOI 10.1093/qjmed/hcp082; Zygalo KD, 2015, ACTA DIABETOL, V52, P231, DOI 10.1007/s00592-014-0604-0	39	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0177283	10.1371/journal.pone.0177283	http://dx.doi.org/10.1371/journal.pone.0177283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683068	Green Published, gold, Green Submitted			2022-12-26	WOS:000405335200001
J	Artioli, G; Angelini, I; Kaufmann, G; Canovaro, C; Dal Sasso, G; Villa, IM				Artioli, Gilberto; Angelini, Ivana; Kaufmann, Gunther; Canovaro, Caterina; Dal Sasso, Gregorio; Villa, Igor Maria			Long-distance connections in the Copper Age: New evidence from the Alpine Iceman's copper axe	PLOS ONE			English	Article							COLLECTOR ICP-MS; LEAD-ISOTOPE; METALLURGY; MINERALOGY; VALLEY; ORES; ALPS	25 years after the discovery in the Otztal Italian Alps, the 5,300-year-old mummy keeps providing key information on human biological and medical conditions, aspects of everyday life and societal organization in the Copper Age. The hand axe found with the body of the Alpine Iceman is one of the rare copper objects that is firmly dated to the early Copper Age because of the radiocarbon dating of the axe wooden shaft. Here we report the measurement of the lead isotope ratios of the copper blade. The results unambiguously indicate that the source of the metal is the ore-rich area of Southern Tuscany, despite ample evidence that Alpine copper ore sources were known and exploited at the time. The experimental results are discussed within the framework of all the available coeval archaeometallurgical data in Central-Southern Europe: they show that the Alps were a neat cultural barrier separating distinct metal circuits. The direct evidence of raw metal or object movement between Central Italy and the Alps is surprising and provides a new perspective on long-distance relocation of goods and relationships between the early Copper Age cultures in the area. The result is in line with the recent investigations re-evaluating the timing and extent of copper production in Central Italy in the 4 th millennium BC.	[Artioli, Gilberto; Canovaro, Caterina; Dal Sasso, Gregorio] Univ Padua, Dept Geosci, Padua, Italy; [Artioli, Gilberto; Angelini, Ivana; Canovaro, Caterina] Consorzio Interuniv Nazl Sci & Tecnol Mat, INSTM, Florence, Italy; [Angelini, Ivana] Univ Padua, Dept Cultural Heritage, Padua, Italy; [Kaufmann, Gunther] Sudtiroler Archaol Museum, Museo Archeol Alto Adige, Bolzano, Italy; [Villa, Igor Maria] Univ Milano Bicocca, Ctr Univ Dataz & Archeometria, Milan, Italy; [Villa, Igor Maria] Univ Bern, Inst Geol, Bern, Switzerland	University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie Molecolari (ISTM-CNR); University of Padua; University of Milano-Bicocca; University of Bern	Artioli, G (corresponding author), Univ Padua, Dept Geosci, Padua, Italy.; Artioli, G (corresponding author), Consorzio Interuniv Nazl Sci & Tecnol Mat, INSTM, Florence, Italy.	gilberto.artioli@unipd.it	Canovaro, Caterina/AAL-8642-2020; Artioli, Gilberto/F-2149-2015; Dal Sasso, Gregorio/J-5074-2017; Angelini, Ivana/A-9839-2016	Canovaro, Caterina/0000-0003-3147-0219; Artioli, Gilberto/0000-0002-8693-7392; Dal Sasso, Gregorio/0000-0002-2176-5446; Villa, Igor M/0000-0002-8070-8142; Angelini, Ivana/0000-0002-7970-3416				Amov BG, 1994, PROBLEMS EARLIEST ME, P122; Angelini I, 2013, LETA RAME IA PIANURA, P101; Angelini I, 2014, MOVING METALS EUROPE; Angelini I, 2011, DEL VENETO, VXXVII, P107; [Anonymous], 3 BOLZ MUMM C; Artioli G, 2007, APPL PHYS A-MATER, V89, P899, DOI 10.1007/s00339-007-4215-2; Artioli G, 2016, J ARCHAEOL SCI, V75, P27, DOI 10.1016/j.jas.2016.09.005; Artioli G, 2015, J ARCHAEOL SCI, V63, P78, DOI 10.1016/j.jas.2015.08.013; Artioli G, 2003, MUMMIA DELLETA RAME, V3, P9; Artioli G., 2014, HIST METALL, V47, P51; Artioli G., 2016, METALLI METALLURGHI, P69; Artioli G., 2009, RIPOSTIGLIO MONTE CA, P167; Artioli G, 2011, EUR J MINERAL, V23, P849, DOI 10.1127/0935-1221/2011/0023-2119; Badocco D, 2014, SPECTROCHIM ACTA B, V96, P8, DOI 10.1016/j.sab.2014.03.013; Baron S, 2014, ARCHAEOMETRY, V56, P665, DOI 10.1111/arcm.12037; Baxter MJ, 1997, J ARCHAEOL SCI, V24, P347, DOI 10.1006/jasc.1996.0119; Begemann F., 2001, EUR J ARCHAEOL, V4, P43, DOI [10.1179/eja.2001.4.1.43, DOI 10.1179/EJA.2001.4.1.43]; Carancini GL, 1998, FERRANTE RITTATORE V, P29; Carancini GL, 1993, VULCANO MEZZANO INSE, P125; Coia V, 2016, SCI REP-UK, V6, DOI 10.1038/srep18932; De Angelis MC, 1995, RIVISTA SCIENZE PREI, V47, P397; de Marinis R. C., 2013, LETA RAME PIANURA PA, P301; De Marinis RC., 2006, RIV SCI PREISTORICHE, V56, P211; De Marinis RC, 1992, MANN EIS, V187, P389; Dickson JH, 2005, SCI AM, V15, P4; Dolfini A, 2013, EUR J ARCHAEOL, V16, P21, DOI 10.1179/1461957112Y.0000000023; Dolfini A, 2010, ANTIQUITY, V84, P707, DOI 10.1017/S0003598X00100183; Egg M, 2009, MONOGRAPHIEN ROMISCH, V77; Gale N, 2000, ANNUARY DEP ARCHAEOL, VIV-V, P102; Hoppner B, 2005, ARCHAEOMETRY, V47, P293, DOI 10.1111/j.1475-4754.2005.00203.x; KAUFMANN G., 2014, RIV SCI PREISTORICHE, VLXIV, P57; KIENLIN T. L., 2008, P PREHIST SOC, V74, P79, DOI DOI 10.1017/S0079497X00000153; Ling J, 2014, J ARCHAEOL SCI, V41, P106, DOI 10.1016/j.jas.2013.07.018; Miari M., 1993, RIV SCI PREISTORICHE, V45, P101; Muller W, 2003, SCIENCE, V302, P862, DOI 10.1126/science.1089837; Nimis P, 2012, EUR J MINERAL, V24, P23, DOI 10.1127/0935-1221/2012/0024-2163; O'Sullivan NJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep31279; Pernicka E., 1997, EURASIA ANTIQUA, V3, P41; Pernicka E., 1993, PRAEHIST Z, V68, P1, DOI DOI 10.1515/PRHZ.1993.68.1.1; Pernicka E., 2013, ARCHAEOMETALLURGY GL, P239, DOI [DOI 10.1007/978-1-4614-9017-3_11, 10.1007/978-1-4614-9017-3_11]; Pernicka E, 2016, ARCHAEOL AUSTRIACA, P19, DOI 10.1553/archaeologia100s19; Perucchetti L, 2015, EUR J ARCHAEOL, V18, P599, DOI 10.1179/1461957115Y.0000000001; Putzer A, 2016, ANTIQUITY, V90, P319, DOI 10.15184/aqy.2015.185; Rehkamper M, 2000, J ANAL ATOM SPECTROM, V15, P1451, DOI 10.1039/b005262k; Robb J. E., 2009, SOCIAL BODIES, P100; Samadelli M, 2015, J CULT HERIT, V16, P753, DOI 10.1016/j.culher.2014.12.005; Sperl G., 1992, MANN EIS, V187, P454; Sperl G. O., 2005, MICROSC TODAY, V13, P8; Spindler K, 1993, SSDIE OTZTALER MUM V; Stos Z.A., 2009, MINE MICROSCOPE ADV, P163, DOI DOI 10.1016/J.JAS.2009.11.021; Stos-Gale ZA, 1998, ARCHAEOMETRY, V40, P217, DOI 10.1111/j.1475-4754.1998.tb00834.x; Stos-Gale ZA, 2009, ARCHAEOL ANTHROP SCI, V1, P195, DOI 10.1007/s12520-009-0011-6; Tapparo A, 2011, ANAL BIOANAL CHEM, V399, P2389, DOI 10.1007/s00216-010-4625-4; Villa I.M., 2016, ISOTOPIC LANDSCAPES, P141, DOI 10.1007/978-3-662-48339-8_8; Villa IM, 2009, ARCHAEOL ANTHROP SCI, V1, P149, DOI 10.1007/s12520-009-0012-5; White WM, 2000, CHEM GEOL, V167, P257, DOI 10.1016/S0009-2541(99)00182-5	56	25	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179263	10.1371/journal.pone.0179263	http://dx.doi.org/10.1371/journal.pone.0179263			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FA2LF	28678801	Green Published, Green Submitted, gold			2022-12-26	WOS:000405272200011
J	Mueller, S; Fiehler, K				Mueller, Stefanie; Fiehler, Katja			Gaze-centered coding of proprioceptive reach targets after effector movement: Testing the impact of online information, time of movement, and target distance	PLOS ONE			English	Article							WEIGHTED INTEGRATION; REFERENCE FRAMES; PERCEPTION; TACTILE; TRANSFORMATIONS; BODY	In previous research, we demonstrated that spatial coding of proprioceptive reach targets depends on the presence of an effector movement (Mueller & Fiehler, Neuropsychologia, 2014, 2016). In these studies, participants were asked to reach in darkness with their right hand to a proprioceptive target (tactile stimulation on the finger tip) while their gaze was varied. They either moved their left, stimulated hand towards a target location or kept it stationary at this location where they received a touch on the fingertip to which they reached with their right hand. When the stimulated hand was moved, reach errors varied as a function of gaze relative to target whereas reach errors were independent of gaze when the hand was kept stationary. The present study further examines whether (a) the availability of proprioceptive online information, i.e. reaching to an online versus a remembered target, (b) the time of the effector movement, i.e. before or after target presentation, or (c) the target distance from the body influences gaze-centered coding of proprioceptive reach targets. We found gaze-dependent reach errors in the conditions which included a movement of the stimulated hand irrespective of whether proprioceptive information was available online or remembered. This suggests that an effector movement leads to gaze-centered coding for both online and remembered proprioceptive reach targets. Moreover, moving the stimulated hand before or after target presentation did not affect gaze-dependent reach errors, thus, indicating a continuous spatial update of positional signals of the stimulated hand rather than the target location per se. However, reaching to a location close to the body rather than farther away (but still within reachable space) generally decreased the influence of a gaze-centered reference frame.	[Mueller, Stefanie; Fiehler, Katja] Justus Liebig Univ Giessen, Dept Expt Psychol, Giessen, Hesse, Germany	Justus Liebig University Giessen	Mueller, S (corresponding author), Justus Liebig Univ Giessen, Dept Expt Psychol, Giessen, Hesse, Germany.	stefanie.mueller@psychol.uni-giessen.de		Mueller, Stefanie/0000-0002-3611-6190	Deutsche Forschungsgemeinschaft [Fi1567/4-2, SFBTRR135]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This project was funded by the Deutsche Forschungsgemeinschaft (http://www.dfg.de); grant numbers: Fi1567/4-2 (assigned to KF) and SFBTRR135 (project A4). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badde S, 2016, COGN NEUROPSYCHOL, V33, P26, DOI 10.1080/02643294.2016.1168791; Badde S, 2016, PSYCHON B REV, V23, P387, DOI 10.3758/s13423-015-0918-0; Badde S, 2015, NEUROPSYCHOLOGIA, V70, P367, DOI 10.1016/j.neuropsychologia.2014.10.001; Bernier PM, 2010, NEURON, V68, P776, DOI 10.1016/j.neuron.2010.11.002; Blangero A., 2005, ADV COGN PSYCHOL, V1, P9, DOI DOI 10.2478/V10053-008-0039-7; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Crawford JD, 2011, ANNU REV NEUROSCI, V34, P309, DOI 10.1146/annurev-neuro-061010-113749; Dijkerman HC, 2007, BEHAV BRAIN SCI, V30, P189, DOI 10.1017/S0140525X07001392; Fiehler K, 2011, VISION RES, V51, P890, DOI 10.1016/j.visres.2010.12.015; Goodale MA, 1998, NEUROSCI BIOBEHAV R, V22, P161, DOI 10.1016/S0149-7634(97)00007-9; Goodale M, 2008, COGN NEUROPSYCHOL, V25, P891, DOI 10.1080/02643290801961984; Henriques DYP, 2002, PROG BRAIN RES, V140, P329; Jones SAH, 2010, NEUROPSYCHOLOGIA, V48, P3782, DOI 10.1016/j.neuropsychologia.2010.10.001; Medendorp WP, 2011, PHILOS T R SOC B, V366, P476, DOI 10.1098/rstb.2010.0089; Mueller S, 2016, NEUROPSYCHOLOGIA, V87, P63, DOI 10.1016/j.neuropsychologia.2016.04.033; Mueller S, 2014, NEUROPSYCHOLOGIA, V62, P184, DOI 10.1016/j.neuropsychologia.2014.07.025; Mueller S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00066; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pouget A, 2002, COGNITION, V83, pB1, DOI 10.1016/S0010-0277(01)00163-9; Pritchett LM, 2012, EXP BRAIN RES, V222, P437, DOI 10.1007/s00221-012-3231-4; Schutz I, 2015, EXP BRAIN RES, V233, P1225, DOI 10.1007/s00221-015-4197-9; Van Pelt S, 2007, J NEUROPHYSIOL, V97, P1209, DOI 10.1152/jn.00882.2006	22	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180782	10.1371/journal.pone.0180782	http://dx.doi.org/10.1371/journal.pone.0180782			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2LF	28678886	gold, Green Submitted, Green Published			2022-12-26	WOS:000405272200090
J	Nguyen, UC; Maffessanti, F; Mafi-Rad, M; Conte, G; Zeemering, S; Regoli, F; Caputo, ML; van Stipdonk, AMW; Bekkers, SCAM; Suerder, D; Moccetti, T; Krause, R; Prinzen', FW; Vernooy', K; Auricchio, A				Nguyen, Uyen Chau; Maffessanti, Francesco; Mafi-Rad, Masih; Conte, Giulio; Zeemering, Stef; Regoli, Francois; Caputo, Maria Luce; van Stipdonk, Antonius M. W.; Bekkers, Sebastiaan C. A. M.; Suerder, Daniel; Moccetti, Tiziano; Krause, Rolf; Prinzen', Frits W.; Vernooy', Kevin; Auricchio, Angelo			Evaluation of the use of unipolar voltage amplitudes for detection of myocardial scar assessed by cardiac magnetic resonance imaging in heart failure patients	PLOS ONE			English	Article							SINUS RHYTHM; NONISCHEMIC CARDIOMYOPATHY; VENTRICULAR TACHYCARDIAS; INTEGRATION; ELECTROGRAMS; INFARCTION; SUBSTRATE; ABLATION; THERAPY; MODEL	Background Validation of voltage-based scar delineation has been limited to small populations using mainly endocardial measurements. The aim of this study is to compare unipolar voltage amplitudes (UnipV) with scar on delayed enhancement cardiac magnetic resonance imaging (DE-CMR). Methods Heart failure patients who underwent DE-CMR and electro-anatomic mapping were included. Thirty-three endocardial mapped patients and 27 epicardial mapped patients were investigated. UnipV were computed peak-to-peak. Electrograms were matched with scar extent of the corresponding DE-CMR segment using a 16-segment/slice model. Non-scar was defined as 0% scar, while scar was defined as 1-100% scar extent. Results UnipVs were moderately lower in scar than in non-scar (endocardial 7.1 [4.6-10.6] vs. 10.3 [7.4-14.2] mV; epicardial 6.7 [3.6-10.5] vs. 7.8 [4.2-12.3] mV; both p< 0.001). The correlation between UnipV and scar extent was moderate for endocardial (R = -0.33, p< 0.001), and poor for epicardial measurements (R = -0.07, p< 0.001). Endocardial UnipV predicted segments with >25%, >50% and >75% scar extent with AUCs of 0.72, 0.73 and 0.76, respectively, while epicardial UnipV were poor scar predictors, independent of scar burden (AUC = 0.47-0.56). UnipV in non-scar varied widely between patients (p< 0.001) and were lower scar compared to non-scar in only 9/22 (41%) endocardial mapped patients and 4/19 (21%) epicardial mapped patients with scar. Conclusion UnipV are slightly lower in scar compared to non-scar. However, significant UnipV differences between and within patients and large overlap between non-scar and scar limits the reliability of accurate scar assessment, especially in epicardial measurements and in segments with less than 75% scar extent.	[Nguyen, Uyen Chau; Zeemering, Stef; Prinzen', Frits W.; Vernooy', Kevin] Maastricht Univ, Cardiovasc Res Inst, Dept Physiol, Maastricht, Netherlands; [Nguyen, Uyen Chau; Mafi-Rad, Masih; van Stipdonk, Antonius M. W.; Bekkers, Sebastiaan C. A. M.; Vernooy', Kevin] Maastricht Univ, Med Ctr, Dept Cardiol, Maastricht, Netherlands; [Nguyen, Uyen Chau; Maffessanti, Francesco; Krause, Rolf; Prinzen', Frits W.; Auricchio, Angelo] Univ Svizzera Italiana, Ctr Computat Med Cardiol, Inst Computat Sci, Lugano, Switzerland; [Conte, Giulio; Regoli, Francois; Caputo, Maria Luce; Suerder, Daniel; Moccetti, Tiziano; Auricchio, Angelo] Fdn Cardioctr Ticino, Dept Cardiol, Lugano, Switzerland	Maastricht University; Maastricht University; Universita della Svizzera Italiana	Nguyen, UC (corresponding author), Maastricht Univ, Cardiovasc Res Inst, Dept Physiol, Maastricht, Netherlands.; Nguyen, UC (corresponding author), Maastricht Univ, Med Ctr, Dept Cardiol, Maastricht, Netherlands.; Nguyen, UC (corresponding author), Univ Svizzera Italiana, Ctr Computat Med Cardiol, Inst Computat Sci, Lugano, Switzerland.	chau27@gmail.com	Bekkers, Sebastiaan C.A.M./Y-1484-2019; Maffessanti, Francesco/ABH-6429-2020; Maffessanti, Francesco/CAF-3033-2022	Maffessanti, Francesco/0000-0001-7364-3734; Vernooy, Kevin/0000-0002-8818-5964; Conte, Giulio/0000-0003-2248-3456; Nguyen, Uyen Chau/0000-0002-4836-2946	Swiss National Science Foundation [32003B_165802]; Swiss Heart Foundation; Biologic Delivery Systems, Division of Biosense Webstera Johnson & Johnson Company; Fondazione Cardiocentro Ticino; Theo Rossidi Montelera Foundation; Mantegazza Foundation; FIDINAM; Maastricht University; Dutch Heart Foundation [2015T61]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Heart Foundation; Biologic Delivery Systems, Division of Biosense Webstera Johnson & Johnson Company; Fondazione Cardiocentro Ticino; Theo Rossidi Montelera Foundation; Mantegazza Foundation; FIDINAM; Maastricht University; Dutch Heart Foundation(Netherlands Heart Foundation)	This work was supported by grants from the Swiss National Science Foundation under project 32003B_165802, from the Swiss Heart Foundation, and by are stricted grant of Biologic Delivery Systems, Division of Biosense Webstera Johnson & Johnson Company. The authors gratefully acknowledge financial support by Fondazione Cardiocentro Ticino, the Theo Rossidi Montelera Foundation, the Mantegazza Foundation, and FIDINAM to the Center of Computational Medicine in Cardiology. UCN received a Kootstra Talent Fellowship research grant from Maastricht University and was additionally funded by a research grant from the Dutch Heart Foundation (grant #2015T61).The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscrip.	Arenal A, 2014, HEART RHYTHM, V11, P1456, DOI 10.1016/j.hrthm.2014.04.022; Bartunek J, 2013, J AM COLL CARDIOL, V61, P2329, DOI 10.1016/j.jacc.2013.02.071; CASSIDY DM, 1984, CIRCULATION, V70, P37, DOI 10.1161/01.CIR.70.1.37; Codreanu A, 2008, J AM COLL CARDIOL, V52, P839, DOI 10.1016/j.jacc.2008.05.038; Hutchinson MD, 2011, CIRC-ARRHYTHMIA ELEC, V4, P49, DOI 10.1161/CIRCEP.110.959957; Kroon W, 2015, HEART RHYTHM, V12, P1259, DOI 10.1016/j.hrthm.2015.03.006; Leyva F, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-29; Nguyen UC, 2016, HEART RHYTHM OFFICIA; Pavo N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113245; Perin EC, 2002, CIRCULATION, V106, P957, DOI 10.1161/01.CIR.0000026394.01888.18; Piers SRD, 2013, EUR HEART J, V34, P586, DOI 10.1093/eurheartj/ehs382; Potse M, 2014, EUROPACE, V16, P56, DOI 10.1093/europace/euu257; Sasaki T, 2013, CIRC-ARRHYTHMIA ELEC, V6, P1139, DOI 10.1161/CIRCEP.113.000159; Soejima K, 2001, CIRCULATION, V104, P664, DOI 10.1161/hc3101.093764; Tung R, 2016, CIRC ARRHYTHM ELECTR, V9; Tung R, 2016, HEART RHYTHM, V13, P1993, DOI 10.1016/j.hrthm.2016.07.003; Tung R, 2010, HEART RHYTHM, V7, P389, DOI 10.1016/j.hrthm.2009.11.023; Wijnmaalen AP, 2011, EUR HEART J, V32, P104, DOI 10.1093/eurheartj/ehq345; Wrobleski D, 2003, J CARDIOVASC ELECTR, V14, P524, DOI 10.1046/j.1540-8167.2003.02499.x	19	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180637	10.1371/journal.pone.0180637	http://dx.doi.org/10.1371/journal.pone.0180637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678875	Green Submitted, Green Published, gold			2022-12-26	WOS:000405272200081
J	Zhang, L; Liu, XR; Liu, JZ; Zhou, ZQ; Song, YX; Cao, BY; An, XP				Zhang, Lei; Liu, Xiaorui; Liu, Junze; Zhou, Zhanqin; Song, Yuxuan; Cao, Binyun; An, Xiaopeng			miR-182 aids in receptive endometrium development in dairy goats by down-regulating PTN expression	PLOS ONE			English	Article							GROWTH-FACTOR PLEIOTROPHIN; NF-KAPPA-B; MESSENGER-RNA; STROMAL CELLS; IN-VITRO; DIFFERENTIAL EXPRESSION; EMBRYO IMPLANTATION; HORMONAL-REGULATION; DIVERSE FUNCTIONS; MENSTRUAL-CYCLE	Increasing evidence has shown that miRNAs play important roles in endometrium development during the menstrual cycle in humans and many other animals. Our previous data indicated that miR-182 levels increase 15.55-fold and pleiotrophin (PTN) levels decrease 20.97-fold in the receptive endometrium (RE, D15) compared with the pre-receptive endometrium (PE, D5) in dairy goats. The present study shows that miR-182 is widely expressed in different tissues of dairy goats and that its expression levels are regulated by E2 and P4 in endometrial epithelium cells (EECs). We confirmed that PTN is a target of miR-182 and that miR-182 regulates the protein levels of AKT, Bcl-2, FAS, MAPK, Caspase-3 and SP1 in EECs. Furthermore, miR-182 up-regulates or maintains the expression levels of osteopontin (OPN), cyclooxygenase-2 (COX-2) and prolactin receptor (PRLR) in EECs, suggesting that miR-182 is an important regulatory factor in the construction of endometrial receptivity in dairy goats. In conclusion, miR-182 participates in the development of endometrial receptivity by down-regulating PTN and affecting the expression of select apoptosis-related genes and increasing or maintaining the expression levels of OPN, COX-2 and PRLR in the EECs of dairy goats.	[Zhang, Lei; Liu, Xiaorui; Liu, Junze; Zhou, Zhanqin; Song, Yuxuan; Cao, Binyun; An, Xiaopeng] Northwest Agr & Forestry Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Cao, BY; An, XP (corresponding author), Northwest Agr & Forestry Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	binyun_cao@163.com; 124495863@qq.com			Shaanxi science and technology innovation project plan;  [2013KTZBO2-02-01];  [2015KTCQ03-08]	Shaanxi science and technology innovation project plan; ; 	Shaanxi science and technology innovation project plan (2013KTZBO2-02-01), Shaanxi science and technology innovation project plan (2015KTCQ03-08). The funders had no role in study design, data collection and analysis, decision to publish ,orpreparation of the manuscript.	Alan E, 2016, MICROSC RES TECHNIQ, V79, P285, DOI 10.1002/jemt.22629; ALBELDA SM, 1990, FASEB J, V4, P2868, DOI 10.1096/fasebj.4.11.2199285; Albini A, 2007, NAT PROTOC, V2, P504, DOI 10.1038/nprot.2006.466; Altmae S, 2013, REPROD SCI, V20, P308, DOI 10.1177/1933719112453507; [Anonymous], 2015, SCI REPORTS, P5; Antonsson B, 2000, EXP CELL RES, V256, P50, DOI 10.1006/excr.2000.4839; Antsiferova YS, 2016, WORLD J OBSTET GYNE, V5; Arai M, 2014, ANIM REPROD SCI, V151, P97, DOI 10.1016/j.anireprosci.2014.10.004; Arai M, 2013, ANIM REPROD SCI, V142, P1, DOI 10.1016/j.anireprosci.2013.08.003; Bagci EZ, 2006, BIOPHYS J, V90, P1546, DOI 10.1529/biophysj.105.068122; Bany BM, 2001, ENDOCRINOLOGY, V142, P955, DOI 10.1210/en.142.2.955; Bauersachs S, 2013, J REPROD IMMUNOL, V97, P20, DOI 10.1016/j.jri.2012.11.002; Blondet B, 2005, J HISTOCHEM CYTOCHEM, V53, P971, DOI 10.1369/jhc.4A6574.2005; Bowden ET, 2002, J BIOL CHEM, V277, P35862, DOI 10.1074/jbc.M203963200; Brigstock DR, 1996, J ENDOCRINOL, V148, P103, DOI 10.1677/joe.0.1480103; Cai JL, 2016, TOXICOLOGY, V365, P25, DOI 10.1016/j.tox.2016.07.017; Cha J., 2013, MOL INTERPLAY SUCCES; CHAKRABORTY I, 1995, J ENDOCRINOL, V147, P339, DOI 10.1677/joe.0.1470339; Chen C, 2015, REPROD SCI, V120, P1297; Chen C, 2016, SCI REP-UK, V6, DOI 10.1038/srep25302; Chen J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/985814; Chu PY, 2006, THERIOGENOLOGY, V66, P1545, DOI 10.1016/j.theriogenology.2006.01.018; Chung HW, 2002, MOL HUM REPROD, V8, P350, DOI 10.1093/molehr/8.4.350; Creighton CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009637; da Costa RPR, 2007, REPROD FERT DEVELOP, V19, P925, DOI 10.1071/RD06159; Das SK, 1997, BIOL REPROD, V56, P1390, DOI 10.1095/biolreprod56.6.1390; Demir R, 2010, ACTA HISTOCHEM, V112, P203, DOI 10.1016/j.acthis.2009.04.004; Deuel TF, 2002, ARCH BIOCHEM BIOPHYS, V397, P162, DOI 10.1006/abbi.2001.2705; Dorjgochoo T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060915; Du CL, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0182-1; Eissing T, 2007, BIOPHYS J, V92, P3332, DOI 10.1529/biophysj.106.100362; Evans PW, 1998, HUM REPROD, V13, P1057, DOI 10.1093/humrep/13.4.1057; Fluhr H, 2013, REPROD BIOL, V13, P113, DOI 10.1016/j.repbio.2013.03.001; Gartner MA, 2016, REPROD FERT DEVELOP, V28, P982, DOI 10.1071/RD14219; Galan A, 2000, BIOL REPROD, V63, P430, DOI 10.1093/biolreprod/63.2.430; Ganeff C, 2009, MOL HUM REPROD, V15, P27, DOI 10.1093/molehr/gan073; Gibson DA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19970; Gillies LA, 2014, J CELL BIOCHEM, V115, P632, DOI 10.1002/jcb.24709; Gown AM, 2002, J HISTOCHEM CYTOCHEM, V50, P449, DOI 10.1177/002215540205000401; Greenbaum LE, 2004, CANCER BIOL THER, V3, P1200, DOI 10.4161/cbt.3.12.1392; Gu CO, 2011, CANCER SCI, V102, P557, DOI 10.1111/j.1349-7006.2010.01829.x; Gu DY, 2007, FEBS LETT, V581, P382, DOI 10.1016/j.febslet.2006.12.043; Gu Y, 2015, INT J CLIN EXP MED, V8, P3227; Gu YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150954; Harada T, 2004, HUM REPROD UPDATE, V10, P29, DOI 10.1093/humupd/dmh007; Henriques S, 2015, Reprod Fertil Dev, DOI 10.1071/RD14245; Horcajadas JA, 2004, ANN NY ACAD SCI, V1034, P166, DOI 10.1196/annals.1335.019; Horikoshi Y, 2003, J CLIN ENDOCR METAB, V88, P914, DOI 10.1210/jc.2002-021235; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Isayama K, 2015, AM J PHYSIOL-ENDOC M, V308, P2462, DOI DOI 10.1152/AJPEND0.00533.2014; Jabbour HN, 1998, J CLIN ENDOCR METAB, V83, P2545, DOI 10.1210/jc.83.7.2545; Jimenez PT, 2016, MOL ENDOCRINOL; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Johnson GA, 2003, BIOL REPROD, V68, P1951, DOI 10.1095/biolreprod.102.012948; Kadomatsu KJ, 2004, CANCER LETT, V204, P127, DOI 10.1016/S0304-3835(03)00450-6; Kanamori Y, 2001, CLIN CANCER RES, V7, P892; Kang YJ, 2015, J CELL SCI, V128, P804, DOI 10.1242/jcs.164004; Kaufmann P, 2004, PLACENTA, V25, P114, DOI 10.1016/j.placenta.2003.10.009; Kennedy TG, 2007, REPRODUCTION, V134, P635, DOI 10.1530/REP-07-0328; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kouri FM, 2015, GENE DEV, V29, P732, DOI 10.1101/gad.257394.114; Krzymowska S, 2001, ACTA VET HUNG, P49; Kuo HP, 2015, J FUNCT FOODS, V17, P600, DOI 10.1016/j.jff.2015.06.006; Laaroubi Khalid, 1995, Progress in Growth Factor Research, V6, P25; Lei R, 2014, ONCOGENE, V33, P1287, DOI 10.1038/onc.2013.65; LESSEY BA, 1994, FERTIL STERIL, V62, P497; Li G, 2006, J BIOL CHEM, V281, P10663, DOI 10.1074/jbc.M512509200; LI R, 1991, CELL, V65, P493, DOI 10.1016/0092-8674(91)90467-D; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Li ZF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028806, 10.1371/journal.pone.0052388]; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lin RK, 2014, BIOMED PHARMACOTHER, V68, P929, DOI 10.1016/j.biopha.2014.10.003; Lin SY, 1996, MOL CELL BIOL, V16, P1668; Mansouri-Attia N, 2009, PHYSIOL GENOMICS, V39, P14, DOI 10.1152/physiolgenomics.90404.2008; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; Maruyama T, 2008, ENDOCR J, V55, P795, DOI 10.1507/endocrj.K08E-067; Mihelich BL, 2011, J BIOL CHEM, V286, P44503, DOI 10.1074/jbc.M111.262915; Miravet-Valenciano JA, 2015, CURR OPIN OBSTET GYN, V27, P187, DOI 10.1097/GCO.0000000000000173; Muramatsu H, 2006, GENES CELLS, V11, P1405, DOI 10.1111/j.1365-2443.2006.01028.x; Muramatsu T, 2002, J BIOCHEM, V132, P359, DOI 10.1093/oxfordjournals.jbchem.a003231; Murphy CR, 2004, CELL RES, V14, P259, DOI 10.1038/sj.cr.7290227; Murray MJ, 1999, SEMIN REPROD ENDOCR, V17, P275, DOI 10.1055/s-2007-1016235; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; NAWAZ S, 1987, AM J PATHOL, V127, P51; Nuchprayoon I, 1999, J BIOL CHEM, V274, P1085, DOI 10.1074/jbc.274.2.1085; Oner H, 2010, FOLIA HISTOCHEM CYTO, V48, P71, DOI 10.2478/v10042-008-0088-2; Otsuki Yoshinori, 2001, Medical Electron Microscopy, V34, P166, DOI 10.1007/s007950100011; Pampfer S, 1999, CELL DEATH DIFFER, V6, P533, DOI 10.1038/sj.cdd.4400516; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Powers C, 2002, J BIOL CHEM, V277, P14153, DOI 10.1074/jbc.M112354200; Pufe T, 2003, OSTEOARTHR CARTILAGE, V11, P260, DOI 10.1016/S1063-4584(02)00385-0; Qi XF, 2012, DOMEST ANIM ENDOCRIN, V42, P210, DOI 10.1016/j.domaniend.2011.12.004; Qi XF, 2012, REPROD BIOL, V12, P309, DOI 10.1016/j.repbio.2012.09.003; Qu Y, 2013, INT J CANCER, V133, P544, DOI 10.1002/ijc.28056; Schulte AM, 2000, ONCOGENE, V19, P3988, DOI 10.1038/sj.onc.1203742; SilosSantiago I, 1996, J NEUROBIOL, V31, P283, DOI 10.1002/(SICI)1097-4695(199611)31:3<283::AID-NEU2>3.0.CO;2-6; Song J, 2002, MOL HUM REPROD, V8, P447, DOI 10.1093/molehr/8.5.447; Song YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122202; Sookvanichsilp N, 2002, CONTRACEPTION, V65, P373, DOI 10.1016/S0010-7824(01)00322-5; Souttou B, 1997, J BIOL CHEM, V272, P19588, DOI 10.1074/jbc.272.31.19588; Souttou B, 2001, J CELL PHYSIOL, V187, P59, DOI 10.1002/1097-4652(2001)9999:9999<00::AID-JCP1051>3.0.CO;2-F; Subramaniam KS, 2016, AM J CANCER RES, V6, P200; Sun X, 2014, MOL CELL BIOCHEM, V388, P11, DOI 10.1007/s11010-013-1895-0; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Talbi S, 2006, ENDOCRINOLOGY, V147, P1097, DOI 10.1210/en.2005-1076; Tamura I, 2014, ENDOCRINOLOGY, V155, P275, DOI 10.1210/en.2013-1569; Tao XJ, 1997, J CLIN ENDOCR METAB, V82, P2738, DOI 10.1210/jc.82.8.2738; Thie M, 2002, CELLS TISSUES ORGANS, V172, P237, DOI 10.1159/000066963; Tranguch S, 2014, INT J DEV BIOL, V58, P79, DOI 10.1387/ijdb.130332st; UDVADIA AJ, 1995, P NATL ACAD SCI USA, V92, P3953, DOI 10.1073/pnas.92.9.3953; VACHEROT F, 1995, IN VITRO CELL DEV-AN, V31, P647; Van Cruchten S, 2003, THERIOGENOLOGY, V60, P1595, DOI 10.1016/S0093-691X(03)00178-X; Van SM, 2015, REPROD FERT DEVELOP; VANDERWINDEN JM, 1992, ANAT EMBRYOL, V186, P387; Vilella F, 2013, J CLIN ENDOCR METAB, V98, P4123, DOI 10.1210/jc.2013-2205; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wallis CJD, 2015, J CANCER, V6, P1295, DOI 10.7150/jca.13176; Wei P, 2005, MOL REPROD DEV, V70, P478, DOI 10.1002/mrd.20215; Wei Q, 2015, THORAC CANCER, V6, P2, DOI 10.1111/1759-7714.12164; Wilkanowska A, 2014, FOLIA BIOL-KRAKOW, V62, P1, DOI 10.3409/fb62_1.1; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zeng J, 2013, EXP CLIN ENDOCR DIAB, V121, P425, DOI 10.1055/s-0033-1345169; Zhang DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123423; Zhang L. L., 2015, SCI REP, P5; Zhang S, 2013, MOL REPROD DEV, V80, P8, DOI 10.1002/mrd.22118; Zhang Y., 2013, J NANOMATER, V2013, P7, DOI DOI 10.1371/J0URNAL.P0NE.0069715; Zhao HH, 2014, J CELL MOL MED, V18, P283, DOI 10.1111/jcmm.12186; Zhu HQ, 2014, INT J CARDIOL, V176, P764, DOI 10.1016/j.ijcard.2014.07.095	130	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179783	10.1371/journal.pone.0179783	http://dx.doi.org/10.1371/journal.pone.0179783			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678802	gold, Green Submitted, Green Published			2022-12-26	WOS:000405272200027
J	Ge, F; Huang, X; Hu, HM; Zhang, YL; Li, ZL; Zou, CY; Peng, HW; Li, LJ; Gao, SB; Pan, GT; Shen, Y				Ge, Fei; Huang, Xing; Hu, Hongmei; Zhang, Yanling; Li, Zhaoling; Zou, Chaoying; Peng, Huanwei; Li, Lujiang; Gao, Shibin; Pan, Guangtang; Shen, Yaou			Endogenous small interfering RNAs associated with maize embryonic callus formation	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; MICRORNA REGULATION; DNA-METHYLATION; AUXIN; GENE; EMBRYOGENESIS; BIOGENESIS; STRESS; CELLS	The induction efficiency of maize embryonic callus is highly dependent on the genotype, and only a few lines possess a high capacity for callus formation. Although certain genes and pathways have been reported to contribute to the regulation of callus induction, to the best of our knowledge, the functions of the small interfering RNAs (siRNAs) involved in this process remain unknown. In this study, we identified 861 differentially expressed siRNAs and 576 target genes in the callus induction process. These target genes were classified into 3 clusters, and their functions involve controlling metalloexopeptidase activity, catalase activity, transcription regulation, and O-methyltransferase activity. In addition, certain genes related to auxin transport and stem cell or meristem development (e.g., PLT5-like, ARF15, SAUR-like, FAS1-like, Fea3, SCL5, and Zmwox2A) were regulated by the differentially expressed siRNAs. Moreover, zma-siR004119-2 directly cleaves the 5' UTR of Homeobox-transcription factor 25, which further leads to the down-regulation of its expression. Twelve 24-nt-siRNAs led to the hyper-methylation of GRMZM2G013465, which further decreases its expression. These results suggest that differentially expressed siRNAs regulate callus formation by controlling the expression of their target genes.	[Ge, Fei; Huang, Xing; Hu, Hongmei; Zhang, Yanling; Li, Zhaoling; Zou, Chaoying; Li, Lujiang; Gao, Shibin; Pan, Guangtang; Shen, Yaou] Sichuan Agr Univ, Key Lab Biol & Genet Improvement Maize Southwest, Maize Res Inst, Chengdu, Sichuan, Peoples R China; [Peng, Huanwei] Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Shen, Y (corresponding author), Sichuan Agr Univ, Key Lab Biol & Genet Improvement Maize Southwest, Maize Res Inst, Chengdu, Sichuan, Peoples R China.	shenyaou@aliyun.com			National Natural Science Foundation of China [31271739, 31471512]; Yong Scientists Fund of Sichuan Province [2016JQ0008]; Project of Transgenic New Variety Cultivation [2016ZX080030 03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yong Scientists Fund of Sichuan Province; Project of Transgenic New Variety Cultivation	This study was supported by the National Natural Science Foundation of China (31271739 and 31471512, http://www.nsfc.gov.cn/), the Yong Scientists Fund of Sichuan Province (2016JQ0008, http://www.qnjj.sc.cn/) and the Project of Transgenic New Variety Cultivation (2016ZX080030 03,http://www.nmp.gov.cn/zxjs/200901/ t20090113_2113.htm). All of the funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Barber WT, 2012, P NATL ACAD SCI USA, V109, P10444, DOI 10.1073/pnas.1202073109; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Eshed Y, 2001, CURR BIOL, V11, P1251, DOI 10.1016/S0960-9822(01)00392-X; Gallavotti A, 2008, PLANT PHYSIOL, V147, P1913, DOI 10.1104/pp.108.121541; Ge F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01280-8; Il Je B, 2016, NAT GENET, V48, P785, DOI 10.1038/ng.3567; Izhaki A, 2007, PLANT CELL, V19, P495, DOI 10.1105/tpc.106.047472; Kasai M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-63; Kaya H, 2001, CELL, V104, P131, DOI 10.1016/S0092-8674(01)00197-0; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Ledwon A, 2009, PLANT CELL REP, V28, P1677, DOI 10.1007/s00299-009-0767-2; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Li TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043451; Liu HJ, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1055-x; Lowe K, 2016, PLANT CELL, V28, P1998, DOI 10.1105/tpc.16.00124; Ma Li, 2007, Fen Zi Xi Bao Sheng Wu Xue Bao, V40, P164; Marsoni M, 2008, PLANT CELL REP, V27, P347, DOI 10.1007/s00299-007-0438-0; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Pasternak TP, 2002, PLANT PHYSIOL, V129, P1807, DOI 10.1104/pp.000810; Qi X, 2013, PLANT MOL BIOL, V83, P459, DOI 10.1007/s11103-013-0104-6; Shen Y, 2013, BIOCHEM BIOPH RES CO, V441, P425, DOI 10.1016/j.bbrc.2013.10.113; Shen Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032237; Sun LF, 2013, PLANT CELL TISS ORG, V113, P103, DOI 10.1007/s11240-012-0255-1; Tan BC, 2013, PLANT MOL BIOL REP, V31, P1220, DOI 10.1007/s11105-013-0590-3; Varhanikova M, 2014, J PROTEOMICS, V104, P57, DOI 10.1016/j.jprot.2014.02.003; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Verdeil JL, 2007, TRENDS PLANT SCI, V12, P245, DOI 10.1016/j.tplants.2007.04.002; Vernoux T, 2005, CURR OPIN GENET DEV, V15, P388, DOI 10.1016/j.gde.2005.06.008; Williams L, 2005, CURR OPIN PLANT BIOL, V8, P582, DOI 10.1016/j.pbi.2005.09.010; Wu XM, 2015, PLANT BIOTECHNOL J, V13, P383, DOI 10.1111/pbi.12317; Wu YJ, 2013, BIOORGAN MED CHEM, V21, P2217, DOI 10.1016/j.bmc.2013.02.010; Xu C, 2013, PROTEIN CELL, V4, P656, DOI 10.1007/s13238-013-3052-7; Yang X., 2012, P 20 ACM INT C MULT, P1057, DOI [10.1145/2393347.2396382, DOI 10.1145/2393347.2396382]; Yang XY, 2013, J EXP BOT, V64, P1521, DOI 10.1093/jxb/ert013; Zhang TQ, 2017, PLANT CELL; Zhang XM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r20; Zhong SH, 2013, P NATL ACAD SCI USA, V110, P9171, DOI 10.1073/pnas.1219655110	38	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180567	10.1371/journal.pone.0180567	http://dx.doi.org/10.1371/journal.pone.0180567			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672003	gold, Green Published, Green Submitted			2022-12-26	WOS:000405268500068
J	Ghotbaddini, M; Cisse, K; Carey, A; Powell, JB				Ghotbaddini, Maryam; Cisse, Keyana; Carey, Alexis; Powell, Joann B.			Simultaneous inhibition of aryl hydrocarbon receptor (AhR) and Src abolishes androgen receptor signaling	PLOS ONE			English	Article							PROSTATE-CANCER PROGRESSION; TYROSINE PHOSPHORYLATION; GROWTH; ACTIVATION; CELLS; IDENTIFICATION	Altered c-Src activity has been strongly implicated in the development, growth, progression, and metastasis of human cancers including prostate cancer. Src is known to regulate several biological functions of tumor cells, including proliferation. There are several Src inhibitors under evaluation for clinical effectiveness but have shown little activity in monotherapy trials of solid tumors. Combination studies are being explored by in vitro analysis and in clinical trials. Here we investigate the effect of simultaneous inhibition of the aryl hydrocarbon receptor (AhR) and Src on androgen receptor (AR) signaling in prostate cancer cells. AhR has also been reported to interact with the Src signaling pathway during prostate development. c-Src protein kinase is associated with the AhR complex in the cytosol and upon ligand binding to AhR, c-Src is activated and released from the complex. AhR has also been shown to regulate AR signaling which remains functionally important in the development and progression of prostate cancer. We provide evidence that co-inhibition of AhR and Src abolish AR activity. Evaluation of total protein and cellular fractions revealed decreased pAR expression and AR nuclear localization. Assays utilizing an androgen responsive element (ARE) and qRT-PCR analysis of AR genes revealed decreased AR promoter activity and transcriptional activity in the presence of both AhR and Src inhibitors. Furthermore, coinhibition of AhR and Src reduced the growth of prostate cancer cells compared to individual treatments. Several studies have revealed that AhR and Src individually inhibit cellular proliferation. However, this study is the first to suggest simultaneous inhibition of AhR and Src to inhibit AR signaling and prostate cancer cell growth.	[Ghotbaddini, Maryam; Cisse, Keyana; Carey, Alexis; Powell, Joann B.] Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, Atlanta, GA 30314 USA	Clark Atlanta University	Powell, JB (corresponding author), Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, Atlanta, GA 30314 USA.	jpowell@cau.edu		Carey, Alexis/0000-0002-8555-8139; Powell, Joann/0000-0002-9864-6744	NIH-NIMHD [2G12MD007590-29]; National Institute on Minority Health and Health Disparities [G12MD007590] Funding Source: NIH RePORTER	NIH-NIMHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NIH-NIMHD Grant: 2G12MD007590-29.	Asim M, 2008, ONCOGENE, V27, P3596, DOI 10.1038/sj.onc.1211016; Chang YM, 2007, NEOPLASIA, V9, P90, DOI 10.1593/neo.06694; Tran C, 2013, BIOCHEM PHARMACOL, V85, P753, DOI 10.1016/j.bcp.2012.12.010; DaSilva J, 2009, CANCER RES, V69, P7402, DOI 10.1158/0008-5472.CAN-08-4687; Dong B, 2011, BBA-GEN SUBJECTS, V1810, P427, DOI 10.1016/j.bbagen.2010.11.007; Drake JM, 2012, P NATL ACAD SCI USA, V109, P1643, DOI 10.1073/pnas.1120985109; Enan E, 1996, BIOCHEM PHARMACOL, V52, P1599, DOI 10.1016/S0006-2952(96)00566-7; Frauenstein K, 2015, ARCH TOXICOL, V89, P1329, DOI 10.1007/s00204-014-1321-8; Gioeli D, 2006, MOL ENDOCRINOL, V20, P503, DOI 10.1210/me.2005-0351; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Kraus S, 2006, CANCER RES, V66, P11047, DOI 10.1158/0008-5472.CAN-06-0596; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; Mehta V, 2011, DIFFERENTIATION, V82, P211, DOI 10.1016/j.diff.2011.05.011; Migliaccio A, 2007, ONCOGENE, V26, P6619, DOI 10.1038/sj.onc.1210487; Ojemuyiwa MA, 2014, EXPERT OPIN EMERG DR, V19, P459, DOI 10.1517/14728214.2014.969239; Ponguta LA, 2008, J BIOL CHEM, V283, P20989, DOI 10.1074/jbc.M802392200; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Su B, 2013, CANCER MED-US, V2, P784, DOI 10.1002/cam4.144; Suzman DL, 2014, THER ADV MED ONCOL, V6, P167, DOI 10.1177/1758834014529176; Tatarov O, 2009, CLIN CANCER RES, V15, P3540, DOI 10.1158/1078-0432.CCR-08-1857; Vlaeminck-Guillem V, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00222; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; Xie GF, 2012, AM J PHYSIOL-GASTR L, V302, pG1006, DOI 10.1152/ajpgi.00427.2011; Yang XH, 2008, J CELL BIOCHEM, V104, P402, DOI 10.1002/jcb.21630; Yu J, 2012, BIOCHEM BIOPH RES CO, V424, P538, DOI 10.1016/j.bbrc.2012.06.151	27	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0179844	10.1371/journal.pone.0179844	http://dx.doi.org/10.1371/journal.pone.0179844			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671964	Green Published, gold, Green Submitted			2022-12-26	WOS:000405268500006
J	Magennis, EP; Francini, N; Mastrotto, F; Catania, R; Redhead, M; Fernandez-Trillo, F; Bradshaw, D; Churchley, D; Winzer, K; Alexander, C; Mantovani, G				Magennis, Eugene P.; Francini, Nora; Mastrotto, Francesca; Catania, Rosa; Redhead, Martin; Fernandez-Trillo, Francisco; Bradshaw, David; Churchley, David; Winzer, Klaus; Alexander, Cameron; Mantovani, Giuseppe			Polymers for binding of the gram-positive oral pathogen Streptococcus mutans	PLOS ONE			English	Article							IN-VITRO CYTOTOXICITY; ANTIMICROBIAL POLYMERS; GENE DELIVERY; BACTERIA; SURFACES; GLYCOPOLYMERS; BIOFILM; COLOCALIZATION; AGGREGATION; ANTIBODIES	Streptococcus mutans is the most significant pathogenic bacterium implicated in the formation of dental caries and, both directly and indirectly, has been associated with severe conditions such as multiple sclerosis, cerebrovascular and peripheral artery disease. Polymers able to selectively bind S. mutans and/or inhibit its adhesion to oral tissue in a non-lethal manner would offer possibilities for addressing pathogenicity without selecting for populations resistant against bactericidal agents. In the present work two libraries of 2-(dimethylamino) ethyl methacrylate (pDMAEMA)-based polymers were synthesized with various proportions of either N, N, N-trimethylethanaminium cationic-or sulfobetaine zwitterionic groups. These copolymers where initially tested as potential macromolecular ligands for S. mutans NCTC 10449, whilst Escherichia coli MG1655 was used as Gram-negative control bacteria. pDMAEMA-derived materials with high proportions of zwitterionic repeating units were found to be selective for S. mutans, in both isolated and S. mutans-E. coli mixed bacterial cultures. Fully sulfobetainized pDMAEMA was subsequently found to bind/cluster preferentially Gram-positive S. mutans and S. aureus compared to Gram negative E. coli and V. harveyi. A key initial stage of S. mutans pathogenesis involves a lectin-mediated adhesion to the tooth surface, thus the range of potential macromolecular ligands was further expanded by investigating two glycopolymers bearing a-mannopyranoside and beta-galactopyranoside pendant units. Results with these polymers indicated that preferential binding to either S. mutans or E. coli can be obtained by modulating the glycosylation pattern of the chosen multivalent ligands without incurring unacceptable cytotoxicity in a model gastrointestinal cell line. Overall, our results allowed to identify a structure-property relationship for the potential antimicrobial polymers investigated, and suggest that preferential binding to Gram-positive S. mutans could be achieved by fine-tuning of the recognition elements in the polymer ligands.	[Magennis, Eugene P.; Mastrotto, Francesca; Catania, Rosa; Redhead, Martin; Alexander, Cameron; Mantovani, Giuseppe] Univ Nottingham, Sch Pharm, Nottingham, England; [Francini, Nora] Univ Nottingham, Sch Med, Nottingham, England; [Mastrotto, Francesca] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Fernandez-Trillo, Francisco] Univ Birmingham, Sch Chem, Haworth Bldg, Birmingham, W Midlands, England; [Bradshaw, David; Churchley, David] GlaxoSmithKline, St Georges Ave, Weybridge, Surrey, England; [Winzer, Klaus] Univ Nottingham, Sch Life Sci, BBSRC EPSRC Synthet Biol Res Ctr SBRC, Nottingham, England	University of Nottingham; University of Nottingham; University of Padua; University of Birmingham; GlaxoSmithKline; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of Nottingham	Alexander, C; Mantovani, G (corresponding author), Univ Nottingham, Sch Pharm, Nottingham, England.	cameron.alexander@nottingham.ac.uk; giuseppe.mantovani@nottingham.ac.uk	Gao, Jing/M-8264-2018; Mastrotto, Francesca/AEU-4019-2022; Mantovani, Giuseppe/O-3430-2016; Fernandez-Trillo, Paco/D-7192-2013; Alexander, Cameron/N-7729-2014	Mantovani, Giuseppe/0000-0002-0837-0351; Fernandez-Trillo, Paco/0000-0002-6680-5683; Alexander, Cameron/0000-0001-8337-1875; Francini, Nora/0000-0001-7681-6442; Mastrotto, Francesca/0000-0002-2499-5490; Winzer, Klaus/0000-0002-3956-8096; Catania, Rosa/0000-0002-4717-808X	Biotechnology and Biological Sciences Research Council [BB/H53052X/1]; Engineering and Physical Sciences Research Council [EP/H005625/1, EP/G042462/1, EP/I01375X/1]; GSK Consumer Healthcare; EPSRC [EP/G042462/1, EP/H005625/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); GSK Consumer Healthcare; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council [grant number BB/H53052X/1] (UK, http://www.bbsrc.ac.uk) with GSK Consumer Healthcare, to EPM; and the Engineering and Physical Sciences Research Council [grant numbers EP/H005625/1, EP/G042462/1, EP/I01375X/1] (UK, http://www.epsrc.ac.uk) with the first grant to EPM, and the second and third grants to EP.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; Aherne A, 1996, J AM CHEM SOC, V118, P8771, DOI 10.1021/ja960123c; Ahmed M, 2012, BIOCONJUGATE CHEM, V23, P1050, DOI 10.1021/bc3000723; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Alvarez-Paino M, 2015, BIOMACROMOLECULES, V16, P295, DOI 10.1021/bm5014876; Angelis ID, 2001, CURRENT PROTOCOLS TO; [Anonymous], 2010, NAT REV MICROBIOL, V8, P244, DOI 10.1038/nrmicro2345; Avila M, 2009, DNA CELL BIOL, V28, P405, DOI 10.1089/dna.2009.0874; Baek MG, 2000, BIOCONJUGATE CHEM, V11, P777, DOI 10.1021/bc000026f; Banas JA, 2003, CRIT REV ORAL BIOL M, V14, P89, DOI 10.1177/154411130301400203; Beyth N, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/246012; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Cao B, 2016, CHEM SCI, V7, P1976, DOI 10.1039/c5sc03887a; Chen J, 2014, CHEM COMMUN, V50, P14482, DOI 10.1039/c4cc03001j; Cheng G, 2007, BIOMATERIALS, V28, P4192, DOI 10.1016/j.biomaterials.2007.05.041; Cheng G, 2009, BIOMATERIALS, V30, P5234, DOI 10.1016/j.biomaterials.2009.05.058; CHOKSAKULNIMITR S, 1995, J CONTROL RELEASE, V34, P233, DOI 10.1016/0168-3659(95)00007-U; De Geest BG, 2005, ADV MATER, V17, P2357, DOI 10.1002/adma.200401951; Deng ZC, 2009, J POLYM SCI POL CHEM, V47, P614, DOI 10.1002/pola.23187; DICKSON JS, 1989, APPL ENVIRON MICROB, V55, P832, DOI 10.1128/AEM.55.4.832-836.1989; Disney MD, 2004, J AM CHEM SOC, V126, P13343, DOI 10.1021/ja047936i; Du JZ, 2005, J AM CHEM SOC, V127, P17982, DOI 10.1021/ja056514l; Fine DH, 2001, J CLIN PERIODONTOL, V28, P697, DOI 10.1034/j.1600-051x.2001.028007697.x; Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3; Gestwicki JE, 2002, NATURE, V415, P81, DOI 10.1038/415081a; GOLDBERG S, 1990, J BACTERIOL, V172, P5650, DOI 10.1128/jb.172.10.5650-5654.1990; Gottenbos B, 2001, J ANTIMICROB CHEMOTH, V48, P7, DOI 10.1093/jac/48.1.7; Huang CJ, 2012, BIOMATERIALS, V33, P3626, DOI 10.1016/j.biomaterials.2012.01.059; Jain A, 2014, ADV HEALTHC MATER, V3, P1969, DOI 10.1002/adhm.201400418; JENKINS S, 1988, J CLIN PERIODONTOL, V15, P415, DOI 10.1111/j.1600-051X.1988.tb01595.x; Kamma JJ, 1999, J PERIODONTAL RES, V34, P25, DOI 10.1111/j.1600-0765.1999.tb02218.x; Kenawy ER, 2007, BIOMACROMOLECULES, V8, P1359, DOI 10.1021/bm061150q; Kiessling LL, 2006, ANGEW CHEM INT EDIT, V45, P2348, DOI 10.1002/anie.200502794; Koo H, 2010, J BACTERIOL, V192, P3024, DOI 10.1128/JB.01649-09; Krishnamurthy VM, 2006, BIOMATERIALS, V27, P3663, DOI 10.1016/j.biomaterials.2006.02.006; Kuroda K, 2013, WIRES NANOMED NANOBI, V5, P49, DOI 10.1002/wnan.1199; Ladmiral V, 2006, J AM CHEM SOC, V128, P4823, DOI 10.1021/ja058364k; LEVINE MJ, 1978, INFECT IMMUN, V19, P107, DOI 10.1128/IAI.19.1.107-115.1978; Lieberzeit PA, 2005, SENSORS-BASEL, V5, P509, DOI 10.3390/s5120509; LIGTENBERG AJM, 1990, ARCH ORAL BIOL, V35, pS141, DOI 10.1016/0003-9969(90)90145-Z; Little TJ, 2012, NAT MED, V18, P217, DOI 10.1038/nm.2572; Liu QS, 2016, LANGMUIR, V32, P7866, DOI 10.1021/acs.langmuir.6b01329; LOESCHE WJ, 1975, INFECT IMMUN, V11, P1252, DOI 10.1128/IAI.11.6.1252-1260.1975; Louzao I, 2015, EUR J PHARM BIOPHARM, V95, P47, DOI 10.1016/j.ejpb.2015.05.026; Lui LT, 2013, NAT CHEM, V5, P1058, DOI [10.1038/NCHEM.1793, 10.1038/nchem.1793]; Lundquist JJ, 2002, CHEM REV, V102, P555, DOI 10.1021/cr000418f; Lussi A, 2011, CLIN ORAL INVEST, P1; Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014; Ma F, 2015, ANAL CHEM, V87, P1560, DOI 10.1021/ac502712q; Magennis EP, 2014, NAT MATER, V13, P748, DOI [10.1038/NMAT3949, 10.1038/nmat3949]; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Marthaler TM, 2004, CARIES RES, V38, P173, DOI 10.1159/000077752; McCormack MG, 2015, AM J INFECT CONTROL, V43, P35, DOI 10.1016/j.ajic.2014.09.015; Metallo SJ, 2003, J AM CHEM SOC, V125, P4534, DOI 10.1021/ja030045a; Mi L, 2012, BIOMATERIALS, V33, P2001, DOI 10.1016/j.biomaterials.2011.11.071; Miura Y, 2016, CHEM REV, V116, P1673, DOI 10.1021/acs.chemrev.5b00247; Molander A, 1998, INT ENDOD J, V31, P1, DOI 10.1046/j.1365-2591.1998.t01-1-00111.x; Munoz-Bonilla A, 2015, MATERIALS, V8, P2276, DOI 10.3390/ma8052276; Munoz-Bonilla A, 2015, EUR POLYM J, V65, P46, DOI 10.1016/j.eurpolymj.2015.01.030; Munoz-Bonilla A, 2012, PROG POLYM SCI, V37, P281, DOI 10.1016/j.progpolymsci.2011.08.005; Nagata K, 1982, J DENTAL HLTH, V32, P386; Ohara-Nemoto Y, 2008, J MED MICROBIOL, V57, P95, DOI 10.1099/jmm.0.47561-0; Pasparakis G, 2008, ANGEW CHEM INT EDIT, V47, P4847, DOI 10.1002/anie.200801098; Pasparakis G, 2007, J AM CHEM SOC, V129, P11014, DOI 10.1021/ja074349z; Pennisi E, 2005, SCIENCE, V307, P1899, DOI 10.1126/science.307.5717.1899; Putnam D, 2001, P NATL ACAD SCI USA, V98, P1200, DOI 10.1073/pnas.031577698; Ravi P, 2005, J PHYS CHEM B, V109, P22791, DOI 10.1021/jp053088h; Rawlinson LAB, 2010, BIOMACROMOLECULES, V11, P443, DOI 10.1021/bm901166y; Salton M. R. J., 1996, MED MICROBIOLOGY; Schirhagl R, 2012, ANALYST, V137, P1495, DOI 10.1039/c2an15927a; Seemann R, 2001, CARIES RES, V35, P156, DOI 10.1159/000047448; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; Sharon N, 2006, BBA-GEN SUBJECTS, V1760, P527, DOI 10.1016/j.bbagen.2005.12.008; Sheiham A, 2006, BRIT DENT J, V201, P625, DOI 10.1038/sj.bdj.4814259; Siedenbiedel F, 2012, POLYMERS-BASEL, V4, P46, DOI 10.3390/polym4010046; Smith AJ, 2003, BRIT DENT J, V195, P701, DOI 10.1038/sj.bdj.4810832; Soenen SJH, 2009, BIOMATERIALS, V30, P6803, DOI 10.1016/j.biomaterials.2009.08.050; Souto R, 2006, BRAZ J MICROBIOL, V37, P208, DOI 10.1590/S1517-83822006000300002; Tiller JC, 2002, BIOTECHNOL BIOENG, V79, P465, DOI 10.1002/bit.10299; Timofeeva L, 2011, APPL MICROBIOL BIOT, V89, P475, DOI 10.1007/s00253-010-2920-9; Ting SRS, 2010, POLYM CHEM-UK, V1, P1392, DOI 10.1039/c0py00141d; Tu Q, 2013, COLLOID SURFACE B, V102, P361, DOI 10.1016/j.colsurfb.2012.08.033; van de Wetering P, 1998, J CONTROL RELEASE, V53, P145, DOI 10.1016/S0168-3659(97)00248-4; Wang YZ, 2014, ANAL CHEM, V86, P10164, DOI 10.1021/ac502583b; Xue X, 2011, ANGEW CHEM INT EDIT, V50, P9852, DOI 10.1002/anie.201103130; Yan XB, 2015, BIOMACROMOLECULES, V16, P1827, DOI 10.1021/acs.biomac.5b00413; Yilmaz Gokhan, 2014, Front Bioeng Biotechnol, V2, P39, DOI 10.3389/fbioe.2014.00039; You YZ, 2007, J CONTROL RELEASE, V122, P217, DOI 10.1016/j.jconrel.2007.04.020; Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580; Zhang Q, 2013, ADV POLYM SCI, V262, P39, DOI 10.1007/12_2013_254; Zhao J, 2011, J MEMBRANE SCI, V369, P5, DOI 10.1016/j.memsci.2010.10.046	93	12	12	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180087	10.1371/journal.pone.0180087	http://dx.doi.org/10.1371/journal.pone.0180087			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672031	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000405268500014
J	Enomoto, Y; Nakamura, Y; Colby, TV; Johkoh, T; Sumikawa, H; Nishimoto, K; Yoshimura, K; Matsushima, S; Oyama, Y; Hozumi, H; Kono, M; Fujisawa, T; Enomoto, N; Inui, N; Iwashita, T; Suda, T				Enomoto, Yasunori; Nakamura, Yutaro; Colby, Thomas V.; Johkoh, Takeshi; Sumikawa, Hiromitsu; Nishimoto, Koji; Yoshimura, Katsuhiro; Matsushima, Sayomi; Oyama, Yoshiyuki; Hozumi, Hironao; Kono, Masato; Fujisawa, Tomoyuki; Enomoto, Noriyuki; Inui, Naoki; Iwashita, Toshihide; Suda, Takafumi			Radiologic pleuroparenchymal fibroelastosis-like lesion in connective tissue disease-related interstitial lung disease	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; CLASSIFICATION CRITERIA; APICAL CAP; RHEUMATOID-ARTHRITIS; AMERICAN-COLLEGE; PNEUMONIA; DIAGNOSIS; SURVIVAL; ENTITY	Background Radiologic pleuroparenchymal fibroelastosis (PPFE)-like lesion including pulmonary apical cap can be occasionally observed in clinical settings. However, the significance of radiologic PPFE-like lesion is unclear in connective tissue disease (CTD)-related interstitial lung disease (ILD). Materials and methods A total of 113 patients with CTD-related ILD were enrolled and assessed for radiologic PPFE-like lesion, which was defined as bilateral, upper lobe, and subpleural dense consolidations with or without pleural thickening on chest high-resolution computed tomography. The clinical, radiologic, and pathologic characteristics were evaluated. Results Radiologic PPFE-like lesion was found in 21 patients (19%) and were relatively frequent in those with systemic sclerosis (6/14: 43%) and primary Sjogren's syndrome (4/14: 29%). Patients with PPFE-like lesion were significantly older, had lower body mass index, higher ratio of residual volume to total lung capacity, and higher complication rate of pneumothorax and/or pneumomediastinum than those without. Twelve of the 21 patients were diagnosed radiologically as usual interstitial pneumonia (UIP) or possible UIP pattern. Two of three patients who underwent surgical lung biopsy of the upper lobes showed UIP on histopathology. Another patient was confirmed to have upper lobe PPFE on autopsy. During the clinical course, progression of the radiologic PPFE-like lesions was observed in 13 of 21 patients. Six patients died (mortality rate: 29%) and their PPFE-like lesions were commonly progressive. In the total cohort, our multivariate analysis identified the presence of PPFE-like lesion as a significant risk factor for respiratory death (hazard ratio: 4.10, 95% confidence interval: 1.33-12.65, p = 0.01). Conclusion In patients with CTD-related ILD, radiologic PPFE-like lesion, which may present as not only PPFE but also apical cap and upper lobe subpleural fibrosis commonly due to UIP, was not uncommon and was associated with poor prognosis. Clinicians should be cautious with this radiologic finding, particularly when it is progressive.	[Enomoto, Yasunori; Nakamura, Yutaro; Nishimoto, Koji; Yoshimura, Katsuhiro; Matsushima, Sayomi; Oyama, Yoshiyuki; Hozumi, Hironao; Kono, Masato; Fujisawa, Tomoyuki; Enomoto, Noriyuki; Inui, Naoki; Suda, Takafumi] Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Shizuoka, Japan; [Enomoto, Yasunori; Matsushima, Sayomi; Iwashita, Toshihide] Hamamatsu Univ Sch Med, Dept Regenerat & Infect Pathol, Shizuoka, Japan; [Colby, Thomas V.] Mayo Clin Arizona, Dept Lab Med & Pathol, Scottsdale, AZ USA; [Johkoh, Takeshi] Mutual Aid Assoc Publ Teachers, Kinki Cent Hosp, Dept Radiol, Itami, Hyogo, Japan; [Sumikawa, Hiromitsu] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Radiol, Osaka, Japan; [Inui, Naoki] Hamamatsu Univ Sch Med, Dept Clin Pharmacol & Therapeut, Shizuoka, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Mayo Clinic; Mayo Clinic Phoenix; Osaka Medical Center for Cancer & Cardiovascular Diseases; Hamamatsu University School of Medicine	Enomoto, Y; Nakamura, Y (corresponding author), Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Shizuoka, Japan.; Enomoto, Y (corresponding author), Hamamatsu Univ Sch Med, Dept Regenerat & Infect Pathol, Shizuoka, Japan.	enomotoy@hama-med.ac.jp; nakayuta@hama-med.ac.jp	Enomoto, Noriyuki/GLS-0691-2022	Enomoto, Noriyuki/0000-0003-3187-4264; Yoshimura, Katsuhiro/0000-0001-9522-3220				Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Enomoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073774; EUWER RL, 1993, J INVEST DERMATOL, V100, pS124, DOI 10.1038/jid.1993.35; Fischer A, 2015, EUR RESPIR J, V46, P976, DOI 10.1183/13993003.00150-2015; Frankel SK, 2004, CHEST, V126, P2007, DOI 10.1378/chest.126.6.2007; Goldin JG, 2008, CHEST, V134, P358, DOI 10.1378/chest.07-2444; Katzenstein ALA, 2008, HUM PATHOL, V39, P1275, DOI 10.1016/j.humpath.2008.05.009; Lagstein A, 2015, ARCH PATHOL LAB MED, V139, P1258, DOI 10.5858/arpa.2015-0224-RA; Leslie KO, 2011, PRACTICAL PULMONARY, P232; Lynch DA, 2005, AM J RESP CRIT CARE, V172, P488, DOI 10.1164/rccm.200412-1756OC; MCLOUD TC, 1981, AM J ROENTGENOL, V137, P299, DOI 10.2214/ajr.137.2.299; Mooney JJ, 2013, CHEST, V144, P586, DOI 10.1378/chest.12-2623; Nakatani T, 2015, EUR RESPIR J, V45, P1183, DOI 10.1183/09031936.00214714; Oda T, 2014, CHEST, V146, P1248, DOI 10.1378/chest.13-2866; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Reddy TL, 2012, EUR RESPIR J, V40, P377, DOI 10.1183/09031936.00165111; Ryerson CJ, 2014, CHEST, V145, P723, DOI 10.1378/chest.13-1474; Shea BS, 2015, NEW ENGL J MED, V372, P1749, DOI 10.1056/NEJMcpc1415200; Shiboski SC, 2012, ARTHRIT CARE RES, V64, P475, DOI 10.1002/acr.21591; Suda T, 2009, RESP MED, V103, P846, DOI 10.1016/j.rmed.2008.12.019; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Tsuchiya Y, 2011, EUR RESPIR J, V37, P1411, DOI 10.1183/09031936.00019210; Watanabe K, 2012, RESPIR INVESTIG, V50, P88, DOI 10.1016/j.resinv.2012.06.003; Yousem SA, 2001, AM J SURG PATHOL, V25, P679, DOI 10.1097/00000478-200105000-00018	28	48	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180283	10.1371/journal.pone.0180283	http://dx.doi.org/10.1371/journal.pone.0180283			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666014	gold, Green Published, Green Submitted			2022-12-26	WOS:000404608700081
J	Jernigan, NL; Naik, JS; Weise-Cross, L; Detweiler, ND; Herbert, LM; Yellowhair, TR; Resta, TC				Jernigan, Nikki L.; Naik, Jay S.; Weise-Cross, Laura; Detweiler, Neil D.; Herbert, Lindsay M.; Yellowhair, Tracylyn R.; Resta, Thomas C.			Contribution of reactive oxygen species to the pathogenesis of pulmonary arterial hypertension	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; INDUCED CA2+ SENSITIZATION; CHRONICALLY HYPOXIC RATS; FAWN-HOODED RATS; RHO-KINASE; CELL-PROLIFERATION; HYDROGEN-PEROXIDE; MOLECULAR CHAPERONE; NADPH OXIDASE; NITRIC-OXIDE	Pulmonary arterial hypertension is associated with a decreased antioxidant capacity. However, neither the contribution of reactive oxygen species to pulmonary vasoconstrictor sensitivity, nor the therapeutic efficacy of antioxidant strategies in this setting are known. We hypothesized that reactive oxygen species play a central role in mediating both vasoconstrictor and arterial remodeling components of severe pulmonary arterial hypertension. We examined the effect of the chemical antioxidant, TEMPOL, on right ventricular systolic pressure, vascular remodeling, and enhanced vasoconstrictor reactivity in both chronic hypoxia and hypoxia/SU5416 rat models of pulmonary hypertension. SU5416 is a vascular endothelial growth factor receptor antagonist and the combination of chronic hypoxia/SU5416 produces a model of severe pulmonary arterial hypertension with vascular plexiform lesions/fibrosis that is not present with chronic hypoxia alone. The major findings from this study are: 1) compared to hypoxia alone, hypoxia/SU5416 exposure caused more severe pulmonary hypertension, right ventricular hypertrophy, adventitial lesion formation, and greater vasoconstrictor sensitivity through a superoxide and Rho kinase-dependent Ca2+ sensitization mechanism. 2) Chronic hypoxia increased medial muscularization and superoxide levels, however there was no effect of SU5416 to augment these responses. 3) Treatment with TEMPOL decreased right ventricular systolic pressure in both hypoxia and hypoxia/SU5416 groups. 4) This effect of TEMPOL was associated with normalization of vasoconstrictor responses, but not arterial remodeling. Rather, medial hypertrophy and adventitial fibrotic lesion formation were more pronounced following chronic TEMPOL treatment in hypoxia/SU5416 rats. Our findings support a major role for reactive oxygen species in mediating enhanced vasoconstrictor reactivity and pulmonary hypertension in both chronic hypoxia and hypoxia/SU5416 rat models, despite a paradoxical effect of antioxidant therapy to exacerbate arterial remodeling in animals with severe pulmonary arterial hypertension in the hypoxia/SU5416 model.	[Jernigan, Nikki L.; Naik, Jay S.; Weise-Cross, Laura; Detweiler, Neil D.; Herbert, Lindsay M.; Yellowhair, Tracylyn R.; Resta, Thomas C.] Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Vasc Physiol Grp, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center	Jernigan, NL (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Vasc Physiol Grp, Albuquerque, NM 87131 USA.	njernigan@salud.unm.edu	Naik, Jay/AHD-1227-2022; Jernigan, Nikki/AAE-7649-2020	Detweiler, Neil/0000-0003-4014-9988; Resta, Thomas/0000-0002-7219-6159; Jernigan, Nikki/0000-0001-6269-2274	National Heart, Lung, and Blood Institute [R01 HL111084, R01 HL132883, R01 HL088192, T32 HL007736]; American Heart Association [16GRNT27700010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111084, R01HL088192, R01HL132883, T32HL007736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088021, R25GM060201] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Heart, Lung, and Blood Institute grants R01 HL111084 (to N.L. Jernigan), R01 HL132883, R01 HL088192, T32 HL007736 (to T.C. Resta), and American Heart Association grant 16GRNT27700010 (to T.C. Resta). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Adesina SE, 2015, FREE RADICAL BIO MED, V87, P36, DOI 10.1016/j.freeradbiomed.2015.05.042; Aggarwal S, 2013, COMPR PHYSIOL, V3, P1011, DOI 10.1002/cphy.c120024; Archer SL, 2010, CIRCULATION, V121, P2661, DOI 10.1161/CIRCULATIONAHA.109.916098; Bogaard HJ, 2009, CIRCULATION, V120, P1951, DOI 10.1161/CIRCULATIONAHA.109.883843; Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008; Brennan LA, 2003, CIRC RES, V92, P683, DOI 10.1161/01.RES.0000063424.28903.BB; Broughton BRS, 2008, AM J PHYSIOL-LUNG C, V294, pL797, DOI 10.1152/ajplung.00253.2007; Broughton BRS, 2010, AM J PHYSIOL-LUNG C, V298, pL232, DOI 10.1152/ajplung.00276.2009; BURKE TM, 1987, AM J PHYSIOL, V252, pH721, DOI 10.1152/ajpheart.1987.252.4.H721; Chaumais MC, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-65; Day Regina M., 2005, Dose-Response, V3, P425, DOI 10.2203/dose-response.003.03.010; Dennis KE, 2009, AM J PHYSIOL-LUNG C, V297, pL596, DOI 10.1152/ajplung.90568.2008; Elmedal B, 2004, BRIT J PHARMACOL, V141, P105, DOI 10.1038/sj.bjp.0705580; Fagan KA, 2004, AM J PHYSIOL-LUNG C, V287, pL656, DOI 10.1152/ajplung.00090.2003; Fike CD, 2008, AM J PHYSIOL-LUNG C, V295, pL881, DOI 10.1152/ajplung.00047.2008; Fike CD, 2013, ANTIOXID REDOX SIGN, V18, P1727, DOI 10.1089/ars.2012.4823; Fresquet F, 2006, BRIT J PHARMACOL, V148, P714, DOI 10.1038/sj.bjp.0706779; Frid MG, 1997, CIRC RES, V81, P940; Gharaee-Kermani M, AM J PATHOLOGY, V184, P732; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Hartney T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027531; Hoshikawa Y, 2001, J APPL PHYSIOL, V90, P1299, DOI 10.1152/jappl.2001.90.4.1299; Howell K, 2003, J PHYSIOL-LONDON, V547, P133, DOI 10.1113/jphysiol.2002.030676; Hu HL, 2010, AM J RESP CELL MOL, V42, P661, DOI 10.1165/rcmb.2009-0017OC; Hyvelin JM, 2005, CIRC RES, V97, P185, DOI 10.1161/01.RES.0000174287.17953.83; Ingold KU, 1997, J AM CHEM SOC, V119, P12364, DOI 10.1021/ja972886l; Jernigan NL, 2008, AM J PHYSIOL-LUNG C, V295, pL515, DOI 10.1152/ajplung.00355.2007; Jernigan NL, 2004, AM J PHYSIOL-LUNG C, V287, pL1220, DOI 10.1152/ajplung.00196.2004; Jernigan NL, 2004, AM J PHYSIOL-LUNG C, V286, pL947, DOI 10.1152/ajplung.00215.2003; Jones RD, 2000, PHARMACOL THERAPEUT, V88, P153, DOI 10.1016/S0163-7258(00)00089-9; Kamezaki F, 2008, AM J RESP CRIT CARE, V177, P219, DOI 10.1164/rccm.200702-264OC; Lachmanova V, 2005, LIFE SCI, V77, P175, DOI 10.1016/j.lfs.2004.11.027; Liu JQ, 2006, AM J PHYSIOL-LUNG C, V290, pL2, DOI 10.1152/ajplung.00135.2005; Masri FA, 2008, CTS-CLIN TRANSL SCI, V1, P99, DOI 10.1111/j.1752-8062.2008.00035.x; Mata M., 2012, OXID MED CELL LONGEV, V2012, DOI DOI 10.1155/2012/236572; Michelakis ED, 2002, CIRC RES, V90, P1307, DOI 10.1161/01.RES.0000024689.07590.C2; Nagaoka T, 2004, AM J PHYSIOL-LUNG C, V287, pL665, DOI 10.1152/ajplung.00050.2003; Nagata K, 1998, MATRIX BIOL, V16, P379, DOI 10.1016/S0945-053X(98)90011-7; Nitta CH, 2014, AM J PHYSIOL-HEART C, V306, pH41, DOI 10.1152/ajpheart.00269.2013; Nozik-Grayck E, 2008, AM J PHYSIOL-LUNG C, V295, pL422, DOI 10.1152/ajplung.90293.2008; Nozik-Grayck E, 2007, ADV EXP MED BIOL, V618, P101; Oka M, 2007, CIRC RES, V100, P923, DOI 10.1161/01.RES.0000261658.12024.18; Plomaritas DR, 2014, AM J PHYSIOL-LUNG C, V307, pL419, DOI 10.1152/ajplung.00095.2014; Porter KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098532; Pourmahram GE, 2008, FREE RADICAL BIO MED, V45, P1468, DOI 10.1016/j.freeradbiomed.2008.08.020; Ramiro-Diaz JM, 2013, AM J PHYSIOL-LUNG C, V304, pL613, DOI 10.1152/ajplung.00408.2012; Rehman J, 2010, ADV EXP MED BIOL, V661, P171, DOI 10.1007/978-1-60761-500-2_11; Seo YH, 2009, P NATL ACAD SCI USA, V106, P16163, DOI 10.1073/pnas.0903015106; Steinhorn RH, 2001, AM J RESP CRIT CARE, V164, P834, DOI 10.1164/ajrccm.164.5.2010104; Tabima DM, 2012, FREE RADICAL BIO MED, V52, P1970, DOI 10.1016/j.freeradbiomed.2012.02.041; Taguchi T, 2007, TRENDS MOL MED, V13, P45, DOI 10.1016/j.molmed.2006.12.001; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; TSIEN R, 1989, TRANSPORT MEMBRANE I; Vanderpool RR, 2011, J APPL PHYSIOL, V110, P188, DOI 10.1152/japplphysiol.00533.2010; Voelkel NF, 2013, ANTIOXID REDOX SIGN, V18, P1810, DOI 10.1089/ars.2012.4828; Wedgwood S, 2011, ANTIOXID REDOX SIGN, V15, P1497, DOI 10.1089/ars.2010.3630; Weigand L, 2006, AM J PHYSIOL-LUNG C, V290, pL284, DOI 10.1152/ajplung.00449.2004; Wilcox CS, 2008, PHARMACOL REV, V60, P418, DOI 10.1124/pr.108.000240; Wong CM, 2013, ANTIOXID REDOX SIGN, V18, P1789, DOI 10.1089/ars.2012.4568; Zhang JH, 1998, AM J RESP CELL MOL, V19, P324, DOI 10.1165/ajrcmb.19.2.3209	61	41	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180455	10.1371/journal.pone.0180455	http://dx.doi.org/10.1371/journal.pone.0180455			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666030	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608700009
J	Nakatsuka, T; Tateishi, K; Kudo, Y; Yamamoto, K; Nakagawa, H; Fujiwara, H; Takahashi, R; Miyabayashi, K; Asaoka, Y; Tanaka, Y; Ijichi, H; Hirata, Y; Otsuka, M; Kato, M; Sakai, J; Tachibana, M; Aburatani, H; Shinkai, Y; Koike, K				Nakatsuka, T.; Tateishi, K.; Kudo, Y.; Yamamoto, K.; Nakagawa, H.; Fujiwara, H.; Takahashi, R.; Miyabayashi, K.; Asaoka, Y.; Tanaka, Y.; Ijichi, H.; Hirata, Y.; Otsuka, M.; Kato, M.; Sakai, J.; Tachibana, M.; Aburatani, H.; Shinkai, Y.; Koike, K.			Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation	ONCOGENE			English	Article							ADVANCED HEPATOCELLULAR-CARCINOMA; MUTATIONAL LANDSCAPE; GENE-EXPRESSION; STEM-CELLS; IN-VIVO; CANCER; LIVER; IDENTIFICATION; JMJD1A; JHDM2A	Epigenetic gene regulation linked to oncogenic pathways is an important focus of cancer research. KDM3A, a histone H3 lysine 9 (H3K9) demethylase, is known to have a pro-tumorigenic function. Here, we showed that KDM3A contributes to liver tumor formation through the phosphatidylinositol 3-kinase (PI3K) pathway, which is often activated in hepatocellular carcinoma. Loss of Kdm3a attenuated tumor formation in Pik3ca transgenic (Tg) mouse livers. Transcriptome analysis of pre-cancerous liver tissues revealed that the expression of activator protein 1 (AP-1) target genes was induced by PI3K activation, but blunted upon Kdm3a ablation. Particularly, the expression of Cd44, a liver cancer stem marker, was regulated by AP-1 in a Kdm3a-dependent manner. We identified Cd44-positive hepatocytes with epithelial-mesenchymal transition-related expression profiles in the Pik3ca Tg liver and confirmed their in vivo tumorigenic capacity. Notably, the number and tumor-initiating capacity of Cd44-positive hepatocytes were governed by Kdm3a. As a mechanism in Kdm3a-dependent AP-1 transcription, Kdm3a recruited c-Jun to the AP-1 binding sites of Cd44, Mmp7 and Pdgfrb without affecting c-Jun expression. Moreover, Brg1, a component of the SWI/SNF chromatin remodeling complex, interacted with c-Jun in a Kdm3a-dependent manner and was bound to the AP-1 binding site of these genes. Finally, KDM3A and c-JUN were co-expressed in 33% of human premalignant lesions with PI3K activation. Our data suggest a critical role for KDM3A in the PI3K/AP-1 oncogenic axis and propose a novel strategy for inhibition of KDM3A against liver tumor development under PI3K pathway activation.	[Nakatsuka, T.; Tateishi, K.; Kudo, Y.; Yamamoto, K.; Nakagawa, H.; Fujiwara, H.; Takahashi, R.; Miyabayashi, K.; Asaoka, Y.; Tanaka, Y.; Ijichi, H.; Hirata, Y.; Otsuka, M.; Koike, K.] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan; [Kato, M.] RIKEN, Adv Sci Inst, Cellular Memory Lab, Wako, Saitama, Japan; [Sakai, J.] Univ Tokyo, RCAST, Div Metab Med, Meguro Ku, Tokyo, Japan; [Tachibana, M.] Tokushima Univ, Inst Enzyme Res, Dept Enzyme Chem, Tokushima, Tokushima, Japan; [Aburatani, H.] Univ Tokyo, RCAST, Genome Sci Div, Meguro Ku, Tokyo, Japan	University of Tokyo; RIKEN; University of Tokyo; Tokushima University; University of Tokyo	Tateishi, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	ktate-tky@umin.ac.jp	Otsuka, Motoyuki/H-9067-2019; Ijichi, Hideaki/AAE-6692-2022; Nakagawa, Hayato/I-2837-2012; Asaoka, Yoshinari/ABC-5412-2021; Ijichi, Hideaki/V-2720-2019; Nakatsuka, Takuma/T-6886-2017; IJICHI, Hideaki/AGZ-2874-2022; Masaki, Kato/AAW-2603-2020; Yamamoto, Keisuke/AAT-2794-2021	Otsuka, Motoyuki/0000-0003-2869-2881; Ijichi, Hideaki/0000-0002-2379-7986; Nakagawa, Hayato/0000-0002-6973-5094; Asaoka, Yoshinari/0000-0002-2805-8226; Nakatsuka, Takuma/0000-0002-5727-5385; IJICHI, Hideaki/0000-0002-2379-7986; Yamamoto, Keisuke/0000-0002-6323-9540; Tanaka, Yasuo/0000-0002-2917-3365; Sakai, Juro/0000-0003-4043-1035	Japan Society for the Promotion of Science [23590962]; New Energy and Industrial Technology Development Organization (NEDO); Research Program on Hepatitis from Japan Agency for Medical Research and Development (AMED); Grants-in-Aid for Scientific Research [17H06424, 16H01218, 16H01409] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Research Program on Hepatitis from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This project is supported by Grants-in-Aid for Scientific Research (23590962) from Japan Society for the Promotion of Science, the grant from New Energy and Industrial Technology Development Organization (NEDO), and the Research Program on Hepatitis from Japan Agency for Medical Research and Development (AMED). We thank Dr E.P. Sandgren for MUP-uPA mice, Mitsuko Tsubouchi for providing assistance with various cell cultures, and all the lab members for their helpful comments.	Abe Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8052; Beyaz S, 2016, NATURE, V531, P53, DOI 10.1038/nature17173; Bitzer M, 2016, J HEPATOL, V65, P280, DOI 10.1016/j.jhep.2016.02.043; Chu TH, 2014, ONCOTARGET, V5, P1475, DOI 10.18632/oncotarget.1745; Ding XM, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003884; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fan L, 2015, 11 INT C WIR COMM NE, V2015, P1; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Friedman JR, 2004, P NATL ACAD SCI USA, V101, P12986, DOI 10.1073/pnas.0402875101; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Fujimoto A, 2016, NAT GENET, V48, P500, DOI 10.1038/ng.3547; Hasenfuss SC, 2014, CELL METAB, V19, P84, DOI 10.1016/j.cmet.2013.11.018; He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Inagaki T, 2009, GENES CELLS, V14, P991, DOI 10.1111/j.1365-2443.2009.01326.x; Ito T, 2001, J BIOL CHEM, V276, P2852, DOI 10.1074/jbc.M009633200; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09; Kudo Y, 2011, J HEPATOL, V55, P1400, DOI 10.1016/j.jhep.2011.03.025; Kuroki S, 2013, SCIENCE, V341, P1106, DOI 10.1126/science.1239864; Llovet JM, 2015, NAT REV CLIN ONCOL, V12, P408, DOI [10.1038/nrclinonc.2015.103, 10.1038/nrclinonc.2015.121]; Maass T, 2011, INT J CANCER, V128, P1259, DOI 10.1002/ijc.25469; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mann DA, 2014, HEPATOLOGY, V60, P1418, DOI 10.1002/hep.27131; Min LH, 2012, NAT CELL BIOL, V14, P1203, DOI 10.1038/ncb2590; Minguez B, 2009, CURR OPIN GASTROEN, V25, P186, DOI 10.1097/MOG.0b013e32832962a1; Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001; Nakagawa H, 2014, P NATL ACAD SCI USA, V111, P1090, DOI 10.1073/pnas.1322731111; Okabe H, 2014, Br J Cancer, V110, P958, DOI 10.1038/bjc.2013.759; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Osawa T, 2013, CANCER RES, V73, P3019, DOI 10.1158/0008-5472.CAN-12-3231; Park SJ, 2013, BIOCHEM BIOPH RES CO, V434, P722, DOI 10.1016/j.bbrc.2013.03.091; Ramadoss S, 2017, ONCOGENE, V36, P47, DOI 10.1038/onc.2016.174; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Shakya A, 2011, J BIOL CHEM, V286, P450, DOI 10.1074/jbc.M110.174045; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126; Uemura M, 2010, CLIN CANCER RES, V16, P4636, DOI 10.1158/1078-0432.CCR-10-0407; Weglarz TC, 2000, AM J PATHOL, V157, P1963, DOI 10.1016/S0002-9440(10)64835-3; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Xin HW, 2013, GUT, V62, P1777, DOI 10.1136/gutjnl-2012-303261; Yamada D, 2012, ANN SURG ONCOL, V19, pS355, DOI 10.1245/s10434-011-1797-x; Yamamoto K, 2014, CARCINOGENESIS, V35, P2404, DOI 10.1093/carcin/bgu136; Yamamoto S, 2013, CARCINOGENESIS, V34, P2380, DOI 10.1093/carcin/bgt174; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Zeybel M, 2013, J HEPATOL, V59, P1349, DOI 10.1016/j.jhep.2013.05.039; Zhu AX, 2014, JAMA-J AM MED ASSOC, V312, P57, DOI 10.1001/jama.2014.7189; Zhu Z, 2010, INT J CANCER, V126, P2067, DOI 10.1002/ijc.24868; Zucman-Rossi J, 2015, GASTROENTEROLOGY, V149, P1226, DOI 10.1053/j.gastro.2015.05.061	53	33	35	5	15	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 9	2017	36	45					6262	6271		10.1038/onc.2017.222	http://dx.doi.org/10.1038/onc.2017.222			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FM1WY	28692045				2022-12-26	WOS:000414774800005
J	Yoshizaki, K; Hu, LZ; Nguyen, T; Sakai, K; Ishikawa, M; Takahashi, I; Fukumoto, S; DenBesten, PK; Bikle, DD; Oda, Y; Yamada, Y				Yoshizaki, Keigo; Hu, Lizhi; Thai Nguyen; Sakai, Kiyoshi; Ishikawa, Masaki; Takahashi, Ichiro; Fukumoto, Satoshi; DenBesten, Pamela K.; Bikle, Daniel D.; Oda, Yuko; Yamada, Yoshihiko			Mediator 1 contributes to enamel mineralization as a coactivator for Notch1 signaling and stimulates transcription of the alkaline phosphatase gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-GLAND DEVELOPMENT; RNA-POLYMERASE-II; TOOTH MORPHOGENESIS; CELL-DIFFERENTIATION; SUBUNIT MED1; MICE; DEFECTS; COMPLEX; LINEAGE	Tooth enamel is mineralized through the differentiation of multiple dental epithelia including ameloblasts and the stratum intermedium (SI), and this differentiation is controlled by several signaling pathways. Previously, we demonstrated that the transcriptional coactivator Mediator 1 (MED1) plays a critical role in enamel formation. For instance, conditional ablation of Med1 in dental epithelia causes functional changes in incisor-specific dental epithelial stem cells, resulting in mineralization defects in the adult incisors. However, the molecular mechanism by which Med1 deficiency causes these abnormalities is not clear. Here, we demonstrated that Med1 ablation causes early SI differentiation defects resulting in enamel hypoplasia of the Med1-deficient molars. Med1 deletion prevented Notch1-mediated differentiation of the SI cells resulting in decreased alkaline phosphatase (ALPL), which is essential for mineralization. However, it does not affect the ability of ameloblasts to produce enamel matrix proteins. Using the dental epithelial SF2 cell line, we demonstrated that MED1 directly activates transcription of the Alpl gene through the stimulation of Notch1 signaling by forming a complex with cleaved Notch1-RBP-Jk on the Alpl promoter. These results suggest that MED1 may be essential for enamel matrix mineralization by serving as a coactivator for Notch1 signaling regulating transcription of the Alpl gene.	[Yoshizaki, Keigo; Sakai, Kiyoshi; Ishikawa, Masaki; Yamada, Yoshihiko] NIH, Lab Cell & Dev Biol, NIDCR, Bldg 10, Bethesda, MD 20892 USA; [Yoshizaki, Keigo; Takahashi, Ichiro] Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Fukuoka 8128582, Japan; [Hu, Lizhi; Thai Nguyen; Bikle, Daniel D.; Oda, Yuko] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Hu, Lizhi; Thai Nguyen; Bikle, Daniel D.; Oda, Yuko] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94158 USA; [Hu, Lizhi; Thai Nguyen; Bikle, Daniel D.; Oda, Yuko] Vet Affairs Med Ctr, Endocrine Res 111N MB,1700 Owens St, San Francisco, CA 94158 USA; [Fukumoto, Satoshi] Tohoku Univ, Grad Sch Dent, Dept Oral Hlth & Dev Sci, Div Pediat Dent, Sendai, Miyagi 9808575, Japan; [DenBesten, Pamela K.] Univ Calif San Francisco, Sch Dent, San Francisco, CA 94143 USA; [Hu, Lizhi] Tianjin Med Univ, Minist Educ, Key Lab Immune Microenvironm & Dis, Dept Immunol, Tianjin 300070, Peoples R China; [Sakai, Kiyoshi] Nagoya Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Nagoya, Aichi 4668550, Japan; [Ishikawa, Masaki] Tohoku Univ, Grad Sch Dent, Div Operat Dent, Dept Restorat Dent, Sendai, Miyagi 9808575, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Kyushu University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Tohoku University; University of California System; University of California San Francisco; Tianjin Medical University; Nagoya University; Tohoku University	Yamada, Y (corresponding author), Vet Affairs Med Ctr, Endocrine Res 111N MB,1700 Owens St, San Francisco, CA 94158 USA.; Oda, Y (corresponding author), NIH, NIDCR, 30 Convent Dr,Bldg 30,Rm 430, Bethesda, MD 20814 USA.	yuko.oda@ucsf.edu; yoshi.yamada@nih.gov		Yoshizaki, Keigo/0000-0002-0598-5879; Fukumoto, Satoshi/0000-0002-5046-6891	National Institutes of Health from NIDCR Intramural Research Program [DE000720-07]; National Institutes of Health [R21 DE025357, R21 DE023411, R01 AR050023]; U. S. Department of Defense [CA110338]; Veterans Affairs Merit Review Award; Ministry of Education, Science, and Culture of Japan [15H05688, 26670886, 26670880]; NEXT program [LS010]; Japan Society for the Promotion of Science for Young Scientists [09J03228]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE025357, R21DE023411, ZIADE000720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000720] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15H05688] Funding Source: KAKEN	National Institutes of Health from NIDCR Intramural Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Department of Defense(United States Department of Defense); Veterans Affairs Merit Review Award(US Department of Veterans Affairs); Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NEXT program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by National Institutes of Health Grant DE000720-07 (to Y. Y.) from the NIDCR Intramural Research Program and National Institutes of Health Grants R21 DE025357 (to Y. O.), R21 DE023411 (to P. D.), and R01 AR050023 (to D. D. B.). This work also was supported by U. S. Department of Defense Grant CA110338 (to D. D. B.), a Veterans Affairs Merit Review Award (to D. D. B.), Grants-in-aid for Scientific Research 15H05688 and 26670886 (to K. Y.), Grant-in-aid 26670880 (to S. F.) from the Ministry of Education, Science, and Culture of Japan, and Grant LS010 from the NEXT program (to S. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by Research Fellowship 09J03228 from the Japan Society for the Promotion of Science for Young Scientists.	Arakaki M, 2012, J BIOL CHEM, V287, P10590, DOI 10.1074/jbc.M111.285874; Bikle D, 2007, J STEROID BIOCHEM, V103, P396, DOI 10.1016/j.jsbmb.2006.12.063; Blazek E, 2005, CHROMOSOMA, V113, P399, DOI 10.1007/s00412-005-0329-5; Bourbon HM, 2004, MOL CELL, V14, P553, DOI 10.1016/j.molcel.2004.05.011; Cai X, 2011, CELL PROLIFERAT, V44, P495, DOI 10.1111/j.1365-2184.2011.00780.x; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Fukumoto S, 2005, CONNECT TISSUE RES, V46, P220, DOI 10.1080/03008200500344017; Gasque KCS, 2015, BONE, V72, P137, DOI 10.1016/j.bone.2014.11.017; Harada H, 2006, BIOCHEM BIOPH RES CO, V340, P611, DOI 10.1016/j.bbrc.2005.12.053; Jia YZ, 2005, J BIOL CHEM, V280, P10766, DOI 10.1074/jbc.M413331200; Jiang PP, 2010, P NATL ACAD SCI USA, V107, P6765, DOI 10.1073/pnas.1001814107; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kawano S, 2004, J DENT RES, V83, P129, DOI 10.1177/154405910408300209; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; McKee MD, 2013, J DENT RES, V92, P721, DOI 10.1177/0022034513490958; Mitsiadis TA, 2010, DEVELOPMENT, V137, P3025, DOI 10.1242/dev.049528; Nakamura T, 2008, J BIOL CHEM, V283, P4825, DOI 10.1074/jbc.M708388200; Oda Y, 2012, J INVEST DERMATOL, V132, P1075, DOI 10.1038/jid.2011.430; Oda Y, 2010, J INVEST DERMATOL, V130, P2377, DOI 10.1038/jid.2010.148; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Stumpf M, 2010, P NATL ACAD SCI USA, V107, P21541, DOI 10.1073/pnas.1005794107; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yadav MC, 2012, J BONE MINER RES, V27, P1722, DOI 10.1002/jbmr.1619; Yoshizaki K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099991; Yoshizaki K, 2013, ORTHOD WAVES, V72, P1, DOI 10.1016/j.odw.2013.01.040; Yue XJ, 2011, P NATL ACAD SCI USA, V108, P17105, DOI 10.1073/pnas.1109095108	27	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13531	13540		10.1074/jbc.M117.780866	http://dx.doi.org/10.1074/jbc.M117.780866			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28673966	hybrid, Green Published			2022-12-26	WOS:000407942400034
J	Jafari, Z; Mehla, J; Afrashteh, N; Kolb, BE; Mohajerani, MH				Jafari, Zahra; Mehla, Jogender; Afrashteh, Navvab; Kolb, Bryan E.; Mohajerani, Majid H.			Corticosterone response to gestational stress and postpartum memory function in mice	PLOS ONE			English	Article							ALTERS DENDRITIC MORPHOLOGY; AFFECTS SPATIAL REFERENCE; NOISE-INDUCED HEARING; MORRIS WATER MAZE; PRENATAL STRESS; HIPPOCAMPAL NEUROGENESIS; MATERNAL STRESS; WORKING-MEMORY; PLASMA-CORTICOSTERONE; PREFRONTAL CORTEX	Maternal stress is a common adversity during pregnancy. Gestational corticosterone alternations are thought to contribute to the etiology of postpartum behavioral disturbances. However, the impact of stress during pregnancy, in particular noise exposure, on gestational corticosterone fluctuations and spatial cognition in postpartum mice has not been fully understood yet. We hypothesized that noise exposure during pregnancy negatively affects gestational corticosterone levels and postpartum memory function in the dams similar to the physical stressors. Pregnant C57BL/6 mice were randomly assigned to either one of two stress conditions or a control condition. The noise stress (NS) was induced by presenting a loud intermittent 3000 Hz frequency on gestational days (GDs) 12, 14, and 16 for 24 hours, whereas the physical stress ( PS) consisted of restraint and exposure to an elevated platform on GDs 12 -16. Plasma corticosterone level was collected on GDs 11 and 17, and Morris water task (MWT) was carried out 30 days after parturition. Compared to the control group, the level of corticosterone in the stressed groups was significantly increased on GD17 relative to GD11. Significantly longer swim time and lower swim speed were observed in both stressed groups relative to the control group. Probe time was significantly shorter in the NS group than the other groups. The delta corticosterone level was significantly correlated with the swim time as well as the probe time in the three groups. Given the results, the adverse effects of gestational noise exposure on the hypothalamic pituitary-adrenal (HPA) axis activation and postpartum spatial learning and memory function were as large as/or a bit stronger than the physical stresses. The findings suggest the significance of conservation against loud noise exposure in daily living, as well as need to further notice to the different aspects of gestational stress in mothers' behavior like offspring.	[Jafari, Zahra; Mehla, Jogender; Afrashteh, Navvab; Kolb, Bryan E.; Mohajerani, Majid H.] Univ Lethbridge, CCBN, Dept Neurosci, Lethbridge, AB, Canada; [Jafari, Zahra] Iran Univ Med Sci IUMS, Sch Rehabil Sci, Tehran, Iran	University of Lethbridge; Iran University of Medical Sciences	Kolb, BE; Mohajerani, MH (corresponding author), Univ Lethbridge, CCBN, Dept Neurosci, Lethbridge, AB, Canada.	kolb@uleth.ca; mohajerani@uleth.ca	Jafari, Zahra/GXF-1615-2022; Mehla, Jogender/M-1055-2019	Afrashteh, Navvab/0000-0002-3451-4793; Mohajerani, Majid H./0000-0003-0964-2977	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant [40352]; Campus Alberta for Innovation Program Chair; Alberta Alzheimer Research Program; Canadian Institute for Advanced Research grant [43300]	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Campus Alberta for Innovation Program Chair; Alberta Alzheimer Research Program; Canadian Institute for Advanced Research grant	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant #40352 (MHM), Campus Alberta for Innovation Program Chair, Alberta Alzheimer Research Program (MHM), and a Canadian Institute for Advanced Research grant #43300 (BK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akatsu S, 2015, NEUROSCI RES, V101, P15, DOI 10.1016/j.neures.2015.07.002; ARCK PC, 1995, AM J REPROD IMMUNOL, V33, P74, DOI 10.1111/j.1600-0897.1995.tb01141.x; Baldi E, 2005, NEUROSCI LETT, V378, P176, DOI 10.1016/j.neulet.2004.12.029; Barriga C, 2001, J PINEAL RES, V30, P180, DOI 10.1034/j.1600-079X.2001.300307.x; Barzegar M, 2015, HIPPOCAMPUS, V25, P187, DOI 10.1002/hipo.22363; Basner M, 2014, LANCET, V383, P1325, DOI 10.1016/S0140-6736(13)61613-X; Belnoue L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072972; Benoit JD, 2015, BEHAV BRAIN RES, V281, P1, DOI 10.1016/j.bbr.2014.12.001; Berglund B, 1996, J ACOUST SOC AM, V99, P2985, DOI 10.1121/1.414863; Browne CA, 2014, STRESS, V17, P471, DOI 10.3109/10253890.2014.954104; Burton PJ, 1996, BIOL REPROD, V55, P1023, DOI 10.1095/biolreprod55.5.1023; Bustamante C, 2010, INT J DEV NEUROSCI, V28, P605, DOI 10.1016/j.ijdevneu.2010.07.229; Chang TY, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-37; Charil A, 2010, BRAIN RES REV, V65, P56, DOI 10.1016/j.brainresrev.2010.06.002; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Cottrell EC, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.019.2009; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; Del Cerro MCR, 2015, HORM BEHAV, V73, P142, DOI 10.1016/j.yhbeh.2015.07.004; Del Cerro MCR, 2010, BEHAV BRAIN RES, V208, P593, DOI 10.1016/j.bbr.2010.01.003; Diaz R, 1998, J NEUROSCI, V18, P2570; Erickson ZT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0092132, 10.1371/journal.pone.0107491]; Gatewood JD, 2005, BRAIN RES BULL, V66, P91, DOI 10.1016/j.brainresbull.2005.03.016; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Gong S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117503; Gonzalez-Perez O, 2011, NEUROSCI RES, V70, P243, DOI 10.1016/j.neures.2011.03.013; Graignic-Philippe R, 2014, NEUROSCI BIOBEHAV R, V43, P137, DOI 10.1016/j.neubiorev.2014.03.022; Haque SF, 2004, J REPROD DEVELOP, V50, P185, DOI 10.1262/jrd.50.185; Hare BD, 2014, NEUROPSYCHOPHARMACOL, V39, P1262, DOI 10.1038/npp.2013.329; HEFFNER H, 1980, J ACOUST SOC AM, V68, P1584, DOI 10.1121/1.385213; Heffner HE, 2007, J AM ASSOC LAB ANIM, V46, P20; Holscher C, 1999, BEHAV BRAIN RES, V100, P225, DOI 10.1016/S0166-4328(98)00134-X; Hu LL, 2014, PHYSIOL BEHAV, V123, P105, DOI 10.1016/j.physbeh.2013.09.010; Jafari Z, 2016, REV NEUROSCI; Jafari Z, SCI REP IN PRESS; Kinsley CH, 2006, SCI AM, V294, P72, DOI 10.1038/scientificamerican0106-72; Kolb B, 2013, PROG BRAIN RES, V207, P35, DOI 10.1016/B978-0-444-63327-9.00005-9; Kolb B, 2012, P NATL ACAD SCI USA, V109, P17186, DOI 10.1073/pnas.1121251109; Kondoh E, 2009, HUM REPROD, V24, P945, DOI 10.1093/humrep/den461; Kraus KS, 2010, NEUROSCIENCE, V167, P1216, DOI 10.1016/j.neuroscience.2010.02.071; Lemaire V, 2006, EUR J NEUROSCI, V23, P3368, DOI 10.1111/j.1460-9568.2006.04870.x; Lipp HP, 1998, CURR OPIN NEUROBIOL, V8, P272, DOI 10.1016/S0959-4388(98)80151-7; Liu LJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep20374; Love G, 2005, BEHAV NEUROSCI, V119, P1084, DOI 10.1037/0735-7044.119.4.1084; Lupien SJ, 2001, BEHAV BRAIN RES, V127, P137, DOI 10.1016/S0166-4328(01)00361-8; Macbeth AH, 2010, NEUROSCI BIOBEHAV R, V34, P452, DOI 10.1016/j.neubiorev.2009.08.011; Malisch JL, 2008, GEN COMP ENDOCR, V156, P210, DOI 10.1016/j.ygcen.2008.01.020; Malisch JL, 2007, PHYSIOL BIOCHEM ZOOL, V80, P146, DOI 10.1086/508828; Mazurek B, 2010, HEARING RES, V259, P55, DOI 10.1016/j.heares.2009.10.006; Muhammad A, 2012, NEUROSCIENCE, V216, P103, DOI 10.1016/j.neuroscience.2012.04.041; Mychasiuk R, 2012, SYNAPSE, V66, P308, DOI 10.1002/syn.21512; Negron-Oyarzo I, 2015, CEREB CORTEX, V25, P3132, DOI 10.1093/cercor/bhu108; OHKAWA T, 1991, EXP CLIN ENDOCRINOL, V98, P123, DOI 10.1055/s-0029-1211108; Ortega-Martinez S, 2015, BEHAV BRAIN RES, V281, P309, DOI 10.1016/j.bbr.2014.12.036; Pawluski JL, 2015, NEUROSCIENCE, V290, P379, DOI 10.1016/j.neuroscience.2015.01.048; Pawluski JL, 2006, HORM BEHAV, V49, P143, DOI 10.1016/j.yhbeh.2005.05.016; Pawluski JL, 2006, BEHAV BRAIN RES, V175, P157, DOI 10.1016/j.bbr.2006.08.017; PEDERSEN CA, 1991, LIFE SCI, V48, P1537, DOI 10.1016/0024-3205(91)90278-J; Plamondon A, 2015, EARLY HUM DEV, V91, P23, DOI 10.1016/j.earlhumdev.2014.11.004; Reid KM, 2015, SOC SCI RES, V54, P246, DOI 10.1016/j.ssresearch.2015.08.009; Roes M, 2016, SEX DIFFERENCES IN THE CENTRAL NERVOUS SYSTEM, P197, DOI 10.1016/B978-0-12-802114-9.00009-3; Salari AA, 2016, BEHAV BRAIN RES, V311, P354, DOI 10.1016/j.bbr.2016.05.062; SAPOLSKY RM, 1994, ANN NY ACAD SCI, V746, P294; Stansfeld SA, 2003, BRIT MED BULL, V68, P243, DOI 10.1093/bmb/ldg033; Tomizawa K, 2003, NAT NEUROSCI, V6, P384, DOI 10.1038/nn1023; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Vorhees CV, 2014, NEUROTOXICOL TERATOL, V45, P75, DOI 10.1016/j.ntt.2014.07.003; Ward ID, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-S1-S9; Weinstock M, 2017, NEUROBIOL STRESS, V6, P3, DOI 10.1016/j.ynstr.2016.08.004; White DR, 1998, J ACOUST SOC AM, V103, P1566, DOI 10.1121/1.421303; Zhao DP, 2013, J NEUROSCI RES, V91, P535, DOI 10.1002/jnr.23172	70	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180306	10.1371/journal.pone.0180306	http://dx.doi.org/10.1371/journal.pone.0180306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692696	Green Published, Green Submitted, gold			2022-12-26	WOS:000405544800032
J	Pelerito, A; Cordeiro, R; Matos, R; Santos, MA; Soeiro, S; Santos, J; Manita, C; Rio, C; Santo, M; Paixao, E; Nunes, A; Nuncio, S				Pelerito, Ana; Cordeiro, Rita; Matos, Rita; Santos, Maria Augusta; Soeiro, Sofia; Santos, Joao; Manita, Carla; Rio, Carla; Santo, M.; Paixao, Eleonora; Nunes, Alexandra; Nuncio, Sofia			Human brucellosis in Portugal-Retrospective analysis of suspected clinical cases of infection from 2009 to 2016	PLOS ONE			English	Article								Brucellosis is a zoonosis that is emerging in some regions of the world. Although brucellosis is a disease of obligatory declaration and is not eradicated in Portugal, no prevalence data is available in this country. In this study, we retrospectively analyzed the data available at the Reference Laboratory at the Portuguese National Institute of Health during the past 7 years (2009 -2016) in order to get insight into the epidemiological scenario of brucellosis in Portugal. A total of 2313 biological samples from patients with clinical suspicion of brucellosis were subjected to immunological techniques for laboratory diagnosis. From 2010 to 2015, a subset of 259 samples was subjected to molecular methods. According to the available data, 167 out of 2313 (7.2%) samples had positive serology for Brucella spp. and 43 out of 259 samples (16.6%) were positive for B. melitensis by real time PCR, being classified as biovar 1 and 3. This study draws attention to the importance of integrating clinical and laboratory data of human cases in order to increase the efficacy of the response measures in case of outbreaks.	[Pelerito, Ana; Cordeiro, Rita; Nuncio, Sofia] Natl Inst Hlth, Dept Infect Dis, Emergency Response & Biopreparedness Unit, Lisbon, Portugal; [Matos, Rita; Santos, Maria Augusta; Soeiro, Sofia; Santos, Joao; Manita, Carla; Rio, Carla; Santo, M.] Natl Inst Hlth, Dept Infect Dis, Immunol Lab, Lisbon, Portugal; [Paixao, Eleonora] Alentejo Reg Adm Hlth, Nucleus Support Area Stat, Lisbon, Portugal; [Nunes, Alexandra] Natl Inst Hlth, Dept Infect Dis, Bioinformat Unit, Lisbon, Portugal		Pelerito, A (corresponding author), Natl Inst Hlth, Dept Infect Dis, Emergency Response & Biopreparedness Unit, Lisbon, Portugal.	ana.pelerito@insa.min-saude.pt	Nunes, Alexandra/ABE-3699-2020; Cordeiro, Rita/GYV-1929-2022	Nunes, Alexandra/0000-0001-6449-8053; Almeida Santos, Joao/0000-0002-8564-1098; Nuncio, Maria Sofia/0000-0001-5182-6150; Cordeiro, Rita/0000-0001-5321-3657				Araj GF, 2010, INT J ANTIMICROB AG, V36, pS12, DOI 10.1016/j.ijantimicag.2010.06.014; Baldi PC, 2013, REV SCI TECH OIE, V32, P117; CDC, 1999, MMWR-MORBID MORTAL W, V49, P509; Corbel M.J, 2006, BRUC HUM AN; deSa I., 2013, MAGAZINE DA SPM; Ferreira Ana Cristina, 2012, PLoS One, V7, pe42514, DOI 10.1371/journal.pone.0042514; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; Gopaul KK, 2008, BMC MICROBIOL, P1; Hinic V, 2008, J MICROBIOL METH, V75, P375, DOI 10.1016/j.mimet.2008.07.002; Jacobs MK, 2004, DERMATOL CLIN, V22, P231, DOI 10.1016/j.det.2004.03.008; Marianelli C, 2006, MICROBES INFECT, V8, P860, DOI 10.1016/j.micinf.2005.10.008; Moreno E, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00213; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Scholz HC, 2016, INT J SYST EVOL MICR, V66, P2090, DOI 10.1099/ijsem.0.000998; Seleem MN, 2010, VET MICROBIOL, V140, P392, DOI 10.1016/j.vetmic.2009.06.021; Tzaneva V, 2007, EUROSURVEILLANCE 200, V14; Whatmore AM, 2009, INFECT GENET EVOL, V9, P1168, DOI 10.1016/j.meegid.2009.07.001; Young EJ, 2005, PRINCIPLES PRACTICE, V6th, P2669	18	6	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0179667	10.1371/journal.pone.0179667	http://dx.doi.org/10.1371/journal.pone.0179667			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692674	gold, Green Published, Green Submitted			2022-12-26	WOS:000405544800012
J	Zhang, Y; Hou, YL; Wang, XY; Ping, JH; Ma, ZY; Suo, C; Lei, ZH; Li, X; Zhang, Z; Jia, CC; Su, J				Zhang, Ying; Hou, Yuanlong; Wang, Xiaoyan; Ping, Jihui; Ma, Zhiyu; Suo, Chuan; Lei, Zhihai; Li, Xiang; Zhang, Zheng; Jia, Cuicui; Su, Juan			The effects of kisspeptin-10 on serum metabolism and myocardium in rats	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; FOCAL ADHESION KINASE; CARDIAC-HYPERTROPHY; ARACHIDONIC-ACID; HEART-FAILURE; CELL-ADHESION; AMINO-ACIDS; INTEGRINS; GENE; MODULATION	Kisspeptin is a peptide encoded by the Kiss 1 gene and is also called metastin. Previous studies have generally focused on several functions of this peptide, including metastasis, puberty, vasoconstriction and reproduction. However, few studies have focused on the cardiac functions of kisspeptin. In the present study, cardiac histomorphology was observed via TEM (transmission electron microscope) and HE and Masson staining to observe instinctive changes. Serum metabolites levels were also measured and analyzed using GC/TOF-MS after injection with kisspeptin-10. A gene chip was employed to screen the potential genes and pathways in the myocardium at the transcriptional leve, while RT-PCR and Western Blot were conducted to verify the relevant mRNA and protein expression, respectively. Histopathological findings demonstrated that there were many irregular wavy contractions through HE staining and increased fibrosis around the heart cells through Masson staining after treatment with kisspeptin-10. Additionally, the main changes in ultrastructure, including changes in mitochondrial and broken mitochondrial cristae, could be observed with TEM after treatment with kisspeptin-10. The PCA scores plot of the serum metabolites was in the apparent partition after injection of kisspeptin-10. Twenty-six obviously changed metabolites were detected and classified as amino acids, carbohydrate metabolites, organic acids and other metabolites. Furthermore, gene chip analysis showed 1112 differentially expressed genes after treatment with kisspeptin-10, including 330 up-regulated genes and 782 downregulated genes. These genes were enriched in several signaling pathways related to heart diseases. The RT-PCR result for ITGB8, ITGA4, ITGB7, MYL7, HIF1-a and BNP corresponded with the gene chip assay. Moreover, the upregulated genes ITGB8, ITGA4 and BNP also displayed consistent protein levels in Western Blot results. In summary, these findings suggest that kisspeptin-10 could alter the morphology and structure of myocardial cells, serum metabolite levels, and expression of genes and proteins in heart tissues. Our work determined the profound effects of kisspeptin-10 on the heart, which could further lead to the development of therapeutics related to kisspeptin-10, including antagonists and analogs.	[Zhang, Ying; Hou, Yuanlong; Ping, Jihui; Ma, Zhiyu; Suo, Chuan; Lei, Zhihai; Li, Xiang; Zhang, Zheng; Jia, Cuicui; Su, Juan] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China; [Wang, Xiaoyan] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Syst Biomed, Shanghai Ctr Syst Biomed, Shanghai, Peoples R China; [Wang, Xiaoyan] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai, Peoples R China	Nanjing Agricultural University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Su, J (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	sujuan@njau.edu.cn		Wang, Xiaoyan/0000-0001-5568-2131	Priority Academic Program Development of Jiangsu Higher Education Institutions [280100745113]; Fundamental research funds for the central Universities [KYZ201526]	Priority Academic Program Development of Jiangsu Higher Education Institutions; Fundamental research funds for the central Universities(Fundamental Research Funds for the Central Universities)	All the fundings of support received during this specific study: 1. A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. Grant Number: 280100745113. The URLs: http://jsycw.ec.js.edu.cn/default.aspx; 2. The Fundamental research funds for the central Universities. Grant Number: KYZ201526. b. Roles of the funder in the study: Purchasing animal and reagents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babbitt CJ, 2002, HISTOCHEM CELL BIOL, V118, P431, DOI 10.1007/s00418-002-0476-1; BAQUET A, 1991, BIOCHEM J, V273, P57, DOI 10.1042/bj2730057; Bauer PM, 2001, J BIOL CHEM, V276, P34458, DOI 10.1074/jbc.M105219200; Baylin A, 2004, J NUTR, V134, P3095, DOI 10.1093/jn/134.11.3095; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; BING RJ, 1953, AM J MED, V15, P284, DOI 10.1016/0002-9343(53)90082-5; Chen Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125209; Del Vesco AP, 2014, J ANIM SCI, V92, P806, DOI 10.2527/jas.2013-6829; Gullberg Donald, 1998, Frontiers in Bioscience, V3, pD1039; Hill JA, 2011, PEDIATR CARDIOL, V32, P282, DOI 10.1007/s00246-010-9883-6; Hjelte LE, 2005, J NUTR, V135, P2271, DOI 10.1093/jn/135.9.2271; Horikoshi Y, 2003, J CLIN ENDOCR METAB, V88, P914, DOI 10.1210/jc.2002-021235; Horowitz JD, 2010, CURR OPIN CARDIOL, V25, P329, DOI 10.1097/HCO.0b013e328339f191; Hou YL, 2015, J PROTEOME RES, V14, P1495, DOI 10.1021/pr501312t; Huang Y, 2011, CARDIOVASC RES, V90, P220, DOI 10.1093/cvr/cvr070; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Katta A, 2010, AM J PHYSIOL-REG I, V299, pR1666, DOI 10.1152/ajpregu.00229.2010; KATZ R, 1978, CIRCULATION, V58, P434, DOI 10.1161/01.CIR.58.3.434; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; KUBALAK SW, 1994, J BIOL CHEM, V269, P16961; Li F, 2014, J PHARMACEUT BIOMED, V88, P225, DOI 10.1016/j.jpba.2013.09.002; Li RJ, 2015, J HAZARD MATER, V287, P392, DOI 10.1016/j.jhazmat.2015.02.006; Li XF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008334; Liu YT, 2014, J PHARMACEUT BIOMED, V90, P35, DOI 10.1016/j.jpba.2013.11.008; Lu HZ, 2006, CIRCULATION, V114, P2271, DOI 10.1161/CIRCULATIONAHA.106.642330; Maguire JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027601; Maguire JJ, 2009, HYPERTENSION, V54, P598, DOI 10.1161/HYPERTENSIONAHA.109.134619; Mead EJ, 2007, BRIT J PHARMACOL, V151, P1143, DOI 10.1038/sj.bjp.0707295; Mead EJ, 2007, ENDOCRINOLOGY, V148, P140, DOI 10.1210/en.2006-0818; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Muir AI, 2001, J BIOL CHEM, V276, P28969, DOI 10.1074/jbc.M102743200; Navenot JM, 2009, MOL PHARMACOL, V75, P1300, DOI 10.1124/mol.109.055095; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Nishijima Y, 2011, CARDIOVASC RES, V91, P71, DOI 10.1093/cvr/cvr087; Nishimura J, 2010, J NUTR, V140, P496, DOI 10.3945/jn.109.108977; Osborne John D, 2007, Methods Mol Biol, V377, P223; PEGG AE, 1980, AM J PHYSIOL, V239, pE372, DOI 10.1152/ajpendo.1980.239.5.E372; Peng X, 2008, P NATL ACAD SCI USA, V105, P6638, DOI 10.1073/pnas.0802319105; Proud CG, 2002, EUR J BIOCHEM, V269, P5338, DOI 10.1046/j.1432-1033.2002.03292.x; Putri SP, 2013, J BIOSCI BIOENG, V115, P579, DOI 10.1016/j.jbiosc.2012.12.007; Qiu YP, 2014, CLIN CANCER RES, V20, P2136, DOI 10.1158/1078-0432.CCR-13-1939; Ross RS, 2001, CIRC RES, V88, P1112, DOI 10.1161/hh1101.091862; Ross RS, 1998, CIRC RES, V82, P1160, DOI 10.1161/01.RES.82.11.1160; Rottbauer W, 2006, CIRC RES, V99, P323, DOI 10.1161/01.RES.0000234807.16034.fe; Sawyer I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014671; Schwartz MA, 2001, J CELL SCI, V114, P2553; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Shah SH, 2012, CIRCULATION, V126, P1110, DOI 10.1161/CIRCULATIONAHA.111.060368; Tantini B, 2006, J MOL CELL CARDIOL, V40, P775, DOI 10.1016/j.yjmcc.2006.03.002; Valencik ML, 2006, CIRC RES, V99, P1403, DOI 10.1161/01.RES.0000252291.88540.ac; van Bilsen M, 2009, CARDIOVASC RES, V81, P420, DOI 10.1093/cvr/cvn282; Wang XY, 2012, J PROTEOME RES, V11, P6223, DOI 10.1021/pr300891v; West A, 1998, GENOMICS, V54, P145, DOI 10.1006/geno.1998.5566; WINKELMANN DA, 1991, J CELL BIOL, V114, P701, DOI 10.1083/jcb.114.4.701; Wu Y, 2009, OMICS, V13, P81, DOI 10.1089/omi.2008.0061; Xu G, 2001, DIABETES, V50, P353, DOI 10.2337/diabetes.50.2.353; YANG JT, 1995, DEVELOPMENT, V121, P549	61	5	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0179164	10.1371/journal.pone.0179164	http://dx.doi.org/10.1371/journal.pone.0179164			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692647	Green Published, Green Submitted, gold			2022-12-26	WOS:000405544800008
J	Han, C; Kim, MJ; Ding, DL; Park, HJ; White, K; Walker, L; Gu, TJ; Tanokura, M; Yamasoba, T; Linser, P; Salvi, R; Someya, S				Han, Chul; Kim, Mi-Jung; Ding, Dalian; Park, Hyo-Jin; White, Karessa; Walker, Logan; Gu, Tongjun; Tanokura, Masaru; Yamasoba, Tatsuya; Linser, Paul; Salvi, Richard; Someya, Shinichi			GSR is not essential for the maintenance of antioxidant defenses in mouse cochlea: Possible role of the thioredoxin system as a functional backup for GSR	PLOS ONE			English	Article							GLUTATHIONE-REDUCTASE; HEARING-LOSS; INBRED STRAINS; NOISE EXPOSURE; DEFICIENCY; GENE; METABOLISM; MECHANISMS; PROTECTION; CATALYSIS	Glutathione reductase (GSR), a key member of the glutathione antioxidant defense system, converts oxidized glutathione (GSSG) to reduced glutathione (GSH) and maintains the intracellular glutathione redox state to protect the cells from oxidative damage. Previous reports have shown that Gsr deficiency results in defects in host defense against bacterial infection, while diquat induces renal injury in Gsr hypomorphic mice. In flies, overexpression of GSR extended lifespan under hyperoxia. In the current study, we investigated the roles of GSR in cochlear antioxidant defense using Gsr homozygous knockout mice that were backcrossed onto the CBA/CaJ mouse strain, a normal-hearing strain that does not carry a specific Cdh23 mutation that causes progressive hair cell degeneration and early onset of hearing loss. Gsr(-/-) mice displayed a significant decrease in GSR activity and GSH/GSSG ratios in the cytosol of the inner ears. However, Gsr deficiency did not affect ABR (auditory brainstem response) hearing thresholds, wave I amplitudes or wave I latencies in young mice. No histological abnormalities were observed in the cochlea of Gsr(-/-) mice. Furthermore, there were no differences in the activities of cytosolic glutathione-related enzymes, including glutathione peroxidase and glutamate-cysteine ligase, or the levels of oxidative damage markers in the inner ears between WT and Gsr(-/-) mice. In contrast, Gsr deficiency resulted in increased activities of cytosolic thioredoxin and thioredoxin reductase in the inner ears. Therefore, under normal physiological conditions, GSR is not essential for the maintenance of antioxidant defenses in mouse cochlea. Given that the thioredoxin system is known to reduce GSSG to GSH in multiple species, our findings suggest that the thioredoxin system can support GSSG reduction in the mouse peripheral auditory system.	[Han, Chul; Kim, Mi-Jung; Park, Hyo-Jin; White, Karessa; Walker, Logan; Someya, Shinichi] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL 32611 USA; [Ding, Dalian; Salvi, Richard] SUNY Buffalo, Ctr Hearing & Deafness, Buffalo, NY USA; [Park, Hyo-Jin; Linser, Paul] Univ Florida, Whitney Lab, 9505 Ocean Shore Blvd, St Augustine, FL 32086 USA; [Gu, Tongjun] Univ Florida, Bioinformat, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA; [Tanokura, Masaru] Univ Tokyo, Dept Appl Biol Chem, Yayoi, Japan; [Yamasoba, Tatsuya] Univ Tokyo, Dept Otolaryngol, Tokyo, Japan	State University System of Florida; University of Florida; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Tokyo; University of Tokyo	Someya, S (corresponding author), Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL 32611 USA.	someya@ufl.edu	Gu, Tongjun/AAE-4801-2020	Tanokura, Masaru/0000-0001-5072-2480; White, Karessa/0000-0003-3967-4486	National Institute of Health and National Institute on Deafness and Communication Disorders [R03 DC011840, R01 DC012552, R01 DC014437]; American Federation for Aging Research [12388]; National Institute of Health and National Institute on Aging [1 P30 AG028740]; Japan Society for the Promotion of Science (JSPS) [23228003]; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC011840, R01DC012552] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD012210] Funding Source: NIH RePORTER	National Institute of Health and National Institute on Deafness and Communication Disorders; American Federation for Aging Research; National Institute of Health and National Institute on Aging; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by R03 DC011840 (Shinichi Someya), R01 DC012552 (Shinichi Someya) and R01 DC014437 (Shinichi Someya) and from the National Institute of Health and National Institute on Deafness and Communication Disorders, American Federation for Aging Research Grant 12388 (Shinichi Someya), the Claude D. Pepper Older Americans Independence Centers at the University of Florida (1 P30 AG028740) from the National Institute of Health and National Institute on Aging, and the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (S) (Grant number, 23228003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2007, INTRO CATEGORICAL DA, Vxvii; Brown-Borg HM, 2005, EXP GERONTOL, V40, P115, DOI 10.1016/j.exger.2004.11.004; Calabrese V, 2010, NEUROCHEM RES, V35, P2208, DOI 10.1007/s11064-010-0304-2; Chen GD, 2014, HEARING RES, V317, P1, DOI 10.1016/j.heares.2014.08.004; Chen Y, 2005, J BIOL CHEM, V280, P33766, DOI 10.1074/jbc.M504604200; Dalton TP, 2000, BIOCHEM BIOPH RES CO, V279, P324, DOI 10.1006/bbrc.2000.3930; Deponte M, 2013, BBA-GEN SUBJECTS, V1830, P3217, DOI 10.1016/j.bbagen.2012.09.018; DiMauro S., 1993, GENEREVIEWS R; Ding D, 1999, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V13, P510; Ding DL, 2016, AGING-US, V8, P730, DOI 10.18632/aging.100927; Ding DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079817; Evans P, 1999, ANN NY ACAD SCI, V884, P19, DOI 10.1111/j.1749-6632.1999.tb08633.x; Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5; Han C, 2016, NEUROBIOL AGING, V43, P58, DOI 10.1016/j.neurobiolaging.2016.03.023; Henderson D, 1999, ANN NY ACAD SCI, V884, P368, DOI 10.1111/j.1749-6632.1999.tb08655.x; Jacono AA, 1998, HEARING RES, V117, P31, DOI 10.1016/S0378-5955(97)00214-1; Kamerbeek NM, 2007, BLOOD, V109, P3560, DOI 10.1182/blood-2006-08-042531; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kanzok SM, 2000, J BIOL CHEM, V275, P40180, DOI 10.1074/jbc.M007633200; Laborde E, 2010, CELL DEATH DIFFER, V17, P1373, DOI 10.1038/cdd.2010.80; Li MN, 2014, BIOMED REP, V2, P831, DOI 10.3892/br.2014.359; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Lushchak Volodymyr I, 2012, J Amino Acids, V2012, P736837, DOI 10.1155/2012/736837; Mari M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]; Marty L, 2009, P NATL ACAD SCI USA, V106, P9109, DOI 10.1073/pnas.0900206106; McIlwain CC, 2006, ONCOGENE, V25, P1639, DOI 10.1038/sj.onc.1209373; Mockett RJ, 1999, FASEB J, V13, P1733, DOI 10.1096/fasebj.13.13.1733; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Njalsson R, 2005, CELL MOL LIFE SCI, V62, P1938, DOI 10.1007/s00018-005-5163-7; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; Ohinata Y, 2000, HEARING RES, V146, P28, DOI 10.1016/S0378-5955(00)00096-4; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P237, DOI 10.1159/000013847; Ohlemiller KK, 2000, JARO-J ASSOC RES OTO, V1, P243, DOI 10.1007/s101620010043; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Rebrin I, 2008, ADV DRUG DELIVER REV, V60, P1545, DOI 10.1016/j.addr.2008.06.001; Rogers LK, 2004, TOXICOL SCI, V82, P367, DOI 10.1093/toxsci/kfh268; Rogers LK, 2006, TOXICOL APPL PHARM, V217, P289, DOI 10.1016/j.taap.2006.08.012; SCHUKNECHT HF, 1974, LARYNGOSCOPE, V84, P1777; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Tan SX, 2010, J BIOL CHEM, V285, P6118, DOI 10.1074/jbc.M109.062844; Tanaka C, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.027; Tipple TE, 2007, AM J RESP CELL MOL, V37, P405, DOI 10.1165/rcmb.2006-0376OC; Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197; Winkler A, 2011, BIOCHEM BIOPH RES CO, V412, P121, DOI 10.1016/j.bbrc.2011.07.056; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Yamasoba T, 1998, BRAIN RES, V804, P72, DOI 10.1016/S0006-8993(98)00660-X; Yamasoba T, 1998, BRAIN RES, V784, P82, DOI 10.1016/S0006-8993(97)01156-6; Yamasoba T, 2013, HEARING RES, V303, P30, DOI 10.1016/j.heares.2013.01.021; Yan J, 2013, FREE RADICAL BIO MED, V61, P320, DOI 10.1016/j.freeradbiomed.2013.04.015; ZEREZ CR, 1987, ANAL BIOCHEM, V164, P367, DOI 10.1016/0003-2697(87)90506-9; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9; Zhou XM, 2006, BRAIN RES, V1091, P16, DOI 10.1016/j.brainres.2006.01.107	52	12	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180817	10.1371/journal.pone.0180817	http://dx.doi.org/10.1371/journal.pone.0180817			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686716	Green Published, gold, Green Submitted			2022-12-26	WOS:000405464100110
J	Ji, WP; Wang, B; Fan, QP; Xu, C; He, YW; Chen, YF				Ji, Weiping; Wang, Bo; Fan, Qiuping; Xu, Chao; He, Youwu; Chen, Youfen			Chemosensitizing indomethacin-conjugated dextran-based micelles for effective delivery of paclitaxel in resistant breast cancer therapy	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; TUMOR-CELLS; IN-VITRO; DOXORUBICIN; PROTEINS; NANOPARTICLES; CARCINOMA; TOXICITY; MRP1	Multidrug resistance (MDR) against chemotherapeutic agents has become the major obstacle to successful cancer therapy and multidrug resistance-associated proteins (MRPs) mediated drug efflux is the key factor for MDR. Indomethacin (IND), one of the non-steroidal anti-inflammatory agents, has been demonstrated to increase cytotoxic effects of anti-tumor agents as MRP substrates. In this study, dextran-g-indomethacin (DEX-IND) polymeric micelles were designed to delivery paclitaxel (PTX) for the treatment of MDR tumors. The DEX-IND polymer could effectively encapsulate PTX with high loading content and DEXIND/ PTX micelles present a small size distribution. Compared with free PTX, the release of PTX from DEX-IND/PTX micelles could be prolonged to 48 h. Cellular uptake test showed that the internalization of DEX-IND/PTX micelles by drug-sensitive MCF-7/ADR cells was significantly higher than free PTX benefiting from the inhibitory effect of IND on MRPs. In vitro cytotoxicity test further demonstrated that DEX-IND/PTX micelles could enhance the cytotoxicity of PTX against MCF-7/ADR tumor cells. In vivo pharmacokinetic results showed that DEX-IND/PTX micelles had longer systemic circulation time and slower plasma elimination rate in comparison to PTX. The anti-tumor efficacy test showed that DEX-IND/PTX micelles exhibited greater tumor growth-inhibition effects on MDR tumor-bearing mice, with good correlation between in vitro and in vivo. Overall, the cumulative evidence indicates that DEX-IND/PTX micelles hold significant promise for the treatment of MDR tumors.	[Ji, Weiping; Wang, Bo; Fan, Qiuping; Xu, Chao; He, Youwu] Wenzhou Med Univ, Dept Orthoped, Affiliated Hosp 6, Lishui, Peoples R China; [Chen, Youfen] Ningbo Univ, Affiliated Yangming Hosp, Dept Hematol & Oncol, Yuyao, Peoples R China	Wenzhou Medical University; Ningbo University	Chen, YF (corresponding author), Ningbo Univ, Affiliated Yangming Hosp, Dept Hematol & Oncol, Yuyao, Peoples R China.	youfen_chen@126.com		He, You-Wu/0000-0002-4036-5843				Arts HJG, 1999, CLIN CANCER RES, V5, P2798; Cheng TJ, 2016, THERANOSTICS, V6, P1277, DOI 10.7150/thno.15133; Du YZ, 2010, ACS NANO, V4, P6894, DOI 10.1021/nn100927t; Du YZ, 2010, CARBOHYD POLYM, V79, P1034, DOI 10.1016/j.carbpol.2009.10.032; Duffy CP, 1998, EUR J CANCER, V34, P1250, DOI 10.1016/S0959-8049(98)00045-8; Hu R, 2012, THERANOSTICS, V2, P723, DOI 10.7150/thno.4275; Joshi AA, 2016, PHARM RES-DORDR, V33, P2847, DOI 10.1007/s11095-016-2028-8; Li C, 2016, DRUG DELIV, V23, P888, DOI 10.3109/10717544.2014.920429; Lu JF, 2015, DRUG METAB REV, V47, P406, DOI 10.3109/03602532.2015.1105253; Matsunaga S, 2006, CANCER CHEMOTH PHARM, V58, P348, DOI 10.1007/s00280-005-0162-9; Reinecke P, 2000, CANCER INVEST, V18, P614, DOI 10.3109/07357900009032828; Rezazadeh M, 2016, DRUG DELIV, V23, P1707, DOI 10.3109/10717544.2014.954281; Silverman J A, 1999, Pharm Biotechnol, V12, P353; Situ JQ, 2015, INT J NANOMED, V10, P665, DOI 10.2147/IJN.S76307; Sodani K, 2012, CHIN J CANCER, V31, P58, DOI 10.5732/cjc.011.10329; Stein WD, 2004, CURR DRUG TARGETS, V5, P333, DOI 10.2174/1389450043345489; Yuan H, 2008, INT J PHARMACEUT, V348, P137, DOI 10.1016/j.ijpharm.2007.07.012; Zhang YK, 2015, AAPS J, V17, P802, DOI 10.1208/s12248-015-9757-1; Zhou SF, 2008, CURR MED CHEM, V15, P1981, DOI 10.2174/092986708785132870	19	18	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180037	10.1371/journal.pone.0180037	http://dx.doi.org/10.1371/journal.pone.0180037			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686704	Green Submitted, Green Published, gold			2022-12-26	WOS:000405464100033
J	Kim, MA; Yoon, HS; Park, SH; Kim, DY; Pyo, A; Kim, HS; Min, JJ; Hong, Y				Kim, Min-A; Yoon, Hee Seung; Park, Seung-Hwan; Kim, Dong-Yeon; Pyo, Ayoung; Kim, Hyeon Sik; Min, Jung-Joon; Hong, Yeongjin			Engineering of monobody conjugates for human EphA2-specific optical imaging	PLOS ONE			English	Article							EPHA2 RECEPTOR; TYROSINE KINASE; IN-VIVO; PROTEIN; TUMOR; LIGAND; BINDING; EXPRESSION; INVASION; EPHRINS	In a previous study, we developed an E1 monobody specific for the tumor biomarker hEphA2 [PLoS ONE (2015) 10(7): e0132976]. E1 showed potential as a molecular probe for in vitro and in vivo targeting of cancers overexpressing hEphA2. In the present study, we constructed expression vectors for E1 conjugated to optical reporters such as Renilla luciferase variant 8 (Rluc8) or enhanced green fluorescent protein (EGFP) and purified such recombinant proteins by affinity chromatography in E. coli. E1-Rluc8 and E1-EGFP specifically bound to hEphA2 in human prostate cancer PC3 cells but not in human cervical cancer HeLa cells, which express hEphA2 at high and low levels, respectively. These recombinant proteins maintained >40% activity in mouse serum at 24 h. In vivo optical imaging for 24 h did not detect E1-EGFP signals, whereas E1-Rluc8 showed tumor-specific luminescence signals in PC3 but not in HeLa xenograft mice. E1-Rluc8 signals were detected at 4 h, peaked at 12 h, and were undetectable at 24 h. These results suggest the potential of E1-Rluc8 as an EphA2-specific optical imaging agent.	[Kim, Min-A; Hong, Yeongjin] Chonnam Natl Univ, Dept Microbiol, Med Sch, Gwangju, South Korea; [Kim, Min-A; Yoon, Hee Seung] Chonnam Natl Univ, Dept Mol Med BK21Plus, Med Sch, Gwangju, South Korea; [Yoon, Hee Seung; Kim, Dong-Yeon; Pyo, Ayoung; Kim, Hyeon Sik; Min, Jung-Joon] Chonnam Natl Univ, Dept Nucl Med, Med Sch, Gwangju, South Korea; [Park, Seung-Hwan] KRIBB, Biol Resource Ctr, Jeongeup, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Hong, Y (corresponding author), Chonnam Natl Univ, Dept Microbiol, Med Sch, Gwangju, South Korea.	yjhong@jnu.ac.kr		Park, Seung-Hwan/0000-0003-4613-4680	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2015R1D1A1A01060171]; Basic Science Research Program throug NRF - Ministry of Education [NRF-2014R1A6A3A04057492]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Basic Science Research Program throug NRF - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2015R1D1A1A01060171). S.-H.P. was supported by the Basic Science Research Program through the NRF funded by the Ministry of Education (NRF-2014R1A6A3A04057492).	Baldwin C, 2006, AM J PHYSIOL-RENAL, V291, pF960, DOI 10.1152/ajprenal.00020.2006; BARTLEY TD, 1994, NATURE, V368, P558, DOI 10.1038/368558a0; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Bloom L, 2009, DRUG DISCOV TODAY, V14, P949, DOI 10.1016/j.drudis.2009.06.007; Cai WB, 2007, EUR J NUCL MED MOL I, V34, P2024, DOI 10.1007/s00259-007-0503-5; Chang Q, 2008, BRIT J CANCER, V99, P1074, DOI 10.1038/sj.bjc.6604676; Choy Garry, 2003, Mol Imaging, V2, P303, DOI 10.1162/153535003322750646; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; DICKINSON CD, 1994, J MOL BIOL, V236, P1079, DOI 10.1016/0022-2836(94)90013-2; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; Gobin AM, 2008, INT J NANOMED, V3, P351; Hafner C, 2004, CLIN CHEM, V50, P490, DOI 10.1373/clinchem.2003.026849; Halder J, 2006, CLIN CANCER RES, V12, P4916, DOI 10.1158/1078-0432.CCR-06-0021; Herath NI, 2010, INT J CANCER, V126, P2003, DOI 10.1002/ijc.25147; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Himanen JP, 2009, EMBO REP, V10, P722, DOI 10.1038/embor.2009.91; Jackson D, 2008, CANCER RES, V68, P9367, DOI 10.1158/0008-5472.CAN-08-1933; Kinch MS, 2003, CLIN EXP METASTAS, V20, P59, DOI 10.1023/A:1022546620495; Koolpe M, 2002, J BIOL CHEM, V277, P46974, DOI 10.1074/jbc.M208495200; Lee HY, 2016, CANCER INVEST, V34, P293, DOI 10.1080/07357907.2016.1201678; Lee JW, 2010, CLIN CANCER RES, V16, P2562, DOI 10.1158/1078-0432.CCR-10-0017; Lipovsek D, 2011, PROTEIN ENG DES SEL, V24, P3, DOI 10.1093/protein/gzq097; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Luker GD, 2008, J NUCL MED, V49, P1, DOI 10.2967/jnumed.107.045799; MAIN AL, 1992, CELL, V71, P671, DOI 10.1016/0092-8674(92)90600-H; Mitra S, 2010, BIOCHEMISTRY-US, V49, P6687, DOI 10.1021/bi1006223; Mosch B, 2010, J ONCOL, V2010, DOI 10.1155/2010/135285; Noberini R, 2008, J BIOL CHEM, V283, P29461, DOI 10.1074/jbc.M804103200; Ogawa K, 2000, ONCOGENE, V19, P6043, DOI 10.1038/sj.onc.1204004; Park SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132976; Parri M, 2009, CANCER RES, V69, P2072, DOI 10.1158/0008-5472.CAN-08-1845; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; RUIZ JC, 1994, MECH DEVELOP, V46, P87; Seiradake E, 2010, NAT STRUCT MOL BIOL, V17, P398, DOI 10.1038/nsmb.1782; Taddei ML, 2009, AM J PATHOL, V174, P1492, DOI 10.2353/ajpath.2009.080473; Tandon M, 2011, EXPERT OPIN THER TAR, V15, P31, DOI 10.1517/14728222.2011.538682; Troy Tamara, 2004, Mol Imaging, V3, P9, DOI 10.1162/153535004773861688; Venisnik KM, 2006, PROTEIN ENG DES SEL, V19, P453, DOI 10.1093/protein/gzl030; Wykosky J, 2007, MOL CANCER THER, V6, P3208, DOI 10.1158/1535-7163.MCT-07-0200; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244	40	5	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180786	10.1371/journal.pone.0180786	http://dx.doi.org/10.1371/journal.pone.0180786			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686661	Green Submitted, Green Published, gold			2022-12-26	WOS:000405464100105
J	Luo, JX; Lv, PY; Zhang, J; Fane, AG; McDougald, D; Rice, SA				Luo, Jinxue; Lv, Pengyi; Zhang, Jinsong; Fane, Anthony G.; McDougald, Diane; Rice, Scott A.			Succession of biofilm communities responsible for biofouling of membrane bioreactors (MBRs)	PLOS ONE			English	Article							WASTE-WATER TREATMENT; MICROBIAL COMMUNITY; BACTERIAL COMMUNITY; ACTIVATED-SLUDGE; SCALE; IMPACT; DIVERSITY; SPACE; FLUX; RNA	Biofilm formation is one of the main factors associated with membrane biofouling in membrane bioreactors (MBRs). As such, it is important to identify the responsible organisms to develop targeted strategies to control biofouling. This study investigated the composition and changes in the microbial communities fouling MBR membranes over time and correlated those changes with an increase in transmembrane pressure (TMP). Based on qPCR data, bacteria were the dominant taxa of the biofilm (92.9-98.4%) relative to fungi (1.5-6.9%) and archaea (0.03-0.07%). NMDS analysis indicated that during the initial stages of operation, the biofilm communities were indistinguishable from those found in the sludge. However, the biofilm community significantly diverged from the sludge over time and ultimately showed a unique biofilm profile. This suggested that there was strong selection for a group of organisms that were biofilm specialists. This pattern of succession and selection was correlated with the rapid increase in TMP, where bacteria including Rhodospirillales, Sphingomonadales and Rhizobiales dominated the biofilm at this time. While most of the identified fungal OTUs matched Candida sp., the majority of fungal communities were unclassified by 18S rRNA gene sequencing. Collectively, the data suggests that bacteria, primarily, along with fungi may play an important role in the rapid TMP increase and loss of system performance.	[Luo, Jinxue; McDougald, Diane; Rice, Scott A.] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Luo, Jinxue] Nanyang Technol Univ, Adv Environm Biotechnol Ctr, Nanyang Environm & Water Res Inst, Singapore, Singapore; [Luo, Jinxue] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China; [Lv, Pengyi] China Univ Min & Technol, Sch Chem & Environm Engn, Beijing, Peoples R China; [Zhang, Jinsong; Fane, Anthony G.] Nanyang Technol Univ, Singapore Membrane Technol Ctr, Nanyang Environm & Water Res Inst, Singapore, Singapore; [McDougald, Diane; Rice, Scott A.] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore, Singapore; [McDougald, Diane; Rice, Scott A.] Univ Technol Sydney, Ithree Inst, Sydney, NSW, Australia; [Rice, Scott A.] Univ New South Wales, Ctr Marine Bioinnovat, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); China University of Mining & Technology; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Technology Sydney; University of New South Wales Sydney	Rice, SA (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.; Rice, SA (corresponding author), Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore, Singapore.; Rice, SA (corresponding author), Univ Technol Sydney, Ithree Inst, Sydney, NSW, Australia.; Rice, SA (corresponding author), Univ New South Wales, Ctr Marine Bioinnovat, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	RSCOTT@NTU.EDU.SG	McDougald, Diane/AAF-4799-2020; Rice, Scott/A-6084-2019; McDougald, Diane/B-5564-2009	McDougald, Diane/0000-0001-5827-8441; Rice, Scott/0000-0002-9486-2343; McDougald, Diane/0000-0001-5827-8441	EWI Singapore [MEWRC651/06/177, 1301-IRIS-57]; National Research Foundation Singapore; Ministry of Education; Nanyang Technological University; National University of Singapore; Research Centre of Excellence Programme	EWI Singapore; National Research Foundation Singapore(National Research Foundation, Singapore); Ministry of Education; Nanyang Technological University(Nanyang Technological University); National University of Singapore(National University of Singapore); Research Centre of Excellence Programme	This study was supported by EWI Singapore (MEWRC651/06/177 and 1301-IRIS-57). Specific funding support for this project from The National Research Foundation Singapore, Ministry of Education, Nanyang Technological University and National University of Singapore, under its Research Centre of Excellence Programme, for general support of laboratories and infrastructure.	Ahn S, 2008, DESALINATION, V221, P494, DOI 10.1016/j.desal.2007.01.110; Al Ashhab A, 2014, WATER RES, V50, P341, DOI 10.1016/j.watres.2013.10.044; Awad M. F., 2011, Mycology - An International Journal on Fungal Biology, V2, P276; Awad MF, 2011, CAN J MICROBIOL, V57, P693, DOI [10.1139/W11-056, 10.1139/w11-056]; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bojsen RK, 2012, FEMS IMMUNOL MED MIC, V65, P169, DOI 10.1111/j.1574-695X.2012.00943.x; Burke C, 2011, ISME J, V5, P590, DOI 10.1038/ismej.2010.164; Calderon K, 2011, BIORESOURCE TECHNOL, V102, P4618, DOI 10.1016/j.biortech.2011.01.007; Chandrasekar PH, 2008, FUTURE MICROBIOL, V3, P19, DOI 10.2217/17460913.3.1.19; Chong TH, 2008, J MEMBRANE SCI, V325, P840, DOI 10.1016/j.memsci.2008.09.011; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cytryn E, 2012, APPL ENVIRON MICROB, V78, P6576, DOI 10.1128/AEM.01545-12; de Andrade LH, 2014, DESALIN WATER TREAT, V52, P2920, DOI 10.1080/19443994.2013.799048; Flemming HC, 2002, APPL MICROBIOL BIOT, V59, P629, DOI 10.1007/s00253-002-1066-9; Foster M Lauren, 2013, Vet Med Int, V2013, P658373, DOI 10.1155/2013/658373; Gillings M. R., 2006, BIOFILMS, V3, P19; Gorley C.K., 2006, GETTING STARTED PRIM; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Hai FI, 2013, BIORESOURCE TECHNOL, V141, P29, DOI 10.1016/j.biortech.2013.02.020; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; Huang LN, 2008, ENVIRON SCI TECHNOL, V42, P8360, DOI 10.1021/es801283q; Hung CH, 2011, INT J HYDROGEN ENERG, V36, P8704, DOI 10.1016/j.ijhydene.2010.06.010; Hwang BK, 2012, J MEMBRANE SCI, V419, P33, DOI 10.1016/j.memsci.2012.06.031; Ivnitsky H, 2007, WATER RES, V41, P3924, DOI 10.1016/j.watres.2007.05.021; Kraume M, 2010, CHEM ENG TECHNOL, V33, P1251, DOI 10.1002/ceat.201000104; Lan WS, 2010, MICROB ECOL, V60, P105, DOI 10.1007/s00248-010-9707-5; Lee C, 2008, FEMS MICROBIOL ECOL, V65, P544, DOI 10.1111/j.1574-6941.2008.00530.x; Li J, 2013, APPL MECH MATER, V295-298, P1045, DOI 10.4028/www.scientific.net/AMM.295-298.1045; Lim S, 2012, DESALINATION, V287, P209, DOI 10.1016/j.desal.2011.09.030; Liu RY, 2012, SCI TOTAL ENVIRON, V435, P124, DOI 10.1016/j.scitotenv.2012.07.022; Lopez-Ribot JL, 2005, CURR BIOL, V15, pR453, DOI 10.1016/j.cub.2005.06.020; Luo JX, 2015, MICROB BIOTECHNOL, V8, P549, DOI 10.1111/1751-7915.12261; Luo JX, 2015, J ENVIRON SCI-CHINA, V29, P115, DOI 10.1016/j.jes.2014.07.025; Luo JX, 2014, BIOFOULING, V30, P1093, DOI 10.1080/08927014.2014.971238; Miura Y, 2007, ENVIRON SCI TECHNOL, V41, P632, DOI 10.1021/es0615371; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Mutamim NSA, 2013, CHEM ENG J, V225, P109, DOI 10.1016/j.cej.2013.02.131; Pang CM, 2005, ENVIRON SCI TECHNOL, V39, P7541, DOI 10.1021/es050170h; Piasecka A, 2012, BIOFOULING, V28, P225, DOI 10.1080/08927014.2012.662640; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ramesh A, 2007, APPL MICROBIOL BIOT, V74, P699, DOI 10.1007/s00253-006-0706-x; Ravi S, 2009, MYCOPATHOLOGIA, V167, P307, DOI 10.1007/s11046-008-9180-6; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Suwarno SR, 2012, J MEMBRANE SCI, V405, P219, DOI 10.1016/j.memsci.2012.03.012; Wang ZJ, 2013, BIORESOURCE TECHNOL, V144, P74, DOI 10.1016/j.biortech.2013.06.093; Xia SQ, 2010, BIORESOURCE TECHNOL, V101, P6601, DOI 10.1016/j.biortech.2010.03.082; Yang C, 2011, ENVIRON SCI TECHNOL, V45, P7408, DOI 10.1021/es2010545; Zhang K, 2008, WATER ENVIRON RES, V80, P2209, DOI 10.2175/106143008X325809; Zhang QY, 2014, WATER RES, V58, P141, DOI 10.1016/j.watres.2014.03.052	50	30	31	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179855	10.1371/journal.pone.0179855	http://dx.doi.org/10.1371/journal.pone.0179855			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686622	Green Published, gold			2022-12-26	WOS:000405464100023
J	Rifbjerg-Madsen, S; Christensen, AW; Christensen, R; Hetland, ML; Bliddal, H; Kristensen, LE; Danneskiold-Samsoe, B; Amris, K				Rifbjerg-Madsen, S.; Christensen, A. W.; Christensen, R.; Hetland, M. L.; Bliddal, H.; Kristensen, L. E.; Danneskiold-Samsoe, B.; Amris, K.			Pain and pain mechanisms in patients with inflammatory arthritis: A Danish nationwide cross-sectional DANBIO registry survey	PLOS ONE			English	Article							HEALTH-ASSESSMENT QUESTIONNAIRE; CHRONIC WIDESPREAD PAIN; RHEUMATOID-ARTHRITIS; ANKYLOSING-SPONDYLITIS; CENTRAL SENSITIZATION; PSORIATIC-ARTHRITIS; NEUROPATHIC PAIN; FIBROMYALGIA; OSTEOARTHRITIS; PAINDETECT	Background Central pain mechanisms may be prominent in subsets of patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and other spondyloarthritis (SpA). The painDETECT questionnaire (PDQ) identifies neuropathic pain features, which may act as a proxy for centrally mediated pain. The objectives were to quantify and characterize pain phenotypes (non-neuropathic vs. neuropathic features) among Danish arthritis patients using the PDQ, and to assess the association with on-going inflammation. Methods The PDQ was included onto the DANBIO touch screens at 22 departments of Rheumatology in Denmark for six months. Clinical data and patient reported outcomes were obtained from DANBIO. A PDQ-score 18 indicated neuropathic pain features, 13-18 unclear pain mechanism and <13 non-neuropathic pain. Results Pain data (visual analogue scale, VAS) was available for 15,978 patients. 7,054 patients completed the PDQ (RA: 3,826, PsA: 1,180, SpA: 1,093). 52% of all patients and 63% of PDQcompleters had VAS pain score >= 30 mm. The distribution of the PDQ classification-groups (<13/13-18/> 8) were; RA: 56%/24%/20%. PsA: 45%/27%/28%. SpA: 55% /24%/21%. More patients with PsA had PDQ score > 18 compared to RA and SpA (p<0.001). For PDQ > 18 significantly higher scores were found for all patient reported outcomes and disease activity scores. No clinical difference in CRP or swollen joint count was found. Logistic regression showed increased odds for having VAS pain >= 39mm(the median) for a PDQ-score >18 compared to <13 (OR = 10.4; 95% CI 8.6-12.5). Conclusions More than 50% of the Danish arthritis patients reported clinically significant pain. More than 20% of the PDQ-completers had indication of neuropathic pain features, which was related to a high pain-level. PDQ-score was associated with DAS28-CRP and VAS pain but not with indicators of peripheral inflammation (CRP and SJC). Thus, pain classification by PDQ may assist in mechanism-based pain treatment.	[Rifbjerg-Madsen, S.; Christensen, A. W.; Christensen, R.; Bliddal, H.; Kristensen, L. E.; Danneskiold-Samsoe, B.; Amris, K.] Copenhagen Univ Hosp Bispebjerg & Frederiksberg, Parker Inst, Frederiksberg, Denmark; [Hetland, M. L.] Rigshosp, Ctr Rheumatol & Spine Dis, DANBIO, Glostrup, Denmark; [Hetland, M. L.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Amris, K.] Copenhagen Univ Hosp Bispebjerg & Frederiksberg, Dept Rheumatol, Frederiksberg, Denmark	University of Copenhagen; Bispebjerg Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Rifbjerg-Madsen, S (corresponding author), Copenhagen Univ Hosp Bispebjerg & Frederiksberg, Parker Inst, Frederiksberg, Denmark.	PARKER.Frederiksberg@regionh.dk	amris, kirstine/AAZ-2007-2020; Hetland, Merete L/AAE-5297-2019; Kristensen, Lars Erik/AAZ-2615-2020; Bliddal, Henning/AAB-3168-2019	Hetland, Merete L/0000-0003-4229-6818; Bliddal, Henning/0000-0002-7951-1668; Christensen, Robin/0000-0002-6600-0631				Ahmed S, 2014, J PAIN RES, V7, P579, DOI 10.2147/JPR.S69011; Almodovar R, 2010, CLIN EXP RHEUMATOL, V28, pS33; Aloush V, 2007, RHEUMATOL INT, V27, P865, DOI 10.1007/s00296-007-0344-3; Amris K, 2010, PAIN, V151, P664, DOI 10.1016/j.pain.2010.08.023; Azevedo VF, 2010, REV BRAS REUMATOL, V50, P650; BLACKMORE MG, 1995, J RHEUMATOL, V22, P886; CALIN A, 1994, J RHEUMATOL, V21, P2281; Eder L, 2017, ARTHRITIS RHEUMATOL, V69, P622, DOI 10.1002/art.39973; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Gwilym SE, 2009, ARTHRIT RHEUM-ARTHR, V61, P1226, DOI 10.1002/art.24837; Hetland ML, 2008, ANN RHEUM DIS, V67, P1023, DOI 10.1136/ard.2007.087262; Hetland ML, 2011, RHEUMATOLOGY, V50, P69, DOI 10.1093/rheumatology/keq309; Hetland ML, 2014, CLIN EXP RHEUMAT S85, V32, pS; Hochman JR, 2013, OSTEOARTHR CARTILAGE, V21, P1236, DOI 10.1016/j.joca.2013.06.023; JENKINSON TR, 1994, J RHEUMATOL, V21, P1694; Kato K, 2006, ARCH INTERN MED, V166, P1649, DOI 10.1001/archinte.166.15.1649; Koop SMW, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0761-8; Koroschetz J, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-55; Kristensen LE, 2014, ARTHRIT CARE RES, V66, P173, DOI 10.1002/acr.22107; Lage-Hansen PR, 2016, SCAND J RHEUMATOL, V45, P45, DOI 10.3109/03009742.2015.1046484; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lee YC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3353; Magrey MN, 2013, ARTHRITIS, V2013; Maletic V, 2009, FRONT BIOSCI-LANDMRK, V14, P5291, DOI 10.2741/3598; Marchesoni A, 2012, J RHEUMATOL, V39, P849, DOI 10.3899/jrheum.110893; Meeus M, 2012, SEMIN ARTHRITIS RHEU, V41, P556, DOI 10.1016/j.semarthrit.2011.08.001; Moreton BJ, 2015, ARTHRIT CARE RES, V67, P519, DOI 10.1002/acr.22431; Mundal I, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-213; Ohtori S, 2012, YONSEI MED J, V53, P801, DOI 10.3349/ymj.2012.53.4.801; Pollard LC, 2012, J RHEUMATOL, V39, P28, DOI 10.3899/jrheum.110668; Rehm SE, 2010, RHEUMATOLOGY, V49, P1146, DOI 10.1093/rheumatology/keq066; Roussou E, 2010, CLIN RHEUMATOL, V29, P869, DOI 10.1007/s10067-010-1411-9; Salaffi F, 2009, CLIN EXP RHEUMATOL, V27, P552; Salaffi F, 2014, RHEUMATOL INT; Schaible HG, 2010, ANN NY ACAD SCI, V1193, P60, DOI 10.1111/j.1749-6632.2009.05301.x; Thorsen H, 2001, SCAND J RHEUMATOL, V30, P103; Tubach F, 2012, ARTHRIT CARE RES, V64, P1699, DOI 10.1002/acr.21747; van der Heijde D, 2009, ANN RHEUM DIS, V68, P1811, DOI 10.1136/ard.2008.100826; Wolfe F, 2004, J RHEUMATOL, V31, P695; Wolfe F, 2007, J RHEUMATOL, V34, P1674; Wolfe F, 2014, ARTHRIT CARE RES, V66, P1465, DOI 10.1002/acr.22300; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Wu Q, 2013, ARTHRITIS RHEUM	44	63	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180014	10.1371/journal.pone.0180014	http://dx.doi.org/10.1371/journal.pone.0180014			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686639	Green Published, Green Submitted, gold			2022-12-26	WOS:000405464100030
J	Wu, ZX; Li, SF; Chen, H; Song, JX; Gao, YF; Zhang, F; Cao, CF				Wu, Ze-Xuan; Li, Su-Fang; Chen, Hong; Song, Jun-Xian; Gao, Yuan-Feng; Zhang, Feng; Cao, Cheng-Fu			The changes of gut microbiota after acute myocardial infarction in rats	PLOS ONE			English	Article							TRIMETHYLAMINE-N-OXIDE; INTESTINAL MICROBIOTA; HEART-FAILURE; BACTERIAL MUTUALISM; L-CARNITINE; DIVERSITY; METABOLISM; DISEASE; PERMEABILITY; SEQUENCES	Recent studies suggested that gut microbiota was involved in the development of coronary artery disease. However, the changes of gut microbiota following acute myocardial infarction (AMI) remain unknown. In this study, a total of 66 male Wistar rats were randomly divided into control, AMI and SHAM groups. The controls (n = 6) were sacrificed after anesthesia. The AMI model was built by ligation of left anterior descending coronary artery. The rats of AMI and SHAM groups were sacrificed at 12 h, 1 d, 3 d, 7 d and 14 d post-operation respectively. Gut microbiota was analyzed by 16S rDNA high throughput sequencing. The gut barrier injuries were evaluated through histopathology, transmission electron microscope and immunohistochemical staining. The richness of gut microbiota was significantly higher in AMI group than SHAM group at 7 d after AMI (P<0.05). Principal coordinate analysis with unweighted UniFrac distances revealed microbial differences between AMI and SHAM groups at 7 d. The gut barrier impairment was also the most significant at 7 d post-AMI. We further identified the differences of microorganisms between AMI and SHAM group at 7 d. The abundance of Synergistetes phylum, Spirochaetes phylum, Lachnospiraceae family, Syntrophomonadaceae family and Tissierella Soehngenia genus was higher in AMI group compared with SHAM group at 7 d post-operation (q<0.05). Our study showed the changes of gut microbiota at day 7 post AMI which was paralleled with intestinal barrier impairment. We also identified the microbial organisms that contribute most.	[Wu, Ze-Xuan; Li, Su-Fang; Chen, Hong; Song, Jun-Xian; Gao, Yuan-Feng; Zhang, Feng; Cao, Cheng-Fu] Peking Univ, Dept Cardiol, Peoples Hosp, Beijing, Peoples R China; [Wu, Ze-Xuan; Li, Su-Fang; Chen, Hong; Song, Jun-Xian; Gao, Yuan-Feng; Zhang, Feng; Cao, Cheng-Fu] Peking Univ, Peoples Hosp, Beijing Key Lab Early Predict & Intervent Acute M, Beijing, Peoples R China; [Wu, Ze-Xuan; Li, Su-Fang; Chen, Hong; Song, Jun-Xian; Gao, Yuan-Feng; Zhang, Feng; Cao, Cheng-Fu] Peking Univ, Peoples Hosp, Ctr Cardiovasc Translat Res, Beijing, Peoples R China; [Wu, Ze-Xuan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Guangdong, Peoples R China	Peking University; Peking University; Peking University; Sun Yat Sen University	Chen, H (corresponding author), Peking Univ, Dept Cardiol, Peoples Hosp, Beijing, Peoples R China.; Chen, H (corresponding author), Peking Univ, Peoples Hosp, Beijing Key Lab Early Predict & Intervent Acute M, Beijing, Peoples R China.; Chen, H (corresponding author), Peking Univ, Peoples Hosp, Ctr Cardiovasc Translat Res, Beijing, Peoples R China.	chenhongbj@medmail.com.cn		Li, Sufang/0000-0002-3904-0881	National Natural Science Foundation of China [81470473, 81270274]; Beijing Science and Technology Major Project [D141100003014002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Science and Technology Major Project	This work was supported by the National Natural Science Foundation of China (81470473, 81270274) and Beijing Science and Technology Major Project (No. D141100003014002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alauzet C, 2014, SYST APPL MICROBIOL, V37, P23, DOI 10.1016/j.syapm.2013.09.007; Allen-Blevins CR, 2017, PEERJ, V5, DOI 10.7717/peerj.2876; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bischoff SC, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0189-7; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Bull Matthew J, 2014, Integr Med (Encinitas), V13, P17; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cheng PK, 2016, ADV SCI, V3, DOI 10.1002/advs.201600254; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Clemente-Postigo M, 2012, J LIPID RES, V53, P973, DOI 10.1194/jlr.P020909; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dinan TG, 2012, PSYCHONEUROENDOCRINO, V37, P1369, DOI 10.1016/j.psyneuen.2012.03.007; FREIS ED, 1952, J CLIN INVEST, V31, P131, DOI 10.1172/JCI102584; Gan XT, 2014, CIRC-HEART FAIL, V7, P491, DOI 10.1161/CIRCHEARTFAILURE.113.000978; Hsiao JK, 2009, INVEST RADIOL, V44, P329, DOI 10.1097/RLI.0b013e3181a16762; Huang Ying, 2014, Zhongguo Weishengtaxixue Zazhi / Chinese Journal of Microecology, V26, P1004; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Khan MS, 2014, J PAK MED ASSOC, V64, P488; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Kosik-Bogacka DI, 2011, EXP PARASITOL, V127, P398, DOI 10.1016/j.exppara.2010.09.001; Mao Y, 2011, INT J CARDIOL, V146, P432, DOI 10.1016/j.ijcard.2010.10.102; Marchandin H, 2010, RES MICROBIOL, V161, P91, DOI 10.1016/j.resmic.2009.12.008; Marcinkiewicz AL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00328; Nagatomo Y, 2015, J CARD FAIL, V21, P973, DOI 10.1016/j.cardfail.2015.09.017; Nakamura S, 2017, METHODS MOL BIOL, V1593, P243, DOI 10.1007/978-1-4939-6927-2_19; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Seropian IM, 2015, EUROPEAN HEART J ACU; SMITH GLF, 1989, ORAL MICROBIOL IMMUN, V4, P135, DOI 10.1111/j.1399-302X.1989.tb00240.x; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Takala J, 1996, BRIT J ANAESTH, V77, P50, DOI 10.1093/bja/77.1.50; Tran CD, 2015, FUTURE MICROBIOL, V10, P1339, DOI 10.2217/FMB.15.54; Troseid M, 2015, J INTERN MED, V277, P717, DOI 10.1111/joim.12328; Troseid M., 2017, EUR HEART J; Ussher JR, 2013, ATHEROSCLEROSIS, V231, P456, DOI 10.1016/j.atherosclerosis.2013.10.013; Voreades N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00494; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yu XL, 2016, MICROB PATHOGENESIS, V94, P90, DOI 10.1016/j.micpath.2015.11.029	42	35	40	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180717	10.1371/journal.pone.0180717	http://dx.doi.org/10.1371/journal.pone.0180717			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686722	Green Published, Green Submitted, gold			2022-12-26	WOS:000405464100096
J	Turker, MS; Grygoryev, D; Lasarev, M; Ohlrichl, A; Rwatambuga, FA; Johnson, S; Dan, C; Eckelmann, B; Hryciw, G; Mao, JH; Snijders, AM; Gauny, S; Kronenberg, A				Turker, Mitchell S.; Grygoryev, Dmytro; Lasarev, Michael; Ohlrichl, Anna; Rwatambuga, Furaha A.; Johnson, Sorrel; Dan, Cristian; Eckelmann, Bradley; Hryciw, Gwen; Mao, Jian-Hua; Snijders, Antoine M.; Gauny, Stacey; Kronenberg, Amy			Simulated space radiation-induced mutants in the mouse kidney display widespread genomic change	PLOS ONE			English	Article							AUTOSOMAL MUTATIONS; IONIZING-RADIATION; SOLID TISSUES; MULTIPLE MUTATIONS; CELL-LINES; HEAVY-IONS; IN-VIVO; HETEROZYGOSITY; INSTABILITY; EXPOSURE	Exposure to a small number of high-energy heavy charged particles (HZE ions), as found in the deep space environment, could significantly affect astronaut health following prolonged periods of space travel if these ions induce mutations and related cancers. In this study, we used an in vivo mutagenesis assay to define the mutagenic effects of accelerated Fe-56 ions (1 GeV/amu, 151 keV/mu m) in the mouse kidney epithelium exposed to doses ranging from 0.25 to 2.0 Gy. These doses represent fluences ranging from 1 to 8 particle traversals per cell nucleus. The Aprt locus, located on chromosome 8, was used to select induced and spontaneous mutants. To fully define the mutagenic effects, we used multiple endpoints including mutant frequencies, mutation spectrum for chromosome 8, translocations involving chromosome 8, and mutations affecting non-selected chromosomes. The results demonstrate mutagenic effects that often affect multiple chromosomes for all Fe ion doses tested. For comparison with the most abundant sparsely ionizing particle found in space, we also examined the mutagenic effects of high-energy protons (1 GeV, 0.24 keV/mu m) at 0.5 and 1.0 Gy. Similar doses of protons were not as mutagenic as Fe ions for many assays, though genomic effects were detected in Aprt mutants at these doses. Considered as a whole, the data demonstrate that Fe ions are highly mutagenic at the low doses and fluences of relevance to human spaceflight, and that cells with considerable genomic mutations are readily induced by these exposures and persist in the kidney epithelium. The level of genomic change produced by low fluence exposure to heavy ions is reminiscent of the extensive rearrangements seen in tumor genomes suggesting a potential initiation step in radiation carcinogenesis.	[Turker, Mitchell S.; Grygoryev, Dmytro; Lasarev, Michael; Ohlrichl, Anna; Rwatambuga, Furaha A.; Johnson, Sorrel; Dan, Cristian; Eckelmann, Bradley; Hryciw, Gwen] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA; [Turker, Mitchell S.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Mao, Jian-Hua; Snijders, Antoine M.; Gauny, Stacey; Kronenberg, Amy] Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA USA; [Eckelmann, Bradley] Texas A&M Hlth Sci Ctr, Bryan, TX USA	Oregon Health & Science University; Oregon Health & Science University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Turker, MS (corresponding author), Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA.; Turker, MS (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA.	turkerm@ohsu.edu	Mao, Jian-Hua/EIZ-8595-2022	Mao, Jian-Hua/0000-0001-9320-6021; Lasarev, Michael R/0000-0002-1896-2705; Turker, Mitchell/0000-0002-1438-7475	NASA [NNX1OAC12G, NNX14AC97G, NNJ12HB881, NNJ16HP23I]; Murdock Scholar Fellowships; Oregon Institute of Occupational Health Sciences; Ted. R. Lilley Cancer Cure fellowship	NASA(National Aeronautics & Space Administration (NASA)); Murdock Scholar Fellowships; Oregon Institute of Occupational Health Sciences; Ted. R. Lilley Cancer Cure fellowship	This work was supported by NASA grants NNX1OAC12G, NNX14AC97G, NNJ12HB881, and NNJ16HP23I, Murdock Scholar Fellowships to Gwen Hryciw and Sorrel Johnson, and an Oregon Institute of Occupational Health Sciences summer fellowship to Bradley Eckelmann, and the Ted. R. Lilley Cancer Cure fellowship for high school students. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPEN EL, 1994, ADV SPACE RES, V14, P573, DOI 10.1016/0273-1177(94)90512-6; Chang PY, 2001, PHYS MEDICA, V17, P189; Chang PY, 2001, MUTAGENESIS, V16, P7, DOI 10.1093/mutage/16.1.7; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; Cucinotta FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074988; Cucinotta FA, 2010, MUTAT RES-FUND MOL M, V687, P49, DOI 10.1016/j.mrfmmm.2010.01.012; Curtis S B, 1989, Adv Space Res, V9, P293, DOI 10.1016/0273-1177(89)90452-3; CURTIS SB, 1992, ADV SPACE RES-SERIES, V12, P407, DOI 10.1016/0273-1177(92)90137-M; Dan C, 2011, GENE CHROMOSOME CANC, V50, P239, DOI 10.1002/gcc.20849; Durante M, 2005, ADV SPACE RES, V35, P180, DOI 10.1016/j.asr.2004.12.034; Durante M, 2002, RADIAT RES, V158, P581, DOI 10.1667/0033-7587(2002)158[0581:KOHLET]2.0.CO;2; Durante M, 2008, NAT REV CANCER, V8, P465, DOI 10.1038/nrc2391; Gao RL, 2016, NAT GENET, V48, P1119, DOI 10.1038/ng.3641; Grygoryev D, 2016, MUTAT RES-FUND MOL M, V788, P32, DOI 10.1016/j.mrfmmm.2016.03.004; Grygoryev D, 2014, RADIAT RES, V181, P452, DOI 10.1667/RR13654.1; HORN PL, 1984, J CELL PHYSIOL, V121, P309, DOI 10.1002/jcp.1041210207; Hryciw G, 2015, RADIAT RES, V184, P367, DOI 10.1667/RR14130.1; Kagawa Y, 1999, MUTAGENESIS, V14, P199, DOI 10.1093/mutage/14.2.199; Kiefer J, 2002, J RADIAT RES, V43, pS21; Kraemer SM, 2000, RADIAT RES, V153, P743, DOI 10.1667/0033-7587(2000)153[0743:MTSOMI]2.0.CO;2; Kronenberg A, 2013, RADIAT RES, V179, P511, DOI 10.1667/RR3182.1; Kronenberg A, 2012, HEALTH PHYS, V103, P556, DOI 10.1097/HP.0b013e3182690caf; Kronenberg A, 2009, RADIAT RES, V172, P550, DOI 10.1667/RR1804.1; Little JB, 1997, RADIAT RES, V148, P299, DOI 10.2307/3579514; Loeb LA, 2003, P NATL ACAD SCI USA, V100, P776, DOI 10.1073/pnas.0334858100; Loeb LA, 1996, MUTAT RES-FUND MOL M, V350, P279, DOI 10.1016/0027-5107(95)00117-4; Maalouf M, 2011, J RADIAT RES, V52, P126, DOI 10.1269/jrr.10128; Masumura K, 2002, ENVIRON MOL MUTAGEN, V40, P207, DOI 10.1002/em.10108; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morgan WF, 2003, ONCOGENE, V22, P7094, DOI 10.1038/sj.onc.1206992; MuCullagh P, 1989, GENERALIZED LINEAR M; NELSON SL, 1995, RADIAT RES, V141, P2, DOI 10.2307/3579083; Padilla-Nash HM, 2012, GENE CHROMOSOME CANC, V51, P353, DOI 10.1002/gcc.21921; Plante I, RAD PROT DOSIMETRY, V143, P156; Ponomareva ON, 2002, CANCER RES, V62, P1518; Sasaki MS, 2009, INT J RADIAT BIOL, V85, P26, DOI 10.1080/09553000802641185; Shao CS, 1999, P NATL ACAD SCI USA, V96, P9230, DOI 10.1073/pnas.96.16.9230; Sudo H, 2008, RADIAT RES, V170, P23, DOI 10.1667/RR1317.1; Townshead LW, 2006, INFORM NEEDED MAKE R; Trani D, 2014, RADIAT RES, V181, P162, DOI 10.1667/RR13502.1; Tsuruoka C, 2016, RADIAT RES, V186, P407, DOI 10.1667/RR14499.1; Turker MS, 2007, AGING CELL, V6, P73, DOI 10.1111/j.1474-9726.2006.00264.x; Turker MS, 2013, RADIAT RES, V179, P521, DOI 10.1667/RR3174.1; Turker MS, 2009, RADIAT RES, V172, P558, DOI 10.1667/RR1805.1; Turker MS, 1997, MUTAT RES-FUND MOL M, V374, P201, DOI 10.1016/S0027-5107(96)00230-8; Turker MS, 2003, MUTAGENESIS, V18, P1, DOI 10.1093/mutage/18.1.1; Turker MS, 1999, CANCER RES, V59, P4781; Waldren C, 1998, ADV SPACE RES, V22, P579, DOI 10.1016/S0273-1177(98)00080-5; Wang X, 2015, RADIAT RES, V183, P233, DOI 10.1667/RR13884.1; Wiese C, 2001, CANCER RES, V61, P1129; Wilson C, 2005, HUM MOL GENET, V14, P1839, DOI 10.1093/hmg/ddi190; Yatagai Fumio, 2004, Biol Sci Space, V18, P224, DOI 10.2187/bss.18.224	52	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180412	10.1371/journal.pone.0180412	http://dx.doi.org/10.1371/journal.pone.0180412			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683078	Green Published, gold			2022-12-26	WOS:000405335200032
J	Versace, A; Sharma, V; Bertocci, MA; Bebko, G; Lyengar, S; Dwojak, A; Boner, L; Periman, SB; Schirda, C; Travis, M; Gill, MK; Diwadkar, VA; Sunshine, JL; Holland, SK; Kowatch, RA; Birmaher, B; Axelson, D; Frazier, TW; Arnold, LE; Fristad, MA; Youngstrom, EA; Horwitz, SM; Findling, RL; Phillips, ML				Versace, Amelia; Sharma, Vinod; Bertocci, Michele A.; Bebko, Genna; Lyengar, Satish; Dwojak, Amanda; Boner, Lisa; Periman, Susan B.; Schirda, Claudiu; Travis, Michael; Gill, Mary Kay; Diwadkar, Vaibhav A.; Sunshine, Jeffrey L.; Holland, Scott K.; Kowatch, Robert A.; Birmaher, Boris; Axelson, David; Frazier, Thomas W.; Arnold, L. Eugene; Fristad, Mary A.; Youngstrom, Eric A.; Horwitz, Sarah M.; Findling, Robert L.; Phillips, Mary L.			Using machine learning and surface reconstruction to accurately differentiate different trajectories of mood and energy dysregulation in youth	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; MANIC SYMPTOMS; LONGITUDINAL ASSESSMENT; CORTICAL THICKNESS; EMOTION DYSREGULATION; BIPOLAR DISORDER; FAMILIAL RISK; CHILDREN; ADOLESCENTS; REGRESSION	Difficulty regulating positive mood and energy is a feature that cuts across different pediatric psychiatric disorders. Yet, little is known regarding the neural mechanisms underlying different developmental trajectories of positive mood and energy regulation in youth. Recent studies indicate that machine learning techniques can help elucidate the role of neuroimaging measures in classifying individual subjects by specific symptom trajectory. Cortical thickness measures were extracted in sixty-eight anatomical regions covering the entire brain in 115 participants from the Longitudinal Assessment of Manic Symptoms (LAMS) study and 31 healthy comparison youth (12.5 y/o;-Male/Female = 15/16; -IQ = 104;-Right/Left handedness = 24/5). Using a combination of trajectories analyses, surface reconstruction, and machine learning techniques, the present study aims to identify the extent to which measures of cortical thickness can accurately distinguish youth with higher (n = 18) from those with lower (n = 34) trajectories of manic -like behaviors in a large sample of LAMS youth (n = 115; 13.6 y/o; M/F = 68/47, IQ = 100.1, R/L = 108/7). Machine learning analyses revealed that widespread cortical thickening in portions of the left dorsolateral prefrontal cortex, right inferior and middle temporal gyrus, bilateral precuneus, and bilateral paracentral gyri and cortical thinning in portions of the right dorsolateral prefrontal cortex, left ventrolateral prefrontal cortex, and right parahippocampal gyrus accurately differentiate (Area Under Curve = 0.89;p = 0.03) youth with different (higher vs lower) trajectories of positive mood and energy dysregulation over a period up to 5years, as measured by the Parent General Behavior Inventory-10 Item Mania Scale. Our findings suggest that specific patterns of cortical thickness may reflect transdiagnostic neural mechanisms associated with different temporal trajectories of positive mood and energy dysregulation in youth. This approach has potential to identify patterns of neural markers of future clinical course.	[Versace, Amelia; Sharma, Vinod; Bertocci, Michele A.; Bebko, Genna; Dwojak, Amanda; Boner, Lisa; Periman, Susan B.; Schirda, Claudiu; Travis, Michael; Gill, Mary Kay; Birmaher, Boris; Phillips, Mary L.] Univ Pittsburgh, Western Psychiat Inst & Clin, Dept Psychiat, Med Ctr, Pittsburgh, PA 15213 USA; [Lyengar, Satish] Univ Pittsburgh, Dept Stat, Pittsburgh, PA USA; [Diwadkar, Vaibhav A.] Wayne State Univ, Dept Psychiat & Behav Neurosci, Detroit, MI 48207 USA; [Sunshine, Jeffrey L.] Case Western Reserve Univ, Case Med Ctr, Univ Hosp, Cleveland, OH 44106 USA; [Holland, Scott K.] Case Western Reserve Univ, Med Ctr, Univ Hosp, Dept Radiol, Cleveland, OH USA; [Kowatch, Robert A.] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Axelson, David; Arnold, L. Eugene; Fristad, Mary A.] Ohio State Univ, Dept Psychiat, Columbus, OH 43210 USA; [Frazier, Thomas W.] Cleveland Clin, Pediat Inst, Cleveland, OH 44106 USA; [Youngstrom, Eric A.] Univ N Carolina, Dept Psychol, Chapel Hill, NC USA; [Horwitz, Sarah M.] NYU, Dept Child & Adolescent Psychiat, Sch Med, New York, NY USA; [Findling, Robert L.] Johns Hopkins Univ, Dept Psychiat, Baltimore, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wayne State University; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; University Hospitals of Cleveland; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Cleveland Clinic Foundation; University of North Carolina; University of North Carolina Chapel Hill; New York University; Johns Hopkins University	Versace, A (corresponding author), Univ Pittsburgh, Western Psychiat Inst & Clin, Dept Psychiat, Med Ctr, Pittsburgh, PA 15213 USA.	versacea@upmc.edu	bertocci, michele/AAQ-2875-2021; Youngstrom, Eric A./ABE-3258-2020; Versace, Amelia/G-1772-2018; Fristad, Mary A/AAW-6472-2021	Youngstrom, Eric A./0000-0003-2251-6860; Versace, Amelia/0000-0001-9925-5203; Horwitz, Sarah/0000-0002-5262-1170; Schirda, Claudiu/0000-0002-5036-0640	National Institute of Mental Health [2R01 MH73953-06A1]; Pittsburgh Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073801, R01MH073967, R01MH073953, T32MH018951, R01MH073816] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Pittsburgh Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the National Institute of Mental Health grant 2R01 MH73953-06A1 (BB and MLP, University of Pittsburgh) and by the Pittsburgh Foundation (MLP, University of Pittsburgh Emmerling Endowed Chair in Psychotic Disorders). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreescu C, 2008, INT PSYCHOGERIATR, V20, P221, DOI 10.1017/S1041610207006667; Axelson D, 2003, J CHILD ADOL PSYCHOP, V13, P463, DOI 10.1089/104454603322724850; Bebko G, 2014, JAMA PSYCHIAT, V71, P71, DOI 10.1001/jamapsychiatry.2013.2870; Berkman ET, 2013, CURR DIR PSYCHOL SCI, V22, P45, DOI 10.1177/0963721412469394; Bertocci MA, 2013, BIOL PSYCHIAT, V73, p195S; Birmaher B, 1997, J AM ACAD CHILD PSY, V36, P545, DOI 10.1097/00004583-199704000-00018; Birmaher B, 2009, AM J PSYCHIAT, V166, P795, DOI 10.1176/appi.ajp.2009.08101569; Bunford N, 2015, J ABNORM CHILD PSYCH, V43, P133, DOI 10.1007/s10802-014-9902-9; Carlson GA, 1998, J AFFECT DISORDERS, V51, P123, DOI 10.1016/S0165-0327(98)00211-0; Cavanagh M, 2014, J ATTEN DISORD, V13, P13; Cole P.M., 1994, MONOGRAPHS SOC RES C, V59, P73, DOI [10.2307/1166139, DOI 10.2307/1166139]; Copeland WE, 2013, AM J PSYCHIAT, V170, P173, DOI 10.1176/appi.ajp.2012.12010132; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Findling RL, 2013, BIPOLAR DISORD, V15, P669, DOI 10.1111/bdi.12100; Findling RL, 2010, J CLIN PSYCHIAT, V71, P1664, DOI 10.4088/JCP.09m05859yel; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Foland-Ross LC, 2015, J ABNORM PSYCHOL, V124, P476, DOI 10.1037/abn0000050; Frazier TW, 2011, J CLIN PSYCHIAT, V72, P846, DOI 10.4088/JCP.10m06081yel; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gogtay N, 2007, J CHILD PSYCHOL PSYC, V48, P852, DOI 10.1111/j.1469-7610.2007.01747.x; Group-based modeling of development, 2005, CHOIC CURR REV AC LI, V43, P375; Hastie T., 2009, ELEMENTS STAT LEARNI, Vxxii; Hazell PL, 2003, J AM ACAD CHILD PSY, V42, P552, DOI 10.1097/01.CHI.0000046830.95464.33; Heller AS, 2016, DEVELOPMENTAL SCI, V19, P3, DOI 10.1111/desc.12373; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Horwitz SM, 2010, J CLIN PSYCHIAT, V71, P1511, DOI 10.4088/JCP.09m05835yel; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Insel TR, 2014, JAMA PSYCHIAT, V71, P745, DOI 10.1001/jamapsychiatry.2014.426; Janssen J, 2014, SCHIZOPHR RES, V158, P91, DOI 10.1016/j.schres.2014.06.040; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Jones BL, 2013, SOCIOL METHOD RES, V42, P608, DOI 10.1177/0049124113503141; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kuo SY, 2011, PSYCHOL MED, V41, P1665, DOI 10.1017/S0033291710002473; Larson RW, 2002, CHILD DEV, V73, P1151, DOI 10.1111/1467-8624.00464; Leibenluft E, 2003, BIOL PSYCHIAT, V53, P1009, DOI 10.1016/S0006-3223(03)00069-6; McCarthy CS, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00379; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Papmeyer M, 2015, BIOL PSYCHIAT, V78, P58, DOI 10.1016/j.biopsych.2014.10.018; Paternoster R, 1998, CRIMINOLOGY, V36, P859, DOI 10.1111/j.1745-9125.1998.tb01268.x; Rosen PJ, 2015, ADHD-ATTEND DEFICIT, V7, P281, DOI 10.1007/s12402-015-0175-0; Salters-Pedneault K, 2006, COGNITIVE THER RES, V30, P469, DOI 10.1007/s10608-006-9055-4; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2006, ARCH GEN PSYCHIAT, V63, P540, DOI 10.1001/archpsyc.63.5.540; Shaw P, 2014, AM J PSYCHIAT, V171, P276, DOI 10.1176/appi.ajp.2013.13070966; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wallace GL, 2014, J AM ACAD CHILD PSY, V53, P456, DOI 10.1016/j.jaac.2013.12.008; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Youngstrom E, 2005, BIPOLAR DISORD, V7, P507, DOI 10.1111/j.1399-5618.2005.00269.x; Youngstrom EA, 2008, J CLIN PSYCHIAT, V69, P831, DOI 10.4088/JCP.v69n0517; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	53	1	1	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180221	10.1371/journal.pone.0180221	http://dx.doi.org/10.1371/journal.pone.0180221			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA3HX	28683115	Green Published, gold, Green Submitted			2022-12-26	WOS:000405335200019
J	Balseiro, A; Altuzarra, R; Vidal, E; Moll, X; Espada, Y; Sevilla, IA; Domingo, M; Garrido, JM; Juste, RA; Prieto, M; de Val, BP				Balseiro, Ana; Altuzarra, Raul; Vidal, Enric; Moll, Xavier; Espada, Yvonne; Sevilla, Iker A.; Domingo, Mariano; Garrido, Joseba M.; Juste, Ramon A.; Prieto, Miguel; Perez de Val, Bernat			Assessment of BCG and inactivated Mycobacterium bovis vaccines in an experimental tuberculosis infection model in sheep	PLOS ONE			English	Article							CALMETTE-GUERIN VACCINATION; DEER ODOCOILEUS-VIRGINIANUS; ORAL VACCINATION; ANTIBODY-RESPONSES; BRUSHTAIL POSSUMS; CATTLE; BACILLUS; BADGERS; PROTECTION; PATHOLOGY	Background/Aims Animal tuberculosis (TB) is a complex animal health problem that causes disruption to trade and significant economic losses. TB involves a multi-host system where sheep, traditionally considered a rare host of this infection, have been recently included. The aims of this study were to develop an experimental TB infection model in sheep with a Mycobacterium caprae field strain isolated from a tuberculous diseased ewe, and to use this to evaluate the safety and efficacy of two vaccines against TB in sheep, the live-attenuated M. bovis BCG vaccine (Danish strain) and a heat-inactivated M. bovis (HIMB) vaccine. Methods Eighteen 2 month-old lambs were experimentally challenged with M. caprae by the endotracheal route (1.5 x 10(3) CFU). They were separated per treatment group into parenterally vaccinated with a live BCG Danish strain vaccine (n = 6), orally vaccinated with a suspension of HIMB (n = 6) and unvaccinated controls (n = 6). Clinical, immunological, pathological and bacteriological parameters of infection were measured. Results All lambs were successfully infected and developed gross TB lesions in the respiratory system. The BCG vaccine conferred considerable protection against experimental TB in lambs, as measured by a reduction of the gross lesion volumes and bacterial load. However, HIMB vaccinated animals did not show protection. Conclusions This study proposes a reliable new experimental model for a better understanding of tuberculosis in sheep. BCG vaccination offers an effective prospect for controlling the disease. Moreover alternative doses and/or routes of administration should be considered to evaluate the efficacy of the HIMB vaccine candidate.	[Balseiro, Ana; Juste, Ramon A.; Prieto, Miguel] SERIDA, Serv Reg Invest & Desarrollo Agroalimentario, Ctr Biotecnol Anim, Gijon, Asturias, Spain; [Altuzarra, Raul; Moll, Xavier; Espada, Yvonne] Univ Autonoma Barcelona, Dept Med & Cirugia Anim, Barcelona, Catalonia, Spain; [Vidal, Enric; Domingo, Mariano; Perez de Val, Bernat] UAB, Ctr Recerca Sanitat Anim CReSA, IRTA, Campus Univ Autanoma Barcelona, Barcelona, Spain; [Sevilla, Iker A.; Garrido, Joseba M.] NEIKER Tecnalia, Inst Vasco Invest & Desarrollo Agr, Dept Sanidad Anim, Bizkaia, Pais Vasco, Spain; [Domingo, Mariano] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Barcelona, Catalonia, Spain	Servicio Regional Investigacion Desarrollo Agroalimentario - SERIDA; Autonomous University of Barcelona; Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona	Balseiro, A (corresponding author), SERIDA, Serv Reg Invest & Desarrollo Agroalimentario, Ctr Biotecnol Anim, Gijon, Asturias, Spain.	abalseiro@serida.org	Balseiro, Ana/O-1794-2019; Juste, Ramon A./C-3570-2008; Moll, Xavier/H-3203-2018; DE VAL, BERNAT PÉREZ/G-6865-2012; Prieto Lage, Miguel Angel/G-4516-2011; Vidal, Enric/P-2901-2019; Vidal, Enric/I-1679-2014; Sevilla, Iker A/O-6060-2014; Domingo, Mariano/A-1015-2009	Balseiro, Ana/0000-0002-5121-7264; Juste, Ramon A./0000-0001-6037-5873; Moll, Xavier/0000-0002-2992-9361; DE VAL, BERNAT PÉREZ/0000-0003-3127-9182; Prieto Lage, Miguel Angel/0000-0002-3513-0054; Vidal, Enric/0000-0002-4965-3286; Vidal, Enric/0000-0002-4965-3286; Sevilla, Iker A/0000-0003-3968-3390; Domingo, Mariano/0000-0002-9623-4826; Joseba M., Garrido/0000-0002-7559-0653	Instituto Nacionalde Investigacio y Tecnologo Aa Agrariay Alimentaria (INIA) - FEDER [RTA2014-0002-C02-01]; CERCA Programme/Generalitat de Catalunya	Instituto Nacionalde Investigacio y Tecnologo Aa Agrariay Alimentaria (INIA) - FEDER; CERCA Programme/Generalitat de Catalunya	This work was funded by a grant from Instituto Nacionalde Investigacio y Tecnologo Aa Agrariay Alimentaria (INIA), reference number RTA2014-0002-C02-01 (FEDER co-funded). IRTA is supported by CERCA Programme/Generalitat de Catalunya.	Ballesteros C, 2009, VACCINE, V27, P6662, DOI 10.1016/j.vaccine.2009.08.095; Caswell J. L., 2007, PALMERIS PATHOL DOME, V2, P523; Chambers MA, 2014, VET REC, V175, P90, DOI 10.1136/vr.102581; Chambers MA, 2004, VACCINE, V22, P1063, DOI 10.1016/j.vaccine.2003.05.002; Chambers MA, 2011, P ROY SOC B-BIOL SCI, V278, P1913, DOI 10.1098/rspb.2010.1953; CORDES DO, 1981, NEW ZEAL VET J, V29, P60, DOI 10.1080/00480169.1981.34798; Corner LAL, 2007, RES VET SCI, V83, P53, DOI 10.1016/j.rvsc.2006.10.016; Corner LAL, 2002, RES VET SCI, V73, P145, DOI 10.1016/S0034-5288(02)00038-3; Cousins DV, 2001, REV SCI TECH OIE, V20, P71, DOI 10.20506/rst.20.1.1263; Garrido JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024905; Gortazar C, 2011, VET MICROBIOL, V151, P170, DOI 10.1016/j.vetmic.2011.02.041; GRANGE JM, 1990, J APPL BACTERIOL, V68, P411, DOI 10.1111/j.1365-2672.1990.tb02892.x; Griffin J. F. T., 1999, Tubercle and Lung Disease, V79, P135, DOI 10.1054/tuld.1998.0202; Jones GJ, 2016, VET IMMUNOL IMMUNOP, V182, P85, DOI 10.1016/j.vetimm.2016.10.010; Lopez V, 2016, VET IMMUNOL IMMUNOP, V172, P21, DOI 10.1016/j.vetimm.2016.03.003; Lopez-Valencia G, 2010, RES VET SCI, V88, P44, DOI 10.1016/j.rvsc.2009.05.022; Lyashchenko K, 2004, INFECT IMMUN, V72, P2462, DOI 10.1128/IAI.72.5.2462-2467.2004; Murphy D, 2014, VET J, V200, P362, DOI 10.1016/j.tvjl.2014.02.031; Nol P, 2008, J WILDLIFE DIS, V44, P247, DOI 10.7589/0090-3558-44.2.247; Palmer MV, 2007, VACCINE, V25, P6589, DOI 10.1016/j.vaccine.2007.06.056; de Val BP, 2017, TRANSBOUND EMERG DIS, V64, P275, DOI 10.1111/tbed.12368; de Val BP, 2016, VACCINE, V34, P881, DOI 10.1016/j.vaccine.2016.01.004; de Val BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081317; de Val BP, 2011, CLIN VACCINE IMMUNOL, V18, P1872, DOI 10.1128/CVI.05323-11; Tompkins DM, 2009, P ROY SOC B-BIOL SCI, V276, P2987, DOI 10.1098/rspb.2009.0414; Vordermeier HM, 2016, ANNU REV ANIM BIOSCI, V4, P87, DOI 10.1146/annurev-animal-021815-111311; Vordermeier HM, 2014, RES VET SCI, V97, pS53, DOI 10.1016/j.rvsc.2014.04.015; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Waters WR, 2006, CLIN VACCINE IMMUNOL, V13, P648, DOI 10.1128/CVI.00061-06; Waters WR, 2012, VACCINE, V30, P2611, DOI 10.1016/j.vaccine.2012.02.018; Wilton S, 1992, GENOME RES, V1, P269, DOI DOI 10.1101/GR.1.4.269	31	19	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180546	10.1371/journal.pone.0180546	http://dx.doi.org/10.1371/journal.pone.0180546			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678885	Green Published, gold, Green Submitted			2022-12-26	WOS:000405272200072
J	Trudeau-Fisette, P; Tiede, M; Menard, L				Trudeau-Fisette, Pamela; Tiede, Mark; Menard, Lucie			Compensations to auditory feedback perturbations in congenitally blind and sighted speakers: Acoustic and articulatory data	PLOS ONE			English	Article							SENSORIMOTOR ADAPTATION; SPEECH ACQUISITION; NEURAL THEORY; MOTOR; PITCH; COORDINATION; SPECIFICITY; PERCEPTION; FREQUENCY; LANGUAGE	This study investigated the effects of visual deprivation on the relationship between speech perception and production by examining compensatory responses to real-time perturbations in auditory feedback. Specifically, acoustic and articulatory data were recorded while sighted and congenitally blind French speakers produced several repetitions of the vowel /phi/. At the acoustic level, blind speakers produced larger compensatory responses to altered vowels than their sighted peers. At the articulatory level, blind speakers also produced larger displacements of the upper lip, the tongue tip, and the tongue dorsum in compensatory responses. These findings suggest that blind speakers tolerate less discrepancy between actual and expected auditory feedback than sighted speakers. The study also suggests that sighted speakers have acquired more constrained somatosensory goals through the influence of visual cues perceived in face-to-face conversation, leading them to tolerate less discrepancy between expected and altered articulatory positions compared to blind speakers and thus resulting in smaller observed compensatory responses.	[Trudeau-Fisette, Pamela; Menard, Lucie] Univ Quebec Montreal, Lab Phonet, Ctr Res Brain Language & Mus, Montreal, PQ, Canada; [Tiede, Mark] Haskins Labs Inc, New Haven, CT USA	University of Quebec; University of Quebec Montreal; Yale University; Haskins Laboratories	Trudeau-Fisette, P (corresponding author), Univ Quebec Montreal, Lab Phonet, Ctr Res Brain Language & Mus, Montreal, PQ, Canada.	ptrudeaufisette@gmail.com			Social Sciences and Humanities Research Council of Canada (Canada Graduate Scholarships Master's Program) [766-20140 255]; Social Sciences and Humanities Research Council of Canada (Insight Grant) [4102 010-1785]; Natural Sciences and Engineering (LM) [RGPIN-2015-06544]	Social Sciences and Humanities Research Council of Canada (Canada Graduate Scholarships Master's Program); Social Sciences and Humanities Research Council of Canada (Insight Grant); Natural Sciences and Engineering (LM)	Funded by Grant number: 766-20140 255 - Social Sciences and Humanities Research Council of Canada (Canada Graduate Scholarships Master's Program) - http://www.sshrc-crsh.gc.ca/home-accueil-eng.aspx (PTF), Grant number: 4102 010-1785- Social Sciences and Humanities Research Council of Canada (Insight Grant) - http://www.sshrc-crsh.gc.ca/home-accueil-eng.aspx (LM), Grant number: RGPIN-2015-06544 - Natural Sciences and Engineering (LM). The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	ABBS JH, 1984, J MOTOR BEHAV, V16, P195; Burnett TA, 1998, J ACOUST SOC AM, V103, P3153, DOI 10.1121/1.423073; Dohen M, 2009, LANG SPEECH, V52, P177, DOI 10.1177/0023830909103166; ELMAN JL, 1981, J ACOUST SOC AM, V70, P45, DOI 10.1121/1.386580; Feng YQ, 2011, J NEUROPHYSIOL, V106, P667, DOI 10.1152/jn.00638.2010; Gomi H, 1996, SCIENCE, V272, P117, DOI 10.1126/science.272.5258.117; Gori M, 2010, CURR BIOL, V20, P223, DOI 10.1016/j.cub.2009.11.069; Gribble PL, 1998, J NEUROPHYSIOL, V79, P1409, DOI 10.1152/jn.1998.79.3.1409; Guenther F.H., 2004, SPEECH MOTOR CONTROL, P29; Guenther FH, 2006, J COMMUN DISORD, V39, P350, DOI 10.1016/j.jcomdis.2006.06.013; Guenther FH, 2012, J NEUROLINGUIST, V25, P408, DOI 10.1016/j.jneuroling.2009.08.006; Hickok G, 2012, NAT REV NEUROSCI; Houde JF, 1998, SCIENCE, V279, P1213, DOI 10.1126/science.279.5354.1213; Houde JF, 2002, J COGNITIVE NEUROSCI, V14, P1125, DOI 10.1162/089892902760807140; Houde JF, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00082; HUGHES OM, 1976, PHONETICA, V33, P199; Jones JA, 2000, J ACOUST SOC AM, V108, P1246, DOI 10.1121/1.1288414; Jones JA, 2005, CURR BIOL, V15, P1768, DOI 10.1016/j.cub.2005.08.063; Jones JA, 2003, J ACOUST SOC AM, V113, P532, DOI 10.1121/1.1529670; Katseff S, 2012, LANG SPEECH, V55, P295, DOI 10.1177/0023830911417802; Kawahara H, 1998, COMPUTATIONAL AUDITO, P335; Krakauer JW, 2006, PLOS BIOL, V4, P1798, DOI 10.1371/journal.pbio.0040316; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Kroos C, 2012, J PHONETICS, V40, P453, DOI 10.1016/j.wocn.2012.03.002; Lametti DR, 2012, J NEUROSCI, V32, P9351, DOI 10.1523/JNEUROSCI.0404-12.2012; Larson CR, 2008, EXP BRAIN RES, V187, P613, DOI 10.1007/s00221-008-1330-z; Leclerc A, 2007, ROLE VISION PRODUCTI; Liu H, 2012, PLOS ONE, V7; Liu HJ, 2011, CLIN NEUROPHYSIOL, V122, P951, DOI 10.1016/j.clinph.2010.08.010; MacDonald EN, 2011, J ACOUST SOC AM, V129, P955, DOI 10.1121/1.3531932; MacDonald EN, 2010, J ACOUST SOC AM, V127, P1059, DOI 10.1121/1.3278606; Maeda S., 1979, ACT 10 JOURN ET PAR, P152; Max L, 2003, P 15 INT C PHONETIC, P1053; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Menard L, 2013, P ANN C INT SPEECH C; Menard L, 2013, NEW PERSPECTIVES ORI; Menard L, FOLIA PHONI IN PRESS; Menard L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160088; Menard L, 2016, CLIN LINGUIST PHONET, V30, P227, DOI 10.3109/02699206.2015.1079247; Menard L, 2014, J SPEECH LANG HEAR R, V57, P793, DOI 10.1044/2014_JSLHR-S-12-0395; Menard L, 2009, J ACOUST SOC AM, V126, P1406, DOI 10.1121/1.3158930; Mitsuya T, 2013, J ACOUST SOC AM, V133, P2993, DOI 10.1121/1.4795786; Mitsuya T, 2011, J ACOUST SOC AM, V130, P2978, DOI 10.1121/1.3643826; Munhall KG, 2009, J ACOUST SOC AM, V125, P384, DOI 10.1121/1.3035829; Neufeld C, 2013, MULTIMODAL TARGETS S; Orfanidis S.J., 1988, OPTIMUM SIGNAL PROCE; Perkell JS, 2012, J NEUROLINGUIST, V25, P382, DOI 10.1016/j.jneuroling.2010.02.011; Purcell DW, 2006, J ACOUST SOC AM, V120, P966, DOI 10.1121/1.2217714; Purcell DW, 2006, J ACOUST SOC AM, V119, P2288, DOI 10.1121/1.2173514; Robert-Ribes J, 1998, J ACOUST SOC AM, V103, P3677, DOI 10.1121/1.423069; Rochet-Capellan A, 2012, J NEUROPHYSIOL, V107, P1711, DOI 10.1152/jn.00773.2011; Savariaux C, 2017, J SPEECH LANG HEAR R, V60, P322, DOI 10.1044/2016_JSLHR-S-15-0223; Shiller DM, 2009, J ACOUST SOC AM, V125, P1103, DOI 10.1121/1.3058638; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Tian X, 2015, J COGNITIVE NEUROSCI, V27, P352, DOI 10.1162/jocn_a_00692; Tian X, 2013, J COGNITIVE NEUROSCI, V25, P1020, DOI 10.1162/jocn_a_00381; Tian X, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00166; Tourville JA, 2011, LANG COGNITIVE PROC, V26, P952, DOI 10.1080/01690960903498424; Trudeau-Fisette P, 2013, P M AC; Villacorta VM, 2007, J ACOUST SOC AM, V122, P2306, DOI 10.1121/1.2773966; Villacorta VM, 2006, SENSORIMOTOR ADAPTAT	61	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180300	10.1371/journal.pone.0180300	http://dx.doi.org/10.1371/journal.pone.0180300			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2LF	28678819	gold, Green Published, Green Submitted			2022-12-26	WOS:000405272200048
J	Mailleux, L; Jaspers, E; Ortibus, E; Simon-Martinez, C; Desloovere, K; Molenaers, G; Klingels, K; Feys, H				Mailleux, Lisa; Jaspers, Ellen; Ortibus, Els; Simon-Martinez, Cristina; Desloovere, Kaat; Molenaers, Guy; Klingels, Katrijn; Feys, Hilde			Clinical assessment and three-dimensional movement analysis: An integrated approach for upper limb evaluation in children with unilateral cerebral palsy	PLOS ONE			English	Article							IMPAIRED FOREARM ROTATION; UPPER EXTREMITY; MOTION ANALYSIS; SCALE; MOTOR; IMPAIRMENTS; RELIABILITY; PERFORMANCE; PATTERNS; VALIDITY	Introduction The clinical application of upper limb (UL) three-dimensional movement analysis (3DMA) in children with unilateral cerebral palsy (uCP) remains challenging, despite its benefits compared to conventional clinical scales. Moreover, knowledge on UL movement pathology and how this relates to clinical parameters remains scarce. Therefore, we investigated UL kinematics across different manual ability classification system (MACS) levels and explored the relation between clinical and kinematic parameters in children with uCP. Patients and methods Fifty children (MACS: I = 15, II = 26, III = 9) underwent an UL evaluation of sensorimotor impairments (grip force, muscle strength, muscle tone, two-point discrimination, stereognosis), bimanual performance (Assisting Hand Assessment, AHA), unimanual capacity (Melbourne Assessment 2, MA2) and UL-3DMA during hand-to-head, hand-to-mouth and reach-to-grasp tasks. Global parameters (Arm Profile Score (APS), duration, (timing of) maximum velocity, trajectory straightness) and joint specific parameters (angles at task endpoint, ROM and Arm Variable Scores (AVS)) were extracted. The APS and AVS refer respectively to the total amount of movement pathology and movement deviations of wrist, elbow, shoulder, scapula and trunk. Results Longer movement durations and increased APS were found with higher MACS-levels (p< 0.001). Increased APS was also associated with more severe sensorimotor impairments r = -0.30-(-0.73)) and with lower AHA and MA2-scores (r = -0.50-(-0.86)). For the joint specific parameters, stronger movement deviations distally were significantly associated with increased muscle weakness (r = -0.32-(-0.74)) and muscle tone (r = 0.33-(-0.61)); proximal movement deviations correlated only with muscle weakness (r = -0.35 - 0.59). Regression analysis exposed grip force as the most important predictor for the variability in APS (p< 0.002). Conclusion We found increased movement pathology with increasing MACS-levels and demonstrated the adverse impact of especially muscle weakness. The lower correlations suggest that 3DMA provides additional information regarding UL motor function, particularly for the proximal joints. Integrating both methods seems clinically meaningful to obtain a comprehensive representation of all aspects of a child's UL functioning.	[Mailleux, Lisa; Jaspers, Ellen; Simon-Martinez, Cristina; Desloovere, Kaat; Klingels, Katrijn; Feys, Hilde] Univ Leuven, Dept Rehabil Sci, KU Leuven, Leuven, Belgium; [Jaspers, Ellen] ETH, Dept Hlth Sci & Technol, Neural Control Movement Lab, Zurich, Switzerland; [Ortibus, Els; Molenaers, Guy] Univ Leuven, Dept Dev & Regenerat, KU Leuven, Leuven, Belgium; [Desloovere, Kaat] Univ Hosp Leuven, Clin Motion Anal Lab, Leuven, Belgium; [Molenaers, Guy] Univ Hosp Leuven, Dept Orthopaed Med, Leuven, Belgium; [Klingels, Katrijn] UHasselt Hasselt Univ, Rehabil Res Ctr REVAL, BIOMED, Diepenbeek, Belgium	KU Leuven; Swiss Federal Institutes of Technology Domain; ETH Zurich; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; Hasselt University	Mailleux, L (corresponding author), Univ Leuven, Dept Rehabil Sci, KU Leuven, Leuven, Belgium.	lisa.mailleux@kuleuven.be	Simon-Martinez, Cristina/P-2346-2018; Ortibus, Els/GYJ-3215-2022; Desloovere, Kaat/F-3240-2014; Mailleux, Lisa/J-6248-2019	Simon-Martinez, Cristina/0000-0001-6694-6358; Desloovere, Kaat/0000-0002-8507-5276; Mailleux, Lisa/0000-0002-9955-098X; Klingels, Katrijn/0000-0001-5853-9680	Fund Scientific Research Flanders [G087213N]; Special Research Fund, KU Leuven [OT/14/127]; Marie Curie Intra-European Fellowship for Career Development [623396]	Fund Scientific Research Flanders; Special Research Fund, KU Leuven; Marie Curie Intra-European Fellowship for Career Development	This study was supported by a grant from the Fund Scientific Research Flanders (grant G087213N, http://www.fwo.be/) and from the Special Research Fund, KU Leuven (grant OT/14/127). E. Jaspers received a Marie Curie Intra-European Fellowship for Career Development (FP7-PEOPLE-2013-IEF/Proposal No.623396, http://ec.europa.eu/research/mariecurieactions/about-mca/ actions/ief/index_en.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, APPL STAT BEHAV SCI; Bar-On L, 2013, GAIT POSTURE, V38, P141, DOI 10.1016/j.gaitpost.2012.11.003; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Brochard S, 2012, CLIN BIOMECH, V27, P652, DOI 10.1016/j.clinbiomech.2012.04.001; Butler EE, 2012, J BIOMECH, V45, P945, DOI 10.1016/j.jbiomech.2012.01.018; Butler EE, 2010, GAIT POSTURE, V32, P301, DOI 10.1016/j.gaitpost.2010.05.013; Butler EE, 2010, GAIT POSTURE, V32, P72, DOI 10.1016/j.gaitpost.2010.03.011; Chruscikowski E, 2017, GAIT POSTURE, V52, P107, DOI 10.1016/j.gaitpost.2016.11.031; de Bruin M, 2013, J ELECTROMYOGR KINES, V23, P516, DOI 10.1016/j.jelekin.2012.10.013; Eliasson AC, 2006, DEV MED CHILD NEUROL, V48, P549, DOI 10.1017/S0012162206001162; Fitoussi F, 2011, J CHILD ORTHOP, V5, P363, DOI 10.1007/s11832-011-0365-z; Fleuren JFM, 2010, J NEUROL NEUROSUR PS, V81, P46, DOI 10.1136/jnnp.2009.177071; Hoare BJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003469.pub4; HOLM S, 1979, SCAND J STAT, V6, P65; Jaspers E, 2011, RES DEV DISABIL, V32, P2283, DOI 10.1016/j.ridd.2011.07.038; Jaspers E, 2011, GAIT POSTURE, V34, P227, DOI 10.1016/j.gaitpost.2011.05.003; Jaspers E, 2011, GAIT POSTURE, V33, P568, DOI 10.1016/j.gaitpost.2011.01.011; Jaspers E, 2009, GAIT POSTURE, V30, P395, DOI 10.1016/j.gaitpost.2009.07.110; Klingels K, 2010, DISABIL REHABIL, V32, P409, DOI 10.3109/09638280903171469; Klingels K, 2012, EUR J PAEDIATR NEURO, V16, P475, DOI 10.1016/j.ejpn.2011.12.008; Klingels K, 2012, EUR J PAEDIATR NEURO, V16, P257, DOI 10.1016/j.ejpn.2011.08.001; Klotz MCM, 2014, RES DEV DISABIL, V35, P2950, DOI 10.1016/j.ridd.2014.07.021; Kreulen M, 2007, GAIT POSTURE, V25, P485, DOI 10.1016/j.gaitpost.2006.05.015; Kreulen M, 2006, DEV MED CHILD NEUROL, V48, P436, DOI 10.1017/S0012162206000958; Krumlinde-Sundholm L, 2007, DEV MED CHILD NEUROL, V49, P259, DOI 10.1111/j.1469-8749.2007.00259.x; Mackey AH, 2006, ARCH PHYS MED REHAB, V87, P207, DOI 10.1016/j.apmr.2005.10.023; Nieuwenhuys A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152697; Pataky TC, 2010, J BIOMECH, V43, P1976, DOI 10.1016/j.jbiomech.2010.03.008; Perruchoud D, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00458; Randall M, 2014, DEV MED CHILD NEUROL, V56, P665, DOI 10.1111/dmcn.12391; Sakzewski L, 2014, PEDIATRICS, V133, pE175, DOI 10.1542/peds.2013-0675; SCHENAU GJV, 1989, HUM MOVEMENT SCI, V8, P301; van Bolhuis BM, 1998, J PHYSIOL-LONDON, V508, P313, DOI 10.1111/j.1469-7793.1998.313br.x; Wagner LV, 2016, DEV MED CHILD NEUROL, V58, P612, DOI 10.1111/dmcn.12949; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042	35	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180196	10.1371/journal.pone.0180196	http://dx.doi.org/10.1371/journal.pone.0180196			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671953	Green Published, gold, Green Submitted			2022-12-26	WOS:000405268500025
J	von Mollendorf, C; Tempia, S; von Gottberg, A; Meiring, S; Quan, V; Feldman, C; Cloete, J; Madhi, SA; O'Brien, KL; Klugman, KP; Whitney, CG; Cohen, C				von Mollendorf, Claire; Tempia, Stefano; von Gottberg, Anne; Meiring, Susan; Quan, Vanessa; Feldman, Charles; Cloete, Jeane; Madhi, Shabir A.; O'Brien, Katherine L.; Klugman, Keith P.; Whitney, Cynthia G.; Cohen, Cheryl			Estimated severe pneumococcal disease cases and deaths before and after pneumococcal conjugate vaccine introduction in children younger than 5 years of age in South Africa	PLOS ONE			English	Article							EPIDEMIOLOGY; SURVEILLANCE; BACTEREMIA; INFECTION; PNEUMONIA; BURDEN; ADULTS; KENYA; AREA	Introduction Streptococcus pneumoniae is a leading cause of severe bacterial infections globally. A full understanding of the impact of pneumococcal conjugate vaccine (PCV) on pneumococcal disease burden, following its introduction in 2009 in South Africa, can support national policy on PCV use and assist with policy decisions elsewhere. Methods We developed a model to estimate the national burden of severe pneumococcal disease, i. e. disease requiring hospitalisation, pre-(2005-2008) and post-PCV introduction (2012-2013) in children aged 0-59 months in South Africa. We estimated case numbers for invasive pneumococcal disease using data from the national laboratory-based surveillance, adjusted for specimen-taking practices. We estimated non-bacteraemic pneumococcal pneumonia case numbers using vaccine probe study data. To estimate pneumococcal deaths, we applied observed case fatality ratios to estimated case numbers. Estimates were stratified by HIV status to account for the impact of PCV and HIV-related interventions. We assessed how different assumptions affected estimates using a sensitivity analysis. Bootstrapping created confidence intervals. Results In the pre-vaccine era, a total of approximately 107,600 (95% confidence interval [CI] 83,000-140,000) cases of severe hospitalised pneumococcal disease were estimated to have occurred annually. Following PCV introduction and the improvement in HIV interventions, 41,800 (95% CI 28,000-50,000) severe pneumococcal disease cases were estimated in 2012-2013, a rate reduction of 1,277 cases per 100,000 child-years. Approximately 5000 (95% CI 3000-6000) pneumococcal-related annual deaths were estimated in the prevaccine period and 1,900 (95% CI 1000-2500) in 2012-2013, a mortality rate difference of 61 per 100,000 child-years. Conclusions While a large number of hospitalisations and deaths due to pneumococcal disease still occur among children 0-59 months in South Africa, we found a large reduction in this estimate that is temporally associated with PCV introduction. In HIV-infected individuals the scale-up of other interventions, such as improvements in HIV care, may have also contributed to the declines in pneumococcal burden.	[von Mollendorf, Claire; von Gottberg, Anne; Madhi, Shabir A.; Cohen, Cheryl] Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [von Mollendorf, Claire; Cohen, Cheryl] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Tempia, Stefano] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Tempia, Stefano] Ctr Dis Control & Prevent, Influenza Program, Pretoria, South Africa; [von Gottberg, Anne] Univ Witwatersrand, Sch Pathol, Fac Hlth Sci, Johannesburg, South Africa; [Meiring, Susan; Quan, Vanessa] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Div Publ Hlth Surveillance & Response, Johannesburg, South Africa; [Feldman, Charles] Charlotte Maxeke Johannesburg Acad Hosp, Dept Internal Med, Johannesburg, South Africa; [Feldman, Charles] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Cloete, Jeane] Univ Pretoria, Steve Biko Acad Hosp, Dept Paediat & Child Hlth, Pretoria, South Africa; [Madhi, Shabir A.] Univ Witwatersrand, MRC, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [O'Brien, Katherine L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Int Vaccine Access Ctr, Baltimore, MD USA; [Klugman, Keith P.] Emory Univ, Hubert Sch Publ Hlth, Atlanta, GA 30322 USA; [Klugman, Keith P.] Bill & Melinda Gates Fdn, Seattle, WA USA	National Institute for Communicable Diseases (NICD); University of Witwatersrand; Centers for Disease Control & Prevention - USA; University of Witwatersrand; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Witwatersrand; University of Pretoria; University of Witwatersrand; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Emory University; Bill & Melinda Gates Foundation	von Mollendorf, C (corresponding author), Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Johannesburg, South Africa.; von Mollendorf, C (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa.	clairevonmollendorf@yahoo.com.au	Meiring, Susan/M-1463-2019; Feldman, Charles/ABF-3315-2020	Meiring, Susan/0000-0003-4508-5469; Feldman, Charles/0000-0002-6881-8314; O'Brien, Katherine/0000-0002-0164-4030; von Gottberg, Anne/0000-0002-0243-7455; Cohen, Cheryl/0000-0003-0376-2302; Cloete, Jeane/0000-0001-6548-2475	National Institute for Communicable Diseases/National Health Laboratory Service (NICD/NHLS), South Africa; Centers for Disease Control and Prevention (CDC) Global AIDS Program (GAP) [U62/PSO022901]	National Institute for Communicable Diseases/National Health Laboratory Service (NICD/NHLS), South Africa; Centers for Disease Control and Prevention (CDC) Global AIDS Program (GAP)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Development of this publication was partially funded by the National Institute for Communicable Diseases/National Health Laboratory Service (NICD/NHLS), South Africa and the Centers for Disease Control and Prevention (CDC) Global AIDS Program (GAP) Cooperative Agreement (U62/PSO022901). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC or NICD/NHLS.	[Anonymous], 2008, HIB PNEUMOCOCCAL DEA; Ayieko P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067324; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Cohen C, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3272; Collins S, 2016, 10 INT S PNEUM PNEUM; Feikin DR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-186; Greenwood B, 1999, PHILOS T R SOC B, V354, P777, DOI 10.1098/rstb.1999.0430; Huang SS, 2011, VACCINE, V29, P3398, DOI 10.1016/j.vaccine.2011.02.088; Huebner RE, 1999, S AFR MED J, V89, P924; Izadnegahdar R, 2013, LANCET RESP MED, V1, P574, DOI 10.1016/S2213-2600(13)70075-4; Johnson LF, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.30314; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Mackenzie GA, 2016, LANCET INFECT DIS, V16, P703, DOI 10.1016/S1473-3099(16)00054-2; Madhi SA, 2005, CLIN INFECT DIS, V40, P1511, DOI 10.1086/429828; Madhi SA, 2015, THORAX, V70, P1149, DOI 10.1136/thoraxjnl-2014-206593; Meiring S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149104; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; ODempsey TJD, 1996, PEDIATR INFECT DIS J, V15, P431, DOI 10.1097/00006454-199605000-00010; Statistics South Africa, 2011, 030005 STAT S AFR; Statistics South Africa, 2013, MORT CAUS DEATH S AF; von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914; von Gottberg A, 2013, VACCINE, V31, P4200, DOI 10.1016/j.vaccine.2013.04.077; von Mollendorf C, 2015, CLIN INFECT DIS, V60, P1346, DOI 10.1093/cid/civ059; Wahl B, 2016, 10 INT S PNEUM PNEUM; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6	27	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0179905	10.1371/journal.pone.0179905	http://dx.doi.org/10.1371/journal.pone.0179905			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671978	Green Published, Green Submitted, gold			2022-12-26	WOS:000405268500008
J	Pein, H; Koeberle, SC; Voelkel, M; Schneider, F; Rossi, A; Thurmer, M; Loeser, K; Sautebin, L; Morrison, H; Werz, O; Koeberle, A				Pein, Helmut; Koeberle, Solveigh C.; Voelkel, Maria; Schneider, Freya; Rossi, Antonietta; Thuermer, Maria; Loeser, Konstantin; Sautebin, Lidia; Morrison, Helen; Werz, Oliver; Koeberle, Andreas			Vitamin A regulates Akt signaling through the phospholipid fatty acid composition	FASEB JOURNAL			English	Article						bioactive lipid; lipidomics; phosphatidylcholine; kinase; retinoic acid	TRANS-RETINOIC ACID; PHOSPHOINOSITIDE 3-KINASE/AKT PATHWAY; INDUCED DIFFERENTIATION; ACYLTRANSFERASE 3; DEFICIENT RATS; LINOLEIC-ACID; CELLS; METABOLISM; GROWTH; IDENTIFICATION	Protein kinases, including the serine/threonine kinase Akt, mediate manifold bioactivities of vitamin A, although the mechanisms behind the sustained kinase activation are diffuse. To investigate the role of cellular lipids as targetable factors in Akt signaling, we combined mass spectrometry-based lipidomics with immunologic detection of Akt (Ser473) phosphorylation. A screening campaign revealed retinol (vitamin A alcohol) and all-trans retinoic acid (vitamin A acid) (RA) as hits that time-dependently (>= 24 h) deplete phosphatidylcholine-bound polyunsaturated fatty acids (PUFA-PCs) from NIH-3T3 mouse fibroblasts while inducing Akt activation (EC50 approximate to 0.1-1 mu M). Other mitogenic and stress-regulated kinases were hardly affected. Organized in a coregulated phospholipid subcluster, PUFA-PCs compensated for the RA-induced loss of cellular PUFA-PCs and diminished Akt activation when supplemented. The counter-regulation of phospholipids and Akt by RA was mimicked by knockdown of lysophosphatidylcholine acyltransferase-3 or the selective retinoid X receptor (RXR) agonist bexarotene and prevented by the selective RXR antagonist Hx531. Treatment of mice with retinol decreased the tissue ratio of PUFA-PC and enhanced basal Akt activation preferentially in brain, which was attributed to astrocytes in dissociated cortical cultures. Together, our findings show that RA regulates the long-term activation of Akt by changes in the phospholipid composition.Pein, H., Koeberle, S. C., Voelkel, M., Schneider, F., Rossi, A., Thurmer, M., Loeser, K., Sautebin, L., Morrison, H., Werz, O., Koeberle, A. Vitamin A regulates Akt signaling through the phospholipid fatty acid composition.	[Pein, Helmut; Voelkel, Maria; Schneider, Freya; Thuermer, Maria; Loeser, Konstantin; Werz, Oliver; Koeberle, Andreas] Friedrich Schiller Univ, Inst Pharm, Philosophenweg 14, D-07743 Jena, Germany; [Koeberle, Solveigh C.; Morrison, Helen] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Rossi, Antonietta; Sautebin, Lidia] Univ Naples Federico II, Sch Med, Dept Pharm, Naples, Italy	Friedrich Schiller University of Jena; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Naples Federico II	Koeberle, A (corresponding author), Friedrich Schiller Univ, Inst Pharm, Philosophenweg 14, D-07743 Jena, Germany.	andreas.koeberle@uni-jena.de	Morrison, Helen/F-9748-2014; Koeberle, Andreas/ABB-2356-2020	Morrison, Helen/0000-0003-4938-1409; Koeberle, Andreas/0000-0001-6269-5088; Koeberle, Solveigh/0000-0002-8008-494X; Antonietta, Rossi/0000-0002-3237-2584	German Research Council [GRK 1715, KO 4589/4-1]; Phospholipid Research Center Heidelberg (Heidelberg, Germany)	German Research Council(German Research Foundation (DFG)); Phospholipid Research Center Heidelberg (Heidelberg, Germany)	This work was supported by the German Research Council (GRK 1715; KO 4589/4-1) and the Phospholipid Research Center Heidelberg (Heidelberg, Germany). The authors declare no conflicts of interest.	Bastien J, 2006, ONCOGENE, V25, P2040, DOI 10.1038/sj.onc.1209241; Bavelloni A, 2014, FASEB J, V28, P2009, DOI 10.1096/fj.13-244368; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Ben-Sasson H, 2011, FERTIL STERIL, V95, P2080, DOI 10.1016/j.fertnstert.2011.01.155; Carta G, 2014, NUTRIENTS, V6, P1262, DOI 10.3390/nu6031262; Chidester E., 1930, ANAT REC, V47, P304; Chidester F E, 1932, Science, V76, P436, DOI 10.1126/science.76.1976.436; Conaway HH, 2013, ENDOCR REV, V34, P766, DOI 10.1210/er.2012-1071; Dal Col J, 2012, CANCER RES, V72, P1825, DOI 10.1158/0008-5472.CAN-11-2505; del Rincon SV, 2003, ONCOGENE, V22, P3353, DOI 10.1038/sj.onc.1206485; di Masi A, 2015, MOL ASPECTS MED, V41, P1, DOI 10.1016/j.mam.2014.12.003; ECKHOFF C, 1991, J NUTR, V121, P1016, DOI 10.1093/jn/121.7.1016; Endersby R, 2011, CANCER RES, V71, P4106, DOI 10.1158/0008-5472.CAN-10-3597; Finsterwald C, 2015, CURR PHARM DESIGN, V21, P3570, DOI 10.2174/1381612821666150710144502; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; Huang PX, 2014, CHEM REV, V114, P233, DOI 10.1021/cr400161b; HUNT TK, 1986, J AM ACAD DERMATOL, V15, P817, DOI 10.1016/S0190-9622(86)70238-7; Ishida S, 2004, BIOCHEM PHARMACOL, V68, P2177, DOI 10.1016/j.bcp.2004.08.017; Janssen CIF, 2014, PROG LIPID RES, V53, P1, DOI 10.1016/j.plipres.2013.10.002; Koeberle A, 2016, FUTURE MED CHEM, V8, P2169, DOI 10.4155/fmc-2016-0182; Koeberle A, 2015, FASEB J, V29, P2439, DOI 10.1096/fj.14-268474; Koeberle A, 2013, P NATL ACAD SCI USA, V110, P2546, DOI 10.1073/pnas.1216182110; Koeberle A, 2012, FASEB J, V26, P169, DOI 10.1096/fj.11-184879; Koeberle A, 2010, FASEB J, V24, P4929, DOI 10.1096/fj.10-162818; Koberlin MS, 2015, CELL, V162, P170, DOI 10.1016/j.cell.2015.05.051; KRAUSE RF, 1974, J NUTR, V104, P629, DOI 10.1093/jn/104.5.629; KRAUSE RF, 1971, J NUTR, V101, P161, DOI 10.1093/jn/101.2.161; Lopez-Carballo G, 2002, J BIOL CHEM, V277, P25297, DOI 10.1074/jbc.M201869200; Bonet ML, 2012, BBA-MOL CELL BIOL L, V1821, P177, DOI 10.1016/j.bbalip.2011.06.001; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matkovic K, 2006, LEUKEMIA, V20, P941, DOI 10.1038/sj.leu.2404204; Miranda MB, 2007, MOL CANCER THER, V6, P3081, DOI 10.1158/1535-7163.MCT-07-0514; Qiao JB, 2012, BIOCHEM BIOPH RES CO, V424, P421, DOI 10.1016/j.bbrc.2012.06.125; Read DE, 2009, CELL MOL LIFE SCI, V66, P2975, DOI 10.1007/s00018-009-0057-8; Reed LL, 1932, SCIENCE, V76, P300, DOI 10.1126/science.76.1970.300; Shearer KD, 2012, TRENDS NEUROSCI, V35, P733, DOI 10.1016/j.tins.2012.08.005; Uruno A, 2005, CIRCULATION, V112, P727, DOI 10.1161/CIRCULATIONAHA.104.500959; Yamasaki D, 2011, EUR J CELL BIOL, V90, P657, DOI 10.1016/j.ejcb.2011.02.005; Zhang R, 2007, NEUROCHEM RES, V32, P2194, DOI 10.1007/s11064-007-9417-7; Zhao KN, 2013, CELL CALCIUM, V54, P151, DOI 10.1016/j.ceca.2013.05.009	41	4	4	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4566	4577		10.1096/fj.201700078R	http://dx.doi.org/10.1096/fj.201700078R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28687611				2022-12-26	WOS:000413397400032
J	Guo, XH; Li, TT; Xu, Y; Xu, XY; Zhu, ZY; Zhang, Y; Xu, JQ; Xu, KH; Cheng, HQ; Zhang, X; Ke, YH				Guo, Xiaohong; Li, Tingting; Xu, Yun; Xu, Xiayan; Zhu, Zhengyi; Zhang, Yun; Xu, Jiaqi; Xu, Kaihong; Cheng, Hongqiang; Zhang, Xue; Ke, Yuehai			Increased levels of Gab1 and Gab2 adaptor proteins skew interleukin-4 (IL-4) signaling toward M2 macrophage-driven pulmonary fibrosis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adaptor protein; Akt PKB; macrophage; pulmonary fibrosis; STAT transcription factor; AKT signaling; Gabs; M2 polarization; STAT6 signaling	ALTERNATIVELY ACTIVATED MACROPHAGES; GROWTH-FACTOR; LUNG FIBROSIS; IN-VIVO; DOCKING PROTEIN; TISSUE-REPAIR; MOUSE LUNG; POLARIZATION; PATHWAY; CELLS	M2-polarized macrophages, also known as alternatively activated macrophages, have long been associated with pulmonary fibrosis; however, the mechanism has not been fully defined. Gab1 and Gab2 proteins belong to the Gab family of adaptors and are integral components of the signal specificity in response to various extracellular stimuli. In this report, we found that levels of both Gab1 and Gab2 were elevated in M2-polarized macrophages isolated from bleomycin-induced fibrotic lungs. In vitro Gab1/2 deficiency in bone marrow-derived macrophages abrogated IL-4-mediated M2 polarization. Furthermore, in vivo conditional removal of Gab1 (Gab1(MyKO)) and germ line knock-out of Gab2 (Gab2(-/-)) in macrophages prevented a bias toward the M2 phenotype and attenuated bleomycin-induced fibrotic lung remodeling. In support of these observations, Gab1/2 were involved in responses predominated by IL-4 signaling, an essential determinant for macrophage M2 polarization. Further investigation revealed that both Gab1 and -2 are recruited to the IL-4 receptor, synergistically enhancing downstream signal amplification but conferring IL-4 signal preference. Mechanistically, the loss of Gab1 attenuated AKT activation, whereas the absence of Gab2 suppressed STAT6 activation in response to IL-4 stimulation, both of which are commonly attributed to M2-driven pulmonary fibrosis in mice. Taken together, these observations define a non-redundant role of Gab docking proteins in M2 polarization, adding critical insights into the pathogenesis of idiopathic pulmonary fibrosis.	[Guo, Xiaohong; Li, Tingting; Xu, Yun; Xu, Xiayan; Zhu, Zhengyi; Zhang, Yun; Xu, Jiaqi; Cheng, Hongqiang; Zhang, Xue; Ke, Yuehai] Zhejiang Univ, Dept Pathol & Pathophysiol, Sch Med, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [Guo, Xiaohong; Li, Tingting; Xu, Yun; Xu, Xiayan; Zhu, Zhengyi; Zhang, Yun; Xu, Jiaqi; Cheng, Hongqiang; Zhang, Xue; Ke, Yuehai] Zhejiang Univ, Program Mol Cell Biol, Sch Med, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [Cheng, Hongqiang; Zhang, Xue; Ke, Yuehai] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Kaihong] Zhejiang Univ, Womens Hosp, Dept Gynecol, Sch Med, Hangzhou 310006, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	Zhang, X; Ke, YH (corresponding author), Zhejiang Univ, Dept Pathol & Pathophysiol, Sch Med, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.; Zhang, X; Ke, YH (corresponding author), Zhejiang Univ, Program Mol Cell Biol, Sch Med, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	zhangxue@zju.edu.cn; yke@zju.edu.cn			Key Project of the National Natural Science Foundation of China [81530001]; Chinese Ministry of Science and Technology [2016YFA0501800]; National Natural Science Foundation of China [81671426]	Key Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Key Project of the National Natural Science Foundation of China Grant 81530001 (to Y.K.), Chinese Ministry of Science and Technology Grant 2016YFA0501800 (to Y.K.), and National Natural Science Foundation of China Grant 81671426 (to K.X.). The authors declare that they have no conflicts of interest with the contents of this article.	ADAMS DO, 1984, ANNU REV IMMUNOL, V2, P283, DOI 10.1146/annurev.immunol.2.1.283; Ballinger MN, 2015, J IMMUNOL, V194, P1894, DOI 10.4049/jimmunol.1402377; Byrne AJ, 2016, TRENDS MOL MED, V22, P303, DOI 10.1016/j.molmed.2016.02.004; Caron C, 2009, CELL SIGNAL, V21, P943, DOI 10.1016/j.cellsig.2009.02.004; Chung MJ, 2007, J PATHOL, V212, P180, DOI 10.1002/path.2161; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Das A, 2015, AM J PATHOL, V185, P2596, DOI 10.1016/j.ajpath.2015.06.001; Dhaliwal K, 2012, AM J RESP CRIT CARE, V186, P514, DOI 10.1164/rccm.201112-2132OC; Gangadharan B, 2008, J LEUKOCYTE BIOL, V84, P50, DOI 10.1189/jlb.0507270; Gharaee-Kermani M, 2005, AM J PATHOL, V166, P1593, DOI 10.1016/S0002-9440(10)62470-4; Gharib SA, 2014, J LEUKOCYTE BIOL, V95, P9, DOI 10.1189/jlb.1112587; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Gu HH, 2001, NATURE, V412, P186, DOI 10.1038/35084076; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Gu HH, 1998, MOL CELL, V2, P729, DOI 10.1016/S1097-2765(00)80288-9; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Herbst R, 1996, CELL, V85, P899, DOI 10.1016/S0092-8674(00)81273-8; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; HolgadoMadruga M, 1997, P NATL ACAD SCI USA, V94, P12419, DOI 10.1073/pnas.94.23.12419; Itoh M, 2000, MOL CELL BIOL, V20, P3695, DOI 10.1128/MCB.20.10.3695-3704.2000; Ke Y, 2007, ONCOGENE, V26, P4951, DOI 10.1038/sj.onc.1210315; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Korthagen NM, 2011, RESP MED, V105, P106, DOI 10.1016/j.rmed.2010.09.012; Laramee M, 2007, J BIOL CHEM, V282, P7758, DOI 10.1074/jbc.M611327200; Li D, 2014, J ALLERGY CLIN IMMUN, V134, P1422, DOI 10.1016/j.jaci.2014.05.011; Liu J., 2014, EURASIP J ADV SIG PR, V2014, P1, DOI DOI 10.1016/J.EJMECH.2013.11.036; Lock LS, 2002, MOL BIOL CELL, V13, P2132, DOI 10.1091/mbc.02-02-0031; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Meng SS, 2005, BIOCHEM J, V391, P143, DOI 10.1042/BJ20050229; Minutti CM, 2017, SCIENCE, V356, P1076, DOI 10.1126/science.aaj2067; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Mora AL, 2006, AM J RESP CELL MOL, V35, P466, DOI 10.1165/rcmb.2006-0121OC; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nakaoka Y, 2007, J CLIN INVEST, V117, P1771, DOI 10.1172/JCI30651; Nishida K, 2003, CANCER SCI, V94, P1029, DOI 10.1111/j.1349-7006.2003.tb01396.x; Nishida K, 2002, BLOOD, V99, P1866, DOI 10.1182/blood.V99.5.1866; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; Orthgiess J, 2016, EUR J IMMUNOL, V46, P1529, DOI 10.1002/eji.201546108; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Sachs M, 2000, J CELL BIOL, V150, P1375, DOI 10.1083/jcb.150.6.1375; Sarmay G, 2006, IMMUNOL LETT, V104, P76, DOI 10.1016/j.imlet.2005.11.017; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Schutzman JL, 2001, MOL CELL BIOL, V21, P8104, DOI 10.1128/MCB.21.23.8104-8116.2001; Seiffert M, 2003, MOL CELL BIOL, V23, P2415, DOI 10.1128/MCB.23.7.2415-2424.2003; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Tao B, 2014, J IMMUNOL, V193, P2801, DOI 10.4049/jimmunol.1303463; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wada T, 2005, NAT MED, V11, P394, DOI 10.1038/nm1203; Wickrema A, 1999, J BIOL CHEM, V274, P24469, DOI 10.1074/jbc.274.35.24469; Wills-Karp M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1.51.pe55; Wohrle FU, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-22; Wolf I, 2002, MOL CELL BIOL, V22, P231, DOI 10.1128/MCB.22.1.231-244.2002; Woodruff PG, 2005, AM J RESP CRIT CARE, V172, P1383, DOI 10.1164/rccm.200505-686OC; Wurster AL, 2002, MOL CELL BIOL, V22, P117, DOI 10.1128/MCB.22.1.117-126.2002; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yao YY, 2016, MOL THER, V24, P915, DOI 10.1038/mt.2016.36; Zhang X, 2012, FASEB J, V26, P4603, DOI 10.1096/fj.12-211755; Zhang YR, 2016, J STAT MECH-THEORY E, P1, DOI 10.1088/1742-5468/2016/11/113207	71	31	34	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14003	14015		10.1074/jbc.M117.802066	http://dx.doi.org/10.1074/jbc.M117.802066			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28687632	Green Published, hybrid			2022-12-26	WOS:000408439800009
J	Williams, RM; Winkfein, RJ; Ginger, RS; Green, MR; Schnetkamp, PP; Wheeler, GN				Williams, Ruth M.; Winkfein, Robert J.; Ginger, Rebecca S.; Green, Martin R.; Schnetkamp, Paul P.; Wheeler, Grant N.			A functional approach to understanding the role of NCKX5 in Xenopus pigmentation	PLOS ONE			English	Article							SODIUM-CALCIUM EXCHANGER; MOLECULAR-CLONING; GENE FAMILY; EXPRESSION; RESIDUES; SLC24A5; CA2+; MUTATIONS; ALBINISM; MEMBER	NCKX5 is an ion exchanger expressed mostly in pigment cells; however, the functional role for this protein in melanogenesis is not clear. A variant allele of SLC24A5, the gene encoding NCKX5, has been shown to correlate with lighter skin pigmentation in humans, indicating a key role for SLC24A5 in determining human skin colour. SLC24A5 expression has been found to be elevated in melanoma. Knockdown analyses have shown SLC24A5 to be important for pigmentation, but to date the function of this ion exchanger in melanogenesis has not been fully established. Our data suggest NCKX5 may have an alternative activity that is key to its role in the regulation of pigmentation. Here Xenopus laevis is employed as an in vivo model system to further investigate the function of NCKX5 in pigmentation. SLC24A5 is expressed in the melanophores as they differentiate from the neural crest and develop in the RPE of the eye. Morpholino knockdown and rescue experiments were designed to elucidate key residues and regions of the NCKX5 protein. Unilateral morpholino injection at the 2 cell stage resulted in a reduction of pigmentation in the eye and epidermis of one lateral side of the tadpole. Xenopus and human SLC24A5 can rescue the morpholino effects. Further rescue experiments including the use of ion exchange inactive SLC24A5 constructs raise the possibility that full ion exchanger function of NCKX5 may not be required for rescue of pigmentation.	[Williams, Ruth M.; Wheeler, Grant N.] Univ East Anglia, Sch Biol Sci, Norwich, Norfolk, England; [Winkfein, Robert J.; Schnetkamp, Paul P.] Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Ginger, Rebecca S.; Green, Martin R.] Unilever Res Labs, Colworth Sci Pk, Sharnbrook, Beds, England; [Williams, Ruth M.] Univ Oxford, Weatherall Inst Mol Med, Oxford, England	University of East Anglia; University of Calgary; Unilever; University of Oxford	Wheeler, GN (corresponding author), Univ East Anglia, Sch Biol Sci, Norwich, Norfolk, England.	grant.wheeler@uea.ac.uk	Wheeler, Grant N/D-3023-2009	Wheeler, Grant N/0000-0002-4335-8577	Unilever RD; BBSRC	Unilever RD(Unilever); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Unilever R&D provided support in the form of salaries for MG and RSG in addition to a supplement to the student stipend of RMW and a contribution to the research costs of the project. The specific roles of these authors are articulated in the author contributions section. Unilever R&D was also involved in the design of the project and analysis of the results. They had no further role in the decision to publish or preparation of the manuscript. This project was part of a BBSRC funded CASE Studentship.	Boissy RE, 2011, GIORN ITAL DERMAT V, V146, P69; Brenner M, 2008, PHOTOCHEM PHOTOBIOL, V84, P539, DOI 10.1111/j.1751-1097.2007.00226.x; Garcia-Morales C, 2009, DEV BIOL, V335, P143, DOI 10.1016/j.ydbio.2009.08.021; Ginger RS, 2008, J BIOL CHEM, V283, P5486, DOI 10.1074/jbc.M707521200; Jalloul AH, 2016, J BIOL CHEM, V291, P13113, DOI 10.1074/jbc.M116.728824; Kang K, 2003, BIOCHEMISTRY-US, V42, P9438, DOI 10.1021/bi0342261; Kang KJ, 2005, J BIOL CHEM, V280, P6823, DOI 10.1074/jbc.M407933200; KIMURA M, 1993, J BIOL CHEM, V268, P6874; Kinjo TG, 2004, BIOCHEMISTRY-US, V43, P7940, DOI 10.1021/bi049538y; Kinjo TG, 2003, BIOCHEMISTRY-US, V42, P2485, DOI 10.1021/bi0270788; Kraev A, 2001, J BIOL CHEM, V276, P23161, DOI 10.1074/jbc.M102314200; Kumasaka M, 2003, PIGM CELL RES, V16, P455, DOI 10.1034/j.1600-0749.2003.00064.x; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Leonard SE, 2011, CURR OPIN CHEM BIOL, V15, P88, DOI 10.1016/j.cbpa.2010.11.012; Li XF, 2002, J BIOL CHEM, V277, P48410, DOI 10.1074/jbc.M210011200; Li XF, 2006, J BIOL CHEM, V281, P6273, DOI 10.1074/jbc.M512137200; Li XF, 2014, J BIOL CHEM, V289, P25445, DOI 10.1074/jbc.M114.564450; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Mallick CB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003912; Oetting WS, 1999, HUM MUTAT, V13, P99, DOI 10.1002/(SICI)1098-1004(1999)13:2<99::AID-HUMU2>3.3.CO;2-3; Poon S, 2000, AM J PHYSIOL-CELL PH, V278, pC651, DOI 10.1152/ajpcell.2000.278.4.C651; Prinsen CFM, 2000, J NEUROSCI, V20, P1424; Schallreuter KU, 2008, EXP DERMATOL, V17, P395, DOI 10.1111/j.1600-0625.2007.00675.x; Scherer D, 2010, MUTAT RES-REV MUTAT, V705, P141, DOI 10.1016/j.mrrev.2010.06.002; Schnetkamp PPM, 2013, MOL ASPECTS MED, V34, P455, DOI 10.1016/j.mam.2012.07.008; SCHNETKAMP PPM, 1991, J BIOL CHEM, V266, P198; Stephan AB, 2012, NAT NEUROSCI, V15, P131, DOI 10.1038/nn.2943; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; Tanaka Toshihiro, 2005, Nihon Rinsho, V63 Suppl 12, P29; Tomlinson ML, 2009, MOL BIOSYST, V5, P376, DOI 10.1039/b818695b; Vogel P, 2008, VET PATHOL, V45, P264, DOI 10.1354/vp.45-2-264; Walters ZS, 2009, J PHYSIOL-LONDON, V587, P521, DOI 10.1113/jphysiol.2008.161562; Wei AH, 2013, J INVEST DERMATOL, V133, P1834, DOI 10.1038/jid.2013.49; Wilson S, 2013, ADV EXP MED BIOL, V961, P95, DOI 10.1007/978-1-4614-4756-6_9; Winkfein RJ, 2003, BIOCHEMISTRY-US, V42, P543, DOI 10.1021/bi026982x	35	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180465	10.1371/journal.pone.0180465	http://dx.doi.org/10.1371/journal.pone.0180465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692664	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000405544800043
J	Lumbreras, B; Vilar, J; Gonzalez-Alvarez, I; Guilabert, M; Pastor-Valero, M; Parker, LA; Vilar-Palop, J; Hernandez-Aguado, I				Lumbreras, Blanca; Vilar, Jose; Gonzalez-Alvarez, Isabel; Guilabert, Mercedes; Pastor-Valero, Maria; Parker, Lucy Anne; Vilar-Palop, Jorge; Hernandez-Aguado, Ildefonso			Avoiding fears and promoting shared decision-making: How should physicians inform patients about radiation exposure from imaging tests?	PLOS ONE			English	Article							RISK; KNOWLEDGE; CT; AWARENESS; BENEFITS	Objective We aimed to evaluate the population's awareness about the radiation exposure associated with five specific imaging tests, and their preference regarding three different formats for receiving the information before undergoing an imaging test. Methods A quantitative and qualitative evaluation through a survey and focal groups including general population from two health departments in Spain. The sampling was carried out in stages (according to health department size) and stratified by age and sex, to get a representative sample. We randomly selected the participants from these stages to be contacted by telephone by a trained nurse. Oral informed consent was obtained. Results xdOf 602 participants in the quantitative survey, 418 (70.3%) stated that they were aware of the risk associated with radiation. While the majority of these 418 participants knew that x-rays involve radiation (85.4%), fewer were aware that CT (42%) and mammography (38%) also involve radiation, and a substantial proportion believed, incorrectly, that MRI (38%) and ultrasound (18.4%) expose patients to radiation. The population preference was to receive the information using both oral and written formats, accompanied by a table showing the equivalence of the radiation associated with the imaging test to either a number of chest Xrays and exposure number of days of background radiation. Discussion The general population does not receive enough information regarding radiation exposure and the associated risks related to imaging tests. Initiatives should be designed to reinforce the patient's awareness when ordering a diagnostic imaging test.	[Lumbreras, Blanca; Pastor-Valero, Maria; Parker, Lucy Anne; Hernandez-Aguado, Ildefonso] Miguel Hernandez Univ, Dept Publ Hlth Hist Sci & Gynecol, Alicante, Spain; [Lumbreras, Blanca; Pastor-Valero, Maria; Parker, Lucy Anne; Hernandez-Aguado, Ildefonso] CIBER Epidemiol & Salud Publ, Madrid, Spain; [Vilar, Jose] Peset Hosp, Radiodiagnost Dept, Valencia, Spain; [Gonzalez-Alvarez, Isabel] San Juan Hosp, Radiodiagnost Dept, Alicante, Spain; [Guilabert, Mercedes] Miguel Hernandez Univ, Psychol Dept, Alicante, Spain; [Vilar-Palop, Jorge] Ctr Nacl Dosimetria Radon, Valencia, Spain; [Vilar-Palop, Jorge] CRC, Valencia, Spain	Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidad Miguel Hernandez de Elche	Lumbreras, B (corresponding author), Miguel Hernandez Univ, Dept Publ Hlth Hist Sci & Gynecol, Alicante, Spain.; Lumbreras, B (corresponding author), CIBER Epidemiol & Salud Publ, Madrid, Spain.	blumbreras@umh.es	Guilabert, Mercedes/U-6135-2019; Hernandez-Aguado, Ildefonso/I-2634-2015	Guilabert, Mercedes/0000-0002-0706-9911; Vilar Palop, Jorge/0000-0003-4845-4282; Hernandez-Aguado, Ildefonso/0000-0003-1911-5759; Pastor-Valero, Maria/0000-0001-9282-5787; Lumbreras, Blanca/0000-0003-1665-0860	Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (Plan Nacional de I+D+I) [PI13/01576]; Fondo Europeo de Desarrollo Regional (FEDER)	Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (Plan Nacional de I+D+I); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	This study has received funding by the Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (Plan Nacional de I+D+I) PI13/01576 and co-funded by the Fondo Europeo de Desarrollo Regional (FEDER). Role of the Sponsors: Funders had no involvement in any aspect of the design of this study, preparation of results, or decision to submit for publication.	Caverly TJ, 2013, JAMA INTERN MED, V173, P1658, DOI 10.1001/jamainternmed.2013.8194; Dauer LT, 2011, AM J ROENTGENOL, V196, P756, DOI 10.2214/AJR.10.5956; Elliott A, 2009, J RADIOL PROT, V29, pA107, DOI 10.1088/0952-4746/29/2A/S07; European Commission (EC), 2013, OFF J EUR COMMUN L, V124, P210, DOI [10.3000/19770677.L_2013.124.eng, DOI 10.3000/19770677.L_2013.124.ENG]; Harpaz-Rotem I, 2009, ARCH GEN PSYCHIAT, V66, P417, DOI 10.1001/archgenpsychiatry.2008.536; Lam DL, 2014, AM J ROENTGENOL, V203, P952, DOI 10.2214/AJR.14.13049; Lee CI, 2004, RADIOLOGY, V231, P393, DOI 10.1148/radiol.2312030767; Ludwig Rebecca L, 2002, J Allied Health, V31, P159; Malone J, 2012, BRIT J RADIOL, V85, P523, DOI 10.1259/bjr/42893576; Montori VM, 2013, JAMA-J AM MED ASSOC, V310, P2503, DOI 10.1001/jama.2013.281422; Pandharipande PV, 2013, AM J ROENTGENOL, V200, P1275, DOI 10.2214/AJR.12.10011; Picano E, 2004, BMJ-BRIT MED J, V329, P849, DOI 10.1136/bmj.329.7470.849; Puri S, 2012, AM J ROENTGENOL, V199, P1328, DOI 10.2214/AJR.12.8581; Ricketts ML, 2013, CAN ASSOC RADIOL J, V64, P208, DOI 10.1016/j.carj.2012.05.002; Sheridan SL, 2016, JAMA INTERN MED, V176, P31, DOI 10.1001/jamainternmed.2015.7339; Takakuwa KM, 2010, AM J ROENTGENOL, V195, P1151, DOI 10.2214/AJR.09.3847; Youssef NA, 2014, J EMERG MED, V46, P208, DOI 10.1016/j.jemermed.2013.07.016; Zwank MD, 2014, EMERG MED J, V31, P824, DOI 10.1136/emermed-2012-202294	18	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180592	10.1371/journal.pone.0180592	http://dx.doi.org/10.1371/journal.pone.0180592			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686656	Green Published, gold, Green Submitted			2022-12-26	WOS:000405464100080
J	Denefrio, S; Simmons, A; Jha, A; Dennis-Tiwary, TA				Denefrio, Samantha; Simmons, Akeesha; Jha, Amishi; Dennis-Tiwary, Tracy A.			Emotional cue validity effects: The role of neurocognitive responses to emotion	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; VISUAL-ATTENTION; POSITIVE AFFECT; BRAIN POTENTIALS; NEUROPHYSIOLOGICAL MECHANISMS; INDIVIDUAL-DIFFERENCES; FOCUSED ATTENTION; ANXIETY; FACES; ERP	The beneficial effect of valid compared to invalid cues on attention performance is a basic attentional mechanism, but the impact of emotional content on cue validity is poorly understood. We tested whether the effect of cue validity on attention performance differed when cues were angry, happy, or neutral faces. Moreover, we used scalp-recorded event-related potentials (ERPs) reflecting the capture of early visual attention (P1, N170) to test whether effects were strengthened when neurocognitive responses to angry or happy cues were enhanced (larger P1 and N170 amplitudes). Twenty-five participants completed a modified flanker task using emotional face cues to measure the effects of emotion on conflict interference. Attention performance was enhanced following valid versus invalid cues, but effects did not differ by emotion cue type. However, for participants showing relatively larger N170 amplitudes to angry face cues, attention performance was specifically disrupted on those trials. Conversely, participants with relatively larger N170 amplitudes to happy face cues showed facilitated performance across all valid trials. These findings suggest that individual neurocognitive sensitivities to emotion predict the impact of emotional content on the basic attentional phenomenon of cue validity.	[Denefrio, Samantha; Dennis-Tiwary, Tracy A.] CUNY, Grad Ctr, New York, NY 10021 USA; [Simmons, Akeesha; Dennis-Tiwary, Tracy A.] CUNY, Hunter Coll, New York, NY 10021 USA; [Jha, Amishi] Univ Miami, Miami, FL USA	City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY); University of Miami	Dennis-Tiwary, TA (corresponding author), CUNY, Grad Ctr, New York, NY 10021 USA.; Dennis-Tiwary, TA (corresponding author), CUNY, Hunter Coll, New York, NY 10021 USA.	tracy.dennis@hunter.cuny.edu			National Institute of General Medical Sciences, National Institutes of Health [SC1MH104907]; National Center for Advancing Translational Sciences, National Institutes of Health [TR000457]; Research Centers in Minority Institutions Program grant from the National Institute on Minority Health and Health Disparities, National Institutes of Health [MD007599]	National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Research Centers in Minority Institutions Program grant from the National Institute on Minority Health and Health Disparities, National Institutes of Health	This research was made possible by grant SC1MH104907 awarded to TDT from the National Institute of General Medical Sciences, grant TR000457 of the National Center for Advancing Translational Sciences, and by and a Research Centers in Minority Institutions Program grant from the National Institute on Minority Health and Health Disparities (MD007599), all of the National Institutes of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIMHD or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir N, 2003, BEHAV RES THER, V41, P1325, DOI 10.1016/S0005-7967(03)00039-1; Ashby FG, 1999, PSYCHOL REV, V106, P529, DOI 10.1037/0033-295X.106.3.529; Bar-Haim Y, 2005, BRAIN COGNITION, V59, P11, DOI 10.1016/j.bandc.2005.03.005; Basso M R, 1996, J Int Neuropsychol Soc, V2, P249; Batty M, 2006, DEVELOPMENTAL SCI, V9, P207, DOI 10.1111/j.1467-7687.2006.00480.x; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Biss RK, 2010, MOTIV EMOTION, V34, P73, DOI 10.1007/s11031-010-9156-y; Blau Vera C, 2007, Behav Brain Funct, V3, P7; Clore GL, 2007, TRENDS COGN SCI, V11, P393, DOI 10.1016/j.tics.2007.08.005; Clore GL, 2009, EMOT REV, V1, P39, DOI 10.1177/1754073908097185; Davies PL, 2001, BIOL PSYCHOL, V56, P191, DOI 10.1016/S0301-0511(01)00080-1; Dennis TA, 2007, BIOL PSYCHOL, V76, P1, DOI 10.1016/j.biopsycho.2007.05.001; Dennis TA, 2007, INT J PSYCHOPHYSIOL, V65, P10, DOI 10.1016/j.ijpsycho.2007.02.006; Dennis TA, 2009, DEV NEUROPSYCHOL, V34, P85, DOI 10.1080/87565640802564887; Derryberry D., 1994, HEARTS EYE EMOTIONAL, P167, DOI [10.1016/B978-0-12-410560-7.50014-4, DOI 10.1016/B978-0-12-410560-7.50014-4]; Drollette ES, 2014, DEV COGN NEUROS-NETH, V7, P53, DOI 10.1016/j.dcn.2013.11.001; EASON RG, 1981, B PSYCHONOMIC SOC, V18, P203; EASTERBROOK JA, 1959, PSYCHOL REV, V66, P183, DOI 10.1037/h0047707; Eastwood JD, 2003, PERCEPT PSYCHOPHYS, V65, P352, DOI 10.3758/BF03194566; Eckstein MP, 2002, J VISION, V2, P25, DOI 10.1167/2.1.3; Eger E, 2003, NEUROPSYCHOLOGIA, V41, P808, DOI 10.1016/S0028-3932(02)00287-7; Eimer M, 2000, COGNITIVE BRAIN RES, V10, P145, DOI 10.1016/S0926-6410(00)00038-0; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; Eimer M, 2010, CEREB CORTEX, V20, P2442, DOI 10.1093/cercor/bhp312; Eimer M, 2008, J NEUROPSYCHOL, V2, P165, DOI 10.1348/174866407X245411; Estrada CA, 1997, ORGAN BEHAV HUM DEC, V72, P117, DOI 10.1006/obhd.1997.2734; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2011, BRAIN COGNITION, V70, P209; Fenske MJ, 2003, EMOTION, V3, P327, DOI 10.1037/1528-3542.3.4.327; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Fox E, 2002, COGNITION EMOTION, V16, P355, DOI 10.1080/02699930143000527; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; Fredrickson BL, 2005, COGNITION EMOTION, V19, P313, DOI 10.1080/02699930441000238; Fredrickson BL, 1998, COGNITION EMOTION, V12, P191; Friedman RS, 2010, PSYCHOL BULL, V136, P875, DOI 10.1037/a0020495; Gable P.A., 2008, NETHERLANDS J PSYCHO, V64, P132, DOI [10.1007/BF03076416, DOI 10.1007/BF03076416]; Gable P, 2010, PSYCHOL SCI, V21, P211, DOI 10.1177/0956797609359622; Gable PA, 2008, PSYCHOL SCI, V19, P476, DOI 10.1111/j.1467-9280.2008.02112.x; Gable PA, 2011, BIOL PSYCHOL, V87, P303, DOI 10.1016/j.biopsycho.2011.02.007; Garland EL, 2010, CLIN PSYCHOL REV, V30, P849, DOI 10.1016/j.cpr.2010.03.002; Gevins A, 2000, CEREB CORTEX, V10, P829, DOI 10.1093/cercor/10.9.829; Harmon-Jones E, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00073; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Huntsinger JR, 2012, J EXP PSYCHOL GEN, V141, P595, DOI 10.1037/a0027709; ISEN AM, 1987, J PERS SOC PSYCHOL, V52, P1122, DOI 10.1037/0022-3514.52.6.1122; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Kappenman ES, 2015, SOC COGN AFFECT NEUR, V10, P577, DOI 10.1093/scan/nsu098; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Luck SJ, 1995, BEHAV BRAIN RES, V71, P113, DOI 10.1016/0166-4328(95)00041-0; LUCK SJ, 1990, ELECTROEN CLIN NEURO, V75, P528, DOI 10.1016/0013-4694(90)90139-B; Luck SJ, 1995, NEURAL SYSTEMS MEDIA; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; MANGUN GR, 1991, J EXP PSYCHOL HUMAN, V17, P1057, DOI 10.1037/0096-1523.17.4.1057; MANGUN GR, 1988, ELECTROEN CLIN NEURO, V70, P417, DOI 10.1016/0013-4694(88)90019-3; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; MANGUN GR, 1990, PERCEPT PSYCHOPHYS, V47, P532, DOI 10.3758/BF03203106; Mangun GR, 1990, NEUROBIOLOGY HIGHER; MANGUN GRR, 1987, HUM FACTORS, V29, P195, DOI 10.1177/001872088702900207; Mueller EM, 2009, PSYCHOL MED, V39, P1141, DOI 10.1017/S0033291708004820; O'Toole LJ, 2013, DEV NEUROPSYCHOL, V38, P352, DOI 10.1080/87565641.2013.802321; Pizzagalli DA, 2002, NEUROIMAGE, V16, P663, DOI 10.1006/nimg.2002.1126; Pollak SD, 2003, J ABNORM PSYCHOL, V112, P323, DOI 10.1037/0021-843X.112.3.323; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Schmitz TW, 2009, J NEUROSCI, V29, P7199, DOI 10.1523/JNEUROSCI.5387-08.2009; Smith NK, 2003, NEUROPSYCHOLOGIA, V41, P171, DOI 10.1016/S0028-3932(02)00147-1; Talarico J, 2009, COGNITION EMOTION, V23, P380, DOI 10.1080/02699930801993999; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Vanlessen N, 2013, COGN AFFECT BEHAV NE, V13, P60, DOI 10.3758/s13415-012-0130-x; Vossel S, 2006, NEUROIMAGE, V32, P1257, DOI 10.1016/j.neuroimage.2006.05.019; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Walentowska W, 2012, INT J PSYCHOPHYSIOL, V85, P27, DOI 10.1016/j.ijpsycho.2011.12.004; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; WRIGHT MJ, 1995, BIOL PSYCHOL, V41, P183, DOI 10.1016/0301-0511(95)05128-7; Wronka E, 2011, PSYCHOPHYSIOLOGY, V48, P1047, DOI 10.1111/j.1469-8986.2011.01180.x	77	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0179714	10.1371/journal.pone.0179714	http://dx.doi.org/10.1371/journal.pone.0179714			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA3HX	28683069	Green Published, gold			2022-12-26	WOS:000405335200011
J	Crouzet, M; Claverol, S; Lomenech, AM; Le Senechal, C; Costaglioli, P; Barthe, C; Garbay, B; Bonneu, M; Vilain, S				Crouzet, Marc; Claverol, Stephane; Lomenech, Anne-Marie; Le Senechal, Caroline; Costaglioli, Patricia; Barthe, Christophe; Garbay, Bertrand; Bonneu, Marc; Vilain, Sebastien			Pseudomonas aeruginosa cells attached to a surface display a typical proteome early as 20 minutes of incubation	PLOS ONE			English	Article							BIOFILM FORMATION; ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; RNA-POLYMERASE; BACTERIAL SURVIVAL; TWITCHING MOTILITY; STRESS RESPONSES; DI-GMP; RESISTANCE; EXPRESSION	Biofilms are present in all environments and often result in negative effects due to properties of the biofilm lifestyle and especially antibiotics resistance. Biofilms are associated with chronic infections. Controlling bacterial attachment, the first step of biofilm formation, is crucial for fighting against biofilm and subsequently preventing the persistence of infection. Thus deciphering the underlying molecular mechanisms involved in attachment could allow discovering molecular targets from it would be possible to develop inhibitors against bacterial colonization and potentiate antibiotherapy. To identify the key components and pathways that aid the opportunistic pathogen Pseudomonas aeruginosa in attachment we performed for the first time a proteomic analysis as early as after 20 minutes of incubation using glass wool fibers as a surface. We compared the protein contents of the attached and unattached bacteria. Using mass spectrometry, 3043 proteins were identified. Our results showed that, as of 20 minutes of incubation, using stringent quantification criteria 616 proteins presented a modification of their abundance in the attached cells compared to their unattached counterparts. The attached cells presented an overall reduced gene expression and characteristics of slow-growing cells. The over-accumulation of outer membrane proteins, periplasmic folding proteins and O-antigen chain length regulators was also observed, indicating a profound modification of the cell envelope. Consistently the sigma factor AlgU required for cell envelope homeostasis was highly over-accumulated in attached cells. In addition our data suggested a role of alarmone (p) ppGpp and polyphosphate during the early attachment phase. Furthermore, almost 150 proteins of unknown function were differentially accumulated in the attached cells. Our proteomic analysis revealed the existence of distinctive biological features in attached cells as early as 20 minutes of incubation. Analysis of some mutants demonstrated the interest of this proteomic approach in identifying genes involved in the early phase of adhesion to a surface.	[Crouzet, Marc; Le Senechal, Caroline; Costaglioli, Patricia; Barthe, Christophe; Bonneu, Marc; Vilain, Sebastien] Univ Bordeaux, Inst Natl Polytech Bordeaux, CNRS, UMR 5248,Spectrometrie Masse Macromol Biol Chim B, Bordeaux, France; [Claverol, Stephane; Lomenech, Anne-Marie; Bonneu, Marc; Vilain, Sebastien] Univ Bordeaux, Ctr Genom Fonct Bordeaux, Plateforme Prote, Bordeaux, France; [Garbay, Bertrand] Univ Bordeaux, Inst Natl Polytech Bordeaux, CNRS, Lab Chim Polymeres Organ,UMR 5629, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux	Vilain, S (corresponding author), Univ Bordeaux, Inst Natl Polytech Bordeaux, CNRS, UMR 5248,Spectrometrie Masse Macromol Biol Chim B, Bordeaux, France.; Vilain, S (corresponding author), Univ Bordeaux, Ctr Genom Fonct Bordeaux, Plateforme Prote, Bordeaux, France.	sebastien.vilain@ipb.fr	Vilain, Sebastien/AAD-8031-2021; patricia, costaglioli/AAD-4560-2020	patricia, costaglioli/0000-0002-7953-427X; Vilain, Sebastien/0000-0003-0134-8511	University of Bordeaux, Bordeaux INP; CNRS	University of Bordeaux, Bordeaux INP; CNRS(Centre National de la Recherche Scientifique (CNRS))	The University of Bordeaux, Bordeaux INP and the CNRS financed this work through the recurrent funding of the research team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Baker MD, 2006, BIOESSAYS, V28, P9, DOI 10.1002/bies.20343; Balasubramanian D, 2013, NUCLEIC ACIDS RES, V41, P1, DOI 10.1093/nar/gks1039; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Bhavsar Rital B., 2010, Human Genomics, V4, P327; Bisicchia P, 2013, MBIO, V4, DOI 10.1128/mBio.00856-13; Bjarnsholt T, 2013, TRENDS MICROBIOL, V21, P466, DOI 10.1016/j.tim.2013.06.002; Brown MRW, 2008, TRENDS BIOCHEM SCI, V33, P284, DOI 10.1016/j.tibs.2008.04.005; Bryers JD, 2008, BIOTECHNOL BIOENG, V100, P1, DOI 10.1002/bit.21838; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; BUTLER K, 1970, J INFECT DIS, V122, pS1, DOI 10.1093/infdis/122.Supplement_1.S1; Byrd MS, 2009, MOL MICROBIOL, V73, P622, DOI 10.1111/j.1365-2958.2009.06795.x; Calhoun LN, 2011, J APPL MICROBIOL, V110, P375, DOI 10.1111/j.1365-2672.2010.04890.x; Coggan KA, 2012, CURR ISSUES MOL BIOL, V14, P47; Cohen D, 2015, P NATL ACAD SCI USA, V112, P11359, DOI 10.1073/pnas.1421450112; Colvin KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001264; Confer AW, 2013, VET MICROBIOL, V163, P207, DOI 10.1016/j.vetmic.2012.08.019; Cooley RB, 2016, J BACTERIOL, V198, P66, DOI 10.1128/JB.00369-15; Creuzenet C, 2001, MOL MICROBIOL, V41, P1295, DOI 10.1046/j.1365-2958.2001.02589.x; Crouzet M, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0253-z; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Daniels C, 2002, ENVIRON MICROBIOL, V4, P883, DOI 10.1046/j.1462-2920.2002.00288.x; de la Fuente-Nunez C, 2015, CHEM BIOL, V22, P196, DOI 10.1016/j.chembiol.2015.01.002; de la Fuente-Nunez C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004152; de Paz LEC, 2012, APPL ENVIRON MICROB, V78, P1627, DOI 10.1128/AEM.07036-11; Deziel E, 2003, MICROBIOL-SGM, V149, P2005, DOI 10.1099/mic.0.26154-0; Diggle SP, 2006, ENVIRON MICROBIOL, V8, P1095, DOI 10.1111/j.1462-2920.2006.001001.x; Edrington TC, 2011, J BIOL CHEM, V286, P39211, DOI 10.1074/jbc.M111.280933; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; Ferrandez A, 2002, J BACTERIOL, V184, P4374, DOI 10.1128/JB.184.16.4374-4383.2002; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fraley CD, 2007, P NATL ACAD SCI USA, V104, P3526, DOI 10.1073/pnas.0609733104; Francklyn CS, 2010, FEBS LETT, V584, P366, DOI 10.1016/j.febslet.2009.11.045; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; Fuchs EL, 2010, J BACTERIOL, V192, P3553, DOI 10.1128/JB.00363-10; Gomes SL, 2009, ENCY MICROBIOLOGY, P464; Guvener ZT, 2007, MOL MICROBIOL, V66, P1459, DOI 10.1111/j.1365-2958.2007.06008.x; Guvener ZT, 2006, MOL MICROBIOL, V61, P106, DOI 10.1111/j.1365-2958.2006.05218.x; He K, 2014, TRENDS MICROBIOL, V22, P389, DOI 10.1016/j.tim.2014.04.004; HEDSTROM RC, 1982, J BACTERIOL, V152, P255; Held K, 2012, J BACTERIOL, V194, P6387, DOI 10.1128/JB.01479-12; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; HOOPER DC, 1987, AM J MED, V82, P12; Horn G, 2007, CELL MOL LIFE SCI, V64, P1457, DOI 10.1007/s00018-007-6388-4; Huangyutitham V, 2013, MBIO, V4, DOI 10.1128/mBio.00242-13; Ivanov IE, 2011, J BACTERIOL, V193, P1259, DOI 10.1128/JB.01308-10; Jonas K, 2009, FUTURE MICROBIOL, V4, P341, DOI [10.2217/fmb.09.7, 10.2217/FMB.09.7]; Justice SS, 2005, J BACTERIOL, V187, P7680, DOI 10.1128/JB.187.22.7680-7686.2005; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; King JD, 2009, INNATE IMMUN-LONDON, V15, P261, DOI 10.1177/1753425909106436; Kostakioti M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010306; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Kumar A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018759, 10.1371/journal.pone.0026520, 10.1371/journal.pone.0020701]; Lamour V, 2008, J MOL BIOL, V383, P367, DOI 10.1016/j.jmb.2008.08.011; Leaper D, 2010, ANN ROY COLL SURG, V92, P453, DOI 10.1308/003588410X12699663905276; Lebeaux D, 2014, MICROBIOL MOL BIOL R, V78, P510, DOI 10.1128/MMBR.00013-14; Loots K, 2008, VACCINE, V26, P546, DOI 10.1016/j.vaccine.2007.11.030; Luo Y, 2015, MBIO, V6, DOI 10.1128/mBio.02456-14; Mace C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003897; Mignan SE, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-43; Mikkelsen H, 2011, ENVIRON MICROBIOL, V13, P1666, DOI 10.1111/j.1462-2920.2011.02495.x; Neznansky A, 2014, FASEB J, V28, P5223, DOI 10.1096/fj.14-258293; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Oggioni MR, 2006, MOL MICROBIOL, V61, P1196, DOI 10.1111/j.1365-2958.2006.05310.x; Ohniwa RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019172; Otto K, 2002, P NATL ACAD SCI USA, V99, P2287, DOI 10.1073/pnas.042521699; Palmer SO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080252; Park AJ, 2014, MOL CELL PROTEOMICS, V13, P1095, DOI 10.1074/mcp.M113.033985; Perron K, 2005, MOL MICROBIOL, V56, P1087, DOI 10.1111/j.1365-2958.2005.04597.x; Petrova OE, 2012, J BACTERIOL, V194, P2413, DOI 10.1128/JB.00003-12; Poole K, 2012, J ANTIMICROB CHEMOTH, V67, P2069, DOI 10.1093/jac/dks196; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; Reed D, 2009, OCHSNER J, V9, P27; Rutherford ST, 2012, COLD SPRING HARB PER, V2; Rutherford ST, 2007, J MOL BIOL, V366, P1243, DOI 10.1016/j.jmb.2006.12.013; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Shephard JJ, 2010, LANGMUIR, V26, P8659, DOI 10.1021/la1007878; Shrout JD, 2011, MRS BULL, V36, P367, DOI 10.1557/mrs.2011.67; Sobel ML, 2005, J BACTERIOL, V187, P1246, DOI 10.1128/JB.187.4.1246-1253.2005; SOMPOLINSKY D, 1972, J BACTERIOL, V110, P468, DOI 10.1128/JB.110.2.468-476.1972; Southey-Pillig CJ, 2005, J BACTERIOL, V187, P8114, DOI 10.1128/JB.187.23.8114-8126.2005; Sriramulu DD, 2005, PROTEOMICS, V5, P3712, DOI 10.1002/pmic.200401227; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Stewart PS, 2015, ANTIMICROB AGENTS CH, V59, P3838, DOI 10.1128/AAC.00433-15; Sugisaki K, 2013, MICROBIOL-SGM, V159, P1379, DOI 10.1099/mic.0.066597-0; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taylor PK, 2014, J BIOTECHNOL, V191, P121, DOI 10.1016/j.jbiotec.2014.09.003; Toutain CM, 2007, RES MICROBIOL, V158, P471, DOI 10.1016/j.resmic.2007.04.001; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wehbi H, 2011, J BACTERIOL, V193, P540, DOI 10.1128/JB.01048-10; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Williamson KS, 2012, J BACTERIOL, V194, P2062, DOI 10.1128/JB.00022-12; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Wood LF, 2012, MBIO, V3, DOI 10.1128/mBio.00094-12; Wuichet K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000724; Yahr T, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00082; Zhang L, 2008, J BACTERIOL, V190, P4447, DOI 10.1128/JB.01655-07; Zhang ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041202; Zhang P, 2015, PROTEOME SCI, V13, DOI 10.1186/s12953-015-0066-5; 2004, AM J INFECT CONTROL, V32, P470, DOI DOI 10.1016/J.AJIC.2004.10.001	100	29	29	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180341	10.1371/journal.pone.0180341	http://dx.doi.org/10.1371/journal.pone.0180341			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678862	Green Published, gold, Green Submitted			2022-12-26	WOS:000405272200056
J	Halpern, BS; Frazier, M; Afflerbach, J; O'Hara, C; Katona, S; Lowndes, JSS; Jiang, N; Pacheco, E; Scarborough, C; Polsenberg, J				Halpern, Benjamin S.; Frazier, Melanie; Afflerbach, Jamie; O'Hara, Casey; Katona, Steven; Lowndes, Julia S. Stewart; Jiang, Ning; Pacheco, Erich; Scarborough, Courtney; Polsenberg, Johanna			Drivers and implications of change in global ocean health over the past five years	PLOS ONE			English	Article							IMPACT	Growing international and national focus on quantitatively measuring and improving ocean health has increased the need for comprehensive, scientific, and repeated indicators to track progress towards achieving policy and societal goals. The Ocean Health Index (OHI) is one of the few indicators available for this purpose. Here we present results from five years of annual global assessment for 220 countries and territories, evaluating potential drivers and consequences of changes and presenting lessons learned about the challenges of using composite indicators to measure sustainability goals. Globally scores have shown little change, as would be expected. However, individual countries have seen notable increases or declines due in particular to improvements in the harvest and management of wild-caught fisheries, the creation of marine protected areas (MPAs), and decreases in natural product harvest. Rapid loss of sea ice and the consequent reduction of coastal protection from that sea ice was also responsible for declines in overall ocean health in many Arctic and sub-Arctic countries. The OHI performed reasonably well at predicting near-term future scores for many of the ten goals measured, but data gaps and limitations hindered these predictions for many other goals. Ultimately, all indicators face the substantial challenge of informing policy for progress toward broad goals and objectives with insufficient monitoring and assessment data. If countries and the global community hope to achieve and maintain healthy oceans, we will need to dedicate significant resources to measuring what we are trying to manage.	[Halpern, Benjamin S.; Frazier, Melanie; Afflerbach, Jamie; O'Hara, Casey; Lowndes, Julia S. Stewart; Jiang, Ning; Scarborough, Courtney] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Halpern, Benjamin S.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Halpern, Benjamin S.] Imperial Coll London, Silwood Pk Campus, Ascot, Berks, England; [Katona, Steven; Pacheco, Erich; Polsenberg, Johanna] Conservat Int, Arlington, VA USA	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Imperial College London; Conservation International	Halpern, BS (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA.; Halpern, BS (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.; Halpern, BS (corresponding author), Imperial Coll London, Silwood Pk Campus, Ascot, Berks, England.	halpern@nceas.unsb.edu	Frazier, Melanie R/A-2367-2012; O'Hara, Casey/AGF-2964-2022	O'Hara, Casey/0000-0003-2968-7005; Lowndes, Julia/0000-0003-1682-3872; Scarborough, Courtney/0000-0001-7270-9228	Pacific Life Foundation	Pacific Life Foundation	Beau and Heather Wrigley generously provided the founding grant to the Ocean Health Index. The Pacific Life Foundation is the Founding Presenting Sponsor. Financial support has also been provided by Jayne and Hans Hufschmid and Dan Sten Olsson, CEO of Stena AB.	[Anonymous], 2021, LANG ENV STAT COMP; BirdLife International & NatureServe, 2015, BIRD SPEC DISTR MAPS; Branch TA, 2013, NATURE, V495, pE5, DOI 10.1038/nature11974; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Frazier M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160377; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117863; Halpern BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098995; Halpern BS, 2012, NATURE; Hovila J., 2013, OMI AURA SURFACE UVB, DOI 10.5067/Aura/OMI/DATA3009; IUCN, 2015, INT UN CONS NAT; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Kaschner K., 2015, AQUAMAPS PREDICTED R; Kaufmann D, 2010, 1682130 SOC SCI RES; Lowndes JSS, 2015, PEERJ, V3, DOI 10.7717/peerj.1503; Martell S, 2013, FISH FISH, V14, P504, DOI 10.1111/j.1467-2979.2012.00485.x; Nardo M, 2005, 21682 EUR EN; Nicholls RJ, 2010, SCIENCE, V328, P1517, DOI 10.1126/science.1185782; Northeast Regional Planning Body, 2016, NE OC PLAN; O'Hara CC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175739; Pauly D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10244; Pinheiro J., 2019, NLME LINEAR NONLINEA; Republic of China, 2016, 13 5 YEAR PLAN EC SO; Republic of Ecuador, 2009, NAT PLAN GOOD LIV; Republic of South Africa, 2011, NAT STRAT SUST DEV A; Ricard D, 2012, FISH FISH, V13, P380, DOI 10.1111/j.1467-2979.2011.00435.x; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Samhouri JF, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00366.1; Stern S, 2016, SOCIAL PROGR INDEX M; United Nations Environment Program, 2010, C PART DEC X 2 STRAT; United Nations Statistical Commission, 2015, REP 46 SESS; Zuur Alain F., 2009, P1	32	25	25	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0178267	10.1371/journal.pone.0178267	http://dx.doi.org/10.1371/journal.pone.0178267			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678881	Green Submitted, Green Published, gold			2022-12-26	WOS:000405272200003
J	Kataya, ARA; Creighton, MT; Napitupulu, TP; Saetre, C; Heidari, B; Ruoff, P; Lillo, C				Kataya, Amr R. A.; Creighton, Maria T.; Napitupulu, Toga P.; Saetre, Christine; Heidari, Behzad; Ruoff, Peter; Lillo, Cathrine			PLATINUM SENSITIVE 2 LIKE impacts growth, root morphology, seed set, and stress responses	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; DOUBLE-STRAND BREAKS; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; HOMOLOGOUS RECOMBINATION; PROTEIN PHOSPHATASES; POSITIVE REGULATOR; CONSERVED PROTEIN; ABSCISIC-ACID; PP4	Eukaryotic protein phosphatase 4 (PP4) is a PP2A-type protein phosphatase that is part of a conserved complex with regulatory factors PSY2 and PP4R2. Various lines of Arabidopsis thaliana with mutated PP4 subunit genes were constructed to study the so far completely unknown functions of PP4 in plants. Mutants with knocked out putative functional homolog of the PSY2 LIKE (PSY2L) gene were dwarf and bushy, while plants with knocked out PP4R2 LIKE (PP4R2L) looked very similar to WT. The psy2l seedlings had short roots with disorganized morphology and impaired meristem. Seedling growth was sensitive to the genotoxin cisplatin. Global transcript analysis (RNA-seq) of seedlings and rosette leaves revealed several groups of genes, shared between both types of tissues, strongly influenced by knocked out PSY2L. Receptor kinases, CRINKLY3 and WAG1, important for growth and development, were down-regulated 3-7 times. EUKARYOTIC ELONGATION FACTOR5A1 was down-regulated 4-6 fold. Analysis of hormone sensitive genes indicated that abscisic acid levels were high, while auxin, cytokinin and gibberellic acid levels were low in psy2l. Expression of specific transcription factors involved in regulation of anthocyanin synthesis were strongly elevated, e. g. the master regulator PAP1, and intriguingly TT8, which is otherwise mainly expressed in seeds. The psy2l mutants accumulated anthocyanins under conditions where WT did not, pointing to PSY2L as a possible upstream negative regulator of PAP1 and TT8. Expression of the sugar-phosphate transporter GPT2, important for cellular sugar and phosphate homeostasis, was enhanced 7-8 times. Several DNA damage response genes, including the cell cycle inhibitor gene WEE1, were up-regulated in psy2l. The activation of DNA repair signaling genes, in combination with phenotypic traits showing aberrant root meristem and sensitivity to the genotoxic cisplatin, substantiate the involvement of Arabidopsis PSY2L in maintenance of genome integrity.	[Kataya, Amr R. A.; Creighton, Maria T.; Napitupulu, Toga P.; Saetre, Christine; Heidari, Behzad; Ruoff, Peter; Lillo, Cathrine] Univ Stavanger, Ctr Organelle Res, Fac Sci & Technol, Stavanger, Norway	Universitetet i Stavanger	Lillo, C (corresponding author), Univ Stavanger, Ctr Organelle Res, Fac Sci & Technol, Stavanger, Norway.	cathrine.lillo@uis.no	Ahootapeh, Behzad Heidari/R-3074-2018	Lillo, Cathrine/0000-0002-8470-8983; Kataya, Amr R.A./0000-0003-1349-0363	Norwegian Research Council [213853/F20]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by a grant from the Norwegian Research Council (grant no 213853/F20 to CL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts MGM, 1995, PLANT CELL, V7, P2115, DOI 10.1105/tpc.7.12.2115; Abe K, 2005, PLANT PHYSIOL, V139, P896, DOI 10.1104/pp.105.065243; ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Amiard S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00405; BREWIS ND, 1993, EMBO J, V12, P987, DOI 10.1002/j.1460-2075.1993.tb05739.x; Chen GI, 2008, J BIOL CHEM, V283, P29273, DOI 10.1074/jbc.M803443200; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; Cohen PTW, 2005, FEBS LETT, V579, P3278, DOI 10.1016/j.febslet.2005.04.070; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; De Schutter K, 2007, PLANT CELL, V19, P211, DOI 10.1105/tpc.106.045047; del Pozo JC, 1999, PLANT J, V19, P579, DOI 10.1046/j.1365-313X.1999.00562.x; Demko V, 2016, PLANTA, V244, P275, DOI 10.1007/s00425-016-2526-2; Desvoyes B, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00369; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dyson BC, 2015, PLANT CELL ENVIRON, V38, P1404, DOI 10.1111/pce.12495; Feyissa DN, 2009, PLANTA, V230, P747, DOI 10.1007/s00425-009-0978-3; Frank J, 2008, PLANT PHYSIOL, V148, P1354, DOI 10.1104/pp.108.127027; Fulda M, 2002, PLANT J, V32, P93, DOI 10.1046/j.1365-313X.2002.01405.x; Furukawa T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00357; Gingras AC, 2005, MOL CELL PROTEOMICS, V4, P1725, DOI 10.1074/mcp.M500231-MCP200; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Helps NR, 1998, J CELL SCI, V111, P1331; Hincha DK, 2012, BIOCHEM SOC T, V40, P1000, DOI 10.1042/BST20120109; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Huang JH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/623573; Kataya ARA, 2016, PLANTA, V243, P699, DOI 10.1007/s00425-015-2439-5; Kleinboelting N, 2012, NUCLEIC ACIDS RES, V40, pD1211, DOI 10.1093/nar/gkr1047; Lee DH, 2012, EMBO J, V31, P2403, DOI 10.1038/emboj.2012.86; Lee SB, 2015, PLANT CELL REP, V34, P71, DOI 10.1007/s00299-014-1688-2; Lillo C, 2008, PLANT CELL ENVIRON, V31, P587, DOI 10.1111/j.1365-3040.2007.01748.x; Lillo C, 2014, PLANT CELL ENVIRON, V37, P2631, DOI 10.1111/pce.12364; Lipinszki Z, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6894; Liu Z, 2008, J EXP BOT, V59, P939, DOI 10.1093/jxb/ern017; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; Ma CL, 2006, PLANT PHYSIOL, V141, P47, DOI 10.1104/pp.105.073841; Ma H, 2014, MOL CELL BIOL, V34, P452, DOI 10.1128/MCB.00279-13; Marshall WF, 2009, CURR OPIN CELL BIOL, V21, P14, DOI 10.1016/j.ceb.2009.01.008; Matre P, 2009, PLANTA, V230, P935, DOI 10.1007/s00425-009-0998-z; Mendoza MC, 2005, MOL CELL BIOL, V25, P7839, DOI 10.1128/MCB.25.17.7839-7853.2005; Moller SG, 2003, PLANT CELL, V15, P1111, DOI 10.1105/tpc.008649; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nakada S, 2008, EMBO REP, V9, P1251, DOI 10.1038/embor.2008.204; Nikonorova N, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00880; O'Neill BM, 2007, P NATL ACAD SCI USA, V104, P9290, DOI 10.1073/pnas.0703252104; Olczak M, 2003, ACTA BIOCHIM POL, V50, P1245; Oler AJ, 2012, EMBO J, V31, P1440, DOI 10.1038/emboj.2011.501; Olvera-Carrillo Y, 2010, PLANT PHYSIOL, V154, P373, DOI 10.1104/pp.110.158964; Onate-Sanchez Luis, 2008, BMC Res Notes, V1, P93, DOI 10.1186/1756-0500-1-93; Otero S, 2016, PLANT CELL, V28, P1361, DOI 10.1105/tpc.15.01003; Re DA, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-150; Ren H, 2015, MOL PLANT, V8, P1153, DOI 10.1016/j.molp.2015.05.003; SAMUEL MA, 2006, INT REV CYTOL, V253, P1, DOI DOI 10.1016/S0074-7696(06)53001-3; Santner AA, 2006, PLANT J, V45, P752, DOI 10.1111/j.1365-313X.2005.02641.x; Scheffzek K, 2012, FEBS LETT, V586, P2662, DOI 10.1016/j.febslet.2012.06.006; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Uhrig RG, 2013, TRENDS PLANT SCI, V18, P505, DOI 10.1016/j.tplants.2013.05.004; Van Bel M, 2012, PLANT PHYSIOL, V158, P590, DOI 10.1104/pp.111.189514; Wang SC, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-81; Waterworth WM, 2016, P NATL ACAD SCI USA, V113, P9647, DOI 10.1073/pnas.1608829113; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wolff S, 2006, CELL, V124, P1039, DOI 10.1016/j.cell.2005.12.042; Wu HI, 2004, CANCER RES, V64, P3940, DOI 10.1158/0008-5472.CAN-03-3113; Xu WJ, 2015, TRENDS PLANT SCI, V20, P176, DOI 10.1016/j.tplants.2014.12.001; Yi D, 2014, PLANT CELL, V26, P296, DOI 10.1105/tpc.113.118943; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yoon YS, 2010, P NATL ACAD SCI USA, V107, P17704, DOI 10.1073/pnas.1012665107; Yuan DK, 2014, DNA REPAIR, V21, P140, DOI 10.1016/j.dnarep.2014.04.006; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383	74	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180478	10.1371/journal.pone.0180478	http://dx.doi.org/10.1371/journal.pone.0180478			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678890	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000405272200067
J	Yang, L; Ge, M; Jin, D; He, DX; Fu, HZ; Wang, J; Cao, XC				Yang, Liang; Ge, Meng; Jin, Di; He, Dongxiao; Fu, Huazhu; Wang, Jing; Cao, Xiaochun			Exploring the roles of cannot-link constraint in community detection via Multi-variance Mixed Gaussian Generative Model	PLOS ONE			English	Article							COMPLEX NETWORKS	Due to the demand for performance improvement and the existence of prior information, semi-supervised community detection with pairwise constraints becomes a hot topic. Most existing methods have been successfully encoding the must-link constraints, but neglect the opposite ones, i.e., the cannot-link constraints, which can force the exclusion between nodes. In this paper, we are interested in understanding the role of cannot-link constraints and effectively encoding pairwise constraints. Towards these goals, we define an integral generative process jointly considering the network topology, must-link and cannot-link constraints. We propose to characterize this process as a Multi-variance Mixed Gaussian Generative (MMGG) Model to address diverse degrees of confidences that exist in network topology and pairwise constraints and formulate it as a weighted nonnegative matrix factorization problem. The experiments on artificial and real-world networks not only illustrate the superiority of our proposed MMGG, but also, most importantly, reveal the roles of pairwise constraints. That is, though the must-link is more important than cannot-link when either of them is available, both must-link and cannot-link are equally important when both of them are available. To the best of our knowledge, this is the first work on discovering and exploring the importance of cannot-link constraints in semi-supervised community detection.	[Yang, Liang] Tianjin Univ Commerce, Sch Informat Engn, Tianjin, Peoples R China; [Yang, Liang; Cao, Xiaochun] Chinese Acad Sci, Inst Informat Engn, State Key Lab Informat Secur, Beijing, Peoples R China; [Ge, Meng; Jin, Di] Tianjin Univ, Sch Comp Software, Tianjin, Peoples R China; [Jin, Di; He, Dongxiao] Tianjin Univ, Sch Comp Sci & Technol, Tianjin, Peoples R China; [Fu, Huazhu] ASTAR, Inst Infocomm Res, Singapore, Singapore; [Wang, Jing] Bournemouth Univ, Fac Sci & Technol, Bournemouth, Dorset, England	Tianjin University of Commerce; Chinese Academy of Sciences; Institute of Information Engineering, CAS; Tianjin University; Tianjin University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R); Bournemouth University	Yang, L (corresponding author), Tianjin Univ Commerce, Sch Informat Engn, Tianjin, Peoples R China.; Yang, L (corresponding author), Chinese Acad Sci, Inst Informat Engn, State Key Lab Informat Secur, Beijing, Peoples R China.	yangliang@iie.ac.cn	Jin, Di/AAC-3716-2019; Fu, Huazhu/A-1411-2014	Fu, Huazhu/0000-0002-9702-5524; Yang, Liang/0000-0002-3358-4052	National Natural Science Foundation of China [61503281, 6102334, 61303110, 61422213]; National Basic Research Program of China [2013CB329305]; Open Funding Project of Tianjin Key Laboratory of Cognitive Computing and Application, Foundation for the Young Scholars by Tianjin University of Commerce [150113]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Open Funding Project of Tianjin Key Laboratory of Cognitive Computing and Application, Foundation for the Young Scholars by Tianjin University of Commerce; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Natural Science Foundation of China (No. 61503281, 6102334, 61303110, 61422213), National Basic Research Program of China (2013CB329305), Open Funding Project of Tianjin Key Laboratory of Cognitive Computing and Application, Foundation for the Young Scholars by Tianjin University of Commerce (150113)	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; Allahverdyan AE, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/18002; Eaton E., 2012, P AAAI C ART INT, P900; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Li HJ, 2016, IEEE T KNOWL DATA EN, V28, P2349, DOI 10.1109/TKDE.2016.2563425; Li HJ, 2016, J INTELL FUZZY SYST, V31, P2887, DOI 10.3233/JIFS-169171; Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225; Ma XK, 2010, PHYSICA A, V389, P187, DOI 10.1016/j.physa.2009.09.018; Malliaros FD, 2013, PHYS REP, V533, P95, DOI 10.1016/j.physrep.2013.08.002; Nadakuditi RR, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.188701; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Traud AL, 2012, PHYSICA A, V391, P4165, DOI 10.1016/j.physa.2011.12.021; Xie JR, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2501654.2501657; Yang L., 2016, P 25 INT JOINT C ART, P2252, DOI [10.55553060832.3060936////, DOI 10.5555/3060832.3060936]; Yang L, 2015, IEEE T CYBERNETICS, V45, P2585, DOI 10.1109/TCYB.2014.2377154; Yang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep09039; Zhang Z-Y, SCI REP, P3; Zhang ZY, 2013, EPL-EUROPHYS LETT, V101, DOI 10.1209/0295-5075/101/48005	23	7	8	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0178029	10.1371/journal.pone.0178029	http://dx.doi.org/10.1371/journal.pone.0178029			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678864	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000405272200002
J	Bennion, DM; Isenberg, JD; Harmel, AT; DeMars, K; Dang, AN; Jones, CH; Pignataro, ME; Graham, JT; Steckelings, UM; Alexander, JC; Febo, M; Krause, EG; de Kloet, AD; Candelario-Jalil, E; Sumners, C				Bennion, Douglas M.; Isenberg, Jacob D.; Harmel, Allison T.; DeMars, Kelly; Dang, Alex N.; Jones, Chad H.; Pignataro, Megan E.; Graham, Justin T.; Steckelings, U. Muscha; Alexander, Jon C.; Febo, Marcelo; Krause, Eric G.; de Kloet, Annette D.; Candelario-Jalil, Eduardo; Sumners, Colin			Post-stroke angiotensin II type 2 receptor activation provides long-term neuro-protection in aged rats	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; ISCHEMIC-STROKE; CAUSES NEUROPROTECTION; COMPOUND 21; BRAIN; STIMULATION; CEREBROPROTECTION; SYSTEM; MODEL; MICE	Activation of the angiotensin II type 2 receptor (AT2R) by administration of Compound 21 (C21), a selective AT2R agonist, induces neuroprotection in models of ischemic stroke in young adult animals. The mechanisms of this neuroprotective action are varied, and may include direct and indirect effects of AT2R activation. Our objectives were to assess the long-term protective effects of post-stroke C21 treatments in a clinically-relevant model of stroke in aged rats and to characterize the cellular localization of AT2Rs in the mouse brain of transgenic reporter mice following stroke. Intraperitoneal injections of C21 (0.03mg/kg) after ischemic stroke induced by transient monofilament middle cerebral artery occlusion resulted in protective effects that were sustained for up to at least 3-weeks post-stroke. These included improved neurological function across multiple assessments and a significant reduction in infarct volume as assessed by magnetic resonance imaging. We also found AT2R expression to be on neurons, not astrocytes or microglia, in normal female and male mouse brains. Stroke did not induce altered cellular localization of AT2R when assessed at 7 and 14 days post-stroke. These findings demonstrate that the neuroprotection previously characterized only during earlier time points using stroke models in young animals is sustained long-term in aged rats, implying even greater clinical relevance for the study of AT2R agonists for the acute treatment of ischemic stroke in human disease. Further, it appears that this sustained neuroprotection is likely due to a mix of both direct and indirect effects stemming from selective activation of AT2Rs on neurons or other cells besides astrocytes and microglia.				csumners@ufl.edu	Candelario-Jalil, Eduardo/I-1139-2019; Febo, Marcelo/X-6769-2019	Candelario-Jalil, Eduardo/0000-0003-3631-1989; Febo, Marcelo/0000-0001-8981-4163; Steckelings, Ulrike Muscha/0000-0002-5430-4275; de Kloet, Annette/0000-0002-7213-6957; Krause, Eric/0000-0002-2718-3113; Sumners, Colin/0000-0002-9689-2255	American Heart Association [12PRE11940010]; National Heart Lung and Blood Institute [2T32HL083810-06A1]; McKnight Brain Institute at the University of Florida; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065849] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); McKnight Brain Institute at the University of Florida; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support for this study was provided by the American Heart Association (12PRE11940010, CS), National Heart Lung and Blood Institute (2T32HL083810-06A1, DMB), and the McKnight Brain Institute at the University of Florida (DMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alhusban A, 2015, J HYPERTENS, V33, P170, DOI 10.1097/HJH.0000000000000364; Bennion DM, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-014-0512-2; Bosnyak S, 2011, CLIN SCI, V121, P297, DOI 10.1042/CS20110036; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; de Kloet AD, 2014, BRAIN STRUCT FUNCT; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Fouda AY, 2016, CLIN SCI, V130, P221, DOI 10.1042/CS20150350; Hawkins KE, 2013, J NEUROCHEM; Joseph JP, 2014, NEUROPHARMACOLOGY, V81, P134, DOI 10.1016/j.neuropharm.2014.01.044; Kagiyama T, 2003, REGUL PEPTIDES, V110, P241, DOI 10.1016/S0167-0115(02)00223-9; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Lee Seyoung, 2012, Exp Transl Stroke Med, V4, P16, DOI 10.1186/2040-7378-4-16; Li J, 2005, FASEB J, V19, P617, DOI 10.1096/fj.04-2960fje; Makino I, 1996, NEUROPEPTIDES, V30, P596, DOI 10.1016/S0143-4179(96)90043-8; Mateos L, 2016, BIOCHIM BIOPHYS ACTA; McCarthy CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095762; McCarthy CA, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0440-1; McCarthy CA, 2012, HYPERTENSION, V60, P1531, DOI 10.1161/HYPERTENSIONAHA.112.199646; McCarthy CA, 2009, STROKE, V40, P1482, DOI 10.1161/STROKEAHA.108.531509; Mecca AP, 2011, EXP PHYSIOL, V96, P1084, DOI 10.1113/expphysiol.2011.058578; Mecca AP, 2009, EXP PHYSIOL, V94, P937, DOI 10.1113/expphysiol.2009.047936; Min LJ, 2014, AM J HYPERTENS, V27, P1036, DOI 10.1093/ajh/hpu015; Miyamoto N, 2008, NEUROSCI RES, V61, P249, DOI 10.1016/j.neures.2008.03.003; Regenhardt RW, 2013, NEUROPHARMACOLOGY, V71, P154, DOI 10.1016/j.neuropharm.2013.03.025; Schwengel K, 2016, J MOL MED BERL; Villela D, 2015, CLIN SCI, V128, P227, DOI 10.1042/CS20130515	26	15	16	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180738	10.1371/journal.pone.0180738	http://dx.doi.org/10.1371/journal.pone.0180738			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671997	Green Published, gold, Green Submitted			2022-12-26	WOS:000405268500084
J	Moradi, S; Sahebi, Z; Valojerdi, AE; Rohani, F; Ebrahimi, H				Moradi, Sedighe; Sahebi, Zeinab; Valojerdi, Ameneh Ebrahim; Rohani, Farzaneh; Ebrahimi, Hooman			ocr v56 The association between the number of office visits and the control of cardiovascular risk factors in Iranian patients with type2 diabetes	PLOS ONE			English	Article							GLYCEMIC CONTROL; ENCOUNTER FREQUENCY; BLOOD-PRESSURE; ADHERENCE; BARRIERS; MANAGEMENT; MELLITUS; QUALITY; GLUCOSE	Introduction Patients with diabetes type2 should receive regular medical care. We aimed at investigating the association between the number of office visits and improvement of their cardiovascular- risk factors. Methods Four hundred and ninety patients with type 2 diabetes mellitus who were followed in a tertiary center were enrolled in this longitudinal study. The minimum follow up period was 3 years. Patient data were extracted from manual or electronic records. Results Sixty-four percent of cases were females, the mean age was 61 +/- 12.45 years, and the mean disease duration was 6.5 +/- 7.9 years. The mean number of office visits was 2.69 +/- 0.91 per year. Comparing the means of each of the cardio-vascular risk factors showed a significant decrease in all cardiovascular risk factors, while there was a significant weight gain over the same period. The association between changes in these parameters and the number of patients' office visits per year were not statistically significant. In patients with disease duration less than 5 years, each additional office visits by one visit per year was associated with a decrease in serum total cholesterol by 6.94 mg/dl. The mean number of office visits per year in patients older than 60 years old was more than younger patient (p = 0.001). Conclusion The decrease in the mean values of the investigated parameters was statistically significant between the first year of follow up and the following years. Yet, these changes were not related to the mean number of patients' office visits per year, which may reflect the poor compliance of patients to treatment regardless of the number of their office visits.	[Moradi, Sedighe; Sahebi, Zeinab] Iran Univ Med Sci, Inst Endocrinol & Metab, Endocrine Res Ctr, Tehran, Iran; [Valojerdi, Ameneh Ebrahim] Iran Univ Med Sci, Inst Endocrinol & Metab, Div Biostat, Endocrine Res Ctr, Tehran, Iran; [Rohani, Farzaneh] Iran Univ Med Sci, Inst Endocrinol & Metab, Endocrine Res Ctr, Res Ctr Growth & Dev Childhood & Adolescence, Tehran, Iran; [Ebrahimi, Hooman] Univ Tehran Med Sci, Students Sci Res Ctr, Tehran, Iran	Iran University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences; Tehran University of Medical Sciences	Moradi, S (corresponding author), Iran Univ Med Sci, Inst Endocrinol & Metab, Endocrine Res Ctr, Tehran, Iran.	Moradi.s@iums.ac.ir	Moradi, Sedighe/AAE-8262-2020; Rohani, Farzaneh/O-9952-2018	Moradi, Sedighe/0000-0002-1840-6186; Rohani, Farzaneh/0000-0002-2277-4862; ebrahimi, hooman/0000-0001-5939-3185				Aikens JE, 2013, DIABETIC MED, V30, P338, DOI 10.1111/dme.12046; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; [Anonymous], 2015, DIABETES CARE, V38, pS33, DOI 10.2337/dc15-S009; [Anonymous], 1997, AGE ADJUSTED PERCENT; Ashman JJ, NCHS DATA BRIEF, V2014, P1; Bhattacharyya OK, 2011, INT J CIRCUMPOL HEAL, V70, P552, DOI 10.3402/ijch.v70i5.17848; Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278; De Geest Sabina, 2003, Eur J Cardiovasc Nurs, V2, P323; Fenton JJ, 2006, ANN FAM MED, V4, P32, DOI 10.1370/afm.421; Gregg EW, 2000, DIABETES CARE, V23, P1272, DOI 10.2337/diacare.23.9.1272; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; Huang ES, 2009, MULTIDISCIPLINARY AP; Kaufman FR, 1999, PEDIATRICS, V103, P948, DOI 10.1542/peds.103.5.948; Martin S, 2006, DIABETOLOGIA, V49, P271, DOI 10.1007/s00125-005-0083-5; Morrison F, 2011, ARCH INTERN MED, V171, P1542, DOI 10.1001/archinternmed.2011.400; Munshi MN, 2013, DIABETES CARE, V36, P543, DOI 10.2337/dc12-1303; National Diabetes Fact Sheet, 2011, NATL DIABETES FACT S; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Patel I, 2010, INT J DIABETES MELLI, V2, P122, DOI DOI 10.1016/J.IJDM.2010.05.003; Rodbard HW, 2009, ENDOCR PRACT, V15, P540, DOI 10.4158/EP.15.6.540; Ross SA, 2013, AM J MED, V126, pS38, DOI 10.1016/j.amjmed.2013.06.012; Takahashi PY, 2015, DIABET METAB SYND OB, V8, P1, DOI 10.2147/DMSO.S71726; Turchin A, 2010, HYPERTENSION, V56, P68, DOI 10.1161/HYPERTENSIONAHA.109.148791; Vijan S, 1997, J GEN INTERN MED, V12, P567, DOI 10.1046/j.1525-1497.1997.07111.x; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	25	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179190	10.1371/journal.pone.0179190	http://dx.doi.org/10.1371/journal.pone.0179190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666031	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608700030
J	Bartel, A; Gohler, A; Hopf, V; Breitbach, K				Bartel, Alexander; Goehler, Andre; Hopf, Verena; Breitbach, Katrin			Caspase-6 mediates resistance against Burkholderia pseudomallei infection and influences the expression of detrimental cytokines	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CELL-DEATH; IN-VITRO; ACTIVATION; APOPTOSIS; SURVIVAL; IMMUNITY; INTERLEUKIN-10; MELIOIDOSIS; INTERFERON	Caspase-6 is a member of the executioner caspases and known to play a role in innate and adaptive immune processes. However, its role in infectious diseases has rarely been addressed yet. We here examined the impact of caspase-6 in an in vivo infection model using the Gram-negative rod Burkholderia pseudomallei, causing the infectious disease melioidosis that is endemic in tropical and subtropical areas around the world. Caspase-6(-/-) and C57BL/6 wild type mice were challenged with B. pseudomallei for comparing mortality, bacterial burden and inflammatory cytokine expression. Bone-marrow derived macrophages were used to analyse the bactericidal activity in absence of caspase-6. Caspase-6 deficiency was associated with higher mortality and bacterial burden in vivo after B. pseudomallei infection. The bactericidal activity of caspase-6(-/-)macrophages was impaired compared to wild type cells. Caspase-6(-/-)mice showed higher expression of the IL-1 beta gene, known to be detrimental in murine melioidosis. Expression of the IL-10 gene was also increased in caspase6(-/-)mice as early as 6 hours after infection. Treatment with exogenous IL-10 rendered mice more susceptible against B. pseudomallei challenge. Thus, caspase-6 seems to play a crucial role for determining resistance against the causative agent of melioidosis. To our knowledge this is the first report showing that caspase-6 is crucial for mediating resistance in an in vivo infection model. Caspase-6 influences the expression of detrimental cytokines and therefore seems to be important for achieving a well-balanced immune response that contributes for an efficient elimination of the pathogen.	[Bartel, Alexander; Goehler, Andre; Hopf, Verena; Breitbach, Katrin] Univ Med Greifswald, Friedrich Loeffler Inst Med Microbiol, Greifswald, Germany; [Hopf, Verena] Fzmb GmbH, Res Ctr Med Technol & Biotechnol, Bad Langensalza, Germany; [Breitbach, Katrin] Schon Klin Bad Bramstedt, Bad Bramstedt, Germany	Friedrich Loeffler Institute; Greifswald Medical School	Breitbach, K (corresponding author), Univ Med Greifswald, Friedrich Loeffler Inst Med Microbiol, Greifswald, Germany.; Breitbach, K (corresponding author), Schon Klin Bad Bramstedt, Bad Bramstedt, Germany.	breitbach.katrin@gmail.com	Goehler, André/AAZ-7067-2020	Goehler, André/0000-0002-4006-3511; Bartel, Alexander/0000-0002-1280-6138				Bast A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003986; Breitbach K, 2006, INFECT IMMUN, V74, P6300, DOI 10.1128/IAI.00966-06; Breitbach K, 2009, INFECT IMMUN, V77, P1589, DOI 10.1128/IAI.01257-08; Ceballos-Olvera I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002452; Chandra V, 2013, J BIOL CHEM, V288, P10692, DOI 10.1074/jbc.M113.455915; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Currie BJ, 2000, ACTA TROP, V74, P121, DOI 10.1016/S0001-706X(99)00060-1; Eske K, 2009, J IMMUNOL METHODS, V342, P13, DOI 10.1016/j.jim.2008.11.011; Gafni J, 2012, J NEUROSCI, V32, P7454, DOI 10.1523/JNEUROSCI.6379-11.2012; Graham RK, 2011, TRENDS NEUROSCI, V34, P646, DOI 10.1016/j.tins.2011.09.001; Haque A, 2006, J INFECT DIS, V194, P1241, DOI 10.1086/508217; Klaiman G, 2009, BBA-MOL CELL RES, V1793, P592, DOI 10.1016/j.bbamcr.2008.12.004; Kobayashi H, 2011, J IMMUNOL, V186, P403, DOI 10.4049/jimmunol.1001906; LeBlanc A, 1999, J BIOL CHEM, V274, P23426, DOI 10.1074/jbc.274.33.23426; Levkau B, 1999, NAT CELL BIOL, V1, P227, DOI 10.1038/12050; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Norman JM, 2010, AUTOPHAGY, V6, P1042, DOI 10.4161/auto.6.8.13337; Nyormoi O, 2001, MOL CELL BIOL, V21, P4856, DOI 10.1128/MCB.21.15.4856-4867.2001; O'Leary S, 2011, AM J RESP CELL MOL, V45, P172, DOI 10.1165/rcmb.2010-0319OC; OSWALD IP, 1992, P NATL ACAD SCI USA, V89, P8676, DOI 10.1073/pnas.89.18.8676; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rouaux C, 2003, EMBO J, V22, P6537, DOI 10.1093/emboj/cdg615; Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5; Santanirand P, 1999, INFECT IMMUN, V67, P3593, DOI 10.1128/IAI.67.7.3593-3600.1999; Schmeck B, 2004, INFECT IMMUN, V72, P4940, DOI 10.1128/IAI.72.9.4940-4947.2004; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Simpson AJH, 2000, J INFECT DIS, V181, P621, DOI 10.1086/315271; Sun GW, 2005, CELL MICROBIOL, V7, P1447, DOI 10.1111/j.1462-5822.2005.00569.x; Tattoli I, 2008, MICROBES INFECT, V10, P1114, DOI 10.1016/j.micinf.2008.06.004; Tsao CH, 2008, J GEN VIROL, V89, P1930, DOI 10.1099/vir.0.2008/000182-0; Tsuji NM, 2004, INT IMMUNOL, V16, P335, DOI 10.1093/intimm/dxh041; van Raam BJ, 2013, CELL DEATH DIFFER, V20, P86, DOI 10.1038/cdd.2012.98; Wang XJ, 2015, ANNU REV PHARMACOL, V55, P553, DOI 10.1146/annurev-pharmtox-010814-124414; Watanabe C, 2008, J IMMUNOL, V181, P6810, DOI 10.4049/jimmunol.181.10.6810; West TE, 2013, J IMMUNOL, V190, P3373, DOI 10.4049/jimmunol.1202974; Wiersinga WJ, 2007, INFECT IMMUN, V75, P3739, DOI 10.1128/IAI.00080-07; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Yan N, 2005, ANNU REV CELL DEV BI, V21, P35, DOI 10.1146/annurev.cellbio.21.012704.131040	40	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180203	10.1371/journal.pone.0180203	http://dx.doi.org/10.1371/journal.pone.0180203			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686630	Green Published, Green Submitted, gold			2022-12-26	WOS:000405464100039
J	Cassim, H; Otwombe, K; Lazarus, E; Liberty, A; Gray, GE; Greeff, OBW; Violari, A				Cassim, Haseena; Otwombe, Kennedy; Lazarus, Erica; Liberty, Afaaf; Gray, Glenda E.; Greeff, Oppel B. W.; Violari, Avy			A retrospective case-cohort study comparing treatment outcomes in abacavir versus stavudine containing first line antiretroviral treatment regimens in children <3yrs old, at a paediatric programme based in Soweto, South Africa	PLOS ONE			English	Article							THERAPY; GROWTH	Introduction The current World Health Organization guideline for first line antiretroviral therapy (ART) in HIV-infected children recommends the use of abacavir and lamivudine as nucleoside backbones and no longer includes stavudine. We compared treatment outcomes with abacavir (ABC) versus stavudine (d4T) in a cohort of HIV-1 infected children 6 and 12 months after antiretroviral therapy was initiated. Methods This was a retrospective case-cohort study, using programmatic data from children enrolled in the Paediatric Wellness Programme at the Perinatal HIV Research Unit in Soweto, South Africa between 2005 and 2013. Children on abacavir/stavudine who had initiated ART at age < 3 years with a regimen including lamivudine and lopinavir/ritonavir and had at least one 6 or 12 month viral load result were eligible. All ABC cases identified were matched for age at ART initiation and gender to eligible d4T controls (1: 2). Outcomes analysed at 6 and 12 months post ART initiation included virological failure, mortality, immunological failure and anthropometry. Chi-square tests compared categorical measures while Kruskal-Wallis compared continuous measures. Results We identified 57 eligible ABC cases and selected 114 matched d4T controls. Overall, 57% were females and 89% started treatment at age < 1year. The median age at ART initiation was 3.11 (IQR: 1.98-6.05) months. There was no difference in the proportion of children virologically suppressed between the groups at 6 (ABC 54.5% vs. d4T 67.0%, p = 0.125) and 12 (ABC 66.7% vs. d4T 71.6%, p = 0.53) months post ART-initiation. The proportion of children with adherence levels > 90% for ABC and d4T were similar too (95% in ABC vs. 86% in d4T, p = 0.10). The proportion of children who died over 12 months was 3.5% in the ABC and 7.9% in the d4T group (p = 0.27). Similarly, the anthropometric measures were comparable. Conclusions It is reassuring that in the short term, in this group of patients, the treatment outcomes were similar.	[Cassim, Haseena; Otwombe, Kennedy; Lazarus, Erica; Liberty, Afaaf; Gray, Glenda E.; Violari, Avy] Univ Witwatersrand, Perinatal HIV Res Unit, Fac Hlth Sci, Johannesburg, South Africa; [Gray, Glenda E.] South African Med Res Council, Cape Town, South Africa; [Greeff, Oppel B. W.] Univ Pretoria, Dept Pharmacol, Pretoria, South Africa	University of Witwatersrand; South African Medical Research Council; University of Pretoria	Cassim, H (corresponding author), Univ Witwatersrand, Perinatal HIV Res Unit, Fac Hlth Sci, Johannesburg, South Africa.	cassimh@phru.co.za			South Africa Mission of the US Agency for International Development (USAID) [674-A-0 0-08-00009-00]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069453] Funding Source: NIH RePORTER	South Africa Mission of the US Agency for International Development (USAID)(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Perinatal HIV Research Unit received funding for their paediatric HIV observational cohort "Paediatric Wellness Programme" from the South Africa Mission of the US Agency for International Development (USAID) under the terms of Cooperative Agreement Number 674-A-0 0-08-00009-00 (HC,KO,EL,AL,GEG,AV). The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Adetokunboh OO, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1183-6; Cotton MF, 2013, LANCET, V382, P1555, DOI 10.1016/S0140-6736(13)61409-9; Gsponer T, 2012, PEDIATRICS, V130, pE966, DOI 10.1542/peds.2011-3020; Lancet, 2002, LANCET, V359; Musiime V, 2014, REV ANTIVIRAL THER I, V6; Sutcliffe CG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-54; Technau K, 2013, POOR EARLY VIROLOGIC; Technau KG, 2014, PEDIATR INFECT DIS J, V33, P617, DOI 10.1097/INF.0000000000000222; UNAIDS, 2014, THE GAP REP; UNICEF, 2015, PAEDIAT TREATM CAR; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Weigel R, 2010, TROP MED INT HEALTH, V15, P934, DOI 10.1111/j.1365-3156.2010.02561.x; Welch S, 2009, HIV MED, V10, P591, DOI 10.1111/j.1468-1293.2009.00759.x; WHO, GLOB UPD HIV TREATM; World Health Organisation, 2006, ANT THER HIV INF INF; World Health Organisation, ANT TER HIV INF INF	16	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180645	10.1371/journal.pone.0180645	http://dx.doi.org/10.1371/journal.pone.0180645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686654	Green Submitted, Green Published, gold			2022-12-26	WOS:000405464100085
J	Mukherjee, S; Subramaniam, R; Chen, H; Smith, A; Keshava, S; Shams, H				Mukherjee, Sanjay; Subramaniam, Renuka; Chen, Han; Smith, Anthony; Keshava, Shiva; Shams, Homayoun			Boosting efferocytosis in alveolar space using BCG vaccine to protect host against influenza pneumonia	PLOS ONE			English	Article							APOPTOTIC CELL CLEARANCE; ACTIVATED RECEPTOR-GAMMA; MALIGNANT-MELANOMA; NUCLEAR RECEPTORS; VIRUS INFECTION; PPAR-GAMMA; IN-VITRO; GM-CSF; MACROPHAGES; LUNG	Efferocytosis by alveolar phagocytes (APs) is pivotal in maintenance of lung homeostasis. Increased efferocytosis by APs results in protection against lethal acute lung injury due to pulmonary infections whereas defective efferocytosis by APs results in chronic lung inflammation. In this report, we show that pulmonary delivery of Bacillus Calmette-Guerin (BCG) significantly enhances efferocytosis by APs. Increased efferocytosis by APs maintains lung homeostasis and protects mice against lethal influenza pneumonia. Intranasally treated wild type C57Bl/6 (WT) mice with BCG showed significant increase in APs efferocytosis in vivo compared to their PBS-treated counterparts. All BCG-treated WT mice survived lethal influenza A virus (IAV) infection whereas all PBS-treated mice succumbed. BCG-induced resistance was abrogated by depleting AP prior to IAV infection. BCG treatment increased uptake, and digestion/removal of apoptotic cells by APs. BCG significantly increased the expression of TIM4 on APs and increased expression of Rab5 and Rab7. We demonstrated that increased efferocytosis by APs through pulmonary delivery of BCG initiated rapid clearance of apoptotic cells from the alveolar space, maintained lung homeostasis, reduced inflammation and protected host against lethal IAV pneumonia.	[Mukherjee, Sanjay; Subramaniam, Renuka; Chen, Han; Smith, Anthony; Shams, Homayoun] Univ Texas Hlth Sci Ctr Tyler, CPIDC, Tyler, TX 75708 USA; [Keshava, Shiva] Univ Texas Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX USA; [Subramaniam, Renuka] Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA; [Subramaniam, Renuka] Harvard Med Sch, Boston, MA USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Shams, H (corresponding author), Univ Texas Hlth Sci Ctr Tyler, CPIDC, Tyler, TX 75708 USA.	homayoun.shams@uthct.edu	Mukherjee, Sanjay/R-9913-2019	Mukherjee, Sanjay/0000-0003-4853-2332				Gonzalez N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00211; Borges VM, 2009, AM J PHYSIOL-LUNG C, V297, pL586, DOI 10.1152/ajplung.90569.2008; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Castrillo A, 2004, ANNU REV CELL DEV BI, V20, P455, DOI 10.1146/annurev.cellbio.20.012103.134432; Donnelly LE, 2012, CHEST, V141, P1055, DOI 10.1378/chest.11-2348; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fujimori T, 2015, MUCOSAL IMMUNOL, V8, P1021, DOI 10.1038/mi.2014.129; Fujimoto I, 2000, J VIROL, V74, P3399, DOI 10.1128/JVI.74.7.3399-3403.2000; Golpon HA, 2004, FASEB J, V18, P1716, DOI 10.1096/fj.04-1853fje; GONZALEZ N, 2009, IMMUNITY, V31, P245, DOI DOI 10.1016/J.IMMUNI.2009.06.018; Grabiec AM, 2016, SEMIN IMMUNOPATHOL, V38, P409, DOI 10.1007/s00281-016-0555-3; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Huang FF, 2011, AM J RESP CRIT CARE, V184, P259, DOI 10.1164/rccm.201012-2036OC; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Johann AM, 2006, CELL DEATH DIFFER, V13, P1533, DOI 10.1038/sj.cdd.4401832; Kirby AC, 2006, J INFECT DIS, V193, P205, DOI 10.1086/498874; Kiss RS, 2006, CURR BIOL, V16, P2252, DOI 10.1016/j.cub.2006.09.043; Lanz RB, 2006, NUCLEIC ACIDS RES, V34, pD221, DOI 10.1093/nar/gkj029; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lea S, 2014, EUR RESPIR J, V43, P409, DOI 10.1183/09031936.00187812; Leentjens J, 2015, J INFECT DIS, V212, P1930, DOI 10.1093/infdis/jiv332; Liu Q, 2016, CELL MOL IMMUNOL, V13, P3, DOI 10.1038/cmi.2015.74; Luca Simona, 2013, Maedica (Bucur), V8, P53; Martin CJ, 2014, CURR OPIN MICROBIOL, V17, P17, DOI 10.1016/j.mib.2013.10.007; Martin CJ, 2012, CELL HOST MICROBE, V12, P289, DOI 10.1016/j.chom.2012.06.010; MBAWUIKE IN, 1986, INFECT IMMUN, V51, P483, DOI 10.1128/IAI.51.2.483-489.1986; MORTON DL, 1974, ANN SURG, V180, P635, DOI 10.1097/00000658-197410000-00029; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; PATERSON AHG, 1984, CAN MED ASSOC J, V131, P744; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Richens TR, 2009, AM J RESP CRIT CARE, V179, P1011, DOI 10.1164/rccm.200807-1148OC; Rodriguez-Manzanet R, 2010, P NATL ACAD SCI USA, V107, P8706, DOI 10.1073/pnas.0910359107; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Schneider C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004053; Serban KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176073; Setia MS, 2006, LANCET INFECT DIS, V6, P162, DOI 10.1016/S1473-3099(06)70412-1; Short KR, 2014, LANCET INFECT DIS, V14, P57, DOI 10.1016/S1473-3099(13)70286-X; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; SPENCER JC, 1977, J INFECT DIS, V136, P171, DOI 10.1093/infdis/136.2.171; Subramaniam R, 2016, MUCOSAL IMMUNOL, V9, P873, DOI 10.1038/mi.2015.120; Subramaniam R, 2013, J INFECT DIS; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	50	34	35	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180143	10.1371/journal.pone.0180143	http://dx.doi.org/10.1371/journal.pone.0180143			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686604	Green Published, Green Submitted, gold			2022-12-26	WOS:000405464100038
J	Ran, G; Ying, L; Li, L; Yan, QQ; Yi, WJ; Ying, CJ; Wu, HM; Ye, XL				Ran, Gai; Ying, Li; Li, Lin; Yan, Qiaoqiao; Yi, Weijie; Ying, Chenjiang; Wu, Hongmei; Ye, Xiaolei			Resveratrol ameliorates diet-induced dysregulation of lipid metabolism in zebrafish (Danio rerio)	PLOS ONE			English	Article							INDUCED OBESITY; CALORIE RESTRICTION; HEPATIC STEATOSIS; PPAR-GAMMA; AUTOPHAGY; EXPRESSION; MICE; CAVEOLIN-1; ADIPOCYTES; CELLS	Defective lipid metabolism is associated with increased risk of various chronic diseases, such as obesity, cardiovascular diseases, and diabetes. Resveratrol (RSV), a natural polyphenol, has been shown the potential of ameliorating disregulations of lipid metabolism. The objective of this study was to investigate the effects of feed intake and RSV on lipid metabolism in zebrafish (Danio rerio). The adult males were randomly allocated to 6 groups: control (Con, 8 mg cysts/fish/day), control with 20 ae mol/L RSV (Con+ RSV), calorie restriction (CR, 5 mg cysts/fish/day), calorie restriction with RSV (CR+ RSV), overfeed (OF, 60 mg cysts/fish/day), and overfeed with RSV (OF+ RSV) groups. The treatment period was 8 weeks. Results showed that CR reduced body length, body weight, and condition factor of zebrafish. CR reduced levels of plasma triglyceride (TG) and induced protein expression of phosphorylated AMP-activated protein kinase-a (pAMPK alpha), silent information regulator 2 homolog 1 (Sirt1), and peroxisome proliferator activated receptor gamma coactivator-1a (PGC1 alpha). RSV attenuated CR-induced pAMPKa/AMPKaincreases. RSV increased levels of Sirt1 protein in the OF zebrafish, and decreased OF-induced increase in peroxisome proliferator-activated receptor-gamma (PPAR gamma) protein level. Additionally, RSV down-regulated caveolin-1 and up-regulated microtubule-associated protein 1 light chain 3 -II (LC3-II) protein levels in OF zebrafish. In conclusion, these results suggest that 1) CR reduces plasma TG level through activation of the AMPK alpha-Sirt1-PGC1 alpha pathway; 2) under different dietary stress conditions RSV might regulate AMPK phosphorylation bi-directionally; 3) RSV might regulate lipid metabolism through the AMPK alpha-Sirt1-PPAR. pathway in OF zebrafish.	[Ran, Gai; Li, Lin; Yan, Qiaoqiao; Wu, Hongmei; Ye, Xiaolei] Wenzhou Med Univ, Sch Publ Hlth & Management, Dept Prevent Med, Wenzhou, Peoples R China; [Ying, Li] Wenzhou Med Univ, Sch Stomatol, Wenzhou, Peoples R China; [Yi, Weijie; Ying, Chenjiang] Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Nutr & Food Hyg, Tongji Med Coll, Wuhan, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Huazhong University of Science & Technology	Wu, HM; Ye, XL (corresponding author), Wenzhou Med Univ, Sch Publ Hlth & Management, Dept Prevent Med, Wenzhou, Peoples R China.	hongmeiwwu@hotmail.com; yexiaolei302@163.com	Ying, Chen/GRX-5695-2022; Ying, Chen Jiang/H-7708-2019	Ying, Chen Jiang/0000-0003-4813-5951	National Natural Science Foundation of China [81273060, 81373007, 81302423]; National Training Programs of Innovation and Entrepreneurship for Undergraduates [201310343013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Training Programs of Innovation and Entrepreneurship for Undergraduates	This work was supported by National Natural Science Foundation of China: Grant No. 81273060; No. 81373007; No. 81302423, https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list; National Training Programs of Innovation and Entrepreneurship for Undergraduates: Grant No. 201310343013.	Ahn J, 2008, J HEPATOL, V49, P1019, DOI 10.1016/j.jhep.2008.08.012; Anderson RM, 2009, TOXICOL PATHOL, V37, P47, DOI 10.1177/0192623308329476; Birse RT, 2010, CELL METAB, V12, P533, DOI 10.1016/j.cmet.2010.09.014; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Casper RC, 2008, PSYCHOPHARMACOLOGY, V199, P313, DOI 10.1007/s00213-008-1102-2; Chen SF, 2011, CAN J PHYSIOL PHARM, V89, P793, DOI 10.1139/Y11-077; Chen ZH, 2014, AM J PHYSIOL-LUNG C, V306, pL1016, DOI 10.1152/ajplung.00268.2013; Choi MS, 2013, EXP DERMATOL, V22, P491, DOI 10.1111/exd.12175; Cohen AW, 2004, DIABETES, V53, P1261, DOI 10.2337/diabetes.53.5.1261; Cottart CH, 2014, MOL NUTR FOOD RES, V58, P7, DOI 10.1002/mnfr.201200589; Dolinsky VW, 2011, BBA-MOL BASIS DIS, V1812, P1477, DOI 10.1016/j.bbadis.2011.06.010; Earle K.E., 1994, J NUTR, V124, p2616S, DOI [10.1093/jn/, DOI 10.1093/JN]; Echarri A, 2015, J CELL SCI, V128, P2747, DOI 10.1242/jcs.153940; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Gomez-Zorita S, 2012, BRIT J NUTR, V107, P202, DOI 10.1017/S0007114511002753; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hasumura T, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-73; Holtta-Vuori M, 2010, BIOCHEM J, V429, P235, DOI 10.1042/BJ20100293; Huang R, 2015, MOL CELL, V57, P456, DOI 10.1016/j.molcel.2014.12.013; Joseph AM, 2013, EXP GERONTOL, V48, P858, DOI 10.1016/j.exger.2013.05.061; Kim S, 2011, BIOCHEM PHARMACOL, V81, P1343, DOI 10.1016/j.bcp.2011.03.012; Kitada M, 2013, BBA-GEN SUBJECTS, V1830, P4820, DOI 10.1016/j.bbagen.2013.06.014; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; la Fleur SE, 2011, INT J OBESITY, V35, P595, DOI 10.1038/ijo.2010.164; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Le Lay S, 2010, AUTOPHAGY, V6, P754, DOI 10.4161/auto.6.6.12574; Morais S, 2007, PHYSIOL GENOMICS, V28, P239, DOI 10.1152/physiolgenomics.00136.2006; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Oka Takehiko, 2010, BMC Physiol, V10, P21, DOI 10.1186/1472-6793-10-21; Andrade JMO, 2014, NUTRITION, V30, P915, DOI 10.1016/j.nut.2013.11.016; Peng XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113716; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Qin L, 2014, ACTA PHARMACOL SIN, V35, P1129, DOI 10.1038/aps.2014.10; Rivera L, 2009, BIOCHEM PHARMACOL, V77, P1053, DOI 10.1016/j.bcp.2008.11.027; Schirmer H, 2012, MOL BIOL REP, V39, P3281, DOI 10.1007/s11033-011-1096-4; Singh R., 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/282041; Szkudelski T, 2011, ANN NY ACAD SCI, V1215, P34, DOI 10.1111/j.1749-6632.2010.05844.x; Tainaka T, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-88; Walczak R, 2002, J LIPID RES, V43, P177; Wang BS, 2014, J CHEM-NY, V2014, DOI 10.1155/2014/693573; Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001; Wang SB, 2015, EXPERT REV ENDOCRINO, V10, P561, DOI 10.1586/17446651.2015.1096771; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Wu YY, 2011, CELL PHYSIOL BIOCHEM, V27, P539, DOI 10.1159/000329955; Zhang Y, 2015, MOL NUTR FOOD RES, V59, P1443, DOI 10.1002/mnfr.201500016	45	34	35	7	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180865	10.1371/journal.pone.0180865	http://dx.doi.org/10.1371/journal.pone.0180865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686680	Green Submitted, Green Published, gold			2022-12-26	WOS:000405464100117
J	Kim, Y; Seok, JM; Park, J; Kim, KH; Min, JH; Cho, JW; Park, S; Kim, HJ; Kim, BJ; Youn, J				Kim, Younsoo; Seok, Jin Myoung; Park, Jongkyu; Kim, Kun-Hyun; Min, Ju-Hong; Cho, Jin Whan; Park, Suyeon; Kim, Hyun-jin; Kim, Byoung Joon; Youn, Jinyoung			The composite autonomic symptom scale 31 is a useful screening tool for patients with Parkinsonism	PLOS ONE			English	Article							MULTIPLE SYSTEM ATROPHY; DISEASE; DIFFERENTIATION; QUANTIFICATION; DYSFUNCTION; DIAGNOSIS	Differentiation of multiple system atrophy with predominant parkinsonism (MSA-P) and Parkinson's disease (PD) is important, but an effective tool for differentiation has not been identified. We investigated the efficacy of the composite autonomic symptom scale 31 (COMPASS 31) questionnaire as a tool for evaluating autonomic function in parkinsonism patients. In this study, we enrolled drug-naive patients with MSA-P and PD, and administered the COMPASS-31 and an objective autonomic dysfunction test (AFT). Demographic and clinical data, including parkinsonism and autonomic dysfunction, were compared between the two groups. Additionally, we determined the optimal COMPASS 31 cut-off score to differentiate MSA-P from PD for use as a screening tool. In this study, 27 MSA-P patients and 41 PD patients were recruited. The total COMPASS 31 score was well correlated with the objective AFT results. When we compared the COMPASS 31 score between the two groups, MSA-P patients showed higher total scores and sub-scores in the orthostatic intolerance, gastrointestinal, and bladder domains compared with PD patients. Similarly, MSA-P patients had more abnormalities in expiration to inspiration ratio, Valsalva ratio and pressure recovery time than PD patients in objective AFT. With 13.25 as the cut-off score for diagnosis of MSA-P, the total COMPASS-31 score demonstrated high sensitivity (92.6%) and moderate specificity (51.2%) with an area under the curve of 0.765. Based on our results, the COMPASS 31 is an effective tool for evaluation of autonomic function in patients with parkinsonism. The COMPASS-31 could be used as a sensitive and convenient screening tool, especially for the differentiation between MSA-P and PD.	[Kim, Younsoo] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Dept Neurol, Chang Won, South Korea; [Seok, Jin Myoung] Soonchunhyang Univ, Cheonan Hosp, Coll Med, Dept Neurol, Cheonan, South Korea; [Park, Jongkyu] Soonchunhyang Univ, Dept Neurol, Gumi, South Korea; [Kim, Kun-Hyun; Min, Ju-Hong; Cho, Jin Whan; Kim, Hyun-jin; Kim, Byoung Joon; Youn, Jinyoung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Kim, Kun-Hyun; Min, Ju-Hong; Cho, Jin Whan; Kim, Byoung Joon; Youn, Jinyoung] Samsung Med Ctr, Neurosci Ctr, Seoul, South Korea; [Park, Suyeon] Soonchunhyang Univ, Seoul Hosp, Coll Med, Dept Biostat, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Soonchunhyang University; Soonchunhyang University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Soonchunhyang University	Kim, BJ; Youn, J (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea.; Kim, BJ; Youn, J (corresponding author), Samsung Med Ctr, Neurosci Ctr, Seoul, South Korea.	bjkim@skku.edu; genian@skku.edu	Youn, Jinyoung/ABD-4588-2020	Seok, Jin Myoung/0000-0002-1484-2968				Baschieri F, 2015, PARKINSONISM RELAT D, V21, P477, DOI 10.1016/j.parkreldis.2015.02.011; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Chung EJ, 2009, MOVEMENT DISORD, V24, P1650, DOI 10.1002/mds.22649; Cortez MM, 2015, MULT SCLER RELAT DIS, V4, P258, DOI 10.1016/j.msard.2015.03.007; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Hoehn MM, 1967, NEUROLOGY, P50; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Kang JH, 2016, ANN REHABIL MED-ARM, V40, P301, DOI 10.5535/arm.2016.40.2.301; Kim JS, 2016, J MOV DISORD, V9, P97, DOI 10.14802/jmd.16001; Kimpinski K, 2012, J NEUROL SCI, V317, P92, DOI 10.1016/j.jns.2012.02.023; Lipp A, 2009, ARCH NEUROL-CHICAGO, V66, P742, DOI 10.1001/archneurol.2009.71; LOW PA, 1993, MAYO CLIN PROC, V68, P748, DOI 10.1016/S0025-6196(12)60631-4; Novak P, 2011, JOVE-J VIS EXP, DOI 10.3791/2502; Reimann M, 2010, J NEURAL TRANSM, V117, P69, DOI 10.1007/s00702-009-0313-y; Riley DE, 2003, J NEUROL NEUROSUR PS, V74, P56, DOI 10.1136/jnnp.74.1.56; Sletten DM, 2012, MAYO CLIN PROC, V87, P1196, DOI 10.1016/j.mayocp.2012.10.013; Treister R, 2015, EUR J NEUROL, V22, P1124, DOI 10.1111/ene.12717; Vogel ER, 2005, NEUROLOGY, V65, P1533, DOI 10.1212/01.wnl.0000184504.13173.ef; YOKOTA T, 1991, BRAIN, V114, P1381, DOI 10.1093/brain/114.3.1381	19	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180744	10.1371/journal.pone.0180744	http://dx.doi.org/10.1371/journal.pone.0180744			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683089	Green Published, gold, Green Submitted			2022-12-26	WOS:000405335200064
J	Nieves-Moreno, M; Martinez-de-la-Casa, JM; Cifuentes-Canorea, P; Sastre-Ibanez, M; Santos-Bueso, E; Saenz-Frances, F; Morales-Fernandez, L; Garcia-Feijoo, J				Nieves-Moreno, Maria; Martinez-de-la-Casa, Jose M.; Cifuentes-Canorea, Pilar; Sastre-Ibanez, Marina; Santos-Bueso, Enrique; Saenz-Frances, Federico; Morales-Fernandez, Laura; Garcia-Feijoo, Julian			Normative database for separate inner retinal layers thickness using spectral domain optical coherence tomography in Caucasian population	PLOS ONE			English	Article							NERVE-FIBER LAYER; EARLY GLAUCOMA; EYES; ABILITY; OCT	Purpose Develop the first normative database of the thickness of every inner retinal layer in the macular area in a healthy, Caucasian population between 18 to 87 years old, using Spectralis Optical Coherence Tomography (OCT). Methods On this transversal, observational study, 300 patients between 18 to 87 years old and without an ophthalmological condition were recruited. Macular OCT scans were performed on all patients (Spectralis OCT, Heidelberg Engineering). An axial length measurement, and keratometry were performed using an optical biometer. The volume and thickness of the different macular sectors of the inner retinal layers (retinal nerve fiber layer (RNFL), ganglion cells layer (CGL) and inner plexiform layer (IPL)) were analyzed with the Spectralis OCT segmentation software. An eye was randomly selected for each patient. Results 297 patients (179 females and 118 males) were included in the study. The mean age was 56.07 years (range: 40.50-72). The multivariate analysis showed a positive correlation between the RNFL thickness and the axial length (p < 0.001). The mean central retinal thickness was 278.2 mu m (range: 266-291), the mean central RNFL thickness was 12.61 mu m (range: 11-14), the mean central CGL thickness was 17.63 mu m (range: 14-21) and the mean central IPL thickness was 22.02 mu m (range: 20-25). The multivariate analysis showed a negative correlation between age and CGL thickness and inner IPL thickness (p< 0.001). Conclusion This study provides a normative database of the volume of each of the inner retinal layers on a Caucasian population.	[Martinez-de-la-Casa, Jose M.] Hosp Clin San Carlos, Serv Oftalmol, Madrid, Spain; Univ Complutense Madrid, Fac Med, Dept Oftalmol, Madrid, Spain; Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid, Spain	Hospital Clinico San Carlos; Complutense University of Madrid; Hospital Clinico San Carlos	Martinez-de-la-Casa, JM (corresponding author), Hosp Clin San Carlos, Serv Oftalmol, Madrid, Spain.	martinezcasa@ya.com	Ibáñez, Marina Sastre-/R-1346-2019; GARCIA FEIJOO, JULIAN/G-9762-2017; Saenz-Frances, Federico/A-3350-2012; Santos-Bueso, Enrique/G-9870-2017	GARCIA FEIJOO, JULIAN/0000-0002-7772-5718; Sastre Ibanez, Marina/0000-0003-0640-894X; Martinez-de-la-Casa, Jose Maria/0000-0001-9441-0542; Saenz-Frances, Federico/0000-0002-3196-1491; Nieves-Moreno, Maria/0000-0001-6972-0880; Santos-Bueso, Enrique/0000-0002-0097-1726				Akashi A, 2015, INVEST OPHTH VIS SCI, V56, P6573, DOI 10.1167/iovs.15-17635; Appukuttan B, 2014, INDIAN J OPHTHALMOL, V62, P316, DOI 10.4103/0301-4738.116466; Balendra SI, 2015, EYE, V29, P1260, DOI 10.1038/eye.2015.154; Cavallotti CAP., 2008, AGE RELATED CHANGES, DOI 10.1007/978-1-59745-507-7; Chan A, 2006, ARCH OPHTHALMOL-CHIC, V124, P193, DOI 10.1001/archopht.124.2.193; Chauhan DS, 1999, INVEST OPHTH VIS SCI, V40, P2332; Ctori I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129005; Demirkaya N, 2013, INVEST OPHTH VIS SCI, V54, P4934, DOI 10.1167/iovs.13-11913; Grover S, 2009, AM J OPHTHALMOL, V148, P266, DOI 10.1016/j.ajo.2009.03.006; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; Kanai Kaname, 2002, Nippon Ganka Gakkai Zasshi, V106, P162; Kelty PJ, 2008, INVEST OPHTH VIS SCI, V49, P2668, DOI 10.1167/iovs.07-1000; Knighton RW, 2012, INVEST OPHTH VIS SCI, V53, P3653, DOI 10.1167/iovs.12-9719; Leung CKS, 2008, INVEST OPHTH VIS SCI, V49, P4893, DOI 10.1167/iovs.07-1326; Manassakorn A, 2008, JPN J OPHTHALMOL, V52, P450, DOI 10.1007/s10384-008-0538-6; Massin P, 2002, EUR J OPHTHALMOL, V12, P102, DOI 10.1177/112067210201200205; Mwanza JC, 2014, OPHTHALMOLOGY, V121, P849, DOI 10.1016/j.ophtha.2013.10.044; Mwanza JC, 2012, OPHTHALMOLOGY, V119, P1151, DOI 10.1016/j.ophtha.2011.12.014; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; Realini T, 2014, J GLAUCOMA; Shin HY, 2014, OPHTHALMOLOGY, V121, P93, DOI 10.1016/j.ophtha.2013.06.041; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; Vajzovic L, 2012, AM J OPHTHALMOL, V154, P779, DOI 10.1016/j.ajo.2012.05.004	23	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180450	10.1371/journal.pone.0180450	http://dx.doi.org/10.1371/journal.pone.0180450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678834	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000405272200064
J	Tao, S; Way, SF; Garland, J; Chrispin, J; Ciuffo, LA; Balouch, MA; Nazarian, S; Spragg, DD; Marine, JE; Berger, RD; Calkins, H; Ashikaga, H				Tao, Susumu; Way, Samuel F.; Garland, Joshua; Chrispin, Jonathan; Ciuffo, Luisa A.; Balouch, Muhammad A.; Nazarian, Saman; Spragg, David D.; Marine, Joseph E.; Berger, Ronald D.; Calkins, Hugh; Ashikaga, Hiroshi			Ablation as targeted perturbation to rewire communication network of persistent atrial fibrillation	PLOS ONE			English	Article							SMALL-WORLD NETWORKS; CATHETER ABLATION; FOCAL IMPULSE; BRAIN ACTIVITY; ASSOCIATION; HEART; SYNCHRONIZATION; ENHANCEMENT; MECHANISMS; RESONANCE	Persistent atrial fibrillation (AF) can be viewed as disintegrated patterns of information transmission by action potential across the communication network consisting of nodes linked by functional connectivity. To test the hypothesis that ablation of persistent AF is associated with improvement in both local and global connectivity within the communication networks, we analyzed multi-electrode basket catheter electrograms of 22 consecutive patients (63.5 +/- 9.7 years, 78% male) during persistent AF before and after the focal impulse and rotor modulation-guided ablation. Eight patients (36%) developed recurrence within 6 months after ablation. We defined communication networks of AF by nodes (cardiac tissue adjacent to each electrode) and edges (mutual information between pairs of nodes). To evaluate patient-specific parameters of communication, thresholds of mutual information were applied to preserve 10% to 30% of the strongest edges. There was no significant difference in network parameters between both atria at baseline. Ablation effectively rewired the communication network of persistent AF to improve the overall connectivity. In addition, successful ablation improved local connectivity by increasing the average clustering coefficient, and also improved global connectivity by decreasing the characteristic path length. As a result, successful ablation improved the efficiency and robustness of the communication network by increasing the small-world index. These changes were not observed in patients with AF recurrence. Furthermore, a significant increase in the small-world index after ablation was associated with synchronization of the rhythm by acute AF termination. In conclusion, successful ablation rewires communication networks during persistent AF, making it more robust, efficient, and easier to synchronize. Quantitative analysis of communication networks provides not only a mechanistic insight that AF may be sustained by spatially localized sources and global connectivity, but also patient-specific metrics that could serve as a valid endpoint for therapeutic interventions.	[Tao, Susumu; Chrispin, Jonathan; Ciuffo, Luisa A.; Balouch, Muhammad A.; Spragg, David D.; Marine, Joseph E.; Berger, Ronald D.; Calkins, Hugh; Ashikaga, Hiroshi] Johns Hopkins Univ, Sch Med, Cardiac Arrhythmia Serv, Baltimore, MD 21218 USA; [Way, Samuel F.] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Garland, Joshua] Santa Fe Inst, Santa Fe, NM 87501 USA; [Nazarian, Saman] Univ Penn, Perelman Sch Med, Sect Cardiac Electrophysiol, Philadelphia, PA 19104 USA; [Berger, Ronald D.; Ashikaga, Hiroshi] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA	Johns Hopkins University; University of Colorado System; University of Colorado Boulder; The Santa Fe Institute; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University	Ashikaga, H (corresponding author), Johns Hopkins Univ, Sch Med, Cardiac Arrhythmia Serv, Baltimore, MD 21218 USA.; Ashikaga, H (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	hashika1@jhmi.edu	Nazarian, Saman/ABC-8000-2020	Nazarian, Saman/0000-0002-8369-0259; Ashikaga, Hiroshi/0000-0003-3689-6892	W. W. Smith Charitable Trust; Johns Hopkins University Institute of Clinical and Translational Research; Edward St. John Foundation for AF Research; Roz and Marvin H Weiner and Family Foundation; Dr. Francis P. Chiaramonte Foundation; Marilyn and Christian Poindexter Arrhythmia Research Fund; Norbert and Louise Grunwald Cardiac Arrhythmia Research Fund	W. W. Smith Charitable Trust; Johns Hopkins University Institute of Clinical and Translational Research; Edward St. John Foundation for AF Research; Roz and Marvin H Weiner and Family Foundation; Dr. Francis P. Chiaramonte Foundation; Marilyn and Christian Poindexter Arrhythmia Research Fund; Norbert and Louise Grunwald Cardiac Arrhythmia Research Fund	This work was supported by grants from the W. W. Smith Charitable Trust (to Ashikaga), the Johns Hopkins University Institute of Clinical and Translational Research (to Ashikaga), the Edward St. John Foundation for AF Research (to Calkins), The Roz and Marvin H Weiner and Family Foundation (to Calkins), The Dr. Francis P. Chiaramonte Foundation (to Calkins), The Marilyn and Christian Poindexter Arrhythmia Research Fund (to Calkins), and The Norbert and Louise Grunwald Cardiac Arrhythmia Research Fund (to Calkins).	Allessie MA, 2010, CIRC-ARRHYTHMIA ELEC, V3, P606, DOI 10.1161/CIRCEP.109.910125; Alonso S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166972; Alonso S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.158101; Ashikaga H, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1201; Barahona M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.054101; Benharash P, 2015, CIRC-ARRHYTHMIA ELEC, V8, P554, DOI 10.1161/CIRCEP.115.002721; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Chen J, 2008, EUROPACE, V10, P263, DOI 10.1093/europace/eun029; Chrispin J, 2016, HEART RHYTHM, V13, P654, DOI 10.1016/j.hrthm.2015.11.011; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; Damiano RJ, 2011, J THORAC CARDIOV SUR, V141, P113, DOI 10.1016/j.jtcvs.2010.08.067; ERDOS P, 1960, B INT STATIST INST, V38, P343; Fassini G, 2005, J CARDIOVASC ELECTR, V16, P1150, DOI 10.1111/j.1540-8167.2005.50192.x; Fenton F, 1998, CHAOS, V8, P20, DOI 10.1063/1.166311; Ganesan AN, 2013, CIRC-ARRHYTHMIA ELEC, V6, P48, DOI 10.1161/CIRCEP.112.976654; Garrey WE, 1914, AM J PHYSIOL, V33, P397, DOI 10.1152/ajplegacy.1914.33.3.397; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Iwasaki YK, 2011, CIRCULATION, V124, P2264, DOI 10.1161/CIRCULATIONAHA.111.019893; Jais P, 2004, CIRCULATION, V110, P2996, DOI 10.1161/01.CIR.0000146917.75041.58; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Kitajo K, 2007, EPL-EUROPHYS LETT, V80, DOI 10.1209/0295-5075/80/40009; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Leong-Sit P, 2013, J CARDIOVASC ELECTR, V24, P617, DOI 10.1111/jce.12088; Lever NA, 2007, EUROPACE, V9, P1054, DOI 10.1093/europace/eum194; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lizier JT, 2014, FRONT ROBOT AI, DOI 10.3389/frobt.2014.00011; Marrouche NF, 2014, JAMA-J AM MED ASSOC, V311, P498, DOI 10.1001/jama.2014.3; Masuda N, 2004, BIOL CYBERN, V90, P302, DOI 10.1007/s00422-004-0471-9; McWilliam J A, 1887, J Physiol, V8, P296; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Mori T, 2002, INT J BIFURCAT CHAOS, V12, P2631, DOI 10.1142/S0218127402006151; Narayan SM, 2012, J AM COLL CARDIOL, V60, P628, DOI 10.1016/j.jacc.2012.05.022; Narayan SM, 2012, J CARDIOVASC ELECTR, V23, P447, DOI 10.1111/j.1540-8167.2012.02332.x; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Netoff TI, 2004, J NEUROSCI, V24, P8075, DOI 10.1523/JNEUROSCI.1509-04.2004; Nishikawa T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.014101; Panfilov AV, 2006, HEART RHYTHM, V3, P862, DOI 10.1016/j.hrthm.2005.12.022; Patel MS, 2017, CIRCULATION, V135; Roxin A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198101; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2009, HUM BRAIN MAPP, V30, P403, DOI 10.1002/hbm.20517; Sahadevan J, 2004, CIRCULATION, V110, P3293, DOI 10.1161/01.CIR.0000147781.02738.13; Sanders P, 2007, EUR HEART J, V28, P1862, DOI 10.1093/eurheartj/ehl548; Scherr D, 2015, CIRC-ARRHYTHMIA ELEC, V8, P18, DOI 10.1161/CIRCEP.114.001943; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Skanes AC, 1998, CIRCULATION, V98, P1236, DOI 10.1161/01.CIR.98.12.1236; Sporns O., 2010, NETWORKS BRAIN; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tass PA, 2003, BIOL CYBERN, V89, P81, DOI [10.1007/s00422-003-0425-7, 10.1007/S00422-003-0425-7]; Vaquero M, 2008, HEART RHYTHM, V5, P872, DOI 10.1016/j.hrthm.2008.02.034; Verma A, 2015, NEW ENGL J MED, V372, P1812, DOI 10.1056/NEJMoa1408288; Vigmond E, 2016, HEART RHYTHM, V13, P1536, DOI 10.1016/j.hrthm.2016.03.019; Ward LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014371; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029; Yu QB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025423; Zahid S, 2016, HEART RHYTHM, V13, P1687, DOI 10.1016/j.hrthm.2016.04.009; Zhou Y, 2007, SCHIZOPHR RES, V97, P194, DOI 10.1016/j.schres.2007.05.029	65	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179459	10.1371/journal.pone.0179459	http://dx.doi.org/10.1371/journal.pone.0179459			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678805	Green Published, Green Submitted, gold			2022-12-26	WOS:000405272200016
J	Palma, RE; Gutierrez-Tapia, P; Gonzalez, JF; Boric-Bargetto, D; Torres-Perez, F				Eduardo Palma, R.; Gutierrez-Tapia, Pablo; Gonzalez, Juan F.; Boric-Bargetto, Dusan; Torres-Perez, Fernando			Mountaintops phylogeography: A case study using small mammals from the Andes and the coast of central Chile	PLOS ONE			English	Article							LAST GLACIAL MAXIMUM; SPECIES DISTRIBUTIONS; QUATERNARY GLACIATIONS; STATISTICAL-MODEL; LAKE DISTRICT; ISLA GRANDE; CLIMATE; RODENTIA; EVOLUTION; SEQUENCE	We evaluated if two sigmodontine rodent taxa (Abrothrix olivacea and Phyllotis darwini) from the Andes and Coastal mountaintops of central Chile, experienced distributional shifts due to altitudinal movements of habitat and climate change during and after the Last Glacial Maximum (LGM). We tested the hypothesis that during LGM populations of both species experienced altitudinal shifts from the Andes to the lowlands and the coastal Cordillera, and then range retractions during interglacial towards higher elevations in the Andes. These distributional shifts may have left remnants populations on the mountaintops. We evaluated the occurrence of intraspecific lineages for each species, to construct distribution models at LGM and at present, as extreme climatic conditions for each lineage. Differences in distribution between extreme climatic conditions were interpreted as post-glacial distributional shifts. Abrothrix olivacea displayed a lineage with shared sequences between both mountain systems, whereas a second lineage was restricted to the Andes. A similar scenario of panmictic unit in the past was recovered for A. olivacea in the Andes, along with an additional unit that included localities from the rest of its distribution. For P. darwini, both lineages recovered were distributed in coastal and Andean mountain ranges at present as well, and structuring analyses for this species recovered coastal and Andean localities as panmictic units in the past. Niche modeling depicted differential postglacial expansions in the recovered lineages. Results suggest that historical events such as LGM triggered the descending of populations to Andean refuge areas (one of the A. olivacea's lineages), to the lowlands, and to the coastal Cordillera. Backward movements of populations after glacial retreats may have left isolates on mountaintops of the coastal Cordillera, suggesting that current species distribution would be the outcome of climate change and habitat reconfiguration after LGM.	[Eduardo Palma, R.; Gonzalez, Juan F.] Pontificia Univ Catolica Chile, Dept Ecol, Santiago, Chile; [Gutierrez-Tapia, Pablo] Univ Santiago Chile, Lab Ecol & Biodiversidad, Fac Quim & Biol, Santiago, Chile; [Boric-Bargetto, Dusan; Torres-Perez, Fernando] Pontificia Univ Catolica Valparaiso, Inst Biol, Valparaiso, Chile	Pontificia Universidad Catolica de Chile; Universidad de Santiago de Chile; Pontificia Universidad Catolica de Valparaiso	Palma, RE (corresponding author), Pontificia Univ Catolica Chile, Dept Ecol, Santiago, Chile.	epalma@bio.puc.cl	Palma, Eduardo/N-1416-2014; Torres-Perez, Fernando/B-5002-2008	Torres-Perez, Fernando/0000-0001-8655-7288; Boric-Bargetto, Dusan/0000-0002-4568-8828	Fondo Nacional de Cienciay Tecnologo Aa (FONDECYT, Chile) [1100558, 1040929]; Grant USA [1555]	Fondo Nacional de Cienciay Tecnologo Aa (FONDECYT, Chile); Grant USA	This work was supported by Grants 1100558 and 1040929 from Fondo Nacional de Cienciay Tecnologo Aa (FONDECYT, Chile) funded to REP and FTP, respectively, url: http://www.conicyt.cl/fondecyt/; Grant USA 1555. The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allnutt TR, 1999, MOL ECOL, V8, P975, DOI 10.1046/j.1365-294x.1999.00650.x; [Anonymous], CONVERGENCE MEDITERR; Bacigalupe LD, 2004, PHYSIOL BIOCHEM ZOOL, V77, P805, DOI 10.1086/422229; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; Brown J. H., 1998, BIOGEOGRAPHY; BROWN JH, 1971, AM NAT, V105, P467, DOI 10.1086/282738; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Bull-Herenu K, 2005, J BIOGEOGR, V32, P1129, DOI 10.1111/j.1365-2699.2004.01209.x; Cianferoni F, 2013, ZOOTAXA, V3619, P59, DOI 10.11646/zootaxa.3619.1.3; CLAPPERTON CM, 1990, QUATERNARY SCI REV, V9, P299, DOI 10.1016/0277-3791(90)90024-5; CLAPPERTON CM, 1993, PALAEOGEOGR PALAEOCL, V101, P189, DOI 10.1016/0031-0182(93)90012-8; CLAPPERTON CM, 1994, REV CHIL HIST NAT, V67, P369; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darwin C, 1859, ORIGIN SPECIES MEANS; Denton GH, 1999, GEOGR ANN A, V81A, P167, DOI 10.1111/1468-0459.00057; Dress AWM, 2004, IEEE ACM T COMPUT BI, V1, P109, DOI 10.1109/TCBB.2004.27; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; FUENTES ER, 1979, ARCH BIOL MED EXP, V12, P179; Garcia Berguecio N, 2006, ANALISIS FLORISTICO; GRAF K, 1994, REV CHIL HIST NAT, V67, P405; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guralnick R, 2007, GLOBAL ECOL BIOGEOGR, V16, P14, DOI [10.1111/j.1466-822X.2006.00260.x, 10.1111/j.1466-8238.2006.00260.x]; Gutierrez-Tapia P, 2016, DIVERS DISTRIB, V22, P638, DOI 10.1111/ddi.12433; HARRISON SP, 2000, PALEOCLIMATE MODELLI, P25; Hasumi H, 2004, 1 K 1; HEUSSER CJ, 1983, SCIENCE, V219, P1429, DOI 10.1126/science.219.4591.1429; HEUSSER CJ, 1990, PALAEOGEOGR PALAEOCL, V80, P107, DOI 10.1016/0031-0182(90)90124-P; Heusser CJ, 1999, GEOGR ANN A, V81A, P231, DOI 10.1111/1468-0459.00058; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holling J.T., 1981, LAST GREAT ICE SHEET, P179; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jezkova T, 2009, J MAMMAL, V90, P306, DOI 10.1644/08-MAMM-A-243.1; Kelt DA, 2010, J MAMMAL, V91, P1524, DOI 10.1644/10-MAMM-A-306.1; Knowles LL, 2000, EVOLUTION, V54, P1337, DOI 10.1111/j.0014-3820.2000.tb00566.x; Lamy F, 1999, QUATERNARY RES, V51, P83, DOI 10.1006/qres.1998.2010; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; Matocq MD, 2007, MOL PHYLOGENET EVOL, V42, P637, DOI 10.1016/j.ympev.2006.08.011; MERCER JH, 1983, ANNU REV EARTH PL SC, V11, P99, DOI 10.1146/annurev.ea.11.050183.000531; MESERVE P L, 1987, Fieldiana Zoology, P413; MESERVE PL, 1981, J ANIM ECOL, V50, P745, DOI 10.2307/4134; MESERVE PL, 1978, J BIOGEOGR, V5, P135, DOI 10.2307/3038168; Mills JN, 1995, J MAMMAL, V76; MURRAY V, 1989, NUCLEIC ACIDS RES, V17, P8889, DOI 10.1093/nar/17.21.8889; Otto-Bliesner BL, 2006, J CLIMATE, V19, P2526, DOI 10.1175/JCLI3748.1; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Pagel M, 2005, MATHEMATICS OF EVOLUTION AND PHYLOGENY, P121; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; PATTON JL, 1992, EVOLUTION, V46, P174, DOI 10.1111/j.1558-5646.1992.tb01992.x; Paula M, 2006, CONSERV GENET, V7, P591, DOI 10.1007/s10592-005-9069-6; Pearson RG, 2002, ECOL MODEL, V154, P289, DOI 10.1016/S0304-3800(02)00056-X; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Premoli AC, 2000, J BIOGEOGR, V27, P251, DOI 10.1046/j.1365-2699.2000.00402.x; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; RABASSA J, 1990, QUATERNARY SCI REV, V9, P153, DOI 10.1016/0277-3791(90)90016-4; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rodriguez-Serrano E, 2006, J MAMMAL, V87, P971, DOI 10.1644/05-MAMM-A-393R2.1; Romero F, 2003, B SOC ARGENT BOT, V38, P237; Rowe KC, 2004, P NATL ACAD SCI USA, V101, P10355, DOI 10.1073/pnas.0401338101; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Simpson BB, 1983, REV CHIL HIST NAT, V56, P109; Spotorno AE, 2001, REV CHIL HIST NAT, V74, P151; Steppan SJ, 1998, J MAMMAL, V79, P573, DOI 10.2307/1382988; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; Villagran C, 2001, REV CHIL HIST NAT, V74, P793; Villagran C, 2005, FITOGEOGRAFIA HIST C, P99; Villagran C., 2004, HIST NATURAL PARQUE, P3; VUILLEUMIER SB, 1971, SCIENCE, V173, P771, DOI 10.1126/science.173.3999.771; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Walton A. I, 2008, MAMIFEROS CHILE	84	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180231	10.1371/journal.pone.0180231	http://dx.doi.org/10.1371/journal.pone.0180231			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672032	Green Submitted, Green Published, gold			2022-12-26	WOS:000405268500030
J	Ploug, T; Holm, S				Ploug, Thomas; Holm, Soren			Clinical genome sequencing and population preferences for information about 'incidental' findings D From medically actionable genes (MAGs) to patient actionable genes (PAGs)	PLOS ONE			English	Article							GENETICS PROFESSIONALS; CHAIR PERSPECTIVES; DISCLOSURE; RETURN; ATTITUDES; AUTONOMY; RESEARCHERS; SPECIALISTS; MEDICINE; ETHICS	Whole genome or exome sequencing is increasingly used in the clinical contexts, and ` incidental' findings are generated. There is need for an adequate policy for the reporting of these findings to individuals. Such a policy has been suggested by the American College of Medical Genetics and Genomics (ACMG). We argue that ACMG's policy is overly paternalistic, and that an adequate policy must take into account population preferences. We conducted a choice based conjoint survey of population preferences for reporting in a representative sample of the Danish population. In a 12 task survey respondents were asked about their preference for reporting in relation to three scenarios with seven different attributes. Of 1200 respondents 66.4% participated. We show that population preferences for reporting differs from ACMG's recommendations, and suggest a new policy based on both medically and patient actionable genes.	[Ploug, Thomas] Aalborg Univ, Ctr Appl Eth & Philosophy Sci, Dept Commun, Kbh Sv, Denmark; [Holm, Soren] Univ Manchester, Sch Law, Ctr Social Eth & Policy, Manchester, Lancs, England; [Holm, Soren] Univ Oslo, Ctr Med Eth, Fac Med, Oslo, Norway; [Holm, Soren] Aalborg Univ, Ctr Appl Eth, Aalborg, Denmark	Aalborg University; University of Manchester; University of Oslo; Aalborg University	Ploug, T (corresponding author), Aalborg Univ, Ctr Appl Eth & Philosophy Sci, Dept Commun, Kbh Sv, Denmark.	ploug@hum.aau.dk		Holm, Soren/0000-0002-7200-5607; Ploug, Thomas/0000-0002-3693-0547				American College of Medical Genetics and Genomics, 2013, GENET MED, V15; Bollinger JM, 2014, GENET MED, V16, P932, DOI 10.1038/gim.2014.50; Bollinger JM, 2013, GENET TEST MOL BIOMA, V17, P424, DOI 10.1089/gtmb.2012.0453; Brandt DS, 2013, J GENET COUNS, V22, P544, DOI 10.1007/s10897-013-9583-5; Cho MK, 2008, J LAW MED ETHICS, V36, P280, DOI 10.1111/j.1748-720X.2008.00270.x; Christenhusz GM, 2013, EUR J MED GENET, V56, P529, DOI 10.1016/j.ejmg.2013.08.006; Christenhusz GM, 2013, EUR J HUM GENET, V21, P248, DOI 10.1038/ejhg.2012.130; Chrzan K, 2000, RES PAPER SERIES OVE; Clift KE, 2015, APPL TRANSL GENOM, V4, P38, DOI 10.1016/j.atg.2015.02.005; Downing NR, 2013, PATIENT EDUC COUNS, V90, P133, DOI 10.1016/j.pec.2012.09.010; Driessnack M, 2013, J COMMUN GENET, V4, P435, DOI 10.1007/s12687-013-0145-1; Evans JP, 2013, GENET MED, V15, P852, DOI 10.1038/gim.2013.150; Green RC, 2013, JAMA-J AM MED ASSOC, V310, P365, DOI 10.1001/jama.2013.41703; Green RC, 2012, GENET MED, V14, P405, DOI 10.1038/gim.2012.21; Grove ME, 2014, J GENET COUNS, V23, P531, DOI 10.1007/s10897-013-9611-5; Haga SB, 2012, GENET TEST MOL BIOMA, V16, P193, DOI 10.1089/gtmb.2011.0118; Haga SB, 2012, GENET TEST MOL BIOMA, V16, P21, DOI 10.1089/gtmb.2011.0045; Haga SB, 2011, GENET MED, V13, P723, DOI 10.1097/GIM.0b013e31821afcc0; Hayeems RZ, 2011, EUR J HUM GENET, V19, P740, DOI 10.1038/ejhg.2011.34; Klitzman R, 2013, JAMA-J AM MED ASSOC, V310, P369, DOI 10.1001/jama.2013.41709; Kohane IS, 2006, JAMA-J AM MED ASSOC, V296, P212, DOI 10.1001/jama.296.2.212; Lazaro-Munoz G, 2015, AM J BIOETHICS, V15, P3, DOI 10.1080/15265161.2015.1039721; Lemke AA, 2013, CLIN GENET, V84, P230, DOI 10.1111/cge.12060; Lohn Z, 2013, AM J MED GENET A, V161A, P542, DOI 10.1002/ajmg.a.35794; Matsui K, 2008, J EPIDEMIOL, V18, P217, DOI 10.2188/jea.JE2007425; McGuire AL, 2013, SCIENCE, V340, P1047, DOI 10.1126/science.1240156; McGuire AL, 2013, JAMA-J AM MED ASSOC, V309, P1465, DOI 10.1001/jama.2013.1438; Meacham MC, 2010, J EMPIR RES HUM RES, V5, P31, DOI 10.1525/jer.2010.5.3.31; Middleton A, 2016, EUR J HUM GENET, V24, P21, DOI 10.1038/ejhg.2015.58; O'Daniel J, 2011, PUBLIC HEALTH GENOM, V14, P346, DOI 10.1159/000324933; Prucka SK, 2015, BIOETHICS, V29, P82, DOI 10.1111/bioe.12073; Regier DA, 2015, CAN MED ASSOC J, V187, pE190, DOI 10.1503/cmaj.140697; Ries NM, 2010, BMC MED ETHICS, V11, DOI 10.1186/1472-6939-11-4; Ross LF, 2013, JAMA-J AM MED ASSOC, V310, P367, DOI 10.1001/jama.2013.41700; Sawtooth Software, 2007, TECHN PAP SER CBC LA; Sawtooth Software, 2013, TECHN PAP SER CBC SY; Sawtooth Software, 2009, TECHN PAP SER CBC HB; Simon CM, 2011, J EMPIR RES HUM RES, V6, P53, DOI 10.1525/jer.2011.6.4.53; Strong KA, 2014, CLIN GENET, V86, P461, DOI 10.1111/cge.12390; Tabor HK, 2007, GENET MED, V9, P626, DOI 10.1097/GIM.0b013e3181485688; Townsend A, 2012, AM J MED GENET A, V158A, P2519, DOI 10.1002/ajmg.a.35554; Ubel PA, 2003, QUAL LIFE RES, V12, P599, DOI 10.1023/A:1025119931010; Van Ness B, 2008, J LAW MED ETHICS, V36, P292, DOI 10.1111/j.1748-720X.2008.00272.x; Wachbroit R, 1998, KENNEDY INST ETHIC J, V8, P131, DOI 10.1353/ken.1998.0013; Watson M, 2013, GENET MED, V15, P664, DOI 10.1038/gim.2013.82; Watson MS, 2015, GENET MED, V17, DOI [10.1038/gim.2015.94, 10.1038/gim.2014.151]; Williams JK, 2012, GENET TEST MOL BIOMA, V16, P508, DOI 10.1089/gtmb.2011.0248; Wolf SM, 2008, J LAW MED ETHICS, V36, P219, DOI 10.1111/j.1748-720X.2008.00266.x; Wolf SM, 2013, SCIENCE, V340, P1049, DOI 10.1126/science.1239119; Wolf SM, 2012, GENET MED, V14, P361, DOI 10.1038/gim.2012.23; Yu JH, 2014, AM J HUM GENET, V95, P77, DOI 10.1016/j.ajhg.2014.06.004	51	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0179935	10.1371/journal.pone.0179935	http://dx.doi.org/10.1371/journal.pone.0179935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671958	Green Published, Green Submitted, gold			2022-12-26	WOS:000405268500010
J	Smidak, R; Kofeler, HC; Hoeger, H; Lubec, G				Smidak, Roman; Kofeler, Harald C.; Hoeger, Harald; Lubec, Gert			Comprehensive identification of age-related lipidome changes in rat amygdala during normal aging	PLOS ONE			English	Article							FEAR-POTENTIATED STARTLE; ALZHEIMERS-DISEASE; PHOSPHATIDIC-ACID; HUMAN BRAIN; MOUSE; INCREASES; RECEPTOR; CERAMIDE; KINASE; PROTEINS	Brain lipids are integral components of brain structure and function. However, only recent advancements of chromatographic techniques together with mass spectrometry allow comprehensive identification of lipid species in complex brain tissue. Lipid composition varies between the individual areas and the majority of previous reports was focusing on individual lipids rather than a lipidome. Herein, a mass spectrometry-based approach was used to evaluate age-related changes in the lipidome of the rat amygdala obtained from young (3 months) and old (20 months) males of the Sprague-Dawley rat strain. A total number of 70 lipid species with significantly changed levels between the two animal groups were identified spanning four main lipid classes, i.e. glycerolipids, glycerophospholipids, sphingolipids and sterol lipids. These included phospholipids with pleiotropic brain function, such as derivatives of phosphatidylcholine, phosphatidylserine, and phosphatidylethanolamine. The analysis also revealed significant level changes of phosphatidic acid, diacylglycerol, sphingomyelin and ceramide that directly represent lipid signaling and affect amygdala neuronal activity. The amygdala is a crucial brain region for cognitive functions and former studies on rats and humans showed that this region changes its activity during normal aging. As the information on amygdala lipidome is very limited the results obtained in the present study represent a significant novelty and may contribute to further studies on the role of lipid molecules in ageassociated changes of amygdala function.	[Smidak, Roman; Lubec, Gert] Univ Vienna, Dept Pharmaceut Chem, Fac Life Sci, Vienna, Austria; [Kofeler, Harald C.] Med Univ Graz, Ctr Med Res ZMF, Graz, Austria; [Hoeger, Harald] Med Univ Vienna, Div Lab Anim Sci & Genet, Core Unit Biomed Res, Himberg, Austria; [Lubec, Gert] Neuroprote Lab, Sci Pk,Ilkovicova 8, Bratislava, Slovakia	University of Vienna; Medical University of Graz; Medical University of Vienna	Lubec, G (corresponding author), Univ Vienna, Dept Pharmaceut Chem, Fac Life Sci, Vienna, Austria.; Lubec, G (corresponding author), Neuroprote Lab, Sci Pk,Ilkovicova 8, Bratislava, Slovakia.	lubec@gmx.at		Kofeler, Harald/0000-0002-2725-9616				Almaguer W, 2002, NEUROBIOL AGING, V23, P319, DOI 10.1016/S0197-4580(01)00278-0; Barrier L, 2010, INT J ALZHEIMERS DIS, V2011; BAUDRY M, 1991, BEHAV NEURAL BIOL, V55, P137, DOI 10.1016/0163-1047(91)80134-Z; Bozek K, 2015, NEURON, V85, P695, DOI 10.1016/j.neuron.2015.01.003; Brugger B, 2014, ANNU REV BIOCHEM, V83, P79, DOI 10.1146/annurev-biochem-060713-035324; Calderini G, 1985, Prog Clin Biol Res, V192, P383; Chan RB, 2012, J BIOL CHEM, V287, P2678, DOI 10.1074/jbc.M111.274142; CHAVKO M, 1993, MOL CHEM NEUROPATHOL, V18, P123, DOI 10.1007/BF03160026; Cheng D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017299; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; Costantini Claudio, 2005, Alzheimers Dement, V1, P43, DOI 10.1016/j.jalz.2005.06.004; Dawson G, 2015, BBA-MOL CELL BIOL L, V1851, P1026, DOI 10.1016/j.bbalip.2015.02.007; Fauland A, 2011, J LIPID RES, V52, P2314, DOI 10.1194/jlr.D016550; Favreliere S, 2000, NEUROBIOL AGING, V21, P653, DOI 10.1016/S0197-4580(00)00170-6; Ghosh S, 2003, J BIOL CHEM, V278, P45690, DOI 10.1074/jbc.M302933200; Giusto NM, 2002, NEUROCHEM RES, V27, P1513, DOI 10.1023/A:1021604623208; Graber TE, 2013, LEARN MEMORY, V20, P518, DOI 10.1101/lm.027664.112; Han XL, 2002, J NEUROCHEM, V82, P809, DOI 10.1046/j.1471-4159.2002.00997.x; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Huang BX, 2011, J CELL BIOL, V192, P979, DOI 10.1083/jcb.201005100; Kim HY, 2014, PROG LIPID RES, V56, P1, DOI 10.1016/j.plipres.2014.06.002; Kim HY, 2000, J BIOL CHEM, V275, P35215, DOI 10.1074/jbc.M004446200; Krishnan B, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv139; Krishnan B, 2016, NEUROBIOL LEARN MEM, V128, P65, DOI 10.1016/j.nlm.2015.12.009; Krishnan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025639; Li G, 2014, NEUROSCI BULL, V30, P497, DOI 10.1007/s12264-013-1403-2; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; Mather M, 2016, ANNU REV PSYCHOL, V67, P213, DOI 10.1146/annurev-psych-122414-033540; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Meyza KZ, 2011, BEHAV BRAIN RES, V225, P192, DOI 10.1016/j.bbr.2011.07.011; Muller CP, 2015, BBA-MOL CELL BIOL L, V1851, P1052, DOI 10.1016/j.bbalip.2014.12.014; Nabavi S, 2014, NATURE, V511, P348, DOI 10.1038/nature13294; Naudi A, 2015, INT REV NEUROBIOL, V122, P133, DOI 10.1016/bs.irn.2015.05.008; NEWTON AC, 1994, BIOCHEMISTRY-US, V33, P6651, DOI 10.1021/bi00187a035; Nothdurfter C, 2013, INT J NEUROPSYCHOPH, V16, P1361, DOI 10.1017/S146114571200140X; Oliveira TG, 2016, MOL PSYCHIATR, V21, P80, DOI 10.1038/mp.2015.14; Oliveira TG, 2010, J NEUROSCI, V30, P16419, DOI 10.1523/JNEUROSCI.3317-10.2010; Oliveira TG, 2010, BBA-MOL CELL BIOL L, V1801, P799, DOI 10.1016/j.bbalip.2010.04.004; Oresic M, 2012, GENOME MED, V4, DOI 10.1186/gm300; PALESTINI P, 1990, J NEUROCHEM, V54, P230, DOI 10.1111/j.1471-4159.1990.tb13305.x; Paoletti L, 2011, IUBMB LIFE, V63, P714, DOI 10.1002/iub.521; Piomelli D, 2007, NAT REV NEUROSCI, V8, P743, DOI 10.1038/nrn2233; Prasain JK, 2015, METABOLITES, V5, P677, DOI 10.3390/metabo5040677; Rappley I, 2009, J NEUROCHEM, V111, P15, DOI 10.1111/j.1471-4159.2009.06290.x; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Ruiperez V, 2010, PROG LIPID RES, V49, P420, DOI 10.1016/j.plipres.2010.05.004; Sacket SJ, 2009, ACTA PHARMACOL SIN, V30, P1454, DOI 10.1038/aps.2009.136; Salvador GA, 2005, J NEUROSCI RES, V81, P244, DOI 10.1002/jnr.20565; Shen JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077047; Sjogren B, 2007, ACTA PHYSIOL, V190, P47, DOI 10.1111/j.1748-1716.2007.01687.x; Smiljanic K, 2013, LIPIDS, V48, P1069, DOI 10.1007/s11745-013-3836-9; Spijker S, 2011, NEUROMETHODS, V57, P13, DOI 10.1007/978-1-61779-111-6_2; Tajima Y, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-68; Triebl A, 2017, J CHROMATOGR B, V1053, P72, DOI 10.1016/j.jchromb.2017.03.027; Venkataraman K, 2000, TRENDS CELL BIOL, V10, P408, DOI 10.1016/S0962-8924(00)01830-4; Walker DL, 2002, PHARMACOL BIOCHEM BE, V71, P379, DOI 10.1016/S0091-3057(01)00698-0; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Wood PL, 2014, SCHIZOPHR RES, V159, P365, DOI 10.1016/j.schres.2014.08.029; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044	61	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180675	10.1371/journal.pone.0180675	http://dx.doi.org/10.1371/journal.pone.0180675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2JX	28672041	Green Published, gold, Green Submitted			2022-12-26	WOS:000405268500078
J	Stromberg, ZR; Johnson, JR; Fairbrother, JM; Kilbourne, J; Van Goor, A; Curtiss, R; Mellata, M				Stromberg, Zachary R.; Johnson, James R.; Fairbrother, John M.; Kilbourne, Jacquelyn; Van Goor, Angelica; Curtiss, Roy, III; Mellata, Melha			Evaluation of Escherichia coli isolates from healthy chickens to determine their potential risk to poultry and human health	PLOS ONE			English	Article							VIRULENCE-ASSOCIATED GENES; RETAIL CHICKEN; EXTRAINTESTINAL INFECTIONS; ANTIMICROBIAL-RESISTANT; UROPATHOGENIC STRAINS; PREVALENCE; MENINGITIS; SEQUENCE; ANIMALS; EXPEC	Extraintestinal pathogenic Escherichia coli (ExPEC) strains are important pathogens that cause diverse diseases in humans and poultry. Some E. coli isolates from chicken feces contain ExPEC-associated virulence genes, so appear potentially pathogenic; they conceivably could be transmitted to humans through handling and/or consumption of contaminated meat. However, the actual extraintestinal virulence potential of chicken-source fecal E. coli is poorly understood. Here, we assessed whether fecal E. coli isolates from healthy production chickens could cause diseases in a chicken model of avian colibacillosis and three rodent models of ExPEC-associated human infections. From 304 E. coli isolates from chicken fecal samples, 175 E. coli isolates were screened by PCR for virulence genes associated with human-source ExPEC or avian pathogenic E. coli (APEC), an ExPEC subset that causes extraintestinal infections in poultry. Selected isolates genetically identified as ExPEC and non-ExPEC isolates were assessed in vitro for virulence-associated phenotypes, and in vivo for disease-causing ability in animal models of colibacillosis, sepsis, meningitis, and urinary tract infection. Among the study isolates, 13% (40/304) were identified as ExPEC; the majority of these were classified as APEC and uropathogenic E. coli, but none as neonatal meningitis E. coli. Multiple chicken-source fecal ExPEC isolates resembled avian and human clinical ExPEC isolates in causing one or more ExPEC-associated illnesses in experimental animal infection models. Additionally, some isolates that were classified as non-ExPEC were able to cause ExPEC-associated illnesses in animal models, and thus future studies are needed to elucidate their mechanisms of virulence. These findings show that E. coli isolates from chicken feces contain ExPEC-associated genes, exhibit ExPEC-associated in vitro phenotypes, and can cause ExPEC-associated infections in animal models, and thus may pose a health threat to poultry and consumers.	[Stromberg, Zachary R.; Van Goor, Angelica; Mellata, Melha] Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA 50011 USA; [Johnson, James R.] Vet Affairs Med Ctr, Minneapolis, MN USA; [Johnson, James R.] Univ Minnesota, Minneapolis, MN USA; [Fairbrother, John M.] Univ Montreal, Fac Vet Med, OIE Reference Lab Escherichia Coli, St Hyacinthe, PQ, Canada; [Kilbourne, Jacquelyn; Curtiss, Roy, III; Mellata, Melha] Arizona State Univ, Biodesign Inst, Tempe, AZ 85281 USA; [Curtiss, Roy, III] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Curtiss, Roy, III] Univ Florida, Dept Infect Dis & Pathol, Gainesville, FL USA	Iowa State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; Universite de Montreal; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; State University System of Florida; University of Florida	Mellata, M (corresponding author), Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA 50011 USA.; Mellata, M (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85281 USA.	mmellata@iastate.edu	Stromberg, Zachary R/H-8711-2018; Mellata, Melha/AAP-5491-2020; Stromberg, Zachary/ABF-4365-2021	Stromberg, Zachary R/0000-0002-1137-1128; Stromberg, Zachary/0000-0002-1137-1128; Mellata, Melha/0000-0002-4967-7173	U.S. Department of Agriculture National Research Initiative USDA-NIFA-AFRI [20116 7005-30182]; Office of Research and Development, Medical Research Service, Department of Veterans Affairs [1 I01CX00019201]	U.S. Department of Agriculture National Research Initiative USDA-NIFA-AFRI; Office of Research and Development, Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs)	This research was supported by a grant from the U.S. Department of Agriculture National Research Initiative USDA-NIFA-AFRI grant 20116 7005-30182 (M.M. and R.C.), and by Office of Research and Development, Medical Research Service, Department of Veterans Affairs grant # 1 I01CX00019201 (J.R.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2009, APPL ENVIRON MICROB, V75, P3522, DOI 10.1128/AEM.02685-08; Ballou AL, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00002; Belanger L, 2011, FEMS IMMUNOL MED MIC, V62, P1, DOI 10.1111/j.1574-695X.2011.00797.x; Berry RE, 2009, INFECT IMMUN, V77, P2762, DOI 10.1128/IAI.00323-09; BETTELHEIM K A, 1976, Infection, V4, P174, DOI 10.1007/BF01638945; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; DAVIES JK, 1975, J BACTERIOL, V123, P102, DOI 10.1128/JB.123.1.102-117.1975; Delicato ER, 2003, VET MICROBIOL, V94, P97, DOI 10.1016/S0378-1135(03)00076-2; Dezfulian H, 2003, J CLIN MICROBIOL, V41, P1375, DOI 10.1128/JCM.41.4.1375-1385.2003; Ewers C, 2005, AVIAN DIS, V49, P269, DOI 10.1637/7293-102604R; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Ewers C, 2009, APPL ENVIRON MICROB, V75, P184, DOI 10.1128/AEM.01324-08; Garenaux A, 2011, VET MICROBIOL, V153, P89, DOI 10.1016/j.vetmic.2011.05.023; Hall MR, 2014, SURG INFECT, V15, P1, DOI 10.1089/sur.2012.129; HUANG SH, 1995, INFECT IMMUN, V63, P4470, DOI 10.1128/IAI.63.11.4470-4475.1995; Jakobsen L, 2012, EUR J CLIN MICROBIOL, V31, P1121, DOI 10.1007/s10096-011-1417-5; Jakobsen L, 2010, INT J FOOD MICROBIOL, V142, P264, DOI 10.1016/j.ijfoodmicro.2010.06.025; Johnson JR, 2006, J INFECT DIS, V194, P71, DOI 10.1086/504921; Johnson JR, 2005, FOODBORNE PATHOG DIS, V2, P38, DOI 10.1089/fpd.2005.2.38; Johnson JR, 2012, INFECT IMMUN, V80, P1554, DOI 10.1128/IAI.06388-11; Johnson JR, 2005, J INFECT DIS, V191, P1040, DOI 10.1086/428451; Johnson JR, 2003, J INFECT DIS, V188, P759, DOI 10.1086/377455; Johnson JR, 2003, ANTIMICROB AGENTS CH, V47, P2161, DOI 10.1128/AAC.47.7.2161-2168.2003; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P7043, DOI 10.1128/AEM.01395-08; Johnson TJ, 2012, J BACTERIOL, V194, P2846, DOI 10.1128/JB.06375-11; Johnson TJ, 2009, FOODBORNE PATHOG DIS, V6, P657, DOI 10.1089/fpd.2009.0266; Johnson TJ, 2008, J CLIN MICROBIOL, V46, P3987, DOI 10.1128/JCM.00816-08; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Kao JS, 1997, INFECT IMMUN, V65, P2812, DOI 10.1128/IAI.65.7.2812-2820.1997; LEE MD, 1991, AVIAN DIS, V35, P892, DOI 10.2307/1591625; Maluta RP, 2014, VET MICROBIOL, V169, P89, DOI 10.1016/j.vetmic.2013.12.013; Manges AR, 2012, CLIN INFECT DIS, V55, P712, DOI 10.1093/cid/cis502; Mellata M, 2003, INFECT IMMUN, V71, P494, DOI 10.1128/IAI.71.1.494-503.2003; Mellata M, 2003, INFECT IMMUN, V71, P536, DOI 10.1128/IAI.71.1.536-540.2003; Mellata M, 2013, FOODBORNE PATHOG DIS, V10, P916, DOI 10.1089/fpd.2013.1533; Mellata M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004232; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Mitchell NM, 2015, APPL ENVIRON MICROB, V81, P1177, DOI 10.1128/AEM.03524-14; Moulin-Schouleur M, 2007, J CLIN MICROBIOL, V45, P3366, DOI 10.1128/JCM.00037-07; Ngeleka M, 2002, AVIAN DIS, V46, P143, DOI 10.1637/0005-2086(2002)046[0143:POAECA]2.0.CO;2; Obeng AS, 2012, VET MICROBIOL, V154, P305, DOI 10.1016/j.vetmic.2011.07.010; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Rodriguez-Siek KE, 2005, MICROBIOL-SGM, V151, P2097, DOI 10.1099/mic.0.27499-0; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Russo TA, 2003, MICROBES INFECT, V5, P449, DOI 10.1016/S1286-4579(03)00049-2; Schouler C, 2012, J CLIN MICROBIOL, V50, P1673, DOI 10.1128/JCM.05057-11; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Singer RS, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00028; Singer RS, 2000, VET MICROBIOL, V75, P59, DOI 10.1016/S0378-1135(00)00205-4; Tenke P, 2012, WORLD J UROL, V30, P51, DOI 10.1007/s00345-011-0689-9; Thai K.H., 2010, J VIS EXP; Tivendale KA, 2010, INFECT IMMUN, V78, P3412, DOI 10.1128/IAI.00347-10; Wu GH, 2012, VET MICROBIOL, V160, P197, DOI 10.1016/j.vetmic.2012.05.029; Yao YF, 2006, INFECT IMMUN, V74, P2196, DOI 10.1128/IAI.74.4.2196-2206.2006; Zhao CW, 2001, APPL ENVIRON MICROB, V67, P5431, DOI 10.1128/AEM.67.12.5431-5436.2001	56	70	74	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180599	10.1371/journal.pone.0180599	http://dx.doi.org/10.1371/journal.pone.0180599			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671990	Green Published, Green Submitted, gold			2022-12-26	WOS:000405268500075
J	Swigart, TM; Bonvecchio, A; Theodore, FL; Zamudio-Haas, S; Villanueva-Borbolla, MA; Thrasher, JF				Swigart, Tessa M.; Bonvecchio, Anabelle; Theodore, Florence L.; Zamudio-Haas, Sophia; Villanueva-Borbolla, Maria Angeles; Thrasher, James F.			Breastfeeding practices, beliefs, and social norms in low-resource communities in Mexico: Insights for how to improve future promotion strategies	PLOS ONE			English	Article							PERCEIVED INSUFFICIENT MILK; MATERNAL KNOWLEDGE; ATTITUDES; BEHAVIOR; HEALTH; INTENTIONS; TRANSITION; DURATION; INFANT; WOMEN	Introduction Breastfeeding is recommended exclusively for the first 6 months after birth, with continued breastfeeding for at least 2 years. Yet prevalence of these recommendations is low globally, although it is an effective and cost-effective way to prevent serious infections and chronic illness. Previous studies have reported that social support greatly influences breastfeeding, but there is little evidence on perceived social norms in Mexico and how they affect actual behavior. Objective Our objective was to investigate breastfeeding intention, practices, attitudes, and beliefs, particularly normative, among low-resource communities in central and southern Mexico. Methods We performed a secondary analysis using the theory of planned behavior with cross-sectional data, which included semi-structured individual interviews with fathers (n 10), 8 focus groups with mothers (n 50), and 8 focus groups with women community leaders (n 44) with a total of 104 participants. Our data also included a quantitative survey among pregnant women and mothers (n 321). Results Women reported supplementing breast milk with water and teas soon after birth, as well as introducing small bites of solid food a few months after birth. Social norms appeared to support breastfeeding, but not exclusive breastfeeding or breastfeeding for periods longer than about a year. This may be partially explained by: a) behavioral beliefs that for the first 6 months breast milk alone is insufficient for the baby, and that water in addition to breast milk is necessary to hydrate an infant and b) normative beliefs related to the appropriateness of breastfeeding in public and as the child gets older. Conclusions Future strategies should focus on positively influencing social norms to support recommended practices, and emphasize the specific reasons behind the recommendations. Future efforts should take a multi-pronged approach using a variety of influences, not only directed at healthcare providers but close family members, including fathers.	[Swigart, Tessa M.; Bonvecchio, Anabelle; Theodore, Florence L.; Villanueva-Borbolla, Maria Angeles; Thrasher, James F.] Natl Inst Publ Health, Nutr & Hlth Res Ctr, Cuernavaca, Morelos, Mexico; [Zamudio-Haas, Sophia] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Thrasher, James F.] Univ South Carolina, Dept Hlth Promot Educ & Behav, Columbia, SC USA	Instituto Nacional de Salud Publica; University of California System; University of California San Francisco; University of South Carolina System; University of South Carolina Columbia	Bonvecchio, A (corresponding author), Natl Inst Publ Health, Nutr & Hlth Res Ctr, Cuernavaca, Morelos, Mexico.	bonvecchio@insp.mx		Theodore, Florence L./0000-0002-8111-0871	Mexican National Commission of Social Protection in Health; Mexican Ministry of Health; National Coordination of the Prospera Program; Mexican Ministry of Social Development; Bloomberg Philanthropies	Mexican National Commission of Social Protection in Health; Mexican Ministry of Health; National Coordination of the Prospera Program; Mexican Ministry of Social Development; Bloomberg Philanthropies	The Mexican National Commission of Social Protection in Health, the Mexican Ministry of Health, the National Coordination of the Prospera Program, and the Mexican Ministry of Social Development funded the study. This study was possible in part thanks to an unrestricted research grant from Bloomberg Philanthropies to the INSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ahluwalia IB, 2005, PEDIATRICS, V116, P1408, DOI 10.1542/peds.2005-0013; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Anderson JW, 1999, AM J CLIN NUTR, V70, P525; Colchero MA, 2015, AM J CLIN NUTR, V101, P579, DOI 10.3945/ajcn.114.092775; Arenz S, 2004, INT J OBESITY, V28, P1247, DOI 10.1038/sj.ijo.0802758; BAGOZZI RP, 1992, SOC PSYCHOL QUART, V55, P178, DOI 10.2307/2786945; Bar-Yam N B, 1997, J Hum Lact, V13, P45, DOI 10.1177/089033449701300116; Bonvecchio A., 2016, LACTANCIA MATERNA ME, P77; Bonvecchio A, 2007, J NUTR, V137, P440, DOI 10.1093/jn/137.2.440; Bryant CA, 1991, NAACOGS CLIN ISSU PE, V3, P723; Bueno-Gutierrez D, 2015, PUBLIC HEALTH NUTR, V18, P3371, DOI 10.1017/S1368980015000452; Bueno-Gutierrez D, 2015, BREASTFEED MED, V10, P124, DOI 10.1089/bfm.2014.0109; Dodgson JE, 2003, NURS RES, V52, P148, DOI 10.1097/00006199-200305000-00004; Duckett L, 1998, NURS RES, V47, P325, DOI 10.1097/00006199-199811000-00006; Dykes F, 1999, MIDWIFERY, V15, P232, DOI 10.1054/midw.1999.0185; Fairbank L., 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/hta4250; Fernald LC, 2007, EUR J CLIN NUTR, V61, P623, DOI 10.1038/sj.ejcn.1602558; Fernald LCH, 2009, LANCET, V374, P1997, DOI 10.1016/S0140-6736(09)61676-7; Fishbein M, 2008, MED DECIS MAKING, V28, P834, DOI 10.1177/0272989X08326092; Foss KA, 2013, HEALTH COMMUN, V28, P329, DOI 10.1080/10410236.2012.685692; Goksen F, 2002, SOC SCI MED, V54, P1743, DOI 10.1016/S0277-9536(01)00145-9; de Cossio TG, 2013, J NUTR, V143, P664, DOI 10.3945/jn.112.163097; Guerrero ML, 1999, B WORLD HEALTH ORGAN, V77, P323; Guest G., 2011, APPL THEMAT ANAL; HARRISON GG, 1993, SOC SCI MED, V36, P1063, DOI 10.1016/0277-9536(93)90124-M; Ineichen B, 1997, J ADOLESCENCE, V20, P505, DOI 10.1006/jado.1997.0105; Kelishadi Roya, 2014, Adv Biomed Res, V3, P3, DOI 10.4103/2277-9175.124629; Khoury AJ, 2005, WOMEN HEALTH ISS, V15, P64, DOI 10.1016/j.whi.2004.09.003; Klement E, 2004, AM J CLIN NUTR, V80, P1342, DOI 10.1093/ajcn/80.5.1342; Kramer MS, 2004, ADV EXP MED BIOL, V554, P63; Ladomenou F, 2010, ARCH DIS CHILD, V95, P1004, DOI 10.1136/adc.2009.169912; Lapinski MK, 2005, COMMUN THEOR, V15, P127, DOI 10.1093/ct/15.2.127; Li Y, 1999, PEDIATR INT, V41, P648, DOI 10.1046/j.1442-200x.1999.01149.x; Mirkovic KR, 2014, J HUM LACT, V30, P416, DOI 10.1177/0890334414543522; Monterrosa EC, 2013, J NUTR, V143, P915, DOI 10.3945/jn.112.169235; Neufeld LM, 2008, EXTERN EVAL OPORTUNI, V107; O'Donoghue T., 2003, QUALITATIVE ED RES A; Oglethorpe J., 1995, J CONSUM POLICY, V18, P293; Otsuka K, 2008, JOGNN-J OBST GYN NEO, V37, P546, DOI 10.1111/j.1552-6909.2008.00277.x; Oweis A, 2009, INT J NURS PRACT, V15, P32, DOI 10.1111/j.1440-172X.2008.01720.x; PEREZESCAMILLA R, 1992, ECOL FOOD NUTR, V27, P91, DOI 10.1080/03670244.1992.9991231; Ping E., 2014, KEEPING ABREAST MULT, V1; Rivera JA, 2004, NUTR REV, V62, pS149, DOI 10.1111/j.1753-4887.2004.tb00086.x; Rivera JA, 2002, PUBLIC HEALTH NUTR, V5, P113, DOI 10.1079/PHN2001282; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Sacco LM, 2006, J HUM LACT, V22, P277, DOI 10.1177/0890334406287817; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Wambach KA, 1997, RES NURS HEALTH, V20, P51, DOI 10.1002/(SICI)1098-240X(199702)20:1<51::AID-NUR6>3.0.CO;2-T; Weinreich NK., 1996, SOC MARK Q, V3, P53, DOI [10.1080/15245004.1996.9960961, DOI 10.1080/15245004.1996.9960961]; Williams Helen G, 2006, Breastfeed Rev, V14, P5; WRIGHT AL, 1988, PEDIATRICS, V82, P496; Xiang N, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3883	53	33	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180185	10.1371/journal.pone.0180185	http://dx.doi.org/10.1371/journal.pone.0180185			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2JX	28671954	Green Published, gold			2022-12-26	WOS:000405268500024
J	Andreu-Cazenave, M; Subida, MD; Fernandez, M				Andreu-Cazenave, Miguel; Subida, Maria Dulce; Fernandez, Miriam			Exploitation rates of two benthic resources across management regimes in central Chile: Evidence of illegal fishing in artisanal fisheries operating in open access areas	PLOS ONE			English	Article							TERRITORIAL USER RIGHTS; SMALL-SCALE FISHERIES; MODEL STOCK SYNTHESIS; CATCH; COMANAGEMENT; CONSERVATION; RECRUITMENT; MORTALITY; WORLD; VARIABILITY	There is an urgent need to quantify the impacts of artisanal fisheries and define management practices that allow for the recovery and conservation of exploited stocks. The extent of illegal catch is particularly critical as a driver of overexploitation in artisanal fisheries. However, the lack of data at proper spatial scales limits the evaluation of illegal fishing and effectiveness of management practices. We used a catch curve analysis to estimate total instantaneous mortality as a proxy of fishing pressure in the artisanal benthic fishery in central Chile. We compared the patterns of total mortality in fishing grounds under the well-studied territorial use rights for fisheries system (TURF) immersed in a landscape of open access areas (OAA; no access restriction), and from these patterns determined the extent of illegal fishing in open access areas focusing on the two most frequently extracted resources: locos (Concholepas concholepas) and keyhole limpets (Fissurella spp.). The beauty of this seascape is the presence of the no-take (NT) area of Las Cruces as control (no fishing), allowing us to estimate natural mortality. Loco exploitation is banned in OAAs. However, loco mortality in OAAs was 92% higher than in the NT, and 42% higher than in TURFs. Keyhole limpet mortality was similar between TURFs and the NT, but doubled in OAAs. We also found strong differences in mortality among fishing grounds with the same level of protection (i.e. TURFs), and over time. Our results highlight (a) the high level of illegal fishing that may occur in artisanal fisheries under traditional management regimes, and (b) that TURFs can be effective to reduce fishing mortality. However, large variability among TURFs suggests the need for a deeper understanding of the drivers of success of TURFs.	[Andreu-Cazenave, Miguel; Subida, Maria Dulce; Fernandez, Miriam] Pontificia Univ Catolica Chile, Nucleo Milenio Ctr Conservac Marina CCM, Estn Costera Invest Marinas, Dept Ecol,Fac Ciencias Biol, Santiago, Chile	Pontificia Universidad Catolica de Chile	Fernandez, M (corresponding author), Pontificia Univ Catolica Chile, Nucleo Milenio Ctr Conservac Marina CCM, Estn Costera Invest Marinas, Dept Ecol,Fac Ciencias Biol, Santiago, Chile.	mfernandez@bio.puc.cl		Subida, Maria Dulce/0000-0003-0205-8276	Fondo de Innovacion para la Competitividad, Ministerio de Economia y Fomento [CCM RC-130004]	Fondo de Innovacion para la Competitividad, Ministerio de Economia y Fomento	We thank FONDECYT 1130976 and 1171603 to MF, FONDECYT 11130580 to MDS and ICM project CCM RC-130004 (Fondo de Innovacion para la Competitividad, Ministerio de Economia y Fomento).	Aburto J, 2013, OCEAN COAST MANAGE, V71, P284, DOI 10.1016/j.ocecoaman.2012.09.015; ACUNA-S E, 1977, Revista de Biologia Marina, V16, P117; Afflerbach JC, 2014, GLOB ECOL CONSERV, V2, P97, DOI 10.1016/j.gecco.2014.08.001; Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; Aiken CM, 2011, MAR ECOL PROG SER, V428, P77, DOI 10.3354/meps09079; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bandin RM, 2014, LAT AM J AQUAT RES, V42, P547, DOI 10.3856/vol42-issue3-fulltext-14; Berkes F., 2003, ENVIRONMENTS, V31, P5; Berkes F., 2001, MANAGING SMALL SCALE; Beverton RJH, 1957, QUANTITATIVE FISHERI; Bitecma, 1999, 731999 AMERB BIT; BRETOS M, 1980, BIOL BULL-US, V159, P606, DOI 10.2307/1540826; Camus PA, 2001, REV CHIL HIST NAT, V74, P587, DOI 10.4067/S0716-078X2001000300008; Carruthers TR, 2014, FISH RES, V153, P48, DOI 10.1016/j.fishres.2013.12.014; Castilla J.C., 1986, Canadian Special Publication of Fisheries and Aquatic Sciences, V92, P133; Castilla J. C., 2012, CONTRIBUTIONS SCI, V8, P11; CASTILLA JC, 1985, OIKOS, V45, P391, DOI 10.2307/3565575; Castilla JC, 1998, ECOL APPL, V8, pS124, DOI 10.1890/1051-0761(1998)8[S124:SBFICO]2.0.CO;2; Castilla Juan C., 1998, Canadian Special Publication of Fisheries and Aquatic Sciences, V125, P407; Cavole LM, 2015, FISH RES, V168, P1, DOI 10.1016/j.fishres.2015.03.012; Quynh NT, 2017, MAR POLICY, V75, P41, DOI 10.1016/j.marpol.2016.10.004; Cope JM, 2013, FISH RES, V142, P3, DOI 10.1016/j.fishres.2012.03.006; Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Defeo O, 2005, REV FISH BIOL FISHER, V15, P265, DOI 10.1007/s11160-005-4865-0; Dowling NA, 2015, FISH RES, V171, P141, DOI 10.1016/j.fishres.2014.11.005; Dowling N. A., 2016, TOOLS STRATEGIES ASS; Dunn A, 2002, FISH RES, V59, P149, DOI 10.1016/S0165-7836(01)00407-6; FAO, 2010, STAT WORLD FISH AQ O, V2014, P2016; Fernandez M, 2005, CONSERV BIOL, V19, P1752, DOI 10.1111/j.1523-1739.2005.00277.x; Fernandez M., 2017, LAT AM J AQUAT RES; Free CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143960; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Gallardo-Fernandez GL, 2011, INT J COMMONS, V5, P433; Gallucci V. F., 1995, STOCK ASSESSMENT QUA; Geaghan J.P., 1986, Canadian Special Publication of Fisheries and Aquatic Sciences, V92, P168; Gelcich S, 2008, ENVIRON CONSERV, V35, P36, DOI 10.1017/S0376892908004475; Gelcich S, 2008, ECOL APPL, V18, P273, DOI 10.1890/06-1896.1; Gelcich S, 2012, CONSERV BIOL, V26, P1005, DOI 10.1111/j.1523-1739.2012.01928.x; Gelcich S, 2010, P NATL ACAD SCI USA, V107, P16794, DOI 10.1073/pnas.1012021107; Gelcich S, 2009, OCEAN COAST MANAGE, V52, P424, DOI 10.1016/j.ocecoaman.2009.07.005; Gonzalez J, 2006, B MAR SCI, V78, P499; Gordon HR, 2004, J SHELLFISH RES, V23, P935; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Hauck M, 2013, MARIT STUD, V12, DOI 10.1186/2212-9790-12-3; Hilborn R, 2005, PHILOS T R SOC B, V360, P47, DOI 10.1098/rstb.2004.1569; Hilborn R, 2014, ICES J MAR SCI, V71, P1040, DOI 10.1093/icesjms/fsu034; Kay MC, 2012, ENVIRON CONSERV, V39, P215, DOI 10.1017/S0376892911000695; Martinez HDR, 2015, ANAL INTERACTIONS FI; McClanahan TR, 1999, CORAL REEFS, V18, P321, DOI 10.1007/s003380050205; Molina P, 2014, OCEAN COAST MANAGE, V93, P121, DOI 10.1016/j.ocecoaman.2014.03.005; Navarrete SA, 2002, LIMNOL OCEANOGR, V47, P791, DOI 10.4319/lo.2002.47.3.0791; Navarrete SA, 2008, ECOLOGY, V89, P1308, DOI 10.1890/07-0728.1; Navarrete SA, 2010, REV CHIL HIST NAT, V83, P143; Orensanz JM, 2005, B MAR SCI, V76, P527; Orensanz JM, 2012, 582 FAO FISH AQ; Panayotou T., 1982, 228 FAO FISH; Parma A.M., 2003, SUSTAINABILITY DATA, P8; Parma AM, 2010, SAMUDRA, V55, P42; Pauly D, 1997, AM FISH S S, V20, P40; Rabi Miguel, 1997, Scientia Marina, V61, P49; Raemaekers S, 2011, OCEAN COAST MANAGE, V54, P433, DOI 10.1016/j.ocecoaman.2011.02.001; Ricard D, 2012, FISH FISH, V13, P380, DOI 10.1111/j.1467-2979.2011.00435.x; Rivera A, 2014, MAR POLICY, V50, P300, DOI 10.1016/j.marpol.2014.07.011; Rogers-Bennett L, 2016, ADV PURE MATH, V6, P321, DOI DOI 10.4236/APM.2016.65023; Salas S, 2007, FISH RES, V87, P5, DOI 10.1016/j.fishres.2007.06.015; Schumann S, 2007, MAR POLICY, V31, P101, DOI 10.1016/j.marpol.2006.05.008; SERNAPESCA, 2013, REG PESQ ART PESC EM; Smith MW, 2012, N AM J FISH MANAGE, V32, P956, DOI 10.1080/02755947.2012.711270; Song, 2011, MARITIME STUDIES, V10, P5; Stotz W, 2010, 200851 FIP, P51; Stotz W, 2008, 200654 FIP, P54; Stotz W, 2000, 9736 FIP; Subsecretaria de Pesca y Acuicultura, 2020, EST SIT PRINC PESQ C; Thorson JT, 2011, T AM FISH SOC, V140, P356, DOI 10.1080/00028487.2011.557016; Tognelli MF, 2009, BIOL CONSERV, V142, P3147, DOI 10.1016/j.biocon.2009.08.016; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; Wetzel CR, 2011, MAR FRESHWATER RES, V62, P927, DOI 10.1071/MF11006; WOLFF M, 1989, STUD NEOTROP FAUNA E, V24, P87, DOI 10.1080/01650528909360779; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	79	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180012	10.1371/journal.pone.0180012	http://dx.doi.org/10.1371/journal.pone.0180012			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666013	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608700053
J	Torrente, L; Sanchez, C; Moreno, R; Chowdhry, S; Cabello, P; Isono, K; Koseki, H; Honda, T; Hayes, JD; Dinkova-Kostova, AT; de la Vega, L				Torrente, L.; Sanchez, C.; Moreno, R.; Chowdhry, S.; Cabello, P.; Isono, K.; Koseki, H.; Honda, T.; Hayes, J. D.; Dinkova-Kostova, A. T.; de la Vega, L.			Crosstalk between NRF2 and HIPK2 shapes cytoprotective responses	ONCOGENE			English	Article							INTERACTING PROTEIN KINASE-2; TUMOR-SUPPRESSOR FUNCTION; TRANSCRIPTION FACTOR NRF2; DNA-DAMAGE RESPONSE; LUNG-CANCER; CELL-PROLIFERATION; MOLECULAR-MECHANISM; GENE-EXPRESSION; GROWTH ARREST; FEEDBACK LOOP	Homeodomain interacting protein kinase-2 (HIPK2) is a member of the HIPK family of stress-responsive kinases that modulates cell growth, apoptosis, proliferation and development. HIPK2 has several well-characterised tumour suppressor roles, but recent studies suggest it can also contribute to tumour progression, although the underlying mechanisms are unknown. Herein, we have identified novel crosstalk between HIPK2 and the cytoprotective transcription factor NRF2. We show that HIPK2 is a direct transcriptional target of NRF2, identifying a functional NRF2 binding site in the HIPK2 gene locus and demonstrating for the first time a transcriptional mode of regulation for this kinase. In addition, HIPK2 is required for robust NRF2 responsiveness in cells and in vivo. By using both gain-of-function and loss-of-function approaches, we demonstrate that HIPK2 can elicit a cytoprotective response in cancer cells via NRF2. Our results have uncovered a new downstream effector of HIPK2, NRF2, which is frequently activated in human tumours correlating with chemoresistance and poor prognosis. Furthermore, our results suggest that modulation of either HIPK2 levels or activity could be exploited to impair NRF2-mediated signalling in cancer cells, and thus sensitise them to chemotherapeutic drugs.	[Torrente, L.; Sanchez, C.; Moreno, R.; Chowdhry, S.; Cabello, P.; Hayes, J. D.; Dinkova-Kostova, A. T.; de la Vega, L.] Univ Dundee, Div Canc Res, Jacqui Wood Canc Ctr, Sch Med,Ninewells Hosp & Med Sch, James Arrott Dr, Dundee DD1 9SY, Scotland; [Koseki, H.] RIKEN Ctr Integrat Med Sci IMS, Dev Genet, Yokohama, Kanagawa, Japan; [Honda, T.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Honda, T.] SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA	University of Dundee; RIKEN; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	de la Vega, L (corresponding author), Univ Dundee, Div Canc Res, Jacqui Wood Canc Ctr, Sch Med,Ninewells Hosp & Med Sch, James Arrott Dr, Dundee DD1 9SY, Scotland.	l.delavega@dundee.ac.uk	de la Vega, Laureano/AAE-5456-2020	de la Vega, Laureano/0000-0003-2707-7414; Torrente, Laura/0000-0003-0343-0287; Hayes, John/0000-0002-2927-5548; Dinkova-Kostova, Albena/0000-0003-0316-9859; Isono, Kyoichi/0000-0002-4609-8985	Cancer Research UK [C52419/A22869]; Tenovus Scotland [T14/62]; Reata Pharmaceuticals; Stony Brook Foundation; Ninewells Cancer Campaign; Medical Research Institute of the University of Dundee; Grants-in-Aid for Scientific Research [16H02622] Funding Source: KAKEN; Cancer Research UK [13786, 22869] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Tenovus Scotland; Reata Pharmaceuticals; Stony Brook Foundation; Ninewells Cancer Campaign; Medical Research Institute of the University of Dundee; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Cancer Research UK(Cancer Research UK)	We thank Prof Donna D Zhang (University of Arizona) for providing plasmids; Prof Issay Kitabayashi (National Cancer Center Research Institute Tokyo) and Prof Masayuki Yamamoto (Tohoku University) for cell lines; Prof Shyam Biswal (Johns Hopkins University) for sharing their ChIP-seq data; Prof Stephen M Keyse (University of Dundee) for critical reading and insightful comments on the manuscript. We are extremely grateful to the Medical Research Institute of the University of Dundee, Cancer Research UK (C52419/A22869), the Ninewells Cancer Campaign, Tenovus Scotland (grant number T14/62), Reata Pharmaceuticals and Stony Brook Foundation for financial support.	Aikawa Y, 2006, EMBO J, V25, P3955, DOI 10.1038/sj.emboj.7601273; Akaike Y, 2015, ONCOGENE, V34, P3463, DOI 10.1038/onc.2014.278; Al-Beiti MAM, 2008, AUST NZ J OBSTET GYN, V48, P329, DOI 10.1111/j.1479-828X.2008.00874.x; Ann EJ, 2016, CANCER RES, V76, P4728, DOI 10.1158/0008-5472.CAN-15-3310; Berber S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19582; Calzado MA, 2009, NAT CELL BIOL, V11, P85, DOI 10.1038/ncb1816; Canet MJ, 2015, DRUG METAB DISPOS, V43, P93, DOI 10.1124/dmd.114.060103; Choi DW, 2013, MOL CELL, V51, P374, DOI 10.1016/j.molcel.2013.06.010; Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Dauth I, 2007, CANCER RES, V67, P2274, DOI 10.1158/0008-5472.CAN-06-2884; de la Vega L, 2013, NUCLEIC ACIDS RES, V41, P5731, DOI 10.1093/nar/gkt262; de la Vega L, 2012, MOL CELL, V46, P472, DOI 10.1016/j.molcel.2012.03.003; de la Vega L, 2011, BBA-MOL CELL RES, V1813, P283, DOI 10.1016/j.bbamcr.2010.11.022; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Deshmukh H, 2008, ONCOGENE, V27, P4745, DOI 10.1038/onc.2008.110; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; Du W, 2013, CANCER LETT, V337, P58, DOI 10.1016/j.canlet.2013.05.016; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Garufi A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.163; Giachino C, 2015, CANCER CELL, V28, P730, DOI 10.1016/j.ccell.2015.10.008; Giraud S, 2004, J VIROL, V78, P2984, DOI 10.1128/JVI.78.6.2984-2993.2004; Gresko E, 2006, EMBO J, V25, P1883, DOI 10.1038/sj.emboj.7601077; Hailemariam K, 2010, J CELL SCI, V123, P3863, DOI 10.1242/jcs.073627; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Hofmann TG, 2005, J BIOL CHEM, V280, P29224, DOI 10.1074/jbc.M503921200; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Homma S, 2009, CLIN CANCER RES, V15, P3423, DOI 10.1158/1078-0432.CCR-08-2822; Honda T, 2011, J MED CHEM, V54, P1762, DOI 10.1021/jm101445p; Iacovelli S, 2009, CELL PROLIFERAT, V42, P373, DOI 10.1111/j.1365-2184.2009.00601.x; Imberg-Kazdan K, 2013, GENOME RES, V23, P581, DOI 10.1101/gr.144774.112; Isono K, 2006, MOL CELL BIOL, V26, P2758, DOI 10.1128/MCB.26.7.2758-2771.2006; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jin YM, 2012, NAT MED, V18, P580, DOI 10.1038/nm.2685; Kalra S, 2012, CANCER PREV RES, V5, P973, DOI 10.1158/1940-6207.CAPR-12-0041; Kawamoto Y, 2000, J BIOL CHEM, V275, P11291, DOI 10.1074/jbc.275.15.11291; Kelleher MO, 2009, CARCINOGENESIS, V30, P1754, DOI 10.1093/carcin/bgp182; Kelly VP, 2000, CANCER RES, V60, P957; Kemmerer ZA, 2015, TOXICOL LETT, V238, P83, DOI 10.1016/j.toxlet.2015.07.004; Kim YR, 2010, J PATHOL, V220, P446, DOI 10.1002/path.2653; Lapin V, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.45; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee OH, 2007, J BIOL CHEM, V282, P36412, DOI 10.1074/jbc.M706517200; Li QK, 2011, J HUM GENET, V56, P230, DOI 10.1038/jhg.2010.172; Lobry C, 2014, BLOOD, V123, P2451, DOI 10.1182/blood-2013-08-355818; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Munoz IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109752; Naidu SD, 2016, MOL CELL BIOL, V36, P2403, DOI 10.1128/MCB.00292-16; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Pi JB, 2007, FREE RADICAL BIO MED, V42, P1797, DOI 10.1016/j.freeradbiomed.2007.03.001; PROCHASKA HJ, 1988, ANAL BIOCHEM, V169, P328, DOI 10.1016/0003-2697(88)90292-8; Puca R, 2010, FREE RADICAL BIO MED, V48, P1338, DOI 10.1016/j.freeradbiomed.2010.02.015; Rada P, 2012, MOL CELL BIOL, V32, P3486, DOI 10.1128/MCB.00180-12; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Rojo AI, 2014, ANTIOXID REDOX SIGN, V21, P2498, DOI 10.1089/ars.2014.5843; Sasaki H, 2013, INT J MOL MED, V31, P1135, DOI 10.3892/ijmm.2013.1324; Satoh H, 2013, CANCER RES, V73, P4158, DOI 10.1158/0008-5472.CAN-12-4499; Saul VV, 2013, J MOL CELL BIOL, V5, P27, DOI 10.1093/jmcb/mjs053; Schulten HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153681; Shang YL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001527; Shibata T, 2008, GASTROENTEROLOGY, V135, P1358, DOI 10.1053/j.gastro.2008.06.082; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Sjolund J, 2014, P NATL ACAD SCI USA, V111, P7373, DOI 10.1073/pnas.1322275111; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Wei GW, 2007, P NATL ACAD SCI USA, V104, P13040, DOI 10.1073/pnas.0703213104; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743	74	49	49	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 2	2017	36	44					6204	6212		10.1038/onc.2017.221	http://dx.doi.org/10.1038/onc.2017.221			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FL5CU	28692050	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000414249800013
J	Shay, AE; Diwakar, BT; Guan, BJ; Narayan, V; Urban, JF; Prabhu, KS				Shay, Ashley E.; Diwakar, Bastihalli T.; Guan, Bo-Jhih; Narayan, Vivek; Urban, Joseph F., Jr.; Prabhu, K. Sandeep			IL-4 up-regulates cyclooxygenase-1 expression in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONIC MYOFIBROBLAST MIGRATION; FES PROTOONCOGENE PRODUCT; RECEPTOR PPAR-GAMMA; ALTERNATIVE ACTIVATION; LIPID MEDIATORS; GENE-EXPRESSION; DENDRITIC CELLS; PROTEIN-KINASE; CANCER CELLS; INFLAMMATION	Macrophages use various cell-surface receptors to sense their environment and undergo polarized responses. The cytokines, interleukin (IL)-4 and IL-13, released from T-helper type 2 (Th2) cells, drive macrophage polarization toward an alternatively activated phenotype (M2). This phenotype is associated with the expression of potent pro-resolving mediators, such as the prostaglandin (PG) D2-derived cyclopentenone metabolite, 15d-PGJ2, produced by the cyclooxygenase (Ptgs; Cox) pathway. Interestingly, IL-4 treatment of bone marrow-derived macrophages (BMDMs) significantly down-regulates Cox-2 protein expression, whereas Cox-1 levels are significantly increased. This phenomenon not only challenges the dogma that Cox-1 is only developmentally regulated, but also demonstrates a novel mechanism in which IL-4-dependent regulation of Cox-1 involves the activation of the mechanistic target of rapamycin complex (mTORC). Using specific chemical inhibitors, we demonstrate here that IL-4-dependent Cox-1 up-regulation occurs at the post-transcriptional level via the Fes-Akt-mTORC axis. Activation of AMP-activated protein kinase (AMPK) by metformin, inhibition of mTORC by torin 1, or CRISPR/Cas9-mediated genetic knock-out of tuberous sclerosis complex-2 (Tsc2) blocked the IL-4-dependent expression of Cox-1 and the ability of macrophages to polarize to M2. However, use of 15d-PGJ2 partially rescued the effects of AMPK activation, suggesting the importance of Cox-1 in macrophage polarization as also observed in a model of gastrointestinal helminth clearance. In summary, these findings suggest a new paradigm where IL-4-dependent up-regulation of Cox-1 expression may play a key role in tissue homeostasis and wound healing during Th2-mediated immune responses, such as parasitic infections.	[Shay, Ashley E.; Diwakar, Bastihalli T.; Prabhu, K. Sandeep] Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA; [Shay, Ashley E.; Diwakar, Bastihalli T.; Prabhu, K. Sandeep] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA; [Guan, Bo-Jhih] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Narayan, Vivek] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Urban, Joseph F., Jr.] ARS, USDA, Beltsville Human Nutr Res Ctr, Diet Genom & Immunol Lab, Beltsville, MD 20705 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Case Western Reserve University; Cleveland Clinic Foundation; United States Department of Agriculture (USDA)	Prabhu, KS (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA.; Prabhu, KS (corresponding author), Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA.	ksprabhu@psu.edu	Tukaramra, Diwakar Bastihalli/AFC-2245-2022	Tukaramra, Diwakar Bastihalli/0000-0002-9503-3424; Urban, Joseph/0000-0002-1590-8869; Narayan, Vivek/0000-0002-3232-7898	United States Public Health Service National Institutes of Health and Office of Dietary Supplements Grant [R01DK077152]; USDA Hatch Funds [4605]; National Institutes of Health [5T32AI074551-05]; NATIONAL CANCER INSTITUTE [R01CA162665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077152] Funding Source: NIH RePORTER	United States Public Health Service National Institutes of Health and Office of Dietary Supplements Grant; USDA Hatch Funds; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by the United States Public Health Service National Institutes of Health and Office of Dietary Supplements Grant R01DK077152, and by USDA Hatch Funds Grant 4605 (to K. S. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health T32 Training Grant 5T32AI074551-05.	Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Camberis Mali, 2003, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1912s55; Caughey GE, 2001, J IMMUNOL, V167, P2831, DOI 10.4049/jimmunol.167.5.2831; Cho W, 2011, MOL IMMUNOL, V48, P966, DOI 10.1016/j.molimm.2011.01.007; Chu E, 2017, J SURG RES, V209, P191, DOI 10.1016/j.jss.2016.10.014; Das A, 2015, AM J PATHOL, V185, P2596, DOI 10.1016/j.ajpath.2015.06.001; Ding L, 2015, ONCOTARGET, V6, P36441, DOI 10.18632/oncotarget.5541; Erices R, 2013, REPROD SCI, V20, P1433, DOI 10.1177/1933719113488441; Fagone P, 2012, INFLAMM RES, V61, P1131, DOI 10.1007/s00011-012-0506-y; Fitzpatrick FA, 2004, CURR PHARM DESIGN, V10, P577, DOI 10.2174/1381612043453144; Gandhi UH, 2011, J BIOL CHEM, V286, P27471, DOI 10.1074/jbc.M111.260547; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Guan BJ, 2014, J BIOL CHEM, V289, P12593, DOI 10.1074/jbc.M113.543215; Harrington LS, 2008, FASEB J, V22, P4005, DOI 10.1096/fj.08-107979; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Incio J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141392; Izuhara K, 1996, BLOOD, V88, P3910, DOI 10.1182/blood.V88.10.3910.bloodjournal88103910; IZUHARA K, 1994, J BIOL CHEM, V269, P18623; Jiang H, 2000, J ALLERGY CLIN IMMUN, V105, P1063, DOI 10.1067/mai.2000.107604; Jiang H, 2001, J IMMUNOL, V166, P2627, DOI 10.4049/jimmunol.166.4.2627; Kabashima K, 2003, NAT IMMUNOL, V4, P694, DOI 10.1038/ni943; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Kihara Y, 2014, BIOPHYS J, V106, P966, DOI 10.1016/j.bpj.2014.01.015; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Langenbach R, 1999, BIOCHEM PHARMACOL, V58, P1237, DOI 10.1016/S0006-2952(99)00158-6; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; Miller-Graziano Carol L, 2008, Novartis Found Symp, V291, P196; Mohammadi A, 2016, INFLAMMATION, V39, P1116, DOI 10.1007/s10753-016-0343-1; Morita I, 2002, PROSTAG OTH LIPID M, V68-9, P165, DOI 10.1016/S0090-6980(02)00029-1; Nelson SM, 2016, J BIOL CHEM, V291, P2787, DOI 10.1074/jbc.M115.684738; Nelson SM, 2011, J NUTR, V141, P1754, DOI 10.3945/jn.111.141176; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oeser K, 2015, MUCOSAL IMMUNOL, V8, P672, DOI 10.1038/mi.2014.101; Park CS, 2012, BIOCHEM PHARMACOL, V84, P1660, DOI 10.1016/j.bcp.2012.09.025; Peebles RS, 2002, AM J RESP CRIT CARE, V165, P1154, DOI 10.1164/rccm.2106025; Ramos P, 2013, NAT MED, V19, P437, DOI 10.1038/nm.3126; Reece JJ, 2006, INFECT IMMUN, V74, P4970, DOI 10.1128/IAI.00687-06; Saini S, 2016, J SURG RES, V204, P145, DOI 10.1016/j.jss.2016.04.034; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Ueno N, 2001, J BIOL CHEM, V276, P34918, DOI 10.1074/jbc.M100429200; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Vunta H, 2007, J BIOL CHEM, V282, P17964, DOI 10.1074/jbc.M703075200; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Zhu LN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5696	53	12	12	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14544	14555		10.1074/jbc.M117.785014	http://dx.doi.org/10.1074/jbc.M117.785014			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28684424	Green Published, hybrid			2022-12-26	WOS:000408747500020
J	Oparinde, A; Abdoulaye, T; Mignouna, DB; Bamire, AS				Oparinde, Adewale; Abdoulaye, Tahirou; Mignouna, Djana Babatima; Bamire, Adebayo Simeon			Will farmers intend to cultivate Provitamin A genetically modified (GM) cassava in Nigeria? Evidence from a k-means segmentation analysis of beliefs and attitudes	PLOS ONE			English	Article							PLANNED BEHAVIOR; STAKEHOLDER ATTITUDES; EXPERIMENTAL AUCTIONS; CONSUMER ACCEPTANCE; SOUTH-AFRICA; FOOD; CROPS; BIOTECHNOLOGY; INFORMATION; BENEFITS	Analysis of market segments within a population remains critical to agricultural systems and policy processes for targeting new innovations. Patterns in attitudes and intentions toward cultivating Provitamin A GM cassava are examined through the use of a combination of behavioural theory and k-means cluster analysis method, investigating the interrelationship among various behavioural antecedents. Using a state-level sample of smallholder cassava farmers in Nigeria, this paper identifies three distinct classes of attitude and intention denoted as low opposition, medium opposition and high opposition farmers. It was estimated that only 25% of the surveyed population of farmers was highly opposed to cultivating Provitamin A GM cassava.	[Oparinde, Adewale] Int Food Policy Res Inst, Washington, DC 20036 USA; [Abdoulaye, Tahirou; Mignouna, Djana Babatima] Int Inst Trop Agr, Ibadan, Nigeria; [Bamire, Adebayo Simeon] Obafemi Awolowo Univ, Ife, Nigeria	CGIAR; International Food Policy Research Institute (IFPRI); CGIAR; International Institute of Tropical Agriculture (IITA); Obafemi Awolowo University	Oparinde, A (corresponding author), Int Food Policy Res Inst, Washington, DC 20036 USA.	a.oparinde@cgiar.org		Oparinde, Adewale/0000-0002-4518-9404				Abubakar A., 2016, COUNTRY PROFILE RELI; Adenle A. A., 2012, AGR FOOD SECURITY, V1, P15; Aerni P, 2006, WORLD DEV, V34, P557, DOI 10.1016/j.worlddev.2005.08.007; Aerni P, 2005, ENVIRON SCI POLICY, V8, P464, DOI 10.1016/j.envsci.2005.07.001; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; AJZEN I, 1986, J EXP SOC PSYCHOL, V22, P453, DOI 10.1016/0022-1031(86)90045-4; Ajzen I, 2007, SCOPE OF SOCIAL PSYCHOLOGY: THEORY AND APPLICATIONS, P43; Albarracin D, 2001, PSYCHOL BULL, V127, P142, DOI 10.1037//0033-2909.127.1.142; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Berman J, 2013, PLANT MOL BIOL, V83, P5, DOI 10.1007/s11103-013-0027-2; Birol E., 2012, AgBioForum, V15, P175; Bouis HE, 2014, IMPROVING DIETS AND NUTRITION: FOOD-BASED APPROACHES, P202, DOI 10.1079/9781780642994.0202; Bredahl L., 1998, MAPP Working Paper, DOI 10.1023/A:1006940724167; Breustedt G, 2008, J AGR ECON, V59, P237, DOI 10.1111/j.1477-9552.2007.00147.x; Brown DR, 2006, AFJARE, V1; Buah J. N., 2011, American Journal of Food Technology, V6, P541, DOI 10.3923/ajft.2011.541.554; Burke D, 2004, EMBO REP, V5, P432, DOI 10.1038/sj.embor.7400160; Burkhalter JE, 2009, NICOTINE TOB RES, V11, P1312, DOI 10.1093/ntr/ntp140; Chern Wen S., 2002, AgBioForum, V5, P105; Chung JW, 2006, LECT NOTES COMPUT SC, V4224, P807; Coleman J., 1990, FDN SOCIAL THEORY; Cooke J. G., 2010, REPORT CSIS GLOBAL F; Corrigan JR, 2009, AM J AGR ECON, V91, P837, DOI 10.1111/j.1467-8276.2009.01267.x; Curtis K. R., 2004, AgBioForum, V7, P70; De Moura FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129436; De Wit JBF, 2000, PSYCHOL HEALTH, V15, P325, DOI 10.1080/08870440008401996; Demont M, 2013, NEW BIOTECHNOL, V30, P426, DOI 10.1016/j.nbt.2013.04.004; Dofonsou S.G., 2007, AM AGR EC ASS ANN M; DOWNS DS, 2005, J PHYS ACT HEALTH, V2, P76, DOI DOI 10.1123/jpah.2.1.76; Everitt B. S., 2001, CLUSTER ANAL; FAO, 2009, FEED WORLD 2050 SPEC; Fishbein M., 1975, BELIEF ATTITUDE INTE; Francis J., 2004, CONSTRUCTING QUESTIO, V5th ed.; Ganiere P, 2006, J AGR RESOUR ECON, V31, P129; Godin G, 1996, AM J HEALTH PROMOT, V11, P87, DOI 10.4278/0890-1171-11.2.87; Gonzalez C, 2009, J AGR ECON, V60, P604, DOI 10.1111/j.1477-9552.2009.00219.x; Grebmer K., 2014, 2014 GLOBAL HUNGER I; Gyau A, 2009, INT FOOD AGRIBUS MAN, V12, P61; Hardin Russell, 2002, RUSSELL SAGE FDN SER; Hebden WC, 2005, CHOICES, V20, P243; Herring JR, 2009, GLOBAL RIFTS BIOTECH; Huffman WE, 2007, J ECON BEHAV ORGAN, V63, P193, DOI 10.1016/j.jebo.2005.04.019; Kikulwe EM, 2011, APPETITE, V57, P401, DOI 10.1016/j.appet.2011.06.001; Kimenju SC, 2005, AFR J BIOTECHNOL, V4, P1066; Kolady D. E., 2006, AgBioForum, V9, P94; Lewis CP, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-407; Lusk JL, 2004, EUR REV AGRIC ECON, V31, P179, DOI 10.1093/erae/31.2.179; Lyon F, 2009, CAMB J ECON, V33, P903, DOI 10.1093/cje/bem008; Manyong V.M., 2000, CONTRIBUTION IITA IM; Maziya-Dixon BB, 2006, J NUTR, V136, P2255, DOI 10.1093/jn/136.8.2255; Meenakshi JV, 2010, WORLD DEV, V38, P64, DOI 10.1016/j.worlddev.2009.03.014; Morris SH, 2001, BRIT FOOD J, V102, P669; Mushunje A., 2011, African Journal of Agricultural Research, V6, P5918; Pachico D, 2002, P 6 INT ICABR C JUL, P155; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Rousu M. C., 2009, AgBioForum, V12, P226; Sahin I., 2006, TURKISH ONLINE J ED, V5; Sampson IT, 2014, OXF J LAW RELIG, V3, P311, DOI 10.1093/ojlr/rwt026; Sayre R. T., 2011, BIOFORTIFICATION CAS; Scoones I, 2008, J AGRAR CHANGE, V8, P315, DOI 10.1111/j.1471-0366.2008.00172.x; Seppanen E., 2005, IND MARKET MANAG, V36, P249; Skevas T., 2012, AgBioForum, V15, P242; Smale M., 2007, Research Report - International Food Policy Research Institute; Smale Melinda, 2003, African Journal of Biotechnology, V2, P586; Spence A, 2006, RISK ANAL, V26, P657, DOI 10.1111/j.1539-6924.2006.00777.x; Stead M, 2005, HEALTH EDUC RES, V20, P36, DOI 10.1093/her/cyg093; Stone GD, 2002, CURR ANTHROPOL, V43, P611, DOI 10.1086/341532; Tegene A, 2003, USDA TECHNICAL BULLE, V1903; Vermeulen H, 2005, AGREKON, V44, P657; Zhang C, 2004, AM AGR EC ASS ANN M; Zhang XY, 2010, FOOD POLICY, V35, P456, DOI 10.1016/j.foodpol.2010.04.008	71	9	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0179427	10.1371/journal.pone.0179427	http://dx.doi.org/10.1371/journal.pone.0179427			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TI	28700605	Green Published, gold			2022-12-26	WOS:000405649400003
J	Pereira, APD; de Andrade, PAM; Bini, D; Durrer, A; Robin, A; Bouillet, JP; Andreote, FD; Cardoso, EJBN				de Araujo Pereira, Arthur Prudencio; Maia de Andrade, Pedro Avelino; Bini, Daniel; Durrer, Ademir; Robin, Agnes; Bouillet, Jean Pierre; Andreote, Fernando Dini; Bran Nogueira Cardoso, Elke Jurandy			Shifts in the bacterial community composition along deep soil profiles in monospecific and mixed stands of Eucalyptus grandis and Acacia mangium	PLOS ONE			English	Article							SPECIES PLANTATIONS; MICROBIAL COMMUNITIES; GROWTH DYNAMICS; NITROGEN; CARBON; DIVERSITY; BRAZIL; TREES; QUANTIFICATION; RHIZOSPHERE	Our knowledge of the rhizosphere bacterial communities in deep soils and the role of Eucalyptus and Acacia on the structure of these communities remains very limited. In this study, we targeted the bacterial community along a depth profile (0 to 800 cm) and compared community structure in monospecific or mixed plantations of Acacia mangium and Eucalyptus grandis. We applied quantitative PCR (qPCR) and sequence the V6 region of the 16S rRNA gene to characterize composition of bacterial communities. We identified a decrease in bacterial abundance with soil depth, and differences in community patterns between monospecific and mixed cultivations. Sequence analysis indicated a prevalent effect of soil depth on bacterial communities in the mixed plant cultivation system, and a remarkable differentiation of bacterial communities in areas solely cultivated with Eucalyptus. The groups most influenced by soil depth were Proteobacteria and Acidobacteria (more frequent in samples between 0 and 300 cm). The predominant bacterial groups differentially displayed in the monospecific stands of Eucalyptus were Firmicutes and Proteobacteria. Our results suggest that the addition of an N2-fixing tree in a monospecific cultivation system modulates bacterial community composition even at a great depth. We conclude that co-cultivation systems may represent a key strategy to improve soil resources and to establish more sustainable cultivation of Eucalyptus in Brazil.	[de Araujo Pereira, Arthur Prudencio; Maia de Andrade, Pedro Avelino; Durrer, Ademir; Andreote, Fernando Dini; Bran Nogueira Cardoso, Elke Jurandy] Univ Sao Paulo, ESALQ USP, Luiz de Queiroz Coll Agr, Dept Soil Sci, Piracicaba, SP, Brazil; [Bini, Daniel] Univ Ctr Oeste, UNICTR, Guarapuava, Parana, Brazil; [Robin, Agnes; Bouillet, Jean Pierre] CIRAD, Agr Res Dev, Montpellier, France	Universidade de Sao Paulo; CIRAD	Pereira, APD (corresponding author), Univ Sao Paulo, ESALQ USP, Luiz de Queiroz Coll Agr, Dept Soil Sci, Piracicaba, SP, Brazil.	arthur.prudencio@usp.br; ejbncard@usp.br	de Araujo Pereira, Arthur Prudêncio/H-2275-2018; Andrade, Pedro Avelino A M/K-2384-2017; de Araujo Pereira, Arthur Prudêncio/Y-4251-2019; Andreote, Fernando Dini/B-8499-2012; Robin, Agnes/C-5238-2015	de Araujo Pereira, Arthur Prudêncio/0000-0001-9402-3243; Andrade, Pedro Avelino A M/0000-0001-7767-9101; de Araujo Pereira, Arthur Prudêncio/0000-0001-9402-3243; Andreote, Fernando Dini/0000-0002-9883-9968; Robin, Agnes/0000-0003-3044-2304	FAPESP [122790]; CNPq [476122]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The work was supported by the following: FAPESP (proc.no 122790); CNPq(proc. no 476122)	ABRAF-Brazilian Association of Forest Plantation Producers, 2013, YB STAT ABRAF 2013 B; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Berthrong ST, 2009, ECOL APPL, V19, P2228, DOI 10.1890/08-1730.1; Bini D, 2013, APPL SOIL ECOL, V63, P57, DOI 10.1016/j.apsoil.2012.09.012; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bouillet JP, 2008, FOREST ECOL MANAG, V255, P3918, DOI 10.1016/j.foreco.2007.10.050; Bouillet JP, 2013, FOREST ECOL MANAG, V301, P89, DOI 10.1016/j.foreco.2012.09.019; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clarke K.R., 2006, PRIMER; Curtis P, 2002, ARCH MICROBIOL, V178, P65, DOI 10.1007/s00203-002-0427-1; De Bellis T, 2007, MYCOLOGIA, V99, P356, DOI 10.3852/mycologia.99.3.356; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eilers KG, 2012, SOIL BIOL BIOCHEM, V50, P58, DOI 10.1016/j.soilbio.2012.03.011; EMBRAPA, 1997, MANUAL METODOS ANALI; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Forrester DI, 2006, FOREST ECOL MANAG, V233, P211, DOI 10.1016/j.foreco.2006.05.012; Forrester DI, 2004, FOREST ECOL MANAG, V193, P81, DOI 10.1016/j.foreco.2004.01.024; Garbeva P, 2006, ENVIRON MICROBIOL, V8, P233, DOI 10.1111/j.1462-2920.2005.00888.x; Grayston SJ, 2001, SOIL BIOL BIOCHEM, V33, P533, DOI 10.1016/S0038-0717(00)00194-2; Gregory PJ, 2006, EUR J SOIL SCI, V57, P2, DOI 10.1111/j.1365-2389.2005.00778.x; Hartmann M, 2009, ENVIRON MICROBIOL, V11, P3045, DOI 10.1111/j.1462-2920.2009.02008.x; Helgason BL, 2014, AGR ECOSYST ENVIRON, V196, P94, DOI 10.1016/j.agee.2014.06.029; Hoque MS, 2011, INT J SYST EVOL MICR, V61, P299, DOI 10.1099/ijs.0.021014-0; JAMES R, 2005, PLANTED FORESTS TREE; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Jourdan C, 2008, FOREST ECOL MANAG, V256, P396, DOI 10.1016/j.foreco.2008.04.034; Kasel S, 2008, SOIL BIOL BIOCHEM, V40, P1724, DOI 10.1016/j.soilbio.2008.02.011; Kourtev PS, 2002, ECOLOGY, V83, P3152, DOI 10.1890/0012-9658(2002)083[3152:EPSATM]2.0.CO;2; Laclau JP, 2008, FOREST ECOL MANAG, V255, P3905, DOI 10.1016/j.foreco.2007.10.049; Laclau JP, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00243; Laclau JP, 2013, OECOLOGIA, V172, P903, DOI 10.1007/s00442-012-2526-2; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lejon DPH, 2005, MICROB ECOL, V50, P614, DOI 10.1007/s00248-005-5130-8; Li CH, 2014, SOIL BIOL BIOCHEM, V75, P264, DOI 10.1016/j.soilbio.2014.04.023; Liu Hua, 2010, Journal of Sustainable Development, V3, P197; Lopez-Gutierrez JC, 2004, J MICROBIOL METH, V57, P399, DOI 10.1016/j.mimet.2004.02.009; Lopez-Mondejar R, 2015, SOIL BIOL BIOCHEM, V87, P43, DOI 10.1016/j.soilbio.2015.04.008; Lorenzo P, 2010, APPL SOIL ECOL, V44, P245, DOI 10.1016/j.apsoil.2010.01.001; LYNCH JM, 1990, PLANT SOIL, V129, P1, DOI 10.1007/BF00011685; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Mosoni P, 2007, J APPL MICROBIOL, V103, P2676, DOI 10.1111/j.1365-2672.2007.03517.x; Neufeld JD, 2005, APPL ENVIRON MICROB, V71, P5710, DOI 10.1128/AEM.71.10.5710-5718.2005; Nielsen UN, 2010, J BIOGEOGR, V37, P1317, DOI 10.1111/j.1365-2699.2010.02281.x; Nouvellon Y, 2012, TREE PHYSIOL, V32, P680, DOI 10.1093/treephys/tps041; Paula RR, 2015, SOIL BIOL BIOCHEM, V91, P99, DOI 10.1016/j.soilbio.2015.08.017; Peralta RM, 2013, SCI TOTAL ENVIRON, V443, P725, DOI 10.1016/j.scitotenv.2012.11.052; Rachid CTCC, 2013, SOIL BIOL BIOCHEM, V66, P146, DOI 10.1016/j.soilbio.2013.07.005; Rachid CTCC, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-170; Raij BV, 1997, EMBRAPA, V285, P29; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Rampelotto Pabulo Henrique, 2010, Sustainability, V2, P1602, DOI 10.3390/su2061602; Schimel J, 2007, ECOLOGY, V88, P1386, DOI 10.1890/06-0219; Schutz K, 2010, FEMS MICROBIOL ECOL, V72, P445, DOI 10.1111/j.1574-6941.2010.00855.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stone MM, 2015, SOIL BIOL BIOCHEM, V80, P273, DOI 10.1016/j.soilbio.2014.10.019; Stursova M, 2012, FEMS MICROBIOL ECOL, V80, P735, DOI 10.1111/j.1574-6941.2012.01343.x; Uroz S, 2013, MICROB ECOL, V66, P404, DOI 10.1007/s00248-013-0199-y; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; WARDLE DA, 1992, BIOL REV, V67, P321, DOI 10.1111/j.1469-185X.1992.tb00728.x; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Yin CT, 2010, SOIL BIOL BIOCHEM, V42, P2111, DOI 10.1016/j.soilbio.2010.08.006	62	56	56	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180371	10.1371/journal.pone.0180371	http://dx.doi.org/10.1371/journal.pone.0180371			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686690	gold, Green Published, Green Submitted			2022-12-26	WOS:000405464100057
J	Gasljevic, G; Edhemovic, I; Cemazar, M; Brecelj, E; Gadzijev, EM; Music, MM; Sersa, G				Gasljevic, Gorana; Edhemovic, Ibrahim; Cemazar, Maja; Brecelj, Erik; Gadzijev, Eldar M.; Music, Maja M.; Sersa, Gregor			Histopathological findings in colorectal liver metastases after electrochemotherapy	PLOS ONE			English	Article							IRREVERSIBLE ELECTROPORATION; HEPATOCELLULAR-CARCINOMA; RAT MODEL; TUMORS; BLEOMYCIN; ABLATION	Electrochemotherapy of colorectal liver metastases has been proven to be feasible, safe and effective in a phase I/II study. In that study, a specific group of patients underwent two-stage operation, and the detailed histopathological evaluation of the resected tumors is presented here. Regressive changes in electrochemotherapy-treated liver metastases were evaluated after the second operation (in 8-10 weeks) in 7 patients and 13 metastases when the treated metastases were resected. Macroscopic and microscopic changes were analyzed. Electrochemotherapy induced coagulation necrosis in the treated area encompassing both tumor and a narrow band of normal tissue. The area became necrotic, encapsulated in a fibrous envelope while preserving the functionality of most of the vessels larger than 5 mm in diameter and a large proportion of biliary structures, but the smaller blood vessels displayed various levels of damage. At the time of observation, 8-10 weeks after electrochemo-therapy, regenerative changes were already seen in the peripheral parts of the treated area. This study demonstrates regressive changes in the whole electrochemotherapy-treated area of the liver. Further evidence of disruption of vessels less than 5mm in diameter and preservation of the larger vessels by electrochemotherapy is provided. These findings are important because electrochemotherapy has been indicated for the therapy of metastases near major blood vessels in the liver to provide a safe approach with good antitumor efficacy.	[Gasljevic, Gorana] Inst Oncol Ljubljana, Dept Pathol, Ljubljana, Slovenia; [Edhemovic, Ibrahim; Brecelj, Erik; Gadzijev, Eldar M.] Inst Oncol Ljubljana, Dept Surg Oncol, Ljubljana, Slovenia; [Cemazar, Maja; Sersa, Gregor] Inst Oncol Ljubljana, Dept Expt Oncol, Ljubljana, Slovenia; [Cemazar, Maja] Univ Primorska, Fac Hlth Sci, Izola, Slovenia; [Music, Maja M.] Inst Oncol Ljubljana, Dept Radiol, Ljubljana, Slovenia; [Sersa, Gregor] Univ Ljubljana, Fac Hlth Sci, Ljubljana, Slovenia	Institute of Oncology - Slovenia; Institute of Oncology - Slovenia; Institute of Oncology - Slovenia; University of Primorska; Institute of Oncology - Slovenia; University of Ljubljana	Sersa, G (corresponding author), Inst Oncol Ljubljana, Dept Expt Oncol, Ljubljana, Slovenia.; Sersa, G (corresponding author), Univ Ljubljana, Fac Hlth Sci, Ljubljana, Slovenia.	gsersa@onko-i.si		Sersa, Gregor/0000-0002-7641-5670	Slovenian Research Agency (ARRS) [P3-003, J3-5505]	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia)	This work was supported by the Slovenian Research Agency (ARRS), grant No. P3-003 and No. J3-5505. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander H R, 2001, CANC PRINCIPLES PRAC; Aschoff AJ, 2001, J MAGN RESON IMAGING, V13, P57, DOI 10.1002/1522-2586(200101)13:1<57::AID-JMRI1009>3.0.CO;2-N; Campana LG, 2016, RADIOL ONCOL, V50, P1, DOI 10.1515/raon-2016-0006; Cemazar M, 2001, BRIT J CANCER, V84, P565, DOI 10.1054/bjoc.2000.1625; Czymek R, 2012, SURG ONCOL, V21, P79, DOI 10.1016/j.suronc.2010.10.007; Edhemovic I, 2011, TECHNOL CANCER RES T, V10, P475, DOI 10.7785/tcrt.2012.500224; Edhemovic I, 2014, J SURG ONCOL, V110, P320, DOI 10.1002/jso.23625; Goldberg SN, 2009, J VASC INTERV RADIOL, V20; Gonzalez Hector Daniel, 2007, HPB (Oxford), V9, P251, DOI 10.1080/13651820701457992; Jarm T, 2010, EXPERT REV ANTICANC, V10, P729, DOI 10.1586/ERA.10.43; Jaroszeski MJ, 2001, EUR J CANCER, V37, P414, DOI 10.1016/S0959-8049(00)00407-X; Jaroszeski MJ, 2001, EUR J CANCER, V37, P422, DOI 10.1016/S0959-8049(00)00412-3; Jiang CL, 2015, IEEE T BIO-MED ENG, V62, P4, DOI 10.1109/TBME.2014.2367543; Kasper HU, 2010, PATHOL INT, V60, P149, DOI 10.1111/j.1440-1827.2009.02498.x; Kos B, 2015, RADIOL ONCOL, V49, P234, DOI 10.1515/raon-2015-0031; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Mali B, 2013, EJSO-EUR J SURG ONC, V39, P4, DOI 10.1016/j.ejso.2012.08.016; Miklavcic D, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/1475-925X-14-S3-I1; Misiakos EP, 2011, WORLD J GASTROENTERO, V17, P4067, DOI 10.3748/wjg.v17.i36.4067; Niessen C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43687; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P255, DOI 10.1177/153303460700600401; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; Sersa G, 2008, EJSO-EUR J SURG ONC, V34, P232, DOI 10.1016/j.ejso.2007.05.016; Sersa G, 2008, BRIT J CANCER, V98, P388, DOI 10.1038/sj.bjc.6604168; TOUNEKTI O, 1995, EXP CELL RES, V217, P506, DOI 10.1006/excr.1995.1116; Yarmush ML, 2014, ANNU REV BIOMED ENG, V16, P295, DOI 10.1146/annurev-bioeng-071813-104622	26	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180709	10.1371/journal.pone.0180709	http://dx.doi.org/10.1371/journal.pone.0180709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686650	Green Published, Green Submitted, gold			2022-12-26	WOS:000405464100092
J	Leventer-Roberts, M; Hammerman, A; Brufman, I; Hoshen, M; Braun, M; Ashur, Y; Lieberman, N; Balicer, R				Leventer-Roberts, Maya; Hammerman, Ariel; Brufman, Ilan; Hoshen, Moshe; Braun, Marius; Ashur, Yaffa; Lieberman, Nicky; Balicer, Ran			Effectiveness of dasabuvir/ombitasvir/ paritaprevir/ritonavir for hepatitis C virus in clinical practice: A population-based observational study	PLOS ONE			English	Article							GENOTYPE 1; HCV; RIBAVIRIN; INFECTION; DASABUVIR; REGIMENS; ABT-450/R-OMBITASVIR; CIRRHOSIS; THERAPY; ISRAEL	Background Direct acting antivirals for hepatitis C virus have shown dramatic results in clinical trials. However, their effectiveness has yet to be demonstrated within observational cohorts which lack exclusion criteria found in randomized control trials. Aim To determine the effectiveness of dasabuvir/ombitasvir/paritaprevir/ritonavir in achieving sustained virological response. Methods Retrospective observational cohort study of all Clalit Health Services members with hepatitis C virus genotype 1 who were dispensed dasabuvir/ombitasvir/paritaprevir/ritonavir from January 1, 2015 to- November 31, 2015. Results There were 564 participants during the study period. The average age was 61.9 years, 52.0% were male, and 61.5% were born Eastern/Central Europe or Central Asia. The prevalence of diabetes was 31.7% and 70.3% were overweight/obese. Cirrhosis was present in 41.0% of participants, of whom 52.8% had stage 4 fibrosis. Of the cohort, 416 ( 74.8%) had follow- up viral load testing at 10 or more weeks after the end of treatment. We report a sustained virological response of 98.8% among those tested. Conclusions Treatment with dasabuvir/ombitasvir/paritaprevir/ritonavir demonstrated a near universal effectiveness in achieving a sustained virological response among HCV patients in a large cohort.	[Leventer-Roberts, Maya; Brufman, Ilan; Hoshen, Moshe; Balicer, Ran] Clalit Res Inst, Tel Aviv, Israel; [Leventer-Roberts, Maya] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Hammerman, Ariel; Braun, Marius; Balicer, Ran] Clalit Hlth Serv, Chief Phys Off, Tel Aviv, Israel; [Braun, Marius] Beilinson Med Ctr, Liver Unit, Petah Tiqwa, Israel; [Braun, Marius] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Ashur, Yaffa] Clalit Hlth Serv, Hepatol, Tel Aviv, Israel; [Lieberman, Nicky] Clalit Hlth Serv, Community Med Div, Tel Aviv, Israel; [Balicer, Ran] Ben Gurion Univ Negev, Dept Epidemiol, Fac Hlth Sci, Beer Sheva, Israel	Icahn School of Medicine at Mount Sinai; Clalit Health Services; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Clalit Health Services; Clalit Health Services; Ben Gurion University	Leventer-Roberts, M (corresponding author), Clalit Res Inst, Tel Aviv, Israel.; Leventer-Roberts, M (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	mayale3@clalit.org.il	Hammerman, Ariel/AAG-4399-2020	Hammerman, Ariel/0000-0002-4396-5246	Abbvie; MSD; Jansen; Gilead; Novartis; Roche; BMS	Abbvie(AbbVie); MSD; Jansen; Gilead(Gilead Sciences); Novartis(Novartis); Roche(Roche Holding); BMS(Bristol-Myers Squibb)	Dr. Braun reports receiving consulting fees from Abbvie, MSD, and Jansen; educational travel grants from Gilead and Novartis; and personal fees from Roche and BMS. All other authors have no conflicts of interest to disclose. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Andreone P, 2014, GASTROENTEROLOGY, V147, P359, DOI 10.1053/j.gastro.2014.04.045; [Anonymous], 2014, J HOPK ACG SYST VERS; Ara A Kardashian, 2015, Gastroenterol Hepatol (N Y), V11, P458; Backus LI, 2016, ALIMENT PHARM THER, V44, P400, DOI 10.1111/apt.13696; Backus LI, 2015, ALIMENT PHARM THER, V42, P559, DOI 10.1111/apt.13300; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Fabrizi F, 2015, EXPERT REV CLIN PHAR, V8, P785, DOI 10.1586/17512433.2015.1086266; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Gutierrez JA, 2015, J VIRAL HEPATITIS, V22, P861, DOI 10.1111/jvh.12422; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Ioannou GN, 2016, GASTROENTEROLOGY; Karpati T, 2014, POPUL HEALTH METR, V12, DOI 10.1186/s12963-014-0032-y; Klibanov OM, 2015, ANN PHARMACOTHER, V49, P566, DOI 10.1177/1060028015570729; Kohli A, 2015, ANN INTERN MED, V163, P899, DOI 10.7326/M15-0642; Maruyama A, 2015, NEPHROL DIAL TRANSPL; Najafzadeh M, 2015, ANN INTERN MED, V162, P407, DOI 10.7326/M14-1152; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Saeed S, 2016, CLIN INFECT DIS, V62, P919, DOI 10.1093/cid/civ1222; Shmueli A, 2007, HEALTH ECON POLICY L, V2, P251, DOI 10.1017/S1744133107004100; Sulkowski MS, 2015, JAMA-J AM MED ASSOC, V313, P1223, DOI 10.1001/jama.2015.1328; Suwanthawornkul T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145953; Walker DR, 2015, ADV THER, V32, P1117, DOI 10.1007/s12325-015-0258-5; Wilder JM, 2015, THER ADV CHRONIC DIS, V6, P314, DOI 10.1177/2040622315603642; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561	24	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0176858	10.1371/journal.pone.0176858	http://dx.doi.org/10.1371/journal.pone.0176858			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686590	gold, Green Published, Green Submitted			2022-12-26	WOS:000405464100003
J	Marild, K; Tapia, G; Haugen, M; Dahl, SR; Cohen, AS; Lundqvist, M; Lie, BA; Stene, LC; Stordal, K				Marild, Karl; Tapia, German; Haugen, Margareta; Dahl, Sandra R.; Cohen, Arieh S.; Lundqvist, Marika; Lie, Benedicte A.; Stene, Lars C.; Stordal, Ketil			Maternal and neonatal vitamin D status, genotype and childhood celiac disease	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; GENOME-WIDE ASSOCIATION; NORWEGIAN MOTHER; NATIONWIDE COHORT; PREGNANT-WOMEN; D DEFICIENCY; D LEVEL; RISK; BIRTH; MOBA	Background Low concentration of 25-hydroxyvitamin D during pregnancy may be associated with offspring autoimmune disorders. Little is known about environmental triggers except gluten for celiac disease, a common immune-mediated disorder where seasonality of birth has been reported as a risk factor. We therefore aimed to test whether low maternal and neonatal 25hydroxyvitamin D predicted higher risk of childhood celiac disease. Methods and Findings In this Norwegian nationwide pregnancy cohort (n = 113,053) and nested case-control study, we analyzed 25-hydroxyvitamin D in maternal blood from mid-pregnancy, postpartum and cord plasma of 416 children who developed celiac disease and 570 randomly selected controls. Mothers and children were genotyped for established celiac disease and vitamin D metabolism variants. We used mixed linear regression models and logistic regression to study associations. There was no significant difference in average 25-hydroxyvitamin D between cases and controls (63.1 and 62.1 nmol/l, respectively, p = 0.28), and no significant linear trend (adjusted odds ratio per 10 nM increase 1.05, 95% CI: 0.93 +/- 1.17). Results were similar when analyzing the mid-pregnancy, postpartum or cord plasma separately. Genetic variants for vitamin D deficiency were not associated with celiac disease (odds ratio per risk allele of the child, 1.00; 95% CI, 0.90 to 1.10, odds ratio per risk allele of the mother 0.94; 95% CI 0.85 to 1.04). Vitamin D intake in pregnancy or by the child in early life did not predict later celiac disease. Adjustment for established genetic risk markers for celiac disease gave similar results. Conclusions We found no support for the hypothesis that maternal or neonatal vitamin D status is related to the risk of childhood celiac disease.	[Marild, Karl; Tapia, German; Haugen, Margareta; Stene, Lars C.; Stordal, Ketil] Norwegian Inst Publ Hlth, Oslo, Norway; [Dahl, Sandra R.] Oslo Univ Hosp, Aker Hormone Lab, Oslo, Norway; [Cohen, Arieh S.; Lundqvist, Marika] Statens Serum Inst, Danish Ctr Newborn Screening, Copenhagen, Denmark; [Lie, Benedicte A.] Univ Oslo, Dept Med Genet, Oslo, Norway; [Lie, Benedicte A.] Oslo Univ Hosp, Oslo, Norway; [Stordal, Ketil] Ostfold Hosp Trust, Dept Pediat, Gralum, Norway	Norwegian Institute of Public Health (NIPH); University of Oslo; Statens Serum Institut; University of Oslo; University of Oslo	Stordal, K (corresponding author), Norwegian Inst Publ Hlth, Oslo, Norway.; Stordal, K (corresponding author), Ostfold Hosp Trust, Dept Pediat, Gralum, Norway.	ketil.stordal@fhi.no	Tapia, German/AAS-8467-2020	Tapia, German/0000-0002-1770-1183; Stordal, Ketil/0000-0001-7826-8646	Norwegian Ministry of Health and Care Services; Ministry of Education and Research, NIH/NIEHS [N01-ES-75558]; NIH/NINDS [1 UO1 NS 047537-01, 2 UO1 NS 047537-06A1]; Research Council of Norway; Oak Foundation, Geneva, Switzerland	Norwegian Ministry of Health and Care Services; Ministry of Education and Research, NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Research Council of Norway(Research Council of Norway); Oak Foundation, Geneva, Switzerland	The Norwegian Mother and Child Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research, NIH/NIEHS (contract no N01-ES-75558), NIH/NINDS (grant no.1 UO1 NS 047537-01 and grant no.2 UO1 NS 047537-06A1). The sub-study was funded by a research grant from the Research Council of Norway. Dr Stordal was supported by an unrestricted grant from Oak Foundation, Geneva, Switzerland.	Aghajafari F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1169; Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Aitken RJ, 2016, METHODS MOL BIOL, V1433, P13, DOI 10.1007/7651_2015_307; [Anonymous], [No title captured]; Aronsson CA, 2015, PEDIATRICS, V135, P239, DOI 10.1542/peds.2014-1787; BOUILLON R, 1981, J CLIN INVEST, V67, P589, DOI 10.1172/JCI110072; Brantsaeter AL, 2008, MATERN CHILD NUTR, V4, P28, DOI 10.1111/j.1740-8709.2007.00103.x; Brantsaeter AL, 2007, ANN NUTR METAB, V51, P146, DOI 10.1159/000103275; Camargo CA, 2011, PEDIATRICS, V127, pE180, DOI 10.1542/peds.2010-0442; Capriati T, 2015, EUR J PEDIATR, V174, P1657, DOI 10.1007/s00431-015-2589-2; Chen YH, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/1476-069X-14-9; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; Dilthey A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002877; Guillot X, 2010, JOINT BONE SPINE, V77, P552, DOI 10.1016/j.jbspin.2010.09.018; Haugen M, 2008, ANN NUTR METAB, V52, P272, DOI 10.1159/000146274; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holvik K, 2015, AM J CLIN NUTR, V102, P1289, DOI 10.3945/ajcn.115.110528; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Ivarsson A, 2003, J EPIDEMIOL COMMUN H, V57, P36, DOI 10.1136/jech.57.1.36; Lebwohl B, 2013, ARCH DIS CHILD, V98, P48, DOI 10.1136/archdischild-2012-302360; Lewy H, 2009, J PEDIATR GASTR NUTR, V48, P181, DOI 10.1097/MPG.0b013e3181709530; Liu E, 2014, NEW ENGL J MED, V371, P42, DOI 10.1056/NEJMoa1313977; Lohi S, 2007, ALIMENT PHARM THERAP, V26, P1217, DOI 10.1111/j.1365-2036.2007.03502.x; Magnus MC, 2013, PAEDIATR PERINAT EP, V27, P532, DOI 10.1111/ppe.12080; Magnus P, 2016, INT J EPIDEMIOL, V45, P382, DOI 10.1093/ije/dyw029; Marild K, 2015, ACTA PAEDIAT; Marild K, 2015, AM J GASTROENTEROL, V110, P1475, DOI 10.1038/ajg.2015.287; Meltzer HM, 2008, MATERN CHILD NUTR, V4, P14, DOI 10.1111/j.1740-8709.2007.00104.x; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Morales E, 2012, EPIDEMIOLOGY, V23, P64, DOI 10.1097/EDE.0b013e31823a44d3; Munger KL, 2016, JAMA NEUROL; Myleus A, 2009, J PEDIATR GASTR NUTR, V49, P170, DOI 10.1097/MPG.0b013e31818c52cc; Namatovu F, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0613-y; Nissen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089907; Pettifor JM, 2005, ENDOCRIN METAB CLIN, V34, P537, DOI 10.1016/j.ecl.2005.04.002; Pourshahidi LK, 2015, P NUTR SOC, V74, P115, DOI 10.1017/S0029665114001578; Romanos J, 2014, GUT, V63, P415, DOI 10.1136/gutjnl-2012-304110; Ronningen KS, 2006, EUR J EPIDEMIOL, V21, P619, DOI 10.1007/s10654-006-9041-x; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V137, P88, DOI 10.1053/j.gastro.2009.03.059; Saccone D, 2015, GENE, V561, P171, DOI 10.1016/j.gene.2015.02.024; Selvaraj P, 2009, J CLIN IMMUNOL, V29, P470, DOI 10.1007/s10875-009-9277-9; Shea MK, 2009, EUR J CLIN NUTR, V63, P458, DOI 10.1038/sj.ejcn.1602959; Sorensen IM, 2012, DIABETES, V61, P175, DOI 10.2337/db11-0875; Tanpowpong P, 2013, J PEDIATR-US, V162, P501, DOI 10.1016/j.jpeds.2012.08.056; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Wang YT, 2009, AM J EPIDEMIOL, V170, P88, DOI 10.1093/aje/kwp086	47	18	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179080	10.1371/journal.pone.0179080	http://dx.doi.org/10.1371/journal.pone.0179080			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686601	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000405464100009
J	Miazgowski, T; Kucharski, R; Soltysiak, M; Taszarek, A; Miazgowski, B; Widecka, K				Miazgowski, Tomasz; Kucharski, Robert; Soltysiak, Marta; Taszarek, Aleksandra; Miazgowski, Bartosz; Widecka, Krystyna			Visceral fat reference values derived from healthy European men and women aged 20-30 years using GE Healthcare dual-energy x-ray absorptiometry	PLOS ONE			English	Article							METABOLIC SYNDROME; ADIPOSE-TISSUE; INSULIN-RESISTANCE; ASSOCIATIONS; OBESITY; MASS; ACCUMULATION; REDUCTION; DENSITY; LUNAR	Dual energy X-ray absorptiometry (DXA) is an established technique used in clinical and research settings to evaluate total and regional fat. Additionally, recently developed software allow to quantify visceral adipose tissue (VAT). Currently, there are no reference values available for GE Healthcare DXA systems for VAT. The aim of this study was to develop reference values for VAT in healthy European adults aged 20-30 years using a GE Healthcare Prodigy densitometer along with the dedicated CoreScan application. We also assessed the associations of VAT with traditional cardiometabolic risk factors. In 421 participants (207 men; 214 women), we performed DXA whole-body scans and calculated total body fat (BF) and VAT (in gender-specific percentiles). We also measured blood pressure and fasting glucose, insulin, and blood lipids. Males, in comparison with females, had 2-fold greater VAT both in units of mass (542 +/- 451 g; 95% CI: 479.6-605.1 g vs. 258 +/- 226 g; 95% CI: 226.9-288.6 g) and volume (570 +/- 468 cm(3); 95% CI: 505.1-635.2 cm 3 vs. 273 +/- 237 cm 3; 95% CI: 240.6-305.3 cm(3)). They also had significantly higher the VAT/BF ratio. VAT showed a stronger positive correlation than BF with blood pressure, triglycerides, LDL-cholesterol, glucose, insulin, and homeostasis model assessment-insulin resistance index and a stronger negative correlation with HDL-cholesterol. Among these variables, VAT had the highest area under the curve for triglycerides >= 150 mg/dL (0.727 in males and 0.712 in females). In conclusion, we provide reference values for VAT obtained from healthy adults using the GE Healthcare DXA. These values may be useful in the diagnosis of visceral obesity, for identifying subjects with high obesity-related risks, in epidemiological studies, as a target for therapies, and in physically trained individuals. In both genders, VAT was associated with traditional cardiometabolic risk factors, particularly hypertriglyceridemia.	[Miazgowski, Tomasz; Kucharski, Robert; Soltysiak, Marta; Taszarek, Aleksandra; Miazgowski, Bartosz; Widecka, Krystyna] Pomeranian Med Univ, Dept Hypertens & Internal Med, Szczecin, Poland; [Kucharski, Robert] Med Univ Warsaw, Dept Gen Transplant & Liver Surg, Liver & Internal Med Unit, Warsaw, Poland	Pomeranian Medical University; Medical University of Warsaw	Miazgowski, T (corresponding author), Pomeranian Med Univ, Dept Hypertens & Internal Med, Szczecin, Poland.	miazgowski@interia.pl	Miazgowski, Tomasz/H-9448-2014; Widecka, Krystyna/A-9510-2016	Miazgowski, Tomasz/0000-0002-4819-9376; Widecka, Krystyna/0000-0003-4574-927X	Polish Osteoporosis Foundation	Polish Osteoporosis Foundation	This study was financially supported by funding grant from the Polish Osteoporosis Foundation. The funders had no role in study design, data collection and analysis, decisionto publish, or preparation of the manuscrip	Arakaki Shingo, 2016, World J Gastrointest Pharmacol Ther, V7, P261, DOI 10.4292/wjgpt.v7.i2.261; Bazzocchi A, 2016, EUR J RADIOL, V85, P1481, DOI 10.1016/j.ejrad.2016.04.004; Bednarek-Tupikowska G, 2012, ENDOKRYNOL POL, V63, P447; Bi X, 2015, EUR J CLIN NUTR, V69, P329, DOI 10.1038/ejcn.2014.227; Bouchi R, 2017, ENDOCR J, V64, P269, DOI 10.1507/endocrj.EJ16-0449; Brede S, 2016, VISC MED, V32, P336, DOI 10.1159/000449028; Gillette-Guyonnet S, 2003, MECH AGEING DEV, V124, P317, DOI 10.1016/S0047-6374(02)00199-9; Guerrero-Romero F, 2016, ARCH MED RES, V47, P382, DOI 10.1016/j.arcmed.2016.08.012; Jung SH, 2016, YONSEI MED J, V57, P674, DOI 10.3349/ymj.2016.57.3.674; Kaul S, 2012, OBESITY, V20, P1313, DOI 10.1038/oby.2011.393; Kawada T, 2013, INT J ENDOCRINOL MET, V11, DOI 10.5812/ijem.10418; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Keswell D, 2016, CARDIOVASC J AFR, V27, P177, DOI 10.5830/CVJA-2015-088; Kwon MS, 2016, IRAN J PUBLIC HEALTH, V45, P949; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Matsuzawa Y, 2011, J ATHEROSCLER THROMB, V18, P629, DOI 10.5551/jat.7922; Mellis MG, 2014, EUR J CLIN NUTR, V68, P1365, DOI 10.1038/ejcn.2014.213; Miazgowski T, 2014, ENDOCRINE, V47, P500, DOI 10.1007/s12020-014-0180-7; Moreno B, 2016, ENDOCRINE, V54, P681, DOI 10.1007/s12020-016-1050-2; Neeland IJ, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.28; Patel P, 2013, NUTRIENTS, V5, P2019, DOI 10.3390/nu5062019; Reinhardt M, 2017, OBESITY, V25, P332, DOI 10.1002/oby.21722; Shepherd JA, 2012, J BONE MINER RES, V27, P2208, DOI 10.1002/jbmr.1654; Shuster A, 2012, BRIT J RADIOL, V85, P1, DOI 10.1259/bjr/38447238; Taverna MJ, 2011, EUR J ENDOCRINOL, V164, P559, DOI 10.1530/EJE-10-1039; Van Wijk DF, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002823	26	30	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180614	10.1371/journal.pone.0180614	http://dx.doi.org/10.1371/journal.pone.0180614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683146	gold, Green Submitted, Green Published			2022-12-26	WOS:000405335200054
J	Tovar-Salazar, A; Weinberg, A				Tovar-Salazar, Adriana; Weinberg, Adriana			Cytomegalovirus infection in HIV-infected and uninfected individuals is characterized by circulating regulatory T cells of unconstrained antigenic specificity	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; ACTIVE ANTIRETROVIRAL THERAPY; PERSISTENT VIRUS; CUTTING EDGE; IN-VITRO; RISK; DISEASE; CD4(+); AIDS; CMV	Cytomegalovirus (CMV) infection is associated with immune-suppression in immune-compromised hosts and old adults. We previously showed that ex vivo CMV restimulation of peripheral blood mononuclear cells (PBMC) of CMV-seropositive volunteers expanded CD4+CD27-CD28-regulatory T cells (Tregs). Here we evaluate the phenotype and function of circulating CD4+CD27-CD28-T cells of CMV-seropositive adults. Compared with CMV-seronegative, CMV-seropositive adults had 10-fold higher CD4+CD27-CD28-% T cells in PBMC. Circulating CD4+CD27-CD28-T cells from both CMV-seropositive and seronegative donors expressed higher levels of TGF beta, granzyme B, CD39, CD147 and IL-35, and lower levels of CD127, compared with their parent circulating CD4+T cells. However, only CMV-seropositive circulating CD4+CD27-CD28-had increased FOXP3 expression. CD4+CD27-CD28-sorted from the PBMC of CMV-seropositive donors expanded ex vivo in the presence of rhIL2 and inhibited ex vivo proliferation of autologous PBMC restimulated with CMV, varicella-zoster virus or C. albicans antigens. CD4+CD27CD28- sorted from CMV-seronegative PBMC did not expand in the presence of rhIL2 and did not inhibit autologous PBMC proliferation. CD3+CD27-CD28-circulating T cells (>= 80% CD8+) from CMV-seropositive HIV-infected donors also inhibited ex vivo proliferation of autologous PBMC restimulated with CMV or HIV. These data indicate that CMVseropositive individuals have circulating Tregs that inhibit cell-mediated immune responses to CMV and other antigens and may be contribute to an immune-suppressive effect of CMV infection. Moreover, the phenotypic similarity between circulating CD4 +CD27-CD28-Tregs with differentiated effector T cells suggests that the two T-cell subsets might evolve in parallel or in sequence from the same progenitor cells in response to CMV stimulation during reactivations.	[Tovar-Salazar, Adriana; Weinberg, Adriana] Univ Colorado Denver, Anschutz Med Ctr, Sch Med, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Weinberg, A (corresponding author), Univ Colorado Denver, Anschutz Med Ctr, Sch Med, Aurora, CO 80045 USA.	adriana.weinberg@ucdenver.edu		Tovar Salazar, Adriana/0000-0002-5083-755X	National institute of Allergy and Infectious Diseases [R21AI073121]	National institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the National institute of Allergy and Infectious Diseases Grant Number R21AI073121. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Deayton JR, 2004, LANCET, V363, P2116, DOI 10.1016/S0140-6736(04)16500-8; Derhovanessian E, 2014, J IMMUNOL, V193, P3624, DOI 10.4049/jimmunol.1303361; Derhovanessian E, 2013, VACCINE, V31, P685, DOI 10.1016/j.vaccine.2012.11.041; Duhen T, 2012, BLOOD, V119, P4430, DOI 10.1182/blood-2011-11-392324; DuPage M, 2016, NAT REV IMMUNOL, V16, P149, DOI 10.1038/nri.2015.18; Duppach J, 2014, J VIROL, V88, P13892, DOI 10.1128/JVI.01941-14; Egli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043937; Endharti AT, 2005, J IMMUNOL, V175, P7093, DOI 10.4049/jimmunol.175.11.7093; Frasca D, 2015, VACCINE, V33, P1433, DOI 10.1016/j.vaccine.2015.01.071; Furman D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2293; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Holderried TAW, 2013, P NATL ACAD SCI USA, V110, P21089, DOI 10.1073/pnas.1320999110; Hu ZT, 2013, J IMMUNOL, V191, P312, DOI 10.4049/jimmunol.1201773; Jabs DA, 2005, OPHTHALMOLOGY, V112, P771, DOI 10.1016/j.ophtha.2004.10.049; Jahrsdorfer B, 2010, BLOOD, V115, P1156, DOI 10.1182/blood-2009-07-235382; Jesser RD, 2006, VIROLOGY, V352, P408, DOI 10.1016/j.virol.2006.04.035; Johnstone J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108481; Karlsson I, 2007, J VIROL, V81, P13444, DOI 10.1128/JVI.01466-07; Lichtner M, 2015, J INFECT DIS, V211, P178, DOI 10.1093/infdis/jiu417; Molloy MJ, 2011, J IMMUNOL, V186, P6218, DOI 10.4049/jimmunol.1003812; Nigam P, 2010, J IMMUNOL, V184, P1690, DOI 10.4049/jimmunol.0902955; Pawelec G, 2011, VIRUS RES, V157, P175, DOI 10.1016/j.virusres.2010.09.010; Rosenblum MD, 2016, NAT REV IMMUNOL, V16, P90, DOI 10.1038/nri.2015.1; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; RUBIN RH, 1989, JAMA-J AM MED ASSOC, V261, P3607; RUBIN RH, 1990, REV INFECT DIS, V12, pS754; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Shevach EM, 2006, IMMUNOL REV, V212, P60, DOI 10.1111/j.0105-2896.2006.00415.x; Slyker JA, 2009, AIDS, V23, P117, DOI 10.1097/QAD.0b013e32831c8abd; Spencer JV, 2002, J VIROL, V76, P1285, DOI 10.1128/JVI.76.3.1285-1292.2002; Suzuki M, 2012, J IMMUNOL, V189, P2118, DOI 10.4049/jimmunol.1200122; Terrazzini N, 2014, J INFECT DIS, V209, P1382, DOI 10.1093/infdis/jit576; Tovar-Salazar A, 2010, VIROLOGY, V398, P158, DOI 10.1016/j.virol.2009.11.038; Turner JE, 2014, AGE, V36, P287, DOI 10.1007/s11357-013-9557-4; Verschoor CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104522; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; von Herrath MG, 2001, CURR DIRECT AUTOIMMU, V4, P91; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Wang F, 2014, J VIROL, V88, P1011, DOI 10.1128/JVI.02586-13; Weinberg A, 2014, JAIDS-J ACQ IMM DEF, V66, P25, DOI 10.1097/QAI.0000000000000095; Wolf KJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153705; Yu YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028948; Zhao DM, 2006, BLOOD, V107, P3925, DOI 10.1182/blood-2005-11-4502	43	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180691	10.1371/journal.pone.0180691	http://dx.doi.org/10.1371/journal.pone.0180691			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683106	gold, Green Published, Green Submitted			2022-12-26	WOS:000405335200060
J	Bashir, S; Teo, YY; Naeem, S; Ramesh, S; Ramesh, K				Bashir, Shahid; Teo, Yin Yin; Naeem, Sumaira; Ramesh, S.; Ramesh, K.			pH responsive N-succinyl chitosan/Poly (acrylamide-co-acrylic acid) hydrogels and in vitro release of 5-fluorouracil	PLOS ONE			English	Article							DRUG-DELIVERY; INTERPOLYMERIC PH; SENSITIVE HYDROGELS; SWELLING BEHAVIOR; SODIUM ALGINATE; SEMI-IPN; CHITIN; MICROSPHERES; DERIVATIVES; SYSTEM	There has been significant progress in the last few decades in addressing the biomedical applications of polymer hydrogels. Particularly, stimuli responsive hydrogels have been inspected as elegant drug delivery systems capable to deliver at the appropriate site of action within the specific time. The present work describes the synthesis of pH responsive semi-interpenetrating network (semi-IPN) hydrogels of N-succinyl-chitosan (NSC) via Schiff base mechanism using glutaraldehyde as a crosslinking agent and Poly (acrylamide-co-acrylic acid)(Poly (AAm-co-AA)) was embedded within the N-succinyl chitosan network. The physico-chemical interactions were characterized by Fourier transform infrared (FTIR), X-ray diffraction (XRD), thermogravimetric analysis (TGA), and field emission scanning electron microscope (FESEM). The synthesized hydrogels constitute porous structure. The swelling ability was analyzed in physiological mediums of pH 7.4 and pH 1.2 at 37 degrees C. Swelling properties of formulations with various amounts of NSC/Poly (AAm-co-AA) and crosslinking agent at pH 7.4 and pH 1.2 were investigated. Hydrogels showed higher swelling ratios at pH 7.4 while lower at pH 1.2. Swelling kinetics and diffusion parameters were also determined. Drug loading, encapsulation efficiency, and in vitro release of 5-fluorouracil (5FU) from the synthesized hydrogels were observed. In vitro release profile revealed the significant influence of pH, amount of NSC, Poly (AAm-co-AA), and crosslinking agent on the release of 5-FU. Accordingly, rapid and large release of drug was observed at pH 7.4 than at pH 1.2. The maximum encapsulation efficiency and release of 5-FU from SP2 were found to be 72.45% and 85.99%, respectively. Kinetics of drug release suggested controlled release mechanism of 5-FU is according to trend of non-Fickian. From the above results, it can be concluded that the synthesized hydrogels have capability to adapt their potential exploitation as targeted oral drug delivery carriers.	[Bashir, Shahid; Teo, Yin Yin; Naeem, Sumaira] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur, Malaysia; [Ramesh, S.; Ramesh, K.] Univ Malaya, Dept Phys, Ctr Ion, Fac Sci, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Bashir, S (corresponding author), Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur, Malaysia.; Ramesh, S (corresponding author), Univ Malaya, Dept Phys, Ctr Ion, Fac Sci, Kuala Lumpur, Malaysia.	shahidbashirbaig@gmail.com; rameshtsubra@gmail.com	Ramesh, T.Subramaniam/C-2353-2009; Kasi, Ramesh/B-4765-2011; TEO, YIN YIN/B-9948-2010; Bashir, Shahid/AAH-1116-2019; Naeem, Dr. Sumaira/ACV-6371-2022	Ramesh, T.Subramaniam/0000-0002-5505-6429; Kasi, Ramesh/0000-0001-7843-5723; TEO, YIN YIN/0000-0002-2755-5589; Bashir, Shahid/0000-0001-6745-8874; 	Ministry of Education, Malaysia [H21001-F000046];  [RP025A-14 AFR];  [RP017C-14AFR]	Ministry of Education, Malaysia(Ministry of Education, Malaysia); ; 	This work was supported by the High Impact Research Grant (H21001-F000046) from the Ministry of Education, Malaysia, and University of Malaya Research Grants (RP025A-14 AFR and RP017C-14AFR).	Abdelaal MY, 2007, J APPL POLYM SCI, V103, P2864, DOI 10.1002/app.25154; Abreu Fernanda R. de, 2005, Polímeros, V15, P79, DOI 10.1590/S0104-14282005000200004; Alexander-Bryant AA, 2013, ADV CANCER RES, V118, P1, DOI 10.1016/B978-0-12-407173-5.00002-9; Babu VR, 2006, INT J PHARMACEUT, V325, P55, DOI 10.1016/j.ijpharm.2006.06.020; Bashir S, 2016, POLYMER, V92, P36, DOI 10.1016/j.polymer.2016.03.045; Bashir S, 2015, REV CHEM ENG, V31, P563, DOI 10.1515/revce-2015-0016; BRANNONPEPPAS L, 1990, BIOMATERIALS, V11, P635, DOI 10.1016/0142-9612(90)90021-H; Casettari L, 2012, PROG POLYM SCI, V37, P659, DOI 10.1016/j.progpolymsci.2011.10.001; Cheng R, 2013, BIOMATERIALS, V34, P3647, DOI 10.1016/j.biomaterials.2013.01.084; Costa ES, 2009, CARBOHYD POLYM, V76, P472, DOI 10.1016/j.carbpol.2008.11.015; Damaghi M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00370; Dash M, 2012, MATER CHEM PHYS, V135, P1070, DOI 10.1016/j.matchemphys.2012.06.019; El-Sherbiny IM, 2005, EUR POLYM J, V41, P2584, DOI 10.1016/j.eurpolymj.2005.05.035; Feng ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100732; Finetti F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168727; Fournier E, 2003, INT J PHARMACEUT, V268, P31, DOI 10.1016/j.ijpharm.2003.08.014; Ge HC, 2014, CARBOHYD POLYM, V113, P296, DOI 10.1016/j.carbpol.2014.06.078; Gupta P, 2002, DRUG DISCOV TODAY, V7, P569, DOI 10.1016/S1359-6446(02)02255-9; Hashim AI, 2011, NMR BIOMED, V24, P582, DOI 10.1002/nbm.1644; Hawary DL, 2011, J RADIOANAL NUCL CH, V290, P557, DOI 10.1007/s10967-011-1310-9; Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010; Hu XY, 2014, CARBOHYD POLYM, V105, P135, DOI 10.1016/j.carbpol.2014.01.051; Islam A, 2012, CARBOHYD POLYM, V88, P1055, DOI 10.1016/j.carbpol.2012.01.070; Jagadish RS, 2011, FOOD HYDROCOLLOID, V25, P1572, DOI 10.1016/j.foodhyd.2011.01.009; Kajjari PB, 2013, POLYM BULL, V70, P3387, DOI 10.1007/s00289-013-1029-6; Khor E, 2002, CURR OPIN SOLID ST M, V6, P313, DOI 10.1016/S1359-0286(02)00002-5; Kulkarni RV, 2012, J COLLOID INTERF SCI, V367, P509, DOI 10.1016/j.jcis.2011.10.025; Kurita K, 2001, PROG POLYM SCI, V26, P1921, DOI 10.1016/S0079-6700(01)00007-7; Kurita K, 2006, MAR BIOTECHNOL, V8, P203, DOI 10.1007/s10126-005-0097-5; Lee WF, 2001, J APPL POLYM SCI, V82, P2487, DOI 10.1002/app.2099; Li P, 2007, MACROMOL MATER ENG, V292, P962, DOI 10.1002/mame.200700081; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu XH, 2013, ISRN MATH PHYS, V2013, P1, DOI DOI 10.1016/J.MICR0REL.2012.06.140; Malik NS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172727; Mall ID, 2006, COLLOID SURFACE A, V278, P175, DOI 10.1016/j.colsurfa.2005.12.017; Mathur AM, 1996, J MACROMOL SCI R M C, VC36, P405; Mirzaei BE, 2013, INT J POLYM MATER PO, V62, P605, DOI 10.1080/00914037.2013.769165; Mohan YM, 2005, J APPL POLYM SCI, V96, P1153, DOI 10.1002/app.21565; Mourya VK, 2008, REACT FUNCT POLYM, V68, P1013, DOI 10.1016/j.reactfunctpolym.2008.03.002; Mukhopadhyay P, 2014, CARBOHYD POLYM, V112, P627, DOI 10.1016/j.carbpol.2014.06.045; Mukhopadhyay P, 2013, J APPL POLYM SCI, V129, P835, DOI 10.1002/app.38814; Mura C, 2011, CARBOHYD POLYM, V85, P578, DOI 10.1016/j.carbpol.2011.03.017; Nadeem M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158084; Pal K, 2009, DES MONOMERS POLYM, V12, P197, DOI 10.1163/156855509X436030; Patil NS, 1996, BIOMATERIALS, V17, P2343, DOI 10.1016/S0142-9612(96)00089-0; PEPPAS NA, 1993, ADV DRUG DELIVER REV, V11, P1, DOI 10.1016/0169-409X(93)90025-Y; Rama AR, 2015, INT J MOL SCI, V16, P12601, DOI 10.3390/ijms160612601; Ravichandran P, 1997, INT J PHARM, V154, P89, DOI 10.1016/S0378-5173(97)00131-2; Ray D, 2008, J BIOMAT SCI-POLYM E, V19, P1487, DOI 10.1163/156856208786140382; Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001; RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4; Rizwan M, 2017, POLYMERS-BASEL, V9, DOI 10.3390/polym9040137; ROORDA WE, 1986, PHARM WEEKBLAD, V8, P165, DOI 10.1007/BF01959775; Sagara A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164250; Samanta HS, 2014, CARBOHYD POLYM, V106, P109, DOI 10.1016/j.carbpol.2014.01.097; Samanta HS, 2014, CARBOHYD POLYM, V99, P666, DOI 10.1016/j.carbpol.2013.09.004; Sashiwa H, 2003, MACROMOL BIOSCI, V3, P231, DOI 10.1002/mabi.200390029; Sastre RL, 2007, INT J PHARMACEUT, V338, P180, DOI 10.1016/j.ijpharm.2007.02.001; Shantha KL, 2000, INT J PHARM, V207, P65, DOI 10.1016/S0378-5173(00)00533-0; Shim JW, 2003, J APPL POLYM SCI, V90, P3270, DOI 10.1002/app.12992; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Tharanathan RN, 2003, CRIT REV FOOD SCI, V43, P61, DOI 10.1080/10408690390826455; Thurmer MB, 2014, MATER RES-IBERO-AM J, V17, P109, DOI 10.1590/1516-1439.223613; Wang Q, 2005, J APPL POLYM SCI, V96, P808, DOI 10.1002/app.21518; Yan C., 2006, J PHARM SOC JAPAN, V126, P789; Zeitoun AA, 2003, COMP SINGLE DOSE BIO; Zhang JT, 2010, ACTA BIOMATER, V6, P1297, DOI 10.1016/j.actbio.2009.11.005; Zhang XZ, 2002, INT J PHARMACEUT, V235, P43, DOI 10.1016/S0378-5173(01)00976-0; Zhou JQ, 2009, ENZYME MICROB TECH, V45, P299, DOI 10.1016/j.enzmictec.2009.07.007; Zhu AP, 2007, CARBOHYD POLYM, V69, P363, DOI 10.1016/j.carbpol.2006.11.023	70	51	51	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179250	10.1371/journal.pone.0179250	http://dx.doi.org/10.1371/journal.pone.0179250			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678803	gold, Green Published, Green Submitted			2022-12-26	WOS:000405272200010
J	Biadgo, B; Shiferaw, E; Woldu, B; Alene, KA; Melku, M				Biadgo, Belete; Shiferaw, Elias; Woldu, Berhanu; Alene, Kefyalew Addis; Melku, Mulugeta			Transfusion-transmissible viral infections among blood donors at the North Gondar district blood bank, northwest Ethiopia: A three year retrospective study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C VIRUS; SYPHILIS INFECTIONS; SEROPREVALENCE; HIV; PREVALENCE; DISEASES; SEROEPIDEMIOLOGY; HBV	Background Transfusion-transmissible viral infections, such as hepatitis C virus (HCV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV), remain a major public health problem in developing countries. The prevalence of these viral infections among blood donors may reflect the burden of these diseases among populations. Therefore, the aim of this study was to assess the sero-prevalence of transfusion-transmissible viral infections among blood donors. Methods A retrospective study was conducted using data obtained from registration books of blood donors from the Ethiopian North Gondar District Blood Bank from 2010 to 2012. Descriptive statistics, such as percentages, medians and interquartile ranges were computed. A binary logistic regression model was fitted to identify factors associated with each viral infection. The odds ratio with a 99% confidence interval was calculated. A p-value < 0.01 was considered statistically significant. Result A total of 6,471 blood donors were included in the study. Of these, 5,311 (82.1%) were male, and 382 (5.9%) were voluntary blood donors. Overall, 424 (6.55%) of the blood donors were sero-reactive for at least one transfusion-transmissible viral infection. Of all study participants, 233 (3.6%) were sero-reactive for HBV, 145 (2.24%) were sero-reactive for HIV, and 51 (0.8%) were sero-reactive for HCV. Four (0.062%) of the study's participants were co-infected: 3 (75%) with HBV-HCV and 1 (25%) with HIV-HBV-HCV. Being a farmer, unemployed or employed donor was significantly associated with transfusion-transmissible viral infections compared to being a student donor. Conclusion The prevalence of transfusion-transmissible viral infections is substantial and has increased overtime. Hence, it demands more vigilance in routine screening of donated blood prior to transfusion. Further community-based studies to identify societal risk factors are necessary.	[Biadgo, Belete] Univ Gondar, Sch Biomed & Lab Sci, Dept Clin Chem, Coll Med & Hlth Sci, Gondar, Ethiopia; [Shiferaw, Elias; Woldu, Berhanu; Melku, Mulugeta] Univ Gondar, Sch Biomed & Lab Sci, Dept Hematol & Immunohematol, Coll Med & Hlth Sci, Gondar, Ethiopia; [Alene, Kefyalew Addis] Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Melku, M (corresponding author), Univ Gondar, Sch Biomed & Lab Sci, Dept Hematol & Immunohematol, Coll Med & Hlth Sci, Gondar, Ethiopia.	mulugeta.melku@gmail.com	Alene, Dr Kefyalew Addis/V-8240-2018	Alene, Dr Kefyalew Addis/0000-0002-1904-4682				Abdallah TM., 2012, J MED MED SCI, V3, P260; Abeje G, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0756-8; Amiwero CE., 2013, IJMBR, V1, P1, DOI [10.33500/ijmbr.2013.1.001, DOI 10.33500/IJMBR.2013.1.001]; [Anonymous], FED DEM REP ETH NAT; Apata Ibironke W, 2014, MMWR Morb Mortal Wkly Rep, V63, P613; Awases M., 2004, WORLD HLTH ORGAN, V65, P38; Azene Dessie, 2007, Ethiopian Journal of Health Development, V21, P68; Bekele Abebe, 2014, Ethiop Med J, V52, P107; Belyhun Y, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2090-1; Birhaneselassie M, 2016, LAB MED, V47, P134, DOI 10.1093/labmed/lmw003; Bisetegen FS, CANADIAN J INFECT DI, V2016; Buseri FI, 2009, BLOOD TRANSFUS-ITALY, V7, P293, DOI 10.2450/2009.0071-08; CSA ICF, 2012, ETH DEM HLTH SURV 20; Diro Ermias, 2008, Ethiop Med J, V46, P7; Farshadpour F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157615; Federal Democratic Republic of Ethiopia MoH, 2005, NAT BLOOD TRANSF SER; Geberemicheal A, 2013, J ENV OCCUP SCI, V2, P9, DOI DOI 10.5455/JEOS.20130220105759; Gelaw B., 2007, ETHIOP J HEALTH DEV, V22, P3; Halile Meskal F, SURVEY HARMFUL TRADI; Jaddee A., 2014, MED J SRISAKET SURIN, V28, P197; KEFENE H, 1988, J MED VIROL, V24, P75, DOI 10.1002/jmv.1890240110; Khattab MA, 2010, AM J INFECT CONTROL, V38, P640, DOI 10.1016/j.ajic.2009.12.016; Liu CJ, 2006, J CLIN VIROL, V36, pS33, DOI 10.1016/S1386-6532(06)80007-7; Matee MIN, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-21; Mohammed Yusuf, 2016, BMC Res Notes, V9, P129, DOI 10.1186/s13104-016-1925-6; Montana LS, 2008, SEX TRANSM INFECT, V84, pI78, DOI 10.1136/sti.2008.030106; Nada HA., 2013, J BLOOD DISORDERS TR, V5, P177, DOI DOI 10.4172/2155-9864.1000177; Nagalo MB, 2011, BLOOD TRANSFUS-ITALY, V9, P419, DOI 10.2450/2011.0112-10; Noubiap JJN, 2013, INT J INFECT DIS, V17, pE832, DOI 10.1016/j.ijid.2012.12.007; Nwankwo E, 2012, TURK J MED SCI, V42, P337, DOI 10.3906/sag-1009-1176; Nwobegahay JM, 2016, MICROBIOL RES INT, V4, P6; Oner S, 2011, TURK J MED SCI, V41, P335, DOI 10.3906/sag-0906-64; Quadri S. A., 2013, Al Ameen Journal of Medical Sciences, V6, P180; Rerambiah LK, 2014, BLOOD TRANSFUS-ITALY, V12, P330, DOI 10.2450/2013.0144-13; Ryoo SM, 2012, J FORMOS MED ASSOC, V111, P113, DOI 10.1016/j.jfma.2011.05.005; Sermoneta-Gertel S, 2001, INFECT CONT HOSP EP, V22, P754, DOI 10.1086/501858; Sharew B., 2015, CURR RES MICROBIOL B, V3, P614; Song Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094528; Sube KL, 2011, S SUDAN MED J, V7, P76; Teklehaimanot HD, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2918-z; Tesfa Habtie, 2013, BMC Res Notes, V6, P164, DOI 10.1186/1756-0500-6-164; Tessema B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-111; Torbenson M, 2002, LANCET INFECT DIS, V2, P479, DOI 10.1016/S1473-3099(02)00345-6; Tserenpuntsag B, 2008, J INFECT DEV COUNTR, V2, P73, DOI 10.3855/jidc.326; Tserenpuntsag B, 2010, TRANSFUSION, V50, P92, DOI 10.1111/j.1537-2995.2009.02387.x; Tyagi S, 2013, J CLIN DIAGN RES, V7, P1930, DOI 10.7860/JCDR/2013/6002.3360; Walana W., 2014, British Microbiology Research Journal, V4, P1491, DOI 10.9734/BMRJ/2014/12160; WHO, GLOB DAT BLOOD SAF; WHO, BLOOD SAF ETH WHO RE; World Health Organization, GLOB POL REP PREV CO; World Health Organization, BLOOD DON SEL GUID A	51	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180416	10.1371/journal.pone.0180416	http://dx.doi.org/10.1371/journal.pone.0180416			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678865	Green Submitted, gold, Green Published			2022-12-26	WOS:000405272200062
J	Holland, AE; Byrne, ME; Bryan, AL; DeVault, TL; Rhodes, OE; Beasley, JC				Holland, Amanda E.; Byrne, Michael E.; Bryan, A. Lawrence; DeVault, Travis L.; Rhodes, Olin E.; Beasley, James C.			Fine-scale assessment of home ranges and activity patterns for resident black vultures (Coragyps atratus) and turkey vultures (Cathartes aura)	PLOS ONE			English	Article							BROWNIAN BRIDGE MOVEMENT; DESPOTIC DISTRIBUTION; AIRCRAFT COLLISIONS; AVIAN SCAVENGERS; FLIGHT BEHAVIOR; BENEFITS; ECOLOGY; BIRDS; IDENTIFICATION; MIGRATION	Knowledge of black vulture (Coragyps atratus) and turkey vulture (Cathartes aura) spatial ecology is surprisingly limited despite their vital ecological roles. Fine-scale assessments of space use patterns and resource selection are particularly lacking, although development of tracking technologies has allowed data collection at finer temporal and spatial resolution. Objectives of this study were to conduct the first assessment of monthly home range and core area sizes of resident black and turkey vultures with consideration to sex, as well as elucidate differences in monthly, seasonal, and annual activity patterns based on fine-scale movement data analyses. We collected 2.8-million locations for 9 black and 9 turkey vultures from June 2013 -August 2015 using solar-powered GSM/GPS transmitters. We quantified home ranges and core areas using the dynamic Brownian bridge movement model and evaluated differences as a function of species, sex, and month. Mean monthly home ranges for turkey vultures were similar to 50% larger than those of black vultures, although mean core area sizes did not differ between species. Turkey vulture home ranges varied little across months, with exception to a notable reduction in space-use in May, which corresponds with timing of chick-rearing activities. Black vulture home ranges and core areas as well as turkey vulture core areas were larger in breeding season months (January-April). Comparison of space use between male and female vultures was only possible for black vultures, and space use was only slightly larger for females during breeding months (February-May). Analysis of activity patterns revealed turkey vultures spend more time in flight and switch motion states (between flight and stationary) more frequently than black vultures across temporal scales. This study reveals substantive variability in space use and activity rates between sympatric black and turkey vultures, providing insights into potential behavioral mechanisms contributing to niche differentiation between these species.	[Holland, Amanda E.; Beasley, James C.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Holland, Amanda E.; Byrne, Michael E.; Bryan, A. Lawrence; Rhodes, Olin E.; Beasley, James C.] Savannah River Ecol Lab, Aiken, SC 29808 USA; [DeVault, Travis L.] USDA APHIS WS Natl Wildlife Res Ctr, Sandusky, OH USA; [Rhodes, Olin E.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; United States Department of Energy (DOE); Savannah River Ecology Laboratory; United States Department of Agriculture (USDA); University System of Georgia; University of Georgia	Holland, AE (corresponding author), Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.; Holland, AE (corresponding author), Savannah River Ecol Lab, Aiken, SC 29808 USA.	aeholland@gmail.com		Holland, Amanda/0000-0001-5963-2692; DeVault, Travis/0000-0001-6413-1104	UnitedStates Department of Energy [DE-FC090 7SR22506]; United States Department of Agriculture's Animal and Plant Health Inspection Service/Wildlife Services and National Wild life Research Center [13-7439-0959-CA]; Georgia Museum of Natural History , Graduate Laerm Award	UnitedStates Department of Energy(United States Department of Energy (DOE)); United States Department of Agriculture's Animal and Plant Health Inspection Service/Wildlife Services and National Wild life Research Center; Georgia Museum of Natural History , Graduate Laerm Award	This work was funded by UnitedStates Department of Energy, Award No. DE-FC090 7SR22506; United States Department of Agriculture's Animal and Plant Health Inspection Service/Wildlife Services and National Wild life Research Center, Award No.13-7439-0959-CA; and Georgia Museum of Natural History, 2013 Graduate Laerm Award, http://museum.nhm.uga. edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Avery Michael L., 2004, Proceedings of the Vertebrate Pest Conference, V21, P116; Avery ML, 2011, J WILDLIFE MANAGE, V75, P1581, DOI 10.1002/jwmg.205; Beasley J.C., 2015, CARRION ECOLOGY EVOL, P107; Blackwell BF, 2006, J RAPTOR RES, V40, P76, DOI 10.3356/0892-1016(2006)40[76:CORHBJ]2.0.CO;2; Buckley NJ, 1998, WILSON BULL, V110, P122; Buckley NJ, 1997, BEHAV ECOL SOCIOBIOL, V41, P267, DOI 10.1007/s002650050388; Buckley NJ, 1999, ACCOUNT 411 BIRDS N; Bunnefeld N, 2011, J ANIM ECOL, V80, P466, DOI 10.1111/j.1365-2656.2010.01776.x; Byrne ME, 2017, CONDOR, V119, P389, DOI 10.1650/CONDOR-16-76.1; Coleman JS, 1998, J WILDLIFE MANAGE, V53, P782; Cortes-Avizanda A, 2016, FRONT ECOL ENVIRON, V14, P191, DOI 10.1002/fee.1257; DeVault T. L, 2016, WHY DO BIRDS MATTER; DeVault TL, 2005, J WILDLIFE MANAGE, V69, P601, DOI 10.2193/0022-541X(2005)069[0601:FBOBAT]2.0.CO;2; DeVault TL, 2004, CONDOR, V106, P706, DOI 10.1650/7461; DeVault TL, 2013, WILDL MANAGE CONSERV, P1; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; DeVault TL, 2016, J WILDLIFE MANAGE, V80, P746, DOI 10.1002/jwmg.1041; Deygout C, 2010, BEHAV ECOL, V21, P1131, DOI 10.1093/beheco/arq120; Dodge S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0195; Donazar JA, 1999, BEHAV ECOL SOCIOBIOL, V45, P55, DOI 10.1007/s002650050539; Ferguson-Lees J, 2012, RAPTORS WORLD; Fischer JW, 2013, CONDOR, V115, P298, DOI 10.1525/cond.2013.110168; Harel R, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0397; Houston CS, 2011, WILSON J ORNITHOL, V123, P472, DOI 10.1676/10-090.1; HOUSTON DC, 1986, CONDOR, V88, P318, DOI 10.2307/1368878; International Union for Conservation of Nature, 2016, IUCN RED LIST THREAT; Ito H, 2003, ZOOL SCI, V20, P339, DOI 10.2108/zsj.20.339; Jackson J.A., 1983, P245; Kelly NE, 2007, WILSON J ORNITHOL, V119, P267, DOI 10.1676/05-095.1; Kiff Lloyd F., 2000, P175; KIRK DA, 1995, BEHAV ECOL SOCIOBIOL, V36, P323, DOI 10.1007/BF00167793; Kirk DA, 1998, ACCOUNT 339 BIRDS N; Kranstauber B, 2012, J ANIM ECOL, V81, P738, DOI 10.1111/j.1365-2656.2012.01955.x; Kuznetsova A., 2016, J STAT SOFTW, V2, P33; Lopez-Lopez P, 2013, PLOS ONE, V8, P1; Mallon JM, 2016, AUK, V133, P79, DOI 10.1642/AUK-15-114.1; Mandel JT, 2008, P NATL ACAD SCI USA, V105, P19102, DOI 10.1073/pnas.0801789105; Margalida A, 2016, SCI REP-UK, V6, DOI 10.1038/srep35746; Margalida A, 2016, NATURE, V536, P274, DOI 10.1038/536274d; Markandya A, 2008, ECOL ECON, V67, P194, DOI 10.1016/j.ecolecon.2008.04.020; Martin James A., 2011, Human-Wildlife Interactions, V5, P198; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; Microwave Telemetry, 2013, SOL GSM GPS TRANSM; Monsarrat S, 2013, PLOS ONE, V8, P1, DOI DOI 10.1371/J0URN; Negro JJ, 2002, NATURE, V416, P807, DOI 10.1038/416807a; Ogada DL, 2012, CONSERV BIOL, V26, P453, DOI 10.1111/j.1523-1739.2012.01827.x; Ogada DL, 2012, ANN NY ACAD SCI, V1249, P57, DOI 10.1111/j.1749-6632.2011.06293.x; Platt SG, 2015, J RAPTOR RES, V49, P518, DOI 10.3356/rapt-49-04-518-520.1; Rivers JW, 2014, BIRD CONSERV INT, V24, P492, DOI 10.1017/S0959270913000592; Rolando A, 2002, REV ECOL-TERRE VIE, V57, P53; Sauer J. R., 2012, N AM BREEDING SURVEY; WALLACE MP, 1987, AUK, V104, P290, DOI 10.1093/auk/104.2.290; Walter WD, 2012, APPL GEOGR, V35, P53, DOI 10.1016/j.apgeog.2012.05.002; White David L., 2000, Studies in Avian Biology, V21, P8; Wilson EE, 2011, TRENDS ECOL EVOL, V26, P129, DOI 10.1016/j.tree.2010.12.011	56	34	35	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179819	10.1371/journal.pone.0179819	http://dx.doi.org/10.1371/journal.pone.0179819			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678813	Green Published, Green Submitted, gold			2022-12-26	WOS:000405272200029
J	Tijet, N; Faccone, D; Rapoport, M; Seah, C; Pasteran, F; Ceriana, P; Albornoz, E; Corso, A; Petroni, A; Melano, RG				Tijet, Nathalie; Faccone, Diego; Rapoport, Melina; Seah, Christine; Pasteran, Fernando; Ceriana, Paola; Albornoz, Ezequiel; Corso, Alejandra; Petroni, Alejandro; Melano, Roberto G.			Molecular characteristics of mcr-1-carrying plasmids and new mcr-1 variant recovered from polyclonal clinical Escherichia coli from Argentina and Canada	PLOS ONE			English	Article							RESISTANCE GENE MCR-1; ENTEROBACTERIACEAE; MECHANISMS; STRAIN	We have characterized nine mcr-1-harboring plasmids from clinical Escherichia coli isolates previously described in Argentina and Canada. Three of these plasmids carried a mcr-1-variant called here mcr-1.5. All these E. coli isolates were not clonally related and were recovered in different years and locations. However, their mcr-1-harboring plasmids showed high identity among them and to others characterized in other countries, which strongly suggests that this plasmid-type is playing an important role in spreading this mechanism of resistance to polymyxins.	[Tijet, Nathalie; Seah, Christine; Melano, Roberto G.] Publ Hlth Ontario Lab, Toronto, ON, Canada; [Faccone, Diego; Rapoport, Melina; Pasteran, Fernando; Ceriana, Paola; Albornoz, Ezequiel; Corso, Alejandra; Petroni, Alejandro] Inst Nacl Enfermedades Infecciosas INEI ANLIS Dr, Serv Antimicrobianos, Natl & Reg Reference Lab Antimicrobial Resistance, Buenos Aires, DF, Argentina; [Faccone, Diego] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina; [Melano, Roberto G.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Toronto	Melano, RG (corresponding author), Publ Hlth Ontario Lab, Toronto, ON, Canada.; Melano, RG (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	roberto.melano@oahpp.ca		Petroni, Alejandro/0000-0003-1177-7037	internal budget, Public Health Ontario	internal budget, Public Health Ontario	The work was supported by internal budget, Public Health Ontario.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Baron S, 2016, INT J ANTIMICROB AG, V48, P583, DOI 10.1016/j.ijantimicag.2016.06.023; Catry B, 2015, INT J ANTIMICROB AG, V46, P297, DOI 10.1016/j.ijantimicag.2015.06.005; Clinical and Laboratory Standards Institute (CLSI), 2016, M100S262016 CLSI; Di Pilato V, 2016, ANTIMICROB AGENTS CH, V60, P5612, DOI 10.1128/AAC.01075-16; Dominguez JE, 2017, REV ARGENT MICROBIOL; Ellis C, 2013, DIAGN MICR INFEC DIS, V76, P399, DOI 10.1016/j.diagmicrobio.2013.04.017; Elnahriry SS, 2016, ANTIMICROB AGENTS CH, V60, P3249, DOI 10.1128/AAC.00269-16; European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2016, BREAKP TABL INT MICS; Falgenhauer L, 2016, EMERG INFECT DIS, V22, P1689, DOI 10.3201/eid2209.160692; Gao RS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005957; Hu ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep38793; Kieffer N, 2017, ANTIMICROB AGENTS CH; Li AQ, 2016, ANTIMICROB AGENTS CH, V60, P4351, DOI 10.1128/AAC.00550-16; Liakopoulos A, 2016, J ANTIMICROB CHEMOTH, V71, P2335, DOI 10.1093/jac/dkw262; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Lu X, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.02632-16, 10.1128/AAC.02632-16]; Mulvey MR, 2016, LANCET INFECT DIS, V16, P289, DOI [10.1016/S1473-3099(16)00067-0, 10.1016/S1473-3099(15)00540-X]; Olaitan AO, 2016, INT J ANTIMICROB AG, V47, P1, DOI 10.1016/j.ijantimicag.2015.11.009; Payne M, 2016, EMERG INFECT DIS, V22, P1673, DOI 10.3201/eid2209.160177; Petrillo M, 2016, LANCET INFECT DIS, V16, P280, DOI 10.1016/S1473-3099(16)00005-0; Poirel L, 2017, CLIN MICROBIOL REV, V30, P557, DOI 10.1128/CMR.00064-16; Poirel L, 2016, J ANTIMICROB CHEMOTH, V71, P2326, DOI 10.1093/jac/dkw074; Poirel L, 2016, ANTIMICROB AGENTS CH, V60, P4394, DOI 10.1128/AAC.00444-16; Rapoport M, 2016, ANTIMICROB AGENTS CH, V60, P4412, DOI 10.1128/AAC.00573-16; Rhouma M, 2016, INT J ANTIMICROB AG, V48, P119, DOI 10.1016/j.ijantimicag.2016.04.008; Rocha IV, 2017, INT J ANTIMICROB AG, V49, P655, DOI 10.1016/j.ijantimicag.2017.03.001; Schaufler K, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv155; Schwarz S, 2016, J ANTIMICROB CHEMOTH, V71, P2066, DOI 10.1093/jac/dkw274; Sellera FP, 2017, J ANTIMICROB CHEMOTH, V72, P1255, DOI 10.1093/jac/dkw543; Snesrud E, 2016, ANTIMICROB AGENTS CH, V60, P6973, DOI 10.1128/AAC.01457-16; Sonnevend A, 2016, INT J INFECT DIS, V50, P85, DOI 10.1016/j.ijid.2016.07.007; Stojanoski V, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0303-0; Tijet N, 2016, J ANTIMICROB CHEMOTH, V71, P344, DOI 10.1093/jac/dkv356; Turrientes MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105395; Walkty Andrew, 2016, CMAJ Open, V4, pE641, DOI 10.9778/cmajo.20160080; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Xavier B. B., 2016, EURO SURVEILL, V21; Xavier BB, 2016, EUROSURVEILLANCE, V21, DOI [DOI 10.2807/1560-7917.ES.201621.2730280, 10.2807/1560-7917.ES.201621.2730280]; Yang YQ, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.01204-16, 10.1128/AAC.01204-16]; Yu CY, 2017, J ANTIMICROB CHEMOTH, V72, P1253, DOI 10.1093/jac/dkw541; Yu H, 2016, ANTIMICROB AGENTS CH, V60, P5033, DOI 10.1128/AAC.00440-16; Zurfluh K., 2016, SDRP J FOOD SCI TECH, V1, DOI [10.15436/JFST.1.4.5, DOI 10.15436/JFST.1.4.5]; Zurfuh K, 2016, ANTIMICROB AGENTS CH, V60, P2594, DOI 10.1128/AAC.00066-16	44	44	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180347	10.1371/journal.pone.0180347	http://dx.doi.org/10.1371/journal.pone.0180347			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678874	Green Published, gold			2022-12-26	WOS:000405272200058
J	Zehender, G; Veo, C; Ebranati, E; Carta, V; Rovida, F; Percivalle, E; Moreno, A; Lelli, D; Calzolari, M; Lavazza, A; Chiapponi, C; Baioni, L; Capelli, G; Ravagnan, S; Da Rold, G; Lavezze, E; Palu, G; Baldanti, F; Barzon, L; Galli, M				Zehender, Gianguglielmo; Veo, Carla; Ebranati, Erika; Carta, Valentina; Rovida, Francesca; Percivalle, Elena; Moreno, Ana; Lelli, Davide; Calzolari, Mattia; Lavazza, Antonio; Chiapponi, Chiara; Baioni, Laura; Capelli, Gioia; Ravagnan, Silvia; Da Rold, Graziana; Lavezze, Enrico; Palu, Giorgio; Baldanti, Fausto; Barzon, Luisa; Galli, Massimo			Reconstructing the recent West Nile virus lineage 2 epidemic in Europe and Italy using discrete and continuous phylogeography	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; RT-PCR; TRANSMISSION; ENCEPHALITIS; CIRCULATION; DYNAMICS; OUTBREAK; HUMANS; SPREAD; GREECE	West Nile virus lineage 2 (WNV-2) was mainly confined to sub-Saharan Africa until the early 2000s, when it was identified for the first time in Central Europe causing outbreaks of human and animal infection. The aim of this study was to reconstruct the origin and dispersion of WNV-2 in Central Europe and Italy on a phylodynamic and phylogeographical basis. To this aim, discrete and continuous space phylogeographical models were applied to a total of 33 newly characterised full-length viral genomes obtained from mosquitoes, birds and humans in Northern Italy in the years 2013-2015 aligned with 64 complete sequences isolated mainly in Europe. The European isolates segregated into two highly significant clades: a small one including three sequences and a large clade including the majority of isolates obtained in Central Europe since 2004. Discrete phylogeographical analysis showed that the most probable location of the root of the largest European clade was in Hungary a mean 12.78 years ago. The European clade bifurcated into two highly supported subclades: one including most of the Central/East European isolates and the other encompassing all of the isolates obtained in Greece. The continuous space phylogeographical analysis of the Italian clade showed that WNV-2 entered Italy in about 2008, probably by crossing the Adriatic sea and reaching a central area of the Po Valley. The epidemic then spread simultaneously eastward, to reach the region of the Po delta in 2013, and westward to the border area between Lombardy and Piedmont in 2014; later, the western strain changed direction southward, and reached the central area of the Po valley once again in 2015. Over a period of about seven years, the virus spread all over an area of northern Italy by following the Po river and its main tributaries.	[Zehender, Gianguglielmo; Veo, Carla; Ebranati, Erika; Carta, Valentina; Galli, Massimo] Univ Milan, Dept Biomed & Clin Sci L Sacco, Milan, Italy; [Zehender, Gianguglielmo; Veo, Carla; Ebranati, Erika; Carta, Valentina; Galli, Massimo] Univ Milan, CRC Coordinated Res Ctr EpiSoMI, Milan, Italy; [Rovida, Francesca; Percivalle, Elena; Baldanti, Fausto] Fdn IRCCS Policlin San Matteo, Microbiol & Virol Dept, Mol Virol Unit, Pavia, Italy; [Moreno, Ana; Lelli, Davide; Lavazza, Antonio] Expt Zooprophylact Inst Lombardy & Emilia Romagna, Brescia, Italy; [Calzolari, Mattia] Expt Zooprophylact Inst Lombardy & Emilia Romagna, Reggio Emilia, Italy; [Chiapponi, Chiara; Baioni, Laura] Expt Zooprophylact Inst Lombardy & Emilia Romagna, Parma, Italy; [Capelli, Gioia; Ravagnan, Silvia; Da Rold, Graziana] Expt Zooprophylact Inst Venice, Padua, Italy; [Lavezze, Enrico; Palu, Giorgio; Barzon, Luisa] Univ Padua, Dept Mol Med, Padua, Italy	University of Milan; Luigi Sacco Hospital; University of Milan; IRCCS Fondazione San Matteo; IZS delle Venezie; University of Padua	Zehender, G (corresponding author), Univ Milan, Dept Biomed & Clin Sci L Sacco, Milan, Italy.; Zehender, G (corresponding author), Univ Milan, CRC Coordinated Res Ctr EpiSoMI, Milan, Italy.	gianguglielmo.zehender@unimi.it	Lelli, Davide/AAB-6996-2019; Barzon, Luisa/K-7961-2016; Rovida, Francesca/K-7984-2016; Moreno, Ana/Q-2173-2019; Lelli, Davide DL/K-5178-2016; Baldanti, Fausto/J-4924-2018; Da Rold, Graziana/G-9255-2019; percivalle, elena/K-7994-2016; Calzolari, Mattia/AAB-9487-2019	Lelli, Davide/0000-0002-5775-6058; Barzon, Luisa/0000-0003-0720-8456; Rovida, Francesca/0000-0003-2345-2790; Moreno, Ana/0000-0002-8497-9708; Baldanti, Fausto/0000-0002-3358-8969; Da Rold, Graziana/0000-0002-4935-0349; percivalle, elena/0000-0002-3355-1410; Calzolari, Mattia/0000-0001-7489-2556; Lavezzo, Enrico/0000-0002-3902-8356; Carta, Valentina/0000-0003-1054-1348; Chiapponi, Chiara/0000-0001-8808-4680; Ravagnan, Silvia/0000-0002-7146-6452	"NANOMAX" Bandiera project - Italian Ministry for Education, University and Research [G42I12000180005]	"NANOMAX" Bandiera project - Italian Ministry for Education, University and Research	This work was partially financed by the "NANOMAX" Bandiera project (2013-2015) funded by Italian Ministry for Education, University and Research (grant number G42I12000180005).	Autorino GL, 2002, EMERG INFECT DIS, V8, P1372, DOI 10.3201/eid0812.020234; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bagnarelli P, 2011, EUROSURVEILLANCE, V16, P5; Bakonyi T, 2006, EMERG INFECT DIS, V12, P618; Bakonyi T, 2013, VET MICROBIOL, V165, P61, DOI 10.1016/j.vetmic.2013.03.005; Barzon L, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.07.018; Barzon L, 2013, EUROSURVEILLANCE, V18, P11, DOI 10.2807/1560-7917.ES2013.18.38.20591; Barzon L, 2013, INT J ENV RES PUB HE, V10, P4669, DOI 10.3390/ijerph10104669; Bielejec F, 2016, MOL BIOL EVOL, V33, P2167, DOI 10.1093/molbev/msw082; Colpitts TM, 2012, CLIN MICROBIOL REV, V25, P635, DOI 10.1128/CMR.00045-12; Del Amo J, 2013, J VIROL METHODS, V189, P321, DOI 10.1016/j.jviromet.2013.02.019; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Faria NR, 2012, INFECT GENET EVOL, V12, P453, DOI 10.1016/j.meegid.2011.04.028; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hernandez-Triana LM, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00271; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kolodziejek J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126381; Lemey P., 2009, PLOS CURR-TREE LIFE, V1, DOI [10.1371/currents.rrn1031, 10.1371/currents.RRN1031, DOI 10.1371/CURRENTS.RRN1031]; Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067; Magurano F, 2012, CLIN MICROBIOL INFEC, V18, pE545, DOI 10.1111/1469-0691.12018; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; Papa A, 2010, EUROSURVEILLANCE, V15; Papa A, 2010, VECTOR-BORNE ZOONOT, V10, P655, DOI 10.1089/vbz.2010.0042; Petric D, MOSQUITOES THEIR CON; Platonov AE, 2001, ANN NY ACAD SCI, V951, P102; Platonov AE, 2011, ZH MIKROBIOL EPIDEMI, V2, P29; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007; Ravagnan S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1031-y; Rizzo C, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.37.30340; Rizzoli A, 2015, EUROSURVEILLANCE, V20, P28, DOI 10.2807/1560-7917.ES2015.20.20.21135; Savini G, 2012, VET MICROBIOL, V158, P267, DOI 10.1016/j.vetmic.2012.02.018; Sirbu A., 2010, EUROSURVEILLANCE, V2011, P16; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Tang YL, 2006, J CLIN VIROL, V36, P177, DOI 10.1016/j.jcv.2006.02.008; Troupin A, 2016, METHODS MOL BIOL, V1435, P15, DOI 10.1007/978-1-4939-3670-0_2; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; van Leeuwen M, 2010, J CLIN MICROBIOL, V48, P1787, DOI 10.1128/JCM.02452-09; Wodak E, 2011, VET MICROBIOL, V149, P358, DOI 10.1016/j.vetmic.2010.12.012; Zehender G, 2011, INFECT GENET EVOL, V11, P646, DOI 10.1016/j.meegid.2011.02.003; Zeller HG, 2004, EUR J CLIN MICROBIOL, V23, P147, DOI 10.1007/s10096-003-1085-1	44	35	35	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179679	10.1371/journal.pone.0179679	http://dx.doi.org/10.1371/journal.pone.0179679			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678837	Green Submitted, gold, Green Published			2022-12-26	WOS:000405272200022
J	Lumbala, C; Bessell, PR; Lutumba, P; Baloji, S; Bieler, S; Ndung'u, JM				Lumbala, Crispin; Bessell, Paul R.; Lutumba, Pascal; Baloji, Sylvain; Bieler, Sylvain; Ndung'u, Joseph M.			Performance of the SD BIOLINE (R) HAT rapid test in various diagnostic algorithms for gambiense human African trypanosomiasis in the Democratic Republic of the Congo	PLOS ONE			English	Article							SLEEPING SICKNESS; BRUCEI-GAMBIENSE; SERODIAGNOSIS; ELIMINATION; ACCURACY; OPTIONS; MAECT; GENE; DRUG	We carried out a study to compare the performance, in terms of sensitivity and specificity, of the new SD BIOLINE (R) HAT rapid diagnostic test (RDT) with the card agglutination test for trypanosomiasis (CATT) for diagnosis of human African trypanosomiasis (HAT) in the Democratic Republic of the Congo (DRC). Participants were enrolled actively by four mobile teams, and passively at four health facilities in three provinces. Consenting participants were tested concurrently with the RDT and CATT on whole blood. Those found positive by either test were tested with CATT on serial dilutions of plasma, and with a parasitological composite reference standard (CRS). Cases were only the individuals found positive by the CRS, while controls were negative by both CATT and RDT, as well as those that were positive by CATT or RDT, but were negative by the CRS, and had no history of HAT. Over five months, 131 cases and 13,527 controls were enrolled. The sensitivity of the RDT was 92.0% (95% confidence interval (CI) = 86.1-95.5), which was significantly higher than CATT (sensitivity 69.1%; 95% CI = 60.7-76.4). The sensitivity of CATT on plasma at a dilution of 1: 8 was 59.0% (95% CI = 50.2-67.2). The specificity of the RDT was 97.1% (95% CIs = 96.8-97.4) while that of CATT was 98.0% (95% CIs = 97.8, 98.2) and specificities of algorithms involving CATT at 1: 8 dilution were 99.6% (95% CI = 99.5-99.7). Reproducibility of results was excellent. We concluded that an algorithm in which the SD BIOLINE (R) HAT RDT is used for screening is optimal for case detection in both passive and active screening settings. However, the lower specificity of the RDT compared to that of CATT would result in a larger number of false positive individuals undergoing confirmatory testing.	[Lumbala, Crispin; Baloji, Sylvain] PNLTHA, Batiment PNMLS,1 Blvd Triomphal, Kinshasa, DEM REP CONGO; [Bessell, Paul R.] Epi Intervent Ltd, 32 Bell Pl, Edinburgh, Midlothian, Scotland; [Lutumba, Pascal] Univ Kinshasa, Fac Med, Kinshasa, DEM REP CONGO; [Lutumba, Pascal] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Bieler, Sylvain; Ndung'u, Joseph M.] FIND, Campus Biotech,9 Chemin Mines, Geneva, Switzerland	Universite de Kinshasa; Institute Nacional de Recherche Biomedical; Foundation For Innovative New Diagnostics	Bessell, PR (corresponding author), Epi Intervent Ltd, 32 Bell Pl, Edinburgh, Midlothian, Scotland.	prbessell@gmail.com			FIND; Bill & Melinda Gates Foundation; Department for International Development (DFID) of the United Kingdom; Epi Interventions Ltd	FIND; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Department for International Development (DFID) of the United Kingdom; Epi Interventions Ltd	This project was supported by FIND with funding from the Bill & Melinda Gates Foundation and the Department for International Development (DFID) of the United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, o rpreparation of the manuscript. Epi Interventions Ltd. provided support in the form of salaries for author PRB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions'section	Archer E., 2016, RFPERMUTE ESTIMATE P; Barrett MP, 2010, CURR OPIN INFECT DIS, V23, P603, DOI 10.1097/QCO.0b013e32833f9fd0; Bisser S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004608; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Buscher P, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000471; Buscher P, 2014, LANCET GLOB HEALTH, V2, pE359, DOI 10.1016/S2214-109X(14)70203-7; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; Checchi F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001233; DUKES P, 1992, ACTA TROP, V51, P123, DOI 10.1016/0001-706X(92)90054-2; Eperon G, 2014, EXPERT REV ANTI-INFE, V12, P1407, DOI 10.1586/14787210.2014.959496; Franco JR, 2014, PARASITOLOGY, V141, P748, DOI 10.1017/S0031182013002102; Grewal AS, 2016, CURR TOP MED CHEM, V16, P2245, DOI 10.2174/1568026616666160413125335; Harrell FE, 2014, CONTRIBUTIONS CHARLE; Hasker E, 2011, TROP MED INT HEALTH, V16, P869, DOI 10.1111/j.1365-3156.2011.02772.x; Holmes P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003244; Hutchinson OC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-234; Ilboudo H, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004469; Jamonneau V, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003480; Jamonneau V, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000917; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lutumba P, 2006, TROP MED INT HEALTH, V11, P470, DOI 10.1111/j.1365-3156.2006.01591.x; Lutumba P, 2005, EMERG INFECT DIS, V11, P1382; Mitashi P, 2015, TROP MED INT HEALTH, V20, P98, DOI 10.1111/tmi.12404; Mitashi P, 2015, MICROSC RES TECHNIQ, V03, P17, DOI [DOI 10.4236/MR.2015.32003, 10.4236/mr.2015.32003]; Mitashi P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001919; Mukadi P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146450; Nakazawa M., 2014, FMSB FUNCTIONS MED S; Robays J, 2004, TROP MED INT HEALTH, V9, P542, DOI 10.1111/j.1365-3156.2004.01240.x; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Steinmann P, 2015, TROP MED INT HEALTH, V20, P707, DOI 10.1111/tmi.12483; Sternberg JM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003373; Tarral A, 2014, CLIN PHARMACOKINET, V53, P565, DOI 10.1007/s40262-014-0136-3; Van Nieuwenhove L, 2013, TROP MED INT HEALTH, V18, P461, DOI 10.1111/tmi.12058; VanMeirvenne N, 1995, ACTA TROP, V60, P189, DOI 10.1016/0001-706X(95)00127-Z; WHO, 2013, WHO TECH REP SER, V984, P1; WHO Expert Comm, 1998, WHO TECH REP SER, V881, P1	36	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180555	10.1371/journal.pone.0180555	http://dx.doi.org/10.1371/journal.pone.0180555			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672036	Green Published, Green Submitted, gold			2022-12-26	WOS:000405268500066
J	Shimada, T; Tanaka, K; Ishihama, A				Shimada, Tomohiro; Tanaka, Kan; Ishihama, Akira			The whole set of the constitutive promoters recognized by four minor sigma subunits of Escherichia coli RNA polymerase	PLOS ONE			English	Article							PROKARYOTIC GENOME REGULATION; STATIONARY-PHASE; GENE-EXPRESSION; CHROMATIN IMMUNOPRECIPITATION; TRANSCRIPTION ACTIVATION; SIGMA(S)-DEPENDENT GENES; INTRACELLULAR LEVELS; REGULATORY SYSTEM; FLAGELLAR; REGULON	The promoter selectivity of Escherichia coli RNA polymerase (RNAP) is determined by the sigma subunit. The model prokaryote Escherichia coli K-12 contains seven species of the sigma subunit, each recognizing a specific set of promoters. For identification of the | constitutive promoters that are recognized by each RNAP holoenzyme alone in the absence of other supporting factors, we have performed the genomic SELEX screening in vitro for their binding sites along the E. coli K-12 W3110 genome using each of the reconstituted RNAP holoenzymes and a collection of genome DNA segments of E. coli K-12. The whole set of constitutive promoters for each RNAP holoenzyme was then estimated based on the location of RNAP-binding sites. The first successful screening of the constitutive promoters was achieved for RpoD (sigma(70)), the principal sigma for transcription of growth-related genes. As an extension, we performed in this study the screening of constitutive promoters for four minor sigma subunits, stationary-phase specific RpoS (sigma(38)), heat-shock specific RpoH (sigma(32)), flagellar-chemotaxis specific RpoF (sigma(28)) and extra-cytoplasmic stress-response RpoE (sigma(24)). The total number of constitutive promoters were: 129179 for RpoS; 101142 for RpoH; 3441 for RpoF; and 77106 for RpoE. The list of constitutive promoters were compared with that of known promoters identified in vivo under various conditions and using varieties of E. coli strains, altogether allowing the estimation of | inducible promoters in the presence of additional supporting factors.	[Shimada, Tomohiro; Ishihama, Akira] Hosei Univ, Res Ctr Micronano Technol, Koganei, Tokyo, Japan; [Shimada, Tomohiro; Tanaka, Kan] Tokyo Inst Technol, Inst Innovat Res, Lab Chem & Life Sci, Yokohama, Kanagawa, Japan; [Shimada, Tomohiro] Meiji Univ, Sch Agr, Kawasaki, Kanagawa, Japan	Hosei University; Tokyo Institute of Technology; Meiji University	Ishihama, A (corresponding author), Hosei Univ, Res Ctr Micronano Technol, Koganei, Tokyo, Japan.	aishiham@hosei.ac.jp	Shimada, Tomohiro/E-7660-2014; Tanaka, Kan/E-3724-2015	Shimada, Tomohiro/0000-0002-8361-0730; Tanaka, Kan/0000-0001-7560-7884; Ishihama, Akira/0000-0002-6339-9042	National Institute of Genetics; MEXT [21241047, 18310133, 25430173, 24710214, 2082012 (S0801037)]; IFO (Institute for Fermentation, Osaka); MEXT Cooperative Research Program of Network Joint Research Center for Materials and Devices; Grants-in-Aid for Scientific Research [16K07195] Funding Source: KAKEN	National Institute of Genetics; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); IFO (Institute for Fermentation, Osaka); MEXT Cooperative Research Program of Network Joint Research Center for Materials and Devices; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by National Institute of Genetics to YY; MEXT Grants-in-Aid for Scientific Research (A) (21241047), (B) (18310133), and (C) (25430173) to Al; MEXT Grant-in-Aid for Young Scientists (B) (24710214) to TS; Research Fund from IFO (Institute for Fermentation, Osaka) to TS; funding from the MEXT Cooperative Research Program of Network Joint Research Center for Materials and Devices to Al and KT; and funding to Al and TS from the MEXT-Supported Program for the Strategic Research Foundation at Private Universities 2082012 (S0801037) to Hosei University.	ARNOSTI DN, 1989, P NATL ACAD SCI USA, V86, P830, DOI 10.1073/pnas.86.3.830; Barembruch C, 2007, MOL MICROBIOL, V65, P76, DOI 10.1111/j.1365-2958.2007.05770.x; Beck BJ, 1997, J BACTERIOL, V179, P6504, DOI 10.1128/jb.179.21.6862-6864.1997; CHUANG SE, 1993, J BACTERIOL, V175, P5242, DOI 10.1128/JB.175.16.5242-5252.1993; Collet A, 2008, J PROTEOME RES, V7, P4659, DOI 10.1021/pr8001723; Conway T, 2014, MBIO, V5, DOI 10.1128/mBio.01442-14; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fitzgerald DM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004649; FUJITA N, 1987, J BIOL CHEM, V262, P1855; Fujita N, 1996, METHOD ENZYMOL, V273, P121; Glover WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007316; Gogol EB, 2011, P NATL ACAD SCI USA, V108, P12875, DOI 10.1073/pnas.1109379108; Grainger DC, 2006, NUCLEIC ACIDS RES, V34, P4642, DOI 10.1093/nar/gkl542; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Guisbert E, 2008, MICROBIOL MOL BIOL R, V72, P545, DOI 10.1128/MMBR.00007-08; Haas BJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-734; HERMAN C, 1995, P NATL ACAD SCI USA, V92, P3516, DOI 10.1073/pnas.92.8.3516; Herring CD, 2005, J BACTERIOL, V187, P6166, DOI 10.1128/JB.187.17.6166-6174.2005; Hong SH, 2012, MICROB BIOTECHNOL, V5, P509, DOI 10.1111/j.1751-7915.2011.00327.x; Ide N, 1997, GENE, V199, P19, DOI 10.1016/S0378-1119(97)00233-3; IGARASHI K, 1991, CELL, V65, P1015, DOI 10.1016/0092-8674(91)90553-B; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Ishihama A, 1999, GENES CELLS, V4, P135, DOI 10.1046/j.1365-2443.1999.00247.x; Ishihama A, 1997, CURR OPIN GENET DEV, V7, P582, DOI 10.1016/S0959-437X(97)80003-2; Ishihama A., 2016, STRESS ENV CONTROL G, P23; Ishihama A., 1999, NUCLEOID OVERVIEW EC; Ishihama A, 2016, NUCLEIC ACIDS RES, V44, P2058, DOI 10.1093/nar/gkw051; Ishihama A, 2012, P JPN ACAD B-PHYS, V88, P485, DOI 10.2183/pjab.88.485; Ishihama A, 2010, FEMS MICROBIOL REV, V34, P628, DOI 10.1111/j.1574-6976.2010.00227.x; Jishage M, 1997, J BACTERIOL, V179, P959, DOI 10.1128/jb.179.3.959-963.1997; Jishage M, 1996, J BACTERIOL, V178, P5447, DOI 10.1128/jb.178.18.5447-5451.1996; JISHAGE M, 1995, J BACTERIOL, V177, P6832, DOI 10.1128/jb.177.23.6832-6835.1995; Johansen J, 2006, J MOL BIOL, V364, P1, DOI 10.1016/j.jmb.2006.09.004; Karp P, 2014, ECOSAL PLUS; KAWAKAMI K, 1979, MOL GEN GENET, V174, P107, DOI 10.1007/BF00268348; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Kundu TK, 1997, J BACTERIOL, V179, P4264, DOI 10.1128/jb.179.13.4264-4269.1997; KUTSUKAKE K, 1994, J BACTERIOL, V176, P3598, DOI 10.1128/JB.176.12.3598-3605.1994; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; Land M, 2015, FUNCT INTEGR GENOMIC, V15, P141, DOI 10.1007/s10142-015-0433-4; LEMAUX PG, 1978, CELL, V13, P427, DOI 10.1016/0092-8674(78)90317-3; Liu XY, 1996, MOL MICROBIOL, V21, P613, DOI 10.1111/j.1365-2958.1996.tb02569.x; LOEWEN PC, 1994, ANNU REV MICROBIOL, V48, P53, DOI 10.1146/annurev.mi.48.100194.000413; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; MACNAB RM, 1992, ANNU REV GENET, V26, P131, DOI 10.1146/annurev.ge.26.120192.001023; Maeda H, 2000, J BACTERIOL, V182, P1181, DOI 10.1128/JB.182.4.1181-1184.2000; Maeda H, 2000, NUCLEIC ACIDS RES, V28, P3497, DOI 10.1093/nar/28.18.3497; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; Nagamitsu H, 2013, J MOL MICROB BIOTECH, V23, P227, DOI 10.1159/000350370; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; OCHS M, 1995, MOL MICROBIOL, V15, P119, DOI 10.1111/j.1365-2958.1995.tb02226.x; Ogasawara H, 2010, MICROBIOL-SGM, V156, P2470, DOI 10.1099/mic.0.039131-0; OHNISHI K, 1990, MOL GEN GENET, V221, P139, DOI 10.1007/BF00261713; Oshima T, 2002, MOL MICROBIOL, V46, P281, DOI 10.1046/j.1365-2958.2002.03170.x; Panyukov VV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062601; Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2; Peano C, 2015, SCI REP-UK, V5, DOI 10.1038/srep10469; Perez-Rueda E, 2000, NUCLEIC ACIDS RES, V28, P1838, DOI 10.1093/nar/28.8.1838; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; Rasmussen AA, 2005, MOL MICROBIOL, V58, P1421, DOI 10.1111/j.1365-2958.2005.04911.x; Rezuchova B, 2003, FEMS MICROBIOL LETT, V225, P1, DOI 10.1016/S0378-1097(03)00480-4; Richmond CS, 1999, NUCLEIC ACIDS RES, V27, P3821, DOI 10.1093/nar/27.19.3821; Salgado H., 2006, NUCLEIC ACIDS RES, V32, pD303; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Shimada T, 2005, GENES CELLS, V10, P907, DOI 10.1111/j.1365-2443.2005.00888.x; Shimada T, 2004, J BACTERIOL, V186, P7112, DOI 10.1128/JB.186.21.7112-7122.2004; Shimada T, 2008, NUCLEIC ACIDS RES, V36, P3950, DOI 10.1093/nar/gkn339; Shimada T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090447; Shimada T, 2013, GENES CELLS, V18, P123, DOI 10.1111/gtc.12026; Shimada T, 2011, MOL MICROBIOL, V82, P378, DOI 10.1111/j.1365-2958.2011.07818.x; Singer BS, 1997, NUCLEIC ACIDS RES, V25, P781, DOI 10.1093/nar/25.4.781; Thomason MK, 2015, J BACTERIOL, V197, P18, DOI 10.1128/JB.02096-14; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Udekwu KI, 2005, GENE DEV, V19, P2355, DOI 10.1101/gad.354405; WANG QP, 1989, J BACTERIOL, V171, P4248, DOI 10.1128/JB.171.8.4248-4253.1989; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; YAMAMORI T, 1978, J BACTERIOL, V134, P1133, DOI 10.1128/JB.134.3.1133-1140.1978; YURA T, 1993, ANNU REV MICROBIOL, V47, P321, DOI 10.1146/annurev.mi.47.100193.001541; Zhao K, 2005, J BIOL CHEM, V280, P17758, DOI 10.1074/jbc.M500393200	80	28	29	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179181	10.1371/journal.pone.0179181	http://dx.doi.org/10.1371/journal.pone.0179181			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666008	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608700029
J	Beesetti, S; Mavuluri, J; Surabhi, RP; Oberyszyn, TM; Tober, K; Pitani, RS; Joseph, LD; Venkatraman, G; Rayala, SK				Beesetti, S.; Mavuluri, J.; Surabhi, R. P.; Oberyszyn, T. M.; Tober, K.; Pitani, R. S.; Joseph, L. D.; Venkatraman, G.; Rayala, S. K.			Transcriptional regulation of ataxia-telangiectasia and Rad3-related protein by activated p21-activated kinase-1 protects keratinocytes in UV-B-induced premalignant skin lesions	ONCOGENE			English	Article							NF-KAPPA-B; GROWTH-FACTOR RECEPTOR; DNA-DAMAGE; CELLS; PAK1; IRRADIATION; CANCER; PATHWAYS; FOS; PHOSPHORYLATION	Sun-induced skin lesions, in particular actinic keratosis, are generally considered as premalignant skin lesions that can progress into squamous cell carcinoma (SCC) and invasive SCC if left untreated. Therefore, understanding the molecular mechanisms by which the ultraviolet-B (UV-B)-exposed cells are being protected and the signaling pathways that promote the progression of certain premalignant skin lesions to malignant lesions will permit us to prevent or cure skin cancers. In the current study, we found that phospho-p21-activated kinase-1 (Pak1) and Pak1 expression was high in clinical samples of sunlight-induced premalignant skin lesions assessed by immunohistochemistry. Further, we observed that phospho-Pak1 and Pak1 levels are high in UV-B-exposed hairless SKH mouse model skin samples as compared with unexposed skin tissue. Our results from cell line and animal models showed that Pak1 is activated in response to UV-B radiation, and this activated Pak1 translocates from the cytoplasm to the nucleus. Inside the nucleus, Pak1 via C-Fos binds to a specific promoter region of DNA repair kinase ATR (ataxia-telangiectasia and Rad3-related protein) and acts as a transcriptional regulator of ATR. Results from our analysis showed that Pak1 overexpression, knockdown and Pak1 knockout cell line models showed that Pak1 confers protection to keratinocytes from UV-B-induced apoptosis and DNA damage via ATR. To our knowledge, this is the first study that evaluates the functional and clinical significance of a signaling molecule, Pak1, in sun-induced premalignant skin lesions and indicates that increased Pak1 activation and expression could serve as an early warning sign of progression toward non-melanoma skin cancer, if ignored.	[Beesetti, S.; Mavuluri, J.; Surabhi, R. P.; Rayala, S. K.] IITM, Dept Biotechnol, Madras 600036, Tamil Nadu, India; [Oberyszyn, T. M.; Tober, K.] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA; [Pitani, R. S.] Sri Ramachandra Univ, Dept Community Med, Madras, Tamil Nadu, India; [Joseph, L. D.] Sri Ramachandra Univ, Dept Pathol, Madras, Tamil Nadu, India; [Venkatraman, G.] Sri Ramachandra Univ, Dept Human Genet, Madras 600116, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; University System of Ohio; Ohio State University; Sri Ramachandra Institute of Higher Education & Research; Sri Ramachandra Institute of Higher Education & Research; Sri Ramachandra Institute of Higher Education & Research	Rayala, SK (corresponding author), IITM, Dept Biotechnol, Madras 600036, Tamil Nadu, India.; Venkatraman, G (corresponding author), Sri Ramachandra Univ, Dept Human Genet, Madras 600116, Tamil Nadu, India.	ganeshv@sriramachandra.edu.in; rayala@iitm.ac.in	Venkatraman, Ganesh/AAB-1467-2020; beesetti, swarna/ABD-2044-2020; Joseph, Leena Dennis/AAS-9420-2020; Mavuluri, Jayadev/AAW-6724-2021	Venkatraman, Ganesh/0000-0003-0179-9785; Rayala, Suresh/0000-0003-4394-4450; Oberyszyn, Tatiana/0000-0002-5308-0855; Latha, B Swarna/0000-0001-7598-5607	DRDO-LSRB, Government of India [DLS/81/48222/XXIII/LSRB/2009]; NCI [R01CA133629]; NATIONAL CANCER INSTITUTE [R01CA133629] Funding Source: NIH RePORTER	DRDO-LSRB, Government of India; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Barathidasan, Veterinary Pathologist from Mahatma Gandhi Medical College and Research Institute (MGMCRI), Pondicherry for scoring the mice slides. We also thank Rahul and Venu for help with IHC and animal studies. We thank DRDO-LSRB, Government of India, for the financial support to SKR (Grant No: DLS/81/48222/XXIII/LSRB/2009), and NCI R01CA133629 (to TMO) and Indian Institute of Technology Madras (IITM) for all other facilities.	Anna Brozyna, 2007, Expert Rev Dermatol, V2, P451, DOI 10.1586/17469872.2.4.451; Auclair Y, 2009, CELL CYCLE, V8, P1865, DOI 10.4161/cc.8.12.8800; Bender K, 1998, EMBO J, V17, P5170, DOI 10.1093/emboj/17.17.5170; Bhat M Ramesh, 2012, Indian J Dermatol, V57, P158, DOI 10.4103/0019-5154.94298; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Brzoska K, 2009, MUTAGENESIS, V24, P1, DOI 10.1093/mutage/gen056; Carr TD, 2012, CANCER PREV RES, V5, P1394, DOI 10.1158/1940-6207.CAPR-12-0272-T; Chow HY, 2012, CANCER RES, V72, P5966, DOI 10.1158/0008-5472.CAN-12-2246; Cooper SJ, 2007, CURR CANCER DRUG TAR, V7, P325, DOI 10.2174/156800907780809714; Corona R, 1996, Ann Ist Super Sanita, V32, P37; Criscione VD, 2009, CANCER-AM CANCER SOC, V115, P2523, DOI 10.1002/cncr.24284; Dore J F, 2001, IARC Sci Publ, V154, P81; El-Abaseri TB, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/97939; Frost JA, 2000, J BIOL CHEM, V275, P19693, DOI 10.1074/jbc.M909860199; Gan JF, 2015, INT J MOL SCI, V16, P12035, DOI 10.3390/ijms160612035; Ghosal G, 2013, TRANSL CANCER RES, V2, P107, DOI 10.3978/j.issn.2218-676X.2013.04.01; Gill Pavandeep, 2015, CMAJ Open, V3, pE258, DOI 10.9778/cmajo.20140037; HAAS S, 1995, CARCINOGENESIS, V16, P985, DOI 10.1093/carcin/16.5.985; Holm C, 2006, JNCI-J NATL CANCER I, V98, P671, DOI 10.1093/jnci/djj185; Ichihashi M, 2003, TOXICOLOGY, V189, P21, DOI 10.1016/S0300-483X(03)00150-1; Jagadeeshan S, 2015, ONCOGENE, V34, P455, DOI 10.1038/onc.2013.576; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Li DQ, 2012, CELL REP, V2, P1657, DOI 10.1016/j.celrep.2012.11.018; MARKS VJ, 1993, OTOLARYNG CLIN N AM, V26, P23; Motwani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066585; Ong CC, 2013, JNCI-J NATL CANCER I, V105, P606, DOI 10.1093/jnci/djt054; Panda Saumya, 2010, Indian J Dermatol, V55, P373, DOI 10.4103/0019-5154.74551; Radu M, 2014, NAT REV CANCER, V14, P13, DOI 10.1038/nrc3645; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; Sanchez-Solana B, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404061; Sato K, 2013, INT J MOL SCI, V14, P10761, DOI 10.3390/ijms140610761; SCHREIBER M, 1995, EMBO J, V14, P5338, DOI 10.1002/j.1460-2075.1995.tb00218.x; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; Singh RR, 2005, J BIOL CHEM, V280, P18130, DOI 10.1074/jbc.M412607200; Tai MH, 2012, INT J MOL SCI, V13, P4351, DOI 10.3390/ijms13044351; Tse E Y, 2014, J MOL SIGNALING, V9, P7, DOI [10.1186/1750-2187-9-7, DOI 10.1186/1750-2187-9-725093037]; Vodenicharov MD, 2005, COMP SER PHOTOCHEM, V5, P247; Wang N, 2015, ADV APPL BIOTECHNOLO, V65, P627; Wang Y, 2015, MED SCI MONIT BASIC, V21, P21, DOI 10.12659/MSMBR.893143; Ward IM, 2004, J BIOL CHEM, V279, P9677, DOI 10.1074/jbc.C300554200; Xu YR, 2006, J BIOL CHEM, V281, P27389, DOI 10.1074/jbc.M602355200; Xu YR, 2006, AM J PATHOL, V169, P823, DOI 10.2353/ajpath.2006.050449; Yang ZB, 2004, CLIN CANCER RES, V10, P658, DOI 10.1158/1078-0432.CCR-0382-03; Zhou MJ, 2012, BIOMED ENVIRON SCI, V25, P583, DOI 10.3967/0895-3988.2012.05.013	44	4	4	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 2	2017	36	44					6154	6163		10.1038/onc.2017.218	http://dx.doi.org/10.1038/onc.2017.218			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FL5CU	28692051				2022-12-26	WOS:000414249800009
J	Tsoi, H; Lam, KC; Dong, Y; Zhang, X; Lee, CK; Zhang, J; Ng, SC; Ng, SSM; Zheng, S; Chen, Y; Fang, J; Yu, J				Tsoi, H.; Lam, K. C.; Dong, Y.; Zhang, X.; Lee, C. K.; Zhang, J.; Ng, S. C.; Ng, S. S. M.; Zheng, S.; Chen, Y.; Fang, J.; Yu, J.			Pre-45s rRNA promotes colon cancer and is associated with poor survival of CRC patients	ONCOGENE			English	Article							RNA-POLYMERASE-I; UPSTREAM BINDING-FACTOR; SIGNALING PATHWAY; TRANSCRIPTION; PHOSPHORYLATION; INHIBITION; ACTIVATION; CALCIUM; STRESS; MDM2	One characteristic of cancer cells is the abnormally high rate of cell metabolism to sustain their enhanced proliferation. However, the behind mechanism of this phenomenon is still elusive. Here we find that enhanced precursor 45s ribosomal RNA (pre-45s rRNA) is one of the core mechanisms in promoting the pathogenesis of colorectal cancer (CRC). Pre-45s rRNA expression is significantly higher in primary CRC tumor tissues samples and cancer cell lines compared with the non-tumorous colon tissues, and is associated with tumor sizes. Knockdown of pre-45s rRNA inhibits G1/S cell-cycle transition by stabilizing p53 through inducing murine double minute 2 (MDM2) and ribosomal protein L11 (RpL11) interaction. In addition, we revealed that high rate of cancer cell metabolism triggers the passive release of calcium ion from endoplasmic reticulum to the cytoplasm. The elevated calcium ion in the cytoplasm activates the signaling cascade of calcium/calmodulin-dependent protein kinase II, ribosomal S6 kinase (S6K) and ribosomal S6K (CaMKII-S6K-UBF). The activated UBF promotes the transcription of rDNA, which therefore increases pre-45s rRNA. Disruption of CaMKII-S6K-UBF axis by either RNAi or pharmaceutical approaches leads to reduction of pre-45s rRNA expression, which subsequently suppresses cell proliferation in colon cancer cells by causing cell-cycle arrest. Knockdown of APC activates CaMKII-S6-KUBF cascade and thus enhances pre-45s rRNA expression. Moreover, the high expression level of pre-45s rRNA is associated with poor survival of CRC patients in two independent cohorts. Our study identifies a novel mechanism in CRC pathogenesis mediated by pre-45s rRNA and a prognostic factor of pre-45s rRNA in CRC patients.	[Tsoi, H.; Lam, K. C.; Dong, Y.; Zhang, X.; Lee, C. K.; Zhang, J.; Ng, S. C.; Yu, J.] Chinese Univ Hong Kong, Prince Wales Hosp, Inst Digest Dis, Room 707A,7-F,Li Ka Shing Med Sci Bldg, Shatin, Hong Kong, Peoples R China; [Tsoi, H.; Lam, K. C.; Dong, Y.; Zhang, X.; Lee, C. K.; Zhang, J.; Ng, S. C.; Yu, J.] Chinese Univ Hong Kong, Prince Wales Hosp, CUHK Shenzhen Res Inst,Dept Med & Therapeut, State Key Lab Digest Dis,Li Ka Shing Inst Hlth Sc, Shatin, Hong Kong, Peoples R China; [Ng, S. S. M.] Chinese Univ Hong Kong, Dept Surg, Shatin, Hong Kong, Peoples R China; [Zheng, S.] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Key Lab Canc Prevent & Intervent,China Natl Minis, Hangzhou, Zhejiang, Peoples R China; [Zheng, S.] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Canc Inst, Hangzhou, Zhejiang, Peoples R China; [Chen, Y.; Fang, J.; Yu, J.] Shanghai Jiao Tong Univ, Dept Gastroenterol, Renji Hosp, Sch Med, Shanghai, Peoples R China; [Chen, Y.; Fang, J.; Yu, J.] Shanghai Inst Digest Dis, Shanghai, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Zhejiang University; Zhejiang University; Shanghai Jiao Tong University	Yu, J (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Inst Digest Dis, Room 707A,7-F,Li Ka Shing Med Sci Bldg, Shatin, Hong Kong, Peoples R China.; Yu, J (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Room 707A,7-F,Li Ka Shing Med Sci Bldg, Shatin, Hong Kong, Peoples R China.	junyu@cuhk.edu.hk	Ng, Simon S. M./M-1219-2018; ZHANG, Xiang/N-7918-2015; ZHANG, Jingwan/AIC-2560-2022; Ng, Siew Chien/N-4733-2015; Jun, Yu/D-8569-2015	Ng, Simon S. M./0000-0002-5389-9297; ZHANG, Xiang/0000-0002-3222-5824; Ng, Siew Chien/0000-0002-6850-4454; Jun, Yu/0000-0001-5008-2153; tsoi, ho/0000-0003-2037-9575	RGC-GRF Hong Kong [766613, 14106145, 14111216]; HMRF Hong Kong [1196728]; National Key Technology RD Program [2014BAI09B05]; 135 program [2016YFC1303200]; Shenzhen Virtual University	RGC-GRF Hong Kong(Hong Kong Research Grants Council); HMRF Hong Kong; National Key Technology RD Program(National Key Technology R&D Program); 135 program; Shenzhen Virtual University	This project was supported by RGC-GRF Hong Kong (766613, 14106145, 14111216) HMRF Hong Kong (1196728), The National Key Technology R&D Program (2014BAI09B05), 135 program project (2016YFC1303200), and Shenzhen Virtual University Park Support Scheme to CUHK-Shenzhen Research Institute.	Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Fujita T, 2010, LANCET, V376, P331, DOI 10.1016/S0140-6736(10)61183-X; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Grzmil M, 2012, CANCER RES, V72, P3891, DOI 10.1158/0008-5472.CAN-12-0026; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; Hoe KK, 2014, NAT REV DRUG DISCOV, V13, P217, DOI 10.1038/nrd4236; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jimenez-Vidal M, 2010, J BIOL CHEM, V285, P36260, DOI 10.1074/jbc.M110.165555; Kestler HA, 2011, J CELL BIOL, V193, P431, DOI 10.1083/jcb.201103167; Kihm AJ, 1998, P NATL ACAD SCI USA, V95, P14816, DOI 10.1073/pnas.95.25.14816; Kim TH, 2014, ONCOTARGET, V5, P860, DOI 10.18632/oncotarget.1784; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Mullineux ST, 2012, BIOCHIMIE, V94, P1521, DOI 10.1016/j.biochi.2012.02.001; Panner A, 2006, CELL CALCIUM, V40, P253, DOI 10.1016/j.ceca.2006.04.029; Panov KI, 2006, EMBO J, V25, P3310, DOI 10.1038/sj.emboj.7601221; Prevarskaya N, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0097; Rodnina MV, 2009, CURR OPIN CELL BIOL, V21, P435, DOI 10.1016/j.ceb.2009.01.023; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Sasaki M, 2011, NAT MED, V17, P944, DOI 10.1038/nm.2392; Schneikert J, 2007, GUT, V56, P417, DOI 10.1136/gut.2006.093310; Shifman JM, 2006, P NATL ACAD SCI USA, V103, P13968, DOI 10.1073/pnas.0606433103; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	28	24	26	0	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 2	2017	36	44					6109	6118		10.1038/onc.2017.86	http://dx.doi.org/10.1038/onc.2017.86			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FL5CU	28692053	Green Published, hybrid			2022-12-26	WOS:000414249800005
J	Ran, Q; Yang, JY; Yang, WJ; Wei, DT; Qiu, J; Zhang, D				Ran, Qian; Yang, Junyi; Yang, Wenjing; Wei, Dongtao; Qiu, Jiang; Zhang, Dong			The association between resting functional connectivity and dispositional optimism	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; NEURAL CIRCUITRY; EMOTION REGULATION; GENDER-DIFFERENCES; SUBJECTIVE VALUE; BRAIN ACTIVITY; STATE FMRI; ANXIETY; RESPONSES; BASES	Dispositional optimism is an individual characteristic that plays an important role in human experience. Optimists are people who tend to hold positive expectations for their future. Previous studies have focused on the neural basis of optimism, such as task response neural activity and brain structure volume. However, the functional connectivity between brain regions of the dispositional optimists are poorly understood. Previous study suggested that the ventromedial prefrontal cortex (vmPFC) are associated with individual differences in dispositional optimism, but it is unclear whether there are other brain regions that combine with the vmPFC to contribute to dispositional optimism. Thus, the present study used the resting-state functional connectivity (RSFC) approach and set the vmPFC as the seed region to examine if differences in functional brain connectivity between the vmPFC and other brain regions would be associated with individual differences in dispositional optimism. The results found that dispositional optimism was significantly positively correlated with the strength of the RSFC between vmPFC and middle temporal gyrus (mTG) and negativly correlated with RSFC between vmPFC and inferior frontal gyrus (IFG). These findings may be suggested that mTG and IFG which associated with emotion processes and emotion regulation also play an important role in the dispositional optimism.	[Ran, Qian; Zhang, Dong] Third Mil Med Univ, Xin Qiao Hosp, Dept Radiol, Chongqing, Peoples R China; [Yang, Junyi; Yang, Wenjing; Wei, Dongtao; Qiu, Jiang] Minist Educ, SWU, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Yang, Junyi; Yang, Wenjing; Wei, Dongtao; Qiu, Jiang] Southwest Univ, Sch Psychol, Chongqing, Peoples R China	Army Medical University; Southwest University - China	Zhang, D (corresponding author), Third Mil Med Univ, Xin Qiao Hosp, Dept Radiol, Chongqing, Peoples R China.; Qiu, J (corresponding author), Minist Educ, SWU, Key Lab Cognit & Personal, Chongqing, Peoples R China.; Qiu, J (corresponding author), Southwest Univ, Sch Psychol, Chongqing, Peoples R China.	qiuj318@swu.edu.cn; xqfskzd007@163.com						Aarsland D, 2009, MOVEMENT DISORD, V24, P2175, DOI 10.1002/mds.22589; Achat H, 2000, ANN BEHAV MED, V22, P127, DOI 10.1007/BF02895776; Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Andersson G, 1996, PERS INDIV DIFFER, V21, P719, DOI 10.1016/0191-8869(96)00118-3; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; [Anonymous], [No title captured]; Bengtsson SL, 2009, CEREB CORTEX, V19, P797, DOI 10.1093/cercor/bhn127; Blair KS, 2013, NEUROIMAGE, V78, P103, DOI 10.1016/j.neuroimage.2013.03.063; Blair KS, 2013, NEUROIMAGE; Carver CS, 2010, CLIN PSYCHOL REV, V30, P879, DOI 10.1016/j.cpr.2010.01.006; CARVER CS, 1994, J RES PERS, V28, P133, DOI 10.1006/jrpe.1994.1011; Chen SH, 2012, NEUROIMAGE, V60, P299, DOI 10.1016/j.neuroimage.2011.11.092; Chumbley J, 2010, NEUROIMAGE, V49, P3057, DOI 10.1016/j.neuroimage.2009.10.090; D'Argembeau A, 2008, NEUROIMAGE, V40, P398, DOI 10.1016/j.neuroimage.2007.11.025; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; de Souza LC, 2010, NEUROPSYCHOLOGIA, V48, P3733, DOI 10.1016/j.neuropsychologia.2010.09.010; Delgado MR, 2008, NEURON, V59, P829, DOI 10.1016/j.neuron.2008.06.029; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin A, 2015, NAT REV NEUROSCI, V16, P693, DOI 10.1038/nrn4044; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fredrickson BL, 2004, PHILOS T R SOC B, V359, P1367, DOI 10.1098/rstb.2004.1512; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Giltay EJ, 2006, ARCH INTERN MED, V166, P431, DOI 10.1001/.431; Goldin PR, 2005, NEUROIMAGE, V27, P26, DOI 10.1016/j.neuroimage.2005.03.018; Good C.D., 2002, BIOM IM 2002 5 IEEE; Goodin BR, 2012, J BEHAV MED, P1; Greening SG, 2011, NEUROIMAGE, V54, P1432, DOI 10.1016/j.neuroimage.2010.09.017; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; HISCOCK M, 1994, J CLIN EXP NEUROPSYC, V16, P423, DOI 10.1080/01688639408402653; Johnstone T, 2006, SOC COGN AFFECT NEUR, V1, P242, DOI 10.1093/scan/nsl027; Kavallo D, 2003, HARVARD BUS REV; Kim K, 2015, SOC COGN AFFECT NEUR, V10, P494, DOI 10.1093/scan/nsu078; Koch K, 2007, NEUROPSYCHOLOGIA, V45, P2744, DOI 10.1016/j.neuropsychologia.2007.04.012; Koenigsberg HW, 2010, NEUROPSYCHOLOGIA, V48, P1813, DOI 10.1016/j.neuropsychologia.2010.03.002; Konick LC, 2001, BIOL PSYCHIAT, V49, P28, DOI 10.1016/S0006-3223(00)00974-4; KULYNYCH JJ, 1994, CEREB CORTEX, V4, P107, DOI 10.1093/cercor/4.2.107; Lai JCL, 2000, PERS INDIV DIFFER, V28, P781, DOI 10.1016/S0191-8869(99)00138-5; MacLeod AK, 2005, COGNITION EMOTION, V19, P357, DOI 10.1080/02699930441000247; Marcoulides G.A., 1997, MULTIVARIATE STAT ME; Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008; Mitchell DGV, 2009, J NEUROSCI, V29, P10827, DOI 10.1523/JNEUROSCI.0963-09.2009; Morton DL, 2010, NEUROPSYCHOLOGIA, V48, P1958, DOI 10.1016/j.neuropsychologia.2010.03.016; Murty VP, 2010, NEUROPSYCHOLOGIA, V48, P3459, DOI 10.1016/j.neuropsychologia.2010.07.030; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Pavuluri MN, 2007, BIOL PSYCHIAT, V62, P158, DOI 10.1016/j.biopsych.2006.07.011; Peterson C, 2000, AM PSYCHOL, V55, P44, DOI 10.1037/0003-066X.55.1.44; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Quirk GJ, 2003, ANN NY ACAD SCI, V985, P263; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Roy M, 2012, TRENDS COGN SCI, V16, P147, DOI 10.1016/j.tics.2012.01.005; Ruthig JC, 2004, J APPL SOC PSYCHOL, V34, P709, DOI 10.1111/j.1559-1816.2004.tb02566.x; Schacter DL, 2007, NAT NEUROSCI, V10, P1345, DOI 10.1038/nn1107-1345; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; SCHEIER MF, 1987, J PERS, V55, P169, DOI 10.1111/j.1467-6494.1987.tb00434.x; Sharot T, 2007, NATURE, V450, P102, DOI 10.1038/nature06280; Sharot T, 2012, P NATL ACAD SCI USA, V109, P17058, DOI 10.1073/pnas.1205828109; Sharot T, 2011, NAT NEUROSCI, V14, P1475, DOI 10.1038/nn.2949; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Smith DV, 2014, SOC COGN AFFECT NEUR, V9, P2017, DOI 10.1093/scan/nsu005; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tian LX, 2012, NEUROIMAGE, V60, P539, DOI 10.1016/j.neuroimage.2011.11.098; Tindle HA, 2009, CIRCULATION, V120, P656, DOI 10.1161/CIRCULATIONAHA.108.827642; Tugade MM, 2004, J PERS, V72, P1161, DOI 10.1111/j.1467-6494.2004.00294.x; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Wang ZQ, 2013, ARCH GERONTOL GERIAT, V56, P298, DOI 10.1016/j.archger.2012.08.016; Wu JF, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00618; Yan CG, 2013, NEUROIMAGE; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Zung W.W.K., 1986, ASSESSMENT DEPRESSIO, P221, DOI 10.1007/978-3-642-70486-4n_21; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	75	12	12	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180334	10.1371/journal.pone.0180334	http://dx.doi.org/10.1371/journal.pone.0180334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TK	28700613	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649600027
J	Horvat, OJ; Tomas, AD; Kusturica, MMP; Savkov, AV; Bukumiric, DU; Tomic, ZS; Sabo, AJ				Horvat, Olga J.; Tomas, Ana D.; Kusturica, Milica M. Paut; Savkov, Alisa V.; Bukumiric, Dragica U.; Tomic, Zdenko S.; Sabo, Ana J.			Is the level of knowledge a predictor of rational antibiotic use in Serbia?	PLOS ONE			English	Article							PUBLIC KNOWLEDGE; SELF-MEDICATION; ATTITUDES; RESISTANCE; COMMUNITY; BEHAVIOR; HEALTH	Introduction The objective of this study was to investigate the knowledge, attitudes and behavior regarding antibiotics of the general population. Methods The study sample consisted of adult subjects who consulted general practitioners at health centers in Serbia and agreed to complete the questionnaire. A total of 668 questionnaires were distributed; 500 respondents completed the entire questionnaire (response rate 74.85%). Results The average age was 51.65 +/- 16.56 years, 60.80% of the respondents were women. The median antibiotic knowledge score was 9. Predictors of adequate antibiotic knowledge were higher education level and a family member whose ocuppation was related to health-care. Overall, 58.4% of respondents believed that antibiotics could be used to treat common cold. Around a half of the respondents (47.2%) self-medicated with antibiotics at least once during their life-time, and around a quarter (24.2%) during the last treatment of infection. Patients with inadequate knowledge had 3 times higher chances of self-medicating with antibiotics compared to those with adequate knowledge. Although 98.20% of respondents claimed that antibiotic treatment should be started after a visit to a doctor and receiving a prescription, only 65.8% obtained antibiotics with prescription from a doctor during the last infection. Conclusions Although these results demonstrate that respondents had a relatively adequate level of knowledge regarding antibiotics use, some areas of misconceptions and improper behavior were identified. Therefore, further rationalization should be focused on educational campaigns targeting the behavior of patients with regard to antibiotic use.	[Horvat, Olga J.; Tomas, Ana D.; Kusturica, Milica M. Paut] Univ Novi Sad, Fac Med Novi Sad, Dept Pharmacol Toxicol & Clin Pharmacol, Novi Sad, Serbia; [Savkov, Alisa V.; Tomic, Zdenko S.; Sabo, Ana J.] Univ Novi Sad, Ctr Appl Stat, Novi Sad, Serbia; [Bukumiric, Dragica U.] Primary Hlth Care Ctr, Dept Planning Analysing & Stat, Pancevo, Serbia	University of Novi Sad; University of Novi Sad	Horvat, OJ (corresponding author), Univ Novi Sad, Fac Med Novi Sad, Dept Pharmacol Toxicol & Clin Pharmacol, Novi Sad, Serbia.	olga.horvat@mf.uns.ac.rs	Tomas, Ana/L-4426-2018	Tomas, Ana/0000-0003-2361-872X	Ministry of Science and Technological development, Republic of Serbia [41012]; Provincial Secretariat for Science and Technological Development [142-451-3680/2016-03]	Ministry of Science and Technological development, Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia); Provincial Secretariat for Science and Technological Development	This work was supported by the Ministry of Science and Technological development, Republic of Serbia, Project No. 41012. and Provincial Secretariat for Science and Technological Development-142-451-3680/2016-03.	[Anonymous], 2015, INT J ENV RES PUB HE, V12, P7002, DOI DOI 10.3390/IJERPH120607002; [Anonymous], 2014, ANT RES INV CLIN BAC; [Anonymous], 2014, ANN REPORT CENTRAL A; Awad AI, 2015, PLOS ONE, V10; BRITTEN N, 1995, BRIT MED J, V310, P1084, DOI 10.1136/bmj.310.6987.1084; Buke AC, 2003, INT J ANTIMICROB AG, V21, P63, DOI 10.1016/S0924-8579(02)00272-8; Chen Changhua, 2005, Journal of Microbiology Immunology and Infection, V38, P53; Coenen S, 2006, BRIT J GEN PRACT, V56, P183; Davey P, 2002, CLIN MICROBIOL INFEC, V8, P43, DOI 10.1046/j.1469-0691.8.s.2.6.x; European Commission, 2013, SPEC EUR 107 ANT RES; Godycki-Cwirko M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109248; Grigoryan L, 2006, EMERG INFECT DIS, V12, P452, DOI 10.3201/eid1203.050992; Grigoryan L, 2008, J ANTIMICROB CHEMOTH, V61, P1172, DOI 10.1093/jac/dkn054; Hawkings NJ, 2008, PATIENT EDUC COUNS, V73, P146, DOI 10.1016/j.pec.2008.05.025; Horvat O., 2008, THESIS; Kim SS, 2011, J KOREAN ACAD NURS, V41, P742, DOI 10.4040/jkan.2011.41.6.742; Kusturica MP, 2015, CENT EUR J PUBL HEAL, V23, P114; Lim Ka Keat, 2012, South Med Rev, V5, P26; Mangione-Smith R, 2001, ARCH PEDIAT ADOL MED, V155, P800, DOI 10.1001/archpedi.155.7.800; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V60, pI63, DOI 10.1093/jac/dkm161; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V59, P727, DOI 10.1093/jac/dkl558; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084177; Oh AL, 2011, J INFECT DEV COUNTR, V5, P338; Prostran M, 2001, ANTIBIOTICS 2001, P89; Pulcini C, 2011, CLIN MICROBIOL INFEC, V17, P80, DOI 10.1111/j.1469-0691.2010.03179.x; Radosevic N, 2009, PHARMACOEPIDEM DR S, V18, P691, DOI 10.1002/pds.1768; Rouusounides A, 2011, INT J ENV RES PUB HE, V8, P3246, DOI 10.3390/ijerph8083246; Shehadeh M, 2012, SAUDI PHARM J, V20, P125, DOI 10.1016/j.jsps.2011.11.005; Vallin M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152160; Velickovic-Radovanovic R, 2015, J CLIN PHARM THER, V40, P426, DOI 10.1111/jcpt.12283; VELICKOVICRADOV.R, 2012, NIS J CLIN PHARM THE, V37, P32, DOI DOI 10.1111/J.1365-2710.2010.01241.X; WHO, 2015, ANT RES MULT PUBL AW; You JHS, 2008, INFECTION, V36, P153, DOI 10.1007/s15010-007-7214-5	34	21	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180799	10.1371/journal.pone.0180799	http://dx.doi.org/10.1371/journal.pone.0180799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700631	Green Published, gold, Green Submitted			2022-12-26	WOS:000405544800079
J	Yoo, KD; Lee, JP; Lee, SM; Park, JY; Lee, H; Kim, DK; Kang, SW; Yang, CW; Kim, YL; Lim, CS; Joo, KW; Kim, YS				Yoo, Kyung Don; Lee, Jung Pyo; Lee, Su Mi; Park, Jae Yoon; Lee, Hajeong; Kim, Dong Ki; Kang, Shin-Wook; Yang, Chul Woo; Kim, Yong-Lim; Lim, Chun Soo; Joo, Kwon Wook; Kim, Yon Su			Cancer in Korean patients with end-stage renal disease: A 7-year follow-up	PLOS ONE			English	Article							CELL CARCINOMA; DIALYSIS PATIENTS; INCREASED RISK; KIDNEY; TRANSPLANTATION; MALIGNANCY; TAIWAN; IMMUNOSUPPRESSION; HEMODIALYSIS; POPULATION	Background The effectiveness of dialysis on the incidence of cancer in patients with end-stage renal disease (ESRD) remains to be clarified. In this study, we evaluated the incidence rate and type of cancer among patients with ESRD, compared to the general population, through a prospective 7-year follow-up. We also calculated the cumulative incidence rate of cancer associated with ESRD, with stratification to control for the competing risk of death. Methods This prospective observational cohort study was conducted using data from a nationwide study on patients with ESRD in Korea. A total of 5,235 patients, >= 18 years old, with ESRD were identified from the national registry as being treated by dialysis between August 2008 and December 2014. The standardized incidence ratio (SIR) and cumulative incidence rate of specific cancers were evaluated and compared to the general population. Results A total of 5,235 participants were included. During the 7 year observation period, 116 (2.2%) participants had been diagnosed as cancer. The SIR of overall cancer was 0.94 [ 95% confidence interval (CI), 0.72-1.19] and was comparable to the rate for the general population. Although the digestive organs were the most frequent site of a primary site cancer (N = 39, 33.6%), the SIR was highest for urinary tract cancer [ 4.7, 95% CI, 2.42-8.19]. The five year standardized cumulative incidence of cancer was higher for females than for males, and for non-diabetic compared to diabetic causes of ESRD. We estimated that the five year standardized cumulative incidence was highest [ 8.4, 95% CI, 5.07-13.75] in patients with ESRD, caused by glomerulonephritis. Conclusion A screening program should be necessary for urinary tract cancer in Korean patients with ESRD. Cancer screening programs for patients with ESRD in Korea should be emphasized on female patients and patients with non-diabetic ESRD.	[Yoo, Kyung Don; Park, Jae Yoon] Dongguk Univ, Dept Internal Med, Coll Med, Gyeongju, South Korea; [Lee, Jung Pyo; Lim, Chun Soo] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Lee, Su Mi] Dong A Univ, Coll Med, Dept Internal Med, Busan, South Korea; [Lee, Hajeong; Kim, Dong Ki; Joo, Kwon Wook; Kim, Yon Su] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Yang, Chul Woo] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Yong-Lim] Kyungpook Natl Univ Hosp, Dept Internal Med, Daegu, South Korea	Dongguk University; Seoul National University (SNU); Seoul National University Hospital; Dong A University; Seoul National University (SNU); Seoul National University Hospital; Yonsei University; Yonsei University Health System; Catholic University of Korea; Kyungpook National University; Kyungpook National University Hospital	Kim, YS (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.	yonsukim@snu.ac.kr	Kim, Dong Ki/J-5389-2012; Yoo, Kyung Don/AAK-8096-2020	Kim, Dong Ki/0000-0002-5195-7852; Yoo, Kyung Don/0000-0001-6545-6517	Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HC15C1129]	Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HC15C1129).	AKIZAWA T, 1994, NEPHROL DIAL TRANSPL, V9, P162; Butler AM, 2015, AM J KIDNEY DIS, V65, P763, DOI 10.1053/j.ajkd.2014.12.013; Choi JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084257; Chung CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044675; Connor A, 2012, GUT, V61, P1525, DOI 10.1136/gutjnl-2011-300861; Dantal J, 1998, LANCET, V351, P623, DOI 10.1016/S0140-6736(97)08496-1; Denton MD, 2002, KIDNEY INT, V61, P2201, DOI 10.1046/j.1523-1755.2002.00374.x; DOBSON AJ, 1991, STAT MED, V10, P457, DOI 10.1002/sim.4780100317; DUNN SR, 1990, J NATL CANCER I, V82, P783, DOI 10.1093/jnci/82.9.783; DUNNILL MS, 1977, J CLIN PATHOL, V30, P868, DOI 10.1136/jcp.30.9.868; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Gallagher MP, 2010, J AM SOC NEPHROL, V21, P852, DOI 10.1681/ASN.2009101043; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Holley JL, 2007, CLIN J AM SOC NEPHRO, V2, P604, DOI 10.2215/CJN.03931106; Hughson MD, 1996, J AM SOC NEPHROL, V7, P2461; Imao T, 2007, CANCER-AM CANCER SOC, V109, P2109, DOI 10.1002/cncr.22636; ISHIKAWA I, 1990, AM J KIDNEY DIS, V16, P452, DOI 10.1016/S0272-6386(12)80058-8; Jin DC, 2015, KIDNEY RES CLIN PRAC, V34, P132, DOI 10.1016/j.krcp.2015.08.004; Kalbfleish JD, 1980, THE STATISTICAL ANAL; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Kojima Y, 2006, INT J UROL, V13, P1045, DOI 10.1111/j.1442-2042.2006.01498.x; Lee JE, 2009, J KOREAN MED SCI, V24, pS95, DOI 10.3346/jkms.2009.24.S1.S95; Liang JA, 2011, JPN J CLIN ONCOL, V41, P752, DOI 10.1093/jjco/hyr051; Lin HF, 2012, NEPHROL DIAL TRANSPL, V27, P1585, DOI 10.1093/ndt/gfr464; Lin MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122856; Maisonneuve P, 1999, LANCET, V354, P93, DOI 10.1016/S0140-6736(99)06154-1; MARUBINI E, 1995, ANALYSING SURVIVAL D; National Patient Safety Agency (NPSA) England, REDUCING RISK OF HAR; PENN I, 1986, TRANSPLANT P, V18, P210; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Satagopan JM, 2001, BRIT J CANCER, V91, P1229; Satoh S, 2005, J UROLOGY, V174, P1749, DOI 10.1097/01.ju.0000177489.98031.54; SILBIGER SR, 1995, AM J KIDNEY DIS, V25, P515, DOI 10.1016/0272-6386(95)90119-1; Stewart JH, 2003, J AM SOC NEPHROL, V14, P197, DOI 10.1097/01.ASN.0000039608.81046.81; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507; Vamvakas S, 1998, AM J NEPHROL, V18, P89, DOI 10.1159/000013314; Vamvakas S, 1996, TRANSPLANT P, V28, P3468; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Xie J, 2005, STAT MED, V24, P3089, DOI 10.1002/sim.2174; Yang HY, 2009, J EPIDEMIOL, V19, P17, DOI 10.2188/jea.JE20080035	40	15	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0178649	10.1371/journal.pone.0178649	http://dx.doi.org/10.1371/journal.pone.0178649			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692695	Green Submitted, gold, Green Published			2022-12-26	WOS:000405544800006
J	Almutairy, M; Torng, E				Almutairy, Meznah; Torng, Eric			The effects of sampling on the efficiency and accuracy of k-mer indexes: Theoretical and empirical comparisons using the human genome	PLOS ONE			English	Article							MAXIMAL EXACT MATCHES; SEARCH; GENERATION; ALGORITHM; BLAST	One of the most common ways to search a sequence database for sequences that are similar to a query sequence is to use a k-mer index such as BLAST. A big problem with k-mer indexes is the space required to store the lists of all occurrences of all k-mers in the database. One method for reducing the space needed, and also query time, is sampling where only some k-mer occurrences are stored. Most previous work uses hard sampling, in which enough k-mer occurrences are retained so that all similar sequences are guaranteed to be found. In contrast, we study soft sampling, which further reduces the number of stored k-mer occurrences at a cost of decreasing query accuracy. We focus on finding highly similar local alignments (HSLA) over nucleotide sequences, an operation that is fundamental to biological applications such as cDNA sequence mapping. For our comparison, we use the NCBI BLAST tool with the human genome and human ESTs. When identifying HSLAs, we find that soft sampling significantly reduces both index size and query time with relatively small losses in query accuracy. For the human genome and HSLAs of length at least 100 bp, soft sampling reduces index size 4-10 times more than hard sampling and processes queries 2.3-6.8 times faster, while still achieving retention rates of at least 96.6%. When we apply soft sampling to the problem of mapping ESTs against the genome, we map more than 98% of ESTs perfectly while reducing the index size by a factor of 4 and query time by 23.3%. These results demonstrate that soft sampling is a simple but effective strategy for performing efficient searches for HSLAs. We also provide a new model for sampling with BLAST that predicts empirical retention rates with reasonable accuracy by modeling two key problem factors.	[Almutairy, Meznah; Torng, Eric] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA	Michigan State University	Almutairy, M; Torng, E (corresponding author), Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA.	almutai4@msu.edu; torng@msu.edu		Almutairy, Meznah/0000-0001-7254-1867				Abouelhoda M. I., 2004, Journal of Discrete Algorithms, V2, P53, DOI 10.1016/S1570-8667(03)00065-0; Ahmadi A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1246; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Chikhi R, 2014, LECT N BIOINFORMAT, V8394, P35, DOI 10.1007/978-3-319-05269-4_4; Danek A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109384; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; Hatem A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-184; Hormozdiari F, 2011, BIOINFORMATICS, V27, P1915, DOI 10.1093/bioinformatics/btr303; Irizarry K, 2000, NAT GENET, V26, P233, DOI 10.1038/79981; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khiste N, 2015, BIOINFORMATICS, V31, P509, DOI 10.1093/bioinformatics/btu687; Li H., 2016, BIOINFORMATICS; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Movahedi NS, 2012, 2012 IEEE INT C BIOI, P1; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Roberts M, 2004, BIOINFORMATICS, V20, P3363, DOI 10.1093/bioinformatics/bth408; Roberts M, 2004, J COMPUT BIOL, V11, P734; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Vyverman M, 2013, BIOINFORMATICS, V29, P802, DOI 10.1093/bioinformatics/btt042; Wandelt S, 2015, PROC VLDB ENDOW, V8, P461, DOI 10.14778/2735479.2735480; Wandelt S, 2013, PROC VLDB ENDOW, V6, P1534, DOI 10.14778/2536258.2536265; Weese D, 2009, GENOME RES, V19, P1646, DOI 10.1101/gr.088823.108; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Xin HY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S1-S13; Ye CX, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S6-S1; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	30	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179046	10.1371/journal.pone.0179046	http://dx.doi.org/10.1371/journal.pone.0179046			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686614	Green Submitted, gold, Green Published			2022-12-26	WOS:000405464100007
J	Poll, G; Muller, C; Bodden, M; Teubl, F; Eichner, N; Lehmann, G; Griesenbeck, J; Tschochner, H; Milkereit, P				Poell, Gisela; Mueller, Christian; Bodden, Malena; Teubl, Fabian; Eichner, Norbert; Lehmann, Gerhard; Griesenbeck, Joachim; Tschochner, Herbert; Milkereit, Philipp			Structural transitions during large ribosomal subunit maturation analyzed by tethered nuclease structure probing in S.cerevisiae	PLOS ONE			English	Article							REMODELING EVENTS; RNA MATURATION; BIOGENESIS; PROTEINS; COMPLEX; SYSTEM; EXPORT; MODEL; ITS2	Yeast large ribosomal subunit (LSU) precursors are subject to substantial changes in protein composition during their maturation due to coordinated transient interactions with a large number of ribosome biogenesis factors and due to the assembly of ribosomal proteins. These compositional changes go along with stepwise processing of LSU rRNA precursors and with specific rRNA folding events, as revealed by recent cryo-electron microscopy analyses of late nuclear and cytoplasmic LSU precursors. Here we aimed to analyze changes in the spatial rRNA surrounding of selected ribosomal proteins during yeast LSU maturation. For this we combined a recently developed tethered tertiary structure probing approach with both targeted and high throughput readout strategies. Several structural features of late LSU precursors were faithfully detected by this procedure. In addition, the obtained data let us suggest that early rRNA precursor processing events are accompanied by a global transition from a flexible to a spatially restricted rRNA conformation. For intermediate LSU precursors a number of structural hallmarks could be addressed which include the fold of the internal transcribed spacer between 5.8S rRNA and 25S rRNA, the orientation of the central protuberance and the spatial organization of the interface between LSU rRNA domains I and III.	[Poell, Gisela; Mueller, Christian; Bodden, Malena; Teubl, Fabian; Griesenbeck, Joachim; Tschochner, Herbert; Milkereit, Philipp] Univ Regensburg, Lehrstuhl Biochem 3, Regensburg, Germany; [Eichner, Norbert; Lehmann, Gerhard] Univ Regensburg, Lehrstuhl Biochem 1, Regensburg, Germany; [Mueller, Christian] Max F Perutz Labs, Vienna, Austria; [Bodden, Malena] Georg Speyer Haus, Inst Tumor Biol & Expt Therapy, Frankfurt, Germany	University of Regensburg; University of Regensburg; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Octapharma	Griesenbeck, J; Tschochner, H; Milkereit, P (corresponding author), Univ Regensburg, Lehrstuhl Biochem 3, Regensburg, Germany.	joachim.griesenbeck@vkl.uni-regensburg.de; herbert.tschochner@vkl.uni-regensburg.de; philipp.milkereit@vkl.uni-regensburg.de		Griesenbeck, Joachim/0000-0002-7817-6095	"Deutsche Forschungsgemeinschaft" [SFB 960]	"Deutsche Forschungsgemeinschaft"(German Research Foundation (DFG))	This work was supported by a grant which was given in the collaborative research center SFB 960, from the "Deutsche Forschungsgemeinschaft" (www.dfg.de) to JG, HT and PM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Biedka S, 2017, RNA BIOL; Burke D., 2000, METHODS YEAST GENETI; Coleman AW, 2015, TRENDS GENET TIG; Cote CA, 2002, RNA, V8, P786, DOI 10.1017/S1355838202023063; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; Dembowski JA, 2013, RNA, V19, P1639, DOI 10.1261/rna.041194.113; Dembowski JA, 2013, NUCLEIC ACIDS RES, V41, P7889, DOI 10.1093/nar/gkt545; Geerlings TH, 2000, RNA, V6, P1698, DOI 10.1017/S1355838200001540; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Granneman S, 2011, EMBO J, V30, P4006, DOI 10.1038/emboj.2011.256; Greber BJ, 2016, RNA, V22, P1643, DOI 10.1261/rna.057927.116; Greber BJ, 2016, CELL, V164, P91, DOI 10.1016/j.cell.2015.11.027; Hedges J, 2005, EMBO J, V24, P567, DOI 10.1038/sj.emboj.7600547; Hierlmeier T, 2012, NUCL ACIDS RES; Joseph N, 1999, NUCLEIC ACIDS RES, V27, P4533, DOI 10.1093/nar/27.23.4533; Kielpinski LJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku167; Konikkat S, 2017, NUCLEIC ACIDS RES, V45, P4853, DOI 10.1093/nar/gkw1361; Kressler D, 2008, J CELL BIOL, V181, P935, DOI 10.1083/jcb.200801181; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Ma CY, 2017, NAT STRUCT MOL BIOL, V24, P214, DOI 10.1038/nsmb.3364; Mager WH, 1997, NUCLEIC ACIDS RES, V25, P4872, DOI 10.1093/nar/25.24.4872; Malyutin AG, 2017, EMBO J; MIKULSKI AJ, 1969, J BIOL CHEM, V244, P6559; Miles TD, 2005, MOL CELL BIOL, V25, P10419, DOI 10.1128/MCB.25.23.10419-10432.2005; Milkereit P, 2001, CELL, V105, P499, DOI 10.1016/S0092-8674(01)00358-0; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Ohmayer U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068412; Ohmayer U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042449; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poll G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008249; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Reiter A, 2012, EMBO J, V31, P3480, DOI 10.1038/emboj.2012.185; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sarkar A, 2016, NAT STRUCT MOL BIOL; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Talkish J, 2014, MOL CELL BIOL, V34, P1863, DOI 10.1128/MCB.01322-13; Talkish J, 2014, RNA, V20, P713, DOI 10.1261/rna.042218.113; Thomson E, 2009, MOL CELL BIOL; Tutuncuoglu B, 2016, RNA, V22, P1386, DOI 10.1261/rna.055798.115; Venema J, 1998, METH MOL B, V77, P257; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Wu S, 2016, NATURE, V534, P133, DOI 10.1038/nature17942; YEH LCC, 1990, J MOL BIOL, V211, P699, DOI 10.1016/0022-2836(90)90071-S; Zhang J, 2016, NUCL ACIDS RES	48	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179405	10.1371/journal.pone.0179405	http://dx.doi.org/10.1371/journal.pone.0179405			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686620	Green Published, Green Submitted, gold			2022-12-26	WOS:000405464100016
J	Takii, R; Fujimoto, M; Matsuura, Y; Wu, FX; Oshibe, N; Takaki, E; Katiyar, A; Akashi, H; Makino, T; Kawata, M; Nakai, A				Takii, Ryosuke; Fujimoto, Mitsuaki; Matsuura, Yuki; Wu, Fangxu; Oshibe, Namiko; Takaki, Eiichi; Katiyar, Arpit; Akashi, Hiroshi; Makino, Takashi; Kawata, Masakado; Nakai, Akira			HSF1 and HSF3 cooperatively regulate the heat shock response in lizards	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; BINDING-ACTIVITY; GENOME DUPLICATIONS; MOLECULAR-CLONING; FACTOR FAMILY; CELL-DEATH; FACTOR-I; STRESS; GENES; PROTEIN	Cells cope with temperature elevations, which cause protein misfolding, by expressing heat shock proteins (HSPs). This adaptive response is called the heat shock response (HSR), and it is regulated mainly by heat shock transcription factor (HSF). Among the four HSF family members in vertebrates, HSF1 is a master regulator of HSP expression during proteotoxic stress including heat shock in mammals, whereas HSF3 is required for the HSR in birds. To examine whether only one of the HSF family members possesses the potential to induce the HSR in vertebrate animals, we isolated cDNA clones encoding lizard and frog HSF genes. The reconstructed phylogenetic tree of vertebrate HSFs demonstrated that HSF3 in one species is unrelated with that in other species. We found that the DNA-binding activity of both HSF1 and HSF3 in lizard and frog cells was induced in response to heat shock. Unexpectedly, overexpression of lizard and frog HSF3 as well as HSF1 induced HSP70 expression in mouse cells during heat shock, indicating that the two factors have the potential to induce the HSR. Furthermore, knockdown of either HSF3 or HSF1 markedly reduced HSP70 induction in lizard cells and resistance to heat shock. These results demonstrated that HSF1 and HSF3 cooperatively regulate the HSR at least in lizards, and suggest complex mechanisms of the HSR in lizards as well as frogs.	[Takii, Ryosuke; Fujimoto, Mitsuaki; Matsuura, Yuki; Wu, Fangxu; Oshibe, Namiko; Takaki, Eiichi; Katiyar, Arpit; Nakai, Akira] Yamaguchi Univ, Sch Med, Dept Biochem, Ube, Yamaguchi, Japan; [Takii, Ryosuke; Fujimoto, Mitsuaki; Matsuura, Yuki; Wu, Fangxu; Oshibe, Namiko; Takaki, Eiichi; Katiyar, Arpit; Nakai, Akira] Yamaguchi Univ, Sch Med, Dept Mol Biol, Ube, Yamaguchi, Japan; [Akashi, Hiroshi; Makino, Takashi; Kawata, Masakado] Tohoku Univ, Grad Sch Life Sci, Dept Ecol & Evolutionary Biol, Sendai, Miyagi, Japan; [Wu, Fangxu] Kyushu Univ, Med Inst Bioregulat, Fukuoka, Japan	Yamaguchi University; Yamaguchi University; Tohoku University; Kyushu University	Nakai, A (corresponding author), Yamaguchi Univ, Sch Med, Dept Biochem, Ube, Yamaguchi, Japan.; Nakai, A (corresponding author), Yamaguchi Univ, Sch Med, Dept Mol Biol, Ube, Yamaguchi, Japan.	anakai@yamaguchi-u.ac.jp	Makino, Takashi/AAC-5181-2019; Kawata, Masakado/E-3962-2012	Makino, Takashi/0000-0003-4600-9353; Akashi, Hiroshi/0000-0001-5053-3292	JSPS KAKENHI [26116720, 15H04706, 16K08625]; Takeda Science Foundation Special Project Research; Uehara Memorial Foundation; Kato memorial bioscience foundation; Yamaguchi University "Pump-Priming Program"	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation Special Project Research; Uehara Memorial Foundation(Uehara Memorial Foundation); Kato memorial bioscience foundation; Yamaguchi University "Pump-Priming Program"	This work was supported by JSPS KAKENHI grant numbers 26116720, 15H04706, 16K08625 (to A.N., R.T.), Takeda Science Foundation Special Project Research (to A.N.), Uehara Memorial Foundation (to A.N.), Kato memorial bioscience foundation (to R.T.), and The Yamaguchi University Pump-Priming Program (to A.N.).	Akashi HD, 2016, MOL ECOL, V25, P2273, DOI 10.1111/mec.13625; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; CLOS J, 1990, CELL, V63, P1085, DOI 10.1016/0092-8674(90)90511-C; COHEN MM, 1968, CYTOGENETICS, V7, P16, DOI 10.1159/000129968; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; El Fatimy R, 2014, EMBO MOL MED, V6, P1043, DOI 10.15252/emmm.201303311; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Fujimoto M, 2008, J BIOL CHEM, V283, P29961, DOI 10.1074/jbc.M804629200; Fujimoto M, 2010, FEBS J, V277, P4112, DOI 10.1111/j.1742-4658.2010.07827.x; Fujimoto M, 2010, MOL BIOL CELL, V21, P106, DOI 10.1091/mbc.E09-07-0639; Gordon S, 1997, DEV BIOL, V181, P47, DOI 10.1006/dbio.1996.8441; Hayashida N, 2010, EMBO J, V29, P3459, DOI 10.1038/emboj.2010.225; Hilgarth RS, 2004, CELL STRESS CHAPERON, V9, P214, DOI 10.1379/CSC-8R.1; Himly M, 1998, VIROLOGY, V248, P295, DOI 10.1006/viro.1998.9290; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Inouye S, 2003, MOL CELL BIOL, V23, P5882, DOI 10.1128/MCB.23.16.5882-5895.2003; Kawazoe Y, 1999, EUR J BIOCHEM, V265, P688, DOI 10.1046/j.1432-1327.1999.00762.x; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LIS J, 1993, CELL, V74, P1, DOI 10.1016/0092-8674(93)90286-Y; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; McMillan DR, 2002, MOL CELL BIOL, V22, P8005, DOI 10.1128/MCB.22.22.8005-8014.2002; Mercier PA, 1997, J BIOL CHEM, V272, P14147, DOI 10.1074/jbc.272.22.14147; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Miozzo F, 2015, J MOL BIOL, V427, P3793, DOI 10.1016/j.jmb.2015.10.007; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morimoto RI, 2011, COLD SH Q B, V76, P91, DOI 10.1101/sqb.2012.76.010637; Nakai, 2016, HEAT SHOCK FACTOR, DOI 10.1007/978-4-431-55852-1; Nakai A, 1997, MOL CELL BIOL, V17, P469, DOI 10.1128/MCB.17.1.469; Nakai A, 1999, CELL STRESS CHAPERON, V4, P86, DOI 10.1379/1466-1268(1999)004<0086:NAITVH>2.3.CO;2; NAKAI A, 1993, MOL CELL BIOL, V13, P1983, DOI 10.1128/MCB.13.4.1983; NAKAI A, 1995, MOL CELL BIOL, V15, P5268; Nakai A, 2001, EMBO J, V20, P2885, DOI 10.1093/emboj/20.11.2885; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; OVSENEK N, 1990, DEVELOPMENT, V110, P427; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; RABINDRAN SK, 1991, P NATL ACAD SCI USA, V88, P6906, DOI 10.1073/pnas.88.16.6906; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SARGE KD, 1991, GENE DEV, V5, P1902, DOI 10.1101/gad.5.10.1902; SCHUETZ TJ, 1991, P NATL ACAD SCI USA, V88, P6911, DOI 10.1073/pnas.88.16.6911; Shinkawa T, 2011, MOL BIOL CELL, V22, P3571, DOI 10.1091/mbc.E11-04-0330; Sidow A, 1996, CURR OPIN GENET DEV, V6, P715, DOI 10.1016/S0959-437X(96)80026-8; Sinzelle L, 2012, GENESIS, V50, P316, DOI 10.1002/dvg.20822; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; STUMP DG, 1995, GENE, V160, P207, DOI 10.1016/0378-1119(95)00176-7; Swan CL, 2012, CELL STRESS CHAPERON, V17, P623, DOI 10.1007/s12192-012-0337-3; Takii R, 2015, MOL CELL BIOL, V35, P11, DOI 10.1128/MCB.00754-14; Tanabe M, 1998, EMBO J, V17, P1750, DOI 10.1093/emboj/17.6.1750; Tanabe M, 1999, J BIOL CHEM, V274, P27845, DOI 10.1074/jbc.274.39.27845; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wakasa H, 2015, J EXP ZOOL PART B, V324, P410, DOI 10.1002/jez.b.22627; WIEDERRECHT G, 1988, CELL, V54, P841, DOI 10.1016/S0092-8674(88)91197-X; Wolff S, 2014, NATURE, V508, P328, DOI 10.1038/nature13220; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Zatsepina OG, 2000, J EXP BIOL, V203, P1017; ZUO JR, 1995, MOL CELL BIOL, V15, P4319	63	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180776	10.1371/journal.pone.0180776	http://dx.doi.org/10.1371/journal.pone.0180776			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686674	Green Submitted, Green Published, gold			2022-12-26	WOS:000405464100100
J	Elliott, P; G'Sell, M; Snyder, LM; Ross, SE; Ventura, V				Elliott, Peter; G'Sell, Max; Snyder, Lindsey M.; Ross, Sarah E.; Ventura, Valerie			Automated acoustic detection of mouse scratching	PLOS ONE			English	Article							EVALUATION SYSTEM; SPINAL-CORD; MICE; BEHAVIOR; ITCH; QUANTIFICATION; DERMATITIS	Itch is an aversive somatic sense that elicits the desire to scratch. In animal models of itch, scratching behavior is frequently used as a proxy for itch, and this behavior is typically assessed through visual quantification. However, manual scoring of videos has numerous limitations, underscoring the need for an automated approach. Here, we propose a novel automated method for acoustic detection of mouse scratching. Using this approach, we show that chloroquine-induced scratching behavior in C57BL/6 mice can be quantified with reasonable accuracy (85% sensitivity, 75% positive predictive value). This report is the first method to apply supervised learning techniques to automate acoustic scratch detection.	[Elliott, Peter; G'Sell, Max; Ventura, Valerie] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Snyder, Lindsey M.; Ross, Sarah E.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA; [Snyder, Lindsey M.; Ross, Sarah E.] Univ Pittsburgh, Pittsburgh Ctr Pain Res, Pittsburgh, PA USA; [Ross, Sarah E.] Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA USA; [Ross, Sarah E.; Ventura, Valerie] Ctr Neural Basis Cognit, Pittsburgh, PA USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Elliott, P (corresponding author), Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA.	pwelliott@cmu.edu		Snyder, Lindsey/0000-0001-8831-0342	NIH [NS073548, NS092146, AR063772, AR064445, MH064537]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064537] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by NIH training grants NS073548 and NS092146 (LMS), NIH R01 grants AR063772 and AR064445 (SER), and NIH R01 grant MH064537 (VV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2010, ACTA DERM-VENEREOL, V90, P575, DOI 10.2340/00015555-0962; Brash HM, 2005, J NEUROSCI METH, V142, P107, DOI 10.1016/j.jneumeth.2004.08.001; Cuellar JM, 2003, NEUROSCI LETT, V339, P72, DOI 10.1016/S0304-3940(02)01458-1; Elliott GR, 2000, J PHARMACOL TOXICOL, V44, P453, DOI 10.1016/S1056-8719(01)00111-3; Ishii I, 2007, IEEE INT C AUT SCI E; KURAISHI Y, 1995, EUR J PHARMACOL, V275, P229, DOI 10.1016/0014-2999(94)00780-B; Marino M, 2012, J NEUROSCI METH, V211, P1, DOI 10.1016/j.jneumeth.2012.08.002; Nie Y, 2012, SICE J CONTROL MEASU, V4, P322; Noro Y, 2014, J DERMATOL, V41, P233, DOI 10.1111/1346-8138.12405; Orito K, 2004, BRIT J DERMATOL, V150, P33, DOI 10.1111/j.1365-2133.2004.05744.x; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Umeda K, 2006, LIFE SCI, V79, P2144, DOI 10.1016/j.lfs.2006.07.010; Weisshaar E, 2009, ACTA DERM-VENEREOL, V89, P339, DOI 10.2340/00015555-0662; Wiltschko AB, 2015, NEURON, V88, P1121, DOI 10.1016/j.neuron.2015.11.031; Yosipovitch G., 2008, ITCH BASIC MECH THER, P183	16	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179662	10.1371/journal.pone.0179662	http://dx.doi.org/10.1371/journal.pone.0179662			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678797	Green Published, Green Submitted, gold			2022-12-26	WOS:000405272200020
J	Cubizolle, A; Guillou, L; Mollereau, B; Hamel, CP; Brabet, P				Cubizolle, Aurelie; Guillou, Laurent; Mollereau, Bertrand; Hamel, Christian P.; Brabet, Philippe			Fatty acid transport protein 1 regulates retinoid metabolism and photoreceptor development in mouse retina	PLOS ONE			English	Article							ACYL-COA SYNTHETASE; PIGMENT EPITHELIUM; DOCOSAHEXAENOIC ACID; VISUAL CYCLE; LECITHINRETINOL ACYLTRANSFERASE; ROD PHOTORECEPTORS; RPE65; ISOMERASE; RHODOPSIN; DISEASE	In retinal pigment epithelium (RPE), RPE65 catalyzes the isomerization of all-trans-retinyl fatty acid esters to 11-cis-retinol in the visual cycle and controls the rhodopsin regeneration rate. However, the mechanisms by which these processes are regulated are still unclear. Fatty Acid Transport Protein 1 (FATP1) is involved in fatty acid uptake and lipid metabolism in a variety of cell types. FATP1 co-localizes with RPE65 in RPE and inhibits its isomerase activity in vitro. Here, we further investigated the role of FATP1 in the visual cycle using transgenic mice that overexpress human FATP1 specifically in the RPE (hFATP1TG mice). The mice displayed no delay in the kinetics of regeneration of the visual chromophore 11-cis-retinal after photobleaching and had no defects in light sensitivity. However, the total retinoid content was higher in the hFATP1TG mice than in wild type mice, and the transgenic mice also displayed an age-related accumulation (up to 40%) of all-trans-retinal and retinyl esters that was not observed in control mice. Consistent with these results, hFATP1TG mice were more susceptible to light-induced photoreceptor degeneration. hFATP1 overexpression also induced an similar to 3.5-fold increase in retinosome autofluorescence, as measured by two-photon microscopy. Interestingly, hFATP1TG retina contained similar to 25% more photoreceptor cells and similar to 35% longer outer segments than wild type mice, revealing a non-cell-autonomous effect of hFATP1 expressed in the RPE. These data are the first to show that FATP1-mediated fatty acid uptake in the RPE controls both retinoid metabolism in the outer retina and photoreceptor development.	[Cubizolle, Aurelie; Guillou, Laurent; Hamel, Christian P.; Brabet, Philippe] Inst Neurosci Montpellier, INSERM, U1051, Montpellier, France; [Mollereau, Bertrand] Ecole Normale Super Lyon, Lab Biol & Modelisat Cellule, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Ecole Normale Superieure de Lyon (ENS de LYON)	Brabet, P (corresponding author), Inst Neurosci Montpellier, INSERM, U1051, Montpellier, France.	philippe.brabet@inserm.fr	Brabet, Philippe/AAO-8522-2020; Mollereau, Bertrand/S-4447-2017	Brabet, Philippe/0000-0003-2739-1622; Mollereau, Bertrand/0000-0003-4710-8185	National Research Agency [ANR-12-BSV1-0019-02]; Labex EpiGenMed Programme for Future Investment [ANR-10-LABX-12-01]; Inserm	National Research Agency(French National Research Agency (ANR)); Labex EpiGenMed Programme for Future Investment; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by National Research Agency ANR-12-BSV1-0019-02 LipidinRetina and Labex EpiGenMed Programme for Future Investment ANR-10-LABX-12-01 (financial support to AC,BM and PB).r The authors were supported by National Research Agency ANR-12-BSV1-0019-02 LipidinRetina and Inserm. AC was supported byLabex EpiGenMed Programme for Future Investment ANR-10-LABX-12-01 for financial support. We are grateful to Marie Seveno, Nicolas Tricaud, RHEM platform, SEAT transgenesis service (CNRS D UPS44) and the animal facility of INM for technical assistance, and to Montpellier RIO Imaging for providing materials.	Akbar M, 2005, P NATL ACAD SCI USA, V102, P10858, DOI 10.1073/pnas.0502903102; BATES D, 1989, J NEUROL NEUROSUR PS, V52, P18, DOI 10.1136/jnnp.52.1.18; Blakeley LR, 2011, INVEST OPHTH VIS SCI, V52, P3483, DOI 10.1167/iovs.10-6694; Bretillon L, 2008, EXP EYE RES, V87, P521, DOI 10.1016/j.exer.2008.08.010; BROWN MF, 1994, CHEM PHYS LIPIDS, V73, P159, DOI 10.1016/0009-3084(94)90180-5; Chekroud K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050231; Cia D, 2016, J CELL MOL MED, V20, P1651, DOI 10.1111/jcmm.12857; Claybon A, 2011, JOVE-J VIS EXP, DOI 10.3791/2563; DELORGERIL M, 1994, LANCET, V343, P1454, DOI 10.1016/S0140-6736(94)92580-1; DiRusso CC, 2005, J BIOL CHEM, V280, P16829, DOI 10.1074/jbc.M409598200; Dourlen P, 2015, PROG LIPID RES, V60, P30, DOI 10.1016/j.plipres.2015.08.001; Dourlen P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002833; Eroglu A, 2016, J BIOL CHEM, V291, P4966, DOI 10.1074/jbc.M115.685651; Esumi N, 2004, J BIOL CHEM, V279, P19064, DOI 10.1074/jbc.M309881200; Ferguson LR, 2012, BIOL PROCED ONLINE, V14, DOI 10.1186/1480-9222-14-9; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; Guesnet P, 2011, BIOCHIMIE, V93, P7, DOI 10.1016/j.biochi.2010.05.005; Guignard TJP, 2010, J BIOL CHEM, V285, P18759, DOI 10.1074/jbc.M109.064329; Hall AM, 2003, J BIOL CHEM, V278, P43008, DOI 10.1074/jbc.M306575200; Herrmann T, 2001, GENE, V270, P31, DOI 10.1016/S0378-1119(01)00489-9; Iacovelli J, 2011, INVEST OPHTH VIS SCI, V52, P1378, DOI 10.1167/iovs.10-6347; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Ivanovic I, 2011, INVEST OPHTH VIS SCI, V52, P6355, DOI 10.1167/iovs.10-7138; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kaylor JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125921; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Kiser PD, 2010, PROG RETIN EYE RES, V29, P428, DOI 10.1016/j.preteyeres.2010.03.002; Li SH, 2013, J NEUROSCI, V33, P3178, DOI 10.1523/JNEUROSCI.2428-12.2013; Maeda A, 2007, P NATL ACAD SCI USA, V104, P19565, DOI 10.1073/pnas.0707477104; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Ochiai Y, 2017, J NEUROCHEM, V141, P400, DOI 10.1111/jnc.13943; Orban T, 2011, J BIOL CHEM, V286, P17248, DOI 10.1074/jbc.M110.195198; Palczewska G, 2014, NAT MED, V20, P785, DOI 10.1038/nm.3590; Parker RO, 2010, EXP EYE RES, V91, P788, DOI 10.1016/j.exer.2010.08.013; Pollock NL, 2014, BBA-BIOMEMBRANES, V1838, P134, DOI 10.1016/j.bbamem.2013.09.001; Qi RL, 2013, MOL BIOL REP, V40, P2907, DOI 10.1007/s11033-012-2306-4; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Richards MR, 2006, J LIPID RES, V47, P665, DOI 10.1194/jlr.M500514-JLR200; Saari JC, 1998, VISION RES, V38, P1325, DOI 10.1016/S0042-6989(97)00198-3; Sears AE, 2016, BIOCHEMISTRY-US, V55, P3082, DOI 10.1021/acs.biochem.6b00319; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; Sparrrow JR, 2010, CURR MOL MED, V10, P802; SUZUKI T, 1986, VISION RES, V26, P425, DOI 10.1016/0042-6989(86)90185-9; Uauy R, 2001, LIPIDS, V36, P885, DOI 10.1007/s11745-001-0798-1; Wright CB, 2015, PROG MOL BIOL TRANSL, V134, P433, DOI 10.1016/bs.pmbts.2015.06.009; Zhan TZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045087	47	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180148	10.1371/journal.pone.0180148	http://dx.doi.org/10.1371/journal.pone.0180148			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672005	Green Published, gold, Green Submitted			2022-12-26	WOS:000405268500018
J	Hackelberg, S; Tuck, SJ; He, L; Rastogi, A; White, C; Liu, LQ; Prieskorn, DM; Miller, RJ; Chan, C; Loomis, BR; Corey, JM; Miller, JM; Duncan, RK				Hackelberg, Sandra; Tuck, Samuel J.; He, Long; Rastogi, Arjun; White, Christina; Liu, Liqian; Prieskorn, Diane M.; Miller, Ryan J.; Chan, Che; Loomis, Benjamin R.; Corey, Joseph M.; Miller, Josef M.; Duncan, R. Keith			Nanofibrous scaffolds for the guidance of stem cell-derived neurons for auditory nerve regeneration	PLOS ONE			English	Article							SPIRAL GANGLION NEURONS; COCHLEAR IMPLANTATION; SCHWANN-CELLS; MOUSE MODEL; IN-VITRO; DIFFERENTIATION; TRANSPLANTATION; NEUROPATHY; OUABAIN; GROWTH	Impairment of spiral ganglion neurons (SGNs) of the auditory nerve is a major cause for hearing loss occurring independently or in addition to sensory hair cell damage. Unfortunately, mammalian SGNs lack the potential for autonomous regeneration. Stem cell based therapy is a promising approach for auditory nerve regeneration, but proper integration of exogenous cells into the auditory circuit remains a fundamental challenge. Here, we present novel nanofibrous scaffolds designed to guide the integration of human stem cell-derived neurons in the internal auditory meatus (IAM), the foramen allowing passage of the spiral ganglion to the auditory brainstem. Human embryonic stem cells (hESC) were differentiated into neural precursor cells (NPCs) and seeded onto aligned nanofiber mats. The NPCs terminally differentiated into glutamatergic neurons with high efficiency, and neurite projections aligned with nanofibers in vitro. Scaffolds were assembled by seeding GFP-labeled NPCs on nanofibers integrated in a polymer sheath. Biocompatibility and functionality of the NPC-seeded scaffolds were evaluated in vivo in deafened guinea pigs (Cavia porcellus). To this end, we established an ouabain-based deafening procedure that depleted an average 72% of SGNs from apex to base of the cochleae and caused profound hearing loss. Further, we developed a surgical procedure to implant seeded scaffolds directly into the guinea pig IAM. No evidence of an inflammatory response was observed, but post-surgery tissue repair appeared to be facilitated by infiltrating Schwann cells. While NPC survival was found to be poor, both subjects implanted with NPC-seeded and cell-free control scaffolds showed partial recovery of electrically-evoked auditory brainstem thresholds. Thus, while future studies	[Hackelberg, Sandra; He, Long; Liu, Liqian; Prieskorn, Diane M.; Miller, Ryan J.; Loomis, Benjamin R.; Miller, Josef M.; Duncan, R. Keith] Univ Michigan, Kresge Hearing Res Inst, Dept Otolaryngol Head & Neck Surg, 1301 E Ann St, Ann Arbor, MI 48109 USA; [Tuck, Samuel J.; Rastogi, Arjun; White, Christina; Miller, Ryan J.; Chan, Che; Corey, Joseph M.] VAAAHC, GRECC, Ann Arbor, MI USA; [Tuck, Samuel J.; White, Christina; Miller, Ryan J.; Corey, Joseph M.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [He, Long] Jinan Univ, Dept Otorhinolaryngol, Guangzhou Peoples Hosp 1, Sch Med, Guangzhou, Guangdong, Peoples R China; [He, Long] Jinan Univ, Dept Otorhinolaryngol, Affiliated Hosp 1, Sch Med, Guangzhou, Guangdong, Peoples R China; [Chan, Che] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA; [Corey, Joseph M.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Hackelberg, Sandra] Northwestern Univ, Ken & Ruth Davee Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA	University of Michigan System; University of Michigan; Geriatric Research Education & Clinical Center; University of Michigan System; University of Michigan; Jinan University; Jinan University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Northwestern University; Feinberg School of Medicine	Duncan, RK (corresponding author), Univ Michigan, Kresge Hearing Res Inst, Dept Otolaryngol Head & Neck Surg, 1301 E Ann St, Ann Arbor, MI 48109 USA.	rkduncan@umich.edu		Loomis, Benjamin/0000-0002-0212-6403	Department of Defense [W81XWH-12-10 492]; National Institutes of Health (NIH) [P30DC005188]	Department of Defense(United States Department of Defense); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by agrant from the Department of Defense, W81XWH-12-10 492 to RKD, (http://cdmrp.army.mil) and National Institutes of Health (NIH) (P30DC005188). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler RA, 2008, HEARING RES, V242, P110, DOI 10.1016/j.heares.2008.06.004; [Anonymous], 2018, WHO GLOB EST PREV HE; Appler JM, 2013, J NEUROSCI, V33, P3679, DOI 10.1523/JNEUROSCI.4703-12.2013; Bok J, 2011, P NATL ACAD SCI USA, V108, P161, DOI 10.1073/pnas.1010547108; Budenz CL, 2015, SCI REP-UK, V5, DOI 10.1038/srep08619; Callahan LAS, 2013, BIOMATERIALS, V34, P9089, DOI 10.1016/j.biomaterials.2013.08.028; Chanda S, 2014, STEM CELL REP, V3, P282, DOI 10.1016/j.stemcr.2014.05.020; Chen JC, 2013, HEARING RES, V297, P3, DOI 10.1016/j.heares.2012.11.018; Chen W, 2012, NATURE, V490, P278, DOI 10.1038/nature11415; Chen W, 2009, STEM CELLS, V27, P1196, DOI 10.1002/stem.62; Cho YB, 2011, J KOREAN MED SCI, V26, P492, DOI 10.3346/jkms.2011.26.4.492; Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004; Corey JM, 2008, ACTA BIOMATER, V4, P863, DOI 10.1016/j.actbio.2008.02.020; Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285; Corrales CE, 2006, J NEUROBIOL, V66, P1489, DOI 10.1002/neu.20310; Dennis Daniel, 2016, Trends Dev Biol, V9, P77; Duthey B, 2013, PRIORITY MED EUROPE, P4; El-Akabawy G, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-97; Fu Y, 2012, NEUROTOX RES, V22, P158, DOI 10.1007/s12640-012-9320-0; Gerardo-Nava J, 2009, NANOMEDICINE-UK, V4, P11, DOI 10.2217/17435889.4.1.11; Gertz CC, 2010, DEV NEUROBIOL, V70, P589, DOI 10.1002/dneu.20792; Giger RJ, 2010, BIOL, P2; Glueckert R, 2008, J COMP NEUROL, V507, P1602, DOI 10.1002/cne.21619; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Gunewardene N, 2014, BIORESEARCH OPEN ACC, V3, P162, DOI 10.1089/biores.2014.0019; Gunewardene N, 2012, STEM CELL REV REP, V8, P741, DOI 10.1007/s12015-011-9320-0; Guzman MS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001194; Hamada M, 1999, ACTA OTO-LARYNGOL, V119, P778; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Huang EJ, 2001, DEVELOPMENT, V128, P2421; Hynes RO, 2010, EXTRACELLULAR MATRIX, P1216; Jiao Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/356415; Joshi MK, 2015, ACS APPL MATER INTER, V7, P19672, DOI 10.1021/acsami.5b04682; Kim JE, 2011, P NATL ACAD SCI USA, V108, P3005, DOI 10.1073/pnas.1007753108; Krishnan M, 2005, FASEB J; Kujawa SG, 2015, HEARING RES, V330, P191, DOI 10.1016/j.heares.2015.02.009; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Lang HN, 2008, JARO-J ASSOC RES OTO, V9, P225, DOI 10.1007/s10162-008-0119-x; Lawoko-Kerali G, 2004, MECH DEVELOP, V121, P287, DOI 10.1016/j.mod.2003.12.006; Li JP, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1028-0; Liang YJ, 2013, EXP NEUROL, V247, P73, DOI 10.1016/j.expneurol.2013.04.001; Liberman LD, 2015, JARO-J ASSOC RES OTO, V16, P205, DOI 10.1007/s10162-015-0510-3; Lim SH, 2010, BIOMATERIALS, V31, P9031, DOI 10.1016/j.biomaterials.2010.08.021; Liu W, 2015, NEUROSCIENCE, V284, P470, DOI 10.1016/j.neuroscience.2014.09.059; Lu CC, 2011, J NEUROSCI, V31, P10903, DOI 10.1523/JNEUROSCI.2358-11.2011; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Maier EC, 2014, DEV BIOL, V389, P50, DOI 10.1016/j.ydbio.2014.01.023; Marques SR, 2012, IRAN J RADIOL, V9, P71, DOI 10.5812/iranjradiol.7849; Martinez-Monedero R, 2008, DEV NEUROBIOL, V68, P669, DOI 10.1002/dneu.20616; Mcmurtrey RJ., 2014, PATTERNED FUNCTIONAL, V11, P1; Mitchell A, 1997, HEARING RES, V105, P30, DOI 10.1016/S0378-5955(96)00202-X; Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]; Mohtaram NK, 2015, J MATER CHEM B, V3, P7974, DOI 10.1039/c5tb00871a; Moser T, 2016, NAT REV NEUROL, V12, P135, DOI 10.1038/nrneurol.2016.10; Nakamura M, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/1/014110; Nayagam BA, 2016, SPRINGER HANDB AUDIT, V52, P263, DOI 10.1007/978-1-4939-3031-9_9; Nayagam BA, 2011, HEARING RES, V278, P2, DOI 10.1016/j.heares.2011.04.003; Nishimura K, 2014, NEUROSCIENCE, V275, P125, DOI 10.1016/j.neuroscience.2014.05.067; Okano T, 2005, NEUROREPORT, V16, P1919, DOI 10.1097/01.wnr.0000187628.38010.5b; Pettingill LN, 2008, NEUROSCIENCE, V152, P821, DOI 10.1016/j.neuroscience.2007.11.057; Pfingst BE, HEAR RES; Pfingst BE, 2015, HEARING RES, V330, P98, DOI 10.1016/j.heares.2015.07.010; Prieskorn DM, 2000, HEARING RES, V140, P212, DOI 10.1016/S0378-5955(99)00193-8; Purcell EK, 2012, BIOMACROMOLECULES, V13, P3427, DOI 10.1021/bm301220k; Reyes JH, 2008, J NEUROSCI, V28, P12622, DOI 10.1523/JNEUROSCI.0563-08.2008; Riccomagno MM, 2005, GENE DEV, V19, P1612, DOI 10.1101/gad.1303905; Rodriguez K, 2011, BIOMIMETIC CALCIUM P, P681; Sanchez-Rodriguez JE, 2015, J MOL BIOL, V427, P1335, DOI 10.1016/j.jmb.2015.01.011; Schlosser G, 2006, DEV BIOL, V294, P303, DOI 10.1016/j.ydbio.2006.03.009; Schmiedt RA, 2002, JARO, V3, P223, DOI 10.1007/s1016200220017; Shahbazi E, 2011, TISSUE ENG PT A, V17, P3021, DOI [10.1089/ten.tea.2011.0121, 10.1089/ten.TEA.2011.0121]; Shi FX, 2007, EUR J NEUROSCI, V26, P3016, DOI 10.1111/j.1460-9568.2007.05909.x; Shibata SB, 2011, HEARING RES, V281, P56, DOI 10.1016/j.heares.2011.04.019; Swan EEL, 2008, ADV DRUG DELIVER REV, V60, P1583, DOI 10.1016/j.addr.2008.08.001; Triolo D, 2012, VIMENTIN REGULATES P, V1367, P1359; Tsang KY, 2010, CELL TISSUE RES, V339, P93, DOI 10.1007/s00441-009-0893-8; Wan GQ, 2014, ELIFE, V3, DOI 10.7554/eLife.03564; Wang JX, 2012, J BIOMED MATER RES A, V100A, P632, DOI 10.1002/jbm.a.33291; Whitfield TT, 2015, CURR OPIN GENET DEV, V32, P112, DOI 10.1016/j.gde.2015.02.006; Whitlon DS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15960; Wise AK, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/6/065002; Wise AK, 2011, HEARING RES, V278, P69, DOI 10.1016/j.heares.2011.04.010; Xia HJ, 2014, BRAIN RES, V1565, P18, DOI 10.1016/j.brainres.2014.04.002; Yin Y, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-28; Yuan YS, 2014, JARO-J ASSOC RES OTO, V15, P31, DOI 10.1007/s10162-013-0419-7; Zanin MP, 2014, NEUROSCIENCE, V277, P690, DOI 10.1016/j.neuroscience.2014.07.044; Zhou JX, 2007, J COMP NEUROL, V500, P777, DOI 10.1002/cne.21208; Zhou JH, 2013, NEURAL REGEN RES, V8, P1455, DOI 10.3969/j.issn.1673-5374.2013.16.002	88	20	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180427	10.1371/journal.pone.0180427	http://dx.doi.org/10.1371/journal.pone.0180427			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672008	Green Published, gold, Green Submitted			2022-12-26	WOS:000405268500053
J	Mattsson, A; Brunstrom, B				Mattsson, Anna; Brunstrom, Bjorn			Effects of selective and combined activation of estrogen receptor a and beta on reproductive organ development and sexual behaviour in Japanese quail (Coturnix japonica)	PLOS ONE			English	Article							CHICKEN EMBRYOS; VASOTOCIN SYSTEM; ALPHA ACTIVATION; OVO EXPOSURE; ER-ALPHA; DIFFERENTIATION; EXPRESSION; AROMATASE; AGONIST; DIETHYLSTILBESTROL	Excess estrogen exposure of avian embryos perturbs reproductive organ development in both sexes and demasculinizes the reproductive behaviors of adult males. We have previously shown that these characteristic effects on the reproductive organs also can be induced by exposure of Japanese quail (Coturnix japonica) embryos to selective agonists of estrogen receptor alpha (ER alpha). In contrast, the male copulatory behavior is only weakly affected by developmental exposure to an ERa agonist. To further elucidate the respective roles of ER alpha and ER beta in estrogen-induced disruption of sexual differentiation, we exposed Japanese quail embryos in ovo to the selective ER alpha agonist 16 alpha-lactone-estradiol (16 alpha LE2), the selective ER beta agonist WAY-200070, or both substances in combination. The ERa agonist feminized the testes in male embryos and reduced cloacal gland size in adult males. Furthermore, anomalous retention and malformations of the Mullerian ducts/oviducts were seen in embryos and juveniles of both sexes. The ER beta agonist did not induce any of these effects and did not influence the action of the ERa agonist. Male copulatory behavior was not affected by embryonic exposure to either the ER alpha-or the ER beta-selective agonist but was slightly suppressed by treatment with the two compounds combined. Our results suggest that the reproductive organs become sexually differentiated consequent to activation of ER alpha by endogenous estrogens; excessive activation of ER alpha, but not ER beta, during embryonic development may disrupt this process. Our results also suggest that the demasculinizing effect of estrogens on male copulatory behavior is only partly mediated by ER alpha and ER beta, and may rather involve other estrogen-responsive pathways.	[Mattsson, Anna; Brunstrom, Bjorn] Uppsala Univ, Dept Environm Toxicol, Uppsala, Sweden; [Mattsson, Anna; Brunstrom, Bjorn] Ctr Reprod Biol Uppsala CRU, Uppsala, Sweden	Uppsala University	Mattsson, A (corresponding author), Uppsala Univ, Dept Environm Toxicol, Uppsala, Sweden.; Mattsson, A (corresponding author), Ctr Reprod Biol Uppsala CRU, Uppsala, Sweden.	Anna.Mattsson@ebc.uu.se		Mattsson, Anna/0000-0002-5328-6255	Swedish Research Council Formas [2016-20128 99]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	The project was funded by a grant from the Swedish Research Council Formas to BB (http://www.formas.se/en/; grant no. 2016-20128 99). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of themanuscript.	ADKINS E K, 1975, Journal of Comparative and Physiological Psychology, V89, P61, DOI 10.1037/h0076406; ADKINS EK, 1979, NEUROENDOCRINOLOGY, V29, P178, DOI 10.1159/000122920; Andrews JE, 1997, GEN COMP ENDOCR, V108, P182, DOI 10.1006/gcen.1997.6978; Axelsson J, 2007, DEV NEUROBIOL, V67, P1742, DOI 10.1002/dneu.20544; BALTHAZART J, 1992, HORM BEHAV, V26, P179, DOI 10.1016/0018-506X(92)90041-S; Berg C, 2004, REPRODUCTION, V128, P455, DOI 10.1530/rep.1.00211; Berg C, 1999, SCI TOTAL ENVIRON, V233, P57, DOI 10.1016/S0048-9697(99)00179-5; Berg C, 2001, ENVIRON TOXICOL CHEM, V20, P2836, DOI 10.1002/etc.5620201224; Blomqvist A, 2006, BIOL REPROD, V74, P481, DOI 10.1095/biolreprod.105.045104; Brennan PLR, 2014, NEUROSCI BIOBEHAV R, V46, P557, DOI 10.1016/j.neubiorev.2014.08.010; Brunstrom B, 2009, GEN COMP ENDOCR, V163, P97, DOI 10.1016/j.ygcen.2009.01.006; ELBRECHT A, 1992, SCIENCE, V255, P467, DOI 10.1126/science.1734525; Ellis HL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099747; Escande A, 2006, BIOCHEM PHARMACOL, V71, P1459, DOI 10.1016/j.bcp.2006.02.002; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; FRY DM, 1981, SCIENCE, V213, P922, DOI 10.1126/science.7256288; Greenwood AW, 1938, Q J EXP PHYSIOL CMS, V28, P61, DOI 10.1113/expphysiol.1938.sp000765; Halldin K, 2003, ARCH TOXICOL, V77, P116, DOI 10.1007/s00204-002-0417-8; Halldin K, 1999, ENVIRON HEALTH PERSP, V107, P861, DOI 10.2307/3454472; Hanafy Ahmed M., 2005, Journal of Poultry Science, V42, P238, DOI 10.2141/jpsa.42.238; Hanafy Ahmed M., 2004, Journal of Poultry Science, V41, P30, DOI 10.2141/jpsa.41.30; Hill RA, 2007, MOL CELL NEUROSCI, V36, P146, DOI 10.1016/j.mcn.2007.05.012; Hillisch A, 2004, MOL ENDOCRINOL, V18, P1599, DOI 10.1210/me.2004-0050; Hughes ZA, 2008, NEUROPHARMACOLOGY, V54, P1136, DOI 10.1016/j.neuropharm.2008.03.004; Ishimaru Y, 2008, DEVELOPMENT, V135, P677, DOI 10.1242/dev.012856; Jia M, 2015, BEST PRACT RES CL EN, V29, P557, DOI 10.1016/j.beem.2015.04.008; Kohno S, 2015, ENDOCRINOLOGY, V156, P1887, DOI 10.1210/en.2014-1852; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lambeth LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068362; Leitman DC, 2010, CURR OPIN PHARMACOL, V10, P629, DOI 10.1016/j.coph.2010.09.009; Liu F, 2008, NAT NEUROSCI, V11, P334, DOI 10.1038/nn2057; Malamas MS, 2004, J MED CHEM, V47, P5021, DOI 10.1021/jm049719y; Mattsson A, 2008, GEN COMP ENDOCR, V159, P150, DOI 10.1016/j.ygcen.2008.08.012; Mattsson A, 2008, REPRODUCTION, V136, P175, DOI 10.1530/REP-08-0100; Mattsson A, 2011, GEN COMP ENDOCR, V172, P251, DOI 10.1016/j.ygcen.2011.03.010; Mattsson A, 2010, REPROD FERT DEVELOP, V22, P416, DOI 10.1071/RD08293; Miller NR, 2005, ENDOCRINOLOGY, V146, P3070, DOI 10.1210/en.2004-1515; Nakabayashi O, 1998, J MOL ENDOCRINOL, V20, P193, DOI 10.1677/jme.0.0200193; Panzica G, 2005, DOMEST ANIM ENDOCRIN, V29, P436, DOI 10.1016/j.domaniend.2005.02.010; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; RAHIL KS, 1972, GEN COMP ENDOCR, V18, P315, DOI 10.1016/0016-6480(72)90217-1; SCHEIB D, 1985, GEN COMP ENDOCR, V60, P266, DOI 10.1016/0016-6480(85)90323-5; SCHEIB D, 1983, DIFFERENTIATION, V23, pS87; Smith CA, 2004, BIOESSAYS, V26, P120, DOI 10.1002/bies.10400; Vaillant S, 2003, MOL REPROD DEV, V65, P420, DOI 10.1002/mrd.10318; Willer BH, 1935, P NATL ACAD SCI USA, V21, P625, DOI 10.1073/pnas.21.11.625; WOLFF E, 1979, IN VITRO CELL DEV B, V15, P6	47	7	7	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180548	10.1371/journal.pone.0180548	http://dx.doi.org/10.1371/journal.pone.0180548			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671963	Green Published, gold, Green Submitted			2022-12-26	WOS:000405268500063
J	Przybysz, R; Bunch, M				Przybysz, Raymond; Bunch, Martin			Exploring spatial patterns of sudden cardiac arrests in the city of Toronto using Poisson kriging and Hot Spot analyses	PLOS ONE			English	Article							RATES	Introduction Our study looked at out-of-hospital sudden cardiac arrest events in the City of Toronto. These are relatively rare events, yet present a serious global clinical and public health problem. We report on the application of spatial methods and tools that, although relatively well known to geographers and natural resource scientists, need to become better known and used more frequently by health care researchers. Materials and methods Our data came from the population-based Rescu Epistry cardiac arrest database. We limited it to the residents of the City of Toronto who experienced sudden arrest in 2010. The data was aggregated at the Dissemination Area level, and population rates were calculated. Poisson kriging was carried out on one year of data using three different spatial weights. Kriging estimates were then compared in Hot Spot analyses. Results Spatial analysis revealed that Poisson kriging can yield reliable rates using limited data of high quality. We observed the highest rates of sudden arrests in the north and central parts of Etobicoke, western parts of North York as well as the central and southwestern parts of Scarborough while the lowest rates were found in north and eastern parts of Scarborough, downtown Toronto, and East York as well as east central parts of North York. Influence of spatial neighbours on the results did not extend past two rings of adjacent units. Conclusions Poisson kriging has the potential to be applied to a wide range of healthcare research, particularly on rare events. This approach can be successfully combined with other spatial methods. More applied research, is needed to establish a wider acceptance for this method, especially among healthcare researchers and epidemiologists.				ray.prb@gmail.com	; Bunch, Martin/A-7025-2013	Przybysz, Raymond/0000-0001-9976-2408; Bunch, Martin/0000-0001-6940-372X				Allan KS, 2011, CIRCULATION, V124; [Anonymous], INT J MED MED SCI; Asmarian NS, 2013, ASIAN PAC J CANCER P, V14, P11, DOI 10.7314/APJCP.2013.14.1.11; Asmarian Naeimehossadat, 2016, Asian Pac J Cancer Prev, V17, P4587; Auchincloss AH, 2012, ANNU REV PUBL HEALTH, V33, P107, DOI 10.1146/annurev-publhealth-031811-124655; BioMedware, 2011, SPACESTAT SOFTW AN E; DMTI, 2010, GEOPINPOINT SUIT WIN; Environmental Systems Research Institute (ESRI), 2011, ARCGIS DESKT; ESRI, 2010, DATA CLASSIFICATION; ESRI, 2012, HOT SPOT AN GET ORD; ESRI. ArcGIS Resources, 2012, ARCGIS RES ARCGIS HE; Geographic Research Inc, 2012, SIMPLYMAP; Goovaerts P, 2008, ENVIRON ECOL STAT, V15, P421, DOI 10.1007/s10651-007-0064-6; Goovaerts Pierre, 2005, Int J Health Geogr, V4, P31, DOI 10.1186/1476-072X-4-31; Goovaerts Pierre, 2006, Int J Health Geogr, V5, P7, DOI 10.1186/1476-072X-5-7; Goovaerts P, 2009, SPAT SPATIO-TEMPORAL, V1, P61, DOI 10.1016/j.sste.2009.07.001; Goovaerts P, 2010, GEOGR ANAL, V42, P32, DOI 10.1111/j.1538-4632.2009.00781.x; Goovaerts P, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-6; Hampton KH, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-54; Heart and Stroke Foundation of Canada, 2015, CARD ARR 2015; Kyriakidis PC, 2004, GEOGR ANAL, V36, P259, DOI 10.1111/j.1538-4632.2004.tb01135.x; Monestiez P, 2005, QUANT GEO G, V14, P777; Morrison LJ, 2008, RESUSCITATION, V78, P161, DOI 10.1016/j.resuscitation.2008.02.020; Mozaffarian D., 2015, CIRCULATION; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Reinier K, 2011, CAN MED ASSOC J, V183, P1705, DOI 10.1503/cmaj.101512; Samal A, 2008, KRIGING PINCOCK PERS; Weisfeldt ML, 2011, NEW ENGL J MED, V364, P313, DOI 10.1056/NEJMoa1010663	29	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180721	10.1371/journal.pone.0180721	http://dx.doi.org/10.1371/journal.pone.0180721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672029	Green Published, Green Submitted, gold			2022-12-26	WOS:000405268500082
J	Tang, P; Zhang, Q; Yao, XH				Tang, Ping; Zhang, Qiong; Yao, Xiaohong			Comparative transcript profiling explores differentially expressed genes associated with sexual phenotype in kiwifruit	PLOS ONE			English	Article							CHROMOSOME EVOLUTION; ACTINIDIA-CHINENSIS; MALE-STERILITY; CUCUMBER; BIOSYNTHESIS; GENOME; MAIZE; FEMALENESS; GENETICS; FLOWERS	Background Kiwifruit is a perennial, deciduous and functionally dioecious plant. However, very little is known about the whole-genome molecular mechanisms contributing to distinct sexual phenotypes. To gain a global view of genes differentially expressed between male and female flowers, we analyzed genome-wide gene expression profiles in the flowers of male and female plants using high-throughput RNA sequencing. Results A total of 53.5 million reads were generated. Based on the alignments of unigenes to kiwifruit genome predicted genes, a total of 39,040 unique genes with a mean length of 970 bp were identified. There were 2,503 UniGenes differentially expressed between female and male flowers, with 1,793 up-regulated and 710 down-regulated in the female flowers. Moreover, the gene expression pattern of 17 out of 19 unigenes differentially expressed between male and female flowers revealed by RNA-Seq was confirmed by real-time quantitative PCR (qRT-PCR). Conclusions Here, we obtained a large number of EST sequences from female and male flowers of kiwifruit. This comparative transcriptome analysis provides an invaluable resource for gene expression, genomics, and functional genomic studies in A. chinensis and its related species. This study also represents a first step toward the investigation of genes involved in kiwifruit sex determination.	[Tang, Ping; Zhang, Qiong; Yao, Xiaohong] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan, Hubei, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Yao, XH (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan, Hubei, Peoples R China.	yaox@wbgcas.cn			Backbone Talent Program of Wuhan Botanical Garden; Chinese Academy of Sciences [Y655291A04]	Backbone Talent Program of Wuhan Botanical Garden; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Backbone Talent Program of Wuhan Botanical Garden, the Chinese Academy of Sciences (Y655291A04). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth C.C., 1999, SEX DETERMINATION PL, P173; Bagni N, 1999, FERTILIZATION HIGHER, P1; Belrose Inc., 2015, WORLD KIW REV 2015; Bergero R, 2011, CURR BIOL, V21, P1470, DOI 10.1016/j.cub.2011.07.032; Boualem A, 2008, SCIENCE, V321, P836, DOI 10.1126/science.1159023; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; BRUNDELL D J, 1975, New Zealand Journal of Botany, V13, P485; CAUDY M, 1988, CELL, V55, P1061, DOI 10.1016/0092-8674(88)90250-4; Charlesworth D, 2013, J EXP BOT, V64, P405, DOI 10.1093/jxb/ers322; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Crowhurst RN, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-351; Falasca G, 2010, BIOCHEMIST, V48, P565; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Ferguson A. R., 2007, Horticultural Reviews, V33, P1, DOI 10.1002/9780470168011.ch1; Fraser LG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-102; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; HARBERD NP, 1989, GENETICS, V121, P827; Hartwig T, 2011, P NATL ACAD SCI USA, V108, P19814, DOI 10.1073/pnas.1108359108; Harvey CF, 1997, ACTA HORTIC, P85, DOI 10.17660/ActaHortic.1997.444.10; Huang HW., 2014, GENUS ACTINIDIA WORL; Huang SX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3640; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li JQ, 2007, FLORA CHINA, V12, P334, DOI DOI 10.3233/BME-141227; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin A, 2009, NATURE, V461, P1135, DOI 10.1038/nature08498; MARTINTANGUY J, 1996, FLOWER NEWSLETT, V21, P10; Messina R., 1993, Advances in Horticultural Science, V7, P77; Mibus H, 2004, THEOR APPL GENET, V109, P1669, DOI 10.1007/s00122-004-1793-7; Ming R, 2011, ANNU REV PLANT BIOL, V62, P485, DOI 10.1146/annurev-arplant-042110-103914; Papadopoulou E, 2005, HORTSCIENCE, V40, P1763, DOI 10.21273/HORTSCI.40.6.1763; Rhee SJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2186-9; TAKAHASHI H, 1984, PHYTON-INT J EXP BOT, V44, P81; Tang W, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00335; Tennessen JA, 2013, G3-GENES GENOM GENET, V3, P1341, DOI 10.1534/g3.113.006288; TESTOLIN R, 1995, SEX PLANT REPROD, V8, P129, DOI 10.1007/BF00242255; VANDERMEER IM, 1992, PLANT CELL, V4, P253, DOI 10.1105/tpc.4.3.253; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Wan LL, 2011, PLANTA, V233, P309, DOI 10.1007/s00425-010-1301-z; Wang JP, 2012, P NATL ACAD SCI USA, V109, P13710, DOI 10.1073/pnas.1207833109; WINKLER RG, 1995, PLANT CELL, V7, P1307, DOI 10.1105/tpc.7.8.1307; Zhang JS, 2014, CURR OPIN PLANT BIOL, V18, P110, DOI 10.1016/j.pbi.2014.02.012; Zhang Q, 2015, DNA RES, V22, P367, DOI 10.1093/dnares/dsv019	43	11	12	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180542	10.1371/journal.pone.0180542	http://dx.doi.org/10.1371/journal.pone.0180542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672040	Green Published, Green Submitted, gold			2022-12-26	WOS:000405268500062
J	Vidal-Bralo, L; Perez-Pampin, E; Regueiro, C; Montes, A; Varela, R; Boveda, MD; Gomez-Reino, JJ; Gonzalez, A				Vidal-Bralo, Laura; Perez-Pampin, Eva; Regueiro, Cristina; Montes, Ariana; Varela, Rosana; Dolores Boveda, Maria; Gomez-Reino, Juan J.; Gonzalez, Antonio			Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients	PLOS ONE			English	Article							CITRULLINATED PEPTIDE ANTIBODIES; AUTOIMMUNE-DISEASES; EXCESS MORTALITY; CARP ANTIBODIES; HEART-DISEASE; COHORTS; DEATH; RISK; SMOKING; PREDICT	Patients with rheumatoid arthritis (RA) have an increased mortality rate that is associated with the presence of RA-specific autoantibodies in many studies. However, the relative role of rheumatoid factor (RF), anti-CCP antibodies and the most recently established RA-auto-antibodies, directed against carbamylated proteins (anti-CarP antibodies), is unclear. Here, we have assessed the role of these three antibodies in 331 patients with established RA recruited from 2001 to 2009 and followed until November 2015. During this time, 124 patients died (37.5%). This death rate corresponds to a mortality rate 1.53 (95% CI 1.26 to 1.80) folds the observed in the reference population. We used for analysis of all-cause mortality the Cox proportional hazard regression model with adjustment for age, sex and smoking. It showed a trend for association with increased mortality of each of the three RA autoantibodies in antibody-specific analysis (hazards ratio (HR) from 1.37 to 1.79), but only the HR of the anti-CarP antibodies was significant (HR = 1.79, 95% CI 1.23 to 2.61, p = 0.002). In addition, the multivariate analysis that included all autoantibodies showed a marked decrease in the HR of RF and of anti-CCP antibodies, whereas the HR of anti-CarP remained significant. This increase was specific of respiratory system causes of death (HR = 3.19, 95% CI 1.52 to 6.69, p = 0.002). Therefore, our results suggest a specific relation of anti-CarP antibodies with the increased mortality in RA, and drive attention to their possible connection with respiratory diseases.	[Vidal-Bralo, Laura; Perez-Pampin, Eva; Regueiro, Cristina; Montes, Ariana; Varela, Rosana; Gomez-Reino, Juan J.; Gonzalez, Antonio] Hosp Clin Univ Santiago, Lab Invest 10, Inst Invest Sanitaria, Santiago De Compostela, Spain; [Vidal-Bralo, Laura; Perez-Pampin, Eva; Regueiro, Cristina; Montes, Ariana; Varela, Rosana; Gomez-Reino, Juan J.; Gonzalez, Antonio] Hosp Clin Univ Santiago, Rheumatol Unit, Inst Invest Sanitaria, Santiago De Compostela, Spain; [Dolores Boveda, Maria] Hosp Clin Univ Santiago, Unit Diag & Treatment Congenital Metab Dis, Inst Invest Sanitaria, Dept Pediat, Santiago De Compostela, Spain; [Gomez-Reino, Juan J.] Univ Santiago de Compostela, Dept Med, Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela	Gonzalez, A (corresponding author), Hosp Clin Univ Santiago, Lab Invest 10, Inst Invest Sanitaria, Santiago De Compostela, Spain.; Gonzalez, A (corresponding author), Hosp Clin Univ Santiago, Rheumatol Unit, Inst Invest Sanitaria, Santiago De Compostela, Spain.	agmartinezp@ser.es	Gonzalez, Antonio/C-4444-2008; Expósito, Cristina Regueiro/AAC-1405-2021; Gomez-Reino, Juan/ABI-2853-2020; Perez-Pampin, Eva/ABF-7200-2020	Gonzalez, Antonio/0000-0002-2624-0606; Regueiro, Cristina/0000-0002-8567-6784; Perez-Pampin, Eva/0000-0003-0319-4456; Gomez-Reino, Juan/0000-0001-5229-6294	Instituto de Salud Carlos III (Spain) [PI14/01651, PI12/01909, RD12/0009/0008]; European Regional Development Fund of the EU (FEDER)	Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); European Regional Development Fund of the EU (FEDER)	Funding was provided by the Instituto de Salud Carlos III (Spain) through grants PI14/01651 to AG, and PI12/01909 and RD12/0009/0008 to JJG-R. These grants are partially financed by the European Regional Development Fund of the EU (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajeganova S, 2016, ANN RHEUM DIS, V75, P1924, DOI 10.1136/annrheumdis-2015-208579; Aletaha D, 2016, RMD OPEN, V2, DOI 10.1136/rmdopen-2014-000009; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Berg AH, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005218; Castelar-Pinheiro GD, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00320; Catrina AI, 2014, NAT REV RHEUMATOL, V10, P645, DOI 10.1038/nrrheum.2014.115; Demoruelle MK, 2012, ARTHRITIS RHEUM-US, V64, P1756, DOI 10.1002/art.34344; Drechsler C, 2015, KIDNEY INT, V87, P1201, DOI 10.1038/ki.2014.429; England BR, 2016, ARTHRIT CARE RES, V68, P36, DOI 10.1002/acr.22642; Fisher BA, 2014, ANN RHEUM DIS, V73, P741, DOI 10.1136/annrheumdis-2012-202535; Furst DE, 2010, SEMIN ARTHRITIS RHEU, V39, P327, DOI 10.1016/j.semarthrit.2008.10.002; Gonzalez A, 2008, J RHEUMATOL, V35, P1009; Hecht C, 2015, ANN RHEUM DIS, V74, P2151, DOI 10.1136/annrheumdis-2014-205428; Humphreys JH, 2016, ANN RHEUM DIS, V75, P1139, DOI 10.1136/annrheumdis-2015-207326; Lopez-Longo FJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P419, DOI 10.1002/art.24390; Jiang X, 2014, ANN RHEUM DIS, V73, P1761, DOI 10.1136/annrheumdis-2013-205109; Kitas GD, 2011, ANN RHEUM DIS, V70, P8, DOI 10.1136/ard.2010.142133; Kuller LH, 2014, ARTHRITIS RHEUMATOL, V66, P497, DOI 10.1002/art.38268; Liang KP, 2009, J RHEUMATOL, V36, P2462, DOI 10.3899/jrheum.090188; Listing J, 2015, ANN RHEUM DIS, V74, P415, DOI 10.1136/annrheumdis-2013-204021; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Mikuls TR, 2011, RHEUMATOLOGY, V50, P101, DOI 10.1093/rheumatology/keq232; Montes A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161141; Montes A, 2015, ARTHRITIS RHEUMATOL, V67, P2861, DOI 10.1002/art.39302; Montes A, 2012, ARTHRITIS RHEUM-US, V64, P3102, DOI 10.1002/art.34569; Montes A, 2011, ARTHRITIS RHEUM-US, V63, P654, DOI 10.1002/art.30186; Myasoedova Elena, 2010, Curr Rheumatol Rep, V12, P379, DOI 10.1007/s11926-010-0117-y; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; Radovits BJ, 2010, ARTHRIT CARE RES, V62, P362, DOI 10.1002/acr.20105; Rangel-Moreno J, 2006, J CLIN INVEST, V116, P3183, DOI 10.1172/JCI28756; Reynisdottir G, 2016, ANN RHEUM DIS, V75, P1722, DOI 10.1136/annrheumdis-2015-208216; Reynisdottir G, 2014, ARTHRITIS RHEUMATOL, V66, P31, DOI 10.1002/art.38201; Shi J, 2014, ANN RHEUM DIS, V73, P780, DOI 10.1136/annrheumdis-2013-204154; Shi J, 2013, ARTHRITIS RHEUM-US, V65, P911, DOI 10.1002/art.37830; Shi J, 2011, P NATL ACAD SCI USA, V108, P17372, DOI 10.1073/pnas.1114465108; Sihvonen S, 2005, J RHEUMATOL, V32, P2089; Singh JA, 2015, LANCET, V386, P258, DOI 10.1016/S0140-6736(14)61704-9; Skopelja S, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88912; Smolen JS, 2016, LANCET, V388, P2023, DOI 10.1016/S0140-6736(16)30173-8; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Sokolove J, 2013, ARTHRITIS RHEUM-US, V65, P1719, DOI 10.1002/art.37961; Sokolove J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035296; Sparks JA, 2016, ARTHRIT CARE RES, V68, P753, DOI 10.1002/acr.22752; Thomas SL, 2010, AM J PUBLIC HEALTH, V100, P2279, DOI 10.2105/AJPH.2009.180273; Tomasson G, 2010, ANN RHEUM DIS, V69, P1649, DOI 10.1136/ard.2009.110536; van der Woude D, 2010, ANN RHEUM DIS, V69, P1554, DOI 10.1136/ard.2009.124537; Walsh SJ, 2000, AM J PUBLIC HEALTH, V90, P1463, DOI 10.2105/AJPH.90.9.1463; Widdifield J, 2015, ARTHRIT CARE RES, V67, P1047, DOI 10.1002/acr.22553; WOLFE F, 1994, ARTHRITIS RHEUM-US, V37, P481, DOI 10.1002/art.1780370408	51	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180144	10.1371/journal.pone.0180144	http://dx.doi.org/10.1371/journal.pone.0180144			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2JX	28672020	gold, Green Submitted, Green Published			2022-12-26	WOS:000405268500017
J	Yvorel, V; Patoir, A; Casteillo, F; Tissot, C; Fournel, P; Stachowicz, ML; Karpathiou, G; Tiffet, O; Peoc'h, M; Forest, F				Yvorel, Violaine; Patoir, Arnaud; Casteillo, Francois; Tissot, Claire; Fournel, Pierre; Stachowicz, Marie-Laure; Karpathiou, Georgia; Tiffet, Olivier; Peoc'h, Michel; Forest, Fabien			PD-L1 expression in pleomorphic, spindle cell and giant cell carcinoma of the lung is related to TTF-1, p40 expression and might indicate a worse prognosis	PLOS ONE			English	Article							DEATH LIGAND-1 PD-L1; SHOW HIGH-LEVELS; CANCER	Lung sarcomatoid carcinoma of the lung is a rare tumor with a poor prognosis. More than 90% of them are pleomorphic, spindle cell and giant cell carcinoma (PSCGCC). This rare subtype of lung cancer is thought to be more resistant to chemotherapy, and a small subset of them seems to exhibit targetable mutations. Immunotherapy against PD1/PDL-1 is a new emerging treatment, and might be of interest in PSGSCC because they frequently express PD-L1. The aim of our work is to evaluate PD1 and PDL-1 expression in a surgical series of lung PSCGCC and their relationship with morphological and immunohistochemical parameters and prognosis. Thirty-six patients who underwent surgical resection of a PSGSCC were included. PD-L1 (E1L3N) expression on tumor cells and PD1 (NAT105) expression by tumor infiltrating lymphocytes (TILs) were performed by immunohistochemistry. Results were compared to immunohistochemistry tests of TTF1, Napsin A, p40 and to molecular study of EGFR, KRAS, BRAF and HER2. Seventy-five % of PSCGCC were considered as positive for PD-L1. PD-L1 expression in PSGSCC is associated with TTF-1 and/or Napsin A expression (47.2%, p = 0.039). Few p40 positive PSCGCC expressed PD-L1 (8.3%, p = 0.013). PD1 expression was not related to TTF-1 and/or Napsin A expression (p = 0.47), p40 expression (p = 0.68) or survival (p = 0.14). PD-L1 or PD1 expression were not related to the age, gender, pT, pN, stage, visceral pleura invasion, histopathological subtype, the presence of giant cell component, the predominance of sarcomatoid component, and the presence of EGFR or BRAF or HER2 or PIK3CA mutation (p> 0.05). PD-L1 expression was correlated with a worse overall survival in PSCGCC (p = 0.045). PD-L1 expression is frequent in PSCGCC and might be associated with the expression of adenocarcinoma markers (TTF-1, Napsin A) or the lack of expression of squamous cell carcinoma marker (p40).	[Yvorel, Violaine; Casteillo, Francois; Stachowicz, Marie-Laure; Karpathiou, Georgia; Peoc'h, Michel; Forest, Fabien] Univ Hosp St Etienne, North Hosp, Dept Pathol, St Etienne, France; [Patoir, Arnaud; Tiffet, Olivier] Univ Hosp St Etienne, North Hosp, Dept Thorac Surg, St Etienne, France; [Tissot, Claire] Univ Hosp St Etienne, North Hosp, Dept Pneumol, St Etienne, France; [Fournel, Pierre] Lucien Neuwirth Canc Inst, Dept Oncol, St Priest En Jarez, France	CHU de St Etienne; CHU de St Etienne; CHU de St Etienne; Institut de Cancerologie de la Loire	Forest, F (corresponding author), Univ Hosp St Etienne, North Hosp, Dept Pathol, St Etienne, France.	fabien.forest@chu-st-etienne.fr	Forest, Fabien/O-7054-2019; Karpathiou, Georgia/J-5312-2019	Forest, Fabien/0000-0001-7582-3923; Karpathiou, Georgia/0000-0003-0864-935X; Peoc'h, michel/0000-0001-5453-0021	Comite Loire de ia Ligue Contrele Cancer [AL-250/16]	Comite Loire de ia Ligue Contrele Cancer	This work was supported by the Comite Loire de ia Ligue Contrele Cancer (https://www.ligue-cancer.net/cd42/journal; Grant AL-250/16) to FF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop JA, 2012, MODERN PATHOL, V25, P405, DOI 10.1038/modpathol.2011.173; Botti G, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071046; Chang YL, 2016, EUR J CANCER, V60, P125, DOI 10.1016/j.ejca.2016.03.012; Forest F, 2016, HUM PATHOL, V49, P99, DOI 10.1016/j.humpath.2015.10.006; Gniadek TJ, 2017, MODERN PATHOL, V30, P530, DOI 10.1038/modpathol.2016.213; Gounant V, 2016, LUNG CANCER, V99, P162, DOI 10.1016/j.lungcan.2016.07.010; Guo Q, 2016, THORAC CANC; Hirsch F.R.M.A., 2016, J THORAC ONCOL; Huynh TG, 2016, J THORAC ONCOL, V11, P1869, DOI 10.1016/j.jtho.2016.08.134; Ilie M, 2016, ANN ONCOL, V27, P147, DOI 10.1093/annonc/mdv489; Kim MY, 2015, LUNG CANCER, V88, P24, DOI 10.1016/j.lungcan.2015.01.016; Kim SH, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/904142; Pelosi G, 2016, EXPERT REV RESP MED, V10, P1105, DOI 10.1080/17476348.2017.1235975; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Schmidt LH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136023; Schrock AB, 2016, J THORAC ONCOL, V11, P1493, DOI 10.1016/j.jtho.2016.06.004; Sun JM, 2016, J THORAC ONCOL, V11, P1003, DOI 10.1016/j.jtho.2016.04.007; Travis WDBE., 2015, WHO CLASSIFICATION T, V4; Velcheti V, 2013, J THORAC ONCOL, V8, P803, DOI 10.1097/JTO.0b013e318292be18; Vieira T, 2016, LUNG CANCER, V98, P51, DOI 10.1016/j.lungcan.2016.05.013	20	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180346	10.1371/journal.pone.0180346	http://dx.doi.org/10.1371/journal.pone.0180346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671973	Green Published, Green Submitted, gold			2022-12-26	WOS:000405268500044
J	Zhang, J; Jia, CR; Wu, Y; Xia, XF; Xi, BD; Wang, LJ; Zhai, YL				Zhang, Jun; Jia, Chunrong; Wu, Yi; Xia, Xunfeng; Xi, Beidou; Wang, Lijun; Zhai, Youlong			Life cycle energy efficiency and environmental impact assessment of bioethanol production from sweet potato based on different production modes	PLOS ONE			English	Article							FUEL ETHANOL; GHG EMISSIONS; CHINA; BALANCE; SYSTEM; PLANT	The bioethanol is playing an increasingly important role in renewable energy in China. Based on the theory of circular economy, integration of different resources by polygeneration is one of the solutions to improve energy efficiency and to reduce environmental impact. In this study, three modes of bioethanol production were selected to evaluate the life cycle energy efficiency and environmental impact of sweet potato-based bioethanol. The results showed that, the net energy ratio was greater than 1 and the value of net energy gain was positive in the three production modes, in which the maximum value appeared in the circular economy mode (CEM). The environment emission mainly occurred to bioethanol conversion unit in the conventional production mode (CPM) and the cogeneration mode (CGM), and eutrophication potential (EP) and global warming potential (GWP) were the most significant environmental impact category. While compared with CPM and CGM, the environmental impact of CEM significantly declined due to increasing recycling, and plant cultivation unit mainly contributed to EP and GWP. And the comprehensive evaluation score of environmental impact decreased by 73.46% and 23.36%. This study showed that CEM was effective in improving energy efficiency, especially in reducing the environmental impact, and it provides a new method for bioethanol production.	[Zhang, Jun; Jia, Chunrong; Zhai, Youlong] China West Normal Univ, Coll Land & Resources, Nanchong, Sichuan, Peoples R China; [Wu, Yi] Gui Zhou Acad Environm Sci & Designing, Guiyang, Guizhou, Peoples R China; [Xia, Xunfeng; Xi, Beidou; Wang, Lijun] Chinese Res Inst Environm Sci, Beijing, Peoples R China; [Xi, Beidou] Lanzhou Jiaotong Univ, Coll Environm & Municipal Engn, Lanzhou, Gansu, Peoples R China	China West Normal University; Chinese Research Academy of Environmental Sciences; Lanzhou Jiaotong University	Xia, XF (corresponding author), Chinese Res Inst Environm Sci, Beijing, Peoples R China.	Xiaxunfengg@sina.com			National Technology R D Program [2014BAL02B02]; National Water Pollution Control and Treatment Science and Technology Major Project [2015ZX07103-007]	National Technology R D Program; National Water Pollution Control and Treatment Science and Technology Major Project	This work was supported by National Technology R& D Program (2014BAL02B02); National Water Pollution Control and Treatment Science and Technology Major Project (2015ZX07103-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Chen S, 2012, RESOUR ENV, V22, P76; Dai D, 2006, ENERG CONVERS MANAGE, V47, P1686, DOI 10.1016/j.enconman.2005.10.019; Dong XB, 2008, ENERG POLICY, V36, P3882, DOI 10.1016/j.enpol.2008.04.027; Guo Z, 2011, DEV MODEL BASED INTR, P1553; Jury C, 2010, BIOMASS BIOENERG, V34, P54, DOI 10.1016/j.biombioe.2009.09.011; Laude A, 2011, INT J GREENH GAS CON, V5, P1220, DOI 10.1016/j.ijggc.2011.06.004; Leng R, 2008, J CLEAN PROD, V16, P374, DOI 10.1016/j.jclepro.2006.12.003; Li XZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095455; Liu BB, 2013, ENERG POLICY, V56, P210, DOI 10.1016/j.enpol.2012.12.052; Luo L, 2009, RENEW SUST ENERG REV, V13, P1613, DOI 10.1016/j.rser.2008.09.024; Ma L, 2012, SCI TOTAL ENVIRON, V434, P51, DOI 10.1016/j.scitotenv.2012.03.028; Nguyen TLT, 2007, ENERG POLICY, V35, P4585, DOI 10.1016/j.enpol.2007.03.012; Papong S, 2010, BIORESOURCE TECHNOL, V101, pS112, DOI 10.1016/j.biortech.2009.09.006; Rasanen K, 2015, J CLEAN PROD, V89, P65, DOI 10.1016/j.jclepro.2014.11.008; Saga K, 2010, APPL ENERG, V87, P2164, DOI 10.1016/j.apenergy.2009.12.014; Sleeswijk AW, 2000, SCI TOTAL ENVIRON, V390, P227, DOI DOI 10.1016/J.SCIT0TENV.2007.09.040; Wang JY, 2011, ATMOS ENVIRON, V45, P6923, DOI 10.1016/j.atmosenv.2011.09.045; Wang MX, 2014, BIORESOURCE TECHNOL, V163, P74, DOI 10.1016/j.biortech.2014.04.014; Wang MX, 2013, BIORESOURCE TECHNOL, V133, P285, DOI 10.1016/j.biortech.2013.01.067; [王明新 WANG Mingxin], 2006, [农业环境科学学报, Journal of Agro-environment science], V25, P1127; Xia XunFeng, 2012, Research of Environmental Sciences, V25, P1187; [夏训峰 XIA Xunfeng], 2008, [环境科学与技术, Enuivonmental Science and Technology], V31, P154; Yang H, 2011, BIOMASS BIOENERG, V35, P581, DOI 10.1016/j.biombioe.2010.10.027; Zhang Jun, 2010, Research of Environmental Sciences, V23, P248; Zhang L, 2016, J CLEAN PROD, V113, P565, DOI 10.1016/j.jclepro.2015.11.053; Zhang YS, 2011, J ENVIRON MANAGE, V92, P480, DOI 10.1016/j.jenvman.2010.09.018; Zhou W, 2012, APPL ENERG, V95, P305, DOI 10.1016/j.apenergy.2012.02.014; 杨凌波, 2008, [给水排水, Water & Wastewater Engineering], V34, P42	28	5	5	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180685	10.1371/journal.pone.0180685	http://dx.doi.org/10.1371/journal.pone.0180685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672044	Green Published, Green Submitted, gold			2022-12-26	WOS:000405268500079
J	Losfeld, ME; Scibona, E; Lin, CW; Villiger, TK; Gauss, R; Morbidelli, M; Aebi, M				Losfeld, Marie-Estelle; Scibona, Ernesto; Lin, Chia-Wei; Villiger, Thomas K.; Gauss, Robert; Morbidelli, Massimo; Aebi, Markus			Influence of protein/glycan interaction on site-specific glycan heterogeneity	FASEB JOURNAL			English	Article						glycoengineering; glycobiology; glycoprotein maturation; Golgi processing; enzymatic flux	N-LINKED GLYCOSYLATION; ENHANCED AROMATIC SEQUONS; HAMSTER OVARY CELLS; THERAPEUTIC PROTEINS; HIGH-MANNOSE; HOST; ANTIBODY; MICROHETEROGENEITY; OLIGOSACCHARIDES; GLYCOBIOLOGY	To study how the interaction between N-linked glycans and the surrounding amino acids influences oligosaccharide processing, we used protein disulfide isomerase (PDI), a glycoprotein bearing 5 N-glycosylation sites, as a model system and expressed it transiently in a Chinese hamster ovary (CHO)-S cell line. PDI was produced as both secreted Sec-PDI and endoplasmic reticulum-retained glycoprotein (ER)-PDI, to study glycan processing by ER and Golgi resident enzymes. Quantitative site-specific glycosylation profiles were obtained, and flux analysis enabled modeling site-specific glycan processing. By altering the primary sequence of PDI, we changed the glycan/protein interaction and thus the site-specific glycoprofile because of the improved enzymatic fluxes at enzymatic bottlenecks. Our results highlight the importance of direct interactions between N-glycans and surface-exposed amino acids of glycoproteins on processing in the ER and the Golgi and the possibility of changing a site-specific N-glycan profile by modulating such interactions and thus the associated enzymatic fluxes. Altering the primary protein sequence can therefore be used to glycoengineer recombinant proteins.-Losfeld, M.-E., Scibona, E., Lin, C.-W., Villiger, T. K., Gauss, R., Morbidelli, M., Aebi, M. Influence of protein/glycan interaction on site-specific glycan heterogeneity.	[Losfeld, Marie-Estelle; Lin, Chia-Wei; Gauss, Robert; Aebi, Markus] Swiss Fed Inst Technol, Inst Microbiol, Dept Biol, Swiss Fed Inst Technol, Zurich, Switzerland; [Scibona, Ernesto; Villiger, Thomas K.; Morbidelli, Massimo] Swiss Fed Inst Technol, Inst Chem & Bioengn, Dept Chem & Appl Biosci, Swiss Fed Inst Technol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Aebi, M (corresponding author), Inst Microbiol HCI F407, Vladimir Prelog Weg 1-5-10, CH-8093 Zurich, Switzerland.	markus.aebi@micro.biol.ethz.ch	Lin, Chia-wei/ABA-6065-2021; Villiger, Thomas/AAE-8499-2020	Lin, Chia-wei/0000-0003-4777-2916; Villiger, Thomas/0000-0003-0036-2522; Morbidelli, Massimo/0000-0002-0112-414X; Scibona, Ernesto/0000-0002-2012-5674	European Union Seventh Framework Programme [627197]	European Union Seventh Framework Programme(European Commission)	The authors thank the Functional Genomics Center, Zurich, for help with the mass spectrometry analyses. The research leading to these results received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under Grant 627197 to M.-E.L. The authors declare no conflict of interest.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Breitling J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013359; Butler M, 2014, CURR OPIN BIOTECH, V30, P107, DOI 10.1016/j.copbio.2014.06.010; Chen W, 2016, ACS CHEM BIOL, V11, P1852, DOI 10.1021/acschembio.5b01035; Cherepanova N, 2016, CURR OPIN CELL BIOL, V41, P57, DOI 10.1016/j.ceb.2016.03.021; del Val IJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28547; del Val IJ, 2016, BIOTECHNOL J, V11, P610, DOI 10.1002/biot.201400663; del Val IJ, 2011, BIOTECHNOL PROGR, V27, P1730, DOI 10.1002/btpr.688; Dell Anne, 2010, Int J Microbiol, V2010, P148178, DOI 10.1155/2010/148178; Doores KJ, 2015, J VIROL, V89, P1105, DOI 10.1128/JVI.02905-14; Durocher Y, 2009, CURR OPIN BIOTECH, V20, P700, DOI 10.1016/j.copbio.2009.10.008; Faid V, 2006, GLYCOBIOLOGY, V16, P440, DOI 10.1093/glycob/cwj081; GLEESON PA, 1985, BIOCHEMISTRY-US, V24, P493, DOI 10.1021/bi00323a037; Grabenhorst E, 1999, GLYCOCONJUGATE J, V16, P81, DOI 10.1023/A:1026466408042; Gu J, 2009, J PROTEOME RES, V8, P431, DOI 10.1021/pr800674g; Hall MK, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060925; Hang I, 2015, GLYCOBIOLOGY, V25, P1335, DOI 10.1093/glycob/cwv058; Hossler P, 2009, GLYCOBIOLOGY, V19, P936, DOI 10.1093/glycob/cwp079; HSIEH P, 1983, J BIOL CHEM, V258, P2548; Hsu CH, 2016, J AM CHEM SOC, V138, P7636, DOI 10.1021/jacs.6b02879; Hua S, 2012, ANAL BIOANAL CHEM, V403, P1291, DOI 10.1007/s00216-011-5109-x; HUBBARD SC, 1988, J BIOL CHEM, V263, P19303; Khatri K, 2016, MOL CELL PROTEOMICS, V15, P1895, DOI 10.1074/mcp.M116.058016; Lin N, 2015, BIOTECHNOL PROGR, V31, P334, DOI 10.1002/btpr.2038; Mast SW, 2006, METHOD ENZYMOL, V415, P31, DOI 10.1016/S0076-6879(06)15003-X; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Murray AN, 2015, CHEM BIOL, V22, P1052, DOI 10.1016/j.chembiol.2015.06.017; Niwa R, 2004, CANCER RES, V64, P2127, DOI 10.1158/0008-5472.CAN-03-2068; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Price JL, 2012, BIOPOLYMERS, V98, P195, DOI 10.1002/bip.22030; Price JL, 2011, P NATL ACAD SCI USA, V108, P14127, DOI 10.1073/pnas.1105880108; Raju TS, 2014, CURR OPIN BIOTECH, V30, P147, DOI 10.1016/j.copbio.2014.06.014; Ryczko MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23043; Scallon BJ, 2007, MOL IMMUNOL, V44, P1524, DOI 10.1016/j.molimm.2006.09.005; SCHACHTER H, 1991, Glycobiology, V1, P453, DOI 10.1093/glycob/1.5.453; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Shah N, 2008, P NATL ACAD SCI USA, V105, P9570, DOI 10.1073/pnas.0802206105; Stanley Pamela, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a005199; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; TRIMBLE RB, 1983, J BIOL CHEM, V258, P2562; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Varki A, 1998, TRENDS CELL BIOL, V8, P34, DOI 10.1016/S0962-8924(97)01198-7; Villiger TK, 2016, BIOTECHNOL PROGR, V32, P1135, DOI 10.1002/btpr.2315; Wang LX, 2012, ACS CHEM BIOL, V7, P110, DOI 10.1021/cb200429n; Wang Q, 2015, METHODS MOL BIOL, V1321, P287, DOI 10.1007/978-1-4939-2760-9_20; Werner RG, 2007, ACTA PAEDIATR, V96, P17, DOI 10.1111/j.1651-2227.2007.00199.x; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wright RD, 2014, GLYCOBIOLOGY, V24, P1242, DOI 10.1093/glycob/cwu101; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151; Yin BJ, 2015, BIOTECHNOL BIOENG, V112, P2343, DOI 10.1002/bit.25650; Yu XJ, 2013, J AM CHEM SOC, V135, P9723, DOI 10.1021/ja4014375; Zacchi LF, 2016, GLYCOCONJUGATE J, V33, P359, DOI 10.1007/s10719-015-9641-3; Zhang PQ, 2013, ADV BIOCHEM ENG BIOT, V131, P63, DOI 10.1007/10_2012_163; Zhou Q, 2008, BIOTECHNOL BIOENG, V99, P652, DOI 10.1002/bit.21598; Zielinska DF, 2012, MOL CELL, V46, P542, DOI 10.1016/j.molcel.2012.04.031	56	23	23	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4623	4635		10.1096/fj.201700403R	http://dx.doi.org/10.1096/fj.201700403R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28679530				2022-12-26	WOS:000413397400037
J	Kara, E; Marks, JD; Fan, ZY; Klickstein, JA; Roe, AD; Krogh, KA; Wegmann, S; Maesako, M; Luo, CC; Mylvaganam, R; Berezovska, O; Hudry, E; Hyman, BT				Kara, Eleanna; Marks, Jordan D.; Fan, Zhanyun; Klickstein, Jacob A.; Roe, Allyson D.; Krogh, Kelly A.; Wegmann, Susanne; Maesako, Masato; Luo, Christina C.; Mylvaganam, Ravi; Berezovska, Oksana; Hudry, Eloise; Hyman, Bradley T.			Isoform- and cell type-specific structure of apolipoprotein E lipoparticles as revealed by a novel Forster resonance energy transfer assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN INTERACTION; AMYLOID-BETA; DENSITY-LIPOPROTEINS; RECEPTOR-BINDING; MECHANISM; DISEASE; FORMS	Apolipoprotein E (apoE) has an important role in the pathogenesis of Alzheimer's disease with its three isoforms having distinct effects on disease risk. Here, we assessed the conformational differences between those isoforms using a novel flow cytometry-Forster resonance energy transfer (FRET) assay. We showed that the conformation of intracellular apoE within HEK cells and astrocytes adopts a directional pattern; in other words, E4 adopts the most closed conformation, E2 adopts the most open conformation, and E3 adopts an intermediate conformation. However, this pattern was not maintained upon secretion of apoE from astrocytes. Intermolecular interactions between apoE molecules were isoform-specific, indicating a great diversity in the structure of apoE lipoparticles. Finally, we showed that secreted E4 is the most lipidated isoform in astrocytes, suggesting that increased lipidation acts as a folding chaperone enabling E4 to adopt a closed conformation. In conclusion, this study gives insights into apoE biology and establishes a robust screening system to monitor apoE conformation.	[Kara, Eleanna; Marks, Jordan D.; Fan, Zhanyun; Klickstein, Jacob A.; Roe, Allyson D.; Krogh, Kelly A.; Wegmann, Susanne; Maesako, Masato; Berezovska, Oksana; Hudry, Eloise; Hyman, Bradley T.] Harvard Med Sch, Massachusetts Gen Hosp, Alzheimers Dis Res Lab, MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA; [Luo, Christina C.; Mylvaganam, Ravi] Massachusetts Gen Hosp, Mol Pathol, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Hyman, BT (corresponding author), MassGen Inst Neurodegenerat Dis, Alzheimers Dis Res Lab, 114,16th St, Charlestown, MA 02129 USA.	bhyman@mgh.harvard.edu		Kara, Eleanna/0000-0001-5428-6743; Klickstein, Jacob/0000-0002-0759-4724	National Institutes of Health [1S10OD012027-01A1, 1S10OD016372-01, 1S10RR020936-01, 1S10RR023440-01A1]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023440, S10RR020936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG044486, K99AG047336, RF1AG044486, P01AG015379] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016372, S10OD012027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Cytometric findings reported here were performed in the Massachusetts General Hospital Department of Pathology Flow and Image Cytometry Research Core, which obtained support from the National Institutes of Health Shared Instrumentation program with Grants 1S10OD012027-01A1, 1S10OD016372-01, 1S10RR020936-01, and 1S10RR023440-01A1.	Chen HK, 2012, J BIOL CHEM, V287, P5253, DOI 10.1074/jbc.M111.276162; Chen JL, 2011, P NATL ACAD SCI USA, V108, P14813, DOI 10.1073/pnas.1106420108; Chou CY, 2005, BIOPHYS J, V88, P455, DOI 10.1529/biophysj.104.046813; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Davidson WS, 2005, CURR OPIN LIPIDOL, V16, P295, DOI 10.1097/01.mol.0000169349.38321.ad; DeMattos RB, 2001, NEUROCHEM INT, V39, P415, DOI 10.1016/S0197-0186(01)00049-3; Dong LM, 1996, NAT STRUCT BIOL, V3, P718, DOI 10.1038/nsb0896-718; DONG LM, 1994, J BIOL CHEM, V269, P22358; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; Elliott DA, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-23; Fisher CA, 2000, J BIOL CHEM, V275, P33601, DOI 10.1074/jbc.M002643200; Fu Y, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0099-y; Grehan S, 2001, J NEUROSCI, V21, P812, DOI 10.1523/JNEUROSCI.21-03-00812.2001; Hashimoto T, 2012, J NEUROSCI, V32, P15181, DOI 10.1523/JNEUROSCI.1542-12.2012; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Hatters DM, 2005, J BIOL CHEM, V280, P34288, DOI 10.1074/jbc.M506044200; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Jones PB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014586; LaDu MJ, 2006, BIOCHEMISTRY-US, V45, P381, DOI 10.1021/bi051765s; Liu M, 2012, AM J PHYSIOL-REG I, V303, pR903, DOI 10.1152/ajpregu.00219.2012; Morikawa M, 2005, NEUROBIOL DIS, V19, P66, DOI 10.1016/j.nbd.2004.11.005; Morrow JA, 2002, J BIOL CHEM, V277, P50380, DOI 10.1074/jbc.M204898200; Peters-Libeu CA, 2006, J BIOL CHEM, V281, P1073, DOI 10.1074/jbc.M510851200; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; Rebeck GW, 1998, EXP NEUROL, V149, P175, DOI 10.1006/exnr.1997.6710; Tai LM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-2; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; Xu Q, 2004, J BIOL CHEM, V279, P25511, DOI 10.1074/jbc.M311256200	29	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14720	14729		10.1074/jbc.M117.784264	http://dx.doi.org/10.1074/jbc.M117.784264			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28684412	Green Published, hybrid			2022-12-26	WOS:000409902100001
J	Chen, J; Martindale, JL; Cramer, C; Gorospe, M; Atasoy, U; Drew, PD; Yu, SG				Chen, Jing; Martindale, Jennifer L.; Cramer, Carole; Gorospe, Myriam; Atasoy, Ulus; Drew, Paul D.; Yu, Shiguang			The RNA-binding protein HuR contributes to neuroinflammation by promoting C-C chemokine receptor 6 (CCR6) expression on Th17 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; INFLAMMATORY PROTEIN-3-ALPHA/CCL20; AUTOIMMUNE ENCEPHALOMYELITIS; RHEUMATOID-ARTHRITIS; MEDIATED GENERATION; ANTIGEN R; ACTIVATION; DIFFERENTIATION; RECRUITMENT; LINEAGE	In both multiple sclerosis and experimental autoimmune encephalomyelitis (EAE), the C-C chemokine receptor 6 (CCR6) is critical for pathogenicThelper 17 (Th17) cell migration to the central nervous system (CNS). Whereas many cytokines and their receptors are potently regulated via post-transcriptional mechanisms in response to various stimuli, how CCR6 expression is post-transcriptionally regulated in Th17 cells is unknown. Here, using RNA-binding protein HuR conditional knock-out (KO) and wild-type (WT) mice, we present evidence that HuR post-transcriptionally regulates CCR6 expression by binding to and stabilizing Ccr6 mRNA and by promoting CCR6 translation. We also found that HuR down-regulates several microRNA expressions, which could target the 3'-UTR of Ccr6 mRNA for decay. Accordingly, knock-out of HuR reduced CCR6 expression on Th17 cells and impaired their migration to CNS compared with the response of WT Th17 cells and thereby ameliorated EAE. Together, these findings highlight how HuR contributes to Th17 cell-mediated autoimmune neuroinflammation and support the notion that targeting HuR might be a potential therapeutic intervention for managing autoimmune disorders of the CNS.	[Chen, Jing; Cramer, Carole] Arkansas State Univ, Arkansas Biosci Inst, Dept Biol Sci, Jonesboro, AR 72467 USA; [Chen, Jing; Yu, Shiguang] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA; [Chen, Jing] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA; [Martindale, Jennifer L.; Gorospe, Myriam] NIA, Genet Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Atasoy, Ulus] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA; [Atasoy, Ulus] Univ Missouri, Dept Surg, Columbia, MO 65211 USA; [Drew, Paul D.] Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, Coll Med, Little Rock, AR 72205 USA; [Yu, Shiguang] Arkansas State Univ, Arkansas Biosci Inst, Jonesboro, AR 72467 USA	Arkansas State University; Jefferson University; University of Missouri System; University of Missouri Columbia; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Arkansas System; University of Arkansas Medical Sciences; Arkansas State University	Chen, J; Yu, SG (corresponding author), Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA.	jing.chen@jefferson.edu; shiguang.yu@jefferson.edu	Gorospe, Myriam/Y-3613-2019; Martindale, Jennifer Luethy/AAD-1963-2022	Martindale, Jennifer Luethy/0000-0002-3234-6861	National Institutes of Health from the IDeA Networks of Biomedical Research Excellence (INBRE) Program of the National Center for Research Resources [p20GM103429]; National Institutes of Health [R01AI119135]; NIA-Intramural Research Program, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI119135, R01AI080870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000511, ZIAAG000393] Funding Source: NIH RePORTER	National Institutes of Health from the IDeA Networks of Biomedical Research Excellence (INBRE) Program of the National Center for Research Resources; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA-Intramural Research Program, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant p20GM103429 from the IDeA Networks of Biomedical Research Excellence (INBRE) Program of the National Center for Research Resources and National Institutes of Health Grant R01AI119135. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the NIA-Intramural Research Program, National Institutes of Health.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022; Atasoy U, 1998, J CELL SCI, V111, P3145; Axtell RC, 2009, NAT IMMUNOL, V10, P453, DOI 10.1038/ni0509-453; Chen J, 2013, J IMMUNOL, V191, P5441, DOI 10.4049/jimmunol.1301188; Chen WJ, 2015, EUR J IMMUNOL, V45, P958, DOI 10.1002/eji.201444999; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Fujiie S, 2001, INT IMMUNOL, V13, P1255, DOI 10.1093/intimm/13.10.1255; Gubin MM, 2014, MOL MED, V20, P93, DOI 10.2119/molmed.2013.00127; Gunzburg MJ, 2015, CELL CYCLE, V14, P2729, DOI 10.1080/15384101.2015.1069930; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hedrick MN, 2009, J CLIN INVEST, V119, P2317, DOI 10.1172/JCI37378; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Homey B, 2000, J IMMUNOL, V164, P6621, DOI 10.4049/jimmunol.164.12.6621; Ito T, 2011, EXP CELL RES, V317, P613, DOI 10.1016/j.yexcr.2010.12.018; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jeyaraj SC, 2010, J BIOL CHEM, V285, P4432, DOI 10.1074/jbc.M109.062216; Kafasla P, 2014, NAT IMMUNOL, V15, P492, DOI 10.1038/ni.2884; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Liston A, 2009, J IMMUNOL, V182, P3121, DOI 10.4049/jimmunol.0713169; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Lu L, 2014, J BIOL CHEM, V289, P31792, DOI 10.1074/jbc.M114.573246; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; O'Connor RA, 2007, J IMMUNOL, V179, P958, DOI 10.4049/jimmunol.179.2.958; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Palm NW, 2007, NAT IMMUNOL, V8, P549, DOI 10.1038/ni0607-549; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Ransohoff RM, 2009, NATURE, V462, P41, DOI 10.1038/462041a; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Srikantan S, 2012, CURR PROTEIN PEPT SC, V13, P372, DOI 10.2174/138920312801619394; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Steinfelder S, 2011, BLOOD, V117, P2839, DOI 10.1182/blood-2010-06-293027; Stellato C, 2011, J IMMUNOL, V187, P441, DOI 10.4049/jimmunol.1001881; Tracey KJ, 2012, CELL, V148, P392, DOI 10.1016/j.cell.2012.01.025; Varona R, 2001, J CLIN INVEST, V107, pR37, DOI 10.1172/JCI11297; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Villares R, 2009, EUR J IMMUNOL, V39, P1671, DOI 10.1002/eji.200839123; Wan WZ, 2011, CIRC RES, V109, P374, DOI 10.1161/CIRCRESAHA.111.242578; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xie L, 2014, J NEUROIMMUNOL, V273, P31, DOI 10.1016/j.jneuroim.2014.05.015; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yu SG, 2006, J EXP MED, V203, P349, DOI 10.1084/jem.20051438; Yu SG, 2012, INT IMMUNOL, V24, P233, DOI 10.1093/intimm/dxs003; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	53	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14532	14543		10.1074/jbc.M117.782771	http://dx.doi.org/10.1074/jbc.M117.782771			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28684423	Green Published, hybrid			2022-12-26	WOS:000408747500019
J	de Oliveira, JC; Beirigo, RM; Chiapini, M; do Nascimento, AF; Couto, EG; Vidal-Torrado, P				de Oliveira Junior, Jairo Calderari; Beirigo, Raphael Moreira; Chiapini, Mariane; do Nascimento, Alexandre Ferreira; Couto, Eduardo Guimaraes; Vidal-Torrado, Pablo			Origin of mounds in the Pantanal wetlands: An integrated approach between geomorphology, pedogenesis, ecology and soil micromorphology	PLOS ONE			English	Article							LOURENCO FLUVIAL MEGAFAN; CENTRAL BRAZIL; TERMITE MOUNDS; MATO-GROSSO; FERROLYSIS; STABILITY; SYSTEM; INDIA; NESTS; WATER	zVegetated mounds are an important geomorphological feature of the Pantanal, where the influence of floods dictates not only hydropedological processes, but also the distribution and ecology of the flora and fauna. This work aimed to identify factors and processes that influence the formation and spatial distribution of the mounds, which are commonly associated with termite activity. In order to characterize pedological processes, macro and micro morphological descriptions, satellite image interpretation, dating of the sandy sedimentary material using OSL and carbon dating using 14 C AMS were carried out. This dating of the materials indicates that the sediments in which the soils were formed were deposited during the Pleistocene, while the carbonates are from the Holocene. The basin- like format of the laminar structures suggests that part of the more clayey material was deposited in lacustrine environments. The more humid climate in the Holocene intensified argilluviation, which at an advanced stage, led to a more pronounced textural gradient, reducing drainage and leading to ferrolysis and thickening of the E horizon. Besides pedogenic processes, more erosive flooding during the Holocene began reducing and rounding the landscape's more elevated structures (paleolevees). In the final stage, these structures were occupied by termites to shelter from flooding. Thereafter, the bio-cementation action of the termite nests has increased the resistance of the vegetated mounds to processes of erosion.	[de Oliveira Junior, Jairo Calderari] Univ Tecnol Fed Parana, Dept Agron, Dois Vizinhos, Parana, Brazil; [Beirigo, Raphael Moreira] Univ Fed Paraiba, Agr Sci Ctr, Areia, Paraiba, Brazil; [Chiapini, Mariane; Vidal-Torrado, Pablo] Univ Sao Paulo, Dept Soil Sci, Piracicaba, SP, Brazil; [do Nascimento, Alexandre Ferreira] EMBRAPA, Embrapa Agrossilvipastoril, Sinop, MG, Brazil; [Couto, Eduardo Guimaraes] Univ Fed Mato Grosso, Dept Soil & Rural Engn, Cuiaba, MG, Brazil	Pontificia Universidade Catolica do Parana; Universidade Tecnologica Federal do Parana; Universidade Federal da Paraiba; Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Mato Grosso	Vidal-Torrado, P (corresponding author), Univ Sao Paulo, Dept Soil Sci, Piracicaba, SP, Brazil.	pvidal@usp.br	Couto, Eduardo Guimarães/AAF-5790-2019; Oliveira, Jairo/A-2041-2012; Chiapini, Mariane/GWR-1681-2022; Vidal-Torrado, Pablo/C-4020-2012; Couto, Eduardo Guimarães/E-4240-2010; M. Beirigo, Raphael/A-7874-2018; Ferreira do Nascimento, Alexandre/A-2284-2016	Couto, Eduardo Guimarães/0000-0002-5271-9709; Oliveira, Jairo/0000-0003-3818-0513; Vidal-Torrado, Pablo/0000-0001-9228-9910; Couto, Eduardo Guimarães/0000-0002-5271-9709; M. Beirigo, Raphael/0000-0001-6857-149X; Ferreira do Nascimento, Alexandre/0000-0002-0837-343X; Chiapini, Mariane/0000-0001-7111-0555	Fundacao ao Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/54372-0]; FAPESP [2011/11905-9, 2009/50422-3]; CNPQ [300189/2010-9]	Fundacao ao Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by the Fundacao ao Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Research Assistance 2009/54372-0. FAPESP PhD scholarships were given to JCOJ (2011/11905-9) and to AFN (2009/50422-3). PVT received a research grant from CNPQ (300189/2010-9).	Ackerman IL, 2007, APPL SOIL ECOL, V37, P267, DOI 10.1016/j.apsoil.2007.08.005; Assine ML, 2014, SEDIMENT GEOL, V301, P172, DOI 10.1016/j.sedgeo.2013.11.007; Assine ML, 2004, QUATERN INT, V114, P23, DOI 10.1016/S1040-6182(03)00039-9; Barbiero L, 2002, WETLANDS, V22, P528, DOI 10.1672/0277-5212(2002)022[0528:GOWAGW]2.0.CO;2; Beirigo RM, 2011, SOLOS RESERVA PARTIC; BRINKMAN R, 1970, GEODERMA, V3, P199, DOI 10.1016/0016-7061(70)90019-4; Bullock P., 1985, HDB SOIL THIN SECTIO; CORRADINI FA, 2012, REV BRAS GEOCIENC S1, V42, P20, DOI DOI 10.5327/Z0375-75362012000500003; Cramer MD, 2014, PALAEOGEOGR PALAEOCL, V409, P72, DOI 10.1016/j.palaeo.2014.04.026; Cunha CN., 1990, THESIS; Dematte J. L. I., 1992, Revista Brasileira de Ciencia do Solo, V16, P241; do Nascimento AF, 2013, REV BRAS CIENC SOLO, V37, P1113, DOI 10.1590/S0100-06832013000500001; Droubi A, 1976, EQUILIBRES ENTRE MIN, V1, P13; Durand N, 2007, QUATERN INT, V162, P35, DOI 10.1016/j.quaint.2006.10.026; Durand N, 2010, INTERPRETATION OF MICROMORPHOLOGICAL FEATURES OF SOILS AND REGOLITHS, P149, DOI 10.1016/B978-0-444-53156-8.00009-X; EITEN G, 1975, Biotropica, V7, P112, DOI 10.2307/2989754; EMBRAPA, 2011, MAN MET AN SOL, Vsecond; FAO, 2006, GUID SOIL DESCR; Fedoroff N, 1986, C INT SOC SOIL SCI 1, V5, P1551; Funch RR, 2015, J ARID ENVIRON, V122, P27, DOI 10.1016/j.jaridenv.2015.05.010; Furquim SAC, 2010, GEODERMA, V154, P518, DOI 10.1016/j.geoderma.2009.03.014; Gac JY, 1997, CHEM GEOL, V19, P215; Gilardi JD, 1999, J CHEM ECOL, V25, P897, DOI 10.1023/A:1020857120217; Girard P, 2010, HYDROBIOLOGIA, V638, P223, DOI 10.1007/s10750-009-0046-9; Hasenack H, 2010, CLIMA RESERVA PARTIC; Johnson DL, 2012, GEOL SOC AM SPEC PAP, V490, P1, DOI 10.1130/2012.2490(00); Johnson MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064874; Jouquet P, 2004, EUR J SOIL BIOL, V40, P23, DOI 10.1016/j.ejsobi.2004.01.006; Jouquet P, 2015, APPL SOIL ECOL, V96, P282, DOI 10.1016/j.apsoil.2015.08.010; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Kuhn P, 2010, INTERPRETATION OF MICROMORPHOLOGICAL FEATURES OF SOILS AND REGOLITHS, P217, DOI 10.1016/B978-0-444-53156-8.00011-8; Lindbo DL, 2010, INTERPRETATION OF MICROMORPHOLOGICAL FEATURES OF SOILS AND REGOLITHS, P129, DOI 10.1016/B978-0-444-53156-8.00008-8; Mathews A. G. A., 1977, STUDIES TERMITES MAT; McGlue MM, 2012, QUATERNARY RES, V78, P285, DOI 10.1016/j.yqres.2012.05.015; MdC Gutierrez-Castorena, 2010, INTERPRETATION MICRO, P109; Murphy C.P., 1986, THIN SECTION PREPARA; Nascimento AF, 2015, GEODERMA, V255, P58, DOI 10.1016/j.geoderma.2015.04.025; Nichols GJ, 2007, SEDIMENT GEOL, V195, P75, DOI 10.1016/j.sedgeo.2006.07.004; Oliveira ME, 2006, ASIAN WILD PIG NEWS, V6, P16; Pfahler V, 2015, J PLANT NUTR SOIL SC, V178, P468, DOI 10.1002/jpln.201400279; PIPUJOL MD, 1994, PALAEOGEOGR PALAEOCL, V110, P103, DOI 10.1016/0031-0182(94)90112-0; PONCE VM, 1993, J BIOGEOGR, V20, P219, DOI 10.2307/2845673; Renard D, 2012, PLANT SOIL, V351, P337, DOI 10.1007/s11104-011-0967-8; Sanches L, 2010, REV BRAS METEOROL, V5, P448; Sarcinelli TS, 2009, CATENA, V76, P107, DOI 10.1016/j.catena.2008.10.001; Schaetzl RJ, 2005, SOILS: GENESIS AND GEOMORPHOLOGY, P1, DOI 10.1017/CBO9780511815560; Silva LCR, 2010, PLANT SOIL, V336, P3, DOI 10.1007/s11104-010-0329-y; Stoops G., 2003, GUIDELINES ANAL DESC; van Breemen N., 2002, SOIL FORMATION, VSecond; Van Ranst E, 2002, EUR J SOIL SCI, V53, P513, DOI 10.1046/j.1365-2389.2002.00475.x; Vidal-Torrado P., 1999, Revista Brasileira de Ciencia do Solo, V23, P909, DOI 10.1590/S0100-06831999000400018; Wallinga J, 2000, RADIAT MEAS, V32, P529, DOI 10.1016/S1350-4487(00)00091-3; Wiemann P., 2015, END LAKE DWELLINGS C, P101; World Reference Base for soil resources (WRB), 2014, WORLD SOIL RESOURCES	54	6	6	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e179197	10.1371/journal.pone.0179197	http://dx.doi.org/10.1371/journal.pone.0179197			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700595	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649600006
J	Costa, MC; Tozzi, G; Cristofolini, L; Danesi, V; Viceconti, M; Dall'Ara, E				Costa, Maria Cristiana; Tozzi, Gianluca; Cristofolini, Luca; Danesi, Valentina; Viceconti, Marco; Dall'Ara, Enrico			Micro Finite Element models of the vertebral body: Validation of local displacement predictions	PLOS ONE			English	Article							DIGITAL VOLUME CORRELATION; HUMAN CANCELLOUS BONE; TRABECULAR BONE; CORTICAL BONE; MECHANICAL-PROPERTIES; AUGMENTED VERTEBRAE; COMPUTED-TOMOGRAPHY; ELASTIC PROPERTIES; STRAIN; TISSUE	The estimation of local and structural mechanical properties of bones with micro Finite Element (microFE) models based on Micro Computed Tomography images depends on the quality bone geometry is captured, reconstructed and modelled. The aim of this study was to validate microFE models predictions of local displacements for vertebral bodies and to evaluate the effect of the elastic tissue modulus on model's predictions of axial forces. Four porcine thoracic vertebrae were axially compressed in situ, in a step-wise fashion and scanned at approximately 39 mu m resolution in preloaded and loaded conditions. A global digital volume correlation (DVC) approach was used to compute the full-field displacements. Homogeneous, isotropic and linear elastic microFE models were generated with boundary conditions assigned from the interpolated displacement field measured from the DVC. Measured and predicted local displacements were compared for the cortical and trabecular compartments in the middle of the specimens. Models were run with two different tissue moduli defined from microindentation data (12.0GPa) and a back-calculation procedure (4.6GPa). The predicted sum of axial reaction forces was compared to the experimental values for each specimen. MicroFE models predicted more than 87% of the variation in the displacement measurements (R-2 = 0.87-0.99). However, model predictions of axial forces were largely overestimated (80-369%) for a tissue modulus of 12.0GPa, whereas differences in the range 10-80% were found for a back-calculated tissue modulus. The specimen with the lowest density showed a large number of elements strained beyond yield and the highest predictive errors. This study shows that the simplest microFE models can accurately predict quantitatively the local displacements and qualitatively the strain distribution within the vertebral body, independently from the considered bone types.	[Costa, Maria Cristiana; Dall'Ara, Enrico] Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England; [Costa, Maria Cristiana; Viceconti, Marco; Dall'Ara, Enrico] Univ Sheffield, INSIGNEO Inst Silico Med, Sheffield, S Yorkshire, England; [Tozzi, Gianluca] Univ Portsmouth, Zeiss Global Ctr, Sch Engn, Portsmouth, Hants, England; [Cristofolini, Luca; Danesi, Valentina] Alma Mater Studiorum Univ Bologna, Sch Engn & Architecture, Bologna, Italy; [Viceconti, Marco] Univ Sheffield, Dept Mech Engn, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Portsmouth; University of Bologna; University of Sheffield	Dall'Ara, E (corresponding author), Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England.; Dall'Ara, E (corresponding author), Univ Sheffield, INSIGNEO Inst Silico Med, Sheffield, S Yorkshire, England.	e.dallara@sheffield.ac.uk	Dall'Ara, Enrico/ABA-5046-2020; Viceconti, Marco/ABG-5546-2020; Danesi, Valentina/ABE-5647-2020; Cristofolini, Luca/C-4402-2013	Dall'Ara, Enrico/0000-0003-1471-5077; Viceconti, Marco/0000-0002-2293-1530; Danesi, Valentina/0000-0001-9261-6467; Cristofolini, Luca/0000-0002-7473-6868	Sheffield Hospital Charity [141515-1]; Engineering and Physical Sciences Research Council (MultiSim project) [EP/K03877X/1]; Royal Society [RG130831, RG150012]; European Society of Biomechanics (ESB mobility award); EPSRC [EP/K03877X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K03877X/1] Funding Source: researchfish	Sheffield Hospital Charity; Engineering and Physical Sciences Research Council (MultiSim project)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); European Society of Biomechanics (ESB mobility award); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study was partially supported by Sheffield Hospital Charity (grant number: 141515-1; ED, MV; http://www.sheffieldhospitalscharity.org.uk/), the Engineering and Physical Sciences Research Council (MultiSim project, grant number: EP/K03877X/1; MV; https://www.epsrc.ac.uk/), the Royal Society (grant number: RG130831, GT; grant number: RG150012, ED; https://royalsociety.org/), and the European Society of Biomechanics (ESB mobility award 2014; VD; https://esbiomech.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayraktar HH, 2004, J BIOMECH, V37, P27, DOI 10.1016/S0021-9290(03)00257-4; Bevill G, 2009, BONE, V44, P579, DOI 10.1016/j.bone.2008.11.020; Chen Y, 2017, J MECH BEHAV BIOMED, V65, P644, DOI 10.1016/j.jmbbm.2016.09.014; Chen Y, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4028106; Chevalier Y, 2007, J BIOMECH, V40, P3333, DOI 10.1016/j.jbiomech.2007.05.004; Christen D, 2014, J MECH BEHAV BIOMED, V29, P500, DOI 10.1016/j.jmbbm.2013.10.010; Dall'Ara E, 2014, J BIOMECH, V47, P2956, DOI 10.1016/j.jbiomech.2014.07.019; Dall'Ara E, 2012, OSTEOPOROSIS INT, V23, P563, DOI 10.1007/s00198-011-1568-3; Dall'Ara E, 2010, J BIOMECH, V43, P2374, DOI 10.1016/j.jbiomech.2010.04.023; Danesi V, 2016, CLIN BIOMECH, V39, P14, DOI 10.1016/j.clinbiomech.2016.07.010; Danesi V, 2014, J BIOMECH, V47, P313, DOI 10.1016/j.jbiomech.2013.10.005; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Feng L, 2012, J BIOMECH, V45, P1775, DOI 10.1016/j.jbiomech.2012.05.001; Fox J, 1990, MODERN METHODS DATA; Gillard F, 2014, J MECH BEHAV BIOMED, V29, P480, DOI 10.1016/j.jmbbm.2013.09.014; Grassi L, 2015, J MECH BEHAV BIOMED, V50, P43, DOI 10.1016/j.jmbbm.2015.06.006; Gross T, 2012, COMPUT METHOD BIOMEC, V15, P1137, DOI 10.1080/10255842.2011.581236; Hambli R, 2013, BONE, V56, P363, DOI 10.1016/j.bone.2013.06.028; Hara T, 2002, BONE, V31, P107, DOI 10.1016/S8756-3282(02)00782-2; Hardisty MR, 2012, J ORTHOP RES, V30, P1032, DOI 10.1002/jor.22045; Harrison NM, 2013, BIOMECH MODEL MECHAN, V12, P225, DOI 10.1007/s10237-012-0394-7; Hojjat SP, 2012, J BIOMECH, V45, P2342, DOI 10.1016/j.jbiomech.2012.07.004; Homminga J, 2004, BONE, V34, P510, DOI 10.1016/j.bone.2003.12.001; Hou FJ, 1998, J BIOMECH, V31, P1009, DOI 10.1016/S0021-9290(98)00110-9; Hussein AI, 2012, PROC IUTAM, V4, P116, DOI 10.1016/j.piutam.2012.05.013; Jackman TM, 2016, J BIOMECH, V49, P267, DOI 10.1016/j.jbiomech.2015.12.004; Jackman TM, 2015, J BONE MINER RES, P1; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Ladd AJC, 1998, J ORTHOP RES, V16, P622, DOI 10.1002/jor.1100160516; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; MacNeil JA, 2008, BONE, V42, P1203, DOI 10.1016/j.bone.2008.01.017; Manda K, 2017, BIOMECH MODEL MECHAN, V16, P173, DOI 10.1007/s10237-016-0809-y; Mirzaali MJ, 2016, BONE, V93, P196, DOI 10.1016/j.bone.2015.11.018; Morgan EF, 2001, J BIOMECH ENG-T ASME, V123, P1, DOI 10.1115/1.1338122; Nazarian A, 2008, CALCIFIED TISSUE INT, V83, P368, DOI 10.1007/s00223-008-9174-x; Niebur GL, 2000, J BIOMECH, V33, P1575, DOI 10.1016/S0021-9290(00)00149-4; Niebur GL, 1999, J BIOMECH ENG-T ASME, V121, P629, DOI 10.1115/1.2800865; Pahr DH, 2012, COMPUT METHOD BIOMEC, V15, P711, DOI 10.1080/10255842.2011.556627; Palanca M, 2017, J BIOMECH IN PRESS; Palanca M, 2016, J BIOMECH, V49, P3882, DOI 10.1016/j.jbiomech.2016.10.018; Rietbergen V., 2000, COMPUT SIMUL MODEL M, V1, P98; Roberts BC, 2014, J BIOMECH, V47, P923, DOI 10.1016/j.jbiomech.2014.01.001; Sandino C, 2015, J MECH BEHAV BIOMED, V44, P1, DOI 10.1016/j.jmbbm.2014.12.018; Schwiedrzik J, 2016, INT J NUMER METH BIO, V32, DOI 10.1002/cnm.2739; Schwiedrzik JJ, 2014, EXPT THEORETICAL NUM; Sutcliffe P, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17420; Tozzi G, 2016, STRAIN, V52, P446, DOI 10.1111/str.12202; Tozzi G, 2017, J MECH BEHAV BIOMED, V67, P117, DOI 10.1016/j.jmbbm.2016.12.006; Ulrich D, 1998, J BIOMECH, V31, P1187, DOI 10.1016/S0021-9290(98)00118-3; Unnanuntana A, 2010, J BONE JOINT SURG AM, V92A, P743, DOI 10.2106/JBJS.I.00919; van Rietbergen B, 1998, Technol Health Care, V6, P413; VANRIETBERGEN B, 1995, J BIOMECH, V28, P69, DOI 10.1016/0021-9290(95)80008-5; Verhulp E, 2008, J BIOMECH, V41, P1479, DOI 10.1016/j.jbiomech.2008.02.032; Viceconti M., 2016, CAN WE TRUST MICRO F, P1; Wolfram U, 2010, J BIOMECH, V43, P1731, DOI 10.1016/j.jbiomech.2010.02.026; Wolfram U, 2010, BONE, V46, P348, DOI 10.1016/j.bone.2009.09.035; Zauel R, 2006, J BIOMECH ENG-T ASME, V128, P1, DOI 10.1115/1.2146001	57	46	47	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180151	10.1371/journal.pone.0180151	http://dx.doi.org/10.1371/journal.pone.0180151			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700618	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000405649400009
J	Du, ZC; Zhang, WJ; Zhang, DM; Yu, SC; Hao, YT				Du, Zhicheng; Zhang, Wangjian; Zhang, Dingmei; Yu, Shicheng; Hao, Yuantao			Estimating the basic reproduction rate of HFMD using the time series SIR model in Guangdong, China	PLOS ONE			English	Article							MOUTH-DISEASE HFMD; FOOT; HAND	Hand, foot, and mouth disease (HFMD) has caused a substantial burden of disease in China, especially in Guangdong Province. Based on notifiable cases, we use the time series Susceptible-Infected-Recovered model to estimate the basic reproduction rate (R0) and the herd immunity threshold, understanding the transmission and persistence of HFMD more completely for efficient intervention in this province. The standardized difference between the reported and fitted time series of HFMD was 0.009 (< 0.2). The median basic reproduction rate of total, enterovirus 71, and coxsackievirus 16 cases in Guangdong were 4.621 (IQR: 3.907 -5.823), 3.023 (IQR: 2.289 - 4.292) and 7.767 (IQR: 6.903 - 10.353), respectively. The heatmap of R0 showed semiannual peaks of activity, including a major peak in spring and early summer (about the 12 th week) followed by a smaller peak in autumn ( about the 36 th week). The county-level model showed that Longchuan (R0 = 33), Gaozhou ( R0 = 24), Huazhou (R0 = 23) and Qingxin (R0 = 19) counties have higher basic reproduction rate than other counties in the province. The epidemic of HFMD in Guangdong Province is still grim, and strategies like the World Health Organization's expanded program on immunization need to be implemented. An elimination of HFMD in Guangdong might need a Herd Immunity Threshold of 78%.	[Du, Zhicheng; Zhang, Wangjian; Zhang, Dingmei; Hao, Yuantao] Sun Yat Sen Univ, Dept Med Stat & Epidemiol, Guangzhou, Guangdong, Peoples R China; [Du, Zhicheng; Zhang, Wangjian; Zhang, Dingmei; Hao, Yuantao] Sun Yat Sen Univ, Hlth Informat Res Ctr, Guangzhou, Guangdong, Peoples R China; [Du, Zhicheng; Zhang, Wangjian; Zhang, Dingmei; Hao, Yuantao] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Key Lab Med, Guangzhou, Guangdong, Peoples R China; [Du, Zhicheng; Zhang, Wangjian; Zhang, Dingmei; Hao, Yuantao] Minist Educ, Key Lab Trop Dis & Control, Guangzhou, Guangdong, Peoples R China; [Yu, Shicheng] Chinese Ctr Dis Control & Prevent, Publ Hlth Surveillance & Informat Serv Ctr, Beijing, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Chinese Center for Disease Control & Prevention	Hao, YT (corresponding author), Sun Yat Sen Univ, Dept Med Stat & Epidemiol, Guangzhou, Guangdong, Peoples R China.; Hao, YT (corresponding author), Sun Yat Sen Univ, Hlth Informat Res Ctr, Guangzhou, Guangdong, Peoples R China.; Hao, YT (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Key Lab Med, Guangzhou, Guangdong, Peoples R China.; Hao, YT (corresponding author), Minist Educ, Key Lab Trop Dis & Control, Guangzhou, Guangdong, Peoples R China.	haoyt@mail.sysu.edu.cn	Zhang, Wangjian/AAU-6705-2021; Zhang, Wang-Jian/K-2242-2019; Zhang, Dingmei/ABC-7476-2020	Zhang, Wangjian/0000-0001-9655-6385	National Natural Science Foundation of China [81473064]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funded by National Natural Science Foundation of China, Grants 81473064	ANDERSON R M, 1991; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; CST F., 2008, 2 AS INT C MOD SIM A, P947; Daubechies I, 2010, COMMUN PUR APPL MATH, V63, P1, DOI 10.1002/cpa.20303; Deng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056943; Du ZC, 2016, SCI REP-UK, V6, DOI 10.1038/srep36351; Finkenstadt BF, 2002, BIOSTATISTICS, V3, P493, DOI 10.1093/biostatistics/3.4.493; Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187; Guangdong Health Department, 2016, NAT STAT EP SIT INF; KJ R, 1998, MODERN EPIDEMIOLOGY; Li MT, 2017, J MATH ANAL APPL, V446, P1292, DOI 10.1016/j.jmaa.2016.09.043; Li MT, 2014, APPL MATH COMPUT, V237, P582, DOI 10.1016/j.amc.2014.03.094; National Health and Family Planning Commission of China, 2017, NAT STAT EP SIT INF; National Population and Health Science Data Sharing Platform, 2001, NAT POP HLTH SCI DAT; Nilimesh Halder, 2010, RES J APPL SCI, V5, P177, DOI [10.3923/rjasci.2010.177.182, DOI 10.3923/RJASCI.2010.177.182]; Public Health Action Support Team (PHAST), 2008, EP THEOR; Sanicas M., 2016, SEVERE HAND FOOT MOU; WHO, 2011, GUID CLINC MAN PUBL; Wu YF, 2016, J FRANKLIN I, V353, P4772, DOI 10.1016/j.jfranklin.2016.09.012; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Yang JY, 2013, J APPL MATHE COMPUT, V41, P99, DOI 10.1007/s12190-012-0597-1; Zhang WJ, 2016, SCI TOTAL ENVIRON, V553, P366, DOI 10.1016/j.scitotenv.2016.02.023; Zhu Q, 2011, BIOMED ENVIRON SCI, V24, P349, DOI 10.3967/0895-3988.2011.04.005; Zhu YT, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/234509	24	20	23	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0179623	10.1371/journal.pone.0179623	http://dx.doi.org/10.1371/journal.pone.0179623			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692654	Green Published, Green Submitted, gold			2022-12-26	WOS:000405544800011
J	Guiraud, I; Post, A; Diallo, SN; Lompo, P; Maltha, J; Thriemer, K; Tahita, CM; Ley, B; Derra, K; Bottieau, E; Kazienga, A; Schurmans, C; Ravinetto, R; Rouamba, E; Van Griensven, J; Bertrand, S; Tinto, H; Jacobs, J				Guiraud, Issa; Post, Annelies; Diallo, Seydou Nakanabo; Lompo, Palpouguini; Maltha, Jessica; Thriemer, Kamala; Tahita, Christian Marc; Ley, Benedikt; Derra, Karim; Bottieau, Emmanuel; Kazienga, Adama; Schurmans, Celine; Ravinetto, Raffaella; Rouamba, Eli; Van Griensven, Johan; Bertrand, Sophie; Tinto, Halidou; Jacobs, Jan			Population-based incidence, seasonality and serotype distribution of invasive salmonellosis among children in Nanoro, rural Burkina Faso	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; SEROVAR TYPHIMURIUM INFECTION; BLOOD-STREAM INFECTIONS; SUB-SAHARAN AFRICA; TYPHOID-FEVER; DISEASE; SURVEILLANCE; HEALTH; BACTEREMIA; RESISTANCE	Background Bloodstream infections (BSI) caused by Salmonella Typhi and invasive non-Typhoidal Salmonella (iNTS) frequently affect children living in rural sub-Saharan Africa but data about incidence and serotype distribution are rare. Objective The present study assessed the population-based incidence of Salmonella BSI and severe malaria in a Health and Demographic Surveillance System in a rural area with seasonal malaria transmission in Nanoro, Burkina Faso. Methods Children between 2 months D 15 years old with severe febrile illness were enrolled during a one-year surveillance period (May 2013 D May 2014). Thick blood films and blood cultures were sampled and processed upon admission. Population-based incidences were corrected for non-referral, health seeking behavior, non-inclusion and blood culture sensitivity. Adjusted incidence rates were expressed per 100,000 person-years of observations (PYO). Results Among children <5 years old, incidence rates for iNTS, Salmonella Typhi and severe malaria per 100,000 PYO were 4,138 (95% Confidence Interval (CI): 3,740-4,572), 224 (95% CI: 138-340) and 2,866 (95% CI: 2,538-3,233) respectively. Among those aged 5-15 years, corresponding incidence rates were 25 (95% CI: 8-60), 273 (95% CI: 203-355) and 135 (95% CI: 87-195) respectively. Most iNTS occurred during the peak of the rainy season and in parallel with the increase of Plasmodium falciparum malaria; for Salmonella Typhi no clear seasonal pattern was observed. Salmonella Typhi and iNTS accounted for 13.3% and 55.8% of all 118 BSI episodes; 71.6% of iNTS (48/67) isolates were Salmonella enterica serovar Typhimurium and 25.4% (17/67) Salmonella enterica serovar Enteritidis; there was no apparent geographical clustering. Conclusion The present findings from rural West-Africa confirm high incidences of Salmonella Typhi and iNTS, the latter with a seasonal and Plasmodium falciparum-related pattern. It urges prioritization of the development and implementation of Salmonella Typhi as well as iNTS vaccines in this setting.	[Guiraud, Issa; Diallo, Seydou Nakanabo; Lompo, Palpouguini; Tahita, Christian Marc; Derra, Karim; Kazienga, Adama; Rouamba, Eli; Tinto, Halidou] IRSS Clin Res Unit Nanoro CRUN, Nanoro, Burkina Faso; [Guiraud, Issa; Jacobs, Jan] Univ Leuven, Dept Microbiol & Immunol, KU Leuven, Leuven, Belgium; [Post, Annelies; Maltha, Jessica; Thriemer, Kamala; Ley, Benedikt; Bottieau, Emmanuel; Schurmans, Celine; Van Griensven, Johan; Jacobs, Jan] ITM, Dept Clin Sci, Antwerp, Belgium; [Diallo, Seydou Nakanabo] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Maltha, Jessica] Univ Leuven, Ctr Mol & Vasc Biol, KU Leuven, Leuven, Belgium; [Thriemer, Kamala; Ley, Benedikt] Menzies Sch Hlth Res, Darwin, NT, Australia; [Ravinetto, Raffaella] ITM, Dept Publ Hlth, Antwerp, Belgium; [Bertrand, Sophie] Inst Publ Hlth, Brussels, Belgium	KU Leuven; Institute of Tropical Medicine (ITM); Centre Muraz; KU Leuven; Charles Darwin University; Menzies School of Health Research; Institute of Tropical Medicine (ITM)	Guiraud, I (corresponding author), IRSS Clin Res Unit Nanoro CRUN, Nanoro, Burkina Faso.; Guiraud, I (corresponding author), Univ Leuven, Dept Microbiol & Immunol, KU Leuven, Leuven, Belgium.; Post, A (corresponding author), ITM, Dept Clin Sci, Antwerp, Belgium.	guiraudis@yahoo.fr; annelies.post@gmail.com	Issa, GUIRAUD/AGU-8073-2022; Post, Annelies/Q-6745-2016; Kazienga, Adama/HGB-6079-2022; Jacobs, Jan/GRX-7316-2022; Derra, Karim/AAC-1323-2022	Post, Annelies/0000-0002-0471-8250; Derra, Karim/0000-0002-2090-9698; Kazienga, Adama/0000-0002-6093-9648; Tahita, Marc/0000-0003-2158-0182; Tinto, Halidou/0000-0002-0472-3586; Ley, Benedikt/0000-0002-5734-0845	Projects Network Laboratory Quality Management [126]; Clinical Research of the Third Framework [128]; Steunfonds Margeurite-Marie Delacroix; Fund for Scientific Research-Flanders (F.W.O.-Vlaanderen, Belgium) [V453812N]; Junior Mobility program of KU Leuven [JUMO/12/008]	Projects Network Laboratory Quality Management; Clinical Research of the Third Framework; Steunfonds Margeurite-Marie Delacroix; Fund for Scientific Research-Flanders (F.W.O.-Vlaanderen, Belgium)(FWO); Junior Mobility program of KU Leuven	This project was funded by the Projects Network Laboratory Quality Management (Nr. 126) and Clinical Research (128) of the Third Framework Agreement between the Belgian DGD (Ministry of Development Cooperation) and the Institute of Tropical Medicine (ITM), Belgium. (website: http://diplomatie.belgium.be/en/policy/development_cooperation/work_with_us/financing_opportunities/study_and_training_grants). The work of JM was partly funded by Steunfonds Margeurite-Marie Delacroix (No grant number available, website http://www.fondsmmdelacroix.org/nl/nos-activites/bourses-de-recherche/). For this study JM received additional grants from the Fund for Scientific Research-Flanders (F.W.O.-Vlaanderen, Belgium. Grant number V453812N, website http://www.fwo.be/en/) and the Junior Mobility program of KU Leuven (grant JUMO/12/008, website https://www.kuleuven.be/personeel/careercenter/youreca-career-center/yourecaENG/youreca-internationalmobility). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, BAS MAL MICR 1; Ao TT, 2015, EMERG INFECT DIS, V2010, P21, DOI DOI 10.3201/EID2106.140999; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Biggs HM, 2014, CLIN INFECT DIS, V58, P638, DOI 10.1093/cid/cit798; Breiman RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029119; Church J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-31; Connell TG, 2007, PEDIATRICS, V119, P891, DOI 10.1542/peds.2006-0440; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2015, CLIN MICROBIOL REV, V28, P901, DOI 10.1128/CMR.00002-15; Cunnington AJ, 2012, J IMMUNOL, V189, P5336, DOI 10.4049/jimmunol.1201028; Derra K, 2012, INT J EPIDEMIOL, V41, P1293, DOI 10.1093/ije/dys159; District sanitaire de Dande, 2018, PLAN ACT 2019 DISTR; Falay D, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1604-1; Garrett JL, 1999, WORLD DEV, V27, P1955, DOI 10.1016/S0305-750X(99)00091-1; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Gordon MA, 2010, CLIN INFECT DIS, V50, P953, DOI 10.1086/651080; Graham SM, 2000, PEDIATR INFECT DIS J, V19, P1189, DOI 10.1097/00006454-200012000-00016; Institut National de la Statistique et de la De A mographie (INSD), 2010, PHIQ SANT IND MULT B; Kalonji LM, 2015, CLIN INFECT DIS, V61, pS346, DOI 10.1093/cid/civ713; Kariuki S, 2015, VACCINE, V33, pS21, DOI 10.1016/j.vaccine.2015.03.102; Mackenzie G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010568; MacLennan CA, 2014, HUM VACC IMMUNOTHER, V10, P1478, DOI 10.4161/hv.29054; Maltha J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089103; Marks F, 2017, LANCET GLOB HEALTH, V5, pE310, DOI 10.1016/S2214-109X(17)30022-0; Mogasale V, 2014, LANCET GLOB HEALTH, V2, pE570, DOI 10.1016/S2214-109X(14)70301-8; Morpeth SC, 2009, CLIN INFECT DIS, V49, P606, DOI 10.1086/603553; Muthumbi E, 2015, CLIN INFECT DIS, V61, pS290, DOI 10.1093/cid/civ737; Nielsen MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044063; ODEMPSEY TJD, 1994, PEDIATR INFECT DIS J, V13, P122, DOI 10.1097/00006454-199402000-00009; ONUSIDA Burkina Faso, 2014, RAPP ACT RIP SIDA BU; Panzner U, 2016, CLIN INFECT DIS, V62, pS56, DOI 10.1093/cid/civ891; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Roux CM, 2010, INFECT IMMUN, V78, P1520, DOI 10.1128/IAI.00887-09; Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X; Smith LC, 2005, WORLD DEV, V33, P1285, DOI 10.1016/j.worlddev.2005.03.002; Sothmann P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139433; Tabu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031237; Takem EN, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-400; Tennant SM, VACCINE; Thriemer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030350; World Health Organization, 2013, NUTR HLTH DEV	42	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0178577	10.1371/journal.pone.0178577	http://dx.doi.org/10.1371/journal.pone.0178577			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692655	gold, Green Submitted, Green Published			2022-12-26	WOS:000405544800005
J	Calazans, SH; Walters, LJ; Fernandes, FC; Ferreira, CEL; Hoffman, EA				Calazans C, Savio H.; Walters, Linda J.; Fernandes, Flavio C.; Ferreira, Carlos E. L.; Hoffman, Eric A.			Genetic structure provides insights into the geographic origins and temporal change in the invasive charru mussel (Sururu) in the southeastern United States	PLOS ONE			English	Article							MYTELLA-CHARRUANA; POPULATION-STRUCTURE; CREPIDULA-FORNICATA; BIVALVIA MYTILIDAE; DISPERSAL ABILITY; MARINE; DIVERSITY; PATTERNS; LAGOON; DIFFERENTIATION	In 2004, Mytella charruana (d'Orbigny, 1842) (Mollusca: Bivalvia: Mytilidae) became established along the coast of the southeastern United States (SE-US). Using mitochondrial DNA sequencing (cytochrome c oxidase subunit I), we compared genetic variation throughout its native range in South America to its invasive range in the SE-US. Samples from the SE-US were collected in 2006 and 2010 enabling a temporal comparison to evaluate possible genetic changes of the invasive population. We addressed two questions. First, what are the potential source populations (or geographic regions) for the SE-US invasion? Second, how has genetic diversity changed between the two sampling periods within the SE-US? We identified a total of 72 haplotypes, 64 of which were isolated to geographic sites and only 8 were shared among sites. The highly structured native range provides insight into the origin of invasive populations where our results suggest that the introduced SE-US population originated from multiple source populations with the Panama region as the primary source. Additionally, our results indicate that genetic composition of the non-native populations was unchanged between the two sampling periods. Mytella charruana exhibit a significant pattern of genetic structure among natural populations, owing to biogeographic barriers that limit natural dispersal, and an ability to persist in novel habitats, owing to a suite of life-history characters that favor survival under variable conditions. Overall, this study explains why M. charruana may become an increasing threat to locations founded by anthropogenic transportation.	[Calazans C, Savio H.; Ferreira, Carlos E. L.] Univ Fed Fluminense, Dept Biol Marinha, Niteroi, RJ, Brazil; [Calazans C, Savio H.; Fernandes, Flavio C.] Inst Estudos Mar Almirante Paulo Moreira IEAPM, Dept Oceanog, Arraial Do Cabo, RJ, Brazil; [Walters, Linda J.; Hoffman, Eric A.] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA	Universidade Federal Fluminense; State University System of Florida; University of Central Florida	Hoffman, EA (corresponding author), Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA.	eric.hoffman@ucf.edu	Calazans, Savio/AAE-5033-2019	Calazans, Savio/0000-0002-2725-9202; Ferreira, Carlos Eduardo/0000-0002-4311-0491; Fernandes, Flavio/0000-0002-4838-1434	CAPES - National Council for Scientific and Technological Development; Brazilian grant program - Bolsas no Exterior - Ciencia sem Fronteiras / Doutorado Sanduoiche - SWE (CsF) Numero do Processo [245894/2012-8]; US Fulbright program; USDA NIFA Award [2008-32320-04574]; Indian River Lagoon National Estuary Program; University of Central Florida; Universidade Federal Fluminense; Instituto de Estudos do Mar Almirante Paulo Moreira	CAPES - National Council for Scientific and Technological Development; Brazilian grant program - Bolsas no Exterior - Ciencia sem Fronteiras / Doutorado Sanduoiche - SWE (CsF) Numero do Processo; US Fulbright program; USDA NIFA Award; Indian River Lagoon National Estuary Program; University of Central Florida; Universidade Federal Fluminense; Instituto de Estudos do Mar Almirante Paulo Moreira	Thanks for Brazilian CAPES - National Council for Scientific and Technological Development for the Ph.D. fellowship support to SHCC, and the Brazilian grant program - Bolsas no Exterior - Ciencia sem Fronteiras / Doutorado Sanduoiche - SWE (CsF) Numero do Processo: 245894/2012-8, and the US Fulbright program. This research was also supported by USDA NIFA Award No. 2008-32320-04574, the Indian River Lagoon National Estuary Program, the University of Central Florida, the Universidade Federal Fluminense and the Instituto de Estudos do Mar Almirante Paulo Moreira. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves FAS, 2012, J BIOSCI, V176-185; [Anonymous], 2011, PEGASUS REV UCF UNDE; Aristiza A, 2013, BOLETIN CENT INVESTI, V47, P165; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AYVAZIAN SG, 1994, MAR BIOL, V118, P25, DOI 10.1007/BF00699216; Bailey SA, 2015, AQUAT ECOSYST HEAL M, P18; Bax N, 2003, MAR POLICY, V27, P313, DOI 10.1016/S0308-597X(03)00041-1; Bilton DT, 2002, ESTUAR COAST SHELF S, V55, P937, DOI 10.1006/ecss.2002.1037; Boehs G, 2004, SCI MAR, V68, P537, DOI 10.3989/scimar.2004.68n4537; Boudreaux ML, 2006, J SHELLFISH RES, V25, P1079; BULNHEIM HP, 1981, MAR BIOL, V64, P105, DOI 10.1007/BF00397099; Cardenas EB, 2000, B MAR SCI, V66, P13; Carlton James T., 1999, Population and Community Biology Series, V24, P195; Carlton JT, 1992, J SHELLFISH RES, V11; Pineda MC, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2829-7; Ceron-Souza I, 2005, BIOTROPICA, V37, P258, DOI 10.1111/j.1744-7429.2005.00035.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cohen OR, 2014, BIOL INVASIONS, V16, P1743, DOI 10.1007/s10530-013-0624-7; Corredor-Acosta Andrea, 2011, Bol. Invest. Mar. Cost., V40, P33; Crooks JA, 2005, ECOSCIENCE, V12, P316, DOI 10.2980/i1195-6860-12-3-316.1; Dawnay N, 2007, FORENSIC SCI INT, V173, P1, DOI 10.1016/j.forsciint.2006.09.013; de Oliveira MEGC, 2005, GENET MOL RES, V4, P197; de Souza TO, 2015, ESTUAR COAST SHELF S, V156, P165, DOI 10.1016/j.ecss.2014.11.009; DeVanna KM, 2011, J GREAT LAKES RES, V37, P632, DOI 10.1016/j.jglr.2011.07.005; Dudas SE, 2005, J EXP MAR BIOL ECOL, V325, P8, DOI 10.1016/j.jembe.2005.04.015; Dupont L, 2003, MAR ECOL PROG SER, V253, P183, DOI 10.3354/meps253183; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Floeter SR, 2000, J FISH BIOL, V56, P1099, DOI 10.1111/j.1095-8649.2000.tb02126.x; Floeter SR, 2008, ATLANTIC REEF FISH B, P22; Foighil DO, 1999, BIOL BULL-US, V196, P122, DOI 10.2307/1542557; Galimany E, 2016, MAR ECOL PROG SER; Gillis NK, 2009, DIVERS DISTRIB, V15, P784, DOI 10.1111/j.1472-4642.2009.00591.x; Goldstien SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065656; Grantham BA, 2003, ECOL APPL, V13, pS108; Greenbaum G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115203; Grosholz ED, 2005, P NATL ACAD SCI USA, V102, P1088, DOI 10.1073/pnas.0308547102; Hassan M, 2003, J EXP MAR BIOL ECOL, V291, P219, DOI 10.1016/S0022-0981(03)00139-4; Hassol SJ, 1995, REPORT ASPEN GLOBAL; Hilliard, 2004, GLOBAL INVASIVE SPEC; Holland BS, 2001, INVASION BOTTLENECK, P407; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Joyeux JC, 2001, J BIOGEOGR, V28, P831, DOI 10.1046/j.1365-2699.2001.00602.x; Keen A. M., 1971, SEA SHELLS TROPICAL, VSecond; Kimura M., 1953, ANNU REP NAT I GENET, V3, P62; Knutsen H, 2003, MOL ECOL, V12, P385, DOI 10.1046/j.1365-294X.2003.01750.x; Kolbe JJ, 2008, ADMIXTURE DETERMINES, V6, P434; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lee HG, 1987, IMIGRANT MUSSEL SETT; LEONEL R M V, 1988, Boletim de Fisiologia Animal (Sao Paulo), V12, P89; Lessios HA, 2001, EVOLUTION, V55, P955, DOI 10.1554/0014-3820(2001)055[0955:PSASIT]2.0.CO;2; Lessios HA, 1998, P ROY SOC B-BIOL SCI, V265, P583, DOI 10.1098/rspb.1998.0334; Lester SE, 2007, ECOL LETT, V10, P745, DOI 10.1111/j.1461-0248.2007.01070.x; Li W.H., 1997, MOL EVOLUTION, P487; Lymbery Alan J., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P171, DOI 10.1016/j.ijppaw.2014.04.002; Martel C, 2004, J EXP MAR BIOL ECOL, V305, P155, DOI 10.1016/j.jembe.2003.11.011; Mashiko K, 2000, J CRUSTACEAN BIOL, V20, P118, DOI 10.1651/0278-0372(2000)020[0118:DOPWDS]2.0.CO;2; Miloslavich Patricia, 2011, PLoS ONE, V6, P1, DOI [10.1371/journal.pone.0018318, 10.1371/journal.pone.0021326]; Mladenov PV, 1997, NEW ZEAL J MAR FRESH, V31, P261, DOI 10.1080/00288330.1997.9516763; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Nash EF, 2011, UNDERSTANDING INVASI; NOAA, 2010, NATL WEATH SERV WEAT; Olden Julian D., 2011, P224; OLIVEIRA AM, 1993, ESTUAR COAST SHELF S, V37, P575, DOI 10.1006/ecss.1993.1074; Palero F, 2008, MOL PHYLOGENET EVOL, V48, P708, DOI 10.1016/j.ympev.2008.04.022; Palumbi SR, 1998, J HERED, V89, P459; Pechenik JA, 1999, MAR ECOL PROG SER, V177, P269, DOI 10.3354/meps177269; Pelc RA, 2009, J BIOGEOGR, V36, P1881, DOI 10.1111/j.1365-2699.2009.02138.x; Pereira-Barros J. B., 1846, B ESTUDOS PESCA, V9, P29; Puyana Mónica, 2012, Bol. Invest. Mar. Cost., V41, P213; R Core Team, 2012, R LANG ENV STAT COMP; Rilov G, 2004, BIOL INVASIONS, V6, P347, DOI 10.1023/B:BINV.0000034614.07427.96; Rios EC, 1994, SEASHELLS BRAZIL, V2nd; Rocha LA, 2003, PATTERNS DISTRIBUTIO, P1161; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Roman J, 2006, P ROY SOC B-BIOL SCI, V273, P2453, DOI 10.1098/rspb.2006.3597; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santos S, 2006, MOL ECOL, V15, P4361, DOI 10.1111/j.1365-294X.2006.03108.x; Shefer S, 2004, MOL ECOL, V13, P2333, DOI 10.1111/j.1365-294X.2004.02227.x; SIBAJA WG, 1988, REV BIOL TROP, V36, P453; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Spinuzzi Samantha, 2013, Marine Biodiversity Records, V6, pe55, DOI 10.1017/S1755267213000316; Stenyakina A, 2010, MOL REPROD DEV, V77, P222, DOI 10.1002/mrd.21132; Stepien CA, 2005, RISK ANAL, V25, P1043, DOI 10.1111/j.1539-6924.2005.00655.x; Stepien CA, 2002, J EVOLUTION BIOL, V15, P314, DOI 10.1046/j.1420-9101.2002.00385.x; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Szefer P, 1998, ENVIRON INT, V24, P359, DOI 10.1016/S0160-4120(98)00014-2; Tavare S, 1986, AM MATH SOC, V17, P57; Taylor DR, 2007, EVOLUTION, V61, P334, DOI 10.1111/j.1558-5646.2007.00037.x; TEMPLETON AR, 1992, GENETICS, V132, P619; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Viard F, 2006, HELGOLAND MAR RES, V60, P144, DOI 10.1007/s10152-006-0033-8; Watts RJ, 2004, MAR FRESHWATER RES, V55, P641, DOI 10.1071/MF04051; Wilke T, 2000, BIOL J LINN SOC, V70, P89, DOI 10.1111/j.1095-8312.2000.tb00202.x; Wright S., 1969, EVOLUTION GENETICS P, V012; Yuan WS, 2016, BIOL INVASIONS, V18, P689, DOI 10.1007/s10530-015-1040-y; Yuan W, 2010, J SHELLFISH RES, V29, P415, DOI 10.2983/035.029.0218; Yuan WS, 2016, J MARINE BIOL, P14; Zardi GI, 2007, MAR ECOL PROG SER, V337, P135, DOI 10.3354/meps337135; Zardus JD, 2005, MOL ECOL, V14, P3719, DOI 10.1111/j.1365-294X.2005.02701.x	103	13	13	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180619	10.1371/journal.pone.0180619	http://dx.doi.org/10.1371/journal.pone.0180619			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686694	Green Published, gold			2022-12-26	WOS:000405464100083
J	Guerrero-Mendiola, C; Garcia-Trejo, JJ; Encalada, R; Saavedra, E; Ramirez-Silva, L				Guerrero-Mendiola, Carlos; Garcia-Trejo, Jose J.; Encalada, Rusely; Saavedra, Emma; Ramirez-Silva, Leticia			The contribution of two isozymes to the pyruvate kinase activity of Vibrio cholerae: One K (+)- dependent constitutively active and another K (+)- independent with essential allosteric activation	PLOS ONE			English	Article							ESCHERICHIA-COLI; MAGNETIC-RESONANCE; REGULATORY PROPERTIES; KINETIC-PROPERTIES; BINDING-SITE; ENZYME; FRUCTOSE-1,6-BISPHOSPHATE; PHOSPHOENOLPYRUVATE; MECHANISM; TRANSITIONS	In a previous phylogenetic study of the family of pyruvate kinase EC (2.7.1.40), a cluster with Glu117 and another with Lys117 were found (numbered according to the rabbit muscle enzyme). The sequences with Glu117 have been found to be K (+)-dependent, whereas those with Lys117 were K (+)-independent. Interestingly, only.-proteobacteria exhibit sequences in both branches of the tree. In this context, it was explored whether these phylogenetically distinct pyruvate kinases were both expressed and contribute to the pyruvate kinase activity in Vibrio cholerae. The main findings of this work showed that the isozyme with Glu117 is an active K (+)-dependent enzyme. At the same substrate concentration, its Vmax in the absence of fructose 1,6 bisphosphate was 80% of that with its effector. This result is in accordance with the non-essential activation described by allosteric ligands for most pyruvate kinases. In contrast, the pyruvate kinase with Lys117 was a K (+)-independent enzyme displaying an allosteric activation by ribose 5-phosphate. At the same substrate concentration, its activity without the effector was 0.5% of the one obtained in the presence of ribose 5-phosphate, indicating that this sugar monophosphate is a strong activator of this enzyme. This absolute allosteric dependence is a novel feature of pyruvate kinase activity. Interestingly, in the K (+) independent enzyme, Mn (2+) may "mimic" the allosteric effect of Rib 5-P. Despite their different allosteric behavior, both isozymes display a rapid equilibrium random order kinetic mechanism. The intracellular concentrations of fructose 1,6-bisphosphate and ribose 5phosphate in Vibrio cholerae have been experimentally verified to be sufficient to induce maximal activation of both enzymes. In addition, Western blot analysis indicated that both enzymes were co-expressed. Therefore, it is concluded that VcIPK and VcIIPK contribute to the activity of pyruvate kinase in this Y-proteobacterium.	[Guerrero-Mendiola, Carlos; Ramirez-Silva, Leticia] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Ciudad De Mexico, Mexico; [Garcia-Trejo, Jose J.] Univ Nacl Autonoma Mexico, Fac Quim, Dept Biol, Ciudad De Mexico, Mexico; [Encalada, Rusely; Saavedra, Emma] Inst Nacl Cardiol, Dept Bioquim, Ignacio Chavez, Ciudad De Mexic, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Ramirez-Silva, L (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Ciudad De Mexico, Mexico.	lramirez@bq.unam.mx	Saavedra, Emma/ABB-8989-2020	Saavedra, Emma/0000-0001-8661-9813; Ramirez-Silva, Leticia/0000-0002-0488-6385; GUERRERO MENDIOLA, CARLOS/0000-0002-9427-4090	Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico [IN214415, IN221216]; Consejo Nacional de Ciencia y Tecnologia [CB-2011-01-167622]; Consejo Nacional de Ciencia y Tecnologia Ph. D. fellowship [335890]	Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologia Ph. D. fellowship	This work was supported by Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico, Grant IN214415 (to L. Ramirez-Silva), Grant IN221216 (to J.J. Garcia-Trejo); Consejo Nacional de Ciencia y Tecnologia Grant CB-2011-01-167622 (to J.J. Garcia-Trejo); and Consejo Nacional de Ciencia y Tecnologia Ph. D. fellowship, number 335890 (C. Guerrero-Mendiola). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	AINSWORTH S, 1973, BIOCHEM J, V131, P223, DOI 10.1042/bj1310223; ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BLAIR JB, 1984, ARCH BIOCHEM BIOPHYS, V232, P202, DOI 10.1016/0003-9861(84)90536-8; BUCHER T, 1955, METHOD ENZYMOL, V1, P435, DOI 10.1016/0076-6879(55)01071-9; BUSTO F, 1988, BIOCHEM CELL BIOL, V66, P148, DOI 10.1139/o88-020; CARVAJAL N, 1985, COMP BIOCHEM PHYS B, V82, P63, DOI 10.1016/0305-0491(85)90128-2; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; Cholera Li J., 2015, RADIOLOGY INFECT DIS, V2, P75; Cleland W. W, 1970, ENZYMES, V2, P1; Collins RA, 1996, PROTEIN ENG, V9, P1203, DOI 10.1093/protein/9.12.1203; COLLINS RA, 1995, BIOCHEM J, V310, P117, DOI 10.1042/bj3100117; Dela Vega-Ruiz G, 2015, PLOS ONE, V10; Donovan KA, 2016, J BIOL CHEM, V291, P9244, DOI 10.1074/jbc.M115.676270; DOUGHERTY TM, 1985, BIOCHEMISTRY-US, V24, P5875, DOI 10.1021/bi00342a028; ERNEST I, 1994, MOL BIOCHEM PARASIT, V64, P43, DOI 10.1016/0166-6851(94)90133-3; Fenton AW, 2009, METHOD ENZYMOL, V466, P83, DOI 10.1016/S0076-6879(09)66005-5; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; GARCIAOLALLA C, 1987, BIOCHEM J, V241, P573, DOI 10.1042/bj2410573; Gohara DW, 2016, J BIOL CHEM, V291, P20840, DOI 10.1074/jbc.R116.737833; GUPTA RK, 1978, J BIOL CHEM, V253, P8878; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; HELDAL M, 1985, APPL ENVIRON MICROB, V50, P1251, DOI 10.1128/AEM.50.5.1251-1257.1985; Hofmann J, 2013, PROTEIN EXPRES PURIF, V88, P243, DOI 10.1016/j.pep.2013.01.010; Hohle TH, 2012, MOL MICROBIOL, V84, P766, DOI 10.1111/j.1365-2958.2012.08057.x; Ishwar A, 2015, BIOCHEMISTRY-US, V54, P1516, DOI 10.1021/bi501426w; Jakubovics NS, 2001, MICROBIOL-SGM, V147, P1709, DOI 10.1099/00221287-147-7-1709; JETTEN MSM, 1994, APPL ENVIRON MICROB, V60, P2501, DOI 10.1128/AEM.60.7.2501-2507.1994; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; KAPOOR R, 1981, BIOCHEM J, V193, P435, DOI 10.1042/bj1930435; KASAHARA M, 1978, J BIOL CHEM, V253, P4180; Knowles VL, 2001, J BIOL CHEM, V276, P20966, DOI 10.1074/jbc.M008878200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIAO CL, 1971, J BACTERIOL, V106, P37, DOI 10.1128/JB.106.1.37-44.1971; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALCOVATI M, 1982, METHOD ENZYMOL, V90, P170; MATTEVI A, 1995, STRUCTURE, V3, P729, DOI 10.1016/S0969-2126(01)00207-6; Mesecar AD, 1997, BIOCHEMISTRY-US, V36, P6803, DOI 10.1021/bi962870s; Mesecar AD, 1997, BIOCHEMISTRY-US, V36, P6792, DOI 10.1021/bi962869t; MILDVAN AS, 1965, J BIOL CHEM, V240, P238; MILDVAN AS, 1966, J BIOL CHEM, V241, P1178; Morgan HP, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140120; Morgan HP, 2010, J BIOL CHEM, V285, P12892, DOI 10.1074/jbc.M109.079905; MORIKAWA M, 1980, J BIOCHEM-TOKYO, V87, P441, DOI 10.1093/oxfordjournals.jbchem.a132764; Munoz ME, 2003, COMP BIOCHEM PHYS B, V135, P197, DOI 10.1016/S1096-4959(03)00081-2; Naithani A, 2015, BIOPHYS J, V109, P1149, DOI 10.1016/j.bpj.2015.05.040; Oria-Hernandez J, 2005, J BIOL CHEM, V280, P37924, DOI 10.1074/jbc.M508490200; Oria-Hernandez J, 2006, J BIOL CHEM, V281, P30717, DOI 10.1074/jbc.M605310200; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Ramirez-Silva L, 2014, INT J MOL SCI, V15, P22214, DOI 10.3390/ijms151222214; RAMIREZSILVA L, 1993, BIOCHEMISTRY-US, V32, P5332, DOI 10.1021/bi00071a008; REED GH, 1974, BIOCHEMISTRY-US, V13, P3537, DOI 10.1021/bi00714a020; REUBEN J, 1971, J BIOL CHEM, V246, P6227; REYNARD AM, 1961, J BIOL CHEM, V236, P2277; Saavedra E, 2005, FEBS J, V272, P1767, DOI 10.1111/j.1742-4658.2005.04610.x; Saavedra E, 2007, FEBS J, V274, P4922, DOI 10.1111/j.1742-4658.2007.06012.x; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schauer S, 2012, APPL ENVIRON MICROB, V78, P7369, DOI 10.1128/AEM.02190-12; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; SMART JB, 1979, ARCH MICROBIOL, V122, P281, DOI 10.1007/BF00411292; SOLVONUK PF, 1955, CAN J BIOCHEM PHYS, V33, P38; Steiner P, 1998, GENE, V220, P31, DOI 10.1016/S0378-1119(98)00418-1; Susan-Resiga D, 2004, BIOCHEMISTRY-US, V43, P15230, DOI 10.1021/bi049864d; Trucksis M, 1998, P NATL ACAD SCI USA, V95, P14464, DOI 10.1073/pnas.95.24.14464; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; VALENTINI G, 1979, ITAL J BIOCHEM, V28, P345; VALENTINI G, 1979, BIOCHIM BIOPHYS ACTA, V570, P248, DOI 10.1016/0005-2744(79)90145-1; VANSCHAFTINGEN E, 1985, EUR J BIOCHEM, V153, P403, DOI 10.1111/j.1432-1033.1985.tb09316.x; WAYGOOD EB, 1974, J BIOL CHEM, V249, P265; Waygood EB, 1975, CAN J BIOCHEM, V5, P44; YAMADA T, 1975, J BACTERIOL, V124, P562, DOI 10.1128/JB.124.1.562-563.1975; Zheng L, 2014, APPL MICROBIOL BIOT, V98, P1583, DOI 10.1007/s00253-013-4907-9	72	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0178673	10.1371/journal.pone.0178673	http://dx.doi.org/10.1371/journal.pone.0178673			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686591	Green Submitted, gold, Green Published			2022-12-26	WOS:000405464100006
J	Leng, T; Leng, G; MacGregor, DJ				Leng, Trystan; Leng, Gareth; MacGregor, Duncan J.			Spike patterning in oxytocin neurons: Capturing physiological behaviour with Hodgkin-Huxley and integrate-and-fire models	PLOS ONE			English	Article							RAT SUPRAOPTIC NUCLEUS; MAGNOCELLULAR NEUROSECRETORY-CELLS; IN-VITRO; VASOPRESSIN NEURONS; NEUROENDOCRINE CELLS; MEMBRANE-PROPERTIES; HYPOTHALAMUS; VIVO; CONDUCTANCE; MECHANISMS	Integrate-and-fire (IF) models can provide close matches to the discharge activity of neurons, but do they oversimplify the biophysical properties of the neurons? A single compartment Hodgkin-Huxley (HH) model of the oxytocin neuron has previously been developed, incorporating biophysical measurements of channel properties obtained in vitro. A simpler modified integrate-and-fire model has also been developed, which can match well the characteristic spike patterning of oxytocin neurons as observed in vivo. Here, we extended the HH model to incorporate synaptic input, to enable us to compare spike activity in the model with experimental data obtained in vivo. We refined the HH model parameters to closely match the data, and then matched the same experimental data with a modified IF model, using an evolutionary algorithm to optimise parameter matching. Finally we compared the properties of the modified HH model with those of the IF model to seek an explanation for differences between spike patterning in vitro and in vivo. We show that, with slight modifications, the original HH model, like the IF model, is able to closely match both the interspike interval (ISI) distributions of oxytocin neurons and the observed variability of spike firing rates in vivo and in vitro. This close match of both models to data depends on the presence of a slow activity-dependent hyperpolarisation (AHP); this is represented in both models and the parameters used in the HH model representation match well with optimal parameters of the IF model found by an evolutionary algorithm. The ability of both models to fit data closely also depends on a shorter hyperpolarising after potential (HAP); this is explicitly represented in the IF model, but in the HH model, it emerges from a combination of several components. The critical elements of this combination are identified.	[Leng, Trystan; Leng, Gareth; MacGregor, Duncan J.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	University of Edinburgh	MacGregor, DJ (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland.	duncan.macgregor@ed.ac.uk	Leng, Gareth/C-6688-2011	Leng, Gareth/0000-0002-2388-8466; Leng, Trystan/0000-0001-8312-9405	EU [607310]	EU(European Commission)	This work was supported by EU Seventh Framework Programme 607310, https://ec.europa.eu/research/fp7/index_en.cfm, norole.	ANDREW RD, 1984, J PHYSIOL-LONDON, V353, P171, DOI 10.1113/jphysiol.1984.sp015330; Armstrong WE, 2010, J NEUROENDOCRINOL, V22, P330, DOI 10.1111/j.1365-2826.2010.01989.x; Armstrong WE, 1998, PROG BRAIN RES, V119, P101; ARMSTRONG WE, 1994, J PHYSIOL-LONDON, V475, P115, DOI 10.1113/jphysiol.1994.sp020053; BICKNELL RJ, 1988, J EXP BIOL, V139, P51; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; BOURQUE CW, 1987, NEUROSCI LETT, V82, P185, DOI 10.1016/0304-3940(87)90127-3; BOURQUE CW, 1988, J PHYSIOL-LONDON, V397, P331, DOI 10.1113/jphysiol.1988.sp017004; BOURQUE CW, 1991, BRAIN RES, V540, P349, DOI 10.1016/0006-8993(91)90535-4; Brette R, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004114; Brown CH, 2013, J NEUROENDOCRINOL, V25, P678, DOI 10.1111/jne.12051; Brown CH, 2016, COMPR PHYSIOL, V6, P1701, DOI 10.1002/cphy.c150053; Clayton TF, 2010, J NEUROENDOCRINOL, V22, P1290, DOI 10.1111/j.1365-2826.2010.02080.x; COBBETT P, 1987, BRAIN RES, V409, P175, DOI 10.1016/0006-8993(87)90756-6; Destexhe A, 1997, NEURAL COMPUT, V9, P503, DOI 10.1162/neco.1997.9.3.503; Dopico AM, 1999, J PHYSIOL-LONDON, V519, P101, DOI 10.1111/j.1469-7793.1999.0101o.x; DYBALL REJ, 1991, J NEUROENDOCRINOL, V3, P383, DOI 10.1111/j.1365-2826.1991.tb00291.x; GIES U, 1994, J NEUROSCI, V14, P2861; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Jolivet R, 2004, J NEUROPHYSIOL, V92, P959, DOI 10.1152/jn.00190.2004; KIRKPATRICK K, 1995, J PHYSIOL-LONDON, V482, P373, DOI 10.1113/jphysiol.1995.sp020524; Kirkpatrick K, 1996, J PHYSIOL-LONDON, V494, P389, DOI 10.1113/jphysiol.1996.sp021500; Leng G, 2001, J NEUROSCI, V21, P6967, DOI 10.1523/JNEUROSCI.21-17-06967.2001; Leng G, 1999, PROG NEUROBIOL, V57, P625, DOI 10.1016/S0301-0082(98)00072-0; Li CY, 2007, J PHYSIOL-LONDON, V581, P221, DOI 10.1113/jphysiol.2006.123810; Li ZH, 1997, J PHYSIOL-LONDON, V505, P95, DOI 10.1111/j.1469-7793.1997.095bc.x; Luther JA, 2000, J PHYSIOL-LONDON, V523, P193, DOI 10.1111/j.1469-7793.2000.t01-1-00193.x; MacGregor DJ, 2009, J NEUROSCI METH, V176, P45, DOI 10.1016/j.jneumeth.2008.08.011; MacGregor DJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003187; MacGregor DJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002740; MEEKER RB, 1993, ANN NY ACAD SCI, V689, P636, DOI 10.1111/j.1749-6632.1993.tb55614.x; Pittman QJ, 1998, PROG BRAIN RES, V119, P311; Prager-Khoutorsky M, 2015, J NEUROENDOCRINOL, V27, P507, DOI 10.1111/jne.12270; RHODES CH, 1981, J COMP NEUROL, V198, P45, DOI 10.1002/cne.901980106; Roper P, 2004, J NEUROSCI, V24, P4818, DOI 10.1523/JNEUROSCI.4203-03.2004; Roper P, 2003, J COMPUT NEUROSCI, V15, P367, DOI 10.1023/A:1027424128972; Rossoni E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000123; Royo JM, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12358; Sabatier N, 2004, J PHYSIOL-LONDON, V558, P161, DOI 10.1113/jphysiol.2004.063982; Stern JE, 1997, J PHYSIOL-LONDON, V500, P497, DOI 10.1113/jphysiol.1997.sp022036; STERN JE, 1995, J PHYSIOL-LONDON, V488, P701, DOI 10.1113/jphysiol.1995.sp021001; Teruyama R, 2002, J NEUROENDOCRINOL, V14, P933, DOI 10.1046/j.1365-2826.2002.00844.x; Teruyama R, 2007, J NEUROPHYSIOL, V98, P2612, DOI 10.1152/jn.00599.2007	43	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180368	10.1371/journal.pone.0180368	http://dx.doi.org/10.1371/journal.pone.0180368			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683135	Green Submitted, gold, Green Published			2022-12-26	WOS:000405335200027
J	Lin, SP; Lin, WY; Chang, JT; Chu, CF				Lin, Shu-Ping; Lin, Wen-Ye; Chang, Jung-Tzu; Chu, Chun-Feng			Demonstration of disinfection procedure for the development of accurate blood glucose meters in accordance with ISO 15197:2013	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; MONITORING SYSTEMS; BORNE VIRUSES; PREVENTION; SURVIVAL; STORAGE	espite measures to reduce disease transmission, a risk can occur when blood glucose meters (BGMs) are used on multiple individuals or by caregivers assisting a patient. The laboratory and in-clinic performance of a BGM system before and after disinfection should be demonstrated to guarantee accurate readings and reliable control of blood glucose (BG) for patients. In this study, an effective disinfection procedure, conducting wiping 10 times to assure a one minute contact time of the disinfectant on contaminated surface, was first demonstrated using test samples of the meter housing materials, including acrylonitrile butadiene styrene (ABS), polymethyl methacrylate (PMMA), and polycarbonate (PC), in accordance with ISO 15197:2013. After bench studies comprising 10,000 disinfection cycles, the elemental compositions of the disinfected ABS, PMMA, and PC samples were almost the same as in the original samples, as indicated by electron spectroscopy for chemical analysis. Subsequently, the validated disinfection procedure was then directly applied to disinfect 5 commercial BGM systems composed of ABS, PMMA, or PC to observe the effect of the validated disinfection procedure on meter accuracy. The results of HBsAg values after treatment with HBV sera and disinfectant wipes for each material were less than the LoD of each material of 0.020 IU/mL. Before and after the multiple disinfection cycles, 900 of 900 samples (100%) were within the system accuracy requirements of ISO 15197: 2013. All of the systems showed high performance before and after the series of disinfection cycles and met the ISO 15197: 2013 requirements. In addition, our results demonstrated multiple cleaning and disinfection cycles that represented normal use over the lifetime of a meter of 3-5 years. Our validated cleaning and disinfection procedure can be directly applied to other registered disinfectants for cleaning commercial BGM products in the future.	[Lin, Shu-Ping] Natl Chung Hsing Univ, Grad Inst Biomed Engn, Taichung, Taiwan; [Lin, Shu-Ping] Natl Chung Hsing Univ, Res Ctr Sustainable Energy & Nanotechnol, Taichung, Taiwan; [Lin, Wen-Ye] Jen Ai Hosp, Taichung, Taiwan; [Chang, Jung-Tzu; Chu, Chun-Feng] Biotest Med Corp, Taichung, Taiwan	National Chung Hsing University; National Chung Hsing University	Lin, SP (corresponding author), Natl Chung Hsing Univ, Grad Inst Biomed Engn, Taichung, Taiwan.; Lin, SP (corresponding author), Natl Chung Hsing Univ, Res Ctr Sustainable Energy & Nanotechnol, Taichung, Taiwan.	splin@dragon.nchu.edu.tw	Lin, Shu-Ping/AFV-5955-2022	Lin, Shu-Ping/0000-0001-5169-0361	Ministry of Science and Technology of Taiwan [NSC 102-2221-E-005-005-MY3, MOST 105-2221-E-005-009-]; Biotest Medical Corp.Taichung City, Taiwan [105DA198.]; JTC; CFC	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Biotest Medical Corp.Taichung City, Taiwan; JTC; CFC	This work was supported by the Ministry of Science and Technology of Taiwan under grant numbers NSC 102-2221-E-005-005-MY3 and MOST 105-2221-E-005-009-. This work was supported in part by Biotest Medical Corp. (http://www.btm-medical.com/), Taichung City, Taiwan under grant number 105DA198. The Biotest Medical Corp. provided support in the form of salaries for JTC and CFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip	Alvarez-Munoz MT, 2005, ARCH MED RES, V36, P382, DOI 10.1016/j.arcmed.2005.03.010; [Anonymous], 2014, SELF MON BLOOD GLUC; [Anonymous], 2014, BLOOD GLUC MON TEST; [Anonymous], 2015, 510 K PREM NOT; [Anonymous], 2013, VITR DIAGN TEST SYST; [Anonymous], 2012, EV DET CAP CLIN LAB; [Anonymous], 2003, VITR DIAGN TEST SYST; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Bender TJ, 2010, PLOS ONE, V7; BOND WW, 1981, LANCET, V1, P550; Briggs D., 1992, HIGH RESOLUTION XPS; Counard CA, 2010, J AM GERIATR SOC, V58, P306, DOI 10.1111/j.1532-5415.2009.02669.x; Crist BV, 2000, HDB MONACHROMATIC XP; Czupryniak L, 2014, DIABETES TECHNOL THE, V16, P460, DOI 10.1089/dia.2013.0302; Deuffic-Burban S, 2011, J CLIN VIROL, V52, P4, DOI 10.1016/j.jcv.2011.05.016; Erbach Michael, 2016, J Diabetes Sci Technol, V10, P1161, DOI 10.1177/1932296816641433; Fischer R, 2015, EMERG INFECT DIS, V21, P1243, DOI 10.3201/eid2107.150253; Flore KMJ, 2009, PERITON DIALYSIS INT, V29, P377; Freckmann G, 2014, DIABETES TECHNOL THE, V16, P113, DOI 10.1089/dia.2013.0208; Freckmann G, 2010, DIABETES TECHNOL THE, V12, P221, DOI 10.1089/dia.2009.0128; Heinemann Lutz, 2012, J Diabetes Sci Technol, V6, P435; Klonoff David C, 2014, Diabetes Spectr, V27, P174, DOI 10.2337/diaspect.27.3.174; Klonoff David C, 2015, J Diabetes Sci Technol, V9, P895, DOI 10.1177/1932296815584797; Klonoff David C, 2015, J Diabetes Sci Technol, V9, P3, DOI 10.1177/1932296814563643; Klonoff David C, 2011, J Diabetes Sci Technol, V5, P1307; Kropff J, 2015, DIABETES OBES METAB, V17, P343, DOI 10.1111/dom.12378; Louie RF, 2015, GLOBAL POINT CARE ST; Mahoney John J, 2012, J Diabetes Sci Technol, V6, P81; Pfaender S, 2016, REV MED VIROL, V26, P330, DOI 10.1002/rmv.1890; Ramesh A., 2013, OVERVIEW PLASTIC MAT; Schaffzin JK, 2012, AM J INFECT CONTROL, V40, P726, DOI 10.1016/j.ajic.2011.11.002; Thompson Nicola D, 2009, J Diabetes Sci Technol, V3, P283; Thompson SC, 2003, AUST NZ J PUBL HEAL, V27, P602, DOI 10.1111/j.1467-842X.2003.tb00606.x; Vashist SK, 2011, ANAL CHIM ACTA, V703, P124, DOI 10.1016/j.aca.2011.07.024	34	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180617	10.1371/journal.pone.0180617	http://dx.doi.org/10.1371/journal.pone.0180617			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683148	Green Published, gold, Green Submitted			2022-12-26	WOS:000405335200055
J	Mezzetti, F; Fay, JC; Giudici, P; De Vero, L				Mezzetti, Francesco; Fay, Justin C.; Giudici, Paolo; De Vero, Luciana			Genetic variation and expression changes associated with molybdate resistance from a glutathione producing wine strain of Saccharomyces cerevisiae	PLOS ONE			English	Article							OXIDATIVE STRESS-RESPONSE; MOLECULAR CHARACTERIZATION; ADAPTIVE EVOLUTION; READ ALIGNMENT; AMINO-ACIDS; YEAST; SULFATE; PROTEIN; GENOME; BIOSYNTHESIS	Glutathione (GSH) production during wine fermentation is a desirable trait as it can limit must and wine oxidation and protect various aromatic compounds. UMCC 2581 is a Saccharomyces cerevisiae wine strain with enhanced GSH content at the end of wine fermentation. This strain was previously derived by selection for molybdate resistance following a sexual cycle of UMCC 855 using an evolution-based strategy. In this study, we examined genetic and gene expression changes associated with the derivation of UMCC 2581. For genetic analysis we sporulated the diploid UMCC 855 parental strain and found four phenotype classes of segregants related to molybdate resistance, demonstrating the presence of segregating variation from the parental strain. Using bulk segregant analysis we mapped molybdate traits to two loci. By sequencing both the parental and evolved strain genomes we identified candidate mutations within the two regions as well as an extra copy of chromosome 1 in UMCC 2581. Combining the mapped loci with gene expression profiles of the evolved and parental strains we identified a number of candidate genes with genetic and/or gene expression changes that could underlie molybdate resistance and increased GSH levels. Our results provide insight into the genetic basis of GSH production relevant to wine-making and highlight the value of enhancing wine strains using existing variation present in wine strains.	[Mezzetti, Francesco; Giudici, Paolo; De Vero, Luciana] Univ Modena & Reggio Emilia, Dept Life Sci, Reggio Emilia, Italy; [Fay, Justin C.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Fay, Justin C.] Washington Univ, Ctr Genome Sci & Syst Biol, St Louis, MO USA	Universita di Modena e Reggio Emilia; Washington University (WUSTL); Washington University (WUSTL)	De Vero, L (corresponding author), Univ Modena & Reggio Emilia, Dept Life Sci, Reggio Emilia, Italy.	luciana.devero@unimore.it	De Vero, Luciana/AAH-6705-2020	De Vero, Luciana/0000-0002-9887-9994; Fay, Justin/0000-0003-1893-877X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080669] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM080669] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adamis PDB, 2007, TOXICOL LETT, V173, P1, DOI 10.1016/j.toxlet.2007.06.002; Albers E, 2003, J BIOL CHEM, V278, P10264, DOI 10.1074/jbc.M211692200; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Antonela G, 2015, SCI PAP-SER B-HORTIC, V59, P123; Ausubel FM, 2002, CURRENT PROTOCOLS MO, V5, P2; Avendano A, 1997, J BACTERIOL, V179, P5594, DOI 10.1128/jb.179.17.5594-5597.1997; Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; BIDENNE C, 1992, CURR GENET, V22, P1, DOI 10.1007/BF00351734; Bleackley MR, 2011, METALLOMICS, V3, P195, DOI 10.1039/c0mt00035c; Bonciani T, 2016, EUR FOOD RES TECHNOL, V242, P899, DOI 10.1007/s00217-015-2596-6; Borneman AR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001287; Cadiere A, 2011, METAB ENG, V13, P263, DOI 10.1016/j.ymben.2011.01.008; CHEREST H, 1993, J BACTERIOL, V175, P5366, DOI 10.1128/JB.175.17.5366-5374.1993; Cherest H, 1997, GENETICS, V145, P627; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Chloupkova M, 2003, J MOL BIOL, V331, P155, DOI 10.1016/S0022-2836(03)00666-1; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Collinson EJ, 2011, J BIOL CHEM, V286, P2205, DOI 10.1074/jbc.M110.187062; DANCIS A, 1990, MOL CELL BIOL, V10, P2294, DOI 10.1128/MCB.10.5.2294; De Vero L, 2011, LETT APPL MICROBIOL, V53, P572, DOI 10.1111/j.1472-765X.2011.03140.x; De Vero L, 2017, AIMS MICROBIOL, V3, P155, DOI 10.3934/microbiol.2017.2.155; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dhaoui M, 2011, MOL BIOL CELL, V22, P2054, DOI 10.1091/mbc.E10-11-0906; Du J, 2015, GENE, V563, P155, DOI 10.1016/j.gene.2015.03.018; During-Olsen L, 1999, CURR GENET, V35, P609, DOI 10.1007/s002940050459; Ferreira ACS, 2002, J AGR FOOD CHEM, V50, P5919, DOI 10.1021/jf0115847; Filetici P, 1996, YEAST, V12, P1359, DOI 10.1002/(SICI)1097-0061(199610)12:13<1359::AID-YEA3>3.0.CO;2-5; GADD GM, 1989, SPEC PUBL SOC GEN MI, V26, P19; Gall WE, 2002, CURR BIOL, V12, P1623, DOI 10.1016/S0960-9822(02)01148-X; Gharieb MM, 1998, BIOMETALS, V11, P101, DOI 10.1023/A:1009221810760; Giudici P, 2005, APPL MICROBIOL BIOT, V66, P622, DOI 10.1007/s00253-004-1784-2; GIUDICI P, 1994, AM J ENOL VITICULT, V45, P107; Gobbi M, 2014, EUR FOOD RES TECHNOL, V239, P41, DOI 10.1007/s00217-014-2187-y; GRANDORI R, 1994, PROTEIN SCI, V3, P2185, DOI 10.1002/pro.5560031204; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; Griffiths LM, 2009, MOL CELL BIOL, V29, P794, DOI 10.1128/MCB.01357-08; Higgins VJ, 2002, YEAST, V19, P203, DOI 10.1002/yea.811; Hinnebusch A. G., 1992, MOL CELLULAR BIOL YE, P319, DOI DOI 10.1016/J.ACA.2008.01.060; Izquierdo A, 2008, EUKARYOT CELL, V7, P1415, DOI 10.1128/EC.00133-08; JASPERS CJ, 1985, PHYTOCHEMISTRY, V24, P703; Jiang LH, 2014, FEMS YEAST RES, V14, P1263, DOI 10.1111/1567-1364.12220; Kim D, 2006, BIOCHEMISTRY-US, V45, P14772, DOI 10.1021/bi061429r; KOPP M, 1993, J BIOL CHEM, V268, P4766; Kritzinger EC, 2013, J AGR FOOD CHEM, V61, P269, DOI 10.1021/jf303665z; Kutyna DR, 2012, APPL MICROBIOL BIOT, V93, P1175, DOI 10.1007/s00253-011-3622-7; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li H, 2008, FOOD CHEM, V108, P1, DOI 10.1016/j.foodchem.2007.10.065; Li Y, 2004, APPL MICROBIOL BIOT, V66, P233, DOI 10.1007/s00253-004-1751-y; Li ZS, 1996, J BIOL CHEM, V271, P6509, DOI 10.1074/jbc.271.11.6509; Liu HY, 1998, EMBO J, V17, P1096, DOI 10.1093/emboj/17.4.1096; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Markgraf DF, 2009, MOL BIOL CELL, V20, P5276, DOI 10.1091/mbc.E09-06-0521; MASSELOT M, 1975, MOL GEN GENET, V139, P121, DOI 10.1007/BF00264692; McBryde C, 2006, AM J ENOL VITICULT, V57, P423; McNeil JB, 1997, GENE, V186, P13, DOI 10.1016/S0378-1119(96)00670-1; Meadows KL, 2003, NUCLEIC ACIDS RES, V31, P5560, DOI 10.1093/nar/gkg749; Mendoza-Cozatl D, 2005, FEMS MICROBIOL REV, V29, P653, DOI 10.1016/j.femsre.2004.09.004; Mesecke N, 2008, MOL BIOL CELL, V19, P2673, DOI 10.1091/mbc.E07-09-0896; Mezzetti F, 2014, FEMS YEAST RES, V14, P977, DOI 10.1111/1567-1364.12186; Mortimer RK, 2000, GENOME RES, V10, P403, DOI 10.1101/gr.10.4.403; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Otte S, 2001, J CELL BIOL, V152, P503, DOI 10.1083/jcb.152.3.503; Outten CE, 2005, BIOCHEM J, V388, P93, DOI 10.1042/BJ20041914; Paumi CM, 2009, MICROBIOL MOL BIOL R, V73, P577, DOI 10.1128/MMBR.00020-09; Puigpinos J, 2015, MOL BIOL CELL, V26, P104, DOI 10.1091/mbc.E14-06-1137; Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506; Rossignol T, 2003, YEAST, V20, P1369, DOI 10.1002/yea.1046; Ruotolo R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r67; Sakurai H, 2000, J BIOL CHEM, V275, P37251, DOI 10.1074/jbc.M004364200; SMITH FW, 1995, MOL GEN GENET, V247, P709, DOI 10.1007/BF00290402; Stanley D, 2010, J IND MICROBIOL BIOT, V37, P139, DOI 10.1007/s10295-009-0655-3; Sumner ER, 2005, MICROBIOL-SGM, V151, P1939, DOI 10.1099/mic.0.27945-0; Tamas MJ, 2006, TOP CURR GENET, V14, P395; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; Thorsen M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-105; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Treu L, 2014, APPL MICROBIOL BIOT, V98, P4119, DOI 10.1007/s00253-014-5679-6; Ubiyvovk VM, 2006, CELL BIOL INT, V30, P665, DOI 10.1016/j.cellbi.2006.04.006; van Bakel H, 2005, PHYSIOL GENOMICS, V22, P356, DOI 10.1152/physiolgenomics.00055.2005; Wenger JW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000942; Wysocki R, 2010, FEMS MICROBIOL REV, V34, P925, DOI 10.1111/j.1574-6976.2010.00217.x; Young L, 2001, SCIENCE, V291, P2135, DOI 10.1126/science.1056957; Zahringer H, 1997, FEBS LETT, V412, P615, DOI 10.1016/S0014-5793(97)00868-5; Zechmann B, 2011, FEMS YEAST RES, V11, P631, DOI 10.1111/j.1567-1364.2011.00753.x; Zhou X, 2009, GENOMICS, V94, P294, DOI 10.1016/j.ygeno.2009.07.003	87	7	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180814	10.1371/journal.pone.0180814	http://dx.doi.org/10.1371/journal.pone.0180814			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683117	Green Submitted, Green Published, gold			2022-12-26	WOS:000405335200068
J	Duan, YL; Wu, FS; Wang, WF; He, DP; Gu, JD; Feng, HY; Chen, T; Liu, GX; An, LZ				Duan, Yulong; Wu, Fasi; Wang, Wanfu; He, Dongpeng; Gu, Ji-Dong; Feng, Huyuan; Chen, Tuo; Liu, Guangxiu; An, Lizhe			The microbial community characteristics of ancient painted sculptures in Maijishan Grottoes, China	PLOS ONE			English	Article							ALTAMIRA CAVE; WALL PAINTINGS; MOGAO GROTTOES; CULTURAL-HERITAGE; BACTERIAL COMMUNITIES; ROSY DISCOLORATION; AIRBORNE FUNGI; BAYON TEMPLE; ANGKOR THOM; SPAIN	In this study, a culture- independent Illumina MiSeq sequencing strategy was applied to investigate the microbial communities colonizing the ancient painted sculptures of the Maijishan Grottoes, a famous World Cultural Heritage site listed by UNESCO in China. Four mixed samples were collected from Cave 4-4 of the Maijishan Grottoes, the so- called Upper Seven Buddha Pavilion, which was built during the Northern Zhou Dynasty (557581AD). The 16/18S rRNA gene- based sequences revealed a rich bacterial diversity and a relatively low fungal abundance, including the bacterial groups Actinobacteria, Acidobacteria, Bacteroidetes, Cyanobacteria, Chloroflexi, Firmicutes, Proteobacteria and Verrucomicrobia and the fungal groups Ascomycota, Basidiomycota and Chytridiomycota. Among them, the bacteria genera of Pseudonocardia and Rubrobacter and unclassified fungi in the order of Capnodiales were dominant. The relative abundance of Pseudonocardia in the painted layer samples was higher than that in the dust sample, while Cyanobacteria dominated in the dust sample. Many of them have been discovered at other cultural heritage sites and associated with the biodeterioration of cultural relics. The presence and activity of these pioneering microorganisms may lead to an unexpected deterioration of the painted sculptures that are preserved in this heritage site. Thus, proper management strategies and potential risk monitoring should be used in the Maijishan Grottoes to improve the conservation of these precious painted sculptures.	[Duan, Yulong; Wang, Wanfu; Chen, Tuo; Liu, Guangxiu; An, Lizhe] Univ Chinese Acad Sci, Northwest Inst Ecoenvironm & Resources, Key Lab Extreme Environm Microbial Resources & En, Lanzhou, Peoples R China; [Wu, Fasi; Wang, Wanfu; He, Dongpeng] Dunhuang Acad, Natl Res Ctr Conservat Ancient Wall Paintings & E, Dunhuang, Gansu, Peoples R China; [Wu, Fasi; Wang, Wanfu; Feng, Huyuan; An, Lizhe] Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou, Peoples R China; [Gu, Ji-Dong] Univ Hong Kong, Sch Biol Sci, Lab Environm Microbiol & Toxicol, Hong Kong, Hong Kong, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Lanzhou University; University of Hong Kong	Wang, WF (corresponding author), Univ Chinese Acad Sci, Northwest Inst Ecoenvironm & Resources, Key Lab Extreme Environm Microbial Resources & En, Lanzhou, Peoples R China.; Wang, WF (corresponding author), Dunhuang Acad, Natl Res Ctr Conservat Ancient Wall Paintings & E, Dunhuang, Gansu, Peoples R China.; Wang, WF; Feng, HY (corresponding author), Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou, Peoples R China.	wwanfu@hotmail.com; fenghy@lzu.edu.cn	Yulong, Duan/AAC-7281-2022; Gu, Ji-Dong/AAF-2291-2019; Gu, Ji-Dong/AAO-7851-2020; Yang, Xiaoming/GRJ-9483-2022	Yulong, Duan/0000-0002-3759-6149; Yang, Xiaoming/0000-0002-1792-6921; Wu, Fasi/0000-0002-1175-8285	National Natural Science Foundation of China [31560160, 31500430, 31260136]; Gansu Province Science and Technology Plan [1604WKCA003]; Project of Gansu Cultural Relics Bureau [GWJ2014003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Gansu Province Science and Technology Plan; Project of Gansu Cultural Relics Bureau	Funded by National Natural Science Foundation of China (No. 31560160, 31500430, 31260136), Gansu Province Science and Technology Plan (No. 1604WKCA003), Project of Gansu Cultural Relics Bureau (No. GWJ2014003).	BASSI M, 1986, INT BIODETERIOR, V22, P201; Bastian F, 2010, MICROBIOL-SGM, V156, P644, DOI 10.1099/mic.0.036160-0; Bastian F, 2009, NATURWISSENSCHAFTEN, V96, P863, DOI 10.1007/s00114-009-0540-y; Capodicasa S, 2010, INT BIODETER BIODEGR, V64, P727, DOI 10.1016/j.ibiod.2010.08.006; Ciferri O, 1999, APPL ENVIRON MICROB, V65, P879; Cuezva S, 2012, FEMS MICROBIOL ECOL, V81, P281, DOI 10.1111/j.1574-6941.2012.01391.x; De Leo F, 2012, INT J SPELEOL, V41, P125, DOI 10.5038/1827-806X.41.2.1; Dennis KL, 2013, CANCER RES, V73, P5905, DOI 10.1158/0008-5472.CAN-13-1511; Ettenauer J, 2011, SCI TOTAL ENVIRON, V409, P5337, DOI 10.1016/j.scitotenv.2011.08.063; Feng Q., 1998, ACTA MICROBIOL SIN, V38, P131; Feng Q., 1998, ACTA MICROBIOL SIN, V38, P52; Fouhy F, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0738-z; Gu JD, 2003, INT BIODETER BIODEGR, V52, P69, DOI 10.1016/S0964-8305(02)00177-4; Gu JD, 2013, INT BIODETER BIODEGR, V85, P345, DOI 10.1016/j.ibiod.2013.08.018; Heyrman J, 1999, FEMS MICROBIOL LETT, V181, P55, DOI 10.1016/S0378-1097(99)00514-5; Imperi F, 2007, ENVIRON MICROBIOL, V9, P2894, DOI 10.1111/j.1462-2920.2007.01393.x; Jroundi F, 2010, MICROB ECOL, V60, P39, DOI 10.1007/s00248-010-9665-y; Jurado V, 2005, INT J SYST EVOL MICR, V55, P1897, DOI 10.1099/ijs.0.63637-0; Jurado V, 2005, INT J SYST EVOL MICR, V55, P153, DOI 10.1099/ijs.0.63199-0; Jurado V, 2008, INT J SYST EVOL MICR, V58, P2210, DOI 10.1099/ijs.0.65482-0; Jurado V, 2010, INT J SPELEOL, V39, P15, DOI 10.5038/1827-806X.39.1.2; Jurado V, 2009, NATURWISSENSCHAFTEN, V96, P1027, DOI 10.1007/s00114-009-0561-6; Konkol NR, 2012, J CULT HERIT, V13, P115, DOI 10.1016/j.culher.2010.05.002; Kusumi A, 2013, MICROBES ENVIRON, V28, P422, DOI 10.1264/jsme2.ME13033; Laiz L, 2009, NATURWISSENSCHAFTEN, V96, P71, DOI 10.1007/s00114-008-0452-2; Laiz L, 1999, J MICROBIOL METH, V36, P129, DOI 10.1016/S0167-7012(99)00018-4; Lan WS, 2010, MICROB ECOL, V60, P105, DOI 10.1007/s00248-010-9707-5; Lee NM, 2012, LIFE AT EXTREMES: ENVIRONMENTS, ORGANISMS AND STRATEGIES FOR SURVIVAL, P320, DOI 10.1079/9781845938147.0320; Ma YT, 2015, SCI REP-UK, V5, DOI 10.1038/srep07752; Mueller RC, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv153; Nugari MP, 2009, INT BIODETER BIODEGR, V63, P705, DOI 10.1016/j.ibiod.2009.03.013; Otlewska A, 2014, ACTA BIOCHIM POL, V61, P217; Pangallo D, 2012, WORLD J MICROB BIOT, V28, P2015, DOI 10.1007/s11274-012-1004-7; Pepe O, 2010, MICROBIOL RES, V165, P21, DOI 10.1016/j.micres.2008.03.005; Pinar G, 2010, MICROB ECOL, V60, P15, DOI 10.1007/s00248-010-9661-2; Porca E, 2012, FEMS MICROBIOL ECOL, V81, P255, DOI 10.1111/j.1574-6941.2012.01383.x; Portillo MC, 2008, J APPL MICROBIOL, V104, P681, DOI 10.1111/j.1365-2672.2007.03594.x; Principi P, 2011, MICROB ECOL, V61, P214, DOI 10.1007/s00248-010-9741-3; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Sabev H, 2006, FUNGI BIOGEOCHEMICAL; Saiz-Jimenez C, 2012, WORLD J MICROB BIOT, V28, P2453, DOI 10.1007/s11274-012-1070-x; Saiz-Jimenez C, 2011, SCIENCE, V334, P42, DOI 10.1126/science.1206788; Sanchez-Moral S, 1999, SCI TOTAL ENVIRON, V243, P67, DOI 10.1016/S0048-9697(99)00348-4; Santos A, 2009, MICROB ECOL, V58, P692, DOI 10.1007/s00248-009-9564-2; Schabereiter-Gurtner C, 2001, ARCH MICROBIOL, V176, P347, DOI 10.1007/s002030100333; Schabereiter-Gurtner C, 2001, J MICROBIOL METH, V45, P77, DOI 10.1016/S0167-7012(01)00227-5; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sterflinger K, 2013, APPL MICROBIOL BIOT, V97, P9637, DOI 10.1007/s00253-013-5283-1; Sterflinger Katja, 2010, Fungal Biology Reviews, V24, P47, DOI 10.1016/j.fbr.2010.03.003; Stomeo F, 2008, INT BIODETER BIODEGR, V62, P483, DOI 10.1016/j.ibiod.2007.12.011; Vasanthakumar A, 2013, INT BIODETER BIODEGR, V79, P56, DOI 10.1016/j.ibiod.2013.01.014; Viles HA, 2012, GLOBAL CHANGE BIOL, V18, P2406, DOI 10.1111/j.1365-2486.2012.02713.x; Vivar I, 2013, INT BIODETER BIODEGR, V84, P372, DOI 10.1016/j.ibiod.2012.05.021; Wang WF, 2012, AEROBIOLOGIA, V28, P27, DOI 10.1007/s10453-011-9208-0; Wang WF, 2011, INT BIODETER BIODEGR, V65, P726, DOI 10.1016/j.ibiod.2011.04.006; Wang WF, 2010, INT BIODETER BIODEGR, V64, P461, DOI 10.1016/j.ibiod.2010.05.005; Wang WF, 2010, INT BIODETER BIODEGR, V64, P309, DOI 10.1016/j.ibiod.2010.03.004; Wu FS, 2011, DUNHUANG RES, V6, P51; Yan Fei, 2012, Weishengwu Xuebao, V52, P629; Zucconi L, 2012, INT BIODETER BIODEGR, V70, P40, DOI 10.1016/j.ibiod.2011.11.018	61	30	34	5	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179718	10.1371/journal.pone.0179718	http://dx.doi.org/10.1371/journal.pone.0179718			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FA2LF	28678844	Green Submitted, gold, Green Published			2022-12-26	WOS:000405272200024
J	Hadar, A; Hadas, I; Lazarovits, A; Alyagon, U; Eliraz, D; Zangen, A				Hadar, Aviad; Hadas, Itay; Lazarovits, Avi; Alyagon, Uri; Eliraz, Daniel; Zangen, Abraham			Answering the missed call: Initial exploration of cognitive and electrophysiological changes associated with smartphone use and abuse	PLOS ONE			English	Article							MOBILE PHONE USE; DORSOLATERAL PREFRONTAL CORTEX; INTERVAL CORTICAL INHIBITION; HUMAN MOTOR CORTEX; PULSE TMS-EEG; INTERNET ADDICTION; SYMPTOMS; DISORDER; BEHAVIOR; GABA	Background Smartphone usage is now integral to human behavior. Recent studies associate extensive usage with a range of debilitating effects. We sought to determine whether excessive usage is accompanied by measurable neural, cognitive and behavioral changes. Method Subjects lacking previous experience with smartphones (n = 35) were compared to a matched group of heavy smartphone users (n = 16) on numerous behavioral and electrophysiological measures recorded using electroencephalogram (EEG) combined with transcranial magnetic stimulation (TMS) over the right prefrontal cortex (rPFC). In a second longitudinal intervention, a randomly selected sample of the original non-users received smartphones for 3 months while the others served as controls. All measurements were repeated following this intervention. Results Heavy users showed increased impulsivity, hyperactivity and negative social concern. We also found reduced early TMS evoked potentials in the rPFC of this group, which correlated with severity of self-reported inattention problems. Heavy users also obtained lower accuracy rates than nonusers in a numerical processing. Critically, the second part of the experiment revealed that both the numerical processing and social cognition domains are causally linked to smartphone usage. Conclusion Heavy usage was found to be associated with impaired attention, reduced numerical processing capacity, changes in social cognition, and reduced right prefrontal cortex (rPFC) excitability. Memory impairments were not detected. Novel usage over short period induced a significant reduction in numerical processing capacity and changes in social cognition.	[Hadar, Aviad; Zangen, Abraham] Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel; Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Hadar, A; Zangen, A (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel.	avhad@post.bgu.ac.il; azangen@bgu.ac.il	Hadas, Itay/J-5834-2019	Hadas, Itay/0000-0001-7518-1182; Zangen, Abraham/0000-0002-1488-5837; Hadar, Aviad/0000-0002-4994-9255; Lazarovits, Avi/0000-0001-5519-9174	Israeli Ministry of Science under the Prat and Eshkol scholarships	Israeli Ministry of Science under the Prat and Eshkol scholarships	The author received specific funding for this work from the Israeli Ministry of Science under the Prat and Eshkol scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboujaoude E, 2010, WORLD PSYCHIATRY, V9, P85; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Ashcraft M.H., 1995, MATH COGNITION, V1, P3; Augner C, 2012, INT J PUBLIC HEALTH, V57, P437, DOI 10.1007/s00038-011-0234-z; Bachner-Melman R, 2009, EUR J; Berger A, 2013, CHILD DEV, V84, P1616, DOI 10.1111/cdev.12072; Bianchi A, 2005, PSYCHOL PREDICTORS P, P39; Billieux J, 2010, BEHAV RES THER, V48, P1085, DOI 10.1016/j.brat.2010.07.008; Brand M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00375; Casarotto S, 2011, NEUROREPORT, V22, P592, DOI 10.1097/WNR.0b013e328349433a; Cash H, 2012, CURR PSYCHIATRY REV, V8, P292, DOI 10.2174/157340012803520513; Choi JS, 2014, PSYCHIAT RES, V215, P424, DOI 10.1016/j.psychres.2013.12.001; Choi SW, 2015, J BEHAV ADDICT, V4, P308, DOI 10.1556/2006.4.2015.043; Conners CK., 1999, J ATTEN DISORD, V3, P141, DOI [10.1177/108705479900300303, DOI 10.1177/108705479900300303, 10.1177/108705479900300304]; Cortese S, 2012, AM J PSYCHIAT, V169, P1038, DOI 10.1176/appi.ajp.2012.11101521; Daskalakis ZJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2860, DOI 10.1038/npp.2008.22; Daskalakis ZJ, 2014, PLOS ONE, V9; DeStefano D, 2004, EUR J COGN PSYCHOL, V16, P353, DOI 10.1080/09541440244000328; Edden RAE, 2012, ARCH GEN PSYCHIAT, V69, P750, DOI 10.1001/archgenpsychiatry.2011.2280; Falbe J, 2015, PEDIATRICS, V135, pE367, DOI 10.1542/peds.2014-2306; Hadar AA, 2012, BRAIN STIMUL, V5, P652, DOI 10.1016/j.brs.2011.08.001; Hadas I, 2016, SCI REP-UK, V6, DOI 10.1038/srep21129; Hernandez-Pavon JC, 2012, J NEUROSCI METH, V209, P144, DOI 10.1016/j.jneumeth.2012.05.029; Huber R, 2013, CEREB CORTEX, V23, P1, DOI 10.1093/cercor/bhs014; Kadosh RC, 2009, BEHAV BRAIN SCI, V32, P313, DOI 10.1017/S0140525X09990938; Kim SM, 2012, J BEHAV ADDICT, V1, P41, DOI 10.1556/JBA.1.2012.2.1; Kirby KN, 1999, J EXP PSYCHOL GEN, V128, P78, DOI 10.1037/0096-3445.128.1.78; Kwon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056936; Lee YK, 2014, COMPUT HUM BEHAV, V31, P373, DOI 10.1016/j.chb.2013.10.047; Lopez-Fernandez O, 2015, ADDICT BEHAV; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Montag C, 2015, BEHAV SCI-BASEL, V5, P434, DOI 10.3390/bs5040434; Nasar JL, 2013, ACCIDENT ANAL PREV, V57, P91, DOI 10.1016/j.aap.2013.03.021; Noda Y, 2017, AGING-US, V9, P556, DOI 10.18632/aging.101178; Pawlikowski M, 2011, PSYCHIAT RES, V188, P428, DOI 10.1016/j.psychres.2011.05.017; Premoli I, 2014, NEUROIMAGE, V103, P152, DOI 10.1016/j.neuroimage.2014.09.028; Reed P, 2015, COMPUT HUM BEHAV, V49, P512, DOI 10.1016/j.chb.2015.03.064; Rogasch NC, 2015, CORTEX, V64, P68, DOI 10.1016/j.cortex.2014.10.003; Rogasch NC, 2013, J NEUROPHYSIOL, V109, P89, DOI 10.1152/jn.00762.2012; Rosen LD, 2013, COMPUT HUM BEHAV, V29, P1243, DOI 10.1016/j.chb.2012.11.012; Salehan M, 2013, COMPUT HUM BEHAV, V29, P2632, DOI 10.1016/j.chb.2013.07.003; Smith DC, 2013, J SAFETY RES, V47, P19, DOI 10.1016/j.jsr.2013.08.003; Spada MM, 2014, ADDICT BEHAV, V39, P3, DOI 10.1016/j.addbeh.2013.09.007; Stagg CJ, 2011, J PHYSIOL-LONDON, V589, P5845, DOI 10.1113/jphysiol.2011.216978; Takao M, 2009, CYBERPSYCHOL BEHAV, V12, P501, DOI 10.1089/cpb.2009.0022; Thomee S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-66; Thompson LL, 2013, INJURY PREV, V19, P232, DOI 10.1136/injuryprev-2012-040601; Walsh SP, 2011, COMPUT HUM BEHAV, V27, P333, DOI 10.1016/j.chb.2010.08.011; Wang PW, 2014, COMPR PSYCHIAT, V55, P342, DOI 10.1016/j.comppsych.2013.09.006; Weinstein A, 2017, NEUROSCI BIOBEHAV R, V75, P314, DOI 10.1016/j.neubiorev.2017.01.040; Yoo HJ, 2004, PSYCHIAT CLIN NEUROS, V58, P487, DOI 10.1111/j.1440-1819.2004.01290.x; Zheng FZ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1022	52	40	42	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180094	10.1371/journal.pone.0180094	http://dx.doi.org/10.1371/journal.pone.0180094			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2LF	28678870	Green Submitted, Green Published, gold			2022-12-26	WOS:000405272200038
J	Skar, MW; Haugland, GT; Powell, MD; Wergeland, HI; Samuelsen, OB				Skar, Malene W.; Haugland, Gyri T.; Powell, Mark D.; Wergeland, Heidrun I.; Samuelsen, Ole B.			Development of anaesthetic protocols for lumpfish (Cyclopterus lumpus L.): Effect of anaesthetic concentrations, sea water temperature and body weight	PLOS ONE			English	Article							DENTAL AFFERENT NEURONS; SALMON SALMO-SALAR; COD GADUS-MORHUA; ATLANTIC COD; TELEOST FISH; ONCORHYNCHUS-MYKISS; LOCAL-ANESTHETICS; TRICAINE MS-222; PLASMA-CORTISOL; XENOPUS OOCYTES	In recent years, use of lumpfish (Cyclopterus lumpus L.) as cleaner-fish to remove sea-lice have been chosen by many salmon farmers in Europe and Canada as an alternative to medical treatment, which has led to large scale production of lumpfish. At present, there is limited knowledge of how lumpfish respond upon anaesthesia, which anaesthetics and concentrations that are efficient and conditions for euthanasia. We have therefore tested and developed protocols for bath immersion for three commonly used anaesthetics metacaine (Finquel, buffered tricaine methanesulfonate, MS-222 and Tricaine Pharmaq), benzocaine (Benzoak vet) and isoeugenol (Aqui-S), determined concentration for normal and fast anaesthesia and evaluated safety margin for each condition. Also, a behavioral matrix has been developed. We have examined the effect of fish size (10-20 g, 200-400 g and 600-1300 g) and sea water temperature (6 degrees C and 12 degrees C). We found that 200 mg L-1 metacaine is an efficient dose for deep narcosis independently for fish size and temperature due to good safety margins with regards to both exposure times and doses. However, for many tasks lighter anaesthesia is sufficient, and then 100 mg L-1 metacaine can be used. Benzocaine is less efficient than metacaine, but can be used as anaesthetic of fish < 400 g. The optimal doses of benzocaine were 100-200 mg L-1 for small fish (10-20 g) and 200 mg L-1 for medium sized fish (200-400 g). For larger fish (> 600 g), benzocaine is not suitable. Isoeugenol cannot be recommended for full anesthesia of lumpfish. The conditions for lethal doses varied with chosen anaesthetic, fish size and temperature. For small fish (10-20 g), exposure to 1600 mgL(-1) of metacaine in 10 minutes it lethal. Guided protocols for non-lethal anaesthesia will contribute to ensure safe treatment of lumpfish according to an ethical standard for good fish welfare.	[Skar, Malene W.; Haugland, Gyri T.; Powell, Mark D.; Wergeland, Heidrun I.; Samuelsen, Ole B.] Univ Bergen, Dept Biol, Bergen, Norway; [Samuelsen, Ole B.] Inst Marine Res, Bergen, Norway	University of Bergen; Institute of Marine Research - Norway	Haugland, GT (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	Gyr.Haugland@uib.no		Haugland, Gyri/0000-0001-9494-9214	Research Council of Norway [244148 GTH]	Research Council of Norway(Research Council of Norway)	This work was supported by The Research Council of Norway (grant number 244148 GTH)	Ackerman P., 2005, CCAC GUIDELINES FISH; Aoshima H, 1999, BIOSCI BIOTECH BIOCH, V63, P743, DOI 10.1271/bbb.63.743; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; Bell G., CANADIAN TECHNICAL R, P16; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Bowser P.R., 2001, RECENT ADV VET ANEST; Braithwaite VA, 2004, ANIM WELFARE, V13, pS87; Chandroo KP, 2004, APPL ANIM BEHAV SCI, V86, P225, DOI 10.1016/j.applanim.2004.02.004; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; Dunlop R, 2005, J PAIN, V6, P561, DOI 10.1016/j.jpain.2005.02.010; FRAZIER DT, 1975, EUR J PHARMACOL, V33, P313, DOI 10.1016/0014-2999(75)90175-2; GILDERHUS P A, 1987, North American Journal of Fisheries Management, V7, P288, DOI 10.1577/1548-8659(1987)7&lt;288:CEOACO&gt;2.0.CO;2; Hale ME, 2000, AM ZOOL, V40, P1040; Hara K, 2007, ANESTH ANALG, V104, P1434, DOI 10.1213/01.ane.0000261509.72234.a6; Hedrick MS, 2003, AM J PHYSIOL-REG I, V284, pR405, DOI 10.1152/ajpregu.00418.2002; HIKASA Y, 1986, JPN J VET SCI, V48, P341; Hoskonen P, 2004, J FISH BIOL, V64, P1136, DOI 10.1111/j.1095-8649.2004.00359.x; HOUSTON AH, 1976, COMP BIOCHEM PHYS C, V54, P1, DOI 10.1016/0306-4492(76)90016-2; Imsland AK, 2014, AQUACULTURE, V424, P18, DOI 10.1016/j.aquaculture.2013.12.033; Iversen MH, 2014, SEDASJON BERGGYLTE R, P42; Javahery S, 2012, FISH PHYSIOL BIOCHEM, V38, P1545, DOI 10.1007/s10695-012-9682-5; Kiessling A, 2009, AQUACULTURE, V286, P301, DOI 10.1016/j.aquaculture.2008.09.037; Kristan J, 2014, NEUROENDOCRINOL LETT, V35, P81; Lee MH, 2005, J DENT RES, V84, P848, DOI 10.1177/154405910508400913; MARKING LL, 1985, FISHERIES, V10, P2, DOI 10.1577/1548-8446(1985)010<0002:ABANIF>2.0.CO;2; Neiffer DL, 2009, ILAR J, V50, P343, DOI 10.1093/ilar.50.4.343; NEUMCKE B, 1981, PFLUG ARCH EUR J PHY, V390, P230, DOI 10.1007/BF00658267; OLSEN YA, 1995, AQUACULTURE, V134, P155, DOI 10.1016/0044-8486(95)00008-P; Park CK, 2006, J DENT RES, V85, P900, DOI 10.1177/154405910608501005; Popovic NT, 2012, J APPL ICHTHYOL, V28, P553, DOI 10.1111/j.1439-0426.2012.01950.x; Powell AJ, 2017, ROUTL STUD RELIG, P1; Rose JD, 2002, REV FISH SCI, V10, P1, DOI 10.1080/20026491051668; Ross LG, 2008, ANAESTHETIC AND SEDATIVE TECHNIQUES FOR AQUATIC ANIMALS, 3RD EDITION, P1, DOI 10.1002/9781444302264; SAUNDERS RL, 1963, J FISH RES BOARD CAN, V20, P373, DOI 10.1139/f63-031; Schurmann H, 1997, J FISH BIOL, V50, P1166, DOI 10.1006/jfbi.1997.0387; Sneddon LU, 2003, APPL ANIM BEHAV SCI, V83, P153, DOI 10.1016/S0168-1591(03)00113-8; Sneddon LU, 2003, BRAIN RES, V972, P44, DOI 10.1016/S0006-8993(03)02483-1; Sneddon LU, 2002, NEUROSCI LETT, V319, P167, DOI 10.1016/S0304-3940(01)02584-8; Stehly GR, 1999, AQUAC RES, V30, P365, DOI 10.1046/j.1365-2109.1999.00339.x; SYLVESTER JR, 1982, PROG FISH CULT, V44, P138, DOI 10.1577/1548-8659(1982)44[138:IOTWHA]2.0.CO;2; Tsantilas H, 2006, AQUACULTURE, V253, P64, DOI 10.1016/j.aquaculture.2005.07.034; Ueta K, 2007, REGION ANESTH PAIN M, V32, P462, DOI 10.1016/j.rapm.2007.06.391; Wie MB, 1997, NEUROSCI LETT, V225, P93, DOI 10.1016/S0304-3940(97)00195-X; Zahl IH, 2012, FISH PHYSIOL BIOCHEM, V38, P201, DOI 10.1007/s10695-011-9565-1; Zahl IH, 2011, AQUAC RES, V42, P1235, DOI 10.1111/j.1365-2109.2010.02711.x; Zahl IH, 2010, FISH PHYSIOL BIOCHEM, V36, P719, DOI 10.1007/s10695-009-9346-2; Zahl IH, 2009, AQUACULTURE, V295, P52, DOI 10.1016/j.aquaculture.2009.06.019	48	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179344	10.1371/journal.pone.0179344	http://dx.doi.org/10.1371/journal.pone.0179344			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678815	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000405272200013
J	Alcantara, RS; Wall-Scheffler, CM				Alcantara, Ryan S.; Wall-Scheffler, Cara M.			Stroller running: Energetic and kinematic changes across pushing methods	PLOS ONE			English	Article							JOGGING STROLLER; WALKING; RESPONSES; EXERCISE; HUMANS; COST	Objective Running with a stroller provides an opportunity for parents to exercise near their child and counteract health declines experienced during early parenthood. Understanding biomechanical and physiological changes that occur when stroller running is needed to evaluate its health impact, yet the effects of stroller running have not been clearly presented. Here, three commonly used stroller pushing methods were investigated to detect potential changes in energetic cost and lower-limb kinematics. Methods Sixteen individuals (M/F: 10/6) ran at self-selected speeds for 800m under three stroller conditions (2-Hands, 1-Hand, and Push/Chase) and an independent running control. Results A significant decrease in speed (p = 0.001) and stride length (p<0.001) was observed between the control and stroller conditions, however no significant change in energetic cost (p = 0.080) or heart rate (p = 0.393) was observed. Additionally, pushing method had a significant effect on speed (p = 0.001) and stride length (p<0.001). Conclusions These findings suggest that pushing technique influences stroller running speed and kinematics. These findings suggest specific fitness effects may be achieved through the implementation of different pushing methods.	[Alcantara, Ryan S.; Wall-Scheffler, Cara M.] Seattle Pacific Univ, Dept Biol, Seattle, WA 98119 USA; [Wall-Scheffler, Cara M.] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Alcantara, RS (corresponding author), Seattle Pacific Univ, Dept Biol, Seattle, WA 98119 USA.	alcantarar@spu.edu		Alcantara, Ryan/0000-0002-8539-711X; Wall-Scheffler, Cara/0000-0002-0224-0476				Achten J, 2003, SPORTS MED, V33, P517, DOI 10.2165/00007256-200333070-00004; Arellano CJ, 2014, J EXP BIOL, V217, P2456, DOI 10.1242/jeb.100420; Birken CS, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1989-6; Brown GA, 2007, AFR J PHYS HLTH ED R, V14, P240; Garcin M, 1996, EUR J APPL PHYSIOL O, V72, P478, DOI 10.1007/BF00242278; Garfield CF, AM J MENS H IN PRESS; Greany JF, 2013, J WOMENS HLTH PHYS T, V37, P103; Gregory DA, 2012, INT J SPORTS MED, V33, P711, DOI 10.1055/s-0031-1299748; LONDEREE BR, 1995, MED SCI SPORT EXER, V27, P458; Meckes Nathanael, 2013, Int J Exerc Sci, V6, P11; O'Sullivan R, 2016, GAIT POSTURE, V43, P220, DOI 10.1016/j.gaitpost.2015.10.001; Ostbye T, 2009, AM J PREV MED, V37, P173, DOI 10.1016/j.amepre.2009.05.016; Pagliara R, 2014, J EXP BIOL, V217, P2939, DOI 10.1242/jeb.105270; Perl DP, 2012, MED SCI SPORT EXER, V44, P1335, DOI 10.1249/MSS.0b013e318247989e; Perret C, 2006, INT J SPORTS MED, V27, P363, DOI 10.1055/s-2005-865666; Selinger JC, 2015, CURR BIOL, V25, P2452, DOI 10.1016/j.cub.2015.08.016; Smith JD, 2005, J SPORT MED PHYS FIT, V45, P270; Steudel-Numbers KL, 2009, J HUM EVOL, V56, P355, DOI 10.1016/j.jhevol.2008.11.002; Wall-Scheffler CM, 2017, ANAT REC, V300, P764, DOI 10.1002/ar.23553; Wall-Scheffler CM, 2015, INTEGR COMP BIOL, V55, P1155, DOI 10.1093/icb/icv072; Wall-Scheffler CM, 2013, J HUM EVOL, V64, P448, DOI 10.1016/j.jhevol.2013.01.014; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363	22	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180575	10.1371/journal.pone.0180575	http://dx.doi.org/10.1371/journal.pone.0180575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672004	Green Published, Green Submitted, gold			2022-12-26	WOS:000405268500070
J	Ogata, T; Nakamura, M; Sang, MJ; Yoda, H; Hiraoka, K; Yin, DJ; Sang, MX; Shimozato, O; Ozaki, T				Ogata, Takehiro; Nakamura, Mizuyo; Sang, Meijie; Yoda, Hiroyuki; Hiraoka, Kiriko; Yin, Danjing; Sang, Mexiang; Shimozato, Osamu; Ozaki, Toshinori			Depletion of runt- related transcription factor 2 (RUNX2) enhances SAHA sensitivity of p53-mutated pancreatic cancer cells through the regulation of mutant p53 and TAp63	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; SUBEROYLANILIDE HYDROXAMIC ACID; P53-DEPENDENT APOPTOSIS; GEMCITABINE SENSITIVITY; EXPRESSION; PROTEIN; GAIN; GENE; RESISTANCE; INDUCTION	Suberoylanilide hydroxamic acid (SAHA) represents one of the new class of anti-cancer drugs. However, multiple lines of clinical evidence indicate that SAHA might be sometimes ineffective on certain solid tumors including pancreatic cancer. In this study, we have found for the first time that RUNX2/mutant p53/TAp63-regulatory axis has a pivotal role in the determination of SAHA sensitivity of p53-mutated pancreatic cancer MiaPaCa-2 cells. According to our present results, MiaPaCa-2 cells responded poorly to SAHA. Forced depletion of mutant p53 stimulated SAHA-mediated cell death of MiaPaCa-2 cells, which was accomapanied by a further accumulation of.H2AX and cleaved PARP. Under these experimental conditions, pro-oncogenic RUNX2 was strongly down-regulated in mutant p53depleted MiaPaCa-2 cells. Surprisingly, RUNX2 silencing augmented SAHA-dependent cell death of MiaPaCa-2 cells and caused a significant reduction of mutant p53. Consistent with these observations, overexpression of RUNX2 in MiaPaCa-2 cells restored SAHA-mediated decrease in cell viability and increased the amount of mutant p53. Thus, it is suggestive that there exists a positive auto-regulatory loop between RUNX2 and mutant p53, which might amplify their pro-oncogenic signals. Intriguingly, knockdown of mutant p53 or RUNX2 potentiated SAHA-induced up-regulation of TAp63. Indeed, SAHA-stimulated cell death of MiaPaCa-2 cells was partially attenuated by p63 depletion. Collectively, our present observations strongly suggest that RUNX2/mutant p53/TAp63-regulatory axis is one of the key determinants of SAHA sensitivity of p53-mutated pancreatic cancer cells.	[Ogata, Takehiro; Nakamura, Mizuyo; Sang, Meijie; Shimozato, Osamu; Ozaki, Toshinori] Chiba Canc Ctr, Lab DNA Damage Signaling, Res Inst, Chiba, Japan; [Sang, Meijie] Univ Toyama, Grad Sch Med, Dept Regenerat Med, Toyama, Japan; [Yoda, Hiroyuki; Hiraoka, Kiriko] Chiba Canc Ctr, Canc Genet Lab, Res Inst, Chiba, Japan; [Yin, Danjing; Sang, Mexiang] Hebei Med Univ, Hosp 4, Res Ctr, Shijiazhuang, Hebei, Peoples R China	Chiba Cancer Center; University of Toyama; Chiba Cancer Center; Hebei Medical University	Ozaki, T (corresponding author), Chiba Canc Ctr, Lab DNA Damage Signaling, Res Inst, Chiba, Japan.	tozaki@chiba-cc.jp		Yoda, Hiroyuki/0000-0002-5528-8940	JSPS (MEXT) KAKENHI [23501278]; Grants-in-Aid for Scientific Research [15K08412] Funding Source: KAKEN	JSPS (MEXT) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work received support from JSPS (MEXT) KAKENHI Grant Number 23501278.	Allocati N, 2012, EXP CELL RES, V318, P1285, DOI 10.1016/j.yexcr.2012.01.023; Arnold NB, 2007, CLIN CANCER RES, V13, P18, DOI 10.1158/1078-0432.CCR-06-0914; Barnes GL, 2003, CANCER RES, V63, P2631; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Boregowda RK, 2014, CANCER LETT, V348, P61, DOI 10.1016/j.canlet.2014.03.011; Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Butler LM, 2006, INT J CANCER, V119, P944, DOI 10.1002/ijc.21939; Do PM, 2012, GENE DEV, V26, P830, DOI 10.1101/gad.181685.111; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Frazier MW, 1998, MOL CELL BIOL, V18, P3735, DOI 10.1128/MCB.18.7.3735; Gokulnath M, 2015, TUMOR BIOL, V36, P1923, DOI 10.1007/s13277-014-2796-x; Grant S, 2007, NAT REV DRUG DISCOV, V6, P21, DOI 10.1038/nrd2227; Gryder BE, 2012, FUTURE MED CHEM, V4, P505, DOI [10.4155/FMC.12.3, 10.4155/fmc.12.3]; Guo ZJ, 2016, ONCOTARGET, V7, P20999, DOI 10.18632/oncotarget.8236; Haupt S, 2009, CANCER RES, V69, P4818, DOI 10.1158/0008-5472.CAN-08-4010; Ikawa S, 1999, CELL DEATH DIFFER, V6, P1154, DOI 10.1038/sj.cdd.4400631; Kaino M, 1997, J GASTROENTEROL, V32, P40, DOI 10.1007/BF01213295; Kayed H, 2007, BRIT J CANCER, V97, P1106, DOI 10.1038/sj.bjc.6603984; Knudsen ES, 2016, GASTROENTEROLOGY, V150, P48, DOI 10.1053/j.gastro.2015.08.056; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Koutsounas I, 2013, WORLD J GASTROENTERO, V19, P1173, DOI 10.3748/wjg.v19.i8.1173; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; Le A, 2012, CLIN CANCER RES, V18, P4285, DOI 10.1158/1078-0432.CCR-12-0041; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; Lee YJ, 2012, INT J MED SCI, V9, P881, DOI 10.7150/ijms.5011; Li D, 2011, CELL DEATH DIFFER, V18, P1904, DOI 10.1038/cdd.2011.71; Li RZ, 1998, ONCOGENE, V16, P3269, DOI 10.1038/sj.onc.1201867; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Muller PA, 2009, NAT CELL BIOL, V15, P2; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Nakamura M, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.40; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Ozaki T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.127; Ozaki T, 2016, ONCOTARGET; Ozaki T, 2015, FEBS J, V282, P114, DOI 10.1111/febs.13108; Pratap J, 2005, MOL CELL BIOL, V25, P8581, DOI 10.1128/MCB.25.19.8581-8591.2005; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sampath J, 2001, J BIOL CHEM, V276, P39359, DOI 10.1074/jbc.M103429200; Shim SH, 2010, TUMOR BIOL, V31, P659, DOI 10.1007/s13277-010-0083-z; Shin MH, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005884; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Soshnev AA, 2016, MOL CELL, V62, P681, DOI 10.1016/j.molcel.2016.05.004; Stojanovic N, 2016, ONCOGENE, V344; Suenaga Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003996; Sugimoto H, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.10; Wang Q, 2016, ONCOTARGET, V7, P10064, DOI 10.18632/oncotarget.7134; Wang ZT, 2016, CELL SIGNAL, V28, P506, DOI 10.1016/j.cellsig.2016.02.006; Wei SS, 2014, J BIOL CHEM, V289, P8947, DOI 10.1074/jbc.M113.503755; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Zelzer E, 2001, MECH DEVELOP, V106, P97, DOI 10.1016/S0925-4773(01)00428-2; Zheng L, 2014, INT J CANCER, V135, P1721, DOI 10.1002/ijc.28810; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X	54	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0179884	10.1371/journal.pone.0179884	http://dx.doi.org/10.1371/journal.pone.0179884			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671946	Green Published, Green Submitted, gold			2022-12-26	WOS:000405268500007
J	Choi, HY; Kim, SH; Choi, AR; Kim, SG; Kim, H; Lee, JE; Kim, HJ; Park, HC				Choi, Hoon Young; Kim, Seok-hyung; Choi, Ah Ran; Kim, Seung Gyu; Kim, Hyunwook; Lee, Jung Eun; Kim, Hyung Jong; Park, Hyeong Cheon			Hyperuricemia and risk of increased arterial stiffness in healthy women based on health screening in Korean population	PLOS ONE			English	Article							SERUM URIC-ACID; PULSE-WAVE VELOCITY; CARDIOVASCULAR-DISEASE; HORMONE REPLACEMENT; BLOOD-PRESSURE; FOLLOW-UP; ATHEROSCLEROSIS; ASSOCIATION; MORTALITY; IMPACT	Hyperuricemia is a risk factor for cardiovascular disease and is associated with increased arterial stiffness in high-risk populations. However, given the possible sex-related differences in the prevalence of hyperuricemia, the association between elevated serum uric acid (SUA) level and increased arterial stiffness has yielded conflicting results. We investigated the relationship between SUA and arterial stiffness in asymptomatic healthy subjects who underwent a health examination. Subjects who underwent a comprehensive health examination were enrolled. After exclusion of extensive confounding factors, 2,704 healthy subjects with coronary calcium score < 100 were evaluated in the final analysis. All subjects underwent brachial D ankle pulse wave velocity (baPWV) to detect arterial stiffness. The SUA was divided into quartiles for its association with arterial stiffness and was analyzed separately for men and women. The mean SUA level was significantly lower in women than in men. The baPWV was significantly elevated in subjects with the highest quartile of SUA in women, but not in men. After adjusting for age, smoking, systolic blood pressure, body mass index, estimated glomerular filtration rate, fasting plasma glucose, high-density lipoprotein-cholesterol, low-density lipoprotein-cholesterol, and coronary artery calcium score, the highest quartile of SUA in women was significantly associated with increased risk of high baPWV compared with the lowest quartile of SUA (OR = 1.7, p = 0.018), whereas in men, SUA level was not associated with high baPWV. Our study showed that elevated SUA is independently associated with increased baPWV in healthy Korean women, but not in men.	[Choi, Hoon Young; Kim, Seok-hyung; Choi, Ah Ran; Kim, Seung Gyu; Kim, Hyunwook; Park, Hyeong Cheon] Yonsei Univ, Gangnam Severance Hosp, Dept Internal Med, Coll Med, Seoul, South Korea; [Choi, Hoon Young; Park, Hyeong Cheon] Yonsei Univ, Severance Inst Vasc & Metab Res, Coll Med, Seoul, South Korea; [Lee, Jung Eun] Yonsei Univ, Coll Med, Dept Internal Med, Yongin Severance Hosp, Seoul, South Korea; [Kim, Hyung Jong] CHA Univ, Dept Internal Med, CHA Bundang Med Ctr, Seongnam, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Pochon Cha University	Park, HC (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Dept Internal Med, Coll Med, Seoul, South Korea.; Park, HC (corresponding author), Yonsei Univ, Severance Inst Vasc & Metab Res, Coll Med, Seoul, South Korea.; Kim, HJ (corresponding author), CHA Univ, Dept Internal Med, CHA Bundang Med Ctr, Seongnam, South Korea.	khj04@cha.ac.kr; AMP97@yuhs.ac		CHOI, HOON YOUNG/0000-0002-4245-0339; LEE, JUNG EUN/0000-0003-0917-2872; Park, Hyeong-Cheon/0000-0002-1550-0812; Kim, Hyunwook/0000-0002-4274-7562				Cipolli JAA, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-52; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Andres M, 2016, ARTHRITIS RHEUMATOL, V68, P1531, DOI 10.1002/art.39581; Bae JS, 2013, ATHEROSCLEROSIS, V231, P145, DOI 10.1016/j.atherosclerosis.2013.08.017; Baker JF, 2005, AM J MED, V118, P816, DOI 10.1016/j.amjmed.2005.03.043; Barbieri L, 2015, ATHEROSCLEROSIS, V241, P241, DOI 10.1016/j.atherosclerosis.2015.03.030; Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458; Chen SC, 2011, CLIN J AM SOC NEPHRO, V6, P724, DOI 10.2215/CJN.07700910; Chen X, 2010, AM J HYPERTENS, V23, P387, DOI 10.1038/ajh.2009.277; Choo J, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-5; Cicero AFG, 2017, EUR J INTERN MED, V37, P38, DOI 10.1016/j.ejim.2016.07.026; Cicero AFG, 2016, INTERN EMERG MED, V11, P77, DOI 10.1007/s11739-015-1310-9; Cicero AFG, 2014, J HYPERTENS, V32, P57, DOI 10.1097/HJH.0b013e328365b916; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Davidson MB, 1999, J DIABETES COMPLICAT, V13, P52, DOI 10.1016/S1056-8727(98)00017-8; Erdogan D, 2005, INT J CLIN PRACT, V59, P1276, DOI 10.1111/j.1742-1241.2005.00621.x; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Fang JI, 2014, ATHEROSCLEROSIS, V236, P389, DOI 10.1016/j.atherosclerosis.2014.07.024; Grayson PC, 2011, ARTHRIT CARE RES, V63, P102, DOI 10.1002/acr.20344; Hayward CS, 2001, AM J HYPERTENS, V14, P699, DOI 10.1016/S0895-7061(01)01290-0; Hayward CS, 2000, CARDIOVASC RES, V46, P28, DOI 10.1016/S0008-6363(00)00005-5; Heo SH, 2010, J NEUROL SCI, V297, P6, DOI 10.1016/j.jns.2010.07.007; Hoieggen A, 2004, KIDNEY INT, V65, P1041, DOI 10.1111/j.1523-1755.2004.00484.x; Ishizaka N, 2007, ATHEROSCLEROSIS, V192, P131, DOI 10.1016/j.atherosclerosis.2006.04.016; Juraschek SP, 2014, ATHEROSCLEROSIS, V233, P623, DOI 10.1016/j.atherosclerosis.2014.01.026; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kawai T, 2015, HEART VESSELS, V30, P338, DOI 10.1007/s00380-014-0485-8; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Krishnan E, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3322; Lee SH, 2015, YONSEI MED J, V56, P1545, DOI 10.3349/ymj.2015.56.6.1545; LEVINE W, 1989, J CLIN EPIDEMIOL, V42, P257, DOI 10.1016/0895-4356(89)90061-9; Li X, 2015, RHEUMATOLOGY INT; Ljubojevic M, 2004, AM J PHYSIOL-RENAL, V287, pF124, DOI 10.1152/ajprenal.00029.2004; Madsen Troy E, 2005, Am J Nephrol, V25, P45, DOI 10.1159/000084085; Many A, 1996, AM J OBSTET GYNECOL, V174, P288, DOI 10.1016/S0002-9378(96)70410-6; Munakata M, 2003, AM J HYPERTENS, V16, P653, DOI 10.1016/S0895-7061(03)00918-X; Nagahama K, 2004, HYPERTENS RES, V27, P227, DOI 10.1291/hypres.27.227; Ohnishi H, 2003, DIABETES CARE, V26, P437, DOI 10.2337/diacare.26.2.437; Park JS, 2012, MATURITAS, V73, P344, DOI 10.1016/j.maturitas.2012.09.009; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; RAO GN, 1991, J BIOL CHEM, V266, P8604; Ruscica M, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005764; Saijo Y, 2005, J HUM HYPERTENS, V19, P907, DOI 10.1038/sj.jhh.1001913; Schlotte V, 1998, FREE RADICAL BIO MED, V25, P839, DOI 10.1016/S0891-5849(98)00160-9; Shin JY, 2012, VASC MED, V17, P37, DOI 10.1177/1358863X11434197; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Tamariz Leonardo, 2011, Congest Heart Fail, V17, P25, DOI 10.1111/j.1751-7133.2011.00200.x; Tomiyama H, 2003, ATHEROSCLEROSIS, V166, P303, DOI 10.1016/S0021-9150(02)00332-5; Viazzi Francesca, 2006, J Clin Hypertens (Greenwich), V8, P510, DOI 10.1111/j.1524-6175.2006.04755.x; Xiong Z, 2013, J NUTR HEALTH AGING, V17, P30, DOI 10.1007/s12603-012-0076-2; Xiong ZJ, 2012, J ATHEROSCLER THROMB, V19, P970, DOI 10.5551/jat.13326; Yamashina A, 2003, HYPERTENS RES, V26, P801, DOI 10.1291/hypres.26.801; Yamashina A, 2003, HYPERTENS RES, V26, P615, DOI 10.1291/hypres.26.615; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Yousefzadeh G, 2013, ARYA ATHEROSCLER, V9, P332; Yu SS, 2015, GYNECOL ENDOCRINOL, V31, P736, DOI 10.3109/09513590.2015.1056730	57	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180406	10.1371/journal.pone.0180406	http://dx.doi.org/10.1371/journal.pone.0180406			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666027	Green Submitted, gold, Green Published			2022-12-26	WOS:000404608700006
J	Cordero, H; Ceballos-Francisco, D; Cuesta, A; Esteban, MA				Cordero, Hector; Ceballos-Francisco, Diana; Cuesta, Alberto; Angeles Esteban, Maria			Dorso-ventral skin characterization of the farmed fish gilthead seabream (Sparus aurata)	PLOS ONE			English	Article							LYMPHOCYSTIS DISEASE; MUCUS PROTEOME; SEA BREAM; TELEOST; PROFILE; REGENERATION; DORSAL; CELLS; MAP	The skin is the first barrier of defence in fish, protecting against any external stressor and preserving the integrity and homeostasis of the fish body. The aim of this study was to characterise gilthead seabream skin by isolating cells and studying the cell cycle by flow cytometry, to study the skin histology by scanning electron microscopy and the transcription level of some immune-relevant genes by RT-PCR. Furthermore, the results obtained from samples taken from the dorsal and the ventral part of the specimens are compared. No differences were observed in the cell cycle of cells isolated from the dorsal and ventral zones of the skin or in the gene expression of the genes studied in both epidermal zones. However, the epidermis thickness of the ventral skin was higher than that of the dorsal skin, as demonstrated by image analysis using light microscopy. Besides, scanning electron microscopy pointed to a greater cell size and area of microridges in the apical part of the dorsal epidermal cells compared with ventral skin epidermal cells. This study represents a step forward in our knowledge of the skin structure of an important farmed teleost, gilthead seabream, one of the most commonly farmed fish worldwide. Furthermore, for functional characterization, experimental wounds were carried out comparing the wound healing rate between the dorsal and ventral regions of skin over the time. The results showed higher ratio of wound healing in the ventral region, whose wounds were closed after 15 days, compared to dorsal region of skin. Taking into account all together, this study represents a step forward in our knowledge of the skin structure and skin regeneration of an important farmed teleost, gilthead seabream, one of the most commonly farmed fish worldwide.	[Cordero, Hector; Ceballos-Francisco, Diana; Cuesta, Alberto; Angeles Esteban, Maria] Univ Murcia, Dept Cell Biol & Histol, Fish Innate Immune Syst Grp, Fac Biol, Murcia, Spain	University of Murcia	Esteban, MA (corresponding author), Univ Murcia, Dept Cell Biol & Histol, Fish Innate Immune Syst Grp, Fac Biol, Murcia, Spain.	aesteban@um.es	Ceballos, Diana/AAT-4170-2021; Cuesta, Alberto/B-6372-2008; Esteban, MA/D-6709-2011	Ceballos, Diana/0000-0001-5205-5757; Cuesta, Alberto/0000-0002-0906-7995; Esteban, MA/0000-0002-6264-1458; Cordero, Hector/0000-0002-0420-0478	Spanish Ministry of Economy and Competitiveness (MINECO); MINECO; European Regional Development Funds (ERDF/FEDER) [AGL2014-51839-C5-1-R]; Fundacion Seneca de la Region de Murcia [19883/GERM/15]	Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); MINECO(Spanish Government); European Regional Development Funds (ERDF/FEDER); Fundacion Seneca de la Region de Murcia(Fundacion Seneca)	Both F.P.I. grants for H.C. and D.C.F. are entirely funded by the Spanish Ministry of Economy and Competitiveness (MINECO). This research was funded by both MINECO (website: http://www.mineco.gob.es/portal/site/mineco/idi) and the European Regional Development Funds (ERDF/FEDER) (grant number AGL2014-51839-C5-1-R) as well as supported by the Fundacion Seneca de la Region de Murcia (grant number 19883/GERM/15, website: http://fseneca.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bullock A.M., 1974, OCEANOGR MAR BIOL AN, V13, P383; BURTON D, 1989, J FISH BIOL, V35, P845, DOI 10.1111/j.1095-8649.1989.tb03036.x; Castillo-Briceno P, 2011, MOL IMMUNOL, V48, P826, DOI 10.1016/j.molimm.2010.12.004; Cerda-Reverter JM, 2005, ENDOCRINOLOGY, V146, P1597, DOI 10.1210/en.2004-1346; Cerezuela R, 2016, FISH SHELLFISH IMMUN, V49, P100, DOI 10.1016/j.fsi.2015.12.028; Corder H, 2016, FISH SHELLFISH IMMUN, V56, P188, DOI 10.1016/j.fsi.2016.07.018; Cordero H, 2016, J FISH DIS, V39, P1467, DOI 10.1111/jfd.12481; Cordero H, 2015, PROTEOMICS, V15, P4007, DOI 10.1002/pmic.201500120; Cordero H, 2016, J PROTEOMICS, V132, P41, DOI 10.1016/j.jprot.2015.11.017; Elliott Diane G., 2000, P271, DOI 10.1016/B978-012529650-2/50023-8; Esteban Angeles M, 2012, ISRN IMMUNOL, V2012, P853470, DOI [10.5402/2012/853470, DOI 10.5402/2012/853470]; FAO, 2014, STAT WORLD FISH AQ, P1; Ferrer C, 1999, HISTOL HISTOPATHOL, V14, P383, DOI 10.14670/HH-14.383; Guardiola FA, 2015, BIORHEOLOGY, V52, P247, DOI 10.3233/BIR-15052; Guardiola FA, 2014, FISH SHELLFISH IMMUN, V40, P24, DOI 10.1016/j.fsi.2014.06.018; Guardiola FA, 2014, FISH SHELLFISH IMMUN, V36, P545, DOI 10.1016/j.fsi.2014.01.001; HAWKES JW, 1974, CELL TISSUE RES, V149, P159, DOI 10.1007/BF00222271; Ibarz A, 2013, MAR BIOTECHNOL, V15, P629, DOI 10.1007/s10126-013-9513-4; IGER Y, 1990, J FISH BIOL, V36, P421, DOI 10.1111/j.1095-8649.1990.tb05622.x; Jurado J, 2015, J PROTEOMICS, V120, P21, DOI 10.1016/j.jprot.2015.02.019; Lazado CC, 2014, FISH SHELLFISH IMMUN, V36, P113, DOI 10.1016/j.fsi.2013.10.017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machado P, 2002, EUR J DERMATOL, V12, P449; MCDOWELL EM, 1976, ARCH PATHOL LAB MED, V100, P405; PICKERING AD, 1977, J FISH BIOL, V10, P561, DOI 10.1111/j.1095-8649.1977.tb04088.x; Rai AK, 2012, MICROSC RES TECHNIQ, V75, P890, DOI 10.1002/jemt.22009; Rajan B, 2011, FISH SHELLFISH IMMUN, V31, P224, DOI 10.1016/j.fsi.2011.05.006; Salinas I, 2011, DEV COMP IMMUNOL, V35, P1346, DOI 10.1016/j.dci.2011.11.009; Sanahuja I, 2015, FISH SHELLFISH IMMUN, V46, P426, DOI 10.1016/j.fsi.2015.05.056; Sarasquete C, 1998, HISTOL HISTOPATHOL, V13, P37, DOI 10.14670/HH-13.37; Tapia-Paniagua ST, 2014, FISH SHELLFISH IMMUN, V41, P209, DOI 10.1016/j.fsi.2014.08.019; van der Marel M, 2010, J FISH DIS, V33, P431, DOI 10.1111/j.1365-2761.2010.01140.x; Vieira FA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-490; Whitear M., 1986, BIOL INTEGUMENT, P8, DOI DOI 10.1007/978-3-662-00989-5; WILKINS NP, 1979, J FISH BIOL, V15, P299, DOI 10.1111/j.1095-8649.1979.tb03609.x; Xu Z, 2013, P NATL ACAD SCI USA, V110, P13097, DOI 10.1073/pnas.1304319110; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913	37	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180438	10.1371/journal.pone.0180438	http://dx.doi.org/10.1371/journal.pone.0180438			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666033	gold, Green Submitted, Green Published			2022-12-26	WOS:000404608700008
J	Jourdain, E; Vongraven, D; Bisther, A; Karoliussen, R				Jourdain, Eve; Vongraven, Dag; Bisther, Anna; Karoliussen, Richard			First longitudinal study of seal-feeding killer whales (Orcinus orca) in Norwegian coastal waters	PLOS ONE			English	Article							DIETARY SPECIALIZATION; SEASONAL MOVEMENTS; FORAGING BEHAVIOR; ASSOCIATION; TRANSIENT; PATTERNS; INDIVIDUALS; POPULATIONS; PREDATION; ECOTYPES	Killer whales (Orcinus orca) have been documented preying on either fish or marine mammals in several regions, suggesting that this odontocete species has the ability to specialize on different types of prey. Off Norway, killer whales have been shown to rely on the Atlantic herring (Clupea harengus) as a main prey resource. Infrequent observations have revealed seals as an additional component of their diet, yet the extent of predation on marine mammals has remained largely unknown. Here, we present the findings of 29 years of photographic and observational data on seal-feeding killer whale groups identified in Norwegian coastal waters. Four groups have been observed preying and feeding on seals over several years, taking both harbor (Phoca vitulina) and grey (Halichoerus grypus) seals. These stable groups are shown to adopt small group sizes, were typically observed in near-shore areas and were not encountered on herring wintering grounds. Behavioral and social traits adopted by these groups are similar to those of pinniped-feeding killer whales from other regions. The potential ecological reasons and the extent of such prey specializations are discussed.	[Jourdain, Eve; Karoliussen, Richard] Norwegian Orca Survey, Andenes, Norway; [Vongraven, Dag] Norwegian Polar Res Inst, Tromso, Norway; [Bisther, Anna] Reportageborsen, Gothenburg, Sweden	Norwegian Polar Institute	Jourdain, E (corresponding author), Norwegian Orca Survey, Andenes, Norway.	eve@norwegianorcasurvey.no		Jourdain, Eve/0000-0003-2619-7799; Vongraven, Dag/0000-0002-0505-7757	Marine Mammal Program of the National Research Council; Sea World and Busch Gardens Conservation fund; Spare-Bank 1 Nord-Norge; Sea Word and Parks Entertainment	Marine Mammal Program of the National Research Council; Sea World and Busch Gardens Conservation fund; Spare-Bank 1 Nord-Norge; Sea Word and Parks Entertainment	Fieldwork conducted from 1988 through 1993 was partly funded by the Marine Mammal Program of the National Research Council (http://www.forskningsradet.no/en/Home_page/1177315753906) to DV and AB. From 2014 through 2016, fieldwork was financed by grants from Spare-Bank 1 Nord-Norge (https://www.sparebank1.no/bank/privat.html) to RK and EJ, Sea World and Busch Gardens Conservation fund (https://swbg-conservationfund.org) to RK and EJ, and Sea Word and Parks Entertainment (https://seaworldparks.com) to EJ and RK. One of the authors is also employed, at the time of writing, by a commercial company being Reportageborsen. The two commercial funding organizations only provided financial support to the study, and Reportageborsen only provides AB with support in the form of salary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; BAIRD RW, 1992, OECOLOGIA, V89, P125, DOI 10.1007/BF00319024; BAIRD RW, 1995, CAN J ZOOL, V73, P1300, DOI 10.1139/z95-154; Baird RW, 1996, BEHAV ECOL, V7, P408, DOI 10.1093/beheco/7.4.408; Baird RW, 2000, CAN J ZOOL, V78, P2096, DOI 10.1139/cjz-78-12-2096; BarrettLennard LG, 1996, ANIM BEHAV, V51, P553, DOI 10.1006/anbe.1996.0059; Beck S, 2012, BEHAV ECOL, V23, P246, DOI 10.1093/beheco/arr151; Bejder L, 1998, ANIM BEHAV, V56, P719, DOI 10.1006/anbe.1998.0802; Bigg M., 1982, REP INT WHALING COMM, V32, P655; Bigg M.A., 1990, Reports of the International Whaling Commission Special Issue, P383; Bisther A, 1995, STUDIES SOCIAL ECOLO, P169; Bisther A, 2001, 14 BIENN C BIOL MAR; BJORGE A, 1991, BIOL CONSERV, V58, P229, DOI 10.1016/0006-3207(91)90121-O; Cosentino AM, 2015, MARINE BIODIVERSITY, P8; Dahlheim ME, 2010, WILDLIFE BIOL, V16, P308, DOI 10.2981/09-075; de Bruyn PJN, 2013, BIOL REV, V88, P62, DOI 10.1111/j.1469-185X.2012.00239.x; Deecke VB, 2011, AQUAT BIOL, V13, P79, DOI 10.3354/ab00353; ESRI, 2016, ARCGIS DESKT VERS 10; Esteban PR, 2008, ESTRUCTURA SOCIAL ME; Filatova OA, 2015, BIOL BULL+, V42, P674, DOI 10.1134/S1062359015070043; Foote AD, 2009, MOL ECOL, V18, P5207, DOI 10.1111/j.1365-294X.2009.04407.x; Ford J. K., 2014, PRIMATES CETACEANS, P75, DOI DOI 10.1007/978-4-431-54523-1_4; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; Ford JKB, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P650; Forney KA, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P145; GINSBERG JR, 1992, ANIM BEHAV, V44, P377, DOI 10.1016/0003-3472(92)90042-8; GUINET C, 1992, CAN J ZOOL, V70, P1656, DOI 10.1139/z92-231; GUINET C, 1991, CAN J ZOOL, V69, P2712, DOI 10.1139/z91-383; HAUG T, 1994, BIOL CONSERV, V70, P59, DOI 10.1016/0006-3207(94)90299-2; HOELZEL AR, 1991, HEREDITY, V66, P191, DOI 10.1038/hdy.1991.24; Institute of Marine Research, 2016, FISKEN HAVET; Jourdain E, 2016, NORWEGIAN ORCA ID CA, DOI [10.6084/m9.figshare.4205226, DOI 10.6084/M9.FIGSHARE.4205226]; Krahn MM, 2008, MAR MAMMAL SCI, V24, P643, DOI 10.1111/j.1748-7692.2008.00213.x; Kuningas S, 2014, J MAR BIOL ASSOC UK, V94, P1277, DOI 10.1017/S0025315413000933; Marine Research Institute, 2016, CATCH KILL WHAL N AT; Morton A.B., 1990, Reports of the International Whaling Commission Special Issue, P245; Nichol LM, 1996, CAN J ZOOL, V74, P983, DOI 10.1139/z96-111; Nilssen Kjell Tormod, 2010, NAMMCO Scientific Publications, V8, P61; Nilssen Kjell Tormod, 2007, NAMMCO Scientific Publications, V6, P23; Ottensmeyer CA, 2003, CAN J ZOOL, V81, P1327, DOI 10.1139/Z03-127; Panzacchi M, 2008, CAN J ZOOL, V86, P116, DOI 10.1139/Z07-120; Piltz SH, 2014, SIAM J APPL DYN SYST, V13, P658, DOI 10.1137/130910920; Pitman Robert L., 2003, Journal of Cetacean Research and Management, V5, P131; Pitman RL, 2012, MAR MAMMAL SCI, V28, P16, DOI 10.1111/j.1748-7692.2010.00453.x; R Core Team, 2021, R LANGUAGE ENV STAT; Randa LA, 2009, J MAMMAL, V90, P594, DOI 10.1644/08-MAMM-A-092R1.1; Reisinger RR, 2011, AFR J MAR SCI, V33, P99, DOI 10.2989/1814232X.2011.572356; Reisinger RR, 2017, BEHAV ECOL, V28, P750, DOI 10.1093/beheco/arx034; Riesch R, 2012, BIOL J LINN SOC, V106, P1, DOI 10.1111/j.1095-8312.2012.01872.x; Samarra FIP, 2015, AQUAT BIOL, V24, P75, DOI 10.3354/ab00637; Samarra FIP, 2015, MAR BIOL, V162, P809, DOI 10.1007/s00227-015-2626-8; Saulitis E, 2000, MAR MAMMAL SCI, V16, P94, DOI 10.1111/j.1748-7692.2000.tb00906.x; SIMILA T, 1993, CAN J ZOOL, V71, P1494, DOI 10.1139/z93-210; Simila T, 1996, CAN J FISH AQUAT SCI, V53, P769, DOI 10.1139/cjfas-53-4-769; Simon M, 2007, ACTA ETHOL, V10, P47, DOI 10.1007/s10211-007-0029-7; Tavares SB, 2017, BEHAV ECOL, V28, P500, DOI 10.1093/beheco/arw179; Tinker MT, 2008, P NATL ACAD SCI USA, V105, P560, DOI 10.1073/pnas.0709263105; Vongraven D, 1995, DEV MAR BIO, V4, P177; Vongraven D, 2014, J MAR BIOL ASSOC UK, V94, P1357, DOI 10.1017/S0025315413001707; WHITEHEAD H, 1995, BEHAV ECOL, V6, P199, DOI 10.1093/beheco/6.2.199; Whitehead H, 2004, J ANIM ECOL, V73, P190, DOI 10.1111/j.1365-2656.2004.00798.x; Whitehead H, 1999, ADV STUD BEHAV, V28, P33, DOI 10.1016/S0065-3454(08)60215-6; Whitehead H, 2007, COMMUN STAT-SIMUL C, V36, P1233, DOI 10.1080/03610910701569531; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Whitehead Hal, 1999, Animal Behaviour Forum, V57, pF26, DOI 10.1006/anbe.1999.1099; Whitman D. W., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P1; Williams R, 2006, BIOL LETTERS, V2, P497, DOI 10.1098/rsbl.2006.0510	67	18	18	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180099	10.1371/journal.pone.0180099	http://dx.doi.org/10.1371/journal.pone.0180099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666015	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608700061
J	Chen, WY; Tsai, YC; Siu, MK; Yeh, HL; Chen, CL; Yin, JJ; Huang, J; Liu, YN				Chen, W-Y; Tsai, Y-C; Siu, M. K.; Yeh, H-L; Chen, C-L; Yin, J. J.; Huang, J.; Liu, Y-N			Inhibition of the androgen receptor induces a novel tumor promoter, ZBTB46, for prostate cancer metastasis	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CLASSICAL DENDRITIC CELLS; TRANSCRIPTION FACTOR ZDC; DEPRIVATION THERAPY; BONE METASTASIS; EXPRESSION; PROGRESSION; RESISTANCE; ACTIVATION; SUPPRESSOR	Current therapeutic regimens for prostate cancer focus on targeting androgen receptor (AR) signaling. However, the AR is a key factor in luminal epithelium differentiation and was shown to have a role as a tumor suppressor. Thus, its inhibition may activate oncogenic pathways that contribute to metastatic castration-resistant prostate cancer (CRPC). Herein, we report a novel tumor promoter, ZBTB46, which is negatively regulated by AR signaling via microRNA (miR)-1-mediated downregulation. ZBTB46 is associated with malignant prostate cancer and is essential for metastasis. Its overexpression can overcome the antitumor effects of miR-1 and promote androgen-independent proliferation. We demonstrated that ZBTB46 can transcriptionally regulate SNAI1, a key epithelial-to-mesenchymal transition (EMT) driver, which could contribute to induction of the EMT after androgen-deprivation therapy and metastasis. Our findings are supportive of the model that disruption of AR's function may predispose prostate cancer to progress to metastatic CRPC.	[Chen, W-Y; Chen, C-L] Taipei Med Univ, Coll Med, Sch Med, Dept Pathol, Taipei, Taiwan; [Chen, W-Y] Taipei Med Univ, Wan Fang Hosp, Dept Pathol, Taipei, Taiwan; [Tsai, Y-C; Siu, M. K.; Liu, Y-N] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery, 250 Wu Hsing St, Taipei 11031, Taiwan; [Siu, M. K.] Taipei Med Univ, Wan Fang Hosp, Dept Anesthesiol, Taipei, Taiwan; [Yeh, H-L] Natl Tsing Hua Univ, Inst Informat Syst & Applicat, Hsinchu, Taiwan; [Chen, C-L] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Chen, C-L] Taipei Med Univ, Taipei Med Univ Hosp, Dept Pathol, Taipei, Taiwan; [Yin, J. J.] NCI, Lab Genitourinary Canc Pathogenesis, NIH, Bethesda, MD 20892 USA; [Huang, J.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; National Tsing Hua University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Duke University	Liu, YN (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery, 250 Wu Hsing St, Taipei 11031, Taiwan.; Huang, J (corresponding author), Duke Univ, Sch Med, Dept Pathol, Room 301M,Duke South,DUMC 3712,40 Duke Med Circle, Durham, NC 27710 USA.	jiaoti.huang@duke.edu; liuy@tmu.edu.tw	Liu, Yen-Nien/AAW-4698-2021		Ministry of Science and Technology of Taiwan [MOST104-2314-B-038-045-MY3, MOST105-2320-B- 038-044, MOST104-2320-B-038-055-MY3]; National Health Research Institutes of Taiwan [NHRI-EX106-10308BC]; Taipei Medical University [TMU104-AE1-B22]; Health and Welfare Surcharge of Tobacco Products [MOHW106-TDU-B-212-144001]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan); Taipei Medical University; Health and Welfare Surcharge of Tobacco Products	This work was jointly supported by grants from the Ministry of Science and Technology of Taiwan (MOST104-2314-B-038-045-MY3) to YNL, (MOST105-2320-B- 038-044) to WYC, (MOST104-2320-B-038-055-MY3) to YCT, by the National Health Research Institutes of Taiwan (NHRI-EX106-10308BC) to YNL, by Taipei Medical University (TMU104-AE1-B22) to WYC, and by the Health and Welfare Surcharge of Tobacco Products (MOHW106-TDU-B-212-144001) to YNL.	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Beltran H, 2016, NAT MED, V22, P298, DOI 10.1038/nm.4045; Boyd LK, 2012, NAT REV UROL, V9, P652, DOI 10.1038/nrurol.2012.185; Cao JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077922; Crea F, 2015, TRENDS MOL MED, V21, P206, DOI 10.1016/j.molmed.2015.02.005; De Craene B, 2014, CELL DEATH DIFFER, V21, P310, DOI 10.1038/cdd.2013.148; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Eisenberger MA, 1998, NEW ENGL J MED, V339, P1036, DOI 10.1056/NEJM199810083391504; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Ferraldeschi R, 2015, ONCOGENE, V34, P1745, DOI 10.1038/onc.2014.115; Gao J, 2001, CANCER RES, V61, P5038; Gmyrek GA, 2001, AM J PATHOL, V159, P579, DOI 10.1016/S0002-9440(10)61729-4; Han C, 2015, TUMOR BIOL, V36, P6715, DOI 10.1007/s13277-015-3358-6; Hsieh CL, 2015, CANCER RES, V75, P1944, DOI 10.1158/0008-5472.CAN-14-3602; Hudson RS, 2012, NUCLEIC ACIDS RES, V40, P3689, DOI 10.1093/nar/gkr1222; Humphrey PA, 2012, HISTOPATHOLOGY, V60, P59, DOI 10.1111/j.1365-2559.2011.04039.x; Izumi K, 2013, EMBO MOL MED, V5, P1383, DOI 10.1002/emmm.201202367; Jennbacken K, 2010, ENDOCR-RELAT CANCER, V17, P469, DOI 10.1677/ERC-10-0015; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; Karatas OF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098675; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Lee SU, 2012, IMMUNOL REV, V247, P107, DOI 10.1111/j.1600-065X.2012.01116.x; Linja MJ, 2001, CANCER RES, V61, P3550; Litvinov IV, 2003, J CLIN ENDOCR METAB, V88, P2972, DOI 10.1210/jc.2002-022038; Liu YN, 2013, ONCOGENE, V32, P296, DOI 10.1038/onc.2012.58; Liu YN, 2015, MOL CELL BIOL, V35, P1940, DOI 10.1128/MCB.00008-15; Liu YN, 2012, MOL CELL BIOL, V32, P941, DOI 10.1128/MCB.06306-11; MagiGalluzzi C, 1997, MODERN PATHOL, V10, P839; Martens-Uzunova ES, 2012, ONCOGENE, V31, P978, DOI 10.1038/onc.2011.304; Mendiratta P, 2009, J CLIN ONCOL, V27, P2022, DOI 10.1200/JCO.2008.17.2882; Meredith MM, 2012, J EXP MED, V209, P1583, DOI 10.1084/jem.20121003; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schrader AJ, 2014, EUR UROL, V65, P30, DOI 10.1016/j.eururo.2013.06.042; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Siu MK, 2017, PROSTATE CANCER P D, V20, P172, DOI 10.1038/pcan.2017.2; Siu MK, 2014, ONCOTARGET, V5, P3770, DOI 10.18632/oncotarget.1994; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun YT, 2012, CANCER RES, V72, P527, DOI 10.1158/0008-5472.CAN-11-3004; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Varkaris A, 2011, EXPERT OPIN INV DRUG, V20, P1677, DOI 10.1517/13543784.2011.631523; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Yin JJ, 2010, CANCER RES, V70, P8662, DOI 10.1158/0008-5472.CAN-10-1435; Yin JJ, 2007, MOL CELL BIOL, V27, P7538, DOI 10.1128/MCB.00955-07; Yin JJ, 2014, CANCER RES, V74, P4306, DOI 10.1158/0008-5472.CAN-13-3233	50	26	26	4	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 9	2017	36	45					6213	6224		10.1038/onc.2017.226	http://dx.doi.org/10.1038/onc.2017.226			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FM1WY	28692046				2022-12-26	WOS:000414774800001
J	Trinidad, AG; Whalley, N; Rowlinson, R; Delpuech, O; Dudley, P; Rooney, C; Critchlow, SE				Trinidad, A. G.; Whalley, N.; Rowlinson, R.; Delpuech, O.; Dudley, P.; Rooney, C.; Critchlow, S. E.			Pyruvate dehydrogenase kinase 4 exhibits a novel role in the activation of mutant KRAS, regulating cell growth in lung and colorectal tumour cells	ONCOGENE			English	Article							CANCER-CELLS; DICHLOROACETATE DCA; METABOLIC SWITCH; BREAST-CANCER; FATTY-ACIDS; IN-VITRO; RAS; EXPRESSION; PROTEIN; PDK4	RAS signalling is involved in the control of several metabolic pathways including glycolysis, mitochondrial respiration and glutamine metabolism. Importantly, we have found here that loss of PDHK4, a key regulator of the pyruvate dehydrogenase complex, caused a profound cell growth inhibition in tumour cells harbouring KRAS mutations. Using isogenic cells and a panel of colorectal and lung cell lines we demonstrated that KRAS mutant cells showed a dependency on PDHK4 whereas KRAS wild-type cells were significantly resistant to PDHK4 knockdown. We have found that PDHK4 plays a role in the post-translational regulation of mutant KRAS activity. Depletion of PDHK4 causes disruption of KRAS cellular localization, a reduction in KRAS activity which, in turn, results in reduced MAPK signalling. Interestingly, PDHK4 and KRAS depletion resulted in a similar metabolic phenotype consisting of a reduction of glucose and fatty acid oxidation. Moreover, stable expression of PDHK4 increased localization of activated KRAS at the plasma membrane and induced tumour cell growth in vitro and in vivo. Taken together these data support a model where PDHK4 regulates KRAS signalling and its tumorigenic properties and suggest that inhibition of PDHK4 could represent a novel therapeutic strategy to target KRAS mutant colorectal and lung cancers.	[Trinidad, A. G.; Rowlinson, R.; Dudley, P.; Rooney, C.] AstraZeneca iMED Oncol, Alderley Pk, Macclesfield, Cheshire, England; [Trinidad, A. G.; Whalley, N.; Delpuech, O.; Critchlow, S. E.] AstraZeneca iMED Oncol, Cambridge CB10 1XL, England		Trinidad, AG (corresponding author), AstraZeneca iMED Oncol, Cambridge CB10 1XL, England.	antonio.garcia-trinidad@astrazeneca.com			AstraZeneca	AstraZeneca(AstraZeneca)	We would like to thank Dr Oliver Maddocks for helpful discussions, Mike Dymond for fluidigm data analysis support and the AZ laboratory animal sciences group for in vivo support. AZD7545 was discovered by AstraZeneca and the study was funded by the AstraZeneca post-doctoral program.	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Cadoudal T, 2008, DIABETES, V57, P2272, DOI 10.2337/db08-0477; Cao WG, 2008, PROSTATE, V68, P1223, DOI 10.1002/pros.20788; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; DICKSON B, 1992, NATURE, V360, P600, DOI 10.1038/360600a0; Dry JR, 2010, CANCER RES, V70, P2264, DOI 10.1158/0008-5472.CAN-09-1577; Dupuy F, 2015, CELL METAB, V22, P577, DOI 10.1016/j.cmet.2015.08.007; Grassian AR, 2011, GENE DEV, V25, P1716, DOI 10.1101/gad.16771811; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Houten SM, 2009, CELL MOL LIFE SCI, V66, P1283, DOI 10.1007/s00018-009-9066-x; Huang BL, 2002, DIABETES, V51, P276, DOI 10.2337/diabetes.51.2.276; Hwang B, 2009, BIOCHEM J, V423, P243, DOI 10.1042/BJ20090390; James G, 1996, P NATL ACAD SCI USA, V93, P4454, DOI 10.1073/pnas.93.9.4454; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; KATO K, 1992, P NATL ACAD SCI USA, V89, P6403, DOI 10.1073/pnas.89.14.6403; Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim YI, 2006, DIABETES, V55, P2311, DOI 10.2337/db05-1606; Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069; KOROTCHKINA LG, 1995, J BIOL CHEM, V270, P14297, DOI 10.1074/jbc.270.24.14297; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Leclerc D, 2017, BRIT J CANCER, V116, P930, DOI 10.1038/bjc.2017.38; Li G, 2017, ONCOGENE, V36, P989, DOI 10.1038/onc.2016.265; Liu ZB, 2014, J BIOL CHEM, V289, P29739, DOI 10.1074/jbc.M114.584821; Mazar J, 2016, MOL CELL BIOL, V36, P1090, DOI 10.1128/MCB.00762-15; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Morrell JA, 2003, BIOCHEM SOC T, V31, P1168; Munoz-Pinedo C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.123; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Puthanveetil P, 2010, ENDOCRINOLOGY, V151, P2306, DOI 10.1210/en.2009-1072; Salloum D, 2014, MOL CANCER THER, V13, P733, DOI 10.1158/1535-7163.MCT-13-0762; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Sanchez-Arago M, 2010, CARCINOGENESIS, V31, P567, DOI 10.1093/carcin/bgq012; Savkur RS, 2005, BIOCHEM BIOPH RES CO, V329, P391, DOI 10.1016/j.bbrc.2005.01.141; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Srivastava N, 2014, CELL METAB, V20, P650, DOI 10.1016/j.cmet.2014.08.003; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Sun RC, 2010, BREAST CANCER RES TR, V120, P253, DOI 10.1007/s10549-009-0435-9; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Wynn RM, 2008, J BIOL CHEM, V283, P25305, DOI 10.1074/jbc.M802249200; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zhang Y, 2016, J BIOL CHEM, V291, P17405, DOI 10.1074/jbc.M116.713735; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205	50	15	15	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 2	2017	36	44					6164	6176		10.1038/onc.2017.224	http://dx.doi.org/10.1038/onc.2017.224			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FL5CU	28692044	hybrid, Green Published			2022-12-26	WOS:000414249800010
J	Cunha, DA; Cito, M; Grieco, FA; Cosentino, C; Danilova, T; Ladriere, L; Lindahl, M; Domanskyi, A; Bugliani, M; Marchetti, P; Eizirik, DL; Cnop, M				Cunha, Daniel A.; Cito, Monia; Grieco, Fabio Arturo; Cosentino, Cristina; Danilova, Tatiana; Ladriere, Laurence; Lindahl, Maria; Domanskyi, Andrii; Bugliani, Marco; Marchetti, Piero; Eizirik, Decio L.; Cnop, Miriam			Pancreatic beta-cell protection from inflammatory stress by the endoplasmic reticulum proteins thrombospondin 1 and mesencephalic astrocyte-derived neutrotrophic factor (MANF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTROPHIC FACTOR; CANDIDATE GENE; FATTY-ACIDS; TYPE-1; APOPTOSIS; CYTOKINES; DEATH; DYSFUNCTION; ACTIVATION; PATHWAY	Cytokine-induced endoplasmic reticulum (ER) stress is one of the molecular mechanisms underlying pancreatic beta-cell demise in type 1 diabetes. Thrombospondin 1 (THBS1) was recently shown to promote beta-cell survival during lipotoxic stress. Here we show that ER-localized THBS1 is cytoprotective to rat, mouse, andhuman beta-cells exposed to cytokines or thapsigargin-induced ER stress. THBS1 confers cytoprotection by maintaining expression of mesencephalic astrocyte-derived neutrotrophic factor (MANF) in beta-cells and thereby prevents the BH3-only protein BIM (BCL2-interacting mediator of cell death)-dependent triggering of the mitochondrial pathway of apoptosis. Prolonged exposure of beta-cells to cytokines or thapsigargin leads to THBS1 and MANF degradation and loss of this prosurvival mechanism. Approaches that sustain intracellular THBS1 and MANF expression in beta-cells should be explored as a cytoprotective strategy in type 1 diabetes.	[Cunha, Daniel A.; Cito, Monia; Grieco, Fabio Arturo; Cosentino, Cristina; Ladriere, Laurence; Eizirik, Decio L.; Cnop, Miriam] Univ Libre Bruxelles, Fac Med, Ctr Diabet Res, B-1070 Brussels, Belgium; [Danilova, Tatiana; Lindahl, Maria; Domanskyi, Andrii] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Bugliani, Marco; Marchetti, Piero] Univ Pisa, Dept Endocrinol & Metab, I-56100 Pisa, Italy; [Cnop, Miriam] Univ Libre Bruxelles, Erasmus Hosp, Div Endocrinol, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; University of Helsinki; University of Pisa; Universite Libre de Bruxelles	Cnop, M (corresponding author), Univ Libre Bruxelles, ULB Ctr Diabet Res, CP 618,Route Lennik 808, B-1070 Brussels, Belgium.	mcnop@ulb.ac.be	Bugliani, Marco/I-3168-2019; Lindahl, Maria/AHE-1252-2022; Domanskyi, Andrii/H-3437-2012	Bugliani, Marco/0000-0002-1744-1561; Domanskyi, Andrii/0000-0002-4755-5981; Lindahl, Maria/0000-0002-5674-8830; Cnop, Miriam/0000-0002-5112-1692	European Foundation for the Study of Diabetes/Lilly Program; European Union Horizon Research and Innovation Program, Project T2DSystems [667191]; Fonds National de la Recherche Scientifique; Actions de Recherche Concertees de la Communaute Francaise, Belgium; Innovative Medicines Initiative 2 Joint Undertaking, Project INNODIA [115797]; European Union Horizon Research and Innovation Program; EFPIA; JDRF; Leona M. and Harry B. Helmsley Charitable Trust	European Foundation for the Study of Diabetes/Lilly Program; European Union Horizon Research and Innovation Program, Project T2DSystems; Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Actions de Recherche Concertees de la Communaute Francaise, Belgium; Innovative Medicines Initiative 2 Joint Undertaking, Project INNODIA; European Union Horizon Research and Innovation Program; EFPIA; JDRF(Juvenile Diabetes Research Foundation); Leona M. and Harry B. Helmsley Charitable Trust	This was supported by the European Foundation for the Study of Diabetes/Lilly Program; the European Union Horizon 2020 Research and Innovation Program, Project T2DSystems, under Grant Agreement 667191; the Fonds National de la Recherche Scientifique; Actions de Recherche Concertees de la Communaute Francaise, Belgium; and the Innovative Medicines Initiative 2 Joint Undertaking, Project INNODIA, under Grant Agreement 115797, which receives support from the European Union Horizon 2020 Research and Innovation Program, EFPIA, JDRF, and the Leona M. and Harry B. Helmsley Charitable Trust. The authors declare that they have no conflicts of interest with the contents of this article.	Abdulkarim B, 2015, DIABETES, V64, P3951, DOI 10.2337/db15-0477; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Barthson J, 2011, J BIOL CHEM, V286, P39632, DOI 10.1074/jbc.M111.253591; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Brozzi F, 2015, DIABETOLOGIA, V58, P2307, DOI 10.1007/s00125-015-3669-6; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Cnop M, 2008, BIOCHEM SOC T, V36, P348, DOI 10.1042/BST0360348; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; Cnop M, 2014, DIABETES, V63, P1978, DOI 10.2337/db13-1383; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Cunha DA, 2014, CELL DEATH DIFFER, V21, P1313, DOI 10.1038/cdd.2014.53; Cunha DA, 2016, CELL DEATH DIFFER, V23, P1995, DOI 10.1038/cdd.2016.89; Cunha DA, 2012, DIABETES, V61, P2763, DOI 10.2337/db12-0123; Cunha DA, 2009, DIABETES, V58, P2851, DOI 10.2337/db09-0685; Dooley J, 2016, NAT GENET, V48, P519, DOI 10.1038/ng.3531; Drott CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047451; Eizirik DL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002552; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Engin F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006534; Galli E, 2016, SCI REP-UK, V6, DOI 10.1038/srep29058; Gonzalez-Quesada C, 2013, CIRC RES, V113, P1331, DOI 10.1161/CIRCRESAHA.113.302593; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Gurzov EN, 2011, TRENDS CELL BIOL, V21, P424, DOI 10.1016/j.tcb.2011.03.001; Gurzov EN, 2010, J BIOL CHEM, V285, P19910, DOI 10.1074/jbc.M110.122374; Hannah BLA, 2004, J BIOL CHEM, V279, P51915, DOI 10.1074/jbc.M409632200; Hartley T, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-59; Hellman M, 2011, J BIOL CHEM, V286, P2675, DOI 10.1074/jbc.M110.146738; Hu JX, 2016, NAT REV GENET, V17, P615, DOI 10.1038/nrg.2016.87; Lindahl M, 2017, NEUROBIOL DIS, V97, P90, DOI 10.1016/j.nbd.2016.07.009; Lindahl M, 2014, CELL REP, V7, P366, DOI 10.1016/j.celrep.2014.03.023; Lundberg M, 2016, DIABETES, V65, P3104, DOI 10.2337/db16-0616; Lynch JM, 2012, CELL, V149, P1257, DOI 10.1016/j.cell.2012.03.050; Maganti AV, 2016, J BIOL CHEM, V291, P22524, DOI 10.1074/jbc.M116.741694; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Marhfour I, 2012, DIABETOLOGIA, V55, P2417, DOI 10.1007/s00125-012-2604-3; Marroqui L, 2015, DIABETES, V64, P3808, DOI 10.2337/db15-0362; Marroqui L, 2014, DIABETES, V63, P2516, DOI 10.2337/db13-1443; Matlik K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.371; Moore F, 2012, METHODS MOL BIOL, V820, P179, DOI 10.1007/978-1-61779-439-1_11; Moore F, 2011, J BIOL CHEM, V286, P929, DOI 10.1074/jbc.M110.162131; Olerud J, 2008, DIABETES, V57, P1870, DOI 10.2337/db07-0724; Olerud J, 2011, DIABETES, V60, P1946, DOI 10.2337/db10-0277; Oliveira AF, 2015, BIOTECHNIQUES, V58, P228, DOI 10.2144/000114285; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Santin I, 2011, DIABETES, V60, P3279, DOI 10.2337/db11-0758; Synofzik M, 2014, AM J HUM GENET, V95, P689, DOI 10.1016/j.ajhg.2014.10.013; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910; Veliceasa D, 2007, FEBS J, V274, P6365, DOI 10.1111/j.1742-4658.2007.06159.x; Yavarna T, 2015, HUM GENET, V134, P967, DOI 10.1007/s00439-015-1575-0	52	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14977	14988		10.1074/jbc.M116.769877	http://dx.doi.org/10.1074/jbc.M116.769877			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28698383	Green Published, hybrid			2022-12-26	WOS:000409902100021
J	Bian, SS; Zheng, XL; Sun, HQ; Chen, JH; Lu, YL; Liu, YQ; Tao, DC; Ma, YX				Bian, Sha-Sha; Zheng, Xu-Lei; Sun, Hua-Qin; Chen, Jian-Hui; Lu, Yi-Lu; Liu, Yun-Qiang; Tao, Da-Chang; Ma, Yong-Xin			Clock1a affects mesoderm development and primitive hematopoiesis by regulating Nodal-Smad3 signaling in the zebrafish embryo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						clock gene; hematopoiesis; SMAD transcription factor; transcription promoter; zebrafish; mesoderm; nodal	LOOP-HELIX PROTEINS; CIRCADIAN CLOCK; VERTEBRATE DEVELOPMENT; MOUSE EMBRYO; TGF-BETA; SMAD3; TRANSCRIPTION; INDUCTION; CELL; GASTRULATION	Circadian clock and Smad2/3/4-mediated Nodal signaling regulate multiple physiological and pathological processes. However, it remains unknown whether Clock directly cross-talks with Nodal signaling and how this would regulate embryonic development. Here we show that Clock1a coordinated mesoderm development and primitive hematopoiesis in zebrafish embryos by directly up-regulating Nodal-Smad3 signaling. We found that Clock1a is expressed both maternally and zygotically throughout early zebrafish development. We also noted that Clock1a alterations produce embryonic defects with shortened body length, lack of the ventral tail fin, or partial defect of the eyes. Clock1a regulates the expression of the mesodermal markers ntl, gsc, and eve1 and of the hematopoietic markers scl, lmo2, and fli1a. Biochemical analyses revealed that Clock1a stimulates Nodal signaling by increasing expression of Smad2/3/4. Mechanistically, Clock1a activates the smad3a promoter via its E-box1 element (CAGATG). Taken together, these findings provide mechanistic insight into the role of Clock1a in the regulation of mesoderm development and primitive hematopoiesis via modulation of Nodal-Smad3 signaling and indicate that Smad3a is directly controlled by the circadian clock in zebrafish.	[Bian, Sha-Sha; Zheng, Xu-Lei; Chen, Jian-Hui; Lu, Yi-Lu; Liu, Yun-Qiang; Tao, Da-Chang; Ma, Yong-Xin] Sichuan Univ, West China Hosp, Lab Med Genet, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China; [Bian, Sha-Sha; Zheng, Xu-Lei; Chen, Jian-Hui; Lu, Yi-Lu; Liu, Yun-Qiang; Tao, Da-Chang; Ma, Yong-Xin] Collaborat Innovat Ctr, Chengdu, Sichuan, Peoples R China; [Sun, Hua-Qin] Sichuan Univ, West China Univ Hosp 2, Minist Educ,SCU CUHK Joint Lab Reprod Med, Dept Pediat,Key Lab Birth Defects & Related Dis W, Chengdu 610041, Sichuan, Peoples R China	Sichuan University; Sichuan University	Ma, YX (corresponding author), Sichuan Univ, West China Hosp, Lab Med Genet, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China.; Ma, YX (corresponding author), Collaborat Innovat Ctr, Chengdu, Sichuan, Peoples R China.	mayongxin@gmail.com			National Basic Research Program of China (973 Program) [2012CB947600]; National Natural Science Foundation of China [31571381, 31300961]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program, 2012CB947600) and National Natural Science Foundation of China (31571381 and 31300961). The authors declare that they have no conflicts of interest with the contents of this article.	Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Antoch MP, 2005, CELL CYCLE, V4, P901, DOI 10.4161/cc.4.7.1792; Blank U, 2011, LEUKEMIA, V25, P1379, DOI 10.1038/leu.2011.95; Bosler O, 2015, FRONT NEUROENDOCRIN, V38, P50, DOI 10.1016/j.yfrne.2015.02.001; Chen HJ, 2014, BMB REP, V47, P21, DOI 10.5483/BMBRep.2014.47.1.048; Chen Y, 2002, CURR BIOL, V12, P2124, DOI 10.1016/S0960-9822(02)01362-3; Cuesta IH, 2014, CHRONOBIOL INT, V31, P468, DOI 10.3109/07420528.2013.856316; Dekens MPS, 2008, EMBO J, V27, P2757, DOI 10.1038/emboj.2008.183; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Dunn NR, 2004, DEVELOPMENT, V131, P1717, DOI 10.1242/dev.01072; Feillet C, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur2015.00096, 10.3389/fneur.2015.00096]; Feldman B, 2002, CURR BIOL, V12, P2129, DOI 10.1016/S0960-9822(02)01361-1; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Goumans MJ, 2000, INT J DEV BIOL, V44, P253; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Hardin PE, 2004, J BIOL RHYTHM, V19, P348, DOI 10.1177/0748730404268052; Hurley JM, 2016, TRENDS BIOCHEM SCI, V41, P834, DOI 10.1016/j.tibs.2016.07.009; Isorna E, 2017, J ENDOCRINOL, V232, pR141, DOI 10.1530/JOE-16-0330; Jessen JR, 2015, DEV BIOL, V401, P110, DOI 10.1016/j.ydbio.2014.12.022; Jia SJ, 2008, J BIOL CHEM, V283, P2418, DOI 10.1074/jbc.M707578200; Kiecker C, 2016, CELL MOL LIFE SCI, V73, P923, DOI 10.1007/s00018-015-2092-y; Kimelman D, 2006, NAT REV GENET, V7, P360, DOI 10.1038/nrg1837; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kitisin Krit, 2007, Sci STKE, V2007, pcm1, DOI 10.1126/stke.3992007cm1; Li Y, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004086; Lindeman LC, 2009, METHODS MOL BIOL, V567, P75, DOI 10.1007/978-1-60327-414-2_5; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Meyer-Bernstein EL, 2001, NEUROSCIENTIST, V7, P496, DOI 10.1177/107385840100700606; Paik EJ, 2010, INT J DEV BIOL, V54, P1127, DOI 10.1387/ijdb.093042ep; Paranjpe SS, 2015, BBA-GENE REGUL MECH, V1849, P626, DOI 10.1016/j.bbagrm.2015.03.006; Robinson KA, 2000, NUCLEIC ACIDS RES, V28, P1499, DOI 10.1093/nar/28.7.1499; Sato F, 2012, BIOCHEM BIOPH RES CO, V419, P441, DOI 10.1016/j.bbrc.2012.02.076; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Sotak M, 2014, ANN MED, V46, P221, DOI 10.3109/07853890.2014.892296; Sun HQ, 2010, J BIOL CHEM, V285, P4243, DOI 10.1074/jbc.M109.079533; Vaidya Anuradha, 2015, Syst Synth Biol, V9, P1, DOI 10.1007/s11693-015-9161-2; Vatine G, 2011, FEBS LETT, V585, P1485, DOI 10.1016/j.febslet.2011.04.007; Wang H, 2008, MAR GENOM, V1, P69, DOI 10.1016/j.margen.2008.06.003; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Weng Wei, 2003, Birth Defects Research, V69, P325, DOI 10.1002/bdrc.10027; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Ye R, 2014, GENE DEV, V28, P1989, DOI 10.1101/gad.249417.114; Zhang L, 2011, FEBS LETT, V585, P1400, DOI 10.1016/j.febslet.2011.03.018	48	7	7	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14165	14175		10.1074/jbc.M117.794289	http://dx.doi.org/10.1074/jbc.M117.794289			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28687631	hybrid, Green Published			2022-12-26	WOS:000408439800021
J	Buerger, C; Shirsath, N; Lang, V; Berard, A; Diehl, S; Kaufmann, R; Boehncke, WH; Wolf, P				Buerger, Claudia; Shirsath, Nitesh; Lang, Victoria; Berard, Alina; Diehl, Sandra; Kaufmann, Roland; Boehncke, Wolf-Henning; Wolf, Peter			Inflammation dependent mTORC1 signaling interferes with the switch from keratinocyte proliferation to differentiation	PLOS ONE			English	Article							LESIONAL PSORIATIC SKIN; EPIDERMAL DIFFERENTIATION; THERAPEUTIC TARGET; MAMMALIAN TARGET; GENE-EXPRESSION; RAPAMYCIN; ACTIVATION; PATHWAY; PHOSPHORYLATION; DEGRADATION	Psoriasis is a frequent and often severe inflammatory skin disease, characterized by altered epidermal homeostasis. Since we found previously that Akt/mTOR signaling is hyperactivated in psoriatic skin, we aimed at elucidating the role of aberrant mTORC1 signaling in this disease. We found that under healthy conditions mTOR signaling was shut off when keratinocytes switch from proliferation to terminal differentiation. Inflammatory cytokines (IL-1 beta, IL-17A, TNF-alpha) induced aberrant mTOR activity which led to enhanced proliferation and reduced expression of differentiation markers. Conversely, regular differentiation could be restored if mTORC1 signaling was blocked. In mice, activation of mTOR through the agonist MHY1485 also led to aberrant epidermal organization and involucrin distribution. In summary, these results not only identify mTORC1 as an important signal integrator pivotal for the cells fate to either proliferate or differentiate, but emphasize the role of inflammation-dependent mTOR activation as a psoriatic pathomechanism.	[Buerger, Claudia; Lang, Victoria; Berard, Alina; Diehl, Sandra; Kaufmann, Roland] Clin Goethe Univ, Dept Dermatol Venerol & Allergol, Frankfurt, Germany; [Shirsath, Nitesh; Wolf, Peter] Med Univ Graz, Dept Dermatol, Graz, Austria; [Boehncke, Wolf-Henning] Geneva Univ Hosp, Dept Dermatol & Venereol, Geneva, Switzerland; [Boehncke, Wolf-Henning] Univ Geneva, Fac Med, Dept Pathol & Immunol, Geneva, Switzerland	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Medical University of Graz; University of Geneva; University of Geneva	Buerger, C (corresponding author), Clin Goethe Univ, Dept Dermatol Venerol & Allergol, Frankfurt, Germany.	Claudia.buerger@kgu.de	Buerger, Claudia/AAE-4685-2019	Buerger, Claudia/0000-0002-7838-197X; Shirsath, Nitesh/0000-0002-8834-7249	German Research Foundation (DFG) [BU 1840/5-1]; Germany and FWF Austrian Science Fund [W1241]; PhD program Molecular Fundamentals of Inflammation (MOLIN) from the Medical University of Graz, Austria; Swiss National Fonds [ME 9965]	German Research Foundation (DFG)(German Research Foundation (DFG)); Germany and FWF Austrian Science Fund; PhD program Molecular Fundamentals of Inflammation (MOLIN) from the Medical University of Graz, Austria; Swiss National Fonds(Swiss National Science Foundation (SNSF))	This work was funded by a grant to C.B. from the German Research Foundation (DFG) BU 1840/5-1 (http://dfg.de/), Germany and FWF Austrian Science Fund no. W1241 (https://www.fwf.ac.at/) to P.W. N.S. was supported by the PhD program Molecular Fundamentals of Inflammation (MOLIN) from the Medical University of Graz, Austria. W.-H.B. is supported by the Swiss National Fonds ME 9965 (http://www.snf.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinduro O, 2016, J INVEST DERMATOL, V136, P1460, DOI 10.1016/j.jid.2016.03.016; Aymard E, 2011, EXP DERMATOL, V20, P263, DOI 10.1111/j.1600-0625.2010.01157.x; Boehncke WH, 2015, LANCET, V386, P983, DOI 10.1016/S0140-6736(14)61909-7; Buerger C, 2013, BRIT J DERMATOL, V169, P156, DOI 10.1111/bjd.12271; Buerger C, 2012, J INVEST DERMATOL, V132, P2206, DOI 10.1038/jid.2012.123; Chamcheu JC, 2016, ACTA DERM-VENEREOL, V96, P854, DOI 10.2340/00015555-2359; Chen JQ, 2013, CELL BIOCHEM BIOPHYS, V66, P523, DOI 10.1007/s12013-012-9499-y; Chen SJ, 2009, BRIT J DERMATOL, V160, P442, DOI 10.1111/j.1365-2133.2008.08903.x; Choi YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043418; Chowdhari S, 2016, CELL SIGNAL, V28, P25, DOI 10.1016/j.cellsig.2015.10.015; Dibble CC, 2015, TRENDS CELL BIOL, V25, P545, DOI 10.1016/j.tcb.2015.06.002; Ding X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13226; Eckhart L, 2013, BBA-MOL CELL RES, V1833, P3471, DOI 10.1016/j.bbamcr.2013.06.010; Frigerio E, 2007, BRIT J DERMATOL, V156, P372, DOI 10.1111/j.1365-2133.2006.07602.x; Funding AT, 2006, J INVEST DERMATOL, V126, P1784, DOI 10.1038/sj.jid.5700252; Gaubitz C, 2016, TRENDS BIOCHEM SCI, V41, P532, DOI 10.1016/j.tibs.2016.04.001; Hald A, 2013, BRIT J DERMATOL, V168, P302, DOI 10.1111/bjd.12049; Hickerson RP, 2009, J DERMATOL SCI, V56, P82, DOI 10.1016/j.jdermsci.2009.07.008; Huang T, 2014, ACTA DERM-VENEREOL, V94, P371, DOI 10.2340/00015555-1737; Huber LA, 2016, CURR OPIN CELL BIOL, V39, P8, DOI 10.1016/j.ceb.2016.01.006; Kjellerup RB, 2009, BRIT J DERMATOL, V161, P1059, DOI 10.1111/j.1365-2133.2009.09303.x; Korver JEM, 2006, BRIT J DERMATOL, V155, P688, DOI 10.1111/j.1365-2133.2006.07403.x; Laplante M, 2013, J CELL SCI, V126, P1713, DOI 10.1242/jcs.125773; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lizzul PF, 2005, J INVEST DERMATOL, V124, P1275, DOI 10.1111/j.0022-202X.2005.23735.x; Lowes MA, 2013, TRENDS IMMUNOL, V34, P174, DOI 10.1016/j.it.2012.11.005; Matsui T, 2015, INT IMMUNOL, V27, P269, DOI 10.1093/intimm/dxv013; Mitra AD, 2013, J INVEST DERMATOL, V133, P1556, DOI 10.1038/jid.2013.3; Naeem AS, 2015, CELL DEATH DIFFER, V22, P2123, DOI 10.1038/cdd.2015.62; Nandagopal N, 2015, REGULATION OF GLOBAL, V3; O'Shaughnessy RFL, 2007, J BIOL CHEM, V282, P17297, DOI 10.1074/jbc.M610386200; Orecchia V, 2015, EXP DERMATOL, V24, P29, DOI 10.1111/exd.12585; Ormerod AD, 2005, BRIT J DERMATOL, V152, P758, DOI 10.1111/j.1365-2133.2005.06438.x; Raychaudhuri SK, 2014, INDIAN J DERMATOL, V59, P67, DOI 10.4103/0019-5154.123499; Reitamo S, 2001, BRIT J DERMATOL, V145, P438, DOI 10.1046/j.1365-2133.2001.04376.x; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Shirsath N, 2015, EXP DERMATOL, V24, P889, DOI 10.1111/exd.12779; Sully K, 2013, ONCOGENE, V32, P3254, DOI 10.1038/onc.2012.338; Tiberio R, 2002, FEBS LETT, V524, P139, DOI 10.1016/S0014-5793(02)03040-5; Wei KC, 2015, DERMATOL THER, V28, P25, DOI 10.1111/dth.12176; Wolk K, 2009, J MOL MED, V87, P523, DOI 10.1007/s00109-009-0457-0; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Zhao YM, 2008, J INVEST DERMATOL, V128, P2190, DOI 10.1038/jid.2008.81	43	40	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180853	10.1371/journal.pone.0180853	http://dx.doi.org/10.1371/journal.pone.0180853			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700632	Green Published, gold, Green Submitted			2022-12-26	WOS:000405544800088
J	Clark, WR; Ding, XQ; Qiu, HB; Ni, ZH; Chang, P; Fu, P; Xu, JR; Wang, MM; Yang, L; Wang, J; Ronco, C				Clark, William R.; Ding, Xiaoqiang; Qiu, Haibo; Ni, Zhaohui; Chang, Ping; Fu, Ping; Xu, Jiarui; Wang, MinMin; Yang, Li; Wang, Jing; Ronco, Claudio			Renal replacement therapy practices for patients with acute kidney injury in China	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; RANDOMIZED CLINICAL-TRIAL; INTENSIVE-CARE-UNIT; CONTINUOUS HEMOFILTRATION; SURVIVAL; DIALYSIS; FAILURE; NOMENCLATURE; RECOVERY; SCORE	Recent data indicate AKI is very common among hospitalized Chinese patients and continuous renal replacement therapy (CRRT) is increasingly offered for treatment. However, only anecdotal information regarding CRRT's use in relation to other modalities and the specific manner in which it is prescribed exists currently. This report summarizes the results of a comprehensive physician survey designed to characterize contemporary dialytic management of AKI patients in China, especially with respect to the utilization of CRRT. The survey queried both nephrologists and critical care physicians across a wide spectrum of hospitals about factors influencing initial RRT modality selection, especially patient clinical characteristics and willingness to receive RRT, treatment location, and institutional capabilities. For patients initially treated with CRRT, data related to indication, timing of treatment initiation, dose, anticoagulation technique, and duration of therapy were also collected. Among AKI patients considered RRT candidates, the survey indicated 15.1% (95% CI, 12.3%-17.9%) did not actually receive dialysis at Chinese hospitals. The finding was largely attributed to prohibitively high therapy costs in the view of patients or their families. The survey confirmed the dichotomy in RRT delivery in China, occurring both in the nephrology department (with nephrologists responsible) and the intensive care unit (with critical care physicians responsible). For all patients who were offered and received RRT, the survey participants reported 63.9% (56.4%-71.3%) were treated initially with CRRT and 24.8% (19.2%-30.3%) with intermittent hemodialysis (HD) (P<0.001). The mean percentage of patients considered hemodynamically unstable at RRT initiation was 36.2% (31.3%-41.1%), although this figure was two-fold higher in patients treated initially with CRRT (43.1%; 35.8%-50.4%) in comparison to those initially treated with HD (22.4%; 16.4%-28.4%)(P<0.001). An overwhelming majority of intensive care patients were treated initially with CRRT (86.6%; 79.8-93.4%) while it was the initial modality in only 44.6% (33.5-55.7%) of patients treated in a nephrology department (P<0.001). Approximately 70% of respondents overall reported prescribing a CRRT dose in the range of 20-30 mL/kg/hr while approximately 20% of prescriptions fell above this range. Daily prescribed therapy duration demonstrated a marked divergence from values reported in the literature and standard clinical practice. Overall, the most common average prescribed value (50% of respondents) fell in the 10-20 hr range, with only 18% in the 20-24 hr range. Moreover, 32% of respondents reported an average prescribed value of less than 10 hrs per day. While the percentages for the 10-20 hrs range were essentially the same for nephrology and ICU programs, a daily duration of less than 10 hrs was much more common in nephrology programs (48.0%; 38.3%-57.9%) versus ICU programs (16%; 10.0%-24.6%)(P<0.001). Our analysis demonstrates both similarities and differences between RRT practices for AKI in China and those in the developed world. While some differences are driven by non-medical factors, future studies should explore these issues further as Chinese RRT practices are harmonized with those in the rest of the world.	[Clark, William R.] Purdue Univ, Davidson Sch Chem Engn, W Lafayette, IN 47907 USA; [Ding, Xiaoqiang; Xu, Jiarui] Fudan Univ, Zhongshan Hosp, Dept Nephrol, Shanghai, Peoples R China; [Ding, Xiaoqiang; Xu, Jiarui] Shanghai Inst Kidney Dis & Dialysis, Shanghai Qual Control Ctr Dialysis, Shanghai, Peoples R China; [Qiu, Haibo] Southeast Univ, Nanjing Zhongda Hosp, Dept Crit Care Med, Nanjing, Jiangsu, Peoples R China; [Ni, Zhaohui] Shanghai Jiao Tong Univ, Renji Hosp, Dept Nephrol, Sch Med, Shanghai, Peoples R China; [Fu, Ping] Southern Med Univ, Zhujiang Hosp, Dept ICU, Guangzhou, Guangdong, Peoples R China; [Fu, Ping] Sichuan Univ, Div Nephrol, West China Hosp, Chengdu, Peoples R China; [Wang, MinMin; Yang, Li] Baxter Healthcare, Shanghai, Peoples R China; [Wang, Jing] Guanlan Networks CO LTD, Hangzhou, Zhejiang, Peoples R China; [Ronco, Claudio] San Bortolo Hosp, IRRIV, Vicenza, Italy; [Ronco, Claudio] San Bortolo Hosp, Dept Nephrol, Vicenza, Italy	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Fudan University; Southeast University - China; Shanghai Jiao Tong University; Southern Medical University - China; Sichuan University; ULSS 8 Berica; Ospedale San Bortolo di Vicenza; ULSS 8 Berica; Ospedale San Bortolo di Vicenza	Clark, WR (corresponding author), Purdue Univ, Davidson Sch Chem Engn, W Lafayette, IN 47907 USA.	clarkw@purdue.edu	Qiu, Haibo/AAS-9047-2021; Wang, Minmin/AAR-3106-2021; xu, jia/GSD-6347-2022	Qiu, Haibo/0000-0001-8589-4717; Wang, Minmin/0000-0002-7556-2601; Ronco, Claudio/0000-0002-6697-4065	Baxter Healthcare	Baxter Healthcare	The study was supported by a grant from Baxter Healthcare to DXY.cn (GUANLAN NETWORKS (HANGZHOU) CO., Ltd., Hangzhou, China). The grantee at Guanlan Networks CO., LTD. was Dr. Jing Wang. Baxter Healthcare and Guanlan Networks CO., Ltd. provided support in the form of salaries for authors MW, YL, and JW. The funders did not have an additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akhoundi A, 2015, BLOOD PURIFICAT, V39, P333, DOI 10.1159/000380903; [Anonymous], 2015, MEDICAL DEVICES MARK; Bagshaw SM, 2016, NAT REV NEPHROL, V12, P445, DOI 10.1038/nrneph.2016.92; Bell M, 2007, INTENS CARE MED, V33, P773, DOI 10.1007/s00134-007-0590-6; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Bouchard J, 2009, KIDNEY INT, V76, P422, DOI 10.1038/ki.2009.159; Bouman CSC, 2002, CRIT CARE MED, V30, P2205, DOI 10.1097/00003246-200210000-00005; Clark WR, 2004, CONTRIB NEPHROL, V144, P264; Del Granado R Claure-, 2016, BMC NEPHROL, V17, P109; Fang Y, 2015, HEMODIAL INT, V19, P2, DOI 10.1111/hdi.12193; Fang Y, 2010, BLOOD PURIFICAT, V30, P120, DOI 10.1159/000319972; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Foland JA, 2004, CRIT CARE MED, V32, P1771, DOI 10.1097/01.CCM.0000132897.52737.49; Garzotto F, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1355-9; HM Oudemans-van Straaten, 2014, CRIT CARE, V18, P661; Hsu RK, 2013, J AM SOC NEPHROL, V24, P37, DOI 10.1681/ASN.2012080800; KDIGO, 2012, KIDNEY INT S, V2; Lombardi R, 2014, NEPHROL DIAL TRANSPL, V29, P1369, DOI 10.1093/ndt/gfu078; Lu RH, 2014, BLOOD PURIFICAT, V38, P140, DOI 10.1159/000366127; Mehta RL, 2001, KIDNEY INT, V60, P1154, DOI 10.1046/j.1523-1755.2001.0600031154.x; National health and family planning commission of the People's Republic of China, 2015, STAT YB CHIN HLTH FA; Neri M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1489-9; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Pickkers P, 2017, INTENSIVE CARE MED; Rewa OG, 2016, INTENSIVE CARE MED; Ronco C, 2007, INT J ARTIF ORGANS, V30, P89, DOI 10.1177/039139880703000202; Ronco C, 2007, CLIN J AM SOC NEPHRO, V2, P597, DOI 10.2215/CJN.00430107; Saudan P, 2006, KIDNEY INT, V70, P1312, DOI 10.1038/sj.ki.5001705; Vaara ST, 2016, KIDNEY INT, V89, P200, DOI [10.1038/ki.2015.269, 10.1016/j.kint.2015.12.007]; Vaara ST, 2014, CLIN J AM SOC NEPHRO, V9, P1577, DOI 10.2215/CJN.12691213; Vaara ST, 2012, CRIT CARE, V16, DOI 10.1186/cc11682; Vanholder R, 2011, CRIT CARE, V15, DOI 10.1186/cc9345; Vesconi S, 2009, CRIT CARE, V13, DOI 10.1186/cc7784; Villa G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1456-5; Wang YM, 2016, CONTRIB NEPHROL, V187, P1, DOI 10.1159/000443008; Yang L, 2015, LANCET, V386, P1465, DOI 10.1016/S0140-6736(15)00344-X; Zaragoza JJ, 2015, BLOOD PURIFICAT, V39, P246, DOI 10.1159/000381009; Zhang P, 2012, NEPHROL DIAL TRANSPL, V27, P967, DOI 10.1093/ndt/gfr486; Zhu H, 2016, CHINESE HLTH SERVICE, V33, P512	39	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0178509	10.1371/journal.pone.0178509	http://dx.doi.org/10.1371/journal.pone.0178509			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692694	Green Submitted, Green Published, gold			2022-12-26	WOS:000405544800004
J	Olivito, G; Dayan, M; Battistoni, V; Clausi, S; Cercignani, M; Molinari, M; Leggio, M; Bozzali, M				Olivito, Giusy; Dayan, Michael; Battistoni, Valentina; Clausi, Silvia; Cercignani, Mara; Molinari, Marco; Leggio, Maria; Bozzali, Marco			Bilateral effects of unilateral cerebellar lesions as detected by voxel based morphometry and diffusion imaging	PLOS ONE			English	Article							CROSSED CEREBELLOCEREBRAL DIASCHISIS; WHITE-MATTER TRACTS; FUNCTIONAL CONNECTIVITY; SPATIAL STATISTICS; GRAY-MATTER; IN-VIVO; BRAIN; STROKE; TRACTOGRAPHY; MRI	Over the last decades, the importance of cerebellar processing for cortical functions has been acknowledged and consensus was reached on the strict functional and structural cortico-cerebellar interrelations. From an anatomical point of view strictly contralateral interconnections link the cerebellum to the cerebral cortex mainly through the middle and superior cerebellar peduncle. Diffusion MRI(dMRI) based tractography has already been applied to address cortico-cerebellar-cortical loops in healthy subjects and to detect diffusivity alteration patterns in patients with neurodegenerative pathologies of the cerebellum. In the present study we used dMRI-based tractography to determine the degree and pattern of pathological changes of cerebellar white matter microstructure in patients with focal cerebellar lesions. Diffusion imaging and high-resolution volumes were obtained in patients with left cerebellar lesions and in normal controls. Middle cerebellar peduncles and superior cerebellar peduncles were reconstructed by multi fiber diffusion tractography. From each tract, measures of microscopic damage were assessed, and despite the presence of unilateral lesions, bilateral diffusivity differences in white matter tracts were found comparing patients with normal controls. Consistently, bilateral alterations were also evidenced in specific brain regions linked to the cerebellum and involved in higher-level functions. This could be in line with the evidence that in the presence of unilateral cerebellar lesions, different cognitive functions can be affected and they are not strictly linked to the side of the cerebellar lesion.	[Olivito, Giusy; Clausi, Silvia; Leggio, Maria] Santa Lucia Fdn, Ataxia Lab, Rome, Italy; [Olivito, Giusy; Dayan, Michael; Battistoni, Valentina; Cercignani, Mara; Bozzali, Marco] Santa Lucia Fdn, Neuroimaging Lab, Rome, Italy; [Dayan, Michael] Ist Italiano Tecnol, Pattern Anal & Comp Vis, Genoa, Italy; [Clausi, Silvia] Sapienza Univ Rome, Dept Psychol, Rome, Italy; [Cercignani, Mara] Brighton & Sussex Med Sch, Clin Imaging Sci Ctr, Falmer, England; [Molinari, Marco] Santa Lucia Fdn, Neurol & Spinal Cord Injury Rehabil, Dept A, Rome, Italy; [Bozzali, Marco] Univ Sussex, Brighton & Sussex Med Sch, Dept Neurosci, Falmer, England	IRCCS Santa Lucia; IRCCS Santa Lucia; Istituto Italiano di Tecnologia - IIT; Sapienza University Rome; University of Brighton; University of Sussex; IRCCS Santa Lucia; University of Brighton; University of Sussex	Olivito, G (corresponding author), Santa Lucia Fdn, Ataxia Lab, Rome, Italy.; Olivito, G (corresponding author), Santa Lucia Fdn, Neuroimaging Lab, Rome, Italy.	g.olivito@hsantalucia.it	Leggio, Maria G/D-1269-2010; Bozzali, Marco/AAC-1031-2022; Dayan, Michael/G-4760-2016; Molinari, Marco/A-9624-2010; Olivito, Giusy/J-8733-2018; Clausi, Silvia/T-8443-2017	Leggio, Maria G/0000-0003-3750-2760; Dayan, Michael/0000-0002-2666-0969; Molinari, Marco/0000-0001-9808-9688; Olivito, Giusy/0000-0001-5832-8402; Clausi, Silvia/0000-0001-8721-1799; Cercignani, Mara/0000-0002-4550-2456; Bozzali, Marco/0000-0002-0568-2026	Ministry of Education, Universities and Research (MIUR) [C26A1329AR]; Ministry of Health [RF-2011-02348213]	Ministry of Education, Universities and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Ministry of Health	This work was supported by the Ministry of Education, Universities and Research (MIUR) - (Grant Number C26A1329AR) and Ministry of Health (Grant Number RF-2011-02348213) to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afifi AK, 1998, FUNCTIONAL NEUROANAT, P730; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alexander DC, 2005, ANN NY ACAD SCI, V1064, P113, DOI 10.1196/annals.1340.018; Allen G, 2005, NEUROIMAGE, V28, P39, DOI 10.1016/j.neuroimage.2005.06.013; Andersson J., 2008, 14 ANN M ORG HUM BRA, P15; Ashburner J, 2003, LANCET NEUROL, V2, P79, DOI 10.1016/S1474-4422(03)00304-1; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beldarrain MG, 1997, EUR NEUROL, V37, P82; BONI S, 1992, NUCL MED COMMUN, V13, P824, DOI 10.1097/00006231-199211000-00009; BROICH K, 1987, NEUROSCI LETT, V83, P7, DOI 10.1016/0304-3940(87)90207-2; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Catsman-Berrevoets CE, 2010, CORTEX, V46, P933, DOI 10.1016/j.cortex.2009.10.007; Clausi S, 2009, NEUROSCIENCE, V162, P827, DOI 10.1016/j.neuroscience.2009.02.001; Cook PA, 2006, 14TH SCIENTIFIC MEET; Dayan M, 2016, FUNCT NEUROL, V31, P239; Della Nave R, 2008, NEUROIMAGE, V43, P10, DOI 10.1016/j.neuroimage.2008.06.036; Della Nave R, 2008, NEUROIMAGE, V40, P19, DOI 10.1016/j.neuroimage.2007.11.050; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Ferrucci R, 2016, CEREBELLUM, V15, P43, DOI 10.1007/s12311-015-0737-x; Gaudinski MR, 2008, STROKE, V39, P2765, DOI 10.1161/STROKEAHA.107.512269; Grimaldi G, 2014, CEREBELLUM, V13, P121, DOI 10.1007/s12311-013-0514-7; Grimaldi G, 2016, NEUROSCIENTIST, V22, P83, DOI 10.1177/1073858414559409; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Harris AD, 2009, MAGN RESON IMAGING C, V17, P291, DOI 10.1016/j.mric.2009.02.001; Jansons KM, 2003, INVERSE PROBL, V19, P1031, DOI 10.1088/0266-5611/19/5/303; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jissendi P, 2008, J NEURORADIOLOGY, V35, P42, DOI 10.1016/j.neurad.2007.11.001; Kamali A, 2010, J MAGN RESON IMAGING, V32, P809, DOI 10.1002/jmri.22330; Komaba Y, 2000, ACTA NEUROL SCAND, V101, P8, DOI 10.1034/j.1600-0404.2000.00002.x; Manto M, 2006, CEREBELLUM, V5, P187, DOI 10.1080/14734220600925075; Marek M, 2015, J NEUROL, V262, P54, DOI 10.1007/s00415-014-7503-8; Mendoza J. E., 2007, CLINICAL NEUROANATOM; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Middleton FA, 2001, J NEUROSCI, V31, P236; Molinari M, 2002, NEUROSCIENCE, V111, P863, DOI 10.1016/S0306-4522(02)00024-6; Nolte J., 2002, THE HUMAN BRAIN AN I, P650; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; Ramnani N, 2006, NAT REV NEUROSCI, V7, P511, DOI 10.1038/nrn1953; Riva D, 2000, BRAIN, V123, P1051, DOI 10.1093/brain/123.5.1051; Saito M., 1922, ARBEITEN NEUROLOGISC, P74; Salamon N, 2007, J NEURORADIOLOGY, V34, P115, DOI 10.1016/j.neurad.2007.03.002; Salamon N, 2005, NEURORADIOLOGY, V47, P895, DOI 10.1007/s00234-005-1439-8; SCHMAHMANN JD, 1995, NEUROSCI LETT, V199, P175, DOI 10.1016/0304-3940(95)12056-A; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Shereen A, 2001, J CEREB BLOOD FLOW M, V31, P1155; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; SONMEZOGLU K, 1993, ACTA NEUROL SCAND, V87, P275; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Suzuki Y, 2003, NMR BIOMED, V16, P257, DOI 10.1002/nbm.848; Taib NOulad Ben, 2008, BRAIN RES, V1204, P59; Tedesco AM, 2011, BRAIN, V134, P3669, DOI 10.1093/brain/awr266; Trouillas P, 1997, J NEUROL SCI, V145, P205, DOI 10.1016/S0022-510X(96)00231-6; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; van Baarsen KM, 2016, NEUROIMAGE, V124, P724, DOI 10.1016/j.neuroimage.2015.09.014	59	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180439	10.1371/journal.pone.0180439	http://dx.doi.org/10.1371/journal.pone.0180439			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692678	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000405544800040
J	Wang, MT; Wang, YH; Chang, HA; Tsai, CL; Yang, YS; Lin, CW; Kuo, CC; Hsu, YJ				Wang, Meng-Ting; Wang, Yun-Han; Chang, Hsin-An; Tsai, Chen-Liang; Yang, Ya-Sung; Lin, Chen Wei; Kuo, Cheng-Chin; Hsu, Yu-Juei			Benzodiazepine and Z-drug use and risk of pneumonia in patients with chronic kidney disease: A population-based nested casecontrol study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; QUALITY-OF-LIFE; OLDER-PEOPLE; MORTALITY; INSOMNIA; DIAZEPAM; ANXIETY; ADULTS; METAANALYSIS; MEDICATIONS	Background Concerns were raised about pneumonia development from benzodiazepines (BZDs) and Zdrugs, but direct evidence is limited, conflicting and without examining the highly susceptible patients with chronic kidney disease (CKD) nor specifying the risk for different drug utilizations. This study aimed to investigate whether use of BZDs and Z-drugs was each associated with an increased risk of pneumonia in a CKD population. Methods We performed a nested case-control study of 36,880 CKD patients analyzing the Taiwan National Health Insurance Database between 01/1/2000 and 12/31/2011. Among the study cohort, we identified 4,533 cases of pneumonia based on validated disease codes, chest xray examination, and prescriptions of respiratory antibiotics, and randomly selected 16,388 controls from risk sets, matched by sex, age, and number of CKD-related hospitalizations. All prescription filling records of BZDs and Z-drugs in the year before the event/index date were analyzed for cases and controls. Conditional logistic regressions were performed to estimate the odds ratios (ORs). Results Current use of BZDs was associated with a 1.31-fold (95% CI, 1.18-1.26) increased risk of pneumonia compared to nonuse, but not for recent and past use. The risk from current BZD use was confined to new initiation (adjusted OR, 2.47; 95% CI, 2.02-3.03) or use for <= 30 days, and elevated to 2.88-fold (95% CI, 1.87-4.42) with parenteral administration. New initiation and current short-term use of Z-drugs was associated with a 2.94-fold (95% CI, 1.65-5.26) and 1.75-fold (95% CI, 1.13-2.72) increased risk of pneumonia, respectively. The findings were robust to adoption of a case-crossover study that analyzed cases only. Conclusions Use of BZRAs is associated with an increased risk of pneumonia in CKD patients, especially for patients newly initiating BZDs or Z-drugs or those injected with BZDs. Physicians should exercise cautions for signs of pneumonia when prescribing BZDs or Z-drugs to CKD patients.	[Wang, Meng-Ting; Wang, Yun-Han; Lin, Chen Wei] Natl Def Med Ctr, Sch Pharm, Taipei, Taiwan; [Chang, Hsin-An] Natl Def Med Ctr, Dept Psychiat, Triserv Gen Hosp, Taipei, Taiwan; [Tsai, Chen-Liang] Natl Def Med Ctr, Div Pulm & Crit Care, Triserv Gen Hosp, Dept Internal Med, Taipei, Taiwan; [Yang, Ya-Sung] Natl Def Med Ctr, Div Infect Dis & Trop Med, Triserv Gen Hosp, Dept Med, Taipei, Taiwan; [Kuo, Cheng-Chin] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Kuo, Cheng-Chin] Natl Def Med Ctr, Grad Inst Life Sci & Biochem, Taipei, Taiwan; [Kuo, Cheng-Chin] China Med Univ, Metabol Res Ctr, China Med Univ Hosp, Taichung, Taiwan; [Kuo, Cheng-Chin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Hsu, Yu-Juei] Natl Def Med Ctr, Triserv Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan; [Hsu, Yu-Juei] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Hsu, Yu-Juei] Natl Def Med Ctr, Grad Inst Biochem, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Health Research Institutes - Taiwan; National Defense Medical Center; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center	Hsu, YJ (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan.; Hsu, YJ (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.; Hsu, YJ (corresponding author), Natl Def Med Ctr, Grad Inst Biochem, Taipei, Taiwan.	yujuei@mail2000.com.tw	Lin, Chen/GRR-2799-2022	Wang, Yun-Han/0000-0002-7673-7098; Tsai, Chen-Liang/0000-0001-9783-5423; Chang, Hsin-An/0000-0001-5572-7109	National Science Council [102-2314-B-016-006-MY3]; Tri-Service General Hospital [C103-117]; Ministry of National Defense-Medical Affairs Bureau [104-046]	National Science Council(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital; Ministry of National Defense-Medical Affairs Bureau	This work was supported by National Science Council 102-2314-B-016-006-MY3 (YJH); Tri-Service General Hospital-C103-117 (YJH); Ministry of National Defense-Medical Affairs Bureau-104-046 (YJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almirall J, 2008, EUR RESPIR J, V31, P1274, DOI 10.1183/09031936.00095807; Almirall J, 1999, EUR RESPIR J, V13, P349, DOI 10.1183/09031936.99.13234999; [Anonymous], 2015, GUID ATC CLASS DDD A; Aronsky D, 2005, AM J MED QUAL, V20, P319, DOI 10.1177/1062860605280358; Bakken MS, 2014, EUR J CLIN PHARMACOL, V70, P873, DOI 10.1007/s00228-014-1684-z; Bjerre LM, 2000, BRIT MED J, V320, P503, DOI 10.1136/bmj.320.7233.503; Cheng CL, 2015, INT J CARDIOL, V201, P96, DOI 10.1016/j.ijcard.2015.07.075; Chung WS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001110; Cohen SD, 2007, CLIN J AM SOC NEPHRO, V2, P919, DOI 10.2215/CJN.00820207; de Gage SB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6231; Dublin S, 2011, J AM GERIATR SOC, V59, P1899, DOI 10.1111/j.1532-5415.2011.03586.x; FERRARESE C, 1993, PSYCHONEUROENDOCRINO, V18, P3, DOI 10.1016/0306-4530(93)90051-L; File TM, 2010, POSTGRAD MED, V122, P130, DOI 10.3810/pgm.2010.03.2130; FINNERTY M, 1991, IMMUNOPHARMACOLOGY, V22, P185, DOI 10.1016/0162-3109(91)90043-X; Ford ES, 2014, SLEEP, V37, P1283, DOI 10.5665/sleep.3914; Galley HF, 1998, ANESTH ANALG, V86, P1289, DOI 10.1097/00000539-199806000-00030; Glass J, 2005, BMJ-BRIT MED J, V331, P1169, DOI 10.1136/bmj.38623.768588.47; Huemer HP, 2010, VACCINE, V28, P6152, DOI 10.1016/j.vaccine.2010.07.032; Jackson ML, 2004, CLIN INFECT DIS, V39, P1642, DOI 10.1086/425615; James MT, 2009, AM J KIDNEY DIS, V54, P24, DOI 10.1053/j.ajkd.2009.04.005; Kuo CJ, 2013, SCHIZOPHRENIA BULL, V39, P648, DOI 10.1093/schbul/sbr202; Lader M, 2011, ADDICTION, V106, P2086, DOI 10.1111/j.1360-0443.2011.03563.x; Lee YJ, 2013, INT J CLIN PRACT, V67, P363, DOI 10.1111/ijcp.12020; LEPPIK IE, 1983, JAMA-J AM MED ASSOC, V249, P1452, DOI 10.1001/jama.249.11.1452; Maeda T, 2016, INT J GERIATR PSYCH, V31, P186, DOI 10.1002/gps.4310; Massoco C, 2003, VET IMMUNOL IMMUNOP, V95, P11, DOI 10.1016/S0165-2427(03)00097-7; Morisaki H, 1989, Masui, V38, P1588; National health Insurance Administration Ministry of Health and Welfare, ENR STAT ALT TERM FI; Nose M, 2015, PHARMACOEPIDEM DR S, V24, P812, DOI 10.1002/pds.3804; Obiora E, 2013, THORAX, V68, P163, DOI 10.1136/thoraxjnl-2012-202374; Olfson M, 2015, JAMA PSYCHIAT, V72, P136, DOI 10.1001/jamapsychiatry.2014.1763; PASINI FL, 1987, IMMUNOPHARM IMMUNOT, V9, P101, DOI 10.3109/08923978709035204; Sanders RD, 2013, CRIT CARE MED, V41, P1627, DOI 10.1097/CCM.0b013e31827c0c8d; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1532; Stein MB, 2015, NEW ENGL J MED, V373, P2059, DOI 10.1056/NEJMcp1502514; Taiwan National Health Insurance Research Database, INTR NAT HLTH INS RE; Tseng CH, 2004, DIABETES CARE, V27, P1605, DOI 10.2337/diacare.27.7.1605; Viasus D, 2011, NEPHROL DIAL TRANSPL, V26, P2899, DOI 10.1093/ndt/gfq798; Wang WJ, 2014, J BONE MINER RES, V29, P676, DOI 10.1002/jbmr.2061; Wheeler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017152; Winkelman JW, 2015, NEW ENGL J MED, V373, P1437, DOI 10.1056/NEJMcp1412740; Wu CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112257; Wu VC, 2014, J AM SOC NEPHROL, V25, P595, DOI 10.1681/ASN.2013060610; ZAVALA F, 1990, J PHARMACOL EXP THER, V255, P442	44	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0179472	10.1371/journal.pone.0179472	http://dx.doi.org/10.1371/journal.pone.0179472			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692645	Green Submitted, gold, Green Published			2022-12-26	WOS:000405544800010
J	Balazik, MT; Farrae, DJ; Darden, TL; Garman, GC				Balazik, Matthew T.; Farrae, Daniel J.; Darden, Tanya L.; Garman, Greg C.			Genetic differentiation of spring-spawning and fall-spawning male Atlantic sturgeon in the James River, Virginia	PLOS ONE			English	Article							ACIPENSER-OXYRINCHUS-OXYRINCHUS; NORTH-AMERICA; MANAGEMENT; SOFTWARE	Atlantic sturgeon (Acipenser oxyrinchus oxyrinchus, Acipenseridae) populations are currently at severely depleted levels due to historic overfishing, habitat loss, and pollution. The importance of biologically correct stock structure for effective conservation and management efforts is well known. Recent improvements in our understanding of Atlantic sturgeon migrations, movement, and the occurrence of putative dual spawning groups leads to questions regarding the true stock structure of this endangered species. In the James River, VA specifically, captures of spawning Atlantic sturgeon and accompanying telemetry data suggest there are two discrete spawning groups of Atlantic sturgeon. The two putative spawning groups were genetically evaluated using a powerful microsatellite marker suite to determine if they are genetically distinct. Specifically, this study evaluates the genetic structure, characterizes the genetic diversity, estimates effective population size, and measures inbreeding of Atlantic sturgeon in the James River. The results indicate that fall and spring spawning James River Atlantic sturgeon groups are genetically distinct (overall F-ST = 0.048, F'(ST) = 0.181) with little admixture between the groups. The observed levels of genetic diversity and effective population sizes along with the lack of detected inbreeding all indicated that the James River has two genetically healthy populations of Atlantic sturgeon. The study also demonstrates that samples from adult Atlantic sturgeon, with proper sample selection criteria, can be informative when creating reference population databases. The presence of two genetically-distinct spawning groups of Atlantic sturgeon within the James River raises concerns about the current genetic assignment used by managers. Other nearby rivers may also have dual spawning groups that either are not accounted for or are pooled in reference databases. Our results represent the second documentation of genetically distinct dual spawning groups of Atlantic sturgeon in river systems along the U.S. Atlantic coast, suggesting that current reference population database should be updated to incorporate both new samples and our increased understanding of Atlantic sturgeon life history.	[Balazik, Matthew T.; Garman, Greg C.] Virginia Commonwealth Univ, Ctr Environm Studies, Med Coll Virginia Campus, Richmond, VA 23284 USA; [Farrae, Daniel J.; Darden, Tanya L.] Marine Resources Res Inst, South Carolina Dept Nat Resources, Hollings Marine Lab, Charleston, SC 29412 USA	Virginia Commonwealth University	Balazik, MT (corresponding author), Virginia Commonwealth Univ, Ctr Environm Studies, Med Coll Virginia Campus, Richmond, VA 23284 USA.	balazikmt@vcu.edu	Darden, Tanya/B-6915-2019	Darden, Tanya/0000-0001-7295-7360; Farrae, Daniel/0000-0002-6632-3705	NOAA Section 6 grant [NA13NMF4720037]; Virginia Department of Game and Inland Fisheries Award [NA13NMF4720037]; National Marine Fisheries Service	NOAA Section 6 grant; Virginia Department of Game and Inland Fisheries Award; National Marine Fisheries Service	Tis work was supported by NOAA Section 6 grant #NA13NMF4720037, The Virginia Department of Game and Inland Fisheries Award number NA13NMF4720037, and the National Marine Fisheries Service.	ASMFC (Atlantic States Marine Fisheries Commission), 1998, 31 ASMFC; ASSRT (Atlantic Sturgeon Status Review Team), 2007, STAT REV ATL STURG A; Balazik MT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128234; Balazik MT, 2015, N AM J FISH MANAGE, V35, P398, DOI 10.1080/02755947.2015.1011358; Balazik MT, 2012, T AM FISH SOC, V141, P1465, DOI 10.1080/00028487.2012.703157; Balazik MT, 2010, BIOL LETTERS, V6, P708, DOI 10.1098/rsbl.2010.0144; BIRSTEIN VJ, 1993, CONSERV BIOL, V7, P773, DOI 10.1046/j.1523-1739.1993.740773.x; Boreman J, 1997, ENVIRON BIOL FISH, V48, P399, DOI 10.1023/A:1007345806559; Cobb J.N., 1900, REPORT COMMISSIONER, V25, P369; Collins MR, 2000, T AM FISH SOC, V129, P982, DOI 10.1577/1548-8659(2000)129&lt;0982:HUABCO&gt;2.3.CO;2; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Farrae DJ, 2017, CONSERV GENET, V18, P1; Goode G. B., 1887, GEOGRAPHICAL REV FIS; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hilton EJ, 2016, J APPL ICHTHYOL, V32, P30, DOI 10.1111/jai.13242; King TL, 2001, CONSERV GENET, V2, P103, DOI 10.1023/A:1011895429669; McCord JW, 2007, AM FISH S S, V56, P397; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Nei M., 1987, MOL EVOLUTIONARY GEN; NOAA (National Oceanic and Atmospheric Administration), 2012, FED REGISTER, V77, P5880; O'Leary SJ, 2014, CONSERV GENET, V15, P1173, DOI 10.1007/s10592-014-0609-9; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ryder J. A., 1890, B US FISH COMM, V8, P231; Scott W.B., 1988, CANADIAN B FISHERIES, V219, pxxx; Secor DH, 2002, AM FISH S S, V28, P89; SMITH TIJ, 1985, ENVIRON BIOL FISH, V14, P61, DOI 10.1007/BF00001577; Smith TIJ, 1997, ENVIRON BIOL FISH, V48, P335, DOI 10.1023/A:1007307507468; USA Federal Register, 2012, US FED REG, V77, P5914; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	34	8	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179661	10.1371/journal.pone.0179661	http://dx.doi.org/10.1371/journal.pone.0179661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686610	Green Published, gold, Green Submitted			2022-12-26	WOS:000405464100019
J	Dendoncker, K; Timmermans, S; Van Looveren, K; De Cauwer, L; De Bosscher, K; Libert, C				Dendoncker, Karen; Timmermans, Steven; Van Looveren, Kelly; De Cauwer, Lode; De Bosscher, Karolien; Libert, Claude			The nature of the GRE influences the screening for GR-activity enhancing modulators	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; GLUCOCORTICOID-RECEPTOR AGONIST; DOWN-REGULATION; CLASS-I; ACETYLATION; COMPLEXES; CHROMATIN; COACTIVATOR; ACTIVATION; RESISTANCE	Glucocorticoid resistance (GCR), i.e. unresponsiveness to the beneficial anti-inflammatory activities of the glucocorticoid receptor (GR), poses a serious problem in the treatment of inflammatory diseases. One possible solution to try and overcome GCR, is to identify molecules that prevent or revert GCR by hyper-stimulating the biological activity of the GR. To this purpose, we screened for compounds that potentiate the dexamethasone (Dex)induced transcriptional activity of GR. To monitor GR transcriptional activity, the screen was performed using the lung epithelial cell line A549 in which a glucocorticoid responsive element (GRE) coupled to a luciferase reporter gene construct was stably integrated. Histone deacetylase inhibitors (HDACi) such as Vorinostat and Belinostat are two broad-spectrum HDACi that strongly increased the Dex-induced luciferase expression in our screening system. In sharp contrast herewith, results from a genome-wide transcriptome analysis of Dexinduced transcripts using RNAseq, revealed that Belinostat impairs the ability of GR to transactivate target genes. The stimulatory effect of Belinostat in the luciferase screen further depends on the nature of the reporter construct. In conclusion, a profound discrepancy was observed between HDACi effects on two different synthetic promoter-luciferase reporter systems. The favorable effect of HDACi on gene expression should be evaluated with care, when considering them as potential therapeutic agents. GEO accession number GSE96649.	[Dendoncker, Karen; Timmermans, Steven; Van Looveren, Kelly; Libert, Claude] VIB Ctr Inflammat Res, Mouse Genet Inflammat, Ghent, Belgium; [Dendoncker, Karen; Timmermans, Steven; Van Looveren, Kelly; Libert, Claude] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [De Cauwer, Lode; De Bosscher, Karolien] VIB, Med Biotechnol Ctr, Ghent, Belgium; [De Cauwer, Lode; De Bosscher, Karolien] Univ Ghent, Dept Biochem, Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Libert, C (corresponding author), VIB Ctr Inflammat Res, Mouse Genet Inflammat, Ghent, Belgium.; Libert, C (corresponding author), Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium.	Claude.Libert@ugent.be		Dendoncker, Karen/0000-0003-0688-0312; De Cauwer, Lode/0000-0002-6928-8271; De Bosscher, Karolien/0000-0001-5059-9718	Research Foundation Flanders (FWO Vlaanderen); Research Council of Ghent University GOA program; Interuniversity Attraction Poles of the Belgian Science Policy; VIB Nucleomics Core facility	Research Foundation Flanders (FWO Vlaanderen)(FWO); Research Council of Ghent University GOA program; Interuniversity Attraction Poles of the Belgian Science Policy; VIB Nucleomics Core facility	This work was supported by the Research Foundation Flanders (FWO Vlaanderen, http://www.fwo.be/)KD, The Research Council of Ghent University GOA programCL, Interuniversity Attraction Poles of the Belgian Science Policy (IAP-VI-18, http://www.belspo.be/IAP)CL, VIB Nucleomics Core facility (http://www.vib.be/en/research/services/Pages/VIB-Nucleomics-Core.aspx)ST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arlt A, 2016, EXPERT OPINION INVES, P1; Bannister AJ, 2011, CELL RES; Barnes PJ, 2011, BRIT J PHARMACOL, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x; Barnes Peter J, 2009, Ther Adv Respir Dis, V3, P235, DOI 10.1177/1753465809348648; Barrios AP, 2014, MOL CELL BIOL, V34, P2760, DOI 10.1128/MCB.00083-14; Blanchard F, 2005, DRUG DISCOV TODAY, V10, P197, DOI 10.1016/S1359-6446(04)03309-4; Blind RD, 2012, BIOCHEM BIOPH RES CO, V420, P839, DOI 10.1016/j.bbrc.2012.03.084; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Burd CJ, 2013, MOL CELL ENDOCRINOL, V380, P25, DOI 10.1016/j.mce.2013.03.020; Buttgereit F, 2015, CLIN EXP RHEUMATOL, V33, pS29; Cain DW, 2015, BEST PRACT RES CL EN, V29, P545, DOI 10.1016/j.beem.2015.04.007; Carafa V, 2013, EXPERT OPIN THER PAT, V23, P1, DOI 10.1517/13543776.2013.736493; Chakrabarti A, 2016, FUTURE MED CHEM, V8, P1609, DOI 10.4155/fmc-2016-0117; Chinenov Y, 2013, MOL CELL ENDOCRINOL, V380, P55, DOI 10.1016/j.mce.2013.04.006; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; De Bosscher K, 2000, P NATL ACAD SCI USA, V97, P3919, DOI 10.1073/pnas.97.8.3919; De Bosscher K, 2016, TRENDS PHARMACOL SCI, V37, P4, DOI 10.1016/j.tips.2015.09.002; Dejager L, 2014, CYTOKINE GROWTH F R, V25, P21, DOI 10.1016/j.cytogfr.2013.12.006; Dekelbab BH, 2007, STEROIDS, V72, P705, DOI 10.1016/j.steroids.2007.05.007; Dekker FJ, 2014, DRUG DISCOV TODAY, V19, P654, DOI 10.1016/j.drudis.2013.11.012; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Garrett LA, 2016, J OVARIAN RES, V9, DOI 10.1186/s13048-016-0267-2; Gillette TG, 2015, CIRC RES, V116, P1245, DOI 10.1161/CIRCRESAHA.116.303630; Ginter T, 2012, CELL SIGNAL, V24, P1453, DOI 10.1016/j.cellsig.2012.02.018; Guerrero J, 2013, CRIT CARE, V17, DOI 10.1186/cc12774; Hsieh IN, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.133; Huang LL, 2006, J CELL PHYSIOL, V209, P611, DOI 10.1002/jcp.20781; Irwin MH, 2016, DRUG DEVELOP RES, V77, P109, DOI 10.1002/ddr.21294; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Kadiyala V, 2013, J BIOL CHEM, V288, P28900, DOI 10.1074/jbc.M113.505115; Kim BK, 2014, CURR TOP MED CHEM, V14, P2759, DOI 10.2174/1568026615666141208105614; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Ledderose C, 2012, CRIT CARE MED, V40, P2745, DOI 10.1097/CCM.0b013e31825b8ebc; Lee HZ, 2015, CLIN CANCER RES, V21, P2666, DOI 10.1158/1078-0432.CCR-14-3119; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Leus NGJ, 2016, CURR OPIN CHEM BIOL, V33, P160, DOI 10.1016/j.cbpa.2016.06.019; Li Y., 2016, COLD SPRING HARB PER, V6; Li YQ, 2012, SURGERY, V152, P455, DOI 10.1016/j.surg.2012.06.036; Libert C, 2014, CELL REP, V7, P938, DOI 10.1016/j.celrep.2014.04.041; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; McDonough AK, 2008, CURR OPIN RHEUMATOL, V20, P131, DOI 10.1097/BOR.0b013e3282f51031; Meier K, 2014, EPIGENETICS-US, V9, P1485, DOI 10.4161/15592294.2014.971580; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nixon M, 2013, STEROIDS, V78, P59, DOI 10.1016/j.steroids.2012.09.013; Payne, 2015, GENSTAT REFERENCE MA; PERLMANN T, 1988, EMBO J, V7, P3073, DOI 10.1002/j.1460-2075.1988.tb03172.x; Qiu XY, 2017, PROG NEURO-PSYCHOPH, V72, P60, DOI 10.1016/j.pnpbp.2016.09.002; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Qiu Y, 2011, J BIOL CHEM, V286, P7641, DOI 10.1074/jbc.M110.185488; Ratman D, 2013, MOL CELL ENDOCRINOL, V380, P41, DOI 10.1016/j.mce.2012.12.014; Regna NL, 2014, CLIN IMMUNOL, V151, P29, DOI 10.1016/j.clim.2014.01.002; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Roche J, 2016, EUR J MED CHEM, V121, P451, DOI 10.1016/j.ejmech.2016.05.047; Rodriguez JM, 2016, STEROIDS, V115, P182, DOI 10.1016/j.steroids.2016.09.010; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Selvi B. Ruthrotha, 2009, Biotechnology Journal, V4, P375, DOI 10.1002/biot.200900032; Sharma S, 2016, PHARMACOL RES, V113, P320, DOI 10.1016/j.phrs.2016.09.009; Spinelli SL, 2014, EXP EYE RES, V127, P290, DOI 10.1016/j.exer.2014.07.013; Van Bogaert T, 2011, J BIOL CHEM, V286, P26555, DOI 10.1074/jbc.M110.212365; van den Akker ELT, 2009, INTENS CARE MED, V35, P1247, DOI 10.1007/s00134-009-1468-6; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vandevyver S, 2014, ENDOCR REV, V35, P671, DOI 10.1210/er.2014-1010; Vandevyver S, 2013, ENDOCRINOLOGY, V154, P993, DOI 10.1210/en.2012-2045; Vandevyver S, 2012, J CLIN INVEST, V122, P2130, DOI 10.1172/JCI60006; Wang JG, 2007, J BIOL CHEM, V282, P28408, DOI 10.1074/jbc.M703586200; Watson PJ, 2012, NATURE, V481, P335, DOI 10.1038/nature10728; Wu DF, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-212; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Zhang JZ, 2009, MOL VIS, V15, P2606; Zhao T, 2013, SURGERY, V154, P206, DOI 10.1016/j.surg.2013.04.003; Ziesche E, 2013, NUCLEIC ACIDS RES, V41, P90, DOI 10.1093/nar/gks916	78	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0181101	10.1371/journal.pone.0181101	http://dx.doi.org/10.1371/journal.pone.0181101			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686666	Green Published, Green Submitted, gold			2022-12-26	WOS:000405464100133
J	Hamel-Cote, G; Gendron, D; Rola-Pleszczynski, M; Stankova, J				Hamel-Cote, Genevieve; Gendron, Daniel; Rola-Pleszczynski, Marek; Stankova, Jana			Regulation of platelet-activating factor-mediated protein tyrosine phosphatase 1B activation by a Janus kinase 2/calpain pathway	PLOS ONE			English	Article							INTERLEUKIN-6 MESSENGER-RNA; MUSCLE-CELL PROLIFERATION; TUMOR-NECROSIS-FACTOR; IN-GEL ASSAY; FACTOR RECEPTOR; KAPPA-B; SIGNALING PATHWAYS; GENE-EXPRESSION; NUCLEAR-FACTOR; ATHEROSCLEROSIS	Atherosclerosis is a pro-inflammatory condition underlying many cardiovascular diseases. Platelet-activating factor (PAF) and interleukin 6 (IL-6) are actively involved in the onset and progression of atherosclerotic plaques. The involvement of monocyte-derived macrophages is well characterized in the installation of inflammatory conditions in the plaque, but less is known about the contribution of monocyte-derived dendritic cells (Mo-DCs). In the same way, the involvement of calcium, phospholipase C and A2 in PAF-induced IL-6 production, in different cells types, has been shown; however, the importance of the Jak/STAT pathway and its regulation by protein-tyrosine phosphatases in this response have not been addressed. In this study, we report that PAF stimulates PTP1B activity via Jak2, thereby modulating PAF-induced IL-6 production. Using HEK 293 cells stably transfected with the PAF receptor in order to discriminate the pathway components, our results suggest that Jak2 modulates PAF-induced IL-6 production via both positive and negative pathways. Jak2 kinase activity was necessary for maximal transactivation of the IL-6 promoter, as seen by luciferase assays, whereas the same kinase also downregulated this promoter transactivation through the activation of a calcium/calpain/PTP1B pathway. The same pathways were operational in monocyte-derived dendritic cells, since PAF-induced PTP1B activation negatively regulated PAF-induced IL-6 mRNA production and, in addition, Jak2 activated calpain, one of the components involved in PAF-induced PTP1B activation. Results obtained in this study indicate that Jak2 activation is important for maximal IL-6 promoter transactivation by PAF and that PTP1B is involved in the negative regulation of this transactivation. However, PTP1B does not directly regulate Jak2 activ-ation, but rather Jak2 regulates PAF-induced PTP1B activation.	[Hamel-Cote, Genevieve; Gendron, Daniel; Rola-Pleszczynski, Marek; Stankova, Jana] Univ Sherbrooke, Immunol Div, Dept Pediat, Fac Med & Hlth Sci, Sherbrooke, PQ, Canada	University of Sherbrooke	Stankova, J (corresponding author), Univ Sherbrooke, Immunol Div, Dept Pediat, Fac Med & Hlth Sci, Sherbrooke, PQ, Canada.	jana.stankova@usherbrooke.ca	Hamel-Côté, Geneviève/AAQ-3949-2021	Stankova, Jana/0000-0002-4127-8506	Canadian Institutes of Health Research [MT-6822]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by a grant (#MT-6822) from the Canadian Institutes of Health Research to MR-Pand JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KL, 2000, MOL PHARMACOL, V58, P946, DOI 10.1124/mol.58.5.946; Akbarali HI, 2010, NEUROGASTROENT MOTIL, V22, P1045, DOI 10.1111/j.1365-2982.2010.01560.x; Aponte M, 2008, CANCER RES, V68, P5839, DOI 10.1158/0008-5472.CAN-07-5771; Brown SL, 2006, J IMMUNOL, V177, P3242, DOI 10.4049/jimmunol.177.5.3242; Burdon KP, 2006, DIABETES, V55, P651, DOI 10.2337/diabetes.55.03.06.db05-0058; BURRIDGE K, 1995, ANAL BIOCHEM, V232, P56, DOI 10.1006/abio.1995.9961; Carroll CJ, 2013, J INTERF CYTOK RES, V33, P542, DOI 10.1089/jir.2012.0165; CHAO W, 1992, BIOCHEM J, V288, P777, DOI 10.1042/bj2880777; Chatterjee-Kishore M, 2000, EMBO J, V19, P4111, DOI 10.1093/emboj/19.15.4111; Chen ZG, 2003, CELL SIGNAL, V15, P843, DOI 10.1016/S0898-6568(03)00056-1; Cortesio CL, 2008, J CELL BIOL, V180, P957, DOI 10.1083/jcb.200708048; Danesh J, 2008, PLOS MED, V5, P600, DOI 10.1371/journal.pmed.0050078; Demopoulos CA, 2003, EUR J LIPID SCI TECH, V105, P705, DOI 10.1002/ejlt.200300845; Deo DD, 2004, J BIOL CHEM, V279, P3497, DOI 10.1074/jbc.M304497200; Dichmann S, 2000, J CELL PHYSIOL, V185, P394, DOI 10.1002/1097-4652(200012)185:3<394::AID-JCP9>3.3.CO;2-Q; Drolet AM, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/913802; Faggioli L, 1997, EUR J IMMUNOL, V27, P3022, DOI 10.1002/eji.1830271140; Faggioli L, 2004, BBA-MOL CELL RES, V1692, P17, DOI 10.1016/j.bbamcr.2004.03.001; Feldhammer M, 2013, CRIT REV BIOCHEM MOL, V48, P430, DOI 10.3109/10409238.2013.819830; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; Galic S, 2005, MOL CELL BIOL, V25, P819, DOI 10.1128/MCB.25.2.819-829.2005; Garcia-Ramirez M, 2011, CELL SIGNAL, V23, P1596, DOI 10.1016/j.cellsig.2011.05.011; Gaumond F, 1997, J CARDIOVASC PHARM, V30, P169, DOI 10.1097/00005344-199708000-00004; Gulati P, 2004, EMBO REP, V5, P812, DOI 10.1038/sj.embor.7400190; Hartman J, 2014, CARDIOL REV, V22, P147, DOI 10.1097/CRD.0000000000000021; Hasegawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010467; Heinonen KM, 2006, P NATL ACAD SCI USA, V103, P2776, DOI 10.1073/pnas.0508563103; Ibe BO, 2008, CELL PROLIFERAT, V41, P208, DOI 10.1111/j.1365-2184.2008.00517.x; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Kawashima T, 1950, J IMMUNOL BALTIM MD, V167, P3652; Kimura A, 2005, P NATL ACAD SCI USA, V102, P17089, DOI 10.1073/pnas.0508517102; Ko HM, 2005, FEBS LETT, V579, P6451, DOI 10.1016/j.febslet.2005.10.027; Kuchay SM, 2007, MOL CELL BIOL, V27, P6038, DOI 10.1128/MCB.00522-07; Lacasse C, 1997, INFLAMMATION, V21, P145, DOI 10.1023/A:1027314103063; LeGouill C, 1997, J BIOL CHEM, V272, P21289, DOI 10.1074/jbc.272.34.21289; Leloup L, 2010, J BIOL CHEM, V285, P33549, DOI 10.1074/jbc.M110.123604; Leon MLA, 2005, INFLAMM RES, V54, P395, DOI 10.1007/s00011-005-1377-2; Lu DP, 2003, BIOL REPROD, V69, P106, DOI 10.1095/biolreprod.102.014696; Lukashova V, 2001, J BIOL CHEM, V276, P24113, DOI 10.1074/jbc.M100720200; Lukashova V, 1950, J IMMUNOL BALTIM MD, V171, P3794; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Luttrell LM, 2013, PROG MOL BIOL TRANSL, V118, P115, DOI 10.1016/B978-0-12-394440-5.00005-X; Majumder A, 2011, BIOCHEMISTRY-US, V50, P7774, DOI 10.1021/bi200847n; Marriott I, 1998, J CELL PHYSIOL, V177, P232, DOI 10.1002/(SICI)1097-4652(199811)177:2<232::AID-JCP5>3.0.CO;2-O; McAvoy Thomas, 2010, Curr Protoc Mol Biol, VChapter 18, DOI 10.1002/0471142727.mb1818s92; Mellado M, 1950, J IMMUNOL BALTIM MD, V161, P805; Meng TC, 2005, METHODS, V35, P28, DOI 10.1016/j.ymeth.2004.07.005; Montrucchio G, 2000, PHYSIOL REV, V80, P1669, DOI 10.1152/physrev.2000.80.4.1669; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Nakata M, 2005, DIABETES RES CLIN PR, V70, P209, DOI 10.1016/j.diabres.2005.03.036; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; Row BW, 2004, J NEUROCHEM, V89, P189, DOI 10.1111/j.1471-4159.2004.02352.x; Sattayaprasert P, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-11; SCHMAIER AH, 1990, BLOOD, V75, P1273; Schuett H, 2012, ARTERIOSCL THROM VAS, V32, P281, DOI 10.1161/ATVBAHA.111.229435; Smith AW, 2011, J NEUROIMMUNOL, V232, P179, DOI 10.1016/j.jneuroim.2010.09.030; Soriano SF, 2003, EUR J IMMUNOL, V33, P1328, DOI 10.1002/eji.200323897; Southall MD, 2001, J BIOL CHEM, V276, P45548, DOI 10.1074/jbc.M105978200; Storr SJ, 2011, NAT REV CANCER, V11, P364, DOI 10.1038/nrc3050; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; THIVIERGE M, 1992, J ALLERGY CLIN IMMUN, V90, P796, DOI 10.1016/0091-6749(92)90104-A; Thompson C, 2006, AM J RESP CELL MOL, V35, P697, DOI 10.1165/rcmb.2005-0407OC; Trumpler A, 2009, FEBS J, V276, P5622, DOI 10.1111/j.1742-4658.2009.07255.x; Venkatesha RT, 2004, J BIOL CHEM, V279, P44606, DOI 10.1074/jbc.M408035200; Wang H, 2001, BRIT J PHARMACOL, V133, P713, DOI 10.1038/sj.bjp.0704102; Wang JH, 2008, NEUROSCIENCE, V156, P89, DOI 10.1016/j.neuroscience.2008.04.079; Xu HM, 2008, MOL IMMUNOL, V45, P3545, DOI 10.1016/j.molimm.2008.05.006; Zhou WL, 2007, AM J PHYSIOL-HEART C, V292, pH2773, DOI 10.1152/ajpheart.01018.2006; Zhou X, 2011, ATHEROSCLEROSIS, V218, P147, DOI 10.1016/j.atherosclerosis.2011.05.021; Zhuang D, 2008, AM J PHYSIOL-HEART C, V295, pH163, DOI 10.1152/ajpheart.01105.2007	72	6	6	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180336	10.1371/journal.pone.0180336	http://dx.doi.org/10.1371/journal.pone.0180336			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686728	Green Published, gold, Green Submitted			2022-12-26	WOS:000405464100052
J	Piovezan, RD; Hirotsu, C; Feres, MC; Cintra, FD; Andersen, ML; Tufik, S; Poyares, D				Piovezan, Ronaldo D.; Hirotsu, Camila; Feres, Marcia C.; Cintra, Fatima D.; Andersen, Monica L.; Tufik, Sergio; Poyares, Dalva			Obstructive sleep apnea and objective short sleep duration are independently associated with the risk of serum vitamin D deficiency	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ADULTS; POPULATION; SEVERITY	'Background Studies demonstrate an association between vitamin D (25(OH) D) deficiency and sleep disturbances, such as obstructive sleep apnea (OSA) and short sleep duration. However, to date, no studies have concurrently and objectively evaluated the effect of these factors on 25(OH) D. Objectives To evaluate whether OSA and objective short sleep duration are independently associated with reduced 25(OH) D in an adult population sample. Methods A cross-sectional study included 657 individuals from the city of Sao Paulo, Brazil, as part of the ERA project. Participants fulfilled questionnaires and underwent clinical evaluation, polysomnography and blood sample collection for 25(OH) D quantification. OSA was classified into three categories (mild, moderate and severe). The risk of 25(OH) D deficiency was considered as levels<30 ng/mL. Short sleep duration was defined as total sleep time<6 hours. Results The risk of 25(OH) D deficiency was observed in 59.5% of the sample, affecting more individuals of the female gender, obese, with African American ethnicity, and those that were smokers, sedentary and presented hypertension and diabetes. In the final logistic model adjusted for age, gender, ethnicity, obesity, smoking, hypertension, diabetes, sedentary lifestyle, seasonality and creatinine serum levels, both OSA and short sleep duration showed significant independent associations with the risk of 25(OH) D deficiency (moderate OSA: OR for 25(OH) D<30 = 2.21, 95% CI: 1.35-3.64, p<0.01; severe OSA: OR for 25(OH) D<30 = 1.78, 95% CI: 1.06-3.00, p = 0.03; short sleep duration: OR for 25(OH) D<30 = 1.61, 95% CI: 1.15-2.26, p = 0.01). After a subgroup analysis, similar results were observed only in participants >= 50 years. Conclusion OSA and short sleep duration are independently associated with the risk of 25(OH) D deficiency in an adult population. Age-related changes in vitamin D metabolism and the frequency of sleep disorders may be involved in these associations. Future studies exploring whether 25(OH) D levels may modulate OSA and sleep curtailment-related outcomes are needed.	[Piovezan, Ronaldo D.; Hirotsu, Camila; Feres, Marcia C.; Andersen, Monica L.; Tufik, Sergio; Poyares, Dalva] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, SP, Brazil; [Cintra, Fatima D.] Univ Fed Sao Paulo, Dept Med, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Piovezan, RD (corresponding author), Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, SP, Brazil.	rdpiovezan@gmail.com	Cintra, Fatima Dumas/T-8276-2019; Piovezan, Ronaldo/AAY-4017-2020	Piovezan, Ronaldo/0000-0003-2537-8766; Hirotsu, Camila/0000-0002-6760-0663; Dumas Cintra, Fatima/0000-0002-3361-7061	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2014/15259-2, 98/14303-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The support of Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (#2014/15259-2 to CH) was a personal PhD fellowships, and the #98/14303-3 is already finished. Associacao Fundo de Incentivo a Pesquisa (AFIP) is a private philanthropic non-profitable organization that has purchased reagents for the performance of the study. The sponsors had no role in the study design, data collection, and analysis, or in the manuscript writing.	Ahmad Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067548; Allan Rechtschaffen, 1968, MANUAL STANDARDIZED; Andersen ML, 2012, J CLIN SLEEP MED; Ardawi MSM, 2012, OSTEOPOROSIS INT, V23, P675, DOI 10.1007/s00198-011-1606-1; Bauters F, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-015-0556-z; Bertisch SM, 2015, SLEEP; Bozkurt NC, 2012, ENDOCRINE, V41, P518, DOI 10.1007/s12020-012-9595-1; Brouwer-Brolsma EM, 2015, J STEROID BIOCHEM, p[S0960, 30045]; Dashti HS, 2015, ADV NUTR, V6, P648, DOI 10.3945/an.115.008623; de Oliveira DL, 2015, J CLIN SLEEP MED, V11, P1345, DOI 10.5664/jcsm.5206; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Evatt ML, 2015, SLEEP; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Garcion E, 2002, TRENDS ENDOCRIN MET, V13, P100, DOI 10.1016/S1043-2760(01)00547-1; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Iber C., 2007, AASM MANUAL SCORING; Itani O, 2016, SLEEP MED; Kerley CP, 2016, SLEEP, V39, P293, DOI 10.5665/sleep.5430; Kim JH, 2014, J AM GERIATR SOC, V62, P2327, DOI 10.1111/jgs.13148; Kleinbaum DG, 2010, LOGISTIC REGRESSION, DOI DOI 10.1136/bmjopen-2015-008188; Koivula MK, 2013, CLIN LAB, V59, P397, DOI 10.7754/Clin.Lab.2012.120527; Liguori C, 2015, J CLIN SLEEP MED; Liguori C, 2017, SLEEP MED, V29, P81, DOI 10.1016/j.sleep.2016.08.022; Massa J, 2015, SLEEP; McCarty DE, 2014, SLEEP MED REV, V18, P311, DOI 10.1016/j.smrv.2013.07.001; Moraes W, 2014, SLEEP MED, V15, P401, DOI 10.1016/j.sleep.2013.11.791; Nakashima A, 2016, WORLD J DIABETES, V7, P89, DOI 10.4239/wjd.v7.i5.89; Pande RU, 2009, LOW SERUM VITAMIN S, V32, pA136; Persson LJP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038934; Piovezan RD, 2015, AGEING RES REV, V23, P210, DOI 10.1016/j.arr.2015.07.003; Pludowski P, 2013, AUTOIMMUN REV, V12, P976, DOI 10.1016/j.autrev.2013.02.004; Puckrin R, 2015, INT UROL NEPHROL, V47, P1839, DOI 10.1007/s11255-015-1113-y; Ross AC, 2011, PUBLIC HEALTH NUTR, V14, P938, DOI 10.1017/S1368980011000565; Sanders KM, 2014, CURR OSTEOPOROS REP, V12, P74, DOI 10.1007/s11914-014-0193-4; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Unnikrishnan D, 2015, REV ENDOCR METAB DIS, V16, P25, DOI 10.1007/s11154-014-9304-x; Upala S, 2015, J CLIN SLEEP MED, V11, P1347, DOI 10.5664/jcsm.5208; Zhen DH, 2015, BONE, V71, P1, DOI 10.1016/j.bone.2014.09.024	38	32	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180901	10.1371/journal.pone.0180901	http://dx.doi.org/10.1371/journal.pone.0180901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686746	Green Submitted, Green Published, gold			2022-12-26	WOS:000405464100120
J	Quintana, AM; Hernandez, JA; Gonzalez, CG				Quintana, Anita M.; Hernandez, Jose A.; Gonzalez, Cesar G.			Functional analysis of the zebrafish ortholog of HMGCS1 reveals independent functions for cholesterol and isoprenoids in craniofacial development	PLOS ONE			English	Article							NEURAL CREST CELLS; SONIC HEDGEHOG; TREACHER-COLLINS; GENE; BIOSYNTHESIS; INHIBITION; EXPRESSION; DIFFERENTIATION; INACTIVATION; REQUIREMENTS	There are 8 different human syndromes caused by mutations in the cholesterol synthesis pathway. A subset of these disorders such as Smith-Lemli-Opitz disorder, are associated with facial dysmorphia. However, the molecular and cellular mechanisms underlying such facial deficits are not fully understood, primarily because of the diverse functions associated with the cholesterol synthesis pathway. Recent evidence has demonstrated that mutation of the zebrafish ortholog of HMGCR results in orofacial clefts. Here we sought to expand upon these data, by deciphering the cholesterol dependent functions of the cholesterol synthesis pathway from the cholesterol independent functions. Moreover, we utilized loss of function analysis and pharmacological inhibition to determine the extent of sonic hedgehog (Shh) signaling in animals with aberrant cholesterol and/or isoprenoid synthesis. Our analysis confirmed that mutation of hmgcs1, which encodes the first enzyme in the cholesterol synthesis pathway, results in craniofacial abnormalities via defects in cranial neural crest cell differentiation. Furthermore targeted pharmacological inhibition of the cholesterol synthesis pathway revealed a novel function for isoprenoid synthesis during vertebrate craniofacial development. Mutation of hmgcs1 had no effect on Shh signaling at 2 and 3 days post fertilization (dpf), but did result in a decrease in the expression of gli1, a known Shh target gene, at 4 dpf, after morphological deficits in craniofacial development and chondrocyte differentiation were observed in hmgcs1 mutants. These data raise the possibility that deficiencies in cholesterol modulate chondrocyte differentiation by a combination of Shh independent and Shh dependent mechanisms. Moreover, our results describe a novel function for isoprenoids in facial development and collectively suggest that cholesterol regulates craniofacial development through versatile mechanisms.	[Quintana, Anita M.; Hernandez, Jose A.; Gonzalez, Cesar G.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Quintana, Anita M.] Univ Texas El Paso, Border Biomed Res Ctr, NeuroModulat Cluster, El Paso, TX 79968 USA	University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso	Quintana, AM (corresponding author), Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA.; Quintana, AM (corresponding author), Univ Texas El Paso, Border Biomed Res Ctr, NeuroModulat Cluster, El Paso, TX 79968 USA.	aquintana8@utep.edu		Gonzalez, Cesar/0000-0003-3513-1716; Quintana, Anita/0000-0002-3596-1587	NIMH [2G12MD007592, T32MH015442]; University of Texas El Paso Office of Research and Sponsored Projects New Investigator start-up; NIGMS linked awards [RL5GM118969, TL4GM118971, UL1GM118970]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL5GM118969, UL1GM118970, TL4GM118971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015442] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); University of Texas El Paso Office of Research and Sponsored Projects New Investigator start-up; NIGMS linked awards; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Funding for this project was obtained from NIMH Grant no. 2G12MD007592 to the University of Texas El Paso, University of Texas El Paso Office of Research and Sponsored Projects New Investigator start-up funding, NIGMS linked awards RL5GM118969, TL4GM118971, UL1GM118970 and the NIMH Grant no. T32MH015442 to the University of Colorado School of Medicine, Department of Psychology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren SC, 1999, CURR BIOL, V9, P1304, DOI 10.1016/S0960-9822(00)80052-4; AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Berzat AC, 2006, METHOD ENZYMOL, V407, P575, DOI 10.1016/S0076-6879(05)07046-1; Bhatt S, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008326; Bianconi SE, 2015, EXPERT OPIN ORPHAN D, V3, P267, DOI 10.1517/21678707.2015.1014472; Blasky AJ, 2014, DEV DYNAM, V243, P1511, DOI 10.1002/dvdy.24172; Blassberg R, 2016, HUM MOL GENET, V25, P693, DOI 10.1093/hmg/ddv507; Callahan BP, 2015, CANCERS, V7, P2037, DOI 10.3390/cancers7040875; Concordet JP, 1996, DEVELOPMENT, V122, P2835; Cretnik M, 2007, INT J MOL MED, V19, P875; Dale RM, 2011, DEV BIOL, V357, P518, DOI 10.1016/j.ydbio.2011.06.020; Dixon J, 2006, P NATL ACAD SCI USA, V103, P13403, DOI 10.1073/pnas.0603730103; Engelking LJ, 2006, J CLIN INVEST, V116, P2356, DOI 10.1172/JCI28988; Hammond KL, 2009, EVOL DEV, V11, P27, DOI 10.1111/j.1525-142X.2008.00300.x; Herman GE, 2000, BBA-MOL CELL BIOL L, V1529, P357, DOI 10.1016/S1388-1981(00)00160-8; Hudish LI, 2016, DEVELOPMENT, V143, P2292, DOI 10.1242/dev.137844; Hudish LI, 2013, DEV CELL, V27, P387, DOI 10.1016/j.devcel.2013.10.015; Jindal GA, 2015, DIS MODEL MECH, V8, P769, DOI 10.1242/dmm.020339; Kadakia S, 2014, INT J PEDIATR OTORHI, V78, P893, DOI 10.1016/j.ijporl.2014.03.006; Kavalipati Narasaraju, 2015, Indian J Endocrinol Metab, V19, P554, DOI 10.4103/2230-8210.163106; Kawakami T, 2002, DEVELOPMENT, V129, P5753, DOI 10.1242/dev.00178; Kelsh RN, 2006, BIOESSAYS, V28, P788, DOI 10.1002/bies.20445; Koleva MV, 2015, MOL MEMBR BIOL, V32, P65, DOI 10.3109/09687688.2015.1066895; Kucenas S, 2008, NAT NEUROSCI, V11, P143, DOI 10.1038/nn2025; Kurosaka H, 2014, J CLIN INVEST, V124, P1660, DOI 10.1172/JCI72688; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; Lanthaler B, 2015, CLIN GENET, V88, P149, DOI 10.1111/cge.12454; Liu Y, 2013, DEV BIOL, V383, P239, DOI 10.1016/j.ydbio.2013.09.013; Mathews ES, 2016, J NEUROSCI, V36, P7628, DOI 10.1523/JNEUROSCI.0726-16.2016; Mathews ES, 2014, J NEUROSCI, V34, P3402, DOI 10.1523/JNEUROSCI.4587-13.2014; Mejia-Pous C, 2011, CELL PROLIFERAT, V44, P441, DOI 10.1111/j.1365-2184.2011.00771.x; Morand OH, 1997, J LIPID RES, V38, P373; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Ohashi K, 2003, J BIOL CHEM, V278, P42936, DOI 10.1074/jbc.M307228200; Palsuledesai CC, 2015, ACS CHEM BIOL, V10, P51, DOI 10.1021/cb500791f; Pelluard-Nehme F, 2005, ANN PATHOL, V25, P318, DOI 10.1016/S0242-6498(05)80136-1; Porter FD, 2003, CURR OPIN PEDIATR, V15, P607, DOI 10.1097/00008480-200312000-00011; Quintana AM, 2014, DEV BIOL, V396, P94, DOI 10.1016/j.ydbio.2014.09.026; Quintana AM, 2014, DIS MODEL MECH, V7, P265, DOI 10.1242/dmm.012526; Schwend T, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-59; Signore IA, 2016, BIRTH DEFECTS RES A, V106, P814, DOI 10.1002/bdra.23546; Stathopoulou A, 2016, DEV BIOL, V409, P392, DOI 10.1016/j.ydbio.2015.11.023; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tian H, 2005, DEVELOPMENT, V132, P133, DOI 10.1242/dev.01563; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Twigg SRF, 2015, HUM MOL GENET, V24, pR50, DOI 10.1093/hmg/ddv228; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Walker MB, 2006, CLIN GENET, V69, P471, DOI 10.1111/j.0009-9163.2006.00615.x; Xavier GM, 2016, DEV BIOL; Zhang DC, 2014, BIRTH DEFECTS RES C, V102, P275, DOI 10.1002/bdrc.21081	50	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180856	10.1371/journal.pone.0180856	http://dx.doi.org/10.1371/journal.pone.0180856			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686747	gold, Green Published, Green Submitted			2022-12-26	WOS:000405464100116
J	Smith, HF; Hutchison, JH; Townsend, KEB; Adrian, B; Jager, D				Smith, Heather F.; Hutchison, J. Howard; Townsend, K. E. Beth; Adrian, Brent; Jager, Daniel			Morphological variation, phylogenetic relationships, and geographic distribution of the Baenidae (Testudines), based on new specimens from the Uinta Formation (Uinta Basin), Utah (USA)	PLOS ONE			English	Article							TURTLES; ANATOMY; MEXICO	We described newly discovered baenid specimens from the Uintan North American Land Mammal Age (NALMA), in the Uinta Formation, Uinta Basin, Utah. These specimens include a partial skull and several previously undescribed postcranial elements of Baena arenosa, and numerous well-preserved shells of B. arenosa and Chisternon undatum. Baenids from the Uintan NALMA (46.5-40 Ma) are critical in that they provide valuable insight into the morphology and evolution of the diverse and speciose baenid family near the end of its extensive radiation, just prior to the disappearance of this clade from the fossil record. These Uintan specimens greatly increase the known variation in these late-surviving taxa and indicate that several characters thought to define these species should be reassessed. The partial cranium of B. arenosa, including portions of the basicranium, neurocranium, face, and lower jaw, was recently recovered from Uinta B sediments. While its morphology is consistent with known specimens of B. arenosa, we observed several distinct differences: a crescent-shaped condylus occipitalis that is concave dorsally, tuberculum basioccipitale that flare out laterally, and a distinct frontal-nasal suture. The current sample of plastral and carapacial morphology considerably expands the documented variation in the hypodigms of B. arenosa and C. undatum. Novel shell characters observed include sigmoidal extragularhumeral sulci, and small, subtriangular gular scutes. Subadult specimens reveal ontogenetic processes in both taxa, and demonstrate that diagnostic morphological differences between them were present from an early developmental age.	[Smith, Heather F.; Townsend, K. E. Beth; Adrian, Brent; Jager, Daniel] Midwestern Univ, Dept Anat, Glendale, AZ 85308 USA; [Smith, Heather F.; Townsend, K. E. Beth] Midwestern Univ, Coll Vet Med, Glendale, AZ 85308 USA; [Smith, Heather F.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85281 USA; [Hutchison, J. Howard] Univ Calif Berkeley, Univ Calif Museum Paleontol, Berkeley, CA 94720 USA	Midwestern University; Midwestern University; Arizona State University; Arizona State University-Tempe; University of California System; University of California Berkeley	Smith, HF (corresponding author), Midwestern Univ, Dept Anat, Glendale, AZ 85308 USA.; Smith, HF (corresponding author), Midwestern Univ, Coll Vet Med, Glendale, AZ 85308 USA.; Smith, HF (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85281 USA.	hsmith@midwestern.edu	Smith, Heather F./ABG-5436-2020	Smith, Heather F./0000-0002-3738-0903; Adrian, Brent/0000-0002-6167-838X	Midwestern University	Midwestern University	The authors were funded by intramural research funds from Midwestern University (HFS, KET).; Funding for this research was provided by Midwestern University faculty intramural funds (to HFS and KET). We thank Jessica Cundiff (Museum of Comparative Zoology) and Amy Henrici (Carnegie Museum of Natural History) for the loans of relevant comparative fossil material. We also thank Carrie-Levitt Bussian (UMNH) and Steve Sroka (FHM) for permission to study specimens under their care. We also wish to acknowledge the hard work of the Uinta Basin field crew over many productive field seasons, including Penny Higgins, Pat Holroyd, Karen McCormick, Laura Stroik, Jeffrey Westgate, and Jim Westgate. We would like to thank Walter Joyce and Adan Perez-Garcia for their insightful comments and suggestions on this manuscript, which greatly improved it.	Adrian B, 2016, J VERT PALEONTOL, V36S, P86; Andersen DW, 1972, UTAH GEOLOGICAL MINE, V97, P1; Anquetin J, 2012, J SYST PALAEONTOL, V10, P3, DOI 10.1080/14772019.2011.558928; AUFFENBERG WALTER, 1958, BULL FLORIDA STATE MUS BIOL SER, V3, P53; Barbieri R, 2003, GREENHOUSE ICEHOUSE, P452; Batsch JGC, 1788, VERSUCH ANLEITUNG KE; Bohaty SM, 2003, GEOLOGY, V31, P1017, DOI 10.1130/G19800.1; Brinkman D.B., 1991, Journal of Vertebrate Paleontology, V11, P302; Brinkman DB, 2003, J VERTEBR PALEONTOL, V23, P146, DOI 10.1671/0272-4634(2003)23[146:AASOPA]2.0.CO;2; Bryant B, 1989, USGS B J, P1787; Bury BR, 1979, US FISH WILDLIFE SER, V219, P1; Chamberlain CP, 2012, AM J SCI, V312, P213, DOI 10.2475/02.2012.05; CLARK JOHN, 1932, ANN CARNEGIE MUS, V21, P131; Cope E.D., 1882, P AM PHILOS SOC, V10, P139; Davis SJ, 2008, EARTH PLANET SC LETT, V275, P258, DOI 10.1016/j.epsl.2008.08.009; Gaffney E.S., 1972, American Museum Novitates, VNo. 2486, P1; GAFFNEY E S, 1975, Bulletin of the American Museum of Natural History, V155, P387; Gaffney E.S., 1982, American Museum Novitates, P1; Gaffney E.S., 1982, American Museum Novitates, P1; GAFFNEY E S, 1979, Bulletin of the American Museum of Natural History, V164, P69; Gaffney E.S., 1988, Systematics Association Special Volume Series, P157; Gaffney E. S., 1972, B AM MUS NAT HIST, V147, P243; GILMORE C.W., 1916, MEM CARNEGIE MUS, V7, P101; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; Gunnell G.F., 2009, PAPERS GEOLOGY VERTE, V65, P279; Hay OP, 1904, AM J SCI, V18, P261, DOI 10.2475/ajs.s4-18.106.261; Hay OP, 1908, CARNEGIE I WASH PUBL, P1; Hillson S, 2005, AM J PHYS ANTHROPOL, V126, P413, DOI 10.1002/ajpa.10430; Hurley John V., 2003, P223; Hutchison J. Howard, 2001, Paleobios, V21, P12; Hutchison J. Howard, 1992, P451; HUTCHISON JH, 1982, PALAEOGEOGR PALAEOCL, V37, P149, DOI 10.1016/0031-0182(82)90037-2; Hutchison JH, 1996, GUIDE UINTA TURTLES; Hutchison JH, 1987, J VERT PALEONTOL, V3, P148; Jager DM, 2016, J VERT PALEONTOL, V36S, P160; Joyce Walter G., 2007, Bulletin of the Peabody Museum of Natural History, V48, P3, DOI 10.3374/0079-032X(2007)48[3:PROMT]2.0.CO;2; Joyce WG, 2015, B PEABODY MUS NAT HI, V56, P147, DOI 10.3374/014.056.0203; Larson D. W., 2012, MORPHOLOGY EVOLUTION, P389; Leidy J., 1872, P ACAD NAT SCI PHILA, P162; Leidy J, 1870, P ACAD NAT SCI PHILA, V1870, P123; LEIDY J., 1871, P ACAD NAT SCI PHILA, V23, P228; Leidy J., 1873, REPORTS US GEOLOGICA, V1, P14, DOI [10.5962/bhl.title.61805, DOI 10.5962/BHL.TITLE.61805]; Lyson TR, 2016, J PALEONTOL, V90, P305, DOI 10.1017/jpa.2016.47; Lyson TR, 2011, J PALEONTOL, V85, P789, DOI 10.1666/10-081.1; Lyson TR, 2010, J VERTEBR PALEONTOL, V30, P394, DOI 10.1080/02724631003618389; Lyson TR, 2009, J PALEONTOL, V83, P833, DOI 10.1666/09-035.1; Lyson TR, 2009, J PALEONTOL, V83, P457, DOI 10.1666/08-172.1; Methner K, 2016, EARTH PLANET SC LETT, V450, P132, DOI 10.1016/j.epsl.2016.05.053; MILSTEAD WW, 1967, COPEIA, P180; Milstead WW, 1969, FLORIDA ST MUS B, V14, P1; Nelson A. B, 2000, RESTORATION MANAGEME; Osborn H. F., 1895, Bulletin of the American Museum, Vvii, P71; Osborn H. F., 1929, US GEOLOGICAL SURVEY, V1, P1, DOI [10.5962/bhl.title.36431, DOI 10.5962/BHL.TITLE.36431]; Prothero D.R., 1996, TERRESTRIAL EOCENE O, P75; Rasmussen D. T., 1999, VERTEBRATE PALEONTOL, P402; Rasmussen DT, 1995, J VERTEBR PALEONTOL, V15, p49A; Rasmussen DT, 1996, J HUM EVOL, V31, P75; Russell D.A., 1975, GEOL ASSOC CAN SPEC, P119; RYDER RT, 1976, GEOL SOC AM BULL, V87, P496, DOI 10.1130/0016-7606(1976)87<496:ETSITW>2.0.CO;2; SCHUMACHER G. H., 1956, ANAT ANZ, V103, P1; Schumaker G-H, 1954, MITTEILUNG WISS Z MN, P457; Schumaker G-H, 1955, MITTEILUNG WISS Z MN, P501; Smith ME, 2008, GEOL SOC AM BULL, V120, P54, DOI 10.1130/B26073.1; Sterli J, 2013, J SYST PALAEONTOL, V11, P835, DOI 10.1080/14772019.2012.708674; Townsend K. E., 2004, THESIS; Townsend KEB, 2010, PALAEOGEOGR PALAEOCL, V297, P144, DOI 10.1016/j.palaeo.2010.07.024; Townsend KEB, 2006, MOUNTAIN GEOL, V43, P115; Werneburg I, 2013, BIOL OPEN, V2, P1103, DOI 10.1242/bio.20135439; Werneburg L, 2014, J EXPT ZOOLOGY B, V324B, P230; Williams EE, 1950, B AM MUS NAT HIST, V94, P511; Wood HE, 1941, BULL GEOL SOC AM, V52, P1; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zachos JC, 2001, SCIENCE, V292, P274, DOI 10.1126/science.1058288	73	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180574	10.1371/journal.pone.0180574	http://dx.doi.org/10.1371/journal.pone.0180574			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686718	Green Submitted, gold, Green Published			2022-12-26	WOS:000405464100077
J	Tanaka, H; Kataoka, M; Isobe, S; Yamamoto, T; Shirakawa, K; Endo, J; Satoh, T; Hakamata, Y; Kobayashi, E; Sano, M; Fukuda, K				Tanaka, Hiroaki; Kataoka, Masaharu; Isobe, Sarasa; Yamamoto, Tsunehisa; Shirakawa, Kohsuke; Endo, Jin; Satoh, Toru; Hakamata, Yoji; Kobayashi, Eiji; Sano, Motoaki; Fukuda, Keiichi			Therapeutic impact of dietary vitamin D supplementation for preventing right ventricular remodeling and improving survival in pulmonary hypertension	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; INHIBITION; MACITENTAN; REGISTRY; DISEASE; CELLS	Background Pulmonary hypertension (PH), caused by elevated pulmonary vascular resistance, leads to right heart failure and ultimately death. Vitamin D deficiency can predispose individuals to hypertension and left ventricular dysfunction; however, it remains unknown how serum vitamin D level is related to PH and right ventricular (RV) dysfunction. Methods Serum 25-hydroxyvitamin D [25(OH) D] levels were assessed in PH patients for an association with disease severity. To examine whether vitamin D supplementation could prevent the development of pulmonary vascular remodeling and RV dysfunction in PH, a rat model of PH was fed either normal chow or a high vitamin D diet. Results The majority (95.1%) of PH patients had 25(OH) D levels in the insufficiency range, which is associated with increased mean pulmonary artery pressure, increased pulmonary vascular resistance, and decreased cardiac output in PH patients. Vitamin D supplementation significantly increased serum 25(OH) D levels and improved survival in PH rats. Interestingly, while the supplemented rats retained the typical increases in medial thickness of the muscular pulmonary arteries and RV systolic pressure, RV cardiomyocyte hypertrophy and B-type natriuretic peptide expression was significantly attenuated. Conclusions Vitamin D deficiency is frequently seen in patients diagnosed with PH and low serum levels of 25(OH) D are associated with severity of PH and RV dysfunction. Vitamin D supplementation in PH rats improved survival via ameliorating pathological RV hypertrophy. These findings suggest an insufficient intake of vitamin D might potentially accelerate RV dysfunction, leading to a crucial clinical impact of vitamin D supplementation in PH.	[Tanaka, Hiroaki; Kataoka, Masaharu; Isobe, Sarasa; Yamamoto, Tsunehisa; Shirakawa, Kohsuke; Endo, Jin; Sano, Motoaki; Fukuda, Keiichi] Keio Univ, Dept Cardiol, Sch Med, Tokyo, Japan; [Tanaka, Hiroaki] Actelion Pharmaceut Japan Ltd, Tokyo, Japan; [Satoh, Toru] Kyorin Univ, Dept Cardiol, Sch Med, Tokyo, Japan; [Hakamata, Yoji] Nippon Vet & Life Sci Univ, Sch Vet Nursing & Technol, Dept Basic Sci, Fac Vet Sci, Tokyo, Japan; [Kobayashi, Eiji] Keio Univ, Dept Organ Fabricat, Sch Med, Tokyo, Japan	Keio University; Kyorin University; Nippon Veterinary & Life Science University; Keio University	Kataoka, M (corresponding author), Keio Univ, Dept Cardiol, Sch Med, Tokyo, Japan.	m.kataoka09@keio.jp	Hakamata, Yoji/AAF-7759-2020; Sano, Motoaki/L-3405-2013; Isobe, Sarasa/F-8480-2014	Hakamata, Yoji/0000-0002-0138-6692; Yamamoto, Tsunehisa/0000-0002-5241-9482	Health and Labour Sciences Research Grant - Ministry of Health, Labour, and Welfare of Japan; Actelion Pharmaceuticals Japan Ltd	Health and Labour Sciences Research Grant - Ministry of Health, Labour, and Welfare of Japan; Actelion Pharmaceuticals Japan Ltd	This study was financed by the Health and Labour Sciences Research Grant from the Ministry of Health, Labour, and Welfare of Japan, and Actelion Pharmaceuticals Japan Ltd. provided support in the form of salaries for an author [HT], but the funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the "author contributions" section.	Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Chen SC, 2010, J STEROID BIOCHEM, V118, P135, DOI 10.1016/j.jsbmb.2009.11.002; Delcroix M, 2016, CIRCULATION, V133, P859, DOI 10.1161/CIRCULATIONAHA.115.016522; Demir M, 2013, Prague Med Rep, V114, P154; Farber HW, 2015, CHEST, V148, P1043, DOI 10.1378/chest.15-0300; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Iglarz M, 2008, J PHARMACOL EXP THER, V327, P736, DOI 10.1124/jpet.108.142976; Jiang BH, 2016, AM J RESP CELL MOL, V54, P461, DOI 10.1165/rcmb.2014-0488OC; Kuwano K, 2008, J PHARMACOL EXP THER, V326, P691, DOI 10.1124/jpet.108.138305; Latimer CS, 2014, P NATL ACAD SCI USA, V111, pE4359, DOI 10.1073/pnas.1404477111; McLaughlin VV, 2009, J AM COLL CARDIOL, V54, pS97, DOI 10.1016/j.jacc.2009.04.007; Molinari C, 2011, CELL PHYSIOL BIOCHEM, V27, P661, DOI 10.1159/000330075; Muscogiuri G, 2017, ARCH TOXICOL, V91, P97, DOI 10.1007/s00204-016-1804-x; Nakamura K, 2015, BONE, V74, P10, DOI 10.1016/j.bone.2014.12.064; Perros F, 2015, CIRCULATION, V132, P834, DOI 10.1161/CIRCULATIONAHA.115.014207; Pilz S, 2016, NAT REV CARDIOL, V13, P404, DOI 10.1038/nrcardio.2016.73; Pulido T, 2013, NEW ENGL J MED, V369, P809, DOI 10.1056/NEJMoa1213917; Ramirez AM, 2010, J STEROID BIOCHEM, V118, P142, DOI 10.1016/j.jsbmb.2009.11.004; Sitbon O, 2015, NEW ENGL J MED, V373, P2522, DOI 10.1056/NEJMoa1503184; Witte KK, 2016, J AM COLL CARDIOL, V67, P2593, DOI 10.1016/j.jacc.2016.03.508; Yung LM, 2016, AM J RESP CRIT CARE, V194, P1140, DOI 10.1164/rccm.201510-1955OC	21	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180615	10.1371/journal.pone.0180615	http://dx.doi.org/10.1371/journal.pone.0180615			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686688	Green Submitted, Green Published, gold			2022-12-26	WOS:000405464100082
J	Yano, F; Omura, N; Tsuboi, K; Hoshino, M; Yamamoto, S; Akimoto, S; Masuda, T; Kashiwagi, H; Yanaga, K				Yano, Fumiaki; Omura, Nobuo; Tsuboi, Kazuto; Hoshino, Masato; Yamamoto, Seryung; Akimoto, Shunsuke; Masuda, Takahiro; Kashiwagi, Hideyuki; Yanaga, Katsuhiko			Learning curve for laparoscopic Heller myotomy and Dor fundoplication for achalasia	PLOS ONE			English	Article							ORAL ENDOSCOPIC MYOTOMY; ESOPHAGEAL ACHALASIA; SURGERY; OUTCOMES	Purpose Although laparoscopic Heller myotomy and Dor fundoplication (LHD) is widely performed to address achalasia, little is known about the learning curve for this technique. We assessed the learning curve for performing LHD. Methods Of the 514 cases with LHD performed between August 1994 and March 2016, the surgical outcomes of 463 cases were evaluated after excluding 50 cases with reduced port surgery and one case with the simultaneous performance of laparoscopic distal partial gastrectomy. A receiver operating characteristic (ROC) curve analysis was used to identify the cut-off value for the number of surgical experiences necessary to become proficient with LHD, which was defined as the completion of the learning curve. Results We defined the completion of the learning curve when the following 3 conditions were satisfied. 1) The operation time was less than 165 minutes. 2) There was no blood loss. 3) There was no intraoperative complication. In order to establish the appropriate number of surgical experiences required to complete the learning curve, the cut-off value was evaluated by using a ROC curve (AUC 0.717, p < 0.001). Finally, we identified the cut-off value as 16 surgical cases (sensitivity 0.706, specificity 0.646). Conclusion Learning curve seems to complete after performing 16 cases.	[Yano, Fumiaki; Omura, Nobuo; Tsuboi, Kazuto; Hoshino, Masato; Yamamoto, Seryung; Akimoto, Shunsuke; Masuda, Takahiro; Kashiwagi, Hideyuki; Yanaga, Katsuhiko] Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan	Jikei University	Yano, F (corresponding author), Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan.	yano@jikei.ac.jp	Tsuboi, Kazuto/AAN-4313-2021; Yanaga, Katsuhiko/Y-6290-2019	Yanaga, Katsuhiko/0000-0001-8918-4720				[Anonymous], 2016, NIHON GEKA GAKKAI ZA, V21, P689; Bencini L, 2016, WORLD J GASTRO SURG, V8, P52, DOI 10.4240/wjgs.v8.i1.52; Bloomston Mark, 2002, JSLS, V6, P41; Boeckxstaens GE, 2014, LANCET, V383, P83, DOI 10.1016/S0140-6736(13)60651-0; Calhoun JT, 2014, JSLS-J SOC LAPAROEND, V18, P55, DOI 10.4293/108680813X13693422520431; El Zein M, 2016, ENDOSC INT OPEN, V4, pE577, DOI 10.1055/s-0042-104113; Grotenhuis BA, 2008, WORLD J SURG, V32, P1689, DOI 10.1007/s00268-008-9622-9; Hungness ES, 2016, ANN SURG, V264, P508, DOI 10.1097/SLA.0000000000001870; Japanese Society for Esophageal Disease, 2012, DESCR RUL ACH ES; Kurian AA, 2013, GASTROINTEST ENDOSC, V77, P719, DOI 10.1016/j.gie.2012.12.006; Leggett P L, 2002, Surg Endosc, V16, P362, DOI 10.1007/s00464-001-4109-x; Lynch KL, 2012, AM J GASTROENTEROL, V107, P1817, DOI 10.1038/ajg.2012.332; Omura N, 2015, SURG TODAY, V45, P1139, DOI 10.1007/s00595-014-1109-8; Osaka K, 2015, INT J UROL, V22, P1000, DOI 10.1111/iju.12893; Patel KS, 2015, GASTROINTEST ENDOSC, V81, P1181, DOI 10.1016/j.gie.2014.10.002; Pescarus Radu, 2014, Curr Gastroenterol Rep, V16, P369, DOI 10.1007/s11894-013-0369-6; Ricci C, 2015, SURG TODAY, V45, P50, DOI 10.1007/s00595-014-0872-x; Ross SB, 2013, AM SURGEON, V79, P837; Tsuboi K, 2016, SURG ENDOSC, V30, P706, DOI 10.1007/s00464-015-4264-0; Tsuboi K, 2015, WORLD J GASTROENTERO, V21, P10830, DOI 10.3748/wjg.v21.i38.10830; Tsuboi K, 2009, DIS ESOPHAGUS, V22, P169, DOI 10.1111/j.1442-2050.2008.00891.x; Yamakawa T., 2013, BH SURG, V3, P6; Yano Fumiaki, 2008, Int J Surg, V6, P490, DOI 10.1016/j.ijsu.2006.07.007; Zaninotto G, 2014, J GASTROINTEST SURG, V18, P98	24	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180515	10.1371/journal.pone.0180515	http://dx.doi.org/10.1371/journal.pone.0180515			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686640	gold, Green Published			2022-12-26	WOS:000405464100073
J	Kirchner, J; Sawicki, LM; Deusch, C; Gruneisen, J; Beiderwellen, K; Lauenstein, TC; Herrmann, K; Forsting, M; Heusch, P; Umutlu, L				Kirchner, Julian; Sawicki, Lino M.; Deusch, Cornelius; Grueneisen, Johannes; Beiderwellen, Karsten; Lauenstein, Thomas C.; Herrmann, Ken; Forsting, Michael; Heusch, Philipp; Umutlu, Lale			(18) F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine	PLOS ONE			English	Article							DUAL-MODALITY PET/CT; ONCOLOGIC PET/MRI; METASTASES; CT; ADENOMA; CANCER; TUMORS; BOPTA; MRI	Objectives To evaluate the added value of the application of the liver-specific contrast phase of Gadobenate dimeglumine (Gd-BOPTA) for detection and characterization of liver lesions in (18)FFDG PET/MRI. Methods 41 patients with histologically confirmed solid tumors and known / suspected liver metastases or not classifiable lesions in F-18-FDG PET/CT were included in this study. All patients underwent a subsequent Gd-BOPTA enhanced F-18-FDG PET/MRI examination. MRI without liver-specific contrast phase (MRI1), MRI with liver-specific contrast phase (MRI2), F-18-FDG PET/MRI without liver-specific contrast phase (PET/MRI1) and with liver-specific contrast phase (PET/MRI2) were separately evaluated for suspect lesions regarding lesion dignity, characterization, conspicuity and confidence. Results PET/MRI datasets enabled correct identification of 18/18 patients with malignant lesions; MRI datasets correctly identified 17/18 patients. On a lesion-based analysis PET/MRI2 provided highest accuracy for differentiation of lesions into malignant and benign lesions of 98% and 100%. Respective values were 95% and 100% for PET/MRI1, 93% and 96% for MRI2 and 91% and 93% for MRI1. Statistically significant higher diagnostic confidence was found for PET/MRI2 and MRI2 datasets compared to PET/MRI1 and MRI1, respectively (p < 0.001). Conclusion The application of the liver-specific contrast phase in F-18-FDG PET/MRI further increases the diagnostic accuracy and diagnostic confidence for correct assessment of benign and malignant liver lesions.	[Kirchner, Julian; Sawicki, Lino M.; Heusch, Philipp] Univ Dusseldorf, Med Fac, Dept Diagnost & Intervent Radiol, Dusseldorf, Germany; [Deusch, Cornelius; Grueneisen, Johannes; Beiderwellen, Karsten; Lauenstein, Thomas C.; Forsting, Michael; Umutlu, Lale] Univ Hosp Duisburg Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Duisburg, Germany; [Herrmann, Ken] Univ Duisburg Essen, Univ Hosp Essen, Dept Nucl Med, Essen, Germany	Heinrich Heine University Dusseldorf; University of Duisburg Essen; University of Duisburg Essen	Kirchner, J (corresponding author), Univ Dusseldorf, Med Fac, Dept Diagnost & Intervent Radiol, Dusseldorf, Germany.	Julian.Kirchner@med.uni-duesseldorf.de	Herrmann, Ken/GOH-1465-2022	Kirchner, Julian/0000-0001-8224-3433	Bracco, Milano, Italy	Bracco, Milano, Italy	This research was supported in part by a sponsored research agreement with Bracco, Milano, Italy. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Faruque, 2008, Prev Chronic Dis, V5, pA74; Antoch G, 2003, JAMA-J AM MED ASSOC, V290, P3199, DOI 10.1001/jama.290.24.3199; Antoch G, 2003, RADIOLOGY, V229, P526, DOI 10.1148/radiol.2292021598; Beiderwellen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137285; Beiderwellen K, 2013, EUR J RADIOL, V82, pE669, DOI 10.1016/j.ejrad.2013.07.027; Bruegel M, 2008, EUR RADIOL, V18, P477, DOI 10.1007/s00330-007-0785-9; Buchbender C, 2012, J NUCL MED, V53, P1244, DOI 10.2967/jnumed.112.109306; Buchbender C, 2012, J NUCL MED, V53, P928, DOI 10.2967/jnumed.112.105338; Caudana R, 1996, RADIOLOGY, V199, P513, DOI 10.1148/radiology.199.2.8668804; Dokmak S, 2009, GASTROENTEROLOGY, V137, P1698, DOI 10.1053/j.gastro.2009.07.061; Donati OF, 2010, J NUCL MED, V51, P692, DOI 10.2967/jnumed.109.068510; Drzezga A, 2012, J NUCL MED, V53, P845, DOI 10.2967/jnumed.111.098608; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Grazioli L, 2005, RADIOLOGY, V236, P166, DOI 10.1148/radiol.2361040338; Grazioli L, 2013, INT J HEPATOLOGY, V2013, P20; Grueneisen J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157880; Grueneisen J, 2014, INVEST RADIOL, V49, P808, DOI 10.1097/RLI.0000000000000086; Heusch P, 2015, VISZERALMEDIZIN, V31, P387, DOI 10.1159/000441857; Heusch P, 2013, EUR J RADIOL, V82, P870, DOI 10.1016/j.ejrad.2013.01.008; Holzapfel K, 2012, ABDOM IMAGING, V37, P74, DOI 10.1007/s00261-011-9758-1; Imam K, 2000, Magn Reson Imaging Clin N Am, V8, P741; Kele PG, 2010, WORLD J GASTROENTERO, V16, P1567, DOI 10.3748/wjg.v16.i13.1567; Kirchin MA, 1998, INVEST RADIOL, V33, P798, DOI 10.1097/00004424-199811000-00003; Lee DH, 2016, RADIOLOGY, V280, P782, DOI 10.1148/radiol.2016151975; Lee KH, 2013, KOREAN J RADIOL, V14, P894, DOI 10.3348/kjr.2013.14.6.894; Namasivayam Saravanan, 2007, Cancer Imaging, V7, P2, DOI 10.1102/1470-7330.2007.0002; Neri E, 2016, EUR RADIOL, V26, P921, DOI 10.1007/s00330-015-3900-3; Niekel MC, 2010, RADIOLOGY, V257, P674, DOI 10.1148/radiol.10100729; Quick HH, 2014, J MAGN RESON IMAGING, V39, P243, DOI 10.1002/jmri.24523; Riemsma RP, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009498.pub3; Sawicki LM, 2016, EUR J RADIOL, V85, P459, DOI 10.1016/j.ejrad.2015.12.010; Schwartz LH, 1999, RADIOLOGY, V210, P71, DOI 10.1148/radiology.210.1.r99ja0371; Silva AC, 2009, RADIOGRAPHICS, V29, P385, DOI 10.1148/rg.292085123; Spinazzi A, 1999, ACAD RADIOL, V6, P282, DOI 10.1016/S1076-6332(99)80451-6; Thomeer MG, 2016, THER ADV GASTROENTER, V9, P898, DOI 10.1177/1756283X16663882; van Aalten SM, 2012, BRIT J SURG, V99, P911, DOI 10.1002/bjs.8762; van Kessel CS, 2012, ANN SURG ONCOL, V19, P2805, DOI 10.1245/s10434-012-2300-z; Ward J, 2006, Cancer Imaging, V6, P33, DOI 10.1102/1470-7330.2006.0007; WEISS L, 1986, J PATHOL, V150, P195, DOI 10.1002/path.1711500308	39	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180349	10.1371/journal.pone.0180349	http://dx.doi.org/10.1371/journal.pone.0180349			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683109	Green Published, Green Submitted, gold			2022-12-26	WOS:000405335200024
J	Broussard, S; Hickok, G; Saberi, K				Broussard, Sierra; Hickok, Gregory; Saberi, Kourosh			Robustness of speech intelligibility at moderate levels of spectral degradation	PLOS ONE			English	Article							HUMAN LISTENING TESTS; AUDITORY-PERCEPTION; CORTICAL OSCILLATIONS; TEMPORAL ENVELOPE; PHASE SPECTRUM; FINE-STRUCTURE; CUES; DISCRIMINATION; COMPREHENSION; RECOGNITION	The current study investigated how amplitude and phase information differentially contribute to speech intelligibility. Listeners performed a word-identification task after hearing spectrally degraded sentences. Each stimulus was degraded by first dividing it into segments, then the amplitude and phase components of each segment were decorrelated independently to various degrees relative to those of the original segment. Segments were then concatenated into their original sequence to present to the listener. We used three segment lengths: 30 ms (phoneme length), 250 ms (syllable length), and full sentence (non-segmented). We found that for intermediate spectral correlation values, segment length is generally inconsequential to intelligibility. Overall, intelligibility was more adversely affected by phase-spectrum decorrelation than by amplitude-spectrum decorrelation. If the phase information was left intact, decorrelating the amplitude spectrum to intermediate values had no effect on intelligibility. If the amplitude information was left intact, decorrelating the phase spectrum to intermediate values significantly degraded intelligibility. Some exceptions to this rule are described. These results delineate the range of amplitude- and phase-spectrum correlations necessary for speech processing and its dependency on the temporal window of analysis (phoneme or syllable length). Results further point to the robustness of speech information in environments that acoustically degrade cues to intelligibility (e.g., reverberant or noisy environments).	[Broussard, Sierra; Hickok, Gregory; Saberi, Kourosh] Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA	University of California System; University of California Irvine	Broussard, S (corresponding author), Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA.	sbroussa@uci.edu	Saberi, Kourosh/GXG-0944-2022		National Institutes of Health [R01 DC009659]; National Institute on Deafness and Other Disorders [T32DC010775]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Deafness and Other Disorders	This work was supported by National Institutes of Health (nih.gov) grant R01 DC009659 (KS) and National Institute on Deafness and Other Disorders (nidcd.nih.gov) training-grant fellowship T32DC010775 (SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsteris LD, 2006, SPEECH COMMUN, V48, P727, DOI 10.1016/j.specom.2005.10.005; Baltzell LS, 2016, BRAIN RES, V1644, P203, DOI 10.1016/j.brainres.2016.05.029; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; DORMAN MF, 1980, J PHONETICS, V8, P397, DOI 10.1016/S0095-4470(19)31496-2; DRULLMAN R, 1994, J ACOUST SOC AM, V95, P1053, DOI 10.1121/1.408467; Fisher N., 1995, STAT ANAL CIRCULAR D; Fry DB, 1968, MANUAL PHONETICS, P365; Gilbert G, 2006, J ACOUST SOC AM, V119, P2438, DOI 10.1121/1.2173522; Giraud AL, 2007, NEURON, V56, P1127, DOI 10.1016/j.neuron.2007.09.038; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; Greenberg S, 1998, ICSLP; HARRIS KS, 1958, LANG SPEECH, V1, P1; HAZAN V, 1991, PERCEPT PSYCHOPHYS, V49, P187, DOI 10.3758/BF03205038; Howard MF, 2010, J NEUROPHYSIOL, V104, P2500, DOI 10.1152/jn.00251.2010; Lehiste I., 1970, SUPRASEGMENTALS; Liu L, 1997, SPEECH COMMUN, V22, P403, DOI 10.1016/S0167-6393(97)00054-X; Luo H, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00170; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; OPPENHEIM AV, 1981, P IEEE, V69, P529, DOI 10.1109/PROC.1981.12022; Paliwal KK, 2005, SPEECH COMMUN, V45, P153, DOI 10.1016/j.specom.2004.08.001; Peelle JE, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00320; REPP BH, 1978, J EXP PSYCHOL HUMAN, V4, P621, DOI 10.1037/0096-1523.4.4.621; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Shi GJ, 2006, IEEE T AUDIO SPEECH, V14, P1867, DOI 10.1109/TSA.2005.858512; Smith ZM, 2002, NATURE, V416, P87, DOI 10.1038/416087a; SOLI SD, 1983, J ACOUST SOC AM, V73, P2150, DOI 10.1121/1.389539; SUMMERFIELD Q, 1981, PHONETICA, V38, P181, DOI 10.1159/000260022; TRAUNMULLER H, 1987, SPEECH COMMUN, V6, P143, DOI 10.1016/0167-6393(87)90037-9; Zeng FG, 2004, J ACOUST SOC AM, V116, P1351, DOI 10.1121/1.1777938	31	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180734	10.1371/journal.pone.0180734	http://dx.doi.org/10.1371/journal.pone.0180734			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2LF	28678831	Green Published, Green Submitted, gold			2022-12-26	WOS:000405272200087
J	Navarro, BV; Elbl, P; de Souza, AP; Jardim, V; de Oliveira, LF; Macedo, AF; dos Santos, ALW; Buckeridge, MS; Floh, EIS				Navarro, Bruno V.; Elbl, Paula; de Souza, Amanda P.; Jardim, Vinicius; de Oliveira, Leandro F.; Macedo, Amanda F.; dos Santos, Andre L. W.; Buckeridge, Marcos S.; Floh, Eny I. S.			Carbohydrate-mediated responses during zygotic and early somatic embryogenesis in the endangered conifer, Araucaria angustifolia	PLOS ONE			English	Article							NORWAY SPRUCE; SEED DEVELOPMENT; BRAZILIAN PINE; ABSCISIC-ACID; EMBRYO DEVELOPMENT; PROTEOMIC ANALYSIS; GENE-EXPRESSION; PLANT-GROWTH; TREHALOSE-6-PHOSPHATE; METABOLISM	Three zygotic developmental stages and two somatic Araucaria angustifolia cell lines with contrasting embryogenic potential were analyzed to identify the carbohydrate-mediated responses associated with embryo formation. Using a comparison between zygotic and somatic embryogenesis systems, the non-structural carbohydrate content, cell wall sugar composition and expression of genes involved in sugar sensing were analyzed, and a network analysis was used to identify coordinated features during embryogenesis. We observed that carbohydrate-mediated responses occur mainly during the early stages of zygotic embryo formation, and that during seed development there are coordinated changes that affect the development of the different structures (embryo and megagametophyte). Furthermore, sucrose and starch accumulation were associated with the responsiveness of the cell lines. This study sheds light on how carbohydrate metabolism is influenced during zygotic and somatic embryogenesis in the endangered conifer species, A. angustifolia.	[Navarro, Bruno V.; Elbl, Paula; de Oliveira, Leandro F.; Macedo, Amanda F.; dos Santos, Andre L. W.; Floh, Eny I. S.] Univ Sao Paulo, Inst Biosci, Dept Bot, Lab Plant Cell Biol, Sao Paulo, SP, Brazil; [de Souza, Amanda P.; Jardim, Vinicius] Univ Sao Paulo, Inst Biosci, Dept Bot, Lab Plant Physiol Ecol, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Floh, EIS (corresponding author), Univ Sao Paulo, Inst Biosci, Dept Bot, Lab Plant Cell Biol, Sao Paulo, SP, Brazil.	enyfloh@usp.br	de Oliveira, Leandro Francisco/ACG-6315-2022; de Oliveira, Leandro Francisco/I-4521-2012; Buckeridge, Marcos Silveira/E-7773-2012; Macedo, Amanda Ferreira F/L-2166-2014; Navarro, Bruno/N-3800-2014; Iochevet Segal Floh, Eny/D-9526-2012	de Oliveira, Leandro Francisco/0000-0002-5318-2771; de Oliveira, Leandro Francisco/0000-0002-5318-2771; Buckeridge, Marcos Silveira/0000-0002-5455-8136; Navarro, Bruno/0000-0001-9289-4328; De Souza, Amanda/0000-0002-7237-6483; Iochevet Segal Floh, Eny/0000-0001-6529-2065	Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior; Fundagao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo, Brazil	Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior; Fundagao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	BN, AS, LO, VJ and AWS were recipients of fellowships from the Fundagao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapespbr/), Sao Paulo, Brazil. PE was funded by a fellowship from Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (http://wwwcapesgov.br/). This research was carried out with financial support from Fundagao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo, Brazil.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amaral LIV, 2008, HOEHNEA, V34, P425; Anderson GH, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-12; [Anonymous], 2015, PHYTOZOME 11 PLANT G; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Birnbaum KD, 2008, CELL, V132, P697, DOI 10.1016/j.cell.2008.01.040; Blochl A, 2005, PLANT SCI, V168, P1075, DOI 10.1016/j.plantsci.2004.12.004; Braybrook SA, 2008, TRENDS PLANT SCI, V13, P624, DOI 10.1016/j.tplants.2008.09.008; Businge E, 2014, TREE PHYSIOL, V34, P657, DOI 10.1093/treephys/tpu053; Businge E, 2012, TREE PHYSIOL, V32, P232, DOI 10.1093/treephys/tpr142; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caldana C, 2013, PLANT J, V73, P897, DOI 10.1111/tpj.12080; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; de Oliveira LF, 2017, TREE PHYSIOL, V37, P116, DOI 10.1093/treephys/tpw107; de Souza AP, 2013, BIOENERG RES, V6, P564, DOI 10.1007/s12155-012-9268-1; de Souza AP, 2013, AGR FOREST METEOROL, V171, P82, DOI 10.1016/j.agrformet.2012.11.006; Delatte TL, 2011, PLANT PHYSIOL, V157, P160, DOI 10.1104/pp.111.180422; Deprost D, 2005, BIOCHEM BIOPH RES CO, V326, P844, DOI 10.1016/j.bbrc.2004.11.117; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Dobrenel T, 2016, ANNU REV PLANT BIOL, V67, P261, DOI 10.1146/annurev-arplant-043014-114648; Dobrenel T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00093; dos Santos ALW, 2008, BIOL PLANTARUM, V52, P195, DOI 10.1007/s10535-008-0044-1; Eastmond PJ, 2002, PLANT J, V29, P225, DOI 10.1046/j.1365-313x.2002.01220.x; Elbl P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136714; Elbl P, 2015, PLANT CELL TISS ORG, V120, P903, DOI 10.1007/s11240-014-0523-3; Eveland AL, 2012, J EXP BOT, V63, P3367, DOI 10.1093/jxb/err379; Figueroa CM, 2016, PLANT PHYSIOL, V172, P7, DOI 10.1104/pp.16.00417; Fonseca BD, 2014, SEMIN CELL DEV BIOL, V36, P102, DOI 10.1016/j.semcdb.2014.09.014; Gaj MD, 2011, METHODS MOL BIOL, V710, P257, DOI 10.1007/978-1-61737-988-8_18; Gosslova M, 2001, IN VITRO CELL DEV-PL, V37, P24, DOI 10.1007/s11627-001-0005-2; Grigova M, 2007, TREE PHYSIOL, V27, P1533, DOI 10.1093/treephys/27.11.1533; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gutierrez L, 2007, TRENDS PLANT SCI, V12, P294, DOI 10.1016/j.tplants.2007.06.003; Harada JJ, 2010, PLANT EMBRYOGENESIS; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Hincha DK, 2003, BBA-BIOMEMBRANES, V1612, P172, DOI 10.1016/S0005-2736(03)00116-0; Hudec L, 2016, TREE PHYSIOL, V36, P548, DOI 10.1093/treephys/tpw016; Husson F, 2007, FACTOMINER PACKAGE 2; Iraqi D, 2001, J EXP BOT, V52, P2301, DOI 10.1093/jexbot/52.365.2301; Jo L, 2014, TREE PHYSIOL, V34, P94, DOI 10.1093/treephys/tpt102; Kim YW, 2014, PLANT BIOTECHNOL REP, V8, P259, DOI 10.1007/s11816-014-0319-2; Klimaszewska K, 2004, PHYSIOL PLANTARUM, V121, P682, DOI 10.1111/j.1399-3054.2004.00370.x; Konradova H, 2002, J PLANT PHYSIOL, V159, P387, DOI 10.1078/0176-1617-00624; Kube M, 2014, IN VITRO CELL DEV-PL, V50, P45, DOI 10.1007/s11627-013-9589-6; Lastdrager J, 2014, J EXP BOT, V65, P799, DOI 10.1093/jxb/ert474; Leljak-Levanic D, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1875-y; Lelu-Walter MA, 2006, PLANT CELL REP, V25, P767, DOI 10.1007/s00299-006-0115-8; Lelu-Walter MA, 2013, TREE GENET GENOMES, V9, P883, DOI 10.1007/s11295-013-0620-1; Li L, 2016, CURR OPIN PLANT BIOL, V33, P116, DOI 10.1016/j.pbi.2016.06.018; Lipavska H, 2000, IN VITRO CELL DEV-PL, V36, P260, DOI 10.1007/s11627-000-0048-9; Lipavska H, 2004, IN VITRO CELL DEV-PL, V40, P23, DOI 10.1079/IVP2003482; Lunn JE, 2014, PLANT J, V79, P544, DOI 10.1111/tpj.12509; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maegawa K, 2015, MOL GENET GENOMICS, V290, P2019, DOI 10.1007/s00438-015-1056-0; Merkle SA, 2000, CURR OPIN BIOTECH, V11, P298, DOI 10.1016/S0958-1669(00)00099-9; Morel A, 2014, PLANTA, V240, P1075, DOI 10.1007/s00425-014-2125-z; Nishizawa A, 2008, PLANT PHYSIOL, V147, p[1251, 108]; Park YS, 2006, PLANT CELL TISS ORG, V86, P87, DOI 10.1007/s11240-006-9101-7; Pullman GS, 2008, TREE PHYSIOL, V28, P985, DOI 10.1093/treephys/28.7.985; Pullman GS, 2003, PLANT CELL REP, V22, P85, DOI 10.1007/s00299-003-0673-y; R Development Core Team, 2015, LANG ENV STAT COMP R; Radchuk R, 2006, PLANT PHYSIOL, V140, P263, DOI 10.1104/pp.105.071167; Robaglia C, 2012, CURR OPIN PLANT BIOL, V15, P301, DOI 10.1016/j.pbi.2012.01.012; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schlogl PS, 2012, PLANT CELL TISS ORG, V108, P173, DOI 10.1007/s11240-011-0023-7; Silveira V, 2008, BIOL PLANTARUM, V52, P101, DOI 10.1007/s10535-008-0018-3; Smeekens S, 2010, CURR OPIN PLANT BIOL, V13, P274, DOI 10.1016/j.pbi.2009.12.002; Steiner N, 2008, FUNCT PLANT SCI BIOT, V2, P20; Su YH, 2009, PLANT J, V59, P448, DOI 10.1111/j.1365-313X.2009.03880.x; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; ten Hove CA, 2015, DEVELOPMENT, V142, P420, DOI 10.1242/dev.111500; Tereso S, 2007, TREE PHYSIOL, V27, P661, DOI 10.1093/treephys/27.5.661; Tome F, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00353; van Hengel AJ, 2002, PHYSIOL PLANTARUM, V114, P637, DOI 10.1034/j.1399-3054.2002.1140418.x; Vandesteene L, 2012, PLANT PHYSIOL, V160, P884, DOI 10.1104/pp.112.201400; Vieira LD, 2012, PLANT SCI, V195, P80, DOI 10.1016/j.plantsci.2012.06.011; von Arnold S, 2002, PLANT CELL TISS ORG, V69, P233, DOI 10.1023/A:1015673200621; Wahl V, 2013, SCIENCE, V339, P704, DOI 10.1126/science.1230406; dos Santos ALW, 2016, J PROTEOMICS, V130, P180, DOI 10.1016/j.jprot.2015.09.027; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xiang DQ, 2011, PLANT PHYSIOL, V156, P346, DOI 10.1104/pp.110.171702; Xiong Y, 2014, PLANT PHYSIOL, V164, P499, DOI 10.1104/pp.113.229948; Yang HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042438; Zhang Y, 2013, MOL PLANT, V6, P1731, DOI 10.1093/mp/sst094	87	18	18	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180051	10.1371/journal.pone.0180051	http://dx.doi.org/10.1371/journal.pone.0180051			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678868	Green Published, Green Submitted, gold			2022-12-26	WOS:000405272200036
J	Grimm, I; Garben, N; Dreier, J; Knabbe, C; Vollmer, T				Grimm, Imke; Garben, Nina; Dreier, Jens; Knabbe, Cornelius; Vollmer, Tanja			Transcriptome analysis of Streptococcus gallolyticus subsp gallolyticus in interaction with THP-1 macrophage-like cells	PLOS ONE			English	Article							BOVIS; ASSOCIATION; SUSCEPTIBILITY; PHAGOCYTOSIS; PNEUMONIAE; MECHANISMS; BACTERIA; ABILITY; GENOME; ACID	Background Streptococcus gallolyticus subsp. gallolyticus (S. gallolyticus) is a pathogen of infective endocarditis. It was observed previously that this bacterium survives longer in macrophages than other species and the phagocytic uptake by and survival in THP-1 macrophages is strain-dependent. Methods The phagocytosis assay was performed with THP-1 macrophages. S. gallolyticus specific whole genome microarrays were used for transcriptome analysis. Results Better survival in macrophages was observed for UCN34, BAA-2069 and ATCC43143 than for DSM16831 and LMG17956. S. gallolyticus strains show high resistance to tested bactericidal agents (acid, lysozyme and hydrogen peroxide). S. gallolyticus stimulates significant lower cytokine gene expression and causes less lysis of macrophages compared to the control strain Staphylococcus aureus. S. gallolyticus reacts to oxidative burst with a higher gene expression of NADH oxidase initially at the early phase. Expression of genes involved in Dalanylation of teichoic acid, carbohydrate metabolism and transport systems were upregulated thereafter. Conclusion S. gallolyticus is very resistant to bactericidal agents normally causing degradation of bacteria in phagolysosomes. Additionally, the D-alanylation of teichoic acid is an important factor for survival.	[Grimm, Imke; Garben, Nina; Dreier, Jens; Knabbe, Cornelius; Vollmer, Tanja] Ruhr Univ Bochum, Univ Klinikum, Inst Lab & Transfus Med Herz & Diabet Zentrum Nor, Bad Oeynhausen, Germany	Ruhr University Bochum	Vollmer, T (corresponding author), Ruhr Univ Bochum, Univ Klinikum, Inst Lab & Transfus Med Herz & Diabet Zentrum Nor, Bad Oeynhausen, Germany.	tvollmer@hdz-nrw.de	Vollmer, Tanja/F-1149-2013	Vollmer, Tanja/0000-0001-7032-5423				Abdulamir AS, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-11; Abeni Chiara, 2013, J Med Case Rep, V7, P185, DOI 10.1186/1752-1947-7-185; Aderem A, 2003, J INFECT DIS, V187, pS340, DOI 10.1086/374747; Baker JL, 2014, J BACTERIOL, V196, P2166, DOI 10.1128/JB.01542-14; Benoit M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008939; Boleij A, 2011, J INFECT DIS, V203, P1101, DOI 10.1093/infdis/jiq169; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; DARJEE R, 1993, J CLIN PATHOL, V46, P1116, DOI 10.1136/jcp.46.12.1116; Davis KM, 2011, INFECT IMMUN, V79, P562, DOI 10.1128/IAI.00651-10; DEHERDT P, 1995, VET MICROBIOL, V45, P157, DOI 10.1016/0378-1135(95)00035-9; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Dupre-Crochet S, 2013, J LEUKOCYTE BIOL, V94, P657, DOI 10.1189/jlb.1012544; El Aamri F, 2015, MICROBES INFECT, V17, P258, DOI 10.1016/j.micinf.2014.06.006; Haas A, 2007, TRAFFIC, V8, P311, DOI 10.1111/j.1600-0854.2006.00531.x; Hinse D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-400; Jung CJ, 2009, MOL MICROBIOL, V74, P888, DOI 10.1111/j.1365-2958.2009.06903.x; Kaneko M, 2016, YONSEI MED J, V57, P283, DOI 10.3349/ymj.2016.57.2.283; Kohro Takahide, 2004, J Atheroscler Thromb, V11, P88; Kurtovic A, 2003, J CLIN MICROBIOL, V41, P3951, DOI 10.1128/JCM.41.8.3951-3954.2003; Lazarovitch T, 2013, INFECTION, V41, P329, DOI 10.1007/s15010-012-0314-x; Lin IH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020519; Masoudian M, 2015, IRAN J VET RES, V16, P368; Mouithys-Mickalad A, 2004, BIOCHEM BIOPH RES CO, V325, P1122, DOI 10.1016/j.bbrc.2004.10.155; Nusse O, 2011, THESCIENTIFICWORLDJO, V11, P2364, DOI 10.1100/2011/741046; Olmos C, 2016, AM HEART J, V171, P7, DOI 10.1016/j.ahj.2015.10.012; Poyart C, 2003, MOL MICROBIOL, V49, P1615, DOI 10.1046/j.1365-2958.2003.03655.x; Reichmann NT, 2013, MICROBIOL-SGM, V159, P1868, DOI 10.1099/mic.0.069898-0; Romero-Hernandez B, 2015, ANTIMICROB AGENTS CH, V59, P2006, DOI 10.1128/AAC.04083-14; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Rusniok C, 2010, J BACTERIOL, V192, P2266, DOI 10.1128/JB.01659-09; Smith LM, 2013, BIOCHEM SOC T, V41, P475, DOI 10.1042/BST20130014; Song XM, 2009, GENOMICS, V93, P72, DOI 10.1016/j.ygeno.2008.09.008; Srisuwan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110321; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vollmer T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-78; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0	38	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180044	10.1371/journal.pone.0180044	http://dx.doi.org/10.1371/journal.pone.0180044			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672015	gold, Green Published, Green Submitted			2022-12-26	WOS:000405268500013
J	Lucas, JMEX; Crollius, HR				Lucas, Joseph M. E. X.; Crollius, Hugues Roest			High precision detection of conserved segments from synteny blocks	PLOS ONE			English	Article							GENOME REARRANGEMENTS; ADHORE	A conserved segment, i.e. a segment of chromosome unbroken during evolution, is an important operational concept in comparative genomics. Until now, algorithms that are designed to identify conserved segments often return synteny blocks that overlap, synteny blocks that include micro-rearrangements or synteny blocks erroneously short. Here we present definitions of conserved segments and synteny blocks independent of any heuristic method and we describe four new post-processing strategies to refine synteny blocks into accurate conserved segments. The first strategy identifies micro-rearrangements, the second strategy identifies mono-genic conserved segments, the third returns non-overlapping segments and the fourth repairs incorrect ruptures of synteny. All these refinements are implemented in a new version of PhylDiag that has been benchmarked against i-ADHoRe 3.0 and Cyntenator, based on a realistic simulated evolution and true simulated conserved segments.	[Lucas, Joseph M. E. X.; Crollius, Hugues Roest] Univ Paris, Ecole Normale Super, Dept Biol, IBENS,CNRS,Inserm,PSL Res, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite	Lucas, JMEX; Crollius, HR (corresponding author), Univ Paris, Ecole Normale Super, Dept Biol, IBENS,CNRS,Inserm,PSL Res, Paris, France.	jlucas@ens.fr; hrc@ens.fr		ROEST CROLLIUS, Hugues/0000-0002-8209-173X	Centre National de la Recherche Scientifique (CNRS); program "Investissements d'Avenir" launched by the French Government; Agence Nationale de la Recherche (ANR) [ANR-10-BINF-01-03]; Memo Life project [ANR1 0-LABX-54 MEMO LIFE]; Paris Science set Lettres (PSL) Research University [ANR-11-IDEX-0001-02]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); program "Investissements d'Avenir" launched by the French Government(French National Research Agency (ANR)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Memo Life project; Paris Science set Lettres (PSL) Research University	The work of JMEXL and HRC has been funded by Centre National de la Recherche Scientifique (CNRS), the program "Investissements d'Avenir" launched by the French Government, the Agence Nationale de la Recherche (ANR) [Grant: Ancestrome Project ANR-10-BINF-01-03] and received support from the Memo Life project [ANR1 0-LABX-54 MEMO LIFE]. The work of HRC has also been funded by Paris Science set Lettres (PSL) Research University [ANR-11-IDEX-0001-02 PSL* Research University]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafna V, 1996, DISCRETE APPL MATH, V71, P41, DOI 10.1016/S0166-218X(96)00063-7; Chaisson MJ, 2006, P NATL ACAD SCI USA, V103, P19824, DOI 10.1073/pnas.0603984103; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Ghiurcuta CG, 2014, BIOINFORMATICS, V30, P9, DOI 10.1093/bioinformatics/btu259; Kehr B, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-99; Lefebvre JF, 2003, BIOINFORMATICS, V19, pi190, DOI 10.1093/bioinformatics/btg1025; Lemaitre C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-286; Lucas JM, 2016, ETUDE EVOLUTION ORDR; Lucas JM, 2014, BMC BIOINFORMATICS, V15, P1; Ma J, 2008, P NATL ACAD SCI USA, V105, P14254, DOI 10.1073/pnas.0805217105; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; Noutahi E., 2015, EFFICIENT GENE TREE; Pan D, 2008, COMP FUNCT GENOM, DOI 10.1155/2008/545269; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Paten B, 2011, J COMPUT BIOL, V18, P469, DOI 10.1089/cmb.2010.0252; Peng Q, 2006, PLOS COMPUT BIOL, V2, P100, DOI 10.1371/journal.pcbi.0020014; Pevzner P, 2003, P NATL ACAD SCI USA, V100, P7672, DOI 10.1073/pnas.1330369100; Pevzner P, 2003, GENOME RES, V13, P37, DOI 10.1101/gr.757503; Pham SK, 2010, BIOINFORMATICS, V26, P2509, DOI 10.1093/bioinformatics/btq465; Proost S, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr955; Rodelsperger C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008861; Sankoff D, 2006, PLOS COMPUT BIOL, V2, P320, DOI 10.1371/journal.pcbi.0020035; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Tesler G, 2002, BIOINFORMATICS, V18, P492, DOI 10.1093/bioinformatics/18.3.492; Vandepoele K, 2002, GENOME RES, V12, P1792, DOI 10.1101/gr.400202	25	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180198	10.1371/journal.pone.0180198	http://dx.doi.org/10.1371/journal.pone.0180198			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671949	Green Published, Green Submitted, gold			2022-12-26	WOS:000405268500026
J	MacGlashan, D				MacGlashan, Donald, Jr.			FceRI density and spontaneous secretion from human basophils	PLOS ONE			English	Article							BIVALENT PENICILLOYL HAPTENS; IGE-MEDIATED STIMULATION; CELL-SURFACE ANTIBODY; FC-EPSILON-RI; HISTAMINE-RELEASE; LEUKEMIA-CELLS; MEMBRANE TARGETS; IMMUNOGLOBULIN-E; MAST-CELLS; RECEPTOR	Mast cells and basophils depend on aggregation of the high-affinity IgE receptor, FceRI, to initiate secretion. A variety of studies have shown that FceRI densities vary 100 fold among subjects' basophils and it has been speculated that high densities might be responsible for unusual behaviors of the cells, notably sensitivity to certain monomeric IgE antibodies or spontaneous release. These studies experimentally examined the density dependence of spontaneous release and signaling element expression in subjects' basophils with FceRI densities ranging from approximately 6000 to 600,000 per cell. Through the use of numerical simulation, this study examined the expectations for spontaneous receptor aggregation and aggregate persistence at densities of FceRI ranging from 5000 to 500,000. Experimentally, FceRI density was not associated with greater spontaneous histamine release even when secretion was enhanced by the inclusion of deuterium oxide in the buffers. There was also no association of 15 activating or de-activating signaling elements with FceRI density. The numerical simulations demonstrated that at densities of approximate to 500,000 receptors, 13% of receptors were involved in transient aggregates at any given moment but that these aggregates rarely persisted for greater than 10 milliseconds. In contrast, a weak linear antigen aggregator, with ligand affinities known to induce secretion, would generate aggregates persisting for an average of approximate to 60 milliseconds. These results suggest that although a high density of FceRI likely produces a large number of transient aggregates, these aggregates do not persist long enough to induce signaling that results in secretion and do not induce the cells to alter their expression of several signaling elements known to be important in regulating secretion from human basophils. The results set some boundaries on the aggregation requirements for inducing histamine release from human basophils.	[MacGlashan, Donald, Jr.] Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine	MacGlashan, D (corresponding author), Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD 21224 USA.	dmacglas@jhmi.edu			National Institutes of Health [AI20253, AI100952]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI100952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health, grants AI20253 and AI100952 supported all aspects of this study but had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; BALAKRISHNAN K, 1982, J BIOL CHEM, V257, P6427; COOPER AD, 1981, J BIOL CHEM, V256, P9379; DEMBO M, 1978, J IMMUNOL, V121, P354; DEMBO M, 1979, J IMMUNOL, V122, P518; DEMBO M, 1978, J IMMUNOL, V121, P345; GILBERT HS, 1975, BLOOD, V46, P279; GILLESPIE E, 1972, J CLIN INVEST, V51, P2941, DOI 10.1172/JCI107118; Hlavacek WS, 2001, P NATL ACAD SCI US; Ishmael S, 2009, J LEUKOCYTE BIOL, V86, P313, DOI 10.1189/jlb.1208724; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; KANE P, 1990, IMMUNOL INVEST, V19, P1, DOI 10.3109/08820139009042022; Kashiwakura JI, 2012, ALLERGY ASTHMA IMMUN, V4, P332, DOI 10.4168/aair.2012.4.6.332; Kawakami T, 2005, J IMMUNOL, V175, P4167, DOI 10.4049/jimmunol.175.7.4167; Lavens-Phillips SE, 2000, AM J RESP CELL MOL, V23, P566, DOI 10.1165/ajrcmb.23.4.4123; Liu ZJ, 2001, P NATL ACAD SCI USA, V98, P7289, DOI 10.1073/pnas.121171998; MacGlashan D, 2001, J LEUKOCYTE BIOL, V70, P207; MacGlashan D, 2001, J LEUKOCYTE BIOL, V69, P224; MacGlashan DW, 2007, J LEUKOCYTE BIOL, V82, P1003, DOI 10.1189/jlb.0207103; MacGlashan DW, 2007, J ALLERGY CLIN IMMUN, V119, P626, DOI 10.1016/j.jaci.2006.09.040; MacGlashan DW, 2013, J ALLERGY CLIN IMMUN, V132, P906, DOI 10.1016/j.jaci.2013.04.056; MacGlashan DW, 2012, J ALLERGY CLIN IMMUN, V130, P1130, DOI 10.1016/j.jaci.2012.05.038; MACGLASHAN DW, 1983, J IMMUNOL, V130, P4; MACGLASHAN DW, 1985, J IMMUNOL, V135, P4129; MACGLASHAN DW, 1986, J IMMUNOL, V136, P2231; MACGLASHAN DW, 1993, J ALLERGY CLIN IMMUN, V91, P605, DOI 10.1016/0091-6749(93)90266-I; MacGlashan DW, 1997, J IMMUNOL, V158, P1438; Mao SY, 1997, J BIOL CHEM, V272, P14067, DOI 10.1074/jbc.272.22.14067; Schweitzer-Stenner R, 2005, J IMMUNOL, V174, P4461, DOI 10.4049/jimmunol.174.8.4461; Sil D, 2007, ACS CHEM BIOL, V2, P674, DOI 10.1021/cb7001472; SIRAGANIAN RP, 1974, ANAL BIOCHEM, V57, P383, DOI 10.1016/0003-2697(74)90093-1; TUNG R, 1982, J IMMUNOL, V128, P2067; WEIS RM, 1982, J BIOL CHEM, V257, P6440; Wofsy C, 1997, J IMMUNOL, V159, P5984; Xie LP, 2008, J ALLERGY CLIN IMMUN, V121, P1027, DOI 10.1016/j.jaci.2007.12.1157; Zaidi AK, 2010, J ALLERGY CLIN IMMUN, V125, P902, DOI 10.1016/j.jaci.2009.12.996	36	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0179734	10.1371/journal.pone.0179734	http://dx.doi.org/10.1371/journal.pone.0179734			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671980	gold, Green Submitted, Green Published			2022-12-26	WOS:000405268500005
J	Kumar, R; de Mooij, T; Peterson, TE; Kaptzan, T; Johnson, AJ; Daniels, DJ; Parney, IF				Kumar, Ravi; de Mooij, Tristan; Peterson, Timothy E.; Kaptzan, Tatiana; Johnson, Aaron J.; Daniels, David J.; Parney, Ian F.			Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; BROCCOLI SPROUT BEVERAGES; ISOTHIOCYANATE SULFORAPHANE; MACROPHAGE INFILTRATION; IMMUNE SUPPRESSION; PERIPHERAL-BLOOD; CLINICAL-TRIAL; CANCER; GLIOBLASTOMA; EXPRESSION	Glioblastoma is the most common primary tumor of the brain and has few long-term survivors. The local and systemic immunosuppressive environment created by glioblastoma allows it to evade immunosurveillance. Myeloid-derived suppressor cells (MDSCs) are a critical component of this immunosuppression. Understanding mechanisms of MDSC formation and function are key to developing effective immunotherapies. In this study, we developed a novel model to reliably generate human MDSCs from healthy-donor CD14(+) monocytes by culture in human glioma-conditioned media. Monocytic MDSC frequency was assessed by flow cytometry and confocal microscopy. The resulting MDSCs robustly inhibited T cell proliferation. A cytokine array identified multiple components of the GCM potentially contributing to MDSC generation, including Monocyte Chemoattractive Protein-1, interleukin-6, interleukin-8, and Macrophage Migration Inhibitory Factor (MIF). Of these, Macrophage Migration Inhibitory Factor is a particularly attractive therapeutic target as sulforaphane, a naturally occurring MIF inhibitor derived from broccoli sprouts, has excellent oral bioavailability. Sulforaphane inhibits the transformation of normal monocytes to MDSCs by glioma-conditioned media in vitro at pharmacologically relevant concentrations that are non-toxic to normal leukocytes. This is associated with a corresponding increase in mature dendritic cells. Interestingly, sulforaphane treatment had similar pro-inflammatory effects on normal monocytes in fresh media but specifically increased immature dendritic cells. Thus, we have used a simple in vitro model system to identify a novel contributor to glioblastoma immunosuppression for which a natural inhibitor exists that increases mature dendritic cell development at the expense of myeloidderived suppressor cells when normal monocytes are exposed to glioma conditioned media.	[Kumar, Ravi; de Mooij, Tristan; Peterson, Timothy E.; Kaptzan, Tatiana; Daniels, David J.; Parney, Ian F.] Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA; [Johnson, Aaron J.; Parney, Ian F.] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Parney, IF (corresponding author), Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA.; Parney, IF (corresponding author), Mayo Clin, Dept Immunol, Rochester, MN 55905 USA.	parney.ian@mayo.edu		Parney, Ian/0000-0002-9702-8047	Brains Together For a Cure [BTFC-0004]; National Institutes of Health Training Grant [T32NS07494]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007494] Funding Source: NIH RePORTER	Brains Together For a Cure; National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by Brains Together For a Cure (BTFC-0004; http://www.brainstogetherforacure.org). Dr. Kumar received support via the National Institutes of Health Training Grant T32NS07494 (https://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Brian J, 2013, Cancers (Basel), V5, P1379, DOI 10.3390/cancers5041379; Atai NA, 2011, IMMUNOLOGY, V132, P39, DOI 10.1111/j.1365-2567.2010.03335.x; Baron N, 2011, J NEUROSCI RES, V89, P711, DOI 10.1002/jnr.22595; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Bronte V, 2009, EUR J IMMUNOL, V39, P2670, DOI 10.1002/eji.200939892; Chae M, 2014, NEUROONCOL; Chen MF, 2014, ONCOTARGET, V5, P8716, DOI 10.18632/oncotarget.2368; Clarke JD, 2011, PHARM RES-DORDR, V28, P3171, DOI 10.1007/s11095-011-0500-z; Cripps JG, 2011, INT IMMUNOPHARMACOL, V11, P789, DOI 10.1016/j.intimp.2011.01.026; Dietz AB, 2006, TRANSFUSION, V46, P2083, DOI 10.1111/j.1537-2995.2006.01033.x; Doedens AL, 2010, CANCER RES, V70, P7465, DOI 10.1158/0008-5472.CAN-10-1439; Egner PA, 2011, CANCER PREV RES, V4, P384, DOI 10.1158/1940-6207.CAPR-10-0296; Filipazzi P, 2007, J CLIN ONCOL, V25, P2546, DOI 10.1200/JCO.2006.08.5829; Geisel J, 2014, J IMMUNOL, V192, P3530, DOI 10.4049/jimmunol.1300556; Guedez L, 2012, J IMMUNOTHER, V35, P502, DOI 10.1097/CJI.0b013e3182619c8e; Gustafson MP, 2010, NEURO-ONCOLOGY, V12, P631, DOI 10.1093/neuonc/noq001; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hanlon N, 2008, BRIT J NUTR, V99, P559, DOI 10.1017/S0007114507824093; Healy ZR, 2011, CANCER EPIDEM BIOMAR, V20, P1516, DOI 10.1158/1055-9965.EPI-11-0279; Highfill SL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007974; Hu R, 2004, J PHARMACOL EXP THER, V310, P263, DOI 10.1124/jpet.103.064261; Huang B, 2007, CANCER LETT, V252, P86, DOI 10.1016/j.canlet.2006.12.012; Huang MC, 2010, FASEB J, V24, P2558, DOI 10.1096/fj.09-153148; Jackson C, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/732413; Jacobs JFM, 2010, J NEUROIMMUNOL, V225, P195, DOI 10.1016/j.jneuroim.2010.05.020; Kallifatidis G, 2009, GUT, V58, P949, DOI 10.1136/gut.2008.149039; Kallifatidis G, 2011, MOL THER, V19, P188, DOI 10.1038/mt.2010.216; Kelly JJP, 2009, STEM CELLS, V27, P1722, DOI 10.1002/stem.98; Kensler TW, 2012, CARCINOGENESIS, V33, P101, DOI 10.1093/carcin/bgr229; Kensler TW, 2005, CANCER EPIDEM BIOMAR, V14, P2605, DOI 10.1158/1055-9965.EPI-05-0368; Kim EK, 2014, CANCER RES, V74, P6705, DOI 10.1158/0008-5472.CAN-14-1482; Kim HJ, 2008, J ALLERGY CLIN IMMUN, V121, P1255, DOI 10.1016/j.jaci.2008.01.016; Kumar V, 2014, IMMUNOLOGY, V143, P512, DOI 10.1111/imm.12380; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Li CH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086022, 10.1371/journal.pone.0090520]; Mittelbronn M, 2011, ACTA NEUROPATHOL, V122, P353, DOI 10.1007/s00401-011-0858-3; Mok S, 2014, CANCER RES, V74, P153, DOI 10.1158/0008-5472.CAN-13-1816; Munaut C, 2002, NEUROPATH APPL NEURO, V28, P452, DOI 10.1046/j.1365-2990.2002.00416.x; Murat A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005947; Noman MZ, 2014, J EXP MED, V211, P781, DOI 10.1084/jem.20131916; Ostrand-Rosenberg S, 2008, CURR OPIN GENET DEV, V18, P11, DOI 10.1016/j.gde.2007.12.007; Otvos B, 2016, STEM CELLS, V34, P2026, DOI 10.1002/stem.2393; Parney IF, 2012, ADV EXP MED BIOL, V746, P42, DOI 10.1007/978-1-4614-3146-6_4; Parney IF, 2009, J NEUROSURG, V110, P572, DOI 10.3171/2008.7.JNS08475; Parney IF, 2000, NEUROSURGERY, V46, P778, DOI 10.1097/00006123-200004000-00002; Pietras A, 2014, CELL STEM CELL, V14, P357, DOI 10.1016/j.stem.2014.01.005; Pilon-Thomas S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027729; Poschke I, 2010, CANCER RES, V70, P4335, DOI 10.1158/0008-5472.CAN-09-3767; Qu XQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121574; Raychaudhuri B, 2011, NEURO-ONCOLOGY, V13, P591, DOI 10.1093/neuonc/nor042; Ries C, 2014, CELL MOL LIFE SCI, V71, P659, DOI 10.1007/s00018-013-1457-3; Rodrigues JC, 2010, NEURO-ONCOLOGY, V12, P351, DOI 10.1093/neuonc/nop023; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Rupreht RR, 2000, PFLUG ARCH EUR J PHY, V440, pR78, DOI 10.1007/s004240000013; Shapiro TA, 2006, NUTR CANCER, V55, P53, DOI 10.1207/s15327914nc5501_7; Shiina A, 2015, CLIN PSYCHOPHARM NEU, V13, P62, DOI 10.9758/cpn.2015.13.1.62; Sielska M, 2013, J PATHOL, V230, P310, DOI 10.1002/path.4192; Simpson KD, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23337; Simpson KD, 2012, J IMMUNOL, V189, P5533, DOI 10.4049/jimmunol.1201161; Singh K, 2014, P NATL ACAD SCI USA, V111, P15550, DOI 10.1073/pnas.1416940111; Singh SV, 2009, CANCER RES, V69, P2117, DOI 10.1158/0008-5472.CAN-08-3502; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Trikha P, 2014, BBA-REV CANCER, V1846, P55, DOI 10.1016/j.bbcan.2014.04.003; TSUKAMOTO K, 1992, EMBO J, V11, P519, DOI 10.1002/j.1460-2075.1992.tb05082.x; Waigel S, 2016, GENOM DATA, V7, P240, DOI 10.1016/j.gdata.2015.12.025; Waziri A, 2010, NEUROSURG CLIN N AM, V21, P31, DOI 10.1016/j.nec.2009.08.005; Winner M, 2008, CANCER RES, V68, P7253, DOI 10.1158/0008-5472.CAN-07-6227; Wu CT, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-159; Wu CT, 2012, J MOL MED, V90, P1343, DOI 10.1007/s00109-012-0916-x; Wu LY, 2011, AM J PATHOL, V179, P2131, DOI 10.1016/j.ajpath.2011.06.028; Xu L, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/796856; Yaddanapudi K, 2013, J IMMUNOL, V190, P2984, DOI 10.4049/jimmunol.1201650; Youn JI, 2013, NAT IMMUNOL, V14, P211, DOI 10.1038/ni.2526; Zhang H, 2016, ONCOGENE; Zhang YS, 2002, BIOCHEM J, V364, P301, DOI 10.1042/bj3640301; Zhou W, 2015, NATURE CELL BIOL	76	38	40	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179012	10.1371/journal.pone.0179012	http://dx.doi.org/10.1371/journal.pone.0179012			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666020	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608700028
J	Zhang, XW; Wu, SL; Naccarato, T; Prakash-Damani, M; Chou, Y; Chu, CQ; Zhu, Y				Zhang, Xiaowei; Wu, Shili; Naccarato, Ty; Prakash-Damani, Manan; Chou, Yuan; Chu, Cong-Qiu; Zhu, Yong			Regeneration of hyaline-like cartilage in situ with SOX9 stimulation of bone marrow-derived mesenchymal stem cells	PLOS ONE			English	Article							REPAIR-SOCIETY ICRS; TISSUE-ENGINEERING STRATEGIES; ARTICULAR-CARTILAGE; MICROFRACTURE TECHNIQUE; FUNCTIONAL PROTEINS; KNEE ARTHROSCOPIES; COLLAGEN GENE; VIVO; CHONDROGENESIS; DIFFERENTIATION	Microfracture, a common procedure for treatment of cartilage injury, induces fibrocartilage repair by recruiting bone marrow derived mesenchymal stem cells (MSC) to the site of cartilage injury. However, fibrocartilage is inferior biomechanically to hyaline cartilage. SRY-type high-mobility group box-9 (SOX9) is a master regulator of chondrogenesis by promoting proliferation and differentiation of MSC into chondrocytes. In this study we aimed to test the therapeutic potential of cell penetrating recombinant SOX9 protein in regeneration of hyaline cartilage in situ at the site of cartilage injury. We generated a recombinant SOX9 protein which was fused with super positively charged green fluorescence protein (GFP) (scSOX9) to facilitate cell penetration. scSOX9 was able to induce chondrogenesis of bone marrow derived MSC in vitro. In a rabbit cartilage injury model, scSOX9 in combination with microfracture significantly improved quality of repaired cartilage as shown by macroscopic appearance. Histological analysis revealed that the reparative tissue induced by microfracture with scSOX9 had features of hyaline cartilage; and collagen type II to type I ratio was similar to that in normal cartilage. This short term in vivo study demonstrated that when administered at the site of microfracture, scSOX9 was able to induce reparative tissue with features of hyaline cartilage.	[Zhang, Xiaowei; Chou, Yuan; Chu, Cong-Qiu] Oregon Hlth & Sci Univ, Div Arthrit & Rheumat Dis, Portland, OR 97201 USA; [Zhang, Xiaowei; Chou, Yuan; Chu, Cong-Qiu] VA Portland Hlth Care Syst, Rheumatol Sect, Portland, OR 97239 USA; [Wu, Shili; Naccarato, Ty; Prakash-Damani, Manan; Zhu, Yong] VivoScript Inc, Costa Mesa, CA 92626 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System	Chu, CQ (corresponding author), Oregon Hlth & Sci Univ, Div Arthrit & Rheumat Dis, Portland, OR 97201 USA.; Chu, CQ (corresponding author), VA Portland Hlth Care Syst, Rheumatol Sect, Portland, OR 97239 USA.; Zhu, Y (corresponding author), VivoScript Inc, Costa Mesa, CA 92626 USA.	chuc@ohsu.edu; zhu@vivoscript.com		Zhu, Yong/0000-0002-7468-8798	VivoScript, Inc.; VA Merit Review [IBX002858]; Veterans Affairs [I01BX002858] Funding Source: NIH RePORTER	VivoScript, Inc.; VA Merit Review(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a grant from VivoScript, Inc and VA Merit Review (IBX002858). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors SW, TN, MPD and YZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "Author Contributions" section.; This was supported by a grant from VivoScript, Inc (to CQC) and VA Merit Review (IBX002858, to CQC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors SW, TN, MPD and YZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "Author Contributions" section. The authors would like to thank Dr. Brian Johnstone for providing human bone marrow mesenchymal stem cells and Ms. Lijuan Liu for technical assistance in histology.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bernard P, 2003, HUM MOL GENET, V12, P1755, DOI 10.1093/hmg/ddg182; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Cao L, 2011, BIOMATERIALS, V32, P3910, DOI 10.1016/j.biomaterials.2011.02.014; Cronican JJ, 2011, CHEM BIOL, V18, P833, DOI 10.1016/j.chembiol.2011.07.003; Cronican JJ, 2010, ACS CHEM BIOL, V5, P747, DOI 10.1021/cb1001153; Cucchiarini M, 2014, GENE THER, V21, P811, DOI 10.1038/gt.2014.58; Cucchiarini M, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0449-0; Curl WW, 1997, ARTHROSCOPY, V13, P456, DOI 10.1016/S0749-8063(97)90124-9; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Elnager Abuzar, 2014, Adv Hematol, V2014, P814684, DOI 10.1155/2014/814684; Vallone VBF, 2013, DIFFERENTIATION, V85, P1, DOI 10.1016/j.diff.2012.08.004; Gelber AC, 2000, ANN INTERN MED, V133, P321, DOI 10.7326/0003-4819-133-5-200009050-00007; Hattori T, 2010, DEVELOPMENT, V137, P901, DOI 10.1242/dev.045203; Hjelle K, 2002, ARTHROSCOPY, V18, P730, DOI 10.1053/jars.2002.32839; Hoemann C, 2011, CARTILAGE, V2, P153, DOI 10.1177/1947603510397535; Illien-Junger S, 2016, J ORTHOP RES, V34, P876, DOI 10.1002/jor.23088; Jiang YZ, 2010, TISSUE ENG PT A, V16, P1621, DOI [10.1089/ten.tea.2009.0681, 10.1089/ten.TEA.2009.0681]; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Leung VYL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002356; Li L, 2017, FASEB J, V31, P1067, DOI 10.1096/fj.201600918R; Liu CF, 2015, NUCLEIC ACIDS RES, V43, P8183, DOI 10.1093/nar/gkv688; Madry H, 2014, Eur Cell Mater, V27, P17; Madry H, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0450-7; Mainil-Varlet P, 2003, J BONE JOINT SURG AM, V85A, P45, DOI 10.2106/00004623-200300002-00007; Matsui H, 2003, CURR PROTEIN PEPT SC, V4, P151, DOI 10.2174/1389203033487270; McNaughton BR, 2009, P NATL ACAD SCI USA, V106, P6111, DOI 10.1073/pnas.0807883106; Mithoefer K, 2009, AM J SPORT MED, V37, P2053, DOI 10.1177/0363546508328414; Pontikoglou C, 2011, STEM CELL REV REP, V7, P569, DOI 10.1007/s12015-011-9228-8; Rastegar Farbod, 2010, World J Stem Cells, V2, P67, DOI 10.4252/wjsc.v2.i4.67; Richter W, 2009, J INTERN MED, V266, P390, DOI 10.1111/j.1365-2796.2009.02153.x; Sock E, 2003, HUM MOL GENET, V12, P1439, DOI 10.1093/hmg/ddg158; Solchaga LA, 2011, METHODS MOL BIOL, V698, P253, DOI 10.1007/978-1-60761-999-4_20; Strauss E, 2009, AM J SPORT MED, V37, P720, DOI 10.1177/0363546508328415; Tsuchiya H, 2003, BIOCHEM BIOPH RES CO, V301, P338, DOI 10.1016/S0006-291X(02)03026-7; Van den Borne MPJ, 2007, OSTEOARTHR CARTILAGE, V15, P1397, DOI 10.1016/j.joca.2007.05.005; Wayne JS, 2005, TISSUE ENG, V11, P953, DOI 10.1089/ten.2005.11.953; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Yang HS, 2011, TISSUE ENG PT A, V17, P1809, DOI 10.1089/ten.tea.2010.0540; Yokota M, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-49; Yomogida K, 2013, BIOCHEM BIOPH RES CO, V434, P263, DOI 10.1016/j.bbrc.2013.02.114; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	43	19	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180138	10.1371/journal.pone.0180138	http://dx.doi.org/10.1371/journal.pone.0180138			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666028	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608700063
J	Liu, Y; Cheng, Y; Xu, Y; Wang, Z; Du, X; Li, C; Peng, J; Gao, L; Liang, X; Ma, C				Liu, Y.; Cheng, Y.; Xu, Y.; Wang, Z.; Du, X.; Li, C.; Peng, J.; Gao, L.; Liang, X.; Ma, C.			Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers	ONCOGENE			English	Article							NATURAL-KILLER-CELLS; LIGAND 1 EXPRESSION; HEPATOCELLULAR-CARCINOMA; TUMOR MICROENVIRONMENT; IMMUNE-RESPONSES; PD-1 EXPRESSION; GASTRIC-CANCER; T-CELLS; VIRUS; DYSFUNCTION	Abnormal expression of activating/inhibitory receptors leads to natural killer (NK) cells dysfunction in tumor. Here we show that programmed cell death protein 1 (PD-1), a well-known immune checkpoint of T cells, is highly expressed on peripheral and tumor-infiltrating NK cells from patients with digestive cancers including esophageal, liver, colorectal, gastric and biliary cancer. The increased PD-1 expression on NK cells indicates poorer survival in esophageal and liver cancers. Blocking PD-1/PD-L1 signaling markedly enhances cytokines production and degranulation and suppresses apoptosis of NK cells in vitro. PD-1/PD-L1 exerts inhibitory effect through repressing the activation of PI3K/AKT signaling in NK cells. More importantly, a PD-1 blocking antibody was found to significantly suppress the growth of xenografts in nude mice, and this inhibition of tumor growth was completely abrogated by NK depletion. These findings strongly suggested that PD-1 is an inhibitory regulator of NK cells in digestive cancers. PD-1 blockade might be an efficient strategy in NK cell-based tumor immunotherapy.	[Liu, Y.; Xu, Y.; Wang, Z.; Du, X.; Li, C.; Gao, L.; Liang, X.; Ma, C.] Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China; [Liu, Y.; Xu, Y.; Wang, Z.; Du, X.; Li, C.; Gao, L.; Liang, X.; Ma, C.] Shandong Univ, Sch Med, Dept Immunol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China; [Liu, Y.; Cheng, Y.] Shandong Univ, Dept Radiat Oncol, Qilu Hosp, Jinan, Shandong, Peoples R China; [Peng, J.] Shandong Univ, Dept Hematol, Qilu Hosp, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Ma, C (corresponding author), Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.; Ma, C (corresponding author), Shandong Univ, Sch Med, Dept Immunol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	machunhong@sdu.edu.cn	ma, chunhong/C-6043-2008	ma, chunhong/0000-0002-8121-4718; Liu, Yuan/0000-0002-4425-2213; Li, Chunyang/0000-0002-5798-2274	National Science Foundation for Distinguished Young Scholars of China [81425012]; NSFC [91529305, 81371831]; Shandong Provincial Natural Science Foundation [ZR2015HZ005]	National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); NSFC(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province)	We would like to thank Professor Weiming Zhao from the Department of Pathogenic Biology for the gift of anti-asialoGM1. We would like to thank Mingsheng Zhao from the Department of Immunology for help with the in vivo experiments. This work was supported by grants from the National Science Foundation for Distinguished Young Scholars of China (81425012), NSFC (91529305 and 81371831) and the Shandong Provincial Natural Science Foundation (ZR2015HZ005).	Ali AK, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00355; Beldi-Ferchiou A, 2016, ONCOTARGET, V7, P72961, DOI 10.18632/oncotarget.12150; Benson DM, 2010, BLOOD, V116, P2286, DOI 10.1182/blood-2010-02-271874; Blank C, 2005, CANCER IMMUNOL IMMUN, V54, P307, DOI 10.1007/s00262-004-0593-x; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Bucklein V, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1178421; Chen KY, 2016, ONCOTARGET, V7, P30772, DOI 10.18632/oncotarget.8956; Chen Y, 2017, CELL MOL IMMUNOL, V14, P293, DOI 10.1038/cmi.2015.81; Chen YW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001347; Delconte RB, 2016, NAT IMMUNOL, V17, P816, DOI 10.1038/ni.3470; Ferrone C, 2010, J CLIN ONCOL, V28, P4045, DOI 10.1200/JCO.2010.27.9992; Giannelli G, 2014, GUT, V63, P1668, DOI 10.1136/gutjnl-2014-307323; Golden-Mason L, 2008, J IMMUNOL, V180, P3637, DOI 10.4049/jimmunol.180.6.3637; Guillerey C, 2016, NAT IMMUNOL, V17, P1025, DOI 10.1038/ni.3518; Hassan SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137646; Huang BY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134715; Hydes Theresa, 2015, Lancet, V385 Suppl 1, pS45, DOI 10.1016/S0140-6736(15)60360-9; Kamphorst AO, 2013, CURR OPIN IMMUNOL, V25, P381, DOI 10.1016/j.coi.2013.03.003; Kinter AL, 2008, J IMMUNOL, V181, P6738, DOI 10.4049/jimmunol.181.10.6738; Li H, 2012, HEPATOLOGY, V56, P1342, DOI 10.1002/hep.25777; Li YY, 2016, INT J POLYM SCI, V2016, DOI 10.1155/2016/8769360; Lin EW, 2016, ONCOGENE, V35, P5337, DOI 10.1038/onc.2016.34; Ma CQ, 2016, AM J SURG PATHOL, V40, P1496, DOI 10.1097/PAS.0000000000000698; Moreno-Cubero E, 2016, WORLD J GASTROENTERO, V22, P6469, DOI 10.3748/wjg.v22.i28.6469; Norris S, 2012, VIRAL IMMUNOL, V25, P329, DOI 10.1089/vim.2011.0096; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Pesce S, 2017, J ALLERGY CLIN IMMUN, V139, P335, DOI 10.1016/j.jaci.2016.04.025; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Polivka J, 2014, PHARMACOL THERAPEUT, V142, P164, DOI 10.1016/j.pharmthera.2013.12.004; Riley JL, 2009, IMMUNOL REV, V229, P114, DOI 10.1111/j.1600-065X.2009.00767.x; Saito H, 2013, J SURG ONCOL, V107, P517, DOI 10.1002/jso.23281; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shi LR, 2016, CLIN CANCER RES, V22, P1173, DOI 10.1158/1078-0432.CCR-15-1352; Solaymani-Mohammadi S, 2016, J LEUKOCYTE BIOL, V99, P475, DOI 10.1189/jlb.4A0115-003RR; Tarazona R, 2017, CANCER IMMUNOL IMMUN, V66, P233, DOI 10.1007/s00262-016-1882-x; Toh JWT, 2016, CLIN COLORECTAL CANC, V15, P285, DOI 10.1016/j.clcc.2016.07.007; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wargo JA, 2016, CURR OPIN IMMUNOL, V41, P23, DOI 10.1016/j.coi.2016.05.006; Watanabe M, 2010, DIS ESOPHAGUS, V23, P675, DOI 10.1111/j.1442-2050.2010.01073.x; Wiesmayr S, 2012, EUR J IMMUNOL, V42, P541, DOI 10.1002/eji.201141832; Wu Y, 2013, HEPATOLOGY, V57, P1107, DOI 10.1002/hep.26192; Yan WJ, 2015, GUT, V64, P1593, DOI 10.1136/gutjnl-2014-307671; Zhang G, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/384726; Zhang L, 2015, CURR STEM CELL RES T, V10, P245, DOI 10.2174/1574888X09666140812112305	48	199	207	5	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 2	2017	36	44					6143	6153		10.1038/onc.2017.209	http://dx.doi.org/10.1038/onc.2017.209			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FL5CU	28692048	Green Published, hybrid			2022-12-26	WOS:000414249800008
J	Zhang, CG; Liu, ZY; Bunker, E; Ramirez, A; Lee, S; Peng, YH; Tan, AC; Eckhardt, SG; Chapnick, DA; Liu, XD				Zhang, Conggang; Liu, Zeyu; Bunker, Eric; Ramirez, Adrian; Lee, Schuyler; Peng, Yinghua; Tan, Aik-Choon; Eckhardt, S. Gail; Chapnick, Douglas A.; Liu, Xuedong			Sorafenib targets the mitochondrial electron transport chain complexes and ATP synthase to activate the PINK1-Parkin pathway and modulate cellular drug response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; BCL-2 FAMILY PROTEINS; HEPATOCELLULAR-CARCINOMA; RAF/MEK/ERK PATHWAY; PARKINSONS-DISEASE; MITOPHAGY; CANCER; PINK1; DEPOLARIZATION; APOPTOSIS	Sorafenib (Nexavar) is a broad-spectrum multikinase inhibitor that proves effective in treating advanced renal-cell carcinoma and liver cancer. Despite its well-characterized mechanism of action on several established cancer-related protein kinases, sorafenib causes variable responses among human tumors, although the cause for this variation is unknown. In an unbiased screening of an oncology drug library, we found that sorafenib activates recruitment of the ubiquitin E3 ligase Parkin to damaged mitochondria. We show that sorafenib inhibits the activity of both complex II/III of the electron transport chain and ATP synthase. Dual inhibition of these complexes, but not inhibition of each individual complex, stabilizes the serine-threonine protein kinase PINK1 on the mitochondrial outer membrane and activates Parkin. Unlike the protonophore carbonyl cyanide m-chlorophenylhydrazone, which activates the mitophagy response, sorafenib treatment triggers PINK1/Parkin-dependent cellular apoptosis, which is attenuated upon Bcl-2 overexpression. In summary, our results reveal a new mechanism of action for sorafenib as a mitocan and suggest that high Parkin activity levels could make tumor cells more sensitive to sorafenib's actions, providing one possible explanation why Parkin may be a tumor suppressor gene. These insights could be useful in developing new rationally designed combination therapies with sorafenib.	[Zhang, Conggang; Liu, Zeyu; Bunker, Eric; Ramirez, Adrian; Lee, Schuyler; Peng, Yinghua; Chapnick, Douglas A.; Liu, Xuedong] Univ Colorado, Dept Chem & Biochem, 3415 Colorado Ave, Boulder, CO 80309 USA; [Tan, Aik-Choon; Eckhardt, S. Gail] Univ Colorado, Dept Med, Div Med Oncol, Dev Therapeut Program, Anschutz Med Campus, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus	Liu, XD (corresponding author), Univ Colorado, Dept Chem & Biochem, 3415 Colorado Ave, Boulder, CO 80309 USA.	Xuedong.Liu@colorado.edu	Tan, Aik Choon/A-3135-2011; , tanglang/AAD-3372-2020	Tan, Aik Choon/0000-0003-2955-8369; Chapnick, Douglas/0000-0003-3317-5432; LIU, XUEDONG/0000-0001-7209-4964	National Institutes of Health from NCRR [S10 RR026680]; BioFrontiers Advanced Light Microscopy Core; National Institutes of Health [S10 OD021601]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113141] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021601] Funding Source: NIH RePORTER	National Institutes of Health from NCRR; BioFrontiers Advanced Light Microscopy Core; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Drs. Stratford May, Jie Shen, Stefan Constantinescu, Schuyler Van Engelenburg, Jennifer Lippincott-Schwartz, and Sabrina Spencer for providing critical reagents. We thank Drs. Natalie Ahn, Amy Palmer, and Douglas Chapnick for discussion. We thank Graycen Wheeler for critical reading of the manuscript. We thank Steve Wiltgen and Vipat Raksakulthai of Molecular Devices for their help with development of MetaXpress journals for automated imaging analysis. The ImageXpress MicroXL was supported by National Institutes of Health Grant S10 RR026680 from NCRR. We thank Joseph Dragavon and BioFrontiers Advanced Light Microscopy Core for their support. The FACSAria cell sorter was supported by National Institutes of Health Grant S10 OD021601.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Bartolom? F., 2015, PROBING MITOCHONDRIA, P263; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Bull VH, 2012, J PROTEOME RES, V11, P1609, DOI 10.1021/pr200790e; Cabanillas ME, 2010, J CLIN ENDOCR METAB, V95, P2588, DOI 10.1210/jc.2009-1923; Carroll RG, 2014, CELL REP, V9, P1538, DOI 10.1016/j.celrep.2014.10.046; Fujiwara M, 2008, ONCOGENE, V27, P6002, DOI 10.1038/onc.2008.199; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Hollville E, 2014, MOL CELL, V55, P451, DOI 10.1016/j.molcel.2014.06.001; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; Mehdi SJ, 2011, MED ONCOL, V28, P1520, DOI 10.1007/s12032-010-9633-x; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Picchio MC, 2004, CLIN CANCER RES, V10, P2720, DOI 10.1158/1078-0432.CCR-03-0086; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Poulogiannis G, 2010, P NATL ACAD SCI USA, V107, P15145, DOI 10.1073/pnas.1009941107; Prieto-Dominguez N, 2016, J PINEAL RES, V61, P396, DOI 10.1111/jpi.12358; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; SUTHERLAND GR, 1995, CURR OPIN GENET DEV, V5, P323, DOI 10.1016/0959-437X(95)80046-8; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; Wang F, 2004, GENE CHROMOSOME CANC, V40, P85, DOI 10.1002/gcc.20020; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yu CR, 2005, ONCOGENE, V24, P6861, DOI 10.1038/sj.onc.1208841; Zhang CG, 2014, CURR BIOL, V24, P1854, DOI 10.1016/j.cub.2014.07.014	32	47	48	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15105	15120		10.1074/jbc.M117.783175	http://dx.doi.org/10.1074/jbc.M117.783175			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28673964	hybrid, Green Published			2022-12-26	WOS:000409902100032
J	Zarkoob, H; Lewinsky, S; Almgren, P; Melander, O; Fakhrai-Rad, H				Zarkoob, Hadi; Lewinsky, Sarah; Almgren, Peter; Melander, Olle; Fakhrai-Rad, Hossein			Utilization of genetic data can improve the prediction of type 2 diabetes incidence in a Swedish cohort	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RISK LOCI; SUSCEPTIBILITY LOCI; VARIANTS; MELLITUS; METAANALYSIS; KCNQ1; CONSUMPTION; GLUCOSE; HEALTH	The aim of this study was to measure the impact of genetic data in improving the prediction of type 2 diabetes (T2D) in the Malmo Diet and Cancer Study cohort. The current study was performed in 3,426 Swedish individuals and utilizes of a set of genetic and environmental risk data. We first validated our environmental risk model by comparing it to both the Finnish Diabetes Risk Score and the T2D risk model derived from the Framingham Offspring Study. The area under the curve (AUC) for our environmental model was 0.72 [95% CI, 0.69-0.74], which was significantly better than both the Finnish (0.64 [95% CI, 0.61-0.66], p-value < 1 x 10(-4)) and Framingham (0.69 [95% CI, 0.66-0.71], p-value = 0.0017) risk scores. We then verified that the genetic data has a statistically significant positive correlation with incidence of T2D in the studied population. We also verified that adding genetic data slightly but statistically increased the AUC of a model based only on environmental risk factors (RFs, AUC shift + 1.0% from 0.72 to 0.73, p-value = 0.042). To study the dependence of the results on the environmental RFs, we divided the population into two equally sized risk groups based only on their environmental risk and repeated the same analysis within each subpopulation. While there is a statistically significant positive correlation between the genetic data and incidence of T2D in both environmental risk categories, the positive shift in the AUC remains statistically significant only in the category with the lower environmental risk. These results demonstrate that genetic data can be used to increase the accuracy of T2D prediction. Also, the data suggests that genetic data is more valuable in improving T2D prediction in populations with lower environmental risk. This suggests that the impact of genetic data depends on the environmental risk of the studied population and thus genetic association studies should be performed in light of the underlying environmental risk of the population.	[Zarkoob, Hadi; Lewinsky, Sarah; Fakhrai-Rad, Hossein] BaseHealth Inc, Sunnyvale, CA 94086 USA; [Almgren, Peter; Melander, Olle] Lund Univ, Dept Clin Sci, Malmo, Sweden	Lund University	Fakhrai-Rad, H (corresponding author), BaseHealth Inc, Sunnyvale, CA 94086 USA.	rad@basehealth.com		Melander, Olle/0000-0002-2581-484X	Novo Nordisk Fonden [NNF17OC0026936, NNF14OC0009819, NNF13OC0005339] Funding Source: researchfish	Novo Nordisk Fonden(Novo Nordisk Foundation)		Al Safar HS, 2013, ANN HUM GENET, V77, P488, DOI 10.1111/ahg.12036; [Anonymous], 2013, DIABETOLOGIA, V56, P47, DOI [10.1007/s00125-012-2718-7, DOI 10.1007/S00125-012-2718-7]; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Cederholm J, 2008, DIABETES CARE, V31, P2038, DOI 10.2337/dc08-0662; Conen D, 2007, EUROPEAN HEART J; Cui B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022353; Enhorning S, 2013, INT J OBESITY, V37, P598, DOI 10.1038/ijo.2012.88; Freathy RM, 2010, NAT GENET, V42, P430, DOI 10.1038/ng.567; Ganz ML, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-50; Hara K, 2014, HUM MOL GENET, V23, P239, DOI 10.1093/hmg/ddt399; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Hu G, 2006, INT J OBESITY, V30, P1742, DOI 10.1038/sj.ijo.0803341; Huang J, 2012, EUR J HUM GENET, V20, P801, DOI 10.1038/ejhg.2012.3; Imamura M, 2012, HUM MOL GENET, V21, P3042, DOI 10.1093/hmg/dds113; Johansson S, 2007, DIABETES, V56, P3112, DOI 10.2337/db07-0513; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Lee DS, 2013, PUBLIC HEALTH, V127, P554, DOI 10.1016/j.puhe.2013.02.001; Li HX, 2013, DIABETES, V62, P291, DOI 10.2337/db12-0454; Lim S, 2013, AM J CLIN NUTR, V97, P524, DOI 10.3945/ajcn.112.048496; Lindholm E, 2001, EUR J EPIDEMIOL, V17, P983, DOI 10.1023/A:1020036805655; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Ma RCW, 2013, DIABETOLOGIA, V56, P1291, DOI 10.1007/s00125-013-2874-4; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Miyake K, 2008, J HUM GENET, V53, P174, DOI 10.1007/s10038-007-0231-5; Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001; Murea Mariana, 2012, Rev Diabet Stud, V9, P6, DOI 10.1900/RDS.2012.9.6; National Board of Health and Welfare, 2003, PHARMACOEPIDEMIOLOGY; Palmer JR, 2008, ARCH INTERN MED, V168, P1487, DOI 10.1001/archinte.168.14.1487; Palmer ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029202; Parra EJ, 2011, DIABETOLOGIA, V54, P2038, DOI 10.1007/s00125-011-2172-y; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Qi QB, 2009, HUM MOL GENET, V18, P3508, DOI 10.1093/hmg/ddp294; Rich SS, 2009, HORM RES, V71, P17, DOI 10.1159/000178031; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Salonen JT, 2007, AM J HUM GENET, V81, P338, DOI 10.1086/520599; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2013, DIABETES, V62, P1746, DOI 10.2337/db12-1077; Schmidt CO, 2008, INT J PUBLIC HEALTH, V53, P165, DOI 10.1007/s00038-008-7068-3; Sim X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001363; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Tabassum R, 2012, DIABETES; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Talmud PJ, 2014, DIABETES; Tirosh A, 2008, DIABETES CARE, V31, P2032, DOI 10.2337/dc08-0825; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; WHO, 2016, GLOB REP PSOR; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zarkoob H, 2016, INT J MED TECHNOLOGY, V23; Zarkoob H, 2015, INT J MED TECHNOLOGY, V23; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang LX, 2011, DIABETES CARE, V34, P892, DOI 10.2337/dc10-2087	60	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180180	10.1371/journal.pone.0180180	http://dx.doi.org/10.1371/journal.pone.0180180			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700623	gold, Green Submitted, Green Published			2022-12-26	WOS:000405649600021
J	Bodine, TJ; Evangelista, MA; Chang, HT; Ayoub, CA; Samuel, BS; Sucgang, R; Zechiedrich, L				Bodine, Truston J.; Evangelista, Michael A.; Chang, Huan Ting; Ayoub, Christopher A.; Samuel, Buck S.; Sucgang, Richard; Zechiedrich, Lynn			Escherichia coli DNA ligase B may mitigate damage from oxidative stress	PLOS ONE			English	Article							GENE-EXPRESSION; EXCISION-REPAIR; MUTATION; DEATH; MECHANISMS; RESPONSES; PROTEINS; CADMIUM; PATHWAY	Escherichia coli encodes two DNA ligases, ligase A, which is essential under normal laboratory growth conditions, and ligase B, which is not. Here we report potential functions of ligase B. We found that across the entire Enterobacteriaceae family, ligase B is highly conserved in both amino acid identity and synteny with genes associated with oxidative stress. Deletion of ligB sensitized E. coli to specific DNA damaging agents and antibiotics resulted in a weak mutator phenotype, and decreased biofilm formation. Overexpression of ligB caused a dramatic extension of lag phase that eventually resumed normal growth. The ligase function of ligase B was not required to mediate the extended lag phase, as overexpression of a ligase-deficient ligB mutant also blocked growth. Overexpression of ligB during logarithmic growth caused an immediate block of cell growth and DNA replication, and death of about half of cells. These data support a potential role for ligase B in the base excision repair pathway or the mismatch repair pathway.	[Bodine, Truston J.; Zechiedrich, Lynn] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Bodine, Truston J.; Evangelista, Michael A.; Chang, Huan Ting; Ayoub, Christopher A.; Samuel, Buck S.; Zechiedrich, Lynn] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Bodine, Truston J.] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Evangelista, Michael A.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Chang, Huan Ting] Rice Univ, Dept Biosci, Houston, TX USA; [Samuel, Buck S.] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA; [Zechiedrich, Lynn] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Chang, Huan Ting] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Rice University; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zechiedrich, L (corresponding author), Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA.; Zechiedrich, L (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.; Zechiedrich, L (corresponding author), Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA.	elz@bcm.edu	Zechiedrich, Elizabeth Lynn/S-4720-2019; Samuel, Buck/I-3837-2019	Samuel, Buck/0000-0002-4347-3997; Zechiedrich, Lynn/0000-0003-0533-1637; Ayoub, Christopher/0000-0003-0694-1058	National Institutes of Health (NIH) [RO1 AI054830, R56 AI054830, R01 GM115501];  [T32GM088129];  [T32GM007330]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115501] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants RO1 AI054830, R56 AI054830, R01 GM115501 (to LZ), and in part by T32GM088129 and T32GM007330 (to TJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, NUCLEIC ACIDS RES, V42, P13228; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Boyd LB, 2009, ANTIMICROB AGENTS CH, V53, P229, DOI 10.1128/AAC.00722-08; Brotz-Oesterhelt H, 2003, J BIOL CHEM, V278, P39435, DOI 10.1074/jbc.M306479200; Chen JY, 2008, NUCLEIC ACIDS RES, V36, P3781, DOI 10.1093/nar/gkn302; Deibler RW, 2001, GENE DEV, V15, P748, DOI 10.1101/gad.872301; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Dwyer DJ, 2015, ANNU REV PHARMACOL, V55, P313, DOI 10.1146/annurev-pharmtox-010814-124712; Elbing Karen, 2002, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0101s59; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Harcum SW, 2006, J IND MICROBIOL BIOT, V33, P801, DOI 10.1007/s10295-006-0122-3; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Horst JP, 1999, TRENDS MICROBIOL, V7, P29, DOI 10.1016/S0966-842X(98)01424-3; Inokuchi H, 2013, J BIOL CHEM, V288, P32952, DOI 10.1074/jbc.M113.507772; Ito A, 2008, BIOTECHNOL BIOENG, V99, P1462, DOI 10.1002/bit.21695; Jin YH, 2003, NAT GENET, V34, P326, DOI 10.1038/ng1172; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; KOW YW, 1994, ANN NY ACAD SCI, V726, P178, DOI 10.1111/j.1749-6632.1994.tb52812.x; Krishna S, 2007, PLOS COMPUT BIOL, V3, P451, DOI 10.1371/journal.pcbi.0030041; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee H, 2012, P NATL ACAD SCI USA, V109, pE2774, DOI 10.1073/pnas.1210309109; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Long HA, 2016, P NATL ACAD SCI USA, V113, pE2498, DOI 10.1073/pnas.1601208113; Lopez CR, 2005, MOL MICROBIOL, V58, P80, DOI 10.1111/j.1365-2958.2005.04812.x; MA WT, 1992, J APPL PROBAB, V29, P255, DOI 10.2307/3214564; MITRA RS, 1978, J BACTERIOL, V133, P75, DOI 10.1128/JB.133.1.75-80.1978; MITRA RS, 1975, J BACTERIOL, V121, P1180, DOI 10.1128/JB.121.3.1180-1188.1975; Moolenaar GF, 2000, J BACTERIOL, V182, P5706, DOI 10.1128/JB.182.20.5706-5714.2000; Moore SD, 2011, METHODS MOL BIOL, V765, P155, DOI 10.1007/978-1-61779-197-0_10; Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Price A., 2012, 2012 IEEE Symposium on Biological Data Visualization (BioVis 2012), P57, DOI 10.1109/BioVis.2012.6378593; Quan S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002444; Riehle MM, 2003, PHYSIOL GENOMICS, V14, P47, DOI 10.1152/physiolgenomics.00034.2002; Rodriguez-Verdugo A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-50; Rogozin IB, 2004, BRIEF BIOINFORM, V5, P131, DOI 10.1093/bib/5.2.131; Rotman E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011106; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Silander Olin K, 2009, BMC Res Notes, V2, P2, DOI 10.1186/1756-0500-2-2; Simmons LA, 2009, J BACTERIOL, V191, P1152, DOI 10.1128/JB.01292-08; Sriskanda V, 2001, NUCLEIC ACIDS RES, V29, P4930, DOI 10.1093/nar/29.24.4930; STEWART CB, 1993, NATURE, V361, P603, DOI 10.1038/361603a0; Swick MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065961; Tamayo M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-69; Wang XH, 2010, J ANTIMICROB CHEMOTH, V65, P520, DOI 10.1093/jac/dkp486; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Wei Y, 2001, J BACTERIOL, V183, P2259, DOI 10.1128/JB.183.7.2259-2264.2001; Wilkinson A, 2001, MOL MICROBIOL, V40, P1241, DOI 10.1046/j.1365-2958.2001.02479.x; Worden CR, 2009, FEMS MICROBIOL LETT, V293, P58, DOI 10.1111/j.1574-6968.2009.01508.x; Wu TH, 1999, J BIOL CHEM, V274, P5948, DOI 10.1074/jbc.274.9.5948	60	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180800	10.1371/journal.pone.0180800	http://dx.doi.org/10.1371/journal.pone.0180800			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700629	gold, Green Submitted, Green Published			2022-12-26	WOS:000405649400018
J	Begum, A; Ewachiw, T; Jung, C; Huang, A; Norberg, KJ; Marchionni, L; McMillan, R; Penchev, V; Rajeshkumar, NV; Maitra, A; Wood, L; Wang, CG; Wolfgang, C; DeJesus-Acosta, A; Laheru, D; Shapiro, IM; Padval, M; Pachter, JA; Weaver, DT; Rasheed, ZA; Matsui, W				Begum, Asma; Ewachiw, Theodore; Jung, Clinton; Huang, Ally; Norberg, K. Jessica; Marchionni, Luigi; McMillan, Ross; Penchev, Vesselin; Rajeshkumar, N. V.; Maitra, Anirban; Wood, Laura; Wang, Chenguang; Wolfgang, Christopher; DeJesus-Acosta, Ana; Laheru, Daniel; Shapiro, Irina M.; Padval, Mahesh; Pachter, Jonathan A.; Weaver, David T.; Rasheed, Zeshaan A.; Matsui, William			The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma	PLOS ONE			English	Article							I COLLAGEN; MALIGNANT PHENOTYPE; EPITHELIAL CANCER; OVARIAN-CARCINOMA; MULTIPLE-MYELOMA; BREAST-CANCER; SELF-RENEWAL; TUMOR-GROWTH; TGF-BETA; FAK	Cancer stem cells (CSCs) play an important role in the clonogenic growth and metastasis of pancreatic ductal adenocarcinoma (PDAC). A hallmark of PDAC is the desmoplastic reaction, but the impact of the tumor microenvironment (TME) on CSCs is unknown. In order to better understand the mechanisms, we examined the impact of extracellular matrix (ECM) proteins on PDAC CSCs. We quantified the effect of ECM proteins, beta 1-integrin, and focal adhesion kinase (FAK) on clonogenic PDAC growth and migration in vitro and tumor initiation, growth, and metastasis in vivo in nude mice using shRNA and overexpression constructs as well as small molecule FAK inhibitors. Type I collagen increased PDAC tumor initiating potential, self-renewal, and the frequency of CSCs through the activation of FAK. FAK overexpression increased tumor initiation, whereas a dominant negative FAK mutant or FAK kinase inhibitors reduced clonogenic PDAC growth in vitro and in vivo. Moreover, the FAK inhibitor VS-4718 extended the anti-tumor response to gemcitabine and nab-paclitaxel in patient-derived PDAC xenografts, and the loss of FAK expression limited metastatic dissemination of orthotopic xenografts. Type I collagen enhances PDAC CSCs, and both kinase-dependent and independent activities of FAK impact PDAC tumor initiation, selfrenewal, and metastasis. The anti-tumor impact of FAK inhibitors in combination with standard chemotherapy support the clinical testing of this combination.	[Begum, Asma; Ewachiw, Theodore; Jung, Clinton; Huang, Ally; Norberg, K. Jessica; Marchionni, Luigi; McMillan, Ross; Penchev, Vesselin; Rajeshkumar, N. V.; Wang, Chenguang; DeJesus-Acosta, Ana; Laheru, Daniel; Rasheed, Zeshaan A.; Matsui, William] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Maitra, Anirban] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Wood, Laura] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Wolfgang, Christopher] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Shapiro, Irina M.; Padval, Mahesh; Pachter, Jonathan A.; Weaver, David T.] Verastem Inc, Needham, MA USA; [Rasheed, Zeshaan A.] One Medimmune Way, Gaithersburg, MD USA	Johns Hopkins University; Johns Hopkins Medicine; University of Texas System; UTMD Anderson Cancer Center; Johns Hopkins University; Johns Hopkins University	Matsui, W (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA.	matsuwi@jhmi.edu	Marchionni, Luigi/S-6774-2017; Wolfgang, Christopher/HGD-0863-2022	Marchionni, Luigi/0000-0002-7336-8071; 	Pancreatic Cancer Action Network-AACR Pathway; Tempur-Pedic Retailers [10-70-25-RASH]; V Foundation V Scholar Award; National Cancer Institute [R01 CA150142, R01 CA193887]; Lustgarten Foundation; Verastem Inc; NATIONAL CANCER INSTITUTE [K24CA198315, R01CA193887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	Pancreatic Cancer Action Network-AACR Pathway; Tempur-Pedic Retailers; V Foundation V Scholar Award; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lustgarten Foundation; Verastem Inc; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the following grants: 2010 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant, supported by Tempur-Pedic Retailers, Grant Number 10-70-25-RASH, V Foundation 2013 V Scholar Award (ZAR), National Cancer Institute R01 CA150142, R01CA193887 (WM), and Lustgarten Foundation (WM). Verastem Inc. provided support in the form of salaries for authors (MP, JP, DW, IS), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong T, 2004, CLIN CANCER RES, V10, P7427, DOI 10.1158/1078-0432.CCR-03-0825; Bailey JM, 2014, GASTROENTEROLOGY, V146, P245, DOI 10.1053/j.gastro.2013.09.050; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Cance WG, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004021; Conti JA, 2008, CLIN CANCER RES, V14, P6405, DOI 10.1158/1078-0432.CCR-08-0816; Duxbury MS, 2004, SURGERY, V135, P555, DOI 10.1016/j.surg.2003.10.017; Erkan M, 2012, CURR MOL MED, V12, P288, DOI 10.2174/156652412799218921; Fan HP, 2013, J BIOL CHEM, V288, P3322, DOI 10.1074/jbc.M112.420497; Gogate PN, 2014, CANCER LETT, V353, P281, DOI 10.1016/j.canlet.2014.07.032; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Grzesiak JJ, 2006, BRIT J CANCER, V94, P1311, DOI 10.1038/sj.bjc.6603088; Grzesiak JJ, 2011, INT J CANCER, V129, P2905, DOI 10.1002/ijc.25942; Guan JL, 2010, IUBMB LIFE, V62, P268, DOI 10.1002/iub.303; Gurler H, 2015, INT J MOL SCI, V16, P3419, DOI 10.3390/ijms16023419; Halder J, 2007, CANCER RES, V67, P10976, DOI 10.1158/0008-5472.CAN-07-2667; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Infante JR, 2012, J CLIN ONCOL, V30, P1527, DOI 10.1200/JCO.2011.38.9346; Jimeno A, 2009, MOL CANCER THER, V8, P310, DOI 10.1158/1535-7163.MCT-08-0924; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Kakkad SM, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.11.116017; Kirkland SC, 2009, BRIT J CANCER, V101, P320, DOI 10.1038/sj.bjc.6605143; Koenig A, 2006, CANCER RES, V66, P4662, DOI 10.1158/0008-5472.CAN-05-2804; Kurenova E, 2013, ONCOTARGET, V4, P1632, DOI 10.18632/oncotarget.1365; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Lonardo E, 2012, CELL CYCLE, V11, P1282, DOI 10.4161/cc.19679; Lu J, 2014, BRIT J CANCER, V110, P409, DOI 10.1038/bjc.2013.706; Luo M, 2013, CANCER RES, V73, P5591, DOI 10.1158/0008-5472.CAN-13-1351; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; Moen I, 2015, CLIN EXP METASTAS, V32, P799, DOI 10.1007/s10585-015-9752-z; MOLLENHAUER J, 1987, Pancreas, V2, P14, DOI 10.1097/00006676-198701000-00003; Neesse A, 2015, GUT, V64, P1476, DOI 10.1136/gutjnl-2015-309304; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Ou JJ, 2013, STEM CELL RES, V11, P820, DOI 10.1016/j.scr.2013.05.009; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; Paulson AS, 2013, GASTROENTEROLOGY, V144, P1316, DOI 10.1053/j.gastro.2013.01.078; Penchev VR, 2012, CLIN CANCER RES, V18, P4277, DOI 10.1158/1078-0432.CCR-11-3112; Peng X, 2008, P NATL ACAD SCI USA, V105, P6638, DOI 10.1073/pnas.0802319105; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Rasheed Z, 2010, JOURNAL OF VISUALIZE; Rasheed ZA, 2010, JNCI-J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Rognoni E, 2014, NAT MED, V20, P350, DOI 10.1038/nm.3490; Sainz B, 2015, GUT, V64, P1921, DOI 10.1136/gutjnl-2014-308935; Sainz B, 2014, CANCER RES, V74, P7309, DOI 10.1158/0008-5472.CAN-14-1354; Schmitt-Graeff AH, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/347270; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Schultze A, 2010, EXPERT OPIN INV DRUG, V19, P777, DOI 10.1517/13543784.2010.489548; Seguin L, 2015, TRENDS CELL BIOL, V25, P234, DOI 10.1016/j.tcb.2014.12.006; Shapiro IM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008639; Shen YF, 2012, INT J GYNECOL CANCER, V22, P1316, DOI 10.1097/IGC.0b013e318263ef34; Shintani Y, 2006, CANCER RES, V66, P11745, DOI 10.1158/0008-5472.CAN-06-2322; Sottnik JL, 2013, CLIN EXP METASTAS, V30, P569, DOI 10.1007/s10585-012-9561-6; Stokes JB, 2011, MOL CANCER THER, V10, P2135, DOI 10.1158/1535-7163.MCT-11-0261; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; Tanno T, 2014, BLOOD, V123, P725, DOI 10.1182/blood-2013-08-524025; Vaquero EC, 2003, GASTROENTEROLOGY, V125, P1188, DOI 10.1016/S0016-5085(03)01203-4; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wagers AJ, 2012, CELL STEM CELL, V10, P362, DOI 10.1016/j.stem.2012.02.018; Waghray M, 2013, CURR OPIN GASTROEN, V29, P537, DOI 10.1097/MOG.0b013e328363affe; Whatcott CJ, 2015, CLIN CANCER RES, V21, P3561, DOI 10.1158/1078-0432.CCR-14-1051; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wu HW, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-125; Ye J, 2014, TUMOR BIOL, V35, P3945, DOI 10.1007/s13277-013-1561-x; Zhang JL, 2014, CELL CYCLE, V13, P3143, DOI 10.4161/15384101.2014.949550; Zhang K, 2013, NAT CELL BIOL, V15, P677, DOI 10.1038/ncb2743; Zhang Y, 2014, BLOOD, V124, P2675, DOI 10.1182/blood-2014-03-563981	71	51	52	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180181	10.1371/journal.pone.0180181	http://dx.doi.org/10.1371/journal.pone.0180181			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692661	Green Submitted, Green Published, gold			2022-12-26	WOS:000405544800028
J	Gissi, E; Menegon, S; Sarretta, A; Appiotti, F; Maragno, D; Vianello, A; Depellegrin, D; Venier, C; Barbanti, A				Gissi, Elena; Menegon, Stefano; Sarretta, Alessandro; Appiotti, Federica; Maragno, Denis; Vianello, Andrea; Depellegrin, Daniel; Venier, Chiara; Barbanti, Andrea			Addressing uncertainty in modelling cumulative impacts within maritime spatial planning in the Adriatic and Ionian region	PLOS ONE			English	Article							SENSITIVITY-ANALYSIS; HUMAN PRESSURES; SEA; BIODIVERSITY; ECOSYSTEM; CONSERVATION; VULNERABILITY; INFORMATION; ASSUMPTIONS; SCIENTISTS	Maritime spatial planning (MSP) is envisaged as a tool to apply an ecosystem-based approach to the marine and coastal realms, aiming at ensuring that the collective pressure of human activities is kept within acceptable limits. Cumulative impacts (CI) assessment can support science-based MSP, in order to understand the existing and potential impacts of human uses on the marine environment. A CI assessment includes several sources of uncertainty that can hinder the correct interpretation of its results if not explicitly incorporated in the decision-making process. This study proposes a three-level methodology to perform a general uncertainty analysis integrated with the CI assessment for MSP, applied to the Adriatic and Ionian Region (AIR). We describe the nature and level of uncertainty with the help of expert judgement and elicitation to include all of the possible sources of uncertainty related to the CI model with assumptions and gaps related to the case-based MSP process in the AIR. Next, we use the results to tailor the global uncertainty analysis to spatially describe the uncertainty distribution and variations of the CI scores dependent on the CI model factors. The results show the variability of the uncertainty in the AIR, with only limited portions robustly identified as the most or the least impacted areas under multiple model factors hypothesis. The results are discussed for the level and type of reliable information and insights they provide to decision-making. The most significant uncertainty factors are identified to facilitate the adaptive MSP process and to establish research priorities to fill knowledge gaps for subsequent planning cycles. The method aims to depict the potential CI effects, as well as the extent and spatial variation of the data and scientific uncertainty; therefore, this method constitutes a suitable tool to inform the potential establishment of the precautionary principle in MSP.	[Gissi, Elena; Appiotti, Federica; Maragno, Denis] Univ Iuav Venezia, Dept Design & Planning Complex Environm, Venice, Italy; [Menegon, Stefano; Sarretta, Alessandro; Vianello, Andrea; Depellegrin, Daniel; Venier, Chiara; Barbanti, Andrea] CNR, Inst Marine Sci, Venice, Italy; [Vianello, Andrea] EURAC Res, Inst Appl Remote Sensing, Bolzano, Italy	IUAV University Venice; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); European Academy of Bozen-Bolzano	Gissi, E (corresponding author), Univ Iuav Venezia, Dept Design & Planning Complex Environm, Venice, Italy.	egissi@iuav.it	Gissi, Elena/T-1108-2019; Menegon, Stefano/AAK-4256-2021; Venier, Chiara/ABB-1251-2020; Barbanti, Andrea/AAL-1470-2021; Sarretta, Alessandro/AAV-9739-2020; Depellegrin, Daniel/E-4788-2012	Gissi, Elena/0000-0002-1666-8772; Menegon, Stefano/0000-0003-4488-8745; Venier, Chiara/0000-0001-6880-2745; Depellegrin, Daniel/0000-0002-6493-9506; Sarretta, Alessandro/0000-0002-1475-8686; Barbanti, Andrea/0000-0002-4871-7874	ADRIPLAN (ADRiaticIonianmaritimespatial PLANning) project; co-financed by European Commission, Directorate-General for Maritime Affairs and Fisheries, [SI2.666717, MARE/2012/25]; SUPREME (SUpporting maritime spatial Planning in the Eastern Mediterranean) project; European Commission, Executive Agency for Small and Medium-sized Enterprises [SI2.742087, EASME/EMFF/2015/1.2.1.3/01]; Flagship Project RITMARED Italian Research; Italian Ministry of Education, University and Research within the National Research Program	ADRIPLAN (ADRiaticIonianmaritimespatial PLANning) project; co-financed by European Commission, Directorate-General for Maritime Affairs and Fisheries,; SUPREME (SUpporting maritime spatial Planning in the Eastern Mediterranean) project; European Commission, Executive Agency for Small and Medium-sized Enterprises(European CommissionEuropean Commission Joint Research Centre); Flagship Project RITMARED Italian Research; Italian Ministry of Education, University and Research within the National Research Program(Ministry of Education, Universities and Research (MIUR))	This research was supported by the ADRIPLAN (ADRiaticIonianmaritimespatial PLANning) project, co-financed by European Commission, Directorate-General for Maritime Affairs and Fisheries, SI2.666717 call MARE/2012/25,by the SUPREME (SUpporting maritime spatial Planning in the Eastern Mediterranean) project,co-Financed by European Commission, Executive Agency for Small and Medium-sized Enterprises, SI2.742087,call for proposals EASME/EMFF/2015/1.2.1.3/01,and by the the Flagship Project RITMARED Italian Research for the Sea, coordinated by the Italian National Research Council and funded by the Italian Ministry of Education, University and Research within the National Research Program 2011-2013.The funders had no role in study design, data collection andanalysis, decision to publish, or preparation of the manuscript.	Andersen J.H., 2013, 18 DCE AARHUS U; [Anonymous], 2004, RIVM MNP GUIDANCE UN; Ansong J, 2017, OCEAN COAST MANAGE, V141, P65, DOI 10.1016/j.ocecoaman.2017.03.005; Ban NC, 2010, MAR POLICY, V34, P876, DOI 10.1016/j.marpol.2010.01.010; Ban SS, 2014, GLOBAL CHANGE BIOL, V20, P681, DOI 10.1111/gcb.12453; Barbanti A., 2015, DEV MARITIME SPATIAL; Batista MI, 2014, OCEAN COAST MANAGE, V102, P248, DOI 10.1016/j.ocecoaman.2014.09.020; Cameron A, 2011, EUSEAMAP FINAL REPOR; Campolongo F, 2007, ENVIRON MODELL SOFTW, V22, P1509, DOI 10.1016/j.envsoft.2006.10.004; Chiles J.P, 2009, GEOSTATISTICS MODELI, V497; COM, 2000, COMMUNICATION; Costantino G, 2010, CHEM ECOL, V26, P91, DOI 10.1080/02757541003705484; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Dankel DJ, 2012, ICES J MAR SCI, V69, P3, DOI 10.1093/icesjms/fsr179; Ehler C, 2009, IOC MANUAL GUIDES N; Falco P, 2000, J PHYS OCEANOGR, V30, P2055, DOI 10.1175/1520-0485(2000)030<2055:TPITAS>2.0.CO;2; Fraschetti S, 2011, AQUAT CONSERV, V21, P299, DOI 10.1002/aqc.1185; Giakoumi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076449; Gissi E, 2016, MAR POLICY, V74, P43, DOI 10.1016/j.marpol.2016.09.016; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Halpern BS, 2008, OCEAN COAST MANAGE, V51, P203, DOI 10.1016/j.ocecoaman.2007.08.002; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Halpern BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8615; Halpern BS, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00181.1; Homma T, 1996, RELIAB ENG SYST SAFE, V52, P1, DOI 10.1016/0951-8320(96)00002-6; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; INSPIRE Thematic Working Group Coordinate reference systems and Geographical grid systems, 2010, D2 8 1 2 INSPIRE SPE; Judd AD, 2015, ENVIRON SCI POLICY, V54, P254, DOI 10.1016/j.envsci.2015.07.008; Kelly RP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0276; Korpinen S, 2013, MAR POLLUT BULL, V74, P311, DOI 10.1016/j.marpolbul.2013.06.036; Korpinen S, 2012, ECOL INDIC, V15, P105, DOI 10.1016/j.ecolind.2011.09.023; Lester SE, 2010, BIOL CONSERV, V143, P576, DOI 10.1016/j.biocon.2009.11.021; Levin N, 2014, MAR ECOL PROG SER, V508, P261, DOI 10.3354/meps10857; Lilburne L, 2009, INT J GEOGR INF SCI, V23, P151, DOI 10.1080/13658810802094995; Liquete C, 2016, ECOL INDIC, V63, P249, DOI 10.1016/j.ecolind.2015.11.058; Mastrototaro F, 2010, DEEP-SEA RES PT II, V57, P412, DOI 10.1016/j.dsr2.2009.08.021; McKinney F.K., 2007, NO ADRIATIC ECOSYSTE; Menegon S, 2016, PEERJ PREPRINTS, V4; Menegon S, CUMULATIVE IN PRESS; Peifer H., 2011, EEA REFERENCE GRID E; Petersen JK, 2008, ECOL APPL, V18, P497, DOI 10.1890/07-0752.1; Poulain PM, 2001, J MARINE SYST, V29, P3, DOI 10.1016/S0924-7963(01)00007-0; Rudd MA, 2015, GLOBAL ENVIRON CHANG, V33, P44, DOI 10.1016/j.gloenvcha.2015.04.006; Ruggeri P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153061; Saltelli A, 2005, CHEM REV, V105, P2811, DOI 10.1021/cr040659d; Saltelli A, 2002, COMPUT PHYS COMMUN, V145, P280, DOI 10.1016/S0010-4655(02)00280-1; Saltelli A, 2010, COMPUT PHYS COMMUN, V181, P259, DOI 10.1016/j.cpc.2009.09.018; Savini A, 2010, DEEP-SEA RES PT II, V57, P326, DOI 10.1016/j.dsr2.2009.08.014; Selkoe KA, 2009, CORAL REEFS, V28, P635, DOI 10.1007/s00338-009-0490-z; Shucksmith RJ, 2014, MAR POLICY, V50, P27, DOI 10.1016/j.marpol.2014.05.006; Sobol I.M., 1993, MATH MODEL COMPUT EX, V1, P407, DOI DOI 10.18287/0134-2452-2015-39-4-459-461; Souvermezoglou E, 1999, NATO ASI 2, V51, P475; Speranza F, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009475; Spruijt P, 2014, ENVIRON SCI POLICY, V40, P16, DOI 10.1016/j.envsci.2014.03.002; Stelzenmuller V, 2015, MAR POLICY, V51, P151, DOI 10.1016/j.marpol.2014.08.001; Stock A, 2016, GLOBAL ECOL BIOGEOGR, V25, P1321, DOI 10.1111/geb.12493; Tang T, 2006, HYDROL EARTH SYST SC, V3, P3333, DOI [DOI 10.5194/hessd-3-3333-2006, 10.5194/hessd-3-3333-2006, DOI 10.5194/HESSD-3-3333-2006]; Teck SJ, 2010, ECOL APPL, V20, P1402, DOI 10.1890/09-1173.1; Telesca Luca, 2015, SCI REPORTS; Thornton TF, 2012, ECOL SOC, V17, DOI 10.5751/ES-04714-170308; Tursi A, 2004, CHEM ECOL, V20, pS107, DOI 10.1080/02757540310001629170; van der Sluijs J, 2005, WATER SCI TECHNOL, V52, P87, DOI 10.2166/wst.2005.0155; Walker W.E., 2003, INTEGR ASSESS, V4, P5; Weeks R, 2010, BIOL CONSERV, V143, P1236, DOI 10.1016/j.biocon.2010.02.031	65	42	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180501	10.1371/journal.pone.0180501	http://dx.doi.org/10.1371/journal.pone.0180501			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692688	Green Submitted, Green Published, gold			2022-12-26	WOS:000405544800048
J	Sabol, I; Gasperov, NM; Matovina, M; Bozinovic, K; Grubisic, G; Fistonic, I; Belci, D; Alemany, L; Dzebro, S; Dominis, M; Sekerija, M; Tous, S; de Sanjose, S; Grce, M				Sabol, Ivan; Gasperov, Nina Milutin; Matovina, Mihaela; Bozinovic, Ksenija; Grubisic, Goran; Fistonic, Ivan; Belci, Dragan; Alemany, Laia; Dzebro, Sonja; Dominis, Mara; Sekerija, Mario; Tous, Sara; de Sanjose, Silvia; Grce, Magdalena			Cervical HPV type-specific pre-vaccination prevalence and age distribution in Croatia	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; POLYMERASE-CHAIN-REACTION; YOUNG-WOMEN; CANCER; RISK; CLASSIFICATION; NEOPLASIA; GENOTYPES; CYTOLOGY; COMMON	The main etiological factor of precancerous lesion and invasive cervical cancer are oncogenic human papillomaviruses types (HPVs). The objective of this study was to establish the distribution of the most common HPVs in different cervical lesions and cancer prior to the implementation of organized population-based cervical screening and HPV vaccination in Croatia. In this study, 4,432 cervical specimens, collected through a 16-year period, were tested for the presence of HPV-DNA by polymerase chain reaction (PCR) with three sets of broad-spectrum primers and type-specific primers for most common low-risk (LR) types (HPV-6, 11) and the most common high-risk (HR) types (HPV-16, 18, 31, 33, 45, 52, 58). Additional 35 archival formalin-fixed, paraffin embedded tissue of cervical cancer specimens were analyzed using LiPA25 assay. The highest age-specific HPV-prevalence was in the group 18-24 years, which decreased continuously with age (P< 0.0001) regardless of the cytological diagnosis. The prevalence of HR-HPV types significantly increased (P< 0.0001) with the severity of cervical lesions. HPV-16 was the most common type found with a prevalence (with or without another HPV-type) of 6.9% in normal cytology, 15.5% in atypical squamous cells of undetermined significance, 14.4% in low-grade squamous intraepithelial lesions, 33.3% in high-grade squamous intraepithelial lesions, and 60.9% in cervical cancer specimens (P< 0.0001). This study provides comprehensive and extensive data on the distribution of the most common HPV types among Croatian women, which will enable to predict and to monitor the impact of HPV-vaccination and to design effective screening strategies in Croatia.	[Sabol, Ivan; Gasperov, Nina Milutin; Matovina, Mihaela; Bozinovic, Ksenija; Grce, Magdalena] Rudjer Boskovic Inst, Dept Mol Med, Zagreb, Croatia; [Grubisic, Goran] Univ Hosp Sisters Mercy, Clin Obstet & Gynaecol, Zagreb, Croatia; [Fistonic, Ivan] Obstet Gynecol & Menopause Clin, Zagreb, Croatia; [Belci, Dragan] Gen Hosp Pula, Dept Gynecol & Obstet, Pula, Croatia; [Alemany, Laia; Tous, Sara; de Sanjose, Silvia] Catalan Inst Oncol, Unit Infect & Canc, Canc Epidemiol Res Program, Barcelona, Spain; [Alemany, Laia; de Sanjose, Silvia] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Dzebro, Sonja; Dominis, Mara] Univ Zagreb, Univ Hosp Merkur, Sch Med, Dept Pathol & Cytol, Zagreb, Croatia; [Sekerija, Mario] Croatian Inst Publ Hlth, Croatian Natl Canc Registry, Zagreb, Croatia; [Sekerija, Mario] Univ Zagreb, Andrija Stampar Sch Publ Hlth, Sch Med, Zagreb, Croatia	Rudjer Boskovic Institute; Catalan Institute of Oncology; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Zagreb; University of Zagreb	Gasperov, NM (corresponding author), Rudjer Boskovic Inst, Dept Mol Med, Zagreb, Croatia.	nmilutin@irb.hr	Fistonic, Ivan/V-7013-2017; Sabol, Ivan/B-7455-2012; Alemany, Laia/G-9643-2015; GRCE, MAGDALENA/ABD-2768-2020; Sekerija, Mario/W-8550-2019; Matovina, Mihaela/P-7426-2019; Tous, Sara/G-5052-2015	Fistonic, Ivan/0000-0003-3295-9390; Sabol, Ivan/0000-0002-5753-8528; Alemany, Laia/0000-0003-0945-6015; Sekerija, Mario/0000-0001-7508-1501; Matovina, Mihaela/0000-0001-7647-3339; Grce, Magdalena/0000-0001-6178-8418; Tous, Sara/0000-0002-5423-7092	Croatian Ministry of Science, Education and Sports [098-09824642 510]; international project Retrospective International Survey; HPV Time Trends Study Group"	Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia); international project Retrospective International Survey; HPV Time Trends Study Group"	This research has been partially supported by the Croatian Ministry of Science, Education and Sports (grantno.098-09824642 510,URL:zprojekti.mzos.hr), and partially by the international project Retrospective International Survey and HPV Time Trends Study Group" (URL: ico.gencat.cat). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Agodi A, 2009, INT J GYNECOL CANCER, V19, P1094, DOI 10.1111/IGC.0b013e3181a83c9d; [Anonymous], 2007, MON EV CARC RISKS HU; Arbyn M, 2009, CANCER EPIDEM BIOMAR, V18, P321, DOI 10.1158/1055-9965.EPI-08-0510; BELL DA, 1993, J NATL CANCER I, V85, P1159, DOI 10.1093/jnci/85.14.1159; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Blanks RG, 2009, BRIT J CANCER, V100, P1832, DOI 10.1038/sj.bjc.6605069; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Bzhalava D, 2015, VIROLOGY, V476, P341, DOI 10.1016/j.virol.2014.12.028; CHAN SY, 1995, J VIROL, V69, P3074, DOI 10.1128/JVI.69.5.3074-3083.1995; Clifford GM, 2009, LANCET, V374, P1948, DOI 10.1016/S0140-6736(09)61789-X; Clifford GM, 2003, BRIT J CANCER, V89, P101, DOI 10.1038/sj.bjc.6601024; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Coupe VMH, 2008, BRIT J CANCER, V98, P646, DOI 10.1038/sj.bjc.6604162; Croatian National Cancer Registry, 2016, CANC INC MORT CROAT; Cuschieri KS, 2004, J CLIN PATHOL, V57, P68, DOI 10.1136/jcp.57.1.68; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; De Vuyst H, 2009, EUR J CANCER, V45, P2632, DOI 10.1016/j.ejca.2009.07.019; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Gasperov NM, 2008, PATHOL ONCOL RES, V14, P355, DOI 10.1007/s12253-008-9084-2; Grce M, 1997, EUR J EPIDEMIOL, V13, P645, DOI 10.1023/A:1007323405069; Grce M, 2001, ANTICANCER RES, V21, P579; Grce M, 2009, EXPERT REV MOL DIAGN, V9, P851, DOI [10.1586/erm.09.64, 10.1586/ERM.09.64]; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Hadzisejdic I, 2006, COLLEGIUM ANTROPOL, V30, P879; Howell-Jones R, 2012, VACCINE, V30, P3867, DOI 10.1016/j.vaccine.2012.04.006; International Agency for Research on Cancer (IARC), 2005, IARC HDB CANC PREV, V10, P45; Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044; Kovacs K, 2008, J MED VIROL, V80, P1814, DOI 10.1002/jmv.21282; Ljubjoevic N., 2001, GYNAECOL PERINATOL, V10, P85; Maver PJ, 2013, ACTA DERMATOVEN ALP, V21, P7, DOI 10.2478/v10162-012-0025-0; Milutin-Gagperov N, 2007, COLLEGIUM ANTROPOL, V31, P89; Moore RA, 2009, CANCER CAUSE CONTROL, V20, P1387, DOI 10.1007/s10552-009-9365-4; Nicula FA, 2009, EUR J CANCER, V45, P2679, DOI 10.1016/j.ejca.2009.07.025; OVANINRAKIC A, 2003, GYNAECOL PERINATOL, V12, P148; Poljak M, 2013, VACCINE, V31, pH59, DOI 10.1016/j.vaccine.2013.03.029; Ronco G, 2005, EUR J CANCER, V41, P297, DOI 10.1016/j.ejca.2004.07.005; Sabol I, 2008, J CLIN MICROBIOL, V46, P1606, DOI 10.1128/JCM.02328-07; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sargent A, 2008, BRIT J CANCER, V98, P1704, DOI 10.1038/sj.bjc.6604324; Seme K, 2013, ACTA DERMATOVEN ALP, V21, P21, DOI 10.2478/v10162-012-0026-z; Serrano B., 2021, HUMAN PAPILLOMAVIRUS; SPAVENTI R, 1994, EUR J CANCER, V30A, P419, DOI 10.1016/0959-8049(94)90277-1; Tachezy R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079156; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	46	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180480	10.1371/journal.pone.0180480	http://dx.doi.org/10.1371/journal.pone.0180480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692681	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000405544800047
J	Leong, SH; Ong, SH				Leong, Siow Hoo; Ong, Seng Huat			Similarity measure and domain adaptation in multiple mixture model clustering: An application to image processing	PLOS ONE			English	Article							LARGE DATA SETS; SIMULATING DATA; SEGMENTATION; CLASSIFICATION; PERFORMANCE; REDUCTION; ALGORITHM; DATASETS	This paper considers three crucial issues in processing scaled down image, the representation of partial image, similarity measure and domain adaptation. Two Gaussian mixture model based algorithms are proposed to effectively preserve image details and avoids image degradation. Multiple partial images are clustered separately through Gaussian mixture model clustering with a scan and select procedure to enhance the inclusion of small image details. The local image features, represented by maximum likelihood estimates of the mixture components, are classified by using the modified Bayes factor (MBF) as a similarity measure. The detection of novel local features from MBF will suggest domain adaptation, which is changing the number of components of the Gaussian mixture model. The performance of the proposed algorithms are evaluated with simulated data and real images and it is shown to perform much better than existing Gaussian mixture model based algorithms in reproducing images with higher structural similarity index.	[Leong, Siow Hoo] Univ Teknol MARA, Fac Comp & Math Sci, Kota Samarahan, Sarawak, Malaysia; [Ong, Seng Huat] Univ Malaya, Inst Math Sci, Kuala Lumpur, Malaysia	Universiti Teknologi MARA; Universiti Malaya	Leong, SH (corresponding author), Univ Teknol MARA, Fac Comp & Math Sci, Kota Samarahan, Sarawak, Malaysia.; Ong, SH (corresponding author), Univ Malaya, Inst Math Sci, Kuala Lumpur, Malaysia.	ongsh@um.edu.my; leongsh@sarawak.uitm.edu.my	Leong, Siow Hoo/AAW-8938-2020; ONG, Seng Huat/B-9454-2010	ONG, Seng Huat/0000-0002-4288-7637; Leong, Siow Hoo/0000-0002-0325-0115	Fundamental Research Grant Scheme, Ministry of Higher Education, Malaysia [FP045-2015A]	Fundamental Research Grant Scheme, Ministry of Higher Education, Malaysia	Funded by Fundamental Research Grant Scheme, Ministry of Higher Education, Malaysia [FP045-2015A] OSH.	Asuncion A, 2007, UCI MACHINE LEARNING; Banda JM, 2013, SOL PHYS, V288, P435, DOI 10.1007/s11207-013-0304-x; BANFIELD JD, 1993, BIOMETRICS, V49, P803, DOI 10.2307/2532201; BROWNING JD, 1982, PATTERN RECOGN, V15, P1, DOI 10.1016/0031-3203(82)90055-3; Chang PC, 2012, APPL SOFT COMPUT, V12, P3165, DOI 10.1016/j.asoc.2012.06.004; Constantinopoulos C, 2007, LECT NOTES COMPUT SC, V4673, P596; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dong FF, 2014, J VIS COMMUN IMAGE R, V25, P827, DOI 10.1016/j.jvcir.2014.01.014; Duan Lixin, 2012, IEEE Trans Neural Netw Learn Syst, V23, P504, DOI 10.1109/TNNLS.2011.2178556; Fayyad U, 1996, P WORKSH MASS DAT SE, P129; Fraley C, 1998, COMPUT J, V41, P578, DOI 10.1093/comjnl/41.8.578; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Fraley C., 2005, J COMPUTATIONAL GRAP, V14, P1; Fraley C, 2012, 597 U WASH; Gan L, 2007, PROCEEDINGS OF THE 2007 15TH INTERNATIONAL CONFERENCE ON DIGITAL SIGNAL PROCESSING, P403; Gong BQ, 2014, INT J COMPUT VISION, V109, P3, DOI 10.1007/s11263-014-0718-4; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Jeffreys H., 1935, P CAMBR PHIL SOC, P201; Ji ZX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168449; Jiang XP, 2017, NEUROCOMPUTING, V220, P191, DOI 10.1016/j.neucom.2016.04.062; Jin HD, 2005, IEEE T PATTERN ANAL, V27, P1710, DOI 10.1109/TPAMI.2005.226; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kosmidis I, 2010, SUPERVISED SAMPLING; Maitra R, 2010, J COMPUT GRAPH STAT, V19, P354, DOI 10.1198/jcgs.2009.08054; Mandal B, 2012, COMM COM INF SC, V311, P482; Martin D, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL II, PROCEEDINGS, P416, DOI 10.1109/ICCV.2001.937655; Masmoudi A, 2015, SIGNAL IMAGE VIDEO P, V9, P1021, DOI 10.1007/s11760-013-0531-5; Melnykov V, 2012, J STAT SOFTW, V51, P1; Meng T, 2011, INT J MULTIMED DATA, V2, P54, DOI 10.4018/jmdem.2011040104; Naim I, 2014, CYTOM PART A, V85, P408, DOI 10.1002/cyto.a.22446; Nowak E, 2006, LECT NOTES COMPUT SC, V3954, P490; Pelleg D., 2000, P 17 INT C MACH LEAR, P727, DOI DOI 10.1007/3-540-44491-2_3; Pinto RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139931; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Scrucca L, 2016, R J, V8, P289; Shoyaib M, 2012, INT J APPROX REASON, V53, P636, DOI 10.1016/j.ijar.2012.01.003; Singh S, 2007, DIGIT SIGNAL PROCESS, V17, P225, DOI 10.1016/j.dsp.2005.08.003; SMITH AFM, 1980, J ROY STAT SOC B MET, V42, P213; Solomon C, 2011, FUNDAMENTALS DIGITAL, V1st, DOI 10.1002/9780470689776; Sonka M., 2014, J ELECTRON IMAGING, Vxix; Steiner PM, 2007, COMPUT STAT DATA AN, V51, P5416, DOI 10.1016/j.csda.2006.09.014; Tan KS, 2013, APPL SOFT COMPUT, V13, P2017, DOI 10.1016/j.asoc.2012.11.038; Tang CY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165664; Triantafyllidis GA, 2002, IEEE T CIRC SYST VID, V12, P877, DOI 10.1109/TCSVT.2002.804880; Tuia D, 2011, REMOTE SENS ENVIRON, V115, P2232, DOI 10.1016/j.rse.2011.04.022; van den Oord A, 2014, J MACH LEARN RES, V15, P2061; Vatsavai R. R., 2011, PROC 2 INT C COMPUTI, P1, DOI [10.1145/1999320.1999331, DOI 10.1145/1999320.1999331]; Vatsavi RR, 2009, LECT NOTES COMPUT SC, V5545, P375, DOI 10.1007/978-3-642-01973-9_42; Wang LA, 2011, PATTERN RECOGN, V44, P222, DOI 10.1016/j.patcog.2010.08.005; Wang MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091315; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wang Z, SSIM INDEX IMAGE QUA; Wehrens R, 2004, J CLASSIF, V21, P231, DOI 10.1007/s00357-004-0018-8; Wolfe JH, 1971, TECHNICAL B STB; Yang J, P ACM INT C; Zhang T., 1996, P 1996 ACM SIGMOD IN, DOI [10.1145/235968.233324, DOI 10.1145/235968.233324]	57	1	1	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180307	10.1371/journal.pone.0180307	http://dx.doi.org/10.1371/journal.pone.0180307			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686634	gold, Green Published, Green Submitted			2022-12-26	WOS:000405464100049
J	Charych, D; Khalili, S; Dixit, V; Kirk, P; Chang, T; Langowski, J; Rubas, W; Doberstein, SK; Eldon, M; Hoch, U; Zalevsky, J				Charych, Deborah; Khalili, Samira; Dixit, Vidula; Kirk, Peter; Chang, Thomas; Langowski, John; Rubas, Werner; Doberstein, Stephen K.; Eldon, Michael; Hoch, Ute; Zalevsky, Jonathan			Modeling the receptor pharmacology, pharmacokinetics, and pharmacodynamics of NKTR-214, a kinetically-controlled interleukin-2 (IL2) receptor agonist for cancer immunotherapy	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; REGULATORY T-CELLS; HIGH-DOSE INTERLEUKIN-2; LONG-TERM SAFETY; MODULATION THERAPIES; ALPHA-RECEPTOR; LIGAND-BINDING; IL-2; COMPLEXES; CYTOKINE	Cytokines are potent immune modulating agents but are not ideal medicines in their natural form due to their short half-life and pleiotropic systemic effects. NKTR-214 is a clinical-stage biologic that comprises interleukin-2 (IL2) protein bound by multiple releasable polyethylene glycol (PEG) chains. In this highly PEG-bound form, the IL2 is inactive; therefore, NKTR214 is a biologic prodrug. When administered in vivo, the PEG chains slowly release, creating a cascade of increasingly active IL2 protein conjugates bound by fewer PEG chains. The 1-PEG-IL2 and 2-PEG-IL2 species derived from NKTR-214 are the most active conjugatedIL2 species. Free-IL2 protein is undetectable in vivo as it is eliminated faster than formed. The PEG chains on NKTR-214 are located at the region of IL2 that contacts the alpha (a) subunit of the heterotrimeric IL2 receptor complex, IL2Rapy, reducing its ability to bind and activate the heterotrimer. The IL2Rapy complex is constitutively expressed on regulatory T cells (Tregs). Therefore, without the use of mutations, PEGylation reduces the affinity for IL2Rapy to a greater extent than for IL293y, the receptor complex predominant on CD8 T cells. NKTR-214 treatment in vivo favors activation of CD8 T cells over Tregs in the tumor microenvironment to provide anti-tumor efficacy in multiple syngeneic models. Mechanistic modeling based on in vitro and in vivo kinetic data provides insight into the mechanism of NKTR-214 pharmacology. The model reveals that conjugated-IL2 protein derived from NKTR-214 occupy IL-293y to a greater extent compared to free-IL2 protein. The model accurately describes the sustained in vivo signaling observed after a single dose of NKTR214 and explains how the properties of NKTR-214 impart a unique kinetically-controlled immunological mechanism of action.	[Charych, Deborah; Khalili, Samira; Dixit, Vidula; Kirk, Peter; Chang, Thomas; Langowski, John; Rubas, Werner; Doberstein, Stephen K.; Eldon, Michael; Hoch, Ute; Zalevsky, Jonathan] Nektar Therapeut, San Francisco, CA 94158 USA	Nektar Therapeutics	Charych, D (corresponding author), Nektar Therapeut, San Francisco, CA 94158 USA.	DCharych@nektar.com			Nektar Therapeutics, San Francisco, California, United States of America	Nektar Therapeutics, San Francisco, California, United States of America	The study was funded by Nektar Therapeutics, San Francisco, California, United States of America. All authors are salaried employees of Nektar Therapeutics. DC, SK and JZ were involved in the study design, data collection and analysis. DC and JZ were involved in the decision to publish. DC, SK and UH were involved with the writing and preparation of the manuscript. Nektar Therapeutics provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alexandrescu DT, 2005, J IMMUNOTHER, V28, P144, DOI 10.1097/01.cji.0000154250.82007.4a; Assal A, 2015, IMMUNOTHERAPY-UK, V7, P1169, DOI 10.2217/imt.15.78; Bos GW, 2004, EUR J PHARM SCI, V21, P561, DOI 10.1016/j.ejps.2003.12.007; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Busse D, 2010, P NATL ACAD SCI USA, V107, P3058, DOI 10.1073/pnas.0812851107; Charych DH, 2016, CLIN CANCER RES, V22, P680, DOI 10.1158/1078-0432.CCR-15-1631; Craiu A, 2001, AIDS RES HUM RETROV, V17, P873, DOI 10.1089/088922201750290005; Dutcher J, 2002, ONCOLOGY-NY, V16, P4; Feinerman O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.90; Fishburn CS, 2008, J PHARM SCI-US, V97, P4167, DOI 10.1002/jps.21278; Garcia-Martinez K, 2012, INT IMMUNOL, V24, P427, DOI 10.1093/intimm/dxr120; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Konigsberg PJ, 1998, BBA-BIOMEMBRANES, V1370, P243, DOI 10.1016/S0005-2736(97)00269-1; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Le Mercier I, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00418; Leon K, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00439; Letourneau S, 2010, P NATL ACAD SCI USA, V107, P2171, DOI 10.1073/pnas.0909384107; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Lipiainen T, 2015, J PHARM SCI-US, V104, P307, DOI 10.1002/jps.24243; Luheshi NM, 2016, ONCOTARGET, V7, P18508, DOI 10.18632/oncotarget.7610; McDermott DF, 2016, J CLIN ONCOL, V34, P833, DOI 10.1200/JCO.2015.63.7421; McDermott DF, 2015, J CLIN ONCOL, V33, P2013, DOI 10.1200/JCO.2014.58.1041; McDermott DF, 2005, J CLIN ONCOL, V23, P133, DOI 10.1200/JCO.2005.03.206; Myszka DG, 1996, PROTEIN SCI, V5, P2468, DOI 10.1002/pro.5560051209; Payne R, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-13; Penichet Manuel L., 1997, Human Antibodies, V8, P106; Rickert M, 2004, J MOL BIOL, V339, P1115, DOI 10.1016/j.jmb.2004.04.038; Samlowski WE, 2006, J IMMUNOTHER, V29, P524, DOI 10.1097/01.cji.0000211306.05869.25; Schein CH, 2002, CURR PHARM DESIGN, V8, P2113, DOI 10.2174/1381612023393161; Shanafelt AB, 2000, NAT BIOTECHNOL, V18, P1197, DOI 10.1038/81199; Sim GC, 2014, IL 2 CYTOKINE FAMILY; Stauber DJ, 2006, P NATL ACAD SCI USA, V103, P2788, DOI 10.1073/pnas.0511161103; Sznol M, 2015, NEW ENGL J MED, V372, P374, DOI 10.1056/NEJMe1413488; TANIGUCHI T, 1993, CELL, V73, P5, DOI 10.1016/0092-8674(93)90152-G; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; WU ZN, 1995, J BIOL CHEM, V270, P16045, DOI 10.1074/jbc.270.27.16045; Zhang L, 2015, MOL CANC THERAPEUTIC; Zhang L, 2015, MOL CANC THERAPEU S2, V14, pA6	38	92	102	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179431	10.1371/journal.pone.0179431	http://dx.doi.org/10.1371/journal.pone.0179431			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678791	Green Published, gold, Green Submitted			2022-12-26	WOS:000405272200014
J	Jennings, S; Chenevert, M; Liu, LQ; Mottamal, M; Wojcik, EJ; Huckaba, TM				Jennings, Scott; Chenevert, Madeline; Liu, Liqiong; Mottamal, Madhusoodanan; Wojcik, Edward J.; Huckaba, Thomas M.			Characterization of kinesin switch I mutations that cause hereditary spastic paraplegia	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT; KIF5A MUTATIONS; MOTOR DOMAIN; SPG10; PARAPARESIS; PROTEINS; TUBULIN; ATPASE; NEUROPATHOLOGY; MECHANISM	Kif5A is a neuronally-enriched isoform of the Kinesin-1 family of cellular transport motors. 23 separate mutations in the motor domain of Kif5A have been identified in patients with the complicated form of hereditary spastic paraplegia (HSP). We performed in vitro assays on dimeric recombinant Kif5A with HSP-causing mutations in the Switch I domain, which participates in the coordination and hydrolysis of ATP by kinesin. We observed a variety of significantly reduced catalytic and mechanical activities as a result of each mutation, with the shared phenotype from each that motility was significantly reduced. Substitution of Mn (2+) for Mg (2+) in our reaction buffers provides a dose-dependent rescue in both the catalytic and ensemble mechanical properties of the S203C mutant. This work provides mechanistic insight into the cause of HSP in patients with these mutations and points to future experiments to further dissect the root cause of this disease.	[Jennings, Scott; Chenevert, Madeline; Huckaba, Thomas M.] Xavier Univ Louisiana, Dept Biol, New Orleans, LA 70125 USA; [Liu, Liqiong; Wojcik, Edward J.] LSU Sch Med, Dept Biochem & Mol Biol, New Orleans, LA USA; [Liu, Liqiong; Wojcik, Edward J.] Hlth Sci Ctr, New Orleans, LA USA; [Mottamal, Madhusoodanan] Xavier Univ Louisiana, RCMI Mol Modeling Core, New Orleans, LA USA	Xavier University of Louisiana; Louisiana State University System; Louisiana State University; Xavier University of Louisiana	Huckaba, TM (corresponding author), Xavier Univ Louisiana, Dept Biol, New Orleans, LA 70125 USA.	thuckaba@xula.edu		Huckaba, Thomas/0000-0002-6711-9175; Wojcik, Edward/0000-0002-3023-0312	Louisiana Cancer Research Consortium; NIH-RCMI from the National Institutes on Minority Health and Health Disparities [2G12MD007595-06]; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM103424]; National Institute of General Medical Sciences of the National Institutes of Health [5UL1GM118967, R01GM066328]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [UL1GM118967, P20GM103424] Funding Source: NIH RePORTER	Louisiana Cancer Research Consortium; NIH-RCMI from the National Institutes on Minority Health and Health Disparities; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Louisiana Cancer Research Consortium and the NIH-RCMI grant 2G12MD007595-06 from the National Institutes on Minority Health and Health Disparities to TMH, an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health grant P20GM103424 to TMH, a National Institute of General Medical Sciences of the National Institutes of Health grant 5UL1GM118967 to TMH, and a National Institute of General Medical Sciences of the National Institutes of Health grant R01GM066328 to EJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEHAN WMH, 1974, J NEUROL NEUROSUR PS, V37, P8, DOI 10.1136/jnnp.37.1.8; Blair MA, 2006, NEUROGENETICS, V7, P47, DOI 10.1007/s10048-005-0027-8; BRUYN RPM, 1992, CLIN NEUROL NEUROSUR, V94, pS16; Cao LY, 2017, SCI REP-UK, V7, DOI 10.1038/srep42558; Cao LY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6364; Carosi L, 2015, J NEUROL NEUROSUR PS, V86, P702, DOI 10.1136/jnnp-2014-308625; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Crimella C, 2012, CLIN GENET, V82, P157, DOI 10.1111/j.1399-0004.2011.01717.x; Djagaeva I, 2012, GENETICS, V192, P173, DOI 10.1534/genetics.112.140798; Ebbing B, 2008, HUM MOL GENET, V17, P1245, DOI 10.1093/hmg/ddn014; Fichera M, 2004, NEUROLOGY, V63, P1108, DOI 10.1212/01.WNL.0000138731.60693.D2; Finsterer J, 2012, J NEUROL SCI, V318, P1, DOI 10.1016/j.jns.2012.03.025; Frederiksen JK, 2009, METHODS, V49, P148, DOI 10.1016/j.ymeth.2009.07.005; Fuger P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003066; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Gigant B, 2013, NAT STRUCT MOL BIOL, V20, P1001, DOI 10.1038/nsmb.2624; GILBERT SP, 1995, NATURE, V373, P671, DOI 10.1038/373671a0; Goizet C, 2009, HUM MUTAT, V30, pE376, DOI 10.1002/humu.20920; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; Huckaba TM, 2011, J BIOL CHEM, V286, P7457, DOI 10.1074/jbc.M110.167023; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Klebe S, 2015, REV NEUROL-FRANCE, V171, P505, DOI 10.1016/j.neurol.2015.02.017; Kull FJ, 2002, J CELL SCI, V115, P15; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; Liu YT, 2014, NEUROLOGY, V83, P612, DOI 10.1212/WNL.0000000000000691; Lo Giudice M, 2006, ARCH NEUROL-CHICAGO, V63, P284, DOI 10.1001/archneur.63.2.284; Lopez E, 2015, J NEUROL SCI, V358, P422, DOI 10.1016/j.jns.2015.08.1529; MA YZ, 1995, BIOCHEMISTRY-US, V34, P13233, DOI 10.1021/bi00040a039; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McDermott CJ, 2000, J NEUROL NEUROSUR PS, V69, P150, DOI 10.1136/jnnp.69.2.150; Muglia M, 2014, J NEUROL SCI, V343, P218, DOI 10.1016/j.jns.2014.05.063; Musumeci O, 2011, NEUROL SCI, V32, P665, DOI 10.1007/s10072-010-0445-8; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Rinaldi Fabrizio, 2015, J Clin Neuromuscul Dis, V16, P153, DOI 10.1097/CND.0000000000000063; Sack S, 1999, EUR J BIOCHEM, V262, P1, DOI 10.1046/j.1432-1327.1999.00341.x; SADHU A, 1992, J BIOL CHEM, V267, P11352; Schule R, 2008, J NEUROL NEUROSUR PS, V79, P584, DOI 10.1136/jnnp.2007.137596; Tessa A, 2008, J NEUROL, V255, P1090, DOI 10.1007/s00415-008-0840-8; Vale RD, 1996, J CELL BIOL, V135, P291, DOI 10.1083/jcb.135.2.291; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Yun MY, 2001, EMBO J, V20, P2611, DOI 10.1093/emboj/20.11.2611	43	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180353	10.1371/journal.pone.0180353	http://dx.doi.org/10.1371/journal.pone.0180353			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678816	Green Submitted, Green Published, gold			2022-12-26	WOS:000405272200059
J	Rissin, DM; Lopez-Longarela, B; Pernagallo, S; Ilyine, H; Vliegenthart, ADB; Dear, JW; Diaz-Mochon, JJ; Duffy, DC				Rissin, David M.; Lopez-Longarela, Barbara; Pernagallo, Salvatore; Ilyine, Hugh; Vliegenthart, A. D. Bastiaan; Dear, James W.; Diaz-Mochon, Juan J.; Duffy, David C.			Polymerase-free measurement of microRNA-122 with single base specificity using single molecule arrays: Detection of drug-induced liver injury	PLOS ONE			English	Article							NUCLEIC-ACIDS; BIOMARKERS; CHEMISTRY; PLATFORM; PCR; DNA	We have developed a single probe method for detecting microRNA from human serum using single molecule arrays, with sequence specificity down to a single base, and without the use of amplification by polymerases. An abasic peptide nucleic acid (PNA) probe D containing a reactive amine instead of a nucleotide at a specific position in the sequence D for detecting a microRNA was conjugated to superparamagnetic beads. These beads were incubated with a sample containing microRNA, a biotinylated reactive nucleobase D containing an aldehyde group D that was complementary to the missing base in the probe sequence, and a reducing agent. When a target molecule with an exact match in sequence hybridized to the capture probe, the reactive nucleobase was covalently attached to the backbone of the probe by a dynamic covalent chemical reaction. Single molecules of the biotin-labeled probe were then labeled with streptavidin-beta-galactosidase (S beta G), the beads were resuspended in a fluorogenic enzyme substrate, loaded into an array of femtoliter wells, and sealed with oil. The array was imaged fluorescently to determine which beads were associated with single enzymes, and the average number of enzymes per bead was determined. The assay had a limit of detection of 500 fM, approximately 500 times more sensitive than a corresponding analog bead-based assay, with target specificity down to a single base mis-match. This assay was used to measure microRNA-122 (miR-122) D an established biomarker of liver toxicity D extracted from the serum of patients who had acute liver injury due to acetaminophen, and control healthy patients. All patients with liver injury had higher levels of miR-122 in their serum compared to controls, and the concentrations measured correlated well with those determined using RT-qPCR. This approach allows rapid quantification of circulating microRNA with single-based specificity and a limit of quantification suitable for clinical use.	[Rissin, David M.; Duffy, David C.] Quanterix Corp, Lexington, MA 02421 USA; [Lopez-Longarela, Barbara; Pernagallo, Salvatore; Ilyine, Hugh; Diaz-Mochon, Juan J.] DestiNA Genom Ltd, Edinburgh, Midlothian, Scotland; [Lopez-Longarela, Barbara; Pernagallo, Salvatore; Ilyine, Hugh; Diaz-Mochon, Juan J.] DestiNA Genom SL Parque Tecnol Ciencias Salud PTS, Ave Innovac 1,Edificio BIC, Granada, Spain; [Vliegenthart, A. D. Bastiaan; Dear, James W.] Univ Edinburgh, BHF Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Diaz-Mochon, Juan J.] Univ Granada, Pfizer, Junta Andalucia Ctr Genom & Oncol Res GENYO, Parque Tecnol Ciencias Salud PTS, Ave Ilustrac 114, Granada, Spain	University of Edinburgh; Pfizer; University of Granada	Duffy, DC (corresponding author), Quanterix Corp, Lexington, MA 02421 USA.; Diaz-Mochon, JJ (corresponding author), DestiNA Genom Ltd, Edinburgh, Midlothian, Scotland.; Diaz-Mochon, JJ (corresponding author), DestiNA Genom SL Parque Tecnol Ciencias Salud PTS, Ave Innovac 1,Edificio BIC, Granada, Spain.; Diaz-Mochon, JJ (corresponding author), Univ Granada, Pfizer, Junta Andalucia Ctr Genom & Oncol Res GENYO, Parque Tecnol Ciencias Salud PTS, Ave Ilustrac 114, Granada, Spain.	juan@destinagenomics.com; dduffy@quanterix.com	Pernagallo, Salvatore/K-3003-2017; Diaz-Mochon, Juan/A-4297-2009; Pernagallo, Salvatore/P-3224-2019; Diaz-Mochon, Juan/Q-1065-2019	Pernagallo, Salvatore/0000-0002-0259-9008; Diaz-Mochon, Juan/0000-0002-3599-1954; Pernagallo, Salvatore/0000-0002-0259-9008; Diaz-Mochon, Juan/0000-0002-3599-1954	Medical Research Council [MC_PC_12014] Funding Source: Medline; National Centre for the Replacement, Refinement and Reduction of Animals in Research [NC/K001485/1] Funding Source: Medline; National Centre for the Replacement [NC/K001485/1] Funding Source: researchfish; MRC [MC_PC_12014] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Centre for the Replacement, Refinement and Reduction of Animals in Research(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); National Centre for the Replacement; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Antoine DJ, 2013, HEPATOLOGY, V58, P777, DOI 10.1002/hep.26294; Bowler FR, 2010, ANGEW CHEM INT EDIT, V49, P1809, DOI 10.1002/anie.200905699; Dear JW, 2014, EXPERT REV CLIN PHAR, V7, P181, DOI 10.1586/17512433.2014.880650; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Heemstra JM, 2009, J AM CHEM SOC, V131, P11347, DOI 10.1021/ja904712t; Kan CW, 2012, LAB CHIP, V12, P977, DOI 10.1039/c2lc20744c; Khodakov D, 2016, ADV DRUG DELIVER REV, V105, P3, DOI 10.1016/j.addr.2016.04.005; Krauskopf J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177928; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Pernagallo S, 2012, SENSORS-BASEL, V12, P8100, DOI 10.3390/s120608100; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Rissin DM, 2013, LAB CHIP, V13, P2902, DOI 10.1039/c3lc50416f; Rissin DM, 2011, ANAL CHEM, V83, P2279, DOI 10.1021/ac103161b; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Smith SJ, 2017, J AM CHEM SOC, V139, P1020, DOI 10.1021/jacs.6b10850; Song LA, 2013, ANAL CHEM, V85, P1932, DOI 10.1021/ac303426b; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Venkateswaran S, 2016, TALANTA, V161, P489, DOI 10.1016/j.talanta.2016.08.072; Vliegenthart ADB, 2015, SCI REP-UK, V5, DOI 10.1038/srep15501; Wilson DH, 2016, JALA-J LAB AUTOM, V21, P533, DOI 10.1177/2211068215589580; Wu HX, 2014, J AM CHEM SOC, V136, P17942, DOI 10.1021/ja510839r; Zhang L, 2010, PROSTATE, V70, P297, DOI 10.1002/pros.21064	22	38	39	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179669	10.1371/journal.pone.0179669	http://dx.doi.org/10.1371/journal.pone.0179669			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678845	gold, Green Published, Green Submitted			2022-12-26	WOS:000405272200021
J	Wubull, A; Li, YH; Xue, F; Yao, XM; Upur, H; Wushouer, Q				Wubull, Atikaimu; Li, Yuehua; Xue, Feng; Yao, Xuemei; Upur, Halmurat; Wushouer, Qimanguli			Seasonality of active tuberculosis notification from 2005 to 2014 in Xinjiang, China	PLOS ONE			English	Article							VITAMIN-D; PULMONARY TUBERCULOSIS; EPIDEMIOLOGY	Objectives Xinjiang is one of the highest TB- burdened provinces of China. A time- series analysis was conducted to evaluate the trend, seasonality of active TB in Xinjiang, and explore the underlying mechanism of TB seasonality by comparing the seasonal variations of different subgroups. Methods Monthly active TB cases from 2005 to 2014 in Xinjiang were analyzed by the X- 12- ARIMA seasonal adjustment program. Seasonal amplitude (SA) was calculated and compared within the subgroups. Results A total of 277,300 confirmed active TB cases were notified from 2005 to 2014 in Xinjiang, China, with a monthly average of 2311 +/- 577. The seasonality of active TB notification was peaked in March and troughed in October, with a decreasing SA trend. The annual 77.31% SA indicated an annual mean of additional TB cases diagnosed in March as compared to October. The 0-14-year-old group had significantly higher SA than 15-44-year-old group (P<0.05). Students had the highest SA, followed by herder and migrant workers (P<0.05). The pleural TB cases had significantly higher SA than the pulmonary cases (P<0.05). Significant associations were not observed between SA and sex, ethnic group, regions, the result of sputum smear microcopy, and treatment history (P>0.05). Conclusion TB notification in Xinjiang shows an apparent seasonal variation with a peak in March and trough in October. For the underlying mechanism of TB seasonality, our results hypothesize that winter indoor crowding increases the risk of TB transmission, and seasonality was mainly influenced by the recent exogenous infection rather than the endogenous reactivation.	[Wubull, Atikaimu; Yao, Xuemei] Xinjiang Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Urumqi, Xinjiang, Peoples R China; [Li, Yuehua; Xue, Feng] Xinjiang Uygur Autonomous Reg Ctr Dis Control & P, Ctr TB Control & Prevent, Urumqi, Xinjiang, Peoples R China; [Upur, Halmurat] Xinjiang Med Univ, Dept Tradit Uygur Med, Urumqi, Xinjiang, Peoples R China; [Wushouer, Qimanguli] Xinjiang Med Univ, Teaching Hosp 1, Dept Resp Med, Urumqi, Xinjiang, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University	Upur, H (corresponding author), Xinjiang Med Univ, Dept Tradit Uygur Med, Urumqi, Xinjiang, Peoples R China.; Wushouer, Q (corresponding author), Xinjiang Med Univ, Teaching Hosp 1, Dept Resp Med, Urumqi, Xinjiang, Peoples R China.	halmurat@263.net; 1634035430@qq.com	LI, Yue/GRS-8071-2022		Natural Science Fund of Xinjiang Uyghur Autonomous Region [2016D01C189]	Natural Science Fund of Xinjiang Uyghur Autonomous Region	This study was funded by the Natural Science Fund of Xinjiang Uyghur Autonomous Region (grant number: 2016D01C189). AW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-3; Altes HK, 2012, INT J TUBERC LUNG D, V16, P639, DOI 10.5588/ijtld.11.0680; Bai Li-qiong, 2004, Zhonghua Jiehe He Huxi Zazhi, V27, P617; Bras AL, 2014, INT J TUBERC LUNG D, V18, P1202, DOI 10.5588/ijtld.14.0158; Cohen T, 2007, J R SOC INTERFACE, V4, P523, DOI 10.1098/rsif.2006.0193; Douglas AS, 1996, THORAX, V51, P944, DOI 10.1136/thx.51.9.944; Fares A, 2011, J GLOB INFECT DIS, V3, P46, DOI 10.4103/0974-777X.77296; Findley D F, 2000, ANN STAT 10, VX; Findley DF, 1998, J BUS ECON STAT, V16, P127, DOI 10.2307/1392565; Gibney KB, 2008, CLIN INFECT DIS, V46, P443, DOI 10.1086/525268; Godfrey-Faussett P, 2000, LANCET, V356, P1066, DOI 10.1016/S0140-6736(00)02730-6; Koh GCKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057752; Leung CC, 2005, INT J EPIDEMIOL, V34, P924, DOI 10.1093/ije/dyi080; Luquero FJ, 2008, INT J TUBERC LUNG D, V12, P221; MacLachlan JH, 2012, EMERG INFECT DIS, V18, P1879, DOI 10.3201/eid1811.120456; MAES M, 1994, EXPERIENTIA, V50, P821, DOI 10.1007/BF01956463; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P278; Martineaua AR, 2011, P NATL ACAD SCI USA, V108, P19013, DOI 10.1073/pnas.1111825108; Nagayama N, 2006, INT J TUBERC LUNG D, V10, P1117; Naranbat N, 2009, EUR RESPIR J, V34, P921, DOI 10.1183/09031936.00035309; Ricks PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027405; Thorpe LE, 2004, LANCET, V364, P1613, DOI 10.1016/S0140-6736(04)17316-9; Varun Kumar, 2014, TUBERCULOSIS RES TRE, V10; Willis MD, 2012, CLIN INFECT DIS, V54, P1553, DOI 10.1093/cid/cis235; Wingfield T, 2014, J INFECT DIS, V210, P774, DOI 10.1093/infdis/jiu121; Wubuli A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144010; Xin-Xu Li, 2013, PLOS ONE, V8; Yang XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108369; Zhang Z B, 2016, Zhonghua Liu Xing Bing Xue Za Zhi, V37, P1183, DOI 10.3760/cma.j.issn.0254-6450.2016.08.025	29	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180226	10.1371/journal.pone.0180226	http://dx.doi.org/10.1371/journal.pone.0180226			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678873	gold, Green Submitted, Green Published			2022-12-26	WOS:000405272200040
J	Yang, SH; Lee, JC; Guo, JC; Kuo, SH; Tien, YW; Kuo, TC; Cheng, AL; Yeh, KH				Yang, Shih-Hung; Lee, Jen-Chieh; Guo, Jhe-Cyuan; Kuo, Sung-Hsin; Tien, Yu-Wen; Kuo, Ting-Chun; Cheng, Ann-Lii; Yeh, Kun-Huei			Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy	PLOS ONE			English	Article							ONCOPROTEIN MDM2; MUTANT P53; PHASE-III; MUTATIONS; TUMOR; RAS; P16(INK4A); ACTIVATION; CARCINOMA; CELLS	This study evaluated the prognostic roles of murine double minute 2 (MDM2) and p53 in pancreatic cancer patients treated with gemcitabine-based chemotherapy. A total of 137 advanced or recurrent adenocarcinoma patients who were treated with gemcitabine-based palliative chemotherapy were reviewed, selected from 957 patients with pancreatic malignancy between 2008 and 2013 at our hospital. Immunohistochemical staining for MDM2 and p53 with formalin-fixed, paraffin-embedded tumor tissues was independently reviewed. Nuclear or cytoplasmic expression of MDM2 and p53 was found in tumor cells of 30 (21.9%) and 71 (51.8%) patients, respectively. Patients with MDM2 expression had shorter median overall survival (OS) (3.7 vs 5.8 mo; P = .048) and median progression-free survival (PFS) (1.5 vs 2.5 mo; P < .001); by contrast, p53 expression was not correlated with OS or PFS. In the multivariate analysis, MDM2 expression (hazard ratio = 1.731; P = .025) was an independent and unfavorable prognostic factor of OS. Additionally, MDM2 expression was significantly associated with progressive disease (PD) and death (P = .015) following first-line gemcitabine-based therapy. In advanced pancreatic cancer patients, MDM2 expression is associated with shorter OS and PFS after gemcitabine-based chemotherapy.	[Yang, Shih-Hung; Guo, Jhe-Cyuan; Kuo, Sung-Hsin; Cheng, Ann-Lii; Yeh, Kun-Huei] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Yang, Shih-Hung; Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Yang, Shih-Hung; Guo, Jhe-Cyuan; Yeh, Kun-Huei] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Lee, Jen-Chieh] Natl Taiwan Univ Hosp, Dept Pathol, Taipei, Taiwan; [Kuo, Sung-Hsin; Cheng, Ann-Lii; Yeh, Kun-Huei] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei, Taiwan; [Tien, Yu-Wen; Kuo, Ting-Chun] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan; [Kuo, Ting-Chun] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Yeh, KH (corresponding author), Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan.; Yeh, KH (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.; Yeh, KH (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei, Taiwan.	khyeh@ntu.edu.tw	Lee, Jen-Chieh/AAG-3533-2019; Yeh, Kun-Huei/HGD-3316-2022	Lee, Jen-Chieh/0000-0001-7739-5934; KUO, TING-CHUN/0000-0003-1960-1423; Kuo, Sung-Hsin/0000-0003-0054-887X; Guo, Jhe-Cyuan/0000-0002-6689-9640; TIEN, YU-WEN/0000-0002-9126-2705; YEH, Kun-Huei/0000-0002-7306-174X; Cheng, Ann-Lii/0000-0002-9152-6512	Ministry of Health and Welfare [MOHW103T D-B-111-04, MOHW104-TD-B-111-04]	Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by MOHW103T D-B-111-04 and MOHW104-TD-B-111-04, Ministry of Health and Welfare (http://www.mohw. gov.tw/EN/Ministry/).	Achanta G, 2001, CANCER RES, V61, P8723; Birnbaum DJ, 2011, GENE CHROMOSOME CANC, V50, P456, DOI 10.1002/gcc.20870; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Cascallo M, 2005, ONCOLOGY-BASEL, V68, P179, DOI 10.1159/000086772; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Dong M, 2005, WORLD J GASTROENTERO, V11, P2162, DOI 10.3748/wjg.v11.i14.2162; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fiorini C, 2015, BBA-MOL CELL RES, V1853, P89, DOI 10.1016/j.bbamcr.2014.10.003; Galmarini CM, 2002, INT J CANCER, V97, P439, DOI 10.1002/ijc.1628; Gerdes B, 2002, ANN SURG, V235, P51, DOI 10.1097/00000658-200201000-00007; Gu LB, 2002, BLOOD, V99, P3367, DOI 10.1182/blood.V99.9.3367; Gu LB, 2016, CANCER CELL, V30, P623, DOI 10.1016/j.ccell.2016.08.015; Heinemann V, 2006, J CLIN ONCOL, V24, P3946, DOI 10.1200/JCO.2005.05.1490; Hermanova M, 2009, PANCREAS, V38, P565, DOI 10.1097/MPA.0b013e31819fef8b; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; HUANG P, 1991, CANCER RES, V51, P6110; Kimura H, 2013, INT J CLIN EXP PATHO, V6, P1306; Lee JC, 2011, AM J SURG PATHOL, V35, P1177, DOI 10.1097/PAS.0b013e318219cd0b; Lukashchuk N, 2007, MOL CELL BIOL, V27, P8284, DOI 10.1128/MCB.00050-07; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; NAKAMORI S, 1995, JPN J CANCER RES, V86, P174, DOI 10.1111/j.1349-7006.1995.tb03036.x; Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Poplin E, 2009, J CLIN ONCOL, V27, P3778, DOI 10.1200/JCO.2008.20.9007; REDSTON MS, 1994, CANCER RES, V54, P3025; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Ruggeri BA, 1997, CANCER, V79, P700, DOI 10.1002/(SICI)1097-0142(19970215)79:4<700::AID-CNCR7>3.0.CO;2-H; Shi WD, 2014, MOL CELL BIOCHEM, V387, P1, DOI 10.1007/s11010-011-1208-4; Sui X, 2009, ONCOGENE, V28, P709, DOI 10.1038/onc.2008.423; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Ueno H, 2013, J CLIN ONCOL, V31, P1640, DOI 10.1200/JCO.2012.43.3680; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wang W, 2014, GASTROENTEROLOGY, V147, P893, DOI 10.1053/j.gastro.2014.07.001; Wei CH, 2013, PANCREAS, V42, P1303, DOI 10.1097/MPA.0b013e3182a23ae4; Weyrer K, 1996, LAB INVEST, V74, P279; Yang JY, 2006, MOL CELL BIOL, V26, P7269, DOI 10.1128/MCB.00172-06; Yang SH, 2016, J GASTROEN HEPATOL, V31, P2004, DOI 10.1111/jgh.13395; Zeng XY, 1999, MOL CELL BIOL, V19, P3257; Zhang Zhenrong, 2004, J CFHI TECHNOLOGY, V1, P1, DOI DOI 10.1074/JBC	41	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180628	10.1371/journal.pone.0180628	http://dx.doi.org/10.1371/journal.pone.0180628			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678832	Green Published, gold, Green Submitted			2022-12-26	WOS:000405272200080
J	Bartelt, A; Jeschke, A; Muller, B; Gaziano, I; Morales, M; Yorgan, T; Heckt, T; Heine, M; Gagel, RF; Emeson, RB; Amling, M; Niemeier, A; Heeren, J; Schinke, T; Keller, J				Bartelt, Alexander; Jeschke, Anke; Mueller, Brigitte; Gaziano, Isabella; Morales, Michelle; Yorgan, Timur; Heckt, Timo; Heine, Markus; Gagel, Robert F.; Emeson, Ronald B.; Amling, Michael; Niemeier, Andreas; Heeren, Joerg; Schinke, Thorsten; Keller, Johannes			Differential effects of Calca-derived peptides in male mice with diet-induced obesity	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; CONTROLS BONE-FORMATION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; CALCITONIN; PROCALCITONIN; ADRENOMEDULLIN; INFLAMMATION; METABOLISM; EXPRESSION	Key metabolic hormones, such as insulin, leptin, and adiponectin, have been studied extensively in obesity, however the pathophysiologic relevance of the calcitonin family of peptides remains unclear. This family includes calcitonin (CT), its precursor procalcitonin (PCT), and alpha calcitonin-gene related peptide (aCGRP), which are all encoded by the gene Calca. Here, we studied the role of Calca-derived peptides in diet-induced obesity (DIO) by challenging Calcr(-/-) (encoding the calcitonin receptor, CTR), Calca(-/-), and aCGRP(-/-) mice and their respective littermates with high-fat diet (HFD) feeding for 16 weeks. HFD-induced pathologies were assessed by glucose tolerance, plasma cytokine and lipid markers, expression studies and histology. We found that DIO in mice lacking the CTR resulted in impaired glucose tolerance, features of enhanced nonalcoholic steatohepatitis (NASH) and adipose tissue inflammation compared to wildtype littermates. Furthermore, CTR-deficient mice were characterized by dyslipidemia and elevated HDL levels. In contrast, mice lacking Calca were protected from DIO, NASH and adipose tissue inflammation, and displayed improved glucose tolerance. Mice exclusively lacking aCGRP displayed a significantly less improved DIO phenotype compared to Calca-deficient mice. In summary, we demonstrate that the CT/CTR axis is involved in regulating plasma cholesterol levels while Calca, presumably through PCT, seems to have a detrimental effect in the context of metabolic disease. Our study provides the first comparative analyses of the roles of Calca-derived peptides and the CTR in metabolic disease.	[Bartelt, Alexander; Mueller, Brigitte; Gaziano, Isabella; Heine, Markus; Niemeier, Andreas; Heeren, Joerg] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, Hamburg, Germany; [Bartelt, Alexander; Mueller, Brigitte; Gaziano, Isabella; Niemeier, Andreas] Univ Med Ctr Hamburg Eppendorf, Dept Orthoped, Hamburg, Germany; [Jeschke, Anke; Yorgan, Timur; Heckt, Timo; Amling, Michael; Schinke, Thorsten; Keller, Johannes] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, Hamburg, Germany; [Morales, Michelle] Scripps Mercy Hosp, Dept Internal Med, San Diego, CA USA; [Gagel, Robert F.] Univ Texas MD Anderson Canc Ctr, Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA; [Emeson, Ronald B.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Texas System; UTMD Anderson Cancer Center; Vanderbilt University	Keller, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, Hamburg, Germany.	johannes.keller@charite.de	Bartelt, Alexander/ABC-2525-2020	Gaziano, Isabella/0000-0002-9513-5156; Keller, Johannes/0000-0002-8925-7288	Deutsche Forschungsgemeinschaft [Ni 637/2-3, SFB841, AM103/15-1]; Bundesministerium fur Bildung and Forschung (Project ANCYLOSS); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung and Forschung (Project ANCYLOSS)(Federal Ministry of Education & Research (BMBF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from Deutsche Forschungsgemeinschaft to AN (Ni 637/2-3), JH (SFB841) and AM (AM103/15-1,) and Bundesministerium fur Bildung and Forschung (Project ANCYLOSS) to AN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi A, 2010, J CLIN ENDOCR METAB, V95, pE26, DOI 10.1210/jc.2010-0305; Bartelt A, 2011, DIABETOLOGIA, V54, P2900, DOI 10.1007/s00125-011-2274-6; Bartelt A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15010; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bartelt A, 2010, BONE, V47, P736, DOI 10.1016/j.bone.2010.07.002; Becker KL, 2010, BRIT J PHARMACOL, V159, P253, DOI 10.1111/j.1476-5381.2009.00433.x; Becker KL, 2004, J CLIN ENDOCR METAB, V89, P1512, DOI 10.1210/jc.2002-021444; Berbee JFP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7356; Dacquin R, 2004, J CELL BIOL, V164, P509, DOI 10.1083/jcb.200312135; Dahaba AA, 2009, MINERVA ANESTESIOL, V75, P447; Davey RA, 2008, J BONE MINER RES, V23, P1182, DOI 10.1359/JBMR.080310; Eissing L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2537; Feigh M, 2013, MENOPAUSE; Feigh M, 2014, EUR J PHARMACOL, V737, P91, DOI 10.1016/j.ejphar.2014.05.016; Gebre-Medhin S, 1998, MOL BRAIN RES, V63, P180, DOI 10.1016/S0169-328X(98)00269-1; Gebre-Medhin S, 1998, BIOCHEM BIOPH RES CO, V250, P271, DOI 10.1006/bbrc.1998.9308; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gydesen S, 2017, BR J PHARM; Hay DL, 2015, PHARMACOL REV, V67, P564, DOI 10.1124/pr.115.010629; Hoff AO, 2002, J CLIN INVEST, V110, P1849, DOI 10.1172/JCI200214218; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Huebner AK, 2008, ARCH BIOCHEM BIOPHYS, V473, P210, DOI 10.1016/j.abb.2008.02.013; Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763; Keller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6215; Linscheid P, 2005, ENDOCRINOLOGY, V146, P2699, DOI 10.1210/en.2004-1424; Linscheid P, 2003, ENDOCRINOLOGY, V144, P5578, DOI 10.1210/en.2003-0854; Liu T, 2017, ENDOCRINOLOGY; Luna-Luna M, 2015, ARCH MED RES; Matwiyoff GN, 2012, INFLAMM RES, V61, P401, DOI 10.1007/s00011-012-0439-5; Neeland IJ, 2013, OBESITY, V21, pE439, DOI [10.1002/oby.20135, 10.1038/oby.20135]; Nilsson C, 2016, EUR J PHARMACOL, V773, P24, DOI 10.1016/j.ejphar.2016.01.003; NISHIZAWA Y, 1988, J CLIN INVEST, V82, P1165, DOI 10.1172/JCI113713; Popeijus HE, 2008, INT J OBESITY, V32, P1076, DOI 10.1038/ijo.2008.55; Radimerski TM, 2011, INNATE IMMUN-LONDON, V17, P403, DOI 10.1177/1753425910377100; Recober A, 2010, DRUG NEWS PERSPECT, V23, P112, DOI 10.1358/dnp.2010.23.2.1475909; Riera CE, 2014, CELL, V157, P1023, DOI 10.1016/j.cell.2014.03.051; Sampath H, 2011, ANN NY ACAD SCI, V1243, P47, DOI 10.1111/j.1749-6632.2011.06303.x; Sattar N, 2008, LANCET, V371, P1927, DOI 10.1016/S0140-6736(08)60602-9; Schinke T, 2004, J BONE MINER RES, V19, P2049, DOI 10.1359/JBMR.040915; Sexton PM, 2008, CRIT CARE MED, V36, P1637, DOI 10.1097/CCM.0b013e318170a554; Timper K, 2011, J CLIN ENDOCR METAB, V96, pE297, DOI 10.1210/jc.2010-1324; Walker CS, 2013, BRIT J PHARMACOL, V170, P1293, DOI 10.1111/bph.12129; Walker CS, 2010, ENDOCRINOLOGY, V151, P4257, DOI 10.1210/en.2010-0284; ZELISSEN PMJ, 1991, PEPTIDES, V12, P861, DOI 10.1016/0196-9781(91)90147-H; Zhang H, 2016, INT J OBESITY, V40, P852, DOI 10.1038/ijo.2016.2; Zhang SY, 2016, DIABETES, V65, P2342, DOI 10.2337/db15-1626	47	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180547	10.1371/journal.pone.0180547	http://dx.doi.org/10.1371/journal.pone.0180547			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666011	gold, Green Published, Green Submitted			2022-12-26	WOS:000404608700016
J	Zhang, XZ; Wu, X; Chen, WB; Zhang, YW; Jiang, YM; Meng, QX; Zhou, ZM				Zhang, Xinzhuang; Wu, Xin; Chen, Wanbao; Zhang, Yawei; Jiang, Yuming; Meng, Qingxiang; Zhou, Zhenming			Growth performance and development of internal organ, and gastrointestinal tract of calf supplementation with calcium propionate at various stages of growth period	PLOS ONE			English	Article							RUMEN EPITHELIUM; ENERGY; FERMENTATION; DIGESTIBILITY; EXPRESSION; INSULIN; CALVES; FIBER; FEED	To investigate the effects of calcium propionate (CaP) supplementation on performance, the development of the internal organ, and gastrointestinal tract of calves at various stages of growth period, 54 male Jersey calves ( age = 7 +/- 1 d, body weight(BW) = 23.1 +/- 1.2 kg) were randomly allocated to three treatment groups. While control calves were fed basis dietary with no additives (0CaP), other treatment calves were fed basis dietary supplementation with CaP at 50 (5CaP) or 100 (10CaP) g kg(- 1) dry matter. The experiment lasted 160 d and was divided into three feeding stages: Stage 1 (d 0 to 30), Stage 2 (d 31 to 90), and Stage 3 (d 91 to160). Six calves from each group were randomly selected and slaughtered on days 30, 90, and 160 when at the conclusion of each experimental feeding stage. The BW of calves increased with 10CaP after feeding 90 d, whereas it increased with 5CaP and 10CaP at feeding 120d and 160d compared to 0CaP. The 10CaP group improved average daily gain (ADG) of calves at stage 2, and d120-160 of stage 3 compared with the 0CaP group. The ADG of 5CaP was greater than the 0CaP group only at 120-160 d of stage 3 compared with the 0CaP group. The results of feed efficiency were in agreed with ADG as no dry matter intake difference at all stages of growth period. The 10CaP treatment exhibited the greatest spleen weight among the treatment at the end of the experiment; the liver weight of the 5CaP and 10CaP calves at feeding 90 d and of the 10CaP calves at feeding 160 d and were greater than those of the 0CaP animals. The CaP at the tested doses increased the rumen weight after feeding 90d of Jersey calves, and also improved the development of intestine. In conclusion, dietary supplementation with calcium propionate at the tested doses caused a beneficial effect in the growth performance and gastrointestinal tract traits of Jersey calves, thus to add 10% CaP before feeding 90 days was better and 5% CaP supplementation was expected at the period for feeding 90 to160 d.	[Zhang, Xinzhuang; Wu, Xin; Chen, Wanbao; Zhang, Yawei; Jiang, Yuming; Meng, Qingxiang; Zhou, Zhenming] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing, Peoples R China	China Agricultural University	Meng, QX; Zhou, ZM (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing, Peoples R China.	qxmeng@cau.edu.cn; zhouzm@cau.edu.cn	Meng, Q./GSI-6185-2022	Zhang, Yawei/0000-0002-0571-8383	National Natural Science foundation of China [31372335, 31672449]; China Agricultural Research System [CARS-38]; special fund for agro-scientific research in the public interest [201503134]	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC)); China Agricultural Research System; special fund for agro-scientific research in the public interest	National Natural Science foundation of China (No:31372335 and 31672449), the China Agricultural Research System (CARS-38), and the special fund for agro-scientific research in the public interest (No:201503134).	Abeni F, 2000, J DAIRY SCI, V83, P1468, DOI 10.3168/jds.S0022-0302(00)75019-3; Alam S, 2014, FOOD ADDIT CONTAM A, V31, P1896, DOI 10.1080/19440049.2014.963699; Alam S, 2010, J FOOD SCI, V75, pM61, DOI 10.1111/j.1750-3841.2009.01462.x; AOAC, 1990, ASS OFF AN CHEM, V15th; Bergman E., 1975, DIGESTION METABOLISM, P292; Berry BA, 2004, J ANIM SCI, V82, P837; Brown EG, 2005, J DAIRY SCI, V88, P585, DOI 10.3168/jds.S0022-0302(05)72722-3; Bunting LD, 2000, J DAIRY SCI, V83, P2491, DOI 10.3168/jds.S0022-0302(00)75141-1; Cao YuJuan, 2014, Chinese Journal of Animal Nutrition, V26, P90; Fluharty FL, 1999, J ANIM SCI, V77, P816; GILLILAND RL, 1962, J DAIRY SCI, V45, P1211, DOI 10.3168/jds.S0022-0302(62)89598-8; He LW, 2015, POULTRY SCI, V94, P2464, DOI 10.3382/ps/pev237; HUNTINGTON GB, 1990, REPROD NUTR DEV, V30, P35, DOI 10.1051/rnd:19900103; Lane MA, 1997, J DAIRY SCI, V80, P740, DOI 10.3168/jds.S0022-0302(97)75993-9; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee-Rangel HA, 2012, ANIM FEED SCI TECH, V177, P237, DOI 10.1016/j.anifeedsci.2012.08.012; Liu Q, 2010, J ANIM PHYSIOL AN N, V94, P605, DOI 10.1111/j.1439-0396.2009.00945.x; Liu Q, 2009, J AGR SCI-CAMBRIDGE, V147, P201, DOI 10.1017/S0021859609008429; Malhi M, 2013, J DAIRY SCI, V96, P7603, DOI 10.3168/jds.2013-6700; Martin-Diana AB, 2007, TRENDS FOOD SCI TECH, V18, P210, DOI 10.1016/j.tifs.2006.11.027; NRC, 2000, NAT AC; PETERS JP, 1990, J ANIM SCI, V68, P3905; SAKATA T, 1979, J DAIRY SCI, V62, P49, DOI 10.3168/jds.S0022-0302(79)83200-2; SAKATA T, 1980, BRIT J NUTR, V44, P325, DOI 10.1079/BJN19800047; SANO H, 1995, J ANIM SCI, V73, P191; Shen ZM, 2004, J NUTR, V134, P11, DOI 10.1093/jn/134.1.11; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Wang A, 2012, J DAIRY SCI, V95, P1371, DOI 10.3168/jds.2011-4886; Xie XX, 2013, J ANIM SCI, V91, P4315, DOI 10.2527/jas.2012-5731; Zhang XZ, 2015, J ANIM FEED SCI, V24, P100, DOI 10.22358/jafs/65634/2015	30	13	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7								10.1371/journal.pone.0179940	http://dx.doi.org/10.1371/journal.pone.0179940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692656	Green Submitted, gold, Green Published			2022-12-26	WOS:000405544800020
J	Matyushenko, V; Isakova-Sivak, I; Smolonogina, T; Dubrovina, I; Tretiak, T; Rudenko, L				Matyushenko, Victoria; Isakova-Sivak, Irina; Smolonogina, Tatiana; Dubrovina, Irina; Tretiak, Tatiana; Rudenko, Larisa			Genotyping assay for differentiation of wildtype and vaccine viruses in subjects immunized with live attenuated influenza vaccine	PLOS ONE			English	Article							YOUNG-CHILDREN; DOUBLE-BLIND; B VIRUS; SAFETY; IMMUNOGENICITY; AMPLIFICATION; STABILITY; SET	Live attenuated influenza vaccines (LAIVs) are considered as safe and effective tool to control influenza in different age groups, especially in young children. An important part of the LAIV safety evaluation is the detection of vaccine virus replication in the nasopharynx of the vaccinees, with special attention to a potential virus transmission to the unvaccinated close contacts. Conducting LAIV clinical trials in some geographical regions with year-round circulation of influenza viruses warrants the development of robust and reliable tools for differentiating vaccine viruses from wild-type influenza viruses in nasal pharyngeal wash (NPW) specimens of vaccinated subjects. Here we report the development of genotyping assay for the detection of wild-type and vaccine-type influenza virus genes in NPW specimens of young children immunized with Russian-backbone seasonal trivalent LAIV using Sanger sequencing from newly designed universal primers. The new primer set allowed amplification and sequencing of short fragments of viral genes in NPW specimens and appeared to be more sensitive than conventional real-time RT-PCR protocols routinely used for the detection and typing/subtyping of influenza virus in humans. Furthermore, the new assay is capable of defining the origin of wild-type influenza virus through BLAST search with the generated sequences of viral genes fragments.	[Matyushenko, Victoria; Isakova-Sivak, Irina; Smolonogina, Tatiana; Dubrovina, Irina; Tretiak, Tatiana; Rudenko, Larisa] Inst Expt Med, Dept Virol, St Petersburg, Russia	Institute of Experimental Medicine	Isakova-Sivak, I (corresponding author), Inst Expt Med, Dept Virol, St Petersburg, Russia.	isakova.sivak@gmail.com	Isakova-Sivak, Irina/C-1034-2014; Rudenko, Larisa/AAN-9226-2020; Matyushenko, Victoria/AAN-9986-2020; Kotomina, Tatiana S/U-8669-2018	Isakova-Sivak, Irina/0000-0002-2801-1508; Rudenko, Larisa/0000-0002-0107-9959; Kotomina, Tatiana S/0000-0001-9999-089X; Matyushenko, Victoria/0000-0002-4698-6085	PATH (LAIV-specific testing of influenza-positive post-vaccination shedding specimens from LAIV clinical study in Bangladesh); Russian Scientific Foundation [14-15-00034]	PATH (LAIV-specific testing of influenza-positive post-vaccination shedding specimens from LAIV clinical study in Bangladesh); Russian Scientific Foundation(Russian Science Foundation (RSF))	The study was supported by PATH (LAIV-specific testing of influenza-positive post-vaccination shedding specimens from LAIV clinical study in Bangladesh) and Russian Scientific Foundation grant No 14-15-00034 (the development of the assay and genotyping of influenza viruses of various subtypes).	Ambrose CS, 2011, INFLUENZA OTHER RESP, V5, P389, DOI 10.1111/j.1750-2659.2011.00243.x; Barr I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037568; Beerenwinkel N, 2011, CURR OPIN VIROL, V1, P413, DOI 10.1016/j.coviro.2011.07.008; Block SL, 2008, VACCINE, V26, P4940, DOI 10.1016/j.vaccine.2008.07.013; Brooks W.A., 2016, LANCET GLOB HLTH; Brooks WA, 2016, LANCET GLOB HEALTH, V4, pE946, DOI [10.1016/s2214-109x(16)30200-5, 10.1016/S2214-109X(16)30200-5]; Coelingh KL, 2014, EXPERT REV VACCINES, V13, P855, DOI 10.1586/14760584.2014.922417; Deng YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023400; Griffin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023085; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hoffmann E, 2002, P NATL ACAD SCI USA, V99, P11411, DOI 10.1073/pnas.172393399; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Inoue E, 2010, MICROBIOL IMMUNOL, V54, P129, DOI 10.1111/j.1348-0421.2009.00193.x; Isakova-Sivak I, 2015, EXPERT REV VACCINES, V14, P1313, DOI 10.1586/14760584.2015.1075883; Isakova-Sivak I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102339; Karkishchenko N N, 2010, MANUAL LAB ANIMALS A; Kiseleva IV, 2011, MOL GENET MICROBIOL+, V26, P174, DOI 10.3103/S0891416811040045; Kiseleva IV, 2012, VOP VIRUSOL RUSSIAN, V57, P45; KLIMOV AI, 1995, J VIROL METHODS, V52, P41, DOI 10.1016/0166-0934(94)00133-2; Kulkarni PS, 2014, HUM VACCIN IMMUNOTHE, V10; Mallory RM, 2011, VACCINE, V29, P4322, DOI 10.1016/j.vaccine.2011.04.022; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Murphy BR, 2002, VIRAL IMMUNOL, V15, P295, DOI 10.1089/08828240260066242; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Ortiz JR, 2015, VACCINE; Ortiz JR, 2015, VACCINE, V33, P3415, DOI 10.1016/j.vaccine.2015.04.048; Rudenko L, 2011, VACCINE, V29, pA40, DOI 10.1016/j.vaccine.2011.04.122; Shcherbik SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092580; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; Vesikari T, 2006, PEDIATR INFECT DIS J, V25, P590, DOI 10.1097/01.inf.0000220229.51531.47; World Health Organization, 2012, WHO INF MOL DIAGN IN; Zagordi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047046	32	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180497	10.1371/journal.pone.0180497	http://dx.doi.org/10.1371/journal.pone.0180497			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686625	Green Published, Green Submitted, gold			2022-12-26	WOS:000405464100070
J	Tashima, Y; Banno, F; Kita, T; Matsuda, Y; Yanamoto, H; Miyata, T				Tashima, Yuko; Banno, Fumiaki; Kita, Toshiyuki; Matsuda, Yasuyuki; Yanamoto, Hiroji; Miyata, Toshiyuki			Plasminogen Tochigi mice exhibit phenotypes similar to wild-type mice under experimental thrombotic conditions	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; LIGNEOUS CONJUNCTIVITIS; MOLECULAR ABNORMALITY; CEREBRAL-ISCHEMIA; DEFICIENT MICE; HUMAN-DISEASE; ACTIVE-SITE; MUTATION; GENE; SYSTEM	Plasminogen (Plg) is a precursor of plasmin that degrades fibrin. A race-specific A620T mutation in Plg, also known as Plg-Tochigi, originally identified in a patient with recurrent venous thromboembolism, causes dysplasminogenemia with reduced plasmin activity. The Plg-A620T mutation is present in 3 - 4% of individuals in East Asian populations, and as many as 50,000 Japanese are estimated to be homozygous for the mutant 620T allele. In the present study, to understand the changes of thrombotic phenotypes in individuals with the mutant 620T allele, we generated knock-in mice carrying the homozygous Plg-A622T mutation (Plg(T/T)), an equivalent to the A620T mutation in human Plg. Plg(T/T) mice grew normally but showed severely reduced plasmin activity activated by urokinase, equivalent to similar to 8% of that in wild-type mice. In vitro fibrin clot lysis in plasma was significantly slower in Plg T/T mice than in wild-type mice. However, all experimental models of electrolytic deep vein thrombosis, tissue factor-induced pulmonary embolism, transient focal brain ischaemic stroke, or skin-wound healing showed largely similar phenotypes between Plg T/T mice and wild-type mice. Protein S-K196E mutation (Pros1 E/E) is a race-specific genetic risk factor for venous thromboembolism. Coexistence in mice of Plg(T/T) and Pros1 (E/E) did not affect pulmonary embolism symptoms, compared with those in Pros1 (E/E) mice. Hence, the present study showed that the Plg-A622T mutation, which confers similar to 8% plasmin activity, does not increase the risk of thrombotic diseases in mice under experimental thrombotic conditions and does not modify the thrombotic phenotype observed in Pros1 (E/E) mice. Plg (T/T) mice can be used to investigate the potential pathophysiological impact of the Plg-A620T mutation.	[Tashima, Yuko; Banno, Fumiaki; Kita, Toshiyuki; Matsuda, Yasuyuki; Yanamoto, Hiroji; Miyata, Toshiyuki] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Suita, Osaka, Japan; [Yanamoto, Hiroji] Natl Cerebral & Cardiovasc Ctr, Lab Neurol & Neurosurg, Suita, Osaka, Japan; [Miyata, Toshiyuki] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka, Japan; [Tashima, Yuko] Nagoya Univ, Sch Med, Dept Mol & Cellular Biol, Nagoya, Aichi, Japan; [Banno, Fumiaki] Koriyama Womens Univ, Dept Food & Nutr, Koriyama, Fukushima, Japan; [Matsuda, Yasuyuki] Asahikawa Med Univ, Dept Microbiol & Immunochem, Asahikawa, Hokkaido, Japan	National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; Nagoya University; Asahikawa Medical College	Miyata, T (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Suita, Osaka, Japan.; Miyata, T (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka, Japan.	miyata@ncvc.go.jp	Yanamoto, Hiroji/ABF-7320-2020; yanamoto, hiroji/ABB-3923-2020		Ministry of Health, Labour and Welfare of Japan; Japan Society for the Promotion of Science; Japan Cardiovascular Research Foundation; Uehara Memorial Foundation; Takeda Scientific Foundation; Intramural Research Fund; Grants-in-Aid for Scientific Research [16K14696, 16K19045, 16K09834] Funding Source: KAKEN	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Cardiovascular Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Scientific Foundation(Takeda Science Foundation (TSF)); Intramural Research Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Ministry of Health, Labour and Welfare of Japan; the Japan Society for the Promotion of Science; the Japan Cardiovascular Research Foundation; the Uehara Memorial Foundation; the Takeda Scientific Foundation; and the Intramural Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOKI N, 1978, J CLIN INVEST, V61, P1186, DOI 10.1172/JCI109034; Banno F, 2004, J BIOL CHEM, V279, P30896, DOI 10.1074/jbc.M314184200; Banno F, 2006, BLOOD, V107, P3161, DOI 10.1182/blood-2005-07-2765; Banno F, 2015, BLOOD, V126, P2247, DOI 10.1182/blood-2015-06-653162; Barrios M, 2009, THROMB RES, V124, P338, DOI 10.1016/j.thromres.2008.11.001; BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794; Busuttil SJ, 2004, J THROMB HAEMOST, V2, P1798, DOI 10.1111/j.1538-7836.2004.00916.x; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; Das R, 2014, BLOOD, V124, P679, DOI 10.1182/blood-2014-01-549659; Diaz JA, 2013, THROMB HAEMOSTASIS, V109, P1158, DOI 10.1160/TH12-09-0711; Drew AF, 1998, BLOOD, V91, P1616, DOI 10.1182/blood.V91.5.1616.1616_1616_1624; Eura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034298; ICHINOSE A, 1991, P NATL ACAD SCI USA, V88, P115, DOI 10.1073/pnas.88.1.115; Iwaki T, 2010, J THROMB HAEMOST, V8, P2341, DOI 10.1111/j.1538-7836.2010.03995.x; Kawao N, 2010, J THROMB HAEMOST, V8, P1555, DOI 10.1111/j.1538-7836.2010.03870.x; Kimura R, 2006, BLOOD, V107, P1737, DOI 10.1182/blood-2005-09-3892; Kita T, 2012, J THROMB HAEMOST, V10, P1453, DOI 10.1111/j.1538-7836.2012.04776.x; Krampert M, 2005, J BIOL CHEM, V280, P23844, DOI 10.1074/jbc.M412212200; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; MIYATA T, 1982, P NATL ACAD SCI-BIOL, V79, P6132, DOI 10.1073/pnas.79.20.6132; Miyata T, 2006, INT J HEMATOL, V83, P217, DOI 10.1532/IJH97.A20514; Miyata T, 2016, INT J HEMATOL, V104, P223, DOI 10.1007/s12185-016-2021-3; Nagai N, 1999, CIRCULATION, V99, P2440, DOI 10.1161/01.CIR.99.18.2440; NAGAYAMA T, 1993, STROKE, V24, P2104, DOI 10.1161/01.STR.24.12.2104; Okuda T, 2004, MOL CELL BIOL, V24, P3949, DOI 10.1128/MCB.24.9.3949-3956.2004; Ooe A, 1999, THROMB HAEMOSTASIS, V82, P1342; Parker AC, 2004, CIRCULATION, V110, P3594, DOI 10.1161/01.CIR.0000148781.87906.C0; PLOPLIS VA, 1995, CIRCULATION, V92, P2585, DOI 10.1161/01.CIR.92.9.2585; Rijken DC, 2009, J THROMB HAEMOST, V7, P4, DOI 10.1111/j.1538-7836.2008.03220.x; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; SAKATA Y, 1980, J BIOL CHEM, V255, P5442; Schuster V, 2007, J THROMB HAEMOST, V5, P2315, DOI 10.1111/j.1538-7836.2007.02776.x; Schuster V, 1997, BLOOD, V90, P958, DOI 10.1182/blood.V90.3.958.958_958_966; Singh S, 2016, J THROMB HAEMOST; Tashima Y, 2015, THROMB HAEMOSTASIS, V114, P206, DOI 10.1160/TH14-08-0656; Tefs K, 2006, BLOOD, V108, P3021, DOI 10.1182/blood-2006-04-017350; Vercauteren E, 2011, BLOOD, V117, P4615, DOI 10.1182/blood-2010-08-303677; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wu CL, 2003, THROMB HAEMOSTASIS, V90, P414, DOI 10.1160/TH02-09-0104; Yamamoto H, 2011, J BIOL CHEM, V286, P26158, DOI 10.1074/jbc.M111.256446; Yang D, 2014, EUR NEUROL, V71, P4, DOI 10.1159/000356048; Zeng B, 2002, THROMB HAEMOSTASIS, V88, P805, DOI 10.1055/s-0037-1613306	42	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180981	10.1371/journal.pone.0180981	http://dx.doi.org/10.1371/journal.pone.0180981			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686706	Green Published, gold, Green Submitted			2022-12-26	WOS:000405464100126
J	Bogdanowicz, W; Rutkowski, R; Gabrielyan, BK; Ryspaev, A; Asatryan, AN; Mkrtchyan, JA; Bujalska, BM				Bogdanowicz, Wieslaw; Rutkowski, Robert; Gabrielyan, Bardukh K.; Ryspaev, Akylbek; Asatryan, Anzhela N.; Mkrtchyan, Jon A.; Bujalska, Barbara M.			Fish introductions in the former Soviet Union: The Sevan trout (Salmo ischchan)-80 years later	PLOS ONE			English	Article							SALMON SALMO-SALAR; GENETIC DIVERSITY; POPULATION-STRUCTURE; MICROSATELLITE LOCI; CONSERVATION GENETICS; DNA POLYMORPHISM; BROWN TROUT; MITOCHONDRIAL-DNA; RE-IMPLEMENTATION; RAPID EVOLUTION	The Soviet Union played the leading role in fish introductions in Eurasia. However, only 3% of all introductions prior to 1978 gave a commercial benefit. One of the noteworthy examples appears to be the Sevan trout (Salmo ischchan Kessler, 1877) - an endemic salmonid of Lake Sevan in Armenia. This species has been introduced to Kirghizstan, Kazakhstan, and Uzbekistan, however, only the Kirghiz population has persisted in relatively high numbers. In this paper we provide the first extensive molecular study of S. ischchan using samples from the native population from Lake Sevan and three hatcheries in Armenia, as well as from the population introduced to Lake Issyk Kul in Kirghizstan. The Kirghiz population has been isolated since the introductions took place in 1930 and 1936. Our results, based on 11 nuclear microsatellites and a 905 bp fragment of the mitochondrial control region suggest that hatcheries have maintained genetic variability by way of ongoing translocations of individuals from Lake Sevan. Simultaneously, significant Garza-Williamson M-values suggest that bottlenecks could have reduced the genetic variability of the wild populations in the past. This hypothesis is supported by historical data, indicating highly manipulated waterlevel regulations and poaching as two main factors that dramatically impact fish abundance in the lake. On the other hand, a similar situation has been observed in Kirghizstan, but this population likely rebounded from small population size faster than the other populations examined. The Kirghiz population is significantly genetically differentiated from the other groups and have morphological features and biological attributes not observed in the source population. Genetic data imply that the effective population size in the native population is lower than that found in the introduced population, suggesting that some active protection of the Lake Sevan population may be needed urgently.	[Bogdanowicz, Wieslaw; Rutkowski, Robert; Bujalska, Barbara M.] Polish Acad Sci, Museum & Inst Zool, Warsaw, Poland; [Gabrielyan, Bardukh K.] Natl Acad Sci Armenia, Sci Ctr Zool & Hydroecol, Yerevan, Armenia; [Ryspaev, Akylbek] Kirghizstan Natl Acad Sci, Inst Biol & Pedol, Bishkek, Kyrgyzstan; [Asatryan, Anzhela N.; Mkrtchyan, Jon A.] Sevani Ishkhan CJSC, Yerevan, Armenia	Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; National Academy of Sciences of Armenia	Bogdanowicz, W (corresponding author), Polish Acad Sci, Museum & Inst Zool, Warsaw, Poland.	wieslawb@miiz.waw.pl		Rutkowski, Robert/0000-0003-0265-7455; Bogdanowicz, Wieslaw/0000-0003-1196-2494	Ministry of Nature Protection in Armenia; National Science Centre in Poland [N N303 566339]	Ministry of Nature Protection in Armenia; National Science Centre in Poland(National Science Centre, Poland)	Fish sampling in Lake Sevan was granted by the Ministry of Nature Protection in Armenia. Fish from the lake were killed and used for other ichthyologic analyses, but fish from the farms, for which no permission was needed, were released back to the pools. No permission was required to capture Sevan trout in Kirghizstan. The idea of this project emerged during scientific trips of the first author to Armenia and Nagorno Karabakh funded by the National Science Centre in Poland (grant N N303 566339 on the Caucasian refugium). We thank Ron Van Den Bussche (Oklahoma State University, Stillwater, USA) and three anonymous reviewers for critical comments on the manuscript.	Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101; Alamanov A, 2011, AMBIO, V40, P479, DOI 10.1007/s13280-011-0140-x; [Anonymous], 2000, ALIENS INVASIVE SPEC, DOI DOI 10.1614/WT-04-126.1; Avise JC, 2010, CONSERV GENET, V11, P665, DOI 10.1007/s10592-009-0006-y; Ayres RM, 2012, MAR FRESHWATER RES, V63, P1206, DOI 10.1071/MF11279; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERNATCHEZ L, 1995, MOL ECOL, V4, P285, DOI 10.1111/j.1365-294X.1995.tb00222.x; Bernatchez L, 2001, EVOLUTION, V55, P351, DOI 10.1111/j.0014-3820.2001.tb01300.x; Bohling J, 2016, AQUACULTURE, V462, P1, DOI 10.1016/j.aquaculture.2016.04.013; Burmakin E.V., 1963, IZV GOS NAUCHNO ISSL, V53, P1; Caballero P, 2013, REV GENETIC ECOLOGIC, P9; Clegg SM, 2002, P NATL ACAD SCI USA, V99, P8127, DOI 10.1073/pnas.102583399; Cornuet JM, 1996, GENETICS, V144, P2001; Cortey M, 2002, J FISH BIOL, V60, P1058, DOI 10.1111/j.1095-8649.2002.tb02429.x; Dadikyan MG, 1986, FISHES ARMENIA; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Dorofeeva EA, 1988, VOP IKHTIOL, V38, P437; Dorofeyeva EA, 2008, P ZOOL I RAS, V312, P114; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans B, 2004, AQUACULTURE, V233, P109, DOI 10.1016/j.aquaculture.2003.09.037; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAO Fisheries and Aquaculture Department, 2016, INTR SPEC FACT SHEET; Fortunatov MA, 1927, T SEVAN LAKE STATION, V1; Franklin JR, 1980, CONSERVATION BIOL EV, P135; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Funk WC, 2012, TRENDS ECOL EVOL, V27, P489, DOI 10.1016/j.tree.2012.05.012; Gabrielyan BK, 2010, NATL ACAD SCI; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Gemayel R, 2012, GENES-BASEL, V3, P461, DOI 10.3390/genes3030461; Goudet J., 2001, FSTAT V2 9 3 PROGRAM; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; Heath DD, 2003, SCIENCE, V299, P1738, DOI 10.1126/science.1079707; Hedrick PW, 2001, TRENDS ECOL EVOL, V16, P629, DOI 10.1016/S0169-5347(01)02282-0; Hoicik J., 1991, CAN J FISH AQUAT SCI, V48, P13; Huff DD, 2011, MOL ECOL, V20, P4246, DOI 10.1111/j.1365-294X.2011.05271.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kalinowski ST, 2006, CONSERV GENET, V7, P991, DOI 10.1007/s10592-006-9134-9; Khurshut EE, 2006, RYBY UZBEKISTANA; Kohn MH, 2006, TRENDS ECOL EVOL, V21, P629, DOI 10.1016/j.tree.2006.08.001; Koljonen ML, 2002, AQUACULTURE, V212, P69, DOI 10.1016/S0044-8486(01)00808-0; Konurbayev AO, 1981, P 17 SCI C BALKH; Lambert DM, 2005, CONSERV GENET, V6, P1, DOI 10.1007/s10592-004-7857-z; Lavrovsky VV, 1968, 2547 FAO UNDPTA; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lifshits SM, 1979, OBZOR INFORMAT SII N, V1979, P1; Lind D, 2005, ARMENIA ENVIRONS, V29, P29; Linlokken AN, 2014, FISHERIES MANAG ECOL, V21, P515, DOI 10.1111/fme.12101; Luzhin BP., 1956, ISSYK KUL TROUT GEGA; Lynch M., 1997, NMFSNWFSC30 NOAA, P59; McClelland EK, 2007, CONSERV GENET, V8, P397, DOI 10.1007/s10592-006-9178-x; Mila B, 2000, P ROY SOC LOND B BIO, V267, P1033; Mitrofanov VP, 1999, 385 FAO FISH, P149; Mitrofanov VP, 1992, FISHES KAZAKHSTAN; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Narum SR, 2011, MOL ECOL RESOUR, V11, P184, DOI 10.1111/j.1755-0998.2011.02987.x; NEI M, 1978, GENETICS, V89, P583; Nikolic N, 2009, J FISH BIOL, V74, P458, DOI 10.1111/j.1095-8649.2008.02094.x; Norris AT, 1999, AQUACULTURE, V180, P247, DOI 10.1016/S0044-8486(99)00212-4; Osinov A, 1996, J ICHTHYOLOGY, V36, P762; Park SDE, 2001, THESIS; PEAKALL R, 2006, GENALEX V6 GENETIC A; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Petr Tomislav, 1998, Lakes Reservoirs Research and Management, V3, P143, DOI 10.1046/j.1440-1770.1998.00069.x; Pritchard JK, 2000, GENETICS, V155, P945; Purcell KM, 2012, BIOL INVASIONS, V14, P2057, DOI 10.1007/s10530-012-0213-1; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Rambaut A, 2007, VERSION 1 4 HIGHER; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reisenbichler RR, 2004, ONCORHYNCHUS MYKISS, P371; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Savvaitova KA, 1999, 385 FAO FISH, P168; Skaala O, 2004, AQUACULTURE, V240, P131, DOI 10.1016/j.aquaculture.2004.07.009; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; TAJIMA F, 1989, GENETICS, V123, P585; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; vonHaeseler A, 1996, NAT GENET, V14, P135, DOI 10.1038/ng1096-135; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Welcomme LR, 1988, 294 FAO, P1; Williamson-Natesan EG, 2005, CONSERV GENET, V6, P551, DOI 10.1007/s10592-005-9009-5; Wilson GA, 2003, GENETICS, V163, P1177; Wright S, 1931, GENETICS, V16, P0097; Wright S, 1969, THEORY GENE FREQUENC, V2	94	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180605	10.1371/journal.pone.0180605	http://dx.doi.org/10.1371/journal.pone.0180605			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683097	gold, Green Published, Green Submitted			2022-12-26	WOS:000405335200052
J	van Exel, E; Koopman, JJE; van Bodegom, D; Meij, JJ; de Knijff, P; Ziem, JB; Finch, CE; Westendorp, RGJ				van Exel, Eric; Koopman, Jacob J. E.; van Bodegom, David; Meij, Johannes J.; de Knijff, Peter; Ziem, Juventus B.; Finch, Caleb E.; Westendorp, Rudi G. J.			Effect of APOE epsilon 4 allele on survival and fertility in an adverse environment	PLOS ONE			English	Article							APOLIPOPROTEIN-E POLYMORPHISM; ALZHEIMER-DISEASE; TRADE-OFF; GENE; ATHEROSCLEROSIS; POPULATIONS; INFECTION; EVOLUTION	The apolipoprotein-epsilon 4 allele (APOE-epsilon 4) is strongly associated with detrimental outcomes in affluent populations including atherosclerotic disease, Alzheimer's disease, and reduced lifespan. Despite these detrimental outcomes, population frequencies of APOE-epsilon 4 are high. We hypothesize that the high frequency of APOE-epsilon 4 was maintained because of beneficial effects during evolution when infectious pathogens were more prevalent and a major cause of mortality. We examined a rural Ghanaian population with a high pathogen exposure for selective advantages of APOE-epsilon 4, to survival and or fertility.	[van Exel, Eric] VU Univ Med Center GGZinGeest, Dept Psychiat, Amsterdam, Netherlands; [van Exel, Eric] EMGO Inst Hlth & Care Res & Neurosci, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Koopman, Jacob J. E.; van Bodegom, David; Westendorp, Rudi G. J.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [van Bodegom, David; Westendorp, Rudi G. J.] Leyden Acad Vital & Ageing, Leiden, Netherlands; [Meij, Johannes J.] Univ Melbourne, Melbourne Acad Ctr Hlth, Melbourne, Australia; [de Knijff, Peter] Leiden Univ, Dept Human Genet, Leiden, Netherlands; [Ziem, Juventus B.] Univ Dev Studies, Sch Med & Hlth Sci, Dept Clin Lab Sci, Tamale, Ghana; [Finch, Caleb E.] Univ Southern Calif, Davis Sch Gerontol, Los Angeles, CA USA; [Finch, Caleb E.] Univ Southern Calif, Dept Biol Sci, Dornsife Coll, Los Angeles, CA USA; [Westendorp, Rudi G. J.] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Westendorp, Rudi G. J.] Univ Copenhagen, Ctr Hlth Ageing, Copenhagen, Denmark	Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Melbourne; Leiden University; Leiden University - Excl LUMC; University for Development Studies; University of Southern California; University of Southern California; University of Copenhagen; University of Copenhagen	van Exel, E (corresponding author), VU Univ Med Center GGZinGeest, Dept Psychiat, Amsterdam, Netherlands.; van Exel, E (corresponding author), EMGO Inst Hlth & Care Res & Neurosci, Neurosci Campus Amsterdam, Amsterdam, Netherlands.	e.vanexel@ggzingeest.nl	de Knijff, Peter/Y-2519-2018; Meij, Johannes/ABB-6973-2021; Finch, Caleb/AAA-7250-2022	de Knijff, Peter/0000-0002-0899-771X; van Bodegom, David/0000-0002-5691-8342; van Exel, Eric/0000-0002-5737-9600	Netherlands Foundation for the Advancements of Tropical Research [WOTRO93-467]; Netherlands Organization for Scientific Research [NWO 051-14-050]; European Union-funded Network of Excellence Life Span [FP6036894]; Board of Leiden University Medical Center, Stichting Dioraphte; EMGO Institute, VU University Medical Center; NATIONAL INSTITUTE ON AGING [P50AG005142] Funding Source: NIH RePORTER	Netherlands Foundation for the Advancements of Tropical Research; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Union-funded Network of Excellence Life Span; Board of Leiden University Medical Center, Stichting Dioraphte; EMGO Institute, VU University Medical Center; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Netherlands Foundation for the Advancements of Tropical Research (WOTRO93-467), the Netherlands Organization for Scientific Research (NWO 051-14-050), the European Union-funded Network of Excellence Life Span (FP6036894),a grant of the Board of Leiden University Medical Center, Stichting Dioraphte and a grant of the EMGO Institute, VU University Medical Center.	Asienska G, 2015, P BIOL SCI, V282; AUSTAD SN, 1993, J ZOOL, V229, P695, DOI 10.1111/j.1469-7998.1993.tb02665.x; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Boef AGC, 2013, IMMUNOBIOLOGY, V218, P706, DOI 10.1016/j.imbio.2012.08.273; Corbo RM, 2004, MOL HUM REPROD, V10, P617, DOI 10.1093/molehr/gah082; Deelen J, 2011, AGING CELL, V10, P686, DOI 10.1111/j.1474-9726.2011.00705.x; Engelaer FM, 2014, T ROY SOC TROP MED H, V108, P372, DOI 10.1093/trstmh/tru053; Finch CE, 2007, CURR ALZHEIMER RES, V4, P185, DOI 10.2174/156720507780362254; Franceschini Nora, 2011, Circ Cardiovasc Genet, V4, P661, DOI 10.1161/CIRCGENETICS.111.960096; Genin E, 2011, MOL PSYCHIATR, V16, P903, DOI 10.1038/mp.2011.52; Ghana Health Service, 2012, ANN REP E REG; Ghana Health Service, 2003, ANN REPORT; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; Humphries SE, 2004, LANCET NEUROL, V3, P227, DOI 10.1016/S1474-4422(04)00708-2; Koopman JJE, 2016, AGING-US, V8, P1364, DOI 10.18632/aging.100986; Koopman JJE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046855; Kulminski AM, 2011, AGING CELL, V10, P533, DOI 10.1111/j.1474-9726.2011.00689.x; Kuningas M, 2009, PLOS ONE, V11; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Martin GM, 1999, NEUROBIOL AGING, V20, P441, DOI 10.1016/S0197-4580(99)00078-0; Mastana SS, 1998, ANN HUM BIOL, V25, P137, DOI 10.1080/03014469800005512; May L, 2010, BIOL REPROD, V82, P299, DOI 10.1095/biolreprod.109.079111; May Linda, 2009, Immun Ageing, V6, P7, DOI 10.1186/1742-4933-6-7; Meij JJ, 2009, J EVOLUTION BIOL, V22, P1014, DOI 10.1111/j.1420-9101.2009.01713.x; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Sijbrands EJG, 2001, BMJ-BRIT MED J, V322, P1019, DOI 10.1136/bmj.322.7293.1019; Singh PP, 2006, ANN HUM BIOL, V33, P279, DOI 10.1080/03014460600594513; van Bodegom D, 2009, T ROY SOC TROP MED H, V103, P795, DOI 10.1016/j.trstmh.2008.12.003; Vasunilashorn S, 2010, AM J HUM BIOL, V22, P731, DOI 10.1002/ajhb.21074	31	40	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0179497	10.1371/journal.pone.0179497	http://dx.doi.org/10.1371/journal.pone.0179497			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683096	Green Published, Green Submitted, gold			2022-12-26	WOS:000405335200005
J	Zhang, YH; Li, C; Zhang, JX; Wang, JJ; Yang, JW; Lv, YX; Yang, NA; Liu, JP; Wang, XB; Palfalvi, G; Wang, GD; Zheng, LL				Zhang, Yonghong; Li, Chen; Zhang, Jingxuan; Wang, Jiajing; Yang, Jingwei; Lv, Yanxia; Yang, Nian; Liu, Jianping; Wang, Xuanbin; Palfalvi, Gergo; Wang, Guodong; Zheng, Lanlan			Dissection of HY5/HYH expression in Arabidopsis reveals a root-autonomous HY5-mediated photomorphogenic pathway	PLOS ONE			English	Article							FACTOR ELONGATED HYPOCOTYL5; SIGNALING PATHWAYS; PLANT PHOTOMORPHOGENESIS; LIGHT CONTROL; HY5; TRANSCRIPTION; COP1; THALIANA; SHOOT; PHYTOCHROME	ELONGATED HYPOCOTYL 5 (HY5), a member of the bZIP gene family, is a positive regulator of the light signaling pathway in Arabidopsis thaliana. Whereas the hy5 mutant exhibits an elongated hypocotyl when grown in the light, the hy5 homolog (hyh) mutant does not. Although the functions of HY5 and HYH in light-mediated seedling development have been revealed, the tissue-specific expression patterns of HY5 and HYH and their interconnected regulation are largely unknown. Here, we report that HY5 regulates HYH expression in roots and contributes to root growth under different light conditions. We generated HY5 and HYH transcriptional and translational fusion reporter lines to investigate their expression patterns. HY5 was constitutively expressed in all root tissues, while HYH was predominantly expressed in root xylem cells. Root growth after a dark-to-light transition was perturbed in the hy5 and hy5hyh mutant lines, but not in the hyh mutant line, indicating that HY5 plays a major role in light-regulated root growth. Light-induced HY5/HYH expression occurred autonomously in roots. HYH expression in roots was decreased in the hy5 mutant, suggesting that HY5 regulates HYH expression. Collectively, these results indicate that an organ-specific HY5-mediated pathway controls root photomorphogenic development independently of light signaling in the shoot.	[Zhang, Yonghong; Li, Chen; Zhang, Jingxuan; Lv, Yanxia; Yang, Nian; Zheng, Lanlan] Hubei Univ Med, Sch Basic Med, Lab Med Plant, Shiyan, Peoples R China; [Li, Chen; Yang, Nian; Wang, Xuanbin] Hubei Univ Med, Lab Chinese Herbal Pharmacol, Hubei Key Lab Wudang Local Chinese Med Res, Oncol Ctr,Renmin Hosp, Shiyan, Peoples R China; [Wang, Jiajing; Yang, Jingwei; Wang, Guodong] Shaanxi Normal Univ, Coll Life Sci, Natl Engn Lab Resource Dev Endangered Chinese Cru, Key Lab,Minist Educ Med Plant Resource & Nat Phar, Xian, Peoples R China; [Liu, Jianping] Chinese Acad Agr Sci, Tobacco Res Inst, Qingdao, Shandong, Peoples R China; [Palfalvi, Gergo] Univ Pecs, Inst Biol, Fac Sci, Pecs, Hungary	Hubei University of Medicine; Hubei University of Medicine; Shaanxi Normal University; Chinese Academy of Agricultural Sciences; Tobacco Research Institute, CAAS; University of Pecs	Zheng, LL (corresponding author), Hubei Univ Med, Sch Basic Med, Lab Med Plant, Shiyan, Peoples R China.; Wang, GD (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Natl Engn Lab Resource Dev Endangered Chinese Cru, Key Lab,Minist Educ Med Plant Resource & Nat Phar, Xian, Peoples R China.	guodong_wang@snnu.edu.en; zhenglanlan0622@163.com	Wang, Xuanbin/AHE-9819-2022	Wang, Xuanbin/0000-0003-0769-2874; Palfalvi, Gergo/0000-0002-4526-8954	Initial Project for Post-Graduates of Hubei University of Medicine [2016QDJZR14, 2016QDJZR11]; Foundation of Hu'Bei Health and Family planning Commission [WJ2017F068]; Fundamental Research Funds for the Central Universities [GK201702016]	Initial Project for Post-Graduates of Hubei University of Medicine; Foundation of Hu'Bei Health and Family planning Commission; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was partially funded by the Initial Project for Post-Graduates of Hubei University of Medicine to Y.Z. (2016QDJZR14), L.Z. (2016QDJZR11), and C.L., the Foundation of Hu'Bei Health and Family planning Commission (WJ2017F068) to Y.Z. and the Fundamental Research Funds for the Central Universities (GK201702016) to G.W.	Abbas N, 2014, PLANT CELL, V26, P1036, DOI 10.1105/tpc.113.122515; ANG LH, 1994, PLANT CELL, V6, P613, DOI 10.1105/tpc.6.5.613; Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; Arsovski AA, 2012, ARABIDOPSIS BOOK, pe0147; Binkert M, 2014, PLANT CELL, V26, P4200, DOI 10.1105/tpc.114.130716; Briggs WR, 2012, MOL PLANT, V5, P531, DOI 10.1093/mp/sss059; Brown BA, 2008, PLANT PHYSIOL, V146, P576, DOI 10.1104/pp.107.108456; Burbach C, 2012, PLANT SIGNAL BEHAV, V7, P874, DOI 10.4161/psb.21012; Charron JBF, 2009, PLANT CELL, V21, P3732, DOI 10.1105/tpc.109.066845; Chen XB, 2016, CURR BIOL, V26, P640, DOI 10.1016/j.cub.2015.12.066; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cluis CP, 2004, PLANT J, V38, P332, DOI 10.1111/j.1365-313X.2004.02052.x; Delker C, 2014, CELL REP, V9, P1983, DOI 10.1016/j.celrep.2014.11.043; Dyachok J, 2011, PLANT CELL, V23, P3610, DOI 10.1105/tpc.111.088823; Galen C, 2007, PLANT SIGNAL BEHAV, V2, P106, DOI 10.4161/psb.2.2.3638; Gangappa Sreeramaiah N, 2016, MOL PLANT, V9, P1353; Halliday KJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001586; He ZM, 2016, J EXP BOT, V67, P775, DOI 10.1093/jxb/erv495; Holm M, 2002, GENE DEV, V16, P1247, DOI 10.1101/gad.969702; Huang X, 2012, PLANT CELL, V24, P4590, DOI 10.1105/tpc.112.103994; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Jonassen EM, 2009, J PLANT PHYSIOL, V166, P2071, DOI 10.1016/j.jplph.2009.05.010; Kang B, 2008, PLANTA, V227, P1091, DOI 10.1007/s00425-007-0683-z; Kiss John Z, 2003, Gravit Space Biol Bull, V16, P55; Laxmi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001510; Lee Hyo-Jun, 2016, Commun Integr Biol, V9, pe1261769, DOI 10.1080/19420889.2016.1261769; Lee HJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf6530; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Li C, 2017, GENE, V619, P44, DOI 10.1016/j.gene.2017.04.001; Li JG, 2012, PROTEIN CELL, V3, P106, DOI 10.1007/s13238-012-2016-7; Li JG, 2010, PLANT CELL, V22, P3634, DOI 10.1105/tpc.110.075788; Lin RC, 2007, SCIENCE, V318, P1302, DOI 10.1126/science.1146281; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Oyama T, 1997, GENE DEV, V11, P2983, DOI 10.1101/gad.11.22.2983; Ruppel NJ, 2001, PLANTA, V212, P424, DOI 10.1007/s004250000410; Salisbury FJ, 2007, PLANT J, V50, P429, DOI 10.1111/j.1365-313X.2007.03059.x; Sassi M, 2012, DEVELOPMENT, V139, P3402, DOI 10.1242/dev.078212; Sibout R, 2006, PLOS GENET, V2, P1898, DOI 10.1371/journal.pgen.0020202; Singh A, 2012, J BIOL CHEM, V287, P25995, DOI 10.1074/jbc.M111.333906; Smaczniak C, 2012, P NATL ACAD SCI USA, V109, P1560, DOI 10.1073/pnas.1112871109; Xu WF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01273; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007; Yokawa K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00718; Yokawa K, 2013, TRENDS PLANT SCI, V18, P117, DOI 10.1016/j.tplants.2013.01.002; Yokawa K, 2011, PLANT SIGNAL BEHAV, V6, P1460, DOI 10.4161/psb.6.10.18165; Zhang HY, 2011, PLANT J, V65, P346, DOI 10.1111/j.1365-313X.2010.04426.x	46	21	21	5	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180449	10.1371/journal.pone.0180449	http://dx.doi.org/10.1371/journal.pone.0180449			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683099	Green Published, Green Submitted, gold			2022-12-26	WOS:000405335200038
J	Ludke, A; Akolkar, G; Ayyappan, P; Sharma, AK; Singal, PK				Ludke, Ana; Akolkar, Gauri; Ayyappan, Prathapan; Sharma, Anita K.; Singal, Pawan K.			Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C	PLOS ONE			English	Article							CARDIAC MYOCYTE APOPTOSIS; ADRIAMYCIN CARDIOMYOPATHY; INDUCED CARDIOTOXICITY; MITOCHONDRIAL; PATHWAYS; INVOLVEMENT; DYSFUNCTION; TOXICITY; SURVIVAL; KINASES	We previously reported that Vitamin C (Vit C) protects against doxorubicin (Dox)-induced cardiotoxicity by reducing oxidative stress, p38 mitogen-activated kinase (MAPK) and p53 activation and rescuing cell death in isolated adult cardiomyocytes. The pattern of activation and the role of oxidative stress as well as down-stream mechanisms for such protection remain elusive. Therefore the present study aims to analyze time-dependant generation of reactive oxygen species (ROS) and the activation of stress induced signalling pathways in cardiomyocytes treated with Dox and Vit C. The data provides further understanding of heart pathophysiology in response to Dox at the cellular level, and may help to optimize the timing of various therapeutic approaches. Cardiomyocytes isolated from adult SpragueDawley rats were exposed to Dox (10 mu M), Vit C (25 mu M), and Dox + Vit C for different time intervals up to 24 h. p38-JNK (SB203580) and p53 (pifithrin-alpha inhibitors were used to determine the role of each respective signalling protein. Dox administration to cardiomyocytes increased the levels of ROS in a time-dependent manner that followed the activation of stress-induced proteins p53, p38 and JNK MAPKs, culminating in an increase in autophagy and apoptosis markers. Dox-induced increase in ROS was alleviated by Vit C adjuvant treatment at all time-points and this was also correlated with blunting of the activation of the studied signaling pathways leading to the prevention of apoptosis and preservation of cell viability. Protective effect of Vit C against the activation of stress induced proteins, autophagy and apoptosis was mainly attributed to its antioxidant properties even though blockage of p38, JNK and p53 by pharmacological inhibitors also suppressed Dox-induced apoptosis. ROS is defined as a key inducer of cardiomyocyte damage under Dox exposure; Vit C could effectively counteract all Dox-induced changes in cardiomyocytes and may potentially be used as an antioxidant adjuvant therapy to protect against Dox-induced cardiomyopathy.	[Ludke, Ana; Akolkar, Gauri; Ayyappan, Prathapan; Sharma, Anita K.; Singal, Pawan K.] Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med,Dept Physiol & Pathophysiol, Inst Cardiovasc Sci,St Boniface Hosp,Albrechtsen, Winnipeg, MB, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba	Singal, PK (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med,Dept Physiol & Pathophysiol, Inst Cardiovasc Sci,St Boniface Hosp,Albrechtsen, Winnipeg, MB, Canada.	psingal@sbrc.ca		Ayappan, Prathapan/0000-0002-5508-2360	Heart and Stroke Foundation Canada; Research Manitoba; Bank of Montreal; Canadian Circulatory and Respiratory Institute; St. Boniface Hospital and Research Foundation	Heart and Stroke Foundation Canada(Heart & Stroke Foundation of Canada); Research Manitoba; Bank of Montreal; Canadian Circulatory and Respiratory Institute; St. Boniface Hospital and Research Foundation	This work was supported by a fellowship from Heart and Stroke Foundation Canada, Research Manitoba, a studentship from Bank of Montreal, and the Canadian Circulatory and Respiratory Institute. Dr. Singal is the holder of Naranjan Dhalla Chair in Cardiovascular Researched supported by the St. Boniface Hospital and Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Banyasz T, 2008, EXP PHYSIOL, V93, P370, DOI 10.1113/expphysiol.2007.040659; Dhingra S, 2007, AM J PHYSIOL-HEART C, V293, pH3524, DOI 10.1152/ajpheart.00919.2007; DOROSHOW JH, 1980, J CLIN INVEST, V65, P128, DOI 10.1172/JCI109642; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FUJITA K, 1982, CANCER RES, V42, P309; Goncalves TL, 2005, CLIN BIOCHEM, V38, P1071, DOI 10.1016/j.clinbiochem.2005.09.008; GREENE RF, 1983, CANCER RES, V43, P3417; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lebrecht D, 2007, CARDIOVASC TOXICOL, V7, P108, DOI 10.1007/s12012-007-0009-1; LEFRAK EA, 1973, CANCER-AM CANCER SOC, V32, P302, DOI 10.1002/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2; Li DL, 2016, CIRCULATION, V133, P1668, DOI 10.1161/CIRCULATIONAHA.115.017443; Lou H, 2005, AM J PHYSIOL-HEART C, V288, pH1925, DOI 10.1152/ajpheart.01054.2004; Lou Huiquan, 2006, Pathophysiology, V13, P103, DOI 10.1016/j.pathophys.2006.02.004; Ludke A, 2012, MOL CELL BIOCHEM, V360, P215, DOI 10.1007/s11010-011-1059-z; Ludke AR, 2012, AM J PHYSIOL-CELL PH, V303, pC645, DOI 10.1152/ajpcell.00186.2012; Ludke ARL, 2009, CAN J PHYSIOL PHARM, V87, P756, DOI 10.1139/Y09-059; Menna P, 2012, EXPERT OPIN DRUG SAF, V11, pS21, DOI 10.1517/14740338.2011.589834; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Nithipongvanitch R, 2007, ANTIOXID REDOX SIGN, V9, P1001, DOI 10.1089/ars.2007.1632; Ruan Y, 2015, CELL PHYSIOL BIOCHEM, V35, P1116, DOI 10.1159/000373937; SAIJO N, 1973, IMMUNOLOGY, V24, P683; Salvatorelli E, 2013, J PHARMACOL EXP THER, V344, P467, DOI 10.1124/jpet.112.200568; Santos RVT, 2007, CLIN EXP PHARMACOL P, V34, P1294, DOI 10.1111/j.1440-1681.2007.04717.x; SAUBERLICH HE, 1994, ANNU REV NUTR, V14, P371, DOI 10.1146/annurev.nu.14.070194.002103; SHIMPO K, 1991, AM J CLIN NUTR, V54, pS1298, DOI 10.1093/ajcn/54.6.1298s; Singal PK, 1997, FASEB J, V11, P931, DOI 10.1096/fasebj.11.12.9337145; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; SIVESKIILISKOVIC N, 1995, CIRCULATION, V91, P10, DOI 10.1161/01.CIR.91.1.10; Spallarossa P, 2006, CARDIOVASC RES, V69, P736, DOI 10.1016/j.cardiores.2005.08.009; Venkatesan B, 2010, CELL SIGNAL, V22, P809, DOI 10.1016/j.cellsig.2010.01.005; Wallace KB, 2007, CARDIOVASC TOXICOL, V7, P101, DOI 10.1007/s12012-007-0008-2; Wold LE, 2005, CANCER DETECT PREV, V29, P294, DOI 10.1016/j.cdp.2004.07.008; Yamamoto Y, 2008, CARDIOVASC RES, V79, P89, DOI 10.1093/cvr/cvn076; Yeh ETH, 2004, CIRCULATION, V109, P3122, DOI 10.1161/01.CIR.0000133187.74800.B9; Yeh PY, 2001, BIOCHEM BIOPH RES CO, V284, P880, DOI 10.1006/bbrc.2001.5043; Yoshida M, 2009, J MOL CELL CARDIOL, V47, P698, DOI 10.1016/j.yjmcc.2009.07.024; Zhou SY, 2001, CANCER RES, V61, P771	41	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179452	10.1371/journal.pone.0179452	http://dx.doi.org/10.1371/journal.pone.0179452			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678856	Green Published, Green Submitted, gold			2022-12-26	WOS:000405272200015
J	Bughani, U; Saha, A; Kuriakose, A; Nair, R; Sadashivarao, RB; Venkataraman, R; Patel, S; Deshchougule, AT; Kumar, SS; Montero, E; Pai, HV; Palanivelu, DV; Melarkode, R; Nair, P				Bughani, Usha; Saha, Arindam; Kuriakose, Anshu; Nair, Reshmi; Sadashivarao, Ravindra B.; Venkataraman, Rasika; Patel, Swati; Deshchougule, Anuja Tushar; Kumar, Satish S.; Montero, Enrique; Pai, Harish V.; Palanivelu, Dinesh V.; Melarkode, Ramakrishnan; Nair, Pradip			T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab	PLOS ONE			English	Article							CHEMOKINE RECEPTOR EXPRESSION; ROR-GAMMA-T; MULTIPLE-SCLEROSIS; TH17 CELLS; AUTOIMMUNE-DISEASES; MONOCLONAL-ANTIBODY; SURFACE-RECEPTOR; PLAQUE PSORIASIS; RESPONSES; ALCAM	CD6 is associated with T-cell modulation and is implicated in several autoimmune diseases. We previously demonstrated that Itolizumab, a CD6 domain 1 (CD6D1) specific humanized monoclonal antibody, inhibited the proliferation and cytokine production by T lymphocytes stimulated with anti-CD3 antibody or when co-stimulated with ALCAM. Aberrant IL-17 producing CD4(+) helper T-cells (Th17) have been identified as pivotal for the pathogenesis of certain inflammatory autoimmune disorders, including psoriasis. Itolizumab has demonstrated efficacy in human diseases known to have an IL-17 driven pathogenesis. Here, in in vitro experiments we show that by day 3 of human PBMC activation using anti-CD3 and anti-CD28 co-stimulation in a Th17 polarizing milieu, 15-35% of CD4(+) T-cells overexpress CD6 and there is an establishment of differentiated Th17 cells. Addition of Itolizumab reduces the activation and differentiation of T cells to Th17 cells and decreases production of IL-17. These effects are associated with the reduction of key transcription factors pSTAT3 and ROR gamma T. Further, transcription analysis studies in these conditions indicate that Itolizumab suppressed T cell activation by primarily reducing cell cycle, DNA transcription and translation associated genes. To understand the mechanism of this inhibition, we evaluated the effect of this anti-human CD6D1 mAb on ALCAM-CD6 as well as TCR-mediated T cell activation. We show that Itolizumab but not its F(ab') 2 fragment directly inhibits CD6 receptor hyper-phosphorylation and leads to subsequent decrease in associated ZAP70 kinase and docking protein SLP76. Since Itolizumab binds to CD6 expressed only on human and chimpanzee, we developed an antibody binding specifically to mouse CD6D1. This antibody successfully ameliorated the incidence of experimental autoimmune encephalitis in the mice model. These results position CD6 as a key molecule in sustaining the activation and differentiation of T cells and an important target for modulating autoimmune diseases.	[Bughani, Usha; Saha, Arindam; Kuriakose, Anshu; Nair, Reshmi; Sadashivarao, Ravindra B.; Venkataraman, Rasika; Patel, Swati; Deshchougule, Anuja Tushar; Kumar, Satish S.; Montero, Enrique; Pai, Harish V.; Palanivelu, Dinesh V.; Melarkode, Ramakrishnan; Nair, Pradip] Biocon Res Ltd, Res & Dev, Bangalore, Karnataka, India	Biocon Limited	Nair, P (corresponding author), Biocon Res Ltd, Res & Dev, Bangalore, Karnataka, India.	pradip.nair@biocon.com	Patel, Swati/AAT-8352-2020; Capital Partners, L.P., Willow Creek/E-7792-2018	Patel, Swati/0000-0003-2543-0448; Montero, Enrique/0000-0002-7127-6675; Capital Partners, L.P., Willow Creek/0000-0001-9902-2688	Biocon Research Limited	Biocon Research Limited	Please note that the study is funded by Biocon Research Limited. The funder had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	AbuHilal M, 2016, J CUTAN MED SURG, V20, P509, DOI 10.1177/1203475416651605; Aira LE, 2014, MABS-AUSTIN, V6, P782, DOI 10.4161/mabs.28376; Alonso R, 2008, HYBRIDOMA, V27, P291, DOI 10.1089/hyb.2008.0007; Alonso R, 2010, J AUTOIMMUN, V35, P336, DOI 10.1016/j.jaut.2010.07.005; Alonso-Ramirez R, 2010, ARTHRITIS, DOI 10.1155/2010/130646; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Beck A, 2011, MABS, V3, P111; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; BOTT CM, 1994, J IMMUNOL, V153, P1; BOWEN MA, 1995, J EXP MED, V181, P2213, DOI 10.1084/jem.181.6.2213; Brockdorff J, 1999, EUR J IMMUNOL, V29, P2539, DOI 10.1002/(SICI)1521-4141(199908)29:08<2539::AID-IMMU2539>3.0.CO;2-M; Brown MH, 2016, CURR DRUG TARGETS, V17, P619, DOI 10.2174/1389450116666150825120536; Brown MH, 2015, CURRENT DRUG TARGETS, V16, P1; Brucklacher-Waldert V, 2009, BRAIN, V132, P3329, DOI 10.1093/brain/awp289; Canavan TN, 2016, AM J CLIN DERMATOL, V17, P33, DOI 10.1007/s40257-015-0162-4; Carmo AM, 2016, CURR DRUG TARGETS, V17, P618, DOI 10.2174/138945011706160324153314; Castro MAA, 2007, J IMMUNOL, V178, P4351, DOI 10.4049/jimmunol.178.7.4351; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Chappell PE, 2015, STRUCTURE, V23, P1426, DOI 10.1016/j.str.2015.05.019; Chen W, 2016, INT J CLIN EXP PATHO, V9, P7428; Chen Y, 2015, IMMUNOTHERAPY-UK, V7, P1023, DOI 10.2217/imt.15.50; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; Chopra A, 2016, CLIN RHEUMATOL, V35, P1059, DOI 10.1007/s10067-015-2988-9; da Gloria VG, 2014, J IMMUNOL, V193, P391, DOI 10.4049/jimmunol.1400038; de Wit J, 2011, BLOOD, V118, P6107, DOI 10.1182/blood-2011-05-352682; Durelli L, 2009, ANN NEUROL, V65, P499, DOI 10.1002/ana.21652; Gaffen SL, 2008, CYTOKINE, V43, P402, DOI 10.1016/j.cyto.2008.07.017; Gardner D, 2014, AM J TRANSPLANT, V14, P1985, DOI 10.1111/ajt.12834; Garnock-Jones KP, 2015, AM J CLIN DERMATOL, V16, P323, DOI 10.1007/s40257-015-0143-7; Gimferrer I, 2005, J IMMUNOL, V175, P1406, DOI 10.4049/jimmunol.175.3.1406; Gimferrer I, 2004, J IMMUNOL, V173, P2262, DOI 10.4049/jimmunol.173.4.2262; Hassan NJ, 2006, MOL CELL BIOL, V26, P6727, DOI 10.1128/MCB.00688-06; Hernandez P, 2016, CURR DRUG TARGETS, V17, P666, DOI 10.2174/1389450117666160201114308; Huh JR, 2012, EUR J IMMUNOL, V42, P2232, DOI 10.1002/eji.201242740; Ibanez A, 2006, J IMMUNOL, V177, P1152, DOI 10.4049/jimmunol.177.2.1152; Jurewicz A, 2014, J NEUROIMMUNOL, V276, P187, DOI 10.1016/j.jneuroim.2014.08.620; Kleinewietfeld M, 2005, BLOOD, V105, P2877, DOI 10.1182/blood-2004-07-2505; Kofler DM, 2011, J IMMUNOL, V187, P3286, DOI 10.4049/jimmunol.1100626; Krintel SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038539; Krupashankar DS, 2014, J AM ACAD DERMATOL, V71, P484, DOI 10.1016/j.jaad.2014.01.897; Lecuyer MA, 2017, P NATL ACAD SCI USA, V114, pE524, DOI 10.1073/pnas.1614336114; Levesque MC, 1998, ARTHRITIS RHEUM, V41, P2221, DOI 10.1002/1529-0131(199812)41:12<2221::AID-ART18>3.0.CO;2-I; Li Y, 2017, P NATL ACAD SCI USA, V114, P2687, DOI 10.1073/pnas.1615253114; Li Y, 2010, PROCEEDINGS OF 2010 ASIA-PACIFIC YOUTH CONFERENCE ON COMMUNICATION, VOLS 1 AND 2, P10, DOI 10.1371/journal.pbio.1000533; Liao F, 1999, J IMMUNOL, V162, P186; Liu H, 2008, J IMMUNOL, V180, P7948, DOI 10.4049/jimmunol.180.12.7948; Lorenz U, 1996, P NATL ACAD SCI USA, V93, P9624, DOI 10.1073/pnas.93.18.9624; Mease PJ, 2014, NEW ENGL J MED, V370, P2295, DOI 10.1056/NEJMoa1315231; Nair P, 2010, CLIN EXP IMMUNOL, V162, P116, DOI 10.1111/j.1365-2249.2010.04235.x; Oliveira MI, 2012, EUR J IMMUNOL, V42, P195, DOI 10.1002/eji.201040528; Orta-Mascaro M, 2016, J EXP MED, V213, P1387, DOI 10.1084/jem.20151785; Pena-Rossi C, 1999, J IMMUNOL, V163, P6494; Perez-Villar JJ, 1999, MOL CELL BIOL, V19, P2903; Pinto M, 2013, BIODRUGS, V27, P191, DOI 10.1007/s40259-013-0027-4; Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301; Ramos-Casals M, 2001, RHEUMATOLOGY, V40, P1056, DOI 10.1093/rheumatology/40.9.1056; Rodriguez Pedro C, 2012, Results Immunol, V2, P204, DOI 10.1016/j.rinim.2012.11.001; Roncagalli R, 2014, NAT IMMUNOL, V15, P384, DOI 10.1038/ni.2843; Saha A, 2014, MOL CELL, V55, P264, DOI 10.1016/j.molcel.2014.05.028; Saifullah MK, 2004, J IMMUNOL, V173, P6125, DOI 10.4049/jimmunol.173.10.6125; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Santos RF, 2016, CURR DRUG TARGETS, V17, P630, DOI 10.2174/1389450116666150531152439; Sarrias MR, 2007, P NATL ACAD SCI USA, V104, P11724, DOI 10.1073/pnas.0702815104; Sarukhan A, 2016, CURR DRUG TARGETS, V17, P640, DOI 10.2174/1389450116666150316224308; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Singer NG, 1996, IMMUNOLOGY, V88, P537; Singer NG, 2002, INT IMMUNOL, V14, P585, DOI 10.1093/intimm/dxf025; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Swaminathan B, 2010, J NEUROIMMUNOL, V223, P100, DOI 10.1016/j.jneuroim.2010.03.020; TARAKHOVSKY A, 1994, EUR J IMMUNOL, V24, P1678, DOI 10.1002/eji.1830240733; Tibaldi E, 2011, LEUKEMIA, V25, P1768, DOI 10.1038/leu.2011.152; Wagner M, 2014, J NEUROIMMUNOL, V276, P98, DOI 10.1016/j.jneuroim.2014.08.621; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zhang WG, 2000, SEMIN IMMUNOL, V12, P35, DOI 10.1006/smim.2000.0205; Zhu ED, 2014, J IMMUNOL, V192, P5599, DOI 10.4049/jimmunol.1303488; Zimmerman AW, 2006, BLOOD, V107, P3212, DOI 10.1182/blood-2005-09-3881	78	31	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180088	10.1371/journal.pone.0180088	http://dx.doi.org/10.1371/journal.pone.0180088			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672038	gold, Green Submitted, Green Published			2022-12-26	WOS:000405268500015
J	Hammerschmidt-Kamper, C; Biljes, D; Merches, K; Steiner, I; Daldrup, T; Bol-Schoenmakers, M; Pieters, RHH; Esser, C				Hammerschmidt-Kamper, Christiane; Biljes, Daniel; Merches, Katja; Steiner, Irina; Daldrup, Thomas; Bol-Schoenmakers, Marianne; Pieters, Raymond H. H.; Esser, Charlotte			Indole-3-carbinol, a plant nutrient and AhR-Ligand precursor, supports oral tolerance against OVA and improves peanut allergy symptoms in mice	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; REGULATORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SITE-DIRECTED MUTAGENESIS; RETINOIC-ACID; DENDRITIC CELLS; SMALL-INTESTINE; VITAMIN-A; II COLLAGEN; IN-VITRO	In general, dietary antigens are tolerated by the gut associated immune system. Impairment of this so-called oral tolerance is a serious health risk. We have previously shown that activation of the ligand-dependent transcription factor aryl hydrocarbon receptor (AhR) by the environmental pollutant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) affects both oral tolerance and food allergy. In this study, we determine whether a common plant-derived, dietary AhR-ligand modulates oral tolerance as well. We therefore fed mice with indole-3-carbinole (I3C), an AhR ligand that is abundant in cruciferous plants. We show that several I3C metabolites were detectable in the serum after feeding, including the high-affinity ligand 3,3 A -diindolylmethane (DIM). I3C feeding robustly induced the AhR-target gene CYP4501A1 in the intestine; I3C feeding also induced the aldh1 gene, whose product catalyzes the formation of retinoic acid (RA), an inducer of regulatory T cells. We then measured parameters indicating oral tolerance and severity of peanut-induced food allergy. In contrast to the tolerance breaking effect of TCDD, feeding mice with chow containing 2 g/kg I3C lowered the serum anti-ovalbumin IgG1 response in an experimental oral tolerance protocol. Moreover, I3C feeding attenuated symptoms of peanut allergy. In conclusion, the dietary compound I3C can positively influence a vital immune function of the gut.	[Hammerschmidt-Kamper, Christiane; Biljes, Daniel; Merches, Katja; Esser, Charlotte] IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany; [Steiner, Irina; Daldrup, Thomas] Univ Hosp Dusseldorf, Inst Legal Med, Dept Forens Toxicol, Dusseldorf, Germany; [Bol-Schoenmakers, Marianne; Pieters, Raymond H. H.] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands	Leibniz Institut fur Umweltmedizinische Forschung (IUF); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Utrecht University	Esser, C (corresponding author), IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany.	chesser@uni-duesseldorf.de			Deutsche Forschungsgemeinschaft [ES103/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft, ES103/6-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agace WW, 2012, TRENDS IMMUNOL, V33, P42, DOI 10.1016/j.it.2011.10.001; Baba N, 2012, HUM IMMUNOL, V73, P795, DOI 10.1016/j.humimm.2012.05.002; Bhat PV, 1998, FEBS LETT, V426, P260, DOI 10.1016/S0014-5793(98)00355-X; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; BJELDANES LF, 1991, P NATL ACAD SCI USA, V88, P9543, DOI 10.1073/pnas.88.21.9543; Bol-Schoenmakers M, 2011, ALLERGY, V66, P331, DOI 10.1111/j.1398-9995.2010.02479.x; Bunaciu RP, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-39; Bunaciu RP, 2011, CANCER RES, V71, P2371, DOI 10.1158/0008-5472.CAN-10-2299; Chmill S, 2010, TOXICOL SCI, V118, P98, DOI 10.1093/toxsci/kfq232; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Duarte JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079819; Esser C, 2015, PHARMACOL REV, V67, P259, DOI 10.1124/pr.114.009001; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; Faria AMC, 2006, CLIN DEV IMMUNOL, V13, P143, DOI 10.1080/17402520600876804; Farooq SM, 2014, BRAIN BEHAV IMMUN, V42, P118, DOI 10.1016/j.bbi.2014.06.010; Farooq SM, 2014, J CELL MOL MED, V18, P2512, DOI 10.1111/jcmm.12376; Fraccalvieri D, 2013, BIOCHEMISTRY-US, V52, P714, DOI 10.1021/bi301457f; Frericks M, 2008, BBA-GENE REGUL MECH, V1779, P830, DOI 10.1016/j.bbagrm.2008.08.007; FRIEDMAN A, 1994, CHEM IMMUNOL, V58, P259; FRIEDMAN A, 1994, P NATL ACAD SCI USA, V91, P6688, DOI 10.1073/pnas.91.14.6688; Goodyear AW, 2014, J IMMUNOL METHODS, V405, P97, DOI 10.1016/j.jim.2014.01.014; Hanieh H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/520763; Huber A, 2015, MOL IMMUNOL, V63, P215, DOI 10.1016/j.molimm.2014.07.009; HUSBY S, 1994, J IMMUNOL, V152, P4663; Iliev ID, 2009, GUT, V58, P1481, DOI 10.1136/gut.2008.175166; Ito SJ, 2007, J CLIN INVEST, V117, P1940, DOI 10.1172/JCI31647; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jeong KT, 2012, INT IMMUNOPHARMACOL, V13, P377, DOI 10.1016/j.intimp.2012.04.014; Julliard W, 2017, ANN SURG, V265, P1183, DOI 10.1097/SLA.0000000000001830; Kapp K, 2010, EUR J IMMUNOL, V40, P3128, DOI 10.1002/eji.201040701; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Lampen A, 2000, J PHARMACOL EXP THER, V295, P979; Latte KP, 2011, FOOD CHEM TOXICOL, V49, P3287, DOI 10.1016/j.fct.2011.08.019; Li Y, 2011, CELL; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Minich DA, 2007, NUTR REV, V65, P259, DOI 10.1111/j.1753-4887.2007.tb00303.x; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Nwaru BI, 2014, ALLERGY, V69, P992, DOI 10.1111/all.12423; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; Park JH, 2015, IMMUNE NETW, V15, P278, DOI 10.4110/in.2015.15.6.278; Park KS, 2009, MOD RHEUMATOL, V19, P581, DOI 10.1007/s10165-009-0210-0; Pot C, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13592; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Rezende MM, 2011, CLIN EXP ALLERGY, V41, P1324, DOI 10.1111/j.1365-2222.2010.03662.x; Rouse M, 2014, J PHARMACOL EXP THER, V350, P341, DOI 10.1124/jpet.114.214742; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Schulz VJ, 2011, TOXICOL SCI, V123, P491, DOI 10.1093/toxsci/kfr175; Siewert C, 2008, J IMMUNOL, V180, P146, DOI 10.4049/jimmunol.180.1.146; Singh NP, 2016, J IMMUNOL, V196, P1108, DOI 10.4049/jimmunol.1501727; Soshilov AA, 2014, MOL CELL BIOL, V34, P1707, DOI 10.1128/MCB.01183-13; Staack R, 1998, TOXICOL APPL PHARM, V149, P17, DOI 10.1006/taap.1997.8340; Stanford EA, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0240-y; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Thurau SR, 2002, PROG RETIN EYE RES, V21, P577, DOI 10.1016/S1350-9462(02)00039-3; van den Elsen LWJ, 2014, J NUTR, V144, P1970, DOI 10.3945/jn.114.198515; van Wijk F, 2005, J IMMUNOL, V174, P174, DOI 10.4049/jimmunol.174.1.174; Verhoeven DTH, 1997, CHEM-BIOL INTERACT, V103, P79, DOI 10.1016/S0009-2797(96)03745-3; von Boehmer H, 2007, J EXP MED, V204, P1737, DOI 10.1084/jem.20071251; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Wu DL, 2013, MOL CELL BIOL, V33, P4346, DOI 10.1128/MCB.00698-13; Yeste A, 2012, P NATL ACAD SCI USA, V109, P11270, DOI 10.1073/pnas.1120611109	66	21	22	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180321	10.1371/journal.pone.0180321	http://dx.doi.org/10.1371/journal.pone.0180321			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666018	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608700085
J	Smith, EG; Hume, BCC; Delaney, P; Wiedenmann, J; Burt, JA				Smith, Edward G.; Hume, Benjamin C. C.; Delaney, Patrice; Wiedenmann, Jorg; Burt, John A.			Genetic structure of coral-Symbiodinium symbioses on the world's warmest reefs	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENUS POCILLOPORA; LOCAL ADAPTATION; PERSIAN-GULF; DIVERSITY; ITS2; TOOL; SEA; DIVERSIFICATION; SPECIFICITY	Corals in the Arabian/Persian Gulf (PAG) survive extreme sea temperatures (summer mean: >34 degrees C), and it is unclear whether these corals have genetically adapted or physiologically acclimated to these conditions. In order to elucidate the processes involved in the thermal tolerance of PAG corals, it is essential to understand the connectivity between reefs within and outside of the PAG. To this end, this study set out to investigate the genetic structure of the coral, Platygyra daedalea, and its symbiotic algae in the PAG and neighbouring Gulf of Oman. Using nuclear markers (the ITS region and an intron of the Pax-C gene), this study demonstrates genetic divergence of P. daedalea on reefs within the thermally extreme PAG compared with those in the neighbouring Gulf of Oman. Isolation by distance of P. daedalea was supported by the ITS dataset but not the Pax-C intron. In addition, the symbiont community within the PAG was dominated by C3 symbionts, while the purportedly thermotolerant clade D was extremely rare and was common only at sites outside of the PAG. Analysis of the psbA(ncr) indicates that the C3 variant hosted by P. daedalea in the PAG belongs to the newly described species, Symbiodinium thermophilum. The structuring of the coral and symbiont populations suggests that both partners of the symbiosis may contribute to the high bleaching thresholds of PAG corals. While limited gene flow has likely played a role in local adaptation within the PAG, it also indicates limited potential for natural export of thermal tolerance traits to reefs elsewhere in the Indian Ocean threatened by climate change.	[Smith, Edward G.; Delaney, Patrice; Burt, John A.] New York Univ Abu Dhabi, Marine Biol Lab, CGSB, Abu Dhabi, U Arab Emirates; [Hume, Benjamin C. C.; Wiedenmann, Jorg] Univ Southampton, Natl Oceanog Ctr, Coral Reef Lab, Southampton, Hants, England	NERC National Oceanography Centre; University of Southampton	Smith, EG (corresponding author), New York Univ Abu Dhabi, Marine Biol Lab, CGSB, Abu Dhabi, U Arab Emirates.	edsmith@nyu.edu		Hume, Benjamin/0000-0001-7753-3903; Smith, Emily/0000-0001-5715-9459; Sinha, Bireshwar/0000-0002-7408-7474; Burt, John/0000-0001-6087-6424	New York University Abu Dhabi's Research Enhancement Fund; Natural Environment Research Council [NE/I01683X/1]; European Research Council under the European Union's Seventh Framework Programme (FP) / European Research Council [311179]; NERC [NE/I01683X/1] Funding Source: UKRI	New York University Abu Dhabi's Research Enhancement Fund; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council under the European Union's Seventh Framework Programme (FP) / European Research Council; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by New York University Abu Dhabi's Research Enhancement Fund (ES and JB) and by Natural Environment Research Council (NE/I01683X/1 to JW), European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / European Research Council Grant Agreement n. 311179 to JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alosairi Y, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006769; Arif C, 2014, MOL ECOL, V23, P4418, DOI 10.1111/mec.12869; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Barshis DJ, 2010, MOL ECOL, V19, P1705, DOI 10.1111/j.1365-294X.2010.04574.x; Bauman AG, 2013, MAR POLLUT BULL, V72, P302, DOI 10.1016/j.marpolbul.2012.10.013; Burt J, 2011, MAR ENVIRON RES, V72, P225, DOI 10.1016/j.marenvres.2011.08.005; Coles SL, 2013, MAR POLLUT BULL, V72, P323, DOI 10.1016/j.marpolbul.2012.09.006; D'Angelo C, 2015, ISME J, V9, P2551, DOI 10.1038/ismej.2015.80; Dmitriev DA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000113; DOYLE JJ, 1995, SYST BOT, V20, P574, DOI 10.2307/2419811; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Flot JF, 2010, MOL ECOL RESOUR, V10, P162, DOI 10.1111/j.1755-0998.2009.02732.x; Flot JF, 2008, CR BIOL, V331, P239, DOI 10.1016/j.crvi.2007.12.003; Flot JF, 2007, MOL ECOL NOTES, V7, P974, DOI 10.1111/j.1471-8286.2007.01857.x; Flot Jean-Francois, 2013, BMC Research Notes, V6, P144, DOI 10.1186/1756-0500-6-144; Flot Jean-Francois, 2011, BMC Ecology, V11, P22, DOI 10.1186/1472-6785-11-22; Flot JF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-372; Goodbody-Gringley G, 2012, MAR ECOL-EVOL PERSP, V33, P32, DOI 10.1111/j.1439-0485.2011.00452.x; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; Hartle-Mougiou K, 2012, J MAR BIOL ASSOC UK, V92, P687, DOI 10.1017/S0025315411001159; Hume B, 2013, MAR POLLUT BULL, V72, P313, DOI 10.1016/j.marpolbul.2012.11.032; Hume BCC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08562; Hume BCC, 2016, P NATL ACAD SCI USA, V113, P4416, DOI 10.1073/pnas.1601910113; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Kenkel CD, 2013, MOL ECOL, V22, P4322, DOI 10.1111/mec.12390; Keshavmurthy S, 2012, MOL ECOL, V21, P4393, DOI 10.1111/j.1365-294X.2012.05704.x; Kleypas JA, 1999, AM ZOOL, V39, P146; LaJeunesse TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029013; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; Lambeck K, 1996, EARTH PLANET SC LETT, V142, P43, DOI 10.1016/0012-821X(96)00069-6; Lessios HA, 2001, EVOLUTION, V55, P955, DOI 10.1554/0014-3820(2001)055[0955:PSASIT]2.0.CO;2; Mostafavi PG, 2007, MAR BIOL, V153, P25, DOI 10.1007/s00227-007-0796-8; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; REYNOLDS RM, 1993, MAR POLLUT BULL, V27, P35; Sanford E, 2011, ANNU REV MAR SCI, V3, P509, DOI 10.1146/annurev-marine-120709-142756; Schwartz SA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-123; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Shuail D, 2016, MAR POLLUT BULL, V105, P654, DOI 10.1016/j.marpolbul.2016.03.001; Smith EG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01569-8; Smith EG, 2017, ISME J, V11, P1500, DOI 10.1038/ismej.2016.206; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Takabayashi M, 2003, CORAL REEFS, V22, P17, DOI 10.1007/s00338-002-0272-3; Thornhill DJ, 2014, EVOLUTION, V68, P352, DOI 10.1111/evo.12270; Yao F, 2010, J GEOPHYS RES, V115, pC11	45	49	51	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180169	10.1371/journal.pone.0180169	http://dx.doi.org/10.1371/journal.pone.0180169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666005	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000404608700067
J	Huskova, H; Ardin, M; Weninger, A; Vargova, K; Barrin, S; Villar, S; Olivier, M; Stopka, T; Herceg, Z; Hollstein, M; Zavadil, J; Korenjak, M				Huskova, H.; Ardin, M.; Weninger, A.; Vargova, K.; Barrin, S.; Villar, S.; Olivier, M.; Stopka, T.; Herceg, Z.; Hollstein, M.; Zavadil, J.; Korenjak, M.			Modeling cancer driver events in vitro using barrier bypass-clonal expansion assays and massively parallel sequencing	ONCOGENE			English	Article							TUMOR P53 MUTATIONS; SWI/SNF COMPLEXES; SOMATIC MUTATIONS; ARISTOLOCHIC ACID; PATHWAYS; PATTERNS; GENES; CELLS; IMMORTALIZATION; INVESTIGATE	The information on candidate cancer driver alterations available from public databases is often descriptive and of limited mechanistic insight, which poses difficulties for reliable distinction between true driver and passenger events. To address this challenge, we performed in-depth analysis of whole-exome sequencing data from cell lines generated by a barrier bypass-clonal expansion (BBCE) protocol. The employed strategy is based on carcinogen-driven immortalization of primary mouse embryonic fibroblasts and recapitulates early steps of cell transformation. Among the mutated genes were almost 200 COSMIC Cancer Gene Census genes, many of which were recurrently affected in the set of 25 immortalized cell lines. The alterations affected pathways regulating DNA damage response and repair, transcription and chromatin structure, cell cycle and cell death, as well as developmental pathways. The functional impact of the mutations was strongly supported by the manifestation of several known cancer hotspot mutations among the identified alterations. We identified a new set of genes encoding subunits of the BAF chromatin remodeling complex that exhibited Ras-mediated dependence on PRC2 histone methyltransferase activity, a finding that is similar to what has been observed for other BAF subunits in cancer cells. Among the affected BAF complex subunits, we determined Smarcd2 and Smarcc1 as putative driver candidates not yet fully identified by large-scale cancer genome sequencing projects. In addition, Ep400 displayed characteristics of a driver gene in that it showed a mutually exclusive mutation pattern when compared with mutations in the Trrap subunit of the TIP60 complex, both in the cell line panel and in a human tumor data set. We propose that the information generated by deep sequencing of the BBCE cell lines coupled with phenotypic analysis of the mutant cells can yield mechanistic insights into driver events relevant to human cancer development.	[Huskova, H.; Ardin, M.; Villar, S.; Olivier, M.; Hollstein, M.; Zavadil, J.; Korenjak, M.] Int Agcy Res Canc, Mol Mech & Biomarkers Grp, 150 Cours Albert Thomas, F-69008 Lyon, France; [Huskova, H.; Stopka, T.] Charles Univ Prague, Fac Med 1, Biocev, Prague, Czech Republic; [Weninger, A.; Hollstein, M.] Deutsch Krebsforschungszentrum, Heidelberg, Germany; [Vargova, K.] Charles Univ Prague, Fac Med 1, Pathol Physiol, Prague, Czech Republic; [Barrin, S.] Inst Cochin, Inserm U1016, Dynam T Cell Interact Team, Paris, France; [Herceg, Z.] Int Agcy Res Canc, Epigenet Grp, Lyon, France; [Hollstein, M.] Univ Leeds, LIGHT Labs, Fac Med & Hlth, Leeds, W Yorkshire, England	World Health Organization; International Agency for Research on Cancer (IARC); Charles University Prague; Helmholtz Association; German Cancer Research Center (DKFZ); Charles University Prague; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; World Health Organization; International Agency for Research on Cancer (IARC); University of Leeds	Zavadil, J; Korenjak, M (corresponding author), Int Agcy Res Canc, Mol Mech & Biomarkers Grp, 150 Cours Albert Thomas, F-69008 Lyon, France.; Hollstein, M (corresponding author), Univ Leeds, LIGHT Labs, Fac Med & Hlth, Leeds, W Yorkshire, England.	M.Hollstein@leeds.ac.uk; zavadilj@iarc.fr; korenjakm@iarc.fr	Savvulidi Vargova, Karina/ABE-7513-2021; Stopka, Tomáš/D-5864-2017; Zavadil, Jiri/ABG-1780-2020	Savvulidi Vargova, Karina/0000-0002-4969-4133; Stopka, Tomáš/0000-0001-7236-6894; Zavadil, Jiri/0000-0003-0640-5562; Huskova, Hana/0000-0003-3088-4081	INCa-INSERM Plan Cancer [2015 ENV201507]; Ministry of Education, Youth and sports of the Czech Republic [LQ1604]; European Regional Development Fund [CZ.1.05/1.1.00/02.0109]; Czech Science Foundation GACR [GACR 16-27790A]; Ministry of Health/Grant Agency for Health Research of the Czech Republic [AZV 16-27790A]; Charles University in Prague [LH15170, UNCE 204021]; First Faculty of Medicine, Charles University in Prague, Czech Republic; NIH/NCI [P30 CA016087-33]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER	INCa-INSERM Plan Cancer; Ministry of Education, Youth and sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); European Regional Development Fund(European Commission); Czech Science Foundation GACR(Grant Agency of the Czech Republic); Ministry of Health/Grant Agency for Health Research of the Czech Republic; Charles University in Prague; First Faculty of Medicine, Charles University in Prague, Czech Republic; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the group of Hiroyuki Marusawa, Kyoto University, Japan, for providing cells from Hupki-activation-induced cytidine deaminase transgenic mice, Adriana Heguy (NYU Genome Technology Center) for next-generation sequencing support, Christine Carreira (IARC) for antibodies, the Centre Leon Berard in Lyon, France, for providing computational capacity, and Leigh Ellis, Roswell Park Cancer Institute for technical advice. This work was supported by INCa-INSERM Plan Cancer 2015 ENV201507 Grant to JZ; Ministry of Education, Youth and sports of the Czech Republic (LQ1604), European Regional Development Fund (CZ.1.05/1.1.00/02.0109), Czech Science Foundation GACR (GACR 16-27790A) and Ministry of Health/Grant Agency for Health Research of the Czech Republic (AZV 16-27790A) to TS; and Charles University in Prague institutional financing ([LH15170, UNCE 204021) and the Mobility fund, First Faculty of Medicine, Charles University in Prague, Czech Republic to KV. NYU Technology Center is funded in part by grant NIH/NCI P30 CA016087-33.	Alexandrov LB, 2014, CURR OPIN GENET DEV, V24, P52, DOI 10.1016/j.gde.2013.11.014; Blokzijl F, 2016, NATURE, V538, P260, DOI 10.1038/nature19768; Celis JE, 2006, CELL BIOL LAB HDB, P4; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; Feldmeyer N, 2006, MUTAT RES-GEN TOX EN, V608, P163, DOI 10.1016/j.mrgentox.2006.02.017; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gonzalez-Perez A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r106; Gonzalez-Perez A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks743; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Helming KC, 2014, CANCER CELL, V26, P309, DOI 10.1016/j.ccr.2014.07.018; Hollstein M, 2017, ONCOGENE, V36, P158, DOI 10.1038/onc.2016.192; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kim JE, 2017, ONCOGENE, V36, P219, DOI 10.1038/onc.2016.193; Kim KH, 2015, NAT MED, V21, P1491, DOI 10.1038/nm.3968; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leiserson MDM, 2015, NAT GENET, V47, P106, DOI 10.1038/ng.3168; Leiserson MDM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003054; Liu Zhipei, 2007, Genet Eng (N Y), V28, P45, DOI 10.1007/978-0-387-34504-8_3; Liu ZP, 2005, CANCER RES, V65, P2583, DOI 10.1158/0008-5472.CAN-04-3675; Liu ZP, 2004, P NATL ACAD SCI USA, V101, P2963, DOI 10.1073/pnas.0308607101; Miller CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-34; Nedelko T, 2009, INT J CANCER, V124, P987, DOI 10.1002/ijc.24006; Odell A, 2010, AGING-US, V2, P160, DOI 10.18632/aging.100129; Olivier M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04482; Plass C, 2013, NAT REV GENET, V14, P765, DOI 10.1038/nrg3554; Poon SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006086; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Reimand J, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.68; Reinbold M, 2008, ONCOGENE, V27, P2788, DOI 10.1038/sj.onc.1210932; Severson PL, 2014, MUTAT RES-GEN TOX EN, V775, P48, DOI 10.1016/j.mrgentox.2014.10.011; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; STAMPFER MR, 1985, P NATL ACAD SCI USA, V82, P2394, DOI 10.1073/pnas.82.8.2394; Tamborero D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02650; Tamborero D, 2013, BIOINFORMATICS, V29, P2238, DOI 10.1093/bioinformatics/btt395; Vandin F, 2012, GENOME RES, V22, P375, DOI 10.1101/gr.120477.111; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; vom Brocke J, 2006, CARCINOGENESIS, V27, P2141, DOI 10.1093/carcin/bg1101; Westcott PMK, 2015, NATURE, V517, P489, DOI 10.1038/nature13898; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Yeang CH, 2008, FASEB J, V22, P2605, DOI 10.1096/fj.08-108985; Youn A, 2011, BIOINFORMATICS, V27, P175, DOI 10.1093/bioinformatics/btq630; Zhao JF, 2012, BIOINFORMATICS, V28, P2940, DOI 10.1093/bioinformatics/bts564	51	6	6	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 26	2017	36	43					6041	6048		10.1038/onc.2017.215	http://dx.doi.org/10.1038/onc.2017.215			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FK9OT	28692054	Green Published, hybrid			2022-12-26	WOS:000413841400012
J	Wang, B; Wang, ZX; de Avila, JM; Zhu, MJ; Zhang, FY; Gomez, NA; Zhao, L; Tian, QY; Zhao, JX; Maricelli, J; Zhang, H; Rodgers, BD; Du, M				Wang, Bo; Wang, Zhixiu; de Avila, Jeanene M.; Zhu, Mei-Jun; Zhang, Faya; Gomez, Noe Alberto; Zhao, Liang; Tian, Qiyu; Zhao, Junxing; Maricelli, Joseph; Zhang, Hui; Rodgers, Buel D.; Du, Min			Moderate alcohol intake induces thermogenic brown/beige adipocyte formation via elevating retinoic acid signaling	FASEB JOURNAL			English	Article						beige adipocyte; glucose; fatty acids; thermogenesis; obesity	BROWN ADIPOSE-TISSUE; DIET-INDUCED OBESITY; BODY-WEIGHT; VITAMIN-A; IN-VIVO; BEIGE ADIPOGENESIS; LIVER-DISEASE; FATTY LIVER; CONSUMPTION; METABOLISM	Clinically, low and moderate alcohol intake improves human health with protection against metabolic syndromes, including type 2 diabetes; however, mechanisms that are associated with these effects remain to be elucidated. The aims of this study were to investigate the effects of moderate alcohol intake on thermogenic brown/beige adipocyte formation and glucose and lipid homeostasis, as well as the involvement of retinoic acid (RA) signaling in the entire process. C57BL6 male mice were supplemented with 8% (w/v) alcohol in water for 1 or 4 mo. Alcohol intake prevented body weight gain, induced the formation of uncoupling protein 1-positive beige adipocytes in white adipose tissue, and increased thermogenesis in mice, which is associated with decreased serum glucose and triacylglycerol levels. Mechanistically, alcohol intake increased RA levels in serum and adipose tissue, which was associated with increased expression of aldehyde dehydrogenase family 1 subfamily A1 (Aldh1a1). When RA receptor-alpha signaling was conditionally blocked in platelet-derived growth factor receptor-alpha-positive adipose progenitors, the effects of alcohol on beige adipogenesis were largely abolished. Finally, moderate alcohol prevented high-fat diet-induced obesity and metabolic dysfunction. In conclusion, moderate alcohol intake induces thermogenic brown/beige adipocyte formation and promotes glucose and lipid oxidation via elevation of RA signaling.-Wang, B., Wang, Z., de Avila, J. M., Zhu, M.-J., Zhang, F., Gomez, N. A., Zhao, L., Tian, Q., Zhao, J., Maricelli, J., Zhang, H., Rodgers, B. D., Du, M. Moderate alcohol intake induces thermogenic brown/beige adipocyte formation via elevating retinoic acid signaling.	[Wang, Bo; Du, Min] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China; [Wang, Bo; Wang, Zhixiu; de Avila, Jeanene M.; Gomez, Noe Alberto; Zhao, Liang; Tian, Qiyu; Rodgers, Buel D.; Du, Min] Washington State Univ, Dept Anim Sci, Clark Hall 116,100 Dairy Rd, Pullman, WA 99164 USA; [Zhu, Mei-Jun] Washington State Univ, Sch Food Sci, Pullman, WA 99164 USA; [Zhang, Faya; Zhang, Hui] Washington State Univ, Dept Pharmaceut Sci, Coll Pharm, Pullman, WA 99164 USA; [Maricelli, Joseph] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Zhao, Junxing; Du, Min] Shanxi Agr Univ, Coll Anim Sci & Vet Med, Jinzhong, Shanxi, Peoples R China	China Agricultural University; Washington State University; Washington State University; Washington State University; Washington State University; Shanxi Agricultural University	Du, M (corresponding author), Washington State Univ, Dept Anim Sci, Clark Hall 116,100 Dairy Rd, Pullman, WA 99164 USA.	min.du@wsu.edu	Zhang, Faya/Y-4122-2019; Gomez, Noe/ABC-8916-2021; Rodgers, Dan/AAA-5343-2020; Du, Min/H-4311-2011	Zhang, Faya/0000-0001-5311-4667; Gomez, Noe/0000-0002-5959-9367; Du, Min/0000-0002-7232-072X; Rodgers, Buel/0000-0003-0751-1105; Wang, Bo/0000-0003-0604-1607	U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01-HD067449]; NIH National Institute on Aging [R21-AG049976]; U.S. Department of Agriculture, National Institute of Food and Agriculture [2015-67015-23219]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG049976] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development; NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); U.S. Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant R01-HD067449, NIH National Institute on Aging Grant R21-AG049976, and U.S. Department of Agriculture, National Institute of Food and Agriculture Award 2015-67015-23219). The authors thank Dr. Cathy Mendelsohn (Columbia University, New York, NY, USA) for providing ROSA26-RAR alpha DN mice. The authors declare no conflicts of interest.	Arif AA, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-126; Avogaro A, 2004, DIABETES CARE, V27, P1369, DOI 10.2337/diacare.27.6.1369; Berry DC, 2012, DIABETES, V61, P1112, DOI 10.2337/db11-1620; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Blaner WS, 2017, SCI REP-UK, V7, DOI 10.1038/srep43474; Bonet ML, 2003, CELL MOL LIFE SCI, V60, P1311, DOI 10.1007/s00018-003-2290-x; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Clugston RD, 2012, NUTRIENTS, V4, P356, DOI 10.3390/nu4050356; Cordain L, 1997, J AM COLL NUTR, V16, P134; Dani C, 1997, J CELL SCI, V110, P1279; DECASTRO JM, 1990, AM J CLIN NUTR, V52, P246, DOI 10.1093/ajcn/52.2.246; Ekblom B., 2001, INT TXB OBESITY; Fan F, 2014, ACTA PHARMACOL SIN, V35, P1015, DOI 10.1038/aps.2014.46; Ferrieres J, 2004, HEART, V90, P107, DOI 10.1136/heart.90.1.107; Halsted CH, 2004, SEMIN LIVER DIS, V24, P289, DOI 10.1055/s-2004-832941; Jequier E, 1999, AM J CLIN NUTR, V69, P173; Joosten MM, 2010, APPETITE, V55, P124, DOI 10.1016/j.appet.2010.04.217; Kane MA, 2010, FASEB J, V24, P823, DOI 10.1096/fj.09-141572; Kiefer FW, 2012, NAT MED, V18, P918, DOI 10.1038/nm.2757; Kim YK, 2010, METHODS MOL BIOL, V652, P263, DOI 10.1007/978-1-60327-325-1_15; King BM, 2013, AM PSYCHOL, V68, P88, DOI 10.1037/a0030684; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Lee P, 2014, INT J OBESITY, V38, P170, DOI 10.1038/ijo.2013.82; Lee YH, 2013, CELL METAB, V18, P355, DOI 10.1016/j.cmet.2013.08.003; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; LEO MA, 1982, NEW ENGL J MED, V307, P597, DOI 10.1056/NEJM198209023071006; Lind Penelope A., 2008, Human Genomics, V3, P24; LIU SM, 1994, AM J EPIDEMIOL, V140, P912, DOI 10.1093/oxfordjournals.aje.a117179; Lowe CE, 2011, J CELL SCI, V124, P2681, DOI 10.1242/jcs.079699; McCaffery P, 2004, DEV BRAIN RES, V153, P233, DOI 10.1016/j.devbrainres.2004.09.003; Mercader J, 2006, ENDOCRINOLOGY, V147, P5325, DOI 10.1210/en.2006-0760; Moriya A, 2011, ALIMENT PHARM THER, V33, P378, DOI 10.1111/j.1365-2036.2010.04520.x; Moriya A, 2013, HEPATOL INT, V7, P859, DOI 10.1007/s12072-013-9449-9; Noy N, 2013, ADIPOCYTE, V2, P184, DOI 10.4161/adip.23489; Pereira SE, 2012, OBES SURG, V22, P602, DOI 10.1007/s11695-011-0522-y; Peschechera A, 2013, ARCH PHYSIOL BIOCHEM, V119, P151, DOI 10.3109/13813455.2013.796995; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 1996, BIOCHEM J, V317, P827, DOI 10.1042/bj3170827; Purohit V, 2009, ALCOHOL CLIN EXP RES, V33, P191, DOI 10.1111/j.1530-0277.2008.00827.x; Reichert B, 2011, MOL ENDOCRINOL, V25, P799, DOI 10.1210/me.2010-0465; Rosselot C, 2010, DEVELOPMENT, V137, P283, DOI 10.1242/dev.040287; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Shao M, 2017, MOL METAB, V6, P111, DOI 10.1016/j.molmet.2016.11.009; Shelton NJ, 2014, AM J PUBLIC HEALTH, V104, P629, DOI 10.2105/AJPH.2013.301643; Tian LP, 2016, INT J BIOL SCI, V12, P1052, DOI 10.7150/ijbs.15811; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Da Silva LDV, 2007, NUTRITION, V23, P392, DOI 10.1016/j.nut.2007.02.009; Villarroya F, 1999, INT J OBESITY, V23, P1, DOI 10.1038/sj.ijo.0800799; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang B., 2017, J MOL CELL IN PRESS; Wang B, 2017, EBIOMEDICINE, V18, P288, DOI 10.1016/j.ebiom.2017.03.041; Wang B, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-162; Wang FF, 2013, P NATL ACAD SCI USA, V110, P18656, DOI 10.1073/pnas.1314863110; Wang S, 2015, INT J OBESITY, V39, P967, DOI 10.1038/ijo.2015.23; Wannamethee SG, 2003, AM J CLIN NUTR, V77, P1312, DOI 10.1093/ajcn/77.5.1312; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yeomans MR, 2010, PHYSIOL BEHAV, V100, P82, DOI 10.1016/j.physbeh.2010.01.012; Zhang M, 2015, J PHARMACOL SCI, V127, P430, DOI 10.1016/j.jphs.2015.03.001; Zhou HZ, 2002, AM J PHYSIOL-HEART C, V283, pH165, DOI 10.1152/ajpheart.00408.2001; Zhou ZX, 2005, AM J PATHOL, V166, P1681, DOI 10.1016/S0002-9440(10)62478-9; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	62	9	9	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4612	4622		10.1096/fj.201700396R	http://dx.doi.org/10.1096/fj.201700396R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28679528	Green Published			2022-12-26	WOS:000413397400036
J	Kato, S; Chinen, K; Shinoura, S; Kikuchi, K				Kato, Shin; Chinen, Kenji; Shinoura, Susumu; Kikuchi, Kaoru			Predictors for bile duct stone recurrence after endoscopic extraction for naive major duodenal papilla: A cohort study	PLOS ONE			English	Article							LARGE BALLOON DILATION; TERM-FOLLOW-UP; RISK-FACTORS; PERIAMPULLARY DIVERTICULA; SPHINCTEROTOMY; CHOLEDOCHOLITHIASIS; SIZE; ASSOCIATION; DIAMETER; SUCCESS	Background Predictors for bile duct stone recurrence after endoscopic stone extraction have not yet been clearly defined and a study investigating naive major duodenal papilla is warranted because studies focusing only on naive major duodenal papilla are rare. The aim of this study was to observe the long-term outcomes of endoscopic bile duct stone extraction for naive major duodenal papilla and to assess the predictors for recurrence. Methods This was a retrospective cohort study that consisted of 384 patients with naive papilla who underwent initial endoscopic bile duct stone extraction. Patients were followed up in outpatient department subsequent to complete stone clearance. Recurrence was defined as symptomatic repeated stone formation observed at least three months after the procedure. Stone recurrence, predictors of recurrence, and the recurrence rate, depending on each endoscopic treatment for major duodenal papilla, were examined. Results In this study, 34 patients (8.9%) developed stone recurrence. The median time to recurrence was 439 days. Periampullary diverticulum and multiple stones were strong predictors of bile duct stone recurrence (RR, 5.065; 95% CI, 2.435-10.539 and RR: 2.4401; 95% CI: 1.0946-5.4396, respectively). The above two factors were independent predictors of stone recurrence as per logistic regression analysis adjusted for confounders (Periampullary diverticulum: OR, 7.768; 95% CI, 3.27-18.471; multiple stones: OR, 4.144; 95% CI, 1.33-12.915). No recurrence was observed after endoscopic papillary large balloon dilatation (0/20), whereas recurrence was observed in 7 patients after endoscopic papillary balloon dilatation (7/45) and in 27 patients after endoscopic sphincterotomy (27/319). However, these differences were not statistically significant (p = 0.105). Conclusions We determined that the presence of periampullary diverticulum and multiple stones are strong predictors for recurrence after endoscopic stone extraction. Moreover, endoscopic papillary large balloon dilatation tended to be correlated with non-recurrence of bile duct stone.	[Kato, Shin; Chinen, Kenji; Shinoura, Susumu; Kikuchi, Kaoru] Okinawa Prefectural Chubu Hosp, Dept Gastroenterol, Uruma, Okinawa, Japan		Kato, S (corresponding author), Okinawa Prefectural Chubu Hosp, Dept Gastroenterol, Uruma, Okinawa, Japan.	shinchan1231@gmail.com		Kato, Shin/0000-0003-4792-9397				Ando T, 2003, GUT, V52, P116, DOI 10.1136/gut.52.1.116; BENATTAR JM, 1993, DIGEST DIS SCI, V38, P2225, DOI 10.1007/BF01299900; Chang JH, 2014, TURK J GASTROENTEROL, V25, P518, DOI 10.5152/tjg.2014.6457; Costamagna G, 2002, ENDOSCOPY, V34, P273, DOI 10.1055/s-2002-23632; Itokawa F, 2015, J GASTROEN HEPATOL, V30, P223, DOI 10.1111/jgh.12675; Keizman D, 2006, GASTROINTEST ENDOSC, V64, P60, DOI 10.1016/j.gie.2006.01.022; Kim CW, 2013, J GASTROEN HEPATOL, V28, P893, DOI 10.1111/jgh.12184; Kim DI, 2001, GASTROINTEST ENDOSC, V54, P42, DOI 10.1067/mge.2001.115335; Kim KH, 2012, GUT LIVER, V6, P107, DOI 10.5009/gnl.2012.6.1.107; Kim MH, 1998, ENDOSCOPY, V30, P601, DOI 10.1055/s-2007-1001363; KUBOTA Y, 1993, ABDOM IMAGING, V18, P145; Lai KH, 1997, GUT, V41, P399, DOI 10.1136/gut.41.3.399; LAURI A, 1993, GUT, V34, P1718, DOI 10.1136/gut.34.12.1718; Li X, 2012, WORLD J SURG, V36, P2666, DOI 10.1007/s00268-012-1716-8; MIYAZAWA Y, 1995, INT SURG, V80, P120; Oak JH, 2012, GASTROENT RES PRACT, V2012; Pereira-Lima JC, 1998, GASTROINTEST ENDOSC, V48, P457, DOI 10.1016/S0016-5107(98)70085-9; Saito M, 2000, GASTROINTEST ENDOSC, V51, P540, DOI 10.1016/S0016-5107(00)70286-0; Sugiyama M, 2004, GUT, V53, P1856, DOI 10.1136/gut.2004.041020; Sugiyama M, 2001, SCAND J GASTROENTERO, V36, P994, DOI 10.1080/003655201750305549; Sun Z, 2016, GASTROENTEROLOGY RES, V2016; Tanaka M, 1998, GASTROINTEST ENDOSC, V48, P465, DOI 10.1016/S0016-5107(98)70086-0; Tham TCK, 2004, ENDOSCOPY, V36, P1050, DOI 10.1055/s-2004-826043; Wan XJ, 2011, HEPATOB PANCREAT DIS, V10, P403, DOI 10.1016/S1499-3872(11)60068-4; Wojtun S, 1997, ENDOSCOPY, V29, P258, DOI 10.1055/s-2007-1004186; Yasuda I, 2010, GASTROINTEST ENDOSC, V72, P1185, DOI 10.1016/j.gie.2010.07.006	26	7	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180536	10.1371/journal.pone.0180536	http://dx.doi.org/10.1371/journal.pone.0180536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692706	Green Published, gold, Green Submitted			2022-12-26	WOS:000405544800051
J	Leow, LA; Marinovic, W; Riek, S; Carroll, TJ				Leow, Li-Ann; Marinovic, Welber; Riek, Stephan; Carroll, Timothy J.			Cerebellar anodal tDCS increases implicit learning when strategic re-aiming is suppressed in sensorimotor adaptation	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; SENSORY PREDICTION ERRORS; PRISM ADAPTATION; VISUOMOTOR ADAPTATION; OLDER-ADULTS; EXPLICIT STRATEGY; MOVEMENT PREPARATION; INTERNAL-MODELS; MOTOR MEMORIES; DEGENERATION	Neurophysiological and neuroimaging work suggests that the cerebellum is critically involved in sensorimotor adaptation. Changes in cerebellar function alter behaviour when compensating for sensorimotor perturbations, as shown by non-invasive stimulation of the cerebellum and studies involving patients with cerebellar degeneration. It is known, however, that behavioural responses to sensorimotor perturbations reflect both explicit processes (such as volitional aiming to one side of a target to counteract a rotation of visual feedback) and implicit, error-driven updating of sensorimotor maps. The contribution of the cerebellum to these explicit and implicit processes remains unclear. Here, we examined the role of the cerebellum in sensorimotor adaptation to a 30 E rotation of visual feedback of hand position during target-reaching, when the capacity to use explicit processes was manipulated by controlling movement preparation times. Explicit re-aiming was suppressed in one condition by requiring subjects to initiate their movements within 300ms of target presentation, and permitted in another condition by requiring subjects to wait approximately 1050ms after target presentation before movement initiation. Similar to previous work, applying anodal transcranial direct current stimulation (]tDCS; 1.5mA) to the right cerebellum during adaptation resulted in faster compensation for errors imposed by the rotation. After exposure to the rotation, we evaluated implicit remapping in no-feedback trials after providing participants with explicit knowledge that the rotation had been removed. Crucially, movements were more adapted in these no-feedback trials following cerebellar anodal tDCS than after sham stimulation in both long and short preparation groups. Thus, cerebellar anodal tDCS increased implicit remapping during sensorimotor adaptation, irrespective of preparation time constraints. The results are consistent with the possibility that the cerebellum contributes to the formation of new visuomotor maps that correct perturbations in sensory feedback, even when explicit processes are suppressed during sensorimotor adaptation.	[Leow, Li-Ann; Marinovic, Welber; Riek, Stephan; Carroll, Timothy J.] Univ Queensland, Ctr Sensorimotor Performance, Sch Human Movement & Nutr Sci, Bldg 26B, Brisbane, Qld, Australia; [Marinovic, Welber] Curtin Univ, Sch Psychol & Speech Pathol, Bldg 401, Perth, WA, Australia	University of Queensland; Curtin University	Leow, LA (corresponding author), Univ Queensland, Ctr Sensorimotor Performance, Sch Human Movement & Nutr Sci, Bldg 26B, Brisbane, Qld, Australia.	l.leow@uq.edu.au	Carroll, Timothy/C-3513-2008; Riek, Stephan/A-1506-2010; Leow, Li-Ann/D-1051-2016; Marinovic, Welber/F-1755-2010	Carroll, Timothy/0000-0003-0761-1819; Riek, Stephan/0000-0002-8355-8426; Leow, Li-Ann/0000-0002-9655-3181; Marinovic, Welber/0000-0002-2472-7955				Benson BL, 2011, J NEUROPHYSIOL, V105, P2843, DOI 10.1152/jn.00002.2011; Bernard JA, 2013, FRONTIERS HUMAN NEUR; Bernard JA, 2014, NEUROSCI BIOBEHAV R, V42, P193, DOI 10.1016/j.neubiorev.2014.02.011; Block H, 2013, CEREBELLUM, V12, P781, DOI 10.1007/s12311-013-0486-7; Bock O, 2002, NEUROSCI BIOBEHAV R, V26, P761, DOI 10.1016/S0149-7634(02)00063-5; Bond KM, 2015, J NEUROPHYSIOL, V113, P3836, DOI 10.1152/jn.00009.2015; Brooks JX, 2015, NATURE NEUROSCIENCE; Bruijn SM, 2012, J NEUROPHYSIOL, V108, P1149, DOI 10.1152/jn.00018.2012; Chapman HL, 2010, NEUROPSYCHOLOGIA, V48, P2595, DOI 10.1016/j.neuropsychologia.2010.05.006; Christou AI, 2016, SCI REP-UK, V6, DOI 10.1038/srep36633; Clower DM, 1996, NATURE, V383, P618, DOI 10.1038/383618a0; Clower DM, 2001, JNEUROSCI, V21, P6283; Cressman EK, 2010, EXP BRAIN RES, V205, P533, DOI 10.1007/s00221-010-2392-2; Criscimagna-Hemminger SE, 2010, J NEUROPHYSIOL, V103, P2275, DOI 10.1152/jn.00822.2009; CUNNINGHAM HA, 1989, J EXP PSYCHOL HUMAN, V15, P493, DOI 10.1037/0096-1523.15.3.493; Danckert J, 2008, EUR J NEUROSCI, V28, P1696, DOI 10.1111/j.1460-9568.2008.06460.x; Fernandez-Ruiz J, 2011, BEHAV BRAIN RES, V219, P8, DOI 10.1016/j.bbr.2010.11.060; Galea JM, 2011, CEREB CORTEX, V21, P1761, DOI 10.1093/cercor/bhq246; Galea JM, 2009, J NEUROSCI, V29, P9115, DOI 10.1523/JNEUROSCI.2184-09.2009; Gibo TL, 2013, J NEUROPHYSIOL, V110, P322, DOI 10.1152/jn.00745.2012; GORDON J, 1994, EXP BRAIN RES, V99, P97, DOI 10.1007/BF00241415; Haith AM, 2016, J NEUROSCI, V36, P3007, DOI 10.1523/JNEUROSCI.3245-15.2016; Haith AM, 2015, J NEUROSCI, V35, P5109, DOI 10.1523/JNEUROSCI.3869-14.2015; Hanajima R, 2015, J NEUROPHYSIOL, V114, P2460, DOI 10.1152/jn.00145.2015; Hardwick RM, 2014, NEUROBIOL AGING, V35, P2217, DOI 10.1016/j.neurobiolaging.2014.03.030; Henriques DYP, 2014, NEUROPSYCHOLOGIA, V64, P195, DOI 10.1016/j.neuropsychologia.2014.09.029; Herzfeld DJ, 2014, NEUROIMAGE, V98, P147, DOI 10.1016/j.neuroimage.2014.04.076; Heuer H, 2008, PSYCHOL AGING, V23, P190, DOI 10.1037/0882-7974.23.1.190; Heuer H, 2008, ACTA PSYCHOL, V127, P369, DOI 10.1016/j.actpsy.2007.07.006; Howard IS, 2012, J NEUROSCI, V32, P12756, DOI 10.1523/JNEUROSCI.5909-11.2012; Howard IS, 2009, J NEUROSCI METH, V181, P199, DOI 10.1016/j.jneumeth.2009.05.005; Hulst T, 2017, J NEUROPHYSIOLOGY; Izawa J, 2012, J NEUROSCI, V32, P4230, DOI 10.1523/JNEUROSCI.6353-11.2012; Izawa J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002012; JAKOBSON LS, 1989, EXP BRAIN RES, V78, P575; Jalali R, 2017, J NEUROPHYSIOLOGY; Jamil A., 2016, J PHYSL; Jayaram G, 2012, J NEUROPHYSIOL, V107, P2950, DOI 10.1152/jn.00645.2011; Kitago T, 2013, FRONTIERS HUMAN NEUR; Koziol LF, 2014, CEREBELLUM, V13, P151, DOI 10.1007/s12311-013-0511-x; Kuper M, 2014, HUM BRAIN MAPP, V35, P1574, DOI 10.1002/hbm.22274; Leow L-A, 2016, BIORXIV; Luaute J, 2006, NEUROLOGY, V66, P1859, DOI 10.1212/01.wnl.0000219614.33171.01; Luaute J, 2009, J NEUROSCI, V29, P169, DOI 10.1523/JNEUROSCI.3054-08.2009; Marinovic W, 2008, EXP BRAIN RES, V188, P275, DOI 10.1007/s00221-008-1360-6; Marinovic W, 2014, J PHYSIOL-LONDON, V592, P153, DOI 10.1113/jphysiol.2013.254581; Martin TA, 1996, BRAIN, V119, P1183, DOI 10.1093/brain/119.4.1183; Maschke M, 2004, J NEUROPHYSIOL, V91, P230, DOI 10.1152/jn.00557.2003; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; McDougle SD, 2016, P NATL ACAD SCI USA, V113, P6797, DOI 10.1073/pnas.1523669113; McDougle SD, 2015, J NEUROSCI, V35, P9568, DOI 10.1523/JNEUROSCI.5061-14.2015; Morehead J. R., 2015, NEURAL CONTROL MOVEM; Morton SM, 2004, J NEUROPHYSIOL, V92, P2497, DOI 10.1152/jn.00129.2004; Morton SM, 2006, J NEUROSCI, V26, P9107, DOI 10.1523/JNEUROSCI.2622-06.2006; Panouilleres MTN, 2015, J PHYSIOL-LONDON, V593, P3645, DOI 10.1113/JP270484; Peterburs J, 2016, CURR OPIN NEUROBIOL, V40, P38, DOI 10.1016/j.conb.2016.06.011; Pisella L, 2005, NEUROLOGY, V65, P150, DOI 10.1212/01.wnl.0000167945.34177.5e; Rabe K, 2009, J NEUROPHYSIOL, V101, P1961, DOI 10.1152/jn.91069.2008; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; REDDING GM, 1985, PERCEPT PSYCHOPHYS, V37, P225, DOI 10.3758/BF03207568; Saijo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009399; Schlerf J, 2012, J NEUROSCI, V32, P4913, DOI 10.1523/JNEUROSCI.4504-11.2012; Schlerf JE, 2013, J NEUROPHYSIOL, V109, P1164, DOI 10.1152/jn.00654.2011; SCHOUTEN JF, 1967, ACTA PSYCHOL, V27, P143, DOI 10.1016/0001-6918(67)90054-6; Smith MA, 2005, J NEUROPHYSIOL, V93, P2809, DOI 10.1152/jn.00943.2004; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; Taylor JA, 2014, PROG BRAIN RES, V210, P217, DOI 10.1016/B978-0-444-63356-9.00009-1; Taylor JA, 2014, J NEUROSCI, V34, P3023, DOI 10.1523/JNEUROSCI.3619-13.2014; Taylor JA, 2010, CEREBELLUM, V9, P580, DOI 10.1007/s12311-010-0201-x; Therrien AS, 2015, BRAIN; Tseng YW, 2007, J NEUROPHYSIOL, V98, P54, DOI 10.1152/jn.00266.2007; UHLARIK JJ, 1973, J EXP PSYCHOL, V98, P223, DOI 10.1037/h0034364; Vindras P, 2008, ERROR PARSING VISUOM, P1212; WEINER MJ, 1983, NEUROLOGY, V33, P766, DOI 10.1212/WNL.33.6.766; Werner S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123321; Werner S, 2010, EXP BRAIN RES, V201, P429, DOI 10.1007/s00221-009-2052-6; Werner S, 2009, EXP BRAIN RES, V193, P189, DOI 10.1007/s00221-008-1607-2; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Yavari F, 2015, EXP BRAIN RES; Zarahn E, 2008, J NEUROPHYSIOL, V100, P2537, DOI 10.1152/jn.90529.2008	80	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179977	10.1371/journal.pone.0179977	http://dx.doi.org/10.1371/journal.pone.0179977			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686607	Green Submitted, Green Published, gold			2022-12-26	WOS:000405464100028
J	Li, S; Zuo, Q; Wang, XY; Ma, WW; Jin, XX; Shi, JC; Ben-Gal, A				Li, Sen; Zuo, Qiang; Wang, Xiaoyu; Ma, Wenwen; Jin, Xinxin; Shi, Jianchu; Ben-Gal, Alon			Characterizing roots and water uptake in a ground cover rice production system	PLOS ONE			English	Article							DRY-MATTER PRODUCTION; ORYZA-SATIVA L.; USE EFFICIENCY; GRAIN-YIELD; HYDRAULIC CONDUCTIVITY; SIGNAL-TRANSDUCTION; NUTRIENT-UPTAKE; NITROGEN MASS; WINTER-WHEAT; GROWTH	Background and aims Water-saving ground cover rice production systems (GCRPS) are gaining popularity in many parts of the world. We aimed to describe the characteristics of root growth, morphology, distribution, and water uptake for a GCRPS. Methods A traditional paddy rice production system (TPRPS) was compared with GCRPS in greenhouse and field experiments. In the greenhouse, GCRPS where root zone average soil water content was kept near saturation (GCRPS(sat)), field capacity (GCRPS(fwc)) and 80% field capacity (GCRPS(80%)), were evaluated. In a two-year field experiment, GCRPSsat and GCRPS(80%) were applied. Results Similar results were found in greenhouse and field experiments. Before mid-tillering the upper soil temperature was higher for GCRPS, leading to enhanced root dry weight, length, surface area, specific root length, and smaller diameter of roots but lower water uptake rate per root length compared to TPRPS. In subsequent growth stages, the reduced soil water content under GCRPS caused that the preponderance of root growth under GCRPS(sat) disappeared in comparison to TPRPS. Under other GCRPS treatments (GCRPS(fwc) and GCRPS(80%)), significant limitation on root growth, bigger root diameter and higher water uptake rate per root length were found. Conclusions Discrepancies in soil water and temperature between TPRPS and GCRPS caused adjustments to root growth, morphology, distribution and function. Even though drought stress was inevitable after mid-tillering under GCRPS, especially GCRPS(80%), similar or even enhanced root water uptake capacity in comparison to TPRPS might promote allocation of photosynthetic products to shoots and increase water productivity.	[Li, Sen; Zuo, Qiang; Wang, Xiaoyu; Ma, Wenwen; Jin, Xinxin; Shi, Jianchu] China Agr Univ, Dept Soil & Water Sci, Beijing, Peoples R China; [Li, Sen; Zuo, Qiang; Wang, Xiaoyu; Ma, Wenwen; Jin, Xinxin; Shi, Jianchu] Minist Educ, Key Lab Plant Soil Interact, Beijing, Peoples R China; [Li, Sen; Zuo, Qiang; Wang, Xiaoyu; Ma, Wenwen; Jin, Xinxin; Shi, Jianchu] Minist Agr, Key Lab Arable Land Conservat North China, Beijing, Peoples R China; [Ben-Gal, Alon] Agr Res Org, Soil Water & Environm Sci, Gilat Res Ctr, Negev, Israel	China Agricultural University; Ministry of Agriculture & Rural Affairs	Shi, JC (corresponding author), China Agr Univ, Dept Soil & Water Sci, Beijing, Peoples R China.; Shi, JC (corresponding author), Minist Educ, Key Lab Plant Soil Interact, Beijing, Peoples R China.; Shi, JC (corresponding author), Minist Agr, Key Lab Arable Land Conservat North China, Beijing, Peoples R China.	shijianchu@cau.edu.cn	Ben-Gal, Alon/F-5190-2013; , 李森/K-2019-2019	Ben-Gal, Alon/0000-0003-4105-7807; 	National Natural Science Foundation of China ( [51139006, 51621061]; Construction Special for First-class University [4572-18101510]	National Natural Science Foundation of China ((National Natural Science Foundation of China (NSFC)); Construction Special for First-class University	This research was supported partly by the National Natural Science Foundation of China (51139006 and 51621061) and the Construction Special for First-class University (4572-18101510). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asseng S, 1997, PLANT SOIL, V190, P267, DOI 10.1023/A:1004228201299; Asseng S, 1998, PLANT SOIL, V201, P265, DOI 10.1023/A:1004317523264; Azhiri-Sigari Tahere, 2000, Plant Production Science, V3, P180; Bouman BAM, 2007, AGR SYST, V93, P43, DOI 10.1016/j.agsy.2006.04.004; Bouman BAM, 2001, AGR WATER MANAGE, V49, P11, DOI 10.1016/S0378-3774(00)00128-1; [蔡昆争 CAI KunZheng], 2006, [生态学报, Acta Ecologica Sinica], V26, P1903; Chu G, 2014, FIELD CROP RES, V162, P108, DOI 10.1016/j.fcr.2013.11.006; Ding L, 2015, PLANT SCI, V234, P14, DOI 10.1016/j.plantsci.2015.01.016; Dirksen C., 1993, Water flow and solute transport in soils: developments and applications., P99; Feddes R. A., 1978, SIMULATION FIELD WAT; FEDDES RA, 1976, J HYDROL, V31, P13, DOI 10.1016/0022-1694(76)90017-2; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Gao SY, 1998, AGRON J, V90, P505, DOI 10.2134/agronj1998.00021962009000040011x; Gowda VRP, 2011, FIELD CROP RES, V122, P1, DOI 10.1016/j.fcr.2011.03.001; HASEGAWA T, 2001, P 6 S INT SOC ROOT R, P520; He HB, 2014, J ANIM PLANT SCI, V24, P290; HENRY A, 2012, J EXP BOT, V63, P4751, DOI DOI 10.1093/jxb/ers150; Henry A, 2015, J EXP BOT, V66, P1787, DOI 10.1093/jxb/eru506; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Jabran K, 2015, J AGRON CROP SCI, V201, P389, DOI 10.1111/jac.12099; Jabran K, 2015, INT J AGRIC BIOL, V17, P920, DOI 10.17957/IJAB/15.0019; Jiang Y, 2009, J ENVIRON MANAGE, V90, P3185, DOI 10.1016/j.jenvman.2009.04.016; Jin XX, 2016, J HYDROL, V540, P220, DOI 10.1016/j.jhydrol.2016.06.018; Ju CX, 2015, FIELD CROP RES, V175, P47, DOI 10.1016/j.fcr.2015.02.007; Kano-Nakatal M, 2011, PLANT PROD SCI, V14, P307, DOI 10.1626/pps.14.307; Kato Y, 2011, ANN BOT-LONDON, V108, P575, DOI 10.1093/aob/mcr184; Kato Y, 2010, FIELD CROP RES, V117, P9, DOI 10.1016/j.fcr.2009.12.003; Kreye C, 2007, NUTR CYCL AGROECOSYS, V77, P293, DOI 10.1007/s10705-006-9068-0; Kuwagata T, 2007, PLANT CELL PHYSIOL, V48, pS239; Kuwagata T, 2012, PLANT CELL PHYSIOL, V53, P1418, DOI 10.1093/pcp/pcs087; Lin S, WATER WISE RICE PROD; Liu MJ, 2014, FIELD CROP RES, V164, P74, DOI 10.1016/j.fcr.2014.05.018; Liu MJ, 2013, FIELD CROP RES, V150, P19, DOI 10.1016/j.fcr.2013.06.005; Matsuo N, 2009, PLANT SOIL, V316, P25, DOI 10.1007/s11104-008-9755-5; MEYER WS, 1990, AUST J AGR RES, V41, P253, DOI 10.1071/AR9900253; Nagasuga K, 2011, PLANT PROD SCI, V14, P22, DOI 10.1626/pps.14.22; North GB, 2000, ANN BOT-LONDON, V85, P247, DOI 10.1006/anbo.1999.1026; Ojha CSP, 1996, J IRRIG DRAIN ENG, V122, P198, DOI 10.1061/(ASCE)0733-9437(1996)122:4(198); Peret B, 2009, J EXP BOT, V60, P3637, DOI 10.1093/jxb/erp232; Phogat V, 2010, PADDY WATER ENVIRON, V8, P333, DOI 10.1007/s10333-010-0213-7; Pierret A, 2005, NEW PHYTOL, V166, P967, DOI 10.1111/j.1469-8137.2005.01389.x; Poorter H, 2015, NEW PHYTOL, V206, P1188, DOI 10.1111/nph.13438; PRASAD R, 1988, J HYDROL, V99, P297, DOI 10.1016/0022-1694(88)90055-8; Qu H, 2012, AGRON J, V104, P1399, DOI 10.2134/agronj2011.0419; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Seck PA, 2012, FOOD SECUR, V4, P7, DOI 10.1007/s12571-012-0168-1; Shi JC, 2015, J HYDROL, V522, P285, DOI 10.1016/j.jhydrol.2014.12.045; Shi JC, 2014, AGR WATER MANAGE, V146, P163, DOI 10.1016/j.agwat.2014.08.006; Shi JC, 2013, PLANT SOIL, V363, P139, DOI 10.1007/s11104-012-1299-z; Shi JC, 2009, SOIL SCI SOC AM J, V73, P1764, DOI 10.2136/sssaj2009.0002; Singh R, 2006, AGR WATER MANAGE, V82, P253, DOI 10.1016/j.agwat.2005.07.027; Singh R., 2003, WATER PRODUCTIVITY I, P41; Taleisnik E, 1999, ANN BOT-LONDON, V83, P19, DOI 10.1006/anbo.1998.0781; Tan XZ, 2015, AGR WATER MANAGE, V150, P67, DOI 10.1016/j.agwat.2014.12.005; Tao YY, 2015, EUR J AGRON, V68, P13, DOI 10.1016/j.eja.2015.04.002; Tao YY, 2014, FIELD CROP RES, V168, P101, DOI 10.1016/j.fcr.2014.08.014; VANGENUCHTEN MT, 1987, 121 USDAARS US SAL L; Wang LC, 2012, AGR WATER MANAGE, V104, P142, DOI 10.1016/j.agwat.2011.12.008; Wu JQ, 1999, PLANT SOIL, V215, P7, DOI 10.1023/A:1004702807951; Wu WG, 1998, J ANHUI AGR SCI, V3, P4043; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Xu W, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1892-x; Xue Q, 2003, PLANT SOIL, V257, P151, DOI 10.1023/A:1026230527597; Yadav Gulab Singh, 2011, Indian Journal of Agronomy, V56, P365; YAMAUCHI A, 1987, JPN J CROP SCI, V56, P608; Zhang H, 2009, FIELD CROP RES, V113, P31, DOI 10.1016/j.fcr.2009.04.004; Zhang QF, 2007, P NATL ACAD SCI USA, V104, P16402, DOI 10.1073/pnas.0708013104; Zhang ZC, 2008, FIELD CROP RES, V108, P71, DOI 10.1016/j.fcr.2008.03.004; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zuo Q, 2013, ADV AGR SYST MODEL, V4, P93, DOI 10.2134/advagricsystmodel4.c5	70	5	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180713	10.1371/journal.pone.0180713	http://dx.doi.org/10.1371/journal.pone.0180713			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686687	Green Published, Green Submitted, gold			2022-12-26	WOS:000405464100094
J	Michel, AL; Lane, EP; De Klerk-Lorist, LM; Hofmeyr, M; van der Heijden, EMDL; Botha, L; van Helden, P; Miller, M; Buss, P				Michel, Anita L.; Lane, Emily P.; De Klerk-Lorist, Lin-Mari; Hofmeyr, Markus; van der Heijden, Elisabeth M. D. L.; Botha, Louise; van Helden, Paul; Miller, Michele; Buss, Peter			Experimental Mycobacterium bovis infection in three white rhinoceroses (Ceratotherium simum): Susceptibility, clinical and anatomical pathology	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; GAMMA IFN-GAMMA; BLACK RHINOCEROS; SOUTH-AFRICA; PULMONARY TUBERCULOSIS; AMPLIFICATION; DIAGNOSIS; WILDLIFE; ASSAY	Tuberculosis caused by Mycobacterium bovis is endemic in the African buffalo (Syncerus caffer) population in the Kruger National Park and other conservation areas in South Africa. The disease has been diagnosed in a total of 21 free ranging or semi-free ranging wildlife species in the country with highly variable presentations in terms of clinical signs as well as severity and distribution of tuberculous lesions. Most species are spillover or dead-end hosts without significant role in the epidemiology of the disease. White rhinoceroses (Ceratotherium simum) are translocated from the Kruger National Park in substantial numbers every year and a clear understanding of their risk to manifest overt tuberculosis disease and to serve as source of infection to other species is required. We report the findings of experimental infection of three white rhinoceroses with a moderately low dose of a virulent field isolate of Mycobacterium bovis. None of the animals developed clinical signs or disseminated disease. The susceptibility of the white rhinoceros to bovine tuberculosis was confirmed by successful experimental infection based on the ante mortem isolation of M. bovis from the respiratory tract of one rhinoceros, the presence of acid-fast organisms and necrotizing granulomatous lesions in the tracheobronchial lymph nodes and the detection of M. bovis genetic material by PCR in the lungs of two animals.	[Michel, Anita L.; van der Heijden, Elisabeth M. D. L.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, Bovine TB & Brucellosis Res Programme, Onderstepoort, South Africa; [Michel, Anita L.] Natl Zool Gardens South Africa, Pretoria, South Africa; [Lane, Emily P.] Natl Zool Gardens South Africa, Dept Res & Sci Serv, Pretoria, South Africa; [De Klerk-Lorist, Lin-Mari] State Vet Off, Dept Agr Forestry & Fisheries, Kruger Natl Pk, Skukuza, South Africa; [Hofmeyr, Markus; Buss, Peter] South African Natl Parks, Vet Wildlife Serv, Kruger Natl Pk, Skukuza, South Africa; [van der Heijden, Elisabeth M. D. L.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Botha, Louise; van Helden, Paul; Miller, Michele] Stellenbosch Univ, Fac Med & Hlth Sci, MRC Ctr TB Res, DST NRF Ctr Excellence Biomed TB,Div Mol Biol & H, Cape Town, South Africa	University of Pretoria; National Research Foundation - South Africa; National Zoological Gardens of South Africa; National Research Foundation - South Africa; National Zoological Gardens of South Africa; Utrecht University; National Research Foundation - South Africa; Stellenbosch University	Michel, AL (corresponding author), Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, Bovine TB & Brucellosis Res Programme, Onderstepoort, South Africa.; Michel, AL (corresponding author), Natl Zool Gardens South Africa, Pretoria, South Africa.	anita.michel@up.ac.za	Miller, Michele/ABA-1332-2020; Michel, Anita/N-8996-2014	Michel, Anita/0000-0001-9240-2653; van der Heijden, Elisabeth Margaretha Diana Louise/0000-0002-8444-6928; Miller, Michele/0000-0002-5883-6076	NRF and South African MRC; National Research Foundation	NRF and South African MRC; National Research Foundation	Authors acknowledge funding support from the NRF and South African MRC. Processing of the pathology sections was funded by a core grant of the National Research Foundation to Dr E Lane at the NZG. SANParks provided funding relating to the animal experiment (capture, care, housing, veterinary procedures). All participating co-authors provided financial support for their respective activities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai JW, 2016, EMERG MICROBES INF; Bancroft JD, 2002, J NEUROPATH EXP NEUR, V5th; Bengis Roy G., 1999, P101; De Klerk L, 2006, ONDERSTEPOORT J VET, V73, P293; de Klerk LM, 2010, VET IMMUNOL IMMUNOP, V137, P84, DOI 10.1016/j.vetimm.2010.04.013; Duncan AE, 2009, J ZOO WILDLIFE MED, V40, P781, DOI 10.1638/2009-0044.1; EISENACH KD, 1990, J INFECT DIS, V161, P977, DOI 10.1093/infdis/161.5.977; Espie IW, 2009, J WILDLIFE DIS, V45, P1187, DOI 10.7589/0090-3558-45.4.1187; GRIFFIN JFT, 1995, TRENDS MICROBIOL, V3, P418, DOI 10.1016/S0966-842X(00)88994-5; Harmsen D, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-26; Hlokwe TM, 2014, PREV VET MED, V115, P10, DOI 10.1016/j.prevetmed.2014.03.011; Hlokwe TM, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0813-6; Huard RC, 2006, J BACTERIOL, V188, P4271, DOI 10.1128/JB.01783-05; Katale BZ, 2015, TRANSBOUND EMERG DIS, V10; Landolfi JA, 2015, VET PATHOL, V52, P535, DOI 10.1177/0300985814548517; Mathebula N, 2012, J ZOO WILDLIFE MED, V43, P530, DOI 10.1638/2011-0259R.1; Michel AL, 2006, VET MICROBIOL, V112, P91, DOI 10.1016/j.vetmic.2005.11.035; Michel AL, 2003, J ZOO WILDLIFE MED, V34, P364, DOI 10.1638/02-063; Michel AL, 2014, 12 SAVEPM C PORT EL; Michel AL, 2015, TUBERCULOSIS, LEPROSY AND MYCOBACTERIAL DISEASES OF MAN AND ANIMALS: THE MANY HOSTS OF MYCOBACTERIA, P365, DOI 10.1079/9781780643960.0365; Miller J, 1997, J VET DIAGN INVEST, V9, P244, DOI 10.1177/104063879700900304; Miller M, 2016, TRANSBOUND EMERG DIS; Miller M, 2016, J WILDLIFE DIS, V52, pS78, DOI 10.7589/52.2S.S85; Miller M, 2015, J WILDLIFE DIS, V51, P916, DOI 10.7589/2015-03-081; Miller M, 2015, J WILDLIFE DIS, V51, P493, DOI 10.7589/2014-07-170; Miller MA, 2017, EMERG INFECT DIS, V23, P557, DOI 10.3201/eid2303.161622; Miller MA, 2015, TUBERCULOSIS, LEPROSY AND MYCOBACTERIAL DISEASES OF MAN AND ANIMALS: THE MANY HOSTS OF MYCOBACTERIA, P277, DOI 10.1079/9781780643960.0277; Miller MA, 2015, J ZOO WILDLIFE MED, V46, P100, DOI 10.1638/2014-0172R1.1; Morar D, 2007, VET IMMUNOL IMMUNOP, V115, P146, DOI 10.1016/j.vetimm.2006.10.016; Morar D, 2013, TRANSBOUND EMERG DIS, V60, P60, DOI 10.1111/tbed.12132; MORRIS CDW, 1989, Q J MED, V73, P1151; Murakami PS, 2012, J ZOO WILDLIFE MED, V43, P872, DOI 10.1638/2010-0108R.1; Okamura K, 2013, INTERNAL MED, V52, P439, DOI 10.2169/internalmedicine.52.8158; OREILLY LM, 1995, TUBERCLE LUNG DIS, V76, P1, DOI 10.1016/0962-8479(95)90591-X; Pavlik I, 2004, VET MED-CZECH, V49, P427, DOI 10.17221/5733-VETMED; Perrin MR, 1999, S AFR J WILDL RES, V29, P72; Pesciaroli M, 2014, RES VET SCI, V97, pS78, DOI 10.1016/j.rvsc.2014.05.015; Renwick AR, 2007, EPIDEMIOL INFECT, V135, P529, DOI 10.1017/S0950268806007205; Roussos A, 2001, RESP MED, V95, P187, DOI 10.1053/rmed.2000.1019; Stetter MD, 1995, J AM VET MED ASSOC, V207, P1618; Yaranal PJ, 2013, INTERJ HLTH REHAB SC, V2, P50; [No title captured]	42	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179943	10.1371/journal.pone.0179943	http://dx.doi.org/10.1371/journal.pone.0179943			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686714	Green Published, gold			2022-12-26	WOS:000405464100027
J	Watson, AM; Rose, AH; Gibson, GA; Gardner, CL; Sun, CQ; Reed, DS; Lam, LKM; Croix, CMS; Strick, PL; Klimstra, WB; Watkins, SC				Watson, Alan M.; Rose, Annika H.; Gibson, Gregory A.; Gardner, Christina L.; Sun, Chengqun; Reed, Douglas S.; Lam, L. K. Metthew; Croix, Claudette M. St.; Strick, Peter L.; Klimstra, William B.; Watkins, Simon C.			Ribbon scanning confocal for high-speed high-resolution volume imaging of brain	PLOS ONE			English	Article							WHOLE-BRAIN	Whole-brain imaging is becoming a fundamental means of experimental insight; however, achieving subcellular resolution imagery in a reasonable time window has not been possible. We describe the first application of multicolor ribbon scanning confocal methods to collect high- resolution volume images of chemically cleared brains. We demonstrate that ribbon scanning collects images over ten times faster than conventional high speed confocal systems but with equivalent spectral and spatial resolution. Further, using this technology, we reconstruct large volumes of mouse brain infected with encephalitic alphaviruses and demonstrate that regions of the brain with abundant viral replication were inaccessible to vascular perfusion. This reveals that the destruction or collapse of large regions of brain micro vasculature may contribute to the severe disease caused by Venezuelan equine encephalitis virus. Visualization of this fundamental impact of infection would not be possible without sampling at subcellular resolution within large brain volumes.	[Watson, Alan M.; Gardner, Christina L.; Sun, Chengqun; Reed, Douglas S.; Lam, L. K. Metthew; Klimstra, William B.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA; [Watson, Alan M.; Gardner, Christina L.; Sun, Chengqun; Lam, L. K. Metthew; Klimstra, William B.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Rose, Annika H.; Strick, Peter L.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA; [Gibson, Gregory A.; Croix, Claudette M. St.; Watkins, Simon C.] Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA 15260 USA; [Gibson, Gregory A.; Croix, Claudette M. St.; Watkins, Simon C.] Univ Pittsburgh, Dept Cellular Biol, Pittsburgh, PA 15260 USA; [Reed, Douglas S.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Klimstra, WB (corresponding author), Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.; Klimstra, WB (corresponding author), Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.; Watkins, SC (corresponding author), Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA 15260 USA.; Watkins, SC (corresponding author), Univ Pittsburgh, Dept Cellular Biol, Pittsburgh, PA 15260 USA.	klimstra@pitt.edu; simon.watkins@pitt.edu	Watkins, Simon/ABG-2590-2021; Reed, Douglas/AAA-2587-2020	Watkins, Simon/0000-0003-4092-1552; Reed, Douglas/0000-0003-0076-9023; Watson, Alan/0000-0003-0632-8296	Defense Threat Reduction Agency [HDTRA1-15-1-0047]; NIAID [R01 AI09543605]; NINDS [R01 NS24328, P30 NS076405]; NIH Office of the Director [P40 OD010996]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095436] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010996] Funding Source: NIH RePORTER	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the: Defense Threat Reduction Agency, HDTRA1-15-1-0047; NIAID, R01 AI09543605; NINDS, R01 NS24328, P30 NS076405; and NIH Office of the Director, P40 OD010996. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033916; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; De Carlos JA, 2007, BRAIN RES REV, V55, P8, DOI 10.1016/j.brainresrev.2007.03.010; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Pan CC, 2016, NAT METHODS, V13, P859, DOI 10.1038/nmeth.3964; Raux H, 1997, J GEN VIROL, V78, P119, DOI 10.1099/0022-1317-78-1-119; Reed DS, 2014, PATHOG DIS, V71, P225, DOI 10.1111/2049-632X.12157; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Richardson DS, 2015, CELL, V162, P246, DOI 10.1016/j.cell.2015.06.067; Santi PA, 2011, J HISTOCHEM CYTOCHEM, V59, P129, DOI 10.1369/0022155410394857; Sun CQ, 2014, J VIROL, V88, P2035, DOI 10.1128/JVI.02990-13; Susaki EA, 2015, NAT PROTOC, V10, P1709, DOI 10.1038/nprot.2015.085; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042	13	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180486	10.1371/journal.pone.0180486	http://dx.doi.org/10.1371/journal.pone.0180486			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686653	gold, Green Published, Green Submitted			2022-12-26	WOS:000405464100068
J	Huang, WS; Yang, M; Wang, CN; Song, YL				Huang, Wushuang; Yang, Mei; Wang, Changning; Song, Yaling			Evolutionary analysis of FAM83H in vertebrates!	PLOS ONE			English	Article							AMELOGENESIS IMPERFECTA; KERATIN CYTOSKELETON; MUTATION; ENAMEL; ORGANIZATION; CANDIDATE; DELETION; TEETH	Amelogenesis imperfecta is a group of disorders causing abnormalities in enamel formation in various phenotypes. Many mutations in the FAM83H gene have been identified to result in autosomal dominant hypocalcified amelogenesis imperfecta in different populations. However, the structure and function of FAM83H and its pathological mechanism have yet to be further explored. Evolutionary analysis is an alternative for revealing residues or motifs that are important for protein function. In the present study, we chose 50 vertebrate species in public databases representative of approximately 230 million years of evolution, including 1 amphibian, 2 fishes, 7 sauropsidas and 40 mammals, and we performed evolutionary analysis on the FAM83H protein. By sequence alignment, conserved residues and motifs were indicated, and the loss of important residues and motifs of five special species (Malayan pangolin, platypus, minke whale, nine-banded armadillo and aardvark) was discovered. A phylogenetic time tree showed the FAM83H divergent process. Positive selection sites in the Cterminus suggested that the C-terminus of FAM83H played certain adaptive roles during evolution. The results confirmed some important motifs reported in previous findings and identified some new highly conserved residues and motifs that need further investigation. The results suggest that the C-terminus of FAM83H contain key conserved regions critical to enamel formation and calcification.	[Song, Yaling] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Minist Educ, Wuhan, Peoples R China; Wuhan Univ, Sch & Hosp Stomatol, Key Lab Oral Biomed, Minist Educ, Wuhan, Peoples R China	Wuhan University; Wuhan University	Song, YL (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Minist Educ, Wuhan, Peoples R China.	sningya@whu.edu.cn		Song, Yaling/0000-0003-0747-7381	National Natural Science Foundation of China [81670976]; Bureau of Science and Technology of Wuhan [[2014]160]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bureau of Science and Technology of Wuhan	The study was supported by grants from the National Natural Science Foundation of China No.81670976,and from the Bureau of Science and Technology of Wuhan ([2014]160). The funders had no role in study design,data collection and analysis,decision to publish,or preparation of the manuscript	Crawford PJM, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-17; Davit-Beal T, 2009, J ANAT, V214, P477, DOI 10.1111/j.1469-7580.2009.01060.x; Delgado S, 2007, J DENT RES, V86, P326, DOI 10.1177/154405910708600405; Delsuc F, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0431-0; Demere TA, 2008, SYST BIOL, V57, P15, DOI 10.1080/10635150701884632; Ding Y, 2009, J DENT RES, V88, P991, DOI 10.1177/0022034509349454; El-Sayed W, 2009, AM J HUM GENET, V85, P699, DOI 10.1016/j.ajhg.2009.09.014; Foley NM, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0140; Forman OP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002462; Gasse B, 2012, J DENT RES, V91, P1085, DOI 10.1177/0022034512460551; Hart PS, 2004, J MED GENET, V41, P545, DOI 10.1136/jmg.2003.017657; Hedges SB, 2015, MOL BIOL EVOL, V32, P835, DOI 10.1093/molbev/msv037; Horovitz I, 2005, ACTA PALAEONTOL POL, V50, P545; Kawasaki K, 2014, BIOL CHEM, V395, P1003, DOI 10.1515/hsz-2014-0122; Kim JW, 2008, AM J HUM GENET, V82, P489, DOI 10.1016/j.ajhg.2007.09.020; Kim JW, 2005, J MED GENET, V42, P271, DOI 10.1136/jmg.2004.024505; Kueon YS, 2013, ARCH ORAL BIOL, V58, P1148, DOI 10.1016/j.archoralbio.2013.03.001; Kuga T, 2016, SCI REP-UK, V6, DOI 10.1038/srep26557; Kuga T, 2013, J CELL SCI, V126, P4721, DOI 10.1242/jcs.129684; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; LAGERSTROM M, 1991, GENOMICS, V10, P971, DOI 10.1016/0888-7543(91)90187-J; Lee MJ, 2009, ARCH ORAL BIOL, V54, P846, DOI 10.1016/j.archoralbio.2009.05.009; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Meredith RW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000634; Parry DA, 2013, AM J HUM GENET, V92, P307, DOI 10.1016/j.ajhg.2013.01.003; Parry DA, 2012, AM J HUM GENET, V91, P565, DOI 10.1016/j.ajhg.2012.07.020; Poulter JA, 2014, HUM MOL GENET, V23, P5317, DOI 10.1093/hmg/ddu247; Rajpar MH, 2001, HUM MOL GENET, V10, P1673, DOI 10.1093/hmg/10.16.1673; Song YL, 2012, CELLS TISSUES ORGANS, V196, P271, DOI 10.1159/000334210; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura K, 2012, P NATL ACAD SCI USA, V109, P19333, DOI 10.1073/pnas.1213199109; Urzua B, 2015, ARCH ORAL BIOL, V60, P1356, DOI 10.1016/j.archoralbio.2015.06.016; Wang SK, 2016, MOL GENET GENOM MED, V4, P46, DOI 10.1002/mgg3.178; Wright JT, 2009, J DENT RES, V88, P356, DOI 10.1177/0022034509333822; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	38	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180360	10.1371/journal.pone.0180360	http://dx.doi.org/10.1371/journal.pone.0180360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683132	gold, Green Published, Green Submitted			2022-12-26	WOS:000405335200026
J	Hauge, H; Vendramin, N; Taksdal, T; Olsen, AB; Wessel, O; Mikkelsen, SS; Alencar, ALF; Olesen, NJ; Dahle, MK				Hauge, Helena; Vendramin, Niccolo; Taksdal, Torunn; Olsen, Anne Berit; Wessel, Oystein; Mikkelsen, Susie Sommer; Alencar, Anna Luiza Farias; Olesen, Niels Jorgen; Dahle, Maria Krudtaa			Infection experiments with novel Piscine orthoreovirus from rainbow trout (Oncorhynchus mykiss) in salmonids	PLOS ONE			English	Article							SKELETAL-MUSCLE INFLAMMATION; JUNCTIONAL ADHESION MOLECULE; PANCREATIC-NECROSIS-VIRUS; ATLANTIC SALMON; REOVIRUS PRV; SALAR L.; DISEASE; HEART; ERYTHROCYTES; TRANSCRIPTION	A new disease in farmed rainbow trout (Onchorhyncus mykiss) was described in Norway in 2013. The disease mainly affected the heart and resembled heart and skeletal muscle inflammation (HSMI) in Atlantic salmon (Salmo salar L.). HSMI is associated with Piscine orthoreovirus (PRV), and a search for a similar virus in the diseased rainbow trout led to detection of a sequence with 85% similarity to PRV. This finding called for a targeted effort to assess the risk the new PRV-variant pose on farmed rainbow trout and Atlantic salmon by studying infection and disease pathogenesis, aiming to provide more diagnostic knowledge. Based on the genetic relationship to PRV, the novel virus is referred to as PRV-Oncorhynchus mykiss (PRV-Om) in contrast to PRV-Salmo salar (PRV-Ss). In experimental trials, intraperitoneally injected PRV-Om was shown to replicate in blood in both salmonid species, but more effectively in rainbow trout. In rainbow trout, the virus levels peaked in blood and heart of cohabitants 6 weeks post challenge, along with increased expression of antiviral genes (Mx and viperin) in the spleen, with 80-100% of the cohabitants infected. Heart inflammation was diagnosed in all cohabitants examined 8 weeks post challenge. In contrast, less than 50% of the Atlantic salmon cohabitants were infected between 8 and 16 weeks post challenge and the antiviral response in these fish was very low. From 12 weeks post challenge and onwards, mild focal myocarditis was demonstrated in a few virus-positive salmon. In conclusion, PRV-Om infects both salmonid species, but faster transmission, more notable antiviral response and more prominent heart pathology were observed in rainbow trout.	[Hauge, Helena; Taksdal, Torunn; Olsen, Anne Berit; Dahle, Maria Krudtaa] Norwegian Vet Inst, Oslo, Norway; [Hauge, Helena; Taksdal, Torunn; Olsen, Anne Berit; Dahle, Maria Krudtaa] Norwegian Vet Inst, Bergen, Norway; [Vendramin, Niccolo; Mikkelsen, Susie Sommer; Alencar, Anna Luiza Farias; Olesen, Niels Jorgen] Tech Univ Denmark, Natl Vet Inst, Copenhagen, Denmark; [Wessel, Oystein] Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, Oslo, Norway	Norwegian Veterinary Institute; Norwegian Veterinary Institute; Technical University of Denmark; Norwegian University of Life Sciences	Dahle, MK (corresponding author), Norwegian Vet Inst, Oslo, Norway.; Dahle, MK (corresponding author), Norwegian Vet Inst, Bergen, Norway.	maria.dahle@vetinst.no	Alencar, Anna/M-1681-2016; Farias Alencar, Anna Luiza/GYU-1369-2022; Olesen, Niels Jørgen/AAJ-8851-2021; Dahle, Maria K/AAK-5130-2021	Alencar, Anna/0000-0002-4864-9111; Farias Alencar, Anna Luiza/0000-0002-4864-9111; Olesen, Niels Jørgen/0000-0002-0152-4135; Dahle, Maria K/0000-0003-0380-084X; Vendramin, Niccolo/0000-0002-9217-7887	Norwegian Veterinary Institute (NVI); EU Reference Laboratory for Fish Diseases; DTU National Veterinary Institute; FAPESP (Sao Paulo Research Foundation) Research internship abroad [2015/04027-6]; Norwegian Research Council [237315/E40]	Norwegian Veterinary Institute (NVI); EU Reference Laboratory for Fish Diseases; DTU National Veterinary Institute; FAPESP (Sao Paulo Research Foundation) Research internship abroad(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Norwegian Research Council(Research Council of NorwayEuropean Commission)	The pilot study (trial1), the Atlantic salmon main study (trial3), and his to pathological analyses for both species were funded by the Norwegian Veterinary Institute (NVI). The rainbow trout study (trial2) was funded by the EU Reference Laboratory for Fish Diseases, DTU National Veterinary Institute and FAPESP (Sao Paulo Research Foundation) Research internship abroad (2015/04027-6). Experiments perform e dat the Norwegian University of Life Sciences were funded by the Norwegian Research Council grant # 237315/E40. Many thanks to Renate Johansen and Monika Hjortaas (NVI) for fruitful initial discussions on the pilot study design, and to Even Thoen (NVI) for practical assistance setting up the pilot study. The Atlantic salmon trial at VESO Vikan was managed by Anne Ramstad and crew. We greatly appreciate the help from several NVI and DTU Vet technicians. In particular; Elisabeth Dahl Nybo (NVI) for sample handling in the Atlantic salmon main study and RNA preparation for immune analysis, R and i Faller (NVI) for RT-qPCR analysis of immune genes, Linh Tran (NVI) for immuno his to chemistry, Didde Hedegaard Sorensen and Troels Secher Rundqvist (DTU Vet) for nucleic acid purification and RT-qPCR and Kari Karbech Mouritsen (DTU Vet) for sample handling and preparation.	[Anonymous], 2015, EUROPEAN AQUACULTURE; Ballesteros NA, 2015, VET IMMUNOL IMMUNOP, V165, P127, DOI 10.1016/j.vetimm.2015.04.001; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; Campbell JA, 2005, J VIROL, V79, P7967, DOI 10.1128/JVI.79.13.7967-7978.2005; Dahle MK, 2015, FISH SHELLFISH IMMUN, V45, P780, DOI 10.1016/j.fsi.2015.05.049; Finstad OW, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-35; Finstad OW, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-27; Garseth AH, 2013, J FISH DIS, V36, P483, DOI 10.1111/j.1365-2761.2012.01450.x; Garver KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146229; Godoy MG, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0554-y; Grove S, 2013, FISH SHELLFISH IMMUN, V34, P789, DOI 10.1016/j.fsi.2012.12.014; Guglielmi KM, 2007, J BIOL CHEM, V282, P17930, DOI 10.1074/jbc.M702180200; Haatveit HM, 2016, VET RES, V47, DOI 10.1186/s13567-015-0302-0; Hauge H, 2016, VET RES, V47, DOI 10.1186/s13567-016-0343-z; Hodneland K, 2006, J VIROL METHODS, V131, P184, DOI 10.1016/j.jviromet.2005.08.012; Jansen MD, 2016, J FISH DIS, V18, P109; Jensen BB, 2015, DIS AQUAT ORGAN, V114, P177, DOI 10.3354/dao02867; Johansen LH, 2016, MOL IMMUNOL, V73, P138, DOI 10.1016/j.molimm.2016.04.007; Johansen LH, 2015, FISH SHELLFISH IMMUN, V46, P612, DOI 10.1016/j.fsi.2015.07.023; Kibenge MJT, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-230; Kongtorp RT, 2009, J FISH DIS, V32, P253, DOI 10.1111/j.1365-2761.2008.00983.x; Kongtorp RT, 2004, J FISH DIS, V27, P351, DOI 10.1111/j.1365-2761.2004.00549.x; LEE PWK, 1981, VIROLOGY, V108, P156, DOI 10.1016/0042-6822(81)90535-3; Lovoll M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-8; Lovoll M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-309; Lund M, 2016, VET RES, V47, DOI 10.1186/s13567-016-0389-y; Madren JA, 2012, J VIROL, V86, P3466, DOI 10.1128/JVI.06659-11; Markussen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070075; Marty GD, 2015, J FISH DIS, V38, P713, DOI 10.1111/jfd.12285; Mikalsen AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037269; Nomikou K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005056; Olsen AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131638; Orpetveit I, 2010, J VET DIAGN INVEST, V22, P886, DOI 10.1177/104063871002200606; Palacios G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011487; Polinski MP, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3196-y; RHIM JS, 1962, VIROLOGY, V17, P342, DOI 10.1016/0042-6822(62)90125-3; Sibley SD, 2016, J GEN VIROL, V97, P2482, DOI 10.1099/jgv.0.000568; Takano T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165424; Toffolo V, 2007, MOL PHYLOGENET EVOL, V43, P298, DOI 10.1016/j.ympev.2006.08.003; Verrier ER, 2011, DEV COMP IMMUNOL, V35, P1204, DOI 10.1016/j.dci.2011.03.012; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Wessel O, 2015, VET RES, V46, DOI 10.1186/s13567-015-0154-7	42	37	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180293	10.1371/journal.pone.0180293	http://dx.doi.org/10.1371/journal.pone.0180293			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678799	Green Published, Green Accepted, gold			2022-12-26	WOS:000405272200046
J	Frizelle, P; Harte, J; O'Sullivan, K; Fletcher, P; Gibbon, F				Frizelle, Pauline; Harte, Jennifer; O'Sullivan, Kathleen; Fletcher, Paul; Gibbon, Fiona			The relationship between information carrying words, memory and language skills in school age children with specific language impairment	PLOS ONE			English	Article							SHORT-TERM-MEMORY; PHONOLOGICAL WORKING-MEMORY; SENTENCE COMPREHENSION; NONWORD-REPETITION; VOCABULARY DEVELOPMENT; IMMEDIATE RECALL; YOUNG-CHILDREN; SPAN; MARKERS; SPEED	The receptive language measure information-carrying word (ICW) level, is used extensively by speech and language therapists in the UK and Ireland. Despite this it has never been validated via its relationship to any other relevant measures. This study aims to validate the ICW measure by investigating the relationship between the receptive ICW score of children with specific language impairment (SLI) and their performance on standardized memory and language assessments. Twenty-seven children with SLI, aged between 5; 07 and 8; 11, completed a sentence comprehension task in which the instructions gradually increased in number of ICWs. The children also completed subtests from The Working Memory Test Battery for children and The Clinical Evaluation of Language Fundamentals-4. Results showed that there was a significant positive relationship between both language and memory measures and children's ICW score. While both receptive and expressive language were significant in their contribution to children's ICW score, the contribution of memory was solely determined by children's working memory ability. ICW score is in fact a valid measure of the language ability of children with SLI. However therapists should also be cognisant of its strong association with working memory when using this construct in assessment or intervention methods.	[Frizelle, Pauline] Univ Oxford, Dept Expt Psychol, Oxford, England; [Frizelle, Pauline; Harte, Jennifer; Fletcher, Paul; Gibbon, Fiona] Univ Coll Cork, Dept Speech & Hearing Sci, Brookfield Complex, Cork, Ireland; [O'Sullivan, Kathleen] Univ Coll Cork, Sch Math Sci, Cork, Ireland	University of Oxford; University College Cork; University College Cork	Frizelle, P (corresponding author), Univ Oxford, Dept Expt Psychol, Oxford, England.; Frizelle, P (corresponding author), Univ Coll Cork, Dept Speech & Hearing Sci, Brookfield Complex, Cork, Ireland.	p.frizelle@ucc.ie	Gibbon, Fiona E/J-8255-2013		Health Research Award from the Irish Health Research Board [HRA_POR/2012/ 68]	Health Research Award from the Irish Health Research Board	This work was supported by a Health Research Award, research grant HRA_POR/2012/ 68 from the Irish Health Research Board. The grant was awarded to Professor Fiona Gibbon. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloway TP, 2005, EUR J COGN PSYCHOL, V17, P207, DOI 10.1080/09541440440000005; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Bamford J, 2007, HEALTH TECHNOL ASSES, V11, P1; Bayliss DM, 2005, MEMORY, V13, P414, DOI 10.1080/09658210344000332; Bishop DMV, 1989, TEST RECEPTION GRAMM; Bishop DV, PEERJ PREPRINTS, V4; Bishop DVM, 1996, J CHILD PSYCHOL PSYC, V37, P391, DOI 10.1111/j.1469-7610.1996.tb01420.x; BROWN GDA, 1995, J MEM LANG, V34, P594, DOI 10.1006/jmla.1995.1027; CASE R, 1982, J EXP CHILD PSYCHOL, V33, P386, DOI 10.1016/0022-0965(82)90054-6; Coady J, 2010, INT J LANG COMM DIS, V45, P494, DOI 10.3109/13682820903222783; Conti-Ramsden G, 2003, J SPEECH LANG HEAR R, V46, P1029, DOI 10.1044/1092-4388(2003/082); Conti-Ramsden G, 2001, J CHILD PSYCHOL PSYC, V42, P741, DOI 10.1111/1469-7610.00770; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Davis J., 1971, ELEMENTARY SURVEY AN; Donlan C, 1998, INT J LANG COMM DIS, V33, P149, DOI 10.1080/136828298247802; Dunn L.M., 1982, BRIT PICTURE VOCABUL; Durkin K, 2007, CHILD DEV, V78, P1441, DOI 10.1111/j.1467-8624.2007.01076.x; Eisenberg SL, 2001, AM J SPEECH-LANG PAT, V10, P323, DOI 10.1044/1058-0360(2001/028); Epstein B, 2013, INT J LANG COMM DIS, V48, P351, DOI 10.1111/1460-6984.12009; Frizelle P, 2017, J CHILD LANG, P1; Frizelle P, 2015, AM J SPEECH LANG PAT; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; GATHERCOLE SE, 1992, DEV PSYCHOL, V28, P887, DOI 10.1037//0012-1649.28.5.887; GAULIN CA, 1994, PERCEPT MOTOR SKILL, V79, P55, DOI 10.2466/pms.1994.79.1.55; Gray S, 2006, J SPEECH LANG HEAR R, V49, P955, DOI 10.1044/1092-4388(2006/069); Hanten G, 2000, J MEM LANG, V43, P335, DOI 10.1006/jmla.2000.2731; HULME C, 1991, J MEM LANG, V30, P685, DOI 10.1016/0749-596X(91)90032-F; Jones G, 2016, COGNITION, V153, P79, DOI 10.1016/j.cognition.2016.04.017; Jones G, 2015, COGNITION, V144, P1, DOI 10.1016/j.cognition.2015.07.009; Klem M, 2015, DEVELOPMENTAL SCI, V18, P146, DOI 10.1111/desc.12202; Knowles W., 1982, DERBYSHIRE LANGUAGE; Leonard LB, 2007, J SPEECH LANG HEAR R, V50, P408, DOI 10.1044/1092-4388(2007/029); Leonard LB, 2013, J SPEECH LANG HEAR R, V56, P577, DOI 10.1044/1092-4388(2012/11-0254); MCCARTHY RA, 1987, BRAIN, V110, P1545, DOI 10.1093/brain/110.6.1545; McGhee R. L., 2007, TOKEN TEST CHILDREN; Melby-Lervag M, 2012, PSYCHOL SCI, V23, P1092, DOI 10.1177/0956797612443833; Montgomery J, 2004, INT J LANG COMM DIS, V39, P115, DOI 10.1080/13682820310001616985; Montgomery JW, 2007, J SPEECH LANG HEAR R, V50, P778, DOI 10.1044/1092-4388(2007/054); Montgomery JW, 2016, J SPEECH LANG HEAR R, V59, P1491, DOI 10.1044/2016_JSLHR-L-15-0325; Montgomery JW, 2009, APPL PSYCHOLINGUIST, V30, P485, DOI 10.1017/S0142716409090249; Montgomery JW, 2009, J SPEECH LANG HEAR R, V52, P269, DOI 10.1044/1092-4388(2008/07-0116); Montgomery JW, 2000, APPL PSYCHOLINGUIST, V21, P117, DOI 10.1017/S0142716400001065; Montgomery JW, 2000, J SPEECH LANG HEAR R, V43, P293, DOI 10.1044/jslhr.4302.293; MONTGOMERY JW, 1995, J SPEECH HEAR RES, V38, P187, DOI 10.1044/jshr.3801.187; Morgan L, 2013, BULLETIN, V738, P16; Norbury CF, 2002, APPL PSYCHOLINGUIST, V23, P247, DOI 10.1017/S0142716402002059; Pickering S., 2001, WORKING MEMORY TEST; POTTER MC, 1990, J MEM LANG, V29, P633, DOI 10.1016/0749-596X(90)90042-X; Potter MC, 1998, J MEM LANG, V38, P265, DOI 10.1006/jmla.1997.2546; Raven J.C., 2008, RAVENS ED CPM CVS; Riches NG, 2012, INT J LANG COMM DIS, V47, P499, DOI 10.1111/j.1460-6984.2012.00158.x; Robertson EK, 2010, APPL PSYCHOLINGUIST, V31, P141, DOI 10.1017/S0142716409990208; Rummer R, 2001, J MEM LANG, V45, P451, DOI 10.1006/jmla.2000.2788; SCHWEICKERT R, 1993, MEM COGNITION, V21, P168, DOI 10.3758/BF03202729; Semel E., 2006, CLIN EVALUATION LANG, V4th UK ed.; Semel EM, 1987, CLIN EVALUATION LANG	58	3	3	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180496	10.1371/journal.pone.0180496	http://dx.doi.org/10.1371/journal.pone.0180496			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2JX	28672043	Green Published, gold, Green Submitted			2022-12-26	WOS:000405268500059
J	Ma, FQ; Ren, MY; Wang, LH; Wang, Q; Guo, JL				Ma, Fangqin; Ren, Meiyu; Wang, Lihua; Wang, Qi; Guo, Jingli			Visual outcomes of dense pediatric cataract surgery in eastern China	PLOS ONE			English	Article							INTRAOCULAR-LENS IMPLANTATION; CONGENITAL CATARACT; DEVELOPMENTAL CATARACTS; POSTERIOR CHAMBER; CHILDREN; COMPLICATIONS; GLAUCOMA; EXTRACTION; CHILDHOOD; AGE	Purpose To evaluate the visual outcomes of dense pediatric cataract surgery in eastern China. Methods Medical records of children who underwent surgery for dense unilateral or bilateral pediatric cataract in Shandong Provincial Hospital between January 2007 and December 2012 were collected. Patients who cooperated with optical correction and aggressive patching of the sound eye and who had a minimum postoperative follow-up of more than 2 years were included. Risk factors for poor visual outcomes were analyzed. Results Of the 105 eligible patients (181 eyes), 76 had bilateral cataract, and 29 unilateral. With a mean follow up of 46.77 mo (range 24.0-96.0 mo), the final best corrected visual acuity (BCVA) of 158 eyes were recorded, and 4.43% (7/158) achieved 0.1 logarithm of the minimum angle of resolution (logMAR) or better; 15.19% (24/ 158) obtained a BCVA between 0.1 logMAR and 0.3 logMAR; 18.99%, (30/158) between 0.3 logMAR and 0.5 logMAR; 46.84% (74/158), between 0.5 logMAR and 1 logMAR; 14.55%, worse than 1 logMAR. The mean BCVA of the patients who underwent lensectomy before 3 months of age was significantly better than that of patients who underwent lensectomy between 3 and 12 months (p = 0.001). In the same lensectomy age groups, the final BCVA of the children in the bilateral and unilateral groups did not differ significantly (P>0.05). Lensectomy after 3 months of age, postoperative complications, strabismus and nystagmus were shown to be risk factors for poor visual outcomes. Conclusions Lensectomy before 3 months of age, IOL implantation, proper managing of postoperative complications, early optical correction and aggressive postoperative patching of the sound eye would increase the final BCVA for patients with dense pediatric cataract.	[Ma, Fangqin; Ren, Meiyu; Wang, Lihua; Wang, Qi; Guo, Jingli] Shandong Univ, Shandong Prov Hosp, Dept Ophthalmol, Jinan, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Wang, LH (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Ophthalmol, Jinan, Peoples R China.	wang_glasses@163.com						Allen RJ, 2010, EYE, V24, P1263, DOI 10.1038/eye.2009.295; Asrani S, 2000, J AAPOS, V4, P33, DOI 10.1016/S1091-8531(00)90009-0; Birch EE, 1996, INVEST OPHTH VIS SCI, V37, P1532; Birch EE, 2012, J AAPOS, V16, P156, DOI 10.1016/j.jaapos.2011.11.007; Chak M, 2006, INVEST OPHTH VIS SCI, V47, P4262, DOI 10.1167/iovs.05-1160; Garza-Reyes M, 2000, ARCH MED RES, V31, P500, DOI 10.1016/S0188-4409(00)00101-6; HING S, 1990, BRIT J OPHTHALMOL, V74, P73, DOI 10.1136/bjo.74.2.73; Hosal BM, 2000, OPHTHALMOLOGY, V107, P1647, DOI 10.1016/S0161-6420(00)00226-8; Kang Kui Dong, 2006, Korean J Ophthalmol, V20, P41; Khanna RC, 2013, INDIAN J OPHTHALMOL, V61, P65, DOI 10.4103/0301-4738.107194; Kim Kuk Hyoe, 2008, Korean J Ophthalmol, V22, P87, DOI 10.3341/kjo.2008.22.2.87; KnightNanan D, 1996, J CATARACT REFR SURG, V22, P730, DOI 10.1016/S0886-3350(96)80312-9; Lambert SR, 2013, AM J OPHTHALMOL, V156, P355, DOI 10.1016/j.ajo.2013.03.013; Lambert SR, 1996, SURV OPHTHALMOL, V40, P427, DOI 10.1016/S0039-6257(96)82011-X; Lambert SR, 2001, J AAPOS, V5, P70, DOI 10.1067/mpa.2001.111015; Lu Y, 2010, GRAEF ARCH CLIN EXP, V248, P681, DOI 10.1007/s00417-010-1310-4; Magli A, 2008, EUR J OPHTHALMOL, V18, P903, DOI 10.1177/112067210801800608; MILLS MD, 1994, J PEDIATR OPHTHALMOL, V31, P355; O'Keefe M, 2001, J CATARACT REFR SURG, V27, P2006, DOI 10.1016/S0886-3350(01)00973-7; Sjostrand J, 2011, ACTA OPHTHALMOL, V89, P30, DOI 10.1111/j.1755-3768.2009.01618.x; Solebo AL, 2015, BRIT J OPHTHALMOL, V99, P1471, DOI 10.1136/bjophthalmol-2014-306394; Thakur J, 2004, J CATARACT REFR SURG, V30, P1629, DOI 10.1016/j.jcrs.2003.12.047; Thylefors B, 1998, Community Eye Health, V11, P1; Vasavada AR, 2006, CURR OPIN OPHTHALMOL, V17, P54; Weisberg OL, 2005, OPHTHALMOLOGY, V112, P1625, DOI 10.1016/j.ophtha.2005.06.002; Yang ML, 2006, GRAEF ARCH CLIN EXP, V244, P1485, DOI 10.1007/s00417-006-0308-4; You CY, 2011, OPHTHALMOLOGY, V118, P17, DOI 10.1016/j.ophtha.2010.04.014; Zhan H, 2012, J AAPOS, V16, P65, DOI 10.1016/j.jaapos.2011.09.012	28	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180166	10.1371/journal.pone.0180166	http://dx.doi.org/10.1371/journal.pone.0180166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671961	Green Published, gold, Green Submitted			2022-12-26	WOS:000405268500020
J	Samiullah, S; Roberts, J; Wu, SB				Samiullah, Sami; Roberts, Juliet; Wu, Shu-Biao			Reference gene selection for the shell gland of laying hens in response to time-points of eggshell formation and nicarbazin	PLOS ONE			English	Article							SUITABLE REFERENCE GENES; HOUSEKEEPING GENES; RELATIVE QUANTIFICATION; MICROARRAY ANALYSIS; PCR ANALYSIS; EXPRESSION; NORMALIZATION; CHICKENS; PROTOPORPHYRIN; PROTEINS	Ten reference genes were investigated for normalization of gene expression data in the shell gland of laying hens. Analyses performed with geNorm revealed that hypoxanthine phosphoribosyltransferase 1 (HPRT1) and hydroxymethylbilane synthase (HMBS) were the two most stable reference genes in response to post-oviposition time alone (POT) or with nicarbazin treatment (POT+N) of laying hens. NormFinder analyses showed that the two most stable reference genes in response to POT and POT+N were 18S ribosomal RNA (18S rRNA), ribosomal protein L4 (RPL4) and HMBS, RPL4, respectively. BestKeeper analyses showed that 18S rRNA, RPL4 and HPRT1, HMBS were the two most stable reference genes for POT, and POT+N, respectively. Of the ten reference genes, all except B2M showed geNorm M <0.5, suggesting that they were stably expressed in the shell gland tissue. Consensus from these three programs suggested HPRT1 and HMBS could be used as the two most stable reference genes in the present study. Expression analyses of four candidate target genes with the two most and the two least stable genes showed that a combination of stable reference genes leads to more discriminable quantification of expression levels of target genes, while the least stable genes failed to do so. Therefore, HMBS and HPRT1 are recommended as the two most stable reference genes for the normalization of gene expression data at different stages of eggshell formation in brown-egg laying hens. Available statistical programs for reference gene ranking should include more robust analysis capability to analyse the gene expression data generated from factorial design experiments.	[Samiullah, Sami; Roberts, Juliet; Wu, Shu-Biao] Univ New England, Sch Environm & Rural Sci, Anim Sci, Armidale, NSW, Australia	University of New England	Wu, SB (corresponding author), Univ New England, Sch Environm & Rural Sci, Anim Sci, Armidale, NSW, Australia.	shubiao.wu@une.edu.au	Wu, Shu-Biao/R-5951-2019; KHAN, SAMIULLAH/O-3257-2015	Wu, Shu-Biao/0000-0002-1790-6015; KHAN, SAMIULLAH/0000-0002-0292-2979	Australian Egg Corporation Limited (AECL) [AECL1UN121]	Australian Egg Corporation Limited (AECL)(Australian Eggs)	This study was financially supported by Australian Egg Corporation Limited (AECL) under grant number AECL1UN121. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2010, EFSA J, V8, P1551; [Anonymous], 2006, BIORAD APPL USER GUI; ARIAS JL, 1993, INT REV CYTOL, V145, P217, DOI 10.1016/S0074-7696(08)60428-3; Beekman L, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-5; Bilandzic N, 2013, FOOD ADDIT CONTAM B, V6, P90, DOI 10.1080/19393210.2012.727474; Cinar Mehmet Ulas, 2013, BMC Res Notes, V6, P56, DOI 10.1186/1756-0500-6-56; Cinar Mehmet Ulas, 2012, BMC Res Notes, V5, P107, DOI 10.1186/1756-0500-5-107; Dalgaard TS, 2015, VET IMMUNOL IMMUNOP, V164, P79, DOI 10.1016/j.vetimm.2015.01.003; Day AL, 1998, ARCH BIOCHEM BIOPHYS, V359, P160, DOI 10.1006/abbi.1998.0910; Dorne JLCM, 2013, TOXICOL APPL PHARM, V270, P196, DOI 10.1016/j.taap.2010.12.014; Dunn IC, 2009, GEN COMP ENDOCR, V163, P225, DOI 10.1016/j.ygcen.2009.03.006; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; Greer S, 2010, J IMMUNOL METHODS, V355, P76, DOI 10.1016/j.jim.2010.02.006; Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359; HARBIN BM, 1985, BIOCHEMISTRY-US, V24, P366, DOI 10.1021/bi00323a019; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; HUGHES BL, 1991, POULTRY SCI, V70, P476, DOI 10.3382/ps.0700476; Ji H, 2013, ASIAN AUSTRAL J ANIM, V26, P423, DOI 10.5713/ajas.2012.12417; Johnson AL, 2015, REPROD FEMALE; Jonchere V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-57; Kuchipudi SV, 2014, VET RES, V45, DOI 10.1186/s13567-014-0118-3; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; LEESON S, 1989, CAN J ANIM SCI, V69, P757, DOI 10.4141/cjas89-088; Li GQ, 2013, POULTRY SCI, V92, P3120, DOI 10.3382/ps.2013-03484; Liu ZG, 2013, ASIAN AUSTRAL J ANIM, V26, P609, DOI 10.5713/ajas.2012.12398; MAY BK, 1995, PROG NUCLEIC ACID RE, V51, P1, DOI 10.1016/S0079-6603(08)60875-2; MELEK O, 1973, BRIT POULTRY SCI, V14, P493, DOI 10.1080/00071667308416056; Nascimento CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127935; NYS Y, 1986, BRIT POULTRY SCI, V27, P253, DOI 10.1080/00071668608416878; Pereira-Fantini PM, 2016, SCI REP-UK, V6, DOI 10.1038/srep26476; Petriccione M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16961; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Radonic A, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-7; Samiullah S, 2013, POULTRY SCI, V92, P2783, DOI 10.3382/ps.2013-03051; Shivhare R, 2016, SCI REP-UK, V6, DOI 10.1038/srep23036; Song G, 2011, BIOL REPROD, V85, P306, DOI 10.1095/biolreprod.110.089227; Svingen T, 2015, PEERJ, V3, DOI 10.7717/peerj.855; Takahashi S, 1998, BLOOD, V92, P3436, DOI 10.1182/blood.V92.9.3436.421k13_3436_3444; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Uddin Muhammad Jasim, 2011, BMC Res Notes, V4, P441, DOI 10.1186/1756-0500-4-441; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wellman-Labadie O, 2007, WORLD POULTRY SCI J, V63, P421, DOI 10.1017/S0043933907001559; Wu ZJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19748; Yang Falong, 2013, BMC Res Notes, V6, P402, DOI 10.1186/1756-0500-6-402; Yin RF, 2011, BIOCHEM BIOPH RES CO, V413, P537, DOI 10.1016/j.bbrc.2011.08.131	47	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180432	10.1371/journal.pone.0180432	http://dx.doi.org/10.1371/journal.pone.0180432			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671969	gold, Green Published, Green Submitted			2022-12-26	WOS:000405268500054
J	Zhang, ST; Chen, C; Xie, TN; Ye, SD				Zhang, Shutao; Chen, Chun; Xie, Tingna; Ye, Sudan			Identification and validation of reference genes for qRT-PCR studies of the obligate aphid pathogenic fungus Pandora neoaphidis during different developmental stages	PLOS ONE			English	Article							TIME RT-PCR; EXPRESSION ANALYSIS; HOUSEKEEPING GENES; NORMALIZATION; SELECTION; QPCR	The selection of stable reference genes is a critical step for the accurate quantification of gene expression. To identify and validate the reference genes in Pandora neoaphidis-an obligate aphid pathogenic fungus D the expression of 13classical candidate reference genes were evaluated by quantitative real-time reverse transcriptase polymerase chain reaction(qPCR) at four developmental stages (conidia, conidia with germ tubes, short hyphae and elongated hyphae). Four statistical algorithms, including geNorm, NormFinder, BestKeeper and Delta Ct method were used to rank putative reference genes according to their expression stability and indicate the best reference gene or combination of reference genes for accurate normalization. The analysis of comprehensive ranking revealed that ACT1and 18Swas the most stably expressed genes throughout the developmental stages. To further validate the suitability of the reference genes identified in this study, the expression of cell division control protein 25 (CDC25) and Chitinase 1(CHI1) genes were used to further confirm the validated candidate reference genes. Our study presented the first systematic study of reference gene(s) selection for P. neoaphidis study and provided guidelines to obtain more accurate qPCR results for future developmental efforts.	[Zhang, Shutao; Chen, Chun; Xie, Tingna] China Jiliang Univ, Zhejiang Prov Key Lab Biometrol & Inspect Quarant, Hangzhou, Zhejiang, Peoples R China; [Ye, Sudan] Zhejiang Econ & Trade Polytech, Hangzhou, Zhejiang, Peoples R China	China Jiliang University	Chen, C (corresponding author), China Jiliang Univ, Zhejiang Prov Key Lab Biometrol & Inspect Quarant, Hangzhou, Zhejiang, Peoples R China.	aspring@cjlu.edu.cn	Chen, Chun/ABG-4161-2021	Chen, Chun/0000-0002-3053-1019; Ye, Sudan/0000-0002-0587-1812	Natural Science Foundation of China [31461143030]; Science and Technology Planning Project of Zhejiang Province [2013C37087]; Zhejiang Natural Science Foundation [LR12C03001]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Zhejiang Province; Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This study was funded by the Natural Science Foundation of China (31461143030), the Science and Technology Planning Project of Zhejiang Province (2013C37087) and the Zhejiang Natural Science Foundation (LR12C03001).	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Battaglia E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-38; BEAUVAIS A, 1988, J INVERTEBR PATHOL, V51, P175, DOI 10.1016/0022-2011(88)90079-1; Botstein D., 1997, MOL CELLULAR BIOL YE, P1; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Chen C, 2006, ENVIRON MICROBIOL, V8, P69, DOI 10.1111/j.1462-2920.2005.00869.x; Chen C, 2016, BRAZ J MICROBIOL, V47, P259, DOI 10.1016/j.bjm.2015.11.031; Chen C, 2014, BIOL CONTROL, V69, P52, DOI 10.1016/j.biocontrol.2013.10.016; de Almeida MR, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-73; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Fang WG, 2006, MYCOL RES, V110, P1165, DOI 10.1016/j.mycres.2006.04.014; Foldager CB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-94; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Grell MN, 2011, FUNGAL GENET BIOL, V48, P343, DOI 10.1016/j.fgb.2010.12.003; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; HUMBER RA, 1989, MYCOTAXON, V34, P441; Jensen AB, 2008, AGR FOREST ENTOMOL, V10, P279, DOI 10.1111/j.1461-9563.2008.00383.x; Jin K, 2010, APPL ENVIRON MICROB, V76, P254, DOI 10.1128/AEM.00882-09; Kianianmomeni A, 2013, MOL BIOL REP, V40, P6691, DOI 10.1007/s11033-013-2784-z; Lian TT, 2014, FEMS MICROBIOL LETT, V356, P97, DOI 10.1111/1574-6968.12492; Licht HHD, 2016, ADV GENET, V94, P41, DOI 10.1016/bs.adgen.2016.01.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llanos A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1224-y; Maroniche GA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-308; Mascia T, 2010, MOL PLANT PATHOL, V11, P805, DOI [10.1111/j.1364-3703.2010.00646.x, 10.1111/j.1365-3059.2009.02239.x]; Morgan D, 2007, CELL CYCLE PRINCIPLE, P96; Nailis H, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-25; PAPIEROK B, 1989, ANN ENTOMOL FENN, V55, P63; Pell J. K., 2001, Fungi as biocontrol agents: progress, problems and potential, P71, DOI 10.1079/9780851993560.0071; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Robledo D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-648; Rocha-Martins M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043028; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; TANG QY, 2002, DPS DATA PROCESSING, P648; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vieira A, 2011, FUNGAL BIOL-UK, V115, P891, DOI 10.1016/j.funbio.2011.07.002; WILDING N, 1980, T BRIT MYCOL SOC, V75, P297, DOI 10.1016/S0007-1536(80)80092-1; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Yin RF, 2011, BIOCHEM BIOPH RES CO, V413, P537, DOI 10.1016/j.bbrc.2011.08.131	41	1	2	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0179930	10.1371/journal.pone.0179930	http://dx.doi.org/10.1371/journal.pone.0179930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672012	Green Published, gold, Green Submitted			2022-12-26	WOS:000405268500009
J	Ju, HQ; Lu, YX; Wu, QN; Liu, J; Zeng, ZL; Mo, HY; Chen, Y; Tian, T; Wang, Y; Kang, TB; Xie, D; Zeng, MS; Huang, P; Xu, RH				Ju, H-Q; Lu, Y-X; Wu, Q-N; Liu, J.; Zeng, Z-L; Mo, H-Y; Chen, Y.; Tian, T.; Wang, Y.; Kang, T-B; Xie, D.; Zeng, M-S; Huang, P.; Xu, R-H			Disrupting G6PD-mediated Redox homeostasis enhances chemosensitivity in colorectal cancer	ONCOGENE			English	Article							INHIBITS GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; CELLS; MECHANISMS; EXPRESSION; ACETYLATION; OXALIPLATIN; STATISTICS; RESISTANCE; APOPTOSIS; STRESS	Glucose-6-phosphate dehydrogenase (G6PD) is a key enzyme that generates NADPH to maintain reduced glutathione (GSH), which scavenges reactive oxygen species (ROS) to protect cancer cell from oxidative damage. In this study, we mainly investigate the potential roles of G6PD in colorectal cancer (CRC) development and chemoresistance. We discover that G6PD is overexpressed in CRC cells and patient specimens. High expression of G6PD predicts poor prognosis and correlated with poor outcome of oxaliplatin-based first-line chemotherapy in patients with CRC. Suppressing G6PD decreases NADPH production, lowers GSH levels, impairs the ability to scavenge ROS levels, and enhances oxaliplatin-induced apoptosis in CRC via ROS-mediated damage in vitro. In vivo experiments further shows that silencing G6PD with lentivirus or non-viral gene delivery vector enhances oxaliplatin anti-tumor effects in cell based xenografts and PDX models. In summary, our finding indicated that disrupting G6PD-mediated NADPH homeostasis enhances oxaliplatin-induced apoptosis in CRC through redox modulation. Thus, this study indicates that G6PD is a potential prognostic biomarker and a promising target for CRC therapy.	[Ju, H-Q; Lu, Y-X; Wu, Q-N; Zeng, Z-L; Mo, H-Y; Chen, Y.; Tian, T.; Wang, Y.; Kang, T-B; Xie, D.; Zeng, M-S; Huang, P.; Xu, R-H] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China; [Liu, J.; Chen, Y.] Sun Yat Sen Univ, Sch Engn, Dept Biomed Engn, Guangzhou 510060, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Huang, P; Xu, RH (corresponding author), Sun Yat Sen Univ, Canc Ctr, 651 Dongfeng East Rd, Guangzhou 510060, Guangdong, Peoples R China.	huangpeng@sysucc.org.cn; xurh@sysucc.org.cn	xu, rui/GRX-5734-2022; Xu, Rui-Hua/AAW-4766-2021	Xu, Rui-Hua/0000-0001-9771-8534	National Natural Science Foundation of China [81602137, 81372570, 81572392]; National High Technology Research and the Development Program of China [2015AA020103]; Science and the Technology Program of Guangdong [2015B020232008]; Science and Technology Program of Guangzhou [158100066, 15570006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and the Development Program of China(National High Technology Research and Development Program of China); Science and the Technology Program of Guangdong; Science and Technology Program of Guangzhou	This work was supported by grants from the National Natural Science Foundation of China (81602137, 81372570, 81572392); the National High Technology Research and the Development Program of China (2015AA020103); Science and the Technology Program of Guangdong (2015B020232008); the Science and Technology Program of Guangzhou (158100066, 15570006).	Ai GQ, 2016, MOL MED REP, V14, P1726, DOI 10.3892/mmr.2016.5449; Becouarn Y, 1998, J CLIN ONCOL, V16, P2739, DOI 10.1200/JCO.1998.16.8.2739; Biagiotti S, 2016, FEBS J, V283, P3962, DOI 10.1111/febs.13901; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; Choi YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep22172; Fichtner I, 2004, EUR J CANCER, V40, P298, DOI 10.1016/j.ejca.2003.10.011; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Graham J, 2004, NAT REV DRUG DISCOV, V3, P11, DOI 10.1038/nrd1287; Hu YM, 2010, BLOOD, V116, P2732, DOI 10.1182/blood-2009-11-256354; Ju HQ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14437; Ju HQ, 2016, THERANOSTICS, V6, P1160, DOI 10.7150/thno.14848; Ju HQ, 2016, J PINEAL RES, V60, P27, DOI 10.1111/jpi.12285; Ju HQ, 2015, MOL CANCER THER, V14, P788, DOI 10.1158/1535-7163.MCT-14-0420; Kim SY, 2007, MOL CELL BIOCHEM, V302, P27, DOI 10.1007/s11010-007-9421-x; Li SD, 2006, GENE THER, V13, P1313, DOI 10.1038/sj.gt.3302838; Liu B, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.322; Margis R, 2008, FEBS J, V275, P3959, DOI 10.1111/j.1742-4658.2008.06542.x; Oronsky B, 2016, DISCOV MED, V21, P251; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Picco G, 2016, JNCI-J NATL CANCER I, V109, P1; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; Santoro V, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv394; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Wang JX, 2012, TUMOR BIOL, V33, P95, DOI 10.1007/s13277-011-0251-9; Wang X, 2015, EJSO-EUR J SURG ONC, V41, P1293, DOI 10.1016/j.ejso.2015.08.155; Wang YP, 2014, EMBO J, V33, P1304, DOI 10.1002/embj.201387224; Yang Z, 2014, NANOSCALE, V6, P10193, DOI 10.1039/c4nr02395a; Yun J, 2015, SCIENCE, V350, P1391, DOI 10.1126/science.aaa5004; Zeng ZL, 2014, CLIN CANCER RES, V20, P1042, DOI 10.1158/1078-0432.CCR-13-0171; Zhang CH, 2014, ANTI-CANCER AGENT ME, V14, P280, DOI 10.2174/18715206113136660337; Zhou JB, 2012, NAT MATER, V11, P82, DOI [10.1038/NMAT3187, 10.1038/nmat3187]; Zhou LS, 2016, EMBO REP, V17, P811, DOI 10.15252/embr.201541643; Zhou Q, 2015, CHIN J CANCER, V34, P1, DOI 10.1186/s40880-015-0026-6	38	76	81	0	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 9	2017	36	45					6282	6292		10.1038/onc.2017.227	http://dx.doi.org/10.1038/onc.2017.227			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FM1WY	28692052	Green Published, hybrid			2022-12-26	WOS:000414774800007
J	Corkins, ME; Wilson, S; Cocuron, JC; Alonso, AP; Bird, AJ				Corkins, Mark E.; Wilson, Stevin; Cocuron, Jean-Christophe; Alonso, Ana P.; Bird, Amanda J.			The gluconate shunt is an alternative route for directing glucose into the pentose phosphate pathway in fission yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTNER-DOUDOROFF PATHWAY; SCHIZOSACCHAROMYCES-POMBE; HUMAN GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; MASS-SPECTROMETRY; ESCHERICHIA-COLI; ZINC; DEHYDROGENASE; METABOLISM; BINDING; GENE	Glycolysis and the pentose phosphate pathway both play a central role in the degradation of glucose in all domains of life. Another metabolic route that can facilitate glucose breakdown is the gluconate shunt. In this shunt glucose dehydrogenase and gluconate kinase catalyze the two-step conversion of glucose into the pentose phosphate pathway intermediate 6-phosphogluconate. Despite the presence of these enzymes in many organisms, their only established role is in the production of 6-phosphogluconate for the Entner-Doudoroff pathway. In this report we performed metabolic profiling on a strain of Schizosaccharomyces pombe lacking the zinc-responsive transcriptional repressor Loz1 with the goal of identifying metabolic pathways that were altered by cellular zinc status. This profiling revealed that loz1 Delta cells accumulate higher levels of gluconate. We show that the altered gluconate levels in loz1 Delta cells result from increased expression of gcd1. By analyzing the activity of recombinant Gcd1 in vitro and by measuring gluconate levels in strains lacking enzymes of the gluconate shunt we demonstrate that Gcd1 encodes a novel NADP(+)-dependent glucose dehydrogenase that acts in a pathway with the Idn1 gluconate kinase. We also find that cells lacking gcd1 and zwf1, which encode the first enzyme in the pentose phosphate pathway, have a more severe growth phenotype than cells lacking zwf1. We propose that in S. pombe Gcd1 and Idn1 act together to shunt glucose into the pentose phosphate pathway, creating an alternative route for directing glucose into the pentose phosphate pathway that bypasses hexokinase and the rate-limiting enzyme glucose-6-phosphate dehydrogenase.	[Corkins, Mark E.; Wilson, Stevin; Cocuron, Jean-Christophe; Alonso, Ana P.; Bird, Amanda J.] Ohio State Univ, Dept Mol Genet, 1787 Neil Ave, Columbus, OH 43210 USA; [Cocuron, Jean-Christophe; Alonso, Ana P.] Ohio State Univ, Ctr Appl Plant Sci, Columbus, OH 43210 USA; [Bird, Amanda J.] Ohio State Univ, Dept Human Nutr, 1787 Neil Ave, Columbus, OH 43210 USA; [Bird, Amanda J.] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Bird, AJ (corresponding author), Ohio State Univ, Dept Mol Genet, 1787 Neil Ave, Columbus, OH 43210 USA.; Bird, AJ (corresponding author), Ohio State Univ, Dept Human Nutr, 1787 Neil Ave, Columbus, OH 43210 USA.	bird.96@osu.edu	Alonso, Ana Paula/W-4283-2019; Bird, Amanda Jane/ABD-2295-2021	Alonso, Ana Paula/0000-0003-4696-1811; Bird, Amanda Jane/0000-0002-1846-7050; Wilson, Stevin/0000-0002-9662-5501	NIGMS, National Institutes of Health [R01GM105695]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105695] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIGMS, National Institutes of Health Grant R01GM105695 (to A. J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BAUTISTA JM, 1995, FEBS LETT, V366, P61, DOI 10.1016/0014-5793(95)00474-N; CAMPBELL DP, 1982, ARCH BIOCHEM BIOPHYS, V215, P289, DOI 10.1016/0003-9861(82)90307-1; CAVENER DR, 1983, P NATL ACAD SCI-BIOL, V80, P6286, DOI 10.1073/pnas.80.20.6286; Cheah IK, 2012, BBA-MOL BASIS DIS, V1822, P784, DOI 10.1016/j.bbadis.2011.09.017; Chen X, 2016, P NATL ACAD SCI USA, V113, P5441, DOI 10.1073/pnas.1521916113; Cocuron JC, 2014, METHODS MOL BIOL, V1090, P131, DOI 10.1007/978-1-62703-688-7_9; Corkins ME, 2013, P NATL ACAD SCI USA, V110, P15371, DOI 10.1073/pnas.1300853110; Cosgrove MS, 2000, BIOCHEMISTRY-US, V39, P15002, DOI 10.1021/bi0014608; Costello LC, 2004, PROSTATE CANCER P D, V7, P111, DOI 10.1038/sj.pcan.4500712; Costello LC, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-17; Dainty SJ, 2008, EUKARYOT CELL, V7, P454, DOI 10.1128/EC.00408-07; Ehrensberger KM, 2014, J BIOL CHEM, V289, P18087, DOI 10.1074/jbc.M114.551333; Ehrensberger KM, 2013, J BIOL CHEM, V288, P759, DOI 10.1074/jbc.M112.406165; Ferri Stefano, 2011, J Diabetes Sci Technol, V5, P1068; FLIEGE R, 1992, APPL ENVIRON MICROB, V58, P3826, DOI 10.1128/AEM.58.12.3826-3829.1992; Gibon Y, 1997, ANAL BIOCHEM, V251, P153, DOI 10.1006/abio.1997.2283; Harrison DC, 1931, BIOCHEM J, V25, P1016, DOI 10.1042/bj0251016; Heiland S, 2000, J BACTERIOL, V182, P2153, DOI 10.1128/JB.182.8.2153-2162.2000; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kotaka M, 2005, ACTA CRYSTALLOGR D, V61, P495, DOI 10.1107/S0907444905002350; Koubaa M, 2013, ANAL BIOCHEM, V436, P151, DOI 10.1016/j.ab.2013.01.027; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; METZGER RP, 1964, J BIOL CHEM, V239, P1769; Ng CY, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-68; Patra T, 2012, J BACTERIOL, V194, P3377, DOI 10.1128/JB.06379-11; Peekhaus N, 1998, J BACTERIOL, V180, P3495, DOI 10.1128/JB.180.14.3495-3502.1998; PETER M, 1993, CELL, V73, P747, DOI 10.1016/0092-8674(93)90254-N; Rohatgi N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098760; Rolfsson O, 2013, BIOCHEM J, V449, P427, DOI 10.1042/BJ20120980; Slekar KH, 1996, J BIOL CHEM, V271, P28831, DOI 10.1074/jbc.271.46.28831; Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017; Stincone A, 2015, BIOL REV, V90, P927, DOI 10.1111/brv.12140; THOMAS D, 1991, EMBO J, V10, P547, DOI 10.1002/j.1460-2075.1991.tb07981.x; TSAI CS, 1995, ARCH BIOCHEM BIOPHYS, V316, P155, DOI 10.1006/abbi.1995.1023; TSAI CS, 1995, ARCH BIOCHEM BIOPHYS, V316, P163, DOI 10.1006/abbi.1995.1024; Wilson S, 2016, ARCH BIOCHEM BIOPHYS, V611, P30, DOI 10.1016/j.abb.2016.02.031; Wu CY, 2009, J BIOL CHEM, V284, P27544, DOI 10.1074/jbc.M109.042036	37	19	19	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13823	13832		10.1074/jbc.M117.798488	http://dx.doi.org/10.1074/jbc.M117.798488			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28667014	Green Published, hybrid			2022-12-26	WOS:000407942400003
J	Nakajima, A; Nakatani, A; Hasegawa, S; Irie, J; Ozawa, K; Tsujimoto, G; Suganami, T; Itoh, H; Kimura, I				Nakajima, Akira; Nakatani, Akiho; Hasegawa, Sae; Irie, Junichiro; Ozawa, Kentaro; Tsujimoto, Gozoh; Suganami, Takayoshi; Itoh, Hiroshi; Kimura, Ikuo			The short chain fatty acid receptor GPR43 regulates inflammatory signals in adipose tissue M2-type macrophages	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GUT MICROBIOTA; INSULIN SENSITIVITY; MICE DEFICIENT; TNF-ALPHA; OBESITY; ACCUMULATION; ADIPOCYTES; PROPIONATE; EXPRESSION	The regulation of inflammatory responses within adipose tissue by various types of immune cells is closely related to tissue homeostasis and progression of metabolic disorders such as obesity and type 2 diabetes. G-protein-coupled receptor 43 (GPR43), which is activated by short-chain fatty acids (SCFAs), is known to be most abundantly expressed in white adipose tissue and to modulate metabolic processes. Although GPR43 is also expressed in a wide variety of immune cells, whether and how GPR43 in adipose tissue immune cells regulates the inflammatory responses and metabolic homeostasis remains unknown. In this study, we investigated the role of GPR43 in adipose tissue macrophages by using Gpr43deficient mice and transgenic mice with adipose- tissue-specific overexpression of GPR43. We found that GPR43 activation bySCFA resulted in induction of the pro-inflammatory cytokine tumor necrosis factor-a (TNF-a) in anti-inflammatory M2-type macrophages within adipose tissue. By contrast, this effect was not noted in inflammatory M1-type macrophages, suggesting that GPR43 plays distinct functions depending on macrophage types. Local TNF-a signaling derived from steady-state adipose tissue is associated with proper tissue remodeling as well as suppression of fat accumulation. Thus, GPR43-involving mechanism that we have identified supports maintenance of adipose tissue homeostasis and increase in metabolic activity. This newly identified facet of GPR43 in macrophages may have clinical implications for immune-metabolism related episodes.	[Nakajima, Akira; Nakatani, Akiho; Hasegawa, Sae; Kimura, Ikuo] Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Appl Biol Sci, Fuchu, Tokyo, Japan; [Irie, Junichiro] Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, Tokyo, Japan; [Ozawa, Kentaro] Nara Med Univ, Sch Med, Dept Pharmacol, Nara, Japan; [Tsujimoto, Gozoh] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Genom Drug Discovery Sci, Sakyo Ku, Shimoadachi Cho, Kyoto, Japan; [Suganami, Takayoshi] Nagoya Univ, Res Inst Environm Med, Dept Mol Med & Metab, Chikusa Ku, Furo Cho, Nagoya, Aichi, Japan	Tokyo University of Agriculture & Technology; Keio University; Nara Medical University; Kyoto University; Nagoya University	Nakajima, A; Kimura, I (corresponding author), Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Appl Biol Sci, Fuchu, Tokyo, Japan.	anakajima@mol.f.u-tokyo.ac.jp; ikimura@cc.tuat.ac.jp	Kimura, Ikuo/B-4193-2015; Irie, Junichiro/H-7795-2019	Irie, Junichiro/0000-0003-2662-4121	Japan Society for the Promotion of Science [JP15H05344]; Ministry of Education, Culture, Sports, Science and Technology [JP16H01355]; Takeda Science Foundation; Cell Science Research Foundation; Uehara Memorial Foundation; Yakult Bioscience Research Foundation; Tojuro Iijima Foundation for Food Science and Technology; Grants-in-Aid for Scientific Research [16H01355] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Uehara Memorial Foundation(Uehara Memorial Foundation); Yakult Bioscience Research Foundation; Tojuro Iijima Foundation for Food Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JP15H05344, Dr. Ikuo Kimura); Ministry of Education, Culture, Sports, Science and Technology (JP16H01355, Dr. IkuoKimura); Takeda Science Foundation (Dr. IkuoKimura); Cell Science Research Foundation (Dr. IkuoKimura); Uehara Memorial Foundation (Dr.IkuoKimura); Yakult Bioscience Research Foundation (Dr. Akira Nakajima); and Tojuro Iijima Foundation for Food Science and Technology (Dr. IkuoKimura). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip.	Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Awazawa M, 2011, CELL METAB, V13, P401, DOI 10.1016/j.cmet.2011.02.010; Bapat SP, 2015, NATURE, V528, P137, DOI 10.1038/nature16151; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Cho KW, 2014, CELL REP, V9, P605, DOI 10.1016/j.celrep.2014.09.004; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Green A, 2004, DIABETES, V53, P74, DOI 10.2337/diabetes.53.1.74; Hill AA, 2014, IMMUNOL REV, V262, P134, DOI 10.1111/imr.12216; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jin CC, 2013, CELL METAB, V17, P873, DOI 10.1016/j.cmet.2013.05.011; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Liu LS, 1998, DIABETES, V47, P515, DOI 10.2337/diabetes.47.4.515; Lynch L, 2015, NAT IMMUNOL, V16, P85, DOI 10.1038/ni.3047; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Macia L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7734; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mathis D, 2013, CELL METAB, V17, P851, DOI 10.1016/j.cmet.2013.05.008; McNelis JC, 2015, DIABETES, V64, P3203, DOI 10.2337/db14-1938; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Oliver E, 2010, P NUTR SOC, V69, P232, DOI 10.1017/S0029665110000042; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Priyadarshini M, 2015, MOL ENDOCRINOL, V29, P1055, DOI 10.1210/me.2015-1007; Psichas A, 2015, INT J OBESITY, V39, P424, DOI 10.1038/ijo.2014.153; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Sivaprakasam S, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.38; Stolarczyk E, 2013, CELL METAB, V17, P520, DOI 10.1016/j.cmet.2013.02.019; Symonds ME, 2009, NAT REV ENDOCRINOL, V5, P604, DOI 10.1038/nrendo.2009.195; Tang Y, 2011, INT J CANCER, V128, P847, DOI 10.1002/ijc.25638; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Vieira AT, 2015, ARTHRITIS RHEUMATOL, V67, P1646, DOI 10.1002/art.39107; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475	44	64	69	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0179696	10.1371/journal.pone.0179696	http://dx.doi.org/10.1371/journal.pone.0179696			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692672	Green Published, gold, Green Submitted			2022-12-26	WOS:000405544800013
J	Banfi, C; Kemeny, F; Gangl, M; Schulte-Korne, G; Moll, K; Landerl, K				Banfi, Chiara; Kemeny, Ferenc; Gangl, Melanie; Schulte-Koerne, Gerd; Moll, Kristina; Landerl, Karin			Visuo-spatial cueing in children with differential reading and spelling profiles	PLOS ONE			English	Article							VISUAL-SPATIAL ATTENTION; DEVELOPMENTAL DYSLEXIA; DEFICITS; ADULTS; INHIBITION; DIRECTION; RETURN; DISSOCIATION; INFORMATION; ACQUISITION	Dyslexia has been claimed to be causally related to deficits in visuo-spatial attention. In particular, inefficient shifting of visual attention during spatial cueing paradigms is assumed to be associated with problems in graphemic parsing during sublexical reading. The current study investigated visuo-spatial attention performance in an exogenous cueing paradigm in a large sample (N = 191) of third and fourth graders with different reading and spelling profiles (controls, isolated reading deficit, isolated spelling deficit, combined deficit in reading and spelling). Once individual variability in reaction times was taken into account by means of z-transformation, a cueing deficit (i.e. no significant difference between valid and invalid trials) was found for children with combined deficits in reading and spelling. However, poor readers without spelling problems showed a cueing effect comparable to controls, but exhibited a particularly strong right-over-left advantage (position effect). Isolated poor spellers showed a significant cueing effect, but no position effect. While we replicated earlier findings of a reduced cueing effect among poor nonword readers (indicating deficits in sublexical processing), we also found a reduced cueing effect among children with particularly poor orthographic spelling (indicating deficits in lexical processing). Thus, earlier claims of a specific association with nonword reading could not be confirmed. Controlling for ADHD-symptoms reported in a parental questionnaire did not impact on the statistical analysis, indicating that cueing deficits are not caused by more general attentional limitations. Between 31 and 48% of participants in the three reading and/or spelling deficit groups as well as 32% of the control group showed reduced spatial cueing. These findings indicate a significant, but moderate association between certain aspects of visuo-spatial attention and subcomponents of written language processing, the causal status of which is yet unclear.	[Banfi, Chiara; Kemeny, Ferenc; Gangl, Melanie; Landerl, Karin] Karl Franzens Univ Graz, Inst Psychol, Graz, Austria; [Schulte-Koerne, Gerd; Moll, Kristina] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany	University of Graz; University of Munich	Banfi, C (corresponding author), Karl Franzens Univ Graz, Inst Psychol, Graz, Austria.	chiara.banfi@uni-graz.at	Schulte-Körne, Gerd/AAI-4828-2021; Moll, Kristina/AAZ-1087-2021; Kemény, Ferenc/L-8685-2015	Schulte-Körne, Gerd/0000-0002-9960-1572; Kemény, Ferenc/0000-0003-2961-3014; Landerl, Karin/0000-0003-4074-0233	German Research Foundation [MO 2569/2-1]; Austrian Science Fund [I 1658-G22]; Austrian Science Fund; German Research Foundation	German Research Foundation(German Research Foundation (DFG)); Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund(Austrian Science Fund (FWF)); German Research Foundation(German Research Foundation (DFG))	This research was supported by grants from the German Research Foundation http://www.dfg.de/en/ (grant number MO 2569/2-1) and the Austrian Science Fund https://www.fwf.ac.at/en/ (grant number I 1658-G22). CB, MG, KL were funded by the Austrian Science Fund, KM and GS were funded by the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albonico A, 2016, ACTA PSYCHOL, V171, P85, DOI 10.1016/j.actpsy.2016.10.003; BRANNAN JR, 1987, PERCEPT PSYCHOPHYS, V41, P23, DOI 10.3758/BF03208209; Buchholz J, 2005, BRAIN COGNITION, V57, P30, DOI 10.1016/j.bandc.2004.08.017; Buchholz J, 2008, DYSLEXIA, V14, P247, DOI 10.1002/dys.356; Carroll JM, 2016, J CHILD PSYCHOL PSYC, V57, P750, DOI 10.1111/jcpp.12488; Cassim R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106191; Chica AB, 2013, BEHAV BRAIN RES, V237, P107, DOI 10.1016/j.bbr.2012.09.027; Dopfner M., 2008, DISYPS II DIAGNOSTIK; EVIATAR Z, 1995, BRAIN COGNITION, V29, P137, DOI 10.1006/brcg.1995.1273; Facoetti A, 2000, COGNITIVE BRAIN RES, V10, P185, DOI 10.1016/S0926-6410(00)00031-8; Facoetti A, 2000, CORTEX, V36, P109, DOI 10.1016/S0010-9452(08)70840-2; Facoetti A, 2001, NEUROPSYCHOLOGIA, V39, P352, DOI 10.1016/S0028-3932(00)00138-X; Facoetti A, 2000, NEUROSCI LETT, V290, P216, DOI 10.1016/S0304-3940(00)01354-9; Facoetti A, 2006, COGN NEUROPSYCHOL, V23, P841, DOI 10.1080/02643290500483090; Facoetti A, 2010, J COGNITIVE NEUROSCI, V22, P1011, DOI 10.1162/jocn.2009.21232; Faust ME, 1999, PSYCHOL BULL, V125, P777, DOI 10.1037/0033-2909.125.6.777; Franceschini S, 2013, CURR BIOL, V23, P462, DOI 10.1016/j.cub.2013.01.044; Franceschini S, 2012, CURR BIOL, V22, P814, DOI 10.1016/j.cub.2012.03.013; Goldfarb L, 2013, NEUROPSYCHOLOGY, V27, P725, DOI 10.1037/a0034422; Gorissen S.H.M., 2015, CEREB CORTEX, P1; Goswami U, 2015, NAT REV NEUROSCI, V16, P43, DOI 10.1038/nrn3836; Grainger J, 2016, TRENDS COGN SCI, V20, P171, DOI 10.1016/j.tics.2015.12.008; Grund M., 2004, DRT 4 DIAGNOSTISCHER; Hari R, 2001, TRENDS COGN SCI, V5, P525, DOI 10.1016/S1364-6613(00)01801-5; Hari R, 2001, BRAIN, V124, P1373, DOI 10.1093/brain/124.7.1373; Hilchey MD, 2014, J EXP PSYCHOL HUMAN, V40, P1603, DOI 10.1037/a0036859; Judge J, 2013, DYSLEXIA, V19, P55, DOI 10.1002/dys.1452; Kinsey K, 2004, NEUROREPORT, V15, P2215, DOI 10.1097/00001756-200410050-00014; Landerl K, 2013, J CHILD PSYCHOL PSYC, V54, P686, DOI 10.1111/jcpp.12029; Landerl K, 2010, J CHILD PSYCHOL PSYC, V51, P287, DOI 10.1111/j.1469-7610.2009.02164.x; Martelli M, 2009, J VISION, V9, DOI 10.1167/9.4.14; Mayringer H., 2014, SLS 2 9 SALZBURGER L; Mele S, 2012, ACTA PSYCHOL, V141, P281, DOI 10.1016/j.actpsy.2012.09.012; Menghini D, 2010, NEUROPSYCHOLOGIA, V48, P863, DOI 10.1016/j.neuropsychologia.2009.11.003; Moll K., 2010, SLRT II LESE RECHTSC; Moll K, 2016, J LEARN DISABIL-US, V49, P272, DOI 10.1177/0022219414547221; Moll K, 2009, SCI STUD READ, V13, P359, DOI 10.1080/10888430903162878; Moores E, 2015, VISION RES, V111, P55, DOI 10.1016/j.visres.2015.03.019; Muller R., 2004, DRT 3 DIAGNOSTISCHER; Pennington BF, 2006, COGNITION, V101, P385, DOI 10.1016/j.cognition.2006.04.008; Perry C, 2007, PSYCHOL REV, V114, P273, DOI 10.1037/0033-295X.114.2.273; Perry C, 2010, COGNITIVE PSYCHOL, V61, P106, DOI 10.1016/j.cogpsych.2010.04.001; Petermann F., 2011, WISC IV WECHSLER INT; Peterson RL, 2015, ANNU REV CLIN PSYCHO, V11, P283, DOI 10.1146/annurev-clinpsy-032814-112842; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Poynter W, 2010, BRAIN COGNITION, V72, P355, DOI 10.1016/j.bandc.2009.10.014; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; Roach NW, 2008, VISION RES, V48, P193, DOI 10.1016/j.visres.2007.11.001; Roach NW, 2007, BRAIN, V130, P771, DOI 10.1093/brain/awl353; Roach NW, 2004, PSYCHOL SCI, V15, P650, DOI 10.1111/j.0956-7976.2004.00735.x; Ruffino M., 2014, FRONT HUM NEUROSCI, V8, DOI [10.3389/fnhum.2013.00507, DOI 10.3389/fnhum.2014.00331]; Sexton CC, 2012, J LEARN DISABIL-US, V45, P538, DOI 10.1177/0022219411407772; SHARE DL, 1995, COGNITION, V55, P151, DOI 10.1016/0010-0277(94)00645-2; Skoyles J, 2004, BRAIN LANG, V88, P79, DOI 10.1016/S0093-934X(03)00162-7; Smigasiewicz K, 2010, NEUROPSYCHOLOGIA, V48, P2852, DOI 10.1016/j.neuropsychologia.2010.05.027; Spalek TM, 2005, PSYCHOL SCI, V16, P15, DOI 10.1111/j.0956-7976.2005.00774.x; Wei&beta; R.H., 2006, CFT 20 R GRUNDINTELL; Willburger E, 2010, DYSLEXIA, V16, P175, DOI 10.1002/dys.404; Zorzi M, 2012, P NATL ACAD SCI USA, V109, P11455, DOI 10.1073/pnas.1205566109	60	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180358	10.1371/journal.pone.0180358	http://dx.doi.org/10.1371/journal.pone.0180358			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686635	Green Published, Green Submitted, gold			2022-12-26	WOS:000405464100053
J	Choi, SY; Ryu, HM; Oh, EJ; Choi, JY; Cho, JH; Kim, CD; Kim, YL; Park, SH				Choi, Soon-Youn; Ryu, Hye-Myung; Oh, Eun-Joo; Choi, Ji-Young; Cho, Jang-Hee; Kim, Chan-Duck; Kim, Yong-Lim; Park, Sun-Hee			Dipeptidyl peptidase-4 inhibitor gemigliptin protects against vascular calcification in an experimental chronic kidney disease and vascular smooth muscle cells	PLOS ONE			English	Article							ARTERIAL MEDIAL CALCIFICATION; RUNX2 GENE-EXPRESSION; OXIDATIVE STRESS; OSTEOBLASTIC DIFFERENTIATION; UREMIC RATS; PHOSPHATIDYLINOSITOL 3-KINASE; IN-VITRO; PHOSPHATE; CATENIN; AKT	Although dipeptidyl peptidase-4 inhibitors, a class of antidiabetic drugs, have various pleiotropic effects, it remains undetermined whether gemigliptin has a beneficial effect on vascular calcification. Therefore, this study was performed to evaluate the effect of gemigliptin on vascular calcification in a rat model of adenine-induced chronic kidney disease and in cultured vascular smooth muscle cells. Gemigliptin attenuated calcification of abdominal aorta and expression of RUNX2 in adenine-induced chronic kidney disease rats. In cultured vascular smooth muscle cells, phosphate-induced increase in calcium content was reduced by gemigliptin. Gemigliptin reduced phosphate-induced PiT-1 mRNA expression, reactive oxygen species generation, and NADPH oxidase mRNA expression (p22(phox) and NOX4). The reduction of oxidative stress by gemigliptin was associated with the downregulation of phospho-PI3K/AKT expression. High phosphate increased the expression of frizzled-3 (FDZ3) and decreased the expression of dickkopf-related protein-1 (DKK-1) in the Wnt pathway. These changes were attenuated by gemigliptin treatment. Gemigliptin restored the decreased expression of vascular smooth muscle cells markers (alpha-SMA and SM22 alpha) and increased expression of osteogenic makers (CBFA1, OSX, E11, and SOST) induced by phosphate. In conclusion, gemigliptin attenuated vascular calcification and osteogenic trans-differentiation in vascular smooth muscle cells via multiple steps including downregulation of PiT-1 expression and suppression of reactive oxygen species generation, phospho-PI3K/AKT, and the Wnt signaling pathway.	[Choi, Soon-Youn; Ryu, Hye-Myung; Oh, Eun-Joo; Choi, Ji-Young; Cho, Jang-Hee; Kim, Chan-Duck; Kim, Yong-Lim; Park, Sun-Hee] Kyungpook Natl Univ, Sch Med, Div Nephrol, Daegu, South Korea; [Choi, Soon-Youn; Ryu, Hye-Myung; Oh, Eun-Joo; Choi, Ji-Young; Cho, Jang-Hee; Kim, Chan-Duck; Kim, Yong-Lim; Park, Sun-Hee] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Choi, Soon-Youn; Kim, Yong-Lim] Kyungpook Natl Univ, Dept Biomed Sci, Plus Biomed Convergence Program BK21, Daegu, South Korea; [Choi, Soon-Youn; Ryu, Hye-Myung; Kim, Chan-Duck; Kim, Yong-Lim; Park, Sun-Hee] Kyungpook Natl Univ, Cell & Matrix Res Inst, Daegu, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University	Park, SH (corresponding author), Kyungpook Natl Univ, Sch Med, Div Nephrol, Daegu, South Korea.; Park, SH (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea.; Park, SH (corresponding author), Kyungpook Natl Univ, Cell & Matrix Res Inst, Daegu, South Korea.	sh-park@knu.ac.kr	Park, Sun/GSD-9620-2022; Cho, Jang-hee/ABD-3534-2020; Choi, Soon Youn/AHC-8865-2022	Cho, Jang-hee/0000-0002-7031-5214; 	Korea Health Technology R & D Project through Korea Health Industry Development Institute (KHIDI) [HI15C0001, HI13C1232]; Ministry of Health & Welfare, Republic of Korea	Korea Health Technology R & D Project through Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the Korea Health Technology R & D Project through the Korea Health Industry Development Institute (KHIDI) (HI15C0001; HI13C1232), funded by the Ministry of Health & Welfare, Republic of Korea (www.khidi.or.kr) (YLK, CDK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aly Z, 2011, KIDNEY INT, V79, P1044, DOI 10.1038/ki.2010.548; Barbieri M, 2013, ATHEROSCLEROSIS, V227, P349, DOI 10.1016/j.atherosclerosis.2012.12.018; Byon CH, 2008, J BIOL CHEM, V283, P15319, DOI 10.1074/jbc.M800021200; Cai T, 2016, EXP CELL RES, V345, P206, DOI 10.1016/j.yexcr.2016.06.007; Chinda K, 2013, INT J CARDIOL, V167, P451, DOI 10.1016/j.ijcard.2012.01.011; Clempus RE, 2007, ARTERIOSCL THROM VAS, V27, P42, DOI 10.1161/01.ATV.0000251500.94478.18; Ellmark SHM, 2005, CARDIOVASC RES, V65, P495, DOI 10.1016/j.cardiores.2004.10.026; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Hwang HJ, 2015, MOL CELL ENDOCRINOL, V405, P25, DOI 10.1016/j.mce.2015.01.025; Hwang HJ, 2014, MOL CELL ENDOCRINOL, V392, P1, DOI 10.1016/j.mce.2014.04.017; Jono S, 2006, J BONE MINER METAB, V24, P176, DOI 10.1007/s00774-005-0668-6; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; Kim SH, 2016, EUR J PHARMACOL, V788, P54, DOI 10.1016/j.ejphar.2016.06.016; Koska J, 2015, DIABETES VASC DIS RE, V12, P154, DOI 10.1177/1479164114562411; Li XW, 2006, CIRC RES, V98, P905, DOI 10.1161/01.RES.0000216409.20863.e7; Lim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035007; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Manivannan J, 2013, MOL CELL BIOCHEM, V378, P9, DOI 10.1007/s11010-013-1588-8; Manrique C, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0414-5; Martinez-Moreno JM, 2012, AM J PHYSIOL-RENAL, V303, pF1136, DOI 10.1152/ajprenal.00684.2011; Min HS, 2014, LAB INVEST, V94, P598, DOI 10.1038/labinvest.2014.50; Mizobuchi M, 2009, J AM SOC NEPHROL, V20, P1453, DOI 10.1681/ASN.2008070692; Mody N, 2001, FREE RADICAL BIO MED, V31, P509, DOI 10.1016/S0891-5849(01)00610-4; de Oca AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089525; Muteliefu G, 2009, NEPHROL DIAL TRANSPL, V24, P2051, DOI 10.1093/ndt/gfn757; Persy V, 2009, TRENDS MOL MED, V15, P405, DOI 10.1016/j.molmed.2009.07.001; Picatoste B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078330; Qin SF, 2003, BIOCHEMISTRY-US, V42, P2995, DOI 10.1021/bi0205911; Rong S, 2014, CELL PHYSIOL BIOCHEM, V34, P2049, DOI 10.1159/000366400; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Shah Z, 2011, VASC PHARMACOL, V55, P2, DOI 10.1016/j.vph.2011.03.001; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Shimomura A, 2014, J AM SOC NEPHROL, V25, P1954, DOI 10.1681/ASN.2013090967; Sutra T, 2008, FREE RADICAL RES, V42, P789, DOI 10.1080/10715760802400766; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Terawaki Y, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0154-3; Villa-Bellosta R, 2009, ARTERIOSCL THROM VAS, V29, P761, DOI 10.1161/ATVBAHA.108.183384; Vittone F, 2012, DIABETOLOGIA, V55, P2267, DOI 10.1007/s00125-012-2582-5; Wang WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093447; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Yamada S, 2012, J BONE MINER RES, V27, P474, DOI 10.1002/jbmr.539; Yao L, 2015, AM J NEPHROL, V41, P28, DOI 10.1159/000370250; Yoshida T, 2013, J VASC RES, V50, P512, DOI 10.1159/000355263; Yoshiko Y, 2007, MOL CELL BIOL, V27, P4465, DOI 10.1128/MCB.00104-07; Zhan JK, 2015, INT J CARDIOL, V189, P188, DOI 10.1016/j.ijcard.2015.04.086; Zhao MM, 2011, KIDNEY INT, V79, P1071, DOI 10.1038/ki.2011.18; Zhu DX, 2015, J CELL MOL MED, V19, P165, DOI 10.1111/jcmm.12373; Zhu DX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019595	49	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180393	10.1371/journal.pone.0180393	http://dx.doi.org/10.1371/journal.pone.0180393			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686724	Green Submitted, Green Published, gold			2022-12-26	WOS:000405464100059
J	Hayes, MA; Adams, RA				Hayes, Mark A.; Adams, Rick A.			Simulated bat populations erode when exposed to climate change projections for western North America	PLOS ONE			English	Article							FRINGED MYOTIS; WATER HOLES; RESOURCE; RISK	Recent research has demonstrated that temperature and precipitation conditions correlate with successful reproduction in some insectivorous bat species that live in arid and semiarid regions, and that hot and dry conditions correlate with reduced lactation and reproductive output by females of some species. However, the potential long-term impacts of climate-induced reproductive declines on bat populations in western North America are not well understood. We combined results from long-term field monitoring and experiments in our study area with information on vital rates to develop stochastic age-structured population dynamics models and analyzed how simulated fringed myotis (Myotis thysanodes) populations changed under projected future climate conditions in our study area near Boulder, Colorado (Boulder Models) and throughout western North America (General Models). Each simulation consisted of an initial population of 2,000 females and an approximately stable age distribution at the beginning of the simulation. We allowed each population to be influenced by the mean annual temperature and annual precipitation for our study area and a generalized range-wide model projected through year 2086, for each of four carbon emission scenarios (representative concentration pathways RCP2.6, RCP4.5, RCP6.0, RCP8.5). Each population simulation was repeated 10,000 times. Of the 8 Boulder Model simulations, 1 increased (+29.10%), 3 stayed approximately stable (+2.45%, +0.05%, -0.03%), and 4 simulations decreased substantially (-44.10%, -44.70%, -44.95%, -78.85%). All General Model simulations for western North America decreased by >90% (-93.75%, -96.70%, -96.70%, -98.75%). These results suggest that a changing climate in western North America has the potential to quickly erode some forest bat populations including species of conservation concern, such as fringed myotis.	[Hayes, Mark A.; Adams, Rick A.] Univ Northern Colorado, Sch Biol Sci, Greeley, CO 80639 USA; [Hayes, Mark A.] Cherokee Nation Technol, Ft Collins, CO 80521 USA	University of Northern Colorado	Hayes, MA (corresponding author), Univ Northern Colorado, Sch Biol Sci, Greeley, CO 80639 USA.; Hayes, MA (corresponding author), Cherokee Nation Technol, Ft Collins, CO 80521 USA.				University of Northern Colorado's School of Biological Sciences; Colorado Wildlife Conservation Grant program	University of Northern Colorado's School of Biological Sciences; Colorado Wildlife Conservation Grant program	This study was supported by the University of Northern Colorado's School of Biological Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Colorado Wildlife Conservation Grant program, administered cooperatively by Colorado Parks and Wildlife and U.S. Fish and Wildlife Service, and Bureau of Land Management, were generous in supporting the field research described in this paper. The City of Boulder Open Space and Mountain Parks department also was generous in funding, support, and access to their properties. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RA, 2006, J ZOOL, V270, P466, DOI 10.1111/j.1469-7998.2006.00152.x; Adams R.A., 2003, BATS ROCKY MOUNTAIN; Adams R. A., 2000, ONTOGENY FUNCTIONAL; Adams RA, 2003, J ZOOL, V260, P189, DOI 10.1017/S0952836903003613; Adams RA, 2002, ACTA CHIROPTEROL, V4, P195, DOI 10.3161/001.004.0211; Adams RA, 2008, J ANIM ECOL, V77, P1115, DOI 10.1111/j.1365-2656.2008.01447.x; Adams Rick A., 2000, P275, DOI 10.1017/CBO9780511541872.009; Adams RA, 2010, ECOLOGY, V91, P2437, DOI 10.1890/09-0091.1; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Caswell, 2000, MATRIX POPULATION MO; Clark RA, 2003, GLOBAL CHANGE BIOL, V9, P1669, DOI 10.1046/j.1365-2486.2003.00685.x; Cook ER, 2009, J QUATERNARY SCI; Diffenbaugh NS, 2012, CLIMATIC CHANGE, V114, P813, DOI 10.1007/s10584-012-0570-x; Duffy PB, 2014, REG CLIM STUD, P167, DOI 10.1007/978-3-319-03768-4_4; Ellner S.P., 2006, DYNAMIC MODELS BIOL, DOI DOI 10.1139/F10-077; Frick WF, 2010, J ANIM ECOL, V79, P128, DOI 10.1111/j.1365-2656.2009.01615.x; Ghanem SJ, 2012, ADV STUD BEHAV, V44, P279, DOI 10.1016/B978-0-12-394288-3.00007-1; Hallam Thomas G., 2009, P177; Hayes MA., 2011, THESIS; Hayes MA, 2014, WEST N AM NATURALIST, V74, P446, DOI 10.3398/064.074.0410; Hayes MA, 2015, WEST N AM NATURALIST, V75, P460, DOI 10.3398/064.075.0404; Heideman Paul D., 2000, P469, DOI 10.1016/B978-012195670-7/50012-6; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Isaac Joanne L., 2009, Endangered Species Research, V7, P115, DOI 10.3354/esr00093; Jones G, 2015, BAT EVOLUTION ECOLOG, P457; Jones Gareth, 2009, Endangered Species Research, V8, P93, DOI 10.3354/esr00182; Kang B, 2007, J HYDROL ENG, V12, P63, DOI 10.1061/(ASCE)1084-0699(2007)12:1(63); Korine C, 2015, BATS ANTHROPOCENE CO, P215; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; KURTA A, 1989, CAN J ZOOL, V67, P2468, DOI 10.1139/z89-348; Lande R., 2003, OXFORD SERIES ECOLOG; Loeb SC, 2015, SRS208 USDA; Lucan RK, 2013, J ZOOL, V290, P151, DOI 10.1111/jzo.12021; Lukas J., 2014, CLIMATE CHANGE COLOR; Maine JJ, 2015, P NATL ACAD SCI USA, V112, P12438, DOI 10.1073/pnas.1505413112; Mclean JA, 1999, FUNCT ECOL, V13, P360, DOI 10.1046/j.1365-2435.1999.00321.x; Murray JD, 2001, MATH BIOL; O'Donnell Colin F.J., 2009, P158; O'Shea Thomas J., 2004, P297; O'Shea TJ, 2011, J MAMMAL, V92, P433, DOI 10.1644/10-MAMM-A-162.1; O'Shea TJ, 2003, WILDLIFE SOC B, V31, P16; Pachauri RK, 2014, SYNTHESIS REPORT; Pederson GT, 2011, SCIENCE, V333, P332, DOI 10.1126/science.1201570; Perry LG, 2012, GLOBAL CHANGE BIOL, V18, P821, DOI 10.1111/j.1365-2486.2011.02588.x; Racey P.A., 1987, Symposia of the Zoological Society of London, P107; Sherwin H. A., 2012, MAMM REV, DOI 10.1111/j.1365-2907.2012.00214.x; Speakman JR, 2003, BAT ECOLOGY, P430; Stohlgren TJ, 2006, RISK ANAL, V26, P163, DOI 10.1111/j.1539-6924.2006.00707.x; Studier E.H., 1980, Proceedings International Bat Research Conference, V5, P415; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; TUTTLE MD, 1976, ECOLOGY, V57, P587, DOI 10.2307/1936443; van de Pol M, 2010, ECOLOGY, V91, P1192, DOI 10.1890/09-0410.1; Voight C.C., 2016, BATS ANTHROPOCENE CO, DOI 10.1007/978-3-319-25220-9; Wilson D. E., 2005, MAMMAL SPECIES WORLD	54	14	15	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180693	10.1371/journal.pone.0180693	http://dx.doi.org/10.1371/journal.pone.0180693			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686737	Green Published, gold, Green Submitted			2022-12-26	WOS:000405464100091
J	Knafl, D; Thalhammer, F; Vossen, MG				Knafl, Daniela; Thalhammer, Florian; Vossen, Matthias G.			In-vitro release pharmacokinetics of amikacin, teicoplanin and polyhexanide in a platelet rich fibrin D layer (PRF) D a laboratory evaluation of a modern, autologous wound treatment	PLOS ONE			English	Article							CHRONIC LEG ULCERS; HUMAN BETA-DEFENSIN-2	Objectives Platelet rich fibrin (PRF) is an autologous fibrin glue, produced from patients' blood, which, besides intraoperative use, has applications in the treatment of infected wounds. The combination with antimicrobial agents results in a prolonged antibacterial effect allowing for wound dressing change intervals of seven days even in infected wounds. The aim of this study was to evaluate release kinetics of amikacin, teicoplanin or polyhexanide from a PRF- layer. Methods PRF mixed with teicoplanin, amikacin or polyhexanide was sprayed on a silicon gauze patch and put on a colombia agar with bacteria with known minimal inhibitory concentration (MIC) and incubated for 24 hours and afterwards transferred to another agar with the same bacterial strain. Inhibition zones were measured every 24 hours. This was repeated on 7 consecutive days. Antibiotic concentrations were calculated by interpolation. Results More than 1000 mg/L teicoplanin were released within the first 24 hours and 28.22 mg/L after 168 hours. Amikacin release was above 10,000 mg/L within the first 24 hours and still 120.8 mg/L after 120 hours. A release of polyhexanide could be verified for the first 24 hours only. Consequently teicoplanin and amikacin released from PRF showed antimicrobial invitro effects for almost a week, whereas an antimicrobial effect of polyhexanide could only be verified for the first 24 hours. Conclusions Our Results show that a weekly dressing regimen may be justified in wounds treated with PRF plus amikacin or teicoplanin, since bacteria will be eradicated over a considerable period of time after a single application of PRF.	[Knafl, Daniela; Thalhammer, Florian; Vossen, Matthias G.] Med Univ Vienna, Dept Med 1, Div Infect Dis & Trop Med, Vienna, Austria	Medical University of Vienna	Vossen, MG (corresponding author), Med Univ Vienna, Dept Med 1, Div Infect Dis & Trop Med, Vienna, Austria.	matthias.vossen@meduniwien.ac.at	Vossen, Matthias Gerhard/H-8761-2019		Vivostat A/S	Vivostat A/S	F.T. and M.G.V. received an unrestricted research grant from Vivostat A/S. D.K. did not receive any grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.vivostat.com/.	[Anonymous], 2008, WOUND REPAIR REGENER, V16, P356; Bayer A, 2016, EXP DERMATOL, V25, P460, DOI 10.1111/exd.12966; Carter Marissa J, 2011, Eplasty, V11, pe38; EUCAST, 2020, EUR COMM ANT SUSC TE; Giamarellos-Bourboulis EJ, 2005, DIAGN MICR INFEC DIS, V51, P113, DOI 10.1016/j.diagmicrobio.2004.09.004; Hurd T, 2008, INT WOUND J, V5, P296, DOI 10.1111/j.1742-481X.2008.00484.x; Jockenhofer F, 2014, J DTSCH DERMATOL GES, V12, P1121, DOI 10.1111/ddg.12540; Korber A, 2011, J DTSCH DERMATOL GES, V9, P116, DOI 10.1111/j.1610-0387.2010.07535.x; Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x; O'Meara S, 2000, Health Technol Assess, V4, P1; Ruttermann M, 2013, DTSCH ARZTEBL INT, V110, P25, DOI 10.3238/arztebl.2013.0025; Schroder JM, 1999, INT J BIOCHEM CELL B, V31, P645, DOI 10.1016/S1357-2725(99)00013-8; Steenvoorde P, 2008, J Wound Care, V17, P60; Tohidnezhad M, 2011, HISTOCHEM CELL BIOL, V135, P453, DOI 10.1007/s00418-011-0808-0; Tohidnezhad M, 2012, PLATELETS, V23, P217, DOI 10.3109/09537104.2011.610908; Tohidnezhad M, 2011, INJURY, V42, P682, DOI 10.1016/j.injury.2010.12.010	16	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0181090	10.1371/journal.pone.0181090	http://dx.doi.org/10.1371/journal.pone.0181090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686663	Green Submitted, gold, Green Published			2022-12-26	WOS:000405464100131
J	Magnes, T; Melchardt, T; Weiss, L; Mittermair, C; Neureiter, D; Klieser, E; Gampenrieder, S; Moser, G; Gaggl, A; Greil, R; Egle, A				Magnes, Teresa; Melchardt, Thomas; Weiss, Lukas; Mittermair, Christof; Neureiter, Daniel; Klieser, Eckhard; Gampenrieder, Simon; Moser, Gerhard; Gaggl, Alexander; Greil, Richard; Egle, Alexander			Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; C-REACTIVE PROTEIN; OPEN-LABEL; HUMAN-PAPILLOMAVIRUS; LYMPHOCYTE RATIO; PLUS CETUXIMAB; CISPLATIN; FLUOROURACIL; MULTICENTER; DOCETAXEL	Despite modern treatment approaches, survival of patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) remains low and it is difficult to identify patients who derive optimal benefit from treatment. We therefore analyzed which commonly available laboratory and clinical parameters may help improve the prognostication in this patient group. This retrospective monocenter analysis includes 128 patients with recurrent or metastatic SCCHN treated with cetuximab alone or in combination with polychemotherapy as first line therapy. Factors with independent prognostic power in the multivariate analysis were used to build up a score separating patient groups with different survival. Patients had a median age of 61 years and 103 patients were treated with polychemotherapy plus cetuximab. An ECOG score above 1, high CRP and leukocyte levels, less intensive treatment and a time below 12 months from primary diagnosis to relapse remained as independent negative prognostic factors in multivariate analysis. Patients with 0 to 1 risk factors had a median OS of 13.6 months compared to a median OS of less than one month for patients 4 to 5 risk factors (p< 0.001). This study identifies 5 clinical and serum values that influence survival of patients with recurrent or metastatic SCCHN treated with cetuximab. By combining these factors to create a score for OS, it is possible to distinguish a group of patients with significantly improved survival and define those most likely to have no benefit from cetuximab treatment.	[Magnes, Teresa; Melchardt, Thomas; Weiss, Lukas; Mittermair, Christof; Gampenrieder, Simon; Greil, Richard; Egle, Alexander] Paracelsus Med Univ, Med Dept 3, Salzburg, Austria; [Magnes, Teresa; Melchardt, Thomas; Weiss, Lukas; Mittermair, Christof; Gampenrieder, Simon; Greil, Richard; Egle, Alexander] Salzburg Canc Res Inst, Salzburg, Austria; [Magnes, Teresa; Melchardt, Thomas; Weiss, Lukas; Mittermair, Christof; Gampenrieder, Simon; Greil, Richard; Egle, Alexander] Canc Cluster Salzburg, Salzburg, Austria; [Neureiter, Daniel; Klieser, Eckhard] Paracelsus Med Univ, Inst Pathol, Salzburg, Austria; [Moser, Gerhard] Paracelsus Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Salzburg, Austria; [Gaggl, Alexander] Paracelsus Med Univ, Dept Oral & Maxillofacial Surg, Salzburg, Austria	Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University	Egle, A (corresponding author), Paracelsus Med Univ, Med Dept 3, Salzburg, Austria.; Egle, A (corresponding author), Salzburg Canc Res Inst, Salzburg, Austria.; Egle, A (corresponding author), Canc Cluster Salzburg, Salzburg, Austria.	a.egle@salk.at	Gampenrieder, Simon Peter/AFM-7798-2022; Egle, Alexander/AAC-3787-2020; Moser, Gerhard/N-7402-2013	Egle, Alexander/0000-0003-0648-4416; Weiss, Lukas/0000-0002-2174-5613; Moser, Gerhard/0000-0003-4916-5490	PMU Research Fund- PMU FFF [R-16/02/081-MAM]; province of Salzburg; company Merck	PMU Research Fund- PMU FFF; province of Salzburg; company Merck	This work was supported by the PMU Research Fund- PMU FFF [grant number: R-16/02/081-MAM] and the province of Salzburg. The author Thomas Melchardt received an unrestricted grant from the company Merck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiris A, 2004, CANCER, V101, P2222, DOI 10.1002/cncr.20640; Argiris A, 2014, ANN ONCOL, V25, P1410, DOI 10.1093/annonc/mdu167; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Bektas-Kayhan K, 2012, ORAL DIS, V18, P55, DOI 10.1111/j.1601-0825.2011.01843.x; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; de Mello RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086697; Fang HY, 2013, LARYNGOSCOPE, V123, P2690, DOI 10.1002/lary.24105; Ferris RL, 2016, NEW ENGL J MED, V375, P1856, DOI 10.1056/NEJMoa1602252; Guo Y, 2015, HEAD NECK-J SCI SPEC, V37, P1081, DOI 10.1002/hed.23707; Jalali MM, 2011, ASIAN PAC J CANCER P, V12, P1731; Keil F, 2013, EUR J CANCER, V49, P352, DOI 10.1016/j.ejca.2012.08.004; Khandavilli SD, 2009, ORAL ONCOL, V45, P912, DOI 10.1016/j.oraloncology.2009.03.015; Lassen P, 2009, J CLIN ONCOL, V27, P1992, DOI 10.1200/JCO.2008.20.2853; Lynggaard CD, 2015, ACTA ONCOL, V54, P1071, DOI 10.3109/0284186X.2014.964308; Melchardt T, 2015, J NATL COMPR CANC NE, V13, P1501, DOI 10.6004/jnccn.2015.0178; Millrud CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051120; Misiukiewicz K, 2014, ANN ONCOL, V25, P1667, DOI 10.1093/annonc/mdu194; Nakayama M, 2015, HEAD NECK-J SCI SPEC, V37, P1745, DOI 10.1002/hed.23823; Perisanidis C, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0334-5; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Purdue MP, 2013, BLOOD, V122, P951, DOI 10.1182/blood-2013-01-481077; Ramsey S, 2006, BRIT J CANCER, V95, P1076, DOI 10.1038/sj.bjc.6603387; Rischin D, 2010, J CLIN ONCOL, V28, P4142, DOI 10.1200/JCO.2010.29.2904; Seiwert TY, 2016, LANCET ONCOL, V17, P956, DOI 10.1016/S1470-2045(16)30066-3; Selzer E, 2015, STRAHLENTHER ONKOL, V191, P486, DOI 10.1007/s00066-014-0803-1; Stotz M, 2013, BRIT J CANCER, V109, P416, DOI 10.1038/bjc.2013.332; Troppan KT, 2014, BRIT J CANCER, V111, P55, DOI 10.1038/bjc.2014.277; Ueda M, 2010, AURIS NASUS LARYNX, V37, P488, DOI 10.1016/j.anl.2009.11.012; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; Vermorken JB, 2007, J CLIN ONCOL, V25, P2171, DOI 10.1200/JCO.2006.06.7447; Vermorken JB, 2013, LANCET ONCOL, V14, P697, DOI 10.1016/S1470-2045(13)70181-5	32	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180995	10.1371/journal.pone.0180995	http://dx.doi.org/10.1371/journal.pone.0180995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686697	Green Submitted, Green Published, gold			2022-12-26	WOS:000405464100130
J	Snow, KJ; Richards, AH; Kinner, SA				Snow, Kathryn J.; Richards, Alun H.; Kinner, Stuart A.			Use of multiple data sources to estimate hepatitis C seroprevalence among prisoners: A retrospective cohort study	PLOS ONE			English	Article							VIRUS-INFECTION; INJECT DRUGS; VALIDITY; PEOPLE	Hepatitis C is a major cause of preventable morbidity and mortality. Prisoners are a key population for hepatitis C control programs, and with the advent of highly effective therapies, prisons are increasingly important sites for hepatitis C diagnosis and treatment. Accurate estimates of hepatitis C prevalence among prisoners are needed in order to plan and resource service provision, however many prevalence estimates are based on surveys compromised by limited and potentially biased participation. We aimed to compare estimates derived from three different data sources, and to assess whether the use of selfreport as a supplementary data source may help researchers assess the risk of selection bias. We used three data sources to estimate the prevalence of hepatitis C antibodies in a large cohort of Australian prisoners-prison medical records, self-reported status during a face-to-face interview prior to release from prison, and data from a statewide notifiable conditions surveillance system. Of 1,315 participants, 33.8% had at least one indicator of hepatitis C seropositivity, however less than one third of these (9.5% of the entire cohort) were identified by all three data sources. Among participants of known status, self-report had a sensitivity of 80.1% and a positive predictive value of 97.8%. Any one data source used in isolation would have under-estimated the prevalence of hepatitis C in this cohort. Using multiple data sources in studies of hepatitis C seroprevalence among prisoners may improve case detection and help researchers assess the risk of selection bias due to non-participation in serological testing.	[Snow, Kathryn J.; Kinner, Stuart A.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Snow, Kathryn J.] Univ Melbourne, Dept Paediat, Ctr Int Child Hlth, Melbourne, Australia; [Snow, Kathryn J.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Australia; [Richards, Alun H.] Queensland Govt, Prevent Div, Communicable Dis Branch, Dept Hlth, Brisbane, Qld, Australia; [Kinner, Stuart A.] Griffith Univ, Griffith Criminol Inst, Brisbane, Qld, Australia; [Kinner, Stuart A.] Univ Queensland, Mater Res Inst, Brisbane, Qld, Australia; [Kinner, Stuart A.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Kinner, Stuart A.] Murdoch Childrens Res Inst, Ctr Adolescent Hlth, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Queensland Health; Griffith University; Mater Research; University of Queensland; Monash University; Murdoch Children's Research Institute	Snow, KJ (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia.; Snow, KJ (corresponding author), Univ Melbourne, Dept Paediat, Ctr Int Child Hlth, Melbourne, Australia.; Snow, KJ (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Australia.	kathryn.snow@unimelb.edu.au; s.kinner@unimelb.edu.au		Snow, Kathryn J/0000-0002-6625-5175	NHMRC Strategic Award [409966]; NHMRC Project Grant [1002463]	NHMRC Strategic Award(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Project Grant(National Health and Medical Research Council (NHMRC) of Australia)	This study is funded by NHMRC Strategic Award #409966 and NHMRC Project Grant #1002463. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2014, PRISONERS AUSTR; Brameld KJ, 1999, AUST NZ J PUBL HEAL, V23, P464, DOI 10.1111/j.1467-842X.1999.tb01299.x; Butler T, 2015, NATL PRISON ENTRANTS; Craine N, 2014, EUR J PUBLIC HEALTH; Dolan K, 2016, LANCET, V388, P1089, DOI 10.1016/S0140-6736(16)30466-4; Fisher DG, 2007, SEX TRANSM DIS, V34, P389, DOI 10.1097/01.olq.0000245916.45429.ec; Guirgis M, 2012, INTERN MED J, V42, P497, DOI 10.1111/j.1445-5994.2011.02440.x; Hagan H, 2006, PUBLIC HEALTH REP, V121, P710, DOI 10.1177/003335490612100611; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Kinner SA, 2013, CONTEMP CLIN TRIALS, V36, P198, DOI 10.1016/j.cct.2013.07.001; Kinner SA, 2012, DRUG ALCOHOL DEPEN, V126, P156, DOI 10.1016/j.drugalcdep.2012.05.008; Martin NK, 2016, HEPATOLOGY, V63, P1796, DOI 10.1002/hep.28497; Mina MM, 2014, MED J AUSTRALIA, V200, P15, DOI 10.5694/mja13.10654; O'Keefe D, 2013, DRUG ALCOHOL REV, V32, P208, DOI 10.1111/j.1465-3362.2012.00502.x; Queensland Health, 2012, HEP C QUEENSL HLTH G; Reekie JM, 2014, MED J AUSTRALIA, V200, P277, DOI 10.5694/mja13.11062; Rowe S, 2012, VICTORIAN INFECT DIS, V15; Rumble C, 2015, EUR J PUBLIC HEALTH; Teutsch S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-633; Topp L, 2009, DRUG ALCOHOL REV, V28, P669, DOI 10.1111/j.1465-3362.2009.00060.x; Treloar C, 2012, DRUG ALCOHOL REV, V31, P918, DOI 10.1111/j.1465-3362.2012.00468.x; van Gamert CB I, 2011, EVALUATION HEPATITIS; WHO, 2016, MYANM NATL SIMPL TRE; World Health Organization, 2012, GUID PREV VIR HEP B	25	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180646	10.1371/journal.pone.0180646	http://dx.doi.org/10.1371/journal.pone.0180646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686715	Green Published, Green Submitted, gold			2022-12-26	WOS:000405464100086
J	Rasmussen, D; Voelker, A; Eliasmith, C				Rasmussen, Daniel; Voelker, Aaron; Eliasmith, Chris			A neural model of hierarchical reinforcement learning	PLOS ONE			English	Article							ORBITOFRONTAL CORTEX; BASAL GANGLIA; COMPUTATIONAL MODEL; PREFRONTAL CORTEX; SELECTION; TIME	We develop a novel, biologically detailed neural model of reinforcement learning (RL) processes in the brain. This model incorporates a broad range of biological features that pose challenges to neural RL, such as temporally extended action sequences, continuous environments involving unknown time delays, and noisy/imprecise computations. Most significantly, we expand the model into the realm of hierarchical reinforcement learning (HRL), which divides the RL process into a hierarchy of actions at different levels of abstraction. Here we implement all the major components of HRL in a neural model that captures a variety of known anatomical and physiological properties of the brain. We demonstrate the performance of the model in a range of different environments, in order to emphasize the aim of understanding the brain's general reinforcement learning ability. These results show that the model compares well to previous modelling work and demonstrates improved performance as a result of its hierarchical ability. We also show that the model's behaviour is consistent with available data on human hierarchical RL, and generate several novel predictions.	[Rasmussen, Daniel; Eliasmith, Chris] Appl Brain Res Inc, Waterloo, ON, Canada; [Voelker, Aaron; Eliasmith, Chris] Univ Waterloo, Ctr Theoret Neurosci, Waterloo, ON, Canada	University of Waterloo	Rasmussen, D (corresponding author), Appl Brain Res Inc, Waterloo, ON, Canada.	daniel.rasmussen@appliedbrainresearch.com			Canada Foundation for Innovation; Ontario Innovation Trust; Canada Research Chairs, National Science and Engineering Research Council of Canada Discovery [261453]; Office of Naval Research [N000141310419]; Air Force Office of Scientific Research [FA8655-13-1-3084]	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Innovation Trust; Canada Research Chairs, National Science and Engineering Research Council of Canada Discovery; Office of Naval Research(Office of Naval Research); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by Canada Foundation for Innovation and Ontario Innovation Trust infrastructure funding and grants from Canada Research Chairs, National Science and Engineering Research Council of Canada Discovery grant 261453,Office of Naval Research grant N000141310419, and Air Force Office of Scientific Research grant FA8655-13-1-3084.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DR, CE are employees of Applied Brain Research, Inc.The funder provided support in the form of salaries for DR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2004, ACM INT C P SERIES, DOI DOI 10.1145/1015330.1015353; [Anonymous], 2003, NEURAL ENG COMPUTATI; [Anonymous], 2001, P 18 INT C MACHINE L; [Anonymous], 2012, OXFORD HDB COMPOSITI; Badre D, 2010, NEURON, V66, P315, DOI 10.1016/j.neuron.2010.03.025; Baras D, 2007, NEURAL COMPUT, V19, P2245, DOI 10.1162/neco.2007.19.8.2245; Barto AG, 2003, DISCRETE EVENT DYN S, P1; Barton-Gooden A, 2015, CLIN NURS RES, V24, P73, DOI 10.1177/1054773813493112; Bekolay T, 2014, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00048; Botvinick M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0480; Botvinick MM, 2009, COGNITION, V113, P262, DOI 10.1016/j.cognition.2008.08.011; Botvinick MM, 2004, PSYCHOL REV; Braver TS, 1999, PROGR BRAIN RES, V121; Carlson JM, 2011, NEUROIMAGE, V57, P1608, DOI 10.1016/j.neuroimage.2011.05.037; Collins AGE, 2013, PSYCHOL REV, V120, P190, DOI 10.1037/a0030852; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Dayan P., 1992, ADV NEURAL INF PROCE, V5, P271; Dayana P, 2008, CURR OPIN NEUROBIOL, V18, P185, DOI 10.1016/j.conb.2008.08.003; Dietterich TG, 2000, J ARTIF INTELL RES, V13, P227, DOI 10.1613/jair.639; Diuk C, 2012, COMPUTATION IN PRESS; Diuk C, 2013, J NEUROSCI, V33, P5797, DOI 10.1523/JNEUROSCI.5445-12.2013; Eliasmith C, 2005, NEURAL COMPUT, V17, P1276, DOI 10.1162/0899766053630332; Florian RV, 2007, NEURAL COMPUT, V19, P1468, DOI 10.1162/neco.2007.19.6.1468; Foster DJ, 2000, HIPPOCAMPUS, V10, P1, DOI 10.1002/(SICI)1098-1063(2000)10:1<1::AID-HIPO1>3.0.CO;2-1; Frank MJ, 2012, CEREB CORTEX, V22, P509, DOI 10.1093/cercor/bhr114; Fremaux N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003024; Friedrich J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002092; Gershman SJ, 2015, SCIENCE, V349, P273, DOI 10.1126/science.aac6076; Gurney K, 2001, BIOL CYBERN, V84, P401, DOI 10.1007/PL00007984; Haruno M, 2006, NEURAL NETWORKS, V19, P1242, DOI 10.1016/j.neunet.2006.06.007; Hengst B, 2012, ADAPT LEARN OPTIM, V12, P293; Holroyd CB, 2015, PSYCHOL REV, V122, P54, DOI 10.1037/a0038339; Holroyd CB, 2012, TRENDS COGN SCI, V16, P122, DOI 10.1016/j.tics.2011.12.008; Howard R. A., 1971, DYNAMIC PROBABILISTI; Howard R. A., 1960, DYNAMIC PROGRAMMING; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Joel D, 2002, NEURAL NETWORKS, V15, P535, DOI 10.1016/S0893-6080(02)00047-3; Jong NK, 2008, 7 INT C AUT AG MULT; Klein U., 2004, P 21 INT C MACH LEAR, P71, DOI DOI 10.1145/1015330.1015355; Lapicque L., 1907, J PHYSIOL PATH GEN, V9, P620, DOI DOI 10.1007/S00422-007-0189-6; Lawson CL, 1974, SOLVING LEAST SQUARE; MacNeil D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022885; Mello GBM, 2015, CURR BIOL, V25, P1113, DOI 10.1016/j.cub.2015.02.036; Menache I, 2002, LECT NOTES ARTIF INT, V2430, P295; Neymotin SA, 2013, NEURAL COMPUT, V25, P3263, DOI 10.1162/NECO_a_00521; Niv Y., 2009, J MATH PSYCHOL, P1; O'Reilly RC, 2007, BEHAV NEUROSCI, V121, P31, DOI 10.1037/0735-7044.121.1.31; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; Parr R, 1998, ADV NEURAL INFORM PR; Potjans W, 2009, NEURAL COMPUT, V21, P301, DOI 10.1162/neco.2008.08-07-593; Rasmussen D., 2013, P 35 ANN C COGN SCI, P3257; Rasmussen D, 2014, THESIS; Rasmussen D, 2014, INTELLIGENCE, V42, P53, DOI 10.1016/j.intell.2013.10.003; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Ribas-Fernandes JJF, 2011, NEURON, V71, P370, DOI 10.1016/j.neuron.2011.05.042; Rougier NP, 2002, COGNITIVE SCI, V26, P503, DOI 10.1207/s15516709cog2604_4; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Seung HS, 2003, NEURON, V40, P1063, DOI 10.1016/S0896-6273(03)00761-X; SINGH SP, 1994, PROCEEDINGS OF THE TWELFTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOLS 1 AND 2, P700; Solway A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003779; Stewart T. C., 2010, P 10 INT C COGN MOD, P235; Stewart TC, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00002; Stewart Terrence C, 2009, Front Neuroinform, V3, P7, DOI 10.3389/neuro.11.007.2009; Strosslin T, 2003, INT C ART NEUR NETW; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Sutton RS, 1999, ARTIF INTELL, V112, P181, DOI 10.1016/S0004-3702(99)00052-1; Taylor ME, 2009, J MACH LEARN RES, V10, P1633; Todd MT, 2008, ADV NEURAL INFORM PR; Uithol S, 2012, J COGNITIVE NEUROSCI, V24, P1077, DOI 10.1162/jocn_a_00204; Urbanczik R, 2009, NAT NEUROSCI, V12, P250, DOI 10.1038/nn.2264; Vasilaki E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000586; Wilson RC, 2014, NEURON, V81, P267, DOI 10.1016/j.neuron.2013.11.005	73	16	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e080234	10.1371/journal.pone.0180234	http://dx.doi.org/10.1371/journal.pone.0180234			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA3HX	28683111	Green Submitted, gold, Green Published			2022-12-26	WOS:000405335200021
J	Amorim, T; Metsios, GS; Wyonm, M; Neville, AM; Flouris, AD; Maia, J; Teixeira, E; Machado, JC; Marques, F; Koutedakis, Y				Amorim, Tania; Metsios, George S.; Wyonm, Matthew; Neville, Alan M.; Flouris, Andreas D.; Maia, Jose; Teixeira, Eduardo; Machado, Jose Carlos; Marques, Franklim; Koutedakis, Yiannis			Bone mass of female dance students prior to professional dance training: A cross-sectional study	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; MINERAL DENSITY; WEIGHT-BEARING; BALLET DANCERS; ATHLETE TRIAD; FEMORAL-NECK; EXERCISE; PUBERTY; GIRLS; ACQUISITION	Background Professional dancers are at risk of developing low bone mineral density (BMD). However, whether low BMD phenotypes already exist in pre-vocational dance students is relatively unknown. Aim To cross-sectionally assess bone mass parameters in female dance students selected for professional dance training (first year vocational dance students) in relation to aged- and sex-matched controls. Methods 34 female selected for professional dance training (10.9yrs +/- 0.7) and 30 controls (11.1yrs +/- 0.5) were examined. Anthropometry, pubertal development (Tanner) and dietary data (3day food diary) were recorded. BMD and bone mineral content (BMC) at forearm, femur neck (FN) and lumbar spine (LS) were assessed using Dual-Energy X-Ray Absorptiometry. Volumetric densities were estimated by calculating bone mineral apparent density (BMAD). Results Dancers were mainly at Tanner pubertal stage I (vs. stage IV in controls, p<0.001), and demonstrated significantly lower body weight (p<0.001) and height (p<0.01) than controls. Calorie intake was not different between groups, but calcium intake was significantly greater in dancers (p<0.05). Dancers revealed a significantly lower BMC and BMD values at all anatomical sites (p<0.001), and significantly lower BMAD values at the LS and FN (p<0.001). When adjusted for covariates (body weight, height, pubertal development and calcium intake), dance students continued to display a significantly lower BMD and BMAD at the FN (p<0.05; p<0.001) at the forearm (p<0.01). Conclusion Before undergoing professional dance training, first year vocational dance students demonstrated inferior bone mass compared to controls. Longitudinal models are required to assess how bone health-status changes with time throughout professional training.	[Amorim, Tania; Maia, Jose] Univ Porto, Fac Sports, Ctr Res Educ Innovat & Intervent Sport, Oporto, Portugal; [Amorim, Tania; Metsios, George S.; Wyonm, Matthew; Neville, Alan M.; Koutedakis, Yiannis] Univ Wolverhampton, Fac Educ Hlth & Wellbeing, Walsall, W Midlands, England; [Metsios, George S.; Flouris, Andreas D.; Koutedakis, Yiannis] Univ Thessaly, Sch Exercise Sci, Trikala, Greece; [Wyonm, Matthew] Natl Inst Dance Med & Sci, London, England; [Flouris, Andreas D.] Univ Thessaly, Dept Exercise Sci, FAME Lab, Trikala, Greece; [Teixeira, Eduardo] Univ Porto, Fac Sports, Res Ctr Phys Act Hlth & Leisure, Oporto, Portugal; [Machado, Jose Carlos] Univ Porto, Inst Mol Pathol & Immunol, Oporto, Portugal; [Marques, Franklim] Univ Porto, Fac Pharm, Oporto, Portugal; [Koutedakis, Yiannis] Inst Res & Technol Thessaly, CERTH, Trikala, Greece	Universidade do Porto; University of Wolverhampton; University of Thessaly; University of Thessaly; Universidade do Porto; Universidade do Porto; Universidade do Porto	Amorim, T (corresponding author), Univ Porto, Fac Sports, Ctr Res Educ Innovat & Intervent Sport, Oporto, Portugal.; Amorim, T (corresponding author), Univ Wolverhampton, Fac Educ Hlth & Wellbeing, Walsall, W Midlands, England.	tania_amorim@hotmail.com	Teixeira, Eduardo/AAD-6456-2021; Machado, Jose Carlos/C-5907-2009; Nevill, Alan/Q-1010-2019; Flouris, Andreas/GXG-4893-2022; Marques, Franklim/K-5879-2013	Machado, Jose Carlos/0000-0003-4741-8415; Nevill, Alan/0000-0003-0506-3652; Koutedakis, Yiannis/0000-0002-7065-9447; Teixeira, Eduardo/0000-0002-1696-2111; Marques, Franklim/0000-0001-9362-1217	Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/88585/2012]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	Author Ta Ania Amorim has received a PhD grant from the Portuguese Foundation for Science and Technology (FCT); (SFRH/BD/88585/2012).	Abraham S, 1996, PSYCHOPATHOLOGY, V29, P218, DOI 10.1159/000284996; Amorim T, 2015, SPORTS MED, V45, P257, DOI 10.1007/s40279-014-0268-5; [Anonymous], 2007, MED SCI SPORT EXER, V39, P1867, DOI 10.1249/mss.0b013e318149f111; Armann S, 1990, KINESIOL MED DANCE, V13, P1; Baxter-Jones ADG, 2010, BONE, V46, P208, DOI 10.1016/j.bone.2009.10.017; Bennell K, 2000, PEDIATR EXERC SCI, V12, P371, DOI 10.1123/pes.12.4.371; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Bradney M, 1998, J BONE MINER RES, V13, P1814, DOI 10.1359/jbmr.1998.13.12.1814; Burckhardt Peter, 2011, J Dance Med Sci, V15, P51; Calbet JAL, 1998, CALCIFIED TISSUE INT, V62, P491, DOI 10.1007/s002239900467; Chevalley T, 2009, J CLIN ENDOCR METAB, V94, P3424, DOI 10.1210/jc.2009-0241; CRAWFORD PB, 1994, J AM DIET ASSOC, V94, P626, DOI 10.1016/0002-8223(94)90158-9; Darelid A, 2012, J BONE MINER RES, V27, P2198, DOI 10.1002/jbmr.1675; Faulkner KG, 1996, OSTEOPOROSIS INT, V6, P432, DOI 10.1007/BF01629574; Foldes A, 1996, ORTHOPEDICS CLIN SCI, V18, P296; FREDERICK L, 1992, J AM DIET ASSOC, V92, P299; Gomez-Bruton A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070119; Guadalupe-Grau A, 2009, SPORTS MED, V39, P439, DOI 10.2165/00007256-200939060-00002; HAGIWARA S, 1994, J BONE MINER RES, V9, P1425; Heaney RP, 2000, OSTEOPOROSIS INT, V11, P985, DOI 10.1007/s001980070020; Ishikawa S, 2013, SPORTS MED, V43, P875, DOI 10.1007/s40279-013-0060-y; KATZMAN DK, 1991, J CLIN ENDOCR METAB, V73, P1332, DOI 10.1210/jcem-73-6-1332; Kohrt WM, 2004, MED SCI SPORT EXER, V36, P1985, DOI 10.1249/01.MSS.0000142662.21767.58; Koutedakis Y, 2004, J STRENGTH COND RES, V18, P714; Koutedakis Y, 2004, SPORTS MED, V34, P651, DOI 10.2165/00007256-200434100-00003; Koutedakis Y., 1997, J DANCE MED SCI, V1, P12; Koutedakis Y, 2007, J STRENGTH COND RES, V21, P808; KROGER H, 1993, BONE MINER, V23, P171, DOI 10.1016/S0169-6009(08)80094-3; Lu Y, 2001, OSTEOPOROSIS INT, V12, P438, DOI 10.1007/s001980170087; Ma NS, 2012, J PEDIATR-US, V161, P983, DOI 10.1016/j.jpeds.2012.07.057; Matthews BL, 2006, OSTEOPOROSIS INT, V17, P1043, DOI 10.1007/s00198-006-0093-2; McKay HA, 2000, J BONE MINER RES, V15, P1181, DOI 10.1359/jbmr.2000.15.6.1181; Morris FL, 1997, J BONE MINER RES, V12, P1453, DOI 10.1359/jbmr.1997.12.9.1453; MORRIS NM, 1980, J YOUTH ADOLESCENCE, V9, P271, DOI 10.1007/BF02088471; Mountjoy M, 2014, BRIT J SPORT MED, V48, P491, DOI 10.1136/bjsports-2014-093502; Mughal MZ, 2011, CURR OPIN ENDOCRINOL, V18, P28, DOI 10.1097/MED.0b013e3283416441; Nurmi-Lawton JA, 2004, J BONE MINER RES, V19, P314, DOI 10.1359/JBMR.0301222; Pearson D, 2006, J CLIN DENSITOM, V9, P287, DOI 10.1016/j.jocd.2006.02.006; POCOCK NA, 1992, J BONE MINER RES, V7, P1081; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Shepherd JA, 2002, J BONE MINER RES, V17, P734, DOI 10.1359/jbmr.2002.17.4.734; Torstveit MK, 2005, MED SCI SPORT EXER, V37, P184, DOI 10.1249/01.MSS.0000152677.60545.3A; Valentino R, 2001, J CLIN ENDOCR METAB, V86, P4674, DOI 10.1210/jc.86.10.4674; Vicente-Rodriguez G, 2004, BONE, V35, P1208, DOI 10.1016/j.bone.2004.06.012; Vicente-Rodriguez G, 2006, SPORTS MED, V36, P561, DOI 10.2165/00007256-200636070-00002; WARREN MP, 1991, J CLIN ENDOCR METAB, V72, P847, DOI 10.1210/jcem-72-4-847; Warren MP, 1998, J AM MED WOMEN ASSOC, V54, P115; Yannakoulia M, 2004, INT J SPORT NUTR EXE, V14, P285, DOI 10.1123/ijsnem.14.3.285; YOUNG N, 1994, J CLIN ENDOCR METAB, V78, P449, DOI 10.1210/jc.78.2.449	49	11	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180639	10.1371/journal.pone.0180639	http://dx.doi.org/10.1371/journal.pone.0180639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678833	Green Submitted, gold, Green Published			2022-12-26	WOS:000405272200082
J	Beau, A; Rivollat, M; Reveillas, H; Pemonge, MH; Mendisco, F; Thomas, Y; Lefranc, P; Deguilloux, MF				Beau, Alice; Rivollat, Maite; Reveillas, Helene; Pemonge, Marie-Helene; Mendisco, Fanny; Thomas, Yohann; Lefranc, Philippe; Deguilloux, Marie-France			Multi-scale ancient DNA analyses confirm the western origin of Michelsberg farmers and document probable practices of human sacrifice	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; HUNTER-GATHERERS; GENOMES	In Europe, the Middle Neolithic is characterized by an important diversification of cultures. In northeastern France, the appearance of the Michelsberg culture has been correlated with major cultural changes and interpreted as the result of the settlement of new groups originating from the Paris Basin. This cultural transition has been accompanied by the expansion of particular funerary practices involving inhumations within circular pits and individuals in "non-conventional" positions (deposited in the pits without any particular treatment). If the status of such individuals has been highly debated, the sacrifice hypothesis has been retained for the site of Gougenheim (Alsace). At the regional level, the analysis of the Gougenheim mitochondrial gene pool (SNPs and HVR-I sequence analyses) permitted us to highlight a major genetic break associated with the emergence of the Michelsberg in the region. This genetic discontinuity appeared to be linked to new affinities with farmers from the Paris Basin, correlated to a noticeable hunter-gatherer legacy. All of the evidence gathered supports (i) the occidental origin of the Michelsberg groups and (ii) the potential implication of this migration in the progression of the hunter-gatherer legacy from the Paris Basin to Alsace / Western Germany at the beginning of the Late Neolithic. At the local level, we noted some differences in the maternal gene pool of individuals in "conventional" vs. "non-conventional" positions. The relative genetic isolation of these sub-groups nicely echoes both their social distinction and the hypothesis of sacrifices retained for the site. Our investigation demonstrates that a multi-scale aDNA study of ancient communities offers a unique opportunity to disentangle the complex relationships between cultural and biological evolution.	[Beau, Alice; Rivollat, Maite; Reveillas, Helene; Pemonge, Marie-Helene; Mendisco, Fanny; Deguilloux, Marie-France] Univ Bordeaux, CNRS, Anthropol UMR 5199, Prehist Actuel,Culture,Environm,CS, Allee Geoffroy St Hilaire, Pessac, France; [Rivollat, Maite] Ctr Archeol Prevent Bordeaux Metropole, Direct Batiments & Moyens, Esplanade Charles de Gaulle, Bordeaux, France; [Reveillas, Helene; Thomas, Yohann; Lefranc, Philippe] Ctr Archeol Strasbourg, Inst Natl Rech Archeol Prevent, 10 Rue Altkirch, Strasbourg, France; [Lefranc, Philippe] Univ Strasbourg, Archeol & Hist Ancienne Mediterranee Europe UMR 7, Maison Interuniv Sci Homme Alsace, CS, 5 Allee Gen Rouvillois, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Rivollat, M (corresponding author), Univ Bordeaux, CNRS, Anthropol UMR 5199, Prehist Actuel,Culture,Environm,CS, Allee Geoffroy St Hilaire, Pessac, France.; Lefranc, P (corresponding author), Ctr Archeol Strasbourg, Inst Natl Rech Archeol Prevent, 10 Rue Altkirch, Strasbourg, France.; Lefranc, P (corresponding author), Univ Strasbourg, Archeol & Hist Ancienne Mediterranee Europe UMR 7, Maison Interuniv Sci Homme Alsace, CS, 5 Allee Gen Rouvillois, Strasbourg, France.	rivollat.maite@gmail.com; philippe.lefranc@inrap.fr		Rivollat, Maite/0000-0002-4011-2862	Research National Agency [ANR-10-LABX-52]; Minist Sredel 'Enseignement Supe Arieuret dela Recherche; Conseil Regionald 'Aquitainen E [20030304002FA, 20040305003FA]; European Union, FEDER [2003227]; Investissements davenir, Convention attributive daide [NEANR-10-EQPX-16-01]	Research National Agency; Minist Sredel 'Enseignement Supe Arieuret dela Recherche; Conseil Regionald 'Aquitainen E; European Union, FEDER; Investissements davenir, Convention attributive daide(French National Research Agency (ANR))	This research was funded through a ministerial grant from the Research National Agency as a program of prospects investments ANR-10-LABX-52 (http://www.agence-nationaler echerche.fr/). The study was also financially supported through a PhD research grant from the Minist Sredel 'Enseignement Supe Arieuret dela Recherche for MR (http://www.enseignementsupr echerche.gouv.fr/). Part of the presented experiments (SNP sanalyses) were performed at the Genomic and Sequencing Facility of Bordeaux, grants from the Conseil Regionald 'Aquitainen E 20030304002FA and 20040305003FA, https:// www.nouvelle-aquitaine.fr/, and from the European Union, FEDER no 2003227 and from Investissements davenir, Convention attributive daide NEANR-10-EQPX-16-01, http://www.agencen ationale-recherche.fr/. The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Beeching A, 1991, ID CHASS ACT C INT N; Boulestin B, 2008, BULL SOC PREHIST FR, V105, P103, DOI 10.3406/bspf.2008.13707; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Brandt G, 2015, J HUM EVOL, V79, P73, DOI 10.1016/j.jhevol.2014.06.017; Brandt G, 2013, SCIENCE, V342, P257, DOI 10.1126/science.1241844; Brotherton P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2656; Denaire A, 2016, J ARCHAEOLOGICAL MET; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fernandez E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004401; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; Garanger J., 1972, ARCHEOLOGIE MISE PLA, V1; Goude G, 2015, INT J OSTEOARCHAEOL, V25, P988, DOI 10.1002/oa.2399; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Haak W, 2008, P NATL ACAD SCI USA, V105, P18226, DOI 10.1073/pnas.0807592105; Hofmanova Z, 2016, P NATL ACAD SCI USA, V113, P6886, DOI 10.1073/pnas.1523951113; Jeunesse C., 1982, REV ARCHEOLOGIQUE PI, V4, P49; Jeunesse C., 2006, MORTS ANORMAUX SEPUT, P28; Jeunesse C., 1998, MICHELSBERGER KULTUR, V43, P29; Jeunesse C, 2004, CAHIERS ASS PROMOTIO, V18, P1; Keller M, 2015, AM J PHYS ANTHROPOL, V157, P458, DOI 10.1002/ajpa.22738; Lacan M, 2011, P NATL ACAD SCI USA, V108, P9788, DOI 10.1073/pnas.1100723108; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Le Bolloch MA, 1989, CERAMIQUE MICHELSBER; Lee E, 2014, ARCHAEOL ANTHROP SCI, V6, P199, DOI 10.1007/s12520-013-0173-0; Lefranc P, 2014, NEOLITHIC BODIES NEO; Lefranc P, 2015, DEATH ARCHAEOLOGY TR, P131; Lefranc P., 2009, FOUILLES DECOUVERTES, P25; Lichardus J., 1986, NEOL FRANC, P243; Malmstrom H, 2009, CURR BIOL, V19, P1758, DOI 10.1016/j.cub.2009.09.017; Mathieson I, 2015, NATURE, V528, P499, DOI 10.1038/nature16152; Mendisco F, 2011, ELECTROPHORESIS, V32, P386, DOI 10.1002/elps.201000483; Nickel C., 1998, BERICHT ROMISCH GERM; Olalde I., 2015, MOL BIOL EVOL, DOI DOI 10.1093/MOLBEV/MSV181; Olalde I, 2014, NATURE, V507, P225, DOI 10.1038/nature12960; Omrak A, 2016, CURR BIOL, V26, P270, DOI 10.1016/j.cub.2015.12.019; Price TD, 2000, EUROPES 1 FARMERS; Rivollat M, 2016, EUROPEAN J HUMAN GEN; Rivollat M, 2016, AM J PHYS ANTHROPOL, V161, P522, DOI 10.1002/ajpa.23055; Rivollat M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125521; SCHWEITZER J., 1987, CAHIERS ASS PROMOTIO, V3, P50; SCOLLAR I, 1959, P PREHIST SOC, V25, P52, DOI 10.1017/S0079497X00016509; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Szecsenyi-Nagy A, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0339; Testart A., 2004, SERVITUDE VOLONTAIRE; Thomas L-V, 1980, CADAVRE BIOL EDITONS; Thomas Y, 2016, GOUGENHEIM GINGSHEIM; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Whittle A., 1996, EUROPE NEOLITHIC CRE	51	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179742	10.1371/journal.pone.0179742	http://dx.doi.org/10.1371/journal.pone.0179742			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FA2LF	28678860	Green Submitted, Green Published, gold			2022-12-26	WOS:000405272200026
J	Bhak, Y; Jeon, Y; Jeon, S; Chung, O; Jho, S; Jun, J; Kim, HM; Cho, Y; Yoon, C; Lee, S; Kang, JH; Lim, JD; An, J; Cho, YS; Ryu, DY; Bhak, J				Bhak, Youngjune; Jeon, Yeonsu; Jeon, Sungwon; Chung, Oksung; Jho, Sungwoong; Jun, JeHoon; Kim, Hak-Min; Cho, Yongsoo; Yoon, Changhan; Lee, Seungwoo; Kang, Jung-Hoon; Lim, Jong-Deock; An, Junghwa; Cho, Yun Sung; Ryu, Doug-Young; Bhak, Jong			Myotis rufoniger genome sequence and analyses: M-rufoniger's genomic feature and the decreasing effective population size of Myotis bats	PLOS ONE			English	Article							OCULOCUTANEOUS ALBINISM; CHIROPTERA; ALIGNMENT; GENE; DNA; VESPERTILIONIDAE; IDENTIFICATION; SPERMATOZOA; GENERATION; MUTATIONS	Myotis rufoniger is a vesper bat in the genus Myotis. Here we report the whole genome sequence and analyses of the M. rufoniger. We generated 124 Gb of short-read DNA sequences with an estimated genome size of 1.88 Gb at a sequencing depth of 66x fold. The sequences were aligned to M. brandtii bat reference genome at a mapping rate of 96.50% covering 95.71% coding sequence region at 10x coverage. The divergence time of Myotis bat family is estimated to be 11.5 million years, and the divergence time between M. rufoniger and its closest species M. davidii is estimated to be 10.4 million years. We found 1,239 function-altering M. rufoniger specific amino acid sequences from 929 genes compared to other Myotis bat and mammalian genomes. The functional enrichment test of the 929 genes detected amino acid changes in melanin associated DCT, SLC45A2, TYRP1, and OCA2 genes possibly responsible for the M. rufoniger's red fur color and a general coloration in Myotis. N6AMT1 gene, associated with arsenic resistance, showed a high degree of function alteration in M. rufoniger. We further confirmed that the M. rufoniger also has batspecific sequences within FSHB, GHR, IGF1R, TP53, MDM2, SLC45A2, RGS7BP, RHO, OPN1SW, and CNGB3 genes that have already been published to be related to bat's reproduction, lifespan, flight, low vision, and echolocation. Additionally, our demographic history analysis found that the effective population size of Myotis clade has been consistently decreasing since similar to 30k years ago. M. rufoniger's effective population size was the lowest in Myotis bats, confirming its relatively low genetic diversity.	[Bhak, Youngjune; Jeon, Yeonsu; Jeon, Sungwon; Kim, Hak-Min; Cho, Yongsoo; Yoon, Changhan; Cho, Yun Sung; Bhak, Jong] Ulsan Natl Inst Sci & Technol, Genom Inst, Ulsan, South Korea; [Bhak, Youngjune; Jeon, Yeonsu; Jeon, Sungwon; Kim, Hak-Min; Cho, Yongsoo; Cho, Yun Sung; Bhak, Jong] Ulsan Natl Inst Sci & Technol, Dept Biomed Engn, Sch Life Sci, Ulsan, South Korea; [Chung, Oksung; Jho, Sungwoong; Jun, JeHoon; Cho, Yun Sung; Bhak, Jong] Genome Res Fdn, Personal Genom Inst, Cheongju, South Korea; [Yoon, Changhan] Ulsan Natl Inst Sci & Technol, Dept Biomed Sci, Sch Nanobiosci & Chem Engn, Ulsan, South Korea; [Lee, Seungwoo; Ryu, Doug-Young] Seoul Natl Univ, PLUS Program Creat Vet Sci Res BK21, Res Inst Vet Sci, Seoul, South Korea; [Lee, Seungwoo; Ryu, Doug-Young] Seoul Natl Univ, Coll Vet Med, Seoul, South Korea; [Kang, Jung-Hoon; Lim, Jong-Deock] Cultural Heritage Adm, Natl Res Inst Cultural Heritage, Daejeon, South Korea; [An, Junghwa] Natl Inst Biol Resources, Anim Resources Div, Incheon, South Korea	Ulsan National Institute of Science & Technology (UNIST); Ulsan National Institute of Science & Technology (UNIST); Ulsan National Institute of Science & Technology (UNIST); Seoul National University (SNU); Seoul National University (SNU); National Institute of Biological Resources	Cho, YS; Bhak, J (corresponding author), Ulsan Natl Inst Sci & Technol, Genom Inst, Ulsan, South Korea.; Cho, YS; Bhak, J (corresponding author), Ulsan Natl Inst Sci & Technol, Dept Biomed Engn, Sch Life Sci, Ulsan, South Korea.; Cho, YS; Bhak, J (corresponding author), Genome Res Fdn, Personal Genom Inst, Cheongju, South Korea.; Ryu, DY (corresponding author), Seoul Natl Univ, PLUS Program Creat Vet Sci Res BK21, Res Inst Vet Sci, Seoul, South Korea.; Ryu, DY (corresponding author), Seoul Natl Univ, Coll Vet Med, Seoul, South Korea.	joys0406@gmail.com; dyryu@snu.ac.kr; jongbhak@genomics.org		Bhak, Youngjune/0000-0002-9273-6984; Jeon, Sungwon/0000-0002-2729-9087; Cho, Yun Sung/0000-0003-4490-8769	'the bioinformatics marker discovery analysis system using genomic big data' Research Fund of Ulsan National Institute of Science & Technology (UNIST) [1.150014.01]; 'Software Convergence Technology Development Program' through the Ministry of Science, ICT and Future Planning [S0503-171 007]; PGI of Genome Research Foundation; National Institute of Biological Resources - Ministry of Environment, Republic of Korea [NIBR201603103]; Ulsancity's Genome Korea Project	'the bioinformatics marker discovery analysis system using genomic big data' Research Fund of Ulsan National Institute of Science & Technology (UNIST); 'Software Convergence Technology Development Program' through the Ministry of Science, ICT and Future Planning; PGI of Genome Research Foundation; National Institute of Biological Resources - Ministry of Environment, Republic of Korea; Ulsancity's Genome Korea Project	This work was supported by 'the bioinformatics marker discovery analysis system using genomic big data' Research Fund (1.150014.01) of Ulsan National Institute of Science & Technology (UNIST). It was also supported by 'Software Convergence Technology Development Program' through the Ministry of Science, ICT and Future Planning (S0503-171 007), PGI of Genome Research Foundation internal research fund, a grant (NIBR201603103) from the National Institute of Biological Resources funded by the Ministry of Environment, Republic of Korea, and Ulsancity's Genome Korea Project. Geromics Inc. provided support in the form of salaries for OC, JHJ, and JB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bintanja R, 2008, NATURE, V454, P869, DOI 10.1038/nature07158; Boissy RE, 1996, AM J HUM GENET, V58, P1145; Cho YS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3433; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Chung O, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0780-4; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Hartman CG, 1933, Q REV BIOL, V8, P185, DOI 10.1086/394433; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iannelli M, 2011, COMMUNICATION   0618; Kim S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1071-4; Kim YM, 2011, MITOCHONDR DNA, V22, P71, DOI 10.3109/19401736.2011.624598; KITCHENER DJ, 1975, AUST J ZOOL, V23, P29, DOI 10.1071/ZO9750029; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LEE ST, 1995, GENOMICS, V26, P354, DOI 10.1016/0888-7543(95)80220-G; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Manga P, 1997, AM J HUM GENET, V61, P1095, DOI 10.1086/301603; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller W, 2012, P NATL ACAD SCI USA, V109, pE2382, DOI 10.1073/pnas.1210506109; Monge G, 2014, SCI REPORTS, V5, P14252; Newton JM, 2001, AM J HUM GENET, V69, P981, DOI 10.1086/324340; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; RACEY PA, 1979, J REPROD FERTIL, V56, P391; Ren XF, 2011, ENVIRON HEALTH PERSP, V119, P771, DOI 10.1289/ehp.1002733; Ruedi M, 2015, ZOOTAXA, V3920, P301, DOI 10.11646/zootaxa.3920.2.6; Seim I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3212; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith JDL, 2009, BIOL LETTERS, V5, P347, DOI 10.1098/rsbl.2009.0016; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sturm RA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-248; Tacutu R, 2012, NUCLEIC ACIDS RES; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tarailo-Graovac M., 2009, CURR PROTOC BIOINFOR, V25, p4.10.11, DOI 10.1002/0471250953.bi0410s25; Tomes RF, 1858, P ZOOLOGICAL SOC LON; Xu X, 2013, CURR BIOL, V23, P1031, DOI 10.1016/j.cub.2013.04.054; Yim HS, 2014, NAT GENET, V46, P88, DOI 10.1038/ng.2835; Yu HeeJeong, 2016, Korean Journal of Veterinary Research, V56, P51, DOI 10.14405/kjvr.2016.56.1.51; Zhang G, 2012, SCIENCE	45	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180418	10.1371/journal.pone.0180418	http://dx.doi.org/10.1371/journal.pone.0180418			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678835	gold, Green Published, Green Submitted			2022-12-26	WOS:000405272200063
J	Wotodjo, AN; Doucoure, S; Gaudart, J; Diagne, N; Sarr, FD; Faye, N; Tall, A; Raoult, D; Sokhna, C				Wotodjo, Amele Nyedzie; Doucoure, Souleymane; Gaudart, Jean; Diagne, Nafissatou; Sarr, Fatoumata Diene; Faye, Ngor; Tall, Adama; Raoult, Didier; Sokhna, Cheikh			Malaria in Dielmo, a Senegal village: Is its elimination possible after seven years of implementation of long-lasting insecticide-treated nets?	PLOS ONE			English	Article							BED NETS; PYRETHROID RESISTANCE; ARTEMETHER-LUMEFANTRINE; ARTEMISININ RESISTANCE; FALCIPARUM-MALARIA; HOLOENDEMIC AREA; VECTOR CONTROL; TRANSMISSION; EFFICACY; IMPACT	Background The malaria burden has decreased significantly in recent years in Africa through the widespread use of artemisinin-based combination therapy (ACT) and long-lasting insectici-detreated nets (LLINs). However, the occurrence of malaria resurgences, the loss of immunity of exposed populations constitute among other factors, serious concerns about the future of malaria elimination efforts. This study investigated the evolution of malaria morbidity in Dielmo (Senegal) before and after the implementation of LLINs. Methods A longitudinal study was carried out in Dielmo over eight years, from July 2007 to July 2015. In July 2008, LLINs were offered to all villagers, and in July 2011 and August 2014 the LLINs were renewed. A survey on LLINs use was done each quarter of the year. Thick smears stained with Giemsa, a rapid diagnostic test (RDT) and quantitative polymerase chain reaction (PCR) methods were performed for all cases of fever to assess malaria clinical attacks. Malaria cases were treated with ACT since June 2006. Results Malaria morbidity has decreased significantly since the implementation of LLINs in Dielmo, together with ACT. However, malaria resurgences have occurred twice during the seven years of LLINs use. These resurgences occurred the first time during the third year after the introduction of LLINs (aIRR (adjusted incidence-rate ratio) [95% CI] = 5.90 [3.53; 9.88] p< 0.001) and a second time during the third year after the renewal of LLINs (aIRR [95% CI] = 5.60 [3.34; 9.39] p<0.001). Sixty-nine percent (69%) of the nets tested for their long-lasting insecticidal activity remained effective after 3 years of use. Conclusion Good management of malaria cases by the use of ACT as first-line treatment against malaria in addition to the use of LLINshas significantly reduced malaria in Dielmo and allowed to reach the phase of pre-elimination of the disease. However, the occurrence of malaria resurgences raised serious concerns about malaria elimination, which would require additional tools in this village.	[Wotodjo, Amele Nyedzie; Doucoure, Souleymane; Diagne, Nafissatou; Sokhna, Cheikh] Aix Marseille Univ, Unite Rech Malad Infect & Trop Emergentes, INSERMU1095, IRD198,UM63,CNRS7278, Campus UCAD IRD, Dakar, Senegal; [Wotodjo, Amele Nyedzie; Faye, Ngor] Univ Cheikh Anta Diop Dakar, Fac Sci & Tech, Lab Parasitol, Dakar, Senegal; [Gaudart, Jean] Aix Marseille Univ, IER, INSERM, SESSTIM UMR912, Marseille, France; [Sarr, Fatoumata Diene; Tall, Adama] Inst Pasteur, Unite Epiderniol Malad Infect, Dakar, Senegal; [Raoult, Didier] Aix Marseille Univ, Unite Rech Malad Infect & Trop Emergentes, Inst Hosp Univ Mediterranee Infect, IRD198,UM63,CNRS7278,INSERMU1095, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; University Cheikh Anta Diop Dakar; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Sokhna, C (corresponding author), Aix Marseille Univ, Unite Rech Malad Infect & Trop Emergentes, INSERMU1095, IRD198,UM63,CNRS7278, Campus UCAD IRD, Dakar, Senegal.	cheikh.sokhna@ird.fr	wotodjo, Amélé Nyedzie/AAK-5188-2020; gaudart, jean/D-9071-2013; RAOULT, Didier/A-8434-2008	wotodjo, Amélé Nyedzie/0000-0001-6940-7325; gaudart, jean/0000-0001-9006-5729; RAOULT, Didier/0000-0002-0633-5974	Institut de Recherche pour le Developpement; Pasteur Institute of Dakar	Institut de Recherche pour le Developpement; Pasteur Institute of Dakar	Funded by Institut de Recherche pour le Developpement and the Pasteur Institute of Dakar.	[Anonymous], MALARIA J; [Anonymous], 2019, GUID LAB FIELD TEST; [Anonymous], 2005, GUIDELINES LAB FIELD; [Anonymous], 2008, GLOB MAL ACT PLAN MA; [Anonymous], PLOS ONE; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Atieli HE, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-113; Barnes KI, 2005, ACTA TROP, V94, P230, DOI 10.1016/j.actatropica.2005.04.014; Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330; Berthelemy JC, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-200; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; CHOI HW, 1995, AM J TROP MED HYG, V52, P377, DOI 10.4269/ajtmh.1995.52.377; Chuquiyauri R, 2012, ACTA TROP, V121, P292, DOI 10.1016/j.actatropica.2011.11.003; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Corbel V, 2012, LANCET INFECT DIS, V12, P617, DOI 10.1016/S1473-3099(12)70081-6; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Drakeley C, 2014, LANCET INFECT DIS, V14, P445, DOI 10.1016/S1473-3099(14)70742-X; Egrot M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-247; Faye B, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-80; Fontenille D, 1997, AM J TROP MED HYG, V56, P247, DOI 10.4269/ajtmh.1997.56.247; Greenwood B, 2014, LANCET, V383, P1703, DOI 10.1016/S0140-6736(14)60044-1; Greenwood Brian, 2009, Trans R Soc Trop Med Hyg, V103 Suppl 1, pS2, DOI 10.1016/j.trstmh.2008.10.027; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Henry MC, 2005, AM J TROP MED HYG, V73, P859, DOI 10.4269/ajtmh.2005.73.859; Honjo K, 2013, PARASITOLOGY, V140, P580, DOI 10.1017/S0031182012002077; Kariuki SK, 2003, AM J TROP MED HYG, V68, P108, DOI 10.4269/ajtmh.2003.68.108; Lee PW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-264; Makanga M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-291; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Ndour C T, 2006, Bull Soc Pathol Exot, V99, P290; Noor AM, 2014, LANCET, V383, P1739, DOI 10.1016/S0140-6736(13)62566-0; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; Nuwaha F, 2001, AM J TROP MED HYG, V65, P877, DOI 10.4269/ajtmh.2001.65.877; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544; Roucher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046188; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Trape JF, 2014, LANCET INFECT DIS, V14, P476, DOI 10.1016/S1473-3099(14)70712-1; Trape JF, 2012, J INFECT DIS, V205, P672, DOI 10.1093/infdis/jir805; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2008, GLOB MAL CONTR EL RE; Wondji CS, 2012, P NATL ACAD SCI USA, V109, P19063, DOI 10.1073/pnas.1217229109; Wotodjo AN, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0871-9; Wotodjo AN, 2015, AM J TROP MED HYG, V92, P565, DOI 10.4269/ajtmh.14-0485; Zwang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006358	54	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179528	10.1371/journal.pone.0179528	http://dx.doi.org/10.1371/journal.pone.0179528			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678846	gold, Green Published, Green Submitted			2022-12-26	WOS:000405272200017
J	Ho, SY; Liu, PH; Hsu, CY; Hsia, CY; Lee, YH; Lee, RC; Huang, YH; Lee, FY; Hou, MC; Tsai, YJ; Huo, TI				Ho, Shu-Yein; Liu, Po-Hong; Hsu, Chia-Yang; Hsia, Cheng-Yuan; Lee, Yun-Hsuan; Lee, Rheun-Chuan; Huang, Yi-Hsiang; Lee, Fa-Yauh; Hou, Ming-Chih; Tsai, Ya-Ju; Huo, Teh-Ia			Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization	PLOS ONE			English	Article							HEPATITIS-B; RENAL-FAILURE; CIRRHOSIS; SCORE; FIBROSIS; DISEASE; RISK; DETERMINANTS; VALIDATION; PREDICTION	Background Various noninvasive liver reserve markers were proposed to indicate the severity of liver damage. However, the role and feasibility of these markers to predict the prognosis of patients with hepatocellular carcinoma (HCC) are unknown. We aimed to identify the prognostic role of the 8 currently used hepatic reserve markers in patients with HCC undergoing transarterial chemoembolization (TACE). Methods Between 2002 and 2013, a total of 881 patients with HCC undergoing TACE were prospectively identified and retrospectively analyzed. The baseline characteristics, tumor status and noninvasive markers were collected. Homogeneity and corrected Akaike information criteria (AICc) were compared between these markers. The Cox proportional hazards model was used to identify independent predictors of survival. Results Significant differences in survival distribution were found for albumin-bilirubin (ALBI) grade, Child-Turcotte-Pugh (CTP) class, Lok index, fibrosis index based on 4 factors (FIB-4), Go E teborg University cirrhosis index (GUCI), cirrhosis discriminant index (CDI) and model for endstage liver disease (MELD) score (all p values <0.05). Among these markers, the ALBI grade showed the highest homogeneity and lowest AICc value, indicating a better prognostic performance. Cox multivariate analysis confirmed that ALBI grade 2, ascites, serum alkaline phosphatase and alpha-fetoprotein level, tumor diameter, vascular invasion and performance status were significant independent prognostic predictors. The distribution of the ALBI score well correlated with baseline CTP and MLED scores. Conclusions Our data suggest that among the currently used liver reserve markers, ALBI grade may serve as an objective and feasible surrogate to predict the prognosis of HCC patients undergoing TACE.	[Ho, Shu-Yein; Liu, Po-Hong; Lee, Yun-Hsuan; Huang, Yi-Hsiang; Lee, Fa-Yauh; Hou, Ming-Chih; Huo, Teh-Ia] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan; [Ho, Shu-Yein; Liu, Po-Hong; Hsu, Chia-Yang; Hsia, Cheng-Yuan; Lee, Yun-Hsuan; Lee, Rheun-Chuan; Huang, Yi-Hsiang; Lee, Fa-Yauh; Hou, Ming-Chih; Huo, Teh-Ia] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan; [Liu, Po-Hong] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Hsu, Chia-Yang] Univ Nevada, Sch Med, Dept Internal Med, Reno, NV 89557 USA; [Hsia, Cheng-Yuan] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan; [Lee, Rheun-Chuan] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Huang, Yi-Hsiang] Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei, Taiwan; [Tsai, Ya-Ju] Renown Reg Med Ctr, Reno, NV USA; [Huo, Teh-Ia] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Harvard University; Harvard T.H. Chan School of Public Health; Nevada System of Higher Education (NSHE); University of Nevada Reno; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Huo, TI (corresponding author), Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan.; Huo, TI (corresponding author), Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan.; Huo, TI (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei, Taiwan.	tihuo@vghtpe.gov.tw	Liu, Po-Hong/HGB-9015-2022; Liu, Po-Hong/G-8459-2015	Liu, Po-Hong/0000-0001-6205-3704; Huang, Yi-Hsiang/0000-0001-5241-5425	Center of Excellence for Cancer Research at Taipei Veterans General Hospital Taiwan [MOHW104-TDUB -211-124-001]; Taipei Veterans Genera lHospital Taiwan [V105C-009, V105A-011, VN1061 1]	Center of Excellence for Cancer Research at Taipei Veterans General Hospital Taiwan; Taipei Veterans Genera lHospital Taiwan(Taipei Veterans General Hospital)	This study was supported by grants from the Center of Excellence for Cancer Research at Taipei Veterans General Hospital (MOHW104-TDUB -211-124-001), Taiwan, from Taipei Veterans Genera lHospital (V105C-009,V105A-011,VN1061 1), Taiwan.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bonacini M, 1997, AM J GASTROENTEROL, V92, P1302; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017; Chan AWH, 2016, J GASTROEN HEPATOL, V31, P1300, DOI 10.1111/jgh.13291; Choi WM, 2015, LIVER INT, V35, P1992, DOI 10.1111/liv.12776; Durand F, 2008, SEMIN LIVER DIS, V28, P110, DOI 10.1055/s-2008-1040325; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Hiraoka A, 2016, J GASTROEN HEPATOL, V31, P1031, DOI 10.1111/jgh.13250; Hsu CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118825; Hsu CY, 2013, HEPATOLOGY, V57, P112, DOI 10.1002/hep.25950; Hsu CY, 2010, LIVER INT, V30, P77, DOI 10.1111/j.1478-3231.2009.02128.x; Huang YH, 2005, ALIMENT PHARM THER, V21, P687, DOI 10.1111/j.1365-2036.2005.02404.x; Huo TI, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-146; Huo TI, 2006, J CLIN GASTROENTEROL, V40, P543, DOI 10.1097/00004836-200607000-00014; Huo TI, 2004, ALIMENT PHARM THER, V19, P999, DOI 10.1111/j.1365-2036.2004.01936.x; Ibrahim JG, 2012, J CLIN ONCOL, V30, P3297, DOI 10.1200/JCO.2011.38.7589; Johnson PJ, 2015, J CLIN ONCOL, V33, P550, DOI 10.1200/JCO.2014.57.9151; Kao WY, 2011, WORLD J SURG, V35, P858, DOI 10.1007/s00268-010-0928-z; Lee IC, 2012, HEPATOL INT, V6, P753, DOI 10.1007/s12072-011-9322-7; Lee MH, 2013, HEPATOLOGY, V58, P546, DOI 10.1002/hep.26385; Lee YH, 2014, J CLIN GASTROENTEROL, V48, P734, DOI 10.1097/MCG.0b013e3182a8a254; Liu P. H., 2016, J GASTROENTEROL HEPA; Liu PH, 2016, EUR J CANCER, V63, P25, DOI 10.1016/j.ejca.2016.04.023; Liu PH, 2016, J HEPATOL, V64, P601, DOI 10.1016/j.jhep.2015.10.029; Liu PH, 2015, J SURG ONCOL, V111, P404, DOI 10.1002/jso.23854; Lok ASF, 2005, HEPATOLOGY, V42, P282, DOI 10.1002/hep.20772; Marrero JA, 2005, HEPATOLOGY, V41, P707, DOI 10.1002/hep.20636; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Petrick JL, 2016, J CLIN ONCOL, V34, P1787, DOI 10.1200/JCO.2015.64.7412; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Schutte K, 2009, DIGEST DIS, V27, P80, DOI 10.1159/000218339; Su YW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174333; Tournoux-Facon C, 2011, J HEPATOL, V54, P108, DOI 10.1016/j.jhep.2010.06.015; Udell JA, 2012, JAMA-J AM MED ASSOC, V307, P832, DOI 10.1001/jama.2012.186; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Waked I, 2017, BRIT J CANCER, V116, P448, DOI 10.1038/bjc.2016.423	39	24	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180408	10.1371/journal.pone.0180408	http://dx.doi.org/10.1371/journal.pone.0180408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672011	gold, Green Submitted, Green Published			2022-12-26	WOS:000405268500051
J	Perez-Basterrechea, M; Esteban, MM; Alvarez-Viejo, M; Fontanil, T; Cal, S; Pitiot, MS; Otero, J; Obaya, AJ				Perez-Basterrechea, Marcos; Martinez Esteban, Manuel; Alvarez-Viejo, Maria; Fontanil, Tania; Cal, Santiago; Sanchez Pitiot, Marta; Otero, Jesus; Jesus Obaya, Alvaro			Fibroblasts accelerate islet revascularization and improve long-term graft survival in a mouse model of subcutaneous islet transplantation	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; BETA-CELL REGENERATION; PANCREATIC-ISLETS; ENGRAFTMENT; INTERLEUKIN-6; ANGIOGENESIS; ACTIVATION; SITE; RATS	Pancreatic islet transplantation has been considered for many years a promising therapy for beta-cell replacement in patients with type-1 diabetes despite that long-term clinical results are not as satisfactory. This fact points to the necessity of designing strategies to improve and accelerate islets engraftment, paying special attention to events assuring their revascularization. Fibroblasts constitute a cell population that collaborates on tissue homeostasis, keeping the equilibrium between production and degradation of structural components as well as maintaining the required amount of survival factors. Our group has developed a model for subcutaneous islet transplantation using a plasma-based scaffold containing fibroblasts as accessory cells that allowed achieving glycemic control in diabetic mice. Transplanted tissue engraftment is critical during the first days after transplantation, thus we have gone in depth into the graft-supporting role of fibroblasts during the first ten days after islet transplantation. All mice transplanted with islets embedded in the plasma-based scaffold reversed hyperglycemia, although long-term glycemic control was maintained only in the group transplanted with the fibroblasts-containing scaffold. By gene expression analysis and histology examination during the first days we could conclude that these differences might be explained by overexpression of genes involved in vessel development as well as in beta-cell regeneration that were detected when fibroblasts were present in the graft. Furthermore, fibroblasts presence correlated with a faster graft re-vascularization, a higher insulinpositive area and a lower cell death. Therefore, this work underlines the importance of fibroblasts as accessory cells in islet transplantation, and suggests its possible use in other graft supporting strategies.	[Perez-Basterrechea, Marcos; Alvarez-Viejo, Maria; Otero, Jesus] Hosp Univ Cent Asturias, Unidad Trasplantes Terapia Celular & Med Regenera, Oviedo, Spain; [Martinez Esteban, Manuel; Jesus Obaya, Alvaro] Univ Oviedo, Dept Biol Func, Oviedo, Spain; [Fontanil, Tania; Cal, Santiago] Univ Oviedo, Dept Bioquim & Biol Mol, Oviedo, Spain; [Sanchez Pitiot, Marta] Inst Univ Oncol Principado Asturias, Unidad Histopatol Mol Modelos Anim Canc, Oviedo, Spain	Central University Hospital Asturias; University of Oviedo; University of Oviedo; University of Oviedo; Instituto Universitario de Oncologia de Asturias	Perez-Basterrechea, M (corresponding author), Hosp Univ Cent Asturias, Unidad Trasplantes Terapia Celular & Med Regenera, Oviedo, Spain.	mpbasterrechea@gmail.com	Obaya, Alvaro J./AAQ-6115-2021; López, tania Fontanil/AAM-6512-2020; Basterrechea, Marcos Perez/L-9052-2014	Obaya, Alvaro J./0000-0002-4163-2173; Basterrechea, Marcos Perez/0000-0002-8242-5365; Fontanil, Tania/0000-0003-2261-7661	European Union FEDER Funds; Plande Ciencia, Tecnologia e Innovacion del Principado de Asturias; Fundacion para el Fomento en Asturias de la Investigacion Cientofica Aplicada y la Tecnologia (FICYT)	European Union FEDER Funds(European Commission); Plande Ciencia, Tecnologia e Innovacion del Principado de Asturias; Fundacion para el Fomento en Asturias de la Investigacion Cientofica Aplicada y la Tecnologia (FICYT)	This work was supported by a grant (Grant number: GRUPIN14-069) from the European Union FEDER Funds, Plande Ciencia, Tecnologia e Innovacion del Principado de Asturias, Fundacion para el Fomento en Asturias de la Investigacion Cientofica Aplicada y la Tecnologia (FICYT, http://www.ficyt.es/) to JO. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2001, P NATL ACAD SCI USA, V98, P48, DOI 10.1073/pnas.240458597; Baeza N, 1996, DIABETES METAB, V22, P229; Bassi R, 2011, CURR DIABETES REP, V11, P355, DOI 10.1007/s11892-011-0211-1; Ben Nasr M, 2015, ACTA DIABETOL, V52, P917, DOI 10.1007/s00592-015-0735-y; Bhang SH, 2013, BIOMATERIALS, V34, P7247, DOI 10.1016/j.biomaterials.2013.06.018; Bharat A, 2005, TRANSPLANTATION, V79, P1627, DOI 10.1097/01.TP.0000159145.86990.44; Biarnes M, 2002, DIABETES, V51, P66, DOI 10.2337/diabetes.51.1.66; Brady AC, 2013, TISSUE ENG PT A, V19, P2544, DOI [10.1089/ten.tea.2012.0686, 10.1089/ten.TEA.2012.0686]; Brissova M, 2004, DIABETES, V53, P1318, DOI 10.2337/diabetes.53.5.1318; Calderari S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090045; D'Addio F, 2014, DIABETES, V63, P3041, DOI 10.2337/db14-0295; Delgado E, 2015, EBIOMEDICINE, V2, P2024, DOI 10.1016/j.ebiom.2015.11.003; Dirice E, 2014, DIABETES, V63, P188, DOI 10.2337/db13-0204; Dufour JM, 2005, TISSUE ENG, V11, P1323, DOI 10.1089/ten.2005.11.1323; Fiorina P, 2007, DIABETES, V56, P912, DOI 10.2337/db06-1445; Fiorina P, 2011, J IMMUNOL, V186, P121, DOI 10.4049/jimmunol.1000799; Gu Y, 2001, CELL TRANSPLANT, V10, P453; Juang JH, 1996, TRANSPLANTATION, V61, P1557, DOI 10.1097/00007890-199606150-00001; Kawada M, 2012, ONCOGENE, V31, P3111, DOI 10.1038/onc.2011.498; Krause MD, 2012, J ENDOCRINOL, V214, P301, DOI 10.1530/JOE-12-0223; Lau J, 2009, CURR OPIN ORGAN TRAN, V14, P688, DOI 10.1097/MOT.0b013e32833239ff; Luo C, 2013, MOL CELL ENDOCRINOL, V365, P187, DOI 10.1016/j.mce.2012.10.018; Maffi P, 2015, PHARMACOL RES, V98, P86, DOI 10.1016/j.phrs.2015.04.010; Matsushima H, 2016, CELL TRANSPLANT, V25, P1525, DOI 10.3727/096368916X690854; Najjar M, 2015, BIOTECHNOL BIOENG, V112, P1916, DOI 10.1002/bit.25589; Ngernyuang N, 2014, INT J BIOCHEM CELL B, V51, P45, DOI 10.1016/j.biocel.2014.03.021; Ono M, 2008, CANCER SCI, V99, P1501, DOI 10.1111/j.1349-7006.2008.00853.x; Park KS, 2009, TRANSPL P, V41, P3813, DOI 10.1016/j.transproceed.2009.06.193; Pepper AR, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/352315; Perez-Basterrechea M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073526; Perez-Basterrechea M, 2009, TISSUE ENG PT A, V15, P569, DOI 10.1089/ten.tea.2008.0088; Prokop A, 2001, Diabetes Technol Ther, V3, P245, DOI 10.1089/152091501300209624; PURVES RD, 1992, J PHARMACOKINET BIOP, V20, P501, DOI 10.1007/BF01061468; Rodemann HP, 2011, TUMOR MICROENVIRON, V4, P23, DOI 10.1007/978-94-007-0659-0_2; Sakata N, 2014, DIABETES-METAB RES, V30, P1, DOI 10.1002/dmrr.2463; Shapiro AMJ, 2011, CURR DIABETES REP, V11, P345, DOI 10.1007/s11892-011-0217-8; Shchors K, 2006, GENE DEV, V20, P2527, DOI 10.1101/gad.1455706; Singh B, 2011, J INTERF CYTOK RES, V31, P711, DOI 10.1089/jir.2011.0025; Sorrell JM, 2009, INT REV CEL MOL BIO, V276, P161, DOI 10.1016/S1937-6448(09)76004-6; Staels W, 2016, DIABETES OBES METAB, V18, P115, DOI 10.1111/dom.12556; Tabata Y, 1999, J BIOMAT SCI-POLYM E, V10, P957, DOI 10.1163/156856299X00559; Tezza S, 2015, PHARMACOL RES, V98, P69, DOI 10.1016/j.phrs.2014.06.016; Timper K, 2016, GASTROENTEROLOGY, V151, P165, DOI 10.1053/j.gastro.2016.03.003; UNNO M, 1992, ADV EXP MED BIOL, V321, P61; VANDERVLIET JA, 1988, TRANSPLANTATION, V45, P493; Vantyghem MC, 2014, DIABETES METAB, V40, P108, DOI 10.1016/j.diabet.2013.10.003; Velmurugan K, 2012, J NEUROCHEM, V123, P919, DOI 10.1111/jnc.12036; Wang RN, 1999, J ENDOCRINOL, V163, P181, DOI 10.1677/joe.0.1630181; Wang WJ, 2002, TRANSPLANTATION, V73, P122, DOI 10.1097/00007890-200201150-00023; WATANABE T, 1994, P NATL ACAD SCI USA, V91, P3589, DOI 10.1073/pnas.91.9.3589; Wong T, 2007, BRIT J DERMATOL, V156, P1149, DOI 10.1111/j.1365-2133.2007.07914.x; Xia F, 2016, J LEUKOCYTE BIOL, V99, P1131, DOI 10.1189/jlb.3A0815-371RRR	52	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180695	10.1371/journal.pone.0180695	http://dx.doi.org/10.1371/journal.pone.0180695			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672010	Green Published, Green Submitted, gold			2022-12-26	WOS:000405268500080
J	van Dijk, EHC; Tsonaka, R; Klar-Mohamad, N; Wouters, D; de Vries, APJ; de Jong, EK; van Kooten, C; Boon, CJF				van Dijk, Elon H. C.; Tsonaka, Roula; Klar-Mohamad, Ngaisah; Wouters, Diana; de Vries, Aiko P. J.; de Jong, Eiko K.; van Kooten, Cees; Boon, Camiel J. F.			Systemic complement activation in central serous chorioretinopathy	PLOS ONE			English	Article							MACULAR DEGENERATION; FACTOR-H; LUPUS-ERYTHEMATOSUS; RISK; POLYMORPHISM; VARIANTS; GENE; PATHOPHYSIOLOGY; CORTICOSTEROIDS; PERSPECTIVE	Purpose A clear link between several variants in genes involved in the complement system and chronic central serous chorioretinopathy (CSC) has been described. In age-related macular degeneration, a disease that shows clinical features that overlap with CSC, both genetic risk factors and systemic activation of the complement system have previously been found. In this case-control study, we assessed whether there is evidence of either systemic activation or inhibition of the complement system in patients with chronic CSC. Methods A prospective case-control study of 76 typical chronic CSC patients and 29 controls without ophthalmological history was conducted. Complement activity assays (classical, alternative, and mannose-binding lectin pathway), complement factors 3, 4, 4A, 4B, B, D, H, I, and P, activation products C3d, C5a, and sC5b-C9, and the C3d/C3 ratio were analysed in either serum or plasma. A correction for possible effects of gender, age, body mass index, and smoking status was performed. Results In this study, none of the tested variables, including regulation and activation products, proved to be significantly different between the groups. Moreover, no associations with either CSC disease activity or possible CSC related steroid use were observed. Conclusion Despite the available literature regarding a possible relationship between chronic CSC and variants in genes involved in the complement system, we did not find evidence of an association of chronic CSC with either systemic complement activation or inhibition.	[van Dijk, Elon H. C.; Boon, Camiel J. F.] Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands; [Tsonaka, Roula] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands; [Klar-Mohamad, Ngaisah; van Kooten, Cees] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Wouters, Diana] Acad Med Ctr, Dept Immunopathol, Sanquin Res, Amsterdam, Netherlands; [Wouters, Diana] Acad Med Ctr, Landsteiner Lab, Amsterdam, Netherlands; [de Vries, Aiko P. J.] Leiden Univ, Med Ctr, Dept Med, Div Nephrol & Transplantat, Leiden, Netherlands; [de Jong, Eiko K.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Boon, Camiel J. F.] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam	Boon, CJF (corresponding author), Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands.; Boon, CJF (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands.	c.j.f.boon@lumc.nl	de Jong, Eiko/P-3407-2015; Boon, CJF/P-7534-2014; de Vries, Aiko/J-5397-2015	de Jong, Eiko/0000-0001-6520-0407; Boon, CJF/0000-0002-6737-7932; van Dijk, Elon/0000-0002-6351-7942; de Vries, Aiko/0000-0002-9284-3595	Macula Fonds; Retina Netherlands; Blinden Penning; Landelijke Stichting voor Blindenen Slechtzienden; UitZicht; Rotterdamse Stichting Blindenbelangen; Haagse Stichting Blindenhulp; ZonMw VENI; GiselaThie rFellowship of Leiden University (CJFB)	Macula Fonds; Retina Netherlands; Blinden Penning; Landelijke Stichting voor Blindenen Slechtzienden; UitZicht; Rotterdamse Stichting Blindenbelangen; Haagse Stichting Blindenhulp; ZonMw VENI; GiselaThie rFellowship of Leiden University (CJFB)	This research was supported by the following foundations: Macula Fonds, Retina Netherlands, Blinden Penning, and Landelijke Stichting voor Blindenen Slechtzienden, which contributed through UitZicht, as well as Rotterdamse Stichting Blindenbelangen, Haagse Stichting Blindenhulp, ZonMw VENI Grant, and the GiselaThie rFellowship of Leiden University (CJFB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Awan MA, 2008, CLIN EXP OPTOM, V91, P476, DOI 10.1111/j.1444-0938.2008.00268.x; Bauer ME, 2005, STRESS, V8, P69, DOI 10.1080/10253890500100240; Boon CJF, 2009, MOL IMMUNOL, V46, P1573, DOI 10.1016/j.molimm.2009.02.013; BOUZAS EA, 1993, ARCH OPHTHALMOL-CHIC, V111, P1229, DOI 10.1001/archopht.1993.01090090081024; Breukink MB, 2017, CLIN OPHTHALMOL, V11, P39, DOI 10.2147/OPTH.S115685; Breukink MB, 2015, INVEST OPHTH VIS SCI, V56, P5608, DOI 10.1167/iovs.15-17343; Carvalho-Recchia CA, 2002, OPHTHALMOLOGY, V109, P1834, DOI 10.1016/S0161-6420(02)01117-X; Daruich A, 2015, PROG RETIN EYE RES, V48, P82, DOI 10.1016/j.preteyeres.2015.05.003; de Cordoba SR, 2008, CLIN EXP IMMUNOL, V151, P1, DOI 10.1111/j.1365-2249.2007.03574.x; de Jong EK, 2015, OPHTHALMOLOGY, V122, P562, DOI 10.1016/j.ophtha.2014.09.026; Francis PJ, 2009, J MED GENET, V46, P300, DOI 10.1136/jmg.2008.062737; Gemenetzi M, 2010, EYE, V24, P1743, DOI 10.1038/eye.2010.130; Haimovici R, 2004, OPHTHALMOLOGY, V111, P244, DOI 10.1016/j.ophtha.2003.09.024; Jonas JB, 2005, BRIT J OPHTHALMOL, V89, P386, DOI 10.1136/bjo.2004.054247; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Liew G, 2013, CLIN EXP OPHTHALMOL, V41, P201, DOI 10.1111/j.1442-9071.2012.02848.x; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Miki A, 2014, OPHTHALMOLOGY, V121, P1067, DOI 10.1016/j.ophtha.2013.11.020; Moschos MM, 2016, RETINA-J RET VIT DIS, V36, P402, DOI 10.1097/IAE.0000000000000693; Nicholson B, 2013, SURV OPHTHALMOL, V58, P103, DOI 10.1016/j.survophthal.2012.07.004; Oosterhuis JA, 1996, GRAEF ARCH CLIN EXP, V234, P337, DOI 10.1007/BF00220710; ROTHER E, 1993, CLIN RHEUMATOL, V12, P31, DOI 10.1007/BF02231555; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Schubert C, 2014, HUM MUTAT, V35, P859, DOI 10.1002/humu.22551; Shimura M, 2003, JPN J OPHTHALMOL, V47, P312, DOI 10.1016/S0021-5155(03)00012-1; Smailhodzic D, 2012, OPHTHALMOLOGY, V119, P339, DOI 10.1016/j.ophtha.2011.07.056; Spencer KL, 2008, HUM MOL GENET, V17, P1821, DOI 10.1093/hmg/ddn075; Wang M, 2008, ACTA OPHTHALMOL, V86, P126, DOI 10.1111/j.1600-0420.2007.00889.x; Warrow DJ, 2013, RETINA-J RET VIT DIS, V33, P1659, DOI 10.1097/IAE.0b013e3182953df4; Weenink AC, 2001, OPHTHALMOLOGICA, V215, P183, DOI 10.1159/000050855; Wouters D, 2009, MOL IMMUNOL, V46, P592, DOI 10.1016/j.molimm.2008.07.028; Yannuzzi LA, 2000, OPHTHALMOLOGY, V107, P767, DOI 10.1016/S0161-6420(99)00173-6; Yannuzzi LA, 2010, AM J OPHTHALMOL, V149, P361, DOI 10.1016/j.ajo.2009.11.017	34	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180312	10.1371/journal.pone.0180312	http://dx.doi.org/10.1371/journal.pone.0180312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671968	Green Published, gold, Green Submitted			2022-12-26	WOS:000405268500043
J	Xiao, H; Bid, HK; Chen, X; Wu, XJ; Wei, J; Bian, Y; Zhao, CG; Li, HM; Li, CL; Lin, J				Xiao, Hui; Bid, Hemant Kumar; Chen, Xiang; Wu, Xiaojuan; Wei, Jia; Bian, Yang; Zhao, Chengguang; Li, Huameng; Li, Chenglong; Lin, Jiayuh			Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy	PLOS ONE			English	Article							ESTROGEN-RECEPTOR MODULATOR; ANTI-INTERLEUKIN-6 MONOCLONAL-ANTIBODY; ENDOTHELIAL GROWTH-FACTOR; BREAST-CANCER CELLS; SILTUXIMAB CNTO 328; STAT3 ACTIVATION; SMALL-MOLECULE; POSTMENOPAUSAL OSTEOPOROSIS; CONJUGATED ESTROGENS; CONTROLLED-TRIAL	Interleukins-6 (IL-6)/GP130 signaling pathway represents a promising target for cancer therapy due to its critical role in survival and progression of multiple types of cancer. We have identified Bazedoxifene, a Food and Drug Administration (FDA)-approved drug used for the prevention of postmenopausal osteoporosis, with novel function as inhibitor of IL-6/GP130 interaction. In this study, we investigate the effect of Bazedoxifene in rhabdomyosarcoma and evaluate whether inhibiting IL-6/GP130 signaling is an effective therapeutic strategy for rhabdomyosarcoma. The inhibitory effect of Bazedoxifene was assessed in rhabdomyosarcoma cell lines in vitro and RH30 xenograft model was used to further examine the suppressive efficacy of Bazedoxifene on tumor growth in vivo. Rhabdomyosarcoma cells showed their sensitivity to GP130 inhibition using gene knockdown or neutralized antibody, suggesting IL-6/GP130 as therapeutic target in rhabdomyosarcoma cells. Bazedoxifene decreased the signal transducer and activator of transcription3 (STAT3) phosphorylation, blocked STAT3 DNA binding, and down-regulated the expression of STAT3 downstream genes. Bazedoxifene also induced cell apoptosis, reduced cell viability, and inhibited colony formation in rhabdomyosarcoma cells. The inhibition of colony formation, STAT3 phosphorylation, or cell viability following Bazedoxifene treatment was partially reversed by addition of excess IL-6 or overexpression of constitutive STAT3, respectively, supporting Bazedoxifene acted through IL-6/GP130 signaling. In addition, Bazedoxifene repressed cell invasion and angiogenesis in vitro. Furthermore, oral administration of Bazedoxifene significantly suppressed tumor growth and expression of STAT3 phosphorylation in nude mice bearing established human rhabdomyosarcoma xenograft. Taken together, these findings validate IL-6/GP130 signaling as therapeutic target in rhabdomyosarcoma and provide first evidence that Bazedoxifene may serve as a novel promising drug targeting IL-6/GP130 for treatment of rhabdomyosarcoma.	[Xiao, Hui; Bian, Yang] Nationwide Childrens Hosp, Res Inst, Ctr Childhood Canc & Blood Dis, Columbus, OH USA; [Bid, Hemant Kumar] Univ Michigan, Life Sci Inst, Resonant Therapeut Inc, Ann Arbor, MI 48109 USA; [Chen, Xiang; Wei, Jia; Lin, Jiayuh] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Wu, Xiaojuan] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Pediat Surg, Wuhan, Peoples R China; [Zhao, Chengguang] Wenzhou Med Univ, Sch Pharmaceut Sci, Chem Biol Res Ctr, Wenzhou, Zhejiang, Peoples R China; [Li, Huameng] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA; [Li, Chenglong] Univ Florida, Coll Pharm, Gainesville, FL USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Michigan System; University of Michigan; University System of Maryland; University of Maryland Baltimore; Huazhong University of Science & Technology; Wenzhou Medical University; University System of Ohio; Ohio State University; State University System of Florida; University of Florida	Lin, J (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	JLin@som.umaryland.edu	zhao, chengguang/F-9548-2013		NIH [R21 CA191751-01]; NATIONAL CANCER INSTITUTE [R21CA191751] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the NIH R21 CA191751-01 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Andrews B, 2002, J UROLOGY, V167, P1475, DOI 10.1016/S0022-5347(05)65348-7; [Anonymous], J NATL TAIPEI COLL B, DOI DOI 10.1007/S11010-012-1443-3; Archer DF, 2009, MENOPAUSE, V16, P1109, DOI 10.1097/gme.0b013e3181a818db; Arndt CAS, 2012, MAYO CLIN PROC, V87, P475, DOI 10.1016/j.mayocp.2012.01.015; Bachelot T, 2003, BRIT J CANCER, V88, P1721, DOI 10.1038/sj.bjc.6600956; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Cen L, 2007, BRIT J CANCER, V97, P785, DOI 10.1038/sj.bjc.6603952; Chen CL, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-111; Chen MF, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-26; Chines AA, 2009, DRUG TODAY, V45, P507, DOI 10.1358/dot.2009.45.7.1395293; Dong SM, 2009, J BIOL CHEM, V284, P29514, DOI 10.1074/jbc.M109.027896; Egas-Bejar D, 2014, ADOLESC HEALTH MED T, V5, P115, DOI 10.2147/AHMT.S44582; Fizazi K, 2012, EUR J CANCER, V48, P85, DOI 10.1016/j.ejca.2011.10.014; Greenberg JA, 2008, CANCER RES, V68, P3476, DOI 10.1158/0008-5472.CAN-07-3046; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; He L, 2013, GENET MOL RES, V12, P1012, DOI 10.4238/2013.April.2.17; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Kharode Y, 2008, ENDOCRINOLOGY, V149, P6084, DOI 10.1210/en.2008-0817; KISHIMOTO T, 1994, STEM CELLS, V12, P37; Kitamura Y, 1997, SURG TODAY, V27, P534, DOI 10.1007/BF02385807; Komm BS, 2005, ENDOCRINOLOGY, V146, P3999, DOI 10.1210/en.2005-0030; Lavie O, 2008, INT J GYNECOL CANCER, V18, P352, DOI 10.1111/j.1525-1438.2007.01025.x; Lewiecki EM, 2007, EXPERT OPIN INV DRUG, V16, P1663, DOI 10.1517/13543784.16.10.1663; Lewis-Wambi JS, 2011, MOL PHARMACOL, V80, P610, DOI 10.1124/mol.111.072249; Li RH, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/743716; Liu AG, 2011, CANCER SCI, V102, P1381, DOI 10.1111/j.1349-7006.2011.01932.x; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; NARAZAKI M, 1994, P NATL ACAD SCI USA, V91, P2285, DOI 10.1073/pnas.91.6.2285; Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Palacios S, 2015, MENOPAUSE, V22, P806, DOI [10.1097/gme.0000000000000419, 10.1097/GME.0000000000000419]; Petricoin EF, 2007, CANCER RES, V67, P3431, DOI 10.1158/0008-5472.CAN-06-1344; Pu YS, 2004, PROSTATE, V60, P120, DOI 10.1002/pros.20057; Real PJ, 2002, ONCOGENE, V21, P7611, DOI 10.1038/sj.onc.1206004; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Renshaw J, 2013, CLIN CANCER RES, V19, P5940, DOI 10.1158/1078-0432.CCR-13-0850; Rieck G C, 2005, J Obstet Gynaecol, V25, P39, DOI 10.1080/01443610400024740; Rossi JF, 2010, BRIT J CANCER, V103, P1154, DOI 10.1038/sj.bjc.6605872; Saleh AZM, 2005, BIOCHEMISTRY-US, V44, P10822, DOI 10.1021/bi050439+; Schlessinger K, 2005, CANCER RES, V65, P5828, DOI 10.1158/0008-5472.CAN-05-0317; Siegel DA, 2014, PEDIATRICS, V134, pE945, DOI 10.1542/peds.2013-3926; Song LX, 2011, MOL CANCER THER, V10, P481, DOI 10.1158/1535-7163.MCT-10-0502; Song Y, 2013, ENDOCRINOLOGY, V154, P656, DOI 10.1210/en.2012-2038; Tomita Y, 2006, CLIN CANCER RES, V12, P3070, DOI 10.1158/1078-0432.CCR-05-1732; Trikha M, 2003, CLIN CANCER RES, V9, P4653; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Voorhees PM, 2013, BRIT J HAEMATOL, V161, P357, DOI 10.1111/bjh.12266; Wei CC, 2011, INT J ONCOL, V38, P279, DOI 10.3892/ijo_00000848; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Wei LH, 2003, ONCOGENE, V22, P1517, DOI 10.1038/sj.onc.1206226; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Xu SL, 2013, EXPERT OPIN THER TAR, V17, P1303, DOI 10.1517/14728222.2013.830105; Xu SL, 2013, MOL CANCER THER, V12, P937, DOI 10.1158/1535-7163.MCT-12-1082; Yan S, 2013, ONCOTARGET, V4, P433, DOI 10.18632/oncotarget.930; Zhang YF, 2014, APPL THERM ENG, V65, P1, DOI 10.1016/j.applthermaleng.2013.12.069	61	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180297	10.1371/journal.pone.0180297	http://dx.doi.org/10.1371/journal.pone.0180297			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672024	gold, Green Submitted, Green Published			2022-12-26	WOS:000405268500041
J	Bjorge, JD; Pang, A; Fujita, DJ				Bjorge, Jeffrey D.; Pang, Andy; Fujita, Donald J.			Delivery of gene targeting siRNAs to breast cancer cells using a multifunctional peptide complex that promotes both targeted delivery and endosomal release	PLOS ONE			English	Article							PENETRATING PEPTIDES; TUMOR-CELLS; NANOPARTICLES; BARRIERS; SYSTEMS; GROWTH; OLIGOARGININE; ARGININE; RECEPTOR; CPPS	RNA interference has been used to dissect the importance of individual gene products in various human disease processes, including cancer. Small-interfering RNA, or siRNA, is one of the tools utilized in this regard, but specially-designed delivery agents are required to allow the siRNA to gain optimal access to the cell interior. Our laboratory has utilized two different siRNA-binding delivery peptides containing a polyarginine core, and modified by myristoylation and targeting motifs (iRGD or Lyp-1). A third peptide was designed to assist with endosomal release. Various ratios of the peptides and siRNA were combined and assayed for the ability to form stable complexes, and optimized ratios were determined. The complexes were found to form particles, with the majority having a diameter of 100-300 nm, as visualized by electron microscopy. These siRNA complexes have enhanced protection from nucleases present in serum, as compared to "naked" unprotected siRNA. The particles were internalized by the cells and could be detected in the cell cytoplasm by confocal fluorescence microscopy. In functional assays, peptide/siRNA complexes were shown to cause the knock down of corresponding targeted proteins. The peptide with the LyP-1 targeting motif was more effective at knockdown in MDA-MB-231 breast cancer cells than the peptide with the iRGD motif. Inclusion of the endosomal release peptide in the complexes greatly enhanced the peptide/siRNA effects. Peptide/siRNA complexes simultaneously targeting Stat3 and c-Myc caused a marked reduction in anchorage-independent growth, a property correlated with tumorigenicity. This study demonstrates the ability of a peptide-based siRNA-delivery system to deliver siRNA into breast cancer cells and cause both protein knockdown and suppression of the malignant phenotype. Such peptide complexes are likely to become highly useful siRNA-delivery vehicles for the characterization, and potentially for the treatment, of human cancer.	[Bjorge, Jeffrey D.; Pang, Andy; Fujita, Donald J.] Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Bjorge, Jeffrey D.; Pang, Andy; Fujita, Donald J.] Univ Calgary, Cumming Sch Med, Arnie Charbonneau Canc Inst, Calgary, AB, Canada	University of Calgary; University of Calgary	Bjorge, JD; Fujita, DJ (corresponding author), Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB, Canada.; Bjorge, JD; Fujita, DJ (corresponding author), Univ Calgary, Cumming Sch Med, Arnie Charbonneau Canc Inst, Calgary, AB, Canada.	jbjorge@ucalgary.ca; dfujita@ucalgary.ca			Canada Research Society (Montreal); Alberta Innovates Health Solutions (AHS)	Canada Research Society (Montreal); Alberta Innovates Health Solutions (AHS)	This work was supported by the Canada Research Society (Montreal) to DJF, (http://www.crs-src.ca) and the Alberta Innovates Health Solutions (AHS) to DJF, (http://www.aihealthsolutons.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; Bjorge JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019309; Cantini L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073348; Chu DF, 2015, NANOMED-NANOTECHNOL, V11, P435, DOI 10.1016/j.nano.2014.08.007; Cuellar TL, 2015, NUCLEIC ACIDS RES, V43, P1189, DOI 10.1093/nar/gku1362; Dahlman JE, 2014, NAT NANOTECHNOL, V9, P648, DOI [10.1038/NNANO.2014.84, 10.1038/nnano.2014.84]; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Dominska M, 2010, J CELL SCI, V123, P1183, DOI 10.1242/jcs.066399; Esposito Carla Lucia, 2014, J RNAi Gene Silencing, V10, P500; Fogal V, 2008, CANCER RES, V68, P7210, DOI 10.1158/0008-5472.CAN-07-6752; Kim WL, 2006, MOL THER, V14, P343, DOI 10.1016/j.ymthe.2006.03.022; Ku SH, 2014, ADV HEALTHC MATER, V3, P1182, DOI 10.1002/adhm.201300607; Laakkonen P, 2002, NAT MED, V8, P751, DOI 10.1038/nm720; Lee JM, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/782041, 10.1155/2013/758731]; Li YH, 2015, INT J PHARMACEUT, V495, P527, DOI 10.1016/j.ijpharm.2015.09.006; Lorenzer C, 2015, J CONTROL RELEASE, V203, P1, DOI 10.1016/j.jconrel.2015.02.003; Ly P, 2012, CELL RES, V22, P1605, DOI 10.1038/cr.2012.140; Mansoori B, 2014, ADV PHARM BULL, V4, P313, DOI 10.5681/apb.2014.046; Margus H, 2012, MOL THER, V20, P525, DOI 10.1038/mt.2011.284; Meyer T, 1998, BRIT J CANCER, V77, P530, DOI 10.1038/bjc.1998.86; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; MONTESANO R, 1977, J NATL CANCER I, V59, P1651, DOI 10.1093/jnci/59.6.1651; Nakase I, 2013, MOL BIOSYST, V9, P855, DOI 10.1039/c2mb25467k; Oliveira S, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/63675; PLANK C, 1994, J BIOL CHEM, V269, P12918; Ren Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003778; Sahay G, 2013, NAT BIOTECHNOL, V31, P653, DOI 10.1038/nbt.2614; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Sugahara KN, 2009, CANCER CELL, V16, P510, DOI 10.1016/j.ccr.2009.10.013; Wan C, 2014, DRUG DELIV TRANSL RE, V4, P74, DOI 10.1007/s13346-013-0161-z; Wang J, 2010, AAPS J, V12, P492, DOI 10.1208/s12248-010-9210-4; Wang YH, 2007, J BIOCHEM BIOPH METH, V70, P579, DOI 10.1016/j.jbbm.2007.01.010; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Wu SY, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008362; Xu CF, 2015, ASIAN J PHARM SCI, V10, P1, DOI 10.1016/j.ajps.2014.08.011; Yan RY, 2014, BIOCHEM J, V461, P1, DOI 10.1042/BJ20140173; Zaro JL, 2015, FRONT CHEM SCI ENG, V9, P407, DOI 10.1007/s11705-015-1538-y; Zhou JH, 2013, PHARMACEUTICALS, V6, P85, DOI 10.3390/ph6010085	42	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180578	10.1371/journal.pone.0180578	http://dx.doi.org/10.1371/journal.pone.0180578			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666009	gold, Green Published, Green Submitted			2022-12-26	WOS:000404608700019
J	Molparia, B; Nichani, E; Torkamani, A				Molparia, Bhuvan; Nichani, Eshaan; Torkamani, Ali			Assessment of circulating copy number variant detection for cancer screening	PLOS ONE			English	Article							TUMOR DNA; PROSTATE-CANCER; LANDSCAPE; CLASSIFICATION; IDENTIFICATION; ALLELES	Current high-sensitivity cancer screening methods, largely utilizing correlative biomarkers, suffer from false positive rates that lead to unnecessary medical procedures and debatable public health benefit overall. Detection of circulating tumor DNA (ctDNA), a causal biomarker, has the potential to revolutionize cancer screening. Thus far, the majority of ctDNA studies have focused on detection of tumor-specific point mutations after cancer diagnosis for the purpose of post-treatment surveillance. However, ctDNA point mutation detection methods developed to date likely lack either the scope or analytical sensitivity necessary to be useful for cancer screening, due to the low (< 1%) ctDNA fraction derived from early stage tumors. On the other hand, tumor-derived copy number variant (CNV) detection is hypothetically a superior means of ctDNA-based cancer screening for many tumor types, given that, relative to point mutations, each individual tumor CNV contributes a much larger number of ctDNA fragments to the overall pool of circulating free DNA (cfDNA). A small number of studies have demonstrated the potential of ctDNA CNV-based screening in select cancer types. Here we perform an in silico assessment of the potential for ctDNA CNVbased cancer screening across many common cancers, and suggest ctDNA CNV detection shows promise as a broad cancer screening methodology.	[Molparia, Bhuvan; Torkamani, Ali] Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Molparia, Bhuvan; Torkamani, Ali] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Nichani, Eshaan] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Torkamani, Ali] Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Torkamani, Ali] Scripps Hlth, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Massachusetts Institute of Technology (MIT); Scripps Research Institute	Torkamani, A (corresponding author), Scripps Translat Sci Inst, La Jolla, CA 92037 USA.; Torkamani, A (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.; Torkamani, A (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Torkamani, A (corresponding author), Scripps Hlth, La Jolla, CA 92037 USA.	atorkama@scripps.edu			Scripps Translational Science Institute pilot award from Scripps Genomic Medicine [5 UL1 TR001114]; NIH-NCATS Clinical and Translational Science Award (CTSA) [5 UL1 RR025774]; NHGRI Genome Sequencing Informatics Tools (GS-IT) Program [NIH U01 HG006476]	Scripps Translational Science Institute pilot award from Scripps Genomic Medicine; NIH-NCATS Clinical and Translational Science Award (CTSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHGRI Genome Sequencing Informatics Tools (GS-IT) Program	This work is supported by a Scripps Translational Science Institute pilot award (5 UL1 TR001114) from Scripps Genomic Medicine, a NIH-NCATS Clinical and Translational Science Award (CTSA; 5 UL1 RR025774) to STSI. Further support is provided by NHGRI Genome Sequencing Informatics Tools (GS-IT) Program via grant NIH U01 HG006476.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amant F, 2015, JAMA ONCOL, V1, P814, DOI 10.1001/jamaoncol.2015.1883; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Bianchi DW, 2015, JAMA-J AM MED ASSOC, V314, P162, DOI 10.1001/jama.2015.7120; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borrell B, 2011, NAT MED, V17, P1329, DOI 10.1038/nm1111-1329a; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Chan KCA, 2013, CLIN CHEM, V59, P211, DOI 10.1373/clinchem.2012.196014; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Erikson GA, 2014, GENETICS MED OFFICIA; Fan HC, 2012, NATURE, V487, P320, DOI 10.1038/nature11251; Fan HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010439; Fernandez-Delgado M, 2014, J MACH LEARN RES, V15, P3133; Heidary M, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0421-y; Heitzer E, 2013, GENOME MED, V5, DOI 10.1186/gm434; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Hubbard RA, 2011, ANN INTERN MED, V155, P481, DOI 10.7326/0003-4819-155-8-201110180-00004; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kirkizlar E, 2015, TRANSL ONCOL, V8, P407, DOI 10.1016/j.tranon.2015.08.004; Leary RJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004742; Lefkowitz RB, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.02.030; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin J., 2003, SIGMOD; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Nygren AOH, 2010, CLIN CHEM, V56, P1627, DOI 10.1373/clinchem.2010.146290; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Punglia RS, 2003, NEW ENGL J MED, V349, P335, DOI 10.1056/NEJMoa021659; Rousseeuw PJ, 2011, WIRES DATA MIN KNOWL, V1, P73, DOI 10.1002/widm.2; Shlien A, 2009, GENOME MED, V1, DOI 10.1186/gm62; Singleton MV, 2014, AM J HUM GENET, V94, P599, DOI 10.1016/j.ajhg.2014.03.010; Suh KS, 2010, EXPERT REV MOL DIAGN, V10, P1069, DOI 10.1586/ERM.10.87; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; ZBAR B, 1987, NATURE, V327, P721, DOI 10.1038/327721a0	42	25	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180647	10.1371/journal.pone.0180647	http://dx.doi.org/10.1371/journal.pone.0180647			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686671	gold, Green Published, Green Submitted			2022-12-26	WOS:000405464100087
J	Sawada, T; Arai, D; Jing, XF; Miyajima, M; Frank, SJ; Sakaguchi, K				Sawada, Takahiro; Arai, Daiki; Jing, Xuefeng; Miyajima, Masayasu; Frank, Stuart J.; Sakaguchi, Kazushige			Molecular interactions of EphA4, growth hormone receptor, Janus kinase 2, and signal transducer and activator of transcription 5B	PLOS ONE			English	Article							JAK2 TYROSINE KINASE; ASSOCIATION; DOMAINS; EPHRINS; PHOSPHORYLATION; DETERMINANTS; MEMBRANE; STAT5B; ROLES; MOUSE	We previously reported that EphA4, a member of the Eph family of receptor tyrosine kinases, is an important modulator of growth hormone (GH) signaling, leading to augmented synthesis of insulin-like growth factor 1 (IGF1) for postnatal body growth. In the present study, we report the molecular interactions of EphA4, GH receptor (GHR), Janus kinase 2 (JAK2), and signal transducer and activator of transcription 5B (STAT5B). EphA4 binds to GHR at both its extracellular and intracellular domains and phosphorylates GHR when stimulated with a ligand. The cytoplasmic domain of EphA4 binds to the carboxy-terminus of JAK2 in contrast to the known binding of GHR to the amino-terminus. STAT5B binds to the amino-terminal kinase domain of EphA4. Ligand-activated EphA4 and JAK2 phosphorylate each other and STAT5B, but JAK2 does not appear to phosphorylate EphA4-bound STAT5B. Ligand-activated EphA4 induces the nuclear translocation of STAT5B in a JAK2-independent manner. GHR expression is required for the activation of STAT5B signaling, even via the JAK2-independent pathway. Various ephrins that have affinity for EphA4 induce STAT5B phosphorylation. These findings suggest the molecular mechanisms by which ephrin/EphA4 signaling enhances the canonical GH-IGF1 axis.	[Sawada, Takahiro; Arai, Daiki; Jing, Xuefeng; Sakaguchi, Kazushige] Wakayama Med Univ, Inst Adv Med, Dept Mol Cell Biol & Mol Med, Wakayama, Japan; [Miyajima, Masayasu] Wakayama Med Univ, Lab Anim Ctr, Wakayama, Japan; [Frank, Stuart J.] Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, Birmingham, AL USA; [Frank, Stuart J.] Birmingham VA Med Ctr, Birmingham, AL USA	Wakayama Medical University; Wakayama Medical University; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Sakaguchi, K (corresponding author), Wakayama Med Univ, Inst Adv Med, Dept Mol Cell Biol & Mol Med, Wakayama, Japan.	ksaka@wakayama-med.ac.jp			Research Grant on Priority Areas from Wakayama Medical University; Naito Foundation; Uehara Foundation; Takeda Science Foundation; JSPS KAKENHI [JP26860709, JP25461394]; NIH [R01 DK107441]; VA Merit Review Grant; Veterans Affairs [I01BX003718] Funding Source: NIH RePORTER	Research Grant on Priority Areas from Wakayama Medical University; Naito Foundation(Naito Memorial Foundation); Uehara Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review Grant(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Research Grant on Priority Areas from Wakayama Medical University (K.S.), a Research Grant from the Naito Foundation (K.S.), a Research Grant from the Uehara Foundation (T.S.), a Research Grant from the Takeda Science Foundation (T.S.), JSPS KAKENHI Grant Numbers JP26860709 (D.A.) and JP25461394 (X.J.), NIH R01 DK107441 (S.J.F.), and a VA Merit Review Grant (S.J.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Birzniece V, 2009, REV ENDOCR METAB DIS, V10, P145, DOI 10.1007/s11154-008-9089-x; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Deng L, 2007, MOL ENDOCRINOL, V21, P1537, DOI 10.1210/me.2007-0138; FRANK SJ, 1995, J BIOL CHEM, V270, P14776, DOI 10.1074/jbc.270.24.14776; Girault JA, 1999, TRENDS BIOCHEM SCI, V24, P54, DOI 10.1016/S0968-0004(98)01331-0; He K, 2003, MOL ENDOCRINOL, V17, P2211, DOI 10.1210/me.2003-0256; Jing XF, 2012, CELL REP, V2, P652, DOI 10.1016/j.celrep.2012.08.021; Kofoed EM, 2003, NEW ENGL J MED, V349, P1139, DOI 10.1056/NEJMoa022926; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Liu Y, 2014, MOL ENDOCRINOL, V28, P1807, DOI 10.1210/me.2014-1153; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Rotwein P, 2012, TRENDS ENDOCRIN MET, V23, P186, DOI 10.1016/j.tem.2012.01.001; Rowlinson SW, 2008, NAT CELL BIOL, V10, P740, DOI 10.1038/ncb1737; Sawada T, 2010, GENES CELLS, V15, P297, DOI 10.1111/j.1365-2443.2010.01391.x; Sayeski PP, 2001, J BIOL CHEM, V276, P10556, DOI 10.1074/jbc.M008856200; Smit LS, 1997, ENDOCRINOLOGY, V138, P3426, DOI 10.1210/en.138.8.3426; Stratikopoulos E, 2008, P NATL ACAD SCI USA, V105, P19378, DOI 10.1073/pnas.0809223105; VANDERKUUR JA, 1994, J BIOL CHEM, V269, P21709; Waters MJ, 2015, BIOCHEM J, V466, P1, DOI 10.1042/BJ20141293; Wilkinson DG, 2000, INT REV CYTOL, V196, P177; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2; Xu BXC, 1996, J BIOL CHEM, V271, P19768, DOI 10.1074/jbc.271.33.19768; Yokote H, 2005, P NATL ACAD SCI USA, V102, P18866, DOI 10.1073/pnas.0509741102; Zhang J, 2006, J PATHOL, V208, P453, DOI 10.1002/path.1937; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215; Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813	33	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180785	10.1371/journal.pone.0180785	http://dx.doi.org/10.1371/journal.pone.0180785			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686668	Green Published, gold, Green Submitted			2022-12-26	WOS:000405464100104
J	Han, ZL; Chen, Z; Lan, RF; Di, WC; Li, XH; Yu, HS; Ji, WQ; Zhang, XL; Xu, BA; Xu, W				Han, Zhonglin; Chen, Zheng; Lan, Rongfang; Di, Wencheng; Li, Xiaohong; Yu, Hongsong; Ji, Wenqing; Zhang, Xinlin; Xu, Biao; Xu, Wei			Sex-specific mortality differences in heart failure patients with ischemia receiving cardiac resynchronization therapy	PLOS ONE			English	Article							LONG-TERM SURVIVAL; GENDER-RELATED DIFFERENCES; VENTRICULAR LEAD POSITION; DOPPLER CROSS-CORRELATION; ATRIAL-FIBRILLATION; DEFIBRILLATOR IMPLANTATION; CARDIOVERTER-DEFIBRILLATOR; MECHANICAL DYSSYNCHRONY; CONDUCTION DELAY; ADVERSE EVENTS	Background Recent studies have reported prognosis differences between male and female heart failure patients following cardiac resynchronization therapy (CRT). However, the potential clinical factors that underpin these differences remain to be elucidated. Methods A meta-analysis was performed to investigate the factors that characterize sex-specific differences following CRT. This analysis involved searching the Medline (Pubmed source) and Embase databases in the period from January 1980 to September 2016. Results Fifty-eight studies involving 33445 patients (23.08% of whom were women) were analyzed as part of this study. Only patients receiving CRT with follow-up greater than six months were included in our analysis. Compared with males, females exhibited a reduction of 33% (hazard ratio, 0.67; 95% confidence interval, 0.62-0.73; P < 0.0001) and 42% (hazard ratio, 0.58; 95% confidence interval, 0.46-0.74; P = 0.003) in all-cause mortality and heart failure hospitalization or heart failure, respectively. Following a stratified analysis of all-cause mortality, we observed that ischemic causes (p = 0.03) were likely to account for most of the sex-specific differences in relation to CRT. Conclusion These data suggest that women have a reduced risk of all-cause mortality and heart failure hospitalization or heart failure following CRT. Based on the results from the stratified analysis, we observed more optimal outcomes for females with ischemic heart disease. Thus, ischemia are likely to play a role in sex-related differences associated with CRT in heart failure patients. Further studies are required to determine other indications and the potential mechanisms that might be associated with sex-specific CRT outcomes.	[Han, Zhonglin; Chen, Zheng; Lan, Rongfang; Di, Wencheng; Li, Xiaohong; Yu, Hongsong; Ji, Wenqing; Zhang, Xinlin; Xu, Biao; Xu, Wei] Nanjing Univ, Sch Med, Affiliated Nanjing Drum Tower Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China	Nanjing University	Xu, W (corresponding author), Nanjing Univ, Sch Med, Affiliated Nanjing Drum Tower Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	xuwei2003@medmail.com.cn	li, xiao/GSN-6181-2022; li, xiaofeng/GXF-9442-2022		National Natural Science Foundation of China [81600267]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No.81600267) to Zhonglin Han. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Alaeddini J, 2008, PACE, V31, P468, DOI 10.1111/j.1540-8159.2008.01016.x; Arshad A, 2011, J AM COLL CARDIOL, V57, P814, DOI 10.1016/j.jacc.2010.06.061; Auricchio A, 2007, AM J CARDIOL, V99, P232, DOI 10.1016/j.amjcard.2006.07.087; Bai R, 2008, J CARDIOVASC ELECTR, V19, P1259, DOI 10.1111/j.1540-8167.2008.01234.x; Bogale N, 2012, EUR J HEART FAIL, V14, P61, DOI 10.1093/eurjhf/hfr158; Cheng YJ, 2014, CIRC-ARRHYTHMIA ELEC, V7, P807, DOI 10.1161/CIRCEP.113.001786; Cipriani M, 2016, EUR J HEART FAIL, V18, P1060, DOI 10.1002/ejhf.569; Cipriani M, 2016, J CARDIOVASC MED, V17, P291, DOI 10.2459/JCM.0000000000000187; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Dagres N, 2007, J AM COLL CARDIOL, V49, P572, DOI 10.1016/j.jacc.2006.10.047; Delgado V, 2011, CIRCULATION, V123, P70, DOI 10.1161/CIRCULATIONAHA.110.945345; Di Biase L, 2008, EUR HEART J, V29, P2497, DOI 10.1093/eurheartj/ehn221; Eitel C, 2012, EUROPACE, V14, P358, DOI 10.1093/europace/eur298; El-Saed Aiman, 2009, Clin Cardiol, V32, pE33, DOI 10.1002/clc.20490; Fantoni C, 2008, EUR J HEART FAIL, V10, P298, DOI 10.1016/j.ejheart.2008.01.006; Ferreira AM, 2008, EUROPACE, V10, P809, DOI 10.1093/europace/eun135; Foley PWX, 2011, EUR J HEART FAIL, V13, P43, DOI 10.1093/eurjhf/hfq182; Frigerio M, 2014, INT J CARDIOL, V172, P64, DOI 10.1016/j.ijcard.2013.12.005; Gasparini M, 2015, EUR J HEART FAIL, V17, P717, DOI 10.1002/ejhf.269; Gasparini M, 2014, AM HEART J, V167, P203, DOI 10.1016/j.ahj.2013.10.017; Gold MR, 2015, HEART RHYTHM, V12, P524, DOI 10.1016/j.hrthm.2014.11.014; Herz ND, 2015, J WOMENS HEALTH, V24, P261, DOI 10.1089/jwh.2014.4980; Hoke U, 2014, CIRC-CARDIOVASC QUAL, V7, P437, DOI 10.1161/CIRCOUTCOMES.113.000821; Iler MA, 2008, AM J CARDIOL, V101, P359, DOI 10.1016/j.amjcard.2007.08.043; Jacobsson J, 2016, AM J CARDIOL, V118, P389, DOI 10.1016/j.amjcard.2016.05.017; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kappert K, 2012, CIRCULATION, V126, P934, DOI 10.1161/CIRCULATIONAHA.111.086660; Khatib M, 2014, EUR J HEART FAIL, V16, P802, DOI 10.1002/ejhf.102; Kotecha D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1855; Kreuz J, 2012, EUROPACE, V14, P1596, DOI 10.1093/europace/eus152; Kronborg MB, 2008, EUR J HEART FAIL, V10, P796, DOI 10.1016/j.ejheart.2008.06.013; Leyva F, 2011, PACE, V34, P82, DOI 10.1111/j.1540-8159.2010.02909.x; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lilli A, 2007, PACE, V30, P1349, DOI 10.1111/j.1540-8159.2007.00870.x; Lin G, 2011, EUR HEART J, V32, P184, DOI 10.1093/eurheartj/ehq403; Looi KL, 2014, HEART, V100, P794, DOI 10.1136/heartjnl-2014-305537; Lumens J, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.115.003744; Miller AL, 2011, PACE, V34, P490, DOI 10.1111/j.1540-8159.2010.03014.x; Mitoff PR, 2011, HEART, V97, P382, DOI 10.1136/hrt.2010.199760; Mooyaart EAQ, 2011, AM J CARDIOL, V108, P63, DOI 10.1016/j.amjcard.2011.02.345; Morani G, 2013, EUROPACE, V15, P1273, DOI 10.1093/europace/eut032; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Munir MB, 2016, J CARDIOVASC ELECTR, V27, P730, DOI 10.1111/jce.12951; Nagy VK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143907; Pedram A, 2010, MOL ENDOCRINOL, V24, P2152, DOI 10.1210/me.2010-0154; Perini AP, 2014, EUROPACE, V16, P71, DOI 10.1093/europace/eut190; Pfau G, 2010, J CARDIOTHOR VASC AN, V24, P30, DOI 10.1053/j.jvca.2009.07.009; Poli D, 2015, INT J WOMENS HEALTH, V7, P605, DOI 10.2147/IJWH.S45925; Prochnau D, 2011, CAN J CARDIOL, V27, P363, DOI 10.1016/j.cjca.2010.12.066; Reitan C, 2014, EUROPACE, V16, P1603, DOI 10.1093/europace/euu058; Rickard J, 2015, AM J CARDIOL, V115, P82, DOI 10.1016/j.amjcard.2014.09.052; Rickard J, 2011, AM HEART J, V162, P646, DOI 10.1016/j.ahj.2011.07.008; Risum N, 2013, EUR HEART J, V34, P48, DOI 10.1093/eurheartj/ehs035; Rostom A, 2004, Evid Rep Technol Assess (Summ), P1; Roubicek T, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1113, DOI 10.1161/CIRCEP.115.003004; Sandberg K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-7; Saxon LA, 2006, CIRCULATION, V114, P2766, DOI 10.1161/CIRCULATIONAHA.106.642892; Schuchert A, 2013, CLIN CARDIOL, V36, P683, DOI 10.1002/clc.22203; Shalaby A, 2008, AM J CARDIOL, V101, P238, DOI 10.1016/j.amjcard.2007.07.064; Sharma AK, 2015, AM J CARDIOL, V115, P1249, DOI 10.1016/j.amjcard.2015.01.559; Shekelle PG, 2003, J AM COLL CARDIOL, V41, P1529, DOI 10.1016/S0735-1097(03)00262-6; Shen XD, 2011, INT J CARDIOL, V152, P13, DOI 10.1016/j.ijcard.2010.06.016; Smit MD, 2011, EUR J HEART FAIL, V13, P543, DOI 10.1093/eurjhf/hfr006; Stabile G, 2015, HEART RHYTHM, V12, P2221, DOI 10.1016/j.hrthm.2015.05.020; Stabile G, 2009, PACE, V32, pS141, DOI 10.1111/j.1540-8159.2008.02271.x; Sutton MGS, 2006, CIRCULATION, V113, P266, DOI 10.1161/CIRCULATIONAHA.104.520817; Taneja T, 2001, PACE, V24, P16, DOI 10.1046/j.1460-9592.2001.00016.x; Tayal B, 2015, J AM SOC ECHOCARDIOG, V28, P1474, DOI 10.1016/j.echo.2015.07.021; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Van Bommel RJ, 2011, J AM COLL CARDIOL, V57, P549, DOI 10.1016/j.jacc.2010.06.060; Wilcox JE, 2014, CIRC-HEART FAIL, V7, P146, DOI 10.1161/CIRCHEARTFAILURE.113.000789; Xu YZ, 2012, J CARDIOVASC ELECTR, V23, P172, DOI 10.1111/j.1540-8167.2011.02168.x; Yanagisawa S, 2015, J INTERV CARD ELECTR, V43, P269, DOI 10.1007/s10840-015-0015-3; Yancy CW, 2009, AM HEART J, V157, P754, DOI 10.1016/j.ahj.2008.12.016; Yu CM, 2005, CIRCULATION, V112, P1580, DOI 10.1161/CIRCULATIONAHA.105.538272; Zabarovskaja S, 2012, EUROPACE, V14, P1148, DOI 10.1093/europace/eus039; Zardkoohi O, 2007, PACE, V30, P1344, DOI 10.1111/j.1540-8159.2007.00869.x; Zhang Q, 2009, CLIN SCI, V117, P397, DOI 10.1042/CS20080580; Zusterzeel R, 2016, J CARDIOVASC TRANSL, V9, P12, DOI 10.1007/s12265-015-9663-z; Zusterzeel R, 2014, JAMA INTERN MED, V174, P1340, DOI 10.1001/jamainternmed.2014.2717	81	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180513	10.1371/journal.pone.0180513	http://dx.doi.org/10.1371/journal.pone.0180513			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683134	Green Published, Green Submitted, gold			2022-12-26	WOS:000405335200045
J	Matsunaga, M; Ishii, K; Ohtsubo, Y; Noguchi, Y; Ochi, M; Yamasue, H				Matsunaga, Masahiro; Ishii, Keiko; Ohtsubo, Yohsuke; Noguchi, Yasuki; Ochi, Misaki; Yamasue, Hidenori			Association between salivary serotonin and the social sharing of happiness	PLOS ONE			English	Article							EMOTIONAL CONTAGION; EMPATHY; STRESS; SYSTEM; REWARD; MALTREATMENT; HEALTH; ADULTS; STATES; AGE	Although human saliva contains the monoamine serotonin, which plays a key role in the modulation of emotional states, the association between salivary serotonin and empathic ability remains unclear. In order to elucidate the associations between salivary serotonin levels, trait empathy, and the sharing effect of emotions (i.e., sharing emotional experiences with others), we performed a vignette-based study. Participants were asked to evaluate their happiness when they experience several hypothetical life events, whereby we manipulated the valence of the imagined event (positive, neutral, or negative), as well as the presence of a friend (absent, positive, or negative). Results indicated that the presence of a happy friend significantly enhanced participants' happiness. Correlation analysis demonstrated that salivary serotonin levels were negatively correlated with happiness when both the self and friend conditions were positive. Correlation analysis also indicated a negative relationship between salivary serotonin levels and trait empathy (particularly in perspective taking), which was measured by the Interpersonal Reactivity Index. Furthermore, an exploratory multiple regression analysis suggested that mothers' attention during childhood predicted salivary serotonin levels. Our findings indicate that empathic abilities and the social sharing of happiness decreases as a function of salivary serotonin levels.	[Matsunaga, Masahiro] Aichi Med Univ, Sch Med, Dept Hlth & Psychosocial Med, Nagakute, Aichi, Japan; [Ishii, Keiko; Ohtsubo, Yohsuke; Noguchi, Yasuki; Ochi, Misaki] Kobe Univ, Fac Letters, Grad Sch Humanities, Dept Psychol, Kobe, Hyogo, Japan; [Yamasue, Hidenori] Hamamatsu Univ Sch Med, Dept Psychiat, Hamamatsu, Shizuoka, Japan	Aichi Medical University; Kobe University; Hamamatsu University School of Medicine	Matsunaga, M (corresponding author), Aichi Med Univ, Sch Med, Dept Hlth & Psychosocial Med, Nagakute, Aichi, Japan.	matsunag@aichi-med-u.ac.jp	Ishii, Keiko/H-5607-2019		JSPS Topic-Setting Program; Kobe University	JSPS Topic-Setting Program; Kobe University	This work was supported by a JSPS Topic-Setting Program to Advance Cutting-Edge Humanities and Social Sciences Research (Responding-to-Real-Society) (to KI). This work was also supported by Kobe University (Young Scholar Award) (to YO). The funders had no role in study design, data collection or analysis, the decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aketa H., 1999, PSYCHOL REP SOPHIA U, V2, P19; Beadle JN, 2012, INT PSYCHOGERIATR, V24, P822, DOI 10.1017/S1041610211002547; Berglund KJ, 2013, ALCOHOL CLIN EXP RES, V37, P757, DOI 10.1111/acer.12023; Bravo JA, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00024; Choi Damee., 2016, PSYCHOLOGY, V7, P1240, DOI [10.4236/psych.2016.79126, DOI 10.4236/PSYCH.2016.79126]; Chopik WJ, 2017, J CROSS CULT PSYCHOL, V48, P23, DOI 10.1177/0022022116673910; DOHERTY RW, 1995, PSYCHOL WOMEN QUART, V19, P355, DOI 10.1111/j.1471-6402.1995.tb00080.x; Dolder PC, 2016, NEUROPSYCHOPHARMACOL, V41, P2638, DOI 10.1038/npp.2016.82; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferreira JN, 2013, ORGANOGENESIS, V9, P199, DOI 10.4161/org.25224; Germine L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129612; Groschl M, 2008, CLIN CHEM, V54, P1759, DOI 10.1373/clinchem.2008.108910; Hatfield E., 1993, CURR DIR PSYCHOL SCI, V2, P96, DOI [DOI 10.1111/1467-8721.EP10770953, 10.1111/1467-8721.ep10770953]; Himichi Toshiyuki, 2017, Shinrigaku Kenkyu, V88, P61; Ito Y, 2013, INT J TRYPTOPHAN RES, P75, DOI 10.4137/IJTR.S11760; Izawa S, 2013, BIOL PSYCHOL, V94, P249, DOI 10.1016/j.biopsycho.2013.06.006; Izawa S, 2012, PSYCHONEUROENDOCRINO, V37, P852, DOI 10.1016/j.psyneuen.2011.10.001; Kawamichi H, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00164; Kawamichi H, 2013, SOC NEUROSCI-UK, V8, P90, DOI 10.1080/17470919.2012.744349; Kimura M., 2007, JPN J INTERPERS SOC, V7, P31, DOI DOI 10.18910/6043; Kranz GS, 2010, NEUROSCIENCE, V166, P1023, DOI 10.1016/j.neuroscience.2010.01.036; Lamm C, 2008, BRAIN RES, V1227, P153, DOI 10.1016/j.brainres.2008.06.066; Lin HC, 2012, INFANT BEHAV DEV, V35, P887, DOI 10.1016/j.infbeh.2012.08.001; Mascaro JS, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00109; Matsunaga M, 2016, NEUROIMAGE, V134, P132, DOI 10.1016/j.neuroimage.2016.04.020; Morelli SA, 2015, SOC PERSONAL PSYCHOL, V9, P57, DOI 10.1111/spc3.12157; Morelli SA, 2014, SOC COGN AFFECT NEUR, V9, P39, DOI 10.1093/scan/nss088; Preller KH, 2016, P NATL ACAD SCI USA, V113, P5119, DOI 10.1073/pnas.1524187113; Price J, 2009, BRIT J PSYCHIAT, V195, P211, DOI 10.1192/bjp.bp.108.051110; Ren TH, 2007, AM J PHYSIOL-GASTR L, V292, pG849, DOI 10.1152/ajpgi.00400.2006; RIME B, 1991, COGNITION EMOTION, V5, P435, DOI 10.1080/02699939108411052; Roy A, 2002, PSYCHIAT RES, V112, P69, DOI 10.1016/S0165-1781(02)00176-2; Stafford M, 2016, J POSIT PSYCHOL, V11, P326, DOI 10.1080/17439760.2015.1081971; Steptoe A, 2005, P NATL ACAD SCI USA, V102, P6508, DOI 10.1073/pnas.0409174102; Taillieu TL, 2016, CHILD ABUSE NEGLECT, V59, P1, DOI 10.1016/j.chiabu.2016.07.005; Tan ZL, 2007, NEUROENDOCRINOL LETT, V28, P395; Taylor SE, 2006, BIOL PSYCHIAT, V60, P671, DOI 10.1016/j.biopsych.2006.04.019; Ul-Haq Z, 2014, PSYCHOL MED, V44, P2231, DOI 10.1017/S0033291713002833; Vuoskoski JK, 2012, PSYCHOL AESTHET CREA, V6, P204, DOI 10.1037/a0026937; Wagner U, 2015, SOC COGN AFFECT NEUR, V10, P801, DOI 10.1093/scan/nsu121	42	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180391	10.1371/journal.pone.0180391	http://dx.doi.org/10.1371/journal.pone.0180391			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA3HX	28683075	gold, Green Submitted, Green Published			2022-12-26	WOS:000405335200031
J	Schulte, MJ; Solocinski, J; Wang, M; Kovacs, M; Kilgore, R; Osgood, Q; Underwood, L; Flickinger, MC; Chakraborty, N				Schulte, Mark J.; Solocinski, Jason; Wang, Mian; Kovacs, Michelle; Kilgore, Ryan; Osgood, Quinn; Underwood, Lukas; Flickinger, Michael C.; Chakraborty, Nilay			A technique for lyopreservation of Clostridium ljungdahlii in a biocomposite matrix for CO absorption	PLOS ONE			English	Article							MAMMALIAN-CELLS; PRESERVATION; TREHALOSE; BACTERIA; CRYOPRESERVATION; CARBOXIDIVORANS; MICROORGANISMS; ANHYDROBIOSIS; VITRIFICATION; CYANOBACTERIA	A system capable of biocatalytic conversion of distributed sources of single carbon gases such as carbon monoxide into hydrocarbons can be highly beneficial for developing commercially viable biotechnology applications in alternative energy. Several anaerobic bacterial strains can be used for such conversion. The anaerobic carbon monoxide-fixing bacteria Clostridium ljungdahlii OTA1 is a model CO assimilating microorganism that currently requires cryogenic temperature for storage of the viable strains. If these organisms can be stabilized and concentrated in thin films in advanced porous materials, it will enable development of high gas fraction, biocomposite absorbers with elevated carbon monoxide (CO) mass transfer rate, that require minimal power input and liquid, and demonstrate elevated substrate consumption rate compared to conventional suspended cell bioreactors. We report development of a technique for dry-stabilization of C.ljungdahlii OTA1 on a paper biocomposite. Bacterial samples coated onto paper were desiccated in the presence of trehalose using convective drying and stored at 4 degrees C. Optimal dryness was similar to 1g H2O per gram of dry weight (gDW). CO uptake directly following biocomposite rehydration steadily increases over time indicating immediate cellular metabolic recovery. A high-resolution Raman microspectroscopic hyperspectral imaging technique was employed to spatially quantify the residual moisture content. We have demonstrated for the first time that convectively dried and stored C. ljungdahlii strains were stabilized in a desiccated state for over 38 days without a loss in CO absorbing reactivity. The Raman hyperspectral imaging technique described here is a non-invasive characterization tool to support development of dry-stabilization techniques for microorganisms on inexpensive porous support materials. The present study successfully extends and implements the principles of dry-stabilization for preservation of strictly anaerobic bacteria as an alternative to lyophilization or spray drying that could enable centralized biocomposite biocatalyst fabrication and decentralized bioprocessing of CO to liquid fuels or chemicals.	[Schulte, Mark J.; Kovacs, Michelle; Kilgore, Ryan; Flickinger, Michael C.] North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA; [Solocinski, Jason; Wang, Mian; Osgood, Quinn; Underwood, Lukas; Chakraborty, Nilay] Univ Michigan, Dept Mech Engn, Dearborn, MI 48128 USA; [Flickinger, Michael C.] North Carolina State Univ, Biomfg Training & Educ Ctr, Raleigh, NC 27695 USA; [Wang, Mian] Univ Minnesota, Dept Mech Engn, 111 Church St SE, Minneapolis, MN 55455 USA	University of North Carolina; North Carolina State University; University of Michigan System; University of Michigan; University of North Carolina; North Carolina State University; University of Minnesota System; University of Minnesota Twin Cities	Flickinger, MC (corresponding author), North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.; Chakraborty, N (corresponding author), Univ Michigan, Dept Mech Engn, Dearborn, MI 48128 USA.; Flickinger, MC (corresponding author), North Carolina State Univ, Biomfg Training & Educ Ctr, Raleigh, NC 27695 USA.	mcflicki@ncsu.edu; nilay@umich.edu	Chakraborty, Nilay/AAK-4812-2020	Chakraborty, Nilay/0000-0001-8138-3506; Flickinger, Michael/0000-0002-6814-0427	National Institutes of Health Molecular Biotechnology Training Program [T32 GM008776-11]; Department of Energy Office of Energy Efficiency and Renewable Energy (EERE) [DE-EE0006877]; Golden LEAF Biotechnology Training and Education Center (BTEC) at NCSU; NSF [SusChEM 1510072, CHE 1609440]; University of Michigan [U038726, U046888]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008776] Funding Source: NIH RePORTER	National Institutes of Health Molecular Biotechnology Training Program; Department of Energy Office of Energy Efficiency and Renewable Energy (EERE); Golden LEAF Biotechnology Training and Education Center (BTEC) at NCSU; NSF(National Science Foundation (NSF)); University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institutes of Health (www.nih.gov) Molecular Biotechnology Training Program (T32 GM008776-11), the Department of Energy (www. energy.gov), Office of Energy Efficiency and Renewable Energy (EERE) under Award Number DE-EE0006877, and the Golden LEAF Biotechnology Training and Education Center (BTEC) at NCSU (https://www.btec.ncsu.edu). Authors would also like to acknowledge the NSF (www.nsf.gov) grant numbers SusChEM 1510072 and CHE 1609440. Authors would also like to acknowledge University of Michigan (www.umich.edu) Grant Numbers U038726 and U046888. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker JP, 2002, CELL PRESERV TECHNOL, V1, P129; [Anonymous], 1998, PROPERTIES WATER FOO; Ben M, 2016, J CHEM TECHNOL BIOT, V91, P2817, DOI 10.1002/jctb.4891; Bernal OI, 2014, BIOTECHNOL BIOENG, V111, P1993, DOI 10.1002/bit.25280; BERNY JF, 1991, MYCOLOGIA, V83, P805, DOI 10.2307/3760439; Bjerketorp J, 2006, CURR OPIN BIOTECH, V17, P43, DOI 10.1016/j.copbio.2005.12.005; CARPENTER JF, 1988, CRYOBIOLOGY, V25, P244, DOI 10.1016/0011-2240(88)90032-6; CARPENTER JF, 1991, DEV BIOL STAND, V74, P225; Champagne CP, 1996, FOOD RES INT, V29, P555, DOI 10.1016/0963-9969(95)00050-X; Chen Z, 2001, ANN CLIN LAB SCI, V31, P391; Cheng ZW, 2016, BIORESOURCE TECHNOL, V218, P751, DOI 10.1016/j.biortech.2016.07.001; Crowe J.H., 1992, MEMBRANE INTEGRITY A, P87; Crowe JH, 2001, CRYOBIOLOGY, V43, P89, DOI 10.1006/cryo.2001.2353; Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73; De Giulio B, 2005, WORLD J MICROB BIOT, V21, P739, DOI [10.1007/sl1274-004-4735-2, 10.1007/s11274-004-4735-2]; ELLIOTT GD, 2008, CELL PRESERV TECHNOL, V6, P253; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; Fahy G, 2015, CRYOBIOLOGY, V71, P169; Fernandez-Naveira A, 2017, J CHEM TECHNOLOGY BI; Fernandez-Naveira A, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-016-2188-z; Fernandez-Naveira A, 2016, APPL MICROBIOL BIOT, V100, P3361, DOI 10.1007/s00253-015-7238-1; Hernandez A, 2009, J APPL MICROBIOL, V107, P436, DOI 10.1111/j.1365-2672.2009.04216.x; Iravani S, 2015, J FOOD SCI TECH MYS, V52, P4679, DOI 10.1007/s13197-014-1516-2; Leang C, 2013, APPL ENVIRON MICROB, V79, P1102, DOI 10.1128/AEM.02891-12; LESLIE SB, 1995, APPL ENVIRON MICROB, V61, P3592, DOI 10.1128/AEM.61.10.3592-3597.1995; Morgan CA, 2006, J MICROBIOL METH, V66, P183, DOI 10.1016/j.mimet.2006.02.017; Nystul TG, 2003, SCIENCE, V302, P1038, DOI 10.1126/science.1089705; Oliver AE, 1998, SEED SCI RES, V8, P211, DOI 10.1017/S0960258500004128; Pegg DE, 2015, METHODS MOL BIOL, V1257, P3, DOI 10.1007/978-1-4939-2193-5_1; Peighambardoust SH, 2011, TRENDS FOOD SCI TECH, V22, P215, DOI 10.1016/j.tifs.2011.01.009; Potts M, 1999, EUR J PHYCOL, V34, P319, DOI 10.1017/S0967026299002267; Roser B., 1991, Trends in Food Science & Technology, V2, P166, DOI 10.1016/0924-2244(91)90671-5; Schoebitz M, 2013, AGRON SUSTAIN DEV, V33, P751, DOI 10.1007/s13593-013-0142-0; Schuck P, 2013, INT DAIRY J, V31, P12, DOI 10.1016/j.idairyj.2012.01.006; Schulte MJ, 2016, BIOTECHNOL BIOENG, V113, P1913, DOI 10.1002/bit.25966; SHIER WT, 1988, CRYOBIOLOGY, V25, P110, DOI 10.1016/0011-2240(88)90004-1; Slininger PJ, 2010, BIOCONTROL SCI TECHN, V20, P227, DOI 10.1080/09583150903469525; Solocinski J., 2017, CRYOBIOLOGY	38	1	1	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180806	10.1371/journal.pone.0180806	http://dx.doi.org/10.1371/journal.pone.0180806			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678828	Green Submitted, Green Published, gold			2022-12-26	WOS:000405272200091
J	Sorensen, L; Sorhus, E; Nordtug, T; Incardone, JP; Linbo, TL; Giovanetti, L; Karlsen, O; Meier, S				Sorensen, Lisbet; Sorhus, Elin; Nordtug, Trond; Incardone, John P.; Linbo, Tiffany L.; Giovanetti, Laura; Karlsen, Orjan; Meier, Sonnich			Oil droplet fouling and differential toxicokinetics of polycyclic aromatic hydrocarbons in embryos of Atlantic haddock and cod	PLOS ONE			English	Article							WEATHERED CRUDE-OIL; FISH EMBRYOS; DISPERSED OIL; MELANOGRAMMUS-AEGLEFINUS; ACUTE TOXICITY; PAHS; MORTALITY; RECEPTOR; BIOACCUMULATION; SENSITIVITY	The impact of crude oil pollution on early life stages (ELS) of fish, including larvae and embryos, has received considerable attention in recent years. Of the organic components present in crude oil, polycyclic aromatic hydrocarbons (PAHs) are considered the main class of compounds responsible for toxic effects in marine organisms. Although evidence suggests that they are more toxic, alkylated PAHs remain much less studied than their unsubstituted congeners. Recently, it was established that embryos of Atlantic haddock (Melanogrammus aeglefinus) are particularly sensitive to dispersed crude oil, and it was hypothesized that this was caused by direct interaction with crude oil droplets, which adhered to the chorion of exposed embryos. Such a phenomenon would increase the potential for uptake of less water-soluble compounds, including alkylated PAHs. In the current study, we compared the uptake of parent and alkylated PAHs in Atlantic cod (Gadus morhua) and haddock embryos exposed to dispersed crude oil at a range of environmentally relevant concentrations (10 - 600 mu g oil/ liter seawater). Although the species are biologically very similar, the cod chorion does not become fouled with oil droplets, even when the two species are exposed to dispersions of crude oil droplets under similar conditions. A close correlation between the degree of fouling and toxicological response (heart defects, craniofacial malformation) was observed. Oil droplet fouling in haddock led to both quantitative and qualitative differences in PAH uptake. Finally, kinetic data on a large suite of PAHs showed differential elimination, suggesting differential metabolism of unsubstituted versus alkylated compounds.	[Sorensen, Lisbet; Sorhus, Elin; Karlsen, Orjan; Meier, Sonnich] Inst Marine Res, Bergen, Norway; [Sorensen, Lisbet] Univ Bergen, Dept Chem, Bergen, Norway; [Nordtug, Trond] SINTEF Ocean, Environm Technol, Trondheim, Norway; [Incardone, John P.; Linbo, Tiffany L.] NOAA, Northwest Fisheries Sci Ctr, Seattle, WA USA; [Giovanetti, Laura] Univ Siena, Dept Environm Sci, Siena, Italy	Institute of Marine Research - Norway; University of Bergen; SINTEF; National Oceanic Atmospheric Admin (NOAA) - USA; University of Siena	Sorensen, L (corresponding author), Inst Marine Res, Bergen, Norway.; Sorensen, L (corresponding author), Univ Bergen, Dept Chem, Bergen, Norway.	lisbet.soerensen@imr.no	Karlsen, Ørjan/K-6137-2012; Nordtug, Trond/GZG-7597-2022	Karlsen, Ørjan/0000-0001-5801-4200; Nordtug, Trond/0000-0002-0269-2974; Sorensen, Lisbet/0000-0003-0455-3545; Sorhus, Elin/0000-0003-3542-4201	Norwegian Research Council [234367]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was financed by the Norwegian Research Council (Grant Nr. 234367, my./forskningsradet.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron MG, 2004, MAR ENVIRON RES, V58, P95, DOI 10.1016/j.marenvres.2004.03.001; Barron MG, 2004, TOXICOL SCI, V78, P60, DOI 10.1093/toxsci/kfh051; Bence AE, 1996, ORG GEOCHEM, V24, P7, DOI 10.1016/0146-6380(96)00010-1; Boehm PD., 2010, ENV FORENSICS CONTAM, P313; Bogerd J, 2001, BIOL REPROD, V64, P1633, DOI 10.1095/biolreprod64.6.1633; Brandvik PJ, 2013, MAR POLLUT BULL, V73, P319, DOI 10.1016/j.marpolbul.2013.05.020; Brette F, 2014, SCIENCE, V343, P772, DOI 10.1126/science.1242747; Brinkworth LC, 2003, J TOXICOL ENV HEAL A, V66, P627, DOI 10.1080/15287390309353771; Carls MG, 2008, AQUAT TOXICOL, V88, P121, DOI 10.1016/j.aquatox.2008.03.014; Carls MG, 2009, HUM ECOL RISK ASSESS, V15, P1084, DOI 10.1080/10807030903304708; Carls MG, 1999, ENVIRON TOXICOL CHEM, V18, P481, DOI 10.1002/etc.5620180317; Caroll J., 2011, INTEGRATED MODELING; Devillers J, 1996, CHEMOSPHERE, V33, P1047, DOI 10.1016/0045-6535(96)00246-9; El-Amrani S, 2013, TALANTA, V104, P67, DOI 10.1016/j.talanta.2012.11.025; FRIDGEIRSSON E, 1978, Rit Fiskideildar, V5, P1; Gonzalez-Doncel M, 2008, AQUAT TOXICOL, V87, P280, DOI 10.1016/j.aquatox.2008.02.013; Goodale BC, 2013, TOXICOL APPL PHARM, V272, P656, DOI 10.1016/j.taap.2013.04.024; Hall TE, 2004, J MORPHOL, V259, P255, DOI 10.1002/jmor.10222; Hansen BH, 2012, ECOTOX ENVIRON SAFE, V86, P38, DOI 10.1016/j.ecoenv.2012.09.009; Heintz RA, 1999, ENVIRON TOXICOL CHEM, V18, P494, DOI 10.1002/etc.5620180318; HISLOP JRG, 1987, J FISH BIOL, V31, P1, DOI 10.1111/j.1095-8649.1987.tb05209.x; Hjermann DO, 2007, MAR ECOL PROG SER, V339, P283, DOI 10.3354/meps339283; Incardona JP, 2006, TOXICOL APPL PHARM, V217, P308, DOI 10.1016/j.taap.2006.09.018; Incardona JP, 2016, AQUAT TOXICOL, V177, P515, DOI 10.1016/j.aquatox.2016.06.016; Incardona JP, 2015, SCI REP-UK, V5, DOI 10.1038/srep13499; Incardona JP, 2012, P NATL ACAD SCI USA, V109, pE51, DOI 10.1073/pnas.1108884109; Incardona JP, 2005, ENVIRON HEALTH PERSP, V113, P1755, DOI 10.1289/ehp.8230; Jonsson G, 2004, ENVIRON TOXICOL CHEM, V23, P1538, DOI 10.1897/03-173; Jung JH, 2015, ENVIRON SCI TECHNOL, V49, P13639, DOI 10.1021/acs.est.5b03729; Kang HJ, 2016, J HAZARD MATER, V312, P200, DOI 10.1016/j.jhazmat.2016.03.051; Kuhnert A, 2013, ENVIRON TOXICOL CHEM, V32, P1819, DOI 10.1002/etc.2239; LAURENCE GC, 1976, J CONSEIL, V36, P220; Li M, 1998, MAR POLLUT BULL, V36, P961, DOI 10.1016/S0025-326X(98)00096-4; LONNING S, 1988, SARSIA, V73, P49, DOI 10.1080/00364827.1988.10420671; Malmquist LMV, 2015, ENVIRON SCI TECHNOL, V49, P5713, DOI 10.1021/acs.est.5b01453; Malmquist LMV, 2013, ENVIRON SCI TECHNOL, V47, P5383, DOI 10.1021/es400809p; Mathew R, 2008, ENVIRON TOXICOL CHEM, V27, P1515, DOI 10.1897/07-355.1; Meador JP, 1995, REV ENVIRON CONTA<D>, V143, P79; Morrison C, 1999, CAN J ZOOL, V77, P890, DOI 10.1139/cjz-77-6-890; Nordtug T, 2015, PLOS ONE, V10; Nordtug T, 2011, SCI TOTAL ENVIRON, V412, P148, DOI 10.1016/j.scitotenv.2011.10.021; Nordtug T, 2011, MAR POLLUT BULL, V62, P2106, DOI 10.1016/j.marpolbul.2011.07.015; Olsen E, 2010, ICES J MAR SCI, V67, P87, DOI 10.1093/icesjms/fsp229; Olsen GH, 2013, MAR ENVIRON RES, V90, P9, DOI 10.1016/j.marenvres.2013.05.007; Olsvik PA, 2011, COMP BIOCHEM PHYS C, V154, P333, DOI 10.1016/j.cbpc.2011.07.002; Petersen GI, 1998, ENVIRON TOXICOL CHEM, V17, P1385, DOI 10.1002/etc.5620170724; R Core Team, 2018, R LANG ENV STAT COMP; Rasband W., 1997, IMAGEJ BETHESDA; Sorensen L, 2016, RAPID COMMUN MASS SP, V30, P2052, DOI 10.1002/rcm.7688; Sorensen L, 2016, ANAL BIOANAL CHEM, V408, P1023, DOI 10.1007/s00216-015-9225-x; Sorhus E, 2017, ELIFE, V6, DOI 10.7554/eLife.20707; Sorhus E, 2016, SCI REP-UK, V6, DOI 10.1038/srep31058; STIVER W, 1984, ENVIRON SCI TECHNOL, V18, P834, DOI 10.1021/es00129a006; Turcotte D, 2008, TOXICITY METABOLISM; Turcotte D, 2011, CHEMOSPHERE, V85, P1585, DOI 10.1016/j.chemosphere.2011.08.005; Turcotte D, 2011, ENVIRON TOXICOL CHEM, V30, P487, DOI 10.1002/etc.404; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; Varanasi U., 1989, METABOLISM POLYCYCLI, P93; Vikebo FB, 2014, ICES J MAR SCI, V71, P970, DOI 10.1093/icesjms/fst131; Whyte JJ, 2000, CRIT REV TOXICOL, V30, P347, DOI 10.1080/10408440091159239; Wu DM, 2012, ENVIRON TOXICOL CHEM, V31, P754, DOI 10.1002/etc.1739	61	40	42	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180048	10.1371/journal.pone.0180048	http://dx.doi.org/10.1371/journal.pone.0180048			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678887	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000405272200035
J	Zhang, ZY; Chang, YY; Zhang, JM; Lu, YX; Zheng, L; Hu, YH; Zhang, F; Li, XM; Zhang, WJ; Li, XN				Zhang, Zheying; Chang, Yaya; Zhang, Jianming; Lu, Yanxia; Zheng, Lin; Hu, Yuhan; Zhang, Fan; Li, Xiaomin; Zhang, Wenjuan; Li, Xuenong			HMGB3 promotes growth and migration in colorectal cancer by regulating WNT/beta-catenin pathway	PLOS ONE			English	Article							GASTRIC-CANCER; CELL; METASTASIS; EXPRESSION; PROGRESSION; CARCINOMA; PROTEINS; LIVER	Colorectal cancer (CRC) is the third leading cause of cancer-related deaths and a major health problem. High mobility group box 3 (HMGB3), a member of the high-mobility group box (HMGB) family, was reported to be over-expressed in gastric carcinoma and bladder cancer. However, the function of HMGB3 in CRC remains unclear. Here, we found that HMGB3 was up-regulated in CRC at both mRNA and protein levels. qRT-PCR results showed that high expression of HMGB3 had positive correlation with serosal invasion, lymph metastasis, and tumor-node-metastasis (TNM) stage in CRC patient. Functional experiments showed that HMGB3 can promote CRC cells proliferation and migration in vitro. Moreover, we found HMGB3 can active WNT/beta-catenin pathway to increase the expression level of c-Myc and MMP7. These results may be the reason for HMGB3 oncogene role in CRC. In summary, our data indicated that HMGB3 may serve as an oncoprotein and could be used as a potential prognostic marker in CRC.	[Zhang, Zheying; Chang, Yaya; Zhang, Jianming; Lu, Yanxia; Zheng, Lin; Hu, Yuhan; Zhang, Fan; Li, Xiaomin; Zhang, Wenjuan; Li, Xuenong] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Zhang, Zheying] Xinxiang Med Univ, Dept Pathol, Xinxiang, Henan, Peoples R China; [Chang, Yaya] Capital Med Univ, ShijingShan Teaching Hosp, Beijing, Peoples R China; [Zhang, Jianming] Southern Med Univ, Nanfang Hosp, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Xinxiang Medical University; Capital Medical University; Southern Medical University - China	Li, XN (corresponding author), Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Guangdong, Peoples R China.	nfydlxn@126.com	Hu, Yuhan/F-1634-2016	Li, Xuenong/0000-0003-1535-0735	National Natural Science Foundation of China [81672429, 81502479]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/, No. 81672429 to XNL and No. 81502479 to YXL). XNL designed the experiments and YXL prepared the manuscript.	Agresti A, 2003, CURR OPIN GENET DEV, V13, P170, DOI 10.1016/S0959-437X(03)00023-6; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Chen XD, 2014, TUMOR BIOL, V35, P11081, DOI 10.1007/s13277-014-2405-z; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Elgamal OA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076402; Emmons KM, 2007, CANCER EPIDEM BIOMAR, V16, P2186, DOI 10.1158/1055-9965.EPI-07-0211; Gao J, 2015, INT J CLIN EXP PATHO, V8, P345; Gong Y, 2013, GENET MOL RES, V12, P6032, DOI 10.4238/2013.December.2.1; Herszenyi L, 2010, EUR REV MED PHARMACO, V14, P249; Kang R, 2014, MOL ASPECTS MED, V40, P1, DOI 10.1016/j.mam.2014.05.001; Kostova N, 2010, MOL CELL BIOCHEM, V337, P251, DOI 10.1007/s11010-009-0305-0; Nemeth MJ, 2003, BLOOD, V102, P1298, DOI 10.1182/blood-2002-11-3541; Petit A, 2010, LEUKEMIA, V24, P654, DOI 10.1038/leu.2009.241; Shin YJ, 2013, CANCER BIOL THER, V14, P213, DOI 10.4161/cbt.23292; Smolarczyk R, 2012, POSTEP HIG MED DOSW, V66, P913, DOI 10.5604/17322693.1021108; Song N, 2013, TUMOR BIOL, V34, P2599, DOI 10.1007/s13277-013-0807-y; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Wang XB, 2015, INT J MOL SCI, V16, P22527, DOI 10.3390/ijms160922527; Yuan L, 2015, CANCER LETT, V359, P136, DOI 10.1016/j.canlet.2015.01.003; Zhang ZY, 2016, CANCER LETT, V376, P62, DOI 10.1016/j.canlet.2016.03.022; Zhou C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063142	23	51	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179741	10.1371/journal.pone.0179741	http://dx.doi.org/10.1371/journal.pone.0179741			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678825	Green Submitted, Green Published, gold			2022-12-26	WOS:000405272200025
J	Lee, KH; Lee, SR; Cho, H; Woo, JS; Kang, JH; Jeong, YM; Cheng, XW; Kim, WS; Kim, W				Lee, Kyung Hye; Lee, So-Ra; Cho, Haneul; Woo, Jong Shin; Kang, Jung Hee; Jeong, Yun-Mi; Cheng, Xian Wu; Kim, Woo-Shik; Kim, Weon			Cardioprotective effects of PKG activation by soluble GC activator, BAY 60-2770, in ischemia-reperfusion-injured rat hearts	PLOS ONE			English	Article							GUANYLATE-CYCLASE STIMULATORS; INDEPENDENT STIMULATION; CARDIOVASCULAR-DISEASE; POTASSIUM CHANNELS; OBESE MICE; PROTECTION; EXPRESSION; MITOCHONDRIA; RELAXATION; STRESS	\ Soluble guanylate cyclase (sGC) has been suggested as a therapeutic target for cardiac ischemia-reperfusion (IR) injury. Until now, the molecular mechanism of BAY 60-2770, a sGC activator, in cardiac IR injury has not been assessed. To identify the cardioprotective effects of BAY 60-2770 in IR-injured rat hearts, IR injury was established by occlusion of LAD for 40 min and reperfusion for 7 days, and the effects of BAY 60-2770 on myocardial protection were assessed by echocardiography and TTC staining. 5 nM and 5 mu M of BAY 60-2770 were perfused into isolated rat hearts in a Langendorff system. After 10-or 30-min reperfusion with BAY 60-2770, cGMP and cAMP concentrations and PKG activation status were examined. Hearts were also perfused with 1 mu M KT5823 or 100 mu M 5-HD in conjunction with 5 nM Bay 60-2770 to evaluate the protective role of PKG. Mitochondrial oxidative stress was investigated under hypoxia-reoxygenation in H9c2 cells. In IR-injured rat hearts, BAY 60-2770 oral administration reduced infarct size by TTC staining and improved left ventricular function by echocardiography. Tissue samples from BAY 60-2770-perfused hearts had approximately two-fold higher cGMP levels. BAY 60-2770 increased PKG activity in the myocardium, and the reduced infarct area by BAY 60-2770 was abrogated by KT5823 in isolated myocardium. In H9c2 cardiac myoblasts, hypoxia-reoxygenation-mediated mitochondrial ROS generation was diminished with BAY 60-2770 treatment, but was recovered by pretreatment with KT-5823. BAY 60-2770 demonstrated a protective effect against cardiac IR injury via mitoKATP opening and decreased mitoROS by PKG activation. BAY 60-2770 has a protective effect against cardiac IR injury via mitoKATP opening and decreased mitoROS by PKG activation. These results demonstrated that BAY 60-2770 may be used as a therapeutic agent for cardiac IR injury.	[Lee, Kyung Hye; Lee, So-Ra; Cho, Haneul; Woo, Jong Shin; Kang, Jung Hee; Jeong, Yun-Mi; Cheng, Xian Wu; Kim, Woo-Shik; Kim, Weon] Kyung Hee Univ, Kyung Hee Univ Hosp, Dept Cardiovasc Internal Med, Seoul, South Korea	Kyung Hee University; Kyung Hee University Hospital	Kim, W (corresponding author), Kyung Hee Univ, Kyung Hee Univ Hosp, Dept Cardiovasc Internal Med, Seoul, South Korea.	mylovekw@hanmail.net			Kyung Hee University [KHU-20131361]	Kyung Hee University	This work was supported by a postdoctoral fellowship grant from Kyung Hee University in 2013 (KHU-20131361).	Ahluwalia A, 2004, P NATL ACAD SCI USA, V101, P1386, DOI 10.1073/pnas.0304264101; Akao M, 2002, J AM COLL CARDIOL, V40, P803, DOI 10.1016/S0735-1097(02)02007-7; Alexandre EC, 2014, J PHARMACOL EXP THER, V349, P2, DOI 10.1124/jpet.113.211029; Behrends S, 2002, J HISTOCHEM CYTOCHEM, V50, P1325, DOI 10.1177/002215540205001005; Bice JS, 2014, CARDIOVASC RES, V101, P220, DOI 10.1093/cvr/cvt257; Boerrigter G, 2007, CARDIOVASC DRUG REV, V25, P30, DOI 10.1111/j.1527-3466.2007.00003.x; Brahmajothi MV, 2007, CHANNELS, V1, P353, DOI 10.4161/chan.5189; Costell MH, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00128; Das A, 2009, AM J PHYSIOL-HEART C, V296, pH1236, DOI 10.1152/ajpheart.00100.2009; Dudek M, 2014, PHARMACOL REP, V66, P499, DOI 10.1016/j.pharep.2013.11.001; Facundo HTF, 2006, BBA-MOL BASIS DIS, V1762, P202, DOI 10.1016/j.bbadis.2005.06.003; Follmann M, 2013, ANGEW CHEM INT EDIT, V52, P9442, DOI 10.1002/anie.201302588; Forini F, 2015, INT J MOL SCI, V16, P6312, DOI 10.3390/ijms16036312; Frank A, 2012, SEMIN CARDIOTHORAC V, V16, P123, DOI 10.1177/1089253211436350; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gao JJ, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-19; Ghosh A, 2016, P NATL ACAD SCI USA, V113, pE2355, DOI 10.1073/pnas.1524398113; Hausenloy DJ, 2006, CARDIOVASC RES, V70, P240, DOI 10.1016/j.cardiores.2006.01.017; Jabs A, 2015, VASC PHARMACOL, V71, P181, DOI 10.1016/j.vph.2015.03.007; Kisinska A, 2003, GEN PHYSIOL BIOPHYS, V22, P383; Leiria LO, 2014, J UROLOGY, V191, P539, DOI 10.1016/j.juro.2013.09.020; Malinska D, 2010, FEBS LETT, V584, P2043, DOI 10.1016/j.febslet.2010.01.013; Mendes-Silverio CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047223; Moon JY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150745; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Ong SB, 2015, J MOL CELL CARDIOL, V78, P23, DOI 10.1016/j.yjmcc.2014.11.005; Ozcan C, 2002, AM J PHYSIOL-HEART C, V282, pH531, DOI 10.1152/ajpheart.00552.2001; Pain T, 2000, CIRC RES, V87, P460; Queliconi BB, 2011, BBA-MOL CELL RES, V1813, P1309, DOI 10.1016/j.bbamcr.2010.11.005; Salloum FN, 2012, AM J PHYSIOL-HEART C, V302, pH1347, DOI 10.1152/ajpheart.00544.2011; Samavati L, 2002, AM J PHYSIOL-CELL PH, V283, pC273, DOI 10.1152/ajpcell.00514.2001; Szewczyk A, 2009, IUBMB LIFE, V61, P134, DOI 10.1002/iub.155; Tawa M, 2015, J CARDIOVASC PHARM, V65, P160, DOI 10.1097/FJC.0000000000000173; Wojtovich AP, 2009, BASIC RES CARDIOL, V104, P121, DOI 10.1007/s00395-009-0001-y	34	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180207	10.1371/journal.pone.0180207	http://dx.doi.org/10.1371/journal.pone.0180207			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671970	Green Published, Green Submitted, gold			2022-12-26	WOS:000405268500028
J	Chang, YW; Chou, YC; Yeh, CC; Hu, CJ; Hung, CJ; Lin, CS; Chen, TL; Liao, CC				Chang, Yi-Wen; Chou, Yi-Chun; Yeh, Chun-Chieh; Hu, Chaur-Jong; Hung, Chih-Jen; Lin, Chao-Shun; Chen, Ta-Liang; Liao, Chien-Chang			Outcomes after major surgery in patients with myasthenia gravis: A nationwide matched cohort study	PLOS ONE			English	Article							POPULATION-BASED COHORT; NEUROMUSCULAR-TRANSMISSION; NONCARDIAC SURGERY; ADVERSE OUTCOMES; THYMECTOMY; CRISIS; COMORBIDITY; DISORDERS; MORTALITY; TOXICITY	Objective To validate the comprehensive features of adverse outcomes after surgery for patients with myasthenia gravis. Methods Using reimbursement claims from Taiwan's National Health Insurance Research Database, we analyzed 2290 patients who received major surgery between 2004 and 2010 and were diagnosed with myasthenia gravis preoperatively. Surgical patients without myasthenia gravis (n = 22,900) were randomly selected by matching procedure with propensity score for comparison. The adjusted odds ratios and 95% confidence intervals of postoperative adverse events associated with preoperative myasthenia gravis were calculated under the multiple logistic regressions. Results Compared with surgical patients without myasthenia gravis, surgical patients with myasthenia gravis had higher risks of postoperative pneumonia (OR = 2.09; 95% CI: 1.65-2.65), septicemia (OR = 1.31; 95% CI: 1.05-1.64), postoperative bleeding (OR = 1.71; 95% CI: 1.07-2.72), and overall complications (OR = 1.70; 95% CI: 1.44-2.00). The ORs of postoperative adverse events for patients with myasthenia gravis who had symptomatic therapy, chronic immunotherapy, and short-term immunotherapy were 1.76 (95% CI 1.50-2.08), 1.70 (95% CI 1.36-2.11), and 4.36 (95% CI 2.11-9.04), respectively. Conclusions Patients with myasthenia gravis had increased risks of postoperative adverse events, particularly those experiencing emergency care, hospitalization, and thymectomy for care of myasthenia gravis. Our findings suggest the urgency of revising protocols for perioperative care for these populations.	[Chang, Yi-Wen] Taichung Vet Gen Hosp, Chia Yi Branch, Dept Anesthesiol, Chiayi, Taiwan; [Chang, Yi-Wen; Hung, Chih-Jen] Taichung Vet Gen Hosp, Dept Anesthesiol, Taichung, Taiwan; [Chou, Yi-Chun] China Med Univ Hosp, Dept Phys Med & Rehabil, Taichung, Taiwan; [Yeh, Chun-Chieh] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Yeh, Chun-Chieh] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Hu, Chaur-Jong] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei, Taiwan; [Lin, Chao-Shun; Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Lin, Chao-Shun; Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Hlth Policy Res Ctr, Taipei, Taiwan; [Lin, Chao-Shun; Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ, Sch Med, Dept Anesthesiol, Coll Med, Taipei, Taiwan; [Liao, Chien-Chang] China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan; [Liao, Chien-Chang] Taipei Med Univ, Shuan Ho Hosp, Dept Anesthesiol, New Taipei, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; China Medical University Taiwan; Taipei Medical University; Shuang Ho Hospital	Liao, CC (corresponding author), Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan.; Liao, CC (corresponding author), Taipei Med Univ Hosp, Hlth Policy Res Ctr, Taipei, Taiwan.; Liao, CC (corresponding author), Taipei Med Univ, Sch Med, Dept Anesthesiol, Coll Med, Taipei, Taiwan.; Liao, CC (corresponding author), China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan.; Liao, CC (corresponding author), Taipei Med Univ, Shuan Ho Hosp, Dept Anesthesiol, New Taipei, Taiwan.	ccliao@tmu.edu.tw	Yeh, Chun Chieh/I-4893-2019; Yeh, Chun Chieh/Y-3304-2019	Yeh, Chun Chieh/0000-0001-6753-7564; 	Shuang Ho Hospital; Taipei Medical University [104TMU-SHH-23]; Taiwan's Ministry of Science and Technology [MOST105-2629-B-038-001, MOST105-2314-B-038-025, MOST104-2314-B-038-027-MY2, NSC102-2314-B-038-021-MY3]; Taiwan's Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW106-TDUB-212-113004]	Shuang Ho Hospital; Taipei Medical University; Taiwan's Ministry of Science and Technology; Taiwan's Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This research was supported in part by Shuang Ho Hospital, Taipei Medical University (104TMU-SHH-23), Taiwan's Ministry of Science and Technology (MOST105-2629-B-038-001; MOST105-2314-B-038-025; MOST104-2314-B-038-027-MY2; NSC102-2314-B-038-021-MY3), and Taiwan's Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW106-TDUB-212-113004).	Alshaikh JT, 2016, MUSCLE NERVE, V53, P370, DOI 10.1002/mus.24904; Alshekhlee A, 2009, NEUROLOGY, V72, P1548, DOI 10.1212/WNL.0b013e3181a41211; Andersen JB, 2014, EUR J NEUROL, V21, P948, DOI 10.1111/ene.12439; Ando T, 2015, EUR J CARDIO-THORAC, V48, P705, DOI 10.1093/ejcts/ezu530; BUZELLO W, 1986, ANESTHESIOLOGY, V64, P507, DOI 10.1097/00000542-198604000-00017; Carr AS, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-46; Cheng C, 2013, ANN THORAC SURG, V95, P1035, DOI 10.1016/j.athoracsur.2012.11.074; Chou CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127731; CONNELL WR, 1993, GUT, V34, P1081, DOI 10.1136/gut.34.8.1081; Duggan M, 2005, ANESTHESIOLOGY, V102, P838, DOI 10.1097/00000542-200504000-00021; Fang F, 2015, J INTERN MED, V277, P594, DOI 10.1111/joim.12310; FRAISER LH, 1991, DRUGS, V42, P781, DOI 10.2165/00003495-199142050-00005; Gilhus NE, 2015, EUR J NEUROL, V22, P17, DOI 10.1111/ene.12599; Gilhus NE, 2015, LANCET NEUROL, V14, P1023, DOI 10.1016/S1474-4422(15)00145-3; Guptill JT, 2012, MUSCLE NERVE, V45, P363, DOI 10.1002/mus.22327; Hansen JS, 2016, MUSCLE NERVE, V53, P73, DOI 10.1002/mus.24697; Harvey AM, 1942, J CLIN INVEST, V21, P579, DOI 10.1172/JCI101336; De Lapiscina EHM, 2012, MUSCLE NERVE, V46, P174, DOI 10.1002/mus.23296; Jaretzki A, 2000, NEUROLOGY, V55, P16, DOI 10.1212/WNL.55.1.16; Ke CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133064; Keijzers M, 2015, EUR J CARDIO-THORAC, V48, P40, DOI 10.1093/ejcts/ezu352; Kulaksizoglu IB, 2007, CNS DRUGS, V21, P473, DOI 10.2165/00023210-200721060-00004; Leuzzi G, 2014, EUR J CARDIO-THORAC, V45, pE76, DOI 10.1093/ejcts/ezt641; Liao CC, 2013, ANN SURG, V257, P433, DOI 10.1097/SLA.0b013e31827b9b25; Marulli G, 2013, J THORAC CARDIOV SUR, V145, P730, DOI 10.1016/j.jtcvs.2012.12.031; Marx A, 2013, AUTOIMMUN REV, V12, P875, DOI 10.1016/j.autrev.2013.03.007; Pakzad Z, 2011, NEUROLOGY, V76, P1526, DOI 10.1212/WNL.0b013e318217e735; Plante J, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5389; Ramagopalan SV, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-1; Ramos-Fransi A, 2015, EUR J NEUROL, V22, P1056, DOI 10.1111/ene.12703; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Seneviratne J, 2008, ARCH NEUROL-CHICAGO, V65, P929, DOI 10.1001/archneur.65.7.929; Skeie GO, 2010, EUR J NEUROL, V17, P893, DOI 10.1111/j.1468-1331.2010.03019.x; Spillane J, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8497; Termsarasab P, 2012, J NEUROIMMUNOL, V249, P83, DOI 10.1016/j.jneuroim.2012.04.016; Tomulescu V, 2011, ANN SURG, V254, P761, DOI 10.1097/SLA.0b013e31823686f6; Wijeysundera DN, 2008, LANCET, V372, P562, DOI 10.1016/S0140-6736(08)61121-6; Yeh CC, 2013, DIABETES CARE, V36, P3216, DOI 10.2337/dc13-0770	38	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180433	10.1371/journal.pone.0180433	http://dx.doi.org/10.1371/journal.pone.0180433			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666024	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608700007
J	Lee, S; Seo, DH; Kim, KM; Lee, EY; Kim, HC; Kim, CO; Youm, Y; Rhee, Y				Lee, Seungwon; Seo, Da Hea; Kim, Kyoung Min; Lee, Eun Young; Kim, Hyeon Chang; Kim, Chang Oh; Youm, Yoosik; Rhee, Yumie			Contingent association between the size of the social support network and osteoporosis among Korean elderly women	PLOS ONE			English	Article							BONE-MINERAL DENSITY; NATIONAL-HEALTH; HIP FRACTURE; PREVALENCE; OLDER; MEN; RECIPROCITY; AWARENESS; OUTCOMES; FRIENDS	Objective To investigate the association between the number of personal ties (or the size of the social support network) and the incidence of osteoporosis among older women in Korea. Methods Data from the Korean Urban Rural Elderly Study were used. Bone density was measured by dual-energy X-ray absorptiometry at the lumbar spine (L1-L4) and femur neck. T-score, the standardized bone density compared with what is normally expected in a healthy young adult, was measured and the presence of osteoporosis was determined, if the T-score was < -2.5. The social support network size was measured by self-responses (number of confidants and spouse). Results Of the 1,846 participants, 44.9% were diagnosed with osteoporosis. The association between the social support network size and the incidence of osteoporosis was curvilinear in both bivariate and multivariate analyses. Having more people in one's social support network size was associated with lower risk of osteoporosis until it reached around four. Increasing the social support network size beyond four, in contrast, was associated with a higher risk of osteoporosis. This association was contingent on the average intimacy level of the social network. At the highest average intimacy level (''extremely close''), increasing the number of social support network members from one to six was associated with linear decrease in the predicted probability of osteoporosis from 45% to 30%. However, at the lowest average intimacy level (''not very close''), the predicted probability of osteoporosis dramatically increased from 48% to 80% as the size of the social network increased from one to six. Conclusion Our results show that maintaining a large and intimate social support network is associated with a lower risk of osteoporosis among elderly Korean women, while a large but less-intimate social relationship is associated with a higher risk.	[Lee, Seungwon; Youm, Yoosik] Yonsei Univ, Dept Sociol, Seoul, South Korea; [Seo, Da Hea] Inha Univ, Sch Med, Dept Endocrinol & Metab, Incheon, South Korea; [Kim, Kyoung Min] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea; [Lee, Eun Young] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Endocrinol & Metab, Seoul, South Korea; [Kim, Hyeon Chang; Kim, Chang Oh; Rhee, Yumie] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Yonsei University; Inha University; Seoul National University (SNU); Catholic University of Korea; Seoul St. Mary's Hospital; Yonsei University; Yonsei University Health System	Youm, Y (corresponding author), Yonsei Univ, Dept Sociol, Seoul, South Korea.; Rhee, Y (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	yoosik@yonsei.ac.kr; yumie@yuhs.ac	Rhee, Yumie/L-8020-2019; Kim, Hyeon Chang/F-8796-2019	Rhee, Yumie/0000-0003-4227-5638; Kim, Chang Oh/0000-0002-0773-5443; Kim, Hyeon Chang/0000-0001-7867-1240; Kim, Kyoung Min/0000-0001-8150-0266				Antonucci TC, 1998, FAM RELAT, V47, P379, DOI 10.2307/585268; ANTONUCCI TC, 1990, J SOC PERS RELAT, V7, P519, DOI 10.1177/0265407590074008; Baek J, 2016, J GERIATR CARDIOL, V13, P580, DOI 10.11909/j.issn.1671-5411.2016.07.005; BERKMAN L, 2003, NEIGHBORHOODS HLTH, P288; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; BOLGER N, 1989, J PERS SOC PSYCHOL, V57, P808, DOI 10.1037/0022-3514.57.5.808; Boudou L, 2011, OSTEOPOROSIS INT, V22, P2099, DOI 10.1007/s00198-011-1638-6; BURT RS, 1984, SOC NETWORKS, V6, P293, DOI 10.1016/0378-8733(84)90007-8; Choi YJ, 2012, J BONE MINER RES, V27, P1879, DOI 10.1002/jbmr.1635; Cornwell B, 2009, J GERONTOL B-PSYCHOL, V64, pI47, DOI 10.1093/geronb/gbp042; Davis JA, 1991, NORC GEN SOCIAL SURV; Deelstra JT, 2003, J APPL PSYCHOL, V88, P324, DOI 10.1037/0021-9010.88.2.324; Falci C, 2009, SOC FORCES, V87, P2031; Farahmand BY, 2000, OSTEOPOROSIS INT, V11, P803, DOI 10.1007/s001980070060; Fink HA, 2014, OSTEOPOROSIS INT, V25, P2833, DOI 10.1007/s00198-014-2853-8; Gaipa J.J.L., 1990, PERSONAL RELATIONSHI, P122; Ganda K, 2013, OSTEOPOROSIS INT, V24, P393, DOI 10.1007/s00198-012-2090-y; Ganesan K, 2005, J NATL MED ASSOC, V97, P329; Gowen M, 1983, INTERLEUKIN 1 FACTOR; Haines VA, 2008, SEX ROLES, V59, P164, DOI 10.1007/s11199-008-9441-3; Hall A., 1985, SOCIAL SUPPORT HLTH, P23; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; KAPLAN RM, 1987, HEALTH PSYCHOL, V6, P387, DOI 10.1037/0278-6133.6.5.387; Kim Y, 2015, J KOREAN ACAD NURS, V45, P293, DOI 10.4040/jkan.2015.45.2.293; Lee EY, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-33; Lindstrom M, 2000, SCAND J PUBLIC HEALT, V28, P200, DOI 10.1177/14034948000280030901; Ma L, 2015, PLOS ONE, V10; MEYER HE, 1993, AM J EPIDEMIOL, V137, P1203, DOI 10.1093/oxfordjournals.aje.a116622; Mezuk B, 2008, OSTEOPOROSIS INT, V19, P1, DOI 10.1007/s00198-007-0449-2; Michelson D, 1996, NEW ENGL J MED, V335, P1176, DOI 10.1056/NEJM199610173351602; Miller-Martinez D, 2014, OSTEOPOROSIS INT, V25, P1327, DOI 10.1007/s00198-013-2602-4; Moriwaki K, 2016, OSTEOPOROSIS INT, P1; Nabipour I, 2011, OSTEOPOROSIS INT, V22, P1343, DOI 10.1007/s00198-010-1332-0; Organization WH, 1994, ASS FRACT RISK ITS A; Portes A., 2000, KNOWLEDGE SOCIAL CAP, P43, DOI DOI 10.1016/B978-0-7506-7222-1.50006-4; Resnick Barbara, 2002, Clin Nurs Res, V11, P52, DOI 10.1177/1054773802011001005; ROOK KS, 1984, J PERS SOC PSYCHOL, V46, P1097, DOI 10.1037/0022-3514.46.5.1097; RUEHLMAN LS, 1988, J PERS SOC PSYCHOL, V55, P293, DOI 10.1037/0022-3514.55.2.293; SCHUSTER TL, 1990, AM J COMMUN PSYCHOL, V18, P423, DOI 10.1007/BF00938116; Troisi A, 2001, PHYSIOL BEHAV, V73, P443, DOI 10.1016/S0031-9384(01)00459-0; UEHARA ES, 1995, J SOC PERS RELAT, V12, P483, DOI 10.1177/0265407595124001; US Department of Health and Human Services, 2004, BON HLTH OST REP SUR, P87; Walen HR, 2000, J SOC PERS RELAT, V17, P5, DOI 10.1177/0265407500171001; Wortman CamilleB., 1985, SOCIAL SUPPORT THEOR; Youm Y, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-102	45	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180017	10.1371/journal.pone.0180017	http://dx.doi.org/10.1371/journal.pone.0180017			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TK	28700637	Green Submitted, gold, Green Published			2022-12-26	WOS:000405649600014
J	Balakrishnan, P; Beaty, T; Young, JH; Colantuoni, E; Matsushita, K				Balakrishnan, Poojitha; Beaty, Terri; Young, J. Hunter; Colantuoni, Elizabeth; Matsushita, Kunihiro			Methods to estimate underlying blood pressure: The Atherosclerosis Risk in Communities (ARIC) Study	PLOS ONE			English	Article							ANTIHYPERTENSIVE MEDICATION USE; HYPERTENSION; ADULTS; TRENDS	Antihypertensive medications complicate studies of blood pressure (BP) natural history; BP if untreated ("underlying BP") needs to be estimated. Our objectives were to compare validity of five missing data imputation methods to estimate underlying BP and longitudinal associations of underlying BP and age. We simulated BP treatment in untreated hypertensive participants from Atherosclerosis Risk in Communities (ARIC) in visits 1-5 (1987-2013) using matched treated hypertensive participants. The underlying BP was imputed: #1, set as missing; #2, add 10 mmHg for systolic, 5 mmHg for diastolic; #3, add medication class-specific constant; #4, truncated normal regression; and #5, truncated normal regression including prior visit data. Longitudinal associations were estimated using linear mixed models of imputed underlying BP for simulated treated and measured BP for untreated participants. Method 3 was the best-performing for systolic BP; lowest relative bias (5.3% for intercept at age 50, 0% for age coefficient) and average deviation from expected (0.04 to -1.79). Method 2 performed best for diastolic BP; lowest relative bias (0.6% intercept at age 50, 33.3% age <60, 9.1% age 60+) and average deviation (-1.25 to -1.68). Methods 4 and 5 were comparable or slightly inferior. In conclusion, constant addition methods yielded valid and precise underlying BP and longitudinal associations.	[Balakrishnan, Poojitha] Columbia Univ, Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10027 USA; [Beaty, Terri; Young, J. Hunter; Matsushita, Kunihiro] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Beaty, Terri; Colantuoni, Elizabeth] Johns Hopkins Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Beaty, Terri; Young, J. Hunter; Matsushita, Kunihiro] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; [Young, J. Hunter] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA	Columbia University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Balakrishnan, P (corresponding author), Columbia Univ, Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10027 USA.	pbalakr2@jhu.edu	Matsushita, Kunihiro/AAJ-5817-2020	Matsushita, Kunihiro/0000-0002-7179-718X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007141] Funding Source: NIH RePORTER; NHLBI NIH HHS [HHSN268201100005I, HHSN268201100009C, HHSN268201100005C, HHSN268201100007I, HHSN268201100012C, HHSN268201100009I, HHSN268201100010C, HHSN268201100008C, HHSN268201100005G, HHSN268201100008I, HHSN268201100007C, HHSN268201100011I, HHSN268201100011C, T32 HL007024, HHSN268201100006C] Funding Source: Medline; NIEHS NIH HHS [T32 ES007141] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; ARIC Coordinating Center, ATHEROSCLEROSIS RISK; ARIC Coordinating Center, HOM FIELD CTR PROC A; Cook NR, 1997, STAT MED, V16, P2713, DOI 10.1002/(SICI)1097-0258(19971215)16:23<2713::AID-SIM705>3.0.CO;2-S; Fang J, 2013, MMWR-MORBID MORTAL W, V62, P237; Frohlich E D, 1993, Heart Dis Stroke, V2, P459; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gu QP, 2012, CIRCULATION, V126, P2105, DOI 10.1161/CIRCULATIONAHA.112.096156; Gu QP, 2006, CIRCULATION, V113, P213, DOI 10.1161/CIRCULATIONAHA.105.542290; Hajjar I, 2006, ANNU REV PUBL HEALTH, V27, P465, DOI 10.1146/annurev.publhealth.27.021405.102132; Hindorff L., 2014, CATALOG PUBLISHED GE; Jorgensen NW, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-81; Kang T, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S43; McClelland RL, 2008, STAT MED, V27, P5039, DOI 10.1002/sim.3341; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Padmanabhan S, 2012, TRENDS GENET, V28, P397, DOI 10.1016/j.tig.2012.04.001; Pogue VA, 1996, HYPERTENSION, V28, P713, DOI 10.1161/01.HYP.28.5.713; R Core Team, 2016, R LANG ENV STAT COMP; Sun WJ, 2014, STAT MED, V33, P1288, DOI 10.1002/sim.6037; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Vaitsiakhovich Tatsiana, 2014, BMC Proc, V8, pS83, DOI 10.1186/1753-6561-8-S1-S83; Valderrama Amy L., 2012, Morbidity and Mortality Weekly Report, V61, P703; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wu J, 2005, AM J HYPERTENS, V18, P935, DOI 10.1016/j.amjhyper.2005.01.011	25	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0179234	10.1371/journal.pone.0179234	http://dx.doi.org/10.1371/journal.pone.0179234			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700596	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649400002
J	Jinushi, M; Morita, T; Xu, ZH; Kinoshita, I; Dosaka-Akita, H; Yagita, H; Kawakami, Y				Jinushi, Masahisa; Morita, Tomoko; Xu, Zhihang; Kinoshita, Ichiro; Dosaka-Akita, Hirotoshi; Yagita, Hideo; Kawakami, Yutaka			Autophagy-dependent regulation of tumor metastasis by myeloid cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; GROWTH; INFLAMMATION; TUMORIGENESIS; MECHANISMS; BLOCKADE; IMMUNITY; DISEASE	Autophagy is a vital process controlling the lysosomal degradation of cellular organelles and thereby regulating tissue homeostasis in an environment-dependent fashion. Recent studies have unveiled the critical role of tumor cell-derived autophagy in regulating pro-tumor and anti-tumor processes depending on different stages and tumor microenvironments. However, the precise mechanism whereby autophagy regulates tumor progression remains largely unclear. Since myeloid cells contribute to tumor progression and metastasis, we evaluated the role of myeloid cell-specific autophagy in the regulation of tumor progression. We found that the number and size of metastatic lesions were smaller in myeloid cell-specific autophagy-deficient mice. Furthermore, autophagy-mediated regulation of TGF-beta in myeloid cells was associated with the induction of epithelial-mesenchymal transition (EMT), which increases the invasive and metastatic potentials of tumor cells. Myeloid-derived autophagy also plays a critical role in impairing antitumor immune responses and promoting the survival and accumulation of M2 macrophages in tumor tissues in a CSF-1 and TGF-beta-dependent manner. Taken together, our findings elucidate previously unrecognized mechanisms by which myeloid cells promote tumor progression through autophagy-mediated regulation of malignancy and immune tolerance.	[Jinushi, Masahisa; Xu, Zhihang; Kawakami, Yutaka] Keio Univ, Sch Med, Inst Adv Med Res, Div Cellular Signaling, Tokyo, Japan; [Morita, Tomoko] Hokkaido Univ, Inst Genet Med, Sapporo, Hokkaido, Japan; [Xu, Zhihang] Univ Tradit Chinese Med, Acupuncture & Moxibust Coll Tianjin, Tianjin, Peoples R China; [Kinoshita, Ichiro; Dosaka-Akita, Hirotoshi] Hokkaido Univ, Grad Sch Med, Dept Med Oncol, Sapporo, Hokkaido, Japan; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo, Japan	Keio University; Hokkaido University; Hokkaido University; Juntendo University	Jinushi, M (corresponding author), Keio Univ, Sch Med, Inst Adv Med Res, Div Cellular Signaling, Tokyo, Japan.	jinushi@keio.jp		Xu, Zhifang/0000-0002-0576-163X	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [26670183]; Ministry of Health, Labor and Welfare [H24-B-008]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study is partially supported by a Grant-in-Aid (26670183) for Scientific Research for Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT; http://www.mext.go.jp/en/) and the Ministry of Health, Labor and Welfare (Grant number: H24-B-008 to MJ; http://www.mhlw.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Castillo EF, 2012, P NATL ACAD SCI USA, V109, pE3168, DOI 10.1073/pnas.1210500109; Chaffer CL, 2001, SCIENCE, V331, P1559; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Dorr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437; Dong CF, 2013, CANCER CELL, V23, P316, DOI 10.1016/j.ccr.2013.01.022; Gorelik L, 2001, NAT MED, V7, P1118, DOI 10.1038/nm1001-1118; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gutcher I, 2011, IMMUNITY, V34, P396, DOI 10.1016/j.immuni.2011.03.005; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Huang J, 2012, CANCER RES, V72, P230, DOI 10.1158/0008-5472.CAN-11-2001; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Jinushi M, 2007, J CLIN INVEST, V117, P1902, DOI 10.1172/JCI30966; Jinushi M, 2009, J EXP MED, V206, P1317, DOI 10.1084/jem.20082614; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kiyono K, 2009, CANCER RES, V69, P8844, DOI 10.1158/0008-5472.CAN-08-4401; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lock R, 2014, CANCER DISCOV, V4, P466, DOI 10.1158/2159-8290.CD-13-0841; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P4297, DOI 10.4161/cc.9.21.13817; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407; Ogunjimi AA, 2012, CELL SIGNAL, V24, P476, DOI 10.1016/j.cellsig.2011.09.027; Pang YL, 2013, CANCER DISCOV, V3, P936, DOI 10.1158/2159-8290.CD-12-0527; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Song JR, 2009, AUTOPHAGY, V5, P1131, DOI 10.4161/auto.5.8.9996; Strohecker AM, 2013, CANCER DISCOV, V3, P1272, DOI 10.1158/2159-8290.CD-13-0397; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Valencia T, 2014, CANCER CELL, V26, P121, DOI 10.1016/j.ccr.2014.05.004; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Yan HYH, 2015, CANCER RES, V75, P5283, DOI 10.1158/0008-5472.CAN-15-2282-T; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Zhao XD, 2013, INT J CANCER, V132, P1, DOI 10.1002/ijc.27664	50	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179357	10.1371/journal.pone.0179357	http://dx.doi.org/10.1371/journal.pone.0179357			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686632	Green Submitted, gold, Green Published			2022-12-26	WOS:000405464100015
J	Kim, J; Lee, DY; Park, SE; Park, CY; Lee, WY; Oh, KW; Park, SW; Rhee, EJ				Kim, Jihyun; Lee, Da Young; Park, Se Eun; Park, Cheol-Young; Lee, Won-Young; Oh, Ki-Won; Park, Sung-Woo; Rhee, Eun-Jung			Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; HEPATIC STEATOSIS; SUBCLINICAL ATHEROSCLEROSIS; INSULIN-RESISTANCE; PREVALENCE; ASSOCIATION; OBESITY; GLUCOSE; ADULTS	Background Recent studies have suggested the importance of non-alcoholic fatty liver disease (NAFLD) and systemic inflammation in the development of atherosclerosis. The aim of this study was to compare the risk for coronary artery calcification (CAC) development according to the status of NAFLD and inflammation over four years of follow-up in subjects without baseline CAC. Methods A total of 1,575 participants in a health screening program were divided into four groups according to baseline NAFLD state and high-sensitivity C-reactive protein (hs-CRP) (median 0.06 mg/L) levels as follows: no NAFLD and hs-CRP < 0.06 mg/L, no NAFLD and hs-CRP >= 0.06 mg/L, NAFLD and hs-CRP < 0.06 mg/L, and NAFLD and hs-CRP >= 0.06 mg/ L. Coronary artery calcium score (CACS) was repeatedly measured by multi-detector computed tomography at four-year intervals and CAC development during those intervals was monitored in subjects with baseline CACS = 0. Results Over four years, 148 subjects (9.4%) developed CAC. The proportion of subjects who developed CAC was significantly higher in subjects with NAFLD at baseline compared with those without NAFLD at baseline (6.8 vs. 12.4%, p< 0.01), and it was also higher in subjects with hs-CRP >= 0.06 mg/L compared with those with hs-CRP < 0.06 mg/L (7.2 vs. 11.5%, p< 0.01). In addition, the proportion of subjects who developed CAC was highest in subjects with NAFLD and hs-CRP >= 0.06 mg/dL, followed by subjects with NAFLD, subjects without NAFLD and hs-CRP >= 0.06 mg/L, and subjects without NALFD and hs-CRP < 0.05 mg/L at baseline, in that order (13.7, 10.0, 8.3, and 5.8%, respectively; p for trend< 0.01). The odds ratio for CAC development was highest in subjects with NAFLD and hs-CRP >= 0.06 mg/L (1.67, 95% CI 1.01 - 2.77), though it was attenuated after adjustment for body mass index. Conclusions The concomitant presence of NAFLD and systemic inflammation as assessed by hs-CRP increases the risk of CAC development over four years.	[Kim, Jihyun; Lee, Da Young; Park, Se Eun; Park, Cheol-Young; Lee, Won-Young; Oh, Ki-Won; Park, Sung-Woo; Rhee, Eun-Jung] Sungkyunkwan Univ, Sch Med, Dept Endocrinol & Metab, Kangbuk Samsung Hosp, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Rhee, EJ (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Endocrinol & Metab, Kangbuk Samsung Hosp, Seoul, South Korea.	hongsiri@hanmail.net	, Da Young Lee/AAA-1843-2021; Rhee, Eun-Jung/M-9294-2015; LEE, WON-YOUNG/C-7249-2018	, Da Young Lee/0000-0002-8211-2393; Rhee, Eun-Jung/0000-0002-6108-7758; LEE, WON-YOUNG/0000-0002-1082-7592				Al Rifai M, 2015, ATHEROSCLEROSIS, V239, P629, DOI 10.1016/j.atherosclerosis.2015.02.011; Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004; Blankstein R, 2017, ENDOCRINOL METAB, V32, P47, DOI 10.3803/EnM.2017.32.1.47; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Byrne CD, 2014, ARTERIOSCL THROM VAS, V34, P1155, DOI 10.1161/ATVBAHA.114.303034; Chen CH, 2010, DIGEST DIS SCI, V55, P1752, DOI 10.1007/s10620-009-0935-9; Cho HC, 2016, GUT LIVER, V10, P117, DOI 10.5009/gnl14444; Fargion S, 2014, WORLD J GASTROENTERO, V20, P13306, DOI 10.3748/wjg.v20.i37.13306; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Hecht HS, 2015, JACC-CARDIOVASC IMAG, V8, P580, DOI 10.1016/j.jcmg.2015.02.006; Jimba S, 2005, DIABETIC MED, V22, P1141, DOI 10.1111/j.1464-5491.2005.01582.x; Kolak M, 2007, DIABETES, V56, P1960, DOI 10.2337/db07-0111; Kovacic JC, 2012, ATHEROSCLEROSIS, V221, P176, DOI 10.1016/j.atherosclerosis.2011.11.020; Lazo M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6891; Lee JI, 2016, ENDOCRINOL METAB, V31, P86, DOI 10.3803/EnM.2016.31.1.86; Lee MK, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0253-9; Liu H, 2014, WORLD J GASTROENTERO, V20, P8407, DOI 10.3748/wjg.v20.i26.8407; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McKimmie RL, 2008, AM J GASTROENTEROL, V103, P3029, DOI 10.1111/j.1572-0241.2008.02188.x; Oni ET, 2015, AM J CARDIOL, V115, P34, DOI 10.1016/j.amjcard.2014.09.044; Park HE, 2016, J CLIN ENDOCR METAB, V101, P3134, DOI 10.1210/jc.2016-1525; Park SH, 2006, J GASTROEN HEPATOL, V21, P138, DOI 10.1111/j.1440-1746.2005.04086.x; Povero D, 2016, DIABETES METAB J, V40, P1, DOI 10.4093/dmj.2016.40.1.1; QUINN SF, 1985, AM J ROENTGENOL, V145, P753, DOI 10.2214/ajr.145.4.753; Rumberger JA, 1999, MAYO CLIN PROC, V74, P243, DOI 10.4065/74.3.243; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Sinn DH, 2017, GUT, V66, P323, DOI 10.1136/gutjnl-2016-311854; Targher G, 2007, DIABETES CARE, V30, P1212, DOI 10.2337/dc06-2247; VanWagner LB, 2014, ATHEROSCLEROSIS, V235, P599, DOI 10.1016/j.atherosclerosis.2014.05.962; Yoon HJ, 2014, WORLD J HEPATOL, V6, P800, DOI 10.4254/wjh.v6.i11.800; Younossi ZM, 2002, HEPATOLOGY, V35, P746, DOI 10.1053/jhep.2002.32483	31	17	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180118	10.1371/journal.pone.0180118	http://dx.doi.org/10.1371/journal.pone.0180118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686633	Green Submitted, gold, Green Published			2022-12-26	WOS:000405464100036
J	Zhalyalov, AS; Panteleev, MA; Gracheva, MA; Ataullakhanov, FI; Shibeko, AM				Zhalyalov, Ansar S.; Panteleev, Mikhail A.; Gracheva, Marina A.; Ataullakhanov, Fazoil I.; Shibeko, Alexey M.			Co-ordinated spatial propagation of blood plasma clotting and fibrinolytic fronts	PLOS ONE			English	Article							TISSUE-PLASMINOGEN-ACTIVATOR; ACUTE MYOCARDIAL-INFARCTION; MASSIVE PULMONARY-EMBOLISM; FACTOR-VII ACTIVATION; RANDOMIZED-TRIAL; MODELING FIBRINOLYSIS; THROMBOLYTIC THERAPY; CONFOCAL MICROSCOPY; ENDOTHELIAL-CELLS; POSITIVE FEEDBACK	Fibrinolysis is a cascade of proteolytic reactions occurring in blood and soft tissues, which functions to disintegrate fibrin clots when they are no more needed. In order to elucidate its regulation in space and time, fibrinolysis was investigated using an in vitro reaction-diffusion experimental model of blood clot formation and dissolution. Clotting was activated by a surface with immobilized tissue factor in a thin layer of recalcified blood plasma supplemented with tissue plasminogen activator (TPA), urokinase plasminogen activator or streptokinase. Formation and dissolution of fibrin clot was monitored by videomicroscopy. Computer systems biology model of clot formation and lysis was developed for data analysis and experimental planning. Fibrin clot front propagated in space from tissue factor, followed by a front of clot dissolution propagating from the same source. Velocity of lysis front propagation linearly depended on the velocity clotting front propagation (correlation r(2) = 0.91). Computer model revealed that fibrin formation was indeed the rate-limiting step in the fibrinolysis front propagation. The phenomenon of two fronts which switched the state of blood plasma from liquid to solid and then back to liquid did not depend on the fibrinolysis activator. Interestingly, TPA at high concentrations began to increase lysis onset time and to decrease lysis propagation velocity, presumably due to plasminogen depletion. Spatially non-uniform lysis occurred simultaneously with clot formation and detached the clot from the procoagulant surface. These patterns of spatial fibrinolysis provide insights into its regulation and might explain clinical phenomena associated with thrombolytic therapy.	[Zhalyalov, Ansar S.; Panteleev, Mikhail A.; Ataullakhanov, Fazoil I.; Shibeko, Alexey M.] Ctr Theoret Problems Physicochem Pharmacol RAS, Moscow, Russia; [Panteleev, Mikhail A.; Gracheva, Marina A.; Ataullakhanov, Fazoil I.] Natl Sci & Pract Ctr Pediat Hematol, Oncol & Immunol, Moscow, Russia; [Panteleev, Mikhail A.; Ataullakhanov, Fazoil I.] Moscow MV Lomonosov State Univ, Dept Phys, Moscow, Russia; [Panteleev, Mikhail A.; Ataullakhanov, Fazoil I.] Moscow Inst Phys & Technol, Fac Biol & Med Phys, Dolgoprudnyi, Russia	Russian Academy of Sciences; Lomonosov Moscow State University; Moscow Institute of Physics & Technology	Shibeko, AM (corresponding author), Ctr Theoret Problems Physicochem Pharmacol RAS, Moscow, Russia.	alshibeko@gmail.com	Ataullakhanov, Fazoil/J-8076-2012; Panteleev, Mikhail A/H-5491-2012; Ataullakhanov, Fazoil/O-3458-2019; Gracheva, Marina/A-8559-2014; Shibeko, Alexey/A-9447-2014	Panteleev, Mikhail A/0000-0002-8128-7757; Shibeko, Alexey/0000-0003-1494-3125; Gracheva, Marina/0000-0002-7522-168X	Russian Foundation for Basic Research [15-51-15008, 17-04-01309]; Russian Academy of Sciences; President of Russian Federation Grant [MK-9245.2016.4, MD-229.2017.4]; Russian Science Foundation [16-14-00-224]; Russian Science Foundation [16-14-00224] Funding Source: Russian Science Foundation	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); President of Russian Federation Grant; Russian Science Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	The project was supported by Russian Foundation for Basic Research grants 15-51-15008 and 17-04-01309 to MAP; by Russian Academy of Sciences grants to FIA (Molecular and Cellular Biology, Basic Research for Development of Biomedical Technologies, Molecular Mechanisms of Physiologic Functions) and to MAP (Basic Science for Medicine); by Grant of President of Russian Federation MK-9245.2016.4 to AMS and MD-229.2017.4 to MAP. Theoretical modelling was supported by grant from Russian Science Foundation 16-14-00-224 to FIA (sections Computational model of fibrin clot growth and lysis and Computer simulation of spatial clot growth and lysis; Figures 6 and 7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1970, JAMA-J AM MED ASSOC, V214, p2163/2172; Balandina AN, 2011, BIOPHYS J, V101, P1816, DOI 10.1016/j.bpj.2011.08.034; Bannish BE, 2014, MATH MED BIOL, V31, P17, DOI 10.1093/imammb/dqs029; Bannish BE, 2014, MATH MED BIOL, V31, P45, DOI 10.1093/imammb/dqs030; Bizjak N, 2014, THROMB RES, V133, P908, DOI 10.1016/j.thromres.2014.02.008; Bode C, 1996, CIRCULATION, V94, P891, DOI 10.1161/01.CIR.94.5.891; Bucay I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116350; CALIFF RM, 1991, CIRCULATION, V83, P1543, DOI 10.1161/01.CIR.83.5.1543; Campbell RA, 2008, ARTERIOSCL THROM VAS, V28, P2247, DOI 10.1161/ATVBAHA.108.176008; Campbell RA, 2010, THROMB HAEMOSTASIS, V104, P1281, DOI 10.1160/TH10-07-0442; Campbell RA, 2009, BLOOD, V114, P4886, DOI 10.1182/blood-2009-06-228940; CARR ME, 1978, MACROMOLECULES, V11, P46, DOI 10.1021/ma60061a009; Chernysh IN, 2015, J THROMB HAEMOST, V13, P601, DOI 10.1111/jth.12857; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; COLLEN D, 1980, THROMB HAEMOSTASIS, V43, P77; Collet JP, 2003, J BIOL CHEM, V278, P21331, DOI 10.1074/jbc.M212734200; Collet JP, 2000, ARTERIOSCL THROM VAS, V20, P1354, DOI 10.1161/01.ATV.20.5.1354; Danforth CM, 2009, MATH MED BIOL, V26, P323, DOI 10.1093/imammb/dqp011; Dashkevich NM, 2012, BIOPHYS J, V103, P2233, DOI 10.1016/j.bpj.2012.10.011; DIAMOND SL, 1993, BIOPHYS J, V65, P2622, DOI 10.1016/S0006-3495(93)81314-6; Fadeeva OA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P734, DOI 10.1134/S0006297910060088; GEMMILL JD, 1991, BRIT J CLIN PHARMACO, V31, P143, DOI 10.1111/j.1365-2125.1991.tb05502.x; KRUITHOF EKO, 1987, BLOOD, V70, P1645; LEVIN EG, 1984, J CLIN INVEST, V74, P1988, DOI 10.1172/JCI111620; Lindahl TL, 2015, THROMB RES, V135, P544, DOI 10.1016/j.thromres.2014.12.019; Lipets E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087692; LIU JN, 1991, J CLIN INVEST, V88, P2012, DOI 10.1172/JCI115528; Longstaff C, 2015, J THROMB HAEMOST, V13, pS98, DOI 10.1111/jth.12935; Longstaff C, 2011, BLOOD, V117, P661, DOI 10.1182/blood-2010-06-290338; Luan D, 2007, PLOS COMPUT BIOL, V3, P1347, DOI 10.1371/journal.pcbi.0030142; Meneveau N, 1997, EUR HEART J, V18, P1141; MEYER G, 1992, J AM COLL CARDIOL, V19, P239, DOI 10.1016/0735-1097(92)90472-Y; Meyerovitz MF, 1995, J VASC INTERV RADIOL, V6, P775, DOI 10.1016/S1051-0443(95)71184-8; Michels HR, 1999, J THROMB THROMBOLYS, V8, P213, DOI 10.1023/A:1008914321384; Mutch NJ, 2007, J THROMB HAEMOST, V5, P812, DOI 10.1111/j.1538-7836.2007.02430.x; Ovanesov MV, 2005, J THROMB HAEMOST, V3, P321, DOI 10.1111/j.1538-7836.2005.01128.x; Ovanesov MV, 2003, THROMB HAEMOSTASIS, V89, P235; Ovanesov MV, 2002, BBA-GEN SUBJECTS, V1572, P45, DOI 10.1016/S0304-4165(02)00278-7; Panteleev MA, 2006, BIOPHYS J, V90, P1489, DOI 10.1529/biophysj.105.069062; Panteleev MA, 2004, BIOCHEM J, V381, P779, DOI 10.1042/BJ20031748; Panteleev MA, 2015, THROMB RES, V136, P699, DOI 10.1016/j.thromres.2015.07.025; Panteleev MA, 2010, BIOPHYS J, V98, P1751, DOI 10.1016/j.bpj.2010.01.027; Reed GL, 1999, P NATL ACAD SCI USA, V96, P8879, DOI 10.1073/pnas.96.16.8879; ROSSI E, 1988, THROMB RES, V52, P453, DOI 10.1016/0049-3848(88)90029-1; Ruiz-Bailen M, 2002, MED SCI MONITOR, V8, pI85; Sakharov DV, 1996, J BIOL CHEM, V271, P2133, DOI 10.1074/jbc.271.4.2133; SEIFRIED E, 1989, THROMB HAEMOSTASIS, V61, P497; Sharifi M, 2013, CARDIOVASC INTER RAD, V36, P1586, DOI 10.1007/s00270-013-0569-3; Shibeko AM, 2016, BRIEF BIOINFORM, V17, P429, DOI 10.1093/bib/bbv040; Shibeko AM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-5; Soshitova NP, 2012, BLOOD COAGUL FIBRIN, V23, P498, DOI 10.1097/MBC.0b013e328352e90e; Takahashi K, 1998, AM J PHYSIOL-LUNG C, V275, pL47, DOI 10.1152/ajplung.1998.275.1.L47; TANSWELL P, 1992, J AM COLL CARDIOL, V19, P1071, DOI 10.1016/0735-1097(92)90297-Z; TATE KM, 1987, BIOCHEMISTRY-US, V26, P338, DOI 10.1021/bi00376a002; TORR SR, 1992, J AM COLL CARDIOL, V19, P1085, DOI 10.1016/0735-1097(92)90300-C; Varju I, 2011, J THROMB HAEMOST, V9, P979, DOI 10.1111/j.1538-7836.2011.04203.x; Welsh JD, 2014, BLOOD, V124, P1808, DOI 10.1182/blood-2014-01-550335; WIMAN B, 1978, EUR J BIOCHEM, V87, P143, DOI 10.1111/j.1432-1033.1978.tb12360.x; Wootton DM, 2002, BIOTECHNOL BIOENG, V77, P405, DOI 10.1002/bit.10127	59	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180668	10.1371/journal.pone.0180668	http://dx.doi.org/10.1371/journal.pone.0180668			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686711	Green Published, Green Submitted, gold			2022-12-26	WOS:000405464100089
J	Shukla, A; Bhattacharyya, A; Kuppusamy, L; Srivas, M; Thattai, M				Shukla, Ankit; Bhattacharyya, Arnab; Kuppusamy, Lakshmanan; Srivas, Mandayam; Thattai, Mukund			Discovering vesicle traffic network constraints by model checking	PLOS ONE			English	Article							MEMBRANE; PROTEINS; SNARES	A eukaryotic cell contains multiple membrane-bound compartments. Transport vesicles move cargo between these compartments, just as trucks move cargo between warehouses. These processes are regulated by specific molecular interactions, as summarized in the Rothman-Schekman-Sudhof model of vesicle traffic. The whole structure can be represented as a transport graph: each organelle is a node, and each vesicle route is a directed edge. What constraints must such a graph satisfy, if it is to represent a biologically realizable vesicle traffic network? Graph connectedness is an informative feature: 2-connectedness is necessary and sufficient for mass balance, but stronger conditions are required to ensure correct molecular specificity. Here we use Boolean satisfiability (SAT) and model checking as a framework to discover and verify graph constraints. The poor scalability of SAT model checkers often prevents their broad application. By exploiting the special structure of the problem, we scale our model checker to vesicle traffic systems with reasonably large numbers of molecules and compartments. This allows us to test a range of hypotheses about graph connectivity, which can later be proved in full generality by other methods.	[Shukla, Ankit; Kuppusamy, Lakshmanan] Vellore Inst Technol, Sch Comp Sci & Engn, Vellore, Tamil Nadu, India; [Bhattacharyya, Arnab] Indian Inst Sci, Dept Comp Sci & Automat, Bengaluru, India; [Srivas, Mandayam] Chennai Math Inst, Madras, Tamil Nadu, India; [Thattai, Mukund] Tata Inst Fundamental Res, Simons Ctr Study Living Machines, Natl Ctr Biol Sci, Bengaluru, India	Vellore Institute of Technology; Indian Institute of Science (IISC) - Bangalore; Chennai Mathematical Institute; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Thattai, M (corresponding author), Tata Inst Fundamental Res, Simons Ctr Study Living Machines, Natl Ctr Biol Sci, Bengaluru, India.	thattai@ncbs.res.in	Kuppusamy, Lakshmanan/U-8264-2019	Kuppusamy, Lakshmanan/0000-0003-2358-905X	Wellcome Trust-DBT India Alliance Intermediate Fellowship [500103/Z/09/Z]	Wellcome Trust-DBT India Alliance Intermediate Fellowship(Wellcome Trust DBT India Alliance)	MT was supported in part by a Wellcome Trust-DBT India Alliance Intermediate Fellowship (500103/Z/09/Z).	Alberts B, 2015, MOLECULAR BIOLOGY OF THE CELL, SIXTH EDITION, P1; Bondy J.A., 1976, GRAPH THEORY APPL, V290; Cimatti A., 2002, Computer Aided Verification. 14th International Conference, CAV 2002. Proceedings (Lecture Notes in Computer Science Vol.2404), P359; Clarke E, 2004, LECT NOTES COMPUT SC, V2988, P168, DOI 10.1007/978-3-540-24730-2_15; Clarke E, 2003, CMUCS03126 CARN MELL; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; de Moura L, 2007, LECT NOTES ARTIF INT, V4603, P183; Een N, 2004, LECT NOTES COMPUT SC, V2919, P502, DOI 10.1007/978-3-540-24605-3_37; Giacobbe Mirco, 2015, Tools and Algorithms for the Construction and Analysis of Systems. 21st International Conference, TACAS 2015, held as part of the European Joint Conferences on Theory and Practice of Software, ETAPS 2015. Proceedings: LNCS 9035, P469, DOI 10.1007/978-3-662-46681-0_47; Giunchiglia E, 2016, QUANTIFIED BOOLEAN F; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kloepper TH, 2007, MOL BIOL CELL, V18, P3463, DOI 10.1091/mbc.E07-03-0193; Kroening D., 2016, DECISION PROCEDURES; Mangla K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008906; Mani S, 2016, MOL BIOCHEM PARASIT, V209, P58, DOI 10.1016/j.molbiopara.2016.03.006; Mani S, 2016, ELIFE, V5, DOI 10.7554/eLife.16231; Munro S, 2004, NAT CELL BIOL, V6, P469, DOI 10.1038/ncb0604-469; OEIS Foundation Inc, 2016, ON LINE ENCY INTEGER; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rossi V, 2004, TRENDS BIOCHEM SCI, V29, P682, DOI 10.1016/j.tibs.2004.10.002; Rothman JE, 2002, NAT MED, V8, P1059, DOI 10.1038/nm770; SAT-Race, 2015, 18 INT C THEOR APPL; Soos M., 2016, ADV SAT SOLVER; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Zuliani P, 2015, INT J SOFTW TOOLS TE, V17, P527, DOI 10.1007/s10009-014-0343-0	28	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180692	10.1371/journal.pone.0180692	http://dx.doi.org/10.1371/journal.pone.0180692			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683137	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000405335200061
J	Wen, F; Wu, XZ; Li, TJ; Jia, ML; Liu, XS; Li, P; Zhou, XJ; Ji, XX; Yue, XM				Wen, Feng; Wu, Xiaozhu; Li, Tongjian; Jia, Mingliang; Liu, Xinshen; Li, Peng; Zhou, Xiaojian; Ji, Xinxin; Yue, Xiaomin			Genome-wide survey of heat shock factors and heat shock protein 70s and their regulatory network under abiotic stresses in Brachypodium distachyon	PLOS ONE			English	Article							FACTOR GENE FAMILY; TRANSCRIPTION FACTOR; MOLECULAR CHAPERONES; EXPRESSION PROFILE; BINDING-FACTORS; CELL-DEATH; ARABIDOPSIS; THERMOTOLERANCE; DROUGHT; HSFA1	The heat shock protein 70s (Hsp70s) and heat shock factors (Hsfs) play key roles in protecting plant cells or tissues from various abiotic stresses. Brachypodium distachyon, recently developed an excellent model organism for functional genomics research, is related to the major cereal grain species. Although B. distachyon genome has been fully sequenced, the information of Hsf and Hsp70 genes and especially the regulatory network between Hsfs and Hsp70s remains incomplete. Here, a total of 24 BdHsfs and 29 BdHsp70s were identified in the genome by bioinformatics analysis and the regulatory network between Hsfs and Hsp70s were performed in this study. Based on highly conserved domain and motif analysis, BdHsfs were grouped into three classes, and BdHsp70s divided into six groups, respectively. Most of Hsf proteins contain five conserved domains: DBD, HR-A/B region, NLS and NES motifs and AHA domain, while Hsp70 proteins have three conserved domains: Nterminal nucleotide binding domain, peptide binding domain and a variable C-terminal lid region. Expression data revealed a large number of BdHsfs and BdHsp70s were induced by HS challenge, and a previous heat acclimation could induce the acquired thermotolerance to help seedling suffer the severe HS challenge, suggesting that the BdHsfs and BdHsp70s played a role in alleviating the damage by HS. The comparison revealed that, most BdHsfs and BdHsp70s genes responded to multiple abiotic stresses in an overlapping relationship, while some of them were stress specific response genes. Moreover, co-expression relationships and predicted protein-protein interaction network implied that class A and B Hsfs played as activator and repressors, respectively, suggesting that BdHsp70s might be regulated by both the activation and the repression mechanisms under stress condition. Our genomics analysis of BdHsfs and BdHsp70s provides important evolutionary and functional characterization for further investigation of the accurate regulatory mechanisms among Hsfs and Hsp70s in herbaceous plants.	[Wen, Feng; Wu, Xiaozhu; Li, Tongjian; Jia, Mingliang; Liu, Xinshen; Zhou, Xiaojian; Ji, Xinxin; Yue, Xiaomin] Jiujiang Univ, Sch Pharm & Life Sci, Jiujiang, Peoples R China; [Li, Peng] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Chenshan Plant Sci Res Ctr, Shanghai Chenshan Bot Garden, Shanghai, Peoples R China	Jiujiang University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wen, F (corresponding author), Jiujiang Univ, Sch Pharm & Life Sci, Jiujiang, Peoples R China.	wenfeng332@126.com	Liu, Xinsheng/AAW-2881-2021	Liu, Xinsheng/0000-0001-7609-796X	National Natural Science Foundation of China [31560075, 31460046]; Natural Science Foundation of Jiangxi Province [20151BAB214003, 20161BAB214149]; Foundation of Chinese medicine research of health and family planning commission of Jiangxi province [2015A075]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi Province(Natural Science Foundation of Jiangxi Province); Foundation of Chinese medicine research of health and family planning commission of Jiangxi province	This work was supported by National Natural Science Foundation of China [31560075,31460046] (http://www.nsfc.gov.cn/). The funder played roles in study design,data collection and analysis, decision to publish, and preparation of the manuscript. It was also supported by Natural Science Foundation of Jiangxi Province [20151BAB214003, 20161BAB214149] (http://www.jxstc.gov.cn/). The funder played roles in study design, data collection and analysis. This work was also supported by Foundation of Chinese medicine research of health and family planning commission of Jiangxi province [2015A075] (http://www.jxwst.gov.cn/). The funder played roles in data collection and analysis.	Allakhverdiev SI, 2008, PHOTOSYNTH RES, V98, P529, DOI 10.1007/s11120-008-9334-x; ALVIM FC, 2001, PLANT PHYSL, V126; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bakthisaran R, 2015, BBA-PROTEINS PROTEOM, V1854, P291, DOI 10.1016/j.bbapap.2014.12.019; Bechtold U, 2013, J EXP BOT, V64, P3467, DOI 10.1093/jxb/ert185; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BOORSTEIN WR, 1994, J MOL EVOL, V38, P1; Boston RS, 1996, PLANT MOL BIOL, V32, P191, DOI 10.1007/BF00039383; Chan-Schaminet KY, 2009, J BIOL CHEM, V284, P20848, DOI 10.1074/jbc.M109.007336; Charng YY, 2007, PLANT PHYSIOL, V143, P251, DOI 10.1104/pp.106.091322; Czarnecka-Verner E, 2004, PLANT MOL BIOL, V56, P57, DOI 10.1007/s11103-004-2307-3; Czarnecka-Verner E, 2000, PLANT MOL BIOL, V43, P459, DOI 10.1023/A:1006448607740; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; Doring P, 2000, PLANT CELL, V12, P265, DOI 10.1105/tpc.12.2.265; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Evgen'ev MB, 2004, CHROMOSOMA, V113, P223, DOI 10.1007/s00412-004-0312-6; Farooq M, 2011, CRIT REV PLANT SCI, V30, P491, DOI 10.1080/07352689.2011.615687; Finka A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00029; Guo JK, 2008, J GENET GENOMICS, V35, P105, DOI 10.1016/S1673-8527(08)60016-8; Guo LH, 2008, PLANT CELL PHYSIOL, V49, P1306, DOI 10.1093/pcp/pcn105; Guo M, 2016, FRONT PLANT SCI, P7; Guo M, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0512-7; Hernandez G, 2005, MECH DEVELOP, V122, P865, DOI 10.1016/j.mod.2005.04.002; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hu WH, 2009, PLANT SCI, V176, P583, DOI 10.1016/j.plantsci.2009.01.016; Ikeda M, 2011, PLANT PHYSIOL, V157, P1243, DOI 10.1104/pp.111.179036; Ikeda M, 2009, PLANT CELL PHYSIOL, V50, P970, DOI 10.1093/pcp/pcp048; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Ito M, 2014, J PLANT PHYSIOL, V171, P173, DOI 10.1016/j.jplph.2013.10.012; Jiang SS, 2014, MOL PLANT PATHOL, V15, P907, DOI 10.1111/mpp.12153; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Jung KH, 2013, FUNCT INTEGR GENOMIC, V13, P391, DOI 10.1007/s10142-013-0331-6; Kim BH, 2002, J EXP BOT, V53, P371, DOI 10.1093/jexbot/53.367.371; Kim NH, 2015, PLANT PHYSIOL, V167, P307, DOI 10.1104/pp.114.253898; Kohl M, 2011, METHODS MOL BIOL, V696, P291, DOI 10.1007/978-1-60761-987-1_18; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Kumar M, 2009, MOL PLANT, V2, P152, DOI 10.1093/mp/ssn095; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Latijnhouwers M, 2010, PLANTA, V232, P567, DOI 10.1007/s00425-010-1192-z; Lee JH, 1996, MOL GEN GENET, V252, P11, DOI 10.1007/BF02173200; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Li QB, 1999, PLANT MOL BIOL, V39, P21, DOI 10.1023/A:1006100532501; Liu HC, 2011, PLANT CELL ENVIRON, V34, P738, DOI 10.1111/j.1365-3040.2011.02278.x; Liu JY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-281; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Maruyama D, 2010, P NATL ACAD SCI USA, V107, P1684, DOI 10.1073/pnas.0905795107; Mishra SK, 2002, GENE DEV, V16, P1555, DOI 10.1101/gad.228802; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mittler R, 2012, TRENDS BIOCHEM SCI, V37, P118, DOI 10.1016/j.tibs.2011.11.007; Mohn F, 2009, TRENDS GENET, V25, P129, DOI 10.1016/j.tig.2008.12.005; Nishizawa A, 2006, PLANT J, V48, P535, DOI 10.1111/j.1365-313X.2006.02889.x; Noel LD, 2007, PLANT CELL, V19, P4061, DOI 10.1105/tpc.107.051896; Nover L, 2001, CELL STRESS CHAPERON, V6, P177, DOI 10.1379/1466-1268(2001)006<0177:AATHST>2.0.CO;2; Ohta T, 2008, ENCY LIFE SCI; Opanowicz M, 2008, TRENDS PLANT SCI, V13, P172, DOI 10.1016/j.tplants.2008.01.007; Park CJ, 2015, PLANT PATHOLOGY J, V31, P323, DOI 10.5423/PPJ.RW.08.2015.0150; Perez DE, 2009, PLANT PHYSIOL, V151, P241, DOI 10.1104/pp.109.142125; Priest HD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087499; Qi YC, 2011, FEBS LETT, V585, P231, DOI 10.1016/j.febslet.2010.11.051; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Ryu JY, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-15; Scharf KD, 1998, MOL CELL BIOL, V18, P2240, DOI 10.1128/MCB.18.4.2240; Scharf KD, 2012, BBA-GENE REGUL MECH, V1819, P104, DOI 10.1016/j.bbagrm.2011.10.002; Schneider M, 2004, PLANT PHYSIOL BIOCH, V42, P1013, DOI 10.1016/j.plaphy.2004.10.009; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Skinner MK, 2014, BMC GENOMICS, P15; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Storozhenko S, 1998, PLANT PHYSIOL, V118, P1005, DOI 10.1104/pp.118.3.1005; Su PH, 2008, PLANT PHYSIOL, V146, P1231, DOI 10.1104/pp.107.114496; Sun JT, 2015, PLANT CELL REP, V34, P23, DOI 10.1007/s00299-014-1684-6; Sung DY, 2001, PLANT PHYSIOL, V126, P789, DOI 10.1104/pp.126.2.789; Swindell WR, 2007, BMC GENOMICS, V8; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wen F, 2014, DNA RES, V21, P327, DOI 10.1093/dnares/dst060; Yang KZ, 2009, PLANT J, V57, P870, DOI 10.1111/j.1365-313X.2008.03732.x; Yu A., 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/510319; Zhang J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-532; Zhang LR, 2009, J EXP BOT, V60, P2073, DOI 10.1093/jxb/erp078; Zhou JL, 2007, PLANT MOL BIOL, V63, P591, DOI 10.1007/s11103-006-9111-1	82	18	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180352	10.1371/journal.pone.0180352	http://dx.doi.org/10.1371/journal.pone.0180352			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683139	Green Published, gold, Green Submitted			2022-12-26	WOS:000405335200025
J	Suzuki, S; Arai, K; Munehara, H				Suzuki, Shota; Arai, Katsutoshi; Munehara, Hiroyuki			Karyological evidence of hybridogenesis in Greenlings (Teleostei: Hexagrammidae)	PLOS ONE			English	Article							GENOME EXCLUSION; DNA-CONTENT; FISH; GENUS; HYBRIDIZATION; POECILIOPSIS; REPRODUCTION; CHROMOSOMES; EVOLUTION; STRAINS	Two types of natural hybrids were discovered in populations of three Hexagrammos species (Teleostei: Hexagrammidae) distributed off the southern coast of Hokkaido in the North Pacific Ocean. Both hybrids reproduce by hybridogenesis, in which the maternal haploid genome is transmitted to offspring without recombination and the paternal haploid genome is eliminated during gametogenesis. While natural hybrids are unisexual and reproduce hemiclonally by backcrossing with the paternal species (BC-P), artificial F-1-hybrids between the pure species produce recombinant gametes. Thus, despite having the same genome composition, the natural hybrids and the F-1-hybrids are not genetically identical. Here, to clarify the differences between both hybrids, we examined the karyotypes of the three Hexagrammos species, their natural hybrids, the artificial F-1-hybrids, and several backcrosses. Artificial F-1-hybrids have karyotypes and chromosome numbers that are intermediate between those of the parental species. Conversely, the natural hybrids differed from F-1-hybrids by having several large metacentric chromosomes and microchromosomes. Since the entire maternal haploid genome is inherited by the natural hybrids, maternal backcrosses (BC-M) between natural hybrids and males of the maternal species (H. octogrammus; Hoc) have a hemiclonal Hoc genome with large chromosomes from the mother and a normal Hoc genome from the father. However, the large chromosomes disappear in offspring of BC-M, probably due to fissuring during gametogenesis. Similarly, microsatellite DNA analysis revealed that chromosomes of BC-M undergo recombination. These findings suggest that genetic factors associated with hemiclonal reproduction may be located on the large metacentric chromosomes of natural hybrids.	[Suzuki, Shota; Munehara, Hiroyuki] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan; [Suzuki, Shota; Munehara, Hiroyuki] Hokkaido Univ, Usujiri Fisheries Stn, Field Sci Ctr Northern Biosphere, Hakodate, Hokkaido, Japan; [Arai, Katsutoshi] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Suzuki, S (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan.; Suzuki, S (corresponding author), Hokkaido Univ, Usujiri Fisheries Stn, Field Sci Ctr Northern Biosphere, Hakodate, Hokkaido, Japan.	ainame0501@gmail.com	Munehara, Hiroyuki/A-3445-2012		Japan Society forthe Promotion of Science [KAKENHI23380107, 26292098, 15H02457]	Japan Society forthe Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grants-in-Aid for scientific research from the Japan Society forthe Promotion of Science (KAKENHI23380107 and 26292098 to HM, and 15H02457 toKA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Balanov AA, 2001, J ICHTHYOL+, V41, P766; Burt A, 2006, GENES CONFLICT BIOL; Carmona JA, 1997, GENETICS, V146, P983; CIMINO MC, 1974, CHROMOSOMA, V47, P297, DOI 10.1007/BF00328863; CIMINO MC, 1972, EVOLUTION, V26, P294, DOI 10.1111/j.1558-5646.1972.tb00195.x; CIMINO MC, 1970, COPEIA, P760; Coyne J.A., 2004, SPECIATION; Crow KD, 2007, BIOL J LINN SOC, V91, P135, DOI 10.1111/j.1095-8312.2007.00786.x; Crow KD, 2010, MOL ECOL, V19, P2089, DOI 10.1111/j.1365-294X.2010.04611.x; Crow KD, 2004, MOL PHYLOGENET EVOL, V32, P986, DOI 10.1016/j.ympev.2004.03.012; Dawley Robert M., 1989, New York State Museum Bulletin, V466, P1; Dmitry L. Lajus, 2007, FISH CYTOGENETICS, P261; Kimura MR, 2007, AQUAT BIOL, V1, P187, DOI 10.3354/ab00019; Kimura-Kawaguchi MR, 2014, J FISH BIOL, V85, P189, DOI 10.1111/jfb.12414; Lamatsch DK, 2002, J FISH BIOL, V60, P1417, DOI [10.1111/j.1095-8649.2002.tb02436.x, 10.1006/jfbi.2002.1939]; Lamatsch DK, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P399, DOI 10.1007/978-90-481-2770-2_19; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Makino S., 1937, Zoological Magazine Tokyo, V49, P75; MATSUMIYA T, 1980, JPN J ICHTHYOL, V27, P273; MILLER RR, 1959, SCIENCE, V130, P1656, DOI 10.1126/science.130.3389.1656-a; Moritz C. C., 1989, EVOLUTION ECOLOGY UN, P87; Munehara H, 2016, ECOL EVOL, V6, P7126, DOI 10.1002/ece3.2446; Nakabo T., 2013, FISHES JAPAN PICTORI; Nanda I, 2007, GENETICS, V177, P917, DOI 10.1534/genetics.107.076893; Nishikawa S, 1982, CHROMOSOME INFORM SE, V33, P17; Ogielska M., 2009, REPROD AMPHIBIANS, P343; Ogielska M., 1994, ZOOL POLONIAE, V39, P461; Ojima Y., 1983, FISH CYTOGENETICS; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Rutenberg E, 1970, SURVEY FISH FAMILY H, V59, P1; Schartl A, 1997, CANCER RES, V57, P2993; Schmidt DJ, 2011, MOL ECOL, V20, P3367, DOI 10.1111/j.1365-294X.2011.05206.x; SCHULTZ RJ, 1961, EVOLUTION, V15, P302, DOI 10.2307/2406230; SCHULTZ RJ, 1973, SCIENCE, V179, P180, DOI 10.1126/science.179.4069.180; SCHULTZ RJ, 1969, AM NAT, V103, P605, DOI 10.1086/282629; Shinohara Gento, 1994, Memoirs of the Faculty of Fisheries Hokkaido University, V41, P1; Stock M, 2010, MOL ECOL, V19, P5204, DOI 10.1111/j.1365-294X.2010.04869.x; TINTI F, 1992, MOL REPROD DEV, V33, P235, DOI 10.1002/mrd.1080330302; TUNNER HG, 1991, NATURWISSENSCHAFTEN, V78, P32, DOI 10.1007/BF01134041; VINOGRADOV AE, 1990, GENOME, V33, P619, DOI 10.1139/g90-092; Vrijenhoek RC, 1998, BIOSCIENCE, V48, P617, DOI 10.2307/1313421; Vrijenhoek Robert C., 1989, New York State Museum Bulletin, V466, P19; Vrijenhoek RC, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P99, DOI 10.1007/978-90-481-2770-2_6	44	5	5	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180626	10.1371/journal.pone.0180626	http://dx.doi.org/10.1371/journal.pone.0180626			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678883	Green Submitted, Green Published, gold			2022-12-26	WOS:000405272200079
J	Li, B; Guo, WR; Zhang, F; Liu, MY; Wang, S; Liu, ZH; Xiang, SL; Zeng, YL				Li, Bo; Guo, Wanrong; Zhang, Fan; Liu, Meiyan; Wang, Shang; Liu, Zhonghua; Xiang, Shuanglin; Zeng, Youlin			Synthesis and evaluation of L-arabinose-based cationic glycolipids as effective vectors for pDNA and siRNA in vitro	PLOS ONE			English	Article							MEDIATED DNA-TRANSFECTION; GENE DELIVERY; VIRAL VECTORS; LIPIDS; EFFICIENCY; THERAPY; VIVO; CELLS; MECHANISMS; COMPLEXES	Glycolipids might become a new type of promising non-viral gene delivery systems because of their low cytotoxicity, structural diversity, controllable aqua-and lipo-solubility, appropriate density and distribution of positive charges, high transfer efficiency and potential targeting function. In this study, four kinds of L-arabinose-based cationic glycolipids (Ara-DiC12MA, Ara-DiC14MA, Ara-DiC16MA and Ara-DiC18MA) containing quaternary ammonium as hydrophilic headgroup and two alkane chains as hydrophobic domain were synthesized and characterized. They were observed to have strong affinities for plasmid DNA (pDNA) and siRNA, the pDNA can be completely condensed at N/P ratio less than 2, and the siRNA can be completely retarded at N/P ratio less than 3. The dynamic light scattering (DLS) experiment and atomic force microscopy (AFM) experiment demonstrated that cationic lipids and their lipoplexes possessed suitable particle sizes with near-spherical shape and proper.-potentials for cell transfection. The Ara-DiC16MA liposome was found to have good transfection efficacy in HEK293, PC-3 and Mat cells compared with other three kinds of liposomes, and also maintain low cytotoxicity and better uptake capability in vitro. Furthermore, the gene silencing assay showed that Ara-DiC14MA and Ara-DiC16MA liposomes have demonstrated effective delivery and higher gene knockdown activity (>80%) in the above mentioned cells than Lipofectamine 2000. These results indicated Ara-DiC16MA can be developed for efficient and low toxic gene delivery.	[Li, Bo; Guo, Wanrong; Zhang, Fan; Liu, Meiyan; Zeng, Youlin] Hunan Normal Univ, Coll Chem & Chem Engn, Natl & Local Joint Engn Lab New Petrochem Mat & F, Changsha, Hunan, Peoples R China; [Wang, Shang; Xiang, Shuanglin] Hunan Normal Univ, Coll Life Sci, State Educ Minist China, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China; [Liu, Zhonghua] Hunan Normal Univ, Coll Life Sci, Natl & Local Joint Engn Lab Anim Peptide Drug Dev, Changsha, Hunan, Peoples R China	Hunan Normal University; Hunan Normal University; Hunan Normal University	Zeng, YL (corresponding author), Hunan Normal Univ, Coll Chem & Chem Engn, Natl & Local Joint Engn Lab New Petrochem Mat & F, Changsha, Hunan, Peoples R China.	youlinzengcn@gmail.com	Zeng, Youlin/HCI-6949-2022	zeng, youlin/0000-0002-1110-4759	Nation Nature Sciences Foundation of China [21272064]; Science & Technology Department of Changsha City [K1205221-31]	Nation Nature Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Department of Changsha City	Tis research was financially supported by the Nation Nature Sciences Foundation of China (Gene ral Program: 21272064) and Science & Technology Department of Changsha City (K1205221-31)	Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; ANDERSON WF, 1992, SCIENCE, V256, P808, DOI 10.1126/science.1589762; Bae YU, 2012, MOL PHARMACEUT, V9, P3579, DOI 10.1021/mp300458h; Bovolenta C, 2013, CURR PHARM BIOTECHNO, V14, P488, DOI 10.2174/138920101405131111104009; Byk G, 1998, J MED CHEM, V41, P224, DOI 10.1021/jm9704964; CAPLEN NJ, 1995, GENE THER, V2, P603; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Chan CL, 2012, BIOMATERIALS, V33, P4928, DOI 10.1016/j.biomaterials.2012.03.038; Crooke ST, 2000, ONCOGENE, V19, P6651, DOI 10.1038/sj.onc.1204093; Duan Y, 2009, EXPERT OPIN DRUG DEL, V6, P1351, DOI 10.1517/17425240903287153; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Gopal V, 2006, BIOCONJUGATE CHEM, V17, P1530, DOI 10.1021/bc0601020; Gopal V, 2011, BIOCONJUGATE CHEM, V22, P2244, DOI 10.1021/bc2002874; Gu L, 2014, J CONTROL RELEASE, V184, P28, DOI 10.1016/j.jconrel.2014.04.005; Guillot-Nieckowski M, 2007, NEW J CHEM, V31, P1111, DOI 10.1039/b614877h; Guo QF, 2011, INT J NANOMED, V6, P1641, DOI 10.2147/IJN.S21141; Guo QF, 2009, INT J PHARMACEUT, V379, P82, DOI 10.1016/j.ijpharm.2009.06.010; He CX, 2016, ORG BIOMOL CHEM, V14, P1611, DOI 10.1039/c5ob02107c; Herrera-Carrillo E, 2015, EXPERT OPIN THER TAR, V19, P245, DOI 10.1517/14728222.2014.980236; Jiang TY, 2012, BIOMATERIALS, V33, P9246, DOI 10.1016/j.biomaterials.2012.09.027; JOLLY D, 1994, CANCER GENE THER, V1, P51; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Kedika B, 2012, MOL PHARMACEUT, V9, P1146, DOI 10.1021/mp200435y; Kim HS, 2004, BIOCONJUGATE CHEM, V15, P1095, DOI 10.1021/bc049934t; Koynova R, 2009, MOL PHARMACEUT, V6, P951, DOI 10.1021/mp8002573; Lee SJ, 2016, ADV DRUG DELIVER REV, V104, P2, DOI 10.1016/j.addr.2016.05.010; LEVENTIS R, 1990, BIOCHIM BIOPHYS ACTA, V1023, P124, DOI 10.1016/0005-2736(90)90017-I; Liu JL, 2011, EUR J MED CHEM, V46, P4133, DOI 10.1016/j.ejmech.2011.06.015; Medina-Kauwe LK, 2006, GENE THER GENE THERA, V12, P1734; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Miller AD, 1998, ANGEW CHEM INT EDIT, V37, P1769; Mrsny RJ, 1999, J DRUG TARGET, V7, P1; Mun JY, 2016, BIOMATERIALS, V101, P310, DOI 10.1016/j.biomaterials.2016.05.057; Ojeda E, 2015, ORG BIOMOL CHEM, V13, P1068, DOI 10.1039/c4ob02087a; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Pathak Atul, 2009, Biotechnology Journal, V4, P1559, DOI 10.1002/biot.200900161; Peel AL, 2000, J NEUROSCI METH, V98, P95, DOI 10.1016/S0165-0270(00)00183-7; Qiao WH, 2014, J SURFACTANTS DETERG, V17, P261, DOI 10.1007/s11743-013-1474-0; Rajesh M, 2007, J AM CHEM SOC, V129, P11408, DOI 10.1021/ja0704683; Raper SE, 2002, HUM GENE THER, V13, P163, DOI 10.1089/10430340152712719; Raviv L, 2015, MOL PHARMACEUT, V12, P453, DOI 10.1021/mp5005492; Risbo J., 2010, APPL ENVIRON MICROB, V76, P7925; Santos JL, 2011, CURRENT GENE THERAPY, V11, P35; Sapru MK, 2002, J NEUROSCI METH, V114, P99, DOI 10.1016/S0165-0270(01)00518-0; Sheng RL, 2014, COLLOID SURFACE B, V116, P32, DOI 10.1016/j.colsurfb.2013.12.039; Shi QS, 2014, J BIOMED NANOTECHNOL, V10, P436, DOI 10.1166/jbn.2014.1728; Shi S, 2014, BIOMATERIALS, V35, P4536, DOI 10.1016/j.biomaterials.2014.02.010; Sobajima S, 2004, GENE THER, V11, P390, DOI 10.1038/sj.gt.3302200; Teo PY, 2016, ADV DRUG DELIVER REV, V98, P41, DOI 10.1016/j.addr.2015.10.014; Terada T, 2006, J CONTROL RELEASE, V111, P333, DOI 10.1016/j.jconrel.2005.12.023; Thapa B, 2015, BIOMACROMOLECULES, V16, P3008, DOI 10.1021/acs.biomac.5b00906; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Vora L, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2781-8; Wang F, 2014, ACTA MATER, V80, P77, DOI 10.1016/j.actamat.2014.07.048; Wang N, 2014, EUR J PHARM BIOPHARM, V88, P194, DOI 10.1016/j.ejpb.2014.04.007; Xia YQ, 2016, BIOMATERIALS, V79, P56, DOI 10.1016/j.biomaterials.2015.11.056; YANG NS, 1990, P NATL ACAD SCI USA, V87, P9568, DOI 10.1073/pnas.87.24.9568; Zhang M, 2003, BIOCONJUGATE CHEM, V14, P709, DOI 10.1021/bc034038n; Zhi DF, 2013, BIOCONJUGATE CHEM, V24, P487, DOI 10.1021/bc300381s; Zhi DF, 2010, BIOCONJUGATE CHEM, V21, P563, DOI 10.1021/bc900393r	62	3	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180276	10.1371/journal.pone.0180276	http://dx.doi.org/10.1371/journal.pone.0180276			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672000	Green Submitted, gold, Green Published			2022-12-26	WOS:000405268500037
J	Schregel, J; Kopatz, A; Eiken, HG; Swenson, JE; Hagen, SB				Schregel, Julia; Kopatz, Alexander; Eiken, Hans Geir; Swenson, Jon E.; Hagen, Snorre B.			Sex-specific genetic analysis indicates low correlation between demographic and genetic connectivity in the Scandinavian brown bear (Ursus arctos)	PLOS ONE			English	Article							DEPENDENT NATAL DISPERSAL; POPULATION-STRUCTURE; MICROSATELLITE ANALYSIS; SPATIAL AUTOCORRELATION; RARE ALLELES; DIFFERENTIATION; DIVERSITY; G(ST); FLOW; INFERENCE	The degree of gene flow within and among populations, i.e. genetic population connectivity, may closely track demographic population connectivity. Alternatively, the rate of gene flow may change relative to the rate of dispersal. In this study, we explored the relationship between genetic and demographic population connectivity using the Scandinavian brown bear as model species, due to its pronounced male dispersal and female philopatry. Thus, we expected that females would shape genetic structure locally, whereas males would act as genetic mediators among regions. To test this, we used eight validated microsatellite markers on 1531 individuals sampled noninvasively during country-wide genetic population monitoring in Sweden and Norway from 2006 to 2013. First, we determined sex-specific genetic structure and substructure across the study area. Second, we compared genetic differentiation, migration/gene flow patterns, and spatial autocorrelation results between the sexes both within and among genetic clusters and geographic regions. Our results indicated that demographic connectivity was not a reliable indicator of genetic connectivity. Among regions, we found no consistent difference in long-term gene flow and estimated current migration rates between males and females. Within regions/genetic clusters, only females consistently displayed significant positive spatial autocorrelation, indicating male-biased small-scale dispersal. In one cluster, however, males showed a dispersal pattern similar to females. The Scandinavian brown bear population has experienced substantial recovery over the last decades; however, our results did not show any changes in its large-scale population structure compared to previous studies, suggesting that an increase in population size and dispersal of individuals does not necessary lead to increased genetic connectivity. Thus, we conclude that both genetic and demographic connectivity should be estimated, so as not to make false assumptions about the reality of wildlife populations.				julia.schregel@nibio.no; snorre.hagen@nibio.no	Swenson, Jon/AAE-2890-2019; Hagen, Snorre/O-5220-2015; Kopatz, Alexander/AAC-3967-2022; Kopatz, Alexander/A-3174-2012	Hagen, Snorre/0000-0001-8289-7752; Kopatz, Alexander/0000-0002-9139-1179; Kopatz, Alexander/0000-0002-9139-1179; Eiken, Hans Geir/0000-0002-5368-3648				Aarnes SG, 2016, DNA AN; Andreassen R, 2012, FORENSIC SCI INT-GEN, V6, P798, DOI 10.1016/j.fsigen.2012.03.002; Andren H, 2006, ANN REV ECOLOGY EVOL, V131, P23; Andren H, 2006, BIOL CONSERV, V131, P23, DOI 10.1016/j.biocon.2006.01.025; [Anonymous], 2011, CONSERV LETT; Austerlitz F, 1997, THEOR POPUL BIOL, V51, P148, DOI 10.1006/tpbi.1997.1302; Banks SC, 2012, MOL ECOL, V21, P2092, DOI 10.1111/j.1365-294X.2012.05485.x; BARTON NH, 1986, HEREDITY, V56, P409, DOI 10.1038/hdy.1986.63; Belkhir K, 1996, MOL ECOLOGY RESOURCE; Braaker S, 2017, LANDSCAPE URBAN PLAN, V160, P107, DOI 10.1016/j.landurbplan.2016.12.011; Castric V, 2003, GENETICS, V163, P983; Debeffe L, 2012, J ANIM ECOL, V81, DOI 10.1111/j.1365-2656.2012.02014.x; DeGiorgio M, 2011, GENETICS, V189, P579, DOI 10.1534/genetics.111.129296; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Faubet P, 2007, MOL ECOL, V16, P1149, DOI 10.1111/j.1365-294X.2007.03218.x; Fischer ML, 2017, DIVERS DISTRIB, V23, P409, DOI 10.1111/ddi.12538; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Gangaas KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068849; Gilroy JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038091; Gonzalez EG, 2016, PEERJ, P4; Gonzalez EG, 2016, PEERJ, V4, DOI 10.7717/peerj.1928; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Greminger MP, 2010, MOL ECOL RESOUR, V10, P409, DOI 10.1111/j.1755-0998.2009.02798.x; Hagen SB, 2015, CANADIAN J ZOOLOGY R, V282; Hagen SB, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0092; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Heller R, 2009, MOL ECOL, V18, P2080, DOI 10.1111/j.1365-294X.2009.04185.x; Herborg LM, 2007, MOL ECOL, V16, P231, DOI 10.1111/j.1365-294X.2006.03133.x; Hovestadt T, 2014, AM NAT, V184, P38, DOI 10.1086/676524; Inoue K, 2017, GLOBAL CHANGE BIOL, V23, P94, DOI 10.1111/gcb.13369; JOHNSON ML, 1990, ANNU REV ECOL SYST, V21, P449, DOI 10.1146/annurev.ecolsys.21.1.449; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2009, MOL ECOL, V18, P2088, DOI 10.1111/j.1365-294X.2009.04186.x; Kentie R, 2014, J AVIAN BIOL, V45, P396, DOI 10.1111/jav.00273; Kojola I, 2004, SUURPETOJEN LUKUMAAR, P1; Kopatz A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097558; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Logan ML, 2016, EVOLUTION, V70, P2395, DOI 10.1111/evo.13031; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Ma L, 2015, CURR ZOOL, V61, P886, DOI 10.1093/czoolo/61.5.886; Manel S, 2004, MOL ECOL, V13, P1327, DOI 10.1111/j.1365-294X.2004.02074.x; McLellan BN, 2001, CAN J ZOOL, V79, P838, DOI 10.1139/cjz-79-5-838; Meirmans PG, 2014, MOL ECOL RESOUR, V14, P726, DOI 10.1111/1755-0998.12216; NEI M, 1977, ANN HUM GENET, V41, P225, DOI 10.1111/j.1469-1809.1977.tb01918.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEI M, 1983, ANN HUM GENET, V47, P253, DOI 10.1111/j.1469-1809.1983.tb00993.x; Nussey DH, 2005, MOL ECOL, V14, P3395, DOI 10.1111/j.1365-294X.2005.02692.x; PAETKAU D, 1994, MOL ECOL, V3, P489, DOI 10.1111/j.1365-294X.1994.tb00127.x; PAETKAU D, 1995, MOL ECOL, V4, P133; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pelletier A, 2012, CAN J ZOOL, V90, P999, DOI 10.1139/Z2012-068; Pelletier A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172319; Persson J, 2009, BIOL CONSERV, V142, P325, DOI 10.1016/j.biocon.2008.10.028; Pritchard JK, 2000, GENETICS, V155, P945; Rauset GR, 2016, CONSERV LETT, V9, P334, DOI 10.1111/conl.12226; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ryman N, 2008, EVOLUTION, V62, P2250, DOI 10.1111/j.1558-5646.2008.00453.x; Ryman N, 2009, MOL ECOL, V18, P2084, DOI 10.1111/j.1365-294X.2009.04187.x; Schregel J, 2015, MOL ECOL, V24, P6041, DOI 10.1111/mec.13448; Schregel J, 2012, MOL ECOL, V21, P3474, DOI 10.1111/j.1365-294X.2012.05631.x; Schulte U, 2013, BIOL INVASIONS, V15, P2639, DOI 10.1007/s10530-013-0480-5; SLATKIN M, 1985, EVOLUTION, V39, P53, DOI 10.2307/2408516; Smouse PE, 2008, MOL ECOL, V17, P3389, DOI 10.1111/j.1365-294X.2008.03839.x; Stoen OG, 2005, BEHAV ECOL SOCIOBIOL, V59, P191, DOI 10.1007/s00265-005-0024-9; Stoen OG, 2006, OECOLOGIA, V148, P356, DOI 10.1007/s00442-006-0384-5; Swenson JE, 1995, WILDLIFE BIOL, V1, P11, DOI 10.2981/wlb.1995.005; Taberlet P, 1997, MOL ECOL, V6, P869, DOI 10.1111/j.1365-294X.1997.tb00141.x; Tammeleht E, 2010, MOL ECOL, V19, P5359, DOI 10.1111/j.1365-294X.2010.04885.x; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Verity R, 2014, MOL ECOL, V23, P4216, DOI 10.1111/mec.12856; Waits L, 2000, MOL ECOL, V9, P421, DOI 10.1046/j.1365-294x.2000.00892.x; Wang J, 2015, MOL ECOL, V24, P3546, DOI 10.1111/mec.13204; Wang J, 2012, GENET RES, V94, P275, DOI 10.1017/S0016672312000481; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x; Wilson GA, 2003, GENETICS, V163, P1177; Yamamichi M, 2012, HEREDITY, V108, P362, DOI 10.1038/hdy.2011.83; Zedrosser A, 2007, ANIM BEHAV, V74, P369, DOI 10.1016/j.anbehav.2006.09.015	85	14	14	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180701	10.1371/journal.pone.0180701	http://dx.doi.org/10.1371/journal.pone.0180701			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672045	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000405268500081
J	Yu, L; Lutz, MW; Wilson, RS; Burns, DK; Roses, AD; Saunders, AM; Yang, JY; Gaiteri, C; De Jager, PL; Barnes, LL; Bennett, DA				Yu, Lei; Lutz, Michael W.; Wilson, Robert S.; Burns, Daniel K.; Roses, Allen D.; Saunders, Ann M.; Yang, Jingyun; Gaiteri, Chris; De Jager, Philip L.; Barnes, Lisa L.; Bennett, David A.			APOE epsilon 4-TOMM40'523 haplotypes and the risk of Alzheimer's disease in older Caucasian and African Americans	PLOS ONE			English	Article							APOLIPOPROTEIN-E GENOTYPE; GENETIC-VARIATION; ASSOCIATION; PROMOTER; REPEAT; DEMENTIA; TOMM40; APOE-EPSILON-4; EXPRESSION; COMMUNITY	Patterns of linkage between the epsilon 4 allele of Apolipoprotein E (APOE) and '523 poly-T alleles in the adjacent gene, TOMM40, differ between Caucasian and African Americans. The extent to which this difference affects the risk of Alzheimer's disease (AD) is unclear. We compared the APOE epsilon 4-TOMM40 '523 haplotypes between older Caucasian and African Americans, and examined their relationship with AD dementia. Data came from three community based cohort studies of diverse participants. APOE genotypes were determined by polymorphisms of rs429358 and rs7412. TOMM40 '523 genotypes were defined by the poly-T repeat length of rs10524523 (short ['523-S]: poly-T <= 19, long ['523-L]: 20 <= poly-T <= 29, and very long ['523-VL]: poly-T >= 30). Cox proportional hazards models examined the effect of haplotype variation on the risk of incident AD dementia. A total of 1,848 Caucasian and 540 African American individuals were included in the study. In Caucasians, nearly none (0.8%) of the non-epsilon 4 carriers and almost all (94.2%) of the epsilon 4 carriers had '523-L. The classification was highly concordant. Each epsilon 4 allele doubled the risk for AD dementia and the dose effect was evident. Almost identical effect size and effect pattern were observed for TOMM40 '523-L. In African Americans, nearly none (1.1%) of the non-epsilon 4 carriers had '523-L, but only 47.8% of the epsilon 4 carriers had '523-L. The concordance was weaker compared with Caucasians. The effect patterns on incident AD dementia differed distinctively between epsilon 4 and '523-L carriers. Further, both genotypic and allelic data support that among African Americans the epsilon 4-'523-L haplotype had stronger effect on risk of AD dementia than other epsilon 4-'523 haplotypes.	[Yu, Lei; Wilson, Robert S.; Yang, Jingyun; Gaiteri, Chris; Barnes, Lisa L.; Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Yu, Lei; Wilson, Robert S.; Yang, Jingyun; Gaiteri, Chris; Barnes, Lisa L.; Bennett, David A.] Rush Univ, Dept Neurol Sci, Med Ctr, Chicago, IL 60612 USA; [Lutz, Michael W.; Roses, Allen D.] Duke Univ, Sch Med, Dept Neurol, Durham, NC USA; [Burns, Daniel K.; Roses, Allen D.; Saunders, Ann M.] Zinfandel Pharmaceut Inc, Res Triangle Pk, NC USA; [De Jager, Philip L.] Columbia Univ, Dept Neurol, Med Ctr, Ctr Translat & Computat Neuroimmunol, New York, NY USA; [De Jager, Philip L.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA	Rush University; Rush University; Duke University; Columbia University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Bennett, DA (corresponding author), Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA.; Bennett, DA (corresponding author), Rush Univ, Dept Neurol Sci, Med Ctr, Chicago, IL 60612 USA.	David_A_Bennett@rush.edu	Yang, Jingyun/D-5361-2009; Yu, Lei/AAT-3685-2020	Yang, Jingyun/0000-0002-3495-3710; 	National Instituteon Aging [R01AG17917, P30AG10161, RF1AG15819, RF1AG22018]; Illinois Department of Public Health; Zinfandel Pharmaceuticals,Inc.; NATIONAL INSTITUTE ON AGING [P30AG010161, RF1AG022018, RF1AG015819, R01AG017917] Funding Source: NIH RePORTER	National Instituteon Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Illinois Department of Public Health; Zinfandel Pharmaceuticals,Inc.; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was funded by the National Instituteon Aging R01AG17917, P30AG10161, RF1AG15819, RF1AG22018, and the Illinois Department of Public Health. The study was partially supported by an unrestricted educational grant from Zinfandel Pharmaceuticals,Inc. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. DKB is an employee of Zinfandel Pharmaceuticals,Inc. ADR was the CEO of Zinfandel Pharmaceuticals,Inc. AMS is the CEO of Zinfandel Pharmaceuticals,Inc. The specific roles of these authors are articulated in the'author contributions' section.	Akai J, 1999, GENE, V239, P65, DOI 10.1016/S0378-1119(99)00380-7; Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Barnes LL, 2013, NEUROEPIDEMIOLOGY, V40, P211, DOI 10.1159/000342778; Barnes LL, 2012, CURR ALZHEIMER RES, V9, P734, DOI 10.2174/156720512801322627; Bekris LM, 2012, J HUM GENET, V57, P18, DOI 10.1038/jhg.2011.123; Bennett DA, 2005, J NEUROL NEUROSUR PS, V76, P1194, DOI 10.1136/jnnp.2004.054445; Bennett DA, 2006, NEUROEPIDEMIOLOGY, V27, P169, DOI 10.1159/000096129; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P628; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Chiba-Falek O, 2001, HUM MOL GENET, V10, P3101, DOI 10.1093/hmg/10.26.3101; Chiba-Falek O, 2017, EXPERT REV PRECISION, P1; Chu SH, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.016; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Crenshaw DG, 2013, CLIN PHARMACOL THER, V93, P177, DOI 10.1038/clpt.2012.222; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P1013, DOI 10.1001/archneurol.2011.155; Drzezga A, 2009, NEUROLOGY, V72, P1487, DOI 10.1212/WNL.0b013e3181a2e8d0; Evans DA, 2003, ARCH NEUROL-CHICAGO, V60, P185, DOI 10.1001/archneur.60.2.185; Evans DA, 1997, JAMA-J AM MED ASSOC, V277, P822, DOI 10.1001/jama.277.10.822; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Graff-Radford NR, 2002, ARCH NEUROL-CHICAGO, V59, P594, DOI 10.1001/archneur.59.4.594; Gureje O, 2006, ANN NEUROL, V59, P182, DOI 10.1002/ana.20694; Hefferon TW, 2004, P NATL ACAD SCI USA, V101, P3504, DOI 10.1073/pnas.0400182101; Hendrie HC, 2001, JAMA-J AM MED ASSOC, V285, P739, DOI 10.1001/jama.285.6.739; Jun G, 2012, ARCH NEUROL-CHICAGO, V69, P1270, DOI 10.1001/archneurol.2012.2052; Kline A, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt135; Linnertz C, 2014, ALZHEIMERS DEMENT, V10, P541, DOI 10.1016/j.jalz.2013.08.280; Linnertz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030994; Logue MW, 2011, ARCH NEUROL-CHICAGO, V68, P1569, DOI 10.1001/archneurol.2011.646; Lutz MW, 2010, ALZHEIMERS DEMENT, V6, P125, DOI 10.1016/j.jalz.2010.01.011; MAESTRE G, 1995, ANN NEUROL, V37, P254, DOI 10.1002/ana.410370217; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Mortimer JA, 2009, ALZ DIS ASSOC DIS, V23, P152, DOI 10.1097/WAD.0b013e318190a855; Murrell JR, 2006, ARCH NEUROL-CHICAGO, V63, P431, DOI 10.1001/archneur.63.3.431; Okladnova O, 1998, BIOCHEM BIOPH RES CO, V248, P402, DOI 10.1006/bbrc.1998.8972; Payton A, 2015, NEUROBIOLOGY AGING; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Peters DG, 1999, STROKE, V30, P2612, DOI 10.1161/01.STR.30.12.2612; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Reitz C, 2013, JAMA-J AM MED ASSOC, V309, P1483, DOI 10.1001/jama.2013.2973; Roses AD, 2014, ALZHEIMERS DEMENT, V10, P592, DOI 10.1016/j.jalz.2014.06.009; Roses AD, 2013, ALZHEIMERS DEMENT, V9, P132, DOI 10.1016/j.jalz.2012.10.009; Searle S, 1999, J MED GENET, V36, P295; Shimajiri S, 1999, FEBS LETT, V455, P70, DOI 10.1016/S0014-5793(99)00863-7; Slooter AJC, 2004, NEUROLOGY, V62, P1196, DOI 10.1212/01.WNL.0000118302.66674.E1; Tang MX, 1998, JAMA-J AM MED ASSOC, V279, P751, DOI 10.1001/jama.279.10.751; Tycko B, 2004, ARCH NEUROL-CHICAGO, V61, P1434, DOI 10.1001/archneur.61.9.1434; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Willems T, 2014, GENOME RES, V24, P1894, DOI 10.1101/gr.177774.114; Yu L, 2017, NEUROLOGY, V88, P661, DOI 10.1212/WNL.0000000000003614	51	20	20	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e180356	10.1371/journal.pone.0180356	http://dx.doi.org/10.1371/journal.pone.0180356			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672022	Green Published, gold, Green Submitted			2022-12-26	WOS:000405268500045
J	Tao, T; Yang, X; Zheng, J; Feng, D; Qin, Q; Shi, X; Wang, Q; Zhao, C; Peng, Z; Liu, H; Jiang, WG; He, J				Tao, T.; Yang, X.; Zheng, J.; Feng, D.; Qin, Q.; Shi, X.; Wang, Q.; Zhao, C.; Peng, Z.; Liu, H.; Jiang, W. G.; He, J.			PDZK1 inhibits the development and progression of renal cell carcinoma by suppression of SHP-1 phosphorylation	ONCOGENE			English	Article							TYROSINE-PHOSPHATASE SHP-1; BREAST-CANCER; CLEAR-CELL; COLORECTAL-CANCER; TARGETED THERAPY; PROTEIN; EXPRESSION; GROWTH; TUMORIGENESIS; SURVIVAL	Renal cell carcinoma (RCC) is one of the most aggressive urologic cancers, however, the mechanism on supporting RCC carcinogenesis is still not clear. By using gene expression profile analysis and functional clustering, PDZ domain-containing 1 (PDZK1) was revealed to be downregulated in human clear cell renal cell carcinoma (ccRCC) samples, which was also verified in several independent public ccRCC data sets. Using PDZK1 overexpression and knockdown models in ccRCC cell lines, we demonstrated that PDZK1 inhibited cell proliferation, cell cycle G1/S phase transition, cell migration and invasion, indicating a tumor-suppressor role in the development and progression of ccRCC. Our study further demonstrated that PDZK1 inhibited cell proliferation and migration of ccRCC via targeting SHP-1. PDZK1 was further identified to suppress cell proliferation by blocking SHP-1 phosphorylation at Tyr536 via inhibition of the association between SHP-1 and PLC beta 3, and then retarding Akt phosphorylation and promoting STAT5 phosphorylation in ccRCC cells. Moreover, the inhibitive effects of PDZK1 on SHP-1 phosphorylation and the tumor growth were verified in vivo by xenograft tumor studies. Accordingly, PDZK1 expression was negatively correlated with SHP-1 activation and phosphorylation, advanced pathologic stage, tumor weight and size, and prognosis of ccRCC patients. These findings have provided first lines of evidences that PDZK1 expression is negatively correlated with SHP-1 activation and poor clinical outcomes in ccRCC. PDZK1 was identified as a novel tumor suppressor in ccRCC by negating SHP-1 activity.	[Tao, T.; Yang, X.; Zheng, J.; Qin, Q.; Shi, X.; Wang, Q.; Zhao, C.; Peng, Z.; Liu, H.; He, J.] Capital Med Univ, Dept Biochem & Mol Biol, 10 Xitoutiao, Beijing 100069, Peoples R China; [Yang, X.; Zheng, J.; Qin, Q.; Liu, H.; He, J.] Capital Med Univ, Beijing Int Cooperat Base Sci & Technol China UK, Beijing Key Lab Canc Invas & Metastasis Res, Beijing, Peoples R China; [Feng, D.] Shanxi Med Univ, Hosp 1, Dept Intervent Radiol, Taiyuan, Shanxi, Peoples R China; [Jiang, W. G.] Cardiff Univ, Cardiff China Med Res Collaborat, Sch Med, Heath Pk, Cardiff, S Glam, Wales	Capital Medical University; Capital Medical University; Shanxi Medical University; Cardiff University	Liu, H; He, J (corresponding author), Capital Med Univ, Dept Biochem & Mol Biol, 10 Xitoutiao, Beijing 100069, Peoples R China.	hualh08@ccmu.edu.cn; jq_he@ccmu.edu.cn	Jiang, Wen G/B-1293-2010; jiang, wen/GYI-9662-2022; Jiang, Wen G./AAF-1876-2020	Jiang, Wen G/0000-0002-3283-1111; Jiang, Wen G./0000-0002-3283-1111	National Natural Science Foundation of the People's Republic of China [81472409, 81572333]; Beijing Natural Science Foundation Program; Beijing Municipal Commission of Education [KZ201710025015]; Project of High-level Teachers in Beijing Municipal Universities [IDHT20170516]; Beijing BaiQianWan Talents Program	National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation Program(Beijing Natural Science Foundation); Beijing Municipal Commission of Education(Beijing Municipal Commission of Education); Project of High-level Teachers in Beijing Municipal Universities; Beijing BaiQianWan Talents Program	This work was supported by the National Natural Science Foundation of the People's Republic of China (No. 81472409, 81572333); Beijing Natural Science Foundation Program and Scientific Research Key Program of Beijing Municipal Commission of Education (KZ201710025015); Support Project of High-level Teachers in Beijing Municipal Universities in the Period of 13th Five-year Plan (IDHT20170516); Beijing BaiQianWan Talents Program (2017-2018).	Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Caceres W, 2011, P R HEALTH SCI J, V30, P73; Calvo E, 2016, CANCER TREAT REV, V50, P109, DOI 10.1016/j.ctrv.2016.09.002; Ciccarese C, 2016, CANCER TREAT REV, V49, P37, DOI 10.1016/j.ctrv.2016.07.003; Cooper SJ, 2010, ONCOGENE, V29, P2905, DOI 10.1038/onc.2010.64; Du Y, 2016, ONCOTARGET, V7, P41885, DOI 10.18632/oncotarget.9628; Eyre NS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001130; Gardiol D, 2012, FEBS J, V279, P3529, DOI 10.1111/j.1742-4658.2012.08685.x; Ghosh MG, 2000, CANCER RES, V60, P6367; Golebiewska U, 2010, CRIT REV BIOCHEM MOL, V45, P97, DOI 10.3109/10409231003598812; Inoue J, 2004, AM J PATHOL, V165, P71, DOI 10.1016/S0002-9440(10)63276-2; Kanamori M, 2003, J BIOL CHEM, V278, P38758, DOI 10.1074/jbc.M306324200; Kim JK, 2012, J BIOL CHEM, V287, P21012, DOI 10.1074/jbc.M111.337865; Klatte T, 2007, CLIN CANCER RES, V13, P7388, DOI 10.1158/1078-0432.CCR-07-0411; Kroeze SGC, 2010, CANCER BIOMARK, V7, P261, DOI 10.3233/CBM-2010-0195; Li HL, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0162-x; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Lopez-Beltran A, 2006, EUR UROL, V49, P798, DOI 10.1016/j.eururo.2005.11.035; Ma Q, 2015, ONCOTARGET, V6, P35851, DOI 10.18632/oncotarget.5323; Moch H, 2015, CURR DRUG TARGETS, V16, P125, DOI 10.2174/1389450116666150126110632; Montano X, 2009, ONCOGENE, V28, P3787, DOI 10.1038/onc.2009.143; Polette M, 2005, CANCER RES, V65, P7691, DOI 10.1158/0008-5472.CAN-04-4230; Poole AW, 2005, CELL SIGNAL, V17, P1323, DOI 10.1016/j.cellsig.2005.05.016; Rathmell WK, 2008, EXPERT REV ANTICANC, V8, P63, DOI 10.1586/14737140.8.1.63; Rodriguez-Ubreva FJ, 2010, ONCOGENE, V29, P345, DOI 10.1038/onc.2009.329; Saponaro C, 2014, CANCER BIOMARK, V14, P177, DOI 10.3233/CBM-130329; Sharma Y, 2016, FUTURE ONCOL, V12, P1287, DOI 10.2217/fon-2015-0057; Sooman L, 2014, TUMOR BIOL, V35, P4479, DOI 10.1007/s13277-013-1590-5; Stebbing J, 2014, ONCOGENE, V33, P939, DOI 10.1038/onc.2013.80; Subbaiah VK, 2011, BIOCHEM J, V439, P195, DOI 10.1042/BJ20110903; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun LC, 2016, FASEB J, V30, P578, DOI 10.1096/fj.15-275586; Walsh DR, 2015, PHARMACOL REV, V67, P656, DOI 10.1124/pr.115.010728; Xiao WB, 2010, BLOOD, V116, P6003, DOI 10.1182/blood-2010-05-283937; Yao S, 2015, J PATHOL, V236, P65, DOI 10.1002/path.4502; Zheng JF, 2017, EBIOMEDICINE, V15, P62, DOI 10.1016/j.ebiom.2016.12.003	36	21	22	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 2	2017	36	44					6119	6131		10.1038/onc.2017.199	http://dx.doi.org/10.1038/onc.2017.199			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FL5CU	28692056	Green Accepted			2022-12-26	WOS:000414249800006
J	Villegas-Negrete, N; Robleto, EA; Obregon-Herrera, A; Yasbin, RE; Pedraza-Reyes, M				Villegas-Negrete, Norberto; Robleto, Eduardo A.; Obregon-Herrera, Armando; Yasbin, Ronald E.; Pedraza-Reyes, Mario			Implementation of a loss-of-function system to determine growth and stress-associated mutagenesis in Bacillus subtilis	PLOS ONE			English	Article							STATIONARY-PHASE MUTAGENESIS; THYMIDYLATE SYNTHASE; ADAPTIVE EVOLUTION; ESCHERICHIA-COLI; RNA-POLYMERASE; REPAIR SYSTEM; DNA-DAMAGE; CELLS; TRANSCRIPTION; MUTANTS	A forward mutagenesis system based on the acquisition of mutations that inactivate the thymidylate synthase gene (TMS) and confer a trimethoprim resistant (Tmp(r)) phenotype was developed and utilized to study transcription-mediated mutagenesis (TMM). In addition to thyA, Bacillus subtilis possesses thyB, whose expression occurs under conditions of cell stress; therefore, we generated a thyB(-) thyA(+) mutant strain. Tmp(r) colonies of this strain were produced with a spontaneous mutation frequency of similar to 1.4 x 10(-9). Genetic disruption of the canonical mismatch (MMR) and guanine oxidized (GO) repair pathways increased the Tmp(r) frequency of mutation by similar to 2-3 orders of magnitude. A wide spectrum of base substitutions as well as insertion and deletions in the ORF of thyA were found to confer a Tmp(r) phenotype. Stationary-phase-associated mutagenesis (SPM) assays revealed that colonies with a Tmpr phenotype, accumulated over a period of ten days with a frequency of similar to 60 x 10(-7). The Tmp(r) system was further modified to study TMM by constructing a Delta thyA Delta thyB strain carrying an IPTG-inducible Pspac-thyA cassette. In conditions of transcriptional induction of thyA, the generation of Tmp(r) colonies increased similar to 3-fold compared to conditions of transcriptional repression. Further, the Mfd and GreA factors were necessary for the generation of Tmpr colonies in the presence of IPTG in B. subtilis. Because GreA and Mfd facilitate transcription-coupled repair, our results suggest that TMM is a mechanim to produce genetic diversity in highly transcribed regions in growth-limited B. subtilis cells.	[Villegas-Negrete, Norberto; Obregon-Herrera, Armando; Pedraza-Reyes, Mario] Univ Guanajuato, Dept Biol, Div Nat & Exact Sci, Guanajuato, Mexico; [Robleto, Eduardo A.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Yasbin, Ronald E.] Univ Missouri St Louis, Coll Arts & Sci, St Louis, MO 63121 USA	Universidad de Guanajuato; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Missouri System; University of Missouri Saint Louis	Pedraza-Reyes, M (corresponding author), Univ Guanajuato, Dept Biol, Div Nat & Exact Sci, Guanajuato, Mexico.	pedrama@ugto.mx			NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM110624] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR016464] Funding Source: Medline; NIGMS NIH HHS [R15 GM110624] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambriz-Avina V, 2016, CURR MICROBIOL, V73, P721, DOI 10.1007/s00284-016-1122-9; Behe MJ, 2010, Q REV BIOL, V85, P419, DOI 10.1086/656902; BOYLAN RJ, 1972, J BACTERIOL, V110, P281, DOI 10.1128/JB.110.1.281-290.1972; Bridges BA, 1998, MUTAT RES-DNA REPAIR, V408, P1, DOI 10.1016/S0921-8777(98)00008-1; CAIRNS J, 1988, NATURE, V335, P142, DOI 10.1038/335142a0; Castellanos-Juarez FX, 2006, J BACTERIOL, V188, P2285, DOI 10.1128/JB.188.6.2285-2289.2006; Cohen SE, 2010, CURR BIOL, V20, P80, DOI 10.1016/j.cub.2009.11.039; Cutting S., 1990, MOL BIOL METHODS BAC; Debora BN, 2011, J BACTERIOL, V193, P236, DOI 10.1128/JB.00940-10; Barajas-Ornelas RD, 2014, J BACTERIOL, V196, P3012, DOI 10.1128/JB.01681-14; FARMER JL, 1965, J BACTERIOL, V89, P262, DOI 10.1128/JB.89.1.262-263.1965; Fox KM, 1999, PROTEIN SCI, V8, P538; Fukushima T, 2003, J BIOCHEM, V133, P475, DOI 10.1093/jb/mvg062; Gomez-Marroquin M, 2015, J BACTERIOL, V197, P1963, DOI 10.1128/JB.00147-15; Halas A, 2002, CURR GENET, V42, P140, DOI 10.1007/s00294-002-0334-7; Hawser S, 2006, BIOCHEM PHARMACOL, V71, P941, DOI 10.1016/j.bcp.2005.10.052; Ishikawa S, 2010, J BACTERIOL, V192, P5778, DOI 10.1128/JB.00489-10; ITAYA M, 1989, NUCLEIC ACIDS RES, V17, P4410, DOI 10.1093/nar/17.11.4410; Kamarthapu V, 2015, CURR OPIN MICROBIOL, V24, P15, DOI 10.1016/j.mib.2014.12.005; Kasak L, 1997, P NATL ACAD SCI USA, V94, P3134, DOI 10.1073/pnas.94.7.3134; Kusuya Y, 2011, J BACTERIOL, V193, P3090, DOI 10.1128/JB.00086-11; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MICHAELS ML, 1990, P NATL ACAD SCI USA, V87, P3957, DOI 10.1073/pnas.87.10.3957; Million-Weaver S, 2015, P NATL ACAD SCI USA, V112, pE1096, DOI 10.1073/pnas.1416651112; NEUHARD J, 1978, P NATL ACAD SCI USA, V75, P1194, DOI 10.1073/pnas.75.3.1194; OKADA T, 1962, J BACTERIOL, V84, P602, DOI 10.1128/JB.84.3.602-603.1962; OKADA T, 1960, NATURE, V188, P340, DOI 10.1038/188340a0; OLLINGTON JF, 1981, J BACTERIOL, V147, P432, DOI 10.1128/JB.147.2.432-442.1981; Pedraza-Reyes M, 2004, J BACTERIOL, V186, P6485, DOI 10.1128/JB.186.19.6485-6491.2004; Pybus C, 2010, J BACTERIOL, V192, P3321, DOI 10.1128/JB.00354-10; Quinlivan EP, 2000, FASEB J, V14, P2519, DOI 10.1096/fj.99-1037com; Robleto EA, 2007, CRIT REV BIOCHEM MOL, V42, P327, DOI 10.1080/10409230701597717; Rosenberg SM, 1998, GENETICS, V148, P1559; Ross C, 2006, J BACTERIOL, V188, P7512, DOI 10.1128/JB.00980-06; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sankar TS, 2016, NATURE, V535, P178, DOI 10.1038/nature18316; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; Sung HM, 2002, J BACTERIOL, V184, P5641, DOI 10.1128/JB.184.20.5641-5653.2002; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Vidales LE, 2009, J BACTERIOL, V191, P506, DOI 10.1128/JB.01210-08; WILSON MC, 1966, J BACTERIOL, V92, P186, DOI 10.1128/JB.92.1.186-196.1966; YASBIN RE, 1980, GENE, V12, P155, DOI 10.1016/0378-1119(80)90026-8	42	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0179625	10.1371/journal.pone.0179625	http://dx.doi.org/10.1371/journal.pone.0179625			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700593	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649400004
J	Sanchez-Tejada, L; Sanchez-Ortiga, R; Lamas, C; Camara, R; Riesgo, P; Fajardo, C; Aranda, FI; Pico, A				Sanchez-Tejada, Laura; Sanchez-Ortiga, Ruth; Lamas, Cristina; Camara, Rosa; Riesgo, Pedro; Fajardo, Carmen; Ignacio Aranda, Francisco; Pico, Antonio			Contribution of molecular analysis to the typification of the non-functioning pituitary adenomas	PLOS ONE			English	Article							SILENT CORTICOTROPH ADENOMAS; PROLACTIN GENE-EXPRESSION; CLINICOPATHOLOGICAL CLASSIFICATION; GROWTH-HORMONE; MANAGEMENT; SECRETION; PATHOLOGY	Aim The WHO Classification of Tumours of Endocrine Organs considers the inmunohistochemical characterization of pituitary adenomas (PA) as mandatory for patient diagnosis. Recent advances in the knowledge of the molecular patterns of these tumours could complement this classification with gene expression profiling. Methods Within the context of the Spanish Molecular Registry of Pituitary Adenomas (REMAH), a multicentre clinical- basic research project, we analysed the molecular phenotype of 142 PAs with complete IHC and clinical information. Gene expression levels of all pituitary hormones, type 1 corticotrophin- releasing hormone receptor, dopamine receptors and arginine vasopressin receptor 1b were measured by quantitative real- time polymerase chain reaction. In addition, we used three housekeeping genes for normalization and a pool of nine healthy pituitary glands from autopsies as calibration reference standard. Results Based on the clinically functioning PA (FPA: somatotroph, corticotroph, thyrotroph and lactotroph adenomas), we established the interquartile range of relative expression for all genes studied in each PA subtype. That allowed molecularly the different PA subtypes, including the clinically non- functioning PA (NFPA). Afterwards, we estimated the concordance of the molecular and immunohistochemical classification with clinical diagnosis in FPA and between them in NFPA. The kappa values were higher in molecular than in immunohistochemical classification in FPA and showed a bad concordance in all NFPA subtypes. Conclusions According to these results, the molecular characterization of the PA complements the IHC analysis, allowing a better typification of the NFPA.	[Sanchez-Tejada, Laura] Hosp Gen Univ Alicante, Isabial Fisabio Fdn, Inst Hlth & Biomed Res, Res Unit, Alicante, Spain; [Sanchez-Ortiga, Ruth; Pico, Antonio] Hosp Gen Univ Alicante, Endocrinol Dept, Alicante, Spain; [Lamas, Cristina] Hosp Gen Univ Albacete, Endocrinol Dept, Albacete, Spain; [Camara, Rosa] Hosp Univ Politecn La Fe, Endocrinol Dept, Valencia, Spain; [Riesgo, Pedro] Hosp La Ribera, Neurosurg Dept, Valencia, Spain; [Fajardo, Carmen] Hosp La Ribera, Endocrinol Dept, Alzira, Spain; [Ignacio Aranda, Francisco] Hosp Gen Univ Alicante, Pathol Dept, Alicante, Spain	General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); General University Hospital of Alicante; Hospital Universitari i Politecnic La Fe; General University Hospital of Alicante	Pico, A (corresponding author), Hosp Gen Univ Alicante, Endocrinol Dept, Alicante, Spain.	antonio.pico@umh.es	pico, antonio/B-6439-2018; pico, antonio/E-9061-2011; SANCHEZ-TEJADA, LAURA/B-6336-2015; ARANDA, FRANCISCO I/L-5525-2015	pico, antonio/0000-0002-7549-7563; pico, antonio/0000-0002-7549-7563; SANCHEZ-TEJADA, LAURA/0000-0001-5563-8923; ARANDA, FRANCISCO I/0000-0003-2338-2286; Fajardo-Montanana, Carmen/0000-0002-0784-0761; Lamas Oliveira, Cristina/0000-0003-4622-9508	Spanish Society of Endocrinology and Nutrition (SEEN) - Novartis Oncology	Spanish Society of Endocrinology and Nutrition (SEEN) - Novartis Oncology	This work is the result of analysis of the REMAH project in its Alicante node, sponsored by the Spanish Society of Endocrinology and Nutrition (SEEN) and funded by Novartis Oncology. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Al-Brahim NYY, 2006, J CLIN PATHOL, V59, P1245, DOI 10.1136/jcp.2005.031187; Asa SL, 2008, ARCH PATHOL LAB MED, V132, P1231, DOI 10.1043/1543-2165(2008)132[1231:PPPWDT]2.0.CO;2; Baldeweg SE, 2005, BRIT J NEUROSURG, V19, P38, DOI 10.1080/02688690500081230; Chanson P, 2015, ANN ENDOCRINOL-PARIS, V76, P239, DOI 10.1016/j.ando.2015.04.002; Cho HY, 2010, CLIN ENDOCRINOL, V72, P648, DOI 10.1111/j.1365-2265.2009.03673.x; Cooper O, 2012, BEST PRACT RES CL EN, V26, P447, DOI 10.1016/j.beem.2012.01.002; de Keyzer Y, 1998, CLIN ENDOCRINOL, V49, P475, DOI 10.1046/j.1365-2265.1998.00560.x; Ezzat S, 2004, CANCER-AM CANCER SOC, V101, P613, DOI 10.1002/cncr.20412; Gomez-Hernandez Karen, 2015, Turk Patoloji Derg, V31 Suppl 1, P4, DOI 10.5146/tjpath.2015.01311; Greenman Y, 2009, BEST PRACT RES CL EN, V23, P625, DOI 10.1016/j.beem.2009.05.005; Gruszka A, 2007, ENDOCRINOLOGY, V148, P6107, DOI 10.1210/en.2007-0378; Gruszka A, 2012, MOL CELL ENDOCRINOL, V362, P104, DOI 10.1016/j.mce.2012.05.020; HORVATH E, 1980, AM J PATHOL, V98, P617; Jin L, 1997, J CLIN ENDOCR METAB, V82, P963, DOI 10.1210/jc.82.3.963; KNOSP E, 1993, NEUROSURGERY, V33, P610, DOI 10.1227/00006123-199310000-00008; Lloyd R. V, 2004, WHO CLASSIFICATION T, P10; Luque RM, 2016, ENDOCRINOL NUTR, V63, P274, DOI 10.1016/j.endonu.2016.03.001; Mahta A, 2007, FOLIA NEUROPATHOL, V45, P72; Ohta S, 2002, Pituitary, V5, P221, DOI 10.1023/A:1025321731790; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Petrus M, 1996, ARCH PEDIATRIE, V3, P245, DOI 10.1016/0929-693X(96)81302-9; Raverot G, 2014, EUR J ENDOCRINOL, V170, pR121, DOI 10.1530/EJE-13-1031; Raverot G, 2010, EUR J ENDOCRINOL, V163, P35, DOI 10.1530/EJE-10-0076; Sanchez-Ortiga R, 2013, PITUITARY, V16, P370, DOI 10.1007/s11102-012-0434-4; Sepulveda AR, 2017, AM J CLIN PATHOL, V147, P221, DOI 10.1093/ajcp/aqw209; Sugimoto K, 2007, BRAIN RES BULL, V74, P142, DOI 10.1016/j.brainresbull.2007.06.004; Tateno T, 2007, EUR J ENDOCRINOL, V157, P717, DOI 10.1530/EJE-07-0428; Tateno T, 2007, ENDOCR J, V54, P777, DOI 10.1507/endocrj.K07-059; Trouillas J, 2014, ENDOCR PATHOL, V25, P124, DOI 10.1007/s12022-014-9322-y; Trouillas J, 2013, ACTA NEUROPATHOL, V126, P123, DOI 10.1007/s00401-013-1084-y; True LD, 2008, HISTOCHEM CELL BIOL, V130, P473, DOI 10.1007/s00418-008-0481-0; Vezina J L, 1975, Arq Neuropsiquiatr, V33, P119; Yamakita N, 1999, ENDOCR J, V46, P563, DOI 10.1507/endocrj.46.563	33	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180039	10.1371/journal.pone.0180039	http://dx.doi.org/10.1371/journal.pone.0180039			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692683	Green Published, gold, Green Submitted			2022-12-26	WOS:000405544800023
J	Arca-Diaz, G; Re, TJ; Drottar, M; Fortuno, CR; De Macedo-Rodrigues, K; Im, K; Figueras-Aloy, J; Grant, PE				Arca-Diaz, Gemma; Re, Thomas J.; Drottar, Marie; Fortuno, Carmen Rosa; De Macedo-Rodrigues, Katyucia; Im, Kiho; Figueras-Aloy, Josep; Grant, Patricia Ellen			Can cerebellar and brainstem apparent diffusion coefficient (ADC) values predict neuromotor outcome in term neonates with hypoxic-ischemic encephalopathy (HIE) treated with hypothermia?	PLOS ONE			English	Article							WHOLE-BODY HYPOTHERMIA; PERINATAL ASPHYXIA; RANDOMIZED-TRIAL; BASAL GANGLIA; INJURY; MRI; ANISOTROPY; CHILDREN; NEWBORNS; INFANTS	Background and purpose To determine the apparent diffusion coefficient (ADC) in specific infratentorial brain structures during the first week of life and its relation with neuromotor outcome for Hypoxic-ischemic encephalopathy (HIE) in term neonates with and without whole-body hypothermia (TH). Materials and methods We retrospectively evaluated 45 MRI studies performed in the first week of life of term neonates born between 2010 and 2013 at Boston Children's Hospital. Selected cases were classified into three groups: 1) HIE neonates who underwent TH, 2) HIE normothermics (TN), and 3) controls. The neuromotor outcome was categorized as normal, abnormal and death. The ADC(mean) was calculated for six infratentorial brain regions. Results A total of 45 infants were included: 28 HIE TH treated, 8 HIE TN, and 9 controls. The mean gestational age was 39 weeks; 57.8% were male; 11.1% were non-survivors. The median age at MRI was 3 days (interquartile range, 1-4 days). A statistically significant relationship was shown between motor outcome or death and the ADCmean in the vermis (P = 0.002), cerebellar left hemisphere (P = 0.002), midbrain (P = 0.009), pons (P = 0.014) and medulla (P = 0.005). In patients treated with TH, the ADC (mean) remained significantly lower than that in the controls only in the hemispheres (P = 0.01). In comparison with abnormal motor outcome, ADC(mean) was lowest in the left hemisphere (P = 0.003), vermis (P = 0.003), pons (P = 0.0036) and medulla (P = 0.008) in case of death. Conclusion ADCmean values during the first week of life in the left hemisphere, vermis, pons and medulla are related to motor outcome or death in infants with HIE either with or without hypothermic therapy. Therefore, this objective tool can be assessed prospectively to determine if it can be used to establish prognosis in the first week of life, particularly in severe cases of HIE.	[Arca-Diaz, Gemma; Figueras-Aloy, Josep] Univ Barcelona, IDIBAPS, Hosp St Joan de Deu, Serv Neonatol,Agrupacio Sanitaria Hosp Clin, Barcelona, Spain; [Re, Thomas J.; Drottar, Marie; De Macedo-Rodrigues, Katyucia; Im, Kiho; Grant, Patricia Ellen] Childrens Hosp Boston, Fetal Neonatal Neuroimaging & Dev Sci Ctr, Boston, MA USA; [Fortuno, Carmen Rosa] Boston Childrens Hosp, Fetal Neonatal Neurol Program, Dept Neurol, Boston, MA USA	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Arca-Diaz, G (corresponding author), Univ Barcelona, IDIBAPS, Hosp St Joan de Deu, Serv Neonatol,Agrupacio Sanitaria Hosp Clin, Barcelona, Spain.	garca@clinic.ub.es	de Macedo Rodrigues, Katyucia/W-6049-2019; Grant, Peter/HIR-3733-2022	de Macedo Rodrigues, Katyucia/0000-0002-3649-102X; Arca, Gemma/0000-0003-3647-0656; Grant, Patricia/0000-0003-1005-4013; Figueras-Aloy, Josep/0000-0003-1261-8193	Spanish Society of Neonatology; Hospital Clinic of the University of Barcelona; Ralph Schlaeger Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER	Spanish Society of Neonatology; Hospital Clinic of the University of Barcelona; Ralph Schlaeger Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This publication was made possible by a grant from the Spanish Society of Neonatology (S.E.N.), the support of the Hospital Clinic of the University of Barcelona, and the Ralph Schlaeger Foundation (for support of T.J.Re.).	Alderliesten T, 2011, RADIOLOGY, V261, P235, DOI 10.1148/radiol.11110213; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Bednarek N, 2012, NEUROLOGY, V78, P1420, DOI 10.1212/WNL.0b013e318253d589; Cheong JLY, 2012, ARCH PEDIAT ADOL MED, V166, P634, DOI 10.1001/archpediatrics.2012.284; Coats JS, 2009, PEDIATR NEUROL, V41, P263, DOI 10.1016/j.pediatrneurol.2009.04.013; Connolly DJA, 2007, AM J NEURORADIOL, V28, P16; Garcia-Alix A, 2009, AN PEDIATR, V71, P319, DOI 10.1016/j.anpedi.2009.07.021; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Grant PE, 2006, RADIOL CLIN N AM, V44, P63, DOI 10.1016/j.rcl.2005.08.001; Jacobs S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub2; Johnson AJ, 1999, AM J ROENTGENOL, V172, P219, DOI 10.2214/ajr.172.1.9888771; Karaarslan E, 2008, EUR J RADIOL, V65, P402, DOI 10.1016/j.ejrad.2007.04.023; Le Strange E, 2004, AM J NEURORADIOL, V25, P463; LEVENE MI, 1986, LANCET, V1, P67, DOI 10.1016/S0140-6736(86)90718-X; Liauw L, 2009, AM J NEURORADIOL, V30, P264, DOI 10.3174/ajnr.A1318; Lovblad KO, 2003, NEURORADIOLOGY, V45, P400, DOI 10.1007/s00234-003-1009-x; Martinez-Biarge M, 2011, NEUROLOGY, V76, P2055, DOI 10.1212/WNL.0b013e31821f442d; Martinez-Biarge M, 2010, EARLY HUM DEV, V86, P675, DOI 10.1016/j.earlhumdev.2010.08.013; Massaro AN, 2010, J PERINATOL, V30, P596, DOI 10.1038/jp.2010.7; McKinstry RC, 2002, NEUROLOGY, V59, P824, DOI 10.1212/WNL.59.6.824; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Neil JJ, 1998, RADIOLOGY, V209, P57, DOI 10.1148/radiology.209.1.9769812; Nishida M, 2006, NEUROIMAGE, V32, P1041, DOI 10.1016/j.neuroimage.2006.05.020; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Pelzer EA, 2013, EUR J NEUROSCI, V38, P3106, DOI 10.1111/ejn.12314; Rutherford M, 2004, PEDIATRICS, V114, P1004, DOI 10.1542/peds.2004-0222; Rutherford M, 2010, EARLY HUM DEV, V86, P351, DOI 10.1016/j.earlhumdev.2010.05.014; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Sener RN, 2001, COMPUT MED IMAG GRAP, V25, P299, DOI 10.1016/S0895-6111(00)00083-5; Shah PS, 2010, SEMIN FETAL NEONAT M, V15, P238, DOI 10.1016/j.siny.2010.02.003; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Soul JS, 2001, PEDIATRICS, V108, P1211, DOI 10.1542/peds.108.5.1211; Tagin MA, 2012, ARCH PEDIAT ADOL MED, V166, P558, DOI 10.1001/archpediatrics.2011.1772; Tanner SF, 2000, AM J ROENTGENOL, V174, P1643, DOI 10.2214/ajr.174.6.1741643; Twomey E, 2010, PEDIATR RADIOL, V40, P1526, DOI 10.1007/s00247-010-1692-9; van Laerhoven H, 2013, PEDIATRICS, V131, P88, DOI 10.1542/peds.2012-1297; VANNUCCI RC, 1990, PEDIATRICS, V85, P961; Vermeulen RJ, 2008, RADIOLOGY, V249, P631, DOI 10.1148/radiol.2492071581; Ward P, 2006, PEDIATRICS, V117, pE619, DOI 10.1542/peds.2005-0545; Wolf RL, 2001, RADIOLOGY, V218, P825, DOI 10.1148/radiology.218.3.r01fe47825; Zwiener U, 2003, INTENS CARE MED, V29, P2277, DOI 10.1007/s00134-003-2007-5	41	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0178510	10.1371/journal.pone.0178510	http://dx.doi.org/10.1371/journal.pone.0178510			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686592	Green Published, gold, Green Submitted			2022-12-26	WOS:000405464100005
J	Silva, SL; Albuquerque, A; Amaral, AJ; Li, QZ; Mota, C; Cheynier, R; Victorino, RMM; Pereira-Santos, MC; Sousa, AE				Silva, Susana L.; Albuquerque, Adriana; Amaral, Andreia J.; Li, Quan-Zhen; Mota, Catarina; Cheynier, Remi; Victorino, Rui M. M.; Conceicao Pereira-Santos, M.; Sousa, Ana E.			Autoimmunity and allergy control in adults submitted to complete thymectomy early in infancy	PLOS ONE			English	Article							REGULATORY T-CELLS; NEONATAL THYMECTOMY; IMMUNE FUNCTION; COMPARTMENT; RISK	The contribution of the decline in thymic activity for the emergence of autoimmunity is still debatable. Immune-competent adults submitted to complete thymectomy early in life provide a unique model to address this question. We applied here strict criteria to identify adults lacking thymic activity based on sjTREC levels, to exclude thymic rebound and/or ectopic thymuses. In agreement, they featured severe naive CD4 T-cell depletion and contraction of T-cell receptor diversity. Notwithstanding this, there was neither increased incidence of autoimmune disease in comparison with age-matched controls nor significant changes in their IgG/IgA/IgM/IgE autoreactivity profiles, as assessed through extensive arrays. We reasoned that the observed relative preservation of the regulatory T-cell compartment, including maintenance of naive regulatory CD4 T-cells, may contribute to limit the emergence of autoimmunity upon thymectomy. Our findings have implications in other clinical settings with impaired thymic activity, and are particularly relevant to studies of autoimmunity in ageing.	[Silva, Susana L.; Albuquerque, Adriana; Amaral, Andreia J.; Mota, Catarina; Victorino, Rui M. M.; Conceicao Pereira-Santos, M.; Sousa, Ana E.] Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal; [Silva, Susana L.] Hosp Santa Maria, Ctr Hosp Lisboa Norte, Clin Univ Imunoalergol, Lisbon, Portugal; [Li, Quan-Zhen] Univ Texas Southwestern Med Ctr Dallas, Microarray Core Facil, Dallas, TX 75390 USA; [Mota, Catarina; Victorino, Rui M. M.] Hosp Santa Maria, Ctr Hosp Lisboa Norte, Clin Univ Med 2, Lisbon, Portugal; [Cheynier, Remi] Inst Cochin, INSERM, Cytokines & Viral Infect, Immunol Infect & Inflammat Dept,U1016, Paris, France; [Cheynier, Remi] CNRS, UMR8104, Paris, France; [Cheynier, Remi] Univ Paris 05, Paris, France	Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria; University of Texas System; University of Texas Southwestern Medical Center Dallas; Universidade de Lisboa; Hospital Santa Maria; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Sousa, AE (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal.	asousa@medicina.ulisboa.pt	Cheynier, Remi/E-9921-2010; Sousa, Ana E./L-2642-2014; Amaral, Andreia/O-8168-2015	Cheynier, Remi/0000-0003-1146-660X; Albuquerque, Adriana/0000-0003-3391-0396; Sousa, Ana E./0000-0002-4618-9799; Amaral, Andreia/0000-0003-0958-5570	Fundacco para a Ciencia e Tecnologia (FCT) [POCI2010/IC/83068/2007, PTDC/SAU-MIC/109786/2009]; Gulbenkian Foundation [P132532/2013]; EMBO long-term fellowship [ALT-33-2010]; Marie Curie European Integration [PERG-GA-2009-256595]; Fundação para a Ciência e a Tecnologia [PTDC/SAU-MIC/109786/2009, PIC/IC/83068/2007] Funding Source: FCT	Fundacco para a Ciencia e Tecnologia (FCT); Gulbenkian Foundation; EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Marie Curie European Integration; Fundação para a Ciência e a Tecnologia	This work was supported by Fundacco para a Ciencia e Tecnologia (FCT; POCI2010/IC/83068/2007 to RMMV; PTDC/SAU-MIC/109786/2009 to AES), and Gulbenkian Foundation (P132532/2013 to AES). SLS, ASA and AJA received FCT scholarships. AJA was supported by an EMBO long-term fellowship (ALT-33-2010) and a Marie Curie European Integration Grant (PERG-GA-2009-256595).	Appay V, 2010, AGING-US, V2, P78, DOI 10.18632/aging.100122; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bacher P, 2016, CELL, V167, P1067, DOI 10.1016/j.cell.2016.09.050; BREARLEY S, 1987, CLIN EXP IMMUNOL, V70, P322; Caramalho I, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00395; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; Czaja AJ, 2003, J CLIN GASTROENTEROL, V37, P315, DOI 10.1097/00004836-200310000-00011; Dion Marie-Lise, 2007, Methods Mol Biol, V380, P197; Eysteinsdottir JH, 2004, CLIN EXP IMMUNOL, V136, P349, DOI 10.1111/j.1365-2249.2004.02437.x; Gudmundsdottir J, 2016, J ALLERGY CLIN IMMUN; Gutierrez-Arcelus M, 2016, NAT REV GENET, V17, P160, DOI 10.1038/nrg.2015.33; Halnon NJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/915864; Halnon NJ, 2005, PEDIATR RES, V57, P42, DOI 10.1203/01.PDR.0000147735.19342.DE; Mancebo E, 2008, CLIN EXP IMMUNOL, V154, P375, DOI 10.1111/j.1365-2249.2008.03771.x; Mandapathil M, 2009, J IMMUNOL METHODS, V346, P55, DOI 10.1016/j.jim.2009.05.004; Merayo-Chalico J, 2016, HUM IMMUNOL, V77, P921, DOI 10.1016/j.humimm.2016.06.016; Miyara M, 2011, IMMUNOL CELL BIOL, V89, P346, DOI 10.1038/icb.2010.137; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Prelog M, 2009, CLIN IMMUNOL, V130, P123, DOI 10.1016/j.clim.2008.08.023; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sanei Behnam, 2015, Adv Biomed Res, V4, P18, DOI 10.4103/2277-9175.149849; Sanjuan MA, 2016, J ALLERGY CLIN IMMUN, V137, P1651, DOI 10.1016/j.jaci.2016.04.007; Sauce D, 2009, J CLIN INVEST, V119, P3070, DOI 10.1172/JCI39269; Schadenberg AWL, 2014, J ALLERGY CLIN IMMUN, V133, P277, DOI 10.1016/j.jaci.2013.08.030; Silva SL, 2016, ONCOTARGET; Silva SL, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00020; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Team. RDC, 2007, R LANG ENV STAT COMP; Torfadottir H, 2006, CLIN EXP IMMUNOL, V145, P407, DOI 10.1111/j.1365-2249.2006.03139.x; van den Broek T, 2016, J CLIN INVEST, V126, P1126, DOI 10.1172/JCI84997; van Gent R, 2011, BLOOD, V118, P627, DOI 10.1182/blood-2011-03-341396; Wandstrat AE, 2006, J AUTOIMMUN, V27, P153, DOI 10.1016/j.jaut.2006.09.001; Wickham H., 2009, MEDIA, V35, P10, DOI 10.1007/978-0-387-98141-3; Zhu HL, 2015, GENOM PROTEOM BIOINF, V13, P210, DOI 10.1016/j.gpb.2015.09.001	34	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180385	10.1371/journal.pone.0180385	http://dx.doi.org/10.1371/journal.pone.0180385			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686710	Green Published, Green Submitted, gold			2022-12-26	WOS:000405464100058
J	Sonnleitner, E; Prindl, K; Blasi, U				Sonnleitner, Elisabeth; Prindl, Konstantin; Blaesi, Udo			The Pseudomonas aeruginosa CrcZ RNA interferes with Hfq-mediated riboregulation	PLOS ONE			English	Article							ESCHERICHIA-COLI-HFQ; CARBON CATABOLITE REPRESSION; MESSENGER-RNA; INTERACTION SURFACES; BINDING; GENE; IRON; IDENTIFICATION; COMPETITION; REGULATOR	The RNA chaperone Hfq regulates virulence and metabolism in the opportunistic pathogen Pseudomonas aeruginosa. During carbon catabolite repression (CCR) Hfq together with the catabolite repression control protein Crc can act as a translational repressor of catabolic genes. Upon relief of CCR, the level of the Hfq-titrating RNA CrcZ is increasing, which in turn abrogates Hfq-mediated translational repression. As the interdependence of Hfq-mediated and RNA based control mechanisms is poorly understood, we explored the possibility whether the regulatory RNA CrcZ can interfere with riboregulation. We first substantiate that the P. aeruginosa Hfq is proficient and required for riboregulation of the transcriptional activator gene antR by the small RNA PrrF1-2. Our studies further revealed that CrcZ can interfere with PrrF1-2/Hfq-mediated regulation of antR. The competition for Hfq can be rationalized by the higher affinity of Hfq for CrcZ than for antR mRNA.	[Sonnleitner, Elisabeth; Prindl, Konstantin; Blaesi, Udo] Univ Vienna, Dept Microbiol Immunobiol & Genet, Max F Perutz Labs, Ctr Mol Biol,Vienna Bioctr VBC, Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Sonnleitner, E (corresponding author), Univ Vienna, Dept Microbiol Immunobiol & Genet, Max F Perutz Labs, Ctr Mol Biol,Vienna Bioctr VBC, Vienna, Austria.	elisabeth.sonnleitner@univie.ac.at		Sonnleitner, Elisabeth/0000-0002-6961-9536	Austrian Science Fund [P28711-B22]	Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by grant P28711-B22 (UB, ES) from the Austrian Science Fund (https://www.fwf.ac.at/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beich-Frandsen M, 2011, NUCLEIC ACIDS RES, V39, P4900, DOI 10.1093/nar/gkq1346; Bossi L, 2016, NAT REV MICROBIOL, V14, P775, DOI 10.1038/nrmicro.2016.129; DREYFUS M, 1988, J MOL BIOL, V204, P79, DOI 10.1016/0022-2836(88)90601-8; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; Ellis MJ, 2015, MOL MICROBIOL, V96, P633, DOI 10.1111/mmi.12961; Ferrara S, 2015, ENVIRON MICROBIOL, V17, P199, DOI 10.1111/1462-2920.12590; Geissmann TA, 2004, EMBO J, V23, P396, DOI 10.1038/sj.emboj.7600058; Hussein R, 2011, P NATL ACAD SCI USA, V108, P1110, DOI 10.1073/pnas.1010082108; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Leoni L, 1996, J BACTERIOL, V178, P2299, DOI 10.1128/jb.178.8.2299-2313.1996; Link TM, 2009, P NATL ACAD SCI USA, V106, P19286, DOI 10.1073/pnas.0908744106; Lu P, 2016, MOL MICROBIOL, V102, P244, DOI 10.1111/mmi.13458; Mikulecky PJ, 2004, NAT STRUCT MOL BIOL, V11, P1206, DOI 10.1038/nsmb858; Moll I, 2003, EMBO REP, V4, P284, DOI 10.1038/sj.embor.embor772; Moon K, 2011, MOL MICROBIOL, V82, P1545, DOI 10.1111/j.1365-2958.2011.07907.x; Oglesby AG, 2008, J BIOL CHEM, V283, P15558, DOI 10.1074/jbc.M707840200; Osborne J, 2014, MICROBIOLOGYOPEN, V3, P950, DOI 10.1002/mbo3.220; Panja S, 2013, NUCLEIC ACIDS RES, V41, P7536, DOI 10.1093/nar/gkt521; Ribeiro ED, 2012, NUCLEIC ACIDS RES, V40, P8072, DOI 10.1093/nar/gks510; Robinson KE, 2014, NUCLEIC ACIDS RES, V42, P2736, DOI 10.1093/nar/gkt1171; Rojo F, 2010, FEMS MICROBIOL REV, V34, P658, DOI 10.1111/j.1574-6976.2010.00218.x; Sauer E, 2012, P NATL ACAD SCI USA, V109, P9396, DOI 10.1073/pnas.1202521109; Sauer E, 2011, P NATL ACAD SCI USA, V108, P13065, DOI 10.1073/pnas.1103420108; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Sonnleitner E, 2006, MOL MICROBIOL, V59, P1542, DOI 10.1111/j.1365-2958.2006.05032.x; Sonnleitner E, 2002, MICROBIOL-SGM, V148, P883, DOI 10.1099/00221287-148-3-883; Sonnleitner E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004440; Sonnleitner E, 2009, P NATL ACAD SCI USA, V106, P21866, DOI 10.1073/pnas.pnas.0910308106; Sterzenbach T, 2013, EMBO J, V32, P2872, DOI 10.1038/emboj.2013.206; Vakulskas CA, 2015, MICROBIOL MOL BIOL R, V79, P193, DOI 10.1128/MMBR.00052-14; Vecerek B, 2005, RNA, V11, P976, DOI 10.1261/rna.2360205; Vecerek B, 2008, NUCLEIC ACIDS RES, V36, P133, DOI 10.1093/nar/gkm985; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Zhan YH, 2016, P NATL ACAD SCI USA, V113, pE4348, DOI 10.1073/pnas.1604514113; Zhang AX, 2013, J MOL BIOL, V425, P3678, DOI 10.1016/j.jmb.2013.01.006; Zheng A, 2016, J MOL BIOL, V428, P2259, DOI 10.1016/j.jmb.2016.03.027	37	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180887	10.1371/journal.pone.0180887	http://dx.doi.org/10.1371/journal.pone.0180887			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686727	Green Published, Green Submitted, gold			2022-12-26	WOS:000405464100118
J	Moyes, AJ; Lamb, RM; Ella-Tongwiis, P; Pushkaran, A; Ahmed, I; Shergill, I; Hughes, SF				Moyes, Alyson Jayne; Lamb, Rebecca May; Ella-Tongwiis, Peter; Pushkaran, Anish; Ahmed, Issam; Shergill, Iqbal; Hughes, Stephen Fon			A pilot study evaluating changes to haematological and biochemical tests after Flexible Ureterorenoscopy for the treatment of kidney stones	PLOS ONE			English	Article							COAGULATION	Background Currently there is limited research documenting the changes in blood parameters, following Flexible Ureterorenoscopy. This study aims to determine whether there are any changes in haematology and biochemistry parameters, following Flexible Ureterorenoscopy for the treatment of kidney stones. Methods 40 consecutive patients aged between 27-87 years (median 49 years) undergoing Flexible Ureterorenoscopy for the treatment of kidney stones were recruited (26 male, 14 female). Blood samples were collected from each patient at four time points: baseline (pre-operatively) followed by 30 minutes, 120 minutes and 240 minutes post-operatively. On these samples, routine haematological and biochemistry tests were carried out. In addition to the assessment of clinical parameters prospectively from the medical notes. Results There was a significant decrease observed following Flexible Ureterorenoscopy in the following parameters: lymphocytes (p = 0.007), eosinophils (p = 0.001), basophils (p = 0.001), haemoglobin (p = 0.002), red blood cells (p = 0.001), platelet count (p = 0.001), fibrinogen concentration (p = 0.001), von Willebrand factor (p = 0.046), C reactive protein (p = 0.01), total protein (p = 0.001), albumin (p = 0.001), globulin (p = 0.001) and alkaline phosphatase (p = 0.001). In addition, there was a significant increase observed in the following parameters: white blood cells (p = 0.001), neutrophils (p = 0.001), activated partial thromboplastin time (p = 0.001), total bilirubin (p = 0.012), creatinine (p = 0.008), sodium (p = 0.002) and potassium (p = 0.001). Limiting factors for this study were the sample size, and restriction on the recruitment time points. Conclusions Significant changes were noted to occur in haematology and biochemistry parameters following Flexible Ureterorenoscopy. Some of the data presented in this study may represent the 'normal' post-operative response following FURS, as no major complications occurred, in the majority of our patients. This data on the 'normal response' will need to be validated but may ultimately aid clinicians in distinguishing patients at risk of complications, if reproduced in larger multi-centre studies.	[Moyes, Alyson Jayne; Lamb, Rebecca May; Ella-Tongwiis, Peter; Hughes, Stephen Fon] Univ Chester, Dept Biol Sci, Chester, Cheshire, England; [Moyes, Alyson Jayne; Lamb, Rebecca May; Ella-Tongwiis, Peter; Pushkaran, Anish; Ahmed, Issam; Shergill, Iqbal; Hughes, Stephen Fon] Wrexham Maelor Hosp, NW2URC, BCUHB, Wrexham, Wales; [Moyes, Alyson Jayne; Lamb, Rebecca May; Ella-Tongwiis, Peter; Pushkaran, Anish; Ahmed, Issam; Shergill, Iqbal; Hughes, Stephen Fon] BCUHB Wrexham Maelor Hosp, Dept Urol, Wrexham, Wales; [Moyes, Alyson Jayne] Bangor Univ, Dept Med Sci, Bangor, Gwynedd, Wales	University of Chester; Bangor University	Hughes, SF (corresponding author), Univ Chester, Dept Biol Sci, Chester, Cheshire, England.; Hughes, SF (corresponding author), Wrexham Maelor Hosp, NW2URC, BCUHB, Wrexham, Wales.; Hughes, SF (corresponding author), BCUHB Wrexham Maelor Hosp, Dept Urol, Wrexham, Wales.	Stephen.hughes@wales.nhs.uk		Moyes, Alyson/0000-0002-5408-7039	Women Graduates, Foundation; University of Chester, Knowledge Transfer Award; Cadwaladr University Health Board; Women Graduates, Foundation; University of Chester, Knowledge Transfer Award; Cadwaladr University Health Board	Women Graduates, Foundation; University of Chester, Knowledge Transfer Award; Cadwaladr University Health Board; Women Graduates, Foundation; University of Chester, Knowledge Transfer Award; Cadwaladr University Health Board	Funds for Women Graduates, Foundation award.http://www.ffwg.org.uk/our-grants.html. Institute of Biomedical Science, Research Award. https://www.ibms.org/learning/prizes-and-awards/. University of Chester, Knowledge Transfer Award. https://www.chester.ac.uk/business-supports ervices/rkt-office. Betsi Cadwaladr University Health Board. All of the named funders had no role instudy design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghamir SMK, 2008, J ENDOUROL, V22, P2495, DOI 10.1089/end.2008.0319; Butterfield TA, 2006, J ATHL TRAINING, V41, P457; Cornu JN, 2016, EUR UROL FOCUS, V2, P49, DOI 10.1016/j.euf.2016.03.014; Global Burden of Disease Study 2013 Collaborators, 2015, COCHRANE DB SYST REV, V386, P743; Handa RK, 2010, BJU INT, V103, P1270; Heers H, 2016, BJU INT, V118, P785, DOI 10.1111/bju.13520; Hirakata H, 1991, ANESTHESIOLOGY, V91, P1361; Hughes SF, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-40; Hughes SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125840; Iba T, 2016, BLOOD REV, V30, P149, DOI 10.1016/j.blre.2015.10.002; Khafagy HF, 2010, HEMATOLOGY, V15, P360, DOI 10.1179/102453310X12647083620886; Lakomkin N, 2016, INJURY, V47, P1217, DOI 10.1016/j.injury.2016.03.004; Lingeman JE, 2006, SURG MANAGEMENT URIN; McAteer JA, 2008, SEMIN NEPHROL, V28, P200, DOI 10.1016/j.semnephrol.2008.01.003; Miller NL, 2007, BMJ-BRIT MED J, V334, P468, DOI 10.1136/bmj.39113.480185.80; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Portis AJ, 2001, AM FAM PHYSICIAN, V63, P1329; Romero V, 2010, REV UROL, V12, P86; Arellano-Buendia AS, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4693801; Samhan Y, 2016, EGYPT J ANAESTH, V32, P45, DOI 10.1016/j.egja.2015.09.014; Skolarikos A, 2015, J UROLOGY, V194, P137, DOI 10.1016/j.juro.2015.01.112; Ternstrom L, 2010, THROMB RES, V126, pE128, DOI 10.1016/j.thromres.2010.05.028; Tseng TY, 2015, BMJ CLINICAL EVIDENC, V6, P89; Turk C, 2014, GUIDELINES UROLITHIA, P7; Ucar HI, 2007, HEART SURG FORUM, V10, pE392, DOI 10.1532/HSF98.20071065; Uguz S, 2016, RENAL FAILURE, V38, P974, DOI 10.3109/0886022X.2016.1172941; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wood Kyle, 2011, Rev Urol, V13, P73	28	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0179599	10.1371/journal.pone.0179599	http://dx.doi.org/10.1371/journal.pone.0179599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683066	Green Published, Green Submitted, gold			2022-12-26	WOS:000405335200008
J	Ramilo, DW; Nunes, T; Madeira, S; Boinas, F; da Fonseca, IP				Ramilo, David W.; Nunes, Telmo; Madeira, Sara; Boinas, Fernando; da Fonseca, Isabel Pereira			Geographical distribution of Culicoides (DIPTERA: CERATOPOGONIDAE) in mainland Portugal: Presence/absence modelling of vector and potential vector species	PLOS ONE			English	Article							BLUETONGUE VIRUS; BITING MIDGES; SCHMALLENBERG VIRUS; OBSOLETUS COMPLEX; IMICOLA; ABUNDANCE; EUROPE; SITES; ASSOCIATION; HABITATS	Vector-borne diseases are not only accounted responsible for their burden on human health-care systems, but also known to cause economic constraints to livestock and animal production. Animals are affected directly by the transmitted pathogens and indirectly when animal movement is restricted. Distribution of such diseases depends on climatic and social factors, namely, environmental changes, globalization, trade and unplanned urbanization. Culicoides biting midges are responsible for the transmission of several pathogenic agents with relevant economic impact. Due to a fragmentary knowledge of their ecology, occurrence is difficult to predict consequently, limiting the control of these arthropod vectors. In order to understand the distribution of Culicoides species, in mainland Portugal, data collected during the National Entomologic Surveillance Program for Bluetongue disease (2005 - 2013), were used for statistical evaluation. Logistic regression analysis was preformed and prediction maps (per season) were obtained for vector and potentially vector species. The variables used at the present study were selected from WorldClim (two climatic variables) and CORINE databases (twenty-two land cover variables). This work points to an opposite distribution of C. imicola and species from the Obsoletus group within mainland Portugal. Such findings are evidenced in autumn, with the former appearing in Central and Southern regions. Although appearing northwards, on summer and autumn, C. newsteadi reveals a similar distribution to C. imicola. The species C. punctatus appears in all Portuguese territory throughout the year. Contrary, C. pulicaris is poorly caught in all areas of mainland Portugal, being paradoxical present near coastal areas and higher altitude regions.	[Ramilo, David W.; Nunes, Telmo; Madeira, Sara; Boinas, Fernando; da Fonseca, Isabel Pereira] Univ Lisbon, Fac Vet Med, Ctr Interdisciplinary Res Anim Hlth CIISA, Lisbon, Portugal	Universidade de Lisboa	da Fonseca, IP (corresponding author), Univ Lisbon, Fac Vet Med, Ctr Interdisciplinary Res Anim Hlth CIISA, Lisbon, Portugal.	ifonseca@fmv.ulisboa.pt	Pereira da Fonseca, I/AAR-2441-2021; Boinas, Fernando/AAD-9779-2022; da Fonseca, Isabel Pereira/AAY-1828-2021	Pereira da Fonseca, I/0000-0002-6632-1224; Boinas, Fernando/0000-0001-6259-4404; Madeira, Sara/0000-0001-5804-9745; Ramilo, David/0000-0003-4096-2581; Nunes, Telmo/0000-0003-4388-5366	National Entomologic Surveillance Program of Culicoides biting midges, vectors of Bluetonguevirus, in National Territory; Direcao Geralde Veterinaria/Faculdade de Medicina Veterinaria, Universidade Tecnica de Lisboa; Centre for Interdisciplinary Research in Animal Health (CIISA); Faculty of Veterinary Medicine, University of Lisbon - FCT [UID/CVT/00276/ 2013]; FCT [SFRH/BD/77268/2011]	National Entomologic Surveillance Program of Culicoides biting midges, vectors of Bluetonguevirus, in National Territory; Direcao Geralde Veterinaria/Faculdade de Medicina Veterinaria, Universidade Tecnica de Lisboa; Centre for Interdisciplinary Research in Animal Health (CIISA); Faculty of Veterinary Medicine, University of Lisbon - FCT; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	National Entomologic Surveillance Program of Culicoides biting midges, vectors of Bluetonguevirus, in National Territory, funded by Direcao Geralde Veterinaria/Faculdade de Medicina Veterinaria, Universidade Tecnica de Lisboa. Centre for Interdisciplinary Research in Animal Health (CIISA), Faculty of Veterinary Medicine, University of Lisbon, through the Projects UID/CVT/00276/ 2013 (funded by FCT). FCT Grant SFRH/BD/77268/2011.	[Anonymous], 2009, ENTOMOL FENNICA, V20, P228; Beck LR, 2000, EMERG INFECT DIS, V6, P217, DOI 10.3201/eid0603.000301; Boavida J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36460; Boorman J., 1989, Fauna of Saudi Arabia, V10, P160; BRAVERMAN Y, 1977, RHOD J AGR RES, V15, P101; Calvete C, 2008, MED VET ENTOMOL, V22, P124, DOI 10.1111/j.1365-2915.2008.00728.x; Capela R, 2003, MED VET ENTOMOL, V17, P165, DOI 10.1046/j.1365-2915.2003.00419.x; Caracappa S, 2003, VET REC, V153, P71, DOI 10.1136/vr.153.3.71; Carpenter S, 2008, MED VET ENTOMOL, V22, P175, DOI 10.1111/j.1365-2915.2008.00743.x; Chalghaf B, 2016, AM J TROP MED HYG, V94, P844, DOI 10.4269/ajtmh.15-0345; Conraths FJ, 2013, NEW ZEAL VET J, V61, P63, DOI 10.1080/00480169.2012.738403; Conte A, 2007, VET PARASITOL, V150, P333, DOI 10.1016/j.vetpar.2007.09.021; Dzhafarov SM, 1976, CAIRO FRANKLIN BOOK; Europaea Fauna, 2015, CUL PUL DISTR; European Food Safety Authority, 2007, EFSA J, V479, P1; Falconi C, 2011, VET MICROBIOL, V151, P209, DOI 10.1016/j.vetmic.2011.02.011; Fish D, 1996, ADV ASTRONAUT SCI, V91, P1057; Foxi C, 2010, MED VET ENTOMOL, V24, P199, DOI 10.1111/j.1365-2915.2010.00861.x; Goffredo M, 2015, VET ITAL, V51, P131, DOI 10.12834/VetIt.771.3854.1; Gonzalez de Heredia M.G., 2011, GENERO CULICOIDES PA; Gonzalez M, 2013, VET PARASITOL, V191, P81, DOI 10.1016/j.vetpar.2012.08.025; Guichard S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112491; Ippoliti C, 2013, GEOSPATIAL HEALTH, V8, P267, DOI 10.4081/gh.2013.72; KETTLE DS, 1952, B ENTOMOL RES, V43, P421, DOI 10.1017/S000748530002945X; KONURBAYEV E O, 1965, ENTOMOL REV (ENGL TRANSL ENTOMOL OBOZR), V44, P75; Lemon SM, 2008, VECTOR BORNE DISEASE; Maclachlan NJ, 2013, ANTIVIR RES, V99, P79, DOI 10.1016/j.antiviral.2013.04.021; Meiswinkel R., 2004, Infectious diseases of livestock, Volume One, P93; Meiswinkel R, 2014, VET PARASITOL, V207, P324; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Meneguzzi VC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164580; Miranda MA, 2003, MED VET ENTOMOL, V17, P52, DOI 10.1046/j.1365-2915.2003.00405.x; Nevill E.M, 1967, THESIS; Nevill H, 2007, ONDERSTEPOORT J VET, V74, P97; Ninio C, 2011, PARASITOL RES, V108, P657, DOI 10.1007/s00436-010-2110-9; Osburn B., 2008, VECTORBORNE DIS UNDE, P190; Pena I., 2003, THESIS; Purse BV, 2004, MED VET ENTOMOL, V18, P90, DOI 10.1111/j.0269-283X.2004.00492.x; Ramilo DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034896; Ribeiro R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124019; Romon P, 2012, VET PARASITOL, V186, P415, DOI 10.1016/j.vetpar.2011.11.023; Santiago-Alarcon D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031098; Savini G, 2005, VET REC, V157, P133, DOI 10.1136/vr.157.5.133; Schultz J., 2005, ECOZONES WORLD ECOLO, V2; Scolamacchia F, 2014, MED VET ENTOMOL, V28, P143, DOI 10.1111/mve.12028; Slama D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120528; Steinke S, 2015, VET PARASITOL, V209, P146, DOI 10.1016/j.vetpar.2015.01.027; Sutherst RW, 2004, CLIN MICROBIOL REV, V17, P136, DOI 10.1128/CMR.17.1.136-173.2004; Talavera S, 2015, PLOS ONE, V10, DOI [10.1371/journ, 10.1371/journal.pone.0141667]; Vanbinst T, 2009, TRANSBOUND EMERG DIS, V56, P170, DOI 10.1111/j.1865-1682.2009.01077.x; Verhoef FA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-384; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091; Zimmer JY, 2014, VET PARASITOL, V205, P676, DOI 10.1016/j.vetpar.2014.08.029; Zimmer JY, 2013, ANN SOC ENTOMOL FR, V49, P335, DOI 10.1080/00379271.2013.854100	54	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180606	10.1371/journal.pone.0180606	http://dx.doi.org/10.1371/journal.pone.0180606			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683145	Green Submitted, gold, Green Published			2022-12-26	WOS:000405335200053
J	Aziz, O; Klenk, J; Schwickert, L; Chiari, L; Becker, C; Park, EJ; Mori, G; Robinovitch, SN				Aziz, Omar; Klenk, Jochen; Schwickert, Lars; Chiari, Lorenzo; Becker, Clemens; Park, Edward J.; Mori, Greg; Robinovitch, Stephen N.			Validation of accuracy of SVM-based fall detection system using real-world fall and non-fall datasets	PLOS ONE			English	Article							EMERGENCY RESPONSE SYSTEMS; ALGORITHMS; INABILITY; PEOPLE	Falls are a major cause of injuries and deaths in older adults. Even when no injury occurs, about half of all older adults who fall are unable to get up without assistance. The extended period of lying on the floor often leads to medical complications, including muscle damage, dehydration, anxiety and fear of falling. Wearable sensor systems incorporating accelerometers and/or gyroscopes are designed to prevent long lies by automatically detecting and alerting care providers to the occurrence of a fall. Research groups have reported up to 100% accuracy in detecting falls in experimental settings. However, there is a lack of studies examining accuracy in the real-world setting. In this study, we examined the accuracy of a fall detection system based on real-world fall and non-fall data sets. Five young adults and 19 older adults went about their daily activities while wearing tri-axial accelerometers. Older adults experienced 10 unanticipated falls during the data collection. Approximately 400 hours of activities of daily living were recorded. We employed a machine learning algorithm, Support Vector Machine (SVM) classifier, to identify falls and non-fall events. We found that our system was able to detect 8 out of the 10 falls in older adults using signals from a single accelerometer (waist or sternum). Furthermore, our system did not report any false alarm during approximately 28.5 hours of recorded data from young adults. However, with older adults, the false positive rate among individuals ranged from 0 to 0.3 false alarms per hour. While our system showed higher fall detection and substantially lower false positive rate than the existing fall detection systems, there is a need for continuous efforts to collect realworld data within the target population to perform fall validation studies for fall detection systems on bigger real-world fall and non-fall datasets.	[Aziz, Omar; Robinovitch, Stephen N.] Simon Fraser Univ, Injury Prevent & Mobil Lab, Burnaby, BC, Canada; [Aziz, Omar; Robinovitch, Stephen N.] Simon Fraser Univ, Sch Engn Sci, Burnaby, BC, Canada; [Aziz, Omar; Park, Edward J.] Simon Fraser Univ, Sch Mechatron Syst Engn, Surrey, BC, Canada; [Klenk, Jochen; Schwickert, Lars; Becker, Clemens] Robert Bosch Krankenhaus, Dept Clin Gerontol, Stuttgart, Germany; [Klenk, Jochen] Ulm Univ, Inst Epidemiol & Med Biometry, Ulm, Germany; [Chiari, Lorenzo] Univ Bologna, Dept Elect Elect & Informat Engn Guglielmo Marcon, Bologna, Italy; [Mori, Greg] Simon Fraser Univ, Sch Comp Sci, Burnaby, BC, Canada; [Robinovitch, Stephen N.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada	Simon Fraser University; Simon Fraser University; Simon Fraser University; Bosch; Robert Bosch Krankenhaus; Ulm University; University of Bologna; Simon Fraser University; Simon Fraser University	Aziz, O (corresponding author), Simon Fraser Univ, Injury Prevent & Mobil Lab, Burnaby, BC, Canada.; Aziz, O (corresponding author), Simon Fraser Univ, Sch Engn Sci, Burnaby, BC, Canada.; Aziz, O (corresponding author), Simon Fraser Univ, Sch Mechatron Syst Engn, Surrey, BC, Canada.	oaziz@sfu.ca	Klenk, Jochen/C-2164-2012; Klenk, Jochen/R-3614-2019; Chiari, Lorenzo/N-7622-2015; Becker, Clemens/ABI-5405-2020; PAN, ZEQIANG/X-6341-2018	Klenk, Jochen/0000-0002-5987-447X; Chiari, Lorenzo/0000-0002-2318-4370; Robinovitch, Stephen/0000-0003-3881-6227	Mitacs; Canadian Institutes of Health Research [AMG-100487, TIR-103945]; Canada Research Chairs program	Mitacs; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs)	This work was supported by Mitacs and team grants from the Canadian Institutes of Health Research (funding reference numbers: AMG-100487 and TIR-103945). SNR was also supported by the Canada Research Chairs program. The funding agencies had no direct role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript.	Aziz O, 2017, MED BIOL ENG COMPUT, V55, P45, DOI 10.1007/s11517-016-1504-y; Bailly S, 2014, MATURITAS, V79, P334, DOI 10.1016/j.maturitas.2014.07.017; Bourke AK, 2010, J BIOMECH, V43, P3051, DOI 10.1016/j.jbiomech.2010.07.005; Bourke AK, 2008, IEEE ENG MED BIO, P2844, DOI 10.1109/IEMBS.2008.4649795; Boyle J, 2008, IEEE ENG MED BIO, P1274, DOI 10.1109/IEMBS.2008.4649396; Chen J, 2005, P ANN INT IEEE EMBS, P3551, DOI 10.1109/IEMBS.2005.1617246; Chih-Chung C, ACM T INTELL SYST TE, V2, P1; Conte V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034473, 10.1371/journal.pone.0037062]; Diaz A, 2004, P ANN INT IEEE EMBS, V26, P2180; Fleming J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2227; Heinbuchner B, 2010, Z GERONTOL GERIATR, V43, P219, DOI 10.1007/s00391-010-0127-4; Kangas M, 2007, P ANN INT IEEE EMBS, P1367, DOI 10.1109/IEMBS.2007.4352552; Kangas M, 2008, GAIT POSTURE, V28, P285, DOI 10.1016/j.gaitpost.2008.01.003; KING MB, 1995, J AM GERIATR SOC, V43, P1146, DOI 10.1111/j.1532-5415.1995.tb07017.x; Klenk J, 2011, MED ENG PHYS, V33, P368, DOI 10.1016/j.medengphy.2010.11.003; Lee Y, 2007, P ANN INT IEEE EMBS, P2315, DOI 10.1109/IEMBS.2007.4352789; LEVINE DA, 1995, MT SINAI J MED, V62, P293; Lipsitz LA, 2016, J AM GERIATR SOC, V64, P365, DOI 10.1111/jgs.13708; Liu SH, 2012, SENSORS-BASEL, V12, P12301, DOI 10.3390/s120912301; MALLINSON WJW, 1985, AGE AGEING, V14, P174, DOI 10.1093/ageing/14.3.174; Mann WC, 2005, ASSIST TECHNOL, V17, P82, DOI 10.1080/10400435.2005.10132098; Quagliarella L, 2008, GAIT POSTURE, V28, P699, DOI 10.1016/j.gaitpost.2008.04.011; Robinovitch SN, 2013, LANCET, V381, P47, DOI 10.1016/S0140-6736(12)61263-X; ROUSH RE, 1995, SOUTHERN MED J, V88, P917, DOI 10.1097/00007611-199509000-00006; Tan MP, 2015, GERIATRICS GERONTOLO; TINETTI ME, 1993, JAMA-J AM MED ASSOC, V269, P65, DOI 10.1001/jama.269.1.65	26	44	47	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180318	10.1371/journal.pone.0180318	http://dx.doi.org/10.1371/journal.pone.0180318			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678808	Green Published, Green Submitted, gold			2022-12-26	WOS:000405272200051
J	Kaniak-Golik, A; Kuberska, R; Dzierzbicki, P; Sledziewska-Gojska, E				Kaniak-Golik, Aneta; Kuberska, Renata; Dzierzbicki, Piotr; Sledziewska-Gojska, Ewa			Activation of Dun1 in response to nuclear DNA instability accounts for the increase in mitochondrial point mutations in Rad27/FEN1 deficient S. cerevisiae	PLOS ONE			English	Article							DAMAGE-INDUCIBLE GENE; BASE EXCISION-REPAIR; OKAZAKI FRAGMENT MATURATION; LARGE RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; MISMATCH REPAIR; RIBONUCLEOTIDE REDUCTASE; YEAST MITOCHONDRIA; IMAGE-ANALYSIS; RESISTANCE MUTATIONS	Rad27/FEN1 nuclease that plays important roles in the maintenance of DNA stability in the nucleus has recently been shown to reside in mitochondria. Accordingly, it has been established that Rad27 deficiency causes increased mutagenesis, but decreased microsatellite instability and homologous recombination in mitochondria. Our current analysis of mutations leading to erythromycin resistance indicates that only some of them arise in mitochondrial DNA and that the GC! AT transition is a hallmark of the mitochondrial mutagenesis in rad27 null background. We also show that the mitochondrial mutator phenotype resulting from Rad27 deficiency entirely depends on the DNA damage checkpoint kinase Dun1. DUN1 inactivation suppresses the mitochondrial mutator phenotype caused by Rad27 deficiency and this suppression is eliminated at least in part by subsequent deletion of SML1 encoding a repressor of ribonucleotide reductase. We conclude that Rad27 deficiency causes a mitochondrial mutator phenotype via activation of DNA damage checkpoint kinase Dun1 and that a Dun1-mediated increase of dNTP pools contributes to this phenomenon. These results point to the nuclear DNA instability as the source of mitochondrial mutagenesis. Consistently, we show that mitochondrial mutations occurring more frequently in yeast devoid of Rrm3, a DNA helicase involved in rDNA replication, are also dependent on Dun1. In addition, we have established that overproduction of Exo1, which suppresses DNA damage sensitivity and replication stress in nuclei of Rad27 deficient cells, but does not enter mitochondria, suppresses the mitochondrial mutagenesis. Exo1 overproduction restores also a great part of allelic recombination and microsatellite instability in mitochondria of Rad27 deficient cells. In contrast, the overproduction of Exo1 does not influence mitochondrial direct-repeat mediated deletions in rad27 null background, pointing to this homologous recombination pathway as the direct target of Rad27 activity in mitochondria.	[Kaniak-Golik, Aneta; Kuberska, Renata; Dzierzbicki, Piotr; Sledziewska-Gojska, Ewa] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Kaniak-Golik, A; Sledziewska-Gojska, E (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	aneta.kaniak@gmail.com; esg@ibb.waw.pl	Kaniak-Golik, Aneta/CAF-8607-2022; Sledziewska-Gojska, Ewa/C-7831-2013	Sledziewska-Gojska, Ewa/0000-0001-8409-0864; Kaniak-Golik, Aneta/0000-0003-4027-6282	National Science Center in Poland [2012/07/B/NZ3/02914]	National Science Center in Poland(National Science Centre, Poland)	This work was supported by the grant 2012/07/B/NZ3/02914 from the National Science Center (https//www.ncn.gov.pl/) in Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; Akbari M, 2008, DNA REPAIR, V7, P605, DOI 10.1016/j.dnarep.2008.01.002; Amberg DC., 2005, METHODS YEAST GENETI; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; BAKER KP, 1991, NATURE, V349, P205, DOI 10.1038/349205a0; Baruffini E, 2010, METHODS, V51, P426, DOI 10.1016/j.ymeth.2010.02.023; Becker JR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005659; Blanco MG, 2010, DNA REPAIR, V9, P394, DOI 10.1016/j.dnarep.2009.12.017; Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6; Boldogh IR, 2007, METHOD CELL BIOL, V80, P45, DOI 10.1016/S0091-679X(06)80002-6; Bonawitz ND, 2006, MOL CELL BIOL, V26, P4818, DOI 10.1128/MCB.02360-05; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; CONDE J, 1976, P NATL ACAD SCI USA, V73, P3651, DOI 10.1073/pnas.73.10.3651; DAUM G, 1982, J BIOL CHEM, V257, P3028; Dinur-Mills M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002161; Dmowski M, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006572; Dzierzbicki P, 2012, MUTAT RES-FUND MOL M, V740, P21, DOI 10.1016/j.mrfmmm.2012.12.004; Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367; Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001; Fikus MU, 2000, GENETICS, V154, P73; Fiorentini P, 1997, MOL CELL BIOL, V17, P2764, DOI 10.1128/MCB.17.5.2764; FOURY F, 1992, EMBO J, V11, P2717, DOI 10.1002/j.1460-2075.1992.tb05337.x; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; GASSER SM, 1982, J BIOL CHEM, V257, P3034; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Halas A, 2016, MUTAT RES-FUND MOL M, V791, P10, DOI 10.1016/j.mrfmmm.2016.08.001; Hendry JA, 2015, G3-GENES GENOM GENET, V5, P997, DOI 10.1534/g3.115.016576; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; Johnson RE, 1998, CURR GENET, V34, P21, DOI 10.1007/s002940050362; JOHNSON RE, 1995, SCIENCE, V269, P238, DOI 10.1126/science.7618086; Johnston M, 2002, METHOD ENZYMOL, V350, P290, DOI 10.1016/S0076-6879(02)50970-8; Kalifa L, 2007, DNA REPAIR, V6, P1732, DOI 10.1016/j.dnarep.2007.06.005; Kalifa L, 2009, DNA REPAIR, V8, P1242, DOI 10.1016/j.dnarep.2009.07.008; Kaniak A, 2009, DNA REPAIR, V8, P318, DOI 10.1016/j.dnarep.2008.11.004; Karanja KK, 2009, GENETICS, V183, P63, DOI 10.1534/genetics.109.103937; Karniely S, 2006, EXP CELL RES, V312, P3835, DOI 10.1016/j.yexcr.2006.08.021; Kokoska RJ, 1998, MOL CELL BIOL, V18, P2779, DOI 10.1128/MCB.18.5.2779; Koprowski P, 2003, MOL GENET GENOMICS, V269, P632, DOI 10.1007/s00438-003-0873-8; Koprowski P, 2002, MOL GENET GENOMICS, V266, P988, DOI 10.1007/s00438-001-0621-x; Kreutzer DA, 1998, P NATL ACAD SCI USA, P95; Krol K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120702; LANCASHIRE WE, 1979, MOL GEN GENET, V170, P333, DOI 10.1007/BF00267067; Lewis LK, 2002, GENETICS, V160, P49; Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; McIntyre J, 2007, CURR GENET, V52, P221, DOI 10.1007/s00294-007-0156-8; Mieczkowski PA, 1997, MOL GEN GENET, V253, P655, DOI 10.1007/s004380050369; Mookerjee SA, 2005, CURR GENET, V47, P84, DOI 10.1007/s00294-004-0537-1; Moreau S, 2001, GENETICS, V159, P1423; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; O'Rourke TW, 2005, GENE, V354, P86, DOI 10.1016/j.gene.2005.03.031; OGUR M, 1957, SCIENCE, V125, P928, DOI 10.1126/science.125.3254.928; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petrova VY, 2004, BIOCHEM J, V380, P393, DOI 10.1042/BJ20040042; Phadnis N, 2005, GENETICS, V171, P1549, DOI 10.1534/genetics.105.047092; Ragu S, 2007, P NATL ACAD SCI USA, V104, P9747, DOI 10.1073/pnas.0703192104; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; Regev-Rudzki N, 2005, MOL BIOL CELL, V16, P4163, DOI 10.1091/mbc.e04-11-1028; Richard GF, 1999, MOL GEN GENETICS MGG, V261, P725; Sakamoto AN, 2007, DNA REPAIR, V6, P1829, DOI 10.1016/j.dnarep.2007.07.002; Scheibye-Knudsen M, 2015, TRENDS CELL BIOL, V25, P158, DOI 10.1016/j.tcb.2014.11.002; SCHIESTL RH, 1989, NATURE, V337, P285, DOI 10.1038/337285a0; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schweitzer JK, 1998, HUM MOL GENET, V7, P69, DOI 10.1093/hmg/7.1.69; Sia EA, 2000, P NATL ACAD SCI USA, V97, P250, DOI 10.1073/pnas.97.1.250; Singh P, 2007, J BIOL CHEM, V282, P3465, DOI 10.1074/jbc.M606582200; SLEDZIEWSKA E, 1980, MUTAT RES, V70, P11, DOI 10.1016/0027-5107(80)90053-6; SOMMERS CH, 1995, J BIOL CHEM, V270, P4193, DOI 10.1074/jbc.270.9.4193; SOR F, 1984, NUCLEIC ACIDS RES, V12, P8313, DOI 10.1093/nar/12.22.8313; SOR F, 1982, NUCLEIC ACIDS RES, V10, P6571, DOI 10.1093/nar/10.21.6571; Steele DF, 1996, P NATL ACAD SCI USA, V93, P5253, DOI 10.1073/pnas.93.11.5253; Stein A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005664; Strand Micheline K, 2002, Methods Mol Biol, V197, P151, DOI 10.1385/1-59259-284-8:151; Strand MK, 2003, EUKARYOT CELL, V2, P809, DOI 10.1128/EC.2.4.809-820.2003; Stuart JA, 2006, BBA-BIOENERGETICS, V1757, P79, DOI 10.1016/j.bbabio.2006.01.003; Styles C, 2002, METHOD ENZYMOL, V350, P42, DOI 10.1016/S0076-6879(02)50955-1; Sugawara N, 2000, MOL CELL BIOL, V20, P5300, DOI 10.1128/MCB.20.14.5300-5309.2000; Sun X.-y., 2003, CHINA TEXTILE LEADER, V2, P40; Symington LS, 1998, NUCLEIC ACIDS RES, V26, P5589, DOI 10.1093/nar/26.24.5589; Szczepanowska K, 2015, BBA-BIOENERGETICS, V1847, P1362, DOI 10.1016/j.bbabio.2015.05.016; Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200; Tang HMV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000697; Tann AW, 2011, J BIOL CHEM, V286, P31975, DOI 10.1074/jbc.M110.215715; Taylor SD, 2005, MOL BIOL CELL, V16, P3010, DOI 10.1091/mbc.E05-01-0053; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Tran PT, 2007, DNA REPAIR, V6, P1572, DOI 10.1016/j.dnarep.2007.05.004; Tran PT, 2002, DNA REPAIR, V1, P895, DOI 10.1016/S1568-7864(02)00114-3; Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wang D, 1998, MUTAT RES-FUND MOL M, V400, P99, DOI 10.1016/S0027-5107(98)00066-9; Williams EH, 2007, GENETICS, V175, P1117, DOI 10.1534/genetics.106.064576; Wu XH, 1999, NUCLEIC ACIDS RES, V27, P956, DOI 10.1093/nar/27.4.956; Xie YL, 2001, MOL CELL BIOL, V21, P4889, DOI 10.1128/MCB.21.15.4889-4899.2001; Yonekura SI, 2009, J RADIAT RES, V50, P19, DOI 10.1269/jrr.08080; Zhao XL, 2001, EMBO J, V20, P3544, DOI 10.1093/emboj/20.13.3544; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhao XL, 2002, P NATL ACAD SCI USA, V99, P3746, DOI 10.1073/pnas.062502299	105	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180153	10.1371/journal.pone.0180153	http://dx.doi.org/10.1371/journal.pone.0180153			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678842	Green Published, gold, Green Submitted			2022-12-26	WOS:000405272200039
J	Dornhof, R; Maschowski, C; Osipova, A; Giere, R; Seidl, M; Merfort, I; Humar, M				Dornhof, Regina; Maschowski, Christoph; Osipova, Anastasiya; Giere, Reto; Seidl, Maximilian; Merfort, Irmgard; Humar, Matjaz			Stress fibers, autophagy and necrosis by persistent exposure to PM2.5 from biomass combustion	PLOS ONE			English	Article							HOUSEHOLD AIR-POLLUTION; LUNG EPITHELIAL-CELLS; ELONGATION FACTOR-II; HEAT-SHOCK PROTEINS; P38 MAP KINASE; PARTICULATE MATTER; ACTIN DYNAMICS; WOOD SMOKE; MECHANISMS; PHOSPHORYLATION	Fine particulate matter (PM2.5) can adversely affect human health. Emissions from residential energy sources have the largest impact on premature mortality globally, but their pathological and molecular implications on cellular physiology are still elusive. In the present study potential molecular consequences were investigated during long-term exposure of human bronchial epithelial BEAS-2B cells to PM2.5, collected from a biomass power plant. Initially, we observed that PM2.5 did not affect cellular survival or proliferation. However, it triggered an activation of the stress response p38 MAPK which, along with RhoA GTPase and HSP27, mediated morphological changes in BEAS-2B cells, including actin cytoskeletal rearrangements and paracellular gap formation. The p38 inhibitor SB203580 prevented phosphorylation of HSP27 and ameliorated morphological changes. During an intermediate phase of long-term exposure, PM2.5 triggered proliferative regression and activation of an adaptive stress response necessary to maintain energy homeostasis, including AMPK, repression of translational elongation, and autophagy. Finally, accumulation of intracellular PM2.5 promoted lysosomal destabilization and cell death, which was dependent on lysosomal hydrolases and p38 MAPK, but not on the inflammasome and pyroptosis. TEM images revealed formation of protrusions and cellular internalization of PM2.5, induction of autophagosomes, amphisomes, autophagosome-lysosomal fusion, multiple compartmental fusion, lysosomal burst, swollen mitochondria and finally necrosis. In consequence, persistent exposure to PM2.5 may impair epithelial barriers and reduce regenerative capacity. Hence, our results contribute to a better understanding of PM-associated lung and systemic diseases on the basis of molecular events.	[Dornhof, Regina; Osipova, Anastasiya; Merfort, Irmgard; Humar, Matjaz] Albert Ludwigs Univ Freiburg, Inst Pharmaceut Sci Pharmaceut Biol & Biotechnol, Freiburg, Germany; [Maschowski, Christoph] Albert Ludwigs Univ Freiburg, Inst Earth & Environm Sci, Freiburg, Germany; [Giere, Reto] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; [Giere, Reto] Univ Penn, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA; [Seidl, Maximilian] Albert Ludwigs Univ Freiburg, Inst Surg Pathol, Fac Med, Freiburg, Germany; [Seidl, Maximilian] Albert Ludwigs Univ Freiburg, Fac Med, Ctr Chron Immunodeficiency CCI, Freiburg, Germany; [Merfort, Irmgard] Albert Ludwigs Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Pennsylvania; University of Pennsylvania; University of Freiburg; University of Freiburg; University of Freiburg	Merfort, I; Humar, M (corresponding author), Albert Ludwigs Univ Freiburg, Inst Pharmaceut Sci Pharmaceut Biol & Biotechnol, Freiburg, Germany.; Merfort, I (corresponding author), Albert Ludwigs Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, Freiburg, Germany.	irmgard.merfort@pharmazie.uni-freiburg.de; matjaz.humar@pharmazie.uni-freiburg.de	Seidl, Maxmilian/ABF-3322-2021	Seidl, Maxmilian/0000-0002-5559-4980; Giere, Reto/0000-0001-8507-1956; Maschowski, Christoph/0000-0003-4211-3700	EU; Interreg IV Program ''Oberrhein'' [C35 BIOCOMBUST]; National Institute of Environmental Health Sciences [P30-ES13508]; German Research Foundation (DFG); University of Freiburg; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	EU(European Commission); Interreg IV Program ''Oberrhein''; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The presented work is part of aninter disciplinary EU-funded research project (seehttp : //www.biocombust.eu), supported in part by the Interreg IV Program ''Oberrhein'' (project C35 BIOCOMBUST).This work was also supported in part by the National Institute of Environmental Health Sciences (P30-ES13508). Thearticle processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing.	Acunzo J, 2012, INT J BIOCHEM CELL B, V44, P1622, DOI 10.1016/j.biocel.2012.04.002; [Anonymous], 2016, HOUS AIR POLL HLTH I; Boutilier RG, 2000, COMP BIOCHEM PHYS A, V126, P481, DOI 10.1016/S1095-6433(00)00234-8; Cao DS, 2010, AM J RESP CELL MOL, V42, P88, DOI 10.1165/rcmb.2008-0455OC; CARLBERG U, 1990, EUR J BIOCHEM, V191, P639, DOI 10.1111/j.1432-1033.1990.tb19169.x; Carroll B, 2017, BIOCHEM J, V474, P1453, DOI 10.1042/BCJ20160780; D'Anna C, 2015, LIFE SCI, V126, P10, DOI 10.1016/j.lfs.2015.01.017; Deng XB, 2014, APOPTOSIS, V19, P1099, DOI 10.1007/s10495-014-0980-5; Desai S, 2013, CELL SIGNAL, V25, P1780, DOI 10.1016/j.cellsig.2013.05.025; Dilger M, 2016, ARCH TOXICOL, V90, P3029, DOI 10.1007/s00204-016-1659-1; Duan JC, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0050-8; Duch A, 2012, FEBS LETT, V586, P2925, DOI 10.1016/j.febslet.2012.07.034; Ebeling S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086147; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138; Guay J, 1997, J CELL SCI, V110, P357; Guicciardi ME, 2013, CELL CYCLE, V12, P1995, DOI 10.4161/cc.25317; Hand SC, 1996, ANNU REV PHYSIOL, V58, P539, DOI 10.1146/annurev.ph.58.030196.002543; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Herd HL, 2011, J CONTROL RELEASE, V153, P40, DOI 10.1016/j.jconrel.2011.02.017; Horman S, 2002, CURR BIOL, V12, P1419, DOI 10.1016/S0960-9822(02)01077-1; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kim HP, 2008, AUTOPHAGY, V4, P887, DOI 10.4161/auto.6767; Kim KH, 2011, J HAZARD MATER, V192, P425, DOI 10.1016/j.jhazmat.2011.05.087; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Landry J, 1995, BIOCHEM CELL BIOL, V73, P703, DOI 10.1139/o95-078; Lehane C, 2013, J PHARMACOL EXP THER, V347, P781, DOI 10.1124/jpet.113.205989; Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Liu B, 2009, CANCER LETT, V275, P54, DOI 10.1016/j.canlet.2008.09.042; Mizumura K, 2012, CHEST, V142, P1289, DOI 10.1378/chest.12-0809; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mounier N, 2002, CELL STRESS CHAPERON, V7, P167, DOI 10.1379/1466-1268(2002)007<0167:ACASHS>2.0.CO;2; Muala A, 2015, PART FIBRE TOXICOL, V12, DOI 10.1186/s12989-015-0111-7; Ovrevik J, 2015, BIOMOLECULES, V5, P1399, DOI 10.3390/biom5031399; Petecchia L, 2009, CHEST, V135, P1502, DOI 10.1378/chest.08-1780; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Schweitzer KS, 2011, AM J PHYSIOL-LUNG C, V301, pL836, DOI 10.1152/ajplung.00385.2010; Schwer CI, 2013, INT J BIOCHEM CELL B, V45, P201, DOI 10.1016/j.biocel.2012.09.020; Smith KR, 2014, ANNU REV PUBL HEALTH, V35, P185, DOI 10.1146/annurev-publhealth-032013-182356; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Stern ST, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-20; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Tao ZM, 2009, CHEM RES TOXICOL, V22, P1869, DOI 10.1021/tx900276u; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Valavanidis A, 2008, J ENVIRON SCI HEAL C, V26, P339, DOI 10.1080/10590500802494538; Veljkovic E, 2011, TOXICOL IN VITRO, V25, P446, DOI 10.1016/j.tiv.2010.11.011; Wang SP, 2008, STROKE, V39, P2587, DOI 10.1161/STROKEAHA.107.509158; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; Wolfson RK, 2011, MICROVASC RES, V81, P189, DOI 10.1016/j.mvr.2010.11.010; Yao XF, 2014, FOOD CHEM TOXICOL, V67, P96, DOI 10.1016/j.fct.2014.02.017	55	22	24	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180291	10.1371/journal.pone.0180291	http://dx.doi.org/10.1371/journal.pone.0180291			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671960	Green Published, Green Submitted, gold			2022-12-26	WOS:000405268500039
J	Lahey, KA; Ronaghan, NJ; Shang, J; Dion, SP; Desilets, A; Leduc, R; MacNaughton, WK				Lahey, Kelcie A.; Ronaghan, Natalie J.; Shang, Judie; Dion, Sebastien P.; Desilets, Antoine; Leduc, Richard; MacNaughton, Wallace K.			Signaling pathways induced by serine proteases to increase intestinal epithelial barrier function	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; KINASE C-ZETA; TIGHT JUNCTIONS; FACTOR-ALPHA; CELLS; PHOSPHORYLATION; ACTIVATION; OCCLUDIN; PROTEIN; MATRIPTASE	Changes in barrier function of the gastrointestinal tract are thought to contribute to the inflammatory bowel diseases Crohn's disease and ulcerative colitis. Previous work in our lab demonstrated that apical exposure of intestinal epithelial cell lines to serine proteases results in an increase in transepithelial electrical resistance (TER). However, the underlying mechanisms governing this response are unclear. We aimed to determine the requirement for proteolytic activity, epidermal growth factor receptor (EGFR) activation, and downstream intracellular signaling in initiating and maintaining enhanced barrier function following protease treatment using a canine intestinal epithelial cell line (SCBN). We also examined the role of phosphorylation of myosin regulatory light chain on the serine protease-induced increase in TER through. It was found that proteolytic activity of the serine proteases trypsin and matriptase is required to initiate and maintain the protease-mediated increase in TER. We also show that MMP-independent EGFR activation is essential to the sustained phase of the protease response, and that Src kinases may mediate EGFR transactivation. PI3-K and ERK1/2 signaling were important in reaching a maximal increase in TER following protease stimulation; however, their upstream activators are yet to be determined. CK2 inhibition prevented the increase in TER induced by serine proteases. The bradykinin B(2) receptor was not involved in the change in TER in response to serine proteases, and no change in phosphorylation of MLC was observed after trypsin or matriptase treatment. Taken together, our data show a requirement for ongoing proteolytic activity, EGFR transactivation, as well as downstream PI3-K, ERK1/2, and CK2 signaling in protease-mediated barrier enhancement of intestinal epithelial cells. The pathways mediating enhanced barrier function by proteases may be novel therapeutic targets for intestinal disorders characterized by disrupted epithelial barrier function.	[Lahey, Kelcie A.; Ronaghan, Natalie J.; Shang, Judie; MacNaughton, Wallace K.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Dion, Sebastien P.; Desilets, Antoine; Leduc, Richard] Univ Sherbrooke, Dept Pharmacol, Sherbrooke, PQ, Canada	University of Calgary; University of Sherbrooke	MacNaughton, WK (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada.	wmacnaug@ucalgary.ca		Leduc, Richard/0000-0001-6854-8003; MacNaughton, Wallace/0000-0002-7050-666X; Desilets, Antoine/0000-0001-5081-5564	Canadian Institutes for Health Research; Natural Sciences and Engineering Research Council (Canada); Natural Sciences	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences	This work was supported by a grant to WKM from the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca). NJR was the recipient of a studentship from the Natural Sciences and Engineering Research Council (Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Basuroy S, 2003, J BIOL CHEM, V278, P11916, DOI 10.1074/jbc.M211710200; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Buzza MS, 2013, J BIOL CHEM, V288, P10328, DOI 10.1074/jbc.M112.443432; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; Chen M, 2008, BBA-MOL CELL RES, V1783, P896, DOI 10.1016/j.bbamcr.2007.10.019; Desilets A, 2006, FEBS LETT, V580, P2227, DOI 10.1016/j.febslet.2006.03.030; Dey M, 2010, J PHARMACOL EXP THER, V334, P775, DOI 10.1124/jpet.110.168054; Dorfel MJ, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-40; Dorfel MJ, 2012, ANN NY ACAD SCI, V1257, P38, DOI 10.1111/j.1749-6632.2012.06536.x; Dorfel MJ, 2009, ANN NY ACAD SCI, V1165, P69, DOI 10.1111/j.1749-6632.2009.04043.x; Dorfel MJ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/807356; Fletcher SJ, 2014, BIOCHEM SOC T, V42, P195, DOI 10.1042/BST20130162; FRY DW, 1994, SCIENCE, V265, P1093, DOI 10.1126/science.8066447; Ganz ML, 2016, INFLAMM BOWEL DIS, V22, P1032, DOI 10.1097/MIB.0000000000000742; Garcia-Hernandez V, 2014, J CELL PHYSL; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018; Hecquet C, 2000, MOL PHARMACOL, V58, P828, DOI 10.1124/mol.58.4.828; Jain S, 2011, BIOCHEM J, V437, P289, DOI 10.1042/BJ20110587; Kaplan GG, 2017, GASTROENTEROLOGY, V152, P313, DOI 10.1053/j.gastro.2016.10.020; Kaplan GG, 2015, NAT REV GASTRO HEPAT, V12, P720, DOI 10.1038/nrgastro.2015.150; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Larre I, 2010, P NATL ACAD SCI USA, V107, P11387, DOI 10.1073/pnas.1000500107; LEE DC, 1985, NATURE, V313, P489, DOI 10.1038/313489a0; Li N, 2009, J NUTR, V139, P710, DOI 10.3945/jn.108.101485; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Liu PCC, 2006, CANCER BIOL THER, V5, P657, DOI 10.4161/cbt.5.6.2708; Mankertz J, 2009, CELL TISSUE RES, V336, P67, DOI 10.1007/s00441-009-0751-8; Marcon R, 2013, BRIT J PHARMACOL, V168, P389, DOI 10.1111/j.1476-5381.2012.02136.x; Myhre GM, 2004, AM J PHYSIOL-GASTR L, P1213; Netzel-Arnett S, 2012, INFLAMM BOWEL DIS, V18, P1303, DOI 10.1002/ibd.21930; Nusrat A, 2000, J CELL SCI, V113, P1771; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; Raleigh DR, 2011, J CELL BIOL, V193, P565, DOI 10.1083/jcb.201010065; Ronaghan NJ, 2016, AM J PHYSIOL-GASTR L, V311, pG466, DOI 10.1152/ajpgi.00441.2015; Samak G, 2011, AM J PHYSIOL-GASTR L, V301, pG50, DOI 10.1152/ajpgi.00494.2010; Samak G, 2015, BIOCHEM J, V465, P503, DOI 10.1042/BJ20140450; Shen L, 2006, J CELL SCI, V119, P2095, DOI 10.1242/jcs.02915; Singh AB, 2004, J BIOL CHEM, V279, P3543, DOI 10.1074/jbc.M308682200; Smales C, 2003, FEBS LETT, V545, P161, DOI 10.1016/S0014-5793(03)00525-8; Smyth D, 2012, CELL MICROBIOL; Sutherland C, 2012, J BIOL CHEM, V287, P24064, DOI 10.1074/jbc.M112.371609; Swystun V, 2005, AM J PHYSIOL-LUNG C, V288, pL820, DOI 10.1152/ajplung.00396.2004; Swystun VA, 2009, AM J PHYSIOL-GASTR L, V297, pG60, DOI 10.1152/ajpgi.00096.2009; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Wang LH, 2014, J BIOL CHEM, V289, P20234, DOI 10.1074/jbc.M114.553800; Yan F, 2013, J BIOL CHEM, V288, P30742, DOI 10.1074/jbc.M113.492397; Yu D, 2010, P NATL ACAD SCI USA, V107, P8237, DOI 10.1073/pnas.0908869107; Zha JM, 2016, GENE, V588, P1, DOI 10.1016/j.gene.2016.04.048	51	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180259	10.1371/journal.pone.0180259	http://dx.doi.org/10.1371/journal.pone.0180259			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671992	Green Published, gold, Green Submitted			2022-12-26	WOS:000405268500035
J	Rovetto, F; Carlier, A; Van den Abeele, AM; Illeghems, K; Van Nieuwerburgh, F; Cocolin, L; Houf, K				Rovetto, Francesca; Carlier, Aurelien; Van den Abeele, Anne-Marie; Illeghems, Koen; Van Nieuwerburgh, Filip; Cocolin, Luca; Houf, Kurt			Characterization of the emerging zoonotic pathogen Arcobacter thereius by whole genome sequencing and comparative genomics	PLOS ONE			English	Article							CAMPYLOBACTER-JEJUNI; SP NOV.; HEPTOSYLTRANSFERASE-I; GENE; IDENTIFICATION; PROTEIN; OPERON; TOOL; POLYSACCHARIDE; MECHANISMS	Four Arcobacter species have been associated with human disease, and based on current knowledge, these Gram negative bacteria are considered as potential food and waterborne zoonotic pathogens. At present, only the genome of the species Arcobacter butzleri has been analysed, and still little is known about their physiology and genetics. The species Arcobacter thereius has first been isolated from tissue of aborted piglets, duck and pig faeces, and recently from stool of human patients with enteritis. In the present study, the complete genome and analysis of the A. thereius type strain LMG24486(T), as well as the comparative genome analysis with 8 other A. thereius strains are presented. Genome analysis revealed metabolic pathways for the utilization of amino acids, which represent the main source of energy, together with the presence of genes encoding for respiration-associated and chemotaxis proteins. Comparative genome analysis with the A. butzleri type strain RM4018 revealed a large correlation, though also unique features. Furthermore, in silico DDH and ANI based analysis of the nine A. thereius strains disclosed clustering into two closely related genotypes. No discriminatory differences in genome content nor phenotypic behaviour were detected, though recently the species Arcobacter porcinus was proposed to encompass part of the formerly identified Arcobacter thereius strains. The report of the presence of virulence associated genes in A. thereius, the presence of antibiotic resistance genes, verified by in vitro susceptibility testing, as well as other pathogenic related relevant features, support the classification of A. thereius as an emerging pathogen.	[Rovetto, Francesca; Illeghems, Koen; Houf, Kurt] Univ Ghent, Fac Vet Med, Dept Vet Publ Hlth & Food Safety, Salisburylaan 133, Merelbeke, Belgium; [Rovetto, Francesca; Cocolin, Luca] Univ Torino, Dept Forestry Agr & Food Sci, Largo Braccini 2, Grugliasco, Italy; [Carlier, Aurelien] Univ Ghent, Fac Sci, Microbiol Lab, KL Ledeganckstr 35, Ghent, Belgium; [Van den Abeele, Anne-Marie] St Lucas Hosp, Microbiol Lab, Groenebriel 1, Ghent, Belgium; [Van Nieuwerburgh, Filip] Univ Ghent, Fac Pharmaceut Sci, Lab Pharmaceut Biotechnol, Harelbekestr 72, Ghent, Belgium	Ghent University; University of Turin; Ghent University; Ghent University; Ghent University	Houf, K (corresponding author), Univ Ghent, Fac Vet Med, Dept Vet Publ Hlth & Food Safety, Salisburylaan 133, Merelbeke, Belgium.	Kurt.houf@UGent.be	Houf, Kurt/AAC-4027-2019; Cocolin, Luca/H-5091-2012; Carlier, Aurelien/M-9671-2016; Van Nieuwerburgh, Filip/H-9697-2015	Houf, Kurt/0000-0002-0909-7756; Cocolin, Luca/0000-0003-4799-7074; Carlier, Aurelien/0000-0001-7565-1586; Van Nieuwerburgh, Filip/0000-0001-8815-5485	joint PhD grant of Ghent University; Ghent University research Council [BOF2013-01SF1613]	joint PhD grant of Ghent University; Ghent University research Council(Ghent University)	FR is funded by a joint PhD grant of Ghent University, in collaboration with the University of Torino. Grant is provided by the Ghent University research Council with reference: BOF2013-01SF1613. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelbaqi K, 2007, FEMS IMMUNOL MED MIC, V49, P337, DOI 10.1111/j.1574-695X.2006.00208.x; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berg JM, 2002, CITRIC ACID CYCLE IS; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Boetzer M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-211; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bruen T., 2005, PHIPACK PHI TEST OTH; Bunkova L, 2010, FOOD CHEM, V121, P203, DOI 10.1016/j.foodchem.2009.12.012; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Carattoli A, 2002, FEMS MICROBIOL LETT, V214, P87, DOI 10.1111/j.1574-6968.2002.tb11329.x; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Carnoy C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006531; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Centres for Disease Control and Prevention (CDCP), 2012, NAT ANT RES MON SYST, V104, P75, DOI [10.1093/infdis/jis901, DOI 10.1093/INFDIS/JIS901]; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Collado L, 2011, CLIN MICROBIOL REV, V24, P174, DOI 10.1128/CMR.00034-10; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; De Smet S, 2011, APPL ENVIRON MICROB, V77, P1732, DOI 10.1128/AEM.02409-10; Dhillon BK, 2013, NUCLEIC ACIDS RES, V41, pW129, DOI 10.1093/nar/gkt394; DIORIO C, 1995, J BACTERIOL, V177, P2050, DOI 10.1128/jb.177.8.2050-2056.1995; Douidah L, 2014, FOODBORNE PATHOG DIS, V11, P272, DOI 10.1089/fpd.2013.1661; Douidah L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085487; Douidah L, 2012, J CLIN MICROBIOL, V50, P735, DOI 10.1128/JCM.05872-11; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; EUCAST The European Committee on Antimicrobial Susceptibility Testing, 2021, BREAKP TABL INT MICS; Figueras M. J., 2017, New Microbes and New Infections, V15, P104, DOI 10.1016/j.nmni.2016.11.014; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Grissa I, 2008, NUCLEIC ACIDS RES, V36, pW145, DOI 10.1093/nar/gkn228; Groicher KH, 2000, J BACTERIOL, V182, P1794, DOI 10.1128/JB.182.7.1794-1801.2000; Guccione E, 2008, MOL MICROBIOL, V69, P77, DOI 10.1111/j.1365-2958.2008.06263.x; Guo BQ, 2008, J BACTERIOL, V190, P1879, DOI 10.1128/JB.01796-07; Gupta SK, 2014, ANTIMICROB AGENTS CH, V58, P212, DOI 10.1128/AAC.01310-13; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Ho HTK, 2006, VET MICROBIOL, V115, P1, DOI 10.1016/j.vetmic.2006.03.004; Houf K, 2009, INT J SYST EVOL MICR, V59, P2599, DOI 10.1099/ijs.0.006650-0; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Iovine NM, 2013, VIRULENCE, V4, P230, DOI 10.4161/viru.23753; JI GY, 1992, P NATL ACAD SCI USA, V89, P9474, DOI 10.1073/pnas.89.20.9474; Kaakoush NO, 2010, FEBS J, V277, P1606, DOI 10.1111/j.1742-4658.2010.07587.x; Kanipes MI, 2006, J BACTERIOL, V188, P3273, DOI 10.1128/JB.188.9.3273-3279.2006; Karlyshev AV, 2000, MOL MICROBIOL, V35, P529, DOI 10.1046/j.1365-2958.2000.01717.x; Kehrenberg C, 2005, ANTIMICROB AGENTS CH, V49, P3046, DOI 10.1128/AAC.49.7.3046-3049.2005; Kelly DJ, 2001, J APPL MICROBIOL, V90, p16S, DOI 10.1046/j.1365-2672.2001.01350.x; Klena JD, 1998, GENE, V222, P177, DOI 10.1016/S0378-1119(98)00501-0; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Levican A, 2015, SYST APPL MICROBIOL, V38, P30, DOI 10.1016/j.syapm.2014.10.011; Levican A, 2013, APPL ENVIRON MICROB, V79, P4951, DOI 10.1128/AEM.01073-13; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Liu F, 2006, J BIOL CHEM, V281, P20902, DOI 10.1074/jbc.M602972200; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; Meier-Kolthoff Jan P, 2013, BMC BIOINFORMATICS, V14; Miller WG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001358; Miller WG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-196; Miller WG, 2011, GENOMES OF FOODBORNE AND WATERBORNE PATHOGENS, P49; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oldfield NJ, 2002, J BACTERIOL, V184, P2100, DOI 10.1128/JB.184.8.2100-2107.2002; On SLW, 2003, J APPL MICROBIOL, V95, P1096, DOI 10.1046/j.1365-2672.2003.02100.x; On SLW, 2002, VET MICROBIOL, V85, P159, DOI 10.1016/S0378-1135(01)00503-X; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pingoud A, 2005, CELL MOL LIFE SCI, V62, P685, DOI 10.1007/s00018-004-4513-1; Ren GWN, 2011, FOODBORNE PATHOG DIS, V8, P375, DOI 10.1089/fpd.2010.0676; Richter M, 2015, BIOINFORMATICS, V32; Roberts MC, 1996, FEMS MICROBIOL REV, V19, P1, DOI 10.1111/j.1574-6976.1996.tb00251.x; SCHWAN ET, 1995, MOL MICROBIOL, V15, P267, DOI 10.1111/j.1365-2958.1995.tb02241.x; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; SIRISENA DM, 1992, J BIOL CHEM, V267, P18874; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stolz JF, 1999, FEMS MICROBIOL REV, V23, P615, DOI 10.1016/S0168-6445(99)00024-8; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Van den Abeele AM, 2016, J ANTIMICROB CHEMOTH, V71, P1241, DOI 10.1093/jac/dkv483; Van den Abeele AM, 2014, EMERG INFECT DIS, V20, P1731, DOI 10.3201/eid2010.140433; van Heel AJ, 2013, NUCLEIC ACIDS RES, V41, pW448, DOI 10.1093/nar/gkt391; VANDAMME P, 1991, INT J SYST BACTERIOL, V41, P88, DOI 10.1099/00207713-41-1-88; Vandamme P., 1987, J CLIN MICROBIOL, V25, P2398; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Whiteduck-Leveillee K, 2016, SYST APPL MICROBIOL, V39, P93, DOI 10.1016/j.syapm.2015.12.002; Whiteduck-Leveillee K, 2015, INT J SYST EVOL MICR, V65, P2709, DOI 10.1099/ijs.0.000318; Wybo I, 2004, J CLIN MICROBIOL, V42, P1851, DOI 10.1128/JCM.42.4.1851-1852.2004; Yang J, 2008, NUCLEIC ACIDS RES, V36, pD539, DOI 10.1093/nar/gkm951; Zhang J, 2016, INT J SYST EVOL MICR, V66, P56, DOI [10.1099/ijsem.0.000669, 10.1099/ijsem.0.000751]; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	92	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180493	10.1371/journal.pone.0180493	http://dx.doi.org/10.1371/journal.pone.0180493			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671965	Green Published, gold			2022-12-26	WOS:000405268500058
J	Bratton, E; Vannappagari, V; Kobayashi, MG				Bratton, Emily; Vannappagari, Vani; Kobayashi, Monica G.			Prevalence of and risk for gastrointestinal bleeding and peptic ulcerative disorders in a cohort of HIV patients from a US healthcare claims database	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HELICOBACTER-PYLORI INFECTION; ACTIVE ANTIRETROVIRAL THERAPY; CD4 COUNTS; AIDS; DISEASE; ENDOSCOPY; ERA; HEMORRHAGE; GASTRITIS	The primary study objectives were to estimate the frequencies and rates of gastrointestinal bleeding and peptic ulcerative disorder in HIV-positive patients compared with age- and sex-matched HIV-negative subjects. Data from a US insurance claims database was used for this analysis. Among 89,207 patients with HIV, 9.0% had a GI bleed, 1.0% had an upper gastrointestinal bleed, 5.6% had a lower gastrointestinal bleed, 1.9% had a peptic ulcerative disorder diagnosis, and 0.6% had both gastrointestinal/peptic ulcerative disorder. Among 267,615 HIV-negative subjects, the respective frequencies were 6.9%, 0.6%, 4.3%, 1.4%, and 0.4% (p < 0.0001 for each diagnosis subcategory). After combining effect measure modifiers into comedication and comorbidity strata, gastrointestinal bleeding hazard ratios (HRs) were higher for HIV-positive patients without comedication/comorbidity, and those with comedication alone (HR, 2.73; 95% confidence interval [CI], 2.62-2.84; HR, 1.59; 95% CI, 1.47-1.71). The rate of peptic ulcerative disorder among those without a history of ulcers and no comorbidity/comedication was also elevated (HR, 2.72; 95% CI, 2.48-2.99). Hazard ratios of gastrointestinal bleeding, and peptic ulcerative disorder without a history of ulcers were lower among patients infected with HIV with comedication/comorbidity (HR, 0.64; 95% CI, 0.56-0.73; HR, 0.46; 95% CI, 0.33-0.65). Rates of gastrointestinal bleeding plus peptic ulcerative disorder followed a similar pattern. In summary, the rates of gastrointestinal/peptic ulcerative disorder events comparing HIV-infected subjects to non-HIV-infected subjects were differential based on comorbidity and comedication status.	[Bratton, Emily] QuintilesIMS, Real World Evidence Solut, Durham, NC USA; [Vannappagari, Vani] ViiV Healthcare Ltd, Epidemiol & Real World Evidence, Res Triangle Pk, NC 27709 USA; [Vannappagari, Vani] Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Kobayashi, Monica G.] PAREXEL Int, PAREXEL Access Consulting, Durham, NC USA	IQVIA; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Parexel International	Vannappagari, V (corresponding author), ViiV Healthcare Ltd, Epidemiol & Real World Evidence, Res Triangle Pk, NC 27709 USA.; Vannappagari, V (corresponding author), Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC 27599 USA.	vani.x.vannappagari@viivhealthcare.com						Balderas V, 2006, NAT CLIN PRACT GASTR, V3, P349, DOI 10.1038/ncpgasthep0497; Bashir RM, 1996, J CLIN GASTROENTEROL, V23, P292, DOI 10.1097/00004836-199612000-00011; Bhaijee F, 2011, PATHOLOG RES INT, V2011, DOI DOI 10.4061/2011/247923; Bini EJ, 1999, AM J GASTROENTEROL, V94, P358, DOI 10.1111/j.1572-0241.1999.858_a.x; BLECKER U, 1993, AM J GASTROENTEROL, V88, P1294; Cacciarelli AG, 1996, AM J GASTROENTEROL, V91, P1783; Chalasani N, 1999, AIDS PATIENT CARE ST, V13, P343, DOI 10.1089/apc.1999.13.343; Charpignon C, 2013, ALIMENT PHARM THER, V38, P946, DOI 10.1111/apt.12465; Chiu HM, 2004, J GASTROEN HEPATOL, V19, P423, DOI 10.1111/j.1440-1746.2003.03278.x; Chong VH, 2005, J GASTROEN HEPATOL, V20, P722, DOI 10.1111/j.1440-1746.2005.03793.x; Chubineh S, 2008, INT J STD AIDS, V19, P723, DOI 10.1258/ijsa.2008.008244; EDWARDS PD, 1991, AM J GASTROENTEROL, V86, P1761; Hill A, 2009, AIDS REV, V11, P30; Karus D, 2005, J PAIN SYMPTOM MANAG, V30, P408, DOI 10.1016/j.jpainsymman.2005.04.011; Kelly P, 2014, JAIDS-J ACQ IMM DEF, V67, pS79, DOI 10.1097/QAI.0000000000000260; Monkemuller KE, 2000, AM J GASTROENTEROL, V95, P457, DOI 10.1111/j.1572-0241.2000.01768.x; Najm WI, 2011, PRIMARY CARE, V38, P383, DOI 10.1016/j.pop.2011.05.001; Nevin DT, 2014, HELICOBACTER, V19, P323, DOI 10.1111/hel.12131; Nielsen H, 1995, APMIS, V103, P689, DOI 10.1111/j.1699-0463.1995.tb01424.x; Nkuize M, 2010, HIV MED, V11, P412, DOI 10.1111/j.1468-1293.2009.00807.x; Olmos M, 2004, DIGEST DIS SCI, V49, P1836, DOI 10.1007/s10620-004-9580-5; PARENTE F, 1991, GUT, V32, P987, DOI 10.1136/gut.32.9.987; Szajerka T, 2012, INT J STD AIDS, V23, pE33, DOI 10.1258/ijsa.2009.009074; Vannappagari V, 2010, 18 INT AIDS C JUL 18; Wallace M R, 2000, Curr Gastroenterol Rep, V2, P283, DOI 10.1007/s11894-000-0020-1; Werneck-Silva AL, 2007, J GASTROEN HEPATOL, V22, P1712, DOI 10.1111/j.1440-1746.2007.04897.x; Wilcox CM, 2008, GUT, V57, P861, DOI 10.1136/gut.2006.103432; Williams CD, 2015, AM J PREV MED, V48, P501, DOI 10.1016/j.amepre.2014.11.005	28	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180612	10.1371/journal.pone.0180612	http://dx.doi.org/10.1371/journal.pone.0180612			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666006	Green Submitted, gold, Green Published			2022-12-26	WOS:000404608700020
J	Wang, Q; Zhu, J; Wang, YW; Dai, Y; Wang, YL; Wang, C; Liu, J; Baker, A; Colburn, NH; Yang, HS				Wang, Q.; Zhu, J.; Wang, Y-W; Dai, Y.; Wang, Y-L; Wang, C.; Liu, J.; Baker, A.; Colburn, N. H.; Yang, H-S			Tumor suppressor Pdcd4 attenuates Sin1 translation to inhibit invasion in colon carcinoma	ONCOGENE			English	Article							MAMMALIAN TARGET; DOWN-REGULATION; DEPENDENT TRANSCRIPTION; EUKARYOTIC TRANSLATION; PROMOTES INVASION; BETA-CATENIN/TCF; EXPRESSION; AKT; COMPLEX; PROTEIN	Programmed cell death 4 (Pdcd4), a tumor invasion suppressor, is frequently downregulated in colorectal cancer and other cancers. In this study, we find that loss of Pdcd4 increases the activity of mammalian target of rapamycin complex 2 (mTORC2) and thereby upregulates Snail expression. Examining the components of mTORC2 showed that Pdcd4 knockdown increased the protein but not mRNA level of stress-activated-protein kinase interacting protein 1 (Sin1), which resulted from enhanced Sin1 translation. To understand how Pdcd4 regulates Sin1 translation, the SIN1 5' untranslated region (5'UTR) was fused with luciferase reporter and named as 5'Sin1-Luc. Pdcd4 knockdown/knockout significantly increased the translation of 5' Sin1-Luc but not the control luciferase without the SIN1 5'UTR, suggesting that Sin1 5'UTR is necessary for Pdcd4 to inhibit Sin1 translation. Ectopic expression of wild-type Pdcd4 and Pdcd4(157-469), a deletion mutant that binds to translation initiation factor 4A (eIF4A), sufficiently inhibited Sin1 translation, and thus suppressed mTORC2 kinase activity and invasion in colon tumor cells. By contrast, Pdcd4(157-469)(D253A, D418A), a mutant that does not bind to eIF4A, failed to inhibit Sin1 translation, and consequently failed to repress mTORC2 activity and invasion. In addition, directly inhibiting eIF4A with silvestrol significantly suppressed Sin1 translation and attenuated invasion. These results indicate that Pdcd4-inhibited Sin1 translation is through suppressing eIF4A, and functionally important for suppression of mTORC2 activity and invasion. Moreover, in colorectal cancer tissues, the Sin1 protein but not mRNA was significantly upregulated while Pdcd4 protein was downregulated, suggesting that loss of Pdcd4 might correlate with Sin1 protein level but not mRNA level in colorectal cancer patients. Taken together, our work reveals a novel mechanism by which Pdcd4 inhibits Sin1 translation to attenuatemTORC2 activity and thereby suppresses invasion.	[Wang, Q.; Yang, H-S] Univ Kentucky, Coll Med, Dept Toxicol & Canc Biol, 350 HSRB,800 Rose St, Lexington, KY 40536 USA; [Zhu, J.; Wang, Y-W] Shandong Univ, Qilu Hosp, Dept Breast Surg, 107 West Wenhua Rd, Jinan, Shandong, Peoples R China; [Dai, Y.] Shandong Univ, Qilu Hosp, Dept Colorectal & Anal Surg, Jinan, Shandong, Peoples R China; [Wang, C.] Univ Kentucky, Coll Publ Hlth, Dept Biostat, Lexington, KY 40536 USA; [Wang, C.; Liu, J.; Yang, H-S] Univ Kentucky, Coll Med, Markey Canc Ctr, Lexington, KY 40536 USA; [Baker, A.; Colburn, N. H.] NCI, Lab Canc Prevent, Ctr Canc Res, Frederick, MD 21701 USA	University of Kentucky; Shandong University; Shandong University; University of Kentucky; University of Kentucky; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yang, HS (corresponding author), Univ Kentucky, Coll Med, Dept Toxicol & Canc Biol, 350 HSRB,800 Rose St, Lexington, KY 40536 USA.; Zhu, J (corresponding author), Shandong Univ, Qilu Hosp, Dept Breast Surg, 107 West Wenhua Rd, Jinan, Shandong, Peoples R China.	drjiangzhu@hotmail.com; hyang3@uky.edu	Yang, Hsin-Sheng/AAF-6793-2020; Zhu, Jiang/AAX-7274-2020; Yang, Hsin-Sheng/A-6419-2008	Yang, Hsin-Sheng/0000-0002-0566-3036; Zhu, Jiang/0000-0002-7869-9857; Yang, Hsin-Sheng/0000-0002-0566-3036	NIH/NCI grant [R01CA129015, R03CA187839]; NCI/NIH center core support grant [P30CA177558]; National Natural Science Foundation of China [81402192]; NCI Center Core Support Grant [P30CA177558]; NATIONAL CANCER INSTITUTE [R01CA129015, P30CA177558, R03CA187839] Funding Source: NIH RePORTER	NIH/NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI/NIH center core support grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NCI Center Core Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIH/NCI grant to H.-S. Yang (R01CA129015 and R03CA187839), NCI/NIH center core support grant to C. Wang (P30CA177558) and National Natural Science Foundation of China grant to J. Zhu (81402192). The Flow Cytometry facility is supported in part by NCI Center Core Support Grant (P30CA177558). We thank Dr Jian-Li Wang (Shandong University) for experimental supports and Ms Donna Gilbreath and Ms Catherine Anthony (Markey Cancer Center) for editing the manuscript.	Cencic R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005223; Chang JH, 2009, P NATL ACAD SCI USA, V106, P3148, DOI 10.1073/pnas.0808275106; Chen CH, 2011, J BIOL CHEM, V286, P40386, DOI 10.1074/jbc.M111.282590; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Fehler O, 2014, NUCLEIC ACIDS RES, V42, P11107, DOI 10.1093/nar/gku800; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Gaubitz C, 2016, TRENDS BIOCHEM SCI, V41, P532, DOI 10.1016/j.tibs.2016.04.001; Glidden EJ, 2012, J BIOL CHEM, V287, P581, DOI 10.1074/jbc.M111.304337; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Gulhati P, 2009, CLIN CANCER RES, V15, P7207, DOI 10.1158/1078-0432.CCR-09-1249; Guo Xiaoling, 2011, Genes Cancer, V2, P818, DOI 10.1177/1947601911431082; Hilliard A, 2006, J IMMUNOL, V177, P8095, DOI 10.4049/jimmunol.177.11.8095; Ikenoue T, 2009, METHOD ENZYMOL, V452, P165, DOI 10.1016/S0076-6879(08)03611-2; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Kogure T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076136; Lankat-Buttgereit B, 2008, BIOL CELL, V100, P703, DOI 10.1042/BC20080052; Leupold JH, 2007, ONCOGENE, V26, P4550, DOI 10.1038/sj.onc.1210234; Liu PD, 2015, CANCER DISCOV, V5, P1194, DOI 10.1158/2159-8290.CD-15-0460; Liu PD, 2013, NAT CELL BIOL, V15, P1340, DOI 10.1038/ncb2860; Liwak U, 2012, MOL CELL BIOL, V32, P1818, DOI 10.1128/MCB.06317-11; Loh PG, 2009, EMBO J, V28, P274, DOI 10.1038/emboj.2008.278; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; Moraitis D, 2014, SURGERY, V156, P1542, DOI 10.1016/j.surg.2014.08.095; Nieves-Alicea R, 2009, BREAST CANCER RES TR, V114, P203, DOI 10.1007/s10549-008-9993-5; Rogers GW, 2002, PROG NUCLEIC ACID RE, V72, P307, DOI 10.1016/S0079-6603(02)72073-4; Roulin D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-57; Santhanam AN, 2010, ONCOGENE, V29, P3921, DOI 10.1038/onc.2010.158; Strezoska Z, 2000, MOL CELL BIOL, V20, P5516, DOI 10.1128/MCB.20.15.5516-5528.2000; Svitkin YV, 2001, RNA, V7, P1743; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang Q, 2008, ONCOGENE, V27, P1527, DOI 10.1038/sj.onc.1210793; Wang Q, 2010, ONCOGENE, V29, P128, DOI 10.1038/onc.2009.302; Wang Q, 2013, EUR J CANCER, V49, P1761, DOI 10.1016/j.ejca.2012.12.014; Wang Q, 2012, BBA-MOL CELL RES, V1823, P1807, DOI 10.1016/j.bbamcr.2012.07.004; Wei N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030311; Wei ZT, 2009, CANCER SCI, V100, P1408, DOI 10.1111/j.1349-7006.2009.01210.x; Wiegering A, 2015, CANCER DISCOV, V5, P768, DOI 10.1158/2159-8290.CD-14-1040; Wolfe AL, 2014, NATURE, V513, P65, DOI 10.1038/nature13485; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu JF, 2013, CANCER-AM CANCER SOC, V119, P2247, DOI 10.1002/cncr.28023; Yang G, 2015, CELL REP, V12, P937, DOI 10.1016/j.celrep.2015.07.016; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Yang HS, 2014, TRANSLATION ITS REGU, P135; Zhang Y., 2015, J NANOMATER, V2015, P1, DOI DOI 10.1080/10298436.2015.1019502; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	49	39	42	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 9	2017	36	45					6225	6234		10.1038/onc.2017.228	http://dx.doi.org/10.1038/onc.2017.228			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FM1WY	28692058	Green Accepted			2022-12-26	WOS:000414774800002
J	Kuo, HY; Liu, FC				Kuo, Hsiao-Ying; Liu, Fu-Chin			Valproic acid induces aberrant development of striatal compartments and corticostriatal pathways in a mouse model of autism spectrum disorder	FASEB JOURNAL			English	Article						striatum; striosome; risperidone; ultrasonic vocalizations	BASAL GANGLIA; CEREBRAL-CORTEX; MATRIX COMPARTMENTS; PRENATAL EXPOSURE; PATTERN-FORMATION; NEURONS; MICE; PATCH; FOXP2; RAT	The striatum comprises two neurochemical compartments: striosomes and the matrix. Striosomal and matrix compartments receive inputs from limbic system-related and sensorimotor cortices, respectively. Here, we investigate the impact on the corticostriosomal pathway in the valproic acid (VPA)-induced autism spectrum disorder mouse model. VPA administration during the neurogenesis time windows of striosomes, but not the matrix, resulted in aberrant compartmentation [i.e., maternal VPA injections at embryonic day (E)12.75 decreased -opioid receptor-positive striosomes, but increased calbindin-positive matrix in the rostral striatum]. VPA(E12.75) treatment also impaired the aggregation of cells pulse labeled with 5-bromo-2'-deoxyuridine at E12.75 into striosomal cell clusters, which suggests defective segregation of striosomal cells from matrix cells. This possibility was supported by our findings that VPA(E12.75) treatment altered the expression of ephrinA5 and EphA4, two molecules that are related to compartmental segregation. In the VPA(E12.75) neocortex, Foxp2-positive neurons were decreased in layer VI, but increased in layer V, which projects to the striosomal compartment. We also investigated VPA effects on the corticostriosomal pathway. VPA(E12.75) treatment decreased the putative corticostriosomal synapses of striosomal neurons and induced an aberrant pattern of isolation stress-induced ultrasonic vocalizations. Of interest, risperidone treatments conjointly improved ultrasonic vocalizations and restored the striosomal compartment in VPA(E12.75) pups. Collectively, dysfunctional corticostriatal pathways, particularly via the aberrant striosomal compartment, may be involved in autism spectrum disorder pathophysiology.-Kuo, H.-Y., Liu, F.-C. Valproic acid induces aberrant development of striatal compartments and corticostriatal pathways in a mouse model of autism spectrum disorder.	[Kuo, Hsiao-Ying; Liu, Fu-Chin] Natl Yang Ming Univ, Inst Neurosci, 155 Sect 2,Li Nong St, Taipei 11221, Taiwan	National Yang Ming Chiao Tung University	Liu, FC (corresponding author), Natl Yang Ming Univ, Inst Neurosci, 155 Sect 2,Li Nong St, Taipei 11221, Taiwan.	fuchin@ym.edu.tw		Kuo, Hsiao-Ying/0000-0003-2571-3755	National Science Council [NSC101-2321-B-010-021, NSC102-2321-B-010-018]; Ministry of Science and Technology [MOST103-2321-B-010-009, MOST104-2321-B-010-022, MOST105-2321-B-010-013, MOST104-2311-B-010-010-MY3, MOST106-2321-B-010-012]; Aiming for Top University grant, Taiwan Ministry of Education;  [MOST 105-2811-B-010-036]	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Aiming for Top University grant, Taiwan Ministry of Education; 	The authors thank Pierre Vanderhaeghen (IRIBHM and ULB Neuroscience Institute, Universite Libre de Bruxelles, Brussels, Belgium) for providing probes for in situ hybridization and Chou P. Hung (U.S. Army Research Lab (ARL), Human Research and Engineering Directorate (HRED), Synergistic Human-Machine Interfaces Branch (SHMI), Aberdeen Proving Ground, Aberdeen, MD) for editing the manuscript. This work was supported by National Science Council Grants NSC101-2321-B-010-021 and NSC102-2321-B-010-018; Ministry of Science and Technology Grants MOST103-2321-B-010-009, MOST104-2321-B-010-022, MOST105-2321-B-010-013, MOST104-2311-B-010-010-MY3, and MOST106-2321-B-010-012; an Aiming for Top University grant, Taiwan Ministry of Education (to F.-C.L.); and Postdoctoral Fellowship Grant MOST 105-2811-B-010-036 (to H.-Y.K.). The authors declare no conflicts of interest.	Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], 2007, FDA Consum, V41, P4; Arbogast T, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005709; Arndt TL, 2005, INT J DEV NEUROSCI, V23, P189, DOI 10.1016/j.ijdevneu.2004.11.001; Bromley RL, 2008, NEUROLOGY, V71, P1923, DOI 10.1212/01.wnl.0000339399.64213.1a; Chen YC, 2016, NAT NEUROSCI, V19, P1513, DOI 10.1038/nn.4380; Crandall JE, 2007, J NEUROSCI, V27, P3813, DOI 10.1523/JNEUROSCI.5124-06.2007; Crittenden JR, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00059; DONOGHUE JP, 1986, BRAIN RES, V365, P397, DOI 10.1016/0006-8993(86)91658-6; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; FISHELL G, 1991, J COMP NEUROL, V312, P33, DOI 10.1002/cne.903120104; Fuccillo MV, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00027; Gandal MJ, 2010, BIOL PSYCHIAT, V68, P1100, DOI 10.1016/j.biopsych.2010.09.031; GERFEN CR, 1984, NATURE, V311, P461, DOI 10.1038/311461a0; GERFEN CR, 1989, SCIENCE, V246, P385, DOI 10.1126/science.2799392; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Geschwind DH, 2011, TRENDS COGN SCI, V15, P409, DOI 10.1016/j.tics.2011.07.003; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; GRAYBIEL AM, 1990, TRENDS NEUROSCI, V13, P244, DOI 10.1016/0166-2236(90)90104-I; GRAYBIEL AM, 1982, P NATL ACAD SCI-BIOL, V79, P198, DOI 10.1073/pnas.79.1.198; Haber SN, 2016, DIALOGUES CLIN NEURO, V18, P7; Hage SR, 2010, HBK BEHAV NEUROSCI, V19, P339, DOI 10.1016/B978-0-12-374593-4.00032-2; Hara Y, 2015, BEHAV BRAIN RES, V289, P39, DOI 10.1016/j.bbr.2015.04.022; Hisaoka T, 2010, NEUROSCIENCE, V166, P551, DOI 10.1016/j.neuroscience.2009.12.055; Hollander E, 2005, BIOL PSYCHIAT, V58, P226, DOI 10.1016/j.biopsych.2005.03.040; Janis LS, 1999, J NEUROSCI, V19, P4962; JANSSEN PAJ, 1988, J PHARMACOL EXP THER, V244, P685; Kataoka S, 2013, INT J NEUROPSYCHOPH, V16, P91, DOI 10.1017/S1461145711001714; Kim KC, 2011, TOXICOL LETT, V201, P137, DOI 10.1016/j.toxlet.2010.12.018; Kincaid AE, 1996, J COMP NEUROL, V374, P578; Kolozsi E, 2009, NEUROSCIENCE, V163, P1201, DOI 10.1016/j.neuroscience.2009.07.021; KRUSHEL LA, 1995, EUR J NEUROSCI, V7, P1210, DOI 10.1111/j.1460-9568.1995.tb01111.x; Lee PS, 2009, CEREB CORTEX, V19, P1787, DOI 10.1093/cercor/bhn209; Lee SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045512; Liao WL, 2008, P NATL ACAD SCI USA, V105, P6765, DOI 10.1073/pnas.0802109105; Liegeois F, 2003, NAT NEUROSCI, V6, P1230, DOI 10.1038/nn1138; Mason HA, 2005, DEVELOPMENT, V132, P4247, DOI 10.1242/dev.02008; Moles A, 2004, SCIENCE, V304, P1983, DOI 10.1126/science.1095943; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Nickl-Jockschat T, 2012, HUM BRAIN MAPP, V33, P1470, DOI 10.1002/hbm.21299; Passante L, 2008, DEVELOPMENT, V135, P3281, DOI 10.1242/dev.024778; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Pelphrey KA, 2011, J CHILD PSYCHOL PSYC, V52, P631, DOI 10.1111/j.1469-7610.2010.02349.x; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Pennartz CMA, 2009, J NEUROSCI, V29, P12831, DOI 10.1523/JNEUROSCI.3177-09.2009; Qiu AQ, 2010, J AM ACAD CHILD PSY, V49, P539, DOI 10.1016/j.jaac.2010.02.012; Rinaldi T, 2008, CEREB CORTEX, V18, P763, DOI 10.1093/cercor/bhm117; Rinaldi T, 2007, P NATL ACAD SCI USA, V104, P13501, DOI 10.1073/pnas.0704391104; Rojas DC, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-56; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Smith JB, 2016, NEURON, V91, P1069, DOI 10.1016/j.neuron.2016.07.046; Snow WM, 2008, DEV PSYCHOBIOL, V50, P633, DOI 10.1002/dev.20337; SONG DD, 1994, DEV BRAIN RES, V83, P233, DOI 10.1016/0165-3806(94)00144-8; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Takahashi T, 2016, MOL PSYCHIATR, V21, P1208, DOI 10.1038/mp.2015.190; VANDERKOOY D, 1987, BRAIN RES, V401, P155, DOI 10.1016/0006-8993(87)91176-0; Wagner GC, 2006, J AUTISM DEV DISORD, V36, P779, DOI 10.1007/s10803-006-0117-y; Watkins KE, 1999, AM J HUM GENET, V65, P1215, DOI 10.1086/302631; Yi HG, 2016, CEREB CORTEX, V26, P1409, DOI 10.1093/cercor/bhu236; Yochum CL, 2008, BRAIN RES, V1203, P126, DOI 10.1016/j.brainres.2008.01.055; Yoneshima H, 2006, NEUROSCIENCE, V137, P401, DOI 10.1016/j.neuroscience.2005.08.075	62	22	23	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4458	4471		10.1096/fj.201700054R	http://dx.doi.org/10.1096/fj.201700054R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28687613				2022-12-26	WOS:000413397400023
J	Pinker, F; Schelcher, C; Fernandez-Millan, P; Gobert, A; Birck, C; Thureau, A; Roblin, P; Giege, P; Sauter, C				Pinker, Franziska; Schelcher, Cedric; Fernandez-Millan, Pablo; Gobert, Anthony; Birck, Catherine; Thureau, Aurelien; Roblin, Pierre; Giege, Philippe; Sauter, Claude			Biophysical analysis of Arabidopsis protein-only RNase P alone and in complex with tRNA provides a refined model of tRNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						precursor tRNA (pre-tRNA); ribonuclease P (RNase P); RNA processing; small-angle X-ray scattering (SAXS); X-ray crystallography; PRORP; pentatricopeptide repeat (PPR); tRNA maturation	PENTATRICOPEPTIDE REPEAT PROTEINS; ANGLE SCATTERING DATA; RECOGNITION; PROGRAM; ULTRACENTRIFUGATION; MACROMOLECULES; MITOCHONDRIA; GENERATION; NUCLEUS; SUBUNIT	RNase P is a universal enzyme that removes 5 leader sequences from tRNA precursors. The enzyme is therefore essential for maturation of functional tRNAs and mRNA translation. RNase P represents a unique example of an enzyme that can occur either as ribonucleoprotein or as protein alone. The latter form of the enzyme, called protein-only RNase P (PRORP), is widespread in eukaryotes in which it can provide organellar or nuclear RNase P activities. Here, we have focused on Arabidopsis nuclear PRORP2 and its interaction with tRNA substrates. Affinity measurements helped assess the respective importance of individual pentatricopeptide repeat motifs in PRORP2 for RNA binding. We characterized the PRORP2 structure by X-ray crystallography and by small-angle X-ray scattering in solution as well as that of its complex with a tRNA precursor by small-angle X-ray scattering. Of note, our study reports the first structural data of a PRORP-tRNA complex. Combined with complementary biochemical and biophysical analyses, our structural data suggest that PRORP2 undergoes conformational changes to accommodate its substrate. In particular, the catalytic domain and the RNA-binding domain can move around a central hinge. Altogether, this work provides a refined model of the PRORP-tRNA complex that illustrates how protein-only RNase P enzymes specifically bind tRNA and highlights the contribution of protein dynamics to achieve this specific interaction.	[Pinker, Franziska; Fernandez-Millan, Pablo; Sauter, Claude] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire Architecture & Reactiv, UPR 9002, F-67000 Strasbourg, France; [Pinker, Franziska; Schelcher, Cedric; Gobert, Anthony; Giege, Philippe] Univ Strasbourg, CNRS, Inst Biol Mol Plantes, UPR 2357, F-67084 Strasbourg, France; [Birck, Catherine] Univ Strasbourg, CNRS, Inst Genet & Biol Mol & Cellulaire, UMR 7104, F-67404 Illkirch Graffenstaden, France; [Thureau, Aurelien; Roblin, Pierre] Synchrotron SOLEIL, F-91410 Lorme Des Merisiers, St Aubin, France; [Roblin, Pierre] Inst Natl Rech Agron Ctr Nantes, Unite Rech Biopolymeres Interact Assemblages URBI, UR 1268, 60 Rue Geraudiere, F-44316 Nantes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; SOLEIL Synchrotron; INRAE	Sauter, C (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire Architecture & Reactiv, UPR 9002, F-67000 Strasbourg, France.; Giege, P (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol Plantes, UPR 2357, F-67084 Strasbourg, France.	philippe.giege@ibmp-cnrs.unistra.fr; c.sauter@ibmc-cnrs.unistra.fr	Fernández-Millán, Pablo/N-4930-2016	Fernández-Millán, Pablo/0000-0002-1887-8466; Gobert, Anthony/0000-0003-2626-8788; Schelcher, Cedric/0000-0003-0574-0975; sauter, claude/0000-0002-8766-287X; Giege, Philippe/0000-0003-2285-8190	French CNRS; University of Strasbourg, Agence Nationale de la Recherche (ANR) Blanc "PRO-RNase P" Research Grant [ANR-11-BSV8-008-01/02]; LabEx consortium "MitoCross" in the frame of the French National Program "Investissement d'Avenir" [ANR-11-LABX-0057_MITOCROSS]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05]	French CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Strasbourg, Agence Nationale de la Recherche (ANR) Blanc "PRO-RNase P" Research Grant(French National Research Agency (ANR)); LabEx consortium "MitoCross" in the frame of the French National Program "Investissement d'Avenir"(French National Research Agency (ANR)); French Infrastructure for Integrated Structural Biology (FRISBI)	This work was supported by the French CNRS, the University of Strasbourg, Agence Nationale de la Recherche (ANR) Blanc "PRO-RNase P" Research Grant ANR-11-BSV8-008-01/02 (to P. G. and Cl. S.), and the LabEx consortium "MitoCross" in the frame of the French National Program "Investissement d'Avenir" Grant ANR-11-LABX-0057_MITOCROSS. This work was also supported by the French Infrastructure for Integrated Structural Biology (FRISBI) (Grant ANR-10-INSB-05, which granted access to the resources of FRISBI and Instruct, a Landmark European Strategy Forum on Research Infrastructures project. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altman S, 2007, MOL BIOSYST, V3, P604, DOI 10.1039/b707850c; Anantharaman Vivek, 2006, RNA Biol, V3, P18; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Bonnard G, 2016, PLANT J, V87, P270, DOI 10.1111/tpj.13198; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Brillante N, 2016, NUCLEIC ACIDS RES, V44, P2323, DOI 10.1093/nar/gkw080; Chen TH, 2016, NUCLEIC ACIDS RES, V44, P5344, DOI 10.1093/nar/gkw391; Cheng SF, 2016, PLANT J, V85, P532, DOI 10.1111/tpj.13121; David G, 2009, J APPL CRYSTALLOGR, V42, P892, DOI 10.1107/S0021889809029288; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evrard G, 2011, J APPL CRYSTALLOGR, V44, P1264, DOI 10.1107/S0021889811035758; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fujii S, 2016, PLANT J, V86, P504, DOI 10.1111/tpj.13185; Giege P, 2013, RNA BIOL, V10, P1417, DOI 10.4161/rna.26081; Giege R, 2008, NAT STRUCT MOL BIOL, V15, P1007, DOI 10.1038/nsmb.1498; Gobert A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2358; Gobert A, 2010, NAT STRUCT MOL BIOL, V17, P740, DOI 10.1038/nsmb.1812; Gutmann B, 2012, GENE DEV, V26, P1022, DOI 10.1101/gad.189514.112; Hammani K, 2014, BIOCHIMIE, V100, P141, DOI 10.1016/j.biochi.2013.08.031; Hauenstein S, 2004, NAT STRUCT MOL BIOL, V11, P1134, DOI 10.1038/nsmb849; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Hopper AK, 2010, FEBS LETT, V584, P310, DOI 10.1016/j.febslet.2009.11.053; Howard MJ, 2012, P NATL ACAD SCI USA, V109, P16149, DOI 10.1073/pnas.1209062109; Imai T, 2014, BIOCHEM BIOPH RES CO, V450, P1541, DOI 10.1016/j.bbrc.2014.07.030; Jossinet F, 2010, BIOINFORMATICS, V26, P2057, DOI 10.1093/bioinformatics/btq321; Karasik A, 2016, J MOL BIOL, V428, P26, DOI 10.1016/j.jmb.2015.11.025; Klipcan L, 2012, J MOL BIOL, V415, P527, DOI 10.1016/j.jmb.2011.11.029; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Lai LB, 2010, FEBS LETT, V584, P287, DOI 10.1016/j.febslet.2009.11.048; Lechner M, 2015, MOL BIOL EVOL, V32, P3186, DOI 10.1093/molbev/msv187; Li FZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09878; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Pan H, 2003, P NATL ACAD SCI USA, V100, P12648, DOI 10.1073/pnas.2135585100; Panjkovich A, 2016, PHYS CHEM CHEM PHYS, V18, P5707, DOI 10.1039/c5cp04540a; Pavlova LV, 2012, CHEMBIOCHEM, V13, P2270, DOI 10.1002/cbic.201200434; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pinker F, 2015, ACTA CRYSTALLOGR F, V71, P1372, DOI 10.1107/S2053230X15017033; Pinker F, 2013, RNA BIOL, V10, P1457, DOI 10.4161/rna.25273; Placido A, 2010, NUCLEIC ACIDS RES, V38, P7711, DOI 10.1093/nar/gkq646; Polekhina G, 1996, STRUCTURE, V4, P1141, DOI 10.1016/S0969-2126(96)00122-0; Reinhard L, 2015, NUCLEIC ACIDS RES, V43, P5664, DOI 10.1093/nar/gkv481; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; Schelcher C, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6030030; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P, 2010, BIOPHYS J, V98, P2005, DOI 10.1016/j.bpj.2009.12.4336; Sherrer RL, 2011, NUCLEIC ACIDS RES, V39, P1034, DOI 10.1093/nar/gkq845; Sugita C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108962; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Takenaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065343; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Taschner A, 2012, CELL REP, V2, P19, DOI 10.1016/j.celrep.2012.05.021; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286	55	18	18	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					13904	13913		10.1074/jbc.M117.782078	http://dx.doi.org/10.1074/jbc.M117.782078			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28696260	Green Published, hybrid			2022-12-26	WOS:000408439800001
J	Lima, JJP; Buitink, J; Lalanne, D; Rossi, RF; Pelletier, S; da Silva, EAA; Leprince, O				Pereira Lima, Juliana Joice; Buitink, Julia; Lalanne, David; Rossi, Rubiana Falopa; Pelletier, Sandra; Amaral da Silva, Edvaldo Aparecido; Leprince, Olivier			Molecular characterization of the acquisition of longevity during seed maturation in soybean	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GLYCINE-MAX; 3 GENOTYPES; GERMINATION; VIGOR; EXPRESSION; ACCUMULATION; GALACTINOL; RAFFINOSE; ESTABLISHMENT	Seed longevity, defined as the ability to remain alive during storage, is an important agronomic factor. Poor longevity negatively impacts seedling establishment and consequently crop yield. This is particularly problematic for soybean as seeds have a short lifespan. While the economic importance of soybean has fueled a large number of transcriptome studies during embryogenesis and seed filling, the mechanisms regulating seed longevity during late maturation remain poorly understood. Here, a detailed physiological and molecular characterization of late seed maturation was performed in soybean to obtain a comprehensive overview of the regulatory genes that are potentially involved in longevity. Longevity appeared at physiological maturity at the end of seed filling before maturation drying and progressively doubled until the seeds reached the dry state. The increase in longevity was associated with the expression of genes encoding protective chaperones such as heat shock proteins and the repression of nuclear and chloroplast genes involved in a range of chloroplast activities, including photosynthesis. An increase in the raffinose family oligosaccharides (RFO)/sucrose ratio together with changes in RFO metabolism genes was also associated with longevity. A gene co-expression network analysis revealed 27 transcription factors whose expression profiles were highly correlated with longevity. Eight of them were previously identified in the longevity network of Medicago truncatula, including homologues of ERF110, HSF6AB, NFXL1 and members of the DREB2 family. The network also contained several transcription factors associated with auxin and developmental cell fate during flowering, organ growth and differentiation. A transcriptional transition occurred concomitant with seed chlorophyll loss and detachment from the mother plant, suggesting the activation of a post-abscission program. This transition was enriched with AP2/EREBP and WRKY transcription factors and genes associated with growth, germination and post-transcriptional processes, suggesting that this program prepares the seed for the dry quiescent state and germination.	[Pereira Lima, Juliana Joice; Rossi, Rubiana Falopa; Amaral da Silva, Edvaldo Aparecido] Univ Estadual Paulista, Fac Ciencias Agron, Botucatu, SP, Brazil; [Pereira Lima, Juliana Joice; Buitink, Julia; Lalanne, David; Rossi, Rubiana Falopa; Pelletier, Sandra; Leprince, Olivier] Univ Angers, SFR QUASAV, Agrocampus Ouest, Inst Rech Hort & Semences,INRA, Beaucouze, France	Universidade Estadual Paulista; INRAE; Institut Agro; Agrocampus Ouest; Universite d'Angers	da Silva, EAA (corresponding author), Univ Estadual Paulista, Fac Ciencias Agron, Botucatu, SP, Brazil.; Leprince, O (corresponding author), Univ Angers, SFR QUASAV, Agrocampus Ouest, Inst Rech Hort & Semences,INRA, Beaucouze, France.	amaraldasilva@fca.unesp.br; olivier.leprince@agrocampus-ouest.fr	Amaral da Silva, Edvaldo/AAY-4481-2021; Buitink, Julia/AAR-2872-2020; Pelletier, Sandra/A-3852-2013	Amaral da Silva, Edvaldo/0000-0001-6454-1488; Buitink, Julia/0000-0002-1457-764X; Pelletier, Sandra/0000-0001-7582-2939; Leprince, Olivier/0000-0003-1414-8690				Almoguera C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-75; Angelovici R, 2010, TRENDS PLANT SCI, V15, P211, DOI 10.1016/j.tplants.2010.01.003; Asakura T, 2012, PLANT PHYSIOL BIOCH, V52, P147, DOI 10.1016/j.plaphy.2011.12.007; Ballesteros D, 2011, PLANT J, V68, P607, DOI 10.1111/j.1365-313X.2011.04711.x; Benson, 1985, SPECIAL REPORT, P1; Bilyeu KD, 2016, J AGR FOOD CHEM, V64, P1071, DOI 10.1021/acs.jafc.5b04779; Boca S, 2014, PLANT CELL ENVIRON, V37, P368, DOI 10.1111/pce.12159; Buitink J, 2000, P NATL ACAD SCI USA, V97, P2385, DOI 10.1073/pnas.040554797; Capella M, 2015, NEW PHYTOL, V207, P669, DOI 10.1111/nph.13401; Chatelain E, 2012, PLANT CELL ENVIRON, V35, P1440, DOI 10.1111/j.1365-3040.2012.02501.x; Cheng MC, 2012, PLANT PHYSIOL, V158, P363, DOI 10.1104/pp.111.189738; Debeaujon I, 2000, PLANT PHYSIOL, V122, P403, DOI 10.1104/pp.122.2.403; Dietz KJ, 2010, PROTOPLASMA, V245, P3, DOI 10.1007/s00709-010-0142-8; Duplan V, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00042; Feurtado JA, 2011, PLANT CELL, V23, P1772, DOI 10.1105/tpc.111.085134; Finch-Savage WE, 2016, J EXP BOT, V67, P567, DOI 10.1093/jxb/erv490; Fulcher N, 2009, P NATL ACAD SCI USA, V106, P20984, DOI 10.1073/pnas.0909218106; Gillen AM, 2012, CROP SCI, V52, P2757, DOI 10.2135/cropsci2011.10.0566; Hay FR, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot030; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Huang Y, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005833; Hundertmark M, 2011, SEED SCI RES, V21, P165, DOI 10.1017/S0960258511000079; Jones SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059270; Jones SI, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-136; Kaufmann K, 2009, PLOS BIOL, V7, P854, DOI 10.1371/journal.pbio.1000090; Kaur H, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00713; KUENEMAN EA, 1983, CROP SCI, V23, P5, DOI 10.2135/cropsci1983.0011183X002300010002x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leprince O, 2017, J EXP BOT, V68, P827, DOI 10.1093/jxb/erw363; Li DZ, 2009, TRENDS PLANT SCI, V14, P614, DOI 10.1016/j.tplants.2009.09.005; Li L, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S3-S9; Lisso J, 2006, FEBS LETT, V580, P4851, DOI 10.1016/j.febslet.2006.07.079; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; LOWELL CA, 1989, CROP SCI, V29, P459, DOI 10.2135/cropsci1989.0011183X002900020044x; Marcos-Filho J., 2016, SEED PHYSIOLOGY OF C; Nagel M, 2015, PLANT CELL ENVIRON, V38, P1011, DOI 10.1111/pce.12474; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Nakajima S, 2012, PLANT PHYSIOL, V160, P261, DOI 10.1104/pp.112.196881; Niedzielski M, 2009, SEED SCI RES, V19, P213, DOI 10.1017/S0960258509990110; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Obendorf RL, 2009, CROP SCI, V49, P329, DOI 10.2135/cropsci2008.06.0370; Oge L, 2008, PLANT CELL, V20, P3022, DOI 10.1105/tpc.108.058479; Pádua Gilda Pizzolante de, 2007, Rev. bras. sementes, V29, P128, DOI 10.1590/S0101-31222007000300015; Righetti K, 2015, PLANT CELL, V27, P2692, DOI 10.1105/tpc.15.00632; ROBERTS EH, 1989, ANN BOT-LONDON, V63, P39, DOI 10.1093/oxfordjournals.aob.a087727; Rosnoblet C, 2007, PLANT J, V51, P47, DOI 10.1111/j.1365-313X.2007.03116.x; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sakuraba Y, 2012, PLANT CELL, V24, P507, DOI 10.1105/tpc.111.089474; Salvi P, 2016, SCI REP-UK, V6, DOI 10.1038/srep35088; Sano N, 2016, PLANT CELL PHYSIOL, V57, P660, DOI 10.1093/pcp/pcv186; SARAVITZ DM, 1987, PLANT PHYSIOL, V83, P185, DOI 10.1104/pp.83.1.185; Sattler SE, 2004, PLANT CELL, V16, P1419, DOI 10.1105/tpc.021360; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuster C, 2015, DEVELOPMENT, V142, P3343, DOI 10.1242/dev.120444; Schwember AR, 2010, J EXP BOT, V61, P4423, DOI 10.1093/jxb/erq248; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Shamimuzzaman M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-310; Teixeira RN, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0729-0; Tejedor-Cano J, 2010, PLANT CELL ENVIRON, V33, P1408, DOI 10.1111/j.1365-3040.2010.02159.x; Verdier J, 2013, PLANT PHYSIOL, V163, P757, DOI 10.1104/pp.113.222380; VERTUCCI CW, 1984, PLANT PHYSIOL, V75, P114, DOI 10.1104/pp.75.1.114; Vidigal DD, 2016, PLANT SCI, V246, P112, DOI 10.1016/j.plantsci.2016.02.015; Walters C, 2005, SEED SCI RES, V15, P1, DOI 10.1079/SSR2004195; Walters C, 2010, PLANT SCI, V179, P565, DOI 10.1016/j.plantsci.2010.06.016; Waters ER, 2013, J EXP BOT, V64, P391, DOI 10.1093/jxb/ers355; Waterworth WM, 2010, PLANT J, V63, P848, DOI 10.1111/j.1365-313X.2010.04285.x; Yamaguchi N, 2016, PLANT PHYSIOL, V170, P283, DOI 10.1104/pp.15.00969; ZANAKIS GN, 1994, EXP AGR, V30, P157, DOI 10.1017/S0014479700024108; ZANAKIS GN, 1994, EXP AGR, V30, P139, DOI 10.1017/S0014479700024091; Zhang YY, 2015, PLANT CELL, V27, P620, DOI 10.1105/tpc.114.135368; Zinsmeister J, 2016, PLANT CELL, V28, P2735, DOI 10.1105/tpc.16.00470	71	45	46	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180282	10.1371/journal.pone.0180282	http://dx.doi.org/10.1371/journal.pone.0180282			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700604	Green Published, Green Submitted, gold			2022-12-26	WOS:000405649600025
J	Meyer, AJ; Atuheire, C; Worodria, W; Kizito, S; Katamba, A; Sanyu, I; Andama, A; Ayakaka, I; Cattamanchi, A; Bwanga, F; Huang, L; Davis, JL				Meyer, Amanda J.; Atuheire, Collins; Worodria, William; Kizito, Samuel; Katamba, Achilles; Sanyu, Ingvar; Andama, Alfred; Ayakaka, Irene; Cattamanchi, Adithya; Bwanga, Freddie; Huang, Laurence; Davis, J. Lucian			Sputum quality and diagnostic performance of GeneXpert MTB/RIF among smear-negative adults with presumed tuberculosis in Uganda	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PULMONARY TUBERCULOSIS; XPERT MTB/RIF; MICROSCOPY; IMPACT; ASSAY	Background Introduction of GeneXpert MTB/RIF (Xpert) assay has constituted a major breakthrough for tuberculosis (TB) diagnostics. Several patient factors may influence diagnostic performance of Xpert including sputum quality. Objective We carried out a prospective, observational, cross-sectional study to determine the effect of sputum quality on diagnostic performance of Xpert among presumed TB patients in Uganda. Methods We collected clinical and demographic information and two sputum samples from participants. Staff recorded sputum quality and performed LED fluorescence microscopy and mycobacterial culture on each sample. If both smear examinations were negative, Xpert testing was performed. We calculated diagnostic yield, sensitivity, specificity, and other indicators for Xpert for each stratum of sputum quality in reference to a standard of mycobacterial culture. Results Patients with salivary sputum showed a trend towards a substantially higher proportion of samples that were Xpert-positive (54/286, 19%, 95% CI 15-24) compared with those with all other sputum sample types (221/1496, 15%, 95% CI 13-17). Blood-stained sputum produced the lowest sensitivity (28%; 95% CI 12-49) and salivary sputum the highest (66%; 95% CI 53-77). Specificity didn't vary meaningfully by sample types. Salivary sputum was significantly more sensitive than mucoid sputum (+ 13%, 95% CI + 1 to + 26), while bloodstained sputum was significantly less sensitive (-24%, 95% CI -42 to -5). Conclusions Our findings demonstrate the need to exercise caution in collecting sputum for Xpert and in interpreting results because sputum quality may impact test yield and sensitivity. In particular, it may be wise to pursue additional testing should blood-stained sputum test negative while salivary sputum should be readily accepted for Xpert testing given its higher sensitivity and potentially higher yield than other sample types. These findings challenge conventional recommendations against collecting salivary sputum for TB diagnosis and could inform new standards for sputum quality.	[Meyer, Amanda J.; Davis, J. Lucian] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Atuheire, Collins] Africa Renewal Univ, Dept Hlth Sci & Special Educ, Kampala, Uganda; [Worodria, William; Andama, Alfred] Makerere Univ, Mulago Hosp, Dept Med, Kampala, Uganda; [Kizito, Samuel; Katamba, Achilles] Makerere Univ, Clin Epidemiol Unit, Kampala, Uganda; [Sanyu, Ingvar; Andama, Alfred; Ayakaka, Irene] Mulago Hosp, Infect Dis Res Collaborat, Kampala, Uganda; [Cattamanchi, Adithya; Huang, Laurence] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Bwanga, Freddie] Makerere Univ, Dept Microbiol, Kampala, Uganda; [Huang, Laurence] Univ Calif San Francisco, Div HIV Infect Dis & Global Med, San Francisco, CA 94143 USA; [Davis, J. Lucian] Yale Sch Med, Pulm Crit Care & Sleep Med Sect, New Haven, CT USA	Yale University; Makerere University; Mulago National Referral Hospital; Makerere University; Mulago National Referral Hospital; University of California System; University of California San Francisco; Makerere University; University of California System; University of California San Francisco; Yale University	Davis, JL (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.; Davis, JL (corresponding author), Yale Sch Med, Pulm Crit Care & Sleep Med Sect, New Haven, CT USA.	lucian.davis@yale.edu	Davis, J. Lucian/AAC-8376-2019; Huang, Laurence/AAZ-7120-2021; Samuel, Kizito/AAE-5463-2020; Huang, Laurence/AAE-1590-2019; Kizito, Samuel/GVU-3763-2022	Davis, J. Lucian/0000-0002-8629-9992; Huang, Laurence/0000-0003-3888-2195; Gupta, Amanda J/0000-0003-2318-1783; Kizito, Samuel/0000-0003-2413-0398	National Institutes of Health [R01HL090335, U01HL098964, R01HL128156, K23AI080147]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090335, K24HL087713, R01HL128156, U01HL098964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health, through the following grants: R01HL090335 (LH), U01HL098964 (LH), R01HL128156 (LH), and K23AI080147 (JLD). In addition, the training and mentoring support provided by D43TW009607 (CA, SK, AK, JLD) and K24HL087713 (LH) were critical to the study. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, AUT REAL TIM NUCL AC; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Cattamanchi A, 2011, AM J RESP CRIT CARE, V183, P547, DOI 10.1164/rccm.201008-1207OC; Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024; Churchyard GJ, 2015, LANCET GLOB HEALTH, V3, pE450, DOI 10.1016/S2214-109X(15)00100-X; Davis JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009859; ELLIOTT AM, 1993, J TROP MED HYG, V96, P1; ELLIOTT AM, 1993, TUBERCLE LUNG DIS, V74, P191, DOI 10.1016/0962-8479(93)90010-U; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Hanrahan CF, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw068; Ho J, 2016, INT J TUBERC LUNG D, V20, P319, DOI 10.5588/ijtld.15.0620; Ho J, 2015, INT J TUBERC LUNG D, V19, P537, DOI 10.5588/ijtld.14.0798; JONES BE, 1993, AM REV RESPIR DIS, V148, P1292, DOI 10.1164/ajrccm/148.5.1292; Kalema N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038888; Khan MS, 2007, LANCET, V369, P1955, DOI 10.1016/S0140-6736(07)60916-7; Kyeyune R, 1999, J ACQ IMMUN DEF SYND, V55, P446; ORINA F, 2014, AFRICAN J HLTH SCI, V27, P446; Sharma SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141011; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Stop TB Partnership Geneva Global Laboratory Initiative, 2013, HDB STOP TB PARTN; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; Walusimbi S, 2013, INT J MYCOBACT, V2, P148, DOI 10.1016/j.ijmyco.2013.06.001; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997; WorldHealthOrganization, 2013, AUT REAL TIM NUCL AM; Worodria W, 2010, EUR RESPIR J, V36, P446, DOI 10.1183/09031936.00010210; Yoon SH, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-172	28	29	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180572	10.1371/journal.pone.0180572	http://dx.doi.org/10.1371/journal.pone.0180572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686705	Green Published, Green Submitted, gold			2022-12-26	WOS:000405464100076
J	Raffray, L; Giry, C; Thirapathi, Y; Reboux, AH; Jaffar-Bandjee, MC; Gasque, P				Raffray, Loic; Giry, Claude; Thirapathi, Yoga; Reboux, Anne-Helene; Jaffar-Bandjee, Marie-Christine; Gasque, Philippe			Increased levels of soluble forms of E-selectin and ICAM-1 adhesion molecules during human leptospirosis	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; ACTIVATION; SEPSIS; BIOMARKERS; FAILURE; DISEASE; MARKERS	Leptospirosis is a multisystemic zoonotic disease with infiltration of visceral organs by Leptospira. The capacity of the vascular endothelium to grant immune cell recruitment and activation in target organs during the disease course remains poorly characterized. We ascertained the levels of expression of several soluble cell adhesion molecules (CAM) notably expressed by endothelial cells in human leptospirosis. We prospectively enrolled 20 hospitalized patients and compared them to 10 healthy controls. Disease severity was defined by one or more organ failures, or death. Plasmatic concentrations of soluble CAM were assessed by multiplex bead assay at the time of patient presentation (M0) and 1 month after hospital discharge. The levels of soluble E-selectin (sCD62E) and soluble intercellular adhesion molecule 1 (sICAM-1, sCD53) were significantly increased in patients compared to controls (p< 0.0001) and at 1 month (p< 0.0001) with median values at 978 ng/ml (interquartile ranges 787-1164; sCD62E) and 1021 ng/ml (690-1428; sCD53). At M0, Soluble P-selectin level (sCD62P) was found to be decreased with levels at 60 ng/ml (0-631) versus 711 ng/ml (343-1113) for healthy controls (p< 0.05). Levels of sICAM-3 (sCD50), sVCAM-1 (vascular cell adhesion molecule, sCD106) and sPECAM-1 (platelet endothelial cell adhesion molecule, sCD31) were not different from healthy subjects at M0. This study shows that two adhesion molecules, shed as soluble forms, are elevated during the acute phase of leptospirosis: E-selectin and s-ICAM1. These molecules may interfere with the process of immune cell recruitment to clear Leptospira at tissue levels.	[Raffray, Loic; Jaffar-Bandjee, Marie-Christine; Gasque, Philippe] Univ La Reunion, CHU La Reunion, UMR PIMIT, CNRS 9192,INSERM,U1187,IRD 249,CYROI, St Clotilde, Reunion, France; [Raffray, Loic; Gasque, Philippe] CHU La Reunion, Lab Biol, Site Felix Guyon, St Denis, Reunion, France; [Raffray, Loic] CHU La Reunion, Internal Med Unit, Site Felix Guyon, St Denis, Reunion, France; [Giry, Claude; Jaffar-Bandjee, Marie-Christine] CHU La Reunion, Microbiol Virol Lab, Site Felix Guyon, St Denis, Reunion, France; [Thirapathi, Yoga] GHER Hosp, Internal Med Unit, St Benoit, Reunion, France; [Reboux, Anne-Helene] CHU La Reunion, Nephrol Dialysis & Transplantat Unit, Site Felix Guyon, St Denis, Reunion, France	CHU Reunion; Institut National de la Sante et de la Recherche Medicale (Inserm); University of La Reunion; CHU Reunion; CHU Reunion; CHU Reunion; CHU Reunion	Raffray, L; Gasque, P (corresponding author), Univ La Reunion, CHU La Reunion, UMR PIMIT, CNRS 9192,INSERM,U1187,IRD 249,CYROI, St Clotilde, Reunion, France.; Raffray, L; Gasque, P (corresponding author), CHU La Reunion, Lab Biol, Site Felix Guyon, St Denis, Reunion, France.; Raffray, L (corresponding author), CHU La Reunion, Internal Med Unit, Site Felix Guyon, St Denis, Reunion, France.	loic.raffray@chu-reunion.fr; philippe.gasque@chu-reunion.fr						Adler B, 2015, CURR TOP MICROBIOL, V387, P1, DOI 10.1007/978-3-662-45059-8; Atzingen MV, 2009, J INFECTION, V59, P264, DOI 10.1016/j.jinf.2009.07.010; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bernardi FD, 2012, HUM PATHOL, V43, P1601, DOI 10.1016/j.humpath.2011.11.017; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Connolly-Andersen AM, 2015, J INFECT DIS, V212, P1061, DOI 10.1093/infdis/jiv161; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; De Brito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071743; DOBRINA A, 1995, INFECT IMMUN, V63, P2995, DOI 10.1128/IAI.63.8.2995-2999.1995; Evangelista K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002672; Fijnheer R, 1997, THROMB HAEMOSTASIS, V77, P1081; Fraga TR, 2011, SCAND J IMMUNOL, V73, P408, DOI 10.1111/j.1365-3083.2010.02505.x; Fraga TR, 2014, J INFECT DIS, V209, P876, DOI 10.1093/infdis/jit569; Goeijenbier M, 2015, J INFECTION, V71, P437, DOI 10.1016/j.jinf.2015.05.016; Gomez RM, 2008, MICROB PATHOGENESIS, V45, P315, DOI 10.1016/j.micpath.2008.08.004; Hashimoto VL, 2013, MICROB PATHOGENESIS, V61-62, P29, DOI 10.1016/j.micpath.2013.04.011; Hochedez P, 2015, EMERG INFECT DIS, V21, P2221, DOI 10.3201/eid2112.141099; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Levett PN, 2005, J MED MICROBIOL, V54, P45, DOI 10.1099/jmm.0.45860-0; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liborio AB, 2015, AM J TROP MED HYG, V92, P611, DOI 10.4269/ajtmh.14-0232; Lukasz A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087490; Martinez-Lopez DG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000918; Page AV, 2013, VIRULENCE, V4, P507, DOI 10.4161/viru.24530; Paris DH, 2008, CLIN EXP IMMUNOL, V153, P63, DOI 10.1111/j.1365-2249.2008.03673.x; Raffray L, 2015, MICROBES INFECT, V17, P451, DOI 10.1016/j.micinf.2015.04.001; Smith CW, 1997, CIRCULATION, V95, P1986; Tantitanawat Sompong, 2003, J Med Assoc Thai, V86, P925; Tubiana S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001991; Vieira ML, 2007, FEMS MICROBIOL LETT, V276, P172, DOI 10.1111/j.1574-6968.2007.00924.x; Xing K, 2012, CRIT CARE, V16, DOI 10.1186/cc11145; Zonneveld R, 2014, CRIT CARE, V18, DOI 10.1186/cc13733	34	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180474	10.1371/journal.pone.0180474	http://dx.doi.org/10.1371/journal.pone.0180474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686648	Green Published, gold, Green Submitted			2022-12-26	WOS:000405464100066
J	Rao, K; Sethi, K; Ischia, J; Gibson, L; Galea, L; Xiao, L; Yim, M; Chang, M; Papa, N; Bolton, D; Shulkes, A; Baldwin, GS; Patel, O				Rao, Kenny; Sethi, Kapil; Ischia, Joseph; Gibson, Luke; Galea, Laurence; Xiao, Lin; Yim, Mildred; Chang, Mike; Papa, Nathan; Bolton, Damien; Shulkes, Arthur; Baldwin, Graham S.; Patel, Oneel			Protective effect of zinc preconditioning against renal ischemia reperfusion injury is dose dependent	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; RAT-KIDNEY; GENE-EXPRESSION; FAILURE; COBALT; CELLS; ACTIVATION; INDUCTION; GASTRIN; MODEL	Objectives Ischemia-reperfusion injury (IRI) is a major cause of acute kidney injury and chronic kidney disease. Two promising preconditioning methods for the kidney, intermittent arterial clamping (IC) and treatment with the hypoxia mimetic cobalt chloride, have never been directly compared. Furthermore, the protective efficacy of the chemically related transition metal Zn (2+) against renal IRI is unclear. Although Co (2+) ions have been shown to protect the kidney via hypoxia inducible factor (HIF), the effect of Zn 2+ ions on the induction of HIF1 alpha, HIF2 alpha and HIF3 alpha has not been investigated previously. Materials and methods The efficacy of different preconditioning techniques was assessed using a Sprague-Dawley rat model of renal IRI. Induction of HIF proteins following Zn (2+) treatment of the human kidney cell lines HK-2 (immortalized normal tubular cells) and ACHN (renal cancer) was measured using Western Blot. Results Following 40 minutes of renal ischemia in rats, cobalt preconditioning offered greater protection against renal IRI than IC as evidenced by lower peak serum creatinine and urea concentrations. ZnCl2 (10 mg/kg) significantly lowered the creatinine and urea concentrations compared to saline-treated control rats following a clinically relevant 60 minutes of ischemia. Zn (2+) induced expression of HIF1 alpha and HIF2 alpha but not HIF3 alpha in HK-2 and ACHN cells. Conclusion ZnCl2 preconditioning protects against renal IRI in a dose-dependent manner. Further studies are warranted to determine the possible mechanisms involved, and to assess the benefit of ZnCl2 preconditioning for clinical applications.	[Rao, Kenny; Sethi, Kapil; Ischia, Joseph; Gibson, Luke; Xiao, Lin; Yim, Mildred; Chang, Mike; Bolton, Damien; Shulkes, Arthur; Baldwin, Graham S.; Patel, Oneel] Univ Melbourne Victoria, Dept Surg, Melbourne, Vic, Australia; [Rao, Kenny; Sethi, Kapil; Ischia, Joseph; Gibson, Luke; Papa, Nathan; Bolton, Damien] Austin Hlth, Dept Urol, Heidelberg, Vic, Australia; [Galea, Laurence] Austin Hlth, Dept Anat Pathol, Heidelberg, Vic, Australia	University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Patel, O (corresponding author), Univ Melbourne Victoria, Dept Surg, Melbourne, Vic, Australia.	patelo@unimelb.edu.au	Papa, Nathan/GLV-0589-2022; Sethi, Kapil/AAF-7908-2020	Sethi, Kapil/0000-0002-6037-8895; Papa, Nathan/0000-0002-3188-1803	Austin Health Medical Research Foundation; Foundation for Surgery Research Scholarship from Australasian Urological Foundation; National Health and Medical Research Council of Australia [1020983]	Austin Health Medical Research Foundation; Foundation for Surgery Research Scholarship from Australasian Urological Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was in part supported by the Austin Health Medical Research Foundation (www.austinmrf.org.au). Dr Kapil Sethi was supported by a Foundation for Surgery Research Scholarship from the Australasian Urological Foundation (www.usanz.org.au/auf). Prof Graham Baldwin is supported by a Senior Research Fellowship (1020983) from the National Health and Medical Research Council of Australia (www.nhmrc.gov.au). All the authors confirm that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babula P, 2012, METALLOMICS, V4, P739, DOI 10.1039/c2mt20081c; Balesaria S, 2010, FEBS LETT, V584, P719, DOI 10.1016/j.febslet.2009.12.023; Becker F, 2009, EUR UROL, V56, P625, DOI 10.1016/j.eururo.2009.07.016; Bernhardt WM, 2006, J AM SOC NEPHROL, V17, P1970, DOI 10.1681/ASN.2005121302; Haase H, 2003, EXP CELL RES, V291, P289, DOI 10.1016/S0014-4827(03)00406-3; HEGENAUER J, 1991, Journal of Trace Elements in Experimental Medicine, V4, P103; Islam CF, 1997, BRIT J UROL, V79, P842, DOI 10.1046/j.1464-410X.1997.00209.x; JABLONSKI P, 1983, TRANSPLANTATION, V35, P198, DOI 10.1097/00007890-198303000-00002; Kaltenberg J, 2010, EUR J IMMUNOL, V40, P1496, DOI 10.1002/eji.200939574; Kim SP, 2012, J UROLOGY, V188, P51, DOI [10.1016/j.juro.2012.10.026, 10.1016/j.juro.2012.03.006]; Lempiainen J, 2012, BRIT J PHARMACOL, V166, P1905, DOI 10.1111/j.1476-5381.2012.01895.x; Li DD, 2011, EXP NEUROL, V230, P302, DOI 10.1016/j.expneurol.2011.05.009; Li PF, 1997, CIRCULATION, V96, P3602; Matsumoto M, 2003, J AM SOC NEPHROL, V14, P1825, DOI 10.1097/01.ASN.0000074239.22357.06; Mecinovic J, 2008, CHEMMEDCHEM, V3, P569, DOI 10.1002/cmdc.200700233; Michels C, 2009, WORLD J UROL, V27, P817, DOI 10.1007/s00345-009-0415-z; Morris SD, 1997, J AM COLL CARDIOL, V29, P1599, DOI 10.1016/S0735-1097(97)00087-9; Nardinocchi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015048; Ogawa T, 1999, AM J NEPHROL, V19, P609, DOI 10.1159/000013529; Park KM, 2001, J BIOL CHEM, V276, P11870, DOI 10.1074/jbc.M007518200; Patel SG, 2012, J UROLOGY, V187, P816, DOI 10.1016/j.juro.2011.10.173; Schanz M, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0503-z; Simonsen LO, 2012, SCI TOTAL ENVIRON, V432, P210, DOI 10.1016/j.scitotenv.2012.06.009; Tanaka T, 2005, LAB INVEST, V85, P1292, DOI 10.1038/labinvest.3700328; Toosy N, 1999, BJU INT, V84, P489; Vengellur A, 2005, PHYSIOL GENOMICS, V22, P308, DOI 10.1152/physiolgenomics.00045.2004; Viswanath K, 2011, BIOMETALS, V24, P171, DOI 10.1007/s10534-010-9371-8; Wang HJ, 2012, RENAL FAILURE, V34, P1324, DOI 10.3109/0886022X.2012.725292; Westwood DA, 2014, BBA-MOL CELL RES, V1843, P2471, DOI 10.1016/j.bbamcr.2014.06.016; Wever KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032296; Xiao L, 2014, J MOL ENDOCRINOL, V52, P29, DOI 10.1530/JME-13-0162; Xiao L, 2012, ENDOCRINOLOGY, V153, P3006, DOI 10.1210/en.2011-2069; Xu ZL, 2013, BIOMETALS, V26, P863, DOI 10.1007/s10534-013-9671-x; ZAGER RA, 1984, KIDNEY INT, V26, P689, DOI 10.1038/ki.1984.204; Zhang L, 2016, J CRIT CARE, V33, P224, DOI 10.1016/j.jcrc.2016.01.026	35	32	33	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180028	10.1371/journal.pone.0180028	http://dx.doi.org/10.1371/journal.pone.0180028			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686686	Green Published, gold			2022-12-26	WOS:000405464100032
J	Schaefer, HL; Brandes, H; Ulber, B; Becker, HC; Vidal, S				Schaefer, Heike L.; Brandes, Haiko; Ulber, Bernd; Becker, Heiko C.; Vidal, Stefan			Evaluation of nine genotypes of oilseed rape (Brassica napus L.) for larval infestation and performance of rape stem weevil (Ceutorhynchus napi Gyll.)	PLOS ONE			English	Article							INTEGRATED PEST-MANAGEMENT; CABBAGE SEEDPOD WEEVIL; MELIGETHES-AENEUS; POLLEN BEETLE; COLEOPTERA-CHRYSOMELIDAE; EUROPEAN POPULATIONS; PLANT-DAMAGE; RESISTANCE; OVIPOSITION; LEPIDOPTERA	The rape stem weevil, Ceutorhynchus napi Gyll., is a serious pest of winter oilseed rape (Brassica napus L.) crops in Europe causing severe yield loss. In currently used oilseed rape cultivars no resistance to C. napi has been identified. Resynthesized lines of B. napus have potential to broaden the genetic variability and may improve resistance to insect pests. In this study, the susceptibility to C. napi of three cultivars, one breeding line and five resynthesized lines of oilseed rape was compared in a semi-field plot experiment under multichoice conditions. Plant acceptance for oviposition was estimated by counting the number of C. napi larvae in stems. The larval instar index and the dry body mass were assessed as indicators of larval performance. The extent of larval feeding within stems was determined by the stem injury coefficient. Morphological stem traits and stem contents of glucosinolates were assessed as potential mediators of resistance. The resynthesized line S30 had significantly fewer larvae than the cultivars Express617 and Visby and the resynthesized lines L122 and L16. The low level of larval infestation in S30 was associated with a low larval instar and stem injury index. Low numbers of larvae were not correlated with the length or diameter of stems, and the level of stem glucosinolates. As indicated by the low larval infestation and slow larval development the resistance of S30 to C. napi is based on both antixenotic and antibiotic properties of the genotypes. The resynthesized line S30 should therefore be introduced into B. napus breeding programs to enhance resistance against C. napi.	[Schaefer, Heike L.; Ulber, Bernd; Vidal, Stefan] Georg August Univ, Sect Agr Entomol, Dept Crop Sci, Div Plant Pathol & Plant Protect, Gottingen, Germany; [Brandes, Haiko; Becker, Heiko C.] Georg August Univ, Sect Plant Breeding, Dept Crop Sci, Gottingen, Germany	University of Gottingen; University of Gottingen	Schaefer, HL (corresponding author), Georg August Univ, Sect Agr Entomol, Dept Crop Sci, Div Plant Pathol & Plant Protect, Gottingen, Germany.	heike.schaefer@gmx.com	Vidal, Stefan/AAC-3130-2020	Vidal, Stefan/0000-0002-1673-4055	German Federal Ministry of Food, Agriculture and Consumer Protection (BMELV) [313-06.01-28-1-45.071-10]; Board of support for Private Plant Breeding in Germany (GFP) [OE 137/10 IF]	German Federal Ministry of Food, Agriculture and Consumer Protection (BMELV); Board of support for Private Plant Breeding in Germany (GFP)	The study was funded by German Federal Ministry of Food, Agriculture and Consumer Protection (BMELV; 313-06.01-28-1-45.071-10) and coordinated by the Board of support for Private Plant Breeding in Germany (GFP; OE 137/10 IF; http://www.bdp-online.de/de/GFPi/Abteilungen_Projekte/Abteilung_Oel-_und_Eiweisspflanzen/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alford David V., 2003, P9, DOI 10.1002/9780470750988.ch2; Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; Ballanger Y, 1987, PHYTOMA, V384, P35; Barari H, 2005, BIOCONTROL, V50, P69, DOI 10.1007/s10526-004-0895-0; Barari Hassan, 2004, IOBC-WPRS Bulletin, V27, P263; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Bartlet E., 1999, Bulletin OILB/SROP, V22, P13; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Baur R, 1998, CHEMOECOLOGY, V8, P163, DOI 10.1007/s000490050021; BODNARYK RP, 1992, PHYTOCHEMISTRY, V31, P2671, DOI 10.1016/0031-9422(92)83609-3; Buchi R, 1996, ANZ SCHADLINGSKD PFL, V69, P136, DOI 10.1007/BF01904715; Buchi R, 2002, AGR ECOSYST ENVIRON, V90, P255, DOI 10.1016/S0167-8809(01)00213-4; BUCHI R, 1988, MITT SCHWEIZ LANDWIR, V35, P110; Cleemput S, 2012, GENET RESOUR CROP EV, V59, P539, DOI 10.1007/s10722-011-9701-x; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Dechert G, 2004, AGR FOREST ENTOMOL, V6, P193, DOI 10.1111/j.1461-9555.2004.00220.x; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; Diederichsen E, 1991, P 8 RAP C JUL 9 11 S; Eickerman M, 2014, EUR J ENTOMOL, V111, P243, DOI 10.14411/eje.2014.018; Eickermann M, 2011, B ENTOMOL RES, V101, P287, DOI 10.1017/S0007485310000489; Eickermann M, 2010, J APPL ENTOMOL, V134, P542, DOI 10.1111/j.1439-0418.2009.01449.x; Ferguson AW, 2003, AGR ECOSYST ENVIRON, V95, P509, DOI 10.1016/S0167-8809(02)00200-1; Ferguson AW, 1995, P 9 INT RAP C JUL 4; Gao YL, 2017, ANNU REV ENTOMOL, V62, P165, DOI 10.1146/annurev-ento-031616-035425; GIAMOUSTARIS A, 1995, ANN APPL BIOL, V126, P347, DOI 10.1111/j.1744-7348.1995.tb05371.x; Girke A., 2002, THESIS; Girke A, 2012, GENET RESOUR CROP EV, V59, P1441, DOI 10.1007/s10722-011-9772-8; Gols R, 2008, J CHEM ECOL, V34, P132, DOI 10.1007/s10886-008-9429-z; Gunthart E., 1949, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V22, P441; Herve MR, 2014, ARTHROPOD-PLANT INTE, V8, P383, DOI 10.1007/s11829-014-9321-4; Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623; KOGAN M, 1978, Bulletin of the Entomological Society of America, V24, P175; Kovacs G, 2017, BIOCONTROL, V62, P29, DOI 10.1007/s10526-016-9765-9; Kowalski B. R., 1986, ANAL CHIM ACTA, V185, P17, DOI DOI 10.1016/0003-2670(86)80028-9; Kurtz B, 2010, ENVIRON ENTOMOL, V39, P1532, DOI 10.1603/EN10025; LANCASHIRE PD, 1991, ANN APPL BIOL, V119, P561, DOI 10.1111/j.1744-7348.1991.tb04895.x; Lee RWH, 2014, THEOR APPL GENET, V127, P419, DOI 10.1007/s00122-013-2228-0; LERIN J, 1993, IOBC WPRS B, V16, P160; Moyes CL, 2001, P ROY SOC B-BIOL SCI, V268, P1567, DOI 10.1098/rspb.2001.1685; Nauen R, 2012, PESTIC BIOCHEM PHYS, V103, P173, DOI 10.1016/j.pestbp.2012.04.012; Nilsson C, 2010, BIOCONTROL-BASED INTEGRATED MANAGEMENT OF OILSEED RAPE PESTS, P305, DOI 10.1007/978-90-481-3983-5_11; Nilsson Christer, 2004, IOBC-WPRS Bulletin, V27, P215; Nuss H., 2004, THESIS; Olsson G., 1980, Brassica crops and wild allies. [II]., P167; Renwick JAA, 2002, ENTOMOL EXP APPL, V104, P35, DOI 10.1023/A:1021231732022; RigginBucci TM, 1996, J ECON ENTOMOL, V89, P891, DOI 10.1093/jee/89.4.891; Rojas JC, 1999, ENVIRON ENTOMOL, V28, P588, DOI 10.1093/ee/28.4.588; Rygulla W, 2007, PHYTOPATHOLOGY, V97, P1391, DOI 10.1094/PHYTO-97-11-1391; Sarfraz M, 2006, CROP PROT, V25, P625, DOI 10.1016/j.cropro.2005.09.011; Schutz S, 1997, NATURWISSENSCHAFTEN, V84, P212, DOI 10.1007/s001140050381; Siemens DH, 1996, ENVIRON ENTOMOL, V25, P1344, DOI 10.1093/ee/25.6.1344; Tansey JA, 2011, P 13 INT RAP C 2011; THIES W, 1977, Z PFLANZENZUCHT, V79, P331; Ulmer BJ, 2006, ENTOMOL EXP APPL, V121, P203, DOI [10.1111/j.1570-8703.2006.00480.x, 10.1111/j.1570-7458.2006.00480.x]; Williams IH, 2010, BIOCONTROL-BASED INTEGRATED MANAGEMENT OF OILSEED RAPE PESTS, P1, DOI 10.1007/978-90-481-3983-5_1; Zimmer CT, 2014, ENTOMOL EXP APPL, V150, P279, DOI 10.1111/eea.12162	56	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180807	10.1371/journal.pone.0180807	http://dx.doi.org/10.1371/journal.pone.0180807			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686731	Green Published, Green Submitted, gold			2022-12-26	WOS:000405464100109
J	Yunus, RM; Wazid, SW; Hairi, NN; Choo, WY; Hairi, FM; Sooryanarayana, R; Ahmad, SN; Razak, IA; Peramalah, D; Aziz, SA; Mohamad, ZL; Mohamad, R; Ali, ZM; Mahmud, ABA				Yunus, Raudah Mohd; Wazid, Syeda Wasfeea; Hairi, Noran N.; Choo, Wan Yuen; Hairi, Farizah M.; Sooryanarayana, Rajini; Ahmad, Sharifah N.; Razak, Inayah A.; Peramalah, Devi; Aziz, Suriyati A.; Mohamad, Zaiton L.; Mohamad, Rosmala; Ali, Zainudin M.; Mahmud, Awang B. Awang			Association between elder abuse and poor sleep: A cross-sectional study among rural older Malaysians	PLOS ONE			English	Article							QUALITY INDEX PSQI; CHICAGO HEALTH; MORTALITY RISK; VERBAL ABUSE; SCALE ESS; ADULTS; NEGLECT; PREVALENCE; VALIDATION; DEPRESSION	Objectives To examine the association between elder abuse and poor sleep using a Malay validated version of Pittsburgh Sleep Quality Index (PSQI). Design This study was divided into two phases. Phase I tested the construct validity and reliability of the Malay version of PSQI. Phase II was a population-based, cross-sectional study with a multi-stage cluster sampling method. Home-based interviews were conducted by trained personnel using a structured questionnaire, to determine exposure and outcome. Setting Kuala Pilah, a district in Negeri Sembilan which is one of the fourteen states in Malaysia. Participants 1648 community-dwelling older Malaysians. Results The Malay version of PSQI had significant test re-test reliability with intra-class correlation coefficients of 0.62. Confirmatory factor analyses revealed that one factor PSQI scale with three components (subjective sleep quality, sleep latency, and sleep disturbances) was most suitable. Cronbach's Alpha was 0.60 and composite reliability was 0.63. PSQI scores were highest among neglect (4.11), followed by physical (4.10), psychological (3.96) and financial abuse (3.60). There was a dose-response relationship between clustering of abuse and PSQI scores; 3.41, 3.50 and 3.84 for "no abuse", "1 type of abuse" and "2 types or more". Generalized linear models revealed six variables as significant determinants of sleep quality-abuse, co-morbidities, self-rated health, income, social support and gait speed. Among abuse subtypes, only neglect was significantly associated with poor sleep. Conclusion The Malay PSQI was valid and reliable. Abuse was significantly associated with poor sleep. As sleep is essential for health and is a good predictor for mortality among older adults, management of abuse victims should entail sleep assessment. Interventions or treatment modalities which focus on improving sleep quality among abuse victims should be designed.	[Yunus, Raudah Mohd; Wazid, Syeda Wasfeea; Hairi, Noran N.; Choo, Wan Yuen; Hairi, Farizah M.; Sooryanarayana, Rajini; Peramalah, Devi; Mahmud, Awang B. Awang] Univ Malaya, Dept Social & Prevent Med, JCUM, Kuala Lumpur, Malaysia; [Yunus, Raudah Mohd] Univ Teknol MARA, Dept Populat Hlth & Prevent Med, Sungai Buloh, Selangor, Malaysia; [Ahmad, Sharifah N.; Razak, Inayah A.; Aziz, Suriyati A.; Mohamad, Zaiton L.; Mohamad, Rosmala; Ali, Zainudin M.] Negeri Sembilan State Hlth Dept JKNNS, Negeri Sembilan, Malaysia	Universiti Malaya; Universiti Teknologi MARA	Yunus, RM (corresponding author), Univ Malaya, Dept Social & Prevent Med, JCUM, Kuala Lumpur, Malaysia.; Yunus, RM (corresponding author), Univ Teknol MARA, Dept Populat Hlth & Prevent Med, Sungai Buloh, Selangor, Malaysia.	raudah.yunus@gmail.com	devi@ummc.edu.my, devi@ummc.edu.my/GYU-6462-2022; CHOO, WAN YUEN/B-8399-2010; Choo, Wan Yuen/ABH-3055-2021; HAIRI, NORAN/B-9339-2010; Bulgiba, Awang/B-8271-2010; Hairi, Farizah MOHD/B-8497-2010; Wazid, Syeda Wasfeea/AAH-3802-2021	Choo, Wan Yuen/0000-0002-2644-6073; HAIRI, NORAN/0000-0002-2692-9016; Bulgiba, Awang/0000-0002-5313-0445; Hairi, Farizah MOHD/0000-0002-2582-3121; Wazid, Syeda Wasfeea/0000-0001-9524-4128	University of Malaya Grand Challenge on Preventing Elder Abuse and Neglect Initiative (PEACE) [GC001D-14 HTM]; Postgraduate Research Grant [PG1042 014A]	University of Malaya Grand Challenge on Preventing Elder Abuse and Neglect Initiative (PEACE); Postgraduate Research Grant	This study was funded by the University of Malaya Grand Challenge on Preventing Elder Abuse and Neglect Initiative (PEACE) (GC001D-14 HTM) and Postgraduate Research Grant (PG1042 014A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstedt T, 2006, SCAND J WORK ENV HEA, V32, P493, DOI 10.5271/sjweh.1054; Aloba OO, 2007, SLEEP MED, V8, P266, DOI 10.1016/j.sleep.2006.08.003; Alvaro PK, 2013, SLEEP, V36, P1059, DOI 10.5665/sleep.2810; Anetzberger G., 2012, CLIN MANAGEMENT ELDE; Baker MW, 2009, J AM GERIATR SOC, V57, P1799, DOI 10.1111/j.1532-5415.2009.02429.x; Bertolazi AN, 2011, SLEEP MED, V12, P70, DOI 10.1016/j.sleep.2010.04.020; Buysse D J, 1989, Psychiatry Res, V28, P193; Buysse DJ, 2008, J CLIN SLEEP MED, V4, P563; Chapman DP, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-3; Choo WY, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011057; Cooper C, 2008, AGE AGEING, V37, P151, DOI 10.1093/ageing/afm194; Cricco M, 2001, J AM GERIATR SOC, V49, P1185, DOI 10.1046/j.1532-5415.2001.49235.x; Curcio G, 2013, NEUROL SCI, V34, P511, DOI 10.1007/s10072-012-1085-y; Dahl RE, 2002, J ADOLESCENT HEALTH, V31, P175, DOI 10.1016/S1054-139X(02)00506-2; Dam TTL, 2008, J AM GERIATR SOC, V56, P1665, DOI 10.1111/j.1532-5415.2008.01846.x; Dew MA, 2003, PSYCHOSOM MED, V65, P63, DOI 10.1097/01.PSY.0000039756.23250.7C; Dillon G., 2013, INT J FAMILY MED, DOI 10.1155/2013/313909; Dong XQ, 2015, GERONTOLOGY, V61, P389, DOI 10.1159/000368577; Dong XQ, 2013, JAMA INTERN MED, V173, P911, DOI 10.1001/jamainternmed.2013.238; Dong XQ, 2013, AM J EMERG MED, V31, P693, DOI 10.1016/j.ajem.2012.12.028; Dong XQ, 2008, J ELDER ABUSE NEGL, V20, P25, DOI 10.1300/J084v20n01_02; Dong XQ, 2009, JAMA-J AM MED ASSOC, V302, P517, DOI 10.1001/jama.2009.1109; Drake CL, 2014, SLEEP, V37, P1295, DOI 10.5665/sleep.3916; Fisher BS, 2006, GERONTOLOGIST, V46, P200, DOI 10.1093/geront/46.2.200; Foley D, 2004, J PSYCHOSOM RES, V56, P497, DOI 10.1016/j.jpsychores.2004.02.010; GEORGE LK, 1989, BRIT J PSYCHIAT, V154, P478, DOI 10.1192/bjp.154.4.478; Goldman SE, 2007, SLEEP, V30, P1317, DOI 10.1093/sleep/30.10.1317; Guo SR, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01126; Johannesen M, 2013, AGE AGEING; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; kerstedt AA, 2006, SCAND J WORK ENV HEA, P493; Kirmayer LJ, 2007, PSYCHOSOM MED, V69, P832, DOI 10.1097/PSY.0b013e31815b002c; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Laumann EO, 2008, J GERONTOL B-PSYCHOL, V63, pS248, DOI 10.1093/geronb/63.4.S248; Magee CA, 2011, SLEEP MED, V12, P346, DOI 10.1016/j.sleep.2010.09.013; Maniam R, 2014, SINGAP MED J, V55, P476, DOI 10.11622/smedj.2014119; Mouton CP, 2010, ANN FAM MED, V8, P206, DOI 10.1370/afm.1095; Naughton C, 2011, AGE AGEING; Nazatul SM, 2008, JUMMEC, V11, P66, DOI DOI 10.22452/jummec.vol11no2.5; Newman AB, 1997, J AM GERIATR SOC, V45, P1; O'Donnell D, 2009, J SLEEP RES, V18, P254, DOI 10.1111/j.1365-2869.2008.00719.x; Olofsson N, 2012, PUBLIC HEALTH, V126, P358, DOI 10.1016/j.puhe.2012.01.015; Omachi TA, 2011, ARTHRIT CARE RES, V63, pS287, DOI 10.1002/acr.20544; Patel NP, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-475; Patel SR, 2008, INT J OBESITY, V32, P1825, DOI 10.1038/ijo.2008.198; Phillips B, 2001, SLEEP MED, V2, P99, DOI 10.1016/S1389-9457(00)00083-6; Pillemer K, 2016, GERONTOLOGIST, V56, pS194, DOI 10.1093/geront/gnw004; Pollak C P, 1990, J Community Health, V15, P123, DOI 10.1007/BF01321316; Potvin O, 2014, INT J GERIATR PSYCH, V29, P1262, DOI 10.1002/gps.4106; Razali R, 2016, NEUROLOGY ASIA, V21; Rose, 2000, HDB PSYCHIAT MEASURE, P544; Shochat T, 2007, ISR MED ASSOC J, V9, P853; Smagula SF, 2016, SLEEP MED REV, V25, P21, DOI 10.1016/j.smrv.2015.01.003; Sooryanarayana R, 2015, J AM GERIATR SOC, V63, P180, DOI 10.1111/jgs.13217; Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23; SPSS I, 2011, IBM SPSS STAT WIND V, V440; Stranges S, 2012, SLEEP, V35, P1173, DOI 10.5665/sleep.2012; Suleiman KH, 2010, WESTERN J NURS RES, V32, P250, DOI 10.1177/0193945909348230; Tomfohr LM, 2013, J CLIN SLEEP MED, V9, P61, DOI 10.5664/jcsm.2342; Troxel WM, 2010, J PSYCHOSOM RES, V69, P459, DOI 10.1016/j.jpsychores.2010.04.003; Yan E, 2001, J INTERPERS VIOLENCE, V16, P1158, DOI 10.1177/088626001016011004; Yao Ke-Wu, 2008, J Nurs Res, V16, P131; Yunus RM, 2017, J ELDER ABUSE NEGL, V29, P59, DOI 10.1080/08946566.2016.1260083; Zahari Z, 2015, PEERJ, V3, DOI 10.7717/peerj.839	64	19	19	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180222	10.1371/journal.pone.0180222	http://dx.doi.org/10.1371/journal.pone.0180222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686603	Green Published, gold, Green Submitted			2022-12-26	WOS:000405464100042
J	Elvstam, O; Medstrand, P; Yilmaz, A; Isberg, PE; Gisslen, M; Bjorkman, P				Elvstam, Olof; Medstrand, Patrik; Yilmaz, Aylin; Isberg, Per-Erik; Gisslen, Magnus; Bjorkman, Per			Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment	PLOS ONE			English	Article							HIV-1-INFECTED PATIENTS; INFECTED PATIENTS; DRUG-RESISTANCE; RALTEGRAVIR INTENSIFICATION; COPY-YEARS; THERAPY; INFLAMMATION; RISK; DETERMINANTS; INTERMITTENT	Objective Although most HIV-infected individuals achieve undetectable viremia during antiretroviral therapy (ART), a subset have low-level viremia (LLV) of varying duration and magnitude. The impact of LLV on treatment outcomes is unclear. We investigated the association between LLV and virological failure and/or all-cause mortality among Swedish patients receiving ART. Methods HIV-infected patients from two Swedish HIV centers were identified from the nationwide register InfCare HIV. Subjects aged >= 15 years with triple agent ART were included at 12 months after treatment initiation if >= 2 following viral load measurements were available. Patients with 2 consecutive HIV RNA values >= 1000 copies/mL at this time point were excluded. Participants were stratified into four categories depending on viremia profiles: permanently suppressed viremia (<50 copies/mL), LLV 50-199 copies/mL, LLV 200-999 copies/mL and viremia >= 1000 copies/mL. Association between all four viremia categories and all-cause death was calculated using survival analysis with viremia as a time-varying covariate, so that patients could change viremia category during follow-up. Association between the three lower categories and virological failure >= 2 consecutive measurements >= 1000 copies/mL) was calculated in a similar manner. Results LLV 50-199 copies/mL was recorded in 70/1015 patients (6.9%) and LLV 200-999 copies/mL in 89 (8.8%) during 7812 person-years of follow-up (median 6.5 years). LLV 200-999 copies/mL was associated with virological failure (adjusted hazard ratio 3.14 [95% confidence interval 1.41-7.03, p<0.01]), whereas LLV 50-199 copies/mL was not (1.01 [0.34-4.31, p = 0.99]; median follow-up 4.5 years). LLV 200-999 copies/mL had an adjusted mortality hazard ratio of 2.29 (0.98-5.32, p = 0.05) and LLV 50-199 copies/mL of 2.19 (0.90-5.37, p = 0.09). Conclusions In this Swedish cohort followed during ART for a median of 4.5 years, LLV 200-999 copies/mL was independently associated with virological failure. Patients with LLV had higher rates of all-cause mortality, although not statistically significant in multivariate analysis.	[Elvstam, Olof; Bjorkman, Per] Lund Univ, Dept Translat Med, Clin Infect Med Unit, Malmo, Sweden; [Medstrand, Patrik] Lund Univ, Dept Translat Med, Clin Virol, Malmo, Sweden; [Yilmaz, Aylin; Gisslen, Magnus] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden; [Isberg, Per-Erik] Lund Univ, Dept Stat, Lund, Sweden	Lund University; Lund University; University of Gothenburg; Lund University	Elvstam, O (corresponding author), Lund Univ, Dept Translat Med, Clin Infect Med Unit, Malmo, Sweden.	olof.elvstam@gmail.com	Elvstam, Olof/AAH-6991-2020; Gisslen, Magnus/D-7454-2015	Elvstam, Olof/0000-0003-3799-9869; Gisslen, Magnus/0000-0002-2357-1020	Sahlgrenska University Hospital [ALFGBG-430271]	Sahlgrenska University Hospital	The study was supported by the Sahlgrenska University Hospital (ALFGBG-430271, https://www.sahlgrenska.se). The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alboukadel Kassambara MK, R PACKAGE VERSION 0; Andrade BB, 2013, J INFECT DIS, V207, P1379, DOI 10.1093/infdis/jit033; Bastard JP, 2012, ANTIVIR THER, V17, P915, DOI 10.3851/IMP2093; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; Boillat-Blanco N, 2015, ANTIVIR THER, V20, P165, DOI 10.3851/IMP2815; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Delaugerre C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036673; Eastburn A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026320; Eriksen J, 2017, INFECT DIS-NOR, V49, P1, DOI 10.1080/23744235.2016.1247495; European AIDS Clinical Society, 2015, EUR GUID TREATM HIV; Garcia-Gasco P, 2008, J ANTIMICROB CHEMOTH, V61, P699, DOI 10.1093/jac/dkm516; Geretti AM, 2008, ANTIVIR THER, V13, P927; Gisslen M, 2017, HIV MED, V18, P305, DOI 10.1111/hiv.12431; Greub G, 2002, AIDS, V16, P1967, DOI 10.1097/00002030-200209270-00017; GUNTHARD HF, 2016, JAMA-J AM MED ASSOC, V316, P191, DOI DOI 10.1001/JAMA.2016.8900; Hatano H, 2011, J INFECT DIS, V203, P960, DOI 10.1093/infdis/jiq138; Helleberg M, 2015, AIDS, V29, P221, DOI 10.1097/QAD.0000000000000540; Hermankova M, JAMA; Hofstra LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110749; Hsue PY, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000422; Huffpost, 2015, HUFFPOST; Karlsson AC, 2004, AIDS, V18, P981, DOI 10.1097/00002030-200404300-00005; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Laprise C, 2013, CLIN INFECT DIS, V57, P1489, DOI 10.1093/cid/cit529; Lima V., 2010, PERSISTENT LOW LEVEL; Llibre JM, 2012, ANTIVIR THER, V17, P355, DOI 10.3851/IMP1917; Mackie NE, 2010, J INFECT DIS, V201, P1303, DOI 10.1086/651618; Mugavero MJ, 2011, CLIN INFECT DIS, V53, P927, DOI 10.1093/cid/cir526; Murray M, 2012, HIV MED, V13, P89, DOI 10.1111/j.1468-1293.2011.00940.x; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Obel N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022698; Quiros-Roldan E, 2016, J ANTIMICROB CHEMOTH; Silva J, 2014, J INT AIDS SOC, V17, P117, DOI 10.7448/IAS.17.4.19668; Snapinn SM, 2005, AM STAT, V59, P301, DOI 10.1198/000313005X70371; Sungkanuparph S, 2006, HIV MED, V7, P437, DOI 10.1111/j.1468-1293.2006.00403.x; Swenson LC, 2014, J CLIN MICROBIOL, V52, P517, DOI 10.1128/JCM.02461-13; Taiwo B, 2011, J INFECT DIS, V204, P515, DOI 10.1093/infdis/jir353; Teira R, 2017, HIV MED, V18, P196, DOI 10.1111/hiv.12413; Therneau T, PACKAGE SURVIVAL ANA; Tien PC, 2010, JAIDS-J ACQ IMM DEF, V55, P316, DOI 10.1097/QAI.0b013e3181e66216; Tobin NH, 2005, J VIROL, V79, P9625, DOI 10.1128/JVI.79.15.9625-9634.2005; Vancoillie L, 2015, ANTIVIR THER, V20, P789, DOI 10.3851/IMP2966; Vandenhende MA, 2015, ANTIVIR THER, V20, P655, DOI 10.3851/IMP2949; Vandenhende MA, 2015, AIDS, V29, P373, DOI 10.1097/QAD.0000000000000544; Walsh C., 2007, HIERPART PACKAGE VER; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; World Health Organization, 2015, CONS GUID US ANT DRU; Wright ST, 2014, JAIDS-J ACQ IMM DEF, V66, P55, DOI 10.1097/QAI.0000000000000125; Yilmaz A, 2010, JAIDS-J ACQ IMM DEF, V55, P590, DOI 10.1097/QAI.0b013e3181f5b3d1; Zhang S, 2010, ANTIVIR THER, V15, P555, DOI 10.3851/IMP1564; Zwahlen M, 2009, INT J EPIDEMIOL, V38, P1624, DOI 10.1093/ije/dyp306	51	32	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180761	10.1371/journal.pone.0180761	http://dx.doi.org/10.1371/journal.pone.0180761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683128	gold, Green Published, Green Submitted			2022-12-26	WOS:000405335200066
J	Hondorp, DW; Bennion, DH; Roseman, EF; Holbrook, CM; Boase, JC; Chiotti, JA; Thomas, MV; Wills, TC; Drouin, RG; Kessel, ST; Krueger, CC				Hondorp, Darryl W.; Bennion, David H.; Roseman, Edward F.; Holbrook, Christopher M.; Boase, James C.; Chiotti, Justin A.; Thomas, Michael V.; Wills, Todd C.; Drouin, Richard G.; Kessel, Steven T.; Krueger, Charles C.			Use of navigation channels by Lake Sturgeon: Does channelization increase vulnerability of fish to ship strikes?	PLOS ONE			English	Article							TIDAL STREAM TRANSPORT; ACIPENSER-FULVESCENS; ATLANTIC STURGEON; ROUTE SELECTION; LARGE RIVER; ST-CLAIR; UPPER MISSISSIPPI; CHINOOK SALMON; SPAWNING-SITE; LOWLAND RIVER	Channelization for navigation and flood control has altered the hydrology and bathymetry of many large rivers with unknown consequences for fish species that undergo riverine migrations. In this study, we investigated whether altered flow distributions and bathymetry associated with channelization attracted migrating Lake Sturgeon (Acipenser fulvescens) into commercial navigation channels, potentially increasing their exposure to ship strikes. To address this question, we quantified and compared Lake Sturgeon selection for navigation channels vs. alternative pathways in two multi-channel rivers differentially affected by channelization, but free of barriers to sturgeon movement. Acoustic telemetry was used to quantify Lake Sturgeon movements. Under the assumption that Lake Sturgeon navigate by following primary flow paths, acoustic-tagged Lake Sturgeon in the more-channelized lower Detroit River were expected to choose navigation channels over alternative pathways and to exhibit greater selection for navigation channels than conspecifics in the less-channelized lower St. Clair River. Consistent with these predictions, acoustic-tagged Lake Sturgeon in the more-channelized lower Detroit River selected the higher-flow and deeper navigation channels over alternative migration pathways, whereas in the less-channelized lower St. Clair River, individuals primarily used pathways alternative to navigation channels. Lake Sturgeon selection for navigation channels as migratory pathways also was significantly higher in the more-channelized lower Detroit River than in the less-channelized lower St. Clair River. We speculated that use of navigation channels over alternative pathways would increase the spatial overlap of commercial vessels and migrating Lake Sturgeon, potentially enhancing their vulnerability to ship strikes. Results of our study thus demonstrated an association between channelization and the path use of migrating Lake Sturgeon that could prove important for predicting sturgeon-vessel interactions in navigable rivers as well as for understanding how fish interact with their habitat in landscapes altered by human activity.	[Hondorp, Darryl W.; Bennion, David H.; Roseman, Edward F.] US Geol Survey, Great Lakes Sci Ctr, Ann Arbor, MI 48105 USA; [Holbrook, Christopher M.] US Geol Survey, Great Lakes Sci Ctr, Hammond Bay Biol Stn, Millersburg, MI USA; [Boase, James C.; Chiotti, Justin A.] US Fish & Wildlife Serv, Alpena Fish & Wildlife Conservat Off, Waterford Substn, Waterford, MI USA; [Thomas, Michael V.; Wills, Todd C.] Michigan Dept Nat Resources, Lake St Clair Fisheries Res Stn, Harrison Township, MI USA; [Drouin, Richard G.] Ontario Minist Nat Resources & Forestry, Lake Erie Management Unit, London, ON, Canada; [Kessel, Steven T.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Krueger, Charles C.] Michigan State Univ, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service; Ministry of Natural Resources & Forestry; Michigan State University; Michigan State University	Hondorp, DW (corresponding author), US Geol Survey, Great Lakes Sci Ctr, Ann Arbor, MI 48105 USA.	dhondorp@usgs.gov		Hondorp, Darryl/0000-0002-5182-1963; Roseman, Edward/0000-0002-5315-9838	Great Lakes Fishery Trust [2011.1200]; Great Lakes Restoration Initiative [GL0 0E23010-3]; U. S.Geological Survey via Great Lakes Restoration Initiative Template (Fish Habitat Enhancement Strategies for the Huron Erie Corridors) [70]	Great Lakes Fishery Trust; Great Lakes Restoration Initiative; U. S.Geological Survey via Great Lakes Restoration Initiative Template (Fish Habitat Enhancement Strategies for the Huron Erie Corridors)	This work was funded by grant 2011.1200 of the Great Lakes Fishery Trust (https://www.glft.org/) to DWH and CCK; by Great Lakes Restoration Initiative appropriation GL0 0E23010-3 to the Great Lakes Fishery Commission (http://www.glfc.org/); and by the U. S.Geological Survey via Great Lakes Restoration Initiative Template 70 (Fish Habitat Enhancement Strategies for the Huron Erie Corridors).The funders had no role in study design, data collection andanalysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, ANIM BIOTELEM; [Anonymous], [No title captured]; Balazik MT, 2015, N AM J FISH MANAGE, V35, P398, DOI 10.1080/02755947.2015.1011358; Balazik MT, 2012, N AM J FISH MANAGE, V32, P1062, DOI 10.1080/02755947.2012.716016; Boase JC, 2011, J APPL ICHTHYOL, V27, P58, DOI 10.1111/j.1439-0426.2011.01827.x; Briggs AS, 2016, J FRESHWATER ECOL, V31, P477, DOI 10.1080/02705060.2016.1152321; BROOKER MP, 1985, GEOGR J, V151, P63, DOI 10.2307/633280; Brown JJ, 2010, FISHERIES, V35, P72, DOI 10.1577/1548-8446-35.2.72; Caswell NM, 2004, J APPL ICHTHYOL, V20, P1, DOI 10.1111/j.1439-0426.2004.00499.x; Cooke SJ, 2011, REV FISH BIOL FISHER, V21, P127, DOI 10.1007/s11160-010-9193-3; Dittman AH, 1996, J EXP BIOL, V199, P83; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; Forsythe PS, 2012, J FISH BIOL, V81, P35, DOI 10.1111/j.1095-8649.2012.03308.x; Goodwin RA, 2014, P NATL ACAD SCI USA, V111, P5277, DOI 10.1073/pnas.1311874111; Goodyear CD, ATLAS SPAWNING NURSE; GORE JA, 1995, BIOSCIENCE, V45, P142, DOI 10.2307/1312553; Gutreuter S, 2003, T AM FISH SOC, V132, P646, DOI 10.1577/T01-098; Gutreuter S, 2006, CAN J FISH AQUAT SCI, V63, P2418, DOI 10.1139/F06-129; Guttridge TL, 2013, ANIM COGN, V16, P55, DOI 10.1007/s10071-012-0550-6; Holtschlag DJ, 2002, J GREAT LAKES RES, V28, P379, DOI 10.1016/S0380-1330(02)70592-3; Jansen HM, 2007, ICES J MAR SCI, V64, P1437, DOI 10.1093/icesjms/fsm132; JURAJDA P, 1995, REGUL RIVER, V10, P207, DOI 10.1002/rrr.3450100215; Keefer ML, 2006, CAN J FISH AQUAT SCI, V63, P1752, DOI 10.1139/F06-068; Killgore KJ, 2011, T AM FISH SOC, V140, P570, DOI 10.1080/00028487.2011.581977; LEVY DA, 1995, CAN J FISH AQUAT SCI, V52, P1, DOI 10.1139/f95-001; Miranda LE, 2013, J APPL ICHTHYOL, V29, P316, DOI 10.1111/jai.12132; Montgomery J, 2000, PHILOS T ROY SOC B, V355, P1325, DOI 10.1098/rstb.2000.0693; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nichols SJ, 2003, J GREAT LAKES RES, V29, P383; NIELSEN L A, 1986, Polskie Archiwum Hydrobiologii, V33, P277; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; Northcote T.G., 1984, NATO Conference Series IV Marine Sciences, V14, P317; OGOWER AK, 1995, MAR FRESHWATER RES, V46, P861, DOI 10.1071/MF9950861; Oscoz J, 2005, HYDROBIOLOGIA, V543, P191, DOI 10.1007/s10750-004-7422-2; Parker SJ, 1997, J MAR BIOL ASSOC UK, V77, P871, DOI 10.1017/S0025315400036237; Peake S, 1997, CAN J FISH AQUAT SCI, V54, P1361, DOI 10.1139/cjfas-54-6-1361; Peterson DL, 2007, REV FISH BIOL FISHER, V17, P59, DOI 10.1007/s11160-006-9018-6; Pilcher MW, 2004, BIOLOGIA, V59, P669; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rusak JA, 1997, CAN J ZOOL, V75, P383, DOI 10.1139/z97-048; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Scott WB., 1973, FRESHWATER FISHES CA; Steel AE, 2013, ENVIRON BIOL FISH, V96, P215, DOI 10.1007/s10641-012-9992-6; SWALES S, 1982, FISH MANAGE, V13, P105; Thomas MV, 2002, J APPL ICHTHYOL, V18, P495, DOI 10.1046/j.1439-0426.2002.00387.x; Use of Fishes in Research Committees of the American Fisheries Society and the American Society of Ichthyologists and Herpetologists, 2014, GUIDELINES USE FISHE; Wagner GN, 2011, REV FISH BIOL FISHER, V21, P71, DOI 10.1007/s11160-010-9191-5; Watanabe YY, 2013, ENVIRON BIOL FISH, V96, P123, DOI 10.1007/s10641-012-0019-0; Wohl E., 2004, DISCONNECTED RIVERS	49	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179791	10.1371/journal.pone.0179791	http://dx.doi.org/10.1371/journal.pone.0179791			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678798	Green Published, Green Submitted, gold			2022-12-26	WOS:000405272200028
J	Dos Santos, PC; Panero, J; Stanganelli, C; Nagore, VP; Stella, F; Bezares, R; Slavutsky, I				Carolina Dos Santos, Patricia; Panero, Julieta; Stanganelli, Carmen; Palau Nagore, Virginia; Stella, Flavia; Bezares, Raimundo; Slavutsky, Irma			Dysregulation of H/ACA ribonucleoprotein components in chronic lymphocytic leukemia	PLOS ONE			English	Article							TELOMERE-ASSOCIATED GENES; PROTEIN COMPLEX; MUTATION STATUS; EXPRESSION; SURVIVAL; LENGTH; SUBGROUPS; MAINTENANCE; ABERRATIONS; PROGNOSIS	Telomeres are protective repeats of TTAGGG sequences located at the end of human chromosomes. They are essential to maintain chromosomal integrity and genome stability. Telomerase is a ribonucleoprotein complex containing an internal RNA template (hTR) and a catalytic subunit (hTERT). The human hTR gene consists of three major domains; among them the H/ACA domain is essential for telomere biogenesis. H/ACA ribonucleoprotein (RNP) complex is composed of four evolutionary conserved proteins, including dyskerin (encoded by DKC1 gene), NOP10, NHP2 and GAR1. In this study, we have evaluated the expression profile of the H/ACA RNP complex genes: DKC1, NOP10, NHP2 and GAR1, as well as hTERT and hTR mRNA levels, in patients with chronic lymphocytic leukemia (CLL). Results were correlated with the number and type of genetic alteration detected by conventional cytogenetics and FISH (fluorescence in situ hybridization), IGHV (immunoglobulin heavy chain variable region) mutational status, telomere length (TL) and clinico-pathological characteristics of patients. Our results showed significant decreased expression of GAR1, NOP10, DKC1 and hTR, as well as increased mRNA levels of hTERT in patients compared to controls (p <= 0.04). A positive correlation between the expression of GAR1-NHP2, GAR1NOP10, and NOP10-NHP2 (p<0.0001), were observed. The analysis taking into account prognostic factors showed a significant increased expression of hTERT gene in unmutated-IGHV cases compared to mutated-CLL patients (p = 0.0185). The comparisons among FISH groups exhibited increased expression of DKC1 in cases with two or more alterations with respect to no abnormalities, trisomy 12 and del13q14, and of NHP2 and NOP10 compared to those with del13q14 (p = 0.03). The analysis according to TL showed a significant increased expression of hTERT (p = 0.0074) and DKC1 (p = 0.0036) in patients with short telomeres compared to those with long TL. No association between gene expression and clinical parameters was found. Our results suggest a role for these telomere associated genes in genomic instability and telomere dysfunction in CLL.	[Carolina Dos Santos, Patricia; Panero, Julieta; Palau Nagore, Virginia; Stella, Flavia; Slavutsky, Irma] Consejo Nacl Invest Cient & Tecn, Acad Nacl Med, Inst Med Expt, Lab Genet Neoplasias Linfoides, Buenos Aires, DF, Argentina; [Stanganelli, Carmen] Acad Nacl Med Buenos Aires, Inst Invest Hematol, Div Patol Mol, Buenos Aires, DF, Argentina; [Bezares, Raimundo] Hosp Teodoro Alvarez, Serv Hematol, Buenos Aires, DF, Argentina	Buenos Aires National Academy of Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Buenos Aires National Academy of Medicine; IIHEMA - Instituto de Investigaciones Hematologicas	Slavutsky, I (corresponding author), Consejo Nacl Invest Cient & Tecn, Acad Nacl Med, Inst Med Expt, Lab Genet Neoplasias Linfoides, Buenos Aires, DF, Argentina.	islavutsky@hematologia.anm.edu.ar		Dos Santos, Patricia Carolina/0000-0002-6607-7620	National Agency of Scientific and Technical Promotion (ANPCyT) [PICT-2014-1566]; National Cancer Institute of Argentina	National Agency of Scientific and Technical Promotion (ANPCyT)(ANPCyT); National Cancer Institute of Argentina	This work was supported by grants of the National Agency of Scientific and Technical Promotion (ANPCyT) PICT-2014-1566 and the National Cancer Institute of Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrisani A, 2014, BIOL CHEM, V395, P593, DOI 10.1515/hsz-2013-0287; Bachand F, 2001, NUCLEIC ACIDS RES, V29, P3385, DOI 10.1093/nar/29.16.3385; Bechter OE, 1998, CANCER RES, V58, P4918; Bieche I, 2000, CLIN CANCER RES, V6, P452; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Cao Y, 2002, ONCOGENE, V21, P3130, DOI 10.1038/sj.onc.1205419; Chiodi I, 2013, BBA-MOL CELL RES, V1833, P1885, DOI 10.1016/j.bbamcr.2013.03.030; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; Collins K, 2006, NAT REV MOL CELL BIO, V7, P484, DOI 10.1038/nrm1961; Damle RN, 2004, BLOOD, V103, P375, DOI 10.1182/blood-2003-04-1345; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Darzacq X, 2006, J CELL BIOL, V173, P207, DOI 10.1083/jcb.200601105; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de la Guardia RD, 2012, J CELL MOL MED, V16, P3009, DOI 10.1111/j.1582-4934.2012.01628.x; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Dos Santos P, 2015, TUMOR BIOL, V36, P8317, DOI 10.1007/s13277-015-3556-2; Egan ED, 2012, MOL CELL BIOL, V32, P2428, DOI 10.1128/MCB.00286-12; Fernandez-Garcia I, 2013, INTEGR BIOL-UK, V5, P402, DOI 10.1039/c2ib20219k; Ferri CA, 2015, EUR J HAEMATOL, V94, P270, DOI 10.1111/ejh.12358; Folini M, 2005, EUR J CANCER, V41, P624, DOI 10.1016/j.ejca.2004.12.002; Forsyth NR, 2002, DIFFERENTIATION, V69, P188, DOI 10.1046/j.1432-0436.2002.690412.x; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Hoxha M, 2014, GENE CHROMOSOME CANC, V53, P612, DOI 10.1002/gcc.22171; Lin P, 2015, HISTOCHEM CELL BIOL, V144, P543, DOI 10.1007/s00418-015-1359-6; Mansouri L, 2013, AM J HEMATOL, V88, P647, DOI 10.1002/ajh.23466; Mason PJ, 2011, CANCER GENET-NY, V204, P635, DOI 10.1016/j.cancergen.2011.11.002; Meier UT, 2006, TRENDS BIOCHEM SCI, V31, P311, DOI 10.1016/j.tibs.2006.04.002; Meier UT, 2005, CHROMOSOMA, V114, P1, DOI 10.1007/s00412-005-0333-9; O'Callaghan NJ, 2008, BIOTECHNIQUES, V44, P807, DOI 10.2144/000112761; Panero J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137972; Panero J, 2015, MOL BIOTECHNOL, V57, P155, DOI 10.1007/s12033-014-9811-8; Panero J, 2010, MOL MED, V16, P471, DOI 10.2119/molmed.2010.00057; Pogacic V, 2000, MOL CELL BIOL, V20, P9028, DOI 10.1128/MCB.20.23.9028-9040.2000; Poncet D, 2008, BLOOD, V111, P2388, DOI 10.1182/blood-2007-09-111245; RAI KR, 1975, BLOOD, V46, P219, DOI 10.1182/blood.V46.2.219.219; Rampazzo E, 2012, HAEMATOL-HEMATOL J, V97, P56, DOI 10.3324/haematol.2011.049874; Roos G, 2008, BLOOD, V111, P2246, DOI 10.1182/blood-2007-05-092759; Sbarrato T, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.148; Sellmann L, 2011, INT J HEMATOL, V93, P74, DOI 10.1007/s12185-010-0750-2; Stanganelli C, 2013, CL LYMPH MYELOM LEUK, V13, P447, DOI 10.1016/j.clml.2013.02.019; Tchirkov A, 2004, ANN ONCOL, V15, P1476, DOI 10.1093/annonc/mdh389; Terrin L, 2007, LEUKEMIA, V21, P965, DOI 10.1038/sj.leu.2404607; Travella A, 2013, HEMATOL ONCOL, V31, P339, DOI 10.1002/hon.2025; Ulaner GA, 2004, AM J MED, V117, P262, DOI 10.1016/j.amjmed.2004.02.048; von Stedingk K, 2013, TRANSL ONCOL, V6, P447, DOI 10.1593/tlo.13112; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764	47	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179883	10.1371/journal.pone.0179883	http://dx.doi.org/10.1371/journal.pone.0179883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666010	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608700043
J	Debebe, A; Medina, V; Chen, CY; Mahajan, IM; Jia, C; Fu, D; He, L; Zeng, N; Stiles, BW; Chen, CL; Wang, M; Aggarwal, KR; Peng, Z; Huang, J; Chen, J; Li, M; Dong, T; Atkins, S; Borok, Z; Yuan, W; Machida, K; Ju, C; Kahn, M; Johnson, D; Stiles, BL				Debebe, A.; Medina, V.; Chen, C-Y; Mahajan, I. M.; Jia, C.; Fu, D.; He, L.; Zeng, N.; Stiles, B. W.; Chen, C-L; Wang, M.; Aggarwal, K-R; Peng, Z.; Huang, J.; Chen, J.; Li, M.; Dong, T.; Atkins, S.; Borok, Z.; Yuan, W.; Machida, K.; Ju, C.; Kahn, M.; Johnson, D.; Stiles, B. L.			Wnt/beta-catenin activation and macrophage induction during liver cancer development following steatosis	ONCOGENE			English	Article							INTESTINAL STEM-CELLS; HEPATOCELLULAR-CARCINOMA; LIPID-METABOLISM; BETA-CATENIN; PERIPORTAL HEPATOCYTES; PROGENITOR CELLS; MICE LACKING; FATTY LIVER; PTEN; EXPRESSION	Obesity confers an independent risk for carcinogenesis. In the liver, steatosis often proceeds cancer formation; however, the mechanisms by which steatosis promotes carcinogenesis is unknown. We hypothesize that steatosis alters the microenvironment to promote proliferation of tumor initiating cells (TICs) and carcinogenesis. We used several liver cancer models to address the mechanisms underlying the role of obesity in cancer and verified these findings in patient populations. Using bioinformatics analysis and verified by biochemical assays, we identified that hepatosteatosis resulting from either Pten deletion or transgenic expression of HCV core/NS5A proteins, promotes the activation of Wnt/beta-catenin. We verified that high fat diet lipid accumulation is also capable of inducing Wnt/beta-catenin. Caloric restriction inhibits hepatosteatosis, reduces Wnt/beta-catenin activation and blocks the expansion of TICs leading to complete inhibition of tumorigenesis without affecting the phosphatase and tensin homologue deleted on chromosome 10 (PTEN) loss regulated protein kinase B (AKT) activation. Pharmacological inhibition or loss of the Wnt/beta-catenin signal represses TIC growth in vitro, and decreases the accumulation of TICs in vivo. In human liver cancers, ontology analysis of gene set enrichment analysis (GSEA)-defined Wnt signature genes indicates that Wnt signaling is significantly induced in tumor samples compared with healthy livers. Indeed, Wnt signature genes predict 90% of tumors in a cohort of 558 patient samples. Selective depletion of macrophages leads to reduction of Wnt and suppresses tumor development, suggesting infiltrating macrophages as a key source for steatosis-induced Wnt expression. These data established Wnt/beta-catenin as a novel signal produced by infiltrating macrophages induced by steatosis that promotes growth of tumor progenitor cells, underlying the increased risk of liver tumor development in obese individuals.	[Debebe, A.; Medina, V.; Chen, C-Y; Mahajan, I. M.; Jia, C.; He, L.; Zeng, N.; Aggarwal, K-R; Peng, Z.; Huang, J.; Chen, J.; Li, M.; Dong, T.; Atkins, S.; Kahn, M.; Stiles, B. L.] Univ Southern Calif, Sch Pharm, Pharmacol & Pharmaceut Sci, PSC 402,1985 Zonal Ave, Los Angeles, CA 90089 USA; [Jia, C.] Tongji Univ, Shanghai Peoples Hosp 10, Dept Nucl Med, Shanghai, Peoples R China; [Fu, D.] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Cent Lab Med Res, Shanghai, Peoples R China; [Stiles, B. W.] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Chen, C-L; Yuan, W.; Machida, K.] Univ Southern Calif, Keck Sch Med, Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Wang, M.; Ju, C.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Pharmaceut Sci, Aurora, CO USA; [Borok, Z.] Univ Southern Calif, Keck Sch Med, Will Rogers Inst Pulm Res Ctr, Med, Los Angeles, CA 90033 USA; [Borok, Z.] Univ Southern Calif, Keck Sch Med, Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Borok, Z.; Kahn, M.; Stiles, B. L.] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA; [Johnson, D.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Stiles, B. L.] Univ Southern Calif, Keck Sch Med, Pathol, Los Angeles, CA 90033 USA	University of Southern California; Tongji University; Tongji University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Southern California; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Southern California; University of Southern California; University of Southern California; Baylor College of Medicine; University of Southern California	Stiles, BL (corresponding author), Univ Southern Calif, Sch Pharm, Pharmacol & Pharmaceut Sci, PSC 402,1985 Zonal Ave, Los Angeles, CA 90089 USA.	bstiles@usc.edu	Fu, Da/GXF-2656-2022; Jia, Chengyou/AAV-1153-2021; peng, zhechu/AAA-5942-2022; AVILA, MATIAS A/Y-6342-2019	Dong, Tiange/0000-0002-0612-4261; AVILA, MATIAS A/0000-0001-6570-3557; Peng, Zhechu/0000-0002-9301-7164	NIH [R01CA154986-01, R01 HL112638-01, 1R01AA018857, P50AA11999, R01CA108614-06A1]; NIDDK [R01DK084241-01]; USC center for Liver Disease [P30DK48522]; Norris Comprehensive Cancer Center [P30CA014089]; CIRM; USC; Hastings Foundation; NATIONAL CANCER INSTITUTE [P30CA014089, R01CA154986, R01CA108614] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084241, P30DK048522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM086262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011999, R01AA018857, R01AA025204] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); USC center for Liver Disease; Norris Comprehensive Cancer Center; CIRM(California Institute for Regenerative Medicine); USC; Hastings Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We acknowledge the technical support from Ms Mungoma, Carrithers, Zhang, Barsky and Mr Li, Dr Bryan W Stiles would like to state that 'this work was done as a private venture and not in the author's capacity as an employee of the Jet Propulsion Laboratory, California Institute of Technology'. This work was supported by NIH grants R01CA154986-01 (BLS). Dr Stiles also acknowledges support from NIDDK (R01DK084241-01). Dr Borok was supported by NIH grant R01 HL112638-01. Dr Machida would like to acknowledge NIH grants 1R01AA018857 and P50AA11999. We acknowledge support from USC center for Liver Disease (P30DK48522) and Norris Comprehensive Cancer Center (P30CA014089). Dr Johnson acknowledges funding from NIH grant R01CA108614-06A1. AD, ZP and VM are partially supported by CIRM pre- and post-doctoral and F32 Developmental Biology training fellowship. NZ acknowledges the support of USC provost postdoctoral fellowship. ZB is Edgington Chair in Medicine and was supported by the Hastings Foundation.	Adinolfi LE, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060803; ALBANES D, 1987, Nutrition and Cancer, V9, P199; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Carpentier R, 2011, GASTROENTEROLOGY, V141, P1432, DOI 10.1053/j.gastro.2011.06.049; Casali A, 2009, CELL STEM CELL, V4, P124, DOI 10.1016/j.stem.2009.01.009; Chen CL, 2016, CELL METAB, V23, P206, DOI 10.1016/j.cmet.2015.12.004; Chen CL, 2013, J CLIN INVEST, V123, P2832, DOI 10.1172/JCI65859; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Domagala-Kulawik J, 2015, TRANSL LUNG CANCER R, V4, P177, DOI 10.3978/j.issn.2218-6751.2015.01.11; Eckert C, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00179; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Galicia VA, 2010, GASTROENTEROLOGY, V139, P2170, DOI 10.1053/j.gastro.2010.09.002; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Gentzler R, 2016, IMMUNOTHERAPY-UK, V8, P583, DOI 10.2217/imt-2015-0029; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; He LN, 2010, AM J PATHOL, V176, P2302, DOI 10.2353/ajpath.2010.090931; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Inagawa S, 2002, CLIN CANCER RES, V8, P450; Janabi M, 2000, ARTERIOSCL THROM VAS, V20, P1953, DOI 10.1161/01.ATV.20.8.1953; Johnson DL, 2016, TRENDS ENDOCRIN MET, V27, P742, DOI 10.1016/j.tem.2016.04.016; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Kaler P, 2009, ONCOGENE, V28, P3892, DOI 10.1038/onc.2009.247; Lamb JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020090; Lee JS, 2004, GASTROENTEROLOGY, V127, pS51, DOI 10.1053/j.gastro.2004.09.015; Li Y, 2013, J BIOL CHEM, V288, P25007, DOI 10.1074/jbc.M113.450353; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Monga SP, 2015, GASTROENTEROLOGY, V148, P1294, DOI 10.1053/j.gastro.2015.02.056; Moon BC, 2012, ARTERIOSCL THROM VAS, V32, P236, DOI 10.1161/ATVBAHA.111.241356; Palian BM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004789; Peng WY, 2016, CANCER DISCOV, V6, P202, DOI 10.1158/2159-8290.CD-15-0283; Qian Yan, 2005, Hepatobiliary Pancreat Dis Int, V4, P173; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Rountree CB, 2009, STEM CELLS, V27, P290, DOI 10.1634/stemcells.2008-0332; Spranger S, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1086862; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Staal FJT, 2010, J CELL BIOCHEM, V109, P844, DOI 10.1002/jcb.22467; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Taniguchi CM, 2006, CELL METAB, V3, P343, DOI 10.1016/j.cmet.2006.04.005; Ueda S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002800; Widelitz Randall B, 2008, Organogenesis, V4, P123; Woo SR, 2015, ANNU REV IMMUNOL, V33, P445, DOI 10.1146/annurev-immunol-032414-112043; Xu XL, 2006, J CLIN INVEST, V116, P1843, DOI 10.1172/JCI27282; Yamashita T, 2013, J CLIN INVEST, V123, P1911, DOI 10.1172/JCI66024	47	47	51	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 26	2017	36	43					6020	6029		10.1038/onc.2017.207	http://dx.doi.org/10.1038/onc.2017.207			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FK9OT	28671671	hybrid, Green Published			2022-12-26	WOS:000413841400010
J	Abeyrathne, PD; Grigorieff, N				Abeyrathne, Priyanka D.; Grigorieff, Nikolaus			Expression, purification, and contaminant detection for structural studies of Ralstonia metallidurance ClC protein rm1	PLOS ONE			English	Article							MEMBRANE-PROTEINS; CHLORIDE CHANNEL; CYTOPLASMIC DOMAIN; ACRB CONTAMINATION; ION-CHANNEL; CRYSTALLIZATION; OVEREXPRESSION; TRANSPORTER; DETERGENTS; OPTIMIZATION	Single-particle electron cryo-microscopy (cryo-EM) has become a popular method for highresolution study of the structural and functional properties of proteins. However, sufficient expression and purification of membrane proteins holds many challenges. We describe methods to overcome these obstacles using ClC-rm1, a prokaryotic chloride channel (ClC) family protein from Ralstonia metallidurans, overexpressed in Escherichia coli (E. coli) BL21(DE3) strain. Mass spectrometry and electron microscopy analyses of purified samples revealed multiple contaminants that can obfuscate results of subsequent high-resolution structural analysis. Here we describe the systematic optimization of sample preparation procedures, including expression systems, solubilization techniques, purification protocols, and contamination detection. We found that expressing ClC-rm1 in E. coli BL21(DE3) and using n-dodecyl-beta-D-maltopyranoside as a detergent for solubilization and purification steps resulted in the highest quality samples of those we tested. However, although protein yield, sample stability, and the resolution of structural detail were improved following these changes, we still detected contaminants including Acriflavine resistant protein AcrB. AcrB was particularly difficult to remove as it co-purified with ClC-rm1 due to four intrinsic histidine residues at its C-terminus that bind to affinity resins. We were able to obtain properly folded pure ClC-rm1 by adding eGFP to the C-terminus and overexpressing the protein in the Delta acrB variant of the JW0451-2 E. coli strain.	[Abeyrathne, Priyanka D.; Grigorieff, Nikolaus] Howard Hughes Med Inst, Janelia Res Campus,Helix Dr, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Abeyrathne, PD (corresponding author), Howard Hughes Med Inst, Janelia Res Campus,Helix Dr, Ashburn, VA 20147 USA.	abeyrathnep@janelia.hhmi.org		Grigorieff, Nikolaus/0000-0002-1506-909X	Howard Hughes Medical Institute Internal	Howard Hughes Medical Institute Internal	This work was supported by Howard Hughes Medical Institute Internal to Priyanka D Abeyrathne and Nikolaus Grigorieff.	Abeyrathne PD, 2011, COMPREHENSIVE BIOPHYSICS, VOL 1: BIOPHYSICAL TECHNIQUES FOR STRUCTURAL CHARACTERIZATION OF MACROMOLECULES, P277, DOI 10.1016/B978-0-12-374920-8.00119-3; Abeyrathne PD, 2016, BIOCHIMIE, V128, P154, DOI 10.1016/j.biochi.2016.08.008; Arnold Thomas, 2008, Curr Protoc Protein Sci, VChapter 4, DOI 10.1002/0471140864.ps0408s53; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Bell SP, 2006, BIOCHEMISTRY-US, V45, P6773, DOI 10.1021/bi0523815; Chen Y, 2016, SCIENCE, V353, DOI 10.1126/science.aad8266; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Drew D, 2005, PROTEIN SCI, V14, P2011, DOI 10.1110/ps.051466205; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2007, FEBS LETT, V581, P2839, DOI 10.1016/j.febslet.2007.04.016; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; Glover CAP, 2011, J STRUCT BIOL, V176, P419, DOI 10.1016/j.jsb.2011.09.005; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Kalbermatter D, 2015, J STRUCT BIOL, V191, P376, DOI 10.1016/j.jsb.2015.08.003; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; KUHLBRANDT W, 1988, Q REV BIOPHYS, V21, P429, DOI 10.1017/S0033583500004625; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lucas M, 2010, J MOL BIOL, V396, P800, DOI 10.1016/j.jmb.2009.12.012; Maduke M, 1999, J GEN PHYSIOL, V114, P713, DOI 10.1085/jgp.114.5.713; Markovic S, 2007, STRUCTURE, V15, P715, DOI 10.1016/j.str.2007.04.013; Meyer S, 2006, STRUCTURE, V14, P299, DOI 10.1016/j.str.2005.10.008; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; Mindell JA, 2001, NATURE, V409, P219, DOI 10.1038/35051631; Parcej D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067112; Popot JL, 2011, ANNU REV BIOPHYS, V40, P379, DOI 10.1146/annurev-biophys-042910-155219; Postis V, 2015, BBA-BIOMEMBRANES, V1848, P496, DOI 10.1016/j.bbamem.2014.10.018; Prive GG, 2007, METHODS, V41, P388, DOI 10.1016/j.ymeth.2007.01.007; Psakis G, 2009, J STRUCT BIOL, V166, P107, DOI 10.1016/j.jsb.2008.12.007; Rigaud JL, 2000, BBA-BIOMEMBRANES, V1508, P112, DOI 10.1016/S0005-2736(00)00307-2; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Schlegel S, 2014, BBA-MOL CELL RES, V1843, P1739, DOI 10.1016/j.bbamcr.2013.10.023; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Tribet C, 1996, P NATL ACAD SCI USA, V93, P15047, DOI 10.1073/pnas.93.26.15047; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Veesler D, 2008, ACTA CRYSTALLOGR F, V64, P880, DOI 10.1107/S1744309108028248; Wiseman B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114864; Yang ZR, 2014, PROTEIN SCI, V23, P769, DOI 10.1002/pro.2460; Zubcevic L, 2016, NAT STRUCT MOL BIOL, V23, P180, DOI 10.1038/nsmb.3159	41	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180163	10.1371/journal.pone.0180163	http://dx.doi.org/10.1371/journal.pone.0180163			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692650	Green Published, Green Submitted, gold			2022-12-26	WOS:000405544800027
J	Blount, RJ; Daly, KR; Fong, S; Chang, E; Grieco, K; Greene, M; Stone, S; Balmes, J; Miller, RF; Walzer, PD; Huang, L				Blount, Robert J.; Daly, Kieran R.; Fong, Serena; Chang, Emily; Grieco, Katherine; Greene, Meredith; Stone, Stephen; Balmes, John; Miller, Robert F.; Walzer, Peter D.; Huang, Laurence			Effects of clinical and environmental factors on bronchoalveolar antibody responses to Pneumocystis jirovecii: A prospective cohort study of HIV plus patients	PLOS ONE			English	Article							MAJOR SURFACE GLYCOPROTEIN; CARINII-PNEUMONIA; NITROGEN-DIOXIDE; SEROLOGIC RESPONSES; INFECTED PATIENTS; ACUTE EXPOSURE; LAVAGE FLUID; MICE; OZONE; IMMUNIZATION	Background Humoral immunity plays an important role against Pneumocystis jirovecii infection, yet clinical and environmental factors that impact bronchoalveolar antibody responses to P. jirovecii remain uncertain. Methods From October 2008 D December 2011 we enrolled consecutive HIV-infected adults admitted to San Francisco General Hospital (SFGH) who underwent bronchoscopy for suspected Pneumocystis pneumonia ( PCP). We used local air quality monitoring data to assign ozone, nitrogen dioxide, and fine particulate matter exposures within 14 days prior to hospital admission. We quantified serum and bronchoalveolar lavage fluid (BALF) antibody responses to P. jirovecii major surface glycoprotein (Msg) recombinant constructs using ELISA. We then fit linear regression models to determine whether PCP and ambient air pollutants were associated with bronchoalveolar antibody responses to Msg. Results Of 81 HIV- infected patients enrolled, 47 (58%) were diagnosed with current PCP and 9 (11%) had a prior history of PCP. The median CD4+ count was 51 cells/mu l (IQR 15 -129) and 44% were current smokers. Serum antibody responses to Msg were statistically significantly predictive of BALF antibody responses, with the exception of IgG responses to MsgC8 and MsgC9. Prior PCP was associated with increased BALF IgA responses to Msg and current PCP was associated with decreased IgA responses. For instance, among patients without current PCP, those with prior PCP had a median 73.2 U (IQR 19.2 -169) IgA response to MsgC1 compared to a 5.00 U (3.52 - 12.6) response among those without prior PCP. Additionally, current PCP predicted a 22.5 U (95% CI - 39.2, -5.82) lower IgA response to MsgC1. Ambient ozone within the two weeks prior to hospital admission was associated with decreased BALF IgA responses to Msg while nitrogen dioxide was associated with increased IgA responses. Conclusions PCP and ambient air pollutants were associated with BALF IgA responses to P. jirovecii in HIV-infected patients evaluated for suspected PCP.	[Blount, Robert J.; Balmes, John; Huang, Laurence] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Blount, Robert J.] Univ Calif San Francisco, Div Pediat Pulmonol, San Francisco, CA 94143 USA; [Daly, Kieran R.; Walzer, Peter D.] Univ Cincinnati, Div Infect Dis, Cincinnati, OH USA; [Daly, Kieran R.; Walzer, Peter D.] Vet Adm Med Ctr, Cincinnati, OH 45220 USA; [Fong, Serena; Chang, Emily; Grieco, Katherine; Greene, Meredith; Stone, Stephen; Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA USA; [Balmes, John] Univ Calif Berkeley, Environm Hlth Sci, Berkeley, CA 94720 USA; [Miller, Robert F.] UCL, Inst Epidemiol & Healthcare, Res Dept Infect & Populat Hlth, London, England; [Miller, Robert F.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London, England	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Blount, RJ (corresponding author), Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA.; Blount, RJ (corresponding author), Univ Calif San Francisco, Div Pediat Pulmonol, San Francisco, CA 94143 USA.	robert.blount@ucsf.edu	Huang, Laurence/AAE-1590-2019; blount, robert/ABI-5978-2020; Huang, Laurence/AAZ-7120-2021; Balmes, John/L-6281-2019	Huang, Laurence/0000-0003-3888-2195; Miller, Robert/0000-0003-2067-4291; Blount, Robert/0000-0001-6177-7436; Fong, Serena/0000-0002-9803-3016	National Institute of Environmental Health Science (NIEHS) [F32ES022582, K23ES025807]; National Heart, Lung, and Blood Institute (NHLBI) [T32HL007185, K24HL087713, R01HL090335]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL087713, R01HL128156, R01HL090335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	National Institute of Environmental Health Science (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the following: the National Institute of Environmental Health Science (NIEHS), www.niehs.nih.gov, F32ES022582 (Blount) and K23ES025807 (Blount); and the National Heart, Lung, and Blood Institute (NHLBI), www.nhlbi.nih.gov, T32HL007185 (Blount), K24HL087713 (Huang), and R01HL090335 (Huang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALA, 2016, STAT AIR REP AM LUNG; Alibrahim A, 1998, J ALLERGY CLIN IMMUN, V101, P552, DOI 10.1016/S0091-6749(98)70363-X; Alvaro-Meca A, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19906; Arjomandi M, 2015, AM J PHYSIOL-HEART C, V308, pH1499, DOI 10.1152/ajpheart.00849.2014; BALCHUM OJ, 1965, ARCH ENVIRON HEALTH, V10, P274, DOI 10.1080/00039896.1965.10663995; Bishop LR, 2003, J INFECT DIS, V187, P1844, DOI 10.1086/375354; Blount RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080795; Blount RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051545; CDC, 2010, TOB SMOK CAUS DIS BI, V3; Cetin E, 2007, PEDIATR RADIOL, V37, P329, DOI 10.1007/s00247-006-0375-z; CHANEY S, 1981, ARCH ENVIRON HEALTH, V36, P53, DOI 10.1080/00039896.1981.10667607; Crothers K, 2011, CLIN VACCINE IMMUNOL, V18, P380, DOI 10.1128/CVI.00421-10; Daly KR, 2006, CLIN VACCINE IMMUNOL, V13, P1071, DOI 10.1128/CVI.00140-06; Daly KR, 2006, EMERG INFECT DIS, V12, P1231, DOI 10.3201/eid1708.060230; Daly KR, 2004, EMERG INFECT DIS, V10, P848, DOI 10.3201/eid1005.030497; Daly KR, 2002, J INFECT DIS, V186, P644, DOI 10.1086/341565; Davis JL, 2008, THORAX, V63, P329, DOI 10.1136/thx.2007.088104; Dittrich AM, 2003, EUR J PEDIATR, V162, P432, DOI 10.1007/s00431-003-1200-4; Djawe K, 2013, CLIN INFECT DIS, V56, P74, DOI 10.1093/cid/cis841; Djawe K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014259; Djawe K, 2010, INT J INFECT DIS, V14, pE1060, DOI 10.1016/j.ijid.2010.07.003; Du Rand IA, 2013, THORAX, V68, P1, DOI 10.1136/thoraxjnl-2013-203618; EHRLICH R, 1975, ENVIRON RES, V10, P217, DOI 10.1016/0013-9351(75)90085-7; Empey KM, 2004, INFECT IMMUN, V72, P6211, DOI 10.1128/IAI.72.11.6211-6220.2004; Esteves F, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.11.025; Fei MW, 2009, THORAX, V64, P1070, DOI 10.1136/thx.2009.117846; FUJIMAKI H, 1981, ENVIRON RES, V26, P490, DOI 10.1016/0013-9351(81)90224-3; FURUTA T, 1985, INFECT IMMUN, V47, P544, DOI 10.1128/IAI.47.2.544-548.1985; GAJDUSEK DC, 1957, PEDIATRICS, V19, P543; Gigliotti F, 1997, J INFECT DIS, V176, P1322, DOI 10.1086/514128; Gigliotti F, 2002, INFECT IMMUN, V70, P1069, DOI 10.1128/IAI.70.3.1069-1074.2002; HARMSEN AG, 1991, J PROTOZOOL, V38, pS44; Hashmi H, 2016, AM J RESP CRIT CARE, V193; HIDEKAZU F, 1981, ARCH ENVIRON HEALTH, V36, P114, DOI 10.1080/00039896.1981.10667614; Huang Laurence, 2011, Proc Am Thorac Soc, V8, P294, DOI 10.1513/pats.201009-062WR; JAKAB GJ, 1995, ENVIRON HEALTH PERSP, V103, P77, DOI 10.2307/3432454; Jalil A, 2000, INFECT IMMUN, V68, P1054, DOI 10.1128/IAI.68.3.1054-1060.2000; Kelly MN, 2010, FUTURE MICROBIOL, V5, P43, DOI [10.2217/fmb.09.116, 10.2217/FMB.09.116]; Kim CS, 2011, AM J RESP CRIT CARE, V183, P1215, DOI 10.1164/rccm.201011-1813OC; LAURSEN AL, 1994, EUR RESPIR J, V7, P679, DOI 10.1183/09031936.94.07040679; Marcotte H, 1996, J INFECT DIS, V173, P1034, DOI 10.1093/infdis/173.4.1034; Mei Q, 1998, INFECT IMMUN, V66, P4268; Skalski JH, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov046; Steele C, 2005, MED MYCOL, V43, P1, DOI 10.1080/13693780400015360; Tipirneni R, 2009, EMERG INFECT DIS, V15, P1590, DOI 10.3201/eid1510.090207; Tomas AL, 2016, SCI REP-UK, V6, DOI 10.1038/srep36287; Vargas SL, 2001, CLIN INFECT DIS, V32, P855, DOI 10.1086/319340; WALZER PD, 1981, J LAB CLIN MED, V97, P820; Ward WO, 2015, INHAL TOXICOL, V27, P80, DOI 10.3109/08958378.2014.954172; Wells J, 2006, INFECT IMMUN, V74, P2446, DOI 10.1128/IAI.74.4.2446-2448.2006; Wells J, 2006, INFECT IMMUN, V74, P390, DOI 10.1128/IAI.74.1.390-393.2006; Zheng MQ, 2001, J CLIN INVEST, V108, P1469, DOI 10.1172/JCI13826	52	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180212	10.1371/journal.pone.0180212	http://dx.doi.org/10.1371/journal.pone.0180212			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692651	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000405544800031
J	Chidori, K; Yamamoto, Y				Chidori, Kazuhiro; Yamamoto, Yuji			Effects of the lateral amplitude and regularity of upper body fluctuation on step time variability evaluated using return map analysis	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; OLDER-ADULTS; TRUNK ACCELEROMETRY; CLUSTER-ANALYSIS; ACCELERATION PATTERNS; GAIT VARIABILITY; LEVEL WALKING; HEALTHY; FALLS; RISK	The aim of this study was to evaluate the effects of the lateral amplitude and regularity of upper body fluctuation on step time variability. Return map analysis was used to clarify the relationship between step time variability and a history of falling. Eleven healthy, community-dwelling older adults and twelve younger adults participated in the study. All of the subjects walked 25 m at a comfortable speed. Trunk acceleration was measured using triaxial accelerometers attached to the third lumbar vertebrae (L3) and the seventh cervical vertebrae (C7). The normalized average magnitude of acceleration, the coefficient of determination ($R<^>2$) of the return map, and the step time variabilities, were calculated. Cluster analysis using the average fluctuation and the regularity of C7 fluctuation identified four walking patterns in the mediolateral (ML) direction. The participants with higher fluctuation and lower regularity showed significantly greater step time variability compared with the others. Additionally, elderly participants who had fallen in the past year had higher amplitude and a lower regularity of fluctuation during walking. In conclusion, by focusing on the time evolution of each step, it is possible to understand the cause of stride and/or step time variability that is associated with a risk of falls.	[Chidori, Kazuhiro] Chubu Gakuin Univ, Fac Nursing, 2-1 Kirigaoka, Seki, Gifu, Japan; [Chidori, Kazuhiro] Chubu Gakuin Univ, Rehabil Dept, Phys Therapy, 2-1 Kirigaoka, Seki, Gifu, Japan; [Chidori, Kazuhiro; Yamamoto, Yuji] Nagoya Univ, Grad Sch Educ & Human Dev, Nagoya, Aichi, Japan; [Yamamoto, Yuji] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi, Japan	Nagoya University; Nagoya University	Chidori, K (corresponding author), Chubu Gakuin Univ, Fac Nursing, 2-1 Kirigaoka, Seki, Gifu, Japan.; Chidori, K (corresponding author), Chubu Gakuin Univ, Rehabil Dept, Phys Therapy, 2-1 Kirigaoka, Seki, Gifu, Japan.; Chidori, K (corresponding author), Nagoya Univ, Grad Sch Educ & Human Dev, Nagoya, Aichi, Japan.	chidori@chubu-gu.ac.jp			Koshiyama Science and Technology Foundation; MEXT, Japan [24240085]	Koshiyama Science and Technology Foundation; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Koshiyama Science and Technology Foundation. This work was partially supported by a Grant-in-Aid for Scientific Research (A) no. 24240085 from MEXT, Japan. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvin M, 2015, GAIT POSTURE, V42, P545, DOI 10.1016/j.gaitpost.2015.08.011; Asai T, 2013, GAIT POSTURE, V38, P830, DOI 10.1016/j.gaitpost.2013.04.005; Auvinet B, 2002, GAIT POSTURE, V16, P124, DOI 10.1016/S0966-6362(01)00203-X; Bernstein N, 1967, COORDINATION REGULAT; Callisaya ML, 2011, AGE AGEING, V40, P481, DOI 10.1093/ageing/afr055; CAPPOZZO A, 1982, J BIOMECH, V15, P599, DOI 10.1016/0021-9290(82)90071-9; Descatoire A., 2009, Annals of Physical and Rehabilitation Medicine, V52, P319, DOI 10.1016/j.rehab.2009.02.004; Everitt B. S, 2011, CLUSTER ANAL, DOI DOI 10.1002/9780470977811; GARFINKEL A, 1992, SCIENCE, V257, P1230, DOI 10.1126/science.1519060; Giacomozzi C, 2009, GAIT POSTURE, V29, P220, DOI 10.1016/j.gaitpost.2008.08.004; Gibson M.J., 1990, IMPROVING HLTH OLDER, P296, DOI https://doi.org/10.2307/3342511; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Halkidi M, 2002, SIGMOD RECORD, V31, P40, DOI 10.1145/565117.565124; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hausdorff JM, 1997, ARCH PHYS MED REHAB, V78, P278, DOI 10.1016/S0003-9993(97)90034-4; Henriksen M, 2004, GAIT POSTURE, V19, P288, DOI 10.1016/S0966-6362(03)00069-9; Hill K, 1999, AUST NZ J PUBL HEAL, V23, P41, DOI 10.1111/j.1467-842X.1999.tb01203.x; Kannus P, 1999, JAMA-J AM MED ASSOC, V281, P1895, DOI 10.1001/jama.281.20.1895; Kavanagh JJ, 2004, GAIT POSTURE, V20, P291, DOI 10.1016/j.gaitpost.2003.10.004; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Mazza C, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-30; Mazza C, 2009, GAIT POSTURE, V29, P300, DOI 10.1016/j.gaitpost.2008.09.013; Menz HB, 2003, GAIT POSTURE, V18, P35, DOI 10.1016/S0966-6362(02)00159-5; Menz HB, 2003, J GERONTOL A-BIOL, V58, P446, DOI 10.1093/gerona/58.5.M446; Menz HB, 2003, AGE AGEING, V32, P137, DOI 10.1093/ageing/32.2.137; Moe-Nilssen R, 2002, GAIT POSTURE, V16, P60, DOI 10.1016/S0966-6362(01)00200-4; Moe-Nilssen R, 2004, J BIOMECH, V37, P121, DOI 10.1016/S0021-9290(03)00233-1; Moe-Nilssen R, 1998, ARCH PHYS MED REHAB, V79, P1377, DOI 10.1016/S0003-9993(98)90231-3; Mulroy S, 2003, GAIT POSTURE, V18, P114, DOI 10.1016/S0966-6362(02)00165-0; MURRAY MP, 1969, J GERONTOL, V24, P169, DOI 10.1093/geronj/24.2.169; Nakamura T, 1996, GERONTOLOGY, V42, P108, DOI 10.1159/000213780; Niino N, 2000, J Epidemiol, V10, pS90; Parkkari J, 1999, CALCIFIED TISSUE INT, V65, P183; Rozumalski A, 2009, GAIT POSTURE, V30, P155, DOI 10.1016/j.gaitpost.2009.05.010; SCHIFF SJ, 1994, NATURE, V370, P615, DOI 10.1038/370615a0; Skurvydas A, 2012, HOMO, V63, P114, DOI 10.1016/j.jchb.2012.02.003; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Terrier P, 2015, GAIT POSTURE, V41, P170, DOI 10.1016/j.gaitpost.2014.09.024; Toro B, 2007, GAIT POSTURE, V25, P157, DOI 10.1016/j.gaitpost.2006.02.004; Yamamoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072436	41	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e010898	10.1371/journal.pone.0180898	http://dx.doi.org/10.1371/journal.pone.0180898			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700633	Green Published, gold, Green Submitted			2022-12-26	WOS:000405544800095
J	Figueiredo, AS; Kouril, T; Esser, D; Haferkamp, P; Wieloch, P; Schomburg, D; Ruoff, P; Siebers, B; Schaber, J				Figueiredo, Ana Sofia; Kouril, Theresa; Esser, Dominik; Haferkamp, Patrick; Wieloch, Patricia; Schomburg, Dietmar; Ruoff, Peter; Siebers, Bettina; Schaber, Joerg			Systems biology of the modified branched Entner-Doudoroff pathway in Sulfolobus solfataricus	PLOS ONE			English	Article							CENTRAL CARBOHYDRATE-METABOLISM; GLUCOSE-DEHYDROGENASE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; KINETIC CHARACTERIZATION; YEAST GLYCOLYSIS; KEY-ENZYME; ROBUSTNESS; MODEL; PROMISCUITY; DEGRADATION	Sulfolobus solfataricus is a thermoacidophilic Archaeon that thrives in terrestrial hot springs (solfatares) with optimal growth at 80 degrees C and pH 2-4. It catabolizes specific carbon sources, such as D-glucose, to pyruvate via the modified Entner-Doudoroff(ED) pathway. This pathway has two parallel branches, the semi-phosphorylative and the non-phosphorylative. However, the strategy of S. solfataricus to endure in such an extreme environment in terms of robustness and adaptation is not yet completely understood. Here, we present the first dynamic mathematical model of the ED pathway parameterized with quantitative experimental data. These data consist of enzyme activities of the branched pathway at 70 E C and 80 E C and of metabolomics data at the same temperatures for the wild type and for a metabolic engineered knockout of the semi-phosphorylative branch. We use the validated model to address two questions: 1. Is this system more robust to perturbations at its optimal growth temperature? 2. Is the ED robust to deletion and perturbations? We employed a systems biology approach to answer these questions and to gain further knowledge on the emergent properties of this biological system. Specifically, we applied deterministic and stochastic approaches to study the sensitivity and robustness of the system, respectively. The mathematical model we present here, shows that: 1. Steady state metabolite concentrations of the ED pathway are consistently more robust to stochastic internal perturbations at 80 E C than at 70 E C; 2. These metabolite concentrations are highly robust when faced with the knockout of either branch. Connected with this observation, these two branches show different properties at the level of metabolite production and flux control. These new results reveal how enzyme kinetics and metabolomics synergizes with mathematical modelling to unveil new systemic properties of the ED pathway in S. solfataricus in terms of its adaptation and robustness.	[Figueiredo, Ana Sofia; Schaber, Joerg] Otto von Guericke Univ, Med Fac, Inst Expt Internal Med, Magdeburg, Germany; [Kouril, Theresa; Esser, Dominik; Haferkamp, Patrick; Siebers, Bettina] Univ Duisburg Essen, Fac Chem, Ctr Water & Environm Res, Biofilm Ctr,Mol Enzyme Technol & Biochem,MEB,CWE, Essen, Germany; [Wieloch, Patricia; Schomburg, Dietmar] Tech Univ Carolo Wilhelmina Braunschweig, Bioinformat & Biochem, Braunschweig, Germany; [Ruoff, Peter] Univ Stavanger, CORE, Ctr Organelle Res, Stavanger, Norway; [Figueiredo, Ana Sofia] Heidelberg Univ, Med Fac Mannheim, Dept Anesthesiol & Surg Intens Care Med, Heidelberg, Germany; [Kouril, Theresa] Univ Stellenbosch, Dept Biochem, Stellenbosch, South Africa	Otto von Guericke University; University of Duisburg Essen; Braunschweig University of Technology; Universitetet i Stavanger; Ruprecht Karls University Heidelberg; Stellenbosch University	Figueiredo, AS (corresponding author), Otto von Guericke Univ, Med Fac, Inst Expt Internal Med, Magdeburg, Germany.; Figueiredo, AS (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Anesthesiol & Surg Intens Care Med, Heidelberg, Germany.	sofia.figueiredo@medma.uni-heidelberg.de	Figueiredo, Ana/GWU-6748-2022	Siebers, Bettina/0000-0002-9905-541X	BMBF; DFG [0316188E, 0315004A, 0316188A, 0315004B, 0316188B, SI 642/10-1]	BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	This work was performed within the e:Bio SulfoSYSBIOTEC consortium from the Federal Ministry of Education and Research (BMBF), Germany. The authors acknowledge the BMBF and DFG for financial support: ASF (0316188E), TK, PH, BS (0315004A, 0316188A), PW, DS (0315004B, 0316188B), DE (SI 642/10-1), JS (0316188E).	Ahmed H, 2005, BIOCHEM J, V390, P529, DOI 10.1042/BJ20041711; Ahmed H, 2004, BIOCHEM SOC T, V32, P303, DOI 10.1042/BST0320303; Albers SV, 2009, BIOCHEM SOC T, V37, P58, DOI 10.1042/BST0370058; ANDREESEN JR, 1969, ARCH MIKROBIOL, V69, P160, DOI 10.1007/BF00409760; Barnard D, 2010, ENVIRON TECHNOL, V31, P871, DOI 10.1080/09593331003710236; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brasen C, 2014, MICROBIOL MOL BIOL R, V78, P89, DOI 10.1128/MMBR.00041-13; Buchanan CL, 1999, BIOCHEM J, V343, P563, DOI 10.1042/0264-6021:3430563; BUDGEN N, 1986, FEBS LETT, V196, P207, DOI 10.1016/0014-5793(86)80247-2; Carlson JM, 2000, PHYS REV LETT, V84, P2529, DOI 10.1103/PhysRevLett.84.2529; DEROSA M, 1984, BIOCHEM J, V224, P407, DOI 10.1042/bj2240407; ELZAINY TA, 1973, J BACTERIOL, V114, P457, DOI 10.1128/JB.114.1.457-459.1973; ENTNER N, 1952, J BIOL CHEM, V196, P853; Ettema TJG, 2008, EXTREMOPHILES, V12, P75, DOI 10.1007/s00792-007-0082-1; EYZAGUIRRE J, 1982, ARCH MICROBIOL, V132, P67, DOI 10.1007/BF00690820; Figueiredo AS, 2011, MATH MODELS IL 10 RE; GIARDINA P, 1986, BIOCHEM J, V239, P517, DOI 10.1042/bj2390517; Haferkamp P, 2011, BIOCH STUDIES ENZYME; Haferkamp P, 2011, BIOCHEM SOC T, V39, P77, DOI 10.1042/BST0390077; Hammerstein Peter, 2006, Biological Theory, V1, P90, DOI 10.1162/biot.2006.1.1.90; Isupov MN, 1999, J MOL BIOL, V291, P651, DOI 10.1006/jmbi.1999.3003; Johnsen U, 2001, ARCH MICROBIOL, V175, P52, DOI 10.1007/s002030000237; Kardinahl S, 1999, EUR J BIOCHEM, V260, P540, DOI 10.1046/j.1432-1327.1999.00201.x; Kartal O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008001; Kim S, 2006, BIOSCI BIOTECH BIOCH, V70, P1308, DOI 10.1271/bbb.50566; Kim SH, 2005, BIOCHEM J, V387, P271, DOI 10.1042/BJ20041053; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kouril T, 2012, CHALLENGING METABOLI; Kouril T, 2013, FEBS J, V280, P4666, DOI 10.1111/febs.12438; Kouril T, 2013, FEBS J, V280, P1126, DOI 10.1111/febs.12106; Lamble FJ, 2004, FEBS LETT, V576, P133, DOI 10.1016/j.febslet.2004.08.074; Lamble HJ, 2005, FEBS LETT, V579, P6865, DOI 10.1016/j.febslet.2005.11.028; Lamble HJ, 2003, J BIOL CHEM, V278, P34066, DOI 10.1074/jbc.M305818200; Liebermeister W, 2005, IEE P SYST BIOL, V152, P97, DOI 10.1049/ip-syb:20045033; Lin L, 2013, BIOTECHNOL ADV, V31, P827, DOI 10.1016/j.biotechadv.2013.03.003; Mastascusa V, 2014, ORIGINS LIFE EVOL B, V44, P231, DOI 10.1007/s11084-014-9397-y; Milburn CC, 2006, J BIOL CHEM, V281, P14796, DOI 10.1074/jbc.M601334200; Mulquiney PJ, 1999, BIOCHEM J, V342, P567, DOI 10.1042/0264-6021:3420567; Peekhaus N, 1998, J BACTERIOL, V180, P3495, DOI 10.1128/JB.180.14.3495-3502.1998; Penkler G, 2015, FEBS J, V282, P1481, DOI 10.1111/febs.13237; Saa P, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004195; Schaber J, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.53; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; Smallbone K, 2013, FEBS LETT, V587, P2832, DOI 10.1016/j.febslet.2013.06.043; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Teusink B, 2000, EUR J BIOCHEM, V267, P5313, DOI 10.1046/j.1432-1327.2000.01527.x; TOMLINSON GA, 1974, CAN J MICROBIOL, V20, P1085, DOI 10.1139/m74-170; Warburg O, 1941, NATURWISSENSCHAFTEN, V29, P589, DOI 10.1007/BF01482279; Westerhoff HV, 2009, J MATH BIOL, V58, P7, DOI 10.1007/s00285-008-0160-8; Wieloch P, 2012, METABOLOMANALYSE HYP; Wolf J, 2000, BIOPHYS J, V78, P1145, DOI 10.1016/S0006-3495(00)76672-0; Wolstencroft K, 2011, METHOD ENZYMOL, V500, P629, DOI 10.1016/B978-0-12-385118-5.00029-3; Zaparty M, 2010, EXTREMOPHILES, V14, P119, DOI 10.1007/s00792-009-0280-0; ZILLIG W, 1980, ARCH MICROBIOL, V125, P259, DOI 10.1007/BF00446886	55	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180331	10.1371/journal.pone.0180331	http://dx.doi.org/10.1371/journal.pone.0180331			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692669	Green Published, Green Submitted, gold			2022-12-26	WOS:000405544800034
J	Duthu, RC; Bradley, TH				Duthu, Ray C.; Bradley, Thomas H.			A road damage and life-cycle greenhouse gas comparison of trucking and pipeline water delivery systems for hydraulically fractured oil and gas field development in Colorado	PLOS ONE			English	Article							EMISSIONS; IMPACTS	The process of hydraulic fracturing for recovery of oil and natural gas uses large amounts of fresh water and produces a comparable amount of wastewater, much of which is typically transported by truck. Truck transport of water is an expensive and energy-intensive process with significant external costs including roads damages, and pollution. The integrated development plan (IDP) is the industry nomenclature for an integrated oil and gas infrastructure system incorporating pipeline-based transport of water and wastewater, centralized water treatment, and high rates of wastewater recycling. These IDP have been proposed as an alternative to truck transport systems so as to mitigate many of the economic and environmental problems associated with natural gas production, but the economic and environmental performance of these systems have not been analyzed to date. This study presents a quantification of lifecycle greenhouse gas (GHG) emissions and road damages of a generic oil and gas field, and of an oil and gas development sited in the Denver-Julesburg basin in the northern Colorado region of the US. Results demonstrate that a reduction in economic and environmental externalities can be derived from the development of these IDP-based pipeline water transportation systems. IDPs have marginal utility in reducing GHG emissions and road damage when they are used to replace in-field water transport, but can reduce GHG emissions and road damage by factors of as much as 6 and 7 respectively, when used to replace fresh water transport and waste-disposal routes for exemplar Northern Colorado oil and gas fields.	[Duthu, Ray C.; Bradley, Thomas H.] Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA	Colorado State University	Bradley, TH (corresponding author), Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA.	Thomas.Bradley@ColoState.Edu	Bradley, Thomas/ABF-5356-2021; Bradley, Thomas/AAD-9244-2022	Bradley, Thomas/0000-0003-3533-293X; 	Research Partnership to Secure Energy for America Unconventional Resources Program [11122-55]	Research Partnership to Secure Energy for America Unconventional Resources Program	This work is supported by the Research Partnership to Secure Energy for America 2011 Unconventional Resources Program under project number 11122-55.	Abramzon S, 2014, J INFRASTRUCT SYST, V20, DOI 10.1061/(ASCE)IS.1943-555X.0000203; American Association of State Highway and Transportation Officials, 1993, GUID DES PAV STRUCT; Argonne National Laboratory, 2014, GREET 1 2014; Ariaratnam ST, 2009, J GREEN BUILD, V4, P126, DOI 10.3992/jgb.4.2.126; Bai B, 2015, J UNCONV OIL GAS RES, V12, P1, DOI 10.1016/j.juogr.2015.07.001; Bai B, 2013, J PETROL SCI ENG, V108, P383, DOI 10.1016/j.petrol.2013.05.003; Bai Y, 2009, ESTIMATING HIGHWAY P; Bissoli DD, 2016, J PETROL SCI ENG, V139, P13, DOI 10.1016/j.petrol.2015.12.009; Boschee P., 2012, OIL GAS FACIL, V1, P22; Boudet H, 2014, ENERG POLICY, V65, P57, DOI 10.1016/j.enpol.2013.10.017; Christopherson S., 2011, J TOWN CITY MANAGEME, V2, P350; Clark C., 2012, ANLEVSR125; Clark C. E, 2009, ANLEVSR0911021721007; Colorado Division of Water Resources Colorado Water Conservation Board & Colorado Oil and Gas Conservation Commission, 2015, WAT SOURC DEM HYDR F; Copeland HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007400; Dale AT, 2013, ENVIRON SCI TECHNOL, V47, P5459, DOI 10.1021/es304414q; Etkin D. S, 2009, AM PETROLEUM I PUBLI, P356; Felsburg Holt & Ullevig and BBC Research and Consulting, 2013, 1210901 FHU; Gaines L, 2006, 062567 ARG NAT LAB C; Gaines L., 1998, AIR WAST MAN ASS ANN; Goodwin S., 2013, Journal of Water Resource and Protection, V5, P1262; Goodwin S, 2014, THESIS; Jiang M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034014; Litovitz A, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014017; McDonald RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006802; Piratla KR, 2012, J MANAGE ENG, V28, P22, DOI 10.1061/(ASCE)ME.1943-5479.0000069; Prozzi J., 2011, IMPACTS ENERGY DEV T; Stephenson T, 2011, ENVIRON SCI TECHNOL, V45, P10757, DOI 10.1021/es2024115; U.S. Department of Transportation Federal High Administration, 2015, FLEX HIGHW DES; U.S. Department of Transportation Pipeline and Hazardous Materials Safety Administration, 2010, BUILD STAT COMM PIP; U.S. Energy Information Administration, 2015, ANN EN OUTL; Ziemkiewicz PF, 2014, J NAT GAS SCI ENG, V16, P77, DOI 10.1016/j.jngse.2013.11.003	32	2	2	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180587	10.1371/journal.pone.0180587	http://dx.doi.org/10.1371/journal.pone.0180587			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686682	Green Published, gold, Green Submitted			2022-12-26	WOS:000405464100079
J	Vetsch, JR; Betts, DC; Muller, R; Hofmann, S				Vetsch, Jolanda Rita; Betts, Duncan Colin; Mueller, Ralph; Hofmann, Sandra			Flow velocity-driven differentiation of human mesenchymal stromal cells in silk fibroin scaffolds: A combined experimental and computational approach	PLOS ONE			English	Article							MINERALIZED MATRIX DEPOSITION; MICRO-COMPUTED TOMOGRAPHY; 3D PERFUSION CULTURE; SHEAR-STRESS; IN-VITRO; STEM-CELLS; BONE; CONSTRUCTS; MECHANOTRANSDUCTION; QUANTIFICATION	Mechanical loading plays a major role in bone remodeling and fracture healing. Mimicking the concept of mechanical loading of bone has been widely studied in bone tissue engineering by perfusion cultures. Nevertheless, there is still debate regarding the in-vitro mechanical stimulation regime. This study aims at investigating the effect of two different flow rates (v(low) = 0.001m/s and v(high) = 0.061m/s) on the growth of mineralized tissue produced by human mesenchymal stromal cells cultured on 3-D silk fibroin scaffolds. The flow rates applied were chosen to mimic the mechanical environment during early fracture healing or during bone remodeling, respectively. Scaffolds cultured under static conditions served as a control. Time-lapsed micro-computed tomography showed that mineralized extracellular matrix formation was completely inhibited at v(low) compared to v(high) and the static group. Biochemical assays and histology confirmed these results and showed enhanced osteogenic differentiation at v(high) whereas the amount of DNA was increased at v(low). The biological response at v(low) might correspond to the early stage of fracture healing, where cell proliferation and matrix production is prominent. Visual mapping of shear stresses, simulated by computational fluid dynamics, to 3-D micro-computed tomography data revealed that shear stresses up to 0.39mPa induced a higher DNA amount and shear stresses between 0.55mPa and 24mPa induced osteogenic differentiation. This study demonstrates the feasibility to drive cell behavior of human mesenchymal stromal cells by the flow velocity applied in agreement with mechanical loading mimicking early fracture healing (v(low)) or bone remodeling (v(high)). These results can be used in the future to tightly control the behavior of human mesenchymal stromal cells towards proliferation or differentiation. Additionally, the combination of experiment and simulation presented is a strong tool to link biological responses to mechanical stimulation and can be applied to various in-vitro cultures to improve the understanding of the cause-effect relationship of mechanical loading.	[Vetsch, Jolanda Rita; Betts, Duncan Colin; Mueller, Ralph; Hofmann, Sandra] Swiss Fed Inst Technol Zurich, Inst Biomech, Zurich, Switzerland; [Hofmann, Sandra] Eindhoven Univ Technol, Dept Biomed Engn, Eindhoven, Netherlands; [Hofmann, Sandra] Eindhoven Univ Technol, Inst Complex Mol Syst, Eindhoven, Netherlands	Swiss Federal Institutes of Technology Domain; ETH Zurich; Eindhoven University of Technology; Eindhoven University of Technology	Hofmann, S (corresponding author), Swiss Fed Inst Technol Zurich, Inst Biomech, Zurich, Switzerland.; Hofmann, S (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Eindhoven, Netherlands.; Hofmann, S (corresponding author), Eindhoven Univ Technol, Inst Complex Mol Syst, Eindhoven, Netherlands.	S.Hofmann.Boss@tue.nl	Hofmann, Sandra/F-2832-2010; Müller, Ralph/A-1198-2008	Hofmann, Sandra/0000-0002-2568-8388; Müller, Ralph/0000-0002-5811-7725; Vetsch, Jolanda Rita/0000-0003-4134-2691	European Union's Seventh Framework Programme (FP) [FP7-NMP-2010-LARGE-4]; BIODESIGN - Rational Bioactive Materials Design for Tissue Regeneration; REMOTE [ERC-2013-StG]	European Union's Seventh Framework Programme (FP); BIODESIGN - Rational Bioactive Materials Design for Tissue Regeneration; REMOTE	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP/2007-2013): FP7-NMP-2010-LARGE-4: BIODESIGN - Rational Bioactive Materials Design for Tissue Regeneration (JRV, DCB, RM, SH) and ERC-2013-StG: REMOTE - Real-time monitoring of load induced remodeling in tissue-engineered bone (SH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4; Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599; Bonewald Lynda F, 2006, Bonekey Osteovision, V3, P7; Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; Cartmell SH, 2003, TISSUE ENG, V9, P1197, DOI 10.1089/10763270360728107; Cioffi M, 2006, BIOTECHNOL BIOENG, V93, P500, DOI 10.1002/bit.20740; de Peppo GM, 2013, P NATL ACAD SCI USA, V110, P8680, DOI 10.1073/pnas.1301190110; Delaine-Smith RM, 2011, VITAM HORM, V87, P417, DOI 10.1016/B978-0-12-386015-6.00039-1; Ding DC, 2011, CELL TRANSPLANT, V20, P5, DOI 10.3727/096368910X; DUNCAN RL, 1995, CALCIFIED TISSUE INT, V57, P344, DOI 10.1007/BF00302070; Fan J, 2015, J TISSUE ENG REGEN M, V9, pE210, DOI 10.1002/term.1701; Gardel LS, 2013, J BIOMED MATER RES B, V101, P1377, DOI 10.1002/jbm.b.32955; Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5; Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075; Grayson WL, 2008, TISSUE ENG PT A, V14, P1809, DOI 10.1089/ten.tea.2007.0255; Grayson WL, 2011, BIOTECHNOL BIOENG, V108, P1159, DOI 10.1002/bit.23024; Hagenmueller H, 2007, ANN BIOMED ENG, V35, P1657, DOI 10.1007/s10439-007-9338-2; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019; Holtorf HL, 2005, J BIOMED MATER RES A, V72A, P326, DOI 10.1002/jbm.a.30251; Jaasma MJ, 2008, TISSUE ENG PT A, V14, P1213, DOI [10.1089/ten.tea.2007.0321, 10.1089/tea.2007.0321]; Jungreuthmayer C, 2009, TISSUE ENG PT A, V15, P1141, DOI 10.1089/ten.tea.2008.0204; Kusuzaki K, 2000, BONE, V27, P655, DOI 10.1016/S8756-3282(00)00383-5; Maes F, 2012, J BIOMECH, V45, P1586, DOI 10.1016/j.jbiomech.2012.04.015; Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109; Marolt D, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt10; McCoy RJ, 2010, TISSUE ENG PART B-RE, V16, P587, DOI [10.1089/ten.teb.2010.0370, 10.1089/ten.TEB.2010.0370]; Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010; Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117; Mullender M, 2004, MED BIOL ENG COMPUT, V42, P14, DOI 10.1007/BF02351006; Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e; Ochoa I, 2009, J BIOMECH, V42, P257, DOI 10.1016/j.jbiomech.2008.10.030; Partap S, 2010, J MATER SCI-MATER M, V21, P2325, DOI 10.1007/s10856-009-3966-z; Perez-Rigueiro J, 2000, J APPL POLYM SCI, V75, P1270, DOI 10.1002/(SICI)1097-4628(20000307)75:10<1270::AID-APP8>3.3.CO;2-3; Porter B, 2005, J BIOMECH, V38, P543, DOI 10.1016/j.jbiomech.2004.04.011; Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100; Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7; TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519; van Lenthe GH, 2007, BIOMATERIALS, V28, P2479, DOI 10.1016/j.biomaterials.2007.01.017; Zermatten E, 2014, ANN BIOMED ENG, V42, P1085, DOI 10.1007/s10439-014-0981-0; Zermatten E, 2011, J GLACIOL, V57, P811, DOI 10.3189/002214311798043799; Zhao F, 2007, BIOTECHNOL BIOENG, V96, P584, DOI 10.1002/bit.21184	42	38	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180781	10.1371/journal.pone.0180781	http://dx.doi.org/10.1371/journal.pone.0180781			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686698	Green Submitted, Green Published, gold			2022-12-26	WOS:000405464100103
J	Lee, AF; Chen, MC; Chen, CJ; Yang, CJ; Huang, MS; Liu, YP				Lee, An-Fu; Chen, Man-Chin; Chen, Chao-Ju; Yang, Chih-Jen; Huang, Ming-Shyang; Liu, Yu-Peng			Reverse epithelial-mesenchymal transition contributes to the regain of drug sensitivity in tyrosine kinase inhibitor-resistant non-small cell lung cancer cells	PLOS ONE			English	Article							PROGNOSTIC BIOMARKER; CISPLATIN RESISTANCE; EMT; METASTASIS; ADENOCARCINOMA; SLUG; ACQUISITION; EXPRESSION; PLASTICITY; PHENOTYPE	Tyrosine kinase inhibitors (TKIs) are currently the first-line treatment for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations. These patients receive platinum-based chemotherapy as the second-line treatment after they develop resistance to TKIs. Many patients regain sensitivity to the TKIs used in the first-line treatment after the failure of chemotherapy. However, the molecular mechanism for the regain of TKI sensitivity is largely unknown. In this study, we established gefitinib-resistant PC9 and HCC827 cell lines, which did not harbor the EGFR T790M mutation and MET amplification but exhibited the epithelial-mesenchymal transition (EMT) phenotype. Overexpression of EMT inducers, Snail or Slug, in the parental lines promoted their resistance to gefitinib. The gefitinib-resistant cell lines regained their sensitivity to gefitinib and displayed reverse EMT phenotypes after long-term culture in gefitinib-free culture medium. Blockage of reverse EMT by stable expression of Snail or Slug prevented the regain of TKI sensitivity. In conclusion, reverse EMT is one of the major mechanisms for the regain of TKI sensitivity in TKI-resistant NSCLC cells, suggesting that the development of small molecules targeting the EMT process may prolong the efficacy of TKIs in NSCLC patients with EGFR mutations.	[Lee, An-Fu] Kaohsiung Med Univ, Sch Med, Coll Med, Kaohsiung, Taiwan; [Chen, Man-Chin; Yang, Chih-Jen; Huang, Ming-Shyang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Chao-Ju; Liu, Yu-Peng] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Chen, Chao-Ju] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan; [Yang, Chih-Jen] Kaohsiung Med Univ, Sch Med, Dept Internal Med, Coll Med, Kaohsiung, Taiwan; [Yang, Chih-Jen] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Huang, Ming-Shyang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Geriatr & Gerontol, Dept Internal Med, Kaohsiung, Taiwan; [Liu, Yu-Peng] Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung, Taiwan; [Liu, Yu-Peng] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan; [Liu, Yu-Peng] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Yang, CJ; Huang, MS (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Kaohsiung, Taiwan.; Liu, YP (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan.; Yang, CJ (corresponding author), Kaohsiung Med Univ, Sch Med, Dept Internal Med, Coll Med, Kaohsiung, Taiwan.; Yang, CJ (corresponding author), Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan.; Huang, MS (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Geriatr & Gerontol, Dept Internal Med, Kaohsiung, Taiwan.; Liu, YP (corresponding author), Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung, Taiwan.; Liu, YP (corresponding author), Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan.; Liu, YP (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan.	chjeya@cc.kmu.edu.tw; shyang@kmu.edu.tw; ypliu@kmu.edu.tw		Liu, Yu-Peng/0000-0002-2716-0050	Ministry of Science and Technology of Taiwan [NSC102-2320-B-037-036, MOST 103-2320B-037-027-MY3, MOST 103-2314-B-037-050-MY3, MOST 105-2314-B-037-048]; Kaohsiung Medical University [KMU-TP103E04, KMU-TP104E05, KMU-TP105E05]; New faculty grant [KMU-Q103008]; Kaohsiung Municipal Ta-ung Hospital, Kaohsiung, Taiwan [KMTTH-104-021, KMTTH-105-044]; Kaohsiung Medical University Hospital,Kaohsiung,Taiwan [KMUH104-4F03]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University; New faculty grant; Kaohsiung Municipal Ta-ung Hospital, Kaohsiung, Taiwan; Kaohsiung Medical University Hospital,Kaohsiung,Taiwan	This study is financially supported by the Ministry of Science and Technology of Taiwan (NSC102-2320-B-037-036-, and MOST 103-2320B-037-027-MY3, MOST 103-2314-B-037-050-MY3, and MOST 105-2314-B-037-048-). This study is supported partially by Kaohsiung Medical University "Aim for the Top Universities Grant, grant No. KMU-TP103E04, KMU-TP104E05, and KMU-TP105E05, and "New faculty grant, grant No. KMU-Q103008".This study is also supported by KMTTH-104-021 and KMTTH-105-044 in Kaohsiung Municipal Ta-ung Hospital, Kaohsiung, Taiwan, and by a grant (KMUH104-4F03) from the Kaohsiung Medical University Hospital,Kaohsiung,Taiwan	Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; [Anonymous], 2017, CANC DISCOV; Bai XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149370; Beerling E, 2016, CELL REP, V14, P2281, DOI 10.1016/j.celrep.2016.02.034; Bidarra SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep27072; Chang GC, 2017, LUNG CANCER, V104, P58, DOI 10.1016/j.lungcan.2016.12.002; Chang TH, 2011, AM J RESP CRIT CARE, V183, P1071, DOI 10.1164/rccm.201009-1440OC; Chen T., 2017, J CELL PHYSL; Chen Y, 2016, ONCOTARGET, V7, P71341, DOI 10.18632/oncotarget.11217; Chen YM, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2917-6; Chiu LY, 2017, ONCOGENE, V36, P242, DOI 10.1038/onc.2016.195; Chmielecki J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002356; Chung JH, 2011, LUNG CANCER, V73, P176, DOI 10.1016/j.lungcan.2010.11.011; Haslehurst AM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-91; Hsu CY, 2016, AM J RESP CRIT CARE, V193, P869, DOI 10.1164/rccm.201412-2226OC; Huang JY, 2015, ONCOTARGET, V6, P18613, DOI 10.18632/oncotarget.4317; Jia RJ, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.422; Jiang L, 2015, ONCOGENE, V34, P3908, DOI 10.1038/onc.2014.321; Kim SH, 2012, HISTOL HISTOPATHOL, V27, P581, DOI 10.14670/HH-27.581; Kuiper JL, 2015, CLIN LUNG CANCER, V16, P60, DOI 10.1016/j.cllc.2014.07.008; Kurimoto R, 2016, INT J ONCOL, V48, P1825, DOI 10.3892/ijo.2016.3419; Kurokawa M, 2013, CANCER SCI, V104, P904, DOI 10.1111/cas.12171; Lee CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084597; Lee YH, 2016, ONCOTARGET, V7, P46959, DOI 10.18632/oncotarget.10506; Liu YP, 2013, CANCER RES, V73, P406, DOI 10.1158/0008-5472.CAN-12-1733; Moreno-Bueno G, 2009, NAT PROTOC, V4, P1591, DOI 10.1038/nprot.2009.152; Ogino A, 2007, CANCER RES, V67, P7807, DOI 10.1158/0008-5472.CAN-07-0681; Pallier K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029954; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Sesumi Y, 2017, LUNG CANCER, V104, P85, DOI 10.1016/j.lungcan.2016.12.012; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shi L, 2016, ONCOGENE; Shi YL, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-89; Shih JY, 2011, CARCINOGENESIS, V32, P1299, DOI 10.1093/carcin/bgr110; Soucheray M, 2015, CANCER RES, V75, P4372, DOI 10.1158/0008-5472.CAN-15-0377; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Tong YL, 2016, ONCOTARGET, V7, P31413, DOI 10.18632/oncotarget.8920; Wang H, 2014, EUR J PHARMACOL, V723, P156, DOI 10.1016/j.ejphar.2013.12.004; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Yang CJ, 2016, ONCOTARGETS THER, V9, P1579, DOI 10.2147/OTT.S100164; Yang CJ, 2016, ONCOTARGETS THER, V9, P1511, DOI 10.2147/OTT.S100169; Ye ZQ, 2016, ONCOTARGET, V7, P37524, DOI 10.18632/oncotarget.6852; Yoo SB, 2013, ANN SURG ONCOL, V20, pS545, DOI 10.1245/s10434-013-2970-1; Yoshida T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147344; Yu JS, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-121	45	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180383	10.1371/journal.pone.0180383	http://dx.doi.org/10.1371/journal.pone.0180383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683123	Green Published, gold, Green Submitted			2022-12-26	WOS:000405335200030
J	Scheiermann, J; Klinman, DM				Scheiermann, Julia; Klinman, Dennis M.			Three distinct pneumotypes characterize the microbiome of the lung in BALB/cJ mice	PLOS ONE			English	Article							RESPIRATORY-TRACT; INFLAMMATION; BACTERIA; DISEASES; DATABASE; SEARCH; DNA	Bacteria can rarely be isolated from normal healthy lungs using conventional culture techniques, supporting the traditional belief that the lungs are sterile. Yet recent studies using next generation sequencing report that bacterial DNA commonly found in the upper respiratory tract (URT) is present at lower levels in the lungs. Interpretation of that finding is complicated by the technical limitations and potential for contamination introduced when dealing with low biomass samples. The current work sought to overcome those limitations to clarify the number, type and source of bacteria present in the lungs of normal mice. Results showed that the oral microbiome is diverse and highly conserved whereas murine lung samples fall into three distinct patterns. 33% of the samples were sterile, as they lacked culturable bacteria and their bacterial DNA content did not differ from background. 9% of samples contained comparatively higher amounts of bacterial DNA whose composition mimicked that detected in the URT. A final group (58%) contained smaller amounts of microbial DNA whose composition was correlating to that of rodent chow and cage bedding, likely acquired by inspiration of food and bedding fragments. By analyzing each sample independently rather than working with group averages, this work eliminated the bias introduced by aspiration-contaminated samples to establish that three distinct microbiome pneumotypes are present in normal murine lungs.	[Scheiermann, Julia; Klinman, Dennis M.] NCI, Canc & Inflammat Program, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Klinman, DM (corresponding author), NCI, Canc & Inflammat Program, Frederick, MD 21701 USA.	klinmand@mail.nih.gov			NIH, NCI	NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This manuscript was supported by the Intramural Research Program of the NIH, NCI. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products,or organizations imply endorsement by the United States government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2014, PATHOG, V10; Barfod Kenneth Klingenberg, 2015, Open Microbiol J, V9, P167, DOI 10.2174/1874285801509010167; Barfod KK, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-303; Bassis CM, 2015, MBIO, V6, DOI 10.1128/mBio.00037-15; Belizario JE, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2015.01050, 10.1186/1476-069X-6-20, 10.3389/fmicb.2015.1050]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chao A, 2006, BIOMETRICS, V62, P361, DOI 10.1111/j.1541-0420.2005.00489.x; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Chiba H, 2006, RESPIROLOGY, V11, pS2, DOI 10.1111/j.1440-1843.2006.00797.x; Chuquimia OD, 2013, INFECT IMMUN, V81, P381, DOI 10.1128/IAI.00950-12; Chuquimia OD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032125; Cox MJ, 2015, AM J RESP CRIT CARE, V192, P403, DOI 10.1164/rccm.201506-1138ED; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dickson RP, 2015, AM J PHYSIOL-LUNG C, V309, pL1047, DOI 10.1152/ajplung.00279.2015; Dickson RP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004923; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gao Zhancheng, 2014, Genomics Proteomics & Bioinformatics, V12, P144, DOI 10.1016/j.gpb.2014.06.001; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; Hildebrand F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r4; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; Huffnagle GB, 2015, CLIN IMMUNOL, V159, P177, DOI 10.1016/j.clim.2015.05.022; Kearney SC, 2015, ANN ALLERG ASTHMA IM, V114, P364, DOI 10.1016/j.anai.2015.02.008; Lohmann P, 2014, PEDIATR RES, V76, P294, DOI 10.1038/pr.2014.85; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Nguyen M, 2016, ISME J, V10, P2978, DOI 10.1038/ismej.2016.76; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Pallmann P, 2012, MOL ECOL RESOUR, V12, P1068, DOI 10.1111/1755-0998.12004; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Pezzulo AA, 2013, APPL ENVIRON MICROB, V79, P5936, DOI 10.1128/AEM.01752-13; Poroyko V, 2015, AM J PHYSIOL-LUNG C, V309, pL76, DOI 10.1152/ajplung.00061.2014; Reddy TBK, 2015, NUCLEIC ACIDS RES, V43, pD1099, DOI 10.1093/nar/gku950; Rudkjobing VB, 2011, J CLIN MICROBIOL, V49, P4352, DOI 10.1128/JCM.06092-11; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Samuelson DR, 2015, FRONT MICROBIOL, V6, DOI [10.5389/fmicb.2015.01085, 10.3389/fmicb.2015.01085]; Scheiermann J, 2014, VACCINE, V32, P6377, DOI 10.1016/j.vaccine.2014.06.065; Segal Leopoldo N, 2014, Ann Am Thorac Soc, V11 Suppl 1, pS21, DOI 10.1513/AnnalsATS.201306-189MG; Segal LN, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-19; WEST JB, 1978, CHEST, V74, P426, DOI 10.1378/chest.74.4.426; Willis AL, 2016, AM J RHINOL ALLERGY, V30, P94, DOI 10.2500/ajra.2016.30.4278; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Yun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097289	45	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180561	10.1371/journal.pone.0180561	http://dx.doi.org/10.1371/journal.pone.0180561			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683098	Green Published, Green Submitted, gold			2022-12-26	WOS:000405335200047
J	Bogacka, I; Paukszto, L; Jastrzebski, JP; Czerwinska, J; Chojnowska, K; Kaminska, B; Kurzynska, A; Smolinska, N; Gizejewski, Z; Kaminski, T				Bogacka, Iwona; Paukszto, Lukasz; Jastrzebski, Jan P.; Czerwinska, Joanna; Chojnowska, Katarzyna; Kaminska, Barbara; Kurzynska, Aleksandra; Smolinska, Nina; Gizejewski, Zygmunt; Kaminski, Tadeusz			Seasonal differences in the testicular transcriptome profile of free-living European beavers (Castor fiber L.) determined by the RNA-Seq method	PLOS ONE			English	Article							GENE-EXPRESSION; BASEMENT-MEMBRANE; DIFFERENT PERIODS; K+-CHANNEL; TESTIS; RAT; ANNOTATION; MOUSE; MICE; SPERMATOGENESIS	The European beaver (Castor fiber L.) is an important free-living rodent that inhabits Eurasian temperate forests. Beavers are often referred to as ecosystem engineers because they create or change existing habitats, enhance biodiversity and prepare the environment for diverse plant and animal species. Beavers are protected in most European Union countries, but their genomic background remains unknown. In this study, gene expression patterns in beaver testes and the variations in genetic expression in breeding and non-breeding seasons were determined by high-throughput transcriptome sequencing. Paired-end sequencing in the Illumina HiSeq 2000 sequencer produced a total of 373.06 million of high-quality reads. De novo assembly of contigs yielded 130,741 unigenes with an average length of 1,369.3 nt, N50 value of 1,734, and average GC content of 46.51%. A comprehensive analysis of the testicular transcriptome revealed more than 26,000 highly expressed unigenes which exhibited the highest homology with Rattus norvegicus and Ictidomys tridecemlineatus genomes. More than 8,000 highly expressed genes were found to be involved in fundamental biological processes, cellular components or molecular pathways. The study also revealed 42 genes whose regulation differed between breeding and non-breeding seasons. During the non-breeding period, the expression of 37 genes was up-regulated, and the expression of 5 genes was down-regulated relative to the breeding season. The identified genes encode molecules which are involved in signaling transduction, DNA repair, stress responses, inflammatory processes, metabolism and steroidogenesis. Our results pave the way for further research into season-dependent variations in beaver testes.	[Bogacka, Iwona; Czerwinska, Joanna; Chojnowska, Katarzyna; Kaminska, Barbara; Kurzynska, Aleksandra; Smolinska, Nina; Kaminski, Tadeusz] Univ Warmia & Mazury, Fac Biol & Biotechnol, Dept Anim Physiol, Oczapowskiego 1A, Olsztyn, Poland; [Paukszto, Lukasz; Jastrzebski, Jan P.] Univ Warmia & Mazury, Fac Biol & Biotechnol, Dept Plant Physiol & Biotechnol, Oczapowskiego 1A, Olsztyn, Poland; [Gizejewski, Zygmunt] Polish Acad Sci, Inst Anim Reprod & Food Res, Bydgoska 7, Olsztyn, Poland	University of Warmia & Mazury; University of Warmia & Mazury; Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences	Bogacka, I (corresponding author), Univ Warmia & Mazury, Fac Biol & Biotechnol, Dept Anim Physiol, Oczapowskiego 1A, Olsztyn, Poland.	iwonab@uwn.edu.pl	Kurzyńska, Aleksandra/HHM-4122-2022; Kamińska, Barbara/AHB-2794-2022; Paukszto, Lukasz/AAV-8585-2021; Jastrzebski, Jan/C-3714-2015; Jastrzębski, Jan Paweł/J-3626-2019; Bogacka, Iwona/GYU-5963-2022; Giżejewski, Zygmunt/H-7174-2017; Jastrzębski, Jan Paweł/D-6423-2014	Kamińska, Barbara/0000-0002-1429-114X; Paukszto, Lukasz/0000-0002-3618-1064; Jastrzebski, Jan/0000-0001-8699-7742; Jastrzębski, Jan Paweł/0000-0001-8699-7742; Giżejewski, Zygmunt/0000-0001-7627-3222; Kurzynska, Aleksandra Hanna/0000-0001-7081-6409; Smolinska, Nina/0000-0001-5364-1387; Kaminski, Tadeusz/0000-0003-1643-026X; Bogacka, Iwona/0000-0003-3054-0123	Polish National Science Centre [2012/07/B/NZ9/01335]	Polish National Science Centre	This study was supported by the Polish National Science Centre (project No.2012/07/B/NZ9/01335).	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Barakat B, 2012, MOL CELL ENDOCRINOL, V359, P66, DOI 10.1016/j.mce.2012.02.018; Cerec V, 2007, BIOL REPROD, V76, P241, DOI 10.1095/biolreprod.106.056168; Chen YR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/183624; Chojnowska K, 2015, EUR J WILDLIFE RES, V61, P807, DOI 10.1007/s10344-015-0955-z; Chojnowska K, 2017, THERIOGENOLOGY, V87, P266, DOI 10.1016/j.theriogenology.2016.09.001; Ciechanowski M, 2011, EUR J WILDLIFE RES, V57, P737, DOI 10.1007/s10344-010-0481-y; Collen P, 2001, REV FISH BIOL FISHER, V10, P439; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conner JR, 2008, J EXP MED, V205, P305, DOI 10.1084/jem.20071499; Conner JR, 2010, P NATL ACAD SCI USA, V107, P11477, DOI 10.1073/pnas.1006894107; Criscuolo A, 2013, GENOMICS, V102, P500, DOI 10.1016/j.ygeno.2013.07.011; Czerwinska J, 2017, GEN COMP ENDOCR, V240, P103, DOI 10.1016/j.ygcen.2016.09.013; Czerwinska J, 2015, FOLIA BIOL-KRAKOW, V63, P229, DOI 10.3409/fb63_4.229; Deng TX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147132; DZAU VJ, 1987, ENDOCRINOLOGY, V120, P2334, DOI 10.1210/endo-120-6-2334; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Glattauer V, 2007, REPROD FERT DEVELOP, V19, P473, DOI 10.1071/RD06013; Glover T.D., 1990, P213; Gong XD, 2002, BIOL REPROD, V67, P46, DOI 10.1095/biolreprod67.1.46; Gunawan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063259; Hagaman JR, 1998, P NATL ACAD SCI USA, V95, P2552, DOI 10.1073/pnas.95.5.2552; Itman C, 2008, DEV DYNAM, V237, P97, DOI 10.1002/dvdy.21401; JOHNSON L, 1983, BIOL REPROD, V29, P777, DOI 10.1095/biolreprod29.3.777; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li Q, 2015, EUR J HISTOCHEM, V59, P9, DOI 10.4081/ejh.2015.2456; Liu HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077062; Loveland K, 1998, BIOL REPROD, V58, P1123, DOI 10.1095/biolreprod58.5.1123; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Matzkin ME, 2013, MOL CELL ENDOCRINOL, V367, P41, DOI 10.1016/j.mce.2012.12.015; Mendis SHS, 2011, BIOL REPROD, V84, P379, DOI 10.1095/biolreprod.110.086231; Moghadam HK, 2013, MOL ECOL RESOUR, V13, P696, DOI 10.1111/1755-0998.12096; Naillat F, 2014, MOL ENDOCRINOL, V28, P1534, DOI 10.1210/me.2013-1244; NAIMAN RJ, 1988, BIOSCIENCE, V38, P753, DOI 10.2307/1310784; Nie QH, 2011, DNA RES, V18, P343, DOI 10.1093/dnares/dsr021; Nolet BA, 1998, BIOL CONSERV, V83, P165, DOI 10.1016/S0006-3207(97)00066-9; Obidzinski A, 2011, POL J ECOL, V59, P63; Petrusz P, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-70; Prendergast BJ, 2005, HORM BEHAV, V48, P503, DOI 10.1016/j.yhbeh.2005.05.013; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosell F, 2005, MAMMAL REV, V35, P248, DOI 10.1111/j.1365-2907.2005.00067.x; Sadate-Ngatchou PI, 2004, MOL ENDOCRINOL, V18, P422, DOI 10.1210/me.2003-0188; Salem M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121778; SCHLATT S, 1995, BIOL REPROD, V53, P1169, DOI 10.1095/biolreprod53.5.1169; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Tacken PJ, 2001, TRANSGENIC RES, V10, P211, DOI 10.1023/A:1016682520887; Wilsson L, 1971, VILTREVY, V8, P115; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wu WL, 1998, BBA-BIOMEMBRANES, V1373, P360, DOI 10.1016/S0005-2736(98)00119-9; Zamiri MJ, 2010, SMALL RUMINANT RES, V94, P132, DOI 10.1016/j.smallrumres.2010.07.013; ZUROWSKI W, 1992, ACTA THERIOL, V37, P403	56	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180323	10.1371/journal.pone.0180323	http://dx.doi.org/10.1371/journal.pone.0180323			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678806	gold, Green Submitted, Green Published			2022-12-26	WOS:000405272200052
J	Das, AJ; Murmann, DC; Cohrn, K; Raskar, R				Das, Anshuman J.; Murmann, Denise C.; Cohrn, Kenneth; Raskar, Ramesh			A method for rapid 3D scanning and replication of large paleontological specimens	PLOS ONE			English	Article							KINECT SENSOR; PHOTOGRAPHY; TECHNOLOGY; TOOL	We demonstrate a fast and cost-effective technique to perform three dimensional (3D) scanning and replication of large paleontological specimens, in this case the entire skull of a Tyrannosaurus rex (T.rex) with a volume in the range of 2 m(3). The technique involves timeof-flight (TOF) depth sensing using the Kinect scanning module commonly used in gesture recognition in gaming. Raw data from the Kinect sensor was captured using open source software and the reconstruction was done rapidly making this a viable method that can be adopted by museums and researchers in paleontology. The current method has the advantage of being low-cost as compared to industrial scanners and photogrammetric methods but also of accurately scanning a substantial volume range which is well suited for large specimens. The depth resolution from the Kinect sensor was measured to be around 0.6 mm which is ideal for scanning large specimens with reasonable structural detail. We demonstrate the efficacy of this method on the skull of FMNH PR 2081, also known as SUE, a near complete T.rex at the Field Museum of Natural History.	[Das, Anshuman J.; Raskar, Ramesh] MIT, MIT Media Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Murmann, Denise C.] Murmann Dent Hlth, Naperville, IL USA; [Cohrn, Kenneth] KFCForensics, 422 Teague Trail, Lady Lake, FL USA	Massachusetts Institute of Technology (MIT)	Das, AJ (corresponding author), MIT, MIT Media Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ajdas@mit.edu			MIT Media Lab Consortia	MIT Media Lab Consortia	MIT Media Lab Consortia Funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for one of the authors (KFC), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bates KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004532; Bennett MR, 2016, SCI REP-UK, V6, DOI 10.1038/srep21916; Bimber O, 2002, COMPUTER, V35, P25, DOI 10.1109/MC.2002.1033024; Brink KS, 2015, SCI REP-UK, V5, DOI 10.1038/srep12338; Brochu CA, 2003, J VERTEBR PALEONTOL, V22; Cnudde V, 2006, APPL GEOCHEM, V21, P826, DOI 10.1016/j.apgeochem.2006.02.010; Crabb P, 2001, PALAEONTOLOGY, V44, P659, DOI 10.1111/1475-4983.00196; Cunningham JA, 2014, TRENDS ECOL EVOL, V29, P347, DOI 10.1016/j.tree.2014.04.004; Daanen HAM, 2013, DISPLAYS, V34, P270, DOI 10.1016/j.displa.2013.08.011; Falkingham PL, 2012, PALAEONTOL ELECTRON, V15; FALKINGHAM PL, 2013, J PALEONTOL TECHN, V11, P1; Feigin M, 2016, IEEE SENS J, V16, P3419, DOI 10.1109/JSEN.2015.2421360; Fortuny J, 2016, SCI REP-UK, V6, DOI 10.1038/srep30387; Grosman L, 2008, J ARCHAEOL SCI, V35, P3101, DOI 10.1016/j.jas.2008.06.011; GUTSCHICK RC, 1960, J PALEONTOL, V34, P756; Karasik A, 2008, J ARCHAEOL SCI, V35, P1148, DOI 10.1016/j.jas.2007.08.008; Kerp H, 2011, REV PALAEOBOT PALYNO, V166, P117, DOI 10.1016/j.revpalbo.2011.05.001; Kolb A, 2010, COMPUT GRAPH FORUM, V29, P141, DOI 10.1111/j.1467-8659.2009.01583.x; Lautenschlager S, 2014, J PALEONTOL, V88, P727, DOI 10.1666/13-085; Metallo A., 2011, CURATOR, V54, P63, DOI DOI 10.1111/J.2151-6952.2010.00067.X; Murmann DC, 2006, J FORENSIC SCI, V51, P846, DOI 10.1111/j.1556-4029.2006.00166.x; Niven L, 2009, J ARCHAEOL SCI, V36, P2018, DOI 10.1016/j.jas.2009.05.021; Peterson JE, 2009, PALAIOS, V24, P780, DOI 10.2110/palo.2009.p09-056r; Ren Z, 2013, IEEE T MULTIMEDIA, V15, P1110, DOI 10.1109/TMM.2013.2246148; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; TAUBIN G, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P852, DOI 10.1109/ICCV.1995.466848; Tong J, 2012, IEEE T VIS COMPUT GR, V18, P643, DOI 10.1109/TVCG.2012.56; Tschopp E, 2012, J PALEONTOL TECHN, V10, P1; Wang C, 2015, SCI REP-UK, P5; Wolff EDS, 2009, PLOS ONE, V4; Yang L, 2015, IEEE SENS J, V15, P4275, DOI 10.1109/JSEN.2015.2416651; Yao Y, 2014, IEEE T CIRC SYST VID, V24, P1935, DOI 10.1109/TCSVT.2014.2302538	33	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179264	10.1371/journal.pone.0179264	http://dx.doi.org/10.1371/journal.pone.0179264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2LF	28678817	Green Published, Green Submitted, gold			2022-12-26	WOS:000405272200012
J	Wolf, L; Herr, C; Niederstrasser, J; Beisswenger, C; Bals, R				Wolf, Lisa; Herr, Christian; Niederstrasser, Julia; Beisswenger, Christoph; Bals, Robert			Receptor for advanced glycation endproducts (RAGE) maintains pulmonary structure and regulates the response to cigarette smoke	PLOS ONE			English	Article							ALVEOLAR EPITHELIAL-CELLS; GLYCOSYLATION END-PRODUCTS; TOBACCO-SMOKE; ANTIMICROBIAL PEPTIDE; PROGRESSION FACTOR; INDUCED EMPHYSEMA; SURFACE RECEPTOR; TIGHT JUNCTIONS; KNOCKOUT MICE; IN-VITRO	The receptor for advanced glycation endproducts (RAGE) is highly expressed in the lung but its physiological functions in this organ is still not completely understood. To determine the contribution of RAGE to physiological functions of the lung, we analyzed pulmonary mechanics and structure of wildtype and RAGE deficient (RAGE (-/-)) mice. RAGE deficiency spontaneously resulted in a loss of lung structure shown by an increased mean chord length, increased respiratory system compliance, decreased respiratory system elastance and increased concentrations of serum protein albumin in bronchoalveolar lavage fluids. Pulmonary expression of RAGE was mainly localized on alveolar epithelial cells and alveolar macrophages. Primary murine alveolar epithelial cells isolated from RAGE -/-mice revealed an altered differentiation and defective barrier formation under in vitro conditions. Stimulation of interferone-y (IFNy)-activated alveolar macrophages deficient for RAGE with Toll-like receptor (TLR) ligands resulted in significantly decreased release of proinflammatory cytokines and chemokines. Exposure to chronic cigarette smoke did not affect emphysema- like changes in lung parenchyma in RAGE (-/)-mice. Acute cigarette smoke exposure revealed a modified inflammatory response in RAGE (-/)-mice that was characterized by an influx of macrophages and a decreased keratinocyte-derived chemokine (KC) release. Our data suggest that RAGE regulates the differentiation of alveolar epithelial cells and impacts on the development and maintenance of pulmonary structure. In cigarette smoke-induced lung pathology, RAGE mediates inflammation that contributes to lung damage.	[Wolf, Lisa; Herr, Christian; Niederstrasser, Julia; Beisswenger, Christoph; Bals, Robert] Saarland Univ, Dept Internal Med Pulmonol Allergol & Crit Care M, Homburg, Germany	Universitatsklinikum des Saarlandes	Bals, R (corresponding author), Saarland Univ, Dept Internal Med Pulmonol Allergol & Crit Care M, Homburg, Germany.	robet.bals@uks.eu	Herr, Christian/AAH-5291-2021; Beisswenger, Christoph/GRO-6580-2022	Herr, Christian/0000-0001-9422-6569	Saarland University HOMFOR, DFG [BE 4813/1-1]	Saarland University HOMFOR, DFG	This work was supported by Saarland University HOMFOR2014, DFG BE 4813/1-1.	Al-Robaiy S, 2013, AM J PHYSIOL-LUNG C, V305, pL491, DOI 10.1152/ajplung.00090.2013; Barnes PJ, 2000, CHEST, V117, P10; Beisswenger C, 2004, RESPIRATION, V71, P402, DOI 10.1159/000079647; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Borok Z, 1998, AM J PHYSIOL-LUNG C, V275, pL155, DOI 10.1152/ajplung.1998.275.1.L155; Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; Cerami C, 1997, P NATL ACAD SCI USA, V94, P13915, DOI 10.1073/pnas.94.25.13915; Chen L, 2014, LUNG, V192, P267, DOI 10.1007/s00408-014-9561-1; Daum N, 2012, METHODS MOL BIOL, V806, P31, DOI 10.1007/978-1-61779-367-7_3; DeMaio L, 2009, AM J PHYSIOL-LUNG C, V296, pL1051, DOI 10.1152/ajplung.00021.2009; Demling N, 2006, CELL TISSUE RES, V323, P475, DOI 10.1007/s00441-005-0069-0; Ferhani N, 2010, AM J RESP CRIT CARE, V181, P917, DOI 10.1164/rccm.200903-0340OC; Gonzalez R, 2005, AM J PHYSIOL-LUNG C, V288, pL179, DOI 10.1152/ajplung.00272.2004; Guillot L, 2013, INT J BIOCHEM CELL B, V45, P2568, DOI 10.1016/j.biocel.2013.08.009; Herr C, 2015, EXP TOXICOL PATHOL, V67, P261, DOI 10.1016/j.etp.2015.01.002; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Jungnickel C, 2015, AM J PHYSIOL-LUNG C, V309, pL605, DOI 10.1152/ajplung.00116.2015; Kang R, 2016, J IMMUNOL; Kierdorf K, 2013, J LEUKOCYTE BIOL, V94, P55, DOI 10.1189/jlb.1012519; Kokkola R, 2005, SCAND J IMMUNOL, V61, P1, DOI 10.1111/j.0300-9475.2005.01534.x; Kovach MA, 2012, J IMMUNOL, V189, P304, DOI 10.4049/jimmunol.1103196; Koval M, 2013, ANNU REV PHYSIOL, V75, P551, DOI 10.1146/annurev-physiol-030212-183809; LaFemina MJ, 2014, AM J RESP CELL MOL, V51, P550, DOI 10.1165/rcmb.2013-0456OC; LaFemina MJ, 2010, AM J PHYSIOL-LUNG C, V299, pL724, DOI 10.1152/ajplung.00233.2010; Li D, 2014, ONCOGENE, V33, P2709, DOI 10.1038/onc.2013.248; Li D., 2013, ONCOGENE; Li GL, 2014, AM J RESP CELL MOL, V51, P210, DOI 10.1165/rcmb.2013-0353OC; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Morbini P, 2006, MODERN PATHOL, V19, P1437, DOI 10.1038/modpathol.3800661; Mosser DM, 2008, CURRENT PROTOCOLS IM; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Pouwels SD, 2013, DAMPS ACTIVATING INN; Reynolds PR, 2010, AM J RESP CELL MOL, V42, P545, DOI 10.1165/rcmb.2008-0265OC; Rinaldi M, 2012, DIS MODEL MECH, V5, P333, DOI 10.1242/dmm.008508; Robinson AB, 2012, AM J PHYSIOL-LUNG C, V302, pL1192, DOI 10.1152/ajplung.00099.2012; Sakaguchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023132; Sambamurthy N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118979; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Seimetz M, 2011, CELL, V147, P293, DOI 10.1016/j.cell.2011.08.035; Shirasawa M, 2004, GENES CELLS, V9, P165, DOI 10.1111/j.1356-9597.2004.00712.x; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Smith DJ, 2011, EUR RESPIR J, V37, P516, DOI 10.1183/09031936.00029310; Sorci G, 2013, BBA-MOL CELL RES, V1833, P101, DOI 10.1016/j.bbamcr.2012.10.021; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Sukkar M, 2012, BRIT J PHARMACOL; Sukkar MB, 2011, EUR RESP J; Tuder RM, 2012, J CLIN INVEST, V122, P2749, DOI 10.1172/JCI60324; Voss M, 2015, AM J PHYSIOL-LUNG C, V309, pL188, DOI 10.1152/ajplung.00388.2014; Waseda K, 2014, AM J RESP CELL MOL B; Williams AE, 2015, AM J PHYSIOL-LUNG C, V308, pL539, DOI 10.1152/ajplung.00141.2014; Wonnenberg B, 2014, INT J MED MICROBIOL, V304, P725, DOI 10.1016/j.ijmm.2014.05.002; Wood TT, 2014, AM J PHYSL LUNG CELL; Wood TT, 2014, AM J PHYSIOL-LUNG C, V307, pL758, DOI 10.1152/ajplung.00185.2014; Wu LA, 2011, RESP MED, V105, P329, DOI 10.1016/j.rmed.2010.11.001; Wu XJ, 2013, MOL CELL BIOCHEM, V380, P249, DOI 10.1007/s11010-013-1680-0; Yan SD, 1997, P NATL ACAD SCI USA, V94, P5296, DOI 10.1073/pnas.94.10.5296; Zhao H, 2010, J IMMUNOL, V184, P5308, DOI 10.4049/jimmunol.1000009	60	34	35	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180092	10.1371/journal.pone.0180092	http://dx.doi.org/10.1371/journal.pone.0180092			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678851	gold, Green Submitted, Green Published			2022-12-26	WOS:000405272200037
J	Jang, YR; Shin, Y; Jin, CE; Koo, B; Park, SY; Kim, MC; Kim, T; Chong, YP; Lee, SO; Choi, SH; Kim, YS; Woo, JH; Kim, SH; Yu, E				Jang, Young-Rock; Shin, Yong; Jin, Choong Eun; Koo, Bonhan; Park, Se Yoon; Kim, Min-Chul; Kim, Taeeun; Chong, Yong Pil; Lee, Sang-Oh; Choi, Sang-Ho; Kim, Yang Soo; Woo, Jun Hee; Kim, Sung-Han; Yu, Eunsil			Molecular detection of Coxiella burnetii from the formalin-fixed tissues of Q fever patients with acute hepatitis	PLOS ONE			English	Article							LONG-TERM PERSISTENCE; DIAGNOSIS; INFECTION; ORIGIN	Background Serologic diagnosis is one of the most widely used diagnostic methods for Q fever, but the window period in antibody response of 2 to 3 weeks after symptom onset results in significant diagnostic delay. We investigated the diagnostic utility of Q fever PCR from formalinfixed liver tissues in Q fever patients with acute hepatitis. Methods We reviewed the clinical and laboratory data in patients with Q fever hepatitis who underwent liver biopsy during a 17-year period, and whose biopsied tissues were available. We also selected patients who revealed granuloma in liver biopsy and with no Q fever diagnosis within the last 3 years as control. Acute Q fever hepatitis was diagnosed if two or more of the following clinical, serologic, or histopathologic criteria were met: (1) an infectious hepatitislike clinical feature such as fever (>= 38 degrees C) with elevated hepatic transaminase levels; (2) exhibition of a phase II immunoglobulin G (IgG) antibodies titer by IFA of >= 1:128 in single determination, or a four-fold or greater rise between two separate samples obtained two or more weeks apart; (3) histologic finding of biopsy tissue showing characteristic fibrin ring granuloma. Results A total of 11 patients with acute Q fever hepatitis were selected and analyzed. Of the 11 patients, 3 (27%) had exposure to zoonotic risk factors and 7 (63%) met the serologic criteria. Granulomas with either circumferential or radiating fibrin deposition were observed in 10 cases on liver biopsy and in 1 case on bone marrow biopsy. 8 (73%) revealed positive Coxiella burnetii PCR from their formalin-fixed liver tissues. In contrast, none of 10 patients with alternative diagnosis who had hepatic granuloma revealed positive C. burnetii PCR from their formalin-fixed liver tissues. Conclusions Q fever PCR from formalin-fixed liver tissues appears to be a useful adjunct for diagnosing Q fever hepatitis.	[Jang, Young-Rock; Park, Se Yoon; Kim, Min-Chul; Kim, Taeeun; Chong, Yong Pil; Lee, Sang-Oh; Choi, Sang-Ho; Kim, Yang Soo; Woo, Jun Hee; Kim, Sung-Han] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea; [Jang, Young-Rock] Gachon Univ, Coll Med, Div Infect Dis, Dept Internal Med,Gil Med Ctr, Incheon, South Korea; [Shin, Yong; Jin, Choong Eun; Koo, Bonhan] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Convergence Med, Seoul, South Korea; [Park, Se Yoon] Soonchunhyang Univ, Coll Med, Div Infect Dis, Dept Internal Med,Seoul Hosp, Seoul, South Korea; [Yu, Eunsil] Univ Ulsan, Coll Med, Dept Pathol, Asan Med Ctr, Seoul, South Korea	University of Ulsan; Asan Medical Center; Gachon University; University of Ulsan; Asan Medical Center; Soonchunhyang University; University of Ulsan	Kim, SH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea.; Yu, E (corresponding author), Univ Ulsan, Coll Med, Dept Pathol, Asan Med Ctr, Seoul, South Korea.	kimsunghanmd@hotmail.com; esyu@amc.seoul.kr	Chong, Yong Pil/AAB-2623-2021; Lee, Sang-Oh/AGV-5413-2022	Lee, Sang-Oh/0000-0003-1381-8787; Kim, Sung-Han/0000-0002-6596-8253; Jin, Choong Eun/0000-0002-4462-2333; JANG, YOUNG ROCK/0000-0003-1080-7839	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI16C0272]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant no. HI16C0272).	Anderson A, 2013, MMWR RECOMM REP, V62, P1; DUPONT HL, 1971, ANN INTERN MED, V74, P198, DOI 10.7326/0003-4819-74-2-198; Fenollar F, 2004, J CLIN MICROBIOL, V42, P4919, DOI 10.1128/JCM.42.11.4919-4924.2004; Fournier PE, 1998, J CLIN MICROBIOL, V36, P1823, DOI 10.1128/JCM.36.7.1823-1834.1998; Harris RJ, 2000, EPIDEMIOL INFECT, V124, P543, DOI 10.1017/S0950268899003763; HIGGINS D, 1990, ANN NY ACAD SCI, V590, P271, DOI 10.1111/j.1749-6632.1990.tb42231.x; HOFMANN CE, 1982, GASTROENTEROLOGY, V83, P474; KAZANJIAN PH, 1992, CLIN INFECT DIS, V15, P968, DOI 10.1093/clind/15.6.968; LARSON EB, 1982, MEDICINE, V61, P269, DOI 10.1097/00005792-198209000-00001; Lorenz H, 1998, APPL ENVIRON MICROB, V64, P4234; Marmion BP, 2005, QJM-INT J MED, V98, P7, DOI 10.1093/qjmed/hci009; MUSSO D, 1995, J CLIN MICROBIOL, V33, P3129, DOI 10.1128/JCM.33.12.3129-3132.1995; Schneeberger Peter M, 2010, Clin Vaccine Immunol, V17, P286, DOI 10.1128/CVI.00454-09; TRAVIS LB, 1986, ARCH PATHOL LAB MED, V110, P1017; van Wijk MJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-6; WEIR WRC, 1984, J INFECTION, V8, P56, DOI 10.1016/S0163-4453(84)93354-1	16	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180237	10.1371/journal.pone.0180237	http://dx.doi.org/10.1371/journal.pone.0180237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672014	Green Submitted, Green Published, gold			2022-12-26	WOS:000405268500032
J	Zhao, CC; Hu, SE; Huo, X; Zhang, Y				Zhao, Chengchen; Hu, Sheng'en; Huo, Xiao; Zhang, Yong			Dr. seq2: A quality control and analysis pipeline for parallel single cell transcriptome and epigenome data	PLOS ONE			English	Article							RNA-SEQUENCING DATA; EXPRESSION ANALYSIS; HETEROGENEITY; SUBPOPULATIONS	An increasing number of single cell transcriptome and epigenome technologies, including single cell ATAC-seq (scATAC-seq), have been recently developed as powerful tools to analyze the features of many individual cells simultaneously. However, the methods and software were designed for one certain data type and only for single cell transcriptome data. A systematic approach for epigenome data and multiple types of transcriptome data is needed to control data quality and to perform cell-to-cell heterogeneity analysis on these ultra-high-dimensional transcriptome and epigenome datasets. Here we developed Dr. seq2, a Quality Control (QC) and analysis pipeline for multiple types of single cell transcriptome and epigenome data, including scATAC-seq and Drop-ChIP data. Application of this pipeline provides four groups of QC measurements and different analyses, including cell heterogeneity analysis. Dr. seq2 produced reliable results on published single cell transcriptome and epigenome datasets. Overall, Dr. seq2 is a systematic and comprehensive QC and analysis pipeline designed for parallel single cell transcriptome and epigenome data.	[Zhang, Yong] Tongji Univ, Translat Med Ctr Stem Cell Therapy, Shanghai, Peoples R China; Tongji Univ, Inst Regenerat Med, Shanghai Key Lab Signaling & Dis Res, Sch Life Sci & Technol,Shanghai East Hosp, Shanghai, Peoples R China	Tongji University; Tongji University	Zhang, Y (corresponding author), Tongji Univ, Translat Med Ctr Stem Cell Therapy, Shanghai, Peoples R China.	yzhang@tongji.edu.cn	Zhao, Chengchen/AAH-4166-2019; Zhang, Yong/B-4838-2011	Zhang, Yong/0000-0001-6316-2734; Zhao, Chengchen/0000-0002-8454-6347	National Natural Science Foundation of China [31571365, 31322031, 31371288]; National Key Research and Development Programof China [2016YFA0100400]; Specialized Research Fund for the Doctoral Program of Higher Education [20130072110032]; Program of Shanghai Academic Research Leader [17XD1403600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Programof China; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program of Shanghai Academic Research Leader	This work was supported by National Natural Science Foundation of China (31571365, 31322031 and 31371288), National Key Research and Development Programof China (2016YFA0100400), Specialized Research Fund for the Doctoral Program of Higher Education (20130072110032), and Program of Shanghai Academic Research Leader (17XD1403600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; duVerle,DA, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1175-6; Fan HC, 2015, SCIENCE, V347, DOI 10.1126/science.1258367; Fan J, 2016, NAT METHODS, V13, P241, DOI [10.1038/NMETH.3734, 10.1038/nmeth.3734]; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Gardeux V., 2016, BIORXIV; GOODMAN LA, 1954, J AM STAT ASSOC, V49, P732, DOI 10.2307/2281536; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Guo MZ, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004575; Huo X, 2016, BIOINFORMATICS, V32, P2221, DOI 10.1093/bioinformatics/btw174; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jiang P, 2016, BIOINFORMATICS, V32, P2514, DOI 10.1093/bioinformatics/btw176; Julia M, 2015, BIOINFORMATICS, V31, P3377, DOI 10.1093/bioinformatics/btv368; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Korthauer KD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1077-y; Leng N, 2016, BIOINFORMATICS, V32, P1408, DOI 10.1093/bioinformatics/btw004; Leng N, 2015, NAT METHODS, V12, P947, DOI [10.1038/NMETH.3549, 10.1038/nmeth.3549]; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Marco E, 2014, P NATL ACAD SCI USA, V111, pE5643, DOI 10.1073/pnas.1408993111; Pierson E, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0805-z; Rotem A, 2015, NAT BIOTECHNOL, V33, P1165, DOI 10.1038/nbt.3383; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Vallejos CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004333; Wang B, 2017, NAT METHODS, V14, P414, DOI 10.1038/nmeth.4207; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Xu C, 2015, BIOINFORMATICS, V31, P1974, DOI 10.1093/bioinformatics/btv088; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	36	21	22	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180583	10.1371/journal.pone.0180583	http://dx.doi.org/10.1371/journal.pone.0180583			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671995	Green Published, Green Submitted, gold			2022-12-26	WOS:000405268500074
J	Marti-Pamies, I; Canes, L; Alonso, J; Rodriguez, C; Martinez-Gonzalez, J				Marti-Pamies, Ingrid; Canes, Laia; Alonso, Judith; Rodriguez, Cristina; Martinez-Gonzalez, Jose			The nuclear receptor NOR-1/NR4A3 regulates the multifunctional glycoprotein vitronectin in human vascular smooth muscle cells	FASEB JOURNAL			English	Article						atherosclerosis; extracellular matrix; cell migration	PLASMINOGEN-ACTIVATOR INHIBITOR-1; NF-KAPPA-B; TRANSCRIPTIONAL REGULATORS; NEOINTIMAL HYPERPLASIA; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; NOR-1; INJURY; PROLIFERATION; MIGRATION	The nuclear receptor NOR-1 (NR4A3) has recently been involved in the regulation of extracellular matrix (ECM) proteins associated with neointimal thickening and the vascular control of hemostasis. We sought to find as-yet unidentified NOR-1 target genes in human vascular smooth muscle cells (VSMCs). An in silico analysis identified putative NOR-1 response elements in the proximal promoter region of several genes encoding for ECM proteins, including vitronectin (VTN). Lentiviral overexpression of NOR-1 strongly increased VTN mRNA and protein levels, whereas NOR-1 silencing significantly reduced VTN expression. Deletion and site-directed mutagenesis studies, as well as EMSA and chromatin immunoprecipitation, identified the NBRE(-202/-195) site in the VTN promoter as an essential element for NOR-1 responsiveness. Furthermore, NOR-1 and VTN colocalized in VSMCs in human atherosclerotic lesions. VTN levels were increased in cell supernatants from VSMCs that overexpress NOR-1. Cell supernatants from VSMCs overexpressing NOR-1 induced cell migration to a greater extent than supernatants from control cells, and this effect was attenuated when cell supernatants were preincubated with anti-VTN blocking antibodies or VTN was silenced in supernatant-generating cells. These results indicate that VTN is a target of NOR-1 and suggest that this multifunctional glycoprotein may participate in vascular responses mediated by this nuclear receptor.-Marti-Pamies, I., Canes, L., Alonso, J., Rodriguez, C., Martinez-Gonzalez, J. The nuclear receptor NOR-1/NR4A3 regulates the multifunctional glycoprotein vitronectin in human vascular smooth muscle cells.	[Marti-Pamies, Ingrid; Canes, Laia; Alonso, Judith; Martinez-Gonzalez, Jose] CSIC, IIBB, Barcelona, Spain; [Rodriguez, Cristina] St Pau Biomed Res Inst, ICCC, Madrid, Spain; [Marti-Pamies, Ingrid; Alonso, Judith; Rodriguez, Cristina; Martinez-Gonzalez, Jose] Ctr Invest Biomed Red CIBER Enfermedades Cardiova, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV	Martinez-Gonzalez, J (corresponding author), Hosp Santa Creu & Sant Pau, Inst Catala Ciencies Cardiovasc, Pabellon 11,Avda St Antoni Maria Claret 167, Barcelona 08025, Spain.	jmartinez@csic-iccc.org	Rodriguez, Cristina/D-3099-2011	Rodriguez, Cristina/0000-0002-6472-5647; Marti-Pamies, Ingrid/0000-0002-6870-2231; Canes Esteve, Laia/0000-0002-9579-1321; Alonso Nieto, Judith/0000-0003-0537-0417	Spanish Ministerio de Economia y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII) [PI15/01016, SAF2015-64767-R, RD12/0042/0053]; Fundacio La Marato TV3 [20152330]; Fondo Europeo de Desarrollo Regional (FEDER)	Spanish Ministerio de Economia y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII); Fundacio La Marato TV3; Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	The authors thank Naganari Ohkura (Growth Factor Division, National Cancer Center Research Institute, Tokyo, Japan) and James Hastie (Medical Research Council, University of Dundee, Dundee, United Kingdom) for kindly providing the human NOR-1 cDNA, and the plasmid containing the NOR-1-FLAG, respectively. This work was supported by Spanish Ministerio de Economia y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII) Grants PI15/01016, SAF2015-64767-R and RD12/0042/0053 and Fundacio La Marato TV3 Grant 20152330. This study was cofunded by Fondo Europeo de Desarrollo Regional (FEDER). Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Cardiovasculares is an initiative of ISCIII-MINECO. The authors declare no conflicts of interest.	Alonso J, 2016, SCI REP-UK, V6, DOI 10.1038/srep34056; Bergmeier W, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005132; Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; BROWN SL, 1994, CARDIOVASC RES, V28, P1815, DOI 10.1093/cvr/28.12.1815; Calvayrac O, 2015, J MOL CELL CARDIOL, V80, P34, DOI 10.1016/j.yjmcc.2014.12.015; Calvayrac O, 2011, ARTERIOSCL THROM VAS, V31, P2733, DOI 10.1161/ATVBAHA.111.235721; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chistiakov DA, 2013, CARDIOL REV, V21, P270, DOI 10.1097/CRD.0b013e31828c5ced; Churchman Adrian T., 2009, V467, P127, DOI 10.1007/978-1-59745-241-0_7; Coleman KR, 1999, CIRC RES, V84, P1268, DOI 10.1161/01.RES.84.11.1268; Dufourcq P, 2002, CARDIOVASC RES, V53, P952, DOI 10.1016/S0008-6363(01)00547-8; Dufourcq P, 1998, ARTERIOSCL THROM VAS, V18, P168, DOI 10.1161/01.ATV.18.2.168; Duren RP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150450; Ferran B, 2016, SCI REP-UK, V6, DOI 10.1038/srep25944; Garg N, 2010, J THROMB HAEMOST, V8, P1847, DOI 10.1111/j.1538-7836.2010.03907.x; Gizard F, 2011, J BIOL CHEM, V286, P35485, DOI 10.1074/jbc.M111.295840; Gruber F, 2003, BLOOD, V101, P3042, DOI 10.1182/blood-2002-07-2331; Guadall A, 2011, J BIOL CHEM, V286, P7093, DOI 10.1074/jbc.M110.162917; Halper J, 2014, ADV EXP MED BIOL, V802, P31, DOI 10.1007/978-94-007-7893-1_3; Konstantinides S, 2001, CIRCULATION, V103, P576, DOI 10.1161/01.CIR.103.4.576; Li P, 2013, CARDIOVASC RES, V99, P185, DOI 10.1093/cvr/cvt082; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Martinez-Gonzalez J, 2005, CARDIOVASC RES, V65, P609, DOI 10.1016/j.cardiores.2004.10.002; Martinez-Gonzalez J, 2003, CIRC RES, V92, P96, DOI 10.1161/01.ES.0000050921.53008.47; Martorell L, 2007, J THROMB HAEMOST, V5, P1766, DOI 10.1111/j.1538-7836.2007.02627.x; Martorell L, 2009, MOL CELL BIOL, V29, P5828, DOI 10.1128/MCB.00945-09; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Nomiyama T, 2006, J BIOL CHEM, V281, P33467, DOI 10.1074/jbc.M603436200; Nomiyama T, 2009, CIRCULATION, V119, P577, DOI 10.1161/CIRCULATIONAHA.108.822056; Ohkura N, 1996, BBA-GENE STRUCT EXPR, V1308, P205, DOI 10.1016/0167-4781(96)00101-7; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; Preissner KT, 2011, SEMIN THROMB HEMOST, V37, P408, DOI 10.1055/s-0031-1276590; Preissner KT, 1998, THROMB RES, V89, P1, DOI 10.1016/S0049-3848(97)00298-3; PREISSNER KT, 1989, BLOOD, V74, P1989; Reuning U, 2011, J CELL BIOCHEM, V112, P1909, DOI 10.1002/jcb.23111; Rius J, 2006, ATHEROSCLEROSIS, V184, P276, DOI 10.1016/j.atherosclerosis.2005.04.008; Rius J, 2004, ARTERIOSCL THROM VAS, V24, P697, DOI 10.1161/01.ATV.0000121570.00515.dc; Rodriguez-Calvo R, 2015, THROMB HAEMOSTASIS, V113, P1323, DOI 10.1160/TH14-07-0645; Rodriguez-Calvo R, 2013, HUM MOL GENET, V22, P1949, DOI 10.1093/hmg/ddt042; Sambri I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141932; Sato R, 1994, J Atheroscler Thromb, V1 Suppl 1, pS50; Shimizu S, 2002, BBA-GENE STRUCT EXPR, V1574, P337, DOI 10.1016/S0167-4781(02)00232-4; Thakar RG, 2009, BIOPHYS J, V96, P3423, DOI 10.1016/j.bpj.2008.11.074; Wang YB, 2013, INT J CARDIOL, V168, P163, DOI 10.1016/j.ijcard.2012.09.100; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Wingate AD, 2006, BIOCHEM J, V393, P715, DOI 10.1042/BJ20050967; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Yang P, 2016, ARTERIOSCL THROM VAS, V36, P361, DOI 10.1161/ATVBAHA.115.306891; Zhao Y, 2010, CIRC RES, V107, P501, DOI 10.1161/CIRCRESAHA.110.222083; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163	51	14	14	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4588	4599		10.1096/fj.201700136RR	http://dx.doi.org/10.1096/fj.201700136RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28666984				2022-12-26	WOS:000413397400034
J	Sholts, SB; Gingerich, JAM; Schlager, S; Stanford, DJ; Warmlander, SKTS				Sholts, Sabrina B.; Gingerich, Joseph A. M.; Schlager, Stefan; Stanford, Dennis J.; Warmlander, Sebastian K. T. S.			Tracing social interactions in Pleistocene North America via 3D model analysis of stone tool asymmetry	PLOS ONE			English	Article							CULTURAL TRANSMISSION; SEXUAL-DIMORPHISM; CLOVIS; SYMMETRY; AGE; MORPHOMETRICS; EVOLUTION; AFFINITY; CONTEXT; SURFACE	Stone tools, often the sole remnant of prehistoric hunter-gatherer behavior, are frequently used as evidence of ancient human mobility, resource use, and environmental adaptation. In North America, studies of morphological variation in projectile points have provided important insights into migration and interactions of human groups as early as 12-13 kya. Using new approaches to 3D imaging and morphometric analysis, we here quantify bifacial asymmetry among early North American projectile point styles to better understand changes in knapping technique and cultural transmission. Using a sample of 100 fluted bifaces of Clovis and post-Clovis styles in the eastern United States ca. 13,100-9,000 cal BP (i.e., Clovis, Debert-Vail, Bull Brook, Michaud-Neponset/Barnes, and Crowfield), we employed two different approaches for statistical shape analysis: our previously presented method for analysis of 2D flake scar contours, and a new approach for 3D surface analysis using spherical harmonics (SPHARM). Whereas bifacial asymmetry in point shape does not vary significantly across this stylistic sequence, our measure of asymmetric flake scar patterning shows temporal variation that may signify the beginning of regionalization among early New World colonists.	[Sholts, Sabrina B.; Gingerich, Joseph A. M.; Stanford, Dennis J.] Smithsonian Inst, Dept Anthropol, Natl Museum Nat Hist, Washington, DC 20560 USA; [Gingerich, Joseph A. M.] Ohio Univ, Dept Sociol & Anthropol, Athens, OH 45701 USA; [Schlager, Stefan] Albert Ludwigs Univ Freiburg, Med Fak, Dept Anthropol, Freiburg, Germany; [Warmlander, Sebastian K. T. S.] Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden; [Warmlander, Sebastian K. T. S.] Univ Calif Los Angeles, Cotsen Inst Archaeol, UCLA Getty Conservat Programme, Los Angeles, CA 90095 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; University System of Ohio; Ohio University; University of Freiburg; Stockholm University; University of California System; University of California Los Angeles	Warmlander, SKTS (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden.; Warmlander, SKTS (corresponding author), Univ Calif Los Angeles, Cotsen Inst Archaeol, UCLA Getty Conservat Programme, Los Angeles, CA 90095 USA.	seb@dbb.su.se		Sholts, Sabrina/0000-0003-4168-0578; Schlager, Stefan/0000-0001-6493-9250				Amberg B, 2011, EDITING FACES VIDEOS; ANDERSON D.G., 2015, PALEOAMERICA, V1, P7, DOI DOI 10.1179/2055556314Z.00000000012; Anderson D.G., 2010, ARCHAEOLOGY E N AM, V38, P63; Bettinger RL, 1999, AM ANTIQUITY, V64, P231, DOI 10.2307/2694276; Bodenhofer U, 2008, MATHWARE SOFT COMPUT, V15, P5; Boisvert RA, 2008, NEW HAMPSHIRE ARCHAE, V47, P57; Boisvert RA, E FLUTED POINT TRADI, VII; Bonhomme V, 2014, J STAT SOFTW, V56, P1; Bradley BA, 2010, INT MONOGRAPHS PREHI; Bradley J. W., 2008, ARCHAEOLOGY E N AM, V36, P119; Buchanan B, 2015, J ARCHAEOL SCI-REP, V3, P11, DOI 10.1016/j.jasrep.2015.05.011; Buchanan B, 2014, ARCHAEOL ANTHROP SCI, V6, P145, DOI 10.1007/s12520-013-0168-x; Buchanan B, 2010, J ARCHAEOL SCI, V37, P350, DOI 10.1016/j.jas.2009.09.047; Buchanan B, 2009, AM ANTIQUITY, V74, P279, DOI 10.1017/S0002731600048605; Bulut O, 2016, FORENSIC SCI INT, V261, DOI 10.1016/j.forsciint.2016.01.028; CHRISTENSON AL, 1986, PLAINS ANTHROPOL, V31, P109, DOI 10.1080/2052546.1986.11909324; Eerkens JW, 2007, J ARCHAEOL RES, V15, P239, DOI 10.1007/s10814-007-9013-z; Eerkens JW, 2005, J ANTHROPOL ARCHAEOL, V24, P316, DOI 10.1016/j.jaa.2005.08.001; Ellis C, 2011, J ANTHROPOL ARCHAEOL, V30, P385, DOI 10.1016/j.jaa.2011.05.001; Eren MI, 2015, J HUM EVOL, V80, P159, DOI 10.1016/j.jhevol.2015.01.002; Gingerich JAM, 2014, WORLD ARCHAEOL, V46, P101, DOI 10.1080/00438243.2014.892437; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Graham JH, 1998, BIOL J LINN SOC, V64, P1, DOI 10.1111/j.1095-8312.1998.tb01530.x; Gunn J., 1977, STUDIES VARIABILITY, P167; Hamilton MJ, 2009, J ANTHROPOL ARCHAEOL, V28, P55, DOI 10.1016/j.jaa.2008.10.005; Haynes C.Vance., 1992, ICE AGE HUNTERS ROCK, P83; Haynes G, 2007, SCIENCE, V317, DOI 10.1126/science.1141960; HOLM S, 1979, SCAND J STAT, V6, P65; Klingenberg CP, 2015, SYMMETRY-BASEL, V7, P843, DOI 10.3390/sym7020843; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Lipo CP, 2012, AM ANTIQUITY, V77, P774, DOI 10.7183/0002-7316.77.4.774; Lothrop JC, 2011, QUATERN INT, V242, P546, DOI 10.1016/j.quaint.2011.04.015; McAvoy, 2015, NOTTAWAY RIVER SUR 2; Miller D. Shane, 2013, E FLUTED POINT TRADI, P9; Moller AP, 1998, AM NAT, V151, P174, DOI 10.1086/286110; Morrow JE, 1999, AM ANTIQUITY, V64, P215, DOI 10.2307/2694275; MOSHFEGHI M, 1994, IEEE T IMAGE PROCESS, V3, P128, DOI 10.1109/83.277895; Nain D, 2007, BIOM IM NAN MACR 200; Neiss M, 2016, ARCHAEOL ANTHROP SCI, V8, P651, DOI 10.1007/s12520-014-0200-9; Newby P, 2005, QUATERNARY SCI REV, V24, P141, DOI 10.1016/j.quascirev.2004.04.010; Newby P, 2007, CURRENT RES PLEISTOC, V24, P16; O'Brien MJ, 2015, REPLACE NEANDERTHAL, P121, DOI 10.1007/978-4-431-55363-2_9; O'Brien MJ, 2014, J ANTHROPOL ARCHAEOL, V34, P100, DOI 10.1016/j.jaa.2014.03.001; Palmer A. Richard, 1992, Acta Zoologica Fennica, V191, P57; Palmer AR, 2004, SCIENCE, V306, P828, DOI 10.1126/science.1103707; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; Petaros A, 2015, CLIN ANAT, V28, P593, DOI 10.1002/ca.22545; Prasciunas MM, 2011, AM ANTIQUITY, V76, P107, DOI 10.7183/0002-7316.76.1.107; Prasciunas MM, 2014, CLOVIS EDGE NEW UNDE, P21; Sanchez G, 2014, P NATL ACAD SCI USA, V111, P10972, DOI 10.1073/pnas.1404546111; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Schlager S, 2014, RVCG MANIPULATIONS T; Schlager S, 2017, ANAT REC, V300, P226, DOI 10.1002/ar.23450; Schlager S, 2015, AM J PHYS ANTHROPOL, V156, P278; Shearer BM, 2012, FORENSIC SCI INT, V222, DOI 10.1016/j.forsciint.2012.06.013; Sholts SB, 2012, J ARCHAEOL SCI, V39, P3018, DOI 10.1016/j.jas.2012.04.049; Sholts SB, 2012, FORENSIC SCI INT, V217, DOI 10.1016/j.forsciint.2011.11.016; Sholts SB, 2011, J FORENSIC SCI, V56, P333, DOI 10.1111/j.1556-4029.2011.01701.x; Sholts SB, 2010, J FORENSIC SCI, V55, P871, DOI 10.1111/j.1556-4029.2010.01380.x; Taylor RE, 1996, ANTIQUITY, V70, P515, DOI 10.1017/S0003598X00083678; Wagemans J, 1997, TRENDS COGN SCI, V1, P346, DOI 10.1016/S1364-6613(97)01105-4; Warmlander SKTS, 2011, ENVIRON HEALTH PERSP, V119, P1203, DOI 10.1289/ehp.1103478; Waters MR, 2007, SCIENCE, V315, P1122, DOI 10.1126/science.1137166; ZHANG ZY, 1994, INT J COMPUT VISION, V13, P119, DOI 10.1007/BF01427149	64	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0179933	10.1371/journal.pone.0179933	http://dx.doi.org/10.1371/journal.pone.0179933			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FA7TK	28700598	Green Published, gold, Green Submitted			2022-12-26	WOS:000405649600012
J	Jin, QY; Grama, I; Liu, QS				Jin, Qiyu; Grama, Ion; Liu, Quansheng			Optimal Weights Mixed Filter for removing mixture of Gaussian and impulse noises	PLOS ONE			English	Article							ANISOTROPIC 2ND; MEDIAN FILTERS; IMAGE; ALGORITHM; MODEL	In this paper we consider the problem of restoration of a image contaminated by a mixture of Gaussian and impulse noises. We propose a new statistic called ROADGI which improves the well-known Rank-Ordered Absolute Differences (ROAD) statistic for detecting points contaminated with the impulse noise in this context. Combining ROADGI statistic with the method of weights optimization we obtain a new algorithm called Optimal Weights Mixed Filter (OWMF) to deal with the mixed noise. Our simulation results show that the proposed filter is effective for mixed noises, as well as for single impulse noise and for single Gaussian noise.	[Jin, Qiyu] Inner Mongolia Univ, Sch Math Sci, 235 Daxue West Rd, Hohhot 010021, Peoples R China; [Grama, Ion; Liu, Quansheng] Univ Bretagne Sud, Lab Math Bretagne Atlantique, UMR 6205, Campus Tohaninic,BP 573, F-56017 Vannes, France; [Liu, Quansheng] Nanjing Univ Informat Sci & Technol, Sch Comp & Software, Nanjing 210044, Jiangsu, Peoples R China	Inner Mongolia University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Nanjing University of Information Science & Technology	Liu, QS (corresponding author), Univ Bretagne Sud, Lab Math Bretagne Atlantique, UMR 6205, Campus Tohaninic,BP 573, F-56017 Vannes, France.; Liu, QS (corresponding author), Nanjing Univ Informat Sci & Technol, Sch Comp & Software, Nanjing 210044, Jiangsu, Peoples R China.	quansheng.liu@univ-ubs.fr	Jin, Qiyu/HGD-8010-2022	Jin, Qiyu/0000-0001-8639-233X	National Natural Science Foundation of China [61661039, 11571052, 11401590]; Natural Science Fund of Inner Mongolia Autonomous Region [2016MS0107]; Scientific Research Projection of Higher Schools of Inner Mongolia [NJZY16017]; Hunan Provincial Natural Science Foundation [2017JJ2271]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Inner Mongolia Autonomous Region; Scientific Research Projection of Higher Schools of Inner Mongolia; Hunan Provincial Natural Science Foundation(Natural Science Foundation of Hunan Province)	Jin and Liu have been partially supported by the National Natural Science Foundation of China (Grants No. 61661039, No. 11571052 and No. 11401590), the Natural Science Fund of Inner Mongolia Autonomous Region (Grant No. 2016MS0107), the Scientific Research Projection of Higher Schools of Inner Mongolia (Grant No. NJZY16017), and Hunan Provincial Natural Science Foundation (Grant no. 2017JJ2271).	Abreu E, 1996, IEEE T IMAGE PROCESS, V5, P1012, DOI 10.1109/83.503916; Aharon M, 2006, IEEE T SIGNAL PROCES, V54, P4311, DOI 10.1109/TSP.2006.881199; Bouboulis P, 2010, IEEE T IMAGE PROCESS, V19, P1465, DOI 10.1109/TIP.2010.2042995; Buades A, 2005, PROC CVPR IEEE, P60, DOI 10.1109/cvpr.2005.38; Cai JF, 2008, INVERSE PROBL IMAG, V2, P187; Chan RH, 2004, IEEE SIGNAL PROC LET, V11, P921, DOI 10.1109/LSP.2004.838190; Chen T, 1999, IEEE T IMAGE PROCESS, V8, P1834, DOI 10.1109/83.806630; Chen T, 2001, IEEE SIGNAL PROC LET, V8, P1, DOI 10.1109/97.889633; Chen T, 2001, IEEE T CIRCUITS-II, V48, P784, DOI 10.1109/82.959870; Chen Y, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/9/2667; Crnojevic V, 2004, IEEE SIGNAL PROC LET, V11, P589, DOI 10.1109/LSP.2004.830117; Dabov K, 2007, IEEE T IMAGE PROCESS, V16, P2080, DOI 10.1109/TIP.2007.901238; Delon J, 2016, PARIGI PATCH BASED A, V5, P130; Delon J, 2013, SIAM J IMAGING SCI, V6, P1140, DOI 10.1137/120885000; Dong YQ, 2007, IEEE T IMAGE PROCESS, V16, P1112, DOI 10.1109/TIP.2006.891348; Foi A, P 6 IMA INT C MATH S, P79; Garnett R, 2005, IEEE T IMAGE PROCESS, V14, P1747, DOI 10.1109/TIP.2005.857261; Hammond DK, 2008, IEEE T IMAGE PROCESS, V17, P2089, DOI 10.1109/TIP.2008.2004796; Hirakawa K, 2006, IEEE T IMAGE PROCESS, V15, P2730, DOI 10.1109/TIP.2006.877352; Hu HJ, 2016, J SCI COMPUT, V67, P103, DOI 10.1007/s10915-015-0073-9; HWANG H, 1995, IEEE T IMAGE PROCESS, V4, P499, DOI 10.1109/83.370679; Jin Q, 2017, SIAM J IMAGING SCI; Jin QY, 2014, J SCI COMPUT, V58, P548, DOI 10.1007/s10915-013-9743-7; Katkovnik Vladimir, 2004, 2004 12th European Signal Processing Conference (EUSIPCO), P101; Katkovnik V, 2010, INT J COMPUT VISION, V86, P1, DOI 10.1007/s11263-009-0272-7; Kervrann C, 2008, INT J COMPUT VISION, V79, P45, DOI 10.1007/s11263-007-0096-2; Kervrann C, 2006, IEEE T IMAGE PROCESS, V15, P2866, DOI 10.1109/TIP.2006.877529; Li B, 2010, SCI CHINA SER F, V54, P1; Lien CY, 2013, IEEE T COMPUT, V62, P631, DOI 10.1109/TC.2011.256; Lou YF, 2010, J SCI COMPUT, V42, P185, DOI 10.1007/s10915-009-9320-2; Luisier F, 2011, IEEE T IMAGE PROCESS, V20, P696, DOI 10.1109/TIP.2010.2073477; Luo WB, 2005, IEICE T FUND ELECTR, VE88A, P2579, DOI 10.1093/ietfec/e88-a.10.2579; Nikolova M, 2004, J MATH IMAGING VIS, V20, P99, DOI 10.1023/B:JMIV.0000011920.58935.9c; Polzehl J, 2000, J R STAT SOC B, V62, P335, DOI 10.1111/1467-9868.00235; Roth S, 2009, INT J COMPUT VISION, V82, P205, DOI 10.1007/s11263-008-0197-6; SUN T, 1994, PATTERN RECOGN LETT, V15, P341, DOI 10.1016/0167-8655(94)90082-5; Wang HB, 2012, COMPUT SCI INF SYST, V9, P1493, DOI 10.2298/CSIS120219060W; Wang Y, 2011, ELECTRON LETT, V47, P592, DOI 10.1049/el.2010.3505; Wang YQ, 2013, SIGNAL PROCESS, V93, P2548, DOI 10.1016/j.sigpro.2013.02.020; Wang YQ, 2013, COMPUT MATH APPL, V66, P1729, DOI 10.1016/j.camwa.2013.08.034; Wang Z, 1999, IEEE T CIRCUITS-II, V46, P78, DOI 10.1109/82.749102; Xiao Y, 2011, PATTEEN RECOGN; Xiong B, 2012, IEEE T IMAGE PROCESS, V21, P1663, DOI 10.1109/TIP.2011.2172804; Yu HC, 2008, IEEE SIGNAL PROC LET, V15, P922, DOI 10.1109/LSP.2008.2005051	44	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0179051	10.1371/journal.pone.0179051	http://dx.doi.org/10.1371/journal.pone.0179051			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692667	Green Submitted, Green Published, gold			2022-12-26	WOS:000405544800007
J	Nguyen, PH; Sanghvi, T; Kim, SS; Tran, LM; Afsana, K; Mahmud, Z; Aktar, B; Menon, P				Nguyen, Phuong H.; Sanghvi, Tina; Kim, Sunny S.; Tran, Lan M.; Afsana, Kaosar; Mahmud, Zeba; Aktar, Bachera; Menon, Purnima			Factors influencing maternal nutrition practices in a large scale maternal, newborn and child health program in Bangladesh	PLOS ONE			English	Article							FOLIC ACID SUPPLEMENTATION; CALCIUM SUPPLEMENTATION; IRON SUPPLEMENTATION; PREGNANCY; WOMEN; DETERMINANTS; COUNTRIES; ANEMIA; UNDERNUTRITION; DEFICIENCY	Improving maternal nutrition practices during pregnancy is essential to save lives and improve health outcomes for both mothers and babies. This paper examines the maternal, household, and health service factors influencing maternal nutrition practices in the context of a large scale maternal, newborn, and child health (MNCH) program in Bangladesh. Data were from a household survey of pregnant (n = 600) and recently delivered women (n = 2,000). Multivariate linear and logistic regression analyses were used to examine the determinants of three outcomes: consumption of iron and folic acid (IFA) tablets, calcium tablets, and diverse diets. Women consumed 94 +/- 68 IFA and 82 +/- 66 calcium tablets ( out of 180 as recommended) during pregnancy, and only half of them consumed an adequately diverse diet. Good nutrition knowledge was the key maternal factor associated with higher consumption of IFA (beta = 32.5, 95% CI: 19.5, 45.6) and calcium tablets (beta similar to 31.9, 95% CI: 20.9, 43.0) and diverse diet (OR = 1.8, 95% CI: 1.0 - 3.1), compared to poor knowledge. Women's self- efficacy in achieving the recommended practices and perception of enabling social norms were significantly associated with dietary diversity. At the household level, women who reported a high level of husband's support were more likely to consume IFA (beta = 25.0, 95% CI: 18.0, 32.1) and calcium ( beta = 26.6, 95% CI: 19.4, 33.7) tablets and diverse diet (OR = 1.9, 95% CI: 1.2, 3.3), compared to those who received low support. Health service factors associated with higher intakes of IFA and calcium tablets were early and more prenatal care visits and receipt of free supplements. Combined exposure to several of these factors was attributed to the consumption of an additional 46 IFA and 53 calcium tablets and 17% higher proportions of women consuming diverse diets. Our study shows that improving knowledge, self-efficacy and perceptions of social norms among pregnant women, and increasing husbands' support, early registration in prenatal care, and provision of free supplements will largely improve maternal nutrition practices.	[Nguyen, Phuong H.; Kim, Sunny S.; Menon, Purnima] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20036 USA; [Sanghvi, Tina; Tran, Lan M.; Mahmud, Zeba] Alive & Thr, Washington, DC USA; [Afsana, Kaosar; Aktar, Bachera] BRAC, Dhaka, Bangladesh	CGIAR; International Food Policy Research Institute (IFPRI); Bangladesh Rural Advancement Committee BRAC	Nguyen, PH (corresponding author), Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20036 USA.	P.H.Nguyen@cgiar.org	Aktar, Bachera/AFS-4218-2022	Aktar, Bachera/0000-0003-0242-1792; Nguyen, Phuong H/0000-0003-3418-1674; Afsana, Kaosar/0000-0002-5197-8151	Canadian Department of Foreign Affairs, Trade and Development [7060808]	Canadian Department of Foreign Affairs, Trade and Development	This work was supported by the Canadian Department of Foreign Affairs, Trade and Development, Grant No 7060808, managed by FHI 360. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahn Eric, 2006, BMC Pregnancy Childbirth, V6, P10, DOI 10.1186/1471-2393-6-10; Alam A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1697-2; [Anonymous], [No title captured]; Bendich A, 2001, NUTRITION, V17, P46, DOI 10.1016/S0899-9007(00)00482-2; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Bin Nisar Y, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-305; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Branca F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4173; Coates J, 2007, FOOD NUTR TECHNICAL, V3; COOK JD, 1991, AM J CLIN NUTR, V53, P106, DOI 10.1093/ajcn/53.1.106; *FAO, 1998, JOINT FAO WHO EXP CO; FAO FHI360, 2016, MIN DIETR DIV WOM GU; GALLOWAY R, 1994, SOC SCI MED, V39, P381, DOI 10.1016/0277-9536(94)90135-X; Galloway R, 2002, SOC SCI MED, V55, P529, DOI 10.1016/S0277-9536(01)00185-X; Gwatkin D R, 2007, Niger J Clin Pract, V10, P272; Haider BA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004905.pub4; Hashima-e-Nasreen Ahmed SM, 2010, RES MONOGRAPH SERIES; Hofmeyr GJ, 2014, BJOG-INT J OBSTET GY, V121, P951, DOI 10.1111/1471-0528.12613; Hyder SMZ, 2004, PUBLIC HEALTH NUTR, V7, P1065, DOI 10.1079/PHN2004645; ICN, 2014, 2 INT C NUTR C OUTC; Islam MZ, 2003, EUR J CLIN NUTR, V57, P674, DOI 10.1038/sj.ejcn.1601597; Klemm RW, 2011, CROSS COUNTRY COMPAR; Lacerte P, 2011, ASIA-PAC J PUBLIC HE, V23, P315, DOI 10.1177/1010539511403133; Lunet N, 2008, CAD SAUDE PUBLICA, V24, P1151, DOI 10.1590/S0102-311X2008000500022; Maina-Gathigi L, 2013, MATERN CHILD HLTH J, V17, P1236, DOI 10.1007/s10995-012-1120-x; Martin SL, 2017, J NUTR; Martin-Prevel Y, 2015, FAO REPORT MOVING FO; Nagata JM, 2012, MATERN CHILD NUTR, V8, P1, DOI 10.1111/j.1740-8709.2011.00338.x; Newson RB, 2013, STATA J, V13, P672, DOI 10.1177/1536867X1301300402; Nguyen P.H., 2015, ASSESSING OPERATIONA; NIPORT, 2011, MITR ASS ICF INT BAN; NIPORT (National Institute of Population Research and Training), 2015, MITR ASS ICF INT BAN; Rashid M, 2010, BANGLADESH MEDICAL J, V39; Shaw A, 2012, INT J NONPROFIT VOLU, V17, P325, DOI 10.1002/nvsm.1438; StataCorp, 2021, STATA STAT SOFTWARE; Stevens GA, 2013, LANCET, V1, P16, DOI DOI 10.1016/S2214-109X(13)70001-9; Sununtnasuk C, 2016, PUBLIC HEALTH NUTR, V19, P732, DOI 10.1017/S1368980015001652; Tinago CB, 2016, MATERN CHILD NUTR; Victora CG, 2012, FOOD NUTR BULL, V33, pS6, DOI 10.1177/15648265120332S102; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wendt A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120404; World Health . Organization, 2013, GUID CALC SUPPL PREG	43	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7								10.1371/journal.pone.0179873	http://dx.doi.org/10.1371/journal.pone.0179873			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692689	Green Published, gold, Green Submitted			2022-12-26	WOS:000405544800018
J	Jin, B; Liu, R; Hao, SY; Li, Z; Zhu, CQ; Zhou, X; Chen, P; Fu, TY; Hu, ZK; Wu, Q; Liu, W; Liu, DW; Yu, YX; Zhang, Y; McElhinney, DB; Li, YM; Culver, DS; Alfreds, ST; Stearns, F; Sylvester, KG; Widen, E; Ling, XFB				Jin, Bo; Liu, Rui; Hao, Shiying; Li, Zhen; Zhu, Chunqing; Zhou, Xin; Chen, Pei; Fu, Tianyun; Hu, Zhongkai; Wu, Qian; Liu, Wei; Liu, Daowei; Yu, Yunxian; Zhang, Yan; McElhinney, Doff B.; Li, Yu-Ming; Culver, Devore S.; Alfreds, Shaun T.; Stearns, Frank; Sylvester, Karl G.; Widen, Eric; Ling, Xuefeng B.			Defining and characterizing the critical transition state prior to the type 2 diabetes disease	PLOS ONE			English	Article							EARLY-WARNING SIGNALS; LEADING BIOMOLECULAR NETWORKS; IMPAIRED GLUCOSE-TOLERANCE; EPILEPTIC SEIZURES; COMPLEX DISEASES; BETA-BLOCKERS; LIFE-STYLE; RISK; METAANALYSIS; ANTIBIOTICS	Background Type 2 diabetes mellitus (T2DM), with increased risk of serious long-term complications, currently represents 8.3% of the adult population. We hypothesized that a critical transition state prior to the new onset T2DM can be revealed through the longitudinal electronic medical record (EMR) analysis. Method We applied the transition-based network entropy methodology which previously identified a dynamic driver network (DDN) underlying the critical T2DM transition at the tissue molecular biological level. To profile pre-disease phenotypical changes that indicated a critical transition state, a cohort of 7,334 patients was assembled from the Maine State Health Information Exchange (HIE). These patients all had their first confirmative diagnosis of T2DM between January 1, 2013 and June 30, 2013. The cohort's EMRs from the 24 months preceding their date of first T2DM diagnosis were extracted. Results Analysis of these patients' pre-disease clinical history identified a dynamic driver network (DDN) and an associated critical transition state six months prior to their first confirmative T2DM state. Conclusions This 6-month window before the disease state provides an early warning of the impending T2DM, warranting an opportunity to apply proactive interventions to prevent or delay the new onset of T2DM.	[Jin, Bo; Zhu, Chunqing; Fu, Tianyun; Stearns, Frank; Widen, Eric] HBI Solut Inc, Palo Alto, CA USA; [Liu, Rui; Hao, Shiying; Li, Zhen; Hu, Zhongkai; Zhang, Yan; McElhinney, Doff B.; Sylvester, Karl G.; Ling, Xuefeng B.] Stanford Univ, Stanford, CA 94305 USA; [Liu, Rui] South China Univ Technol, Sch Math, Guangzhou, Guangdong, Peoples R China; [Hao, Shiying; McElhinney, Doff B.; Ling, Xuefeng B.] Lucile Packard Childrens Hosp, Betty Irene Moore Childrens Heart Ctr, Clin & Translat Res Program, Stanford, CA 94304 USA; [Li, Zhen] Southeast Univ, Sch Elect Engn, Nanjing, Jiangsu, Peoples R China; [Zhou, Xin; Li, Yu-Ming] Pingjin Hosp, Tianjin Key Lab Cardiovasc Remodeling & Target Or, Heart Ctr, Tianjin, Peoples R China; [Chen, Pei] South China Univ Technol, Sch Comp Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Wu, Qian; Liu, Wei; Liu, Daowei] China Elect Power Res Inst, Beijing, Peoples R China; [Yu, Yunxian] Zhejiang Univ, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Zhang, Yan] First Hosp Shijiazhuang, Dept Oncol, Shijiazhuang, Hebei, Peoples R China; [Culver, Devore S.; Alfreds, Shaun T.] HealthInfoNet, Portland, ME USA; [Ling, Xuefeng B.] Zhejiang Univ, Sch Publ Hlth, Hlth Care Big Data Ctr, Hangzhou, Zhejiang, Peoples R China	Stanford University; South China University of Technology; Lucile Packard Children's Hospital (LPCH); Southeast University - China; South China University of Technology; Zhejiang University; Zhejiang University	Ling, XFB (corresponding author), Stanford Univ, Stanford, CA 94305 USA.; Ling, XFB (corresponding author), Lucile Packard Childrens Hosp, Betty Irene Moore Childrens Heart Ctr, Clin & Translat Res Program, Stanford, CA 94304 USA.; Ling, XFB (corresponding author), Zhejiang Univ, Sch Publ Hlth, Hlth Care Big Data Ctr, Hangzhou, Zhejiang, Peoples R China.	bxling@stanford.edu	Liu, Rui/AAK-8178-2020	Liu, Rui/0000-0002-4547-8695; Hao, Shiying/0000-0002-7527-2460; McElhinney, Doff/0000-0001-7242-0934; Ling, Bruce/0000-0002-5386-3884; Sylvester, Karl G./0000-0002-8559-0155	HBI	HBI	The authors received no public funding for this work. HBI Solutions, Inc. (HBI) is a private commercial company, and several authors are employed by HBI. HBI provided funding in the form of salaries to the authors employed by HBI: BJ, TF, CZ, FS and EW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Bangalore S, 2007, AM J CARDIOL, V100, P1254, DOI 10.1016/j.amjcard.2007.05.057; Chen LN, 2012, SCI REP-UK, V2, DOI 10.1038/srep00342; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; Gilmore R., 1993, CATASTROPHE THEORY S, Vxvii; Haase CL, 2015, DIABETES, V64, P3328, DOI 10.2337/db14-1603; Hao SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140271; Hao SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112944; He DN, 2012, J MOL CELL BIOL, V4, P140, DOI 10.1093/jmcb/mjs011; Hu ZK, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4976; Hu ZK, 2015, INTERACT J MED RES, V4, P39, DOI 10.2196/ijmr.4022; Inzucchi SE, 2012, NEW ENGL J MED, V367, P542, DOI 10.1056/NEJMcp1103643; JIN B, 2016, BMC EMERG MED, V16, DOI DOI 10.HTTPS://D0I.0RG/10.1186/S12873-016-0074-5; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kyu HH, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3857; Li MY, 2014, BRIEF BIOINFORM, V15, P229, DOI 10.1093/bib/bbt027; Litt B, 2001, NEURON, V30, P51, DOI 10.1016/S0896-6273(01)00262-8; Liu R, 2012, SCI REP-UK, V2, DOI 10.1038/srep00813; Liu XP, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S2-S8; McSharry PE, 2003, NAT MED, V9, P241, DOI 10.1038/nm0303-241; Mikkelsen KH, 2015, J CLIN ENDOCR METAB, V100, P3633, DOI 10.1210/jc.2015-2696; Murray JD.., 2003, MATH BIOL, DOI DOI 10.1007/B98869; Paek SH, 2005, CANCER-AM CANCER SOC, V104, P580, DOI 10.1002/cncr.21190; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Schellenberg ES, 2013, ANN INTERN MED, V159, P543, DOI 10.7326/0003-4819-159-8-201310150-00007; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shen L, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6745; Tan Z, 2015, METHODS, V83, P36, DOI 10.1016/j.ymeth.2015.05.004; Telfer SJ, 2014, MED HYPOTHESES, V83, P263, DOI 10.1016/j.mehy.2014.05.013; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; Wang Y, 2015, INT J MED INFORM, V84, P1039, DOI 10.1016/j.ijmedinf.2015.06.007; WHO, 2016, GLOB REP PSOR; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Zheng L, 2016, JMIR MED INF, V4, P38, DOI 10.2196/medinform.6328	35	8	8	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180937	10.1371/journal.pone.0180937	http://dx.doi.org/10.1371/journal.pone.0180937			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686739	gold, Green Published, Green Submitted			2022-12-26	WOS:000405464100122
J	Wang, LC; Zhou, KH; Zhao, HP; Wang, JH; Zheng, HC; Yu, Y; Chen, W				Wang, Linchuan; Zhou, Kai-Hua; Zhao, He-Ping; Wang, Ji-Han; Zheng, Hai-Chao; Yu, Yan; Chen, Wei			The characteristics of screening and confirmatory test results for HIV in Xi'an, China	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS HIV; COMBINED P24 ANTIGEN; WESTERN-BLOT; AG/AB COMBO; ANTIBODY; INFECTION; ASSAY; DIAGNOSIS; SEROCONVERSION; PERFORMANCE	Objectives Individuals with recent or acute HIV infection are more infectious than those with established infection. Our objective was to analyze the characteristics of detection among HIV infections in Xi'an. Methods A 4(th) -generation kit (Architect HIV Ag/Ab Combo) and three 3(rd) -generationEIA kits (WanTai, XinChuang and Livzon) were used for HIV screening. Overall, 665 individuals were identified as positive and were tested by western blotting (WB). The characteristics of the screening and confirmatory tests were analyzed, including the band patterns, the early detection performance and the false-positive rates. Results In total, 561 of the 665 patients were confirmed as having HIV-1 infection, and no HIV-2 specific band was observed. Among these 561 WB-positive cases, reactivity to greater than or equal to 9 antigens was the most commonly observed pattern (83.18%), and the absence of reactivity to p17, p31 and gp41 was detected in 6.44%, 5.9% and 2.86% of the cases, respectively. Two cases were positive by the 4 (th) -generation assay but negative by the 3(rd)-generation assay for HIV screening and had seroconversion. The false-positive rate of the Architect HIV Ag/Ab Combo (22.01%) was significantly higher than those of WanTai (9.88%), XinChuang (10.87%) and Livzon (8.93%), p< 0.05. Conclusion HIV infection in Xi'an is mainly caused by HIV-1, and individuals are rarely identified at the early phase. Although the false-positive rate of the 4(th) -generation assay was higher than that of the 3 (rd) -generation assay, it is still recommended for use as the initial HIV screening test for high-risk individuals. In Xi'an, a 3rd-generation assay for screening could be considered.	[Wang, Linchuan; Chen, Wei] Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Shaanxi Provinc, Peoples R China; [Zhou, Kai-Hua] Hosp Xian Jiaotong Univ, Xian, Shaanxi Provinc, Peoples R China; [Zhao, He-Ping; Wang, Ji-Han; Yu, Yan] Xi An Jiao Tong Univ, Honghui Hosp, Xian, Shaanxi Provinc, Peoples R China; [Zheng, Hai-Chao] Xian Ctr Dis Control & Prevent, Xian, Shaanxi Provinc, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Chen, W (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Shaanxi Provinc, Peoples R China.; Yu, Y (corresponding author), Xi An Jiao Tong Univ, Honghui Hosp, Xian, Shaanxi Provinc, Peoples R China.	yu.yan74@163.com; 568646799@qq.com	Wang, Linchuan/AAH-8711-2020					Alexander TS, 2016, CLIN VACCINE IMMUNOL, V23, P249, DOI 10.1128/CVI.00053-16; Chavez P, 2011, J CLIN VIROL, V52, pS51, DOI 10.1016/j.jcv.2011.09.010; Chen JM, 2002, J INFECT DIS, V186, P321, DOI 10.1086/341661; Dubravac T, 2013, J CLIN VIROL, V58, pE76, DOI 10.1016/j.jcv.2013.10.020; Duri K, 2011, Z BMC INFECT DIS, V11, P1; Erickson CP, 2006, NEW ENGL J MED, V354, P1422, DOI 10.1056/NEJMc053417; Everett DB, 1969, TROP MED INT HEALTH, V12, P1323; Fanmi AN, 2013, EUR J CLIN MICROBIOL, V32, P425, DOI 10.1007/s10096-012-1760-1; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Goldenberg S, 2007, J MED VIROL, V79, pS23, DOI 10.1002/jmv.20964; Grusky O, 2006, AIDS PATIENT CARE ST, V20, P620, DOI 10.1089/apc.2006.20.620; Guan M, 2007, CLIN VACCINE IMMUNOL, V14, P649, DOI 10.1128/CVI.00393-06; Jensen TO, 2015, J CLIN MICROBIOL, V53, P1709, DOI 10.1128/JCM.03583-14; Kim S, 2010, CLIN VACCINE IMMUNOL, V17, P1642, DOI 10.1128/CVI.00258-10; Lee K, 2013, ANN LAB MED, V33, P420, DOI 10.3343/alm.2013.33.6.420; Ly TD, 2000, J CLIN MICROBIOL, V38, P2459; Ly TD, 2007, J VIROL METHODS, V143, P86, DOI 10.1016/j.jviromet.2007.02.013; Mahajan VS, 2010, CLIN CHEM, V56, P1523, DOI 10.1373/clinchem.2009.139535; Mitchell EO, 2013, J CLIN VIROL, V58, pE79, DOI 10.1016/j.jcv.2013.08.009; Pandori M, 2009, ANTIMICROB AGENTS CH, V53, P4032, DOI 10.1128/AAC.00406-09; Rickman LS., 1981, MMWR-MORBID MORTAL W, V30, P250; SAAH AJ, 1987, J CLIN MICROBIOL, V25, P1605, DOI 10.1128/JCM.25.9.1605-1610.1987; Salmona M, 2014, J CLIN MICROBIOL, V52, P103, DOI 10.1128/JCM.02460-13; Schappert J, 2006, CLIN CHIM ACTA, V372, P158, DOI 10.1016/j.cca.2006.04.017; Shaw GM, 2012, COLD SPRING HARB PER, V2, P705; Shima-Sano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009382; Stekler J, 2007, CLIN INFECT DIS, V44, P459, DOI 10.1086/510747; Talha SM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-325; Talha SM, 2011, J VIROL METHODS, V173, P24, DOI 10.1016/j.jviromet.2011.01.001; Wang Ji-bao, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P998; Wang LC, 2017, J CLIN LAB ANAL, V31, DOI 10.1002/jcla.22015; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Weber B, 2002, J CLIN MICROBIOL, V40, P1420, DOI 10.1128/JCM.40.4.1420-1426.2002	33	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180071	10.1371/journal.pone.0180071	http://dx.doi.org/10.1371/journal.pone.0180071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686629	Green Published, gold, Green Submitted			2022-12-26	WOS:000405464100034
J	Coste, C; Neirinckx, V; Sharma, A; Agirman, G; Rogister, B; Foguenne, J; Lallemend, F; Gothot, A; Wislet, S				Coste, Cecile; Neirinckx, Virginie; Sharma, Anil; Agirman, Gulistan; Rogister, Bernard; Foguenne, Jacques; Lallemend, Francois; Gothot, Andre; Wislet, Sabine			Human bone marrow harbors cells with neural crest-associated characteristics like human adipose and dermis tissues	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; SKIN-DERIVED PRECURSORS; STEM-CELLS; PERIODONTAL-LIGAMENT; PROGENITOR CELLS; DIFFERENTIATION; MELANOCYTES; GENERATION; ONTOGENY; TRUNK	Adult neural crest stem-derived cells (NCSC) are of extraordinary high plasticity and promising candidates for use in regenerative medicine. Several locations such as skin, adipose tissue, dental pulp or bone marrow have been described in rodent, as sources of NCSC. However, very little information is available concerning their correspondence in human tissues, and more precisely for human bone marrow. The main objective of this study was therefore to characterize NCSC from adult human bone marrow. In this purpose, we compared human bone marrow stromal cells to human adipose tissue and dermis, already described for containing NCSC. We performed comparative analyses in terms of gene and protein expression as well as functional characterizations. It appeared that human bone marrow, similarly to adipose tissue and dermis, contains NESTIN+ /SOX9(+) /TWIST+ /SLUG(+) /P75(NTR+) /BRN3A(+)/MSI1(+)/SNAIL1(+) cells and were able to differentiate into melanocytes, Schwann cells and neurons. Moreover, when injected into chicken embryos, all those cells were able to migrate and follow endogenous neural crest migration pathways. Altogether, the phenotypic characterization and migration abilities strongly suggest the presence of neural crest-derived cells in human adult bone marrow.	[Coste, Cecile; Neirinckx, Virginie; Agirman, Gulistan; Rogister, Bernard; Wislet, Sabine] Univ Liege, GIGA Neurosci, Liege, Belgium; [Sharma, Anil; Agirman, Gulistan; Lallemend, Francois] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Rogister, Bernard] Univ Liege, GIGA Dev Stem Cells & Regenerat Med, Liege, Belgium; [Rogister, Bernard] Univ Liege, Dept Neurol, Liege, Belgium; [Foguenne, Jacques; Gothot, Andre] CHU Liege, Dept Lab Hematol & Immunol, Liege, Belgium; [Gothot, Andre] Univ Liege, GIGA I3, Hematol Res Unit, Liege, Belgium	University of Liege; Karolinska Institutet; University of Liege; University of Liege; University of Liege; University of Liege	Wislet, S (corresponding author), Univ Liege, GIGA Neurosci, Liege, Belgium.	s.wislet@ulg.ac.be	Rogister, Bernard/AAJ-9591-2020	Agirman, Gulistan/0000-0003-3379-9632; Sharma, Anil/0000-0002-7442-8494	TeAleAvie-FondsNational de la Recherche Scientifique (FNRS) of Belgium; Fonds Speaciaux of the University of Liege, Belgium; Leon Fredericq Foundation; Swedish Medical Research Council; Karolinska Institute; Ragnar So Ederberg foundation; Knut and Alice Wallenberg Foundation; AkeWiberg foundation; Swedish Brain Foundation	TeAleAvie-FondsNational de la Recherche Scientifique (FNRS) of Belgium; Fonds Speaciaux of the University of Liege, Belgium; Leon Fredericq Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Karolinska Institute(Karolinska Institutet); Ragnar So Ederberg foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); AkeWiberg foundation; Swedish Brain Foundation	This work was supported by a grant from the TeAleAvie-FondsNational de la Recherche Scientifique (FNRS) of Belgium, by a grant of the Fonds Speaciaux of the University of Liege, Belgium, and by a grant of Leon Fredericq Foundation. Francois Lallemend is supported by the Swedish Medical Research Council, Karolinska Institute, Ragnar So Ederberg foundation, Knut and Alice Wallenberg Foundation, AkeWiberg foundation and the Swedish Brain Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abe S, 2016, STEM CELL TRANSL MED, V5, P117, DOI 10.5966/sctm.2015-0111; Abe S, 2012, CELL BIOL INT, V36, P927, DOI 10.1042/CBI20110506; Abzhanov A, 2003, DEVELOPMENT, V130, P4567, DOI 10.1242/dev.00673; Al-Nbaheen M, 2013, STEM CELL REV REP, V9, P32, DOI 10.1007/s12015-012-9365-8; Barraud P, 2010, P NATL ACAD SCI USA, V107, P21040, DOI 10.1073/pnas.1012248107; Biernaskie J, 2010, J INVEST DERMATOL, V130, P1202, DOI 10.1038/jid.2009.449; Billon N, 2007, DEVELOPMENT, V134, P2283, DOI 10.1242/dev.002642; Briquet A, 2010, HAEMATOL-HEMATOL J, V95, P47, DOI 10.3324/haematol.2009.008524; Bueno C, 2013, CELL TRANSPLANT, V22, P2017, DOI 10.3727/096368912X657305; Clewes O, 2011, STEM CELL REV REP, V7, P799, DOI 10.1007/s12015-011-9255-5; Cordeiro IR, 2015, CHICK EMBRYO XENOGRA, P1; Coura GS, 2008, J PERIODONTAL RES, V43, P531, DOI 10.1111/j.1600-0765.2007.01065.x; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dupin E, 2006, ADV EXP MED BIOL, V589, P96; Dupin E, 2013, CYTOM PART A, V83A, P38, DOI 10.1002/cyto.a.22098; Dupin E, 2012, DEV BIOL, V366, P83, DOI 10.1016/j.ydbio.2012.02.035; Fang D, 2006, STEM CELLS, V24, P1668, DOI 10.1634/stemcells.2005-0414; Fernandes KJL, 2008, PHILOS T R SOC B, V363, P185, DOI 10.1098/rstb.2006.2020; Fernandes KJL, 2006, EXP NEUROL, V201, P32, DOI 10.1016/j.expneurol.2006.03.018; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Fournier BP, 2016, EUR CELLS MATER, V31, P40, DOI 10.22203/eCM.v031a04; Gho CG, 2015, CYTOTECHNOLOGY; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hara S, 2014, STEM CELLS DEV, V23, P2190, DOI 10.1089/scd.2013.0387; Hauser S, 2012, STEM CELLS DEV, V21, P742, DOI 10.1089/scd.2011.0419; Hill RP, 2012, PLOS ONE, V7; Hu YF, 2006, STEM CELLS, V24, P2692, DOI 10.1634/stemcells.2006-0233; Isern J, 2014, ELIFE, V3, DOI 10.7554/eLife.03696; Janebodin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027526; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kalcheim C, 2005, INT J DEV BIOL, V49, P105, DOI 10.1387/ijdb.041949ck; Kaltschmidt B, 2012, STEM CELL REV REP, V8, P658, DOI 10.1007/s12015-011-9340-9; Krejci E, 2010, FOLIA BIOL-PRAGUE, V56, P149; Le Douarin NM, 1999, NEURAL CREST, V2; Le Lievre C S, 1975, J Embryol Exp Morphol, V34, P125; Lechanteur C, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0892-y; Li L, 2010, J CELL SCI, V123, P853, DOI 10.1242/jcs.061598; Li X, 2011, PLOS ONE, V6; LORING JF, 1987, DEV BIOL, V121, P220, DOI 10.1016/0012-1606(87)90154-0; Maro GS, 2004, NAT NEUROSCI, V7, P930, DOI 10.1038/nn1299; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Montzka K, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-16; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Neirinckx V, 2014, STEM CELLS, V32, P829, DOI 10.1002/stem.1579; Ohta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016182; Pelaez D, 2013, STEM CELLS DEV, V22, P1; Pierret C, 2006, STEM CELLS DEV, V15, P286, DOI 10.1089/scd.2006.15.286; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; RICHARDSON MK, 1993, DEV BIOL, V157, P348, DOI 10.1006/dbio.1993.1140; Serbedzija GN, 1989, VITAL DYE ANAL TIMIN, V816, P809; Shakhova O, 2010, NEURAL CREST DERIVED; Shakhova O, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004877; Sieber-Blum M, 2004, DEV DYNAM, V231, P258, DOI 10.1002/dvdy.20129; Simoes-Costa M, 2015, DEVELOPMENT, V142, P242, DOI 10.1242/dev.105445; Sowa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084206; Stevens A, 2008, STEM CELLS DEV, V17, P1175, DOI 10.1089/scd.2008.0012; Stolt CC, 2010, INT J BIOCHEM CELL B, V42, P437, DOI 10.1016/j.biocel.2009.07.014; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Tondreau T, 2004, DIFFERENTIATION, V72, P319, DOI 10.1111/j.1432-0436.2004.07207003.x; Trainor PA, 2014, NEURAL CREST CELLS E; Waddington RJ, 2009, CELLS TISSUES ORGANS, V189, P268, DOI 10.1159/000151447; White PM, 1999, DEVELOPMENT, V126, P4351; Wislet-Gendebien S, 2012, CELL MOL LIFE SCI, V69, P2593, DOI 10.1007/s00018-012-0937-1; Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062; Yoshida S, 2006, STEM CELLS, V24, P2714, DOI 10.1634/stemcells.2006-0156	67	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0177962	10.1371/journal.pone.0177962	http://dx.doi.org/10.1371/journal.pone.0177962			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683107	Green Published, Green Submitted, gold			2022-12-26	WOS:000405335200002
J	Maltsev, AV; Parsons, SP; Kim, MS; Tsutsui, K; Stern, MD; Lakatta, EG; Maltsev, VA; Monfredi, O				Maltsev, Alexander V.; Parsons, Sean P.; Kim, Mary S.; Tsutsui, Kenta; Stern, Michael D.; Lakatta, Edward G.; Maltsev, Victor A.; Monfredi, Oliver			Computer algorithms for automated detection and analysis of local Ca2+ releases in spontaneously beating cardiac pacemaker cells	PLOS ONE			English	Article							RYANODINE RECEPTOR; DIASTOLIC DEPOLARIZATION; SPARKS; SYSTEM; CLOCK; WAVES	Local Ca2+ Releases (LCRs) are crucial events involved in cardiac pacemaker cell function. However, specific algorithms for automatic LCR detection and analysis have not been developed in live, spontaneously beating pacemaker cells. In the present study we measured LCRs using a high-speed 2D-camera in spontaneously contracting sinoatrial (SA) node cells isolated from rabbit and guinea pig and developed a new algorithm capable of detecting and analyzing the LCRs spatially in two-dimensions, and in time. Our algorithm tracks points along the midline of the contracting cell. It uses these points as a coordinate system for affine transform, producing a transformed image series where the cell does not contract. Action potential-induced Ca2+ transients and LCRs were thereafter isolated from recording noise by applying a series of spatial filters. The LCR birth and death events were detected by a differential (frame-to-frame) sensitivity algorithm applied to each pixel (cell location). An LCR was detected when its signal changes sufficiently quickly within a sufficiently large area. The LCR is considered to have died when its amplitude decays substantially, or when it merges into the rising whole cell Ca2+ transient. Ultimately, our algorithm provides major LCR parameters such as period, signal mass, duration, and propagation path area. As the LCRs propagate within live cells, the algorithm identifies splitting and merging behaviors, indicating the importance of locally propagating Ca2+-induced-Ca2+-release for the fate of LCRs and for generating a powerful ensemble Ca2+ signal. Thus, our new computer algorithms eliminate motion artifacts and detect 2D local spatiotemporal events from recording noise and global signals. While the algorithms were developed to detect LCRs in sinoatrial nodal cells, they have the potential to be used in other applications in biophysics and cell physiology, for example, to detect Ca2+ wavelets (abortive waves), sparks and embers in muscle cells and Ca2+ puffs and syntillas in neurons.	[Maltsev, Alexander V.; Kim, Mary S.; Tsutsui, Kenta; Stern, Michael D.; Lakatta, Edward G.; Maltsev, Victor A.; Monfredi, Oliver] NIA, Lab Cardiovasc Sci, NIH, Baltimore, MD 21224 USA; [Parsons, Sean P.] McMaster Univ, Farncombe Inst, Hamilton, ON, Canada; [Monfredi, Oliver] Univ Manchester, Div Cardiovasc Sci, Manchester, Lancs, England	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); McMaster University; University of Manchester	Monfredi, O (corresponding author), NIA, Lab Cardiovasc Sci, NIH, Baltimore, MD 21224 USA.; Monfredi, O (corresponding author), Univ Manchester, Div Cardiovasc Sci, Manchester, Lancs, England.	oliver.monfredi2@nih.gov	Tsutsui, Kenta/K-5411-2013; Lakatta, Edward G/AAL-1447-2020; Monfredi, Oliver/AAH-9507-2021; Maltsev, Victor/AAY-9460-2020	Tsutsui, Kenta/0000-0002-5121-6974; Maltsev, Victor/0000-0002-3832-791X; Monfredi, Oliver/0000-0003-1292-2902; Lakatta, Edward/0000-0002-4772-0035; Maltsev, Alexander/0000-0002-2219-1114; Stern, Michael/0000-0003-4476-7425	Intramural Research Program of the National Institute on Aging; National Institute of Health; Canadian Institutes of Heath Research [MOP12984]; Natural Sciences and Engineering Research Council [286877]; NATIONAL INSTITUTE ON AGING [ZIAAG000844] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Heath Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported by the Intramural Research Program of the National Institute on Aging, National Institute of Health. SP was supported by the Canadian Institutes of Heath Research (MOP12984) and the Natural Sciences and Engineering Research Council (286877).The funders had no role in study design, data collection	Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Bogdanov KY, 2001, CIRC RES, V88, P1254, DOI 10.1161/hh1201.092095; Chen BY, 2009, J MOL CELL CARDIOL, V47, P706, DOI 10.1016/j.yjmcc.2009.07.007; Cheng H, 1999, BIOPHYS J, V76, P606, DOI 10.1016/S0006-3495(99)77229-2; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; Huser J, 2000, J PHYSIOL-LONDON, V524, P415, DOI 10.1111/j.1469-7793.2000.00415.x; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Lyashkov AE, 2009, AM J PHYSIOL-HEART C, V297, pH949, DOI 10.1152/ajpheart.01340.2008; Maltsev AV, 2013, CIRC RES, V113, pE94, DOI 10.1161/CIRCRESAHA.113.302465; Maltsev VA, 2009, AM J PHYSIOL-HEART C, V296, pH594, DOI 10.1152/ajpheart.01118.2008; Monfredi O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067247; Picht E, 2007, AM J PHYSIOL-CELL PH, V293, pC1073, DOI 10.1152/ajpcell.00586.2006; Ross WN, 2012, NAT REV NEUROSCI, V13, P157, DOI 10.1038/nrn3168; Sirenko S, 2014, J MOL CELL CARDIOL, V66, P106, DOI 10.1016/j.yjmcc.2013.11.011; Sirenko S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003391; Steele EM, 2014, BIOPHYS J, V106, P566, DOI 10.1016/j.bpj.2013.12.040; STEINIER J, 1972, ANAL CHEM, V44, P1906, DOI 10.1021/ac60319a045; STERN MD, 1992, BIOPHYS J, V63, P497, DOI 10.1016/S0006-3495(92)81615-6; Stern MD, 2014, J GEN PHYSIOL, V143, P577, DOI 10.1085/jgp.201311123; Stuyvers BD, 2005, CIRC RES, V97, P35, DOI 10.1161/01.RES.0000173375.26489.fe; Torrente AG, 2016, CARDIOVASC RES, V109, P451, DOI 10.1093/cvr/cvw006; Vinogradova TM, 2000, CIRC RES, V87, P760, DOI 10.1161/01.RES.87.9.760; Vinogradova TM, 2006, CIRC RES, V98, P505, DOI 10.1161/01.RES.0000204575.94040.d1; Vinogradova TM, 2004, CIRC RES, V94, P802, DOI 10.1161/01.RES.0000122045.55331.0F; Vinogradova TM, 2002, CIRC RES, V90, P73, DOI 10.1161/hh0102.102271	25	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0179419	10.1371/journal.pone.0179419	http://dx.doi.org/10.1371/journal.pone.0179419			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683095	gold, Green Submitted, Green Published			2022-12-26	WOS:000405335200004
J	Wang, LJ; Zheng, H; Zhao, H; Robinson, BE				Wang, Lijuan; Zheng, Hua; Zhao, He; Robinson, Brian E.			Nitrogen balance dynamics during 2000-2010 in the Yangtze River Basin croplands, with special reference to the relative contributions of cropland area and synthetic fertilizer N application rate changes	PLOS ONE			English	Article							BUDGETS; INPUTS; AGROECOSYSTEMS; TRANSFORMATION; MANAGEMENT; HYPOXIA; NITRATE; TRENDS; MAIZE; YIELD	With the increases of cropland area and fertilizer nitrogen (N) application rate, general N balance characteristics in regional agroecosystems have been widely documented. However, few studies have quantitatively analyzed the drivers of spatial changes in the N budget. We constructed a mass balance model of the N budget at the soil surface using a database of county-level agricultural statistics to analyze N input, output, and proportional contribution of various factors to the overall N input changes in croplands during 2000-2010 in the Yangtze River Basin, the largest basin and the main agricultural production region in China. Over the period investigated, N input increased by 9%. Of this 87% was from fertilizer N input. In the upper and middle reaches of the basin, the increased synthetic fertilizer N application rate accounted for 84% and 76% of the N input increase, respectively, mainly due to increased N input in the cropland that previously had low synthetic fertilizer N application rate. In lower reaches of the basin, mainly due to urbanization, the decrease in cropland area and synthetic fertilizer N application rate nearly equally contributed to decreases in N input. Quantifying spatial N inputs can provide critical managerial information needed to optimize synthetic fertilizer N application rate and monitor the impacts of urbanization on agricultural production, helping to decrease agricultural environment risk and maintain sustainable agricultural production in different areas.	[Wang, Lijuan; Zheng, Hua; Zhao, He] Univ Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Wang, Lijuan; Zheng, Hua; Zhao, He] Univ Chinese Acad Sci, Beijing, Peoples R China; [Robinson, Brian E.] McGill Univ, Dept Geog, Montreal, PQ, Canada	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; McGill University	Zheng, H (corresponding author), Univ Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China.; Zheng, H (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	zhenghua@rcees.ac.cn	Robinson, Brian E/AAC-4173-2020	Robinson, Brian E/0000-0002-8972-8318; Zheng, Hua/0000-0002-2301-1744	National Key Research and Development Program of China [2016YFC0503401]; Science and Technology Service Network Initiative of Chinese Academy of Sciences (KFJ-STS-ZDTP); Social Science and Humanities Research Council of Canada [53-2014-00861]	National Key Research and Development Program of China; Science and Technology Service Network Initiative of Chinese Academy of Sciences (KFJ-STS-ZDTP); Social Science and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This work was supported by the National Key Research and Development Program of China (No.2016YFC0503401), the Science and Technology Service Network Initiative of Chinese Academy of Sciences (KFJ-STS-ZDTP) and the Social Science and Humanities Research Council of Canada. Grant (53-2014-00861). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreae MO, 2001, GLOBAL BIOGEOCHEM CY, V15, P955, DOI 10.1029/2000GB001382; Bao X, 2006, SCI TOTAL ENVIRON, V363, P136, DOI 10.1016/j.scitotenv.2005.06.029; Bo S, 2008, SURFACE N BALANCES A, V18, P304; Bouwman A, 2005, GLOBAL BIOGEOCHEMICA, V19, P4; Bouwman AF, 2017, SCI REP-UK, V7, DOI 10.1038/srep40366; Burkart MR, 1999, J ENVIRON QUAL, V28, P850, DOI 10.2134/jeq1999.00472425002800030016x; Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Change IPOC, 2006, IPCC GUIDELINES NATL; Chapin FS., 2011, PRINCIPLES TERRESTRI, V2nd ed.; Chen NW, 2008, BIOGEOCHEMISTRY, V87, P169, DOI 10.1007/s10533-007-9175-2; Chen XP, 2011, P NATL ACAD SCI USA, V108, P6399, DOI 10.1073/pnas.1101419108; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Editorial Committee of Chinese Yearbook of Agriculture, 2009, CHIN AGR YB; Ewing PM, 2015, ECOL SOC, V20, DOI 10.5751/ES-06767-200118; Fang JY, 2014, GLOBAL CHANGE BIOL, V20, P2019, DOI 10.1111/gcb.12512; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Giles J, 2005, NITROGEN STUDY FERTI, P791; Gu BJ, 2015, P NATL ACAD SCI USA, V112, P8792, DOI 10.1073/pnas.1510211112; Han YG, 2014, GEODERMA, V213, P87, DOI 10.1016/j.geoderma.2013.07.019; Howarth RW, 1996, BIOGEOCHEMISTRY, V35, P75, DOI 10.1007/BF02179825; Jin X.C, 1995, LAKES CHINA RES THEI; Li ShuTian, 2011, Scientia Agricultura Sinica, V44, P4207; Liu C, 2009, BIOGEOCHEMISTRY, V94, P175, DOI 10.1007/s10533-009-9317-9; [刘晓利 Liu Xiaoli], 2005, [河北农业大学学报, Journal of Agricultural University of Hebei], V28, P27; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Liu YS, 2010, J ENVIRON MANAGE, V91, P646, DOI 10.1016/j.jenvman.2009.09.028; Ma GuangWen, 2009, Research of Environmental Sciences, V22, P132; Ma L, 2013, ENVIRON SCI TECHNOL, V47, P7260, DOI 10.1021/es400456u; Meng QF, 2013, FIELD CROP RES, V143, P91, DOI 10.1016/j.fcr.2012.09.023; Mueller ND, 2017, GLOBAL BIOGEOCHEM CY, V31, P245, DOI 10.1002/2016GB005515; OECD, 2008, EUROCHOICES, V12, P30; Powlson DS, 2008, J ENVIRON QUAL, V37, P291, DOI 10.2134/jeq2007.0177; Rabalais NN, 2002, ANNU REV ECOL SYST, V33, P235, DOI 10.1146/annurev.ecolsys.33.010802.150513; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Robertson GP, 2009, ANNU REV ENV RESOUR, V34, P97, DOI 10.1146/annurev.environ.032108.105046; Shindo J, 2012, NUTR CYCL AGROECOSYS, V94, P47, DOI 10.1007/s10705-012-9525-x; Smil V, 1999, GLOBAL BIOGEOCHEM CY, V13, P647, DOI 10.1029/1999GB900015; [孙志梅 SUN Zhimei], 2006, [土壤通报, Journal of Soil Science], V37, P782; Ti CP, 2012, BIOGEOCHEMISTRY, V108, P381, DOI 10.1007/s10533-011-9606-y; Van Breemen N, 2002, BIOGEOCHEMISTRY, V57, P267, DOI 10.1023/A:1015775225913; Varshney RK, 2012, NAT BIOTECHNOL, V30, P1172, DOI 10.1038/nbt.2440; Wang A, 2016, SCI CHINA EARTH SCI, P1; Wang QX, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/11/115005; Wu YM, 2006, CHINESE GEOGR SCI, V16, P289, DOI 10.1007/s11769-006-0289-6; Xiong ZQ, 2008, NUTR CYCL AGROECOSYS, V80, P189, DOI 10.1007/s10705-007-9132-4; Xu XP, 2017, FIELD CROP RES, V203, P8, DOI 10.1016/j.fcr.2016.11.013; Yan W., 2001, ACTA GEOGRAPHICA SIN, V68, P505, DOI [10.11821/xb200105001, DOI 10.3321/J.ISSN:0375-5444.2001.05.001]; Yan WJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB002029; Yan WJ, 1999, BIOGEOCHEMISTRY, V45, P1; [张欢 Zhang Huan], 2014, [土壤通报, Chinese Journal of Soil Science], V45, P1119; Zheng MM, 2015, J ENVIRON SCI, V28, P195, DOI 10.1016/j.jes.2014.05.053	52	10	12	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180613	10.1371/journal.pone.0180613	http://dx.doi.org/10.1371/journal.pone.0180613			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678841	Green Published, gold, Green Submitted			2022-12-26	WOS:000405272200076
J	Swayampakula, M; McDonald, PC; Vallejo, M; Coyaud, E; Chafe, SC; Westerback, A; Venkateswaran, G; Shankar, J; Gao, G; Laurent, EMN; Lou, Y; Bennewith, KL; Supuran, CT; Nabi, IR; Raught, B; Dedhar, S				Swayampakula, M.; McDonald, P. C.; Vallejo, M.; Coyaud, E.; Chafe, S. C.; Westerback, A.; Venkateswaran, G.; Shankar, J.; Gao, G.; Laurent, E. M. N.; Lou, Y.; Bennewith, K. L.; Supuran, C. T.; Nabi, I. R.; Raught, B.; Dedhar, S.			The interactome of metabolic enzyme carbonic anhydrase IX reveals novel roles in tumor cell migration and invadopodia/MMP14-mediated invasion	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CANCER STEM-CELLS; BREAST-CANCER; MATRIX-METALLOPROTEINASES; FIBROBLAST COLLAGENASE; PROTEOMIC PIPELINE; THERAPEUTIC TARGET; ACTIVATION-ENERGY; MAMMALIAN-CELLS; METASTASIS	Carbonic anhydrase IX (CAIX) is a hypoxia inducible factor 1-induced, cell surface pH regulating enzyme with an established role in tumor progression and clinical outcome. However, the molecular basis of CAIX-mediated tumor progression remains unclear. Here, we have utilized proximity dependent biotinylation (BioID) to map the CAIX 'interactome' in breast cancer cells in order to identify physiologically relevant CAIX-associating proteins with potential roles in tumor progression. High confidence proteins identified include metabolic transporters, beta 1 integrins, integrin-associated protein CD98hc and matrix metalloprotease 14 (MMP14). Biochemical studies validate the association of CAIX with alpha 2 beta 1 integrin, CD98hc and MMP14, and immunofluorescence microscopy demonstrates colocalization of CAIX with alpha 2 beta 1 integrin and MMP14 in F-actin/cofilin-positive lamellipodia/pseudopodia, and with MMP14 to cortactin/Tks5-positive invadopodia. Modulation of CAIX expression and activity results in significant changes in cell migration, collagen degradation and invasion. Mechanistically, we demonstrate that CAIX associates with MMP14 through potential phosphorylation residues within its intracellular domain, and that CAIX enhances MMP14-mediated collagen degradation by directly contributing hydrogen ions required for MMP14 catalytic activity. These findings establish hypoxia-induced CAIX as a novel metabolic component of cellular migration and invasion structures, and provide new mechanistic insights into its role in tumor cell biology.	[Swayampakula, M.; McDonald, P. C.; Vallejo, M.; Chafe, S. C.; Westerback, A.; Venkateswaran, G.; Lou, Y.; Bennewith, K. L.; Dedhar, S.] BC Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC, Canada; [Vallejo, M.; Dedhar, S.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Coyaud, E.; Laurent, E. M. N.; Raught, B.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Shankar, J.; Gao, G.; Nabi, I. R.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC, Canada; [Supuran, C. T.] Univ Firenze, Lab Chim Bioinorgan, Florence, Italy	British Columbia Cancer Agency; University of British Columbia; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of British Columbia; University of Florence	Dedhar, S (corresponding author), Univ British Columbia, BC Canc Res Ctr, Dept Integrat Oncol, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada.	sdedhar@bccrc.ca	Nabi, Ivan/GWZ-5144-2022; Laurent, Estelle/AFV-5442-2022; COYAUD, Etienne/ABD-9726-2020	Nabi, Ivan/0000-0002-0670-0513; COYAUD, Etienne/0000-0002-5893-4557; Dedhar, Shoukat/0000-0003-4355-1657; Chafe, Shawn/0000-0001-8802-651X	Canadian Institutes for Health Research (CIHR); Canadian Cancer Society Research Institute (CCSRI); Canadian Cancer Society; Pancreas Centre, BC	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute (CCSRI)(Canadian Cancer Society (CCS)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Pancreas Centre, BC	This work was supported by research grants to B. Raught and S. Dedhar from the Canadian Institutes for Health Research (CIHR), the Canadian Cancer Society Research Institute (CCSRI) through funds raised by the Canadian Cancer Society, and Pancreas Centre, BC. KL Bennewith is a Michael Smith Foundation for Health Research Biomedical Research Scholar. We thank Jordan Gillespie and Nancy LePard for help with the in vivo and clonogenic experiments.	Amith SR, 2015, INT J DEV BIOL, V59, P367, DOI 10.1387/ijdb.140336lf; Amith SR, 2017, CELL SIGNAL, V29, P69, DOI 10.1016/j.cellsig.2016.10.005; Artym Vira V., 2009, V522, P211, DOI 10.1007/978-1-59745-413-1_15; Beaty BT, 2014, J CELL BIOL, V205, P737, DOI 10.1083/jcb.201312046; Busco G, 2010, FASEB J, V24, P3903, DOI 10.1096/fj.09-149518; Chafe SC, 2015, CANCER RES, V75, P996, DOI 10.1158/0008-5472.CAN-14-3000; Chafe SC, 2010, MOL BIOL CELL, V21, P2483, DOI 10.1091/mbc.E10-03-0176; Chan PK, 2014, DATA BRIEF, V1, P76, DOI 10.1016/j.dib.2014.10.001; Chen J, 2005, GUT, V54, P920, DOI 10.1136/gut.2004.047340; Chiche J, 2009, CANCER RES, V69, P358, DOI 10.1158/0008-5472.CAN-08-2470; Choi-Rhee E, 2004, PROTEIN SCI, V13, P3043, DOI 10.1110/ps.04911804; Counillon L, 2016, BBA-MOL CELL RES, V1863, P2465, DOI 10.1016/j.bbamcr.2016.02.018; Coyaud E, 2015, MOL CELL PROTEOMICS, V14, P1781, DOI 10.1074/mcp.M114.045658; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; d'Ortho MP, 1997, EUR J BIOCHEM, V250, P751, DOI 10.1111/j.1432-1033.1997.00751.x; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Diaz B, 2013, J CELL BIOL, V201, P279, DOI 10.1083/jcb.201209151; Dingar D, 2015, J PROTEOMICS, V118, P95, DOI 10.1016/j.jprot.2014.09.029; Ditte P, 2011, CANCER RES, V71, P7558, DOI 10.1158/0008-5472.CAN-11-2520; Eng JK, 2013, PROTEOMICS, V13, P22, DOI 10.1002/pmic.201200439; Estrella V, 2013, CANCER RES, V73, P1524, DOI 10.1158/0008-5472.CAN-12-2796; Feral CC, 2005, P NATL ACAD SCI USA, V102, P355, DOI 10.1073/pnas.0404852102; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Gioia M, 2010, J BIOL INORG CHEM, V15, P1219, DOI 10.1007/s00775-010-0680-8; Gould CM, 2014, CELL ADHES MIGR, V8, P226, DOI 10.4161/cam.28346; Gupta GD, 2015, CELL, V163, P1484, DOI 10.1016/j.cell.2015.10.065; Hamilton MJ, 2014, J IMMUNOL, V192, P512, DOI 10.4049/jimmunol.1300096; Hanna SC, 2013, J CLIN INVEST, V123, P2078, DOI 10.1172/JCI66715; Hauff SJ, 2014, OTOLARYNG HEAD NECK, V151, P612, DOI 10.1177/0194599814545083; Innocenti A, 2009, BIOORG MED CHEM LETT, V19, P5825, DOI 10.1016/j.bmcl.2009.08.088; JEFFREY JJ, 1983, J BIOL CHEM, V258, P1123; Jung HY, 2015, CLIN CANCER RES, V21, P962, DOI 10.1158/1078-0432.CCR-13-3173; Kaewprag J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071611; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Lendahl U, 2009, NAT REV GENET, V10, P821, DOI 10.1038/nrg2665; Leong HS, 2014, CELL REP, V8, P1558, DOI 10.1016/j.celrep.2014.07.050; Liu GM, 2010, NAT BIOTECHNOL, V28, P1015, DOI 10.1038/nbt1010-1015; Lloyd MC, 2016, CANCER RES, V76, P3136, DOI 10.1158/0008-5472.CAN-15-2962; Lock FE, 2013, ONCOGENE, V32, P5210, DOI 10.1038/onc.2012.550; Lodillinsky C, 2016, ONCOGENE, V35, P344, DOI 10.1038/onc.2015.87; Lohse I, 2014, CANCERS, V6, P459, DOI 10.3390/cancers6010459; Lou YM, 2008, DEV DYNAM, V237, P2755, DOI 10.1002/dvdy.21658; Lou YM, 2011, CANCER RES, V71, P3364, DOI 10.1158/0008-5472.CAN-10-4261; Lucien F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028851; Macpherson IR, 2014, J CELL SCI, V127, P3893, DOI 10.1242/jcs.135947; Magalhaes MAO, 2011, J CELL BIOL, V195, P903, DOI 10.1083/jcb.201103045; McDonald PC, 2012, ONCOTARGET, V3, P84, DOI 10.18632/oncotarget.422; McIntyre A, 2012, CLIN CANCER RES, V18, P3100, DOI 10.1158/1078-0432.CCR-11-1877; Neri D, 2011, NAT REV DRUG DISCOV, V10, P767, DOI 10.1038/nrd3554; Ng SSW, 2000, CANCER RES, V60, P5451; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Pacchiano F, 2011, J MED CHEM, V54, P1896, DOI 10.1021/jm101541x; Parks SK, 2015, J CELL PHYSIOL, V230, P1954, DOI 10.1002/jcp.24930; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Pedrioli PGA, 2010, METHODS MOL BIOL, V604, P213, DOI 10.1007/978-1-60761-444-9_15; Peitzsch C, 2014, INT J RADIAT BIOL, V90, P636, DOI 10.3109/09553002.2014.916841; Radvak P, 2013, ONCOL REP, V29, P1147, DOI 10.3892/or.2013.2226; Robey IF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/485196; Rosse C, 2014, P NATL ACAD SCI USA, V111, pE1872, DOI 10.1073/pnas.1400749111; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Tomari T, 2009, CANCER SCI, V100, P1284, DOI 10.1111/j.1349-7006.2009.01173.x; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Ward C, 2015, ONCOTARGET, V6, P24856, DOI 10.18632/oncotarget.4498; WELGUS HG, 1981, J BIOL CHEM, V256, P9516; WILBUR KM, 1948, J BIOL CHEM, V176, P147; Yamaguchi H., 2006, ADHESIVE INTERACTION, P37; Yamaguchi H, 2012, EUR J CELL BIOL, V91, P902, DOI 10.1016/j.ejcb.2012.04.005; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278	69	71	72	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 9	2017	36	45					6244	6261		10.1038/onc.2017.219	http://dx.doi.org/10.1038/onc.2017.219			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FM1WY	28692057	Green Published, hybrid			2022-12-26	WOS:000414774800004
J	Vaamonde-Garcia, C; Courties, A; Pigenet, A; Laiguillon, MC; Sautet, A; Houard, X; Kerdine-Romer, S; Meijide, R; Berenbaum, F; Sellam, J				Vaamonde-Garcia, Carlos; Courties, Alice; Pigenet, Audrey; Laiguillon, Marie-Charlotte; Sautet, Alain; Houard, Xavier; Kerdine-Romer, Saadia; Meijide, Rosa; Berenbaum, Francis; Sellam, Jeremie			The nuclear factor-erythroid 2-related factor/heme oxygenase-1 axis is critical for the inflammatory features of type 2 diabetes-associated osteoarthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME OXYGENASE-1; OXIDATIVE STRESS; ARTICULAR CHONDROCYTES; KNEE OSTEOARTHRITIS; UP-REGULATION; NRF2; CARTILAGE; INDUCTION; ARTHRITIS; PATHWAY	Epidemiological findings support the hypothesis that type 2 diabetes mellitus (T2DM) is a risk factor for osteoarthritis (OA). Moreover, OA cartilage from patients with T2DM exhibits a greater response to inflammatory stress, but the molecular mechanism is unclear. To investigate whether the antioxidant defense system participates in this response, we examined here the expression of nuclear factor-erythroid 2-related factor (Nrf2), a master antioxidant transcription factor, and of heme oxygenase-1 (HO-1), one of its main target genes, in OA cartilage from T2DM and non-T2DM patients as well as in murine chondrocytes exposed to high glucose (HG). Ex vivo experiments indicated that Nrf-2 and HO-1 expression is reduced in T2DM versus non-T2DM OA cartilage (0.57-fold Nrf-2 and 0.34-fold HO-1), and prostaglandin E-2 (PGE(2)) release was increased in samples with low HO-1 expression. HG-exposed, IL-1 beta-stimulated chondrocytes had lower Nrf-2 levels in vitro, particularly in the nuclear fraction, than chondrocytes exposed to normal glucose (NG). Accordingly, HO-1 levels were also decreased (0.49-fold) in these cells. The HO-1 inducer cobalt protoporphyrin IX more efficiently attenuated PGE(2) and IL-6 release in HG+IL-1 beta-treated cells than in NG+IL-1 beta-treated cells. Greater reductions in HO-1 expression and increase in PGE(2)/IL-6 production were observed in HG+IL-1 beta-stimulated chondrocytes from Nrf-2(-/-) mice than in chondrocytes from wild-type mice. We conclude that the Nrf-2/HO-1 axis is a critical pathway in the hyperglucidic-mediated dysregulation of chondrocytes. Impairments in this antioxidant system may explain the greater inflammatory responsiveness of OA cartilage from T2DM patients and may inform treatments of such patients.	[Vaamonde-Garcia, Carlos; Courties, Alice; Pigenet, Audrey; Laiguillon, Marie-Charlotte; Sautet, Alain; Houard, Xavier; Berenbaum, Francis; Sellam, Jeremie] UPMC Univ Paris 06, Sorbonne Univ, Paris, France; [Vaamonde-Garcia, Carlos; Courties, Alice; Pigenet, Audrey; Laiguillon, Marie-Charlotte; Houard, Xavier; Berenbaum, Francis; Sellam, Jeremie] St Antoine Med Fac, INSERM, UMR S938, F-75012 Paris, France; [Vaamonde-Garcia, Carlos; Courties, Alice; Pigenet, Audrey; Laiguillon, Marie-Charlotte; Houard, Xavier; Berenbaum, Francis; Sellam, Jeremie] St Antoine Hosp, Inflammat Immunopathol Biotherapy Dept DHU i2B, F-75012 Paris, France; [Vaamonde-Garcia, Carlos; Meijide, Rosa] Univ A Coruna, Dept Med, Tissue Engn & Cellular Therapy Grp, La Coruna 15006, Spain; [Courties, Alice; Berenbaum, Francis; Sellam, Jeremie] St Antoine Hosp, AP HP, Dept Rheumatol, F-75012 Paris, France; [Sautet, Alain] St Antoine Hosp, AP HP, Dept Orthoped Surg, F-75012 Paris, France; [Kerdine-Romer, Saadia] Univ Paris Saclay, Univ Paris Sud, INSERM, UMR 996, F-92296 Chatenay Malabry, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Universidade da Coruna; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Berenbaum, F (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, Paris, France.; Berenbaum, F (corresponding author), St Antoine Med Fac, INSERM, UMR S938, F-75012 Paris, France.; Berenbaum, F (corresponding author), St Antoine Hosp, Inflammat Immunopathol Biotherapy Dept DHU i2B, F-75012 Paris, France.; Berenbaum, F (corresponding author), St Antoine Hosp, AP HP, Dept Rheumatol, F-75012 Paris, France.	francis.berenbaum@aphp.fr	Berenbaum, Francis/AAO-5690-2020; Meijide-Failde, Rosa/H-3446-2016; Kerdine-Römer, Saadia/AAT-9855-2020; Vaamonde-García, Carlos/AAA-4488-2019	Berenbaum, Francis/0000-0001-8252-7815; Meijide-Failde, Rosa/0000-0001-8516-9419; Vaamonde-Garcia, Carlos/0000-0001-8658-5502; Kerdine-Romer, Saadia/0000-0003-3313-952X	French State Transimmunom Funds [ANR-11-IDEX-0004-02]; Fondation Arthritis Jacques Courtin	French State Transimmunom Funds; Fondation Arthritis Jacques Courtin	This work was supported by the French State Transimmunom Funds managed by the ANR within the Investissements d'Avenir Program (ANR-11-IDEX-0004-02) and Fondation Arthritis Jacques Courtin. The authors declare that they have no conflicts of interest with the contents of this article.	Abraham NG, 2003, CIRC RES, V93, P507, DOI 10.1161/01.RES.0000091828.36599.34; Adaikalakoteswari A, 2006, DIABETIC MED, V23, P666, DOI 10.1111/j.1464-5491.2006.01879.x; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Barbagallo I, 2010, J BONE MINER METAB, V28, P276, DOI 10.1007/s00774-009-0134-y; Benallaoua M, 2007, ARTHRITIS RHEUM, V56, P2585, DOI 10.1002/art.22749; Berenbaum F, 2014, JOINT BONE SPINE, V81, P284, DOI 10.1016/j.jbspin.2014.04.001; Berenbaum F, 2011, ANN RHEUM DIS, V70, P1354, DOI 10.1136/ard.2010.146399; Bitar MS, 2011, AM J PHYSIOL-ENDOC M, V301, pE1119, DOI 10.1152/ajpendo.00047.2011; Bruns DR, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/732596; Cai DW, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0774-3; Chang SH, 2002, J BIOL CHEM, V277, P1933, DOI 10.1074/jbc.M108921200; Cheng XH, 2013, DIABETES, V62, P4088, DOI 10.2337/db13-0169; Clerigues V, 2013, CLIN SCI, V125, P99, DOI 10.1042/CS20120491; Clerigues V, 2012, BIOCHEM PHARMACOL, V83, P395, DOI 10.1016/j.bcp.2011.11.024; Courties A, 2015, OSTEOARTHR CARTILAGE, V23, P1955, DOI 10.1016/j.joca.2015.05.016; Davidson RK, 2013, ARTHRITIS RHEUM-US, V65, P3130, DOI 10.1002/art.38133; Denzer I, 2016, PHARMACOL RES, V103, P80, DOI 10.1016/j.phrs.2015.11.019; Donath MY, 2008, NAT CLIN PRACT ENDOC, V4, P240, DOI 10.1038/ncpendmet0783; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; El Ali Z, 2013, TOXICOL SCI, V134, P39, DOI 10.1093/toxsci/kft084; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Guillemin F, 2011, OSTEOARTHR CARTILAGE, V19, P1314, DOI 10.1016/j.joca.2011.08.004; Guillen MI, 2008, J PATHOL, V214, P515, DOI 10.1002/path.2313; Hama M, 2012, ARTHRITIS RHEUM-US, V64, P1518, DOI 10.1002/art.33497; HART DJ, 1995, J RHEUMATOL, V22, P1118; He MH, 2013, INVEST OPHTH VIS SCI, V54, P4092, DOI 10.1167/iovs.13-12004; Herder C, 2015, TRENDS ENDOCRIN MET, V26, P551, DOI 10.1016/j.tem.2015.08.001; Hui W, 2016, ANN RHEUM DIS, V75, P449, DOI 10.1136/annrheumdis-2014-206295; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kaspar JW, 2010, J BIOL CHEM, V285, P153, DOI 10.1074/jbc.M109.040022; Kim HA, 2005, ARTHRITIS RES THER, V7, pR526, DOI 10.1186/ar1705; Kim HA, 2012, RHEUMATOLOGY, V51, P1006, DOI 10.1093/rheumatology/ker525; Laiguillon MC, 2015, OSTEOARTHR CARTILAGE, V23, P1513, DOI 10.1016/j.joca.2015.04.026; Laiguillon MC, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4467; Lau A, 2013, ANTIOXID REDOX SIGN, V18, P91, DOI 10.1089/ars.2012.4754; Li J, 2014, J DIABETES COMPLICAT, V28, P662, DOI 10.1016/j.jdiacomp.2014.06.008; Li M, 2008, DIABETES, V57, P1526, DOI 10.2337/db07-1764; Liu-Bryan R, 2015, NAT REV RHEUMATOL, V11, P35, DOI 10.1038/nrrheum.2014.162; Louati K, 2015, RMD OPEN, V1, DOI 10.1136/rmdopen-2015-000077; Masuko-Hongo K, 2004, ARTHRITIS RHEUM-US, V50, P2829, DOI 10.1002/art.20437; Mawatari T, 2013, J ORTHOP RES, V31, P1943, DOI 10.1002/jor.22394; Megias J, 2009, BIOCHEM PHARMACOL, V77, P1806, DOI 10.1016/j.bcp.2009.03.009; Mishra M, 2014, FREE RADICAL BIO MED, V75, P129, DOI 10.1016/j.freeradbiomed.2014.07.001; Moon SJ, 2014, ARTHRITIS RHEUMATOL, V66, P874, DOI 10.1002/art.38310; Niture SK, 2014, FREE RADICAL BIO MED, V66, P36, DOI 10.1016/j.freeradbiomed.2013.02.008; Nowak WN, 2014, J DIABETES INVEST, V5, P99, DOI 10.1111/jdi.12131; O'Connell MA, 2015, BIOCHEM SOC T, V43, P687, DOI 10.1042/BST20150069; Ochiai S, 2008, J ORTHOP RES, V26, P894, DOI 10.1002/jor.20579; Ozen M, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00084; Rousset F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066478; Salvat C, 2005, OSTEOARTHR CARTILAGE, V13, P243, DOI 10.1016/j.joca.2004.11.008; Schett G, 2013, DIABETES CARE, V36, P403, DOI 10.2337/dc12-0924; Schneider KS, 2013, ADV NUTR, V4, P62, DOI 10.3945/an.112.003103; Seo HA, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/184598; Soares MP, 2015, BIOCHEM SOC T, V43, P663, DOI 10.1042/BST20150054; Takada T, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0792-1; Uruno A, 2013, MOL CELL BIOL, V33, P2996, DOI 10.1128/MCB.00225-13; Wang X, 2015, OSTEOARTHR CARTILAGE, V23, P22, DOI 10.1016/j.joca.2014.10.002; Wruck CJ, 2011, ANN RHEUM DIS, V70, P844, DOI 10.1136/ard.2010.132720; Yan LJ, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/137919; Zhong Q, 2013, INVEST OPHTH VIS SCI, V54, P3941, DOI 10.1167/iovs.13-11598; Zhuo Q, 2012, NAT REV RHEUMATOL, V8, P729, DOI 10.1038/nrrheum.2012.135	62	27	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14505	14515		10.1074/jbc.M117.802157	http://dx.doi.org/10.1074/jbc.M117.802157			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28684418	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000408747500017
J	Gangula, NR; Maddika, S				Gangula, Narmadha Reddy; Maddika, Subbareddy			Interplay between the phosphatase PHLPP1 and E3 ligase RNF41 stimulates proper kinetochore assembly via the outer-kinetochore protein SGT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; E3 ubiquitin ligase; kinetochore; mitosis; phosphatase; PHLPP1; RNF41; SGT1	MICROTUBULE INTERFACE; DEGRADATION; GROWTH; AKT; PHOSPHORYLATION; DIMERIZATION; APOPTOSIS; COMPLEX; POLO	Kinetochores link chromosomes to spindle microtubules and are essential for accurate chromosome segregation during cell division. Kinetochores assemble at the centromeric region of chromosomes as a multiprotein complex. However, the molecular mechanisms of kinetochore assembly have not yet been fully elucidated. In this study, we identified pleckstrin homology domain and leucine-rich repeat protein phosphatase 1 (PHLPP1) as a regulatory phosphatase that facilitates proper kinetochore assembly. We found that PHLPP1 interacted with the essential outer-kinetochore protein SGT1 and stabilized its protein levels. Loss of PHLPP1 from cells led to SGT1 degradation and thereby caused defective kinetochore assembly. We also found that the ring finger protein 41 (RNF41) as an E3 ligase ubiquitinated and degraded SGT1 in a phosphorylation-dependent manner. PHLPP1 dephosphorylated SGT1 at four conserved residues (Ser-17, Ser-249, Ser-289, and Thr-233) and thereby prevented SGT1 from associating with RNF41, in turn, countering SGT1 degradation. Importantly, depletion of RNF41 or expression of a non-phosphorylatable SGT1 mutant rescued the kinetochore defects caused by the loss of PHLPP1. Taken together, our results suggest that PHLPP1 plays an important role in the assembly of kinetochores by counteracting RNF41-mediated SGT1 degradation.	[Gangula, Narmadha Reddy; Maddika, Subbareddy] Ctr DNA Fingerprinting & Diagnost, Lab Cell Death & Cell Survival, Hyderabad 500001, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Maddika, S (corresponding author), Ctr DNA Fingerprinting & Diagnost, Lab Cell Death & Cell Survival, Hyderabad 500001, Andhra Pradesh, India.	msreddy@cdfd.org.in			Wellcome Trust/Department of Biotechnology (DBT) India Alliance Grant Senior Fellowship [IA/S/16/2/502729]; INSPIRE Program of Department of Science and Technology (DST), India; Centre for DNA Fingerprinting and Diagnostics core funds; Department of Biotechnology's Senior IYBA Award [BT/01/IYBA/2009]	Wellcome Trust/Department of Biotechnology (DBT) India Alliance Grant Senior Fellowship; INSPIRE Program of Department of Science and Technology (DST), India(Department of Science & Technology (India)); Centre for DNA Fingerprinting and Diagnostics core funds; Department of Biotechnology's Senior IYBA Award	This work was supported in part by Wellcome Trust/Department of Biotechnology (DBT) India Alliance Grant Senior Fellowship IA/S/16/2/502729 (to S. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a senior research fellowship from the INSPIRE Program of Department of Science and Technology (DST), India, as well as salary support from Centre for DNA Fingerprinting and Diagnostics core funds. This work was submitted in partial fulfillment of the requirements for a Ph. D. at Manipal University.; Recipient of Department of Biotechnology's Senior IYBA Award BT/01/IYBA/2009. To whom correspondence should be addressed. Tel.: 91-4024749353; Fax: 91-40-24749448; E-mail: msreddy@cdfd.org.in.	Bansal PK, 2009, J BIOL CHEM, V284, P18692, DOI 10.1074/jbc.M109.012732; Bansal PK, 2009, J BIOL CHEM, V284, P3586, DOI 10.1074/jbc.M806281200; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a015826; Gangula NR, 2013, J BIOL CHEM, V288, P34545, DOI 10.1074/jbc.M113.503383; Gao GL, 2013, MOL BIOL REP, V40, P2947, DOI 10.1007/s11033-012-2363-8; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gascoigne KE, 2013, J CELL BIOL, V201, P23, DOI 10.1083/jcb.201301006; Godek KM, 2015, NAT REV MOL CELL BIO, V16, P57, DOI 10.1038/nrm3916; Grzechnik AT, 2016, BIOCHEM SOC T, V44, P1675, DOI 10.1042/BST20160170; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Kops GJPL, 2008, FRONT BIOSCI-LANDMRK, V13, P3606, DOI 10.2741/2953; Li X, 2014, GASTROENTEROLOGY, V146, P1301, DOI 10.1053/j.gastro.2014.02.003; Liu JY, 2011, MOL CELL BIOL, V31, P4917, DOI 10.1128/MCB.05799-11; Liu XS, 2012, MOL CELL BIOL, V32, P4053, DOI 10.1128/MCB.00516-12; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Martins T, 2009, EMBO J, V28, P234, DOI 10.1038/emboj.2008.283; Nagpal H, 2016, CHROMOSOMA, V125, P645, DOI 10.1007/s00412-016-0608-3; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; Qiu XB, 2002, P NATL ACAD SCI USA, V99, P14843, DOI 10.1073/pnas.232580999; Steensgaard P, 2004, EMBO REP, V5, P626, DOI 10.1038/sj.embor.7400154; Wauman J, 2011, J CELL SCI, V124, P921, DOI 10.1242/jcs.078055; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Yang MJ, 2015, NAT IMMUNOL, V16, P1253, DOI 10.1038/ni.3258; Zitouni S, 2014, NAT REV MOL CELL BIO, V15, P433, DOI 10.1038/nrm3819	26	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					13947	13958		10.1074/jbc.M117.782896	http://dx.doi.org/10.1074/jbc.M117.782896			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28696259	Green Published, hybrid			2022-12-26	WOS:000408439800005
J	Chaisawang, P; Sirichoat, A; Chaijaroonkhanarak, W; Pannangrong, W; Sripanidkulchai, B; Wigmore, P; Welbat, JU				Chaisawang, Pornthip; Sirichoat, Apiwat; Chaijaroonkhanarak, Wunnee; Pannangrong, Wanassanun; Sripanidkulchai, Bungorn; Wigmore, Peter; Welbat, Jariya Umka			Asiatic acid protects against cognitive deficits and reductions in cell proliferation and survival in the rat hippocampus caused by 5-fluorouracil chemotherapy	PLOS ONE			English	Article							SPATIAL WORKING-MEMORY; ADULT NEUROGENESIS; ADJUVANT CHEMOTHERAPY; BREAST-CANCER; PENTACYCLIC TRITERPENE; THYMIDYLATE SYNTHASE; CENTELLA-ASIATICA; NEWBORN NEURONS; MOUSE MODEL; EXPRESSION	The chemotherapy drug, 5-fluorouracil (5-FU), has been reported to cause cognitive impairments in cancer patients. The drug also reduces cell proliferation and survival in the brain. Asiatic acid (AA) is a triterpene compound found in Centella asiatica that can protect against reduction of neurogenesis in the hippocampus and memory deficits induced by valproic acid (VPA). In the present study, we investigated the preventive effects of AA on the deficits in spatial working memory and cell proliferation and survival caused by 5-FU chemotherapy in a rat model. Male Sprague Dawley rats received 5-FU (5 i.v. injections, 25 mg/kg) on day 8, 11, 14, 17 and 20 of the study. This was co-administered with AA (30 mg/kg, oral gavage tube) either 20 days before receiving 5-FU (preventive), after receiving 5-FU (recovery), or for the entire period of the experiment (throughout). Spatial working memory was determined using the novel object location (NOL) test and hippocampal cell proliferation and survival of dividing cells were quantified using immunohistochemistry. Rats in the 5-FU alone and recovery groups showed memory deficits in the NOL test and reductions in cell proliferation and cell survival in the subgranular zone (SGZ) of the hippocampal dentate gyrus. Rats in the control, AA alone, and both preventive and throughout co-administration groups, however, did not exhibit these characteristics. The results showed that 5-FU chemotherapy impaired memory and reduced cell proliferation and cell survival in the SGZ of the hippocampal dentate gyrus. However, these impairments in the animals receiving 5-FU chemotherapy were restored to control levels when AA was co-administered before and during 5-FU treatment. These data demonstrate that AA can prevent the spatial working memory and hippocampal neurogenesis impairments caused by 5-FU chemotherapy.	[Chaisawang, Pornthip; Sirichoat, Apiwat; Chaijaroonkhanarak, Wunnee; Pannangrong, Wanassanun; Welbat, Jariya Umka] Khon Kaen Univ, Dept Anat, Fac Med, Khon Kaen, Thailand; [Pannangrong, Wanassanun; Sripanidkulchai, Bungorn; Welbat, Jariya Umka] Khon Kaen Univ, Ctr Res & Dev Herbal Hlth Prod, Khon Kaen, Thailand; [Wigmore, Peter] Univ Nottingham, Med Sch, Sch Life Sci, Queens Med Ctr, Nottingham, England; [Welbat, Jariya Umka] Khon Kaen Univ, Neurosci Res & Dev Grp, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; University of Nottingham; Khon Kaen University	Welbat, JU (corresponding author), Khon Kaen Univ, Dept Anat, Fac Med, Khon Kaen, Thailand.; Welbat, JU (corresponding author), Khon Kaen Univ, Ctr Res & Dev Herbal Hlth Prod, Khon Kaen, Thailand.; Welbat, JU (corresponding author), Khon Kaen Univ, Neurosci Res & Dev Grp, Khon Kaen, Thailand.	jariya@kku.ac.th			The Thailand Research Fund [TRG5780086]; Invitation Research of the Faculty of Medicine [IN59312]; Neuroscience Research and Development Group at Khon Kaen University	The Thailand Research Fund(Thailand Research Fund (TRF)); Invitation Research of the Faculty of Medicine; Neuroscience Research and Development Group at Khon Kaen University	The Thailand Research Fund (TRG5780086), Invitation Research of the Faculty of Medicine (grant number: IN59312), and the Neuroscience Research and Development Group at Khon Kaen University funded this project.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Alberi L, 2011, NEURON, V69, P437, DOI 10.1016/j.neuron.2011.01.004; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; ATKINS JN, 1991, AM J CLIN ONCOL-CANC, V14, P526, DOI 10.1097/00000421-199112000-00012; Bower JE, 2008, J CLIN ONCOL, V26, P768, DOI 10.1200/JCO.2007.14.3248; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Chiou SH, 2006, BIOCHEM BIOPH RES CO, V343, P391, DOI 10.1016/j.bbrc.2006.02.180; Chu E, 2003, CANCER CHEMOTH PHARM, V52, pS80, DOI 10.1007/s00280-003-0625-9; Crupi R, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-7; de Ruiter MB, 2011, HUM BRAIN MAPP, V32, P1206, DOI 10.1002/hbm.21102; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Ehninger D, 2008, CELL TISSUE RES, V331, P243, DOI 10.1007/s00441-007-0478-3; ELBeltagy M, 2012, BRAIN RES BULL, V88, P514, DOI 10.1016/j.brainresbull.2012.05.005; ELBeltagy M, 2010, BEHAV BRAIN RES, V208, P112, DOI 10.1016/j.bbr.2009.11.017; Epp JR, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00057; Falleti MG, 2005, BRAIN COGNITION, V59, P60, DOI 10.1016/j.bandc.2005.05.001; Fan HGM, 2005, J CLIN ONCOL, V23, P8025, DOI 10.1200/JCO.2005.01.6550; Fardell JE, 2012, PSYCHOPHARMACOLOGY, V220, P183, DOI 10.1007/s00213-011-2466-2; Foley JJ, 2008, PSYCHOPHARMACOLOGY, V199, P527, DOI 10.1007/s00213-008-1175-y; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Huang SS, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/895857; Imayoshi I, 2009, DEV GROWTH DIFFER, V51, P379, DOI 10.1111/j.1440-169X.2009.01094.x; Khotimah H, 2015, J PSYCHOL, V2, P22; Kreukels BPC, 2008, CLIN BREAST CANCER, V8, P80, DOI 10.3816/CBC.2008.n.006; Krishnamurthy RG, 2009, J NEUROSCI RES, V87, P2541, DOI 10.1002/jnr.22071; Lagace DC, 2010, P NATL ACAD SCI USA, V107, P4436, DOI 10.1073/pnas.0910072107; Lee MK, 2000, RES COMMUN MOL PATH, V108, P75; Lucassen PJ, 2010, EUR NEUROPSYCHOPHARM, V20, P1, DOI 10.1016/j.euroneuro.2009.08.003; Lucassen Paul J., 2006, CNS & Neurological Disorders-Drug Targets, V5, P531, DOI 10.2174/187152706778559273; Lyons L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030010; Lyons L, 2011, PSYCHOPHARMACOLOGY, V215, P105, DOI 10.1007/s00213-010-2122-2; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Manohar S, 2012, NEUROSCIENCE, V202, P169, DOI 10.1016/j.neuroscience.2011.12.013; Matsuda Tomohiro, 2005, Breast Cancer, V12, P279, DOI 10.2325/jbcs.12.279; MAYHEW TM, 1988, PLACENTA, V9, P565, DOI 10.1016/0143-4004(88)90001-X; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; MOORE DH, 1990, GYNECOL ONCOL, V36, P152, DOI 10.1016/0090-8258(90)90127-7; Mustafa S, 2008, EUR J NEUROSCI, V28, P323, DOI 10.1111/j.1460-9568.2008.06325.x; Nasir MN, 2011, J ETHNOPHARMACOL, V134, P203, DOI 10.1016/j.jep.2010.12.010; ORHAN IE, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI DOI 10.1155/2012/946259; PINEDO HM, 1988, J CLIN ONCOL, V6, P1653, DOI 10.1200/JCO.1988.6.10.1653; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Rustum YM, 2004, FRONT BIOSCI-LANDMRK, V9, P2467, DOI 10.2741/1408; Seigers R, 2008, BEHAV BRAIN RES, V186, P168, DOI 10.1016/j.bbr.2007.08.004; Shukla A, 1999, J ETHNOPHARMACOL, V65, P1, DOI 10.1016/S0378-8741(98)00141-X; Sirichoat A, 2015, NUTRIENTS, V7, P8413, DOI 10.3390/nu7105401; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Soussain C, 2009, LANCET, V374, P1639, DOI 10.1016/S0140-6736(09)61299-X; Umka J, 2010, NEUROSCIENCE, V166, P15, DOI 10.1016/j.neuroscience.2009.11.073; Umka Welbat J, 2016, NUTRIENTS, V8; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Vardy J, 2007, CRIT REV ONCOL HEMAT, V63, P183, DOI 10.1016/j.critrevonc.2007.06.001; Wakabayashi T, 2008, NEUROSCI LETT, V442, P249, DOI 10.1016/j.neulet.2008.07.030; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Welbat JU, 2016, ANN ANAT, V206, P7, DOI 10.1016/j.aanat.2016.04.029; Winocur G, 2006, PHARMACOL BIOCHEM BE, V85, P66, DOI 10.1016/j.pbb.2006.07.010; Xu MF, 2012, ACTA PHARMACOL SIN, V33, P578, DOI 10.1038/aps.2012.3; Yeh Kun-Huei, 1994, Journal of the Formosan Medical Association, V93, P721; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	62	25	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180650	10.1371/journal.pone.0180650	http://dx.doi.org/10.1371/journal.pone.0180650			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700628	Green Submitted, Green Published, gold			2022-12-26	WOS:000405544800062
J	Moore, ER; Bullington, BS; Weisberg, AJ; Jiang, Y; Chang, J; Halsey, KH				Moore, Eric R.; Bullington, Briana S.; Weisberg, Alexandra J.; Jiang, Yuan; Chang, Jeff; Halsey, Kimberly H.			Morphological and transcriptomic evidence for ammonium induction of sexual reproduction in Thalassiosira pseudonana and other centric diatoms	PLOS ONE			English	Article							CELL-CYCLE; VEGETATIVE CELL; GENOME REVEALS; LIFE-CYCLES; EVOLUTIONARY; BACILLARIOPHYCEAE; SILICA; LIGHT; SPERMATOGENESIS; IDENTIFICATION	The reproductive strategy of diatoms includes asexual and sexual phases, but in many species, including the model centric diatom Thalassiosira pseudonana, sexual reproduction has never been observed. Furthermore, the environmental factors that trigger sexual reproduction in diatoms are not understood. Although genome sequences of a few diatoms are available, little is known about the molecular basis for sexual reproduction. Here we show that ammonium reliably induces the key sexual morphologies, including oogonia, auxospores, and spermatogonia, in two strains of T. pseudonana, T. weissflogii, and Cyclotella cryptica. RNA sequencing revealed 1,274 genes whose expression patterns changed when T. pseudonana was induced into sexual reproduction by ammonium. Some of the induced genes are linked to meiosis or encode flagellar structures of heterokont and cryptophyte algae. The identification of ammonium as an environmental trigger suggests an unexpected link between diatom bloom dynamics and strategies for enhancing population genetic diversity.	[Moore, Eric R.; Bullington, Briana S.; Halsey, Kimberly H.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Weisberg, Alexandra J.; Halsey, Kimberly H.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Jiang, Yuan] Oregon State Univ, Dept Stat, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University	Halsey, KH (corresponding author), Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.	halseyk@science.oregonstate.edu		Moore, Eric/0000-0001-5834-8753; Halsey, Kimberly/0000-0002-1407-0777; Weisberg, Alexandra/0000-0002-0045-1368; Chang, Jeff/0000-0002-1833-0695; Jiang, Yuan/0000-0001-6409-9159				Ambawat S, 2013, PHYSIOL MOL BIOL PLA, V19, P307, DOI 10.1007/s12298-013-0179-1; Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; Archibald JM, 2009, CURR BIOL, V19, pR81, DOI 10.1016/j.cub.2008.11.067; Armbrust EV, 1999, APPL ENVIRON MICROB, V65, P3121; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; ARMBRUST EV, 1990, J PHYCOL, V26, P470, DOI 10.1111/j.0022-3646.1990.00470.x; Assmy P, 2006, J PHYCOL, V42, P1002, DOI 10.1111/j.1529-8817.2006.00260.x; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Bernstein H, 2010, BIOSCIENCE, V60, P498, DOI 10.1525/bio.2010.60.7.5; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Chen G, 2016, LIMNOL OCEANOGR, V61, P2165, DOI 10.1002/lno.10361; Cheng H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000440; Chepurnov VA, 2004, INT REV CYTOL, V237, P91; Chepurnov VA, 2008, BIOESSAYS, V30, P692, DOI 10.1002/bies.20773; Chepurnov VA, 2006, J PHYCOL, V42, P845, DOI 10.1111/j.1529-8817.2006.00244.x; Chepurnov VA, 2011, CELL ORIG LIFE EXTRE, V19, P167, DOI 10.1007/978-94-007-1327-7_7; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Collos Y, 2014, MAR POLLUT BULL, V80, P8, DOI 10.1016/j.marpolbul.2014.01.006; Cooper KF, 2000, P NATL ACAD SCI USA, V97, P14548, DOI 10.1073/pnas.250351297; d'Ippolito G, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0212-4; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dyhrman ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033768; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edlund MB, 1997, J PHYCOL, V33, P897, DOI 10.1111/j.0022-3646.1997.00897.x; EDLUND MB, 1991, J PHYCOL, V27, P780, DOI 10.1111/j.0022-3646.1991.00780.x; Ezzati J., 2011, TRENDS ANAL CHEM, V30, P9; Frazee AC, 2015, NAT BIOTECHNOL, V33, P243, DOI 10.1038/nbt.3172; FRENCH FW, 1985, J PHYCOL, V21, P477; GALLAGHER JC, 1983, J PHYCOL, V19, P539, DOI 10.1111/j.0022-3646.1983.00539.x; Geitler L, 1932, ARCH PROTISTENKD, V78, P1; Gillard J, 2008, PLANT PHYSIOL, V148, P1394, DOI 10.1104/pp.108.122176; Godhe A, 2014, PROTIST, V165, P401, DOI 10.1016/j.protis.2014.04.006; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Hildebrand M, 2007, J PHYCOL, V43, P730, DOI 10.1111/j.1529-8817.2007.00361.x; Hildebrand M, 2006, J MATER RES, V21, P2689, DOI 10.1557/JMR.2006.0333; Hildebrand M, 2012, BIOFUELS-UK, V3, P221, DOI 10.4155/bfs.11.157; Holtermann KE, 2010, J PHYCOL, V46, P41, DOI 10.1111/j.1529-8817.2009.00792.x; Honda D, 2007, PROTIST, V158, P77, DOI 10.1016/j.protis.2006.08.004; HOOPS HJ, 1979, PHYCOLOGIA, V18, P424, DOI 10.2216/i0031-8884-18-4-424.1; Huysman MJJ, 2014, J EXP BOT, V65, P2573, DOI 10.1093/jxb/ert387; Idei M, 2015, J PHYCOL, V51, P144, DOI 10.1111/jpy.12261; Idei M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041890; JEWSON DH, 1992, PHILOS T ROY SOC B, V336, P191, DOI 10.1098/rstb.1992.0056; Kaczmarska I, 2013, DIATOM RES, V28, P263, DOI 10.1080/0269249X.2013.791344; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Koester JA, 2007, EUR J PHYCOL, V42, P351, DOI 10.1080/09670260701562100; Kroth P, 2007, ADV EXP MED BIOL, V616, P23; LEWIS WM, 1984, AM NAT, V123, P73, DOI 10.1086/284187; Lutzmann M, 2012, MOL CELL, V47, P523, DOI 10.1016/j.molcel.2012.05.048; Mann D. G., 1988, ALGAE AQUATIC ENV, P384; Mann DG, 1999, PHYCOLOGIA, V38, P437, DOI 10.2216/i0031-8884-38-6-437.1; Mazin AV, 2010, DNA REPAIR, V9, P286, DOI 10.1016/j.dnarep.2009.12.006; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mills KE, 2006, BOT MAR, V49, P417, DOI 10.1515/BOT.2006.053; Moeys S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19252; Mouget JL, 2009, FEMS MICROBIOL ECOL, V69, P194, DOI 10.1111/j.1574-6941.2009.00700.x; Nagai S, 1995, PHYCOLOGIA, V34, P533, DOI 10.2216/i0031-8884-34-6-533.1; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Park J, 2013, MOL CELL BIOL, V33, P1632, DOI 10.1128/MCB.01503-12; Patil S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1983-5; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Round F. E., 1972, NOVA HEDWIGIA, V23, P291; Sabbe K, 2004, EUR J PHYCOL, V39, P327, DOI 10.1080/0967026042000236445; Shirokawa Y, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0503; SIMONSEN R, 1979, Bacillaria, V2, P9; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Tillmann U, 2004, J EUKARYOT MICROBIOL, V51, P156, DOI 10.1111/j.1550-7408.2004.tb00540.x; VAULOT D, 1987, J PLANKTON RES, V9, P345, DOI 10.1093/plankt/9.2.345; von Dassow P, 2011, J PLANKTON RES, V33, P3, DOI 10.1093/plankt/fbq137; Werner D, 1977, BOTANICAL MONOGRAPHS, V13, P250; Yoshiyama K, 2006, LIMNOL OCEANOGR, V51, P424, DOI 10.4319/lo.2006.51.1_part_2.0424; Zachariae W, 1998, SCIENCE, V279, P1216, DOI 10.1126/science.279.5354.1216	76	9	9	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0181098	10.1371/journal.pone.0181098	http://dx.doi.org/10.1371/journal.pone.0181098			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686696	gold, Green Submitted, Green Published			2022-12-26	WOS:000405464100132
J	Nicol, S; Chades, I				Nicol, Sam; Chades, Iadine			A preliminary approach to quantifying the overall environmental risks posed by development projects during environmental impact assessment	PLOS ONE			English	Article							BAYESIAN BELIEF NETWORKS; ECOLOGICAL RISK; DIAGNOSIS; KNOWLEDGE	Environmental impact assessment (EIA) is used globally to manage the impacts of development projects on the environment, so there is an imperative to demonstrate that it can effectively identify risky projects. However, despite the widespread use of quantitative predictive risk models in areas such as toxicology, ecosystem modelling and water quality, the use of predictive risk tools to assess the overall expected environmental impacts of major construction and development proposals is comparatively rare. A risk-based approach has many potential advantages, including improved prediction and attribution of cause and effect; sensitivity analysis; continual learning; and optimal resource allocation. In this paper we investigate the feasibility of using a Bayesian belief network (BBN) to quantify the likelihood and consequence of non-compliance of new projects based on the occurrence probabilities of a set of expert-defined features. The BBN incorporates expert knowledge and continually improves its predictions based on new data as it is collected. We use simulation to explore the trade-off between the number of data points and the prediction accuracy of the BBN, and find that the BBN could predict risk with 90% accuracy using approximately 1000 data points. Although a further pilot test with real project data is required, our results suggest that a BBN is a promising method to monitor overall risks posed by development within an existing EIA process given a modest investment in data collection.	[Nicol, Sam; Chades, Iadine] CSIRO Land & Water, Dutton Pk, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Nicol, S (corresponding author), CSIRO Land & Water, Dutton Pk, Qld, Australia.	sam.nicol@csiro.au	Chades, iadine/A-4052-2011; Nicol, Sam/I-1074-2012	Chades, iadine/0000-0002-7442-2850; Nicol, Sam/0000-0002-1160-7444	Australian Department of Environment (DoE)	Australian Department of Environment (DoE)	SN and IC received funding from the Australian Department of Environment (DoE; http://www.environment.gov.au). DoE staff provided indicator categories and initial weightings for the pilot study. The study was designed and the manuscript prepared and written by the authors and does not represent the views of the DoE.	Ahammed AKMR, 2006, ENVIRON IMPACT ASSES, V26, P426, DOI 10.1016/j.eiar.2005.09.002; Al-Rashdan D, 1999, EUR J OPER RES, V118, P30, DOI 10.1016/S0377-2217(97)00079-9; Alexander C, 2000, DISCUSSION PAPERS FI; [Anonymous], 2009, RISK ANAL WATER POLL; Arts J., 2001, IMPACT ASSESS PROJ A, V19, P175, DOI [10.3152/147154601781767014, DOI 10.3152/147154601781767014]; Australian National Audit Office, 2014, MAN COMPL ENV PROT B; Banko M, 2001, 39TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P26, DOI 10.3115/1073012.1073017; Bennett ND, 2013, ENVIRON MODELL SOFTW, V40, P1, DOI 10.1016/j.envsoft.2012.09.011; Bermudez L, 2008, INSUR MATH ECON, V42, P779, DOI 10.1016/j.insmatheco.2007.08.002; Biedermann A, 2005, FORENSIC SCI INT, V147, P49, DOI 10.1016/j.forsciint.2004.04.014; Bouissou M, 1999, REL MAINT S 1999 P A; BURGMAN M, 2005, RISKS DECISIONS CONS, P42; Cain J, 2001, PLANNING IMPROVEMENT; Cardenas IC, 2013, RISK ANAL, V33, P92, DOI 10.1111/j.1539-6924.2012.01829.x; Cowell RG, 2007, J RISK INSUR, V74, P795, DOI 10.1111/j.1539-6975.2007.00235.x; Deb K., 2014, SEARCH METHODOLOGIES, P403, DOI DOI 10.1007/978-1-4614-6940-7_15; Evett IW, 2002, J FORENSIC SCI, V47, P520; Fenton N., 2000, MATH TODAY SOUTHEND, V36, P180, DOI [https://doi.org/10.1111/cogs.12004, DOI 10.1111/COGS.12004]; Fenton N., 2013, RISK ASSESSMENT DECI; Halevy A, 2009, IEEE INTELL SYST, V24, P8, DOI 10.1109/MIS.2009.36; Hallowell MR, 2010, J CONSTR ENG M, V136, P99, DOI 10.1061/(ASCE)CO.1943-7862.0000137; Harding R., 1998, ENV DECISION MAKING; HILDEN J, 1984, COMPUT BIOL MED, V14, P429, DOI 10.1016/0010-4825(84)90043-X; Howes AL, 2010, CONSERV BIOL, V24, P974, DOI 10.1111/j.1523-1739.2010.01451.x; Jalava K, 2015, IMPACT ASSESS PROJ A, V33, P255, DOI 10.1080/14615517.2015.1069997; Kahn CE, 1997, COMPUT BIOL MED, V27, P19, DOI 10.1016/S0010-4825(96)00039-X; KOLLER D., 2009, PROBABILISTIC GRAPHI; Kynn M, 2008, J ROY STAT SOC A STA, V171, P239; Langseth H, 2007, RELIAB ENG SYST SAFE, V92, P92, DOI 10.1016/j.ress.2005.11.037; Marcot BG, 2006, CAN J FOREST RES, V36, P3063, DOI 10.1139/X06-135; Martin TG, 2012, CONSERV BIOL, V26, P29, DOI 10.1111/j.1523-1739.2011.01806.x; Morrison-Saunders A, 2003, IMPACT ASSESS PROJ A, V21, P43, DOI DOI 10.3152/147154603781766527; Ngai EWT, 2011, DECIS SUPPORT SYST, V50, P559, DOI 10.1016/j.dss.2010.08.006; Nicol S, 2015, RISK CALCULATOR SUPP; Nicol S, 2014, DEV RISK BASED APPRO; Niemeijer D, 2008, ECOL INDIC, V8, P14, DOI 10.1016/j.ecolind.2006.11.012; NOAA, 2015, DEEPW HOR OIL SPILL; Norsys Software Corp, NET TUT; Norsys Software Corp, 2010, NET J REF MAN; Nyberg JB, 2006, CAN J FOREST RES, V36, P3104, DOI 10.1139/X06-108; Petts Judith, 1999, P3; Pollino CA, 2007, ENVIRON MODELL SOFTW, V22, P1140, DOI 10.1016/j.envsoft.2006.03.006; Pradhan M, 1996, ARTIFICIAL INTELLIGE, V85, P363; Renooij S, 2001, KNOWL ENG REV, V16, P255, DOI 10.1017/S0269888901000145; Standards Australia/ Standards New Zealand, 2009, 310002009 ASNZS; Sumaila UR, 2012, CAN J FISH AQUAT SCI, V69, P499, DOI [10.1139/F2011-171, 10.1139/f2011-171]; Suter Glenn W. III, 2008, Integrated Environmental Assessment and Management, V4, P285, DOI 10.1897/IEAM_2007-062; SUTER GW, 1992, ENVIRON SCI TECHNOL, V26, P432, DOI 10.1021/es00027a001; Suter GWI, 2006, ECOLOGICAL RISK ASSE; WAGENAAR WA, 1988, LAW HUMAN BEHAV, V12, P499, DOI 10.1007/BF01044630; Wang Y, 2003, ENVIRON IMPACT ASSES, V23, P543, DOI DOI 10.1016/S0195-9255(03)00071-4	51	6	6	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180982	10.1371/journal.pone.0180982	http://dx.doi.org/10.1371/journal.pone.0180982			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686651	Green Published, gold, Green Submitted			2022-12-26	WOS:000405464100127
J	Yan, P; Chen, K; Wang, Q; Yang, DC; Li, D; Yang, YJ				Yan, Peng; Chen, Ken; Wang, Qiang; Yang, Dachun; Li, De; Yang, Yongjian			UCP-2 is involved in angiotensin-II-induced abdominal aortic aneurysm in apolipoprotein E-knockout mice	PLOS ONE			English	Article							UNCOUPLING PROTEIN-2 OVEREXPRESSION; NITRIC-OXIDE; OXIDATIVE STRESS; ACCELERATED ATHEROSCLEROSIS; CELLS; PROGRESSION; DEFICIENCY; MECHANISMS; DISEASE; FAMILY	UCP-2 shows an important role in modulating of mitochondrial membrane potential and cell apoptosis. Whether or not UCP-2 could been a critical factor in preventing AAA formation is not known. We report that UCP-2 protein and mRNA expression were significantly higher in Ang-II-induced AAA of mice. The incident rate of AAA in UCP-2(-/-)ApoE(-/-) mice after Ang-Iltreatment was higher than the rate in the UCP-2(+/+)ApoE(-/-) mice. The abdominal aorta from UCP-2(-/-)ApoE4- mice showed the medial hypertrophy, fragmentation of elastic lamellas and depletion of alpha-SMA. The NADPH oxidase activity and level of MDA was significantly higher in UCP-2-/-ApoE4- mice than UCP-2(+/+)ApoE(-/-) or WT mice. Besides, the SOD activity is increased in UCP-2(+/+)ApoE4- mice as compared with WT mice, whereas deficiency of UCP2 decreased the increasing SOD activity in Ang-II treated ApoE(-/-) mice. UCP-2 knockout up regulated the MMP2 and MMP9 expression in aortic aneurysm. Ang-II induced apoptosis of VSMCs was increased in UCP-24-ApoE(-/-) mice. And the expression of eNOS in vascular tissue from UCP-2(-/-)ApoE(-/-) mice is lower than WT and UCP-2(+/+)ApoE(-/-) mice. This study provides a mechanism by which UCP-2, via anti -oxidants and anti-apoptosis, participates in the preventing of AAA formation.	[Yan, Peng; Chen, Ken; Wang, Qiang; Yang, Dachun; Li, De; Yang, Yongjian] Chengdu Mil Gen Hosp, Dept Cardiol, Chengdu, Sichuan, Peoples R China		Yang, YJ (corresponding author), Chengdu Mil Gen Hosp, Dept Cardiol, Chengdu, Sichuan, Peoples R China.	yangyongiian38@sna.com		Chen, Ken/0000-0002-8958-1088; Yang, Yongjian/0000-0003-1268-166X	National Natural Science Foundation of China [81500224, 81670419, 81470396]; China Postdoctoral Science Foundation [2016M593044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	These studies were supported in part by grants from National Natural Science Foundation of China (no. 81500224; 81670419; 81470396), China Postdoctoral Science Foundation funded project (no. 2016M593044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; Bouillaud F, 2016, BBA-MOL CELL RES, V1863, P2443, DOI 10.1016/j.bbamcr.2016.04.013; Cardoso S, 2015, J BIOENERG BIOMEMBR, V47, P119, DOI 10.1007/s10863-014-9580-x; Chen JQ, 2001, CIRCULATION, V104, P2391, DOI 10.1161/hc4501.099729; Coughlan MT, 2007, ANTIOXID REDOX SIGN, V9, P331, DOI 10.1089/ars.2006.1469; Couplan E, 2002, J BIOL CHEM, V277, P26268, DOI 10.1074/jbc.M202535200; Derdak Z, 2009, METHODS MOL BIOL, V559, P205, DOI 10.1007/978-1-60327-017-5_15; Dromparis P, 2013, CIRC RES, V113, P126, DOI 10.1161/CIRCRESAHA.112.300699; Durdu S, 2012, CARDIOVASC THER, V30, P308, DOI 10.1111/1755-5922.12007; Emeto TI, 2014, CURR DRUG TARGETS, V15, P860; Emeto TI, 2014, CLIN SCI, V126, P517, DOI 10.1042/CS20130425; Forstermann U, 2008, NAT CLIN PRACT CARD, V5, P338, DOI 10.1038/ncpcardio1211; Forstermann U, 2010, PFLUG ARCH EUR J PHY, V459, P923, DOI 10.1007/s00424-010-0808-2; Ge HS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/323246; GILLUM RF, 1995, J CLIN EPIDEMIOL, V48, P1289, DOI 10.1016/0895-4356(95)00045-3; Gomez-Hernandez A, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0108-9; Grabacka M, 2008, PPAR RES, V2008, DOI 10.1155/2008/930705; He RM, 2006, J THORAC CARDIOV SUR, V131, P671, DOI 10.1016/j.jtcvs.2005.09.018; Humphrey JD, 2012, J BIOMECH, V45, P805, DOI 10.1016/j.jbiomech.2011.11.021; Kim HS, 2007, DIABETES RES CLIN PR, V77, pS46, DOI 10.1016/j.diabres.2007.01.032; Kniemeyer HW, 2000, EUR J VASC ENDOVASC, V19, P190, DOI 10.1053/ejvs.1999.0980; Krishna SM, 2012, AM J PATHOL, V181, P706, DOI 10.1016/j.ajpath.2012.04.015; Kuhlencordt PJ, 2001, CIRCULATION, V104, P448, DOI 10.1161/hc2901.091399; Lee KU, 2005, CIRC RES, V96, P1200, DOI 10.1161/01.RES.0000170075.73039.5b; Lizarbe TR, 2009, AM J PATHOL, V175, P1421, DOI 10.2353/ajpath.2009.080845; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Michelakis ED, 2002, CIRC RES, V90, P1307, DOI 10.1161/01.RES.0000024689.07590.C2; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Pecqueur C, 2009, IUBMB LIFE, V61, P762, DOI 10.1002/iub.188; Qin YW, 2012, CARDIOVASC RES, V96, P401, DOI 10.1093/cvr/cvs263; Raaz U, 2015, CIRCULATION, V131, P1783, DOI 10.1161/CIRCULATIONAHA.114.012377; Raaz U, 2014, ANTIOXID REDOX SIGN, V20, P914, DOI 10.1089/ars.2013.5507; Ruiz-Ramirez A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9340654; Sakalihasan N, 2005, LANCET, V365, P1577, DOI 10.1016/S0140-6736(05)66459-8; Sawada H, 2015, ARTERIOSCL THROM VAS, V35, P1507, DOI 10.1161/ATVBAHA.115.305586; Siu KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088899; Sun J, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-69; Teshima Y, 2003, CIRC RES, V93, P192, DOI 10.1161/01.RES.0000085581.60197.4D; Toral M, 2016, BIOCHEM PHARMACOL, V110, P25, DOI 10.1016/j.bcp.2016.05.004; Yang QF, 2007, J MOL MED-JMM, V85, P697, DOI 10.1007/s00109-007-0170-9; Zhang H, 1999, CARDIOVASC RES, V44, P215, DOI 10.1016/S0008-6363(99)00183-2	42	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0179743	10.1371/journal.pone.0179743	http://dx.doi.org/10.1371/journal.pone.0179743			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683125	Green Published, Green Submitted, gold			2022-12-26	WOS:000405335200013
J	de Braganca, AC; Moreau, RLM; de Brito, T; Shimizu, MHM; Canale, D; de Jesus, DA; Silva, AMG; Gois, PH; Seguro, AC; Magaldi, AJ				de Braganca, Ana C.; Moreau, Regina L. M.; de Brito, Thales; Shimizu, Maria H. M.; Canale, Daniele; de Jesus, Denise A.; Silva, Ana M. G.; Gois, Pedro H.; Seguro, Antonio C.; Magaldi, Antonio J.			Ecstasy induces reactive oxygen species, kidney water absorption and rhabdomyolysis in normal rats. Effect of N-acetylcysteine and Allopurinol in oxidative stress and muscle fiber damage	PLOS ONE			English	Article							MDMA ECSTASY; IN-VITRO; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; HYPONATREMIA; TEMPERATURE; VASOPRESSIN; DYSFUNCTION	Background Ecstasy (Ec) use produces hyperthermia, excessive sweating, intense thirst, an inappropriate antidiuretic hormone secretion (SIADH) and a multisystemic toxicity due to oxidative stress (OS). Intense thirst induces high intake of pure water, which associated with SIADH, usually develops into acute hyponatremia (Hn). As Hn is induced rapidly, experiments to check if Ec acted directly on the Inner Medullary Collecting Ducts (IMCD) of rats were conducted. Rhabdomyolysis and OS were also studied because Ec is known to induce Reactive Oxygen Species (ROS) and tissue damage. To decrease OS, the antioxidant inhibitors N-acetylcysteine (NAC) and Allopurinol (Allo) were used. Methods Rats were maintained on a lithium (Li) diet to block the Vasopressin action before Ec innoculation. AQP2 (Aquaporin 2), ENaC (Epitheliun Sodium Channel) and NKCC2 (Sodium, Potassium, 2 Chloride) expression were determined by Western Blot in isolated IMCDs. The TBARS (thiobarbituric acid reactive substances) and GSH (reduced form of Glutathione) were determined in the Ec group (6 rats injected with Ec-10mg/kg), in Ec+NAC groups (NAC 100mg/Kg/bw i.p.) and in Allo+Ec groups (Allo 50mg/Kg/i.p.). Results Enhanced AQP2 expression revealed that Ec increased water transporter expression, decreased by Li diet, but the expression of the tubular transporters did not change. The Ec, Ec+NAC and Allo+Ec results showed that Ec increased TBARS and decreased GSH, showing evidence of ROS occurrence, which was protected by NAC and Allo. Rhabdomyolysis was only protected by Allo. Conclusion Results showed that Ec induced an increase in AQP2 expression, evidencing another mechanism that might contribute to cause rapid hyponatremia. In addition, they showed that NAC and Allo protected against OS, but only Allo decreased rhabdomyolysis and hyperthermia.	[de Braganca, Ana C.; Gois, Pedro H.; Seguro, Antonio C.; Magaldi, Antonio J.] Univ Sao Paulo, Basic Res Lab LIM12, Dept Nephrol, Clin Hosp,Sch Med, Sao Paulo, SP, Brazil; [Moreau, Regina L. M.] Univ Sao Paulo, Dept Clin & Toxicol Anal, Sch Pharmaceut Sci, Sao Paulo, SP, Brazil; [de Brito, Thales; Silva, Ana M. G.] Univ Sao Paulo, Dept Pathol, Sch Med, Inst Trop Med, Sao Paulo, SP, Brazil; [Shimizu, Maria H. M.; Canale, Daniele; de Jesus, Denise A.] Univ Sao Paulo, Sch Med, Dept Nephrol, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Magaldi, AJ (corresponding author), Univ Sao Paulo, Basic Res Lab LIM12, Dept Nephrol, Clin Hosp,Sch Med, Sao Paulo, SP, Brazil.	biomag@usp.br	Shimizu, Maria/B-7887-2013; Canale, Daniele/E-8922-2014; da Silva, Ana Maria Gonçalves/ABD-3920-2020; de Braganca, Ana Carolina/E-7892-2014; Franca Gois, Pedro Henrique/F-3645-2014	Canale, Daniele/0000-0001-8609-683X; Silva, Ana Maria/0000-0001-7554-0894; de Braganca, Ana Carolina/0000-0002-1398-2512; Magaldi, Antonio J/0000-0003-3648-920X; Franca Gois, Pedro Henrique/0000-0002-3520-3225				Asl SS, 2015, METAB BRAIN DIS, V30, P171, DOI 10.1007/s11011-014-9598-0; Bosch X, 2009, NEW ENGL J MED, V361, P62, DOI 10.1056/NEJMra0801327; Budisavljevic MN, 2003, AM J MED SCI, V326, P89, DOI 10.1097/00000441-200308000-00006; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Butler R, 2000, HYPERTENSION, V35, P746, DOI 10.1161/01.HYP.35.3.746; Campbell GA, 2008, CLIN J AM SOC NEPHRO, V3, P1852, DOI 10.2215/CJN.02080508; Carvalho M, 2002, ARCH TOXICOL, V76, P581, DOI 10.1007/s00204-002-0381-3; Carvalho M, 2012, ARCH TOXICOL, V86, P1167, DOI 10.1007/s00204-012-0815-5; da Silva DD, 2014, J APPL TOXICOL, V34, P637, DOI 10.1002/jat.2889; de Paula VF, 2009, NEUROIMMUNOMODULAT, V16, P191, DOI 10.1159/000204233; DIAZ PT, 1994, J APPL PHYSIOL, V77, P2434, DOI 10.1152/jappl.1994.77.5.2434; Eede HV, 2009, J EMERGENCY MED, V42, P655; El-Bassossy HM, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0445-9; Fiaschi AI, 2010, CURR PHARM BIOTECHNO, V11, P444; Ghatol A, 2012, J EMERGENCY MED, V42, P137; Gois PHF, 2016, FREE RADICAL BIO MED, V101, P176, DOI 10.1016/j.freeradbiomed.2016.10.012; Gomez-Cabrera MC, 2003, JAMA-J AM MED ASSOC, V289, P2503, DOI 10.1001/jama.289.19.2503-b; Halpern P, 2011, HUM EXP TOXICOL, V30, P259, DOI 10.1177/0960327110370984; Henry JA, 1998, LANCET, V351, P1784, DOI 10.1016/S0140-6736(05)78744-4; Hoo GWS, 2012, J INTENSIVE CARE MED, V28, P259; Kaandorp JJ, 2014, ARCH DIS CHILD-FETAL, V99, pF144, DOI 10.1136/archdischild-2013-304876; Kalantar-Zadeh K, 2006, NAT CLIN PRACT NEPHR, V2, P283, DOI 10.1038/ncpneph0167; Katz A, 2014, PFLUG ARCH EUR J PHY, V466, P577, DOI 10.1007/s00424-013-1331-z; Keltz Eran, 2013, Muscles Ligaments Tendons J, V3, P303; Kunsdorf-Wnuk Anna, 2005, Pol Merkur Lekarski, V18, P436; Kwon C, 2003, PEDIATR NEPHROL, V18, P820, DOI 10.1007/s00467-003-1164-7; Lin PY, 2011, PEDIATR CRIT CARE ME, V12, pE424, DOI 10.1097/PCC.0b013e3182192c8d; Lourenco TC, 2013, J PHARMACEUT BIOMED, V73, P13, DOI 10.1016/j.jpba.2012.01.025; Matthai SM, 1996, BRIT MED J, V312, P1359, DOI 10.1136/bmj.312.7042.1359b; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; Parrott AC, 2012, DRUG ALCOHOL DEPEN, V121, P1, DOI 10.1016/j.drugalcdep.2011.08.012; Pendergraft WF, 2014, CLIN J AM SOC NEPHRO, V9, P1996, DOI 10.2215/CJN.00360114; Ramaley C, 2014, J ANAL TOXICOL, V38, P249, DOI 10.1093/jat/bku023; SCREATON GR, 1992, LANCET, V339, P677, DOI 10.1016/0140-6736(92)90834-P; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Song BJ, 2010, CURR PHARM BIOTECHNO, V11, P434, DOI 10.2174/138920110791591436; Sprague JE, 2005, CRIT CARE MED, V33, P1311, DOI 10.1097/01.CCM.0000165969.29002.70; Torres PA, 2015, OCHSNER J, V15, P58; Traub SJ, 2002, J URBAN HEALTH, V79, P549, DOI 10.1093/jurban/79.4.549; Vogt BL, 2007, BIOCHEM PHARMACOL, V73, P1613, DOI 10.1016/j.bcp.2007.01.033; Wolff K, 2006, J PSYCHOPHARMACOL, V20, P400, DOI 10.1177/0269881106061514	42	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179199	10.1371/journal.pone.0179199	http://dx.doi.org/10.1371/journal.pone.0179199			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678861	Green Published, gold, Green Submitted			2022-12-26	WOS:000405272200008
J	Jung, JL; Simon, G; Alfonsi, E; Thoraval, D; Kervarec, N; Ben Salem, D; Hassani, S; Domergue, F				Jung, Jean-Luc; Simon, Gaelle; Alfonsi, Eric; Thoraval, Didier; Kervarec, Nelly; Ben Salem, Douraied; Hassani, Sami; Domergue, Frederic			Qualitative and quantitative study of the highly specialized lipid tissues of cetaceans using HR-MAS NMR and classical GC	PLOS ONE			English	Article							BOTTLE-NOSED-DOLPHIN; PORPOISES PHOCOENA-PHOCOENA; FATTY-ACIDS; TURSIOPS-TRUNCATUS; ISOVALERIC ACID; PILOT WHALE; WAX ESTERS; BLUBBER; MELON; BIOSYNTHESIS	Cetacean adipose tissues contain an extremely very wide variety of acyl-chains present in triacylglycerols and / or wax esters. In addition, changes in the lipid composition across organs suggest fine stratification. It therefore remains technically challenging to describe precisely the lipid organization of these tissues. In the present study, we used in parallel HR-MAS NMR (High Resolution Magic Angle Spinning Nuclear Magnetic Resonance) and GC (gas-chromatography) to characterize and quantify the lipids and fatty acyl-chains from the blubber and melon of two odontocete species. Both methods generated very similar compositions, but each presented clear advantages. While GC underestimated the amount of short branched fatty acyl-chains, which are specific to cetacean adipose tissues and most probably of primary importance for their functioning, HR-MAS NMR allowed for their exact quantification. Conversely, when HR-MAS NMR could only discriminate a few types of fatty acyl-chain families, GC unambiguously identified and quantified most of them. In addition, this technique allowed for the determination of the wax esters molecular species. Our results further suggest that the stratification of these adipose tissues relies on changes in the triacylglycerol to wax ester ratio and in the fatty acyl composition of triacylglycerols, but not on changes in the wax esters composition. Altogether, our data show that the complementarities of these two approaches result in lipid analyses of unprecedented precision, paving the way for the detailed description of the fatty acyl composition of cetacean adipose tissues and the understanding of their functioning.	[Jung, Jean-Luc; Alfonsi, Eric] Univ Brest, BioGeMME, UFR Sci & Tech, Brest, France; [Simon, Gaelle; Kervarec, Nelly] Univ Brest, Plateforme Technol Resonance Magnet Nucl Resonanc, Brest, France; [Alfonsi, Eric; Hassani, Sami] Port Plaisance Moulin Blanc, Oceanopolis, Brest, France; [Thoraval, Didier; Domergue, Frederic] Univ Bordeaux, CNRS, UMR 5200, Lab Biogenese Membranaire, Villenave Dornon, France; [Ben Salem, Douraied] Univ Hosp Brest, NSERM, UMR 1101, Unit Forens Imaging,LaTIM, Blvd Tanguy Prigent, Brest, France	Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale	Domergue, F (corresponding author), Univ Bordeaux, CNRS, UMR 5200, Lab Biogenese Membranaire, Villenave Dornon, France.	frederic.domergue@u-bordeaux.fr	Jung, Jean-Luc/H-5108-2011	Jung, Jean-Luc/0000-0002-8795-8056; Domergue, Frederic/0000-0002-0183-7000; BEN SALEM, DOURAIED/0000-0001-5532-2208	CNRS "Exomod"; University of Brest in the frame of its ERCS ("Equipes Reconnues par le Conseil Scientifique") program; Metabo [HUB-ANR-11-INBS-0010]	CNRS "Exomod"; University of Brest in the frame of its ERCS ("Equipes Reconnues par le Conseil Scientifique") program; Metabo	This work was supported by a CNRS "Exomod 2014" grant, by the University of Brestin the frame of its ERCS ("Equipes Reconnues par le Conseil Scientifique") program, and by grant no. Metabo HUB-ANR-11-INBS-0010 to the Functional Genomic Center of the Bordeaux-Metabolome/ Lipidome platform.	ACKMAN RG, 1973, LIPIDS, V8, P661, DOI 10.1007/BF02531831; Ames AL, 2002, COMP BIOCHEM PHYS B, V132, P625, DOI 10.1016/S1096-4959(02)00082-9; Arribart M, 2016, ANAT HISTOL EMBRYOL; Bagge LE, 2012, J EXP BIOL, V215, P4330, DOI 10.1242/jeb.071530; Blomberg J, 1978, Prog Chem Fats Other Lipids, V16, P257, DOI 10.1016/0079-6832(78)90047-2; Cranford TW, 1996, J MORPHOL, V228, P223; Domergue F, 2003, J BIOL CHEM, V278, P35115, DOI 10.1074/jbc.M305990200; Duggan ZPZ, 2009, J COMP PHYSIOL B, V179, P783, DOI 10.1007/s00360-009-0360-6; Gardner SC, 2003, NATURWISSENSCHAFTEN, V90, P528, DOI 10.1007/s00114-003-0472-x; Jung JL, 2009, J MAR BIOL ASSOC UK, V89, P1045, DOI 10.1017/S0025315409000307; Koopman HN, 2008, P ROY SOC B-BIOL SCI, V275, P2327, DOI 10.1098/rspb.2008.0457; Koopman HN, 2007, MAR BIOL, V151, P277, DOI 10.1007/s00227-006-0489-8; Koopman HN, 2006, IEEE J OCEANIC ENG, V31, P95, DOI 10.1109/JOE.2006.872205; Koopman HN, 2003, J COMP PHYSIOL B, V173, P247, DOI 10.1007/s00360-003-0329-9; Koopman HN, 2002, PHYSIOL BIOCHEM ZOOL, V75, P498, DOI 10.1086/342799; Koopman HN, 1996, J COMP PHYSIOL B, V165, P628, DOI 10.1007/BF00301131; LITCHFIELD C, 1973, MAR BIOL, V23, P165, DOI 10.1007/BF00389480; LITCHFIELD C, 1975, COMP BIOCHEM PHYS B, V50, P591, DOI 10.1016/0305-0491(75)90095-4; Lovern JA, 1934, BIOCHEM J, V28, P394, DOI 10.1042/bj0280394; MALINS DC, 1972, BIOCHEM BIOPH RES CO, V48, P314, DOI 10.1016/S0006-291X(72)80052-4; Maxia C, 2007, ANAT REC, V290, P913, DOI 10.1002/ar.20560; McLellan WA, 2002, J ZOOL, V257, P457, DOI 10.1017/S0952836902001061; MORII H, 1982, COMP BIOCHEM PHYS B, V71, P357, DOI 10.1016/0305-0491(82)90395-9; Pond C.M., 1998, FATS LIFE; Samuel AM, 2004, CAN J ZOOL, V82, P1933, DOI 10.1139/Z05-001; Sargent J.R., 1976, CHEM BIOCH NATURAL W, P49; Scano P, 2006, LIPIDS, V41, P1039, DOI 10.1007/s11745-006-5054-1; Scano P, 2005, CHEM PHYS LIPIDS, V134, P21, DOI 10.1016/j.chemphyslip.2004.10.001; Swaim Zachary T., 2009, Endangered Species Research, V6, P259, DOI 10.3354/esr00163; TANAKA K, 1966, P NATL ACAD SCI USA, V56, P236, DOI 10.1073/pnas.56.1.236; VARANASI U, 1971, BIOCHIM BIOPHYS ACTA, V231, P415, DOI 10.1016/0005-2760(71)90158-5; WEDMID Y, 1973, BIOCHIM BIOPHYS ACTA, V326, P439, DOI 10.1016/0005-2760(73)90144-6	32	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180597	10.1371/journal.pone.0180597	http://dx.doi.org/10.1371/journal.pone.0180597			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678824	Green Published, Green Submitted, gold			2022-12-26	WOS:000405272200075
J	Wamser, AF; Cecilio, AB; Nowaki, RHD; Mendoza-Cortez, JW; Urrestarazu, M				Wamser, Anderson Fernando; Cecilio Filho, Arthur Bemardes; Dalmazzo Nowaki, Rodrigo Hiyoshi; Mendoza-Cortez, Juan Waldir; Urrestarazu, Miguel			Influence of drainage and nutrient-solution nitrogen and potassium concentrations on the agronomic behavior of bell-pepper plants cultivated in a substrate	PLOS ONE			English	Article							SWEET-PEPPER; GROWTH; SALINITY; DECREASE; YIELD	The interactive effects of N (6, 9, 12 and 15 mmol L-1) and K (3, 5, 7, and 9 mmol L-1) concentrations in nutrient solutions were evaluated on bell pepper grown in a coconut-coir substrate and fertilized without drainage. An additional treatment with drainage was evaluated using N and K concentrations of 12 and 7 mmol L-1, respectively. The hybrid Eppo cultivar of yellow bell pepper was cultivated for 252 days beginning 9 November 2012. Electrical conductivity (EC), the N and K concentrations in the substrate solution, marketable fruit yield, total dry weight and macronutrient concentrations in shoots were periodically evaluated. Fruit production was lower in the system without drainage, regardless of the N and K concentrations, compared to the recommended 10-20% drainage of the volume of nutrient solution applied. Higher K concentrations in the nutrient solution did not affect plant production in the system without drainage for the substrate with an initial K concentration of 331.3 mg L-1. Fruit yield was higher without drainage at a nutrient-solution N concentration of 10.7 mmol L-1. The upper EC limit of the substrate solution in the system without drainage was exceeded 181 days after planting. Either lower nutrient concentrations in the nutrient solution or a drainage system could thus control the EC in the substrate solution.	[Wamser, Anderson Fernando] Empresa Pesquisa Agr & Extensao Rural Santa Catar, Estacao Expt Cacador, Cacador, SC, Brazil; [Cecilio Filho, Arthur Bemardes; Dalmazzo Nowaki, Rodrigo Hiyoshi] Univ Estadual Paulista, Dept Prod Vegetal, Fac Ciencias Agr & Vet, Sao Paulo, Brazil; [Mendoza-Cortez, Juan Waldir] Univ Nacl Agr La Molina, Fac Agron, Dept Fitotecnia, Lima, Peru; [Urrestarazu, Miguel] Univ Almeria, Dept Agron, Escuela Super Ingn, Almeria, Spain	Universidade Estadual Paulista; University Nacional Agraria La Molina; Universidad de Almeria	Cecilio, AB (corresponding author), Univ Estadual Paulista, Dept Prod Vegetal, Fac Ciencias Agr & Vet, Sao Paulo, Brazil.	rutra@fcay.unesp.br	Cecilio Filho, Arthur Bernardes/AGR-7901-2022; URRESTARAZU, MIGUEL/N-1927-2013; Cecílio Filho, Arthur/D-7237-2012	Cecilio Filho, Arthur Bernardes/0000-0002-6706-5496; URRESTARAZU, MIGUEL/0000-0003-4340-2184; Cecílio Filho, Arthur/0000-0002-6706-5496; Mendoza-Cortez, Juan Waldir/0000-0002-2158-0943	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/17524-7]; Brazilian Agricultural Research Corporation	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Agricultural Research Corporation(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA))	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) - process 2011/17524-7 corresponding to source of funding that have supported this work, which beneficiary was ABCF author. AFW was supported in the form of scholarship by the Brazilian Agricultural Research Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad M, 2002, BIORESOURCE TECHNOL, V82, P241, DOI 10.1016/S0960-8524(01)00189-4; ALMEIDA O. A., 2010, QUALIDADE AGUA IRRIG; Aminifard MH, 2012, J PLANT NUTR, V35, P235, DOI 10.1080/01904167.2012.636126; [Anonymous], 2006, AGR SALINITY DRAINAG; Baixauli Soria C., 2002, CULTIVO SIN SUELO HO; Bataglia O. C., 1983, METODOS ANALISE QUIM; Bres W, 2009, POL J ENVIRON STUD, V18, P341; Calbo AG, 2005, SISTEMA IRRIGAS MANE; Campos VB, 2008, REV BIOL CIENCIAS TE, V8, P72; Castellane P. D., 1994, CULTIVO SEM SOLO HID; Charlo HCD, 2012, HORTIC BRAS, V30, P125, DOI 10.1590/S0102-05362012000100021; Chartzoulakis K, 2000, SCI HORTIC-AMSTERDAM, V86, P247, DOI 10.1016/S0304-4238(00)00151-5; Choi EY, 2014, J PLANT NUTR, V37, P748, DOI 10.1080/01904167.2013.868479; Ferreira EB, 2010, C POSGRADUACAO U FED, V19; Gratieri Luiz Augusto, 2013, ScientificWorldJournal, V2013, P546594, DOI 10.1155/2013/546594; Healy MJR., 1956, J AGR SCI, V47, P205; Henz GP, 2007, REV CULTIVAR HF, V42, P2; Johnson CD, 1996, HORTSCIENCE, V31, P1119, DOI 10.21273/HORTSCI.31.7.1119; Lozano MG, 2005, ACTA HORTIC, P543; Massa D, 2010, AGR WATER MANAGE, V97, P971, DOI 10.1016/j.agwat.2010.01.029; Miranda FR, 2011, PRODUCAO TOMATE SUBS; Munoz P, 2008, AGRON SUSTAIN DEV, V28, P489, DOI 10.1051/agro:2008024; Pardossi A., 2011, FERTIGATION SUBSTRAT; Rubio JS, 2010, EUR J HORTIC SCI, V75, P33; Rubio JS, 2010, SPAN J AGRIC RES, V8, P170, DOI 10.5424/sjar/2010081-1156; Rubio JS, 2011, HORTIC BRAS, V29, P275, DOI 10.1590/S0102-05362011000300003; Sanjuan MCS, 2004, TRATADO CULTIVO SIN, P161; SONNEVELD C, 1994, COMMUN SOIL SCI PLAN, V25, P3199, DOI 10.1080/00103629409369258; SONNEVELD C, 2004, TRATADO CULTIVO SIN, P305; Thompson RB, 2013, SCI HORTIC-AMSTERDAM, V150, P387, DOI 10.1016/j.scienta.2012.11.018; Urrestarazu M, 2015, HORTSCIENCE, V50, P819, DOI 10.21273/HORTSCI.50.6.819	31	3	3	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180529	10.1371/journal.pone.0180529	http://dx.doi.org/10.1371/journal.pone.0180529			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678884	gold, Green Published, Green Submitted			2022-12-26	WOS:000405272200070
J	Zou, K; Xiao, FK; Li, HY; Zhou, Q; Ban, L; Yang, M; Kuo, CF; Zhang, WY				Zou, Kun; Xiao, Fu-Kun; Li, Hong-Ying; Zhou, Qiao; Ban, Lu; Yang, Min; Kuo, Chang-Fu; Zhang, Weiya			Risk of cardiovascular disease in Chinese patients with rheumatoid arthritis: A cross-sectional study based on hospital medical records in 10 years	PLOS ONE			English	Article							OSTEOARTHRITIS; MORTALITY; POPULATION; PREVALENCE	Objective Though the risk of cardiovascular disease (CVD) in rheumatoid arthritis (RA) has been established in Western population, little is known about the risk in Chinese people with RA. Our objective was to estimate the risk of CVD in Chinese people with RA using hospital medical records data. Methods The inpatients medical record database 2005-2015 of Sichuan provincial people's hospital was examined. All individuals with a primary diagnosis of RA were included as cases, and those of osteoarthritis (OA) were included as controls, which consisted of the unmatched dataset. Then, RA cases and OA controls were matched by sex and age at 1: 1 ratio, forming the matched dataset. The morbidity of CVD (including ischemia heart disease (IHD), congestive heart failure (CHF), et al), stroke and arthrosclerosis were extracted from the database, so as the demographic data and comorbidities related to CVD. Multiple logistic regression analysis was used to estimate the risk of CVD in RA adjusted for demographics and comorbidities using the unmatched dataset. Sensitivity analysis was conducted 1) considering interaction terms between RA and comorbidities, and 2) using multivariable conditional logistic regression for the matched dataset. Results The unmatched dataset comprised of 1824RA cases and 1995 OA controls and the matched dataset comprised of 1022 pairs of sex and age matched RA and OA patients. RA exhibited increased odds of prevalent CVD compared with OA, and the adjusted ORs (95% CIs) for CVD, stroke, IHD, CHF, and atherosclerosis were1.86(1.42-2.43), 1.11(0.71-1.74), 1.47(0.97-2.24), 2.09(1.03-4.22), and 2.49 (1.97-3.13), respectively, and was 2.26 (1.29-3.96) for IHD further adjusted for interaction term. The matched dataset analysis found similar results. Conclusions Chinese people with RA were approximated 2 times more likely to have CVD, IHD, CHF and atherosclerosis compared with those with OA. The findings justified the need of further longitudinal study to establish the causal-relationship between RA and CVD and to estimate the precise risk in this population.	[Zou, Kun; Xiao, Fu-Kun; Li, Hong-Ying] Univ Elect Sci & Technol, Sichuan Acad Med Sci, Dept Med Records & Stat, Chengdu, Peoples R China; [Zou, Kun; Xiao, Fu-Kun; Li, Hong-Ying; Zhou, Qiao] Univ Elect Sci & Technol, Affiliate Hosp, Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Zou, Kun; Ban, Lu; Kuo, Chang-Fu; Zhang, Weiya] Univ Nottingham, Sch Med, Div Rheumatol Orthoped & Dermatol, Nottingham, England; [Zhou, Qiao] Univ Elect Sci & Technol, Sichuan Acad Med Sci, Dept Rheumatol & Immunol, Chengdu, Peoples R China; [Ban, Lu] Univ Nottingham, Sch Med, Div Epidemiol & Publ Hlth, Nottingham, England; [Yang, Min] Sichuan Univ, West China Sch Publ Hlth, West China Res Ctr Rural Hlth Dev, Chengdu, Peoples R China; [Kuo, Chang-Fu] Chang Gung Mem Hosp, Div Rheumatol Allergy & Immunol, Taoyuan, Taiwan	Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; University of Nottingham; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; University of Nottingham; Sichuan University; Chang Gung Memorial Hospital	Zou, K (corresponding author), Univ Elect Sci & Technol, Sichuan Acad Med Sci, Dept Med Records & Stat, Chengdu, Peoples R China.; Zou, K (corresponding author), Univ Elect Sci & Technol, Affiliate Hosp, Sichuan Prov Peoples Hosp, Chengdu, Peoples R China.; Zou, K (corresponding author), Univ Nottingham, Sch Med, Div Rheumatol Orthoped & Dermatol, Nottingham, England.	zoukun.jy@outlook.com	Zhang, Weiya/X-9481-2019	Zhang, Weiya/0000-0003-1142-1460; Ban, Lu/0000-0001-9388-9141	Cooperation Innovation Research - University of Electronic Science and Technology, China	Cooperation Innovation Research - University of Electronic Science and Technology, China	QZ was supported by the Cooperation Innovation Research Grant from the University of Electronic Science and Technology, China. The funder had no role in study design, data collection andanalysis, decision to publish, or preparation of the manuscript.	Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Chung WS, 2013, INT J CARDIOL, V168, P4750, DOI 10.1016/j.ijcard.2013.07.233; Hall AJ, 2016, EUR J PREV CARDIOL, V23, P938, DOI 10.1177/2047487315610663; Iribarren C, 1999, NEW ENGL J MED, V340, P1773, DOI 10.1056/NEJM199906103402301; Kitas GD, 2011, ANN RHEUM DIS, V70, P8, DOI 10.1136/ard.2010.142133; Li CQ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-176; National Institute for Health and Care Excellence (NICE), 2015, RHEUM ARTHR MAN RHEU; NICE, 2014, NICE GUID OST CAR MA; Nielen MMJ, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-150; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Raftery AE., 1995, SOCIOLOGICAL METHODO, V25; Rahman MM, 2013, ARTHRIT CARE RES, V65, P1951, DOI 10.1002/acr.22092; Semb AG, 2010, ANN RHEUM DIS, V69, P1996, DOI 10.1136/ard.2009.126128; Sihvonen S, 2004, SCAND J RHEUMATOL, V33, P221, DOI 10.1080/03009740410005845; Skeoch S, 2015, NAT REV RHEUMATOL, V11, P390, DOI 10.1038/nrrheum.2015.40; Ungprasert P, 2016, JOINT BONE SPINE, V83, P290, DOI 10.1016/j.jbspin.2015.05.016; van Halm VP, 2009, ANN RHEUM DIS, V68, P1395, DOI 10.1136/ard.2008.094151; Watson DJ, 2003, J RHEUMATOL, V30, P1196; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205; Young A, 2007, RHEUMATOLOGY, V46, P350, DOI 10.1093/rheumatology/kel253; [曾小峰 Zeng Xiaofeng], 2013, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V13, P300	22	8	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180376	10.1371/journal.pone.0180376	http://dx.doi.org/10.1371/journal.pone.0180376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678807	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000405272200060
J	Bienholz, A; Walter, B; Pless-Petig, G; Guberina, H; Kribben, A; Witzke, O; Rauen, U				Bienholz, Anja; Walter, Bjoern; Pless-Petig, Gesine; Guberina, Hana; Kribben, Andreas; Witzke, Oliver; Rauen, Ursula			Characterization of injury in isolated rat proximal tubules during cold incubation and rewarming	PLOS ONE			English	Article							LIVER ENDOTHELIAL-CELLS; HYPOTHERMIC MACHINE PERFUSION; DONOR KIDNEY-TRANSPLANTATION; PRESERVATION SOLUTION; ORGAN PRESERVATION; INDUCED APOPTOSIS; MITOCHONDRIAL DYSFUNCTION; CHELATABLE IRON; GRAFT FUNCTION; STORAGE	Organ shortage leads to an increased utilization of marginal organs which are particularly sensitive to storage-associated damage. Cold incubation and rewarming-induced injury is iron-dependent in many cell types. In addition, a chloride-dependent component of injury has been described. This work examines the injury induced by cold incubation and rewarm-ing in isolated rat renal proximal tubules. The tissue storage solution TiProtec (R) and a chloride-poor modification, each with and without iron chelators, were used for cold incubation. Incubation was performed 4 degrees C for up to 168 h, followed by rewarming in an extracellular buffer (3 h at 37 degrees C). After 48, 120 and 168 h of cold incubation LDH release was lower in solutions containing iron chelators. After rewarming, injury increased especially after cold incubation in chelator-free solutions. Without addition of iron chelators LDH release showed a tendency to be higher in chloride-poor solutions. Following rewarming after 48 h of cold incubation lipid peroxidation was significantly decreased and metabolic activity was tendentially better in tubules incubated with iron chelators. Morphological alterations included mitochondrial swelling and fragmentation being partially reversible during rewarming. ATP content was better preserved in chloride-rich solutions. During rewarming, there was a further decline of ATP content in the so far best conditions and minor alterations under the other conditions, while oxygen consumption was not significantly different compared to non-stored control tubules. Results show an iron-dependent component of preservation injury during cold incubation and rewarming in rat proximal renal tubules and reveal a benefit of chloride for the maintenance of tubular energy state during cold incubation.	[Bienholz, Anja; Kribben, Andreas] Univ Duisburg Essen, Univ Hosp Essen, Dept Nephrol, Essen, Germany; [Walter, Bjoern; Pless-Petig, Gesine; Rauen, Ursula] Univ Duisburg Essen, Univ Hosp Essen, Inst Physiol Chem, Essen, Germany; [Guberina, Hana; Witzke, Oliver] Univ Duisburg Essen, Univ Hosp Essen, Dept Infect Dis, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Bienholz, A (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Nephrol, Essen, Germany.	anja.bienholz@uk-essen.de	Pless-Petig, Gesine/F-3639-2010	Pless-Petig, Gesine/0000-0001-8843-6607	Dr. Werner Jackstadt-Foundation	Dr. Werner Jackstadt-Foundation	AB and UR received support from the Dr. Werner Jackstadt-Foundation.	Arnau A, 2012, TRANSPL P, V44, P2555, DOI 10.1016/j.transproceed.2012.09.061; Bartels-Stringer M, 2003, CRYOBIOLOGY, V47, P82, DOI 10.1016/S0011-2240(03)00071-3; BELZER FO, 1988, TRANSPLANTATION, V45, P673, DOI 10.1097/00007890-198804000-00001; Bienholz A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094584; ERHARD J, 1994, TRANSPLANT INT, V7, P177, DOI 10.1111/j.1432-2277.1994.tb01287.x; Feldkamp T, 2009, NEPHROL DIAL TRANSPL, V24, P43, DOI 10.1093/ndt/gfn436; Fingas CD, 2011, LIVER TRANSPLANT, V17, P650, DOI 10.1002/lt.22275; Fuckert O, 2000, TRANSPLANTATION, V70, P723, DOI 10.1097/00007890-200009150-00003; Gallinat A, 2013, CRYOBIOLOGY, V66, P131, DOI 10.1016/j.cryobiol.2012.12.007; Garbe S, 2011, J VASC SURG, V53, P1063, DOI 10.1016/j.jvs.2010.10.093; Gizewski ER, 1997, BIOCHEM J, V322, P693, DOI 10.1042/bj3220693; Heuer N, 2010, EUR J MED RES, V15, P31, DOI 10.1186/2047-783X-15-1-31; HOCHACHKA PW, 1986, SCIENCE, V231, P234, DOI 10.1126/science.2417316; Kerkweg U, 2003, TRANSPLANTATION, V76, P501, DOI 10.1097/01.TP.0000069830.78758.1C; Kyllonen LEJ, 2000, TRANSPLANT INT, V13, P122, DOI 10.1111/j.1432-2277.2000.tb01051.x; Lam VWT, 2013, J SURG RES, V180, P176, DOI 10.1016/j.jss.2012.10.055; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Minor T, 2015, TRANSPL INT, V28, P1102, DOI 10.1111/tri.12593; Moers C, 2012, NEW ENGL J MED, V366, P770, DOI 10.1056/NEJMc1111038; NOLL T, 1987, ARCH BIOCHEM BIOPHYS, V252, P284, DOI 10.1016/0003-9861(87)90033-6; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; Peters SMA, 1998, TRANSPLANTATION, V65, P625, DOI 10.1097/00007890-199803150-00005; Petrat F, 1999, HEPATOLOGY, V29, P1171, DOI 10.1002/hep.510290435; Pless G, 2012, CELL TRANSPLANT, V21, P23, DOI 10.3727/096368911X580509; Pless-Petig G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040444; Quiroga I, 2006, NEPHROL DIAL TRANSPL, V21, P1689, DOI 10.1093/ndt/gfl042; Rauen U, 2007, CELL MOL LIFE SCI, V64, P192, DOI 10.1007/s00018-006-6456-1; Rauen U, 2004, J INVEST MED, V52, P299, DOI 10.1136/jim-52-05-29; Rauen U, 2003, FREE RADICAL BIO MED, V35, P1664, DOI 10.1016/j.freeradbiomed.2003.09.018; Rauen U, 1999, FASEB J, V13, P155, DOI 10.1096/fasebj.13.1.155; Rauen U, 2007, CRYOBIOLOGY, V54, P77, DOI 10.1016/j.cryobiol.2006.11.008; Romanello V, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00422; Salahudeen AK, 2004, AM J PHYSIOL-RENAL, V287, pF181, DOI 10.1152/ajprenal.00098.2004; Salahudeen AK, 2003, AM J TRANSPLANT, V3, P273, DOI 10.1034/j.1600-6143.2003.00042.x; Salahudeen AK, 2000, TRANSPLANTATION, V70, P1424, DOI 10.1097/00007890-200011270-00005; Tomaskova Z, 2010, FEBS LETT, V584, P2085, DOI 10.1016/j.febslet.2010.01.035; Vaziri N, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-15; Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001; Weinberg JM, 2000, P NATL ACAD SCI USA, V97, P2826, DOI 10.1073/pnas.97.6.2826; Wille T, 2008, J VASC SURG, V47, P422, DOI 10.1016/j.jvs.2007.09.048; WIRTHENSOHN G, 1990, METHOD ENZYMOL, V191, P325	42	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180553	10.1371/journal.pone.0180553	http://dx.doi.org/10.1371/journal.pone.0180553			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672023	Green Published, gold, Green Submitted			2022-12-26	WOS:000405268500064
J	Cuenca, P; Echeverria, C				Cuenca, Pablo; Echeverria, Cristian			How do protected landscapes associated with high biodiversity and population levels change?	PLOS ONE			English	Article							LAND-USE; TROPICAL DEFORESTATION; HABITAT LOSS; FOREST LOSS; AREAS; FRAGMENTATION; CONSERVATION; ECUADOR; COVER; PARKS	Most protected areas (PA) try to limit logging of forests by means of restrictions on access and use, especially in areas where local communities coexist with the forests and depend on resources derived from PAs. In such contexts, achieving full or effective protection of the forests is almost impossible. This fact has led to researching beyond PAs boundaries in order to examine large surrounding landscapes with multiple forms of properties and restriction on forests use. The present study assessed the change in forest cover and fragmentation between 1990 and 2014, in addition to the drivers that explain such changes in a landscape with the presence of PAs and high-density population belonging to the Choco-Darien bio-diversity hotspot. Results indicated differences in the extent and spatial patterns of change in forest cover of PAs and their surrounding landscapes. Two PAs exhibited a tendency to increase fragmentation and lose their forests in comparison with the stable protection of the forests in other PAs during this period. However, the greatest change in forest cover and fragmentation was observed in the surrounding landscapes, where the best connection to markets and transport networks were the dominating deforestation drivers. Our findings corroborated that the PAs were a shield against the deforestation of the tropical Andean forest, especially in landscapes with high-density population. However, the fragmentation of the forest cannot be avoided around the PAs limits. It is expected that, if this tendency continues in the future, the biodiversity in the Choco-Darien hotspot will be seriously affected.	[Cuenca, Pablo] Univ Reg Amazon IKIAM, Tena, Ecuador; [Echeverria, Cristian] Univ Concepcion, Fac Ciencias Forestales, Lab Ecol Paisaje, Concepcion, Chile	Universidad de Concepcion	Cuenca, P (corresponding author), Univ Reg Amazon IKIAM, Tena, Ecuador.	pablo.cuenca@ikiam.edu.ec	Echeverria, Cristian/ABD-7286-2020		CONICYT (Comisio An Nacional de Investigacion Cientifica y Tecnologica) of Chile; SENESCYT (Secretaria de Educacion Superior, Ciencia, Tecnologia e innovacion) of Ecuador	CONICYT (Comisio An Nacional de Investigacion Cientifica y Tecnologica) of Chile; SENESCYT (Secretaria de Educacion Superior, Ciencia, Tecnologia e innovacion) of Ecuador	P. Cuenca acknowledges support from CONICYT (Comisio An Nacional de Investigacion Cientifica y Tecnologica) of Chile and SENESCYT (Secretaria de Educacion Superior, Ciencia, Tecnologia e innovacion) of Ecuador. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Angelsen A, 1999, WORLD BANK RES OBSER, V14, P73, DOI 10.1093/wbro/14.1.73; [Anonymous], 2010, GEOGR BULL; Armenteras D, 2003, BIOL CONSERV, V113, P245, DOI 10.1016/S0006-3207(02)00359-2; Armsworth PR, 2006, P NATL ACAD SCI USA, V103, P5403, DOI 10.1073/pnas.0505278103; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; Bennett DL, 2006, LINKAGES LANDSCAPES; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Burgi M, 2004, LANDSCAPE ECOL, V19, P857, DOI 10.1007/s10980-004-0245-8; Casto M, 2013, ZONAS PROCESOS HOMOG; Cernea MM, 2006, WORLD DEV, V34, P1808, DOI 10.1016/j.worlddev.2006.02.008; Chapin M., 2004, CHALLENGE CONSERVATI, VNovember/December, P17, DOI DOI 10.1146/ANNUREV.ANTHR0.34.081804.120429; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; Cuenca P, 2016, ENVIRON SCI POLICY, V56, P56, DOI 10.1016/j.envsci.2015.10.014; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; DeFries R, 2007, ECOL APPL, V17, P1031, DOI 10.1890/05-1111; DODSON CH, 1991, ANN MO BOT GARD, V78, P273, DOI 10.2307/2399563; Echeverria C, 2008, ECOL MODEL, V212, P439, DOI 10.1016/j.ecolmodel.2007.10.045; Echeverria C, 2006, BIOL CONSERV, V130, P481, DOI 10.1016/j.biocon.2006.01.017; Echeverria C, 2012, APPL GEOGR, V32, P822, DOI 10.1016/j.apgeog.2011.08.014; Ecuador MdAd, 2006, POL PLAN ESTR SIST N; Ewers RM, 2008, TRENDS ECOL EVOL, V23, P113, DOI 10.1016/j.tree.2007.11.008; Tapia-Armijos MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133701; Fox J., 2018, R COMPANION APPL REG, VThird; Gaveau DLA, 2007, BIOL CONSERV, V134, P495, DOI 10.1016/j.biocon.2006.08.035; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Geldmann J, 2013, BIOL CONSERV, V161, P230, DOI 10.1016/j.biocon.2013.02.018; Gentry AH, 1986, FLORISTIC INVENTORY; Green JMH, 2013, BIOL CONSERV, V164, P62, DOI 10.1016/j.biocon.2013.04.016; Hannah L, 2008, ANN NY ACAD SCI, V1134, P201, DOI 10.1196/annals.1439.009; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Holland MB, 2013, WORLD DEV; Jokisch BD, 2002, GEOGR REV, V92, P235, DOI 10.2307/4140972; Jones DA, 2009, REMOTE SENS ENVIRON, V113, P1346, DOI 10.1016/j.rse.2008.08.018; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P1633, DOI 10.1098/rspb.2010.1713; Jorgensen P. M., 1999, CATALOGUE VASCULAR P; Juffe-Bignoli D, 2014, PROTECTED PLANET REP; Larrea C, 2009, ENERGY SUSTAIN DEV, V13, P219, DOI 10.1016/j.esd.2009.08.003; Laurance WF, 2002, J BIOGEOGR, V29, P737, DOI 10.1046/j.1365-2699.2002.00721.x; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Leon-Yanez S, 2011, LIBRO ROJO PLANTAS E, P957; Loaiza T, 2015, APPL GEOGR, V62, P225, DOI 10.1016/j.apgeog.2015.04.020; MAE, 2005, PLAN MAN GEST PART R; MAE, 2007, PLAN MAN RES EC COT; MAE, 2012, LIN BAS DEF EC CONT; MAE, 1999, EST COMPL TEN TIERR; MAE (Ministerio del Ambiente del Ecuador), 2006, POL PLAN ESTR SIST N; Marquette CM, 1998, HUM ECOL, V26, P573, DOI 10.1023/A:1018797325069; Mateo RG, 2013, BIOL CONSERV, V160, P150, DOI 10.1016/j.biocon.2013.01.014; McGarigal K., 2012, FRAGSTATS V4 SPATIAL; Mena CF, 2008, PHOTOGRAMM ENG REM S, V74, P737, DOI 10.14358/PERS.74.6.737; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 1986, TACKLING MASS EXTINC; Nagendra H, 2004, AGR ECOSYST ENVIRON, V101, P111, DOI 10.1016/j.agee.2003.09.003; Nagendra H, 2006, APPL GEOGR, V26, P96, DOI 10.1016/j.apgeog.2005.11.002; Nagendra H, 2009, ENVIRON MANAGE, V44, P853, DOI 10.1007/s00267-009-9374-9; Nahuelhual L, 2012, LANDSCAPE URBAN PLAN, V107, P12, DOI 10.1016/j.landurbplan.2012.04.006; Newton A, 2007, BIODIVERSITY LOSS AND CONSERVATION IN FRAGMENTED FOREST LANDSCAPES: THE FORESTS OF MONTANE MEXICO AND TEMPERATE SOUTH AMERICA, pXIII, DOI 10.1079/9781845932619.0000; Nolte C, 2015, ORYX, P1; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Plant RE, 2012, SPAT DAT AN EC AGR U; Robbins AST, 2012, RESTOR ECOL, V20, P10, DOI 10.1111/j.1526-100X.2011.00838.x; Schwartzman S, 2000, CONSERV BIOL, V14, P1351, DOI 10.1046/j.1523-1739.2000.99329.x; Sierra R, 2002, LANDSCAPE URBAN PLAN, V59, P95, DOI 10.1016/S0169-2046(02)00006-3; Sierra R, 2001, ECOL ECON, V36, P327, DOI 10.1016/S0921-8009(00)00233-0; Sierra R., 2013, ECUADOR FOREST TREND; Sloep Peter BA, 2005, ENV POLICY INT CONTE; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; SOUTHGATE D, 1991, WORLD DEV, V19, P1145, DOI 10.1016/0305-750X(91)90063-N; Southgate DD, 1990, I ORIGINS DEFORESTAT; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; UNEP-WCMC, 2008, STAT WORLDS PROT AR; Vina A, 2004, AMBIO, V33, P118, DOI 10.1639/0044-7447(2004)033[0118:SCDAOD]2.0.CO;2; Wilson K, 2005, BIOL CONSERV, V122, P9, DOI 10.1016/j.biocon.2004.06.015; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; Wunder S, 2000, EC DEFORESTATION EXA; Wyman MS, 2010, APPL GEOGR, V30, P329, DOI 10.1016/j.apgeog.2009.10.001	78	6	6	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180537	10.1371/journal.pone.0180537	http://dx.doi.org/10.1371/journal.pone.0180537			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2JX	28672002	gold, Green Published			2022-12-26	WOS:000405268500061
J	Pando, MA; Dolezal, C; Marone, RO; Barreda, V; Carballo-Dieguez, A; Avila, MM; Balan, IC				Pando, Maria A.; Dolezal, Curtis; Marone, Ruben O.; Barreda, Victoria; Carballo-Dieguez, Alex; Avila, Maria M.; Balan, Ivan C.			High acceptability of rapid HIV self-testing among a diverse sample of MSM from Buenos Aires, Argentina	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SEX; MEN; INFECTION; COLLECTION; FEASIBILITY; POPULATIONS; ZIMBABWE; BRAZIL; BLOOD	Introduction The objective of this study was to explore the acceptability of rapid HIV self-testing (RHST) among men who have sex with men (MSM). Methods During 2006-2009, a sample of 500 MSM was recruited through Respondent Driven Sampling for an HIV prevalence/incidence study. Attitude toward RHST was explored among HIV negative MSM. Data were weighted prior to analyses. Results Participants reported they were likely to buy RHST (74%), test themselves more frequently than they currently do (77%), and that the procedure would simplify testing (70%). Furthermore, 71% reported they would probably use it alone, 66% would use it with a steady partner, and 56% with a friend/partner. While a majority acknowledged that RHST use would deprive them of receiving counseling (61%), 74% declared they would go for help if they tested positive; 57% would use an RHST in order to avoid condoms. Probability of use surpassed 70% among gay and non-gay identified MSM as well as those with and without a previous HIV test. Those likely to buy RHST were older (p = 0.025) and more likely to identify as gay (p = 0.036). A total of 17% said they would think about killing themselves and 9% would attempt suicide if they tested positive. These MSM were more likely to be younger (p<0.001), with lower mood level (p<0.001) and greater feelings of loneliness (p = 0.026). Conclusions The high acceptability of RHST found among MSM should encourage the authorities to consider the possibility of offering it for self-testing, as it can improve early diagnosis and prevention of future transmissions. However, further research is needed to understand how to	[Pando, Maria A.; Avila, Maria M.] Univ Buenos Aires, CONICET, Inst Invest Biomed Retrovirus & Sida INBIRS, Buenos Aires, DF, Argentina; [Dolezal, Curtis; Carballo-Dieguez, Alex; Balan, Ivan C.] New York State Psychiat Inst & Hosp, HIV Ctr Clin & Behav Studies, New York, NY 10032 USA; [Dolezal, Curtis; Carballo-Dieguez, Alex; Balan, Ivan C.] Columbia Univ, New York, NY USA; [Marone, Ruben O.; Barreda, Victoria] Nexo Asociac Civil, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; New York State Psychiatry Institute; Columbia University	Pando, MA (corresponding author), Univ Buenos Aires, CONICET, Inst Invest Biomed Retrovirus & Sida INBIRS, Buenos Aires, DF, Argentina.	mpando@fmed.uba.ar			US National Institute of Mental Health (NIMH) at the New York State Psychiatric Institute and Columbia University [R01 MH073410]; NIMH at New York State Psychiatric Institute and Columbia University [P30 MH43520]	US National Institute of Mental Health (NIMH) at the New York State Psychiatric Institute and Columbia University; NIMH at New York State Psychiatric Institute and Columbia University	This work was supported with funds from the US National Institute of Mental Health (NIMH) to the HIV Center for Clinical and Behavioral Studies at the New York State Psychiatric Institute and Columbia University (R01 MH073410; Principal Investigator: Alex Carballo D ieguez, Ph.D.).Additional funds came from a grant from NIMH to the HIV Center for Clinical and Behavioral Studies at New York State Psychiatric Institute and Columbia University (P30 MH43520; Principal Investigator: Robert H. Remien and P30 MH43520; Principal Investigator: Anke A. Ehrhardt, Ph.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIMH or the NIH	[Anonymous], 2013, B OFICIAL REPUBLICA; Appiah LT, 2009, AIDS PATIENT CARE ST, V23, P365, DOI 10.1089/apc.2008.0224; Balan Ivan C, 2011, Actual SIDA, V19, P26; Belza MJ, 2012, SEX TRANSM INFECT, V88, P218, DOI 10.1136/sextrans-2011-050131; Beral V, 2004, AIDS, V18, P51, DOI [10.1097/00002030-200401020-00006, 10.1097/01.aids.0000096908.73209.5d]; Bilardi JE, 2013, AIDS BEHAV, V17, P2093, DOI 10.1007/s10461-012-0395-7; Branson BM, 1998, JAMA-J AM MED ASSOC, V280, P1699, DOI 10.1001/jama.280.19.1699; Brito AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130445; Carballo-Dieguez A, 2014, AIDS CARE, V26, P33, DOI 10.1080/09540121.2013.793277; Carballo-Dieguez A, 2012, AIDS BEHAV, V16, P1753, DOI 10.1007/s10461-012-0274-2; Carballo-Dieguez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027447; Centers for Disease Control and Prevention (CDC), 2007, MMWR Morb Mortal Wkly Rep, V56, P1233; Choko AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001102; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Corbett EL, 2006, PLOS MED, V3, P1005, DOI 10.1371/journal.pmed.0030238; Dalal W, 2013, JAIDS-J ACQ IMM DEF, V62, pE47, DOI 10.1097/QAI.0b013e318276bea0; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Figueroa C, 2015, AIDS BEHAV, V19, P1949, DOI 10.1007/s10461-015-1097-8; Fisher M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120810; Flowers P, 2017, SEX HLTH; Frith L, 2007, LANCET, V369, P243, DOI 10.1016/S0140-6736(07)60113-5; Girardi E, 2007, JAIDS-J ACQ IMM DEF, V46, pS3, DOI 10.1097/01.qai.0000286597.57066.2b; Goel S, 2010, P NATL ACAD SCI USA, V107, P6743, DOI 10.1073/pnas.1000261107; Greacen T, 2012, SEX TRANSM INFECT, V88, P368, DOI 10.1136/sextrans-2011-050405; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Hutchinson AB, 2006, AIDS, V20, P1597, DOI 10.1097/01.aids.0000238405.93249.16; Bustamante MJ, 2017, INT J STD AIDS, V28, P133, DOI 10.1177/0956462416630674; Katz DA, 2015, 8 INT AIDS SOC C HIV; Krause J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-735; Lane T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111063; Lippman S.A., 2015, 8 INT AIDS SOC C HIV; Lippman SA, 2014, CAD SAUDE PUBLICA, V30, P724, DOI 10.1590/0102-311X00008913; Ma QQ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2591-7; Ministerio de Salud Presidencia de la Nacio, 2016, B VIH SID ARG, V33; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Montlahuc C, 2013, JAIDS-J ACQ IMM DEF, V64, P197, DOI 10.1097/QAI.0b013e31829cfbfa; Morin SF, 2006, JAIDS-J ACQ IMM DEF, V41, P218, DOI 10.1097/01.qai.0000179455.01068.ab; Negin J, 2009, TROP MED INT HEALTH, V14, P849, DOI 10.1111/j.1365-3156.2009.02304.x; Osmond DH, 2000, J ACQ IMMUN DEF SYND, V24, P363; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Pando MA, 2011, AIDS RES HUM RETROV, V27, P17, DOI 10.1089/aid.2010.0013; Pando MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039834; Paz-Bailey G, 2013, AIDS BEHAV, V17, P3081, DOI 10.1007/s10461-013-0589-7; Roberts KJ, 2007, AIDS PATIENT CARE ST, V21, P621, DOI 10.1089/apc.2006.0196; Salganik MJ, 2006, J URBAN HEALTH, V83, pI98, DOI 10.1007/s11524-006-9106-x; Sharma A, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-109; Smith LV, 2006, AIDS PATIENT CARE ST, V20, P693, DOI 10.1089/apc.2006.20.693; U. S. Food and Drug Administration, 2012, FDA APPR 1 OV THE CO; Volk JE, 2016, INT J STD AIDS, V27, P531, DOI 10.1177/0956462415586676; Volz E, 2008, J OFF STAT, V24, P79; Wurcel A, 2005, AIDS PATIENT CARE ST, V19, P499, DOI 10.1089/apc.2005.19.499	51	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180361	10.1371/journal.pone.0180361	http://dx.doi.org/10.1371/journal.pone.0180361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2JX	28672037	Green Published, gold, Green Submitted			2022-12-26	WOS:000405268500046
J	Song, F; Wang, P; Chen, SX; Wang, ZD; Fan, GR				Song, Fei; Wang, Peng; Chen, Shangxing; Wang, Zongde; Fan, Guorong			Ordered lamellar supermicroporous titania templating by rosin-derived quaternary ammonium salt	PLOS ONE			English	Article							MESOPOROUS MOLECULAR-SIEVES; MESOSTRUCTURED LAMELLAR; TEMPERATURE SYNTHESIS; POROUS SILICA; SURFACTANT; TIO2; LIQUID; COPOLYMER; PHASES; OXIDES	By using dehydroabietyltrimethyl ammonium bromine (DTAB), a novel rosin-derived quaternary ammonium salt, as template and peroxotitanium acid as precursor, ordered lamellar supermicroporous titania has been synthesized via a hydrothermal process. The template agent: titanium source molar ratio in the synthesis system and the hydrothermal temperature have great impact on the microstructure characteristics of the samples. The increase of DTAB: TiO2 molar ratio from 0.04:1 to 0.10:1 is favorable to the increase of regularity of pore structures, but has no significant effects on the crystalline structures. The increase of the hydrothermal temperature from 343 to 393 K can induce an increase in crystallinity of the samples. However, the exorbitant hydrothermal temperature will reduce the regularity of pore structures. When the mole ratio of DTAB: TiO2 is 0.10:1 and the hydrothermal temperature is 373 K, the as-synthesized sample possesses pore structure with the highest level of long-range order, as well as pore wall with semicrystallized anatase phase. The pore size and the pore wall thickness are about 2.0 nm and 1.0 nm, respectively.	[Song, Fei; Wang, Peng; Chen, Shangxing; Wang, Zongde; Fan, Guorong] Jiangxi Agr Univ, Coll Forestry, Nanchang, Jiangxi, Peoples R China	Jiangxi Agricultural University	Wang, P (corresponding author), Jiangxi Agr Univ, Coll Forestry, Nanchang, Jiangxi, Peoples R China.	pengwang1981@126.com		Wang, Peng/0000-0001-8350-691X	National Natural Science Foundation of China [31500484]; Natural Science Foundation of Jiangxi Province, China [20151BAB214019, 20161BAB204186)]; Open Foundation of Guangxi Key Laboratory of Chemistry and Engineering of Forest Products [GXFC14-05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi Province, China(Natural Science Foundation of Jiangxi Province); Open Foundation of Guangxi Key Laboratory of Chemistry and Engineering of Forest Products	This work was supported by the National Natural Science Foundation of China (grant No. 31500484), the Natural Science Foundation of Jiangxi Province, China (grant No. 20151BAB214019 and 20161BAB204186) and the Open Foundation of Guangxi Key Laboratory of Chemistry and Engineering of Forest Products (grant no. GXFC14-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (grant No. 31500484), the Natural Science Foundation of Jiangxi Province, China (grant No. 20151BAB214019 and 20161BAB204186) and the Open Foundation of Guangxi Key Laboratory of Chemistry and Engineering of Forest Products (grant no. GXFC14-05).	ANTONELLI DM, 1995, ANGEW CHEM INT EDIT, V34, P2014, DOI 10.1002/anie.199520141; BAGSHAW SA, 1995, SCIENCE, V269, P1242, DOI 10.1126/science.269.5228.1242; Bagshaw SA, 2001, MICROPOR MESOPOR MAT, V44, P81, DOI 10.1016/S1387-1811(01)00171-8; Bagshaw SA, 2001, ADV MATER, V13, P1011, DOI 10.1002/1521-4095(200107)13:12/13<1011::AID-ADMA1011>3.0.CO;2-T; Bastakoti BP, 2014, ACS APPL MATER INTER, V6, P854, DOI 10.1021/am4039954; BECK JS, 1994, CHEM MATER, V6, P1816, DOI 10.1021/cm00046a040; BECK JS, 1992, J AM CHEM SOC, V114, P10834, DOI 10.1021/ja00053a020; Chandra D, 2008, MICROPOR MESOPOR MAT, V112, P533, DOI 10.1016/j.micromeso.2007.10.035; Corma A, 1997, CHEM REV, V97, P2373, DOI 10.1021/cr960406n; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Di Y, 2006, LANGMUIR, V22, P3068, DOI 10.1021/la0521342; Fukasawa Y, 2010, CHEM LETT, V39, P236, DOI 10.1246/cl.2010.236; Gu D, 2014, CHEM SOC REV, V43, P313, DOI 10.1039/c3cs60155b; Huang YY, 1997, CHEM COMMUN, P1181, DOI 10.1039/a700974g; Huo QS, 1996, CHEM MATER, V8, P1147, DOI 10.1021/cm960137h; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Kruk M, 1997, J PHYS CHEM B, V101, P583, DOI 10.1021/jp962000k; Lin YS, 2004, MICROPOR MESOPOR MAT, V76, P203, DOI 10.1016/j.micromeso.2004.08.015; Liu G, 2012, ENERG ENVIRON SCI, V5, P9603, DOI 10.1039/c2ee22930g; Liu H, 2015, J AM CHEM SOC, V137, P13161, DOI 10.1021/jacs.5b08743; Liu XY, 2002, ANGEW CHEM INT EDIT, V41, P3876, DOI 10.1002/1521-3773(20021018)41:20<3876::AID-ANIE3876>3.0.CO;2-R; Mori K, 2016, ACS CATAL, V6, P3128, DOI 10.1021/acscatal.6b00715; On DT, 1999, LANGMUIR, V15, P8561, DOI 10.1021/la9905463; Ryoo R, 2001, J AM CHEM SOC, V123, P1650, DOI 10.1021/ja0038326; Serrano DP, 2000, CHEM COMMUN, P2041, DOI 10.1039/b006186g; Shibata H, 2005, J AM CHEM SOC, V127, P16396, DOI 10.1021/ja0552601; Song K, 2009, APPL SURF SCI, V255, P5843, DOI 10.1016/j.apsusc.2009.01.016; TANEV PT, 1995, SCIENCE, V267, P865, DOI 10.1126/science.267.5199.865; VARTULI JC, 1994, CHEM MATER, V6, P2317, DOI 10.1021/cm00048a018; Wang P, 2015, RSC ADV, V5, P11223, DOI 10.1039/c4ra12113a; Wang RL, 2013, J COLLOID INTERF SCI, V407, P128, DOI 10.1016/j.jcis.2013.06.033; Wang RL, 2007, J PHYS CHEM C, V111, P10955, DOI 10.1021/jp0716029; Yang PD, 1998, NATURE, V396, P152; Yu CZ, 2000, CHEM COMMUN, P575, DOI 10.1039/b000603n; Yu CZ, 2002, J AM CHEM SOC, V124, P4556, DOI 10.1021/ja025548f; Zhang JY, 2011, ADV ENERGY MATER, V1, P241, DOI 10.1002/aenm.201000004; Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548; Zhao XS, 1999, CHEM COMMUN, P1391; Zhou Y, 2004, CHEM MATER, V16, P544, DOI 10.1021/cm034442w; Zhou Y, 2003, ADV MATER, V15, P1452, DOI 10.1002/adma.200305265; Zhu YM, 2014, CHEM LETT, V43, P1170, DOI 10.1246/cl.140327	41	3	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180178	10.1371/journal.pone.0180178	http://dx.doi.org/10.1371/journal.pone.0180178			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666012	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608700068
J	Khan, KA; Naylor, AJ; Khan, A; Noy, PJ; Mambretti, M; Lodhia, P; Athwal, J; Korzystka, A; Buckley, CD; Willcox, BE; Mohammed, F; Bicknell, R				Khan, K. A.; Naylor, A. J.; Khan, A.; Noy, P. J.; Mambretti, M.; Lodhia, P.; Athwal, J.; Korzystka, A.; Buckley, C. D.; Willcox, B. E.; Mohammed, F.; Bicknell, R.			Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface	ONCOGENE			English	Article							TUMOR ANGIOGENESIS; MOLECULAR CHARACTERIZATION; SPROUTING ANGIOGENESIS; ELEVATED EXPRESSION; COLORECTAL-CANCER; IN-VITRO; ENDOSIALIN; MARKER; GROWTH; RECEPTOR	The C-type lectin domain containing group 14 family members CLEC14A and CD93 are proteins expressed by endothelium and are implicated in tumour angiogenesis. CD248 (alternatively known as endosialin or tumour endothelial marker-1) is also a member of this family and is expressed by tumour-associated fibroblasts and pericytes. Multimerin-2 (MMRN2) is a unique endothelial specific extracellular matrix protein that has been implicated in angiogenesis and tumour progression. We show that the group 14 C-type lectins CLEC14A, CD93 and CD248 directly bind to MMRN2 and only thrombomodulin of the family does not. Binding to MMRN2 is dependent on a predicted long-loop region in the C-type lectin domain and is abrogated by mutation within the domain. CLEC14A and CD93 bind to the same non-glycosylated coiled-coil region of MMRN2, but the binding of CD248 occurs on a distinct non-competing region. CLEC14A and CD248 can bind MMRN2 simultaneously and this occurs at the interface between endothelium and pericytes in human pancreatic cancer. A recombinant peptide of MMRN2 spanning the CLEC14A and CD93 binding region blocks CLEC14A extracellular domain binding to the endothelial cell surface as well as increasing adherence of human umbilical vein endothelial cells to the active peptide. This MMRN2 peptide is anti-angiogenic in vitro and reduces tumour growth in mouse models. These findings identify novel protein interactions involving CLEC14A, CD93 and CD248 with MMRN2 as targetable components of vessel formation.	[Khan, K. A.; Khan, A.; Noy, P. J.; Mambretti, M.; Lodhia, P.; Athwal, J.; Korzystka, A.; Bicknell, R.] Univ Birmingham, Inst Biomed Res & Cardiovasc Sci, Coll Med & Dent Sci, Mol Angiogenesis Lab, Birmingham B15 2TT, W Midlands, England; [Naylor, A. J.; Buckley, C. D.] Univ Birmingham, Inst Inflammat & Ageing, Rheumatol Res Grp, Birmingham, W Midlands, England; [Willcox, B. E.; Mohammed, F.] Univ Birmingham, Inst Immunol & Immunotherapy, Canc Immunol & Immunotherapy Ctr, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham	Bicknell, R (corresponding author), Univ Birmingham, Inst Biomed Res & Cardiovasc Sci, Coll Med & Dent Sci, Mol Angiogenesis Lab, Birmingham B15 2TT, W Midlands, England.	r.bicknell@bham.ac.uk	Buckley, Christopher/AAN-6378-2021; Khan, Kabir/U-8350-2018	Buckley, Christopher/0000-0001-6924-6402; Khan, Kabir/0000-0001-8453-3485; Noy, Peter/0000-0001-6142-8957; Khan, Abdullah/0000-0003-0825-3179; Bicknell, Roy/0000-0002-0941-8919; Mambretti, Marco/0000-0003-2765-3805; Naylor, Amy/0000-0001-8384-8215	UoB; MRC [GBT1465]; Versus Arthritis [19791] Funding Source: researchfish	UoB; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Versus Arthritis(Versus Arthritis)	We thank the University of Birmingham (UoB) Protein expression facility for use of CD248-ECD-Fc; Raj Mehta and Tassos Konstantinou from Cancer Research Technologies for useful discussions. This work was funded by UoB and MRC grant GBT1465.	Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Bao LL, 2016, BIOCHEM BIOPH RES CO, V476, P467, DOI 10.1016/j.bbrc.2016.05.146; Bohlson SS, 2005, J IMMUNOL, V175, P1239, DOI 10.4049/jimmunol.175.2.1239; Brady J, 2004, J NEUROPATH EXP NEUR, V63, P1274, DOI 10.1093/jnen/63.12.1274; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Christian S, 2001, J BIOL CHEM, V276, P48588, DOI 10.1074/jbc.M106152200; Colladel R, 2016, ONCOTARGET, V7, P2022, DOI 10.18632/oncotarget.6515; Diaz LA, 2015, CLIN CANCER RES, V21, P1281, DOI 10.1158/1078-0432.CCR-14-1829; Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036; GUAN E, 1991, J BIOL CHEM, V266, P20345; Huber MA, 2006, J CUTAN PATHOL, V33, P145, DOI 10.1111/j.0303-6987.2006.00446.x; Kastrup JS, 1998, ACTA CRYSTALLOGR D, V54, P757, DOI 10.1107/S0907444997016806; Kaur S, 2011, ARTERIOSCL THROM VAS, V31, P657, DOI 10.1161/ATVBAHA.110.216341; Ki MK, 2013, ONCOGENE, V32, P5449, DOI 10.1038/onc.2013.156; Kontsekova S, 2016, NEOPLASMA, V63, P183, DOI 10.4149/202_15090N474; Langenkamp E, 2015, CANCER RES, V75, P4504, DOI 10.1158/0008-5472.CAN-14-3636; Lee SM, 2013, Publication number, Patent No. [WO2013187724 A1, 2013187724]; Lorenzon E, 2012, ONCOGENE, V31, P3136, DOI 10.1038/onc.2011.487; Masiero M, 2013, CANCER CELL, V24, P229, DOI 10.1016/j.ccr.2013.06.004; McGreal EP, 2002, J IMMUNOL, V168, P5222, DOI 10.4049/jimmunol.168.10.5222; Naylor AJ, 2012, ARTHRITIS RHEUM-US, V64, P3334, DOI 10.1002/art.34556; Nepomuceno RR, 1998, J IMMUNOL, V160, P1929; Noy PJ, 2015, ONCOGENE, V34, P5821, DOI 10.1038/onc.2015.34; Noy PJ, 2016, FASEB J, V30, P2311, DOI 10.1096/fj.201500122R; O'Callaghan CA, 1999, ANAL BIOCHEM, V266, P9, DOI 10.1006/abio.1998.2930; Olsen RS, 2015, INT J COLORECTAL DIS, V30, P883, DOI 10.1007/s00384-015-2247-1; Opavsky R, 2001, J BIOL CHEM, V276, P38795, DOI 10.1074/jbc.M105241200; Petrenko O, 1999, IMMUNITY, V10, P691, DOI 10.1016/S1074-7613(00)80068-0; Rho SS, 2011, BIOCHEM BIOPH RES CO, V404, P103, DOI 10.1016/j.bbrc.2010.11.075; Rmali KA, 2005, WORLD J GASTROENTERO, V11, P1283, DOI 10.3748/wjg.v11.i9.1283; Simonavicius N, 2008, MODERN PATHOL, V21, P308, DOI 10.1038/modpathol.3801006; Simonavicius N, 2012, BLOOD, V120, P1516, DOI 10.1182/blood-2011-01-332338; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Tomkowicz B, 2007, P NATL ACAD SCI USA, V104, P17965, DOI 10.1073/pnas.0705647104; Wilson E, 2014, J CELL SCI, V127, P3039, DOI 10.1242/jcs.140434; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zanivan S, 2013, MOL CELL PROTEOMICS, V12, P3599, DOI 10.1074/mcp.M113.031344; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	38	34	35	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 2	2017	36	44					6097	6108		10.1038/onc.2017.214	http://dx.doi.org/10.1038/onc.2017.214			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FL5CU	28671670	Green Published, hybrid			2022-12-26	WOS:000414249800004
J	Ahn, KW; Root, MJ				Ahn, Koree W.; Root, Michael J.			Complex interplay of kinetic factors governs the synergistic properties of HIV-1 entry inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VIRAL MEMBRANE-FUSION; CCR5 DENSITY LEVELS; CD4 T-CELLS; ENVELOPE GLYCOPROTEIN; SMALL-MOLECULE; IN-VITRO; MONOCLONAL-ANTIBODIES; POTENT INHIBITORS; HELICAL DOMAIN	The homotrimeric HIV-1 envelope glycoprotein (Env) undergoes receptor-triggered structural changes that mediate viral entry through membrane fusion. This process is inhibited by chemokine receptor antagonists (CoRAs) that block Envreceptor interactions and by fusion inhibitors (FIs) that disrupt Env conformational transitions. Synergy between CoRAs and FIs has been attributed to a CoRA-dependent decrease in the rate of viral membrane fusion that extends the lifetime of the intermediate state targeted by FIs. Here, we demonstrated that the magnitude of CoRA/FI synergy unexpectedly depends on FI-binding affinity and the stoichiometry of chemokine receptor binding to trimeric Env. For C-peptide FIs (clinically represented by enfuvirtide), synergy waned as binding strength decreased until inhibitor combinations behaved additively. Curiously, this affinity dependence on synergy was absent for 5-Helix-type FIs. We linked this complex behavior to the CoRA dependence of Env deactivation following FI binding. For both FI classes, reducing chemokine receptor levels on target cells or eliminating competent chemokine receptor-binding sites on Env trimers resulted in a loss of synergistic activity. These data imply that the stoichiometry required for CoRA/FI synergy exceeds that required for HIV-1 entry. Our analysis suggests two distinct roles for chemokine receptor binding, one to trigger formation of the FI-sensitive intermediate state and another to facilitate subsequent conformational transitions. Together, our results could explain the wide variety of previously reported activities for CoRA/FI combinations. These findings also have implications for the combined use of CoRAs and FIs in antiviral therapies and point to a multifaceted role for chemokine receptor binding in promoting HIV-1 entry.	[Ahn, Koree W.; Root, Michael J.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA	Jefferson University	Root, MJ (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St,Rm 802, Philadelphia, PA 19107 USA.	michael.root@jefferson.edu			National Institutes of Health NCI Cancer Center Support Grant [P30 CA056036]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066682] Funding Source: NIH RePORTER	National Institutes of Health NCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. D. Kabat for cell lines JC.10 and JC.53; Dr. M. Kay for D-peptide PIE12 trimer; Drs. M. Khasnis and K. Halkidis for helpful discussions; Drs. J. Benovic, P. Wedegaertner, C. Scott, and members of the Root laboratory for critical evaluation of the manuscript. Research in this publication includes work carried out at the Sidney Kimmel Cancer Center X-ray Crystallography and Molecular Characterization Shared Resource at Thomas Jefferson University, which is supported in part by National Institutes of Health NCI Cancer Center Support Grant P30 CA056036.	ABACIOGLU YH, 1994, AIDS RES HUM RETROV, V10, P371, DOI 10.1089/aid.1994.10.371; Abrahamyan LG, 2005, J VIROL, V79, P106, DOI 10.1128/JVI.79.1.106-115.2005; Armand-Ugon M, 2003, ANTIVIR RES, V59, P137, DOI 10.1016/S0166-3542(03)00071-8; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Berkhout B, 2012, CURR OPIN VIROL, V2, P50, DOI 10.1016/j.coviro.2012.01.002; Biswas P, 2007, EXPERT OPIN PHARMACO, V8, P923, DOI 10.1517/14656566.8.7.923; Bjorndal A, 1997, J VIROL, V71, P7478; Breitinger HG, 2012, TOXICITY AND DRUG TESTING, P143; BRIDGER GJ, 1995, J MED CHEM, V38, P366, DOI 10.1021/jm00002a019; Champagne K, 2009, J BIOL CHEM, V284, P3619, DOI 10.1074/jbc.M809269200; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; CHEN BK, 1994, J VIROL, V68, P654, DOI 10.1128/JVI.68.2.654-660.1994; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; DE CLERCQ E, 1994, ANTIMICROB AGENTS CH, V38, P668, DOI 10.1128/AAC.38.4.668; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Eckert DM, 2001, P NATL ACAD SCI USA, V98, P11187, DOI 10.1073/pnas.201392898; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Emmelkamp JM, 2007, EUR J MED RES, V12, P409; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Gupta RK, 2007, INT J STD AIDS, V18, P630, DOI 10.1258/095646207781568493; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Heredia A, 2007, ANTIMICROB AGENTS CH, V51, P2489, DOI 10.1128/AAC.01602-06; Heredia A, 2007, AIDS, V21, P1317, DOI 10.1097/QAD.0b013e32815278ea; Ji C, 2007, MOL PHARMACOL, V72, P18, DOI 10.1124/mol.107.035055; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kahle KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000674; Ketas TJ, 2012, VIROLOGY, V422, P22, DOI 10.1016/j.virol.2011.09.019; Khasnis MD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006098; Kilgore NR, 2003, J VIROL, V77, P7669, DOI 10.1128/JVI.77.13.7669-7672.2003; Koshiba T, 2003, J BIOL CHEM, V278, P7573, DOI 10.1074/jbc.M211154200; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lederman MM, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-116; Lieberman-Blum SS, 2008, CLIN THER, V30, P1228, DOI 10.1016/S0149-2918(08)80048-3; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Louis JM, 2001, J BIOL CHEM, V276, P29485, DOI 10.1074/jbc.C100317200; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-55; Melikyan GB, 2011, CURR TOP MEMBR, V68, P81, DOI 10.1016/B978-0-12-385891-7.00004-0; Miyauchi K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000585; Munoz-Barroso I, 1998, J CELL BIOL, V140, P315, DOI 10.1083/jcb.140.2.315; Murga JD, 2006, ANTIMICROB AGENTS CH, V50, P3289, DOI 10.1128/AAC.00699-06; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Platt EJ, 2005, J VIROL, V79, P4357, DOI 10.1128/JVI.79.7.4357-4368.2005; Platt EJ, 2005, J VIROL, V79, P4347, DOI 10.1128/JVI.79.7.4347-4356.2005; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Ray N, 2007, J VIROL, V81, P3240, DOI 10.1128/JVI.02413-06; Reeves JD, 2004, J VIROL, V78, P5476, DOI 10.1128/JVI.78.10.5476-5485.2004; Reeves JD, 2005, J VIROL, V79, P4991, DOI 10.1128/JVI.79.8.4991-4999.2005; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Root MJ, 2004, CURR PHARM DESIGN, V10, P1805, DOI 10.2174/1381612043384448; Root MJ, 2003, P NATL ACAD SCI USA, V100, P5016, DOI 10.1073/pnas.0936926100; Shaheen F, 2004, CURR OPIN INFECT DIS, V17, P7, DOI 10.1097/00001432-200402000-00003; Steger HK, 2006, J BIOL CHEM, V281, P25813, DOI 10.1074/jbc.M601457200; Tremblay CL, 2002, ANTIMICROB AGENTS CH, V46, P1336, DOI 10.1128/AAC.46.5.1336-1339.2002; Tremblay CL, 2000, J ACQ IMMUN DEF SYND, V25, P99, DOI 10.1097/00126334-200010010-00001; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Welch BD, 2010, J VIROL, V84, P11235, DOI 10.1128/JVI.01339-10; White TA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001249; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Zanetti G, 2006, PLOS PATHOG, V2, DOI 10.1371/journal.ppat.0020083	71	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16498	16510		10.1074/jbc.M117.791731	http://dx.doi.org/10.1074/jbc.M117.791731			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28696261	Green Published, hybrid			2022-12-26	WOS:000412414800008
J	Nava, A; Bondioli, L; Coppa, A; Dean, C; Rossi, PF; Zanolli, C				Nava, Alessia; Bondioli, Luca; Coppa, Alfredo; Dean, Christopher; Rossi, Paola Francesca; Zanolli, Clement			New regression formula to estimate the prenatal crown formation time of human deciduous central incisors derived from a Roman Imperial sample (Velia, Salerno, Italy, I-II cent. CE)	PLOS ONE			English	Article							SKELETAL REMAINS; ENAMEL GROWTH; DENTAL REMAINS; NEONATAL LINE; PRIMARY TEETH; HARD TISSUES; PERIODICITY; AGE; THICKNESS; HISTOLOGY	The characterization and quantification of human dental enamel microstructure, in both permanent and deciduous teeth, allows us to document crucial growth parameters and to identify stressful events, thus contributing to the reconstruction of the past life history of an individual. Most studies to date have focused on the more accessible post-natal portion of the deciduous dental enamel, even though the analysis of prenatal enamel is pivotal in understanding fetal growth, and reveals information about the mother's health status during pregnancy. This contribution reports new data describing the prenatal enamel development of 18 central deciduous incisors from the Imperial Roman necropolis of Velia (I-II century CE, Salerno, Italy). Histomorphometrical analysis was performed to collect data on prenatal crown formation times, daily secretion rates and enamel extension rates. Results for the Velia sample allowed us to derive a new regression formula, using a robust statistical approach, that describes the average rates of deciduous enamel formation. This can now be used as a reference for pre-industrial populations. The same regression formula, even when daily incremental markings are difficult to visualize, may provide a clue to predicting the proportion of infants born full term and pre-term in an archaeological series.	[Nava, Alessia; Coppa, Alfredo] Univ Roma La Sapienza, Dipartimento Biol Ambientale, Rome, Italy; [Nava, Alessia; Bondioli, Luca; Rossi, Paola Francesca] Museo Nazl Preistor Etnog Luigi Pigorini, Museo Civilta, Sect Bioarchaeol, Rome, Italy; [Dean, Christopher] UCL, Dept Cell & Dev Biol, London, England; [Zanolli, Clement] Univ Toulouse III, Lab AMIS, UMR 5288, Toulouse, France	Sapienza University Rome; University of London; University College London; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Nava, A (corresponding author), Univ Roma La Sapienza, Dipartimento Biol Ambientale, Rome, Italy.	alessia.nava@uniroma1.it	Nava, Alessia/AAH-1754-2019	Nava, Alessia/0000-0002-6319-0425	Environmental Biology Doctoral School of Sapienza University of Rome (AN); Italian Ministry of Cultural Heritage and Tourism (AN,LB,PFR).	Environmental Biology Doctoral School of Sapienza University of Rome (AN); Italian Ministry of Cultural Heritage and Tourism (AN,LB,PFR).	Funded by Environmental Biology Doctoral School of Sapienza University of Rome (AN) and Italian Ministry of Cultural Heritage and Tourism (AN,LB,PFR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlQahtani SJ, 2010, AM J PHYS ANTHROPOL, V142, P481, DOI 10.1002/ajpa.21258; Antoine D, 2009, J ANAT, V214, P45, DOI 10.1111/j.1469-7580.2008.01010.x; Birch W, 2014, J FORENSIC LEG MED, V22, P127, DOI 10.1016/j.jflm.2013.12.002; Birch W, 2011, THESIS; Birch W, 2009, FRONT ORAL BIOL, V13, P116, DOI 10.1159/000242402; Bondioli L., 2016, ACTA IMEKO, V5, P19, DOI [DOI 10.1002/ajpa.10130, DOI 10.21014/ACTA_IMEKO.V5I2.333]; BOYDE A, 1990, MG PRIMATOL, V14, P229; BOYDE A, 1963, EXCERPTA MED INT C S, V80, P36; Boyde A., 1964, THESIS; Caropreso S, 2000, J MICROSC-OXFORD, V199, P244, DOI 10.1046/j.1365-2818.2000.00731.x; Cleveland W.S., 1993, STAT METHODS S, P309; Craig OE, 2009, AM J PHYS ANTHROPOL, V139, P572, DOI 10.1002/ajpa.21021; Cunningham C., 2016, DEV JUV OST 2 ED; Dean C, 2004, J HUM EVOL, V46, P633, DOI 10.1016/j.jhevol.2004.03.001; Dean MC, 2006, P ROY SOC B-BIOL SCI, V273, P2799, DOI 10.1098/rspb.2006.3583; Dean M Christopher, 2012, Methods Mol Biol, V915, P89, DOI 10.1007/978-1-61779-977-8_5; Dean MC, 2010, PHILOS T R SOC B, V365, P3397, DOI 10.1098/rstb.2010.0052; Dean MC, 2009, FRONT ORAL BIOL, V13, P68, DOI 10.1159/000242394; DEAN MC, 1987, J HUM EVOL, V16, P157, DOI 10.1016/0047-2484(87)90074-1; Fazekas Istvan G., 1978, FORENSIC FETAL OSTEO; Fiammenghi C.A., 2003, QUADERNI CTR STUDI M, V1, P49; FitzGerald C, 2009, FRONT ORAL BIOL, V13, P178, DOI 10.1159/000242414; FitzGerald CM, 1998, J HUM EVOL, V35, P371, DOI 10.1006/jhev.1998.0232; Guatelli Steinberg D., 2016, WHAT TEETH REVEAL AB; Guatelli-Steinberg D, 2012, J HUM EVOL, V63, P475, DOI 10.1016/j.jhevol.2012.05.006; Gustafson G., 1967, STRUCTURAL CHEM ORG, P135; Gysi A., 1939, DENT DIG, V37, P661; Hillson S., 2014, TOOTH DEVELOPMENT IN; Huda T, 1994, INT J OSTEOARCHAEOL, V4, P49; Janardhanan Mahija, 2011, J Forensic Dent Sci, V3, P8, DOI 10.4103/0975-1475.85284; Kajiyama S., 1965, NIHON U DENT J, V39, P77; Katzenberg MA, 2005, INT J OSTEOARCHAEOL, V15, P61, DOI 10.1002/oa.748; Koller M, 2011, COMPUT STAT DATA AN, V55, P2504, DOI 10.1016/j.csda.2011.02.014; Lacruz RS, 2016, DEVELOPMENTAL APPROACHES TO HUMAN EVOLUTION, P61; Lacruz RS, 2012, J BIOL RHYTHM, V27, P237, DOI 10.1177/0748730412442830; Le Cabec A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123019; Leeuwenhoek A, 1665, PHIL T ROYAL SOC, V12, P1002; Lewis S. J., 1999, CURRENT RECENT RES O, P54; Macchiarelli R, 2006, NATURE, V444, P748, DOI 10.1038/nature05314; Mahoney P, 2015, AM J PHYS ANTHROPOL, V156, P407, DOI 10.1002/ajpa.22666; Mahoney P, 2012, AM J PHYS ANTHROPOL, V147, P637, DOI 10.1002/ajpa.22029; Mahoney P, 2011, AM J PHYS ANTHROPOL, V144, P204, DOI 10.1002/ajpa.21386; Maresh M. M., 1970, HUMAN GROWTH DEV, P157; NOREN JG, 1983, ACTA ODONTOL SCAND, V41, P355, DOI 10.3109/00016358309162347; Pickerill HP, 1912, THE PREVENTION OF DE; Preiswerk G., 1895, BEITRAGE ZUR KENNTNI; R Core Team, 2017, R A LANGUAGE AND ENV; Retzius A., 1837, ARCH ANAT PHYSL, V1837, P486; RISNES S, 1986, SCAND J DENT RES, V94, P394; Rythen M, 2008, INT J PAEDIATR DENT, V18, P397, DOI 10.1111/j.1365-263X.2008.00928.x; Sabel N, 2008, ARCH ORAL BIOL, V53, P954, DOI 10.1016/j.archoralbio.2008.05.003; SCHOUR I., 1940, JOUR AMER DENTAL ASSOC, V27, P1918; SCHOUR ISAAC, 1936, JOUR AMER DENTAL ASSOC, V23, P1946; Schwartz JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009177; Seow WK, 2005, PEDIATR DENT, V27, P374; SHELLIS RP, 1984, ARCH ORAL BIOL, V29, P697, DOI 10.1016/0003-9969(84)90175-4; Simpson Scott W., 1999, HUMAN GROWTH STUDIES, P241; SKINNER M, 1993, J FORENSIC SCI, V38, P1383; SKINNER M, 1991, J FORENSIC SCI, V36, P939; Smith P, 2005, J ARCHAEOL SCI, V32, P83, DOI 10.1016/j.jas.2004.06.008; Smith TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118118; Smith TM, 2011, VERTEBR PALEOBIOL PA, P155, DOI 10.1007/978-94-007-0492-3_13; Smith TM, 2006, J ANAT, V208, P99, DOI 10.1111/j.1469-7580.2006.00499.x; Smith TM, 2006, J ANAT, V208, P125, DOI 10.1111/j.1469-7580.2006.00500.x; STRINGER CB, 1990, MG PRIMATOL, V14, P115; Tafforeau P, 2008, J HUM EVOL, V54, P272, DOI 10.1016/j.jhevol.2007.09.018; Tafforeau P, 2012, J HUM EVOL, V62, P424, DOI 10.1016/j.jhevol.2012.01.001; Takiguchi H, 1966, NIHON U DENT, V40, P391; Ubelaker DH, 1978, HUMAN SKELETAL REMAI; Wissler H., 1916, FESTIGKEIBERECHUNG R; Witzel C, 2008, AM J PHYS ANTHROPOL, V136, P400, DOI 10.1002/ajpa.20822; Witzel C, 2014, ANTHROPOL ANZ, V71, P87, DOI 10.1127/0003-5548/2014/0386; Wood S., 2006, GEN ADDITIVE MODELS, DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Zanolli C, 2016, CR PALEVOL, V15, P209, DOI 10.1016/j.crpv.2015.02.001; Zanolli C, 2014, J HUM EVOL, V74, P96, DOI 10.1016/j.jhevol.2014.04.005; Zanolli C, 2011, HUM BIOL, V83, P695, DOI 10.3378/027.083.0603; Zheng L, 2014, EXP CELL RES, V325, P83, DOI 10.1016/j.yexcr.2014.02.007; Zheng L, 2013, BONE, V55, P158, DOI 10.1016/j.bone.2013.02.011	78	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180104	10.1371/journal.pone.0180104	http://dx.doi.org/10.1371/journal.pone.0180104			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TK	28700601	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000405649600017
J	Huang, YH; Yeh, CH; Cheng, NM; Lin, CY; Wang, HM; Ko, SF; Toh, CH; Yen, TC; Liao, CT; Ng, SH				Huang, Yu-Han; Yeh, Chih-Hua; Cheng, Nai-Ming; Lin, Chien-Yu; Wang, Hung-Ming; Ko, Sheung-Fat; Toh, Cheng-Hong; Yen, Tzu-Chen; Liao, Chun-Ta; Ng, Shu-Hang			Cystic nodal metastasis in patients with oropharyngeal squamous cell carcinoma receiving chemoradiotherapy: Relationship with human papillomavirus status and failure patterns	PLOS ONE			English	Article							COMPUTED TOMOGRAPHIC DENSITY; CISPLATIN-BASED CHEMOTHERAPY; NECK-CANCER; LYMPH-NODES; HEAD; AREA; EXPRESSION; SURVIVAL; TAIWAN	Objectives We investigated the relationships of cystic nodal metastasis, human papillomavirus (HPV) status, and treatment failure patterns in patients with oropharyngeal squamous cell carcinoma (OPSCC) treated with chemoradiotherapy. Methods We retrospectively reviewed pretreatment MRI and clinical courses of patients with OPSCC whose tumors were tested for HPV-induced p16 expression via immunohistochemistry and who completed chemoradiotherapy. Cervical cystic nodal metastasis and necrotic nodal metastasis were classified on MRI. Results Of 98 patients eligible for analysis, 33 were p16-positive. Cystic nodal metastasis was significantly more prevalent in p16-positive than in p16-negative patients (39.4% versus 18.5%, respectively; p = 0.025). Necrotic nodal metastasis was significantly more prevalent in p16-negative than in p16-positive patients (73.8% versus 51.5%, respectively; p = 0.027). On multivariate analysis, necrotic nodal metastasis (odds ratio [OR] = 7.310, p = 0.011) was an independent predictor of regional failure, while advanced nodal stage (OR = 4.119, p = 0.022) and cystic nodal metastases (OR = 0.087, p = 0.026) were independent positive and negative predictors of distant failure, respectively. Conclusions Cervical cystic and necrotic nodal metastases are associated with HPV-induced p16-positive and p16-negative OPSCC, respectively. Patients with necrotic nodal metastasis at presentation have an increased risk of regional failure. Distant failure is directly and inversely correlated with advanced nodal stage and cystic nodal metastasis, respectively.	[Huang, Yu-Han] Taipei Med Univ, Shuang Ho Hosp, Dept Radiol, Taipei, Taiwan; [Yeh, Chih-Hua; Cheng, Nai-Ming; Toh, Cheng-Hong; Yen, Tzu-Chen; Ng, Shu-Hang] Chang Gung Mem Hosp, Mol Imaging Ctr, Linkou, Taiwan; [Yeh, Chih-Hua; Ko, Sheung-Fat; Toh, Cheng-Hong; Ng, Shu-Hang] Chang Gung Univ, Chang Gung Mem Hosp, Dept Diagnost Radiol, Taoyuan, Taiwan; [Cheng, Nai-Ming; Yen, Tzu-Chen] Chang Gung Univ, Chang Gung Mem Hosp, Dept Nucl Med, Taoyuan, Taiwan; [Lin, Chien-Yu] Chang Gung Univ, Chang Gung Mem Hosp, Dept Radiat Oncol, Taoyuan, Taiwan; [Wang, Hung-Ming] Chang Gung Univ, Chang Gung Mem Hosp, Dept Med Oncol, Taoyuan, Taiwan; [Liao, Chun-Ta] Chang Gung Univ, Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Taoyuan, Taiwan	Taipei Medical University; Shuang Ho Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Ng, SH (corresponding author), Chang Gung Mem Hosp, Mol Imaging Ctr, Linkou, Taiwan.; Ng, SH (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Diagnost Radiol, Taoyuan, Taiwan.	shuhangng@gmail.com	Yeh, Chih-Hua/N-5165-2018	Yeh, Chih-Hua/0000-0001-6988-8739; Toh, Cheng Hong/0000-0002-8871-5101; Ng, Shu-Hang/0000-0002-1842-6179	National Science Council-Taiwan [NSC102-2314-B-182A-098-MY2]	National Science Council-Taiwan(Ministry of Science and Technology, Taiwan)	This study was partially supported by a grant from the National Science Council-Taiwan (NSC102-2314-B-182A-098-MY2).	Amin MB, 2017, AJCC CANC STAGING MA; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Applebaum KM, 2007, JNCI-J NATL CANCER I, V99, P1801, DOI 10.1093/jnci/djm233; Cantrell SC, 2013, AM J NEURORADIOL, V34, P2005, DOI 10.3174/ajnr.A3524; Chien CY, 2008, ORAL ONCOL, V44, P174, DOI 10.1016/j.oraloncology.2007.01.018; Corey A, 2013, NEUROIMAG CLIN N AM, V23, P47, DOI 10.1016/j.nic.2012.08.005; El-Naggar AK, 2012, HEAD NECK-J SCI SPEC, V34, P459, DOI 10.1002/hed.21974; Gillison ML, 2004, SEMIN ONCOL, V31, P744, DOI 10.1053/j.seminoncol.2004.09.011; Goldenberg D, 2008, HEAD NECK-J SCI SPEC, V30, P898, DOI 10.1002/hed.20796; Ho PS, 2002, J ORAL PATHOL MED, V31, P213, DOI 10.1034/j.1600-0714.2002.310404.x; Jaju S, 2014, J CANCER RES THER, V10, P284, DOI 10.4103/0973-1482.136566; JANOT F, 1993, HEAD NECK-J SCI SPEC, V15, P222, DOI 10.1002/hed.2880150309; Martinez I, 2007, EUR J CANCER, V43, P415, DOI 10.1016/j.ejca.2006.09.001; Mirghani H, 2014, ORAL ONCOL, V50, P1, DOI 10.1016/j.oraloncology.2013.10.008; Mokhtari S, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-6; Morani AC, 2013, J COMPUT ASSIST TOMO, V37, P343, DOI 10.1097/RCT.0b013e318282d7c3; MUNCK JN, 1991, J NATL CANCER I, V83, P569, DOI 10.1093/jnci/83.8.569; Okami K, 2016, INT J CLIN ONCOLOGY; Regauer S, 1999, BRIT J CANCER, V79, P1437, DOI 10.1038/sj.bjc.6690229; Regauer S, 2000, HUM PATHOL, V31, P1096, DOI 10.1053/hupa.2000.6279; Thompson LDR, 1998, CANCER, V82, P944, DOI 10.1002/(SICI)1097-0142(19980301)82:5<944::AID-CNCR21>3.0.CO;2-#; Vergeer MR, 2006, RADIOTHER ONCOL, V79, P39, DOI 10.1016/j.radonc.2006.03.008; VERMAN K, 1995, ACTA CYTOL, V39, P478; Wang HM, 1996, CANCER, V78, P1972, DOI 10.1002/(SICI)1097-0142(19961101)78:9<1972::AID-CNCR19>3.0.CO;2-V; Wang HM, 2002, CANCER, V94, P2989, DOI 10.1002/cncr.10570; Wilson L, 2014, J OTOLARYNGOL-HEAD N, V43, DOI 10.1186/1916-0216-43-19	26	15	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180779	10.1371/journal.pone.0180779	http://dx.doi.org/10.1371/journal.pone.0180779			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686646	Green Submitted, Green Published, gold			2022-12-26	WOS:000405464100102
J	Murphy, SF; Stallard, RF; Scholl, MA; Gonzalez, G; Torres-Sanchez, AJ				Murphy, Sheila F.; Stallard, Robert F.; Scholl, Martha A.; Gonzalez, Grizelle; Torres-Sanchez, Angel J.			Reassessing rainfall in the Luquillo Mountains, Puerto Rico: Local and global ecohydrological implications	PLOS ONE			English	Article							EXPERIMENTAL FOREST; LONG-TERM; OROGRAPHIC PRECIPITATION; CLIMATE-CHANGE; SOUTHERN ALPS; LAND-COVER; WATER; EVAPOTRANSPIRATION; STREAMFLOW; GRADIENTS	Mountains receive a greater proportion of precipitation than other environments, and thus make a disproportionate contribution to the world's water supply. The Luquillo Mountains receive the highest rainfall on the island of Puerto Rico and serve as a critical source of water to surrounding communities. The area's role as a long-term research site has generated numerous hydrological, ecological, and geological investigations that have been included in regional and global overviews that compare tropical forests to other ecosystems. Most of the forest-and watershed-wide estimates of precipitation (and evapotranspiration, as inferred by a water balance) have assumed that precipitation increases consistently with elevation. However, in this new analysis of all known current and historical rain gages in the region, we find that similar to other mountainous islands in the trade wind latitudes, leeward (western) watersheds in the Luquillo Mountains receive lower mean annual precipitation than windward (eastern) watersheds. Previous studies in the Luquillo Mountains have therefore overestimated precipitation in leeward watersheds by up to 40%. The Icacos watershed, however, despite being located at elevations 200 - 400 m below the tallest peaks and to the lee of the first major orographic barrier, receives some of the highest precipitation. Such lee-side enhancement has been observed in other island mountains of similar height and width, and may be caused by several mechanisms. Thus, the long-reported discrepancy of unrealistically low rates of evapotranspiration in the Icacos watershed is likely caused by previous underestimation of precipitation, perhaps by as much as 20%. Rainfall/runoff ratios in several previous studies suggested either runoff excess or runoff deficiency in Luquillo watersheds, but this analysis suggests that in fact they are similar to other tropical watersheds. Because the Luquillo Mountains often serve as a wet tropical archetype in global assessments of basic ecohydrological processes, these revised estimates are relevant to regional and global assessments of runoff efficiency, hydrologic effects of reforestation, geomorphic processes, and climate change.	[Murphy, Sheila F.; Stallard, Robert F.] US Geol Survey, Boulder, CO 80303 USA; [Scholl, Martha A.] US Geol Survey, 959 Natl Ctr, Reston, VA 22092 USA; [Gonzalez, Grizelle] US Forest Serv, USDA, Int Inst Forestry, Rio Piedras, PR USA; [Torres-Sanchez, Angel J.] US Geol Survey, Guaynabo, PR USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of Agriculture (USDA); United States Forest Service; United States Department of the Interior; United States Geological Survey	Murphy, SF (corresponding author), US Geol Survey, Boulder, CO 80303 USA.	sfmurphy@usgs.gov		Murphy, Sheila/0000-0002-5481-3635; Gonzalez, Grizelle/0000-0003-3007-5540	United States Geological Survey National Research Program; United States Geological Survey Climate Mission Area's Research and Development Program; National Science Foundation [DEB-0218039, 1239764, EAR-1331841]; Division Of Earth Sciences [1331841] Funding Source: National Science Foundation; Division Of Environmental Biology [1546686] Funding Source: National Science Foundation	United States Geological Survey National Research Program; United States Geological Survey Climate Mission Area's Research and Development Program(United States Geological Survey); National Science Foundation(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the United States Geological Survey National Research Program, https://www.usgs.gov/ (SFM, RFS, MAS); United States Geological Survey Climate Mission Areas Research and Development Program, https://www.usgs.gov/ (SFM, RFS, MAS, AJT); National Science Foundation grants to the Luquillo Long-Term Ecological Research Site DEB-0218039 and 1239764 (GG); National Science Foundation grant to the Luquillo Critical Zone Observatory EAR-1331841 (GG, MAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; [Anonymous], THESIS; [Anonymous], 2003, INT J CLIMATOLOGY, V23, P1359; ASBURY CE, 1994, ATMOS ENVIRON, V28, P1773, DOI 10.1016/1352-2310(94)90139-2; Austin GL, 2006, ENCY HYDROLOGICAL SC, V3, P1; Baldocchi DD, 2011, ECOL STUD-ANAL SYNTH, V216, P101, DOI 10.1007/978-94-007-1363-5_5; Barker BS, 2015, ECOGRAPHY, V38, P769, DOI 10.1111/ecog.01327; Bassiouni M, 2017, AGR FOREST METEOROL, V243, P100, DOI 10.1016/j.agrformet.2017.04.010; Bawiec W., 1999, 9838 US GEOL SURV; Beck HE, 2013, HYDROL EARTH SYST SC, V17, P2613, DOI 10.5194/hess-17-2613-2013; Beck HE, 2013, WATER RESOUR RES, V49, P7843, DOI 10.1002/2013WR013918; Bogart DB, 1964, US GEOLOGICAL SURVEY, V4; Briscoe C., 1966, ITF3 USDA FOR SERV I; Brocard GY, 2016, J GEOPHYS RES-EARTH, V121, P1182, DOI 10.1002/2015JF003678; Brocard GY, 2015, APPL GEOCHEM, V63, P586, DOI 10.1016/j.apgeochem.2015.04.001; Brokaw N., 2012, CARIBBEAN FOREST TAP, DOI 10.1093/acprof:osobl/9780195334692.001.0001; Brown S., 1983, SO44 USDA FOR SERV S; Browning K. A., 1981, Weather, V36, P326, DOI 10.1002/j.1477-8696.1981.tb05354.x; Bruijnzeel LA, 2011, HYDROL PROCESS, V25, P465, DOI 10.1002/hyp.7974; Bruijnzeel LA, 2004, AGR ECOSYST ENVIRON, V104, P185, DOI 10.1016/j.agee.2004.01.015; Calvesbert RJ, 1970, CLIMATE PUERTO RICO; Chater AM, 1998, INT J CLIMATOL, V18, P77, DOI 10.1002/(SICI)1097-0088(199801)18:1<77::AID-JOC218>3.0.CO;2-M; Colle B.A., 2013, MOUNTAIN WEAR RES, P291, DOI [DOI 10.1007/978-94-007-4098-3_6, https://doi.org/10.1007/978-94-007-4098-3_6]; Comarazamy DE, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015414; Crook KE, 2004, IITFGTR34 USDA FOR S; Daley R., 1991, ATMOSPHERIC DATA ANA; DALY C, 1994, J APPL METEOROL, V33, P140, DOI 10.1175/1520-0450(1994)033&lt;0140:ASTMFM&gt;2.0.CO;2; Daly C, 2017, INT J CLIMATOLOGY; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Desvars A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020377; Ewel J.J., 1973, ECOLOGICAL LIFE ZONE; Falcone J.A., 2011, GAGES 2 GEOSPATIAL A, DOI [10.3133/70046617, DOI 10.3133/70046617]; Farrick KK, 2013, HYDROL PROCESS, V27, P3254, DOI 10.1002/hyp.9935; Ferguson PR, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008431; Funk C, 2004, J APPL METEOROL, V43, P1366, DOI 10.1175/JAM2138.1; Garcia-Martino A.R., 1996, CARIBB J SCI, V32, P413; Giambelluca TW, 2013, B AM METEOROL SOC, V94, P313, DOI 10.1175/BAMS-D-11-00228.1; GIUSTI E V, 1967, Caribbean Journal of Science, V7, P87; Giusti EV, 1978, 1012 US GEOL SURV; GLM Engineering, MEAN ANN RAINF MAP P; Gonzalez G., 2013, ECOLOGICAL GRADIENT; Gould WA, 2008, PUERTO RICO GAP ANAL; Harmsen E.W., 2008, INT J SYST APPL ENG, V2, P91; Harris N.L., 2012, LUQUILLO EXPT FOREST; Hayhoe K., 2013, QUNTIFYING KEY DRIVE; Heartsill-Scalley T, 2007, J HYDROL, V333, P472, DOI 10.1016/j.jhydrol.2006.09.019; Helsel D, 2002, A3 US GEOL SURV, VA3; Hengl T, 2007, COMPUT GEOSCI-UK, V33, P1301, DOI 10.1016/j.cageo.2007.05.001; Holben B, 1979, CEERT40 U PUERT RIC, P57; Holwerda F, 2006, J HYDROL, V327, P592, DOI 10.1016/j.jhydrol.2005.12.014; Holwerda F, 2012, J HYDROL, V414, P1, DOI 10.1016/j.jhydrol.2011.07.033; Houze RA, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000365; Hovind, 1964, J APPL METEOROL, V3, P235; Karmalkar AV, 2013, ATMOSFERA, V26, P283, DOI 10.1016/S0187-6236(13)71076-2; Khalyani AH, 2016, J APPL METEOROL CLIM, V55, P265, DOI 10.1175/JAMC-D-15-0182.1; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Komatsu H, 2012, J HYDROL, V420, P380, DOI 10.1016/j.jhydrol.2011.12.030; Kume T, 2011, AGR FOREST METEOROL, V151, P1183, DOI 10.1016/j.agrformet.2011.04.005; Kurtz AC, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009853; LARSEN MC, 1998, 3 INT S WAT RES K CA, P199; Luquillo Critical Zone Observatory, LUQ MOUNT SPAT DAT; Malhi Y, 2010, GLOBAL CHANGE BIOL, V16, P3171, DOI 10.1111/j.1365-2486.2010.02323.x; MCDOWELL WH, 1994, LIMNOL OCEANOGR, V39, P111, DOI 10.4319/lo.1994.39.1.0111; Meyerhoff HA, 1931, SCI SURVEY PORTO R 3, VII, P201; Moore S, 2013, NATURE, V493, P660, DOI 10.1038/nature11818; Murphy S.F, 2006, STATE WATERSHED WATE; Murphy SF, 1998, GEOCHIM COSMOCHIM AC, V62, P227, DOI 10.1016/S0016-7037(97)00336-0; Murphy SF, 2012, US GEOLOGICAL SURVEY, V1789, P292; Murphy SF, 2012, WATER QUALITY LANDSC, P48; Murphy SF, 2003, COMPREHENSIVE WATER, P5; National Aeronautics and Space Administration, TROP RAINF MEAS MISS; National Aeronautics and Space Administration, ADV SPAC THERM EM RE; National Oceanic and Atmospheric Administration National Weather Service, ADV HYDR PRED SERV; National Weather Service, 2016, MEAN ANN RAINF PUERT; Odum H. T., 1970, TROPICAL RAIN FOREST; Odum HT, 1970, TROPICAL RAIN FOREST, pB347; Ohte N, 2011, ECOL STUD-ANAL SYNTH, V216, P261, DOI 10.1007/978-94-007-1363-5_12; Padron RS, 2015, J HYDROMETEOROL, V16, P985, DOI 10.1175/JHM-D-14-0135.1; Peters NE, 2006, SCI TOTAL ENVIRON, V358, P221, DOI 10.1016/j.scitotenv.2005.04.044; Porder S, 2015, GEODERMA, V249, P100, DOI 10.1016/j.geoderma.2015.03.002; Post DA, 2001, ADV WATER RESOUR, V24, P1195, DOI 10.1016/S0309-1708(01)00036-7; Puerto Rico Climate Change Council, 2013, STAT PUERT RIC CLIM; Ralph FM, 2003, J HYDROMETEOROL, V4, P1243, DOI 10.1175/1525-7541(2003)004<1243:TIOAPR>2.0.CO;2; Ramirez-Beltran Nazario D., 2008, WSEAS Transactions on Systems, V7, P1016; Ramseyer CA, 2016, CLIM DYNAM, V47, P2515, DOI 10.1007/s00382-016-2980-3; Rauber RM, 2007, B AM METEOROL SOC, V88, P1912, DOI 10.1175/BAMS-88-12-1912; ROBERTS JM, 2005, INT HYDROL SER, P287; Roberts JM, 2009, FORESTS FOREST PLANT; Robinson M., 2005, ENCY HYDROLOGICAL SC, P537, DOI DOI 10.1002/0470848944.HSA039; Roe GH, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001521; Rollenbeck R, 2007, J ATMOS OCEAN TECH, V24, P156, DOI 10.1175/JTECH1970.1; Rossi MW, 2016, J GEOPHYS RES-EARTH, V121, P128, DOI 10.1002/2015JF003446; Ryu Y, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2011GB004053; Scalley TH, 2012, J TROP ECOL, V28, P127, DOI 10.1017/S0266467411000733; Scatena F. N., 1990, Tropical hydrology and Caribbean water resources. Proceedings of the International symposium on tropical hydrology and Fourth Caribbean Islands Water Resources Congress., P237; Schellekens J, 2000, WATER RESOUR RES, V36, P2183, DOI 10.1029/2000WR900074; Schellekens J, 2000, PHYS CHEM EARTH PT B, V25, P659, DOI 10.1016/S1464-1909(00)00081-2; Schellekens J, 1998, PORTRAIT AM JEWISH C, P29; Scholl MA, 2014, WATER RESOUR RES, V50, P4305, DOI 10.1002/2013WR014413; Sevruk B., 2005, ENCY HYDROLOGICAL SC, P1; Sharples JJ, 2005, J APPL METEOROL, V44, P1850, DOI 10.1175/JAM2289.1; Sinclair MR, 1997, J APPL METEOROL, V36, P428, DOI 10.1175/1520-0450(1997)036<0428:FATDAS>2.0.CO;2; Smith RB, 2012, B AM METEOROL SOC, V93, P1567, DOI 10.1175/BAMS-D-11-00194.1; Snyder N. F. R., 1987, PARROTS LUQUILLO NAT; Stallard RF, 1998, GLOBAL BIOGEOCHEM CY, V12, P231, DOI 10.1029/98GB00741; STALLARD RF, 1995, ANNU REV EARTH PL SC, V23, P11, DOI 10.1146/annurev.ea.23.050195.000303; Stocks G, 2008, BIOTROPICA, V40, P397, DOI 10.1111/j.1744-7429.2007.00393.x; Taylor MA, 2013, INT J CLIMATOL, V33, P784, DOI 10.1002/joc.3461; U. S. Geological Survey, USGS WAT DAT NAT; U. S. Geological Survey, USGS NAT EL DAT NED; University of Hawaii at Manoa, SHOR IM HAW ISL 2016; Van Beusekom AE, 2017, ATMOSPHERIC CHEM PHY; Van Beusekom AE, 2016, INT J CLIMATOL, V36, P3370, DOI 10.1002/joc.4560; Van Beusekom AE, 2014, J AM WATER RESOUR AS, V50, P1575, DOI 10.1111/jawr.12227; Viviroli D, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005653; Wadsworth FH, 1970, TROPICAL RAINFOREST; Wang HQ, 2003, FOREST ECOL MANAG, V179, P69, DOI 10.1016/S0378-1127(02)00489-9; Weaver P. L., 1972, CARIBB J SCI, V12, P129; WEAVER P. L., 2012, IITFGTR44 USDA FOR S; WEAVER PL, 1991, INTERCIENCIA, V16, P142; Weaver PL, 2000, INTERCIENCIA, V25, P254; West AJ, 2005, EARTH PLANET SC LETT, V235, P211, DOI 10.1016/j.epsl.2005.03.020; WHITE AF, 1995, GEOCHIM COSMOCHIM AC, V59, P1729, DOI 10.1016/0016-7037(95)00078-E; White AF, 1998, GEOCHIM COSMOCHIM AC, V62, P209, DOI 10.1016/S0016-7037(97)00335-9; Whiteman C.D., 2000, MOUNTAIN METEOROLOGY; Wilson AM, 2014, J ATMOS SCI, V71, P1783, DOI 10.1175/JAS-D-13-0228.1; Wu W, 2006, J HYDROL, V328, P733, DOI 10.1016/j.jhydrol.2006.01.020; Wu W, 2007, HYDROL PROCESS, V21, P2944, DOI 10.1002/hyp.6515; Y-L Lin, 2007, MESOSCALE DYNAMICS; Yu C.-K., 2000, MONTHLY WEATHER REV, V136, P497, DOI DOI 10.1175/2007MWR2129.1	130	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180987	10.1371/journal.pone.0180987	http://dx.doi.org/10.1371/journal.pone.0180987			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686734	Green Published, Green Submitted, gold			2022-12-26	WOS:000405464100128
J	Yordanov, YS; Ma, C; Yordanova, E; Meilan, R; Strauss, SH; Busov, VB				Yordanov, Yordan S.; Ma, Cathleen; Yordanova, Elena; Meilan, Richard; Strauss, Steven H.; Busov, Victor B.			BIG LEAF is a regulator of organ size and adventitious root formation in poplar	PLOS ONE			English	Article							GENETIC-CONTROL; GROWTH; AINTEGUMENTA; TRANSFORMATION; SYSTEM; DNA; DIVISION; TRAITS; KEY	Here we report the discovery through activation tagging and subsequent characterization of the BIG LEAF (BL) gene from poplar. In poplar, BL regulates leaf size via positively affecting cell proliferation. Up and downregulation of the gene led to increased and decreased leaf size, respectively, and these phenotypes corresponded to increased and decreased cell numbers. BL function encompasses the early stages of leaf development as native BL expression was specific to the shoot apical meristem and leaf primordia and was absent from the later stages of leaf development and other organs. Consistently, BL downregulation reduced leaf size at the earliest stages of leaf development. Ectopic expression in mature leaves resulted in continued growth most probably via sustained cell proliferation and thus the increased leaf size. In contrast to the positive effect on leaf growth, ectopic BL expression in stems interfered with and significantly reduced stem thickening, suggesting that BL is a highly specific activator of growth. In addition, stem cuttings from BL overexpressing plants developed roots, whereas the wild type was difficult to root, demonstrating that BL is a positive regulator of adventitious rooting. Large transcriptomic changes in plants that over-expressed BL indicated that BL may have a broad integrative role, encompassing many genes linked to organ growth. We conclude that BL plays a fundamental role in control of leaf size and thus may be a useful tool for modifying plant biomass productivity and adventitious rooting.	[Yordanov, Yordan S.; Yordanova, Elena; Busov, Victor B.] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA; [Yordanov, Yordan S.; Yordanova, Elena] Eastern Illinois Univ, Dept Biol Sci, Charleston, IL 61920 USA; [Ma, Cathleen; Strauss, Steven H.] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Meilan, Richard] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA	Michigan Technological University; Eastern Illinois University; Oregon State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Busov, VB (corresponding author), Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA.	vbusov@mtu.edu	Meilan, Richard/T-9269-2017	Meilan, Richard/0000-0002-8680-1110	Office of Science Biological and Environmental Research (BER) program at the U.S. Department of Energy [DE-FG02-06ER64185, DE-FG02-05ER64113, DES C0008462]; U.S. Department of Agriculture (USDA) National Resources Inventory Plant Genome Program [2003-04345]; Consortium for Plant Biotechnology Research, Inc [GO12026-203A]; USDA Biotechnology Risk Assessment Research Grants Program [2004-35300-14687]; USDA McIntire-Stennis Fund [1001498]; USDA National Institute of Food Agriculture [MICW-2011-04378]; Tree Biosafety and Genomics Research Cooperative based at Oreg on State University	Office of Science Biological and Environmental Research (BER) program at the U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Agriculture (USDA) National Resources Inventory Plant Genome Program; Consortium for Plant Biotechnology Research, Inc; USDA Biotechnology Risk Assessment Research Grants Program; USDA McIntire-Stennis Fund(United States Department of Agriculture (USDA)); USDA National Institute of Food Agriculture; Tree Biosafety and Genomics Research Cooperative based at Oreg on State University	This research was supported, in part, by grants from the Office of Science Biological and Environmental Research (BER) program at the U.S. Department of Energy (Grants DE-FG02-06ER64185, DE-FG02-05ER64113, and DES C0008462); U.S. Department of Agriculture (USDA) National Resources Inventory Plant Genome Program (Grant 2003-04345); Consortium for Plant Biotechnology Research, Inc. (Grant GO12026-203A); USDA Biotechnology Risk Assessment Research Grants Program (Grant 2004-35300-14687); USDA McIntire-Stennis Fund (Grant 1001498); USDA National Institute of Food Agriculture (MICW-2011-04378); and industrial members of the Tree Biosafety and Genomics Research Cooperative based at Oreg on State University	Alvarez-Buylla Elena R, 2010, Arabidopsis Book, V8, pe0127, DOI 10.1199/tab.0127; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Busov VB, 2005, NEW PHYTOL, V167, P9, DOI 10.1111/j.1469-8137.2005.01412.x; Busov VB, 2009, ADVENTITIOUS ROOT FO, P85; Busov V, 2011, TREE GENET GENOMES, V7, P91, DOI 10.1007/s11295-010-0317-7; Byzova MV, 1999, GENE DEV, V13, P1002, DOI 10.1101/gad.13.8.1002; Chen YH, 2013, PLANT CELL REP, V32, P219, DOI 10.1007/s00299-012-1356-3; Chu VT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r118; Cnops G, 2004, J EXP BOT, V55, P1529, DOI 10.1093/jxb/erh165; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Du J, 2009, PLANT J, V60, P1000, DOI 10.1111/j.1365-313X.2009.04017.x; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Gonzalez N, 2015, PLANT CELL, V27, P2273, DOI 10.1105/tpc.15.00006; Gonzalez N, 2012, TRENDS PLANT SCI, V17, P332, DOI 10.1016/j.tplants.2012.02.003; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; Hisanaga T, 2015, J EXP BOT, V66, P1055, DOI 10.1093/jxb/erv028; HOLSTERS M, 1978, MOL GEN GENET, V163, P181, DOI 10.1007/BF00267408; Horstman A, 2014, TRENDS PLANT SCI, V19, P146, DOI 10.1016/j.tplants.2013.10.010; Ichihashi Y, 2015, FRONTIERS PLANT SCI, V6; Johnson K, 2011, NEW PHYTOL, V191, P319, DOI 10.1111/j.1469-8137.2011.03737.x; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Karlberg A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002361; Kim GT, 1998, PLANTA, V206, P175, DOI 10.1007/s004250050389; Kraus D., 2014, MED WRIT, V23, P25, DOI DOI 10.1179/2047480613Z.000000000181; Krizek BA, 2000, PLANT CELL, V12, P1357, DOI 10.1105/tpc.12.8.1357; Krizek BA, 1999, DEV GENET, V25, P224, DOI 10.1002/(SICI)1520-6408(1999)25:3&lt;224::AID-DVG5&gt;3.0.CO;2-Y; Krizek BA, 2009, CURR OPIN PLANT BIOL, V12, P17, DOI 10.1016/j.pbi.2008.09.006; LARSON P R, 1971, Canadian Journal of Forest Research, V1, P1, DOI 10.1139/x71-001; LARSON PR, 1980, ANN BOT-LONDON, V46, P757, DOI 10.1093/oxfordjournals.aob.a085973; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Legue V, 2014, PHYSIOL PLANTARUM, V151, P192, DOI 10.1111/ppl.12197; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsui K, 2010, PLANT J, V61, P570, DOI 10.1111/j.1365-313X.2009.04081.x; Meilan R., 2007, AGROBACTERIUM PROTOC, V2, P143; Mizukami Y, 2000, P NATL ACAD SCI USA, V97, P942, DOI 10.1073/pnas.97.2.942; Mizukami Y, 2001, CURR OPIN PLANT BIOL, V4, P533, DOI 10.1016/S1369-5266(00)00212-0; OBRIEN TP, 1964, PROTOPLASMA, V59, P368, DOI 10.1007/BF01248568; Petricka JJ, 2012, ANNU REV PLANT BIOL, V63, P563, DOI 10.1146/annurev-arplant-042811-105501; Rigal A, 2012, PLANT PHYSIOL, V160, P1996, DOI 10.1104/pp.112.204453; Russo G, 2015, IFOREST, V8, P547, DOI 10.3832/ifor1104-007; Sabaghian E, 2015, SCI REP-UK, V5, DOI 10.1038/srep17617; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sicard A, 2016, P NATL ACAD SCI; SINHA NR, 1993, GENE DEV, V7, P787, DOI 10.1101/gad.7.5.787; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stieger PA, 2004, PLANT PHYSIOL, V135, P1798, DOI 10.1104/pp.104.040899; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsai C. J., 2011, Genetics, genomics and breeding of poplar, P112; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; Tsukaya H, 2002, PLANT CELL PHYSIOL, V43, P372, DOI 10.1093/pcp/pcf051; Tsukaya Hirokazu, 2013, Arabidopsis Book, V11, pe0163, DOI [10.1199/tab.0072, 10.1199/tab.0163]; Wang ZB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11192; Wei HR, 2013, NEW PHYTOL, V200, P483, DOI 10.1111/nph.12375; White DWR, 2006, P NATL ACAD SCI USA, V103, P13238, DOI 10.1073/pnas.0604349103; Xie Q, 2002, NATURE, V419, P167, DOI 10.1038/nature00998; Yordanov YS, 2014, P NATL ACAD SCI USA, V111, P10001, DOI 10.1073/pnas.1405621111; Yordanov YS, 2010, PLANT CELL, V22, P3662, DOI 10.1105/tpc.110.078634	60	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180527	10.1371/journal.pone.0180527	http://dx.doi.org/10.1371/journal.pone.0180527			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686626	Green Submitted, Green Published, gold			2022-12-26	WOS:000405464100074
J	Case, A; Brisson, BK; Durham, AC; Rosen, S; Monslow, J; Buza, E; Salah, P; Gillem, J; Ruthel, G; Veluvolu, S; Kristiansen, V; Pure, E; Brown, DC; Sorenmo, KU; Volk, SW				Case, Ashley; Brisson, Becky K.; Durham, Amy C.; Rosen, Suzanne; Monslow, James; Buza, Elizabeth; Salah, Pascale; Gillem, Julie; Ruthel, Gordon; Veluvolu, Sridhar; Kristiansen, Veronica; Pure, Ellen; Brown, Dorothy C.; Sorenmo, Karin U.; Volk, Susan W.			Identification of prognostic collagen signatures and potential therapeutic stromal targets in canine mammary gland carcinoma	PLOS ONE			English	Article							INCIDENCE RATES; IN-SITU; DOGS; TUMORS; POPULATION; EXPRESSION; PROGRESSION; PARAMETERS; NEOPLASMS; SURVIVAL	Increasing evidence indicates that the tumor microenvironment plays a critical role in regulating the biologic behavior of breast cancer. In veterinary oncology, there is a need for improved prognostic markers to accurately identify dogs at risk for local and distant (metastatic) recurrence of mammary gland carcinoma and therefore would benefit from adjuvant therapy. Collagen density and fiber organization have been shown to regulate tumor progression in both mouse and human mammary tumors, with certain collagen signatures predicting poor outcomes in women with breast cancer. We hypothesized that collagen signatures in canine mammary tumor biopsies can serve as prognostic biomarkers and potential targets for treatment. We used second harmonic generation imaging to evaluate fibrillar collagen density, the presence of a tumor-stromal boundary, tumor associated collagen signatures (TACS) and individual collagen fiber characteristics (width, length and straightness) in grade I/II and grade III canine mammary tumors. Collagen density, as well as fiber width, length and straightness, were inversely correlated with patient overall survival time. Notably, grade III cases were less likely to have a tumor-stromal boundary and the lack of a boundary predicted poor outcome. Importantly, a lack of a defined tumor-stromal boundary and an increased collagen fiber width were associated with decreased survival even when tumor grade, patient stage, ovariohysterectomy status at the time of mammary tumor excision, and histologic evidence of lymphovascular invasion were considered in a multivariable model, indicating that these parameters could augment current methods to identify patients at high risk for local or metastatic progression/recurrence. Furthermore, these data, which identify for the first time, prognostic collagen biomarkers in naturally occurring mammary gland neoplasia in the dog, support the use of the dog as a translational model for tumor-stromal interactions in breast cancer.	[Case, Ashley; Brisson, Becky K.; Rosen, Suzanne; Salah, Pascale; Gillem, Julie; Veluvolu, Sridhar; Brown, Dorothy C.; Volk, Susan W.] Univ Penn, Sch Vet Med, Dept Clin Sci & Adv Med, Philadelphia, PA 19104 USA; [Durham, Amy C.; Buza, Elizabeth; Ruthel, Gordon] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Monslow, James; Pure, Ellen; Sorenmo, Karin U.; Volk, Susan W.] Univ Penn, Sch Vet Med, Dept Biomed Sci, Philadelphia, PA 19104 USA; [Kristiansen, Veronica] Norwegian Univ Life Sci, Dept Compan Anim Clin Sci Vet Med & Biosci, Oslo, Norway	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Norwegian University of Life Sciences	Volk, SW (corresponding author), Univ Penn, Sch Vet Med, Dept Clin Sci & Adv Med, Philadelphia, PA 19104 USA.; Sorenmo, KU; Volk, SW (corresponding author), Univ Penn, Sch Vet Med, Dept Biomed Sci, Philadelphia, PA 19104 USA.	karins@vetupenn.edu; strevolk@vet.upenn.edu		Ruthel, Gordon/0000-0001-9193-5589	Greatergood org; Petco Foundation; Blue Buffalo Foundation; National Institutes of Health [510RR027128, 1S100D021633]; Morris Animal Foundation; University of Pennsylvania; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER	Greatergood org; Petco Foundation; Blue Buffalo Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Morris Animal Foundation; University of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding from Greatergood org (to KS and SWV), the Petco Foundation, the Blue Buffalo Foundation (to KS) and a kind gift from the Jack and Mina Ebrahimi Foundation (to SWV). National Institutes of Health grants 510RR027128 and 1S100D021633 provided funding for instrumentation in the Penn Vet Imaging Core facility. Mammary tumor samples and clinical outcome data for dogs treated at the Norwegian University of Life Sciences were in part sponsored by funds from the Morris Animal Foundation (morrisanimalfoundation.org), while funds for the University of Pennsylvania cases enrolled in the prospective study were provided to the Penn Vet Shelter Canine Mammary Tumor Program (to KS).	Acerbi I, 2015, INTEGR BIOL-UK, V7, P1120, DOI 10.1039/c5ib00040h; American Cancer Society, 2011, GLOB CANC FACTS FIG; Benjamin SA, 1999, VET PATHOL, V36, P423, DOI 10.1354/vp.36-5-423; Boyd NF, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2942; Bredfeldt Jeremy S, 2014, J Pathol Inform, V5, P28, DOI 10.4103/2153-3539.139707; Bredfeldt JS, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.016007; Brisson BK, 2015, AM J PATHOL, V185, P1471, DOI 10.1016/j.ajpath.2015.01.029; Bronden LB, 2010, VET REC, V166, P586, DOI 10.1136/vr.b4808; Burke K, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.3.031106; Conklin MW, 2012, CELL ADHES MIGR, V6, P249, DOI 10.4161/cam.20567; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Dobson JM, 2002, J SMALL ANIM PRACT, V43, P240, DOI 10.1111/j.1748-5827.2002.tb00066.x; Drifka CR, 2015, MODERN PATHOL, V28, P1470, DOI 10.1038/modpathol.2015.97; Egenvall A, 2005, PREV VET MED, V69, P109, DOI 10.1016/j.prevetmed.2005.01.014; Elston C W, 2002, Histopathology, V41, P154; Gilkes DM, 2013, CANCER RES, V73, P3285, DOI 10.1158/0008-5472.CAN-12-3963; Hanley CJ, 2016, ONCOTARGET, V7, P6159, DOI 10.18632/oncotarget.6740; Heller DA, 2005, VET PATHOL, V42, P776, DOI 10.1354/vp.42-6-776; Kahn LH, 2008, AM J MED, V121, P169, DOI 10.1016/j.amjmed.2007.09.023; Kakkad Samata M, 2012, J Biomed Opt, V17, P116017, DOI 10.1117/1.JBO.17.11.116017; Karayannopoulou M, 2005, J COMP PATHOL, V133, P246, DOI 10.1016/j.jcpa.2005.05.003; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Kristiansen VM, 2016, J VET INTERN MED, V30, P230, DOI 10.1111/jvim.13812; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lo A, 2015, CANCER RES, V75, P2800, DOI 10.1158/0008-5472.CAN-14-3041; Lopez JI, 2011, INTEGR BIOL-UK, V3, P910, DOI 10.1039/c1ib00043h; Lyons TR, 2011, NAT MED, V17, P1109, DOI 10.1038/nm.2416; Maller O, 2013, J CELL SCI; Marshall EM, 2016, BREAST J; Merlo DF, 2008, J VET INTERN MED, V22, P976, DOI 10.1111/j.1939-1676.2008.0133.x; Misdorp W, 2002, VET QUART, V24, P1; Moe L, 2001, J REP FER S, P439; Munson Linda, 2007, Breast Dis, V28, P7; Pena L, 2013, VET PATHOL, V50, P94, DOI 10.1177/0300985812447830; Pointer KB, 2016, J NEUROSURG, P1; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Rasotto R, 2012, VET PATHOL, V49, P330, DOI 10.1177/0300985811409253; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Rutteman G, 2001, SMALL ANIMAL CLIN ON; Santos M, 2015, ANTICANCER RES, V35, P4219; Santos M, 2014, VET J, V200, P426, DOI 10.1016/j.tvjl.2014.03.019; Sapudom J, 2015, BIOMATERIALS, V52, P367, DOI 10.1016/j.biomaterials.2015.02.022; SCHNEIDER R, 1970, CANCER-AM CANCER SOC, V26, P419, DOI 10.1002/1097-0142(197008)26:2&lt;419::AID-CNCR2820260225&gt;3.0.CO;2-U; Sorenmo KU, 2011, VET PATHOL, V48, P85, DOI 10.1177/0300985810389480; Sorenmo KU, 2009, VET COMP ONCOL, V7, P162, DOI 10.1111/j.1476-5829.2009.00184.x; Takai K, 2016, ONCOTARGET; Tchou J, 2013, HUM PATHOL, V44, P2549, DOI 10.1016/j.humpath.2013.06.016; Tran CM, 2016, VET COMP ONCOL, V14, P252, DOI 10.1111/vco.12092; Uva P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-135; Walker RA, 2001, BREAST CANCER RES, V3, P143, DOI 10.1186/bcr287; Xiong GF, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-1; Yoshimura H, 2011, VET PATHOL, V48, P313, DOI 10.1177/0300985810369901; Zhang K, 2013, NAT CELL BIOL, V15, P677, DOI 10.1038/ncb2743	55	26	26	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180448	10.1371/journal.pone.0180448	http://dx.doi.org/10.1371/journal.pone.0180448			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683102	Green Published, gold, Green Submitted			2022-12-26	WOS:000405335200037
J	Lee, HU; Blasiak, A; Agrawal, DR; Loong, DTB; Thakor, NV; All, AH; Ho, JS; Yang, IH				Lee, Hae Ung; Blasiak, Agata; Agrawal, Devansh R.; Loong, Daniel Teh Boon; Thakor, Nitish V.; All, Angelo H.; Ho, John S.; Yang, In Hong			Subcellular electrical stimulation of neurons enhances the myelination of axons by oligodendrocytes	PLOS ONE			English	Article							DIRECTIONAL MIGRATION; IN-VIVO; DIFFERENTIATION; PRECURSORS; PLATFORM; SYSTEM; CELLS	Myelin formation has been identified as a modulator of neural plasticity. New tools are required to investigate the mechanisms by which environmental inputs and neural activity regulate myelination patterns. In this study, we demonstrate a microfluidic compartmentalized culture system with integrated electrical stimulation capabilities that can induce neural activity by whole cell and focal stimulation. A set of electric field simulations was performed to confirm spatial restriction of the electrical input in the compartmentalized culture system. We further demonstrate that electrode localization is a key consideration for generating uniform the stimulation of neuron and oligodendrocytes within the compartments. Using three configurations of the electrodes we tested the effects of subcellular activation of neural activity on distal axon myelination with oligodendrocytes. We further investigated if oligodendrocytes have to be exposed to the electrical field to induce axon myelination. An isolated stimulation of cell bodies and proximal axons had the same effect as an isolated stimulation of distal axons co-cultured with oligodendrocytes, and the two modes had a non-different result than whole cell stimulation. Our platform enabled the demonstration that electrical stimulation enhances oligodendrocyte maturation and myelin formation independent of the input localization and oligodendrocyte exposure to the electrical field.	[Lee, Hae Ung; Blasiak, Agata; Agrawal, Devansh R.; Loong, Daniel Teh Boon; Thakor, Nitish V.; All, Angelo H.; Ho, John S.; Yang, In Hong] Natl Univ Singapore, Singapore Inst Neurotechnol, Singapore, Singapore; [Thakor, Nitish V.; All, Angelo H.; Yang, In Hong] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [All, Angelo H.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Ho, John S.] Natl Univ Singapore, Dept Elect & Comp Engn, Singapore, Singapore	National University of Singapore; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; National University of Singapore	Yang, IH (corresponding author), Natl Univ Singapore, Singapore Inst Neurotechnol, Singapore, Singapore.; Yang, IH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	iyang3@jhmi.edu	Thakor, Nitish V/A-5878-2008; Loong, Daniel Teh Boon/AAF-6660-2019	Loong, Daniel Teh Boon/0000-0002-4560-8568; Agrawal, Devansh/0000-0002-0236-9077; Ho, John/0000-0002-9458-9033; Blasiak, Agata/0000-0003-0727-7611; Yang, In Hong/0000-0002-1020-0538	Singapore Institute for Neurotechnology Seed Fund [R-175-000-121-733]	Singapore Institute for Neurotechnology Seed Fund	All authors and consumables were funded by R-175-000-121-733 Singapore Institute for Neurotechnology Seed Fund.	All AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047645; [Anonymous], 1956, J RES NBS, V56; [Anonymous], 1992, PRACTICAL ELECTROPHY, P67; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Biasiak A, 2017, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00298; Chang KJ, 2016, NAT NEUROSCI, V19, P190, DOI 10.1038/nn.4200; Charvet G, 2010, IEEE ENG MED BIO, P1804, DOI 10.1109/IEMBS.2010.5626403; de Hoz L, 2015, BIOESSAYS, V37, P60, DOI 10.1002/bies.201400127; FITZGERALD M, 1987, NATURE, V326, P603, DOI 10.1038/326603a0; Fumagalli M, 2011, J BIOL CHEM, V286, P10593, DOI 10.1074/jbc.M110.162867; Gadani DH, 2012, INDIAN J PURE AP PHY, V50, P405; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Hines JH, 2015, NAT NEUROSCI, V18, P683, DOI 10.1038/nn.3992; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Kerman BE, 2015, DEVELOPMENT, V142, P2213, DOI 10.1242/dev.116517; Lee HU, 2016, ACS CHEM NEUROSCI, V7, P1317, DOI 10.1021/acschemneuro.6b00157; Lee S, 2012, NAT METHODS, V9, P917, DOI 10.1038/nmeth.2105; Li Q, 2010, NEUROSCI LETT, V479, P128, DOI 10.1016/j.neulet.2010.05.043; Li YC, 2015, AM J PHYSIOL-CELL PH, V309, pC532, DOI 10.1152/ajpcell.00175.2015; Li YC, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0042-0; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Malone M, 2013, GLIA, V61, P843, DOI 10.1002/glia.22476; McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960; Mensch S, 2015, NAT NEUROSCI, V18, P628, DOI 10.1038/nn.3991; Park HS, 2013, IEEE ENG MED BIO, P2833, DOI 10.1109/EMBC.2013.6610130; Park J, 2009, BIOMED MICRODEVICES, V11, P1145, DOI 10.1007/s10544-009-9331-7; Radman T, 2009, BRAIN STIMUL, V2, P215, DOI 10.1016/j.brs.2009.03.007; Rosenberg SS, 2008, P NATL ACAD SCI USA, V105, P14662, DOI 10.1073/pnas.0805640105; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Walczak P, 2011, GLIA, V59, P499, DOI 10.1002/glia.21119; WAXMAN SG, 1980, MUSCLE NERVE, V3, P141, DOI 10.1002/mus.880030207; Yang IH, 2012, NEUROMOL MED, V14, P112, DOI 10.1007/s12017-012-8170-5; Yang IH, 2009, EXP NEUROL, V218, P124, DOI 10.1016/j.expneurol.2009.04.017; 1999, POLYM DATA HDB	35	24	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0179642	10.1371/journal.pone.0179642	http://dx.doi.org/10.1371/journal.pone.0179642			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671962	Green Published, Green Submitted, gold			2022-12-26	WOS:000405268500004
J	Longato, E; Garrido, M; Saccardo, D; Guevara, CM; Mani, AR; Bolognesi, M; Amodio, P; Facchinetti, A; Sparacino, G; Montagnese, S				Longato, Enrico; Garrido, Maria; Saccardo, Desy; Guevara, Camila Montesinos; Mani, Ali R.; Bolognesi, Massimo; Amodio, Piero; Facchinetti, Andrea; Sparacino, Giovanni; Montagnese, Sara			Expected accuracy of proximal and distal temperature estimated by wireless sensors, in relation to their number and position on the skin	PLOS ONE			English	Article							BODY-TEMPERATURE; SURFACE-TEMPERATURE; CONTACT THERMOMETRY; CIRCADIAN-RHYTHMS; SLEEP; CALORIMETRY; MELATONIN; FORMULAS; SYSTEM; ONSET	A popular method to estimate proximal/distal temperature (T-PROX and T-DIST) consists in calculating a weighted average of nine wireless sensors placed on pre-defined skin locations. Specifically, T-PROX is derived from five sensors placed on the infra-clavicular and mid-thigh area (left and right) and abdomen, and T-DIST from four sensors located on the hands and feet. In clinical practice, the loss/removal of one or more sensors is a common occurrence, but limited information is available on how this affects the accuracy of temperature estimates. The aim of this study was to determine the accuracy of temperature estimates in relation to number/position of sensors removed. Thirteen healthy subjects wore all nine sensors for 24 hours and reference T-PROX and T-DIST time-courses were calculated using all sensors. Then, all possible combinations of reduced subsets of sensors were simulated and suitable weights for each sensor calculated. The accuracy of T-PROX and T-DIST estimates resulting from the reduced subsets of sensors, compared to reference values, was assessed by the mean squared error, the mean absolute error (MAE), the cross-validation error and the 25 th and 75 th percentiles of the reconstruction error. Tables of the accuracy and sensor weights for all possible combinations of sensors are provided. For instance, in relation to T-PROX, a subset of three sensors placed in any combination of three non-homologous areas (abdominal, right or left infra-clavicular, right or left mid-thigh) produced an error of 0.13 degrees C MAE, while the loss/removal of the abdominal sensor resulted in an error of 0.25 degrees C MAE, with the greater impact on the quality of the reconstruction. This information may help researchers/clinicians: i) evaluate the expected goodness of their T-PROX and T-DIST estimates based on the number of available sensors; ii) select the most appropriate subset of sensors, depending on goals and operational constraints.	[Longato, Enrico; Facchinetti, Andrea; Sparacino, Giovanni] Univ Padua, Dept Informat Engn, Padua, Italy; [Garrido, Maria; Saccardo, Desy; Guevara, Camila Montesinos; Bolognesi, Massimo; Amodio, Piero; Montagnese, Sara] Univ Padua, Dept Med, Padua, Italy; [Guevara, Camila Montesinos; Mani, Ali R.] UCL, Div Med, London, England	University of Padua; University of Padua; University of London; University College London	Montagnese, S (corresponding author), Univ Padua, Dept Med, Padua, Italy.	sara.montagnese@unipd.it	Garrido, Maria/AAG-7793-2020; Mani, Alireza/H-3236-2015; BOLOGNESI, MASSIMO/G-4742-2012	Garrido, Maria/0000-0002-6987-1950; Mani, Alireza/0000-0003-0830-2022; Simancas-Racines, Daniel/0000-0002-3641-1501; Amodio, Piero/0000-0002-2395-7599; BOLOGNESI, MASSIMO/0000-0002-9715-5572; Longato, Enrico/0000-0001-5940-645X; Montesinos-Guevara, Camila/0000-0001-6763-3644	Italian Ministry of Health [2009-1604309]; Gobierno de Extremadura [European Regional Development Fund (ERDF)] [P014013]	Italian Ministry of Health(Ministry of Health, Italy); Gobierno de Extremadura [European Regional Development Fund (ERDF)]	The work was partly funded by a grant from The Italian Ministry of Health to S.M. (Giovani Ricercatori 2009-1604309); M.G. holds a research post-doctoral fellowship from Gobierno de Extremadura [jointly financed by the European Regional Development Fund (ERDF); ref. P014013]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach AJE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117907; Batinga H, 2015, AGE, V37, DOI 10.1007/s11357-015-9768-y; Buono MJ, 2007, PHYSIOL MEAS, V28, P855, DOI 10.1088/0967-3334/28/8/008; Burton AC, 1935, J NUTR, V9, P261, DOI 10.1093/jn/9.3.261; Choi JK, 1997, INT J BIOMETEOROL, V41, P68, DOI 10.1007/s004840050056; CRAWSHAW LI, 1975, PFLUG ARCH EUR J PHY, V354, P19, DOI 10.1007/BF00584500; Gagge A.P., 2010, COMPREHENSIVE PHYSL, P69, DOI DOI 10.1002/CPHY.CP090105; Hardy JD, 1938, J NUTR, V15, P461, DOI 10.1093/jn/15.5.461; Hasselberg MJ, 2013, SLEEP MED, V14, P5, DOI 10.1016/j.sleep.2010.12.011; Jones H, 2014, CHRONOBIOL INT, V31, P157, DOI 10.3109/07420528.2013.833516; Jutte LS, 2001, ARCH PHYS MED REHAB, V82, P845, DOI 10.1053/apmr.2001.23195; Krauchi K, 1997, AM J PHYSIOL-REG I, V272, pR1178, DOI 10.1152/ajpregu.1997.272.4.R1178; Krauchi K, 1999, NATURE, V401, P36, DOI 10.1038/43366; Krauchi K, 1999, SLEEP, V22, pS285; Antunez JM, 2016, CHRONOBIOL INT, V33, P1410, DOI 10.1080/07420528.2016.1223092; Martinez-Nicolas A, 2015, PHYSIOL BEHAV, V149, P203, DOI 10.1016/j.physbeh.2015.06.014; MITCHELL D, 1969, J APPL PHYSIOL, V26, P616, DOI 10.1152/jappl.1969.26.5.616; NADEL ER, 1973, PFLUG ARCH EUR J PHY, V340, P71, DOI 10.1007/BF00592198; Ortiz-Tudela E, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2319-9; RAMANATHAN NL, 1964, J APPL PHYSIOL, V19, P531, DOI 10.1152/jappl.1964.19.3.531; Raymann RJEM, 2005, AM J PHYSIOL-REG I, V288, pR1589, DOI 10.1152/ajpregu.00492.2004; Rutkove SB, 2007, PHYSIOL MEAS, V28, P1421, DOI 10.1088/0967-3334/28/11/008; Rutrove SB, 2009, DIABETES CARE, V32, P671, DOI 10.2337/dc08-1844; Sarabia JA, 2008, PHYSIOL BEHAV, V95, P570, DOI 10.1016/j.physbeh.2008.08.005; TEICHNER WH, 1958, J APPL PHYSIOL, V12, P169, DOI 10.1152/jappl.1958.12.2.169; Tyler CJ, 2011, PHYSIOL MEAS, V32, P1541, DOI 10.1088/0967-3334/32/10/003; van den Heuvel CJ, 2003, PHYSIOL MEAS, V24, P717, DOI 10.1088/0967-3334/24/3/308; Lichtenbelt WDV, 2006, PHYSIOL BEHAV, V88, P489, DOI 10.1016/j.physbeh.2006.04.026; Winslow CEA, 1936, AM J PHYSIOL, V116, P641; Zornoza-Moreno M, 2011, CHRONOBIOL INT, V28, P330, DOI 10.3109/07420528.2011.565895	30	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180315	10.1371/journal.pone.0180315	http://dx.doi.org/10.1371/journal.pone.0180315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666029	Green Submitted, gold, Green Published			2022-12-26	WOS:000404608700084
J	Ashikari, D; Takayama, K; Tanaka, T; Suzuki, Y; Obinata, D; Fujimura, T; Urano, T; Takahashi, S; Inoue, S				Ashikari, D.; Takayama, K.; Tanaka, T.; Suzuki, Y.; Obinata, D.; Fujimura, T.; Urano, T.; Takahashi, S.; Inoue, S.			Androgen induces G3BP2 and SUMO-mediated p53 nuclear export in prostate cancer	ONCOGENE			English	Article							GTPASE-ACTIVATING PROTEIN; BINDING-PROTEINS; RECEPTOR; MDM2; PROMOTES; CELLS; EXPRESSION; NETWORK; RNA; TUMORIGENESIS	The androgen receptor (AR) has a central role in prostate cancer progression, particularly treatment-resistance disease including castration-resistant prostate cancer. Loss of the p53 tumor suppressor, a nuclear transcription factor, is also known to contribute to prostate malignancy. Here we report that p53 is translocated to the cytoplasm by androgen-mediated induction of G3BP2, a newly described direct target gene of AR. G3BP2 induces both cell cycle progression and blocks apoptosis. Translocation of p53 is regulated by androgen-dependent sumoylation mediated by the G3BP2-interacting SUMO-E3 ligase, RanBP2. G3BP2 knockdown results in reduced tumor growth and increased nuclear p53 accumulation in mouse xenograft models of prostate cancer with or without long-term androgen deprivation. Moreover, strong cytoplasmic p53 localization is correlated clinically with elevated G3BP2 expression and predicts poor prognosis and disease progression to the hormone-refractory state. Our findings reveal a new AR-mediated mechanism of p53 inhibition that promotes treatment-resistant prostate cancer.	[Ashikari, D.; Takayama, K.; Obinata, D.; Urano, T.; Inoue, S.] Univ Tokyo, Grad Sch Med, Dept Antiaging Med, Tokyo, Japan; [Ashikari, D.; Obinata, D.; Takahashi, S.] Nihon Univ, Sch Med, Dept Urol, Tokyo, Japan; [Takayama, K.; Obinata, D.; Inoue, S.] Tokyo Metropolitan Inst Gerontol, Dept Funct Biogerontol, Tokyo, Japan; [Tanaka, T.] Chiba Univ, Grad Sch Med, Dept Clin Cell Biol, Chiba, Japan; [Tanaka, T.] Chiba Univ, Grad Sch Med, Div Endocrinol & Metab, Chiba, Japan; [Suzuki, Y.] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Lab Funct Genom, Chiba, Japan; [Fujimura, T.] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo, Japan; [Inoue, S.] Saitama Med Univ, Res Ctr Genom Med, Div Gene Regulat & Signal Transduct, Hidaka, Japan	University of Tokyo; Nihon University; Tokyo Metropolitan Institute of Gerontology; Chiba University; Chiba University; University of Tokyo; University of Tokyo; Saitama Medical University	Inoue, S (corresponding author), Tokyo Metropolitan Inst Gerontol, Dept Funct Biogerontol, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.	sinoue@tmig.or.jp	Urano, Tomohiko/AFS-9574-2022; Takayama, Kenichi/AAK-9238-2020	Tanaka, Tomoaki/0000-0002-9761-1750	Grants of the Cell Innovation Program; P-Direct from the MEXT, Japan; JSPS, Japan; MHLW, Japan; Program for Promotion of Fundamental Studies in Health Sciences; NIBIO, Japan; Takeda Science Foundation; Mochida Memorial Research Foundation, Japan; Yasuda Memorial Foundation; Princess Takamatsu Cancer Research Fund	Grants of the Cell Innovation Program; P-Direct from the MEXT, Japan; JSPS, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MHLW, Japan; Program for Promotion of Fundamental Studies in Health Sciences; NIBIO, Japan(National Institute of Biomedical Innovation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Research Foundation, Japan; Yasuda Memorial Foundation; Princess Takamatsu Cancer Research Fund	We thank Professor Takashi Suzuki (Tohoku University) for comments on our pathological analysis. We thank E Sakamoto and N Sasaki for technical assistance. This work was supported by Grants of the Cell Innovation Program and the P-Direct (both to SI) from the MEXT, Japan; by Grants (to SI and KT) from the JSPS, Japan; by Grants-in-Aid (to SI) from the MHLW, Japan; by the Program for Promotion of Fundamental Studies in Health Sciences (to SI), NIBIO, Japan; by Grants from Takeda Science Foundation (to SI and KT); and by Grants from Mochida Memorial Research Foundation (to KT), Japan, the Yasuda Memorial Foundation (to KT) and Princess Takamatsu Cancer Research Fund (to KT).	Brooks CL, 2011, PROTEIN CELL, V2, P456, DOI 10.1007/s13238-011-1063-9; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Chappell WH, 2012, CELL CYCLE, V11, P4579, DOI 10.4161/cc.22852; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Debes JD, 2002, CANCER LETT, V187, P1, DOI 10.1016/S0304-3835(02)00413-5; Dehm SM, 2006, J CELL BIOCHEM, V99, P333, DOI 10.1002/jcb.20794; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; French J, 2002, HISTOCHEM J, V34, P223, DOI 10.1023/A:1021737413055; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Guttler T, 2011, EMBO J, V30, P3457, DOI 10.1038/emboj.2011.287; Guitard E, 2001, CANCER LETT, V162, P213, DOI 10.1016/S0304-3835(00)00638-8; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irvine K, 2004, INT J DEV BIOL, V48, P1065, DOI 10.1387/ijdb.041893ki; Jenkins LMM, 2012, CARCINOGENESIS, V33, P1441, DOI 10.1093/carcin/bgs145; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kim MM, 2007, ONCOGENE, V26, P4209, DOI 10.1038/sj.onc.1210212; Kluth M, 2014, INT J CANCER, V135, P1369, DOI 10.1002/ijc.28784; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Liu CF, 2013, PROSTATE, V73, P418, DOI 10.1002/pros.22583; Lu X, 2013, ONCOGENE, V32, P2900, DOI 10.1038/onc.2012.299; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Misawa A, 2016, J BIOL CHEM, V291, P17861, DOI 10.1074/jbc.M116.718536; Moretti RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093713; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Obinata D, 2012, INT J CANCER, V130, P1021, DOI 10.1002/ijc.26043; Ohtsubo C, 2009, CANCER SCI, V100, P1291, DOI 10.1111/j.1349-7006.2009.01180.x; Parker F, 1996, MOL CELL BIOL, V16, P2561; Quinn DI, 2000, CANCER RES, V60, P1585; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Santiago A, 2013, MOL BIOL CELL, V24, P2739, DOI 10.1091/mbc.E12-10-0771; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Stattin P, 1996, EUR UROL, V30, P65; Takayama K, 2011, ONCOGENE, V30, P619, DOI 10.1038/onc.2010.436; Takayama K, 2014, CANCER RES, V74, P6542, DOI 10.1158/0008-5472.CAN-14-1030; Takayama K, 2013, INT J UROL, V20, P756, DOI 10.1111/iju.12146; Takayama K, 2013, EMBO J, V32, P1665, DOI 10.1038/emboj.2013.99; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Werner A, 2012, MOL CELL, V46, P287, DOI 10.1016/j.molcel.2012.02.017; Winslow S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-156	47	40	44	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 9	2017	36	45					6272	6281		10.1038/onc.2017.225	http://dx.doi.org/10.1038/onc.2017.225			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FM1WY	28692047				2022-12-26	WOS:000414774800006
J	Versteeg, RI; Schrantee, A; Adriaanse, SM; Unmehopa, UA; Booij, J; Reneman, L; Fliers, E; la Fleur, SE; Serlie, MJ				Versteeg, Ruth I.; Schrantee, Anouk; Adriaanse, Sofie M.; Unmehopa, Unga A.; Booij, Jan; Reneman, Liesbeth; Fliers, Eric; la Fleur, Susanne E.; Serlie, Mireille J.			Timing of caloric intake during weight loss differentially affects striatal dopamine transporter and thalamic serotonin transporter binding	FASEB JOURNAL			English	Article						obesity; neuroimaging; brain; striatum; thalamus	BODY-MASS INDEX; D-2/3 RECEPTOR AVAILABILITY; DIET-INDUCED OBESITY; NUCLEUS-ACCUMBENS; FOOD-INTAKE; I-123-FP-CIT SPECT; HEALTHY-VOLUNTEERS; HUMAN HYPOTHALAMUS; BARIATRIC SURGERY; CORTICAL SURFACE	Recent studies have shown that meal timing throughout the day contributes to maintaining or regaining weight after hypocaloric diets. Although brain serotonin and dopamine are well known to be involved in regulating feeding, it is unknown whether meal timing during energy restriction affects these neurotransmitter systems. We studied the effect of a 4 wk hypocaloric diet with either 50% of daily calories consumed at breakfast (BF group) or at dinner (D group) on hypothalamic and thalamic serotonin transporter (SERT) binding and on striatal dopamine transporter (DAT) binding. The BF and D groups lost a similar amount of weight. Striatal DAT and thalamic SERT binding increased in the BF group, while decreasing in the D group after the diet (Delta DAT 0.37 +/- 0.63 vs. -0.53 +/- 0.77, respectively; P = 0.005; Delta SERT 0.12 +/- 0.25 vs. -0.13 +/- 0.26 respectively, P = 0.032). Additional voxel-based analysis showed an increase in DAT binding in the ventral striatum in the BF group and a decrease in the dorsal striatum in the D group. During weight loss, striatal DAT and thalamic SERT binding increased weight independently when 50% of daily calories were consumed at breakfast, whereas it decreased when caloric intake was highest at dinner. These findings may contribute to the earlier reported favorable effect of meal timing on weight maintenance after hypocaloric diets.-Versteeg, R. I., Schrantee, A., Adriaanse, S. M., Unmehopa, U. A., Booij, J., Reneman, L., Fliers, E., la Fleur, S. E., Serlie, M. J. Timing of caloric intake during weight loss differentially affects striatal dopamine transporter and thalamic serotonin transporter binding.	[Versteeg, Ruth I.; Unmehopa, Unga A.; Fliers, Eric; la Fleur, Susanne E.; Serlie, Mireille J.] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, Meibergdreef 9,F5 167, NL-1105 AZ Amsterdam, Netherlands; [Schrantee, Anouk; Reneman, Liesbeth] Univ Amsterdam, Acad Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Adriaanse, Sofie M.; Booij, Jan] Univ Amsterdam, Acad Med Ctr, Dept Nucl Med, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Serlie, MJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, Meibergdreef 9,F5 167, NL-1105 AZ Amsterdam, Netherlands.	m.j.serlie@amc.nl	Booij, Jan/AAD-7159-2019; Unmehopa, Unga A/E-3623-2012	Schrantee, Anouk/0000-0002-4035-4845	Dutch Technology Foundation (STW) [12189]; Netherlands Organisation for Health Research and Development (ZonMw; Investeringen Middelgroot) Grant [91112002]	Dutch Technology Foundation (STW)(Technologiestichting STW); Netherlands Organisation for Health Research and Development (ZonMw; Investeringen Middelgroot) Grant	The authors thank Roos van der Zwan (University of Amsterdam, Amsterdam, The Netherlands) for her help with the acquisition of the SPECT scans. This study was supported by The Dutch Technology Foundation (STW) OnTime Project 12189, and by a grant from the Netherlands Organisation for Health Research and Development (ZonMw; Investeringen Middelgroot) Grant 91112002. M.J.S. serves on the advisory board of Fresenius Kabi Netherlands (Zeist, The Netherlands). J.B. is a consultant at GE Healthcare. The remaining authors declare no conflicts of interest.	Anderson JW, 2001, AM J CLIN NUTR, V74, P579; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Baron KG, 2011, OBESITY, V19, P1374, DOI 10.1038/oby.2011.100; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; Booij J, 1998, J NUCL MED, V39, P1879; Booij J, 2007, J NUCL MED, V48, P359; Borgers AJ, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-34; Chen PS, 2008, NEUROIMAGE, V40, P275, DOI 10.1016/j.neuroimage.2007.11.007; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davis LM, 2009, NEUROENDOCRINOLOGY, V89, P152, DOI 10.1159/000170586; de Weijer BA, 2013, OBESITY, V21, P1143, DOI 10.1002/oby.20220; de Weijer BA, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-37; DeFronzo RA, 2011, DIABETES CARE, V34, P789, DOI 10.2337/dc11-0064; Elfers Clinton Thomas, 2011, Front Endocrinol (Lausanne), V2, P78, DOI 10.3389/fendo.2011.00078; Erritzoe D, 2010, NEUROIMAGE, V52, P284, DOI 10.1016/j.neuroimage.2010.03.086; Ferris MJ, 2014, P NATL ACAD SCI USA, V111, pE2751, DOI 10.1073/pnas.1407935111; Garaulet M, 2013, INT J OBESITY, V37, P604, DOI 10.1038/ijo.2012.229; Garaulet M, 2014, PHYSIOL BEHAV, V134, P44, DOI 10.1016/j.physbeh.2014.01.001; Goldfield GS, 2007, AM J CLIN NUTR, V86, P308, DOI 10.1093/ajcn/86.2.308; Halford JCG, 2007, DRUGS, V67, P27, DOI 10.2165/00003495-200767010-00004; Hesse S, 2014, EUR NEUROPSYCHOPHARM, V24, P1240, DOI 10.1016/j.euroneuro.2014.05.005; Horstmann A, 2015, OBES REV, V16, P821, DOI 10.1111/obr.12303; Jakubowicz D, 2013, OBESITY, V21, P2504, DOI 10.1002/oby.20460; Jakubowicz D, 2012, STEROIDS, V77, P323, DOI 10.1016/j.steroids.2011.12.006; Kassirer JP, 1998, NEW ENGL J MED, V338, P52, DOI 10.1056/NEJM199801013380109; Kelley AE, 2005, J COMP NEUROL, V493, P72, DOI 10.1002/cne.20769; Koopman KE, 2012, J NUCL MED, V53, P1087, DOI 10.2967/jnumed.111.102277; Koopman KE, 2013, MOL METAB, V2, P417, DOI 10.1016/j.molmet.2013.07.006; Koskela AK, 2008, PHYSIOL BEHAV, V93, P724, DOI 10.1016/j.physbeh.2007.11.043; Lee JS, 2015, BRAIN RES, V1598, P97, DOI 10.1016/j.brainres.2014.12.029; Li YH, 2010, PSYCHOPHARMACOLOGY, V212, P251, DOI 10.1007/s00213-010-1948-y; MOORE RY, 1978, J COMP NEUROL, V180, P417, DOI 10.1002/cne.901800302; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Narayanaswami V, 2013, INT J OBESITY, V37, P1095, DOI 10.1038/ijo.2012.178; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Norgren R, 2006, PHYSIOL BEHAV, V89, P531, DOI 10.1016/j.physbeh.2006.05.024; Orosco M, 2000, BRAIN RES, V872, P64, DOI 10.1016/S0006-8993(00)02449-5; Parsons MP, 2007, J COMP NEUROL, V500, P1050, DOI 10.1002/cne.21224; Raeder MB, 2006, J CLIN PSYCHIAT, V67, P1974, DOI 10.4088/JCP.v67n1219; Shinohara M, 2004, J PSYCHIATR NEUROSCI, V29, P134; Sleipness EP, 2007, BRAIN RES, V1129, P34, DOI 10.1016/j.brainres.2006.10.063; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; South T, 2008, NEUROCHEM RES, V33, P598, DOI 10.1007/s11064-007-9483-x; Speed N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025169; Stouffer MA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9543; Sumithran P, 2013, CLIN SCI, V124, P231, DOI 10.1042/CS20120223; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; SWAAB DF, 1993, ANAT EMBRYOL, V187, P317; ter Horst KW, 2015, INT J OBESITY, V39, P1703, DOI 10.1038/ijo.2015.125; Tomasi D, 2013, CRIT REV BIOCHEM MOL, V48, P1, DOI 10.3109/10409238.2012.735642; van de Giessen E, 2014, J PSYCHOPHARMACOL, V28, P866, DOI 10.1177/0269881114531664; van de Giessen E, 2013, NEUROIMAGE, V64, P61, DOI 10.1016/j.neuroimage.2012.09.011; van der Zwaal EM, 2016, EUR NEUROPSYCHOPHARM, V26, P1190, DOI 10.1016/j.euroneuro.2016.04.009; Versteeg R. I., 2016, NEUROENDOCRINOLOGY, V10, DOI [10.1016/j.molmet.2013.07.006, DOI 10.1016/J.MOLMET.2013.07.006]; Volkow ND, 2002, SYNAPSE, V44, P175, DOI 10.1002/syn.10075; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; Wickens JR, 2007, J NEUROSCI, V27, P8181, DOI 10.1523/JNEUROSCI.1671-07.2007	60	15	15	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4545	4554		10.1096/fj.201601234R	http://dx.doi.org/10.1096/fj.201601234R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28679529				2022-12-26	WOS:000413397400030
J	Kember, G; Ardell, JL; Shivkumar, K; Armour, JA				Kember, Guy; Ardell, Jeffrey L.; Shivkumar, Kalyanam; Armour, J. Andrew			Recurrent myocardial infarction: Mechanisms of free-floating adaptation and autonomic derangement in networked cardiac neural control	PLOS ONE			English	Article							CENTRAL COMMAND; NERVOUS-SYSTEM; HEART-FAILURE; EXERCISE; DEATH; TRANSPLANTATION; COMPENSATION; INTERMEDIATE; DENERVATION; ARRHYTHMIAS	The cardiac nervous system continuously controls cardiac function whether or not pathology is present. While myocardial infarction typically has a major and catastrophic impact, population studies have shown that longer-term risk for recurrent myocardial infarction and the related potential for sudden cardiac death depends mainly upon standard atherosclerotic variables and autonomic nervous system maladaptations. Investigative neurocardiology has demonstrated that autonomic control of cardiac function includes local circuit neurons for networked control within the peripheral nervous system. The structural and adaptive characteristics of such networked interactions define the dynamics and a new normal for cardiac control that results in the aftermath of recurrent myocardial infarction and/or unstable angina that may or may not precipitate autonomic derangement. These features are explored here via a mathematical model of cardiac regulation. A main observation is that the control environment during pathology is an extrapolation to a setting outside prior experience. Although global bounds guarantee stability, the resulting closed-loop dynamics exhibited while the network adapts during pathology are aptly described as 'free-floating' in order to emphasize their dependence upon details of the network structure. The totality of the results provide a mechanistic reasoning that validates the clinical practice of reducing sympathetic efferent neuronal tone while aggressively targeting autonomic derangement in the treatment of ischemic heart disease.	[Kember, Guy] Dalhousie Univ, Fac Engn, Dept Engn Math & Internetworking, Halifax, NS, Canada; [Ardell, Jeffrey L.; Shivkumar, Kalyanam; Armour, J. Andrew] Univ Calif Los Angeles, David Geffen Sch Med, Cardiac Arrhythmia Ctr, Los Angeles, CA 90095 USA	Dalhousie University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kember, G (corresponding author), Dalhousie Univ, Fac Engn, Dept Engn Math & Internetworking, Halifax, NS, Canada.	guy.kember@dal.ca	Shivkumar, Kalyanam/AAI-1085-2019	Shivkumar, Kalyanam/0000-0002-4121-1766	National Sciences and Engineering Research Council (NSERC) Discovery Grant [43354]; NIH SPARC [U18EB021799, 1OT2OD023848]	National Sciences and Engineering Research Council (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIH SPARC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Sciences and Engineering Research Council (NSERC) Discovery Grant 43354. (remaining three authors) JLA KS JAA: NIH SPARC U18EB021799 and 1OT2OD023848.	Ajijola OA, 2015, HEART RHYTHM, V12, P1027, DOI 10.1016/j.hrthm.2015.01.045; Ardell JL, 2016, J PHYSIOL-LONDON, V594, P3877, DOI 10.1113/JP271869; Ardell JL, 2016, COMPR PHYSIOL, V6, P1635, DOI 10.1002/cphy.c150046; Armour JA, 2008, EXP PHYSIOL, V93, P165, DOI 10.1113/expphysiol.2007.041178; Arora, 2000, Curr Interv Cardiol Rep, V2, P188; Baker LC, 2000, CIRC RES, V86, P396, DOI 10.1161/01.RES.86.4.396; Billman GE, 2006, PHARMACOL THERAPEUT, V111, P808, DOI 10.1016/j.pharmthera.2006.01.002; Buckley Una, 2015, Curr Heart Fail Rep, V12, P284, DOI 10.1007/s11897-015-0263-7; Cardinal R, 2009, AUTON NEUROSCI-BASIC, V145, P55, DOI 10.1016/j.autneu.2008.11.007; Florea VG, 2014, CIRC RES, V114, P1815, DOI 10.1161/CIRCRESAHA.114.302589; Fukuda K, 2015, CIRC RES, V116, P2005, DOI 10.1161/CIRCRESAHA.116.304679; Gibbons DD, 2012, AM J PHYSIOL-REG I, V302, pR357, DOI 10.1152/ajpregu.00535.2011; GOODWIN GM, 1972, J PHYSIOL-LONDON, V226, P173, DOI 10.1113/jphysiol.1972.sp009979; Guyenet PG, 2014, COMPR PHYSIOL, V4, P1511, DOI 10.1002/cphy.c140004; Habecker BA, 2016, J PHYSL, P1; Hardiman K, 2014, THESIS; Jokhadar M, 2004, AM J EPIDEMIOL, V159, P1040, DOI 10.1093/aje/kwh147; Kember G, 2013, PHYSIOL GENOMICS, V45, P638, DOI 10.1152/physiolgenomics.00027.2013; Kember G, 2011, J THEOR BIOL, V277, P41, DOI 10.1016/j.jtbi.2011.02.013; Kember G, 2014, PLOS ONE, P1; KUO CS, 1983, CIRCULATION, V67, P1356, DOI 10.1161/01.CIR.67.6.1356; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Marder E, 2015, CURR OPIN NEUROBIOL, V31, P156, DOI 10.1016/j.conb.2014.10.012; Murphy DA, 2000, ANN THORAC SURG, V69, P1769, DOI 10.1016/S0003-4975(00)01240-6; O'Leary T, 2014, NEURON, V82, P809, DOI 10.1016/j.neuron.2014.04.002; Potts JT, 1998, AM J PHYSIOL-HEART C, V275, pH2000, DOI 10.1152/ajpheart.1998.275.6.H2000; Rajendran PS, 2016, J PHYSIOL-LONDON, V594, P321, DOI 10.1113/JP271165; Salavatian S, 2016, AM J PHYSL HEART CIR; Shivkumar K, 2016, J PHYSL, P1; Tripathy SJ, 2013, P NATL ACAD SCI USA, V110, P8248, DOI 10.1073/pnas.1221214110; Vaseghi M, 2008, J AM COLL CARDIOL, V51, P2241, DOI 10.1016/j.jacc.2008.02.065; Vaseghi M, 2014, HEART RHYTHM, V11, P360, DOI 10.1016/j.hrthm.2013.11.028; Wang HJ, 2014, HYPERTENSION, V64, P745, DOI 10.1161/HYPERTENSIONAHA.114.03699; Williamson JW, 2015, AUTON NEUROSCI-BASIC, V188, P3, DOI 10.1016/j.autneu.2014.10.011; Williamson JW, 2010, EXP PHYSIOL, V95, P1043, DOI 10.1113/expphysiol.2009.051870; Zucker IH, 2012, HEART FAIL CLIN, V8, P87, DOI 10.1016/j.hfc.2011.08.007	36	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180194	10.1371/journal.pone.0180194	http://dx.doi.org/10.1371/journal.pone.0180194			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692680	Green Submitted, gold, Green Published			2022-12-26	WOS:000405544800029
J	Kraft, LJ; Kopco, J; Harmon, JP; Oliver, KM				Kraft, Laura J.; Kopco, James; Harmon, Jason P.; Oliver, Kerry M.			Aphid symbionts and endogenous resistance traits mediate competition between rival parasitoids	PLOS ONE			English	Article							PRAON-PEQUODORUM HYMENOPTERA; PEA APHID; CONFERRED RESISTANCE; EVOLUTIONARY ECOLOGY; BACTERIAL SYMBIONTS; HOST-RESISTANCE; SUSCEPTIBILITY; COVARIATION; VARIABILITY; PROTECTION	Insects use endogenous mechanisms and infection with protective symbionts to thwart attacks from natural enemies. Defenses that target specific enemies, however, potentially mediate competition between rivals and thereby impact community composition. Following its introduction to North America to control pea aphids (Acyrthosiphon pisum), the parasitoid Aphidius ervi competitively displaced other parasitoids, except for the native Praon pequodorum. The pea aphid exhibits tremendous clonal variation in resistance to A. ervi, primarily through infection with the heritable bacterial symbiont Hamiltonella defensa, although some symbiont-free aphid genotypes encode endogenous resistance. Interestingly, H. defensa strains and aphid genotypes that protect against A. ervi, provide no protection against the closely related, P. pequodorum. Given the specificity of aphid defenses, we hypothesized that aphid resistance traits may contribute to the continued persistence of P. pequodorum. We conducted multiparasitism assays to determine whether aphid resistance traits mediate internal competition between these two solitary parasitoid species, but found this was not the case; P. pequodorum was the successful internal competitor across lines varying in susceptibility to A. ervi. Next, to determine whether resistance traits influence competitive interactions resulting in the stable persistence of P. pequodorum, we established replicated cages varying in the proportion of resistant aphids and recorded successful parasitism for each wasp species over time. As expected, A. ervi outcompeted P. pequodorum in cages containing only susceptible aphids. However, P. pequodorum not only persisted, but was the superior competitor in populations containing any proportion (20-100%) of resistant aphids (20-100%). Smaller scale, better replicated competition cage studies corroborated this finding, and no-competition and behavioral assays provide insight into the processes mediating competition. Genetic variation, including that acquired via infection with protective symbionts, may provide a supply of hosts susceptible only to particular enemies, mediating competition with effects on community richness and stability.	[Kraft, Laura J.; Oliver, Kerry M.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA; [Kopco, James; Harmon, Jason P.] North Dakota State Univ, Dept Entomol, Fargo, ND USA	University System of Georgia; University of Georgia; North Dakota State University Fargo	Oliver, KM (corresponding author), Univ Georgia, Dept Entomol, Athens, GA 30602 USA.	kmoliver@uga.edu	Harmon, Jason/AAW-3036-2021; Oliver, Kerry/H-4498-2017	Harmon, Jason/0000-0002-2533-5005; Oliver, Kerry/0000-0002-2835-4017	National Science Foundation Dimensions in Biodiversity awards [1240804, 1241031]; Division Of Environmental Biology [1240804] Funding Source: National Science Foundation	National Science Foundation Dimensions in Biodiversity awards; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Dimensions in Biodiversity awards 1240804 (KMO) and 1241031 (JPH).	Asplen MK, 2014, ECOL ENTOMOL, V39, P736, DOI 10.1111/een.12153; Auld SKJR, 2013, J EVOLUTION BIOL, V26, P2479, DOI 10.1111/jeb.12243; CHOW FJ, 1985, CAN ENTOMOL, V117, P133, DOI 10.4039/Ent117133-1; CHOW FJ, 1984, CAN ENTOMOL, V116, P1097, DOI 10.4039/Ent1161097-8; Colares F, 2015, BIOL CONTROL, V90, P16, DOI 10.1016/j.biocontrol.2015.05.009; Danyk TP, 1996, BIOL CONTROL, V7, P67, DOI 10.1006/bcon.1996.0066; Danyk TP, 1992, THESIS; Degnan PH, 2008, APPL ENVIRON MICROB, V74, P6782, DOI 10.1128/AEM.01285-08; Dion E, 2011, J EVOLUTION BIOL, V24, P741, DOI 10.1111/j.1420-9101.2010.02207.x; Dion E, 2011, BIOL LETTERS, V7, P743, DOI 10.1098/rsbl.2011.0249; Doremus MR, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.03276-16, 10.1128/aem.03276-16]; Douglas AE, 2006, PHYSIOL ENTOMOL, V31, P262, DOI 10.1111/j.1365-3032.2006.00516.x; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Ferrari J, 2001, EVOLUTION, V55, P1805, DOI 10.1111/j.0014-3820.2001.tb00829.x; Ferrari J, 2012, EVOLUTION, V66, P375, DOI 10.1111/j.1558-5646.2011.01436.x; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Gruner DS, 2009, ECOLOGY, V90, P1721, DOI 10.1890/08-1616.1; Hare J.D., 1992, P278; Henry LM, 2005, ENTOMOL EXP APPL, V116, P167, DOI 10.1111/j.1570-7458.2005.00318.x; HENTER HJ, 1995, EVOLUTION, V49, P427, DOI [10.1111/j.1558-5646.1995.tb02275.x, 10.2307/2410267]; Hufbauer RA, 2001, ECOLOGY, V82, P717, DOI 10.1890/0012-9658(2001)082[0717:PAPIHP]2.0.CO;2; Ives AR, 1999, AM NAT, V154, P652, DOI 10.1086/303269; Kraaijeveld AR, 1998, PARASITOLOGY, V116, pS29, DOI 10.1017/S0031182000084924; Kraaijeveld AR, 2001, P ROY SOC B-BIOL SCI, V268, P259, DOI 10.1098/rspb.2000.1354; Kraaijeveld AR, 1999, AM NAT, V153, pS61, DOI 10.1086/303212; Lukasik P, 2013, ECOL LETT, V16, P214, DOI 10.1111/ele.12031; Mackauer M., 1973, Bulletin ent Soc NZ, V2, P20; Martinez AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154670; Martinez AJ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-127; McLean A. H., 2016, FUNCTIONAL ECOLOGY; McLean AHC, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0977; Meisner M, 2007, POPUL ECOL, V49, P347, DOI 10.1007/s10144-007-0054-4; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Oliver KM, 2008, P R SOC B, V275, P293, DOI 10.1098/rspb.2007.1192; Oliver KM, 2014, CURR OPIN INSECT SCI, V4, P1, DOI 10.1016/j.cois.2014.08.001; Oliver KM, 2014, FUNCT ECOL, V28, P341, DOI 10.1111/1365-2435.12133; Oliver KM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-11; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Oliver KM, 2009, SCIENCE, V325, P992, DOI 10.1126/science.1174463; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Parker BJ, 2013, APPL ENVIRON MICROB, V79, P2455, DOI 10.1128/AEM.03193-12; Poirie M, 2011, ISJ-INVERT SURVIV J, V8, P247; Polin S, 2014, ECOL EVOL, V4, P826, DOI 10.1002/ece3.991; Rouchet R, 2014, EVOLUTION, V68, P1607, DOI 10.1111/evo.12377; Russell JA, 2013, MOL ECOL, V22, P2045, DOI 10.1111/mec.12211; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Schellhorn NA, 2002, ECOLOGY, V83, P2745, DOI 10.1890/0012-9658(2002)083[2745:CBNAIP]2.0.CO;2; Schmid M, 2012, FUNCT ECOL, V26, P207, DOI 10.1111/j.1365-2435.2011.01904.x; SEQUEIRA R, 1987, ENTOMOL GEN, V12, P259; von Burg S, 2008, P ROY SOC B-BIOL SCI, V275, P1089, DOI 10.1098/rspb.2008.0018; Vorburger C, 2011, J EVOLUTION BIOL, V24, P1611, DOI 10.1111/j.1420-9101.2011.02292.x; Vorburger C, 2014, INSECT SCI, V21, P251, DOI 10.1111/1744-7917.12067; Vorburger C, 2010, BIOL LETTERS, V6, P109, DOI 10.1098/rsbl.2009.0642	54	18	18	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180729	10.1371/journal.pone.0180729	http://dx.doi.org/10.1371/journal.pone.0180729			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700614	Green Published, Green Submitted, gold			2022-12-26	WOS:000405544800070
J	Sarkar, O; Li, Y; Anand-Srivastava, MB				Sarkar, Oli; Li, Yuan; Anand-Srivastava, Madhu B.			Nitric oxide attenuates overexpression of Gia proteins in vascular smooth muscle cells from SHR: Role of ROS and ROS-mediated signaling	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; PEPTIDE RECEPTOR-C; NUCLEOTIDE REGULATORY PROTEIN; ENHANCED OXIDATIVE STRESS; GROWTH-FACTOR RECEPTOR; ADENYLYL-CYCLASE; ANGIOTENSIN-II; ALPHA PROTEINS; BLOOD-PRESSURE; ALTERED EXPRESSION	Vascular smooth muscle cells (VSMC) from spontaneously hypertensive rats (SHR) exhibit decreased levels of nitric oxide (NO) that may be responsible for the overexpression of Gia proteins that has been shown as a contributing factor for the pathogenesis of hypertension in SHR. The present study was undertaken to investigate if increasing the intracellular levels of NO by NO donor S-Nitroso-N-acetyl-DL-penicillamine (SNAP) could attenuate the enhanced expression of Gia proteins in VSMC from SHR and explore the underlying mechanisms responsible for this response. The expression of Gia proteins and phosphorylation of ERK1/2, growth factor receptors and c-Src was determined by Western blotting using specific antibodies. Treatment of VSMC from SHR with SNAP for 24 hrs decreased the enhanced expression of Gia-2 and Gia-3 proteins and hyperproliferation that was not reversed by 1H (1, 2, 4) oxadiazole (4, 3-a) quinoxalin-1-one (ODQ), an inhibitor of soluble guanylyl cyclase, however, PD98059, a MEK inhibitor restored the SNAP-induced decreased expression of Gia proteins towards control levels. In addition, the increased production of superoxide anion, NAD(P) H oxidase activity, overexpression of AT1 receptor, Nox4, p22 phox and p47 phox proteins, enhanced levels of TBARS and protein carbonyl, increased phosphorylation of PDGF-R, EGF-R, c-Src and ERK1/2 in VSMC from SHR were all decreased to control levels by SNAP treatment. These results suggest that NO decreased the enhanced expression of Gia-2/3 proteins and hyperproliferation of VSMC from SHR by cGMP-independent mechanism and involves ROS and ROS-mediated transactivation of EGF-R/PDGF-R and MAP kinase signaling pathways.	[Sarkar, Oli; Li, Yuan; Anand-Srivastava, Madhu B.] Univ Montreal, Dept Pharmacol & Physiol, Fac Med, Montreal, PQ, Canada	Universite de Montreal	Anand-Srivastava, MB (corresponding author), Univ Montreal, Dept Pharmacol & Physiol, Fac Med, Montreal, PQ, Canada.	madhu.anand-srivastava@umontreal.ca			Canadian Institutes of Health Research (CIHR) [MOP-53074]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	MBAS was funded by a grant from the Canadian Institutes of Health Research (CIHR) (MOP-53074).	ANANDSRIVASTAVA MB, 1993, AM J HYPERTENS, V6, P72, DOI 10.1093/ajh/6.1.72; ANANDSRIVASTAVA MB, 1992, BIOCHEM J, V288, P79, DOI 10.1042/bj2880079; ANANDSRIVASTAVA MB, 1982, BIOCHEM BIOPH RES CO, V108, P213, DOI 10.1016/0006-291X(82)91853-8; Arejian M, 2009, AM J PHYSIOL-HEART C, V296, pH1859, DOI 10.1152/ajpheart.01108.2008; Bar-Or D, 2001, BIOCHEM BIOPH RES CO, V284, P856, DOI 10.1006/bbrc.2001.5042; Bassil M, 2008, AM J PHYSIOL-HEART C, V294, pH775, DOI 10.1152/ajpheart.00841.2007; Bassil M, 2007, CELL BIOCHEM BIOPHYS, V47, P99, DOI 10.1385/CBB:47:1:99; Bassil M, 2006, FREE RADICAL BIO MED, V41, P1162, DOI 10.1016/j.freeradbiomed.2006.07.004; Berra-Romani R, 2008, AM J PHYSIOL-CELL PH, V295, pC779, DOI 10.1152/ajpcell.00173.2008; Blanco-Rivero J, 2011, EXP PHYSIOL, V96, P275, DOI 10.1113/expphysiol.2010.055822; BOHM M, 1992, HYPERTENSION, V20, P103, DOI 10.1161/01.HYP.20.1.103; Bou Daou G, 2015, CANADIAN J PHYSL PHA, P1; BRAY P, 1986, P NATL ACAD SCI USA, V83, P8893, DOI 10.1073/pnas.83.23.8893; CAHILL PA, 1995, EUR J PHARM-MOLEC PH, V288, P219, DOI 10.1016/0922-4106(95)90197-3; Crabos M, 1997, J MOL CELL CARDIOL, V29, P55, DOI 10.1006/jmcc.1996.0251; Di Fusco F, 2000, J HYPERTENS, V18, P1081; DUBEY RK, 1995, J CLIN INVEST, V96, P141, DOI 10.1172/JCI118014; El Andalousi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076183; FLEMING JW, 1992, CIRCULATION, V85, P420, DOI 10.1161/01.CIR.85.2.420; Fukuda N, 1999, ARTERIOSCL THROM VAS, V19, P1210, DOI 10.1161/01.ATV.19.5.1210; FUKUDA N, 1991, JPN CIRC J, V55, P721, DOI 10.1253/jcj.55.721; Ge C, 2006, CAN J PHYSIOL PHARM, V84, P739, DOI 10.1139/Y05-123; GILMAN AG, 1984, CELL, V36, P577, DOI 10.1016/0092-8674(84)90336-2; Gusan S, 2013, AM J PHYSIOL-CELL PH, V304, pC1198, DOI 10.1152/ajpcell.00269.2012; Hashim S, 2004, J HYPERTENS, V22, P181, DOI 10.1097/00004872-200401000-00028; Hashim S, 2006, AM J PHYSIOL-HEART C, V291, pH3144, DOI 10.1152/ajpheart.00327.2006; Hsieh HL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-152; ITOH H, 1988, J BIOL CHEM, V263, P6656; Kim SO, 2000, BIOCHIMICA ET BIOPHY, V1496, P2; Lahteenmaki T, 1998, BRIT J PHARMACOL, V125, P402, DOI 10.1038/sj.bjp.0702076; Lander HM, 1996, J BIOL CHEM, V271, P19705, DOI 10.1074/jbc.271.33.19705; Lane P, 1999, SEMIN NEPHROL, V19, P215; Lappas G, 2005, J HYPERTENS, V23, P2251, DOI 10.1097/01.hjh.0000191905.26853.f1; LEE RMKW, 1983, BLOOD VESSELS, V20, P72; Li Y, 2002, CIRC RES, V91, P247, DOI 10.1161/01.RES.0000029969.39875.4B; Li Y, 2007, AM J PHYSIOL-HEART C, V292, pH1922, DOI 10.1152/ajpheart.01166.2006; Li Y, 2014, HYPERTENSION, V63, P846, DOI 10.1161/HYPERTENSIONAHA.113.01772; Li YA, 2010, AM J PHYSIOL-HEART C, V299, pH1959, DOI 10.1152/ajpheart.00526.2010; LIAU G, 1989, J BIOL CHEM, V264, P10315; Lin YF, 2004, P NATL ACAD SCI USA, V101, P7799, DOI 10.1073/pnas.0402496101; Lu MH, 2003, CLIN EXP HYPERTENS, V25, P413, DOI 10.1081/CEH-120024985; Madhani M, 2003, BRIT J PHARMACOL, V139, P1289, DOI 10.1038/sj.bjp.0705365; Marcil J, 1998, CARDIOVASC RES, V39, P492, DOI 10.1016/S0008-6363(98)00111-4; Marcil J, 1997, J MOL CELL CARDIOL, V29, P1009, DOI 10.1006/jmcc.1996.0343; McKillop IH, 1999, EUR J GASTROEN HEPAT, V11, P761, DOI 10.1097/00042737-199907000-00014; MOXHAM CM, 1993, SCIENCE, V260, P991, DOI 10.1126/science.8493537; Nakamura A, 1996, J BIOCHEM, V119, P768; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; ROBISHAW JD, 1986, J BIOL CHEM, V261, P9587; RODBELL M, 1971, J BIOL CHEM, V246, P1872; Saha S, 2008, CAN J PHYSIOL PHARM, V86, P190, DOI 10.1139/Y08-012; Saha S, 2008, J MOL CELL CARDIOL, V44, P336, DOI 10.1016/j.yjmcc.2007.11.003; Sandoval YHG, 2011, CELL SIGNAL, V23, P1716, DOI 10.1016/j.cellsig.2011.06.006; Sandoval YHG, 2011, CELL SIGNAL, V23, P354, DOI 10.1016/j.cellsig.2010.10.005; Sandoval YHG, 2009, CAN J PHYSIOL PHARM, V87, P1037, DOI 10.1139/Y09-089; Stotz WH, 2004, J VASC RES, V41, P211, DOI 10.1159/000077577; Sun JZ, 2001, AM J PHYSIOL-LUNG C, V281, pL155, DOI 10.1152/ajplung.2001.281.1.L155; THIBAULT C, 1992, FEBS LETT, V313, P160, DOI 10.1016/0014-5793(92)81435-O; Tonelli AR, 2013, PULM CIRC, V3, P20, DOI 10.4103/2045-8932.109911; Zhang MJ, 2016, HISTOCHEM CELL BIOL, V145, P119, DOI 10.1007/s00418-015-1386-3	61	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0179301	10.1371/journal.pone.0179301	http://dx.doi.org/10.1371/journal.pone.0179301			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692698	Green Published, Green Submitted, gold			2022-12-26	WOS:000405544800009
J	Christiansen, MK; Larsen, SB; Nyegaard, M; Neergaard-Petersen, S; Ajjan, R; Wurtz, M; Grove, EL; Hvas, AM; Jensen, HK; Kristensen, SD				Christiansen, Morten Krogh; Larsen, Sanne Bojet; Nyegaard, Mette; Neergaard-Petersen, Sos; Ajjan, Ramzi; Wurtz, Morten; Grove, Erik Lerkevang; Hvas, Anne-Mette; Jensen, Henrik Kjaerulf; Kristensen, Steen Dalby			Coronary artery disease-associated genetic variants and biomarkers of inflammation	PLOS ONE			English	Article							C-REACTIVE PROTEIN; GENOME-WIDE ASSOCIATION; MYELOID-RELATED PROTEIN-14; HEART-DISEASE; MYOCARDIAL-INFARCTION; LDL-CHOLESTEROL; RISK SCORES; LOCI; APOE; MYELOID-RELATED-PROTEIN-8/14	Introduction Genetic constitution and inflammation both contribute to development of coronary artery disease (CAD). Several CAD-associated single-nucleotide polymorphisms (SNPs) have recently been identified, but their functions are largely unknown. We investigated the associations between CAD-associated SNPs and five CAD-related inflammatory biomarkers. Methods We genotyped 45 CAD-associated SNPs in 701 stable CAD patients in whom levels of highsensitivity C-reactive protein (hsRCP), interleukin-6, calprotectin, fibrinogen and complement component 3 levels had previously been measured. A genetic risk score was calculated to assess the combined risk associated with all the genetic variants. A multiple linear regression model was used to assess associations between the genetic risk score, single SNPs, and the five inflammatory biomarkers. Results The minor allele (G) (CAD risk allele) of rs2075650 (TOMM40/APOE) was associated with lower levels of high-sensitivity C-reactive protein (effect per risk allele: -0.37 mg/l [95% CI -0.56 to -0.18 mg/l]). The inflammatory markers tested showed no association with the remaining 44 SNPs or with the genetic risk score. Conclusions In stable CAD patients, the risk allele of a common CAD-associated marker at the TOMM40/APOE locus was associated with lower hsCRP levels. No other genetic variants or the combined effect of all variants were associated with the five inflammatory biomarkers.	[Christiansen, Morten Krogh; Larsen, Sanne Bojet; Neergaard-Petersen, Sos; Wurtz, Morten; Grove, Erik Lerkevang; Jensen, Henrik Kjaerulf; Kristensen, Steen Dalby] Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark; [Christiansen, Morten Krogh; Larsen, Sanne Bojet; Grove, Erik Lerkevang; Hvas, Anne-Mette; Jensen, Henrik Kjaerulf; Kristensen, Steen Dalby] Aarhus Univ, Inst Clin Med, Fac Hlth, Aarhus, Denmark; [Nyegaard, Mette] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Ajjan, Ramzi] Univ Leeds, Leeds Inst Cardiovasc & Metab Med LICAMM, Leeds, W Yorkshire, England; [Hvas, Anne-Mette] Aarhus Univ Hosp, Dept Clin Biochem, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; University of Leeds; Aarhus University	Christiansen, MK (corresponding author), Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark.; Christiansen, MK (corresponding author), Aarhus Univ, Inst Clin Med, Fac Hlth, Aarhus, Denmark.	mkc@dadlnet.dk	Jensen, Henrik/A-7980-2018; Nyegaard, Mette/M-3379-2019	Jensen, Henrik/0000-0003-1802-4302; Nyegaard, Mette/0000-0003-4973-8543; Christiansen, Morten Krogh/0000-0002-3894-888X	Novo Nordic Foundation [NNF14OC0008817]; Pfizer [WS2632086]; Novo Nordisk Fonden [NNF14OC0008817] Funding Source: researchfish	Novo Nordic Foundation(Novo Nordisk Foundation); Pfizer(Pfizer); Novo Nordisk Fonden(Novo Nordisk Foundation)	Funding was received from the Novo Nordic Foundation (grant no. NNF14OC0008817 to SDK) and Pfizer (unrestricted research grant no. WS2632086 to HKJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham G, 2016, EUR HEART J, V37, P3267, DOI 10.1093/eurheartj/ehw450; Altwegg LA, 2007, EUR HEART J, V28, P941, DOI 10.1093/eurheartj/ehm078; Bekris LM, 2012, J HUM GENET, V57, P18, DOI 10.1038/jhg.2011.123; Chaineau M, 2009, FEBS LETT, V583, P3817, DOI 10.1016/j.febslet.2009.10.026; Chasman DI, 2006, GENES IMMUN, V7, P211, DOI 10.1038/sj.gene.6364289; Christiansen MK, 2017, INT J CARDIOL, P1; Christiansen MK, 2017, ATHEROSCLEROSIS, V257, P172, DOI 10.1016/j.atherosclerosis.2017.01.010; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; de Vries PS, 2016, HUM MOL GENET, V25, P358, DOI 10.1093/hmg/ddv454; Deelen J, 2011, AGING CELL, V10, P686, DOI 10.1111/j.1474-9726.2011.00705.x; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Dorajoo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067650; Ganna A, 2013, ARTERIOSCL THROM VAS, V33, P2267, DOI 10.1161/ATVBAHA.113.301218; Guo YR, 2013, HUM MOL GENET, V22, P184, DOI 10.1093/hmg/dds396; Healy AM, 2006, CIRCULATION, V113, P2278, DOI 10.1161/CIRCULATIONAHA.105.607333; Ionita MG, 2009, ARTERIOSCL THROM VAS, V29, P1220, DOI 10.1161/ATVBAHA.109.190314; Jensen LJN, 2010, J INTERV CARDIOL, V23, P123, DOI 10.1111/j.1540-8183.2010.00532.x; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kaptoge S, 2014, EUR HEART J, V35, P578, DOI 10.1093/eurheartj/eht367; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kocarnik JM, 2014, CIRC-CARDIOVASC GENE, V7, P178, DOI 10.1161/CIRCGENETICS.113.000173; Larsen SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126767; Larsen SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125992; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; McPherson R., 2014, CURR GENET MED REP, V2, P1, DOI [10.1007/s40142-014-0033-y, DOI 10.1007/S40142-014-0033-Y]; Middelberg RPS, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-123; Morrow DA, 2008, AM HEART J, V155, P49, DOI 10.1016/j.ahj.2007.08.018; MUSCARI A, 1995, AM J MED, V98, P357, DOI 10.1016/S0002-9343(99)80314-3; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Naitza S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002480; Neergaard-Petersen S, 2014, THROMB HAEMOSTASIS, V112, P1142, DOI 10.1160/TH14-05-0468; Neergaard-Petersen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071150; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Sabater-Lleal M, 2013, CIRCULATION, V128, P1310, DOI 10.1161/CIRCULATIONAHA.113.002251; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Shah T, 2013, CIRC-CARDIOVASC GENE, V6, P163, DOI 10.1161/CIRCGENETICS.112.964254; Vaara S, 2016, CIRC-CARDIOVASC GENE, V9, P172, DOI 10.1161/CIRCGENETICS.115.001271; Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548; Yang XB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002916	43	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180365	10.1371/journal.pone.0180365	http://dx.doi.org/10.1371/journal.pone.0180365			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686695	Green Published, gold, Green Submitted			2022-12-26	WOS:000405464100054
J	Dorph, A; McDonald, PG				Dorph, Annalie; McDonald, Paul G.			The acoustic repertoire and behavioural context of the vocalisations of a nocturnal dasyurid, the eastern quoll (Dasyurus viverrinus)	PLOS ONE			English	Article							RED DEER; NORTHERN QUOLL; BIRD; COMMUNICATION; HEARING; COMMON; SIZE	Defining an acoustic repertoire is essential to understanding vocal signalling and communicative interactions within a species. Currently, quantitative and statistical definition is lacking for the vocalisations of many dasyurids, an important group of small to medium-sized marsupials from Australasia that includes the eastern quoll (Dasyurus viverrinus), a species of conservation concern. Beyond generating a better understanding of this species' social interactions, determining an acoustic repertoire will further improve detection rates and inference of vocalisations gathered by automated bioacoustic recorders. Hence, this study investigated eastern quoll vocalisations using objective signal processing techniques to quantitatively analyse spectrograms recorded from 15 different individuals. Recordings were collected in conjunction with observations of the behaviours associated with each vocalisation to develop an acoustic-based behavioural repertoire for the species. Analysis of recordings produced a putative classification of five vocalisation types: Bark, Growl, Hiss, Cp-cp, and Chuck. These were most frequently observed during agonistic encounters between conspecifics, most likely as a graded sequence from Hisses occurring in a warning context through to Growls and finally Barks being given prior to, or during, physical confrontations between individuals. Quantitative and statistical methods were used to objectively establish the accuracy of these five putative call types. A multinomial logistic regression indicated a 97.27% correlation with the perceptual classification, demonstrating support for the five different vocalisation types. This putative classification was further supported by hierarchical cluster analysis and silhouette information that determined the optimal number of clusters to be five. Minor disparity between the objective and perceptual classifications was potentially the result of gradation between vocalisations, or subtle differences present within vocalisations not discernible to the human ear. The implication of these different vocalisations and their given context is discussed in relation to the ecology of the species and the potential application of passive acoustic monitoring techniques.	[Dorph, Annalie; McDonald, Paul G.] Univ New England, Sch Environm & Rural Sci, Ctr Behav & Physiol Ecol, Zool, Armidale, NSW, Australia	University of New England	McDonald, PG (corresponding author), Univ New England, Sch Environm & Rural Sci, Ctr Behav & Physiol Ecol, Zool, Armidale, NSW, Australia.	paul.mcdonald@une.edu.au	McDonald, Paul G/A-5928-2010	McDonald, Paul/0000-0002-9541-3304; Dorph, Annalie/0000-0001-8133-080X	University of New England student research funds	University of New England student research funds	This research was supported by University of New England student research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitkin L, 1996, J EXP ZOOL, V276, P394, DOI 10.1002/(SICI)1097-010X(19961215)276:6<394::AID-JEZ3>3.0.CO;2-I; AITKIN LM, 1994, J COMP NEUROL, V349, P377, DOI 10.1002/cne.903490305; Alexander CH, 1997, P SOC STAT SECT AM S; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Bishop Nicolas, 1995, Australian Mammalogy, V18, P99; Blumstein DT, 2011, J APPL ECOL, V48, P758, DOI 10.1111/j.1365-2664.2011.01993.x; Boersma P., 2014, PRAAT DOING PHONETIC; Charlton BD, 2007, ANIM BEHAV, V74, P707, DOI 10.1016/j.anbehav.2006.09.021; Charlton BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045420; CONNER DA, 1982, J MAMMAL, V63, P48, DOI 10.2307/1380670; Croft D.B., 1982, P291; Croissant Y., 2013, MLOGIT MULTINOMIAL L; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dawson DK, 2009, J APPL ECOL, V46, P1201, DOI 10.1111/j.1365-2664.2009.01731.x; Deaux EC, 2013, BEHAVIOUR, V150, P75, DOI 10.1163/1568539X-00003038; Dempster Edith R., 1995, Australian Mammalogy, V18, P27; EISENBERG J F, 1975, Zeitschrift fuer Tierpsychologie, V37, P379; Ellis W, 2011, BEHAV ECOL, V22, P372, DOI 10.1093/beheco/arq216; Fancourt BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129420; Fancourt BA, 2013, AUST MAMMAL, V35, P195, DOI 10.1071/AM13004; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; FLEAY D. H., 1935, JOUR MAMMAL, V16, P10, DOI 10.2307/1374524; FLEAY DAVID, 1932, VICTORIAN NAT, V49, P63; Garcia M, 2016, ETHOLOGY, V122, P329, DOI 10.1111/eth.12472; Glen AS, 2006, J ZOOL, V268, P347, DOI 10.1111/j.1469-7998.2006.00064.x; Godsell J., 1982, P199; Gouzoules H, 2000, ANIM BEHAV, V59, P501, DOI 10.1006/anbe.1999.1318; Harrell FE, 2016, HARRELL MISCELLANEOU; Hasan A, 2015, MNLOGIT MULTINOMIAL; Haselmayer J, 2000, CONDOR, V102, P887, DOI 10.1650/0010-5422(2000)102[0887:ACOPCA]2.0.CO;2; Hobson KA, 2002, WILDLIFE SOC B, V30, P709; Ippi S, 2011, IBIS, V153, P789, DOI 10.1111/j.1474-919X.2011.01165.x; Izrael D., 2009, 2009 SAS GLOB FOR CA; Jones M, 1996, NATURE AUSTR, V25, P46; Jones Menna E., 2001, Mammalian Species, V677, P1, DOI 10.1644/1545-1410(2001)677<0001:DV>2.0.CO;2; Kish Leslie., 1992, J OFF STAT, V8, P183; Kortner G, 2004, WILDLIFE RES, V31, P475, DOI 10.1071/WR03041; Kuhn M, 2021, CARET CLASSIFICATION, DOI DOI 10.1887/0750303123/B365C43; Laiolo P, 2010, BIOL CONSERV, V143, P1635, DOI 10.1016/j.biocon.2010.03.025; Le Roux A, 2009, NATURWISSENSCHAFTEN, V96, P575, DOI 10.1007/s00114-008-0506-5; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Lumley T., 2014, SURVEY ANAL COMPLEX; Maechler M., 2016, CLUSTER CLUSTERANALY; Manser MB, 2014, ADV STUD BEHAV, V46, P281, DOI 10.1016/B978-0-12-800286-5.00006-7; Marler P., 1976, GROWING POINTS ETHOL, P239; Marques TA, 2013, BIOL REV, V88, P287, DOI 10.1111/brv.12001; Mennill DJ, 2012, METHODS ECOL EVOL, V3, P704, DOI 10.1111/j.2041-210X.2012.00209.x; MORTON ES, 1977, AM NAT, V111, P855, DOI 10.1086/283219; MORTON SR, 1978, AUST WILDLIFE RES, V5, P163; Naimi B, 2021, RTS RATER TIME SERIE; Negus VE., 1962, COMP ANATOMY PHYSL L; NHMRC, 2013, AUSTR COD CAR US AN, V8th; Novomestky F, 2015, MOMENTS CUMULANTS SK; PEMBERTON D, 1993, AUST J ZOOL, V41, P507, DOI 10.1071/ZO9930507; Potter F., 1990, P SURV RES METH SECT, P225; R Core Team, 2021, R LANGUAGE ENV STAT; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Reby D, 2006, J ACOUST SOC AM, V120, P4080, DOI 10.1121/1.2358006; Robbins RL, 2000, BEHAVIOUR, V137, P1271, DOI 10.1163/156853900501926; Rogers TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052542; ROUNSEVELL DE, 1991, WILDLIFE RES, V18, P699, DOI 10.1071/WR9910699; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Slocombe KE, 2009, ANIM COGN, V12, P441, DOI 10.1007/s10071-008-0204-x; Szekely GJ, 2005, J CLASSIF, V22, P151, DOI 10.1007/s00357-005-0012-9; TITZE IR, 1987, J SPEECH HEAR RES, V30, P252, DOI 10.1044/jshr.3002.252; Vannoni E, 2007, ETHOLOGY, V113, P223, DOI 10.1111/j.1439-0310.2006.01323.x; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wilson E.O., 1975, P1; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	69	2	2	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179337	10.1371/journal.pone.0179337	http://dx.doi.org/10.1371/journal.pone.0179337			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686679	Green Submitted, Green Published, gold			2022-12-26	WOS:000405464100013
J	Iangrai, B; Pattanayak, A; Khongwir, DEA; Pale, G; Gatphoh, EM; Das, A; Chrungoo, NK				Iangrai, Banshanlang; Pattanayak, Arunava; Khongwir, D. Evanoreen Ann; Pale, Gratify; Gatphoh, Emica Mary; Das, Alpana; Chrungoo, Nikhil Kumar			Development and characterization of a new set of genomic microsatellite markers in rice bean (Vigna umbellata (Thunb.) Ohwi and Ohashi) and their utilization in genetic diversity analysis of collections from North East India	PLOS ONE			English	Article							SEQUENCE REPEATS; LINKAGE MAP; SSR-MARKERS; GERMPLASM; IDENTIFICATION; POLYMORPHISMS; HYBRIDIZATION; CONSTRUCTION; SELECTION; SOFTWARE	Rice bean [Vigna umbellate (Thumb.) Ohwi and Ohashi] is an underutilized crop believed to be domesticated in the Myanmar-Thailand region of Asia. In India, rice bean is mainly cultivated in the North-Eastern Hills, which is a hotspot for biological diversity. A 5' anchored PCR was used to develop microsatellite markers in rice bean. Twenty-eight specific primer pairs were designed and employed to characterize sixty five ricebean accessions collected from North East India. A total of 179 alleles were amplified with an average of 6.393 alleles per locus. The gene diversity was high (mean 0.534) in the accessions collected from Darjeeling, Nagaland and Manipur, which are bordering areas with East Nepal and Myanmar, respectively. Exceptionally high outcrossing rate was observed in the entire population. Population structure analysis identified three distinct clusters in which accessions collected from areas bordering Myanmar and East Nepal grouped separately. Using a combination of STRUCTURE and Principal Coordinate Analysis, relative affinity of the intermediate accessions could be established. However, differences in allelic counts among populations were non-significant. The results showed that there is a high level of genetic diversity within the accessions, with high outcrossing rate.	[Iangrai, Banshanlang; Pattanayak, Arunava; Khongwir, D. Evanoreen Ann; Pale, Gratify; Gatphoh, Emica Mary; Das, Alpana] ICAR Res Complex, Ctr Biotechnol, Res Complex NEH Reg, Umiam, Meghalaya, India; [Chrungoo, Nikhil Kumar] North Eastern Hill Univ, Dept Bot, Shillong, Meghalaya, India; [Pattanayak, Arunava] ICAR Vivekananda Parvatiya Krishi Anusandhan Sans, Almora, Uttarakhand, India; [Das, Alpana] CPCRI, Reg Ctr, Gauhati, Assam, India	Indian Council of Agricultural Research (ICAR); ICAR - ICAR Research Complex for NEH Region; North Eastern Hill University; Indian Council of Agricultural Research (ICAR); ICAR - Vivekananda Parvatiya Krishi Anusandhan Sansthan; Indian Council of Agricultural Research (ICAR); ICAR - Central Plantation Crops Research Institute	Pattanayak, A (corresponding author), ICAR Res Complex, Ctr Biotechnol, Res Complex NEH Reg, Umiam, Meghalaya, India.; Pattanayak, A (corresponding author), ICAR Vivekananda Parvatiya Krishi Anusandhan Sans, Almora, Uttarakhand, India.	apat.icarneh@gmail.com		Pattanayak, Arunava/0000-0002-8397-9466				ARORA RK, 1980, ECON BOT, V34, P260, DOI 10.1007/BF02858644; Bajracharya J, 2010, 7 BANG U COLL NAT SC; Chen HL, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0383-5; Doi K, 2002, GENETICA, V114, P129, DOI 10.1023/A:1015158408227; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fisher PJ, 1996, NUCLEIC ACIDS RES, V24, P4369, DOI 10.1093/nar/24.21.4369; Gante HF, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0392-3; Glastras SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162131; Gupta PK, 1996, CURR SCI INDIA, V70, P45; Gupta S, 2009, J AGR SCI-CAMBRIDGE, V147, P581, DOI 10.1017/S0021859609008715; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Isemura T, 2010, ANN BOT-LONDON, V106, P927, DOI 10.1093/aob/mcq188; Kaga A, 1996, THEOR APPL GENET, V93, P658, DOI 10.1007/BF00224059; KANDPAL RP, 1994, P NATL ACAD SCI USA, V91, P88, DOI 10.1073/pnas.91.1.88; Khate P, 2009, PLANT CELL REP, V29, P1423; KIJAS JMH, 1994, BIOTECHNIQUES, V16, P656; Lewis PO, 2001, GENETIC DATA ANAL GD; Ling LP, 2011, J GENET, V90, pE101; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Moe KT, 2011, J INTEGR PLANT BIOL, V53, P63, DOI 10.1111/j.1744-7909.2010.01012.x; Muthusamy S, 2008, ELECTRON J BIOTECHN, V11, DOI 10.2225/vol11-issue3-fulltext-8; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; OSTRANDER EA, 1992, P NATL ACAD SCI USA, V89, P3419, DOI 10.1073/pnas.89.8.3419; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; PITCHARD JK, 2000, GENETICS, V155, P945; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; Qin Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144108; Roy S, 2015, PLOS ONE, V10, P1; Seehalak W, 2006, GENET RESOUR CROP EV, V53, P1043, DOI 10.1007/s10722-004-7939-2; Shirasawa K, 2013, BREEDING SCI, V63, P21, DOI 10.1270/jsbbs.63.21; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; Temnykh S, 2000, THEOR APPL GENET, V100, P697, DOI 10.1007/s001220051342; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tian J, 2013, GENOME, V56, P717, DOI 10.1139/gen-2013-0118; Tiwari KK, 2015, PLANT BREEDING, V134, P164, DOI 10.1111/pbr.12252; Tomooka N., 2002, ASIAN VIGNA GENUS VI; Toomaka N, 2006, PLANT GENOME BIODIVE, P87; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang LX, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0259-8; Wang LX, 2016, CROP J, V4, P40, DOI 10.1016/j.cj.2015.09.004; WANG Z, 1994, THEOR APPL GENET, V88, P1, DOI 10.1007/BF00222386; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; Yang MH, 2016, CONSERVATION GENET R	44	6	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179801	10.1371/journal.pone.0179801	http://dx.doi.org/10.1371/journal.pone.0179801			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686712	Green Submitted, gold, Green Published			2022-12-26	WOS:000405464100020
J	Pezeshkpoori, B; Schreck, U; Biswas, A; Driesen, J; Berkemeier, AC; Pavlov, A; Muller, J; Oldenburg, J				Pezeshkpoori, Behnaz; Schreck, Ursula; Biswas, Arijit; Driesen, Julia; Berkemeier, Ann-Cristin; Pavlov, Anna; Mueller, Jens; Oldenburg, Johannes			An in silico and in vitro approach to elucidate the impact of residues flanking the cleavage scissile bonds of FVIII	PLOS ONE			English	Article							HEMOPHILIA-A MUTATIONS; FACTOR-VIII ACTIVITY; ONE-STAGE; SUBSTRATE-SPECIFICITY; FACTOR XA; CHROMOGENIC ASSAYS; THROMBIN; ACTIVATION; DISCREPANCY; ENZYME	Coagulation Factor VIII is activated by an ordered limited thrombin proteolysis with different catalytic efficiency at three P1 Arginine residues: Arg(759)> Arg(108)>Arg(391), indicating the flanking residues of the latter to be less optimal. This study aimed to investigate, in silico and in vitro, the impact of possessing hypothetically optimized residues at these three catalytic cleavage sites. The structural impact of the residues flanking Arginine cleavage sites was studied by in silico analysis through comparing the cleavage cleft of the native site with a hypothetically optimized sequence at each site. Moreover, recombinant FVIII proteins were prepared by replacing the sequences flanking native thrombin cleavage sites with the proposed cleavage-optimized sequence. FVIII specific activity was determined by assessing the FVIII activity levels in relation to FVIII antigen levels. We further investigated whether thrombin generation could reflect the haemostatic potential of the variants. Our in silico results show the impact of the residues directly in the cleavage bond, and their neighboring residues on the insertion efficiency of the loop into the thrombin cleavage cleft. Moreover, the in vitro analysis shows that the sequences flanking the Arg(1708) cleavage site seem to be the most close to optimal residues for achieving the maximal proteolytic activation and pro factor activity of FVIII. The residues flanking the scissile bonds of FVIIII affect the cleavage rates and modulate the profactor activation. We were able to provide insights into the mechanisms of the specificity of thrombin for the P1 cleavage sites of FVIII. Thus, the P4-P2' residues surrounding Arg(1708) of FVIII have the highest impact on rates of thrombin proteolysis which contributes to thrombin activation of the profactor and eventually to the thrombin generation potential.	[Pezeshkpoori, Behnaz; Schreck, Ursula; Biswas, Arijit; Driesen, Julia; Berkemeier, Ann-Cristin; Pavlov, Anna; Mueller, Jens; Oldenburg, Johannes] Univ Bonn, Inst Expt Hematol & Transfus Med, Bonn, Germany; [Pezeshkpoori, Behnaz; Schreck, Ursula; Biswas, Arijit; Berkemeier, Ann-Cristin; Pavlov, Anna; Mueller, Jens; Oldenburg, Johannes] Univ Clin Bonn, Ctr Rare Dis Bonn ZSEB, Bonn, Germany	University of Bonn; University of Bonn	Oldenburg, J (corresponding author), Univ Bonn, Inst Expt Hematol & Transfus Med, Bonn, Germany.; Oldenburg, J (corresponding author), Univ Clin Bonn, Ctr Rare Dis Bonn ZSEB, Bonn, Germany.	Johannes.Oldenburg@ukbonn.de	Biswas, A./B-9673-2011; Müller, Jens/A-8264-2012; Oldenburg, Johannes/ABB-7817-2020; Pezeshkpoor, Behnaz/ABB-3194-2020	Müller, Jens/0000-0001-7713-9631; Pezeshkpoor, Behnaz/0000-0002-4796-3424; Oldenburg, Johannes/0000-0002-1585-4100; Biswas, Arijit/0000-0002-4103-5854				Backes BJ, 2000, NAT BIOTECHNOL, V18, P187, DOI 10.1038/72642; Bianchini EP, 2002, J BIOL CHEM, V277, P20527, DOI 10.1074/jbc.M201139200; Chahal G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129511; EATON D, 1986, BIOCHEMISTRY-US, V25, P505, DOI 10.1021/bi00350a035; EATON DL, 1986, PROG HEMOST THROMB, V8, P47; Fay PJ, 2006, INT J HEMATOL, V83, P103, DOI 10.1532/IJH97.05113; FAY PJ, 1986, BIOCHIM BIOPHYS ACTA, V871, P268, DOI 10.1016/0167-4838(86)90208-6; Fay PJ, 2001, J BIOL CHEM, V276, P12434, DOI 10.1074/jbc.M009539200; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; Lippi G, 2009, BLOOD COAGUL FIBRIN, V20, P1, DOI 10.1097/MBC.0b013e32831bc324; LOLLAR P, 1991, MAYO CLIN PROC, V66, P524, DOI 10.1016/S0025-6196(12)62395-7; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; Newell JL, 2007, J BIOL CHEM, V282, P25367, DOI 10.1074/jbc.M703433200; Newell JL, 2009, J BIOL CHEM, V284, P11080, DOI 10.1074/jbc.M900234200; Newell-Caito JL, 2012, BIOCHEMISTRY-US, V51, P3451, DOI 10.1021/bi300070z; Pahl S, 2014, THROMB HAEMOSTASIS, V111, P58, DOI 10.1160/TH13-01-0028; Parker ET, 1997, BIOCHEMISTRY-US, V36, P9365, DOI 10.1021/bi970599o; Pavlova A, 2010, HAEMOPHILIA, V16, P44; Pavlova A, 2014, THROMB HAEMOSTASIS, V111, P851, DOI 10.1160/TH13-08-0690; Petrassi HM, 2005, BIOORG MED CHEM LETT, V15, P3162, DOI 10.1016/j.bmcl.2005.04.019; Peyvandi F, 2016, J THROMB HAEMOST, V14, P248, DOI 10.1111/jth.13215; PIETERS J, 1989, BLOOD, V74, P1021; Pipe SW, 2001, BLOOD, V97, P685, DOI 10.1182/blood.V97.3.685; REGAN LM, 1995, J BIOL CHEM, V270, P8546, DOI 10.1074/jbc.270.15.8546; Sadasivan C, 2000, J BIOL CHEM, V275, P36942, DOI 10.1074/jbc.M006076200; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065	27	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180456	10.1371/journal.pone.0180456	http://dx.doi.org/10.1371/journal.pone.0180456			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683085	Green Submitted, Green Published, gold			2022-12-26	WOS:000405335200039
J	Burnham, JP; Micek, ST; Kollef, MH				Burnham, Jason P.; Micek, Scott T.; Kollef, Marin H.			Augmented renal clearance is not a risk factor for mortality in Enterobacteriaceae bloodstream infections treated with appropriate empiric antimicrobials	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; GLOMERULAR-FILTRATION-RATE; PLASMA CREATININE CONCENTRATIONS; INTENSIVE-CARE-UNIT; CLASSIFICATION; VANCOMYCIN; EQUATION; THERAPY; DISEASE	The main objective of the study was to assess whether augmented renal clearance was a risk factor for mortality in a cohort of patients with Enterobacteriaceae sepsis, severe sepsis, or septic shock that all received appropriate antimicrobial therapy within 12 hours. Using a retrospective cohort from Barnes-Jewish Hospital, a 1,250-bed teaching hospital, we collected data on individuals with Enterobacteriaceae sepsis, severe sepsis, and septic shock who received appropriate initial antimicrobial therapy between June 2009 and December 2013. Clinical outcomes were compared according to renal clearance, as assessed by Modification of Diet in Renal Disease (MDRD) and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formulas, sepsis classification, demographics, severity of illness, and comorbidities. We identified 510 patients with Enterobacteriaceae bacteremia and sepsis, severe sepsis, or septic shock. Sixty-seven patients (13.1%) were nonsurvivors. Augmented renal clearance was uncommon (5.1% of patients by MDRD and 3.0% by CKD-EPI) and was not associated with increased mortality. Our results are limited by the absence of prospective determination of augmented renal clearance. However, in this small cohort, augmented renal clearance as assessed by MDRD and CKD-EPI does not seem to be a risk factor for mortality in patients with Enterobacteriaceae sepsis. Future studies should assess this finding prospectively.	[Burnham, Jason P.] Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA; [Micek, Scott T.] St Louis Coll Pharm, St Louis, MO USA; [Kollef, Marin H.] Washington Univ, Sch Med, Div Pulm & Crit Care Med, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Burnham, JP (corresponding author), Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA.	kollefm@wustl.edu	Burnham, Jason/S-1770-2019	Burnham, Jason/0000-0002-4777-3006	Washington University Institute of Clinical and Translational Sciences - National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) [UL1TR000448]	Washington University Institute of Clinical and Translational Sciences - National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Dr. Burnham reports that the research reported in this publication was supported by the Washington University Institute of Clinical and Translational Sciences grant UL1TR000448 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH).The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adnan S, 2014, ANAESTH INTENS CARE, V42, P715, DOI 10.1177/0310057X1404200606; Baptista JP, 2014, J NEPHROL, V27, P403, DOI 10.1007/s40620-013-0036-x; Baptista JP, 2012, INT J ANTIMICROB AG, V39, P420, DOI 10.1016/j.ijantimicag.2011.12.011; Barletta JF, 2016, J TRAUMA ACUTE CARE, V81, P1115, DOI 10.1097/TA.0000000000001211; Bragadottir G, 2013, CRIT CARE, V17, DOI 10.1186/cc12777; Burnham JP, 2015, CRIT CARE MED, V43, P1580, DOI 10.1097/CCM.0000000000001013; Claus BOM, 2013, J CRIT CARE, V28, P695, DOI 10.1016/j.jcrc.2013.03.003; De Waele JJ, 2015, MINERVA ANESTESIOL, V81, P1079; Hirai K, 2016, THER DRUG MONIT, V38, P706, DOI 10.1097/FTD.0000000000000346; Huttner A, 2015, INT J ANTIMICROB AG, V45, P385, DOI 10.1016/j.ijantimicag.2014.12.017; Jones RN, 2005, DIAGN MICR INFEC DIS, V52, P235, DOI 10.1016/j.diagmicrobio.2005.02.006; Kawano Y, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0187-7; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Luc. M, 2015, COMP DISC DIFFUSION; May CC, 2015, NEUROCRIT CARE, V23, P374, DOI 10.1007/s12028-015-0127-8; Patel J.B., 2015, PERFORMANCE STANDARD; Roberts JA, 2014, CLIN INFECT DIS, V58, P1072, DOI 10.1093/cid/ciu027; Udy AA, 2014, CRIT CARE MED, V42, P520, DOI 10.1097/CCM.0000000000000029; Udy AA, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-250; Udy AA, 2013, CRIT CARE, V17, DOI 10.1186/cc12544; Udy AA, 2012, CHEST, V142, P30, DOI 10.1378/chest.11-1671	23	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180247	10.1371/journal.pone.0180247	http://dx.doi.org/10.1371/journal.pone.0180247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678812	Green Published, Green Submitted, gold			2022-12-26	WOS:000405272200042
J	Filipovic, A; Ghasemian, E; Inic-Kanada, A; Lukic, I; Stein, E; Marinkovic, E; Djokic, R; Kosanovic, D; Schuerer, N; Chalabi, H; Belij-Rammerstorfer, S; Stojanovic, M; Barisani-Asenbauer, T				Filipovic, Ana; Ghasemian, Ehsan; Inic-Kanada, Aleksandra; Lukic, Ivana; Stein, Elisabeth; Marinkovic, Emilija; Djokic, Radmila; Kosanovic, Dejana; Schuerer, Nadine; Chalabi, Hadeel; Belij-Rammerstorfer, Sandra; Stojanovic, Marijana; Barisani-Asenbauer, Talin			The effect of infectious dose on humoral and cellular immune responses in Chlamydophila caviae primary ocular infection	PLOS ONE			English	Article							PIG INCLUSION CONJUNCTIVITIS; CHLAMYDIAL GENITAL-INFECTION; OUTER-MEMBRANE PROTEIN; FEMALE GUINEA-PIGS; CD8(+) T-CELLS; PROTECTIVE MONOCLONAL-ANTIBODIES; ACTIVE TRACHOMA; TRACT INFECTION; IFN-GAMMA; B-CELLS	Following infection, the balance between protective immunity and immunopathology often depends on the initial infectious load. Several studies have investigated the effect of infectious dose; however, the mechanism by which infectious dose affects disease outcomes and the development of a protective immune response is not known. The aim of this study was to investigate how the infectious dose modulates the local and systemic humoral and the cellular immune responses during primary ocular chlamydial infection in the guinea pig animal model. Guinea pigs were infected by ocular instillation of a Chlamydophila caviae-containing eye solution in the conjunctival sac in three different doses: 1x10(2), 1x10(4), and 1x10(6) inclusion forming units (IFUs). Ocular pathology, chlamydial clearance, local and systemic C. caviae-specific humoral and cellular immune responses were assessed. All inocula of C. caviae significantly enhanced the local production of C. caviae-specific IgA in tears, but only guinea pigs infected with the higher doses showed significant changes in C. caviae-specific IgA levels in vaginal washes and serum. On complete resolution of infection, the low dose of C. caviae did not alter the ratio of CD4(+) and CD8(+) cells within guinea pigs' submandibular lymph node (SMLN) lymphocytes while the higher doses increased the percentages of CD4(+) and CD8(+) cells within the SMLN lymphocytes. A significant negative correlation between pathology intensity and the percentage of CD4(+) and CD8(+) cells within SMLN lymphocyte pool at selected time points post-infection was recorded for both 1x10(4), and 1x10(6) IFU infected guinea pigs. The relevance of the observed dose-dependent differences on the immune response should be further investigated in repeated ocular chlamydial infections.	[Filipovic, Ana; Lukic, Ivana; Marinkovic, Emilija; Djokic, Radmila; Kosanovic, Dejana; Stojanovic, Marijana] Inst Virol Vaccines & Sera TORLAK, Dept Res & Dev, Belgrade, Serbia; [Ghasemian, Ehsan; Inic-Kanada, Aleksandra; Stein, Elisabeth; Schuerer, Nadine; Chalabi, Hadeel; Belij-Rammerstorfer, Sandra; Barisani-Asenbauer, Talin] Med Univ Vienna, OCUVAC Ctr Ocular Inflammat & Infect, Laura Bassi Centres Expertise, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria	Medical University of Vienna	Stojanovic, M (corresponding author), Inst Virol Vaccines & Sera TORLAK, Dept Res & Dev, Belgrade, Serbia.; Barisani-Asenbauer, T (corresponding author), Med Univ Vienna, OCUVAC Ctr Ocular Inflammat & Infect, Laura Bassi Centres Expertise, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria.	mstojanovic@torlak.rs; talin.barisani@meduniwien.ac.at	Belij-Rammerstorfer, Sandra/B-8243-2018	Ghasemian, Ehsan/0000-0003-1019-6572; Belij-Rammerstorfer, Sandra/0000-0002-8637-3785; Lukic, Ivana/0000-0002-6330-471X; Stein, Elisabeth/0000-0002-1240-506X; Stojanovic, Marijana/0000-0002-8204-4183; Barisani-Asenbauer, Talin/0000-0002-8661-9183; Inic-Kanada, Aleksandra/0000-0001-7854-3812	"Laura Bassi Centers of Expertise" program of Austrian Federal Ministry of Economy through Austrian Research Promotion Agency (FFG) [822768]; Ministry of Education, Science, and Technological Development of the Republic of Serbia [172049, 451-03-01039/2015-09/04]; OeAD - die osterreichische Agentur fur internationale Mobilitat und Kooperation in Bildung, Wissenschaft und Forschung [SRB 15/2016]	"Laura Bassi Centers of Expertise" program of Austrian Federal Ministry of Economy through Austrian Research Promotion Agency (FFG); Ministry of Education, Science, and Technological Development of the Republic of Serbia; OeAD - die osterreichische Agentur fur internationale Mobilitat und Kooperation in Bildung, Wissenschaft und Forschung	This research was funded by the "Laura Bassi Centers of Expertise'' program of the Austrian Federal Ministry of Economy through the Austrian Research Promotion Agency (FFG project number 822768) (https://www.ffg.at/en); the Ministry of Education, Science, and Technological Development of the Republic of Serbia (grant numbers 172049 and 451-03-01039/2015-09/04) (http://www.mpn.gov.rs/) and OeAD - die osterreichische Agentur fur internationale Mobilitat und Kooperation in Bildung, Wissenschaft und Forschung (grant number SRB 15/2016) (https://oead.at).	Belij-Rammerstorfer S, 2015, MICROBES INFECT I PA; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; BRUNHAM RC, 1983, INFECT IMMUN, V39, P1491, DOI 10.1128/IAI.39.3.1491-1494.1983; Burton MJ, 2011, INFECT IMMUN, V79, P4977, DOI 10.1128/IAI.05718-11; Burton MJ, 2004, INFECT IMMUN, V72, P7352, DOI 10.1128/IAI.72.12.7352-7356.2004; Carey AJ, 2009, IMMUNOL CELL BIOL, V87, P337, DOI 10.1038/icb.2009.3; de Jonge MI, 2011, VACCINE, V29, P5994, DOI 10.1016/j.vaccine.2011.06.037; Holland MJ, 1997, CLIN EXP IMMUNOL, V107, P44, DOI 10.1046/j.1365-2249.1997.2511129.x; Holland MJ, 2006, INFECT IMMUN, V74, P1565, DOI 10.1128/IAI.74.3.1565-1572.2006; Holland MJ, 1996, CLIN EXP IMMUNOL, V105, P429, DOI 10.1046/j.1365-2249.1996.d01-792.x; Igietseme Joseph U., 1993, Regional Immunology, V5, P317; Inic-Kanada A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144380; Johnson RM, 2012, J IMMUNOL, V188, P1896, DOI 10.4049/jimmunol.1102764; Lacy HM, 2011, INFECT IMMUN, V79, P1889, DOI 10.1128/IAI.01257-10; LEVITT D, 1988, J IMMUNOL, V140, P273; Longbottom D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057950; Mabey DCW, 2014, VACCINE, V32, P1572, DOI 10.1016/j.vaccine.2013.10.016; Mahdi OSM, 2001, CLIN EXP IMMUNOL, V123, P68, DOI 10.1046/j.1365-2249.2001.01416.x; MALATY R, 1981, INVEST OPHTH VIS SCI, V21, P833; Maxion HK, 2004, INFECT IMMUN, V72, P6330, DOI 10.1128/IAI.72.11.6330-6340.2004; MEGRAN DW, 1988, J INFECT DIS, V158, P661, DOI 10.1093/infdis/158.3.661; MONNICKENDAM MA, 1980, BRIT J OPHTHALMOL, V64, P279, DOI 10.1136/bjo.64.4.279; MONNICKENDAM MA, 1980, BRIT J OPHTHALMOL, V64, P284, DOI 10.1136/bjo.64.4.284; MORRISON RP, 1995, INFECT IMMUN, V63, P4661, DOI 10.1128/IAI.63.12.4661-4668.1995; Morrison SG, 2000, INFECT IMMUN, V68, P6979, DOI 10.1128/IAI.68.12.6979-6987.2000; MURRAY ES, 1967, AM J OPHTHALMOL, V63, P1263, DOI 10.1016/0002-9394(67)94108-6; MURRAY ES, 1964, J INFECT DIS, V114, P1, DOI 10.1093/infdis/114.1.1; Nogueira CV, 2015, J IMMUNOL, V194, P2319, DOI 10.4049/jimmunol.1402675; Olivares-Zavaleta N, 2014, J IMMUNOL, V192, P4648, DOI 10.4049/jimmunol.1400120; PEDERSEN KB, 1973, ACTA PATH MICRO IM B, V81, P245; Perry LL, 1999, J IMMUNOL, V162, P3541; PETERSON EM, 1991, INFECT IMMUN, V59, P4147, DOI 10.1128/IAI.59.11.4147-4153.1991; Peterson EM, 1998, INFECT IMMUN, V66, P3848, DOI 10.1128/IAI.66.8.3848-3855.1998; Phillips TE, 2010, INVEST OPHTH VIS SCI, V51, P1533, DOI 10.1167/iovs.09-4491; RAMSEY KH, 1988, INFECT IMMUN, V56, P1320, DOI 10.1128/IAI.56.5.1320-1325.1988; Ramsey KH, 2009, INFECT IMMUN, V77, P3284, DOI 10.1128/IAI.00147-09; RANK RG, 1983, INFECT IMMUN, V39, P463, DOI 10.1128/IAI.39.1.463-465.1983; RANK RG, 1988, INFECT IMMUN, V56, P2243, DOI 10.1128/IAI.56.9.2243-2249.1988; Rank RG, 2003, INFECT IMMUN, V71, P6148, DOI 10.1128/IAI.71.11.6148-6154.2003; RANK RG, 1994, METHOD ENZYMOL, V235, P69; RANK RG, 1979, INFECT IMMUN, V26, P573, DOI 10.1128/IAI.26.2.573-579.1979; Rank RG, 2012, VIVO CHLAMYDIAL INFE; Rank RG, 2008, FEMS IMMUNOL MED MIC, V54, P104, DOI 10.1111/j.1574-695X.2008.00459.x; Reinhold P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030125; Roan NR, 2008, CELL MICROBIOL, V10, P9, DOI 10.1111/j.1462-5822.2007.01069.x; Rottenberg ME, 2002, CURR OPIN IMMUNOL, V14, P444, DOI 10.1016/S0952-7915(02)00361-8; Taylor H. R., 2008, TRACHOMA BLINDING SC; Trama AM, 2014, CELL HOST MICROBE, V16, P215, DOI 10.1016/j.chom.2014.07.003; Van Nerom A, 1998, AVIAN DIS, V42, P53, DOI 10.2307/1592576; Wali S, 2017, IMMUNOLOGY CELL BIOL; Wali S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114261; WHITTUMHUDSON JA, 1986, INVEST OPHTH VIS SCI, V27, P64; WHITTUMHUDSON JA, 1995, INVEST OPHTH VIS SCI, V36, P1976; WHO, 2014, 39 WHO; Wilson DP, 2009, J INFECT DIS, V199, P1780, DOI 10.1086/599093; World Health Organization, 2016, TRACH FACT SHEET; Yeruva L, 2013, PATHOG DIS, V68, P88, DOI 10.1111/2049-632X.12052; YOUNG E, 1984, J INFECT DIS, V150, P745, DOI 10.1093/infdis/150.5.745; ZHANG YX, 1987, J IMMUNOL, V138, P575; ZHANG YX, 1989, INFECT IMMUN, V57, P636, DOI 10.1128/IAI.57.2.636-638.1989	61	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180551	10.1371/journal.pone.0180551	http://dx.doi.org/10.1371/journal.pone.0180551			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678871	Green Submitted, Green Published, gold			2022-12-26	WOS:000405272200073
J	Ma, QG; Qian, D; Hu, LF; Wang, L				Ma, Qingguo; Qian, Da; Hu, Linfeng; Wang, Lei			Hello handsome! Male's facial attractiveness gives rise to female's fairness bias in Ultimatum Game scenarios-An ERP study	PLOS ONE			English	Article							MEDIAL FRONTAL NEGATIVITY; EVENT-RELATED POTENTIALS; PHYSICAL ATTRACTIVENESS; BRAIN POTENTIALS; DECISION-MAKING; ORBITOFRONTAL CORTEX; GENDER-DIFFERENCES; NEURAL BASIS; BEAUTY; RESPONSES	The current study delineated how male proposers' facial attractiveness affect female responders' fairness considerations and their subsequent decision outcome during the Ultimatum Game (UG). Event Related Potentials (ERPs) were recorded from 17 female subjects, who played the role as responders and had to decide whether to accept offers from either attractive or unattractive male proposers. Behavioral data (Acceptance Ratio and Response time) revealed that, more offers were accepted from attractive-face conditions; subjects typically responded quicker to unfair offers from unattractive proposers as compared with slower to unfair offers from attractive proposers. The ERP data demonstrated similar N2 amplitudes elicited by both attractive and unattractive faces, and a larger early frontal LPP elicited by the attractive faces compared with unattractive ones, but no significant differences of both late posterior LPP and typical parietal LPP amplitudes were observed between these two face conditions, which was different from our previous study with similar paradigm but male participants. The results suggest that, in comparison to males, females might not experience the potential attention bias towards unattractive opposite-sex faces and are less likely to possess an enhanced processing and evaluation of those faces. This phenomenon might be explained by endogenous gender differences in mate preference. The feedback-related negativity (FRN) and P300 responses during an offer presentation were further measured in both attractive-face and unattractive-face conditions and the results demonstrated that the amplitudes elicited by fair and unfair offers were not statistically different in the former condition, but were different in the latter condition. More specifically, unfair offers generated larger FRN and smaller P300 than fair ones in the unattractive-face condition. Findings suggest that, although females tend to possess less salient evaluation of male's facial attractiveness, the attractiveness of male proposers would still attenuate female responders' fairness consideration during the UG.	[Ma, Qingguo; Qian, Da; Hu, Linfeng; Wang, Lei] Zhejiang Univ, Sch Management, Hangzhou, Zhejiang, Peoples R China; [Ma, Qingguo; Qian, Da; Hu, Linfeng; Wang, Lei] Zhejiang Univ, Neuromanagement Lab, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Wang, L (corresponding author), Zhejiang Univ, Sch Management, Hangzhou, Zhejiang, Peoples R China.; Wang, L (corresponding author), Zhejiang Univ, Neuromanagement Lab, Hangzhou, Zhejiang, Peoples R China.	wang_lei@zju.edu.cn		Qian, Da/0000-0003-0467-1285; Wang, Lei/0000-0001-6383-0624	Chinese Association of Higher Education [11ZD0028]; Ministry of Education of People's Republic of China [09JZD0006]; National Natural Science Foundation of China [71371167, 71471163]	Chinese Association of Higher Education; Ministry of Education of People's Republic of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese Association of Higher Education, Grant number: 11ZD0028. QGM was supported by the Ministry of Education of People's Republic of China (Grant No. 09JZD0006) as a key project and the National Natural Science Foundation of China (Grant No. 71371167). Lei Wang was supported by the National Natural Science Foundation of China (Grant No. 71471163). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Boksem MAS, 2010, SOC NEUROSCI-UK, V5, P118, DOI 10.1080/17470910903202666; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Cameron L, 2013, SCIENCE, V339, P953, DOI 10.1126/science.1230221; Chen J, 2012, NEUROSCI LETT, V517, P65, DOI 10.1016/j.neulet.2012.02.082; Clark CR, 2004, CLIN EEG NEUROSCI, V35, pVI; Cloutier J, 2008, J COGNITIVE NEUROSCI, V20, P941, DOI 10.1162/jocn.2008.20062; Dolan RI, 1999, NAT NEUROSCI, V2, P927, DOI 10.1038/14707; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; EAGLY AH, 1991, PSYCHOL BULL, V110, P109, DOI 10.1037/0033-2909.110.1.109; Eckel CC, 2011, AM ECON REV, V101, P1497, DOI 10.1257/aer.101.4.1497; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; FEINGOLD A, 1992, PSYCHOL BULL, V111, P304, DOI 10.1037/0033-2909.111.2.304; Fugere MA, 2017, EVOLUTIONARY PSYCHOL, P1; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Gibbons JL, 2010, PSYCHOL WOMEN QUART, V34, P127, DOI 10.1111/j.1471-6402.2009.01549.x; Guo XY, 2014, SOC COGN AFFECT NEUR, V9, P1498, DOI 10.1093/scan/nst131; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Hajcak G, 2005, PSYCHOPHYSIOLOGY, V42, P161, DOI 10.1111/j.1469-8986.2005.00278.x; HAMERMESH DS, 1994, AM ECON REV, V84, P1174; Hamm JP, 2002, CLIN NEUROPHYSIOL, V113, P1339, DOI 10.1016/S1388-2457(02)00161-X; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; JACKSON LA, 1995, SOC PSYCHOL QUART, V58, P108, DOI 10.2307/2787149; Jin J, 2017, NEUROSCI LETT, V640, P130, DOI 10.1016/j.neulet.2017.01.037; Johnston VS, 1997, J SEX RES, V34, P188, DOI 10.1080/00224499709551884; Krupp DB, 2011, EVOL HUM BEHAV, V32, P198, DOI 10.1016/j.evolhumbehav.2010.10.001; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Lee DY, 2006, CURR OPIN NEUROBIOL, V16, P191, DOI 10.1016/j.conb.2006.02.001; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Luo Y, 2014, PSYCHOPHYSIOLOGY, V51, P834, DOI 10.1111/psyp.12235; Ma Q, 2015, PLOS ONE, V10; Ma QG, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00077; Martin RS, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00304; Marzi T, 2010, BIOL PSYCHOL, V84, P192, DOI 10.1016/j.biopsycho.2010.01.013; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Moser A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00031; Nieuwenhuis S, 2004, NEUROSCI BIOBEHAV R, V28, P441, DOI 10.1016/j.neubiorev.2004.05.003; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Oliver-Rodriguez JC, 1999, PSYCHOPHYSIOLOGY, V36, P176; Olson IR, 2005, EMOTION, V5, P498, DOI 10.1037/1528-3542.5.4.498; Oosterbeek H, 2004, EXP ECON, V7, P171, DOI 10.1023/B:EXEC.0000026978.14316.74; Pillutla MM, 1996, ORGAN BEHAV HUM DEC, V68, P208, DOI 10.1006/obhd.1996.0100; Polezzi D, 2008, BEHAV BRAIN RES, V190, P218, DOI 10.1016/j.bbr.2008.03.003; Qu C, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00505; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rogers RD, 2004, BIOL PSYCHIAT, V55, P594, DOI 10.1016/j.biopsych.2003.11.012; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schacht A, 2008, COGN AFFECT BEHAV NE, V8, P132, DOI 10.3758/CABN.8.2.132; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Schupp HT, 2007, J NEUROSCI, V27, P1082, DOI 10.1523/JNEUROSCI.3223-06.2007; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Shackelford TK, 2005, PERS INDIV DIFFER, V39, P447, DOI 10.1016/j.paid.2005.01.023; Shackelford TK, 1999, EVOL HUM BEHAV, V20, P71, DOI 10.1016/S1090-5138(98)00036-1; Shen H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35905; Smith FG, 2009, EVOL HUM BEHAV, V30, P393, DOI 10.1016/j.evolhumbehav.2009.06.003; SNYDER M, 1985, J PERS SOC PSYCHOL, V48, P1427, DOI 10.1037/0022-3514.48.6.1427; Solnick SJ, 1999, ORGAN BEHAV HUM DEC, V79, P199, DOI 10.1006/obhd.1999.2843; SPRECHER S, 1994, J PERS SOC PSYCHOL, V66, P1074, DOI 10.1037/0022-3514.66.6.1074; Turner JH, 2006, ANNU REV SOCIOL, V32, P25, DOI 10.1146/annurev.soc.32.061604.123130; Van der Veen FM, 2011, COGN AFFECT BEHAV NE, V11, P516, DOI 10.3758/s13415-011-0050-1; van Hooff JC, 2011, SOC COGN AFFECT NEUR, V6, P477, DOI 10.1093/scan/nsq066; Werheid K, 2007, BIOL PSYCHOL, V76, P100, DOI 10.1016/j.biopsycho.2007.06.008; Wiese H, 2014, NEUROPSYCHOLOGIA, V56, P26, DOI 10.1016/j.neuropsychologia.2013.12.023; Winston JS, 2007, NEUROPSYCHOLOGIA, V45, P195, DOI 10.1016/j.neuropsychologia.2006.05.009; Wu Y, 2009, BRAIN RES, V1286, P114, DOI 10.1016/j.brainres.2009.06.032; Wu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039627; Wu Y, 2011, BIOL PSYCHOL, V88, P253, DOI 10.1016/j.biopsycho.2011.08.009; Xu Q, 2011, NEUROSCI LETT, V505, P200, DOI 10.1016/j.neulet.2011.10.024; Yeung N, 2006, PSYCHOL SCI, V17, P164, DOI 10.1111/j.1467-9280.2006.01680.x; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004; Zeng J, 2012, PLOS ONE, V7, P1; Zhang Y, 2011, J NEUROSCI RES, V89, P1887, DOI 10.1002/jnr.22724	78	18	20	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180459	10.1371/journal.pone.0180459	http://dx.doi.org/10.1371/journal.pone.0180459			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2LF	28678888	Green Submitted, gold, Green Published			2022-12-26	WOS:000405272200066
J	Mahavadi, S; Sriwai, W; Manion, O; Grider, JR; Murthy, KS				Mahavadi, Sunila; Sriwai, Wimolpak; Manion, Olivia; Grider, John R.; Murthy, Karnam S.			Diabetes-induced oxidative stress mediates upregulation of RhoA/Rho kinase pathway and hypercontractility of gastric smooth muscle	PLOS ONE			English	Article							DOUBLE-EDGED-SWORD; INTERSTITIAL-CELLS; NOX ENZYMES; REACTIVE OXYGEN; POLYOL PATHWAY; HIGH-GLUCOSE; RHO-KINASE; PHOSPHORYLATION; EXPRESSION; CAJAL	The pathogenesis of diabetes-associated motility disorders are multifactorial and attributed to abnormalities in extrinsic and intrinsic innervation, and a decrease in the number of interstitial cells of Cajal, and nNOS expression and activity. Here we studied the effect of hyperglycemia on smooth muscle function. Using smooth muscles from the fundus of ob/ob mice and of wild type (WT) mice treated with 30 mM glucose (HG), we identified the molecular mechanism by which hyperglycemia upregulates RhoA/Rho kinase pathway and muscle contraction. RhoA expression, Rho kinase activity and muscle contraction were increased, while miR-133a expression was decreased in smooth muscle of ob/ob mice and in smooth muscle treated with HG. Intraperitoneal injections of pre-miR-133a decreased RhoA expression in WT mice and reversed the increase in RhoA expression in ob/ob mice. Intraperitoneal injections of antagomiR-133a increased RhoA expression in WT mice and augmented the increase in RhoA expression in ob/ob mice. The effect of pre-miR-133a or antagomiR-133a in vitro in smooth muscle treated with HG was similar to that obtained in vivo, suggesting that the expression of RhoA is negatively regulated by miR-133a and a decrease in miR-133a expression in diabetes causes an increase in RhoA expression. Oxidative stress (levels of reactive oxygen species and hydrogen peroxide, and expression of superoxide dismutase 1 and NADPH oxidase 4) was increased in smooth muscle of ob/ob mice and in HG-treated smooth muscle. Treatment of ob/ob mice with N-acetylcysteine (NAC) in vivo or addition of NAC in vitro to HG-treated smooth muscle reversed the effect of glucose on the expression of miR-133a and RhoA, Rho kinase activity and muscle contraction. NAC treatment also reversed the decrease in gastric emptying in ob/ob mice. We conclude that oxidative stress in diabetes causes a decrease in miR-133a expression leading to an increase in RhoA/Rho kinase pathway and muscle contraction.	[Mahavadi, Sunila; Sriwai, Wimolpak; Manion, Olivia; Grider, John R.; Murthy, Karnam S.] Virginia Commonwealth Univ, Dept Physiol & Biophys, VCU Program Enter Neuromuscular Sci, Richmond, VA 23284 USA	Virginia Commonwealth University	Mahavadi, S (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, VCU Program Enter Neuromuscular Sci, Richmond, VA 23284 USA.	sunila.mahavadi@vchealth.org			 [NIDDKD-DK28300]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028300] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by funds from NIDDKD-DK28300.	Abd-Elrahman KS, 2015, CAN J PHYSIOL PHARM, V93, P177, DOI 10.1139/cjpp-2014-0437; [Anonymous], 2003, PHYSIOL REV, V83, P1325; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Araki E, 2010, J DIABETES INVEST, V1, P90, DOI 10.1111/j.2040-1124.2010.00013.x; Asakawa A, 2003, J DIABETES COMPLICAT, V17, P27, DOI 10.1016/S1056-8727(02)00198-8; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bhattacharya S, 2013, AM J PHYSIOL-CELL PH, V305, pC334, DOI 10.1152/ajpcell.00334.2012; Bhetwal BP, 2013, J MUSCLE RES CELL M, V34, P137, DOI 10.1007/s10974-013-9341-1; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Cellek S, 2004, CURR PHARM DESIGN, V10, P3683, DOI 10.2174/1381612043382792; Chandran Manju, 2003, Curr Diab Rep, V3, P43, DOI 10.1007/s11892-003-0052-7; Chiba Y, 2010, J PHARMACOL SCI, V114, P264, DOI 10.1254/jphs.10R10FM; Chiba Y, 2010, J PHARMACOL SCI, V114, P239, DOI 10.1254/jphs.10R03CR; Chiba Y, 2009, AM J RESP CRIT CARE, V180, P713, DOI 10.1164/rccm.200903-0325OC; Choi KM, 2010, GASTROENTEROLOGY, V138, P2399, DOI 10.1053/j.gastro.2010.02.014; Choi KM, 2008, GASTROENTEROLOGY, V135, P2055, DOI 10.1053/j.gastro.2008.09.003; Chung SSM, 2003, J AM SOC NEPHROL, V14, pS233, DOI 10.1097/01.ASN.0000077408.15865.06; de Godoy MAF, 2011, TRENDS PHARMACOL SCI, V32, P384, DOI 10.1016/j.tips.2011.03.005; Descorbeth M, 2010, FREE RADICAL BIO MED, V49, P1395, DOI 10.1016/j.freeradbiomed.2010.07.023; Drel VR, 2006, DIABETES, V55, P3335, DOI 10.2337/db06-0885; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fiorentino TV, 2013, CURR PHARM DESIGN, V19, P5695, DOI 10.2174/1381612811319320005; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; Fu YB, 2010, AM J NEPHROL, V32, P581, DOI 10.1159/000322105; Gangula PRR, 2007, AM J PHYSIOL-GASTR L, V292, pG725, DOI 10.1152/ajpgi.00406.2006; Gao L, 2009, CARDIOVASC RES, V82, P9, DOI 10.1093/cvr/cvp031; Georgiev T, 2017, PHYSIOL RES, V66, P125, DOI 10.33549/physiolres.933373; Gopinath C, 2013, CYTOTHERAPY, V15, P869, DOI 10.1016/j.jcyt.2013.02.015; Goto K, 2010, PHARMACOL RES, V61, P466, DOI 10.1016/j.phrs.2009.12.001; Hagiwara SJ, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/173783; Hu WH, 2007, AM J PHYSIOL-CELL PH, V293, pC1991, DOI 10.1152/ajpcell.00300.2007; Huang J, 2005, AM J PHYSIOL-GASTR L, V288, pG23, DOI 10.1152/ajpgi.00305.2004; Huang J, 2007, AM J PHYSIOL-CELL PH, V292, pC200, DOI 10.1152/ajpcell.00103.2006; Kakehi T, 2008, SEMIN IMMUNOPATHOL, V30, P301, DOI 10.1007/s00281-008-0122-7; Kashyap PC, 2010, AM J PHYSIOL-GASTR L, V298, pG1013, DOI 10.1152/ajpgi.00069.2010; Kato M, 2013, FREE RADICAL BIO MED, V64, P85, DOI 10.1016/j.freeradbiomed.2013.06.009; KUNISAKI M, 1994, DIABETES, V43, P1372, DOI 10.2337/diabetes.43.11.1372; Lambeth JD, 2014, ANNU REV PATHOL-MECH, V9, P119, DOI 10.1146/annurev-pathol-012513-104651; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee AYW, 1999, FASEB J, V13, P23, DOI 10.1096/fasebj.13.1.23; Lindstrom P, 2007, THESCIENTIFICWORLDJO, V7, P666, DOI 10.1100/tsw.2007.117; Magenta A, 2013, INT J MOL SCI, V14, P17319, DOI 10.3390/ijms140917319; McMurray F, 2011, MAMM GENOME, V22, P390, DOI 10.1007/s00335-011-9345-3; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Nunes KP, 2010, CELL MOL LIFE SCI, V67, P3823, DOI 10.1007/s00018-010-0460-1; Ohmasa F, 2011, J SEX MED, V8, P1638, DOI 10.1111/j.1743-6109.2011.02238.x; Ohtsuka M, 2015, J CLIN MED, V4, P1651, DOI 10.3390/jcm4081651; Pinho JF, 2010, BRIT J PHARMACOL, V161, P1458, DOI 10.1111/j.1476-5381.2010.00955.x; Ro S, 2010, GASTROENTEROLOGY, V138, P1068, DOI 10.1053/j.gastro.2009.11.007; Sanders KM, 2006, ANNU REV PHYSIOL, V68, P307, DOI 10.1146/annurev.physiol.68.040504.094718; Searls YM, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-8; Singh J, 2016, AM J PHYSIOL-GASTR L, V311, pG964, DOI 10.1152/ajpgi.00290.2016; Southwell BR, 2008, J GASTROEN HEPATOL, V23, P505, DOI 10.1111/j.1440-1746.2008.05363.x; Srivastava KK, 2015, INDIAN J CLIN BIOCHE, V30, P3, DOI 10.1007/s12291-014-0441-5; Sriwai W, 2008, BIOCHEM J, V411, P543, DOI [10.1042/BJ20071299, 10.1042/bj20071299]; Takahashi T, 1996, AM J PHYSIOL-GASTR L, V270, pG411, DOI 10.1152/ajpgi.1996.270.3.G411; Tang WH, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00087; Touw K, 2012, AM J PHYSIOL-GASTR L, V302, pG66, DOI 10.1152/ajpgi.00183.2011; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; Varga ZV, 2013, J MOL CELL CARDIOL, V62, P111, DOI 10.1016/j.yjmcc.2013.05.009; Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-0019; Vincent HK, 2006, INT J OBESITY, V30, P400, DOI 10.1038/sj.ijo.0803177; Wang XY, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2009.01336.x; Watkins CC, 2000, J CLIN INVEST, V106, P373, DOI 10.1172/JCI8273; Wrzos HF, 1997, DIGEST DIS SCI, V42, P2106, DOI 10.1023/A:1018830820537; Xie ZW, 2006, CARDIOVASC RES, V69, P491, DOI 10.1016/j.cardiores.2005.11.002; Yamamoto T, 2008, J GASTROEN HEPATOL, V23, P660, DOI 10.1111/j.1440-1746.2008.05326.x; Yan LJ, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/137919; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911	70	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0178574	10.1371/journal.pone.0178574	http://dx.doi.org/10.1371/journal.pone.0178574			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678840	Green Published, Green Submitted, gold			2022-12-26	WOS:000405272200005
J	Shevelev, OB; Illarionova, NB; Petrovski, DV; Sarapultsev, AP; Chupakhin, ON; Moshkin, MP				Shevelev, O. B.; Illarionova, N. B.; Petrovski, D. V.; Sarapultsev, A. P.; Chupakhin, O. N.; Moshkin, M. P.			Effects of a compound from the group of substituted thiadiazines with hypothermia inducing properties on brain metabolism in rats, a study in vivo and in vitro	PLOS ONE			English	Article							MAGNETIC-RESONANCE; 1,3,4-THIADIAZINE DERIVATIVES; MODERATE HYPOTHERMIA; SPECTROSCOPY; MECHANISMS; PROTECTION; RECEPTORS; MARKER; INJURY	The aim of the present study was to examine how administration of a compound of 1,3,4-thiadiazine class 2-morpholino-5-phenyl-6H-1,3,4-thiadiazine, hydrobromide (L-17) with hypothermia inducing properties affects the brain metabolism. The mechanism by which L-17 induces hypothermia is unknown; it may involve hypothalamic central thermoregulation as well as act via inhibition of energy metabolism. We tested the hypothesis that L-17 may induce hypothermia by directly inhibiting energy metabolism. The study in vivo was carried out on Sprague-Dawley adult rats. Two doses of L-17 were administered (190 mg/kg and 760 mg/kg). Brain metabolites were analyzed in control and treated groups using magnetic resonance spectroscopy, along with blood flow rate measurements in carotid arteries and body temperature measurements. Further in vitro studies on primary cultures from rat hippocampus were carried out to perform a mitochondria function test of L-17 preincubation (100 mu M, 30 min). Analysis of brain metabolites showed no significant changes in 190 mg/kg treated group along with a significant reduction in body temperature by 1.5 degrees C. However, administration of L-17 in higher dose 760 mg/kg provoked changes in brain metabolites indicative of neurotoxicity as well as reduction in carotid arteries flow rate. In addition, a balance change of excitatory and inhibitory neurotransmitters was observed. The L-17 pre-incubation with cell primary cultures from rat brain showed no significant changes in mitochondrial function. The results obtained in the study indicate that acute administration of L-17 190 mg/kg in rats induces mild hypothermia with no adverse effects onto brain metabolism.	[Shevelev, O. B.; Illarionova, N. B.; Petrovski, D. V.; Moshkin, M. P.] Russian Acad Sci, Fed Res Ctr, Inst Cytol & Genet, Siberian Branch, Novosibirsk, Russia; [Sarapultsev, A. P.] Russian Acad Sci, Inst Immunol & Physiol, Ural Branch, Ekaterinburg, Russia; [Sarapultsev, A. P.; Chupakhin, O. N.] Ural Fed Univ, Fed State Autonomous Educ Inst Higher Profess Edu, Ekaterinburg, Russia; [Chupakhin, O. N.] Russian Acad Sci, Inst Organ Synth, Ural Div, Ekaterinburg, Russia; [Moshkin, M. P.] Tomsk State Univ, Dept Vertebrate Zool, Tomsk, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Institute of Immunology & Physiology UB RAS; Russian Academy of Sciences; Ural Federal University; Russian Academy of Sciences; Postovsky Institute of Organic Synthesis, Ural Branch of Russian Academy of Sciences; Tomsk State University	Shevelev, OB (corresponding author), Russian Acad Sci, Fed Res Ctr, Inst Cytol & Genet, Siberian Branch, Novosibirsk, Russia.	shevelev.oleg.nsk@gmail.com	Illarionova, Nina/AAO-3434-2020; Sarapultsev, Alexey P./K-7220-2012; Moshkin, Mikhail P./N-7620-2014; Chupakhin, Oleg/M-7633-2019; Shevelev, Oleg B/U-9436-2017	Sarapultsev, Alexey P./0000-0003-3101-9655; Chupakhin, Oleg/0000-0002-1672-2476; Shevelev, Oleg B/0000-0003-3200-958X	Russian Science Foundation [14-14-00221]	Russian Science Foundation(Russian Science Foundation (RSF))	The study was supported by the Russian Science Foundation (grant No 14-14-00221) http://www.rscf.ru/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisultanova N, 2014, IZV SAMAR NAUCHNOG 4, V16, P1205; Allen GI, 2013, STAT ANAL DATA MIN, V6, P302, DOI 10.1002/sam.11169; Arranz ME, 1999, BIOORGAN MED CHEM, V7, P2811, DOI 10.1016/S0968-0896(99)00221-7; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BISSETTE G, 1976, NATURE, V262, P607, DOI 10.1038/262607a0; Blier P, 2002, NEUROPSYCHOPHARMACOL, V27, P301, DOI 10.1016/S0893-133X(02)00318-4; Carlin JL, 2016, J PHARMACOL EXP THER, V356, P474, DOI 10.1124/jpet.115.229872; Chaperon F, 2003, NEUROPHARMACOLOGY, V44, P1047, DOI 10.1016/S0028-3908(03)00113-8; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; EBISU T, 1994, J CEREBR BLOOD F MET, V14, P373, DOI 10.1038/jcbfm.1994.48; FREINKEL N, 1972, NEW ENGL J MED, V287, P841, DOI 10.1056/NEJM197210262871702; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Gonzalez-Ibarra Fernando Pavel, 2011, Front Neurol, V2, P4, DOI 10.3389/fneur.2011.00004; Gordon CJ, 2008, TOXICOLOGY, V244, P87, DOI 10.1016/j.tox.2007.10.030; Lewerenz J, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00469; Logvinova Y. S., 2010, Eksperimental'naya i Klinicheskaya Farmakologiya, V73, P21; Moshkin MP, 2014, NMR BIOMED, V27, P399, DOI 10.1002/nbm.3074; Novikova A.P., 1991, CHEM HETEROCYC COMPO, V27, P1159, DOI [10.1007/BF00471738, DOI 10.1007/BF00471738]; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Rantsev MA, 2013, MED ALMANAC, V5, P92; Rawls Scott M, 2011, Front Biosci (Schol Ed), V3, P822; Rawls SM, 2002, J PHARMACOL EXP THER, V301, P963, DOI 10.1124/jpet.301.3.963; Romanovsky AA, 1996, AM J PHYSIOL-REG I, V270, pR693, DOI 10.1152/ajpregu.1996.270.4.R693; Sahu JK, 2014, J ADV PHARM TECHNOL, V5, P90, DOI 10.4103/2231-4040.133434; Sarapultsev AP, 2014, CURR PHARM DESIGN, V20, P1980, DOI 10.2174/13816128113199990492; Sarapultsev AP, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9020027; Sarapultsev P, 2012, INT J EXP PATHOL, V93, P18, DOI 10.1111/j.1365-2613.2011.00794.x; Tuskova R, 2015, BEHAV BRAIN RES, V284, P257, DOI 10.1016/j.bbr.2015.02.016; Vasil'eva T. M., 2009, Eksperimental'naya i Klinicheskaya Farmakologiya, V72, P27; Wang GJ, 2002, NEUROSCIENCE, V114, P1081, DOI 10.1016/S0306-4522(02)00350-0; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Yang YJ, 2011, CHEM PHARM BULL, V59, P1016, DOI 10.1248/cpb.59.1016; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Yuan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107447	35	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180739	10.1371/journal.pone.0180739	http://dx.doi.org/10.1371/journal.pone.0180739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678857	gold, Green Published			2022-12-26	WOS:000405272200089
J	Wan, X; Bovornchutichai, P; Cui, ZF; O'Neill, E; Ye, H				Wan, Xiao; Bovornchutichai, Phurit; Cui, Zhanfeng; O'Neill, Eric; Ye, Hua			Morphological analysis of human umbilical vein endothelial cells co-cultured with ovarian cancer cells in 3D: An oncogenic angiogenesis assay	PLOS ONE			English	Article							GROWTH	Antiangiogenic therapy for cancer is a strategy targeted at tumour vasculature, often in combination with conventional cytotoxicity treatments. Animal testing is still the most common method used for evaluating the efficacy of new drugs but tissue-engineered in vitro models are becoming more acceptable for replacing and reducing the use of animals in anti-cancer drug screening. In this study, a 3D co-culture model of human endothelial cells and ovarian cancer cells was developed. This model has the potential to mimic the interactions between endothelial cells and ovarian cancer cells. The feasibility of applying this model in drug testing was explored here. The complex morphology of the co-culture system, which features development of both endothelial tubule-like structures and tumour structures, was analysed quantitatively by an image analysis method. The co-culture morphology integrity was maintained for 10 days and the potential of the model for anti-cancer drug testing was evaluated using Paclitaxel and Cisplatin, two common anti-tumour drugs with different mechanisms of action. Both traditional cell viability assays and quantitative morphological analyses were applied in the drug testing. Cisplatin proved a good example showing the advantages of morphological analysis of the co-culture model when compared with mono-culture of endothelial cells, which did not reveal an inhibitory effect of Cisplatin on the tubule-like endothelial structures. Thus, the tubule areas of the co-culture reflected the anti-angiogenesis potential of Cisplatin. In summary, in vitro cancer models can be developed using a tissue engineering approach to more closely mimic the characteristics of tumours in vivo. Combined with the image analysis technique, this developed 3D co-culture angiogenesis model will provide more reproducible and reliably quantified results and reveal further information of the drug's effects on both tumour cell growth and tumour angiogenesis.	[Wan, Xiao; Bovornchutichai, Phurit; O'Neill, Eric] Univ Oxford, Med Sci Div, Dept Oncol, CRUK MRC Oxford Inst Radiat Oncol, Oxford, Oxon, England; [Bovornchutichai, Phurit; Cui, Zhanfeng; Ye, Hua] Univ Oxford, Inst Biomed Engn, Dept Engn Sci, Math Phys & Life Sci Div, Oxford, Oxon, England	University of Oxford; University of Oxford	O'Neill, E (corresponding author), Univ Oxford, Med Sci Div, Dept Oncol, CRUK MRC Oxford Inst Radiat Oncol, Oxford, Oxon, England.; Ye, H (corresponding author), Univ Oxford, Inst Biomed Engn, Dept Engn Sci, Math Phys & Life Sci Div, Oxford, Oxon, England.	eric.oneill@oncology.ox.ac.uk; hua.ye@eng.ox.ac.uk	Ye, Hua/L-5408-2019	Ye, Hua/0000-0001-7613-6041; Wan, Xiao/0000-0003-3600-7928; Cui, Zhanfeng/0000-0002-9251-9752	Anandamahidol Foundation; National Centre of the Replacement, Refinement & Reduction of Animals in Research; China-Oxford-Scholarship-Fund - Cancer Research UK [A19277]; Cancer Research UK [19277] Funding Source: researchfish	Anandamahidol Foundation; National Centre of the Replacement, Refinement & Reduction of Animals in Research; China-Oxford-Scholarship-Fund - Cancer Research UK; Cancer Research UK(Cancer Research UK)	P.Bovornchutichai is funded by Anandamahidol Foundation. URL:http://www.ananda mahidolfoundation.org/en. Dr Xiao Wan is a Training Fellow funded by the National Centre of the Replacement, Refinement & Reduction of Animals in Research, and this study was partially funded by the China-Oxford-Scholarship-Fund URL: http://chinaoxford.org/Professor Eric O'Neill is funded by Cancer Research UK. URL: http://www.cancerresearchuk.org/ grant number A19277. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Arbelaez P, 2011, IEEE T PATTERN ANAL, V33, P898, DOI 10.1109/TPAMI.2010.161; Barber PR, 2003, J MICROSC-OXFORD, V211, P54, DOI 10.1046/j.1365-2818.2003.01205.x; Benton G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123312; Buess M, 2009, NEOPLASIA, V11, P987, DOI 10.1593/neo.09670; Chen Y, PLOS ONE, V7; Delibasis KK, 2010, COMPUT METH PROG BIO, V100, P108, DOI 10.1016/j.cmpb.2010.03.004; Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036; Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Ingthorsson Saevar, 2010, BMC Res Notes, V3, P184, DOI 10.1186/1756-0500-3-184; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Khodarev NN, 2003, J CELL SCI, V116, P1013, DOI 10.1242/jcs.00281; L'Azou B, 2005, CELL BIOL TOXICOL, V21, P127, DOI 10.1007/s10565-005-0172-8; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Logan DJ, 2016, METHODS, V96, P6, DOI 10.1016/j.ymeth.2015.12.002; Reynolds PM, 2013, NANO LETT, V13, P570, DOI 10.1021/nl304097p; Russ J. C., 2011, IMAGE PROCESSING HDB, P235; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Seaman ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020807; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Vacca A, 2002, J HEMATOTH STEM CELL, V11, P103, DOI 10.1089/152581602753448577; Wan X, 2016, BIOTECHNOL LETT, V38, P1389, DOI 10.1007/s10529-016-2035-1; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Zhou Jun, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P65, DOI 10.2174/1568011053352569	25	9	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180296	10.1371/journal.pone.0180296	http://dx.doi.org/10.1371/journal.pone.0180296			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671994	Green Submitted, Green Published, gold			2022-12-26	WOS:000405268500040
J	Subramanian, L; Khan, AA; Allu, PKR; Kiranmayi, M; Sahu, BS; Sharma, S; Khullar, M; Mullasari, AS; Mahapatra, NR				Subramanian, Lakshmi; Khan, Abrar A.; Allu, Prasanna K. R.; Kiranmayi, Malapaka; Sahu, Bhavani S.; Sharma, Saurabh; Khullar, Madhu; Mullasari, Ajit S.; Mahapatra, Nitish R.			A haplotype variant of the human chromogranin A gene (CHGA) promoter increases CHGA expression and the risk for cardiometabolic disorders	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiovascular; hypoxia; inflammation; metabolic disease; transcription; c-Rel; chromogranin; haplotype; single nucleotide polymorphisms; transcriptional regulation	NF-KAPPA-B; NECROSIS FACTOR-ALPHA; BLOOD-PRESSURE; CATECHOLAMINE RELEASE; INSULIN-RESISTANCE; RESPONSE ELEMENT; IN-VIVO; HYPERTENSION; PEPTIDE; HYPOXIA	The acidic glycoprotein chromogranin A (CHGA) is co-stored/co-secreted with catecholamines and crucial for secretory vesicle biogenesis in neuronal/neuroendocrine cells. CHGA is dysregulated in several cardiovascular diseases, but the underlying mechanisms are not well established. Here, we sought to identify common polymorphisms in the CHGA promoter and to explore the mechanistic basis of their plausible contribution to regulating CHGA protein levels in circulation. Resequencing of the CHGA promoter in an Indian population (n = 769) yielded nine single-nucleotide polymorphisms (SNPs): G-1106A, A-1018T, T-1014C, T-988G, G-513A, G-462A, T-415C, C-89A, and C-57T. Linkage disequilibrium (LD) analysis indicated strong LD among SNPs at the -1014, -988, -462, and -89 bp positions and between the -1018 and -57 bp positions. Haplotype analysis predicted five major promoter haplotypes that displayed differential promoter activities in neuronal cells; specifically, haplotype 2 (containing variant T alleles at -1018 and -57 bp) exhibited the highest promoter activity. Systematic computational and experimental analyses revealed that transcription factor c-Rel has a role in activating the CHGA promoter haplotype 2 under basal and pathophysiological conditions (viz. inflammation and hypoxia). Consistent with the higher in vitro CHGA promoter activity of haplotype 2, individuals carrying this haplotype had higher plasma CHGA levels, plasma glucose levels, diastolic blood pressure, and body mass index. In conclusion, these results suggest a functional role of the CHGA promoter haplotype 2 (occurring in a large proportion of the world population) in enhancing CHGA expression in haplotype 2 carriers who may be at higher risk for cardiovascular/metabolic disorders.	[Subramanian, Lakshmi; Khan, Abrar A.; Allu, Prasanna K. R.; Kiranmayi, Malapaka; Sahu, Bhavani S.; Mahapatra, Nitish R.] Indian Inst Technol Madras, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India; [Mullasari, Ajit S.] Madras Med Mission, Inst Cardiovasc Dis, Madras 600037, Tamil Nadu, India; [Sharma, Saurabh; Khullar, Madhu] Postgrad Inst Med Educ & Res, Dept Expt Med & Biotechnol, Chandigarh 160012, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Mahapatra, NR (corresponding author), Indian Inst Technol Madras, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	nmahapatra@iitm.ac.in	Mahapatra, Nitish R/D-4123-2014	Mahapatra, Nitish R/0000-0002-0695-3510	Department of Biotechnology [BT/PR9546/MED/12/349/2007]; Science and Engineering Research Board, Government of India [SR/SO/HS-084/2013A]; Ministry of Human Resource Development; Department of Biotechnology; Department of Science & Technology, Government of India; Ministry of Human Resource Development, Government of India; University Grants Commission, Government of India; Council of Scientific and Industrial Research, Government of India; Council of Scientific and Industrial Research, and Defence Research and Development Organization, Government of India	Department of Biotechnology; Science and Engineering Research Board, Government of India; Ministry of Human Resource Development; Department of Biotechnology; Department of Science & Technology, Government of India(Department of Science & Technology (India)); Ministry of Human Resource Development, Government of India(Ministry of Human Resource Development (MHRD), Government of India); University Grants Commission, Government of India(University Grants Commission, India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research, and Defence Research and Development Organization, Government of India	This work was supported in part by Grant BT/PR9546/MED/12/349/2007 from the Department of Biotechnology and Grant SR/SO/HS-084/2013A from the Science and Engineering Research Board, Government of India. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by fellowships from the Ministry of Human Resource Development, Department of Biotechnology and Department of Science & Technology, Government of India.; Supported by a fellowship from the Ministry of Human Resource Development, Government of India.; Supported by a fellowship from the University Grants Commission, Government of India. Present address: Dept. of Medicine, University of California, San Francisco, CA.; Supported by a fellowship from Council of Scientific and Industrial Research, Government of India.; Supported by fellowships from the Council of Scientific and Industrial Research, and Defence Research and Development Organization, Government of India. Present address: Dept. of Integrative Biology and Physiology, University of Minnesota, MN.	AARDAL S, 1993, J NEUROENDOCRINOL, V5, P405, DOI 10.1111/j.1365-2826.1993.tb00501.x; Allu PKR, 2014, J BIOL CHEM, V289, P4455, DOI 10.1074/jbc.M113.520916; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bandyopadhyay GK, 2015, DIABETES, V64, P104, DOI 10.2337/db13-1747; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Capellino S, 2008, J RHEUMATOL, V35, P91; Cappuccio FP, 1997, J HUM HYPERTENS, V11, P571, DOI 10.1038/sj.jhh.1000516; Cayla C, 2004, BIOCHEM PHARMACOL, V67, P469, DOI 10.1016/j.bcp.2003.09.029; Chandalia M, 2007, J DIABETES COMPLICAT, V21, P143, DOI 10.1016/j.jdiacomp.2006.11.003; Chen Y, 2008, KIDNEY INT, V74, P115, DOI 10.1038/ki.2008.113; Chilov D, 1997, J BIOL CHEM, V272, P25176, DOI 10.1074/jbc.272.40.25176; Chiron S, 2011, CIRC-CARDIOVASC GENE, V4, P437, DOI 10.1161/CIRCGENETICS.110.957886; Corti A., 2002, CHROMOGRANINS FUNCTI, P351; Estensen ME, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.05.008; FASCIOTTO BH, 1993, ENDOCRINOLOGY, V133, P461, DOI 10.1210/en.133.2.461; Fesinmeyer MD, 2013, OBESITY, V21, P835, DOI 10.1002/oby.20268; Figueroa YG, 2002, EXP HEMATOL, V30, P1419, DOI 10.1016/S0301-472X(02)00934-7; Gaspar-Pereira S, 2012, AM J PATHOL, V180, P929, DOI 10.1016/j.ajpath.2011.11.007; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Jansson AM, 2009, EUR HEART J, V30, P25, DOI 10.1093/eurheartj/ehn513; Kenneth NS, 2008, BIOCHEM J, V414, P19, DOI 10.1042/BJ20081055; Kesh K, 2015, J BIOL CHEM, V290, P14391, DOI 10.1074/jbc.M114.630129; Kim T, 2001, CELL, V106, P499, DOI 10.1016/S0092-8674(01)00459-7; Kiranmayi M, 2016, HYPERTENSION, V68, P334, DOI 10.1161/HYPERTENSIONAHA.116.06568; KOONG AC, 1994, CANCER RES, V54, P1425; Lan Q, 2007, IMMUNOGENETICS, V59, P839, DOI 10.1007/s00251-007-0253-3; Leeman JR, 2008, ONCOGENE, V27, P6770, DOI 10.1038/onc.2008.284; LOWENTHAL JW, 1989, P NATL ACAD SCI USA, V86, P2331, DOI 10.1073/pnas.86.7.2331; Mahapatra NR, 2008, CARDIOVASC RES, V80, P330, DOI 10.1093/cvr/cvn155; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; Mahata SK, 1997, J CLIN INVEST, V100, P1623, DOI 10.1172/JCI119686; O'Connor DT, 2005, J CLIN ENDOCR METAB, V90, P5414, DOI 10.1210/jc.2005-0408; O'Connor DT, 1999, BLOOD PRESSURE, V8, P285, DOI 10.1080/080370599439508; O'Connor DT, 2002, J HYPERTENS, V20, P1335, DOI 10.1097/00004872-200207000-00020; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Pemberton TJ, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-13; Rao FW, 2012, AM J HYPERTENS, V25, P29, DOI 10.1038/ajh.2011.163; Raychowdhury R, 2002, MOL ENDOCRINOL, V16, P2802, DOI 10.1210/me.2001-0292; Riserus U, 2007, DIABETES CARE, V30, P2928, DOI 10.2337/dc07-0360; Sahu BS, 2010, CELL MOL LIFE SCI, V67, P861, DOI 10.1007/s00018-009-0208-y; Sasi BK, 2014, J MOL BIOL, V426, P116, DOI 10.1016/j.jmb.2013.09.008; Sciolo V, 2009, INFLAMM BOWEL DIS, V15, P867, DOI 10.1002/ibd.20851; Sonawane PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016661; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Sun XH, 2012, AM J PATHOL, V181, P1513, DOI 10.1016/j.ajpath.2012.09.001; TAKIYYUDDIN MA, 1995, HYPERTENSION, V26, P213, DOI 10.1161/01.HYP.26.1.213; TAKIYYUDDIN MA, 1990, HYPERTENSION, V15, P237, DOI 10.1161/01.HYP.15.3.237; TATEMOTO K, 1986, NATURE, V324, P476, DOI 10.1038/324476a0; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Tota B, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00064; Tota B, 2012, FASEB J, V26, P2888, DOI 10.1096/fj.11-201111; Vaingankar SM, 2010, J HYPERTENS, V28, P817, DOI 10.1097/HJH.0b013e328336ed3e; van Luijn MM, 2016, J NEUROPATH EXP NEUR, V75, P86, DOI 10.1093/jnen/nlv004; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Wen G, 2004, AM J HUM GENET, V74, P197, DOI 10.1086/381399; WU HJ, 1995, J CLIN INVEST, V96, P568, DOI 10.1172/JCI118069	56	3	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					13970	13985		10.1074/jbc.M117.778134	http://dx.doi.org/10.1074/jbc.M117.778134			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28667172	hybrid, Green Published			2022-12-26	WOS:000408439800007
J	Rendon, JC; Cortes-Mancera, F; Restrepo-Gutierrez, JC; Hoyos, S; Navas, MC				Cesar Rendon, Julio; Cortes-Mancera, Fabian; Carlos Restrepo-Gutierrez, Juan; Hoyos, Sergio; Navas, Maria-Cristina			Molecular characterization of occult hepatitis B virus infection in patients with end-stage liver disease in Colombia	PLOS ONE			English	Article							SURFACE-ANTIGEN VARIANTS; HBSAG-NEGATIVE PATIENTS; BASAL CORE PROMOTER; HBV INFECTION; HEPATOCELLULAR-CARCINOMA; X-PROTEIN; C-VIRUS; ISOLATED ANTIBODIES; FUNCTIONAL-ANALYSIS; GENETIC-VARIATION	Background Hepatitis B virus (HBV) occult infection (OBI) is a risk factor to be taken into account in transfusion, hemodialysis and organ transplantation. The aim of this study was to identify and characterize at the molecular level OBI cases in patients with end-stage liver disease. Methods Sixty-six liver samples were obtained from patients with diagnosis of end-stage liver disease submitted to liver transplantation in Medellin (North West, Colombia). Samples obtained from patients who were negative for the surface antigen of HBV (n = 50) were tested for viral DNA detection by nested PCR for ORFs S, C, and X and confirmed by Southern-Blot. OBI cases were analyzed by sequencing the viral genome to determine the genotype and mutations; additionally, viral genome integration events were examined by the AluPCR technique. Results In five cases out of 50 patients (10%) the criteria for OBI was confirmed. HBV genotype F (subgenotypes F1 and F3), genotype A and genotype D were characterized in liver samples. Three integration events in chromosomes 5q14.1, 16p13 and 20q12 affecting Receptortype tyrosine-protein phosphatase T, Ras Protein Specific Guanine Nucleotide Releasing Factor 2, and the zinc finger 263 genes were identified in two OBI cases. Sequence analysis of the viral genome of the 5 OBI cases showed several punctual missense and nonsense mutations affecting ORFs S, P, Core and X. Conclusions This is the first characterization of OBI in patients with end-stage liver disease in Colombia. The OBI cases were identified in patients with HCV infection or cryptogenic cirrhosis. The integration events (5q14.1, 16p13 and 20q12) described in this study have not been previously reported. Further studies are required to validate the role of mutations and integration events in OBI pathogenesis.	[Cesar Rendon, Julio; Carlos Restrepo-Gutierrez, Juan; Hoyos, Sergio; Navas, Maria-Cristina] Univ Antioquia, UdeA, Fac Med, Grp Gastrohepatol, Medellin, Colombia; [Cortes-Mancera, Fabian] ITM, Fac Ciencias Exactas & Aplicadas, GI2B, Medellin, Colombia; [Carlos Restrepo-Gutierrez, Juan; Hoyos, Sergio] Hosp Pablo Tobon Uribe, Unidad Hepatol & Trasplante Hepat, Medellin, Colombia	Universidad de Antioquia	Navas, MC (corresponding author), Univ Antioquia, UdeA, Fac Med, Grp Gastrohepatol, Medellin, Colombia.	maria.navas@udea.edu.co	Navas, Maria Cristina/AAE-2528-2022	Rendon, Julio Cesar/0000-0002-4054-3582; Restrepo-Gutierrez, Juan Carlos/0000-0002-1793-5756; Navas, Maria Cristina/0000-0003-2610-9306	Vicerrectoria de Investigacion,Universidad de Antioquia (Proyecto Mediana Cuantoa,) and Instituto Tecnologico Metropolitano (ITM)	Vicerrectoria de Investigacion,Universidad de Antioquia (Proyecto Mediana Cuantoa,) and Instituto Tecnologico Metropolitano (ITM)	The study was funded by Vicerrectoria de Investigacion, Universidad de Antioquia (Proyecto Mediana Cuantoa,) and Instituto Tecnologico Metropolitano (ITM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi-Ardekani B, 2011, HEPAT RES TREAT, V2011; Alencar RSM, 2008, BRAZ J MED BIOL RES, V41, P235, DOI 10.1590/S0100-879X2006005000197; Rios-Ocampo WA, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0206-z; Allen MI, 1998, HEPATOLOGY, V27, P1670, DOI 10.1002/hep.510270628; Mora MVA, 2011, INFECT GENET EVOL, V11, P103, DOI 10.1016/j.meegid.2010.10.003; Mora MVA, 2010, J GEN VIROL, V91, P501, DOI 10.1099/vir.0.015958-0; [Anonymous], 2015, 2015 B EPIDEMIOLOGIC, V52; [Anonymous], 2016, DAT GLOB DON TRANSPL; [Anonymous], 2016, SCI REG TRANSPL REC; Arroyave J, 2011, REV HECH MICROBIOL, P22; BAGINSKI I, 1992, TRANSFUSION, V32, P215, DOI 10.1046/j.1537-2995.1992.32392213803.x; Barros GM, 2008, REV SOC BRAS MED TRO, V41, P596, DOI 10.1590/S0037-86822008000600010; Bautista H, 2012, REV COL GASTROENTERO, V27; Bautista-Amorocho H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114272; Belloni L, 2009, P NATL ACAD SCI USA, V106, P19975, DOI 10.1073/pnas.0908365106; Beltran M, 2011, BIOMEDICA, V31, P580, DOI 10.1590/S0120-41572011000400013; BIRNBAUM F, 1990, J VIROL, V64, P3319, DOI 10.1128/JVI.64.7.3319-3330.1990; Bottecchia M, 2008, J ANTIMICROB CHEMOTH, V62, P626, DOI 10.1093/jac/dkn207; Brechot C, 2001, HEPATOLOGY, V34, P194, DOI 10.1053/jhep.2001.25172; Cacciola I, 1999, NEW ENGL J MED, V341, P22, DOI 10.1056/NEJM199907013410104; Castellanos YZ, 2013, REV HECH MICROBIOL, P17; Chan HLY, 2002, AM J GASTROENTEROL, V97, P1211, DOI 10.1111/j.1572-0241.2002.05706.x; CHAZOUILLERES O, 1994, LANCET, V343, P142, DOI 10.1016/S0140-6736(94)90934-2; Cheung CKY, 2010, LIVER TRANSPLANT, V16, P1314, DOI 10.1002/lt.22169; CHISARI FV, 1986, J VIROL, V60, P880, DOI 10.1128/JVI.60.3.880-887.1986; Coffin CS, 2004, HEPATOLOGY, V40, P1053, DOI 10.1002/hep.20419; Coppola N, 2015, WORLD J GASTROENTERO, V21, P11931, DOI 10.3748/wjg.v21.i42.11931; Cortes-Mancera F, 2011, HEPAT RES TREAT, V2011; De Feo TM, 2005, TRANSPL P, V37, P1238, DOI 10.1016/j.transproceed.2004.12.041; Deny P, 2010, PATHOL BIOL, V58, P245, DOI 10.1016/j.patbio.2010.05.002; Devesa M, 2008, J MED VIROL, V80, P20, DOI 10.1002/jmv.21024; Villa DD, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0402-5; Di Stefano M, 2009, J NEPHROL, V22, P381; Dickson RC, 1997, GASTROENTEROLOGY, V113, P1668, DOI 10.1053/gast.1997.v113.pm9352871; Dong QM, 2008, BIOCHEM BIOPH RES CO, V374, P773, DOI 10.1016/j.bbrc.2008.07.115; Duque-Jaramillo A, 2016, REV COLOMB GASTROENT, V31, P7; Fang Y, 2009, J MED VIROL, V81, P826, DOI 10.1002/jmv.21463; Fernandez-Medarde A, 2011, BBA-REV CANCER, V1815, P170, DOI 10.1016/j.bbcan.2010.11.001; Ferrari TCA, 2014, BRAZ J MED BIOL RES, V47, P990, DOI 10.1590/1414-431X20143782; Freitas N, 2014, J VIROL, V88, P5742, DOI 10.1128/JVI.00430-14; Frietze S, 2010, J BIOL CHEM, V285, P1393, DOI 10.1074/jbc.M109.063032; Gerstenkorn C, 2000, LIVER, V20, P425; Ghisetti V, 2004, LIVER TRANSPLANT, V10, P356, DOI 10.1002/LT.20093; Gouas DA, 2012, CARCINOGENESIS, P33; Gujar SA, 2009, J VIROL, V83, P3861, DOI 10.1128/JVI.02521-08; GUNTHER S, 1995, J VIROL, V69, P5437; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han ZG, 2015, CLIN CHIM ACTA, V438, P266, DOI 10.1016/j.cca.2014.09.007; Hassan ZK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-90; Hofer M, 1998, EUR J CLIN MICROBIOL, V17, P6, DOI 10.1007/BF01584356; Hu KQ, 2002, J VIRAL HEPATITIS, V9, P243, DOI 10.1046/j.1365-2893.2002.00344.x; Hu XL, 2000, P NATL ACAD SCI USA, V97, P1661, DOI 10.1073/pnas.97.4.1661; Huang CH, 2012, J HEPATOL, V57, P720, DOI 10.1016/j.jhep.2012.05.009; HUANG ZM, 1993, J VIROL, V67, P7032, DOI 10.1128/JVI.67.12.7032-7040.1993; Ireland JH, 2000, HEPATOLOGY, V31, P1176, DOI 10.1053/he.2000.6407; Jammeh S, 2008, J GEN VIROL, V89, P901, DOI 10.1099/vir.0.83468-0; Kannangai R, 2004, J VIRAL HEPATITIS, V11, P297, DOI 10.1111/j.1365-2893.2004.00502.x; Kao JH, 2002, J CLIN MICROBIOL, V40, P4068, DOI 10.1128/JCM.40.11.4068-4071.2002; Kim H, 2015, INT J MOL SCI, V16, P13595, DOI 10.3390/ijms160613595; Kim H, 2015, WORLD J GASTROENTERO, V21, P1794, DOI 10.3748/wjg.v21.i6.1794; Kimbi GC, 2005, WORLD J GASTROENTERO, V11, P6416, DOI 10.3748/wjg.v11.i41.6416; Kock J, 2004, J VIROL, V78, P13812, DOI 10.1128/JVI.78.24.13812-13818.2004; Koike K, 1998, J MED VIROL, V54, P249, DOI 10.1002/(SICI)1096-9071(199804)54:4&lt;249::AID-JMV3&gt;3.0.CO;2-4; Krajden Mel, 2005, Can J Infect Dis Med Microbiol, V16, P65; Kumar V, 2004, HANDB EXP PHARM, V166, P377; Lee YS, 2012, J GASTROEN HEPATOL, V27, P300, DOI 10.1111/j.1440-1746.2011.06853.x; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; LIANG TJ, 1991, HEPATOLOGY, V13, P1044, DOI 10.1002/hep.1840130607; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lucifora J, 2011, J HEPATOL, V55, P996, DOI 10.1016/j.jhep.2011.02.015; Ma NF, 2008, CLIN CANCER RES, V14, P5061, DOI 10.1158/1078-0432.CCR-07-5082; Mahboobi N, 2012, TRANSPL INFECT DIS, V14, P445, DOI 10.1111/j.1399-3062.2012.00782.x; Marzano A, 2003, TRANSPL P, V35, P1020, DOI 10.1016/S0041-1345(03)00253-7; Mazzolla R, 2002, FEMS IMMUNOL MED MIC, P32; Menendez-Arias L, 2014, CURR OPIN VIROL, V8, P1, DOI 10.1016/j.coviro.2014.04.005; Michailidis E, 2012, INT J BIOCHEM CELL B, V44, P1060, DOI 10.1016/j.biocel.2012.04.006; MINAMI M, 1995, GENOMICS, V29, P403, DOI 10.1006/geno.1995.9004; Minuk GY, 2004, HEPATOLOGY, V40, P1072, DOI 10.1002/hep.20435; Munoz SJ, 2002, LIVER TRANSPLANT, V8, pS82, DOI 10.1053/jlts.2002.35783; Murakami Y, 2005, GUT, V54, P1162, DOI 10.1136/gut.2004.054452; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; Niu YJ, 2014, CLIN RES HEPATOL GAS, V38, P475, DOI 10.1016/j.clinre.2014.03.016; Nunez M, 2002, AIDS, V16, P2099, DOI 10.1097/00002030-200210180-00024; Ocana S, 2011, WORLD J GASTROENTERO, V17, P1553, DOI 10.3748/wjg.v17.i12.1553; Parekh S, 2003, J VIROL, V77, P6601, DOI 10.1128/JVI.77.12.6601-6612.2003; PATERLINI P, 1993, HEPATOLOGY, V17, P20, DOI 10.1016/0270-9139(93)90186-Q; PATERLINI P, 1990, NEW ENGL J MED, V323, P80, DOI 10.1056/NEJM199007123230202; Pollicino T, 2009, ANTIVIR THER, V14, P649; Polo P, 2009, INFECTIO, V14, P39; Ponde RA, 2015, EUR J CLIN MICROBIOL; Pult I, 2001, J VIROL, V75, P9623, DOI 10.1128/JVI.75.20.9623-9632.2001; Raimondo G, 2007, J HEPATOL, V46, P160, DOI 10.1016/j.jhep.2006.10.007; Raimondo Giovanni, 2005, Ann Hepatol, V4, P100; Raimondo G, 2013, SEMIN IMMUNOPATHOL, V35, P39, DOI 10.1007/s00281-012-0327-7; Ramírez Sánchez Isabel Cristina, 2008, Iatreia, V21, ps10; Ríos Patiño David, 2015, Rev. colomb. Gastroenterol., V30, P11; Samal J, 2012, CLIN MICROBIOL REV, V25, P142, DOI 10.1128/CMR.00018-11; Santos EA, 2003, EUR J CLIN MICROBIOL, V22, P92, DOI 10.1007/s10096-002-0868-0; Schaefer S, 2003, J CLIN VIROL, V27, P30, DOI 10.1016/S1386-6532(02)00108-7; Seigneres B, 2001, J HEPATOL, V34, P114, DOI 10.1016/S0168-8278(00)00074-X; Shetty K, 2008, LIVER TRANSPLANT, V14, P534, DOI 10.1002/lt.21284; Squadrito G, 2006, CANCER-AM CANCER SOC, V106, P1326, DOI 10.1002/cncr.21702; Strasser SI, 1999, BLOOD, V93, P1127, DOI 10.1182/blood.V93.4.1127.404k01_1127_1136; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; TABOR E, 1979, TRANSFUSION, V19, P725, DOI 10.1046/j.1537-2995.1979.19680104098.x; TAKADA S, 1990, P NATL ACAD SCI USA, V87, P5628, DOI 10.1073/pnas.87.15.5628; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tong SP, 2005, J CLIN VIROL, V34, pS134, DOI 10.1016/S1386-6532(05)80023-X; Toniutto P, 2009, CLIN TRANSPLANT, V23, P184, DOI 10.1111/j.1399-0012.2009.00964.x; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Torresi J, 2002, VIROLOGY, V293, P305, DOI 10.1006/viro.2001.1246; Tsui JI, 2007, CLIN INFECT DIS, V45, P736, DOI 10.1086/520989; Vivekanandan P, 2008, CLIN INFECT DIS, V46, P1227, DOI 10.1086/529437; Wakil SM, 2002, J MED VIROL, V68, P311, DOI 10.1002/jmv.10205; Weizmann_Institute_of_Science, 2016, RASGRF2 GEN; Weizmann Institute of Science, 2016, PTPRT GEN; WHO, 2015, HEP B; Wong DKH, 2011, HEPATOLOGY, V54, P829, DOI 10.1002/hep.24551; Zeng GB, 2004, WORLD J GASTROENTERO, V10, P3132; Zhang ZH, 2016, WORLD J GASTROENTERO, V22, P126, DOI 10.3748/wjg.v22.i1.126; Zhang ZH, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0464-z; Zhang ZH, 2015, J MED VIROL, V87, P1890, DOI 10.1002/jmv.24245; Zhong GC, 2013, J VIROL, V87, P7176, DOI 10.1128/JVI.03533-12; Zhong YW, 2012, ANTIVIR RES, V93, P185, DOI 10.1016/j.antiviral.2011.11.012; Zhu HL, 2016, WORLD J GASTROENTERO, V22, P3531, DOI 10.3748/wjg.v22.i13.3531; Zoulim F, 2004, ANTIVIR RES, V64, P1, DOI [10.1016/j.antiviral.2004.07.003, 10.1016/S0166-3542(04)00162-7]	126	10	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180447	10.1371/journal.pone.0180447	http://dx.doi.org/10.1371/journal.pone.0180447			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686707	Green Published, Green Submitted, gold			2022-12-26	WOS:000405464100064
J	Ott, L; Hacker, E; Kunert, T; Karrington, I; Etschel, P; Lang, R; Wiesmann, V; Wittenberg, T; Singh, A; Varela, C; Bhatt, A; Sangal, V; Burkovski, A				Ott, Lisa; Hacker, Elena; Kunert, Timo; Karrington, Ian; Etschel, Philipp; Lang, Roland; Wiesmann, Veit; Wittenberg, Thomas; Singh, Albel; Varela, Cristian; Bhatt, Apoorva; Sangal, Vartul; Burkovski, Andreas			Analysis of Corynebacterium diphtheriae macrophage interaction: Dispensability of corynomycolic acids for inhibition of phagolysosome maturation and identification of a new gene involved in synthesis of the corynomycolic acid layer	PLOS ONE			English	Article							MYCOLIC ACIDS; CORD FACTOR; FATTY-ACID; CELL-WALL; IN-VIVO; MYCOBACTERIAL GROWTH; GAS-CHROMATOGRAPHY; COA HYDRATASE; BIOSYNTHESIS; TUBERCULOSIS	Corynebacterium diphtheriae is the causative agent of diphtheria, a toxin mediated disease of upper respiratory tract, which can be fatal. As a member of the CMNR group, C. diphtheriae is closely related to members of the genera Mycobacterium, Nocardia and Rhodococcus. Almost all members of these genera comprise an outer membrane layer of mycolic acids, which is assumed to influence host-pathogen interactions. In this study, three different C. diphtheriae strains were investigated in respect to their interaction with phagocytic murine and human cells and the invertebrate infection model Caenorhabditis elegans. Our results indicate that C. diphtheriae is able to delay phagolysosome maturation after internalization in murine and human cell lines. This effect is independent of the presence of mycolic acids, as one of the strains lacked corynomycolates. In addition, analyses of NF-kBinduction revealed a mycolate- independent mechanism and hint to detrimental effects of the different strains tested on the phagocytic cells. Bioinformatics analyses carried out to elucidate the reason for the lack of mycolates in one of the strains led to the identification of a new gene involved in mycomembrane formation in C. diphtheriae.	[Ott, Lisa; Hacker, Elena; Kunert, Timo; Karrington, Ian; Etschel, Philipp; Burkovski, Andreas] Friedrich Alexander Univ Erlangen Nurnberg, Mikrobiol, Erlangen, Germany; [Etschel, Philipp; Lang, Roland] Friedrich Alexander Univ Erlangen Nurnberg, Mikrobiol Inst, Univ Klinikum Erlangen, Erlangen, Germany; [Wiesmann, Veit; Wittenberg, Thomas] Fraunhofer Inst Integrierte Schaltungen IIS, Erlangen, Germany; [Singh, Albel; Varela, Cristian; Bhatt, Apoorva] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Singh, Albel; Varela, Cristian; Bhatt, Apoorva] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Sangal, Vartul] Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne, Tyne & Wear, England	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Fraunhofer Gesellschaft; University of Birmingham; University of Birmingham; Northumbria University	Burkovski, A (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Mikrobiol, Erlangen, Germany.	andreas.burkovski@fau.de	Sangal, Vartul/AAB-5426-2020; Wittenberg, Thomas/AAD-6340-2019	Sangal, Vartul/0000-0002-7405-8446; Wittenberg, Thomas/0000-0003-0840-8695; Burkovski, Andreas/0000-0003-1896-4521; Lang, Roland/0000-0003-0502-3677; Ott, Lisa/0000-0002-9779-9052	Deutsche Forschungsgemeinschaft [SFB796]; Fulbright program; Medical Research Foundation; Anniversary Research Fellowship; Higher Education Innovation Funding (HEIF) from Northumbria University, Newcastle upon Tyne, UK	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fulbright program; Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Anniversary Research Fellowship; Higher Education Innovation Funding (HEIF) from Northumbria University, Newcastle upon Tyne, UK	The project was supported by the Deutsche Forschungsgemeinschaft in frame of SFB796 (A4, B6 and MGK) and the Fulbright program (fellowship to I. A. Kline). A. Bhatt acknowledges equipment funding from the Medical Research Foundation. V. Sangal was supported by an Anniversary Research Fellowship and the Higher Education Innovation Funding (HEIF) from Northumbria University, Newcastle upon Tyne, UK.	ABE S, 1967, J GEN APPL MICROBIOL, V13, P279, DOI 10.2323/jgam.13.279; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Ang MLT, 2014, INFECT IMMUN, V82, P1850, DOI 10.1128/IAI.01332-13; Antunes CA, 2015, MICROBIOL-SGM, V161, P639, DOI 10.1099/mic.0.000020; ATHALYE M, 1984, J GEN MICROBIOL, V130, P513; Axelrod S, 2008, CELL MICROBIOL, V10, P1530, DOI 10.1111/j.1462-5822.2008.01147.x; Bahnson BJ, 2002, BIOCHEMISTRY-US, V41, P2621, DOI 10.1021/bi015844p; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bhatt A, 2008, CHEM BIOL, V15, P930, DOI 10.1016/j.chembiol.2008.07.007; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Burkovski A, 2013, ISRN MICROBIOL, V2013, P935736, DOI 10.1155/2013/935736; Burkovski A, 2015, CORYNEBACTERIUM GLUTAMICUM: FROM SYSTEMS BIOLOGY TO BIOTECHNOLOGICAL APPLICATIONS, P1; Cerdeno-Tarraga AM, 2003, NUCLEIC ACIDS RES, V31, P6516, DOI 10.1093/nar/gkg874; Collins MD, 1998, INT J SYST BACTERIOL, V48, P1449, DOI 10.1099/00207713-48-4-1449; COLLINS MD, 1988, FEMS MICROBIOL LETT, V49, P349; Cox JAG, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.6, 10.1038/nmicrobiol.2015.6]; Daffe A M, 2005, CELL ENVELOPE CORYNE; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; dos Santos LS, 2015, MEM I OSWALDO CRUZ, V110, P662, DOI 10.1590/0074-02760140479; Engel CK, 1996, EMBO J, V15, P5135, DOI 10.1002/j.1460-2075.1996.tb00897.x; Fiani ML, 1998, J LEUKOCYTE BIOL, V64, P85, DOI 10.1002/jlb.64.1.85; GAILLY C, 1982, EUR J BIOCHEM, V125, P83, DOI 10.1111/j.1432-1033.1982.tb06654.x; Gande R, 2004, J BIOL CHEM, V279, P44847, DOI 10.1074/jbc.M408648200; Gande R, 2007, J BACTERIOL, V189, P5257, DOI 10.1128/JB.00254-07; Gebhardt H, 2007, MICROBIOL-SGM, V153, P1424, DOI 10.1099/mic.0.2006/003541-0; Geisel RE, 2005, J IMMUNOL, V174, P5007, DOI 10.4049/jimmunol.174.8.5007; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Hacker E, 2016, VIRULENCE, V7, P45, DOI 10.1080/21505594.2015.1125068; HARD GC, 1975, INFECT IMMUN, V12, P1439, DOI 10.1128/IAI.12.6.1439-1449.1975; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Hunter RL, 2006, ANN CLIN LAB SCI, V36, P371; Indrigo J, 2003, MICROBIOL-SGM, V149, P2049, DOI 10.1099/mic.0.26226-0; Knoppova M, 2007, CURR MICROBIOL, V55, P234, DOI 10.1007/s00284-007-0106-1; Lang R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00005; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Lea-Smith DJ, 2007, J BIOL CHEM, V282, P11000, DOI 10.1074/jbc.M608686200; Lee WB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002614; Marrakchi H, 2002, J BIOL CHEM, V277, P44809, DOI 10.1074/jbc.M208920200; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; Nakao H, 1996, J CLIN MICROBIOL, V34, P1711, DOI 10.1128/JCM.34.7.1711-1716.1996; Nataraj V, 2015, MOL MICROBIOL, V98, P7, DOI 10.1111/mmi.13101; Niederweis M, 2010, TRENDS MICROBIOL, V18, P109, DOI 10.1016/j.tim.2009.12.005; Ott L, 2013, MICROBIOL-SGM, V159, P126, DOI 10.1099/mic.0.061879-0; Ott L, 2012, FEMS IMMUNOL MED MIC, V65, P413, DOI 10.1111/j.1574-695X.2012.00963.x; Ott L, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-257; Ott L, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-2; Portevin D, 2005, J BIOL CHEM, V280, P8862, DOI 10.1074/jbc.M408578200; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Portevin D, 2014, MICROBIOLOGYOPEN, V3, P823, DOI 10.1002/mbo3.193; Radmacher E, 2005, MICROBIOL-SGM, V151, P2421, DOI 10.1099/mic.0.28012-0; Rheinlaender J, 2012, EUR BIOPHYS J BIOPHY, V41, P561, DOI 10.1007/s00249-012-0818-4; Riegel P, 2004, INT J MED MICROBIOL, V294, P413, DOI 10.1016/j.ijmm.2004.07.013; Sabbadini PS, 2012, MICROB PATHOGENESIS, V52, P165, DOI 10.1016/j.micpath.2011.12.003; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sangal V, 2016, INFECT GENET EVOL, V43, P364, DOI 10.1016/j.meegid.2016.06.024; Sangal V, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1980-8; Sangal V, 2014, INFECT GENET EVOL, V21, P54, DOI 10.1016/j.meegid.2013.10.019; Sangal V, 2012, J BACTERIOL, V194, P4738, DOI 10.1128/JB.00939-12; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Stephan J, 2005, MOL MICROBIOL, V58, P714, DOI 10.1111/j.1365-2958.2005.04878.x; Sydor T, 2013, CELL MICROBIOL, V15, P458, DOI 10.1111/cmi.12050; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Tatusova T, 2014, NUCLEIC ACIDS RES, V42, pD553, DOI 10.1093/nar/gkt1274; Tauch A, 2014, THE PROKARYOTES; Tauch A, 2008, J BIOTECHNOL, V136, P22, DOI 10.1016/j.jbiotec.2008.03.004; Tippelt A, 2014, GENOME ANOUNC, V2, P1; Tropis M, 2005, J BIOL CHEM, V280, P26573, DOI 10.1074/jbc.M502104200; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Varela C, 2012, CHEM BIOL, V19, P498, DOI 10.1016/j.chembiol.2012.03.006; Wolf A, 2003, MOL MICROBIOL, V49, P1119, DOI 10.1046/j.1365-2958.2003.03625.x	72	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180105	10.1371/journal.pone.0180105	http://dx.doi.org/10.1371/journal.pone.0180105			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686600	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000405464100035
J	Shino, MY; Weigt, SS; Li, N; Palchevskiy, V; Derhovanessian, A; Saggar, R; Sayah, DM; Huynh, RH; Gregson, AL; Fishbein, MC; Ardehali, A; Ross, DJ; Lynch, JP; Elashoff, RM; Belperio, JA				Shino, Michael Y.; Weigt, S. Samuel; Li, Ning; Palchevskiy, Vyacheslav; Derhovanessian, Ariss; Saggar, Rajan; Sayah, David M.; Huynh, Richard H.; Gregson, Aric L.; Fishbein, Michael C.; Ardehali, Abbas; Ross, David J.; Lynch, Joseph P., III; Elashoff, Robert M.; Belperio, John A.			The prognostic importance of CXCR3 chemokine during organizing pneumonia on the risk of chronic lung allograft dysfunction after lung transplantation	PLOS ONE			English	Article							BRONCHIOLITIS OBLITERANS SYNDROME; ACUTE CELLULAR REJECTION; MINIMAL ACUTE REJECTION; WORKING FORMULATION; RETROSPECTIVE ANALYSIS; PULMONARY ALLOGRAFT; STANDARDIZATION; NOMENCLATURE; PATHOGENESIS; SURVIVAL	Rationale Since the pathogenesis of chronic lung allograft dysfunction (CLAD) remains poorly defined with no known effective therapies, the identification and study of key events which increase CLAD risk is a critical step towards improving outcomes. We hypothesized that bronchoalveolar lavage fluid (BALF) CXCR3 ligand concentrations would be augmented during organizing pneumonia (OP) and that episodes of OP with marked chemokine elevations would be associated with significantly higher CLAD risk. Methods All transbronchial biopsies (TBBX) from patients who received lung transplantation between 2000 to 2010 were reviewed. BALF concentrations of the CXCR3 ligands (CXCL9, CXCL10 and CXCL11) were compared between episodes of OP and "healthy" biopsies using linear mixed-effects models. The association between CXCR3 ligand concentrations during OP and CLAD risk was evaluated using proportional hazards models with time-dependent covariates. Results There were 1894 bronchoscopies with TBBX evaluated from 441 lung transplant recipients with 169 (9%) episodes of OP and 907 (49%) non-OP histopathologic injuries. 62 (37%) episodes of OP were observed during routine surveillance bronchoscopy. Eight hundred thirtyeight (44%) TBBXs had no histopathology and were classified as "healthy" biopsies. There were marked elevations in BALF CXCR3 ligand concentrations during OP compared with "healthy" biopsies. In multivariable models adjusted for other injury patterns, OP did not significantly increase the risk of CLAD when BAL CXCR3 chemokine concentrations were not taken into account. However, OP with elevated CXCR3 ligands markedly increased CLAD risk in a dose-response manner. An episode of OP with CXCR3 concentrations greater than the 25th, 50th and 75th percentiles had HRs for CLAD of 1.5 (95% CI 1.0-2.3), 1.9 ( 95% CI 1.2-2.8) and 2.2 ( 95% CI 1.4-3.4), respectively. Conclusions This study identifies OP, a relatively uncommon histopathologic finding after lung transplantation, as a major risk factor for CLAD development when considered in the context of increased allograft expression of interferon-.inducible ELR-CXC chemokines. We further demonstrate for the first time, the prognostic importance of BALF CXCR3 ligand concentrations during OP on subsequent CLAD risk.	[Shino, Michael Y.; Weigt, S. Samuel; Palchevskiy, Vyacheslav; Derhovanessian, Ariss; Saggar, Rajan; Sayah, David M.; Huynh, Richard H.; Ross, David J.; Lynch, Joseph P., III; Belperio, John A.] UCLA, David Geffen Sch Med, Div Pulm & Crit Care Med, Dept Med, Los Angeles, CA 90095 USA; [Li, Ning; Elashoff, Robert M.; Belperio, John A.] Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA USA; [Gregson, Aric L.] UCLA, David Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA; [Fishbein, Michael C.] UCLA, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA; [Ardehali, Abbas] UCLA, David Geffen Sch Med, Dept Surg, Div Cardiothorac Surg, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Shino, MY (corresponding author), UCLA, David Geffen Sch Med, Div Pulm & Crit Care Med, Dept Med, Los Angeles, CA 90095 USA.	mshino@mednet.ucla.edu			NIH/National Center for Advancing Translational Science (NCATS) UCLACTSI [UL1TR000124, 5U01AI113315-02, R01HL112990-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL138256] Funding Source: NIH RePORTER	NIH/National Center for Advancing Translational Science (NCATS) UCLACTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	There search described was supported by NIH/National Center for Advancing Translational Science (NCATS) UCLACTSI Grant Number UL1TR000124 (MYS), 5U01AI113315-02 (SW +JAB) and R01HL112990-01 (JAB).	American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Belperio JA, 2003, J IMMUNOL, V171, P4844, DOI 10.4049/jimmunol.171.9.4844; Belperio JA, 2002, J IMMUNOL, V169, P1037, DOI 10.4049/jimmunol.169.2.1037; Burton CM, 2008, TRANSPLANTATION, V86, P811, DOI 10.1097/TP.0b013e3181852f02; Burton CM, 2008, TRANSPLANTATION, V85, P547, DOI 10.1097/TP.0b013e3181641df9; Burton CM, 2009, J HEART LUNG TRANSPL, V28, P888, DOI 10.1016/j.healun.2009.04.022; Christie JD, 2011, J HEART LUNG TRANSPL, V30, P1104, DOI 10.1016/j.healun.2011.08.004; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; COOPER JD, 1993, J HEART LUNG TRANSPL, V12, P713; Crespo E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117618; Davis WA, 2012, AM J TRANSPLANT, V12, P745, DOI 10.1111/j.1600-6143.2011.03849.x; El-Gamel A, 1999, J HEART LUNG TRANSPL, V18, P828, DOI 10.1016/S1053-2498(99)00047-9; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Girgis RE, 1996, J HEART LUNG TRANSPL, V15, P1200; Glanville AR, 2008, AM J RESP CRIT CARE, V177, P1033, DOI 10.1164/rccm.200706-951OC; Hachem RR, 2005, TRANSPLANTATION, V80, P1406, DOI 10.1097/01.tp.0000181161.60638.fa; Heng D, 1998, J HEART LUNG TRANSPL, V17, P1255; Hopkins PM, 2004, AM J RESP CRIT CARE, V170, P1022, DOI 10.1164/rccm.200302-165oc; Husain AN, 1999, AM J RESP CRIT CARE, V159, P829, DOI 10.1164/ajrccm.159.3.9607099; Khalifah AP, 2005, AM J TRANSPLANT, V5, P2022, DOI 10.1111/j.1600-6143.2005.00953.x; Kroshus TJ, 1997, J THORAC CARDIOV SUR, V114, P195, DOI 10.1016/S0022-5223(97)70144-2; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Paraskeva M, 2013, AM J RESP CRIT CARE, V187, P1360, DOI 10.1164/rccm.201210-1831OC; Sato M, 2012, J HEART LUNG TRANSPL; Sato M, 2011, J HEART LUNG TRANSPL, V30, P735, DOI 10.1016/j.healun.2011.01.712; Sato MS T., 2013, ISHLT 33 ANN M SCI S; Sharples LD, 2002, J HEART LUNG TRANSPL, V21, P271, DOI 10.1016/S1053-2498(01)00360-6; Shino MY, 2013, AM J RESP CRIT CARE, V188, P1117, DOI 10.1164/rccm.201305-0861OC; Stewart S, 2007, J HEART LUNG TRANSPL, V26, P1229, DOI 10.1016/j.healun.2007.10.017; Todd JL, 2014, AM J RESP CRIT CARE, V189, P159, DOI 10.1164/rccm.201306-1155OC; Verleden GM, 2011, TRANSPLANTATION, V92, P703, DOI 10.1097/TP.0b013e31822bf790; Verleden SE, 2013, TRANSPLANTATION, V95, P1167, DOI 10.1097/TP.0b013e318286e076; Weigt SS, 2009, AM J TRANSPLANT, V9, P1903, DOI 10.1111/j.1600-6143.2009.02635.x; Yousem SA, 1996, J HEART LUNG TRANSPL, V15, P1; YOUSEM SA, 1993, AM J SURG PATHOL, V17, P491, DOI 10.1097/00000478-199305000-00008	35	16	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180281	10.1371/journal.pone.0180281	http://dx.doi.org/10.1371/journal.pone.0180281			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686641	gold, Green Published			2022-12-26	WOS:000405464100048
J	Yang, SS; Flores, B; Magal, R; Harris, K; Gross, J; Ewbank, A; Davenport, S; Ormachea, P; Nasser, W; Le, WD; Peacock, WF; Katz, Y; Eagleman, DM				Yang, Suosuo; Flores, Benjamin; Magal, Rotem; Harris, Kyrsti; Gross, Jonathan; Ewbank, Amy; Davenport, Sasha; Ormachea, Pablo; Nasser, Waleed; Le, Weidong; Peacock, W. Frank; Katz, Yael; Eagleman, David M.			Diagnostic accuracy of tablet-based software for the detection of concussion	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; EMERGENCY-DEPARTMENT; RAPID SCREEN; SENSITIVITY; PERFORMANCE; CHILDREN; TESTS; IDENTIFICATION; SPECIFICITY	Despite the high prevalence of traumatic brain injuries (TBI), there are few rapid and straightforward tests to improve its assessment. To this end, we developed a tablet-based software battery ("BrainCheck") for concussion detection that is well suited to sports, emergency department, and clinical settings. This article is a study of the diagnostic accuracy of BrainCheck. We administered BrainCheck to 30 TBI patients and 30 pain-matched controls at a hospital Emergency Department (ED), and 538 healthy individuals at 10 control test sites. We compared the results of the tablet-based assessment against physician diagnoses derived from brain scans, clinical examination, and the SCAT3 test, a traditional measure of TBI. We found consistent distributions of normative data and high test-retest reliability. Based on these assessments, we defined a composite score that distinguishes TBI from non-TBI individuals with high sensitivity (83%) and specificity (87%). We conclude that our testing application provides a rapid, portable testing method for TBI.	[Yang, Suosuo; Le, Weidong] Dalian Med Univ, Dalian, Liaoning Provin, Peoples R China; [Yang, Suosuo; Peacock, W. Frank] Baylor Coll Med, Dept Emergency Med, Houston, TX 77030 USA; [Flores, Benjamin; Magal, Rotem; Harris, Kyrsti; Gross, Jonathan; Ewbank, Amy; Davenport, Sasha; Ormachea, Pablo; Nasser, Waleed; Katz, Yael; Eagleman, David M.] BrainCheck Inc, Houston, TX 77021 USA; [Davenport, Sasha] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Eagleman, David M.] Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Stanford, CA USA	Dalian Medical University; Baylor College of Medicine; Baylor College of Medicine; Stanford University	Le, WD (corresponding author), Dalian Med Univ, Dalian, Liaoning Provin, Peoples R China.; Katz, Y (corresponding author), BrainCheck Inc, Houston, TX 77021 USA.	wdle@sibs.ac.cn; yael@braincheck.com			Brain Check, Inc	Brain Check, Inc	Brain Check, Inc, provided support in the form of salaries for authors DE, YK, BF, RM, KH, AE, SD, WN but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, and only provided financial support in the form of some of the authors' salaries and research materials (the software battery of tests) Nothing about this funding alters our adherence to PLOSONE policies on sharing data and materials. The specific roles of these authors are articulated in the 'author contributions' section.	Archibald SJ, 1999, CHILD NEUROPSYCHOL, V5, P115, DOI 10.1076/chin.5.2.115.3167; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Berg DB, 2011, J SURG EDUC, V68, P10, DOI 10.1016/j.jsurg.2010.08.005; BOONE KB, 1990, DEV NEUROPSYCHOL, V6, P215, DOI 10.1080/87565649009540462; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Comerford VE, 2002, J CLIN EXP NEUROPSYC, V24, P409, DOI 10.1076/jcen.24.4.409.1044; Control CfD, 2011, MMWR-MORBID MORTAL W, V60, P1337; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; De Monte VE, 2010, J CLIN EXP NEUROPSYC, V32, P28, DOI 10.1080/13803390902806519; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Greenwald BD, 2001, J HEAD TRAUMA REHAB, V16, P238, DOI 10.1097/00001199-200106000-00003; Greenwald RM, 2012, CLIN J SPORT MED, V22, P83, DOI 10.1097/JSM.0b013e31824cc5d3; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Homack S, 2004, ARCH CLIN NEUROPSYCH, V19, P725, DOI 10.1016/j.acn.2003.09.003; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kontos AP, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0571-y; Lew HL, 2007, J REHABIL RES DEV, V44, P963, DOI 10.1682/JRRD.2006.12.0169; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Melara RD, 2003, PSYCHOL REV, V110, P422, DOI 10.1037/0033-295X.110.3.422; Miller P, 2015, EMERG MED AUSTRALAS, V27, P225, DOI 10.1111/1742-6723.12369; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; Ortega E, 2003, EXERC IMMUNOL REV, V9, P70; Ricard C, 2013, SANTE PUBLIQUE, V25, P711, DOI 10.3917/spub.136.0711; Rinne MB, 2006, J REHABIL MED, V38, P224, DOI 10.1080/16501970600582989; Rivara FP, 2014, JAMA-J AM MED ASSOC, V311, P239, DOI 10.1001/jama.2013.282985; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Strauss E, 2006, COMPENDIUM NEUROPSYC; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363	33	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e.0179352	10.1371/journal.pone.0179352	http://dx.doi.org/10.1371/journal.pone.0179352			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686616	Green Submitted, Green Published, gold			2022-12-26	WOS:000405464100014
J	Wang, XY; Wang, LH; Zhang, WS; Zhao, H; Li, F				Wang, Xiaoye; Wang, Lihua; Zhang, Weisheng; Zhao, Hong; Li, Feng			Can we differentiate minimally invasive adenocarcinoma and non-invasive neoplasms based on high-resolution computed tomography features of pure ground glass nodules?	PLOS ONE			English	Article							LUNG ADENOCARCINOMA; OPACITY NODULES; PULMONARY NODULES; CT FINDINGS; HELICAL CT; CLASSIFICATION; MANAGEMENT; RESECTION; CANCER; HISTOPATHOLOGY	Objective The purpose of our study was to assess the differentially diagnostic value of radiographic characteristics of pure ground glass nodules (GGNs) between minimally invasive adenocarcinoma and non-invasive neoplasm. Methods Sixty-seven pure GGNs (28 minimally invasive adenocarcinomas (MIA) and 39 pre-invasive lesions) were analyzed from June 2012 to June 2015. Pre-invasive lesions consisted of 15 atypical adenomatous hyperplasia (AAH) and 24 adenocarcinomas in situ (AIS). High-resolution computed tomography (HRCT) features and volume of MIA and pre-invasive lesions were assessed. Fisher exact test, independent sample t test, Mann-Whitney U test and receiver operating characteristic (ROC) curve analysis were performed. Results Inter-observer agreement indexes for the diameter, mean HRCT attenuations and volume of pure GGNs were all high (ICC>0.75). Univariate analyses showed that lesion diameter, mean HRCT attenuation, and volume value differed significantly between two groups. Among HRCT findings, GGN shape as round or oval (F = 13.456, P = 0.002) and lesion borders as smooth or notched (F = 15.742, P = 0.001) frequently appeared in pre-invasive lesions in comparison with MIA. Type II and type III of the relationship between blood vessels and pure GGNs suggested higher possibility of malignancy than type I. Conclusions HRCT features of pure GGNs can help to differentiate MIA from non-invasive neoplasms.	[Wang, Xiaoye; Zhang, Weisheng] Dalian Med Univ, Affiliated Hosp 1, Dept Radiol, Dalian, Peoples R China; [Wang, Xiaoye; Zhao, Hong; Li, Feng] Second Peoples Hosp Zhuhai, Dept Radiol, Zhuhai, Peoples R China; [Wang, Lihua] Qingdao Women & Childrens Hosp, Dept Med Imaging, Qingdao, Peoples R China	Dalian Medical University	Zhang, WS (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Dept Radiol, Dalian, Peoples R China.	11111210027@fudan.edu.cn			Dalian Municipal Science and Technology Plan Project [2015E12SF163]; Liaoning Science and Technology Project [201602245]	Dalian Municipal Science and Technology Plan Project; Liaoning Science and Technology Project	This study was supported by the Dalian Municipal Science and Technology Plan Project (grant number 2015E12SF163), (http://kjjh.dlinfo.gov.cn/index.shtml); and the Liaoning Science and Technology Project (grant number 201602245),(http://kjjh.lninfo.gov.cn/).The funders had no role in study design, data collection and analys, decision to publish, or preparation of the manuscript	Cho S, 2013, ANN THORAC SURG, V96, P1190, DOI 10.1016/j.athoracsur.2013.05.062; Eguchi T, 2014, LUNG CANCER, V84, P242, DOI 10.1016/j.lungcan.2014.03.009; Farooqi AO, 2012, AM J ROENTGENOL, V199, P781, DOI 10.2214/AJR.11.7812; Gao F, 2013, EUR RADIOL, V23, P3271, DOI 10.1007/s00330-013-2954-3; Godoy MCB, 2012, J THORAC IMAG, V27, P240, DOI 10.1097/RTI.0b013e31825d515b; Haro A, 2012, LUNG CANCER, V76, P56, DOI 10.1016/j.lungcan.2011.09.002; Henschke CI, 2002, AM J ROENTGENOL, V178, P1053, DOI 10.2214/ajr.178.5.1781053; Honda T, 2013, CLIN RADIOL, V68, pE21, DOI 10.1016/j.crad.2012.09.002; Ikeda K, 2007, CHEST, V132, P984, DOI 10.1378/chest.07-0793; Jeong YJ, 2008, RADIOLOGIA-MADRID, V50, P183, DOI 10.1016/S0033-8338(08)71964-7; Koo CW, 2012, EUR J RADIOL, V81, P139, DOI 10.1016/j.ejrad.2010.07.001; Lee HY, 2014, AM J ROENTGENOL, V202, pW224, DOI 10.2214/AJR.13.11819; Lee HY, 2011, J THORAC IMAG, V26, P106, DOI 10.1097/RTI.0b013e3181fbaa64; Lee HJ, 2009, EUR RADIOL, V19, P552, DOI 10.1007/s00330-008-1188-2; Lee SM, 2013, RADIOLOGY, V268, P265, DOI 10.1148/radiol.13120949; Lee SW, 2013, RESP MED, V107, P904, DOI 10.1016/j.rmed.2013.02.014; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Nakata M, 2003, ANN THORAC SURG, V75, P1601, DOI 10.1016/S0003-4975(02)04815-4; Noguchi M, 2010, CANCER METAST REV, V29, P15, DOI 10.1007/s10555-010-9210-y; Oda S, 2008, AM J ROENTGENOL, V190, P1363, DOI 10.2214/AJR.07.3101; Raso MG, 2009, CLIN CANCER RES, V15, P5359, DOI 10.1158/1078-0432.CCR-09-0033; Takashima S, 2003, AM J ROENTGENOL, V180, P817, DOI 10.2214/ajr.180.3.1800817; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Yang ZG, 2001, AM J ROENTGENOL, V176, P1399, DOI 10.2214/ajr.176.6.1761399; Yoshizawa A, 2011, MODERN PATHOL, V24, P653, DOI 10.1038/modpathol.2010.232	25	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180502	10.1371/journal.pone.0180502	http://dx.doi.org/10.1371/journal.pone.0180502			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683126	Green Submitted, Green Published, gold			2022-12-26	WOS:000405335200042
J	Kao, KC; Chang, CH; Hung, CY; Chiu, LC; Huang, CC; Hu, HC				Kao, Kuo-Chin; Chang, Chih-Hao; Hung, Chen-Yiu; Chiu, Li-Chung; Huang, Chung-Chi; Hu, Han-Chung			Survival predictor in patients with acute respiratory distress syndrome and diffuse alveolar damage undergoing open lung biopsy	PLOS ONE			English	Article							CORTICOSTEROIDS; ARDS; CLASSIFICATION; MORTALITY; SEVERITY; STAGE	Background Diffuse alveolar damage (DAD) is a typical pathological finding of open lung biopsies in patients with acute respiratory distress syndrome (ARDS). Patients with ARDS and DAD have been reported to have a poorer prognosis than those without DAD. The aim of this study was to investigate the survival predictors in patients with ARDS and DAD. Methods We retrospectively reviewed all ARDS patients who underwent an open lung biopsy which showed evidence of DAD from January 2006 to June 2015 at Chang Gung Memorial Hospital. Clinical data including baseline characteristics, medication, and survival outcomes were analyzed. Results A total of 64 ARDS patients with DAD were eligible for analysis and divided into known etiology (n = 17, 26.6%) and unknown etiology groups (n = 47, 73.4%). There was no significant difference in hospital mortality rate between the two groups (71.9% vs. 70.6%, p = 0.890). Univariate logistic regression analysis revealed that sequential organ failure assessment (SOFA) score at the time of a diagnosis of ARDS, and SOFA score, PaO2/ FiO(2) ratio, and positive end expiratory pressure level when the biopsy was performed were associated with hospital mortality. Multivariate analysis showed that the SOFA score on the day of the biopsy was an independent predictor of hospital mortality (odds ratio 1.413, 95% confidence interval 1.127 - 1.772; p = 0.03). There were no significant differences in the use, dose, duration and timing from ARDS to glucocorticoid therapy between the survivors and nonsurvivors. Conclusion For selected ARDS patients who underwent an open lung biopsy with pathological DAD, SOFA score was an independent predictor of hospital mortality.	[Kao, Kuo-Chin; Chang, Chih-Hao; Hung, Chen-Yiu; Chiu, Li-Chung; Huang, Chung-Chi; Hu, Han-Chung] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Thorac Med, Taoyuan, Taiwan; [Kao, Kuo-Chin; Huang, Chung-Chi; Hu, Han-Chung] Chang Gung Univ, Coll Med, Dept Resp Therapy, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Hu, HC (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Thorac Med, Taoyuan, Taiwan.; Hu, HC (corresponding author), Chang Gung Univ, Coll Med, Dept Resp Therapy, Taoyuan, Taiwan.	h3226@cgmh.org.tw						American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Avnon LS, 2009, ANESTH ANALG, V108, P232, DOI 10.1213/ane.0b013e318188af7a; Bouros D, 2000, EUR RESPIR J, V15, P412, DOI 10.1034/j.1399-3003.2000.15b31.x; Brun-Buisson C, 2011, AM J RESP CRIT CARE, V183, P1200, DOI 10.1164/rccm.201101-0135OC; Calfee CS, 2015, CHEST, V147, P1539, DOI 10.1378/chest.14-2454; Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9; Cardinal-Fernandez P, 2016, J CRIT CARE, V34, P31, DOI 10.1016/j.jcrc.2016.03.015; Cardinal-Fernandez P, 2016, CHEST, V149, P1155, DOI 10.1016/j.chest.2016.02.635; Ferguson ND, 2012, INTENS CARE MED, V38, P1573, DOI 10.1007/s00134-012-2682-1; Guerin C, 2015, INTENS CARE MED, V41, P222, DOI 10.1007/s00134-014-3583-2; Horita N, 2015, INTERNAL MED, V54, P1473, DOI 10.2169/internalmedicine.54.4015; Kao KC, 2006, CRIT CARE, V10, DOI 10.1186/cc4981; Kao KC, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0949-y; KATZENSTEIN ALA, 1976, AM J PATHOL, V85, P210; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Libby LJ, 2014, ANN THORAC SURG, V98, P1254, DOI 10.1016/j.athoracsur.2014.05.029; Lorente JA, 2015, INTENS CARE MED, V41, P1921, DOI 10.1007/s00134-015-4046-0; Mac Sweeney R, 2016, LANCET, V388, P2416, DOI 10.1016/S0140-6736(16)00578-X; Meduri GU, 2016, INTENS CARE MED, V42, P829, DOI 10.1007/s00134-015-4095-4; Meduri GU, 1998, JAMA-J AM MED ASSOC, V280, P159, DOI 10.1001/jama.280.2.159; Papazian L, 1998, ANESTHESIOLOGY, V88, P935, DOI 10.1097/00000542-199804000-00013; Patel SR, 2004, CHEST, V125, P197, DOI 10.1378/chest.125.1.197; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Ruan SY, 2014, CRIT CARE, V18, DOI 10.1186/cc13819; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; Suh GY, 2006, CHEST, V129, P753, DOI 10.1378/chest.129.3.753; Tang BMP, 2009, CRIT CARE MED, V37, P1594, DOI 10.1097/CCM.0b013e31819fb507; Thille AW, 2013, AM J RESP CRIT CARE, V187, P761, DOI 10.1164/rccm.201211-1981OC; Tomashefski JF, 2000, CLIN CHEST MED, V21, P435, DOI 10.1016/S0272-5231(05)70158-1; Tomassetti S, 2016, AM J RESP CRIT CARE, V193, P745, DOI 10.1164/rccm.201504-0711OC; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Vourlekis JS, 2000, MEDICINE, V79, P369, DOI 10.1097/00005792-200011000-00003; Zhao JN, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0194-4	34	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180018	10.1371/journal.pone.0180018	http://dx.doi.org/10.1371/journal.pone.0180018			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678876	Green Published, Green Submitted, gold			2022-12-26	WOS:000405272200034
J	Jazayeri, FS; Amininasab, M; Hosseinkhani, S				Jazayeri, Fatemeh S.; Amininasab, Mehriar; Hosseinkhani, Saman			Structural and dynamical insight into thermally induced functional inactivation of firefly luciferase	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; PROTEIN DYNAMICS; PROPOSED MODEL; AMINO-ACIDS; BIOLUMINESCENCE; THERMOSTABILITY; SIMULATIONS; SUPERFAMILY	Luciferase is the key component of light production in bioluminescence process. Extensive and advantageous application of this enzyme in biotechnology is restricted due to its low thermal stability. Here we report the effect of heating up above T-m on the structure and dynamical properties of luciferase enzyme compared to temperature at 298 K. In this way we demonstrate that the number of hydrogen bonds between N-and C-domain is increased for the free enzyme at 325 K. Increased inter domain hydrogen bonds by three at 325 K suggests that inter domain contact is strengthened. The appearance of simultaneous strong salt bridge and hydrogen bond between K529 and D422 and increased existence probability between R533 and E389 could mechanistically explain stronger contact between N-and C-domain. Mutagenesis studies demonstrated the importance of K529 and D422 experimentally. Also the significant reduction in SASA for experimentally important residues K529, D422 and T343 which are involved in active site region was observed. Principle component analysis (PCA) in our study shows that the dynamical behavior of the enzyme is changed upon heating up which mainly originated from the change of motion modes and associated extent of those motions with respect to 298 K. These findings could explain why heating up of the enzyme or thermal fluctuation of protein conformation reduces luciferase activity in course of time as a possible mechanism of thermal functional inactivation. According to these results we proposed two strategies to improve thermal stability of functional luciferase.	[Jazayeri, Fatemeh S.; Amininasab, Mehriar] Univ Tehran, Sch Biol, Dept Cell & Mol Biol, Coll Sci, Tehran, Iran; [Hosseinkhani, Saman] Tarbiat Modares Univ, Fac Biol Sci, Dept Biochem, Tehran, Iran	University of Tehran; Tarbiat Modares University	Amininasab, M (corresponding author), Univ Tehran, Sch Biol, Dept Cell & Mol Biol, Coll Sci, Tehran, Iran.; Hosseinkhani, S (corresponding author), Tarbiat Modares Univ, Fac Biol Sci, Dept Biochem, Tehran, Iran.	amininasab@khayam.ut.ac.ir; saman_h@modares.ac.ir		Hosseinkhani, Saman/0000-0002-0345-7909				Amadei A, 1999, PROTEINS, V36, P419, DOI 10.1002/(SICI)1097-0134(19990901)36:4<419::AID-PROT5>3.3.CO;2-L; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Azad T, 2014, ANAL BIOANAL CHEM, V406, P5541, DOI 10.1007/s00216-014-7980-8; Badr CE, 2011, TRENDS BIOTECHNOL, V29, P624, DOI 10.1016/j.tibtech.2011.06.010; BEKKER H, 1993, PHYSICS COMPUTING '92, P252; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Branchini BR, 1998, BIOCHEMISTRY-US, V37, P15311, DOI 10.1021/bi981150d; Branchini BR, 2005, BIOCHEMISTRY-US, V44, P1385, DOI 10.1021/bi047903f; Branchini BR, 2003, BIOCHEMISTRY-US, V42, P10429, DOI 10.1021/bi030099x; Branchini BR, 1999, BIOCHEMISTRY-US, V38, P13223, DOI 10.1021/bi991181o; Branchini BR, 2000, BIOCHEMISTRY-US, V39, P5433, DOI 10.1021/bi9928804; Branchini BR, 2007, ANAL BIOCHEM, V361, P253, DOI 10.1016/j.ab.2006.10.043; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLuca M., 1978, Methods in Enzymology, V37, P3; DEWET JR, 1985, P NATL ACAD SCI USA, V82, P7870; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Fan F, 2007, ASSAY DRUG DEV TECHN, V5, P127, DOI 10.1089/adt.2006.053; Fraga H, 2008, PHOTOCH PHOTOBIO SCI, V7, P146, DOI 10.1039/b719181b; Grottesi A, 2002, PROTEINS, V46, P287, DOI 10.1002/prot.10045; HASTINGS JW, 1953, J CELL COMPAR PHYSL, V42, P137, DOI 10.1002/jcp.1030420109; HASTINGS JW, 1983, J MOL EVOL, V19, P309, DOI 10.1007/BF02101634; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hosseinkhani S, 2011, CELL MOL LIFE SCI, V68, P1167, DOI 10.1007/s00018-010-0607-0; Imani M, 2010, PHOTOCH PHOTOBIO SCI, V9, P1167, DOI 10.1039/c0pp00105h; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KAJIYAMA N, 1993, BIOCHEMISTRY-US, V32, P13795, DOI 10.1021/bi00213a007; KARPLUS M, 1990, NATURE, V347, P631, DOI 10.1038/347631a0; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Koksharov MI, 2011, PHOTOCH PHOTOBIO SCI, V10, P931, DOI 10.1039/c0pp00318b; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Law GHE, 2006, BIOCHEM J, V397, P305, DOI 10.1042/BJ20051847; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; McGeagh JD, 2011, BBA-PROTEINS PROTEOM, V1814, P1077, DOI 10.1016/j.bbapap.2010.12.002; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Niwa K, 2010, PHOTOCHEM PHOTOBIOL, V86, P1046, DOI 10.1111/j.1751-1097.2010.00777.x; Pikkemaat MG, 2002, PROTEIN ENG, V15, P185, DOI 10.1093/protein/15.3.185; Polyansky AA, 2004, RUSS J BIOORG CHEM+, V30, P421, DOI 10.1023/B:RUBI.0000043784.51859.41; Roda A, 2009, TRAC-TREND ANAL CHEM, V28, P307, DOI 10.1016/j.trac.2008.11.015; Rycroft CH, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021306; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scott D, 2011, ANNU REV ANAL CHEM, V4, P297, DOI 10.1146/annurev-anchem-061010-113855; SELIGER HH, 1964, J GEN PHYSIOL, V48, P95, DOI 10.1085/jgp.48.1.95; Shimomura O, 2012, BIOLUMINESCENCE CHEM; Teilum K, 2009, CELL MOL LIFE SCI, V66, P2231, DOI 10.1007/s00018-009-0014-6; Tisi LC, 2002, ANAL CHIM ACTA, V457, P115, DOI 10.1016/S0003-2670(01)01496-9; White PJ, 1996, BIOCHEM J, V319, P343, DOI 10.1042/bj3190343; Wintrode PL, 2003, J MOL BIOL, V327, P745, DOI 10.1016/S0022-2836(03)00147-5; Yu HR, 2015, BBA-PROTEINS PROTEOM, V1854, P65, DOI 10.1016/j.bbapap.2014.10.017	54	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180667	10.1371/journal.pone.0180667	http://dx.doi.org/10.1371/journal.pone.0180667			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672033	gold, Green Published, Green Submitted			2022-12-26	WOS:000405268500077
J	Fettig, LM; McGinn, O; Finlay-Schultz, J; LaBarbera, DV; Nordeen, SK; Sartorius, CA				Fettig, L. M.; McGinn, O.; Finlay-Schultz, J.; LaBarbera, D. V.; Nordeen, S. K.; Sartorius, C. A.			Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells	ONCOGENE			English	Article							NEGATIVE RESPONSE ELEMENTS; STEM-CELL; ESTROGEN-RECEPTOR; NUCLEAR RECEPTORS; LINE T-47D; EXPRESSION; POPULATION; ALPHA; RESPONSIVENESS; MODULATORS	Half of estrogen receptor-positive breast cancers contain a subpopulation of cytokeratin 5 (CK5)-expressing cells that are therapy resistant and exhibit increased cancer stem cell (CSC) properties. We and others have demonstrated that progesterone (P4) increases CK5+ breast cancer cells. We previously discovered that retinoids block P4 induction of CK5+ cells. Here we investigated the mechanisms by which progesterone receptors (PR) and retinoic acid receptors (RAR) regulate CK5 expression and breast CSC activity. After P4 treatment, sorted CK5+ compared to CK5 - cells were more tumorigenic in vivo. In vitro, P4-treated breast cancer cells formed larger mammospheres and silencing of CK5 using small hairpin RNA abolished this P4-dependent increase in mammosphere size. Retinoic acid (RA) treatment blocked the P4 increase in CK5+ cells and prevented the P4 increase in mammosphere size. Dual small interfering RNA (siRNA) silencing of RAR alpha and RAR gamma reversed RA blockade of P4-induced CK5. Using promoter deletion analysis, we identified a region 1.1 kb upstream of the CK5 transcriptional start site that is necessary for P4 activation and contains a putative progesterone response element (PRE). We confirmed by chromatin immunoprecipitation that P4 recruits PR to the CK5 promoter near the - 1.1 kb essential PRE, and also to a proximal region near - 130 bp that contains PRE half-sites and a RA response element (RARE). RA induced loss of PR binding only at the proximal site. Interestingly, RARa was recruited to the - 1.1 kb PRE and the - 130 bp PRE/RARE regions with P4, but not RA alone or RA plus P4. Treatment of breast cancer xenografts in vivo with the retinoid fenretinide reduced the accumulation of CK5+ cells during estrogen depletion. This reduction, together with the inhibition of CK5+ cell expansion through RAR/PR cross talk, may explain the efficacy of retinoids in prevention of some breast cancer recurrences.	[Fettig, L. M.; McGinn, O.; Finlay-Schultz, J.; Nordeen, S. K.; Sartorius, C. A.] Univ Colorado, Dept Pathol, Anschutz Med Campus,12801 E 17th Ave MS8104, Aurora, CO 80045 USA; [LaBarbera, D. V.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Anschutz Med Campus, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Sartorius, CA (corresponding author), Univ Colorado, Dept Pathol, Anschutz Med Campus,12801 E 17th Ave MS8104, Aurora, CO 80045 USA.	Carol.Sartorius@ucdenver.edu	McGinn, Olivia/J-8337-2015	McGinn, Olivia/0000-0003-0769-5581; Finlay-Schultz, Jessica/0000-0002-7855-9870	University of Colorado Cancer Center Flow Cytometry, Biorepository Core, and Tissue Culture Cores [P30CA046934]; Colorado Clinical and Translational Sciences Institute NIH [TL1 TR001081]; National Institutes of Health [NIH F31 CA210519, NIH 2R01 CA140985]; Breast Cancer Research Foundation [16-072]; Breast Cancer Research Foundation (CAS); Breast Cancer Research Foundation (co-PI); NATIONAL CANCER INSTITUTE [F31CA210519, R01CA140985, P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	University of Colorado Cancer Center Flow Cytometry, Biorepository Core, and Tissue Culture Cores; Colorado Clinical and Translational Sciences Institute NIH; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; Breast Cancer Research Foundation (CAS); Breast Cancer Research Foundation (co-PI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the University of Colorado Cancer Center Flow Cytometry, Biorepository Core, and Tissue Culture Cores supported by P30CA046934 and the University of Colorado Department of Pathology Sequencing Core for their technical assistance and services. We thank Andrea Osypuk and Story Wilson for their assistance with Aperio imaging and analysis. This work was supported by grants from the Colorado Clinical and Translational Sciences Institute NIH TL1 TR001081 (LMF), National Institutes of Health grants NIH F31 CA210519 (LMF), NIH 2R01 CA140985 (CAS) and Breast Cancer Research Foundation (16-072, CAS, co-PI).	Allan Alison L, 2006, Breast Dis, V26, P87; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Axlund SD, 2013, HORM CANCER-US, V4, P36, DOI 10.1007/s12672-012-0127-5; Boudreau A, 2013, P NATL ACAD SCI USA, V110, pE3937, DOI 10.1073/pnas.1315022110; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Chung BM, 2013, CURR OPIN CELL BIOL, V25, P600, DOI 10.1016/j.ceb.2013.06.008; Cittelly DM, 2013, ONCOGENE, V32, P2555, DOI 10.1038/onc.2012.275; Clarke CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035859; CLARKE CL, 1991, J BIOL CHEM, V266, P18969; CLARKE CL, 1990, J BIOL CHEM, V265, P12694; Daniel AR, 2015, ONCOGENE, V34, P506, DOI 10.1038/onc.2013.579; Finlay-Schultz J, 2015, ONCOGENE, V34, P3676, DOI 10.1038/onc.2014.298; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Garattini E, 2014, CANCER TREAT REV, V40, P739, DOI 10.1016/j.ctrv.2014.01.001; Gianni' M, 2001, BLOOD, V97, P3234, DOI 10.1182/blood.V97.10.3234; Goodman CR, 2016, ONCOGENE, V35, P1373, DOI 10.1038/onc.2015.193; Graham JD, 2009, ENDOCRINOLOGY, V150, P3318, DOI 10.1210/en.2008-1630; Gudas LJ, 2011, J CELL PHYSIOL, V226, P322, DOI 10.1002/jcp.22417; Guedj M, 2012, ONCOGENE, V31, P1196, DOI 10.1038/onc.2011.301; Horwitz KB, 2008, J CLIN ENDOCR METAB, V93, P3295, DOI 10.1210/jc.2008-0938; Horwitzt KB, 2008, P NATL ACAD SCI USA, V105, P5774, DOI 10.1073/pnas.0706216105; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Jho SH, 2001, J BIOL CHEM, V276, P45914, DOI 10.1074/jbc.M103144200; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kabos P, 2012, BREAST CANCER RES TR, V135, P415, DOI 10.1007/s10549-012-2164-8; Kabos P, 2011, BREAST CANCER RES TR, V128, P45, DOI 10.1007/s10549-010-1078-6; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Knox AJ, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0418-6; Knutson TP, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3211; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; le Maire A, 2012, CURR TOP MED CHEM, V12, P505, DOI 10.2174/156802612799436687; LIEBERMAN BA, 1993, MOL ENDOCRINOL, V7, P515, DOI 10.1210/me.7.4.515; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mohammed H, 2015, NATURE, V523, P313, DOI 10.1038/nature14583; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Osborne CK, 2005, BREAST, V14, P458, DOI 10.1016/j.breast.2005.08.024; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Radoja N, 1997, J INVEST DERMATOL, V109, P566, DOI 10.1111/1523-1747.ep12337483; Radoja N, 2000, MOL CELL BIOL, V20, P4328, DOI 10.1128/MCB.20.12.4328-4339.2000; Reid Brian G, 2014, Curr Chem Genom Transl Med, V8, P27, DOI 10.2174/2213988501408010027; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; ROMAN SD, 1992, CANCER RES, V52, P2236; Ross-Innes CS, 2010, GENE DEV, V24, P171, DOI 10.1101/gad.552910; Sato T, 2014, ONCOGENE, V33, P2215, DOI 10.1038/onc.2013.172; Seltmann K, 2013, P NATL ACAD SCI USA, V110, P18507, DOI 10.1073/pnas.1310493110; Singhal H, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501924; Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Veronesi U, 2006, ANN ONCOL, V17, P1065, DOI 10.1093/annonc/mdl047; Widschwendter M, 1997, CANCER RES, V57, P4158; Yoo BH, 2012, J BIOMOL SCREEN, V17, P1211, DOI 10.1177/1087057112452138	58	17	17	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 2	2017	36	44					6074	6084		10.1038/onc.2017.204	http://dx.doi.org/10.1038/onc.2017.204			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FL5CU	28692043	Green Accepted			2022-12-26	WOS:000414249800002
J	Valentino, A; Calarco, A; Di Salle, A; Finicelli, M; Crispi, S; Calogero, R; Riccardo, F; Sciarra, A; Gentilucci, A; Galderisi, U; Margarucci, S; Peluso, G				Valentino, A.; Calarco, A.; Di Salle, A.; Finicelli, M.; Crispi, S.; Calogero, Ra; Riccardo, F.; Sciarra, A.; Gentilucci, A.; Galderisi, U.; Margarucci, S.; Peluso, G.			Deregulation of MicroRNAs mediated control of carnitine cycle in prostate cancer: molecular basis and pathophysiological consequences	ONCOGENE			English	Article							FATTY-ACID OXIDATION; CELL-PROLIFERATION; LIPID OXIDATION; BETA-OXIDATION; METABOLISM; EXPRESSION; PROGRESSION; SIGNATURES; MIGRATION; INVASION	Cancer cells reprogram their metabolism to maintain both viability and uncontrolled proliferation. Although an interplay between the genetic, epigenetic and metabolic rewiring in cancer is beginning to emerge, it remains unclear how this metabolic plasticity occurs. Here, we report that in prostate cancer cells (PCCs) microRNAs (miRNAs) greatly contribute to deregulation of mitochondrial fatty acid (FA) oxidation via carnitine system modulation. We provide evidence that the downregulation of hsa-miR-124-3p, hsa-miR-129-5p and hsa-miR-378 induced an increase in both expression and activity of CPT1A, CACT and CrAT in malignant prostate cells. Moreover, the analysis of human prostate cancer and prostate control specimens confirmed the aberrant expression of miR-124-3p, miR-129-5p and miR-378 in primary tumors. Forced expression of the miRNAs mentioned above affected tumorigenic properties, such as proliferation, migration and invasion, in PC3 and LNCaP cells regardless of their hormone sensitivity. CPT1A, CACT and CrAT overexpression allow PCCs to be more prone on FA utilization than normal prostate cells, also in the presence of high pyruvate concentration. Finally, the simultaneous increase of CPT1A, CACT and CrAT is fundamental for PCCs to sustain FA oxidation in the presence of heavy lipid load on prostate cancer mitochondria. Indeed, the downregulation of only one of these proteins reduces PCCs metabolic flexibility with the accumulation of FA-intermediate metabolites in the mitochondria. Together, our data implicate carnitine cycle as a primary regulator of adaptive metabolic reprogramming in PCCs and suggest new potential druggable pathways for prevention and treatment of prostate cancer.	[Valentino, A.; Calarco, A.; Di Salle, A.; Peluso, G.] CNR, IBAF, Via P Castellino,111, Naples, Italy; [Finicelli, M.; Crispi, S.; Margarucci, S.] CNR, Inst Biosci & BioResources, Naples, Italy; [Calogero, Ra; Riccardo, F.] Univ Turin, Lab Immunol, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Sciarra, A.; Gentilucci, A.] Univ Sapienza, Policlin Umberto 1, Dept Urol, Prostate Canc Unit, Rome, Italy; [Galderisi, U.] Univ Campania Luigi Vanvitelli, Dept Expt Med, Biotechnol & Mol Biol Sect, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Agroambientale e Forestale (IBAF-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); University of Turin; Sapienza University Rome; University Hospital Sapienza Rome; Universita della Campania Vanvitelli	Peluso, G (corresponding author), CNR, IBAF, Via P Castellino,111, Naples, Italy.	gianfranco.peluso@ibaf.cnr.it	Finicelli, Mauro/ABC-1392-2020; Calarco, Anna/P-2568-2019; Di Salle, A/AAF-5416-2019; SCIARRA, ALESSANDRO/AAC-8088-2021; Riccardo, Federica/AGT-3153-2022; Calogero, Raffaele/K-9428-2019; Antonelli, Alessandro/AAU-2291-2020	Calarco, Anna/0000-0002-1441-7662; Di Salle, A/0000-0001-6763-3636; Riccardo, Federica/0000-0002-9692-0172; Calogero, Raffaele/0000-0002-2848-628X; Sciarra, Alessandro/0000-0002-7899-8056; Crispi, Stefania/0000-0002-7566-1554; Finicelli, Mauro/0000-0003-2289-0916; Valentino, Anna/0000-0001-8041-2221; MARGARUCCI, SABRINA/0000-0001-5361-1241	Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy; Progetto PON - 'Ricerca e Competitivita' [PON01_01802, PON01_02512]	Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy(Ministry of Education, Universities and Research (MIUR)); Progetto PON - 'Ricerca e Competitivita'(Ministry of Education, Universities and Research (MIUR))	This work was supported from Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy, Progetto PON - 'Ricerca e Competitivita 2007-2013'- PON01_01802: 'Sviluppo di molecole capaci di modulare vie metaboliche intracellulari redoxsensibili per la prevenzione e la cura di patologie infettive, tumorali, neurodegenerative e loro delivery mediante piattaforme nano tecnologiche', and PON01_02512: 'Ricerca e sviluppo di bioregolatori attivi sui meccanismi epigenetici dei processi infiammatori nelle malattie croniche e degenerative'. Precis: this study reports the critical role of specific miRNAs (hsa-miR-124-3p, hsa-miR-129-5p and hsa-miR-378) to sustain prostate cancer metabolic flexibility via modulation of CPT1A, CACT and CrAT expression.	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Arora Aastha, 2015, Transl Oncogenomics, V7, P11, DOI 10.4137/TOG.S29652; Bastin J, 2014, BIOCHIMIE, V96, P113, DOI 10.1016/j.biochi.2013.05.012; BERTHON P, 1995, INT J ONCOL, V6, P333; Bonnefont Jean-Paul, 2004, Molecular Aspects of Medicine, V25, P495, DOI 10.1016/j.mam.2004.06.004; BRASS EP, 1980, BIOCHEM J, V190, P495, DOI 10.1042/bj1900495; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cardenas-Navia LI, 2008, CANCER RES, V68, P5812, DOI 10.1158/0008-5472.CAN-07-6387; Carrer M, 2012, P NATL ACAD SCI USA, V109, P15330, DOI 10.1073/pnas.1207605109; Costello LC, 2000, ONCOLOGY-BASEL, V59, P269, DOI 10.1159/000012183; Costello LC, 2005, MOL CELL BIOCHEM, V280, P1, DOI 10.1007/s11010-005-8841-8; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DeBerardinis RJ, 2008, GENET MED, V10, P267, DOI 10.1097/GIM.0b013e31818b0d9b; Dong PX, 2016, ONCOTARGET, V7, P20260, DOI 10.18632/oncotarget.7754; Dossing KBV, 2015, GENES-BASEL, V6, P1, DOI 10.3390/genes6010001; Duan LJ, 2014, FEBS LETT, V588, P1644, DOI 10.1016/j.febslet.2014.03.002; Eaton S, 2002, PROG LIPID RES, V41, P197, DOI 10.1016/S0163-7827(01)00024-8; Eichner LJ, 2010, CELL METAB, V12, P352, DOI 10.1016/j.cmet.2010.09.002; Foster DW, 2004, ANN NY ACAD SCI, V1033, P1, DOI 10.1196/annals.1320.001; Fritz V, 2013, ONCOGENE, V32, P5101, DOI 10.1038/onc.2012.523; Gill BS, 2016, TUMOR BIOL, V37, P5683, DOI 10.1007/s13277-016-4900-x; Giordano A, 2005, CELL DEATH DIFFER, V12, P603, DOI 10.1038/sj.cdd.4401636; Ijlst L, 2001, BIOCHEM BIOPH RES CO, V280, P700, DOI 10.1006/bbrc.2000.4178; Jogl G, 2004, ANN NY ACAD SCI, V1033, P17, DOI 10.1196/annals.1320.002; Johnson IR, 2014, PROSTATE, V74, P547, DOI 10.1002/pros.22777; Khanmi K, 2015, CLIN CHIM ACTA, V451, P154, DOI 10.1016/j.cca.2015.09.022; Kim JY, 2000, AM J PHYSIOL-ENDOC M, V279, pE1039, DOI 10.1152/ajpendo.2000.279.5.E1039; Kurisetty VV, 2014, FRONT BIOSCI-LANDMRK, V19, P1, DOI 10.2741/4192; Li XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070987; Liu XL, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-96; Liu Y, 2006, PROSTATE CANCER P D, V9, P230, DOI 10.1038/sj.pcan.4500879; Liu YY, 2010, ANTICANCER RES, V30, P369; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu JR, 2015, CANCER LETT, V356, P156, DOI 10.1016/j.canlet.2014.04.001; Ma N, 2015, BIOCHEM BIOPH RES CO, V461, P618, DOI 10.1016/j.bbrc.2015.04.075; McDunn JE, 2013, PROSTATE, V73, P1547, DOI 10.1002/pros.22704; Modica-Napolitano JS, 2004, MITOCHONDRION, V4, P755, DOI 10.1016/j.mito.2004.07.027; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; Palmieri F, 2010, ESSAYS BIOCHEM, V47, P37, DOI [10.1042/BSE0470037, 10.1042/bse0470037]; Peluso G, 2002, FRONT BIOSCI, V7, pA109, DOI 10.2741/peluso; Pinweha P, 2016, COMPUT STRUCT BIOTEC, V14, P223, DOI 10.1016/j.csbj.2016.05.005; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Price DT, 2002, J UROLOGY, V168, P273, DOI 10.1016/S0022-5347(05)64906-3; Priore P, 2007, BBA-MOL CELL BIOL L, V1771, P1299, DOI 10.1016/j.bbalip.2007.08.005; Ramsay RR, 2001, BBA-PROTEIN STRUCT M, V1546, P21, DOI 10.1016/S0167-4838(01)00147-9; Riehle C, 2012, TRENDS CARDIOVAS MED, V22, P98, DOI 10.1016/j.tcm.2012.07.003; Schaefer A, 2010, UROL ONCOL-SEMIN ORI, V28, P4, DOI 10.1016/j.urolonc.2008.10.021; Schlaepfer IR, 2015, MOL IMAGING BIOL, V17, P529, DOI 10.1007/s11307-014-0814-4; Schlaepfer IR, 2014, MOL CANCER THER, V13, P2361, DOI 10.1158/1535-7163.MCT-14-0183; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shahabi A, 2016, PROSTATE, V76, P1239, DOI 10.1002/pros.23211; Shanware NP, 2011, J MOL MED, V89, P229, DOI 10.1007/s00109-011-0731-9; Shen N, 2016, TUMOR BIOL, V37, P1789, DOI 10.1007/s13277-015-3969-y; Shen RZ, 2010, BIOCHEM BIOPH RES CO, V394, P1047, DOI 10.1016/j.bbrc.2010.03.121; Shi XB, 2015, CANCER RES, V75, P5309, DOI 10.1158/0008-5472.CAN-14-0795; Song CJ, 2015, PROSTATE, V75, P500, DOI 10.1002/pros.22936; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Teahan O, 2011, INT J BIOCHEM CELL B, V43, P1002, DOI 10.1016/j.biocel.2010.07.003; Wang XY, 2016, ONCOL REP, V35, P3115, DOI 10.3892/or.2016.4648; Wu XY, 2014, AM J CLIN EXP UROL, V2, P111	62	39	40	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 26	2017	36	43					6030	6040		10.1038/onc.2017.216	http://dx.doi.org/10.1038/onc.2017.216			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FK9OT	28671672				2022-12-26	WOS:000413841400011
J	Macedo, JP; Currier, RB; Wirdnam, C; Horn, D; Alsford, S; Rentsch, D				Macedo, Juan P.; Currier, Rachel B.; Wirdnam, Corina; Horn, David; Alsford, Sam; Rentsch, Doris			Ornithine uptake and the modulation of drug sensitivity in Trypanosoma brucei	FASEB JOURNAL			English	Article						African trypanosomiasis; chemotherapy; eflornithine; suramin; histidine	SPERMIDINE SYNTHASE; DECARBOXYLASE; TRANSPORTER; LEISHMANIA; EXPRESSION; PERMEASE; TRYPANOTHIONE; METABOLISM; RNAI; DIFLUOROMETHYLORNITHINE	Trypanosoma brucei, protozoan parasites that cause human African trypanosomiasis (HAT), depend on ornithine uptake and metabolism by ornithine decarboxylase (ODC) for survival. Indeed, ODC is the target of the WHO "essential medicine" eflornithine, which is antagonistic to another anti-HAT drug, suramin. Thus, ornithine uptake has important consequences in T. brucei, but the transporters have not been identified. We describe these amino acid transporters (AATs). In a heterologous expression system, TbAAT10-1 is selective for ornithine, whereas TbAAT2-4 transports both ornithine and histidine. These AATs are also necessary to maintain intracellular ornithine and polyamine levels in T. brucei, thereby decreasing sensitivity to eflornithine and increasing sensitivity to suramin. Consistent with competition for histidine, high extracellular concentrations of this amino acid phenocopied a TbAAT2-4 genetic defect. Our findings established TbAAT10-1 and TbAAT2-4 as the parasite ornithine transporters, one of which can be modulated by histidine, but both of which affect sensitivity to important anti-HAT drugs.-Macedo, J. P., Currier, R. B., Wirdnam, C., Horn, D., Alsford, S., Rentsch, D. Ornithine uptake and the modulation of drug sensitivity in Trypanosoma brucei.	[Macedo, Juan P.; Wirdnam, Corina; Rentsch, Doris] Univ Bern, Inst Plant Sci, Altenbergrain 21, CH-3013 Bern, Switzerland; [Currier, Rachel B.; Alsford, Sam] London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England; [Horn, David] Univ Dundee, Sch Life Sci, Wellcome Trust Ctr Antiinfect Res, Dundee, Scotland	University of Bern; University of London; London School of Hygiene & Tropical Medicine; University of Dundee	Rentsch, D (corresponding author), Univ Bern, Inst Plant Sci, Altenbergrain 21, CH-3013 Bern, Switzerland.; Alsford, S (corresponding author), London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	sam.alsford@lshtm.ac.uk; doris.rentsch@ips.unibe.ch	Alsford, Sam/AGD-5139-2022; Macedo, Juan/B-4151-2017	Alsford, Sam/0000-0001-8621-4920; Currier, Rachel/0000-0002-0381-3029; Rentsch, Doris/0000-0003-4313-7683; Macedo, Juan/0000-0001-5759-1196; Horn, David/0000-0001-5173-9284	Swiss National Science Foundation [CRSII3127300, CRSII3141913]; University of Bern; Wellcome Trust (London School of Hygiene and Tropical Medicine Institutional Strategic Support Fund Fellowship); Medical Research Council (MRC) [MR/K011987/1]; UK MRC; UK Department for International Development (DFID) under the MRC/DFID; European Union; Wellcome Trust [100320/Z/12/Z]; MRC [MR/K011987/1] Funding Source: UKRI; Medical Research Council [MR/K011987/1] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Bern; Wellcome Trust (London School of Hygiene and Tropical Medicine Institutional Strategic Support Fund Fellowship); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank P. Butikofer, E. Sigel (University of Bern, Switzerland), and P. Maser (Swiss Tropical and Public Health Institute, Basel, Switzerland) for their valuable input during the development of this work. The authors thank V. Yardley (LSHTM) and P. Maser for providing suramin and eflornithine. J.P.M. thanks M. Suter Grotemeyer and L. Cardoso Alves for technical assistance and helpful discussions. This work was supported by Swiss National Science Foundation Grants CRSII3127300 and CRSII3141913 (to D.R.) and the University of Bern (to D.R.). S.A. was supported by the Wellcome Trust (London School of Hygiene and Tropical Medicine Institutional Strategic Support Fund Fellowship) and Medical Research Council (MRC) Grant MR/K011987/1; jointly funded by the UK MRC and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement and is also part of the European and Developing Countries Clinical Trials Partnership (EDCTP) 2 Program, supported by the European Union. D.H. is a Wellcome Trust Investigator (100320/Z/12/Z). The remaining authors declare no conflicts of interest.	Alsford S, 2005, MOL BIOCHEM PARASIT, V144, P142, DOI 10.1016/j.molbiopara.2005.08.009; Alsford S, 2008, MOL BIOCHEM PARASIT, V161, P76, DOI 10.1016/j.molbiopara.2008.05.006; Alsford S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004130; Alsford S, 2012, NATURE, V482, P232, DOI 10.1038/nature10771; Ariyanayagam MR, 1997, MOL BIOCHEM PARASIT, V84, P111, DOI 10.1016/S0166-6851(96)02788-0; BACCHI CJ, 1980, SCIENCE, V210, P332, DOI 10.1126/science.6775372; BACCHI CJ, 1983, MOL BIOCHEM PARASIT, V7, P209, DOI 10.1016/0166-6851(83)90022-1; Baker N, 2011, MOL BIOCHEM PARASIT, V176, P55, DOI 10.1016/j.molbiopara.2010.11.010; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Brenndorfer M, 2010, MOL BIOCHEM PARASIT, V172, P52, DOI 10.1016/j.molbiopara.2010.03.007; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Burkard GS, 2011, MOL BIOCHEM PARASIT, V175, P91, DOI 10.1016/j.molbiopara.2010.09.002; Carrillo C, 1999, FEBS LETT, V454, P192, DOI 10.1016/S0014-5793(99)00804-2; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Creek DJ, 2013, ANTIMICROB AGENTS CH, V57, P2768, DOI 10.1128/AAC.00044-13; De Muylder G, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003731; DOHMEN RJ, 1991, YEAST, V7, P691, DOI 10.1002/yea.320070704; Duleu S, 2004, J IMMUNOL, V172, P6298, DOI 10.4049/jimmunol.172.10.6298; FAIRLAMB AH, 1987, MOL BIOCHEM PARASIT, V24, P185, DOI 10.1016/0166-6851(87)90105-8; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; Fischer WN, 2002, PLANT J, V29, P717, DOI 10.1046/j.1365-313X.2002.01248.x; Glover L, 2015, NAT PROTOC, V10, P106, DOI 10.1038/nprot.2015.005; Gobert AP, 2000, INFECT IMMUN, V68, P4653, DOI 10.1128/IAI.68.8.4653-4657.2000; Hai Y, 2015, BIOCHEMISTRY-US, V54, P458, DOI 10.1021/bi501366a; Hasne MP, 2010, MOL MICROBIOL, V76, P78, DOI 10.1111/j.1365-2958.2010.07081.x; Hasne MP, 2005, J BIOL CHEM, V280, P15188, DOI 10.1074/jbc.M411331200; Henriques C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0950-y; Holzmuller P, 2008, MICROBES INFECT, V10, P79, DOI 10.1016/j.micinf.2007.10.008; Iniesta V, 2005, INFECT IMMUN, V73, P6085, DOI 10.1128/IAI.73.9.6085-6090.2005; Iten M, 1997, ANTIMICROB AGENTS CH, V41, P1922, DOI 10.1128/AAC.41.9.1922; Jackson AP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-26; Keating J, 2015, ACTA TROP, V150, P4, DOI 10.1016/j.actatropica.2015.06.003; Kim DH, 2015, METABOLOMICS, V11, P1721, DOI 10.1007/s11306-015-0827-2; LeQuesne SA, 1996, BIOCHEM J, V316, P481; Li F, 1998, EXP PARASITOL, V88, P255, DOI 10.1006/expr.1998.4237; MARCHESINI G, 1992, J HEPATOL, V16, P159, DOI 10.1016/S0168-8278(05)80109-6; Mathieu C, 2014, BIOCHEM J, V463, P9, DOI 10.1042/BJ20140719; METCALF BW, 1978, J AM CHEM SOC, V100, P2551, DOI 10.1021/ja00476a050; Miller-Fleming L, 2015, J MOL BIOL, V427, P3389, DOI 10.1016/j.jmb.2015.06.020; Minguet EG, 2008, MOL BIOL EVOL, V25, P2119, DOI 10.1093/molbev/msn161; Mukhopadhyay R, 1996, P NATL ACAD SCI USA, V93, P10383, DOI 10.1073/pnas.93.19.10383; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Pegg AE, 2011, METHODS MOL BIOL, V720, P3, DOI 10.1007/978-1-61779-034-8_1; Raz B, 1997, ACTA TROP, V68, P139, DOI 10.1016/S0001-706X(97)00079-X; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; RENTSCH D, 1995, FEBS LETT, V370, P264, DOI 10.1016/0014-5793(95)00853-2; Rentsch D, 1996, PLANT CELL, V8, P1437, DOI 10.1105/tpc.8.8.1437; Roberts SC, 2004, J BIOL CHEM, V279, P23668, DOI 10.1074/jbc.M402042200; Nguyen S, 2015, J BIOL CHEM, V290, P19987, DOI 10.1074/jbc.M115.656785; t'Kindt R, 2010, ANAL BIOANAL CHEM, V398, P2059, DOI 10.1007/s00216-010-4139-0; TANAKA J, 1985, GENE, V38, P205, DOI 10.1016/0378-1119(85)90219-7; Taylor MC, 2008, BIOCHEM J, V409, P563, DOI 10.1042/BJ20071185; Vincent IM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001618; Vincent IM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001204; Willert E, 2012, TRENDS PARASITOL, V28, P66, DOI 10.1016/j.pt.2011.11.001; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; World Health Organization, 2015, TRYP HUM AFR SLEEP S; Xiao YJ, 2009, EUKARYOT CELL, V8, P747, DOI 10.1128/EC.00047-09; Young GB, 1999, BBA-BIOMEMBRANES, V1415, P306, DOI 10.1016/S0005-2736(98)00196-5	62	8	8	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4649	4660		10.1096/fj.201700311R	http://dx.doi.org/10.1096/fj.201700311R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28679527	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000413397400039
J	Motl, N; Skiba, MA; Kabil, O; Smith, JL; Banerjee, R				Motl, Nicole; Skiba, Meredith A.; Kabil, Omer; Smith, Janet L.; Banerjee, Ruma			Structural and biochemical analyses indicate that a bacterial persulfide dioxygenase-rhodanese fusion protein functions in sulfur assimilation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; hydrogen sulfide; iron; sulfur; X-ray crystallography	HYDROGEN-SULFIDE; CRYSTAL-STRUCTURE; H2S; SULFURTRANSFERASE; ETHE1; MUTATIONS; ELECTROSTATICS; IDENTIFICATION; BIOSYNTHESIS; THIOSULFATE	Hydrogen sulfide (H2S) is a signaling molecule that is toxic at elevated concentrations. In eukaryotes, it is cleared via a mitochondrial sulfide oxidation pathway, which comprises sulfide quinone oxidoreductase, persulfide dioxygenase (PDO), rhodanese, and sulfite oxidase and converts H2S to thiosulfate and sulfate. Natural fusions between the non-heme iron containing PDO and rhodanese, a thiol sulfurtransferase, exist in some bacteria. However, little is known about the role of the PDO-rhodanese fusion (PRF) proteins in sulfur metabolism. Herein, we report the kinetic properties and the crystal structure of a PRF from the Gram-negative endophytic bacterium Burkholderia phytofirmans. The crystal structures of wild-type PRF and a sulfurtransferase-inactivated C314S mutant with and without glutathione were determined at 1.8, 2.4, and 2.7 angstrom resolution, respectively. We found that the two active sites are distant and do not show evidence of direct communication. The B. phytofirmans PRF exhibited robust PDO activity and preferentially catalyzed sulfur transfer in the direction of thiosulfate to sulfite and glutathione persulfide; sulfur transfer in the reverse direction was detectable only under limited turnover conditions. Together with the kinetic data, our bioinformatics analysis reveals that B. phytofirmans PRF is poised to metabolize thiosulfate to sulfite in a sulfur assimilation pathway rather than in sulfide stress response as seen, for example, with the Staphylococcus aureus PRF or sulfide oxidation and disposal as observed with the homologous mammalian proteins.	[Motl, Nicole; Skiba, Meredith A.; Kabil, Omer; Smith, Janet L.; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Med Ctr, Ann Arbor, MI 48109 USA; [Skiba, Meredith A.; Smith, Janet L.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Dept Biol Chem, Med Ctr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Kabil, Omer/AAJ-1435-2020		National Institutes of Health [GM112455]; NIGMS Training Grant [T32GM008353]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008353, R01GM112455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM112455 (to R. B.) and NIGMS Training Grant T32GM008353 (to N. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Banerjee R, 2017, CURR OPIN CHEM BIOL, V37, P115, DOI 10.1016/j.cbpa.2017.02.021; Barton LL, 2014, METAL IONS LIFE SCI, V14, P237, DOI 10.1007/978-94-017-9269-1_10; BEAUCHAMP RO, 1984, CRC CR REV TOXICOL, V13, P25, DOI 10.3109/10408448409029321; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; CHAUNCEY TR, 1987, METHOD ENZYMOL, V143, P350; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Czyzewski BK, 2012, NATURE, V483, P494, DOI 10.1038/nature10881; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FISCHER DS, 1964, CLIN CHEM, V10, P21, DOI 10.1016/0009-8981(64)90210-4; Gao XH, 2015, ELIFE, V4, DOI 10.7554/eLife.10067; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Higgins KA, 2015, BIOCHEMISTRY-US, V54, P2385, DOI 10.1021/acs.biochem.5b00056; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Iwanicka-Nowicka R, 2007, J BACTERIOL, V189, P1675, DOI 10.1128/JB.00592-06; JARABAK R, 1974, BIOCHEMISTRY-US, V13, P3233, DOI 10.1021/bi00713a006; Kabil O, 2014, BBA-PROTEINS PROTEOM, V1844, P1355, DOI 10.1016/j.bbapap.2014.01.002; Kabil O, 2012, J BIOL CHEM, V287, P44561, DOI 10.1074/jbc.M112.407411; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; Libiad M, 2015, J BIOL CHEM, V290, P23579, DOI 10.1074/jbc.M115.675694; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; Lochowska A, 2011, J BACTERIOL, V193, P1843, DOI 10.1128/JB.00483-10; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Luebke JL, 2014, MOL MICROBIOL, V94, P1343, DOI 10.1111/mmi.12835; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; McCoy JG, 2006, ACTA CRYSTALLOGR D, V62, P964, DOI 10.1107/S0907444906020592; Melideo SL, 2014, BIOCHEMISTRY-US, V53, P4739, DOI 10.1021/bi500650h; Mishanina AV, 2015, NAT CHEM BIOL, V11, P457, DOI 10.1038/nchembio.1834; Motl N, 2013, HYDROGEN SULFIDE ITS, P1; Pettinati I, 2015, HUM MOL GENET, V24, P2458, DOI 10.1093/hmg/ddv007; PLOEGMAN JH, 1978, NATURE, V273, P124, DOI 10.1038/273124a0; Sattler SA, 2015, J BIOL CHEM, V290, P18914, DOI 10.1074/jbc.M115.652537; Sessitsch A, 2005, INT J SYST EVOL MICR, V55, P1187, DOI 10.1099/ijs.0.63149-0; Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855; Shen J, 2016, BIOCHEMISTRY-US, V55, P6524, DOI 10.1021/acs.biochem.6b00714; Shen JC, 2015, BIOCHEMISTRY-US, V54, P4542, DOI 10.1021/acs.biochem.5b00584; Singh S, 2011, BBA-PROTEINS PROTEOM, V1814, P1518, DOI 10.1016/j.bbapap.2011.02.004; SORBO BH, 1953, ACTA CHEM SCAND, V7, P1137, DOI 10.3891/acta.chem.scand.07-1137; Spallarossa A, 2004, J MOL BIOL, V335, P583, DOI 10.1016/j.jmb.2003.10.072; Tiranti V, 2006, J MED GENET, V43, P340, DOI 10.1136/jmg.2005.036210; Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Vitvitsky V, 2012, ANTIOXID REDOX SIGN, V17, P22, DOI 10.1089/ars.2011.4310; Wallace JL, 2009, GASTROENTEROLOGY, V137, P569, DOI 10.1053/j.gastro.2009.04.012; Yadav PK, 2016, J AM CHEM SOC, V138, P289, DOI 10.1021/jacs.5b10494; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	52	16	18	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14026	14038		10.1074/jbc.M117.790170	http://dx.doi.org/10.1074/jbc.M117.790170			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28684420	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000408439800011
J	Arellano-Llamas, R; Alfaro-Ruiz, L; Canon, CA; Rosshandler, II; Cruz-Lagunas, A; Zuniga, J; Vega, RR; Wong, CW; Maurer-Stroh, S; Cordoba, SR; Liu, ET; Hidalgo-Miranda, A; Vazquez-Perez, JA				Arellano-Llamas, Rocio; Alfaro-Ruiz, Luis; Arriaga Canon, Cristian; Imaz Rosshandler, Ivan; Cruz-Lagunas, Alfredo; Zuniga, Joaquin; Rebollar Vega, Rosa; Wong, Christopher W.; Maurer-Stroh, Sebastian; Romero Cordoba, Sandra; Liu, Edison T.; Hidalgo-Miranda, Alfredo; Vazquez-Perez, Joel A.			Molecular features of influenza A (H1N1) pdm09 prevalent in Mexico during winter seasons 2012-2014	PLOS ONE			English	Article							INCREASED VIRULENCE; STRUCTURAL BASIS; BINDING-SITE; VIRUS; SWINE; IDENTIFICATION; MUTATIONS; PROTEIN; NS1; HEMAGGLUTININ	Since the emergence of the pandemic H1N1pdm09 virus in Mexico and California, biannual increases in the number of cases have been detected in Mexico. As observed in previous seasons, pandemic A/H1N1 09 virus was detected in severe cases during the 2011-2012 winter season and finally, during the 2013-2014 winter season it became the most prevalent influenza virus. Molecular and phylogenetic analyses of the whole viral genome are necessary to determine the antigenic and pathogenic characteristics of influenza viruses that cause severe outcomes of the disease. In this paper, we analyzed the evolution, antigenic and genetic drift of Mexican isolates from 2009, at the beginning of the pandemic, to 2014. We found a clear variation of the virus in Mexico from the 2011-2014 season due to different markers and in accordance with previous reports. In this study, we identified 13 novel substitutions with important biological effects, including virulence, T cell epitope presented by MHC and host specificity shift and some others substitutions might have more than one biological function. The systematic monitoring of mutations on whole genome of influenza A pH1N1 (2009) virus circulating at INER in Mexico City might provide valuable information to predict the emergence of new pathogenic influenza virus	[Arellano-Llamas, Rocio; Alfaro-Ruiz, Luis; Imaz Rosshandler, Ivan; Rebollar Vega, Rosa; Romero Cordoba, Sandra; Hidalgo-Miranda, Alfredo] Inst Nacl Med Genom, Mexico City, DF, Mexico; [Arriaga Canon, Cristian] Inst Nacl Cancerol, CONACYT, Mexico City, DF, Mexico; [Cruz-Lagunas, Alfredo; Zuniga, Joaquin; Vazquez-Perez, Joel A.] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Mexico City, DF, Mexico; [Wong, Christopher W.] Genome Insitute Singapore, Singapore, Singapore; [Maurer-Stroh, Sebastian] Bioinformat Inst Singapore, Singapore, Singapore; [Liu, Edison T.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA	Instituto Nacional de Medicina Genomica; Instituto Nacional de Cancerologia (INCAN); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Jackson Laboratory	Hidalgo-Miranda, A (corresponding author), Inst Nacl Med Genom, Mexico City, DF, Mexico.; Vazquez-Perez, JA (corresponding author), Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Mexico City, DF, Mexico.	ahidalgo@inmegen.gob.mx; joevazpe@gmail.com	Vazquez-Perez, Joel/F-3476-2019; Romero, Sandra/A-2246-2014; Romero-Cordoba, Sandra/AAY-2625-2020; Hidalgo-Miranda, Alfredo/B-2123-2010; Maurer-Stroh, Sebastian/Q-9476-2019	Vazquez-Perez, Joel/0000-0002-8508-3698; Romero, Sandra/0000-0002-5591-696X; Hidalgo-Miranda, Alfredo/0000-0003-2315-3977; Maurer-Stroh, Sebastian/0000-0003-0813-9640; CRUZ-LAGUNAS, ALFREDO/0000-0001-5487-5919; ARRIAGA, CRISTIAN/0000-0002-4866-9067; Zuniga, Joaquin/0000-0002-7143-0281; REBOLLAR VEGA, ROSA GLORIA/0000-0002-9293-5959; Imaz Rosshandler, Ivan/0000-0001-5975-0138	Mexican National Council of Science and Technology [127004]; CONACYT [CVU 389997]	Mexican National Council of Science and Technology(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was funded by the Mexican National Council of Science and Technology, grant number 127004, granted to AHM. There was no additional external funding received for this study. This work was submitted in partial fulfillment of the requirements to obtain the Ph.D. degree for Rocio Arellano-Llamas at Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico (UNAM) who also received a PhD fellowship from CONACYT (CVU 389997).	Ahn JK, 2010, EURASIP J ADV SIG PR, DOI 10.1155/2010/340717; Babakir-Mina M, 2009, ARCH VIROL, V154, P1349, DOI 10.1007/s00705-009-0438-1; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Belz GT, 2001, J IMMUNOL, V166, P4627, DOI 10.4049/jimmunol.166.7.4627; Carrillo B, 2014, J VIROL, V88, P4113, DOI 10.1128/JVI.03692-13; Cheng A, 2009, CELL RES, V19, P187, DOI 10.1038/cr.2008.288; Chowell G, 2012, PLOS CURRENTS; COLMAN PM, 1993, J VIROL, V67, P2972, DOI 10.1128/JVI.67.6.2972-2980.1993; Das K, 2008, P NATL ACAD SCI USA, V105, P13093, DOI 10.1073/pnas.0805213105; de la Rosa-Zamboni D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050116; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elderfield RA, 2014, J VIROL, V88, P13269, DOI 10.1128/JVI.01636-14; Escalera-Zamudio M, 2012, VIROLOGY, V433, P176, DOI 10.1016/j.virol.2012.08.003; Garten R, 2012, NIH PUBLIC ACCESS, V325, P197; Gulati U, 2002, J VIROL, V76, P12274, DOI 10.1128/JVI.76.23.12274-12280.2002; Hayashi T, 2015, J VIROL, V89, P8042, DOI 10.1128/JVI.00901-15; He JF, 2004, SCIENCE, V303, P1666, DOI 10.1126/science.1092002; Kerry PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017946; Kowalinski E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002831; Lapinsky S., 2010, EPIDEMIC VIRAL PNEUM, P139; Li JW, 2009, VIRUS RES, V144, P123, DOI 10.1016/j.virusres.2009.04.008; Meijers R, 2005, J MOL BIOL, V345, P1099, DOI 10.1016/j.jmb.2004.11.023; Miotto O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S18; Mishel P., 2009, GENOME ANNOUNC, V2015, P3, DOI DOI 10.1128/GEN0MEA.00676-15; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Ohtsu Y, 2002, MICROBIOL IMMUNOL, V46, P167, DOI 10.1111/j.1348-0421.2002.tb02682.x; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Seyer R, 2012, J INFECT DIS, V205, P262, DOI 10.1093/infdis/jir716; Shinde V, 2009, TRIPLE REASSORTANT S, P1; Shinya Y, 2010, PLOS PATHOG, V6, P15; Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102; Squires RB, 2012, INFLUENZA OTHER RESP, V6, P404, DOI 10.1111/j.1750-2659.2011.00331.x; Su YCF, 2015, NATURE COMMUNICATION, V6, P1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vazquez-Perez JA, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-41; Wang WJ, 2012, VACCINE, V30, P872, DOI 10.1016/j.vaccine.2011.11.101; WHO, 2012, FLUNET CHARTS; Wong CW, 2004, TRACKING EVOLUTION S, P398; Yang H, 2014, J VIROL, V88, P4828, DOI 10.1128/JVI.02278-13; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; Yin CF, 2007, J BIOL CHEM, V282, P20584, DOI 10.1074/jbc.M611619200; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zepeda HM, 2010, J CLIN VIROL, V48, P36, DOI 10.1016/j.jcv.2010.02.008; Zhang CY, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-88; Zhang NZ, 2011, J VIROL, V85, P11709, DOI 10.1128/JVI.05040-11; Zhao C, 2009, J VIROL, V83, P9024, DOI 10.1128/JVI.00911-09; Zhou B, 2009, J VIROL, V83, P10309, DOI 10.1128/JVI.01109-09	49	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7								10.1371/journal.pone.0180419	http://dx.doi.org/10.1371/journal.pone.0180419			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692701	Green Submitted, Green Published, gold			2022-12-26	WOS:000405544800038
J	Savolainen, O; Fagerberg, B; Lind, MV; Sandberg, AS; Ross, AB; Bergstrom, G				Savolainen, Otto; Fagerberg, Bjom; Lind, Mads Vendelbo; Sandberg, Ann-Sofie; Ross, Alastair B.; Bergstrom, Goran			Biomarkers for predicting type 2 diabetes development-Can metabolomics improve on existing biomarkers?	PLOS ONE			English	Article							INSULIN-RESISTANCE; ADIPONECTIN LEVELS; RISK; ACID	Aim The aim was to determine if metabolomics could be used to build a predictive model for type 2 diabetes (T2D) risk that would improve prediction of T2D over current risk markers. Methods Gas chromatography-tandem mass spectrometry metabolomics was used in a nested casecontrol study based on a screening sample of 64-year-old Caucasian women (n = 629). Candidate metabolic markers of T2D were identified in plasma obtained at baseline and the power to predict diabetes was tested in 69 incident cases occurring during 5.5 years followup. The metabolomics results were used as a standalone prediction model and in combination with established T2D predictive biomarkers for building eight T2D prediction models that were compared with each other based on their sensitivity and selectivity for predicting T2D. Results Established markers of T2D (impaired fasting glucose, impaired glucose tolerance, insulin resistance (HOMA), smoking, serum adiponectin)) alone, and in combination with metabolomics had the largest areas under the curve (AUC) (0.794 (95% confidence interval [0.738-0.850]) and 0.808 [0.749-0.867] respectively), with the standalone metabolomics model based on nine fasting plasma markers having a lower predictive power (0.657 [0.577-0.736]). Prediction based on non-blood based measures was 0.638 [0.565-0.711]). Conclusions Established measures of T2D risk remain the best predictor of T2D risk in this population. Additional markers detected using metabolomics are likely related to these measures as they did not enhance the overall prediction in a combined model.	[Savolainen, Otto; Lind, Mads Vendelbo; Sandberg, Ann-Sofie; Ross, Alastair B.] Chalmers Univ Technol, Div Food & Nutr Sci, Dept Biol & Biol Engn, Gothenburg, Sweden; [Fagerberg, Bjom] Gothenburg Univ, Sahlgrenska Acad, Ctr Cardiovasc & Metab Res, Wallenberg Lab Cardiovascular Res,Inst Med, Gothenburg, Sweden; [Lind, Mads Vendelbo] Univ Copenhagen, Dept Nutr Exercise & Sports, Fac Sci, Frederiksberg, Denmark; [Bergstrom, Goran] Univ Gothenburg, Dept Mol & Clin Med, Sahlgrenska Acad, Gothenburg, Sweden; [Bergstrom, Goran] Sahlgrens Univ Hosp, Gothenburg, Sweden	Chalmers University of Technology; University of Gothenburg; University of Copenhagen; University of Gothenburg; Sahlgrenska University Hospital	Savolainen, O (corresponding author), Chalmers Univ Technol, Div Food & Nutr Sci, Dept Biol & Biol Engn, Gothenburg, Sweden.	otto.savolainen@chalmers.se	sandberg, ann-sofie/B-6857-2016; Lind, Mads Vendelbo/L-7387-2014	sandberg, ann-sofie/0000-0002-9681-3342; Lind, Mads Vendelbo/0000-0002-4999-1218; Bergstrom, Goran/0000-0003-4289-5722; Ross, Alastair/0000-0002-9585-0141	Chalmers area of advance life science engineering; Swedish Heart and Lung Foundation; Vastra Gotalandsregionen	Chalmers area of advance life science engineering; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Vastra Gotalandsregionen	The work was supported by Chalmers area of advance life science engineering, by grants from the Swedish Heart and Lung Foundation and the LUA-ALF grants from Vastra Gotalandsregionen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bailes Barbara K, 2002, AORN J, V76, P266; Bro R, 2015, METABOLOMICS, V11, P1376, DOI 10.1007/s11306-015-0793-8; Brohall G, 2006, DIABETES CARE, V29, P363, DOI 10.2337/diacare.29.02.06.dc05-1229; Brunius C., 2015, CURR NUTR REP, V4, P348, DOI [10.1007/s13668-015-0144-4, DOI 10.1007/S13668-015-0144-4]; Calcagno V, 2010, J STAT SOFTW, V34, P1; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fagerberg B, 2011, J INTERN MED, V269, P636, DOI 10.1111/j.1365-2796.2010.02336.x; Ferrannini E, 2013, DIABETES, V62, P1730, DOI 10.2337/db12-0707; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Herder C, 2014, DIABETOLOGIA, V57, P16, DOI 10.1007/s00125-013-3061-3; Hochberg Y, 1995, J ROYAL STAT SOC B; Jonsson P, 2005, ANAL CHEM, V77, P5635, DOI 10.1021/ac050601e; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Lind MV, 2016, EUR J EPIDEMIOL, V31, P717, DOI 10.1007/s10654-016-0166-2; Lorenzi M., 2007, J DIABETES RES, V2007, P1; Magnusson M, 2015, DIABETES, V64, P3010, DOI 10.2337/db14-1863; Meiss E, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-0958-0; Menni C, 2013, DIABETES, V62, P4270, DOI 10.2337/db13-0570; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; Oates PJ, 2002, POLYOL PATHWAY DIABE, P325; Palmer ND, 2014, J CLIN ENDOCRINOLOGY, V100, pE463; Roberts LD, 2014, LANCET DIABETES ENDO, V2, P65, DOI 10.1016/S2213-8587(13)70143-8; Savolainen OI, 2016, J PROTEOME RES, V15, P259, DOI 10.1021/acs.jproteome.5b00790; Tuomilehto J, 2003, DIABETES CARE, V26, P61; Wang TJ, 2013, J CLIN INVEST, V123, P4309, DOI 10.1172/JCI64801; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Yaghootkar H, 2013, DIABETES, V62, P3589, DOI 10.2337/db13-0128	32	23	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0177738	10.1371/journal.pone.0177738	http://dx.doi.org/10.1371/journal.pone.0177738			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692646	Green Published, Green Submitted, gold			2022-12-26	WOS:000405544800003
J	Cheng, YY; Kao, TW; Chang, YW; Wu, CJ; Peng, TC; Wu, LW; Yang, HF; Liaw, FY; Chen, WL				Cheng, Yuan-Yuei; Kao, Tung-Wei; Chang, Yaw-Wen; Wu, Chen-Jung; Peng, Tao-Chun; Wu, Li-Wei; Yang, Hui-Fang; Liaw, Fang-Yih; Chen, Wei-Liang			Examining the gender difference in the association between metabolic syndrome and the mean leukocyte telomere length	PLOS ONE			English	Article							NATIONAL-HEALTH; OBESITY; PREVALENCE	The mechanism of cellular aging likely involves decreased telomere length and is associated with age-related diseases such as cardiovascular disease. Metabolic syndrome (MetS) is an important risk factor for CVD. The purpose of this study was to investigate the association between LTL and MetS. We evaluated 7370 participants in the National Health and Nutrition Examination Survey (1999-2002). The association between LTL and individual MetS components and the number of MetS components was analyzed by multivariable regression models, adjusting for gender, race/ethnicity, albumin, C-reactive protein, alanine transaminase, uric acid and medical condition. An increase in the number of MetS components was strongly associated with shorter telomere length, especially in female participants (p for trend < 0.05). In addition, triglycerides were negatively associated with LTL in female participants (p < 0.001). Waist circumstance was associated with decreased LTL (p < 0.05) in both males and females. In summary, our study indicated that an increment of MetS component is strongly associated with shorter LTL, especially in the female population.	[Cheng, Yuan-Yuei; Kao, Tung-Wei; Chang, Yaw-Wen; Wu, Chen-Jung; Peng, Tao-Chun; Wu, Li-Wei; Yang, Hui-Fang; Liaw, Fang-Yih; Chen, Wei-Liang] Natl Def Med Ctr, Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan; [Cheng, Yuan-Yuei; Kao, Tung-Wei; Chang, Yaw-Wen; Wu, Chen-Jung; Peng, Tao-Chun; Wu, Li-Wei; Yang, Hui-Fang; Liaw, Fang-Yih; Chen, Wei-Liang] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Kao, Tung-Wei; Chang, Yaw-Wen; Peng, Tao-Chun; Wu, Li-Wei; Liaw, Fang-Yih; Chen, Wei-Liang] Natl Def Med Ctr, Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan; [Kao, Tung-Wei; Chang, Yaw-Wen; Peng, Tao-Chun; Wu, Li-Wei; Liaw, Fang-Yih; Chen, Wei-Liang] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Chang, Yaw-Wen; Wu, Li-Wei; Liaw, Fang-Yih; Chen, Wei-Liang] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Wu, Chen-Jung] Taoyuan Armed Forces Gen Hosp, Div Family Med, Dept Community Med, Taoyuan, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center	Chen, WL (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	weiliang0508@gmail.com	Peng, Tao‑Chun/AAY-7035-2020; Chang, Yaw-Wen/AAF-2630-2020	Chang, Yaw-Wen/0000-0002-8436-0518; Yang, Hui-Fang/0000-0001-6400-0462				Adaikalakoteswari A, 2007, ATHEROSCLEROSIS, V195, P83, DOI 10.1016/j.atherosclerosis.2006.12.003; Aviv A, 2012, MUTAT RES-FUND MOL M, V730, P68, DOI 10.1016/j.mrfmmm.2011.05.001; Avogaro A, 2010, PFLUG ARCH EUR J PHY, V459, P301, DOI 10.1007/s00424-009-0721-8; Beltran-Sanchez H, 2013, J AM COLL CARDIOL, V62, P697, DOI 10.1016/j.jacc.2013.05.064; Bonomini F, 2015, AGING DIS, V6, P109, DOI 10.14336/AD.2014.0305; Breuer HWM, 2001, CURR MED RES OPIN, V17, P60, DOI 10.1185/03007990152005379; Buxton JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099133; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; D'Mello MJJ, 2015, CIRC-CARDIOVASC GENE, V8, P82, DOI 10.1161/CIRCGENETICS.113.000485; Diker-Cohen T, 2013, LEUKEMIA LYMPHOMA, V54, P2023, DOI 10.3109/10428194.2012.757765; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Franssen FME, 2008, THORAX, V63, P1110, DOI 10.1136/thx.2007.086827; Fuster JJ, 2006, CIRC RES, V99, P1167, DOI 10.1161/01.RES.0000251281.00845.18; Gray KE, 2014, EPIDEMIOLOGY, V25, P139, DOI 10.1097/EDE.0000000000000017; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Grundy SM, 1998, AM J CARDIOL, V81, p18B, DOI 10.1016/S0002-9149(98)00033-2; Guarner V, 2012, AGING DIS, V3, P269; Hunt SC, 2015, CIRC-CARDIOVASC GENE, V8, P4, DOI 10.1161/CIRCGENETICS.114.000964; Kyo S, 1999, CANCER RES, V59, P5917; Laimer M, 2016, INT J OBESITY, V40, P773, DOI 10.1038/ijo.2015.238; Lee DC, 2005, YONSEI MED J, V46, P471, DOI 10.3349/ymj.2005.46.4.471; Lee M, 2011, AM J HUM BIOL, V23, P100, DOI 10.1002/ajhb.21109; Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012; Loprinzi PD, 2017, J SPORTS SCI, P1; Martinez P, 2013, CELL REP, V3, P2059, DOI 10.1016/j.celrep.2013.05.030; Matarese G, 2005, J IMMUNOL, V174, P3137, DOI 10.4049/jimmunol.174.6.3137; Needham BL, 2013, SOC SCI MED, V85, P1, DOI 10.1016/j.socscimed.2013.02.023; Rehkopf DH, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002188; Revesz D, 2015, J CLIN ENDOCR METAB, V100, P3050, DOI 10.1210/JC.2015-1995; Revesz D, 2014, J CLIN ENDOCR METAB, V99, P4607, DOI 10.1210/jc.2014-1851; Robertson JD, 2001, BONE MARROW TRANSPL, V27, P1283, DOI 10.1038/sj.bmt.1703069; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Salpea KD, 2010, ATHEROSCLEROSIS, V209, P42, DOI 10.1016/j.atherosclerosis.2009.09.070; Shammas MA, 2011, CURR OPIN CLIN NUTR, V14, P28, DOI 10.1097/MCO.0b013e32834121b1; Shin YA, 2016, J EXERC REHABIL, V12, P238, DOI 10.12965/jer.1632584.292; Tamura Y, 2016, GERIATR GERONTOL INT, V16, P66, DOI 10.1111/ggi.12738; Tellechea ML, 2017, J HUM HYPERTENS, V31, P99, DOI 10.1038/jhh.2016.45; Townsley DM, 2016, NEW ENGL J MED, V374, P1922, DOI 10.1056/NEJMoa1515319; Tzanetakou IP, 2012, AGEING RES REV, V11, P220, DOI 10.1016/j.arr.2011.12.003; Verhulst S, 2016, DIABETOLOGIA, V59, P1258, DOI 10.1007/s00125-016-3915-6; Wang CQ, 2017, CLIN ENDOCRINOL, V86, P552, DOI 10.1111/cen.13283; Wulaningsih W, 2016, AGING-US, V8, P2689, DOI 10.18632/aging.101036; Yeap BB, 2016, J CLIN ENDOCR METAB, V101, P1299, DOI 10.1210/jc.2015-4139; Yeh JK, 2016, GENES-BASEL, V7, DOI 10.3390/genes7090058; Zhou YL, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-016-0089-2; Zuliani G, 2009, ATHEROSCLEROSIS, V203, P626, DOI 10.1016/j.atherosclerosis.2008.07.038	47	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180687	10.1371/journal.pone.0180687	http://dx.doi.org/10.1371/journal.pone.0180687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686726	Green Published, gold, Green Submitted			2022-12-26	WOS:000405464100090
J	Emukule, GO; Spreeuwenberg, P; Chaves, SS; Mott, JA; Tempia, S; Bigogo, G; Nyawanda, B; Nyaguara, A; Widdowson, MA; van der Velden, K; Paget, JW				Emukule, Gideon O.; Spreeuwenberg, Peter; Chaves, Sandra S.; Mott, Joshua A.; Tempia, Stefano; Bigogo, Godfrey; Nyawanda, Bryan; Nyaguara, Amek; Widdowson, Marc-Alain; van der Velden, Koos; Paget, John W.			Estimating influenza and respiratory syncytial virus-associated mortality in Western Kenya using health and demographic surveillance system data, 2007-2013	PLOS ONE			English	Article							EXCESS MORTALITY; YOUNG-CHILDREN; VERBAL AUTOPSY; UNITED-STATES; SOUTH-AFRICA; RURAL KENYA; INFECTION; DEATHS; BURDEN; AGE	Background Influenza and respiratory syncytial virus (RSV) associated mortality has not been wellestablished in tropical Africa. Methods We used the negative binomial regression method and the rate-difference method (i. e. deaths during low and high influenza/RSV activity months), to estimate excess mortality attributable to influenza and RSV using verbal autopsy data collected through a health and demographic surveillance system in Western Kenya, 2007-2013. Excess mortality rates were calculated for a) all-cause mortality, b) respiratory deaths (including pneumonia), c) HIV-related deaths, and d) pulmonary tuberculosis (TB) related deaths. Results Using the negative binomial regression method, the mean annual all-cause excess mortality rate associated with influenza and RSV was 14.1 (95% confidence interval [ CI] 0.0-93.3) and 17.1 (95% CI 0.0-111.5) per 100,000 person-years (PY) respectively; and 10.5 (95% CI 0.0-28.5) and 7.3 (95% CI 0.0-27.3) per 100,000 PY for respiratory deaths, respectively. Highest mortality rates associated with influenza were among >= 50 years, particularly among persons with TB (41.6[ 95% CI 0.0-122.7]); and with RSV were among < 5 years. Using the rate-difference method, the excess mortality rate for influenza and RSV was 44.8 (95% CI 36.8-54.4) and 19.7 (95% CI 14.7-26.5) per 100,000 PY, respectively, for all-cause deaths; and 9.6 (95% CI 6.3-14.7) and 6.6 (95% CI 3.9-11.0) per 100,000 PY, respectively, for respiratory deaths. Conclusions Our study shows a substantial excess mortality associated with influenza and RSV in Western Kenya, especially among children < 5 years and older persons with TB, supporting recommendations for influenza vaccination and efforts to develop RSV vaccines.	[Emukule, Gideon O.; Chaves, Sandra S.; Mott, Joshua A.; Widdowson, Marc-Alain] Ctr Dis Control & Prevent, Kenya Country Off, Nairobi, Kenya; [Emukule, Gideon O.; van der Velden, Koos; Paget, John W.] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, Nijmegen, Netherlands; [Spreeuwenberg, Peter; Paget, John W.] Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands; [Chaves, Sandra S.; Mott, Joshua A.; Tempia, Stefano] US Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Mott, Joshua A.] US PHS, Rockville, MD USA; [Tempia, Stefano] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [Bigogo, Godfrey; Nyawanda, Bryan; Nyaguara, Amek] Kenya Govt Med Res Ctr, Kisumu, Kenya	Radboud University Nijmegen; Netherlands Institute for Health Services Research; Centers for Disease Control & Prevention - USA; United States Public Health Service; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); Kenya Medical Research Institute	Emukule, GO (corresponding author), Ctr Dis Control & Prevent, Kenya Country Off, Nairobi, Kenya.; Emukule, GO (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, Nijmegen, Netherlands.	uyr9@cdc.gov	van der Velden, J./H-8101-2014; Bigogo, Godfrey/W-3591-2019		Kenya Medical Research Institute; U.S. Centers for Disease Control and Prevention research collaboration	Kenya Medical Research Institute; U.S. Centers for Disease Control and Prevention research collaboration(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by The Kenya Medical Research Institute and U.S. Centers for Disease Control and Prevention research collaboration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; Beeler JA, 2013, MICROB PATHOGENESIS, V55, P9, DOI 10.1016/j.micpath.2012.11.013; Bigogo GM, 2013, J INFECT DIS, V208, pS207, DOI 10.1093/infdis/jit489; Burton DC, 2011, J HEALTH POPUL NUTR, V29, P61, DOI 10.3329/jhpn.v29i1.7567; Chow A, 2006, EMERG INFECT DIS, V12, P114, DOI 10.3201/eid1201.050826; Emukule GO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138708; Emukule GO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105543; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Feikin DR, 2012, B WORLD HEALTH ORGAN, V90, P256, DOI 10.2471/BLT.11.094326; Goldstein E, 2012, EPIDEMIOLOGY, V23, P829, DOI 10.1097/EDE.0b013e31826c2dda; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Jansen AGSC, 2008, VACCINE, V26, P5567, DOI 10.1016/j.vaccine.2008.08.003; Katz MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098615; Katz MA, 2012, J INFECT DIS, V206, pS53, DOI 10.1093/infdis/jis530; Kessaram T, 2015, INFLUENZA OTHER RESP, V9, P14, DOI 10.1111/irv.12292; Kimanga DO, 2014, JAIDS-J ACQ IMM DEF, V66, pS13, DOI 10.1097/QAI.0000000000000124; (KNBS) KNBoS and Macro I, 2010, KEN DEM HLTH SURV; Lin JC, 2001, ARCH INTERN MED, V161, P441, DOI 10.1001/archinte.161.3.441; Madhi SA, 2000, J PEDIATR-US, V137, P78, DOI 10.1067/mpd.2000.105350; Matias G, 2014, INFLUENZA OTHER RESP, V8, P507, DOI 10.1111/irv.12258; Moyes J, 2013, J INFECT DIS, V208, pS217, DOI 10.1093/infdis/jit479; Murray CJL, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-5; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nokes DJ, 2008, CLIN INFECT DIS, V46, P50, DOI 10.1086/524019; Nunes B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020661; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; Odhiambo FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010016; Park M, 2015, AM J PREVENTIVE MED; Phillips-Howard PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047017; SERFLING RE, 1967, AM J EPIDEMIOL, V86, P433, DOI 10.1093/oxfordjournals.aje.a120753; Simonsen L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001558; Tempia S, 2015, EMERG INFECT DIS, V21, P600, DOI 10.3201/eid2104.141033; Tempia S, 2014, CLIN INFECT DIS, V58, P1241, DOI 10.1093/cid/ciu095; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507; UNITAID, 2015, MAL MED LANDSC; van Eijk AM, 2008, TROP MED INT HEALTH, V13, P1314, DOI 10.1111/j.1365-3156.2008.02136.x; van't Hoog AH, 2011, AM J RESP CRIT CARE, V183, P1245, DOI 10.1164/rccm.201008-1269OC; Walaza S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129173; WHO Collaborating Centre for Influenza at CDC Atlanta, CDC PROT REALT RTPCR; Wong CM, 2004, CLIN INFECT DIS, V39, P1611, DOI 10.1086/425315; World Health Organization, 2012 WHO VERB AUT IN; Wu P, 2012, J INFECT DIS, V206, P1862, DOI 10.1093/infdis/jis628; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	46	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180890	10.1371/journal.pone.0180890	http://dx.doi.org/10.1371/journal.pone.0180890			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686692	Green Published, gold, Green Submitted			2022-12-26	WOS:000405464100119
J	Hayat, T; Haider, F; Muhammad, T; Alsaedi, A				Hayat, Tasawar; Haider, Farwa; Muhammad, Taseer; Alsaedi, Ahmed			Three-dimensional rotating flow of carbon nanotubes with Darcy-Forchheimer porous medium	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; HEAT-TRANSFER ENHANCEMENT; STRETCHING SURFACE; THERMAL-CONDUCTIVITY; NATURAL-CONVECTION; MAGNETIC-FIELD; NANOFLUID; FLUID; CHANNEL; NANOPARTICLES	Here we are concerned with the Darcy-Forchheimer three-dimensional flow of carbon nanotubes in a rotating frame. Flow is generated by stretching of the surface. Xue model is adopted for nanofluid transport mechanism. Results for single wall carbon nanotubes (SWCNTs) and multi wall carbon nanotubes are achieved and compared. Flow saturating porous space obeys Darcy-Forchheimer expression. Boundary layer approximations are invoked to simplify governing partial differential system. Optimal homotopy analysis method (OHAM) is utilized for solutions of governing model. The optimal values of auxiliary parameters are computed. Plots have been displayed in order to analyze how the velocities and temperature fields get affected by various flow parameters. Skin-friction coefficients and local Nusselt number are presented through numerical data for both SWCNTs and MWCNTs. Moreover the skin-friction coefficients and local Nusselt number are enhanced for larger values of nanoparticles volume fraction.	[Hayat, Tasawar; Haider, Farwa; Muhammad, Taseer] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed] King Abdulaziz Univ, Dept Math, Nonlinear Anal & Appl Math NAAM Res Grp, Fac Sci, Jeddah, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Muhammad, T (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad, Pakistan.	taseer@math.qau.edu.pk	Muhammad, Taseer/F-9103-2018; Hayat, Tasawar/Y-2524-2019; Alsaedi, Ahmed/A-2094-2013	Muhammad, Taseer/0000-0002-0838-2731; Alsaedi, Ahmed/0000-0003-3452-8922				Abbasbandy S, 2014, INT J NUMER METHOD H, V24, P390, DOI 10.1108/HFF-05-2012-0096; Bakar S.A., 2016, FRONT HEAT MASS TRAN, V7, P38; Choi SUS, 2001, APPL PHYS LETT, V79, P2252, DOI 10.1063/1.1408272; Dehghan M, 2010, NUMER METH PART D E, V26, P448, DOI 10.1002/num.20460; Ding YL, 2006, INT J HEAT MASS TRAN, V49, P240, DOI 10.1016/j.ijheatmasstransfer.2005.07.009; Ellahi R, 2016, INT J NUMER METHOD H, V26, P2160, DOI 10.1108/HFF-11-2014-0348; Ellahi R, 2016, APPL NANOSCI, V6, P641, DOI 10.1007/s13204-015-0481-z; Ellahi R, 2015, IEEE T NANOTECHNOL, V14, P726, DOI 10.1109/TNANO.2015.2435899; Forchheimer P, 1901, Z VER DTSCH ING, V45, P1782; Hayat T, 2017, J MOL LIQ, V229, P541, DOI 10.1016/j.molliq.2017.01.005; Hayat T, 2017, J MOL LIQ, V229, P495, DOI 10.1016/j.molliq.2016.12.095; Hayat T, 2017, J TAIWAN INST CHEM E, V70, P119, DOI 10.1016/j.jtice.2016.11.002; Hayat T, 2016, INT J NUMER METHOD H, V26, P2355, DOI 10.1108/HFF-08-2015-0333; Hayat T, 2015, J MAGN MAGN MATER, V385, P222, DOI 10.1016/j.jmmm.2015.02.046; Hayat T, 2015, AIP ADV, V5, DOI 10.1063/1.4908602; Hayat T, 2017, INT J HEAT MASS TRAN, V112, P248, DOI 10.1016/j.ijheatmasstransfer.2017.04.123; Hayat T, 2017, J MOL LIQ, V233, P278, DOI 10.1016/j.molliq.2017.03.035; Hayat T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174938; Hayat T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168824; Hayat T, 2016, APPL SCI-BASEL, V6, DOI 10.3390/app6110346; Hayat T, 2016, J MOL LIQ, V221, P1121, DOI 10.1016/j.molliq.2016.06.083; Hayat T, 2016, AIP ADV, V6, DOI 10.1063/1.4942091; Imtiaz M, 2016, INT J HEAT MASS TRAN, V101, P948, DOI 10.1016/j.ijheatmasstransfer.2016.05.114; Iqbal Z, 2017, PHYSICA E, V91, P128, DOI 10.1016/j.physe.2017.04.022; Javed T, 2011, INT J NUMER METHOD H, V21, P903, DOI 10.1108/09615531111162855; Jha B. K., 2011, APPL MATH, V2, P1432; Kamali R, 2010, INT COMMUN HEAT MASS, V37, P1153, DOI 10.1016/j.icheatmasstransfer.2010.06.001; Karimipour A, 2016, J MAGN MAGN MATER, V419, P420, DOI 10.1016/j.jmmm.2016.06.063; Khan U, 2017, APPL THERM ENG, V113, P1107, DOI 10.1016/j.applthermaleng.2016.11.104; Liao SJ, 2010, COMMUN NONLINEAR SCI, V15, P2003, DOI 10.1016/j.cnsns.2009.09.002; Malvandi A., 2013, J THERMODYN, V2013, DOI DOI 10.1155/2013/764827; Muskat M., 1946, FLOW HOMOGENEOUS FLU, V763, P100; Mustafa M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149304; Nazar R, 2004, MECH RES COMMUN, V31, P121, DOI 10.1016/j.mechrescom.2003.09.004; Pal D, 2012, INT COMMUN HEAT MASS, V39, P913, DOI 10.1016/j.icheatmasstransfer.2012.05.012; Ramasubramaniam R, 2003, APPL PHYS LETT, V83, P2928, DOI 10.1063/1.1616976; Rosali H, 2015, J MOL LIQ, V211, P965, DOI 10.1016/j.molliq.2015.08.026; Sadiq MA, 2016, RESULTS PHYS, V6, P884, DOI 10.1016/j.rinp.2016.10.019; Safaei MR, 2014, NUMER HEAT TR A-APPL, V66, P1321, DOI 10.1080/10407782.2014.916101; Seddeek MA, 2006, J COLLOID INTERF SCI, V293, P137, DOI 10.1016/j.jcis.2005.06.039; Shafique Z, 2016, RESULTS PHYS, V6, P627, DOI 10.1016/j.rinp.2016.09.006; Shehzad N, 2016, J MOL LIQ, V222, P446, DOI 10.1016/j.molliq.2016.07.052; Shehzad SA, 2016, J MOL LIQ, V224, P274, DOI 10.1016/j.molliq.2016.09.109; Sheikholeslami M, 2016, APPL SCI-BASEL, V6, DOI 10.3390/app6110324; Sheikholeslami M, 2015, INT J HEAT MASS TRAN, V89, P799, DOI 10.1016/j.ijheatmasstransfer.2015.05.110; Sheikholeslami M, 2014, J MOL LIQ, V194, P30, DOI 10.1016/j.molliq.2014.01.005; Takhar HS, 2003, INT J THERM SCI, V42, P23, DOI 10.1016/S1290-0729(02)00004-2; Turkyilmazoglu M, 2016, FILOMAT, V30, P1633, DOI 10.2298/FIL1606633T; Ul Haq R, 2017, RESULTS PHYS, V7, P57, DOI 10.1016/j.rinp.2016.11.057; Umavathi JC, 2017, INT J THERM SCI, V111, P511, DOI 10.1016/j.ijthermalsci.2016.10.002; WANG CY, 1988, Z ANGEW MATH PHYS, V39, P177, DOI 10.1007/BF00945764; Wang JL, 2013, EXP THERM FLUID SCI, V44, P716, DOI 10.1016/j.expthermflusci.2012.09.013; Xue QZ, 2005, PHYSICA B, V368, P302, DOI 10.1016/j.physb.2005.07.024; Zaimi K, 2013, APPL MATH MECH-ENGL, V34, P945, DOI 10.1007/s10483-013-1719-9; Zeeshan A, 2016, J MOL LIQ, V215, P549, DOI 10.1016/j.molliq.2015.12.110	55	69	69	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179576	10.1371/journal.pone.0179576	http://dx.doi.org/10.1371/journal.pone.0179576			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686643	Green Submitted, Green Published, gold			2022-12-26	WOS:000405464100018
J	Nedelkou, IP; Maurer, A; Schubert, A; Leon, J; Pillen, K				Nedelkou, Ioanna-Pavlina; Maurer, Andreas; Schubert, Anne; Leon, Jens; Pillen, Klaus			Exotic QTL improve grain quality in the triparental wheat population SW84	PLOS ONE			English	Article							TURGIDUM SSP DICOCCOIDES; BREAD-MAKING QUALITY; CHROMOSOME-DOUBLED HYBRIDS; SYNTHETIC HEXAPLOID WHEAT; PROTEIN-CONTENT; TRITICUM-AESTIVUM; GENETIC-ANALYSIS; WINTER-WHEAT; POLYPLOID WHEAT; SEDIMENTATION VOLUME	Developing the tri-parental exotic wheat population SW84 Genetic diversity of cultivated wheat was markedly reduced, first, during domestication and, second, since the onset of modern elite breeding. There is an increasing demand for utilizing genetic resources to increase genetic diversity and, simultaneously, to improve agronomic performance of cultivated wheat. To locate favorable effects of exotic wheat alleles, we developed the tri-parental wheat population SW84. The population was derived from crossing the hexaploid spring wheat cultivars Triso and Devon with one synthetic exotic donor accession, Syn084L, followed by two rounds of backcrossing and three rounds of selfing. SW84 consists of 359 BC2F4 lines, split into two families, D84 (Devon*Syn084L) and T84 (Triso*Syn084L). Studying the genetic control of grain quality in SW84 As a case study, grain quality of SW84 was studied in replicated field trials. Transgressive segregation was observed for all studied grain quality traits by evaluating SW84 for two years at two locations under low and high nitrogen supply. Subsequently, a genome-wide association study (GWAS) was carried out based on genomic data derived from a 90k Infinium iSELECT single nucleotide polymorphism (SNP) array. In total, GWAS yielded 37 marker-trait associations, summarized to 16 quantitative trait loci (QTL). These SNPs indicate genetic regulators of grain protein content, grain hardness, sedimentation value and sedimentation ratio. The majority of exotic QTL alleles (75%) exerted favorable effects, increasing grain protein content and sedimentation value in ten and two cases, respectively. For instance, two exotic QTL alleles were associated with a substantial increase of grain protein content and sedimentation value by 1.09% and 7.31 ml, respectively. This finding confirms the potential of exotic germplasm to improve grain quality in cultivated wheat. So far, the molecular nature of most of the detected QTL is unknown. However, two QTL correspond to known genes controlling grain quality: The major QTL on chromosome 6B, increasing grain protein content by 0.70%, on average, co-localizes with the NAM-B1 gene, known to control grain protein content as well as iron and zinc content. Likewise, the major QTL on chromosome 5D, reducing grain hardness by 8.98%, on average, co-localizes with the gene for puroindoline b (Pinb-D1) at the Ha locus. In total, 13 QTL were detected across families, whereas one and three QTL were exclusively detected in families D84 and T84, respectively. Likewise, ten QTL were detected across nitrogen treatments, whereas one and five QTL were exclusively detected under low and high N treatments, respectively. Our data indicate that most effects in SW84 act across families and N levels. Merging of data from two families or two N treatments may, thus, be considered in association studies to increase sample size and, as a result, QTL detection power. Utilizing favorable exotic QTL alleles in wheat breeding Our study serves as a model how favorable exotic QTL alleles can be located in exotic germplasm of wheat. In future, the localized favorable exotic QTL alleles will be utilized in wheat breeding programs to simultaneously improve grain quality and selectively expand genetic diversity of the elite wheat gene pool.	[Nedelkou, Ioanna-Pavlina; Maurer, Andreas; Pillen, Klaus] Martin Luther Univ Halle Wittenberg, Inst Agr & Nutr Sci, Chair Plant Breeding, Halle, Germany; [Schubert, Anne; Leon, Jens] Univ Bonn, Inst Crop Sci & Resource Conservat, Crop Genet & Biotechnol Unit, Katzenburgweg 5, Bonn, Germany	Martin Luther University Halle Wittenberg; University of Bonn	Pillen, K (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Agr & Nutr Sci, Chair Plant Breeding, Halle, Germany.	klaus.pillen@landw.uni-halle.de	Pillen, Klaus/I-6511-2012	Pillen, Klaus/0000-0003-4646-6351; Maurer, Andreas/0000-0002-2916-7475	German Plant Genome Research Initiative (GABI) of the Federal Ministry of Education and Research (BMBF) [312862]; Federal State of Saxony-Anhalt	German Plant Genome Research Initiative (GABI) of the Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Federal State of Saxony-Anhalt	This work was funded by the German Plant Genome Research Initiative (GABI) of the Federal Ministry of Education and Research (BMBF, project 312862) and the Federal State of Saxony-Anhalt.	Arbelbide M, 2006, THEOR APPL GENET, V112, P885, DOI 10.1007/s00122-005-0190-1; Blanco A, 2006, THEOR APPL GENET, V112, P1195, DOI 10.1007/s00122-006-0221-6; Blanco A, 2012, MOL BREEDING, V30, P79, DOI 10.1007/s11032-011-9600-z; Blanco A, 1998, PLANT BREEDING, V117, P413, DOI 10.1111/j.1439-0523.1998.tb01965.x; Bogard M, 2011, J EXP BOT, V62, P3621, DOI 10.1093/jxb/err061; Bogard M, 2010, J EXP BOT, V61, P4303, DOI 10.1093/jxb/erq238; Brevis JC, 2010, J CEREAL SCI, V51, P357, DOI 10.1016/j.jcs.2010.02.004; Brevis JC, 2010, CROP SCI, V50, P93, DOI 10.2135/cropsci2009.02.0057; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Buerstmayr M, 2011, THEOR APPL GENET, V123, P293, DOI 10.1007/s00122-011-1584-x; Capparelli R, 2005, PLANT MOL BIOL, V58, P857, DOI 10.1007/s11103-005-8270-9; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chalupska D, 2008, P NATL ACAD SCI USA, V105, P9691, DOI 10.1073/pnas.0803981105; Chantret N, 2005, PLANT CELL, V17, P1033, DOI 10.1105/tpc.104.029181; Chatzav M, 2010, ANN BOT-LONDON, V105, P1211, DOI 10.1093/aob/mcq024; de Sa RM, 2006, J I BREWING, V112, P9, DOI 10.1002/j.2050-0416.2006.tb00701.x; Deng ZY, 2013, J INTEGR AGR, V12, P2125, DOI 10.1016/S2095-3119(13)60352-4; Distelfeld A, 2007, PHYSIOL PLANTARUM, V129, P635, DOI 10.1111/j.1399-3054.2006.00841.x; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; FAOSTAT, 2016, UN FOOD AGR ORG STAT; Feiz L, 2009, GENETICS, V183, P853, DOI 10.1534/genetics.109.106013; Flaete NES, 2003, J CEREAL SCI, V37, P129, DOI 10.1006/jcrs.2001.0447; Galande AA, 2001, THEOR APPL GENET, V103, P601, DOI 10.1007/PL00002915; Ganal Martin W., 2007, P1, DOI 10.1007/978-1-4020-6297-1_1; Gill BS, 2004, GENETICS, V168, P1087, DOI 10.1534/genetics.104.034769; Groos C, 2007, THEOR APPL GENET, V115, P313, DOI 10.1007/s00122-007-0563-8; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Gupta PK, 2010, MOL BREEDING, V26, P145, DOI 10.1007/s11032-009-9359-7; Gustafson P., 2009, WHEAT SCI TRADE, P3, DOI DOI 10.1002/9780813818832.CH1; Hagenblad J, 2012, THEOR APPL GENET, V125, P1677, DOI 10.1007/s00122-012-1943-2; Hagenblad J, 2012, GENET RESOUR CROP EV, V59, P1185, DOI 10.1007/s10722-011-9754-x; HOLM S, 1979, SCAND J STAT, V6, P65; Honsdorf N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097047; Huang HB, 2008, J FOOD ENG, V87, P303, DOI 10.1016/j.jfoodeng.2007.12.022; Huang XQ, 2006, THEOR APPL GENET, V113, P753, DOI 10.1007/s00122-006-0346-7; Huang XQ, 2003, THEOR APPL GENET, V106, P1379, DOI 10.1007/s00122-002-1179-7; Huang XQ, 2004, THEOR APPL GENET, V109, P933, DOI 10.1007/s00122-004-1708-7; ICC, DET PROT NEAR INFR R, V159; Iqbal M, 2007, PLANT BREEDING, V126, P244, DOI 10.1111/j.1439-0523.2007.01346.x; (IWGSC) TIWGSC, 2014, SCIENCE, V345; Krystkowiak K, 2016, J APPL GENETICS; Kunert A, 2007, THEOR APPL GENET, V115, P683, DOI 10.1007/s00122-007-0600-7; Laidig F, 2017, THEOR APPL GENET, V130, P223, DOI 10.1007/s00122-016-2810-3; LANGE W, 1992, EUPHYTICA, V59, P197, DOI 10.1007/BF00041273; LANGE W, 1992, EUPHYTICA, V59, P213, DOI 10.1007/BF00041274; LEVY AA, 1989, EUPHYTICA, V41, P113, DOI 10.1007/BF00022420; Li Y, 2009, GEOPHYS J INT, V178, P1493, DOI 10.1111/j.1365-246X.2009.04232.x; Long DS, 2008, AGRON J, V100, P247, DOI [10.2134/agrojnl2007.0052, 10.2134/agronj2007.0052]; Mahjourimajd S., 2016, PLOS ONE, V11; Mann G, 2009, THEOR APPL GENET, V118, P1519, DOI 10.1007/s00122-009-1000-y; Maurer A, 2016, J EXP BOT, V67, P2507, DOI 10.1093/jxb/erw070; Maurer A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1459-7; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Moore CM, 2015, EUPHYTICA, V204, P371, DOI 10.1007/s10681-014-1346-3; Morris CF, 2002, PLANT MOL BIOL, V48, P633, DOI 10.1023/A:1014837431178; Narasimhamoorthy B, 2006, THEOR APPL GENET, V112, P787, DOI 10.1007/s00122-005-0159-0; Naz AA, 2008, THEOR APPL GENET, V116, P1095, DOI 10.1007/s00122-008-0738-y; Naz AA, 2015, PLANT BREEDING, V134, P514, DOI 10.1111/pbr.12301; Naz AA, 2012, MOL BREEDING, V30, P1219, DOI 10.1007/s11032-012-9710-2; Nevo E, 2001, ISR J PLANT SCI, V49, pS77, DOI 10.1092/XJQN-9T4H-VTL3-CDXU; Nevo E, 2010, PLANT CELL ENVIRON, V33, P670, DOI 10.1111/j.1365-3040.2009.02107.x; Olson EL, 2013, THEOR APPL GENET, V126, P2477, DOI 10.1007/s00122-013-2148-z; Pasha I, 2010, FOOD SCI TECHNOL INT, V16, P511, DOI 10.1177/1082013210379691; Perretant MR, 2000, THEOR APPL GENET, V100, P1167, DOI 10.1007/s001220051420; Pillen K, 2003, THEOR APPL GENET, V107, P340, DOI 10.1007/s00122-003-1253-9; Prasad M, 2003, THEOR APPL GENET, V106, P659, DOI 10.1007/s00122-002-1114-y; Randhawa HS, 2013, PLANT BREEDING; Roder MS, 1998, GENETICS, V149, P2007; Ross AS, 2009, PASSING TEST WHEAT E, P455; Rutkoski JE, 2013, G3-GENES GENOM GENET, V3, P427, DOI 10.1534/g3.112.005363; Saal B, 2011, EUPHYTICA, V177, P223, DOI 10.1007/s10681-010-0252-6; Schmalenbach I, 2011, G3-GENES GENOM GENET, V1, P187, DOI 10.1534/g3.111.000182; Semagn K, 2006, GENOME, V49, P545, DOI 10.1139/G06-002; Shaaf S, 2016, MOL GENET GENOMICS, V291, P1259, DOI 10.1007/s00438-016-1180-5; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; Shewry PR, 2007, J CEREAL SCI, V46, P239, DOI 10.1016/j.jcs.2007.06.006; Suprayogi Y, 2009, THEORETICAL APPL GEN; Tanksley SD, 1996, THEOR APPL GENET, V92, P191, DOI 10.1007/BF00223376; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Trethowan RM, 2009, SYNTHETIC WHEAT EMER, P369; Turner AS, 2004, J CEREAL SCI, V40, P51, DOI 10.1016/j.jcs.2004.03.001; Uauy C, 2006, J EXP BOT, V57, P2785, DOI 10.1093/jxb/erl047; Utz HF, 2000, GENETICS, V154, P1839; von Korff M, 2006, THEOR APPL GENET, V112, P1221, DOI 10.1007/s00122-006-0223-4; Wang G, 2011, THEOR APPL GENET, V124, P207; Wang L, 2012, J GENET, V91, P303, DOI 10.1007/s12041-012-0190-2; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wang Y, 2012, MOL BREEDING, V29, P661, DOI 10.1007/s11032-011-9580-z; Waters BM, 2009, J EXP BOT, V60, P4263, DOI 10.1093/jxb/erp257; Weightman RM, 2008, J CEREAL SCI, V47, P457, DOI 10.1016/j.jcs.2007.05.011; Wurschum T, 2013, THEOR APPL GENET, V126, P1477, DOI 10.1007/s00122-013-2065-1; Wurschum T, 2016, THEOR APPL GENET, P1; Yang WY, 2009, J GENET GENOMICS, V36, P539, DOI 10.1016/S1673-8527(08)60145-9; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Zanetti S, 2001, PLANT BREEDING, V120, P13, DOI 10.1046/j.1439-0523.2001.00552.x; Zhang W, 2008, THEOR APPL GENET, V117, P1361, DOI 10.1007/s00122-008-0869-1; Zhao LA, 2010, EUPHYTICA, V174, P325, DOI 10.1007/s10681-009-0109-z	97	6	7	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179851	10.1371/journal.pone.0179851	http://dx.doi.org/10.1371/journal.pone.0179851			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686676	Green Published, gold, Green Submitted			2022-12-26	WOS:000405464100022
J	Williams, KE; Huyvaert, KP; Piaggio, AJ				Williams, Kelly E.; Huyvaert, Kathryn P.; Piaggio, Antoinette J.			Clearing muddied waters: Capture of environmental DNA from turbid waters	PLOS ONE			English	Article							FERAL PIG ERADICATION; EXTRACELLULAR DNA; EDNA; MITOCHONDRIAL; PERSISTENCE; PCR; BIODIVERSITY; COMMUNITY; PROGRAM; SAMPLES	Understanding the differences in efficiencies of various methods to concentrate, extract, and amplify environmental DNA (eDNA) is vital for best performance of eDNA detection. Aquatic systems vary in characteristics such as turbidity, eDNA concentration, and inhibitor load, thus affecting eDNA capture efficiency. Application of eDNA techniques to the detection of terrestrial invasive or endangered species may require sampling at intermittent water sources that are used for drinking and cooling; these water bodies may often be stagnant and turbid. We present our best practices technique for the detection of wild pig eDNA in water samples, a protocol that will have wide applicability to the detection of elusive vertebrate species. We determined the best practice for eDNA capture in a turbid water system was to concentrate DNA from a 15 mL water sample via centrifugation, purify DNA with the DNeasy mericon Food kit, and remove inhibitors with Zymo Inhibitor Removal Technology columns. Further, we compared the sensitivity of conventional PCR to quantitative PCR and found that quantitative PCR was more sensitive in detecting lower concentrations of eDNA. We show significant differences in efficiencies among methods in each step of eDNA capture, emphasizing the importance of optimizing best practices for the system of interest.	[Williams, Kelly E.; Piaggio, Antoinette J.] USDA, Wildlife Serv, Natl Wildlife Res Ctr, Wildlife Genet Lab, Ft Collins, CO 80524 USA; [Williams, Kelly E.; Huyvaert, Kathryn P.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Williams, Kelly E.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA	United States Department of Agriculture (USDA); Colorado State University; University of Washington; University of Washington Seattle	Williams, KE (corresponding author), USDA, Wildlife Serv, Natl Wildlife Res Ctr, Wildlife Genet Lab, Ft Collins, CO 80524 USA.; Williams, KE (corresponding author), Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA.; Williams, KE (corresponding author), Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA.	kellwill@rams.colostate.edu	Huyvaert, Kathryn P/A-2710-2009	Huyvaert, Kathryn P/0000-0003-3302-030X; Piaggio, Antoinette/0000-0002-4701-0746				Amberg JJ, 2013, DETECTION ENV DNA BI; [Anonymous], 1996, MANAGING VERTEBRATE; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Caldwell JM, 2007, ENVIRON SCI TECHNOL, V41, P3277, DOI 10.1021/es062912s; Chavarria PM, 2007, LANDSCAPE LEVEL SURV; Coyne KJ, 2001, AQUAT MICROB ECOL, V24, P275, DOI 10.3354/ame024275; Darling John A, 2011, Environ Res, V111, P978, DOI 10.1016/j.envres.2011.02.001; Debroas D, 2009, ENVIRON MICROBIOL, V11, P2412, DOI 10.1111/j.1462-2920.2009.01969.x; Deiner K, 2015, BIOL CONSERV, V183, P53, DOI 10.1016/j.biocon.2014.11.018; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Eichmiller JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112611; Farrington HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117803; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Folloni S, 2012, MOL ECOL RESOUR, V12, P810, DOI 10.1111/j.1755-0998.2012.03168.x; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Furlan EM, 2016, MOL ECOL RESOUR, V16, P641, DOI 10.1111/1755-0998.12483; GARBER RC, 1983, ANAL BIOCHEM, V135, P416, DOI 10.1016/0003-2697(83)90704-2; Goldberg CS, 2015, BIOL CONSERV, V183, P1, DOI 10.1016/j.biocon.2014.11.040; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Hashizume H, 2017, ACTA TROP, V169, P1, DOI 10.1016/j.actatropica.2017.01.008; HONE J, 1983, AUST WILDLIFE RES, V10, P269; Jay MT, 2007, EMERG INFECT DIS, V13, P1908, DOI 10.3201/eid1312.070763; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Martellini A, 2005, WATER RES, V39, P541, DOI 10.1016/j.watres.2004.11.012; Matheson C.D., 2010, OPEN ENZYME INHIB J, V3, P38, DOI [10.2174/1874940201003010038, DOI 10.2174/1874940201003010038]; McKee AM, 2015, BIOL CONSERV, V183, P70, DOI 10.1016/j.biocon.2014.11.031; Nathan LM, 2014, ENVIRON SCI TECHNOL, V48, P12800, DOI 10.1021/es5034052; Nielsen Kaare M., 2007, Environmental Biosafety Research, V6, P37, DOI 10.1051/ebr:2007031; Nielsen KM, 2006, SOIL BIOL, V8, P141; Oh S, 2011, APPL ENVIRON MICROB, V77, P6000, DOI 10.1128/AEM.00107-11; Perez-Mendez A, 2014, J VIROL METHODS, V206, P95, DOI 10.1016/j.jviromet.2014.05.025; Piaggio AJ, 2014, MOL ECOL RESOUR, V14, P374, DOI 10.1111/1755-0998.12180; Pietramellara G, 2009, BIOL FERT SOILS, V45, P219, DOI 10.1007/s00374-008-0345-8; Pilliod D, APPL ENV DNA INVASIV, P4; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Renshaw MA, 2015, MOL ECOL RESOUR, V15, P168, DOI 10.1111/1755-0998.12281; Robson HLA, 2016, MOL ECOL RESOUR, V16, P922, DOI 10.1111/1755-0998.12505; SAUNDERS G, 1988, AUST WILDLIFE RES, V15, P73, DOI 10.1071/WR9880073; Schmidt BR, 2013, METHODS ECOL EVOL, V4, P646, DOI 10.1111/2041-210X.12052; Sutton JT, 2011, MOL ECOL RESOUR, V11, P514, DOI 10.1111/j.1755-0998.2011.02981.x; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Taylor R. B., 1993, FERAL SWINE COMPENDI, P17; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Turner CR, 2015, BIOL CONSERV, V183, P93, DOI 10.1016/j.biocon.2014.11.017; Turner CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114329; United States Department of Agriculture U, 2014, BUDG SUMM ANN PERF P; Valiere N, 2000, MOL ECOL, V9, P2150, DOI 10.1046/j.1365-294X.2000.11142.x; West B.C., 2009, MANAGING WILD PIGS T; WETZEL RG, 1992, HYDROBIOLOGIA, V229, P181, DOI 10.1007/BF00007000; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Zarzoso-Lacoste D, 2013, MOL ECOL RESOUR, V13, P117, DOI 10.1111/1755-0998.12029	61	34	35	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179282	10.1371/journal.pone.0179282	http://dx.doi.org/10.1371/journal.pone.0179282			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686659	Green Published, gold			2022-12-26	WOS:000405464100012
J	Dong, ZY; Yang, YS; Zhang, KP; Li, YW; Wang, JJ; Wang, ZJ; Liu, X; Qin, HJ; Wang, DW				Dong, Zhenying; Yang, Yushuang; Zhang, Kunpu; Li, Yiwen; Wang, Junjun; Wang, Zhaojun; Liu, Xin; Qin, Huanju; Wang, Daowen			Development of a new set of molecular markers for examining Glu-A1 variants in common wheat and ancestral species	PLOS ONE			English	Article							WEIGHT GLUTENIN SUBUNITS; BREAD-MAKING QUALITY; GENETIC DIVERSITY; STORAGE PROTEINS; GENOME EVOLUTION; SEQUENCE; LINES; INSERTION; ALLELES; REGIONS	In common wheat (Triticum aestivum L.), allelic variations of Glu-A1 locus have important influences on grain end-use quality. Among the three Glu-A1 alleles, Glu-A1a and -A1b encode the high-molecular-weight glutenin subunits (HMW-GSs) 1Ax1 and 1Ax2*, respectively, whereas Glu-A1c does not specify any subunit. Here, we detected a total of 11 GluA1 locus haplotypes (H1 to H11) in three wheat species, by developing and using a new set of DNA markers (Xrj5, Xid3, Xrj6, Xid4 and Xrj7). The main haplotypes found in the diploid wheat T. urartu were H1, H4, H5 and H6, with H1 and H4 expressing both 1Ax and 1Ay subunits. The major haplotypes revealed for tetraploid wheat (T. turgidum) were H1, H8 and H9, with the lines expressing both 1Ax and 1Ay belonging to H1, H4 or H7. Four major haplotypes (H1, H9, H10 and H11) were discovered in common wheat, with Glu-A1a associated with H1 and H8, Glu-A1b with H10 or H11, and Glu-A1c with H9. The Glu-A1 locus haplotypes and the new set of DNA markers have potential to be used for more effectively studying and utilizing the molecular variations of Glu-A1 to improve the end-use quality of common wheat are discussed.	[Dong, Zhenying; Yang, Yushuang; Zhang, Kunpu; Li, Yiwen; Wang, Junjun; Wang, Zhaojun; Liu, Xin; Qin, Huanju; Wang, Daowen] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosomal Engn, Beijing, Peoples R China; [Yang, Yushuang] Chinese Acad Trop Agr Sci, Rubber Res Inst, Danzhou, Peoples R China; [Wang, Junjun; Wang, Zhaojun; Wang, Daowen] Grad Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Daowen] Henan Agr Univ, Collaborat Innovat Ctr Grain Crops, Zhengzhou, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Tropical Agricultural Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Henan Agricultural University	Dong, ZY; Wang, DW (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosomal Engn, Beijing, Peoples R China.; Wang, DW (corresponding author), Grad Univ Chinese Acad Sci, Beijing, Peoples R China.; Wang, DW (corresponding author), Henan Agr Univ, Collaborat Innovat Ctr Grain Crops, Zhengzhou, Peoples R China.	zhydong@genetics.ac.cn; dwwang@genetics.ac.cn		wang, dao wen/0000-0002-6230-8735	National Natural Science Foundation of China [31300280]; Ministry of Science and Technology of China [2016YFD0100500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This project was supported by grants from the National Natural Science Foundation of China (31300280) and the Ministry of Science and Technology of China (2016YFD0100500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of themanuscript	Alvarez JB, 2009, CEREAL RES COMMUN, V37, P243, DOI 10.1556/CRC.37.2009.2.11; Anderson OD, 2011, J CEREAL SCI, V54, P280, DOI 10.1016/j.jcs.2011.04.005; Bai JR, 2004, ACTA BOT SIN, V46, P463; Belton PS, 1999, J CEREAL SCI, V29, P103, DOI 10.1006/jcrs.1998.0227; Branlard G, 2001, EUPHYTICA, V119, P59, DOI 10.1023/A:1017586220359; Charmet G, 2011, CR BIOL, V334, P212, DOI 10.1016/j.crvi.2010.12.013; CIAFFI M, 1995, CEREAL CHEM, V72, P465; Dixon J, 2009, WHEAT FACTS FUTURES; Dong LL, 2012, MOL GENET GENOMICS, V287, P855, DOI 10.1007/s00438-012-0721-9; Dong ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083263; Feldman M., 2001, WORLD WHEAT BOOK HIS, P3; Feldman M., 1995, EVOLUTION CROP PLANT, V2nd, P184; Feldman M, 2012, GENETICS, V192, P763, DOI 10.1534/genetics.112.146316; Feng B, 2011, MOL BREEDING, V28, P163, DOI 10.1007/s11032-010-9470-9; FORDE J, 1985, NUCLEIC ACIDS RES, V13, P6817, DOI 10.1093/nar/13.19.6817; Groos C, 2007, THEOR APPL GENET, V115, P313, DOI 10.1007/s00122-007-0563-8; Gu YQ, 2006, GENETICS, V174, P1493, DOI 10.1534/genetics.106.060756; Gu YQ, 2004, PLANT PHYSIOL, V135, P459, DOI 10.1104/pp.103.038083; Hajjar R, 2007, EUPHYTICA, V156, P1, DOI 10.1007/s10681-007-9363-0; HALFORD NG, 1989, PLANT SCI, V62, P207, DOI 10.1016/0168-9452(89)90083-6; HARBERD NP, 1987, MOL GEN GENET, V209, P326, DOI 10.1007/BF00329661; Hu XG, 2012, GENET RESOUR CROP EV, V59, P491, DOI 10.1007/s10722-011-9698-1; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Jiang QT, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-16; LAFIANDRA D, 1993, J CEREAL SCI, V18, P197, DOI 10.1006/jcrs.1993.1046; Li W, 2004, THEOR APPL GENET, V109, P1093, DOI 10.1007/s00122-004-1726-5; Li YW, 2015, MOL PLANT, V8, P332, DOI 10.1016/j.molp.2014.10.002; Liu YN, 2012, THEOR APPL GENET, V125, P1, DOI 10.1007/s00122-012-1829-3; Pang BS, 2008, J INTEGR PLANT BIOL, V50, P329, DOI 10.1111/j.1744-7909.2007.00573.x; Paux E, 2010, PLANT BIOTECHNOL J, V8, P196, DOI 10.1111/j.1467-7652.2009.00477.x; Payne P. I., 1983, Cereal Research Communications, V11, P29; PAYNE PI, 1987, ANNU REV PLANT PHYS, V38, P141, DOI 10.1146/annurev.pp.38.060187.001041; PAYNE PI, 1981, THEOR APPL GENET, V60, P229, DOI 10.1007/BF02342544; Prescott-Allen R, 2013, GENES WILD USING WIL; Reif JC, 2005, THEOR APPL GENET, V110, P859, DOI 10.1007/s00122-004-1881-8; Rogers WJ, 1997, EUPHYTICA, V93, P19, DOI 10.1023/A:1002991206350; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sears E. R., 1978, Proceedings of the fifth international wheat genetics symposium. Volume 1. Session IV. Cytogenetics., P389; Sears E. R., 1966, Chromosome manipulations and plant genetics., P29; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; Shewry Peter R, 2003, Adv Food Nutr Res, V45, P219; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Shiferaw B, 2013, FOOD SECUR, V5, P291, DOI 10.1007/s12571-013-0263-y; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; WAINES JG, 1987, THEOR APPL GENET, V74, P71, DOI 10.1007/BF00290086; Wan Y, 2000, THEOR APPL GENET, V101, P879, DOI 10.1007/s001220051556; Wang SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058947; Wanjugi H, 2009, GENOME, V52, P576, DOI [10.1139/G09-033, 10.1139/g09-033]; Wrigley CW, 2009, WHEAT SCI TRADE, P470; Xu LL, 2009, GENET RESOUR CROP EV, V56, P377, DOI 10.1007/s10722-008-9373-3; Yue SJ, 2008, J CEREAL SCI, V47, P153, DOI 10.1016/j.jcs.2007.03.006; [张平平 ZHANG Ping-Ping], 2009, [作物学报, Acta Agronomica Sinica], V35, P1606	52	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180766	10.1371/journal.pone.0180766	http://dx.doi.org/10.1371/journal.pone.0180766			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683152	Green Published, gold, Green Submitted			2022-12-26	WOS:000405335200067
J	Ribeiro, AA; Azcarate-Peril, MA; Cadenas, MB; Butz, N; Paster, BJ; Chen, T; Bair, E; Arnold, RR				Ribeiro, Apoena Aguiar; Azcarate-Peril, Maria Andrea; Cadenas, Maria Belen; Butz, Natasha; Paster, Bruce J.; Chen, Tsute; Bair, Eric; Arnold, Roland R.			The oral bacterial microbiome of occlusal surfaces in children and its association with diet and caries	PLOS ONE			English	Article							EARLY-CHILDHOOD CARIES; DENTAL-CARIES; STREPTOCOCCUS-MUTANS; IN-VITRO; COMMUNITIES; PLAQUE; LACTOBACILLI; DIVERSITY; HEALTH; CAVITY	Dental caries is the most prevalent disease in humans globally. Efforts to control it have been invigorated by an increasing knowledge of the oral microbiome composition. This study aimed to evaluate the bacterial diversity in occlusal biofilms and its relationship with clinical surface diagnosis and dietary habits. Anamneses were recorded from thirteen 12-year-old children. Biofilm samples collected from occlusal surfaces of 46 permanent second molars were analyzed by 16S rRNA amplicon sequencing combined with the BLASTN-based search algorithm for species identification. The overall mean decayed, missing and filled surfaces modified index [DMFSm Index, including active white spot lesions (AWSL)] value was 8.77 +/- 7.47. Biofilm communities were highly polymicrobial collectively, representing 10 bacterial phyla, 25 classes, 29 orders, 58 families, 107 genera, 723 species. Streptococcus sp_Oral_Taxon_065, Corynebacterium matruchotii, Actinomyces viscosus, Actinomyces sp_Oral_Taxon_175, Actinomyces sp_Oral_Taxon_178, Actinomyces sp_Oral_Taxon_877, Prevotella nigrescens, Dialister micraerophilus, Eubacterium_XI G 1 infirmum were more abundant among surfaces with AWSL, and Streptococcus gordonii, Streptococcus sp._Oral_Taxon_058, Enterobacter sp._str._638 Streptococcus australis, Yersinia mollaretii, Enterobacter cloacae, Streptococcus sp._Oral_Taxon_71, Streptococcus sp._Oral_Taxon_F11, Centipeda sp._Oral_Taxon_D18 were more abundant among sound surfaces. Streptococcus mutans was detected on all surfaces in all patients, while Streptococcus sobrinus was detected only in three patients (mean relative abundances 7.1% and 0.6%, respectively). Neither species differentiated healthy from diseased sites. Diets of nine of the subjects were scored as high in fermentable carbohydrates (>= 2X/day between meals). A direct association between relative abundances of bacteria and carbohydrate consumption was observed among 18 species. High consumption of fermentable carbohydrates and sound surfaces were associated with a reduction in bacterial diversity. PCoA plots displayed differences in bacterial community profiles between sound and diseased surfaces. Our study showed that, in addition to mutans streptococci, other species may be associated with the initiation of dental caries on occlusal surfaces, and that biofilm diversity of tooth surfaces is influenced by carbohydrate consumption and a surface's health status.	[Ribeiro, Apoena Aguiar] Fluminense Fed Univ, Dept Pediat Dent & Cariol, Sch Dent, Nova Friburgo, Brazil; [Ribeiro, Apoena Aguiar; Arnold, Roland R.] Univ N Carolina, Dept Diagnost Sci, Sch Dent, Chapel Hill, NC 27515 USA; [Azcarate-Peril, Maria Andrea] Univ N Carolina, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Azcarate-Peril, Maria Andrea; Cadenas, Maria Belen; Butz, Natasha] Univ N Carolina, Sch Med, Microbiome Core Facil, Chapel Hill, NC USA; [Paster, Bruce J.; Chen, Tsute] Forsyth Inst, Dept Microbiol, Cambridge, MA USA; [Paster, Bruce J.] Harvard Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA USA; [Bair, Eric] Univ N Carolina, Sch Dent, Dept Endodont & Biostat, Chapel Hill, NC USA	Universidade Federal Fluminense; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine; University of North Carolina; University of North Carolina Chapel Hill	Ribeiro, AA (corresponding author), Fluminense Fed Univ, Dept Pediat Dent & Cariol, Sch Dent, Nova Friburgo, Brazil.; Ribeiro, AA (corresponding author), Univ N Carolina, Dept Diagnost Sci, Sch Dent, Chapel Hill, NC 27515 USA.	apoenaribeiro@hotmail.com	Azcarate-Peril, M. Andrea/ABH-5508-2020; Core, UNC Microbiome/AAB-3304-2022; Ribeiro, Apoena/AAZ-8478-2021; Paster, Bruce J/AAP-8559-2021; Chen, Tsute/ABC-2676-2020; Azcarate-Peril, M. Andrea/AFO-7157-2022; Azcarate-Peril, M. Andrea/AAA-9056-2022	Azcarate-Peril, M. Andrea/0000-0003-0325-1289; Azcarate-Peril, M. Andrea/0000-0003-0325-1289; Azcarate-Peril, M. Andrea/0000-0003-0325-1289; de Aguiar Ribeiro, Apoena/0000-0001-7702-6178	Science without Borders Scholarship (Coordenacao de AperfeicEoamento de Pessoal de NoAvel Superior) Brazil [8729/13-1]; National Institute of Diabetes and Digestive and Kidney Diseases NIH [P30DK34987]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE016937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER	Science without Borders Scholarship (Coordenacao de AperfeicEoamento de Pessoal de NoAvel Superior) Brazil; National Institute of Diabetes and Digestive and Kidney Diseases NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	AAR was funded by the Science without Borders Scholarship (Coordenacao de AperfeicEoamento de Pessoal de NoAvel Superior www.capes.gov.br)#8729/13-1; Brazil. The Microbiome Core Facility is funded in part by the National Institute of Diabetes and Digestive and Kidney Diseases NIH grant P30DK34987.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Aas JA, 2008, J CLIN MICROBIOL, V46, P1407, DOI 10.1128/JCM.01410-07; Al-Hebshi NN, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.28934; Allali I, 2015, GUT MICROBES, V6, P161, DOI 10.1080/19490976.2015.1039223; Arcella D, 2002, PUBLIC HEALTH NUTR, V5, P553, DOI 10.1079/PHN2001319; Bagramian RA, 2009, AM J DENT, V22, P3; Beighton D, 1996, ARCH ORAL BIOL, V41, P271, DOI 10.1016/0003-9969(96)84555-9; Belstrom D, 2016, J ORAL MICROBIOL, V8, DOI 10.3402/jom.v8.30170; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Bourgeois DM, 2014, INT DENT J, V64, P27, DOI 10.1111/idj.12129; BRADSHAW DJ, 1989, J DENT RES, V68, P1298, DOI 10.1177/00220345890680090101; Bradshaw DJ, 1998, CARIES RES, V32, P456, DOI 10.1159/000016487; Bradshawa DJ, 2002, CARIES RES, V36, P81, DOI 10.1159/000057864; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Fejerskov O., 2015, DENT CARIES DIS ITS, V4th, P5; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; FITZGERALD RJ, 1981, J DENT RES, V60, P919, DOI 10.1177/00220345810600051201; Georgios A, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.26197; GUGGENHEIM B, 1968, Caries Research, V2, P147; HARPER DS, 1984, ARCH ORAL BIOL, V29, P843, DOI 10.1016/0003-9969(84)90015-3; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Johansson I, 2016, J DENT RES, V95, P80, DOI 10.1177/0022034515609554; Lang N P, 1987, Oral Microbiol Immunol, V2, P39, DOI 10.1111/j.1399-302X.1987.tb00268.x; Li Y, 2007, J CLIN MICROBIOL, V45, P81, DOI 10.1128/JCM.01622-06; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; LOESCHE WJ, 1979, INFECT IMMUN, V26, P498, DOI 10.1128/IAI.26.2.498-507.1979; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Marsh P D, 1994, Adv Dent Res, V8, P263; MEURMAN JH, 1987, SCAND J DENT RES, V95, P32; NCHS, 2010, HLTH US 2009 SPEC FE; Nyvad B, 1999, CARIES RES, V33, P252, DOI 10.1159/000016526; NYVAD B, 1990, CARIES RES, V24, P267, DOI 10.1159/000261281; Nyvad B, 2013, CARIES RES, V47, P89, DOI 10.1159/000345367; Ogaard B, 2012, J ORAL MICROBIOL, V4; Palmer CA, 2010, J DENT RES, V89, P1224, DOI 10.1177/0022034510376543; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Petersen PE, 2003, COMMUNITY DENT ORAL, V31, P3, DOI 10.1046/j..2003.com122.x; Peterson SN, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00108; Peterson SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058487; Pinto AC, 2011, GENET MOL RES, V10, P1707, DOI 10.4238/vol10-3gmr1554; Ribeiro AD, 2013, INT J PAEDIATR DENT, V23, P359, DOI 10.1111/ipd.12008; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Simon-Soro A, 2013, J DENT RES, V92, P616, DOI 10.1177/0022034513488119; Simon-Soro A, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.25443; Slater B, 2003, EUR J CLIN NUTR, V57, P629, DOI 10.1038/sj.ejcn.1601588; Takahashi N, 2008, CARIES RES, V42, P409, DOI 10.1159/000159604; Tanzer J M, 2001, J Dent Educ, V65, P1028; Tenuta LMA, 2006, CARIES RES, V40, P546, DOI 10.1159/000095656; Thompson AL, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00003; Thylstrup A, 1998, QUINTESSENCE INT, V29, P594; Xu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089269; Zaura E, 2012, Adv Dent Res, V24, P81, DOI 10.1177/0022034512449466; Zaura E, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00039; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	57	36	39	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180621	10.1371/journal.pone.0180621	http://dx.doi.org/10.1371/journal.pone.0180621			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678838	Green Published, Green Submitted, gold			2022-12-26	WOS:000405272200077
J	Roy, A; Ramalinga, M; Kim, OJ; Chijioke, J; Lynch, S; Byers, S; Kumar, D				Roy, Arpita; Ramalinga, Malathi; Kim, Okjin J.; Chijioke, Juliet; Lynch, Solomon; Byers, Stephen; Kumar, Deepak			Multiple roles of RARRES1 in prostate cancer: Autophagy induction and angiogenesis inhibition	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; FOXO TRANSCRIPTION FACTORS; PROMOTER HYPERMETHYLATION; GENE-EXPRESSION; DNA METHYLATION; STEM-CELLS; SIRT1; PROTEIN; TIG1; PHOSPHORYLATION	Background Prostate cancer (PCa) poses a major health concern in men worldwide. Retinoic Acid Receptor Responder (RARRES1)/Tazarotene-induced gene-1 (TIG-1) is a putative tumor suppressor gene that exerts its tumor suppressor function via unknown mechanisms. Epigenetic silencing of RARRES1 leads to its loss in several types of cancer, including PCa. Determining the molecular mechanisms that mediate the tumor suppressor role of RARRES1 in PCa is the focus of our study. Findings Our data indicates that RARRES1 over expression in PCa cell lines represses mitogen-activated protein kinase (MAPK) activation. RARRES1 expression induces the levels of autophagy- related genes, beclin, ATG3 and increases LC3B-II conversion. A significant induction of SIRT1 along with mTOR inhibition is noted on RARRES1 expression. Furthermore, RARRES1 over expression elevates the levels of the antioxidant enzyme, catalase. Our results also indicate that RARRES1 expression inhibits angiogenesis in endothelial cells. Conclusions In summary, the data presented here indicate that forced expression of RARRES1 in PCa cells (a) induces ER stress and autophagic response; (b) increases SIRT1 levels; and (c) higher levels of anti-oxidant enzymes. Our study also implicates the role of RARRES1 as a novel anti-angiogenic molecule. Overall this study reports the molecular players that RARRES1 modulates to serve as a tumor suppressor molecule. Future studies will help determine the in vivo mechanisms by which RARRES1 may serve as a target for therapeutic intervention both in cancer and in angiogenesis-related disorders.	[Roy, Arpita; Ramalinga, Malathi; Kim, Okjin J.; Chijioke, Juliet; Lynch, Solomon; Kumar, Deepak] Univ Dist Columbia, Canc Res Lab, Washington, DC 20008 USA; [Byers, Stephen; Kumar, Deepak] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Kumar, Deepak] North Carolina Cent Univ, JLC BBRI Nutr Res Lab, Kannapolis, NC 28081 USA; [Kumar, Deepak] North Carolina Cent Univ, Julius L Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA	University of the District of Columbia; Georgetown University; University of North Carolina; North Carolina Central University; University of North Carolina; North Carolina Central University	Kumar, D (corresponding author), Univ Dist Columbia, Canc Res Lab, Washington, DC 20008 USA.; Kumar, D (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA.; Kumar, D (corresponding author), North Carolina Cent Univ, JLC BBRI Nutr Res Lab, Kannapolis, NC 28081 USA.; Kumar, D (corresponding author), North Carolina Cent Univ, Julius L Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA.	dkumar@nccu.edu			Synergistic Idea Award [W81XWH-12-1-0425]; Department of Defense Prostate Cancer Research Program; National Cancer Institute's [CA141935, CA194730, CA162264]; NATIONAL CANCER INSTITUTE [R21CA162264, U01CA194730] Funding Source: NIH RePORTER	Synergistic Idea Award; Department of Defense Prostate Cancer Research Program(United States Department of Defense); National Cancer Institute's(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by Synergistic Idea Award (W81XWH-12-1-0425) to DK and SB from the Department of Defense Prostate Cancer Research Program. Financial support by National Cancer Institute's grants CA141935, CA194730 and CA162264 is also gratefully acknowledged. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Corcelle E, 2007, AUTOPHAGY, V3, P57, DOI 10.4161/auto.3424; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Daitoku H, 2011, BBA-MOL CELL RES, V1813, P1954, DOI 10.1016/j.bbamcr.2011.03.001; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dieterich S, 2000, CIRCULATION, V101, P33, DOI 10.1161/01.CIR.101.1.33; Ellinger J, 2008, UROLOGY, V71, P161, DOI 10.1016/j.urology.2007.09.056; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Glorieux C, 2011, BIOCHEM PHARMACOL, V82, P1384, DOI 10.1016/j.bcp.2011.06.007; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Keil E, 2013, CELL DEATH DIFFER, V20, P321, DOI 10.1038/cdd.2012.129; Khodayari S, 2013, J GASTROEN HEPATOL, V28, P819, DOI 10.1111/jgh.12141; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim SH, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/904142; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kwong J, 2005, INT J CANCER, V113, P386, DOI 10.1002/ijc.20593; Leonhardt H, 2000, J CELL BIOCHEM, P78; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mizuiri H, 2005, CANCER SCI, V96, P571, DOI 10.1111/j.1349-7006.2005.00082.x; Nagpal S, 1996, J INVEST DERMATOL, V106, P269, DOI 10.1111/1523-1747.ep12340668; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Ou X, 2014, STEM CELLS, V32, P1183, DOI 10.1002/stem.1641; Peng LR, 2011, MOL CELL BIOL, V31, P4720, DOI 10.1128/MCB.06147-11; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rodriguez-Berriguete Gonzalo, 2012, J Signal Transduct, V2012, P169170, DOI 10.1155/2012/169170; Roudier E, 2013, ANGIOGENESIS, V16, P759, DOI 10.1007/s10456-013-9353-x; Sahab ZJ, 2011, CANCER RES, V71, P1219, DOI 10.1158/0008-5472.CAN-10-2294; Shah MH, 2015, BREAST CANC RES TREA; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Singh K, 2012, AUTOPHAGY, V8, P236, DOI 10.4161/auto.8.2.18600; Su ZY, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0321-5; Takai N, 2005, MOL CANCER RES, V3, P261, DOI 10.1158/1541-7786.MCR-04-0110; Wang F, 2015, DRUG DES DEV THER, V9, P575, DOI 10.2147/DDDT.S75221; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wu JC, 2013, CELL RES, V23, P691, DOI 10.1038/cr.2013.36; Wu YY, 2015, METHODS MOL BIOL, V1238, P425, DOI 10.1007/978-1-4939-1804-1_23; Yanatatsaneejit P, 2008, ORAL ONCOL, V44, P400, DOI 10.1016/j.oraloncology.2007.05.008; Yang Hui, 2015, Critical Reviews in Oncogenesis, V20, P49; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Zhang X, 2011, CURR DRUG TARGETS, V12, P1267, DOI 10.2174/138945011796150325; Zhi Xiaoyong, 2015, F1000Prime Rep, V7, P18, DOI 10.12703/P7-18	48	12	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180344	10.1371/journal.pone.0180344	http://dx.doi.org/10.1371/journal.pone.0180344			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678839	Green Published, gold, Green Submitted			2022-12-26	WOS:000405272200057
J	Seawright, JW; Samman, Y; Sridharan, V; Mao, XW; Cao, MH; Singh, P; Meinyk, S; Koturbash, I; Nelson, GA; Hauer-Jensen, M; Boerma, M				Seawright, John W.; Samman, Yusra; Sridharan, Vijayalakshmi; Mao, Xiao Wen; Cao, Maohua; Singh, Preeti; Meinyk, Stepan; Koturbash, Igor; Nelson, Gregory A.; Hauer-Jensen, Martin; Boerma, Marjan			Effects of low-dose rate gamma-irradiation combined with simulated microgravity on markers of oxidative stress, DNA methylation potential, and remodeling in the mouse heart	PLOS ONE			English	Article							RADIATION-INDUCED CHANGES; LONG-TERM SURVIVORS; CARDIAC-FUNCTION; SPACE-FLIGHT; BREAST-CANCER; CARDIOVASCULAR-DISEASE; IONIZING-RADIATION; HUMAN-LYMPHOCYTES; MORTALITY; DAMAGE	Purpose Space travel is associated with an exposure to low-dose rate ionizing radiation and the microgravity environment, both of which may lead to impairments in cardiac function. We used a mouse model to determine short-and long-term cardiac effects to simulated microgravity (hindlimb unloading; HU), continuous low-dose rate.-irradiation, or a combination of HU and low-dose rate.-irradiation. Methods Cardiac tissue was obtained from female, C57BL/6J mice 7 days, 1 month, 4 months, and 9 months following the completion of a 21 day exposure to HU or a 21 day exposure to low-dose rate.-irradiation (average dose rate of 0.01 cGy/h to a total of 0.04 Gy), or a 21 day simultaneous exposure to HU and low-dose rate.-irradiation. Immunoblot analysis, rt-PCR, high-performance liquid chromatography, and histology were used to assess inflammatory cell infiltration, cardiac remodeling, oxidative stress, and the methylation potential of cardiac tissue in 3 to 6 animals per group. Results The combination of HU and.-irradiation demonstrated the strongest increase in reduced to oxidized glutathione ratios 7 days and 1 month after treatment, but a difference was no longer apparent after 9 months. On the other hand, no significant changes in 4-hydroxynonenal adducts was seen in any of the groups, at the measured endpoints. While manganese superoxide dismutase protein levels decreased 9 months after low-dose.-radiation, no changes were observed in expression of catalase or Nrf2, a transcription factor that determines the expression of several antioxidant enzymes, at the measured endpoints. Inflammatory marker, CD-2 protein content was significantly decreased in all groups 4 months after treatment. No significant differences were observed in alpha-smooth muscle cell actin protein content, collagen type III protein content or% total collagen. Conclusions This study has provided the first and relatively broad analysis of small molecule and protein markers of oxidative stress, T-lymphocyte infiltration, and cardiac remodeling in response to HU with simultaneous exposure to low-dose rate gamma-radiation. Results from the late observation time points suggest that the hearts had mostly recovered from these two experimental conditions. However, further research is needed with larger numbers of animals for a more robust statistical power to fully characterize the early and late effects of simulated micro-gravity combined with exposure to low-dose rate ionizing radiation on the heart.	[Seawright, John W.; Samman, Yusra; Sridharan, Vijayalakshmi; Cao, Maohua; Singh, Preeti; Hauer-Jensen, Martin; Boerma, Marjan] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Little Rock, AR 72205 USA; [Mao, Xiao Wen; Nelson, Gregory A.] Loma Linda Univ, Dept Basic Sci & Radiat Med, Loma Linda, CA 92350 USA; [Meinyk, Stepan] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Koturbash, Igor] Univ Arkansas Med Sci, Dept Environm & Occupat Hlth, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; Loma Linda University; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Seawright, JW (corresponding author), Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Little Rock, AR 72205 USA.	JWSeawright@uams.edu		Singh, Preeti/0000-0003-3481-2771	National Space Biomedical Research Institute [RE03701, NCC9-58]; National Aeronautics and Space Administration (NAS Agrantnumber) [NNX13AL97G]; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20 GM109005]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109005] Funding Source: NIH RePORTER	National Space Biomedical Research Institute; National Aeronautics and Space Administration (NAS Agrantnumber); Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Space Biomedical Research Institute (www.nsbri. org) (RE03701) through NCC9-58, the National Aeronautics and Space Administration (www.nasa. gov) (NAS Agrantnumber NNX13AL97G), and through an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (www. nigms.nih.gov) under grant number P20 GM109005.The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript.	Adams MJ, 2003, CRIT REV ONCOL HEMAT, V45, P55, DOI 10.1016/S1040-8428(01)00227-X; Anker SD, 2004, HEART, V90, P464, DOI 10.1136/hrt.2002.007005; Azimzadeh O, 2017, ONCOTARGET, V8, P9067, DOI 10.18632/oncotarget.10424; Barger LK, 1995, RES SPORTS MED INT J, V5, P293, DOI DOI 10.1080/15438629509512026; Barjaktarovic Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027811; Bellone JA, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.19; Boerma M, 2005, CANCER RES, V65, P3100, DOI 10.1158/0008-5472.CAN-04-4333; Boerma M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070479; Casciati A, 2016, ONCOTARGET, V7, P28040, DOI 10.18632/oncotarget.8575; Chancellor Jeffery C., 2014, Life-Basel, V4, P491, DOI 10.3390/life4030491; Chowdhury B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147514; Chowdhury P, 2008, OPEN CLIN CHEM J, V1, P47, DOI DOI 10.2174/1874241600801010047; Constine LS, 1997, INT J RADIAT ONCOL, V39, P897, DOI 10.1016/S0360-3016(97)00467-7; CUZICK J, 1994, J CLIN ONCOL, V12, P447, DOI 10.1200/JCO.1994.12.3.447; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Darby SC, 2005, LANCET ONCOL, V6, P557, DOI 10.1016/S1470-2045(05)70251-5; De Luca C, 2009, TOXICOL IND HEALTH, V25, P259, DOI 10.1177/0748233709103032; FINKELSTEIN JD, 1984, J BIOL CHEM, V259, P9508; Gridley DS, 2008, RADIAT RES, V169, P280, DOI 10.1667/RR1155.1; Gridley DS, 2010, TECHNOL CANCER RES T, V9, P637, DOI 10.1177/153303461000900612; Gridley DS, 2009, J RADIAT RES, V50, P139, DOI 10.1269/jrr.08095; Haas J, 2013, EMBO MOL MED, V5, P413, DOI 10.1002/emmm.201201553; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, V6th; Heidenreich PA, 2005, AM HEART J, V150, P977, DOI 10.1016/j.ahj.2004.12.026; Hollander J, 1998, FREE RADICAL BIO MED, V24, P385, DOI 10.1016/S0891-5849(97)00278-5; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kang JH, 2001, LAB INVEST, V81, P573, DOI 10.1038/labinvest.3780266; Kempf SJ, 2016, ONCOTARGET, V7, P71817, DOI 10.18632/oncotarget.12376; Kimzey SL, 1975, TECHNICAL REPORT; KONSTANTINOVA IV, 1993, J LEUKOCYTE BIOL, V54, P189, DOI 10.1002/jlb.54.3.189; Koturbash I, 2016, MUTAT RES-FUND MOL M, V787, P43, DOI 10.1016/j.mrfmmm.2016.02.009; Kumari R, 2009, J CELL BIOCHEM, V107, P723, DOI 10.1002/jcb.22171; Lawler JM, 2003, FREE RADICAL BIO MED, V35, P9, DOI 10.1016/S0891-5849(03)00186-2; Lee DH, 2009, ENVIRON HEALTH PERSP, P1799; Little MP, 2012, ENVIRON HEALTH PERSP, V120, P1503, DOI 10.1289/ehp.1204982; Loenen WAM, 2006, BIOCHEM SOC T, V34, P330, DOI 10.1042/BST0340330; Mansour HH, 2012, EUR J PHARMACOL, V692, P46, DOI 10.1016/j.ejphar.2012.06.037; Mao XW, 2016, RADIAT RES, V185, P647, DOI 10.1667/RR14267.1; Melnyk S, 1999, J NUTR BIOCHEM, V10, P490, DOI 10.1016/S0955-2863(99)00033-9; Morey-Holton E, 2005, ADV SPACE B, V10, P7, DOI 10.1016/S1569-2574(05)10002-1; Musacchia XJ, 1984, PHYSIOLOGIST S, V28, pS237; O'Leary VB, 2015, CELL REP, V11, P474, DOI 10.1016/j.celrep.2015.03.043; Paneni F, 2013, ATHEROSCLEROSIS, V230, P191, DOI 10.1016/j.atherosclerosis.2013.07.003; Patties I, 2015, STRAHLENTHER ONKOL, V191, P172, DOI 10.1007/s00066-014-0745-7; Pockley AG, 2002, CIRCULATION, V105, P1012, DOI 10.1161/hc0802.103729; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Qin FZ, 2003, AM J PHYSIOL-HEART C, V285, pH822, DOI 10.1152/ajpheart.00015.2003; Ramadan SS, 2016, LIFE SCI SPACE RES, V8, P8, DOI 10.1016/j.lssr.2015.12.001; Rizzo AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032361; Sanzari JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071757; Seemann I, 2012, RADIOTHER ONCOL, V103, P143, DOI 10.1016/j.radonc.2011.10.011; Simonetto C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096309; Singh KP, 2010, J CELL BIOCHEM, V111, P123, DOI 10.1002/jcb.22674; Sonnenfeld G, 1998, INT J SPORTS MED, V19, pS195, DOI 10.1055/s-2007-971992; Soucy KG, 2007, RADIAT ENVIRON BIOPH, V46, P179, DOI 10.1007/s00411-006-0090-z; Spitz DR, 2004, CANCER METAST REV, V23, P311, DOI 10.1023/B:CANC.0000031769.14728.bc; Sridharan V, 2015, RADIAT RES, V183, P357, DOI 10.1667/RR13915.1; Sridharan V, 2014, RADIAT RES, V181, P324, DOI 10.1667/RR13452.1; Sridharan V, 2014, INT J RADIAT ONCOL, V88, P167, DOI 10.1016/j.ijrobp.2013.10.014; Subramanian V, 2017, J PROTEOME RES, V16, P307, DOI 10.1021/acs.jproteome.6b00795; TAYLOR GR, 1992, J LEUKOCYTE BIOL, V51, P129, DOI 10.1002/jlb.51.2.129; Tipton CM, 1996, MED SCI SPORT EXER, V28, P988, DOI 10.1097/00005768-199608000-00009; Vitvitsky V, 2003, REDOX REP, V8, P57, DOI 10.1179/135100003125001260; Westby CM, 2016, J APPL PHYSIOL, V120, P956, DOI 10.1152/japplphysiol.00676.2015; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3; Zimmermann O, 2009, BASIC RES CARDIOL, V104, P591, DOI 10.1007/s00395-009-0026-2	66	16	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180594	10.1371/journal.pone.0180594	http://dx.doi.org/10.1371/journal.pone.0180594			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678877	Green Submitted, gold, Green Published			2022-12-26	WOS:000405272200074
J	Weiss, J; Maurer, M; Ketelsen, D; Notohamiprodjo, M; Zinsser, D; Wichmann, JL; Nikolaou, K; Bamberg, F; Othman, AE				Weiss, Jakob; Maurer, Michael; Ketelsen, Dominik; Notohamiprodjo, Mike; Zinsser, Dominik; Wichmann, Julian L.; Nikolaou, Konstantin; Bamberg, Fabian; Othman, Ahmed E.			Effect of reduced z-axis scan coverage on diagnostic performance and radiation dose of neck computed tomography in patients with suspected cervical abscess	PLOS ONE			English	Article							ITERATIVE RECONSTRUCTION; PERITONSILLAR ABSCESS; IMAGE QUALITY; CT; REDUCTION; RISK; HEAD; AGE	Purpose To evaluate the effect of reduced z-axis scan coverage on diagnostic performance and radiation dose of neck CT in patients with suspected cervical abscess. Methods Fifty-one patients with suspected cervical abscess were included and underwent contrast-enhanced neck CT on a 2nd or 3rd generation dual-source CT system. Image acquisition ranged from the aortic arch to the upper roof of the frontal sinuses (CTstd). Subsequently, series with reduced z-axis coverage (CTred) were reconstructed starting at the aortic arch up to the orbital floor. CTstd and CTred were independently assessed by two radiologists for the presence/absence of cervical abscesses and for incidental and alternative findings. In addition, diagnostic accuracy for the depiction of the cervical abscesses was calculated for both readers. Furthermore, DLP (dose-length-product), effective dose (ED) and organ doses were calculated and compared for CTred and CTstd, using a commercially available dose management platform. Results A total of 41 abscesses and 3 incidental/alternative findings were identified in CTstd. All abscesses and incidental/alternative findings could also be detected on CTred resulting in a sensitivity and specificity of 1.0 for both readers. DLP, ED and organ doses of the brain, the eye lenses, the red bone marrow and the salivary glands of CTred were significantly lower than for CTstd (p<0.001). Conclusions Reducing z-axis coverage of neck CT allows for a significant reduction of effective dose and organ doses at similar diagnostic performance as compared to CTstd.	[Weiss, Jakob; Maurer, Michael; Ketelsen, Dominik; Notohamiprodjo, Mike; Zinsser, Dominik; Nikolaou, Konstantin; Bamberg, Fabian; Othman, Ahmed E.] Eberhard Karls Univ Tuebingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Wichmann, Julian L.] Univ Hosp Frankfurt, Dept Diagnost & Intervent Radiol, Frankfurt, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Notohamiprodjo, M (corresponding author), Eberhard Karls Univ Tuebingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany.	Mike.Notohamiprodjo@uni.tuebingen..de	Ketelsen, Dominik/A-1143-2012	Ketelsen, Dominik/0000-0002-7333-8024; Othman, Ahmed/0000-0002-3827-8695; othman, ahmed mohamed abdel ghany/0000-0002-0405-8918	Siemens Healthineers	Siemens Healthineers	This study was funded by an unrestricted research grant from Siemens Healthineers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bovo R, 2016, EUR ARCH OTO-RHINO-L, V273, P225, DOI 10.1007/s00405-014-3454-z; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Brito TP, 2016, BRAZ J OTORHINOLARYN; Campbell J, 2005, AM J ROENTGENOL, V185, P1525, DOI 10.2214/AJR.04.1512; Celakovsky P, 2014, EUR ARCH OTO-RHINO-L, V271, P1679, DOI 10.1007/s00405-013-2651-5; Christner JA, 2012, RADIOLOGY, V265, P841, DOI 10.1148/radiol.12112365; Christner JA, 2010, AM J ROENTGENOL, V194, P881, DOI 10.2214/AJR.09.3462; Corwin MT, 2015, ABDOM IMAGING, V40, P1177, DOI 10.1007/s00261-014-0280-0; Corwin MT, 2014, J COMPUT ASSIST TOMO, V38, P404, DOI 10.1097/RCT.0b013e3182ab5f35; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Deak PD, 2010, RADIOLOGY, V257, P158, DOI 10.1148/radiol.10100047; Gaddikeri S, 2015, AM J NEURORADIOL, V36, P391, DOI 10.3174/ajnr.A4123; Kallen JA, 2010, EMERG RADIOL, V17, P31, DOI 10.1007/s10140-009-0818-6; Kalra MK, 2004, RADIOLOGY, V233, P649, DOI 10.1148/radiol.2333031150; Kalra MK, 2004, RADIOLOGY, V232, P409, DOI 10.1148/radiol.2322031151; Lepelletier D, 2016, EUR J CLIN MICROBIOL, V35, P867, DOI 10.1007/s10096-016-2609-9; Lin YY, 2012, EUR ARCH OTO-RHINO-L, V269, P585, DOI 10.1007/s00405-011-1622-y; Mayo-Smith WW, 2014, RADIOLOGY, V273, P657, DOI 10.1148/radiol.14132328; McCollough CH, 2011, RADIOLOGY, V259, P311, DOI 10.1148/radiol.11101800; Mukherj SK, 2014, ACR ASNR SPR PRACTIC; Risberg S, 2008, SCAND J INFECT DIS, V40, P792, DOI 10.1080/00365540802195226; Samei E, 2014, PEDIATR RADIOL, V44, P460, DOI 10.1007/s00247-014-3117-7; Schlattl H, 2010, PHYS MED BIOL, V55, P6243, DOI 10.1088/0031-9155/55/20/013; Scholtz JE, 2015, CLIN RADIOL, V70, pE67, DOI 10.1016/j.crad.2015.04.009; Scholtz JE, 2015, EUR RADIOL; Sinclair L, 2015, RADIOLOGY, V277, P471, DOI 10.1148/radiol.2015140971; Vachha B, 2013, EUR J RADIOL, V82, P2222, DOI 10.1016/j.ejrad.2013.08.014; Wang B, 2014, ACTA RADIOL, V55, P945, DOI 10.1177/0284185113509093; Wippold FJ, 2007, J MAGN RESON IMAGING, V25, P453, DOI 10.1002/jmri.20838; Yuan MK, 2013, AM J ROENTGENOL, V201, P626, DOI 10.2214/AJR.12.9652	30	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180671	10.1371/journal.pone.0180671	http://dx.doi.org/10.1371/journal.pone.0180671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678820	Green Submitted, Green Published, gold			2022-12-26	WOS:000405272200084
J	Bray, TJP; Singh, S; Latifoltojar, A; Rajesparan, K; Rahman, F; Narayanan, P; Naaseri, S; Lopes, A; Bainbridge, A; Punwani, S; Hall-Craggs, MA				Bray, Timothy J. P.; Singh, Saurabh; Latifoltojar, Arash; Rajesparan, Kannan; Rahman, Farzana; Narayanan, Priya; Naaseri, Sahar; Lopes, Andre; Bainbridge, Alan; Punwani, Shonit; Hall-Craggs, Margaret A.			Diagnostic utility of whole body Dixon MRI in multiple myeloma: A multi-reader study	PLOS ONE			English	Article							BONE-MARROW; WORKING GROUP; PROGNOSTIC-SIGNIFICANCE; IMAGING TECHNIQUES; QUANTIFICATION; GUIDELINES; MANAGEMENT; CONSENSUS; CRITERIA; TESLA	Objective To determine which of four Dixon image types [in-phase (IP), out-of-phase (OP), fat only (FO) and water-only (WO)] is most sensitive for detecting multiple myeloma (MM) focal lesions on whole body MRI (WB-MRI) images. MethodsThirty patients with clinically-suspected MM underwent WB-MRI at 3 Tesla. Unenhanced IP, OP, FO and WO Dixon images were generated and read by four radiologists. On each image type, each radiologist identified and labelled all visible myeloma lesions in the bony pelvis. Each identified lesion was compared with a reference standard consisting of pre- and post-contrast Dixon and diffusion weighted imaging (read by a further consultant radiologist) to determine whether the lesion was truly positive. Lesion count, true positives, sensitivity, and positive predictive value were compared across the four Dixon image types. Results Lesion count, true positives, sensitivity and confidence scores were all significantly higher on FO images than on IP images (p>0.05). Discussion FO images are more sensitive than other Dixon image types for MM focal lesions, and should be preferentially read by radiologists to improve diagnostic accuracy and reporting efficiency.	[Bray, Timothy J. P.; Singh, Saurabh; Latifoltojar, Arash; Rajesparan, Kannan; Rahman, Farzana; Narayanan, Priya; Naaseri, Sahar; Punwani, Shonit; Hall-Craggs, Margaret A.] UCL, Ctr Med Imaging, London, England; [Lopes, Andre] Canc Res UK & UCL Clin Trials Ctr, London, England; [Bainbridge, Alan] Univ Coll London Hosp, Dept Med Phys, London, England	University of London; University College London; Cancer Research UK; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Bray, TJP (corresponding author), UCL, Ctr Med Imaging, London, England.	t.bray@ucl.ac.uk		Lopes, Andre/0000-0002-1405-7337; Bray, Timothy/0000-0001-8886-5356	Department of Health's the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) funding scheme; NIHR University College London Hospitals BRC; Arthritis Research UK Grant [21369]; CRUK/EPSRC KCL/ UCL Comprehensive Cancer Imaging Centre; Cancer Research UK [15953] Funding Source: researchfish; National Institute for Health Research [CL-2007-18-015] Funding Source: researchfish	Department of Health's the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) funding scheme; NIHR University College London Hospitals BRC; Arthritis Research UK Grant(Versus Arthritis); CRUK/EPSRC KCL/ UCL Comprehensive Cancer Imaging Centre; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was under taken at UCLH/UCL, which receives funding from the Department of Health's the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) funding scheme. The views expressed in this publication are those of the authors and not necessarily those of the UK Department of Health. MHC, SP, TJPB and ALa are supported by the NIHR University College London Hospitals BRC. TJPB is also supported by Arthritis Research UK Grant 21369. This work was supported by CRUK/EPSRC KCL/ UCL Comprehensive Cancer Imaging Centre.	[Anonymous], 2016, EXCELLENCE NI H C MY; Bird JM, 2011, BRIT J HAEMATOL, V154, P32, DOI 10.1111/j.1365-2141.2011.08573.x; Costelloe CM, 2013, MAGN RESON IMAGING, V31, P669, DOI 10.1016/j.mri.2012.10.017; Dimopoulos M, 2009, LEUKEMIA, V23, P1545, DOI 10.1038/leu.2009.89; Dimopoulos M, 2011, INT MYELOMA WORKSHOP, V3, P4701, DOI DOI 10.1182/BL00D-2010-10-299529; DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263; DOnofrio G, 2015, MORPHOLOGY OF BLOOD DISORDERS, 2ND EDITION, P1; Durie Brian G M, 2003, Hematol J, V4, P379; Eggers H, DUAL ECHO DIXON IMAG; Giles SL, 2014, RADIOLOGY, V271, P785, DOI 10.1148/radiol.13131529; Hillengass J, 2014, LEUKEMIA, V28, P174, DOI 10.1038/leu.2013.244; Karampinos DC, 2014, MAGN RESON MED, V71, P1158, DOI 10.1002/mrm.24775; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Lecouvet FE, 1998, RADIOLOGY, V209, P653, DOI 10.1148/radiology.209.3.9844655; Lecouvet FE, 2016, RADIOLOGY, V279, P345, DOI 10.1148/radiol.2016142084; Li XJ, 2011, J MAGN RESON IMAGING, V33, P974, DOI 10.1002/jmri.22489; Liney GP, 2007, J MAGN RESON IMAGING, V26, P787, DOI 10.1002/jmri.21072; Messiou C, 2011, EUR RADIOL, V21, P1713, DOI 10.1007/s00330-011-2116-4; Moulopoulos LA, 2005, ANN ONCOL, V16, P1824, DOI 10.1093/annonc/mdi362; Rajkumar SV, 2014, LANCET ONCOL, V15, pE538, DOI 10.1016/S1470-2045(14)70442-5; Smith D, 2015, BRIT J HAEMATOL, V171, P881, DOI 10.1111/bjh.13446; Sonneveld P, 2016, BLOOD, V127, P2955, DOI 10.1182/blood-2016-01-631200; Takasu M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116842; Takasu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085931; Takasu M, 2012, EUR RADIOL, V22, P1114, DOI 10.1007/s00330-011-2351-8; Walker R, 2007, J CLIN ONCOL, V25, P1121, DOI 10.1200/JCO.2006.08.5803; Weckbach S, 2010, EUR RADIOL, V20, P2907, DOI 10.1007/s00330-010-1865-9; Zamagni E, 2012, BRIT J HAEMATOL, V159, P499, DOI 10.1111/bjh.12007	28	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180562	10.1371/journal.pone.0180562	http://dx.doi.org/10.1371/journal.pone.0180562			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672007	Green Published, gold, Green Submitted			2022-12-26	WOS:000405268500067
J	Wang, Q; Pronin, AN; Levay, K; Almaca, J; Fornoni, A; Caicedo, A; Slepak, VZ				Wang, Qiang; Pronin, Alexey N.; Levay, Konstantin; Almaca, Joana; Fornoni, Alessia; Caicedo, Alejandro; Slepak, Vladlen Z.			Regulator of G-protein signaling G beta 5-R7 is a crucial activator of muscarinic M3 receptor-stimulated insulin secretion	FASEB JOURNAL			English	Article						islet of Langerhans; pupil sphincter; CRISPR-Cas9; UBO-QIC; fluorescent biosensor	PANCREATIC BETA-CELL; RGS PROTEINS; COUPLED RECEPTORS; SUBUNIT G-BETA-5; IN-VITRO; COMPLEX; DOMAIN; RELEASE; BINDING; PHOSPHORYLATION	In pancreatic beta cells, muscarinic cholinergic receptor M3 (M3R) stimulates glucose-induced secretion of insulin. Regulator of G-protein signaling (RGS) proteins are critical modulators of GPCR activity, yet their role in cells remains largely unknown. R7 subfamily RGS proteins are stabilized by the G-protein subunit G beta 5, such that the knockout of the Gnb5 gene results in degradation of all R7 subunits. We found that Gnb5 knockout in mice or in the insulin-secreting MIN6 cell line almost completely eliminates insulinotropic activity of M3R. Moreover, overexpression of G beta 5-RGS7 strongly promotes M3R-stimulated insulin secretion. Examination of this noncanonical mechanism in Gnb5(-/-) MIN6 cells showed that cAMP, diacylglycerol, or Ca2+ levels were not significantly affected. There was no reduction in the amplitude of free Ca2+ responses in islets from the Gnb5(-/-) mice, but the frequency of Ca2+ oscillations induced by cholinergic agonist was lowered by more than 30%. Ablation of Gnb5 impaired M3R-stimulated phosphorylation of ERK1/2. Stimulation of the ERK pathway in Gnb5(-/-) cells by epidermal growth factor restored M3R-stimulated insulin release to near normal levels. Identification of the novel role of G beta 5-R7 in insulin secretion may lead to a new therapeutic approach for improving pancreatic beta-cell function.	[Wang, Qiang; Pronin, Alexey N.; Levay, Konstantin; Slepak, Vladlen Z.] Univ Miami, Leonard M Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Almaca, Joana; Fornoni, Alessia; Caicedo, Alejandro] Univ Miami, Leonard M Miller Sch Med, Dept Med, Miami, FL 33136 USA	University of Miami; University of Miami	Slepak, VZ (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Rosenstiel Med Sci Bldg 6130, Miami, FL 33136 USA.	vslepak@med.miami.edu	Caicedo, Alejandro/AAC-8544-2020	fornoni, Alessia/0000-0002-1313-7773	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R01DK105427, R01DK0090316, R01DK104753, R01DK111538]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111538, R01DK090316, R01DK104753, R01DK105427, K01DK111757, R01DK113093, R56DK084321] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Jongmin Jeon and Junior Tayou (Leonard M. Miller School of Medicine, University of Miami) for sharing technical expertise. This work was supported by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grants R01DK105427 (to V.Z.S.), R01DK0090316 and R01DK104753 (to A.F.), and R01DK111538 (to A.C.). The authors declare no conflicts of interest.	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Ahren B, 2009, NAT REV DRUG DISCOV, V8, P369, DOI 10.1038/nrd2782; Alejandro EU, 2011, FASEB J, V25, P3884, DOI 10.1096/fj.10-180349; Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; de Azua IR, 2012, LIFE SCI, V91, P986, DOI 10.1016/j.lfs.2012.04.010; de Azua IR, 2012, FASEB J, V26, P4275, DOI 10.1096/fj.12-204644; de Azua IR, 2010, P NATL ACAD SCI USA, V107, P7999, DOI 10.1073/pnas.1003655107; Fridlyand LE, 2007, AM J PHYSIOL-CELL PH, V293, pC1924, DOI 10.1152/ajpcell.00555.2006; Gautam D, 2006, CELL METAB, V4, P363, DOI 10.1016/j.cmet.2006.09.008; Gerber KJ, 2016, MOL PHARMACOL, V89, P273, DOI 10.1124/mol.115.102210; Gylfe E, 2014, DIABETES OBES METAB, V16, P102, DOI 10.1111/dom.12345; Hooks SB, 2003, J BIOL CHEM, V278, P10087, DOI 10.1074/jbc.M211382200; Hooks SB, 2008, BIOCHEM PHARMACOL, V75, P76, DOI 10.1016/j.bcp.2007.07.045; Hunt RA, 2003, BIOCHEM BIOPH RES CO, V303, P594, DOI 10.1016/S0006-291X(03)00400-5; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Jain S, 2013, J CLIN INVEST, V123, P1750, DOI 10.1172/JCI66432; Karpinsky-Semper D, 2015, BIOCHEMISTRY-US, V54, P1077, DOI 10.1021/bi500980d; Karpinsky-Semper D, 2014, MOL PHARMACOL, V85, P758, DOI 10.1124/mol.114.091843; KATADA T, 1984, J BIOL CHEM, V259, P3568; Kimple ME, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.40; Kong Kok Choi, 2011, Commun Integr Biol, V4, P489, DOI 10.4161/cib.4.4.15716; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Leitner MG, 2016, BRIT J PHARMACOL, V173, P2555, DOI 10.1111/bph.13538; Levay K, 1999, P NATL ACAD SCI USA, V96, P2503, DOI 10.1073/pnas.96.5.2503; Malmersjo S, 2016, EMBO J, V35, P1810, DOI 10.15252/embj.201694071; Moran BM, 2016, ACTA DIABETOL, V53, P177, DOI 10.1007/s00592-015-0826-9; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; Osei-Owusu P, 2015, PROG MOL BIOL TRANSL, V133, P77, DOI 10.1016/bs.pmbts.2015.02.001; Posokhova E, 2010, CIRC RES, V107, P1350, DOI 10.1161/CIRCRESAHA.110.224212; Pronin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096435; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sandiford SL, 2009, BIOCHEMISTRY-US, V48, P2282, DOI 10.1021/bi801989c; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Selway J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033004; Selway JL, 2012, ACTA DIABETOL, V49, P277, DOI 10.1007/s00592-011-0314-9; Shu YL, 2008, J NEUROSCI, V28, P21, DOI 10.1523/JNEUROSCI.2352-07.2008; Slepak VZ, 2009, PROG MOL BIOL TRANSL, V86, P157, DOI 10.1016/S1877-1173(09)86006-7; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Tengholm A, 2009, MOL CELL ENDOCRINOL, V297, P58, DOI 10.1016/j.mce.2008.07.009; Tewson PH, 2016, J BIOMOL SCREEN, V21, P298, DOI 10.1177/1087057115618608; Villasenor A, 2010, DIS MODEL MECH, V3, P567, DOI 10.1242/dmm.003210; Wang Q, 2011, FASEB J, V25, P3949, DOI 10.1096/fj.11-190157; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; Xie KQ, 2012, PSYCHOPHARMACOLOGY, V219, P823, DOI 10.1007/s00213-011-2409-y; Xie ZH, 2016, AAPS J, V18, P294, DOI 10.1208/s12248-015-9847-0; Yang JQ, 2010, CIRC RES, V107, P1345, DOI 10.1161/CIRCRESAHA.110.224220; Zaima K, 2013, J NAT MED-TOKYO, V67, P196, DOI 10.1007/s11418-012-0644-0	48	12	12	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4734	4744		10.1096/fj.201700197RR	http://dx.doi.org/10.1096/fj.201700197RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28687610	Green Published			2022-12-26	WOS:000413398500007
J	Yuan, LS; Mao, Y; Mao, Y; Luo, W; Wu, WW; Xu, H; Wang, XL; Shen, YH				Yuan, Liangshuai; Mao, Yun; Mao, Yun; Luo, Wei; Wu, Weiwei; Xu, Hao; Wang, Xing Li; Shen, Ying H.			Palmitic acid dysregulates the Hippo-YAP pathway and inhibits angiogenesis by inducing mitochondrial damage and activating the cytosolic DNA sensor cGAS-STING-IRF3 signaling mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGAN SIZE CONTROL; CYCLIC GMP-AMP; DIABETIC FOOT; I INTERFERON; REGENERATION; DISEASE; DYSFUNCTION; MEMBRANE; PROTEIN; CELLS	Impaired angiogenesis and wound healing carry significant morbidity and mortality in diabetic patients. Metabolic stress from hyperglycemia and elevated free fatty acids have been shown to inhibit endothelial angiogenesis. However, the underlying mechanisms remain poorly understood. In this study, we show that dysregulation of the Hippo-Yes-associated protein (YAP) pathway, an important signaling mechanism in regulating tissue repair and regeneration, underlies palmitic acid (PA)induced inhibition of endothelial angiogenesis. PA inhibited endothelial cell proliferation, migration, and tube formation, which were associated with increased expression of mammalian Ste20-like kinases 1 (MST1), YAP phosphorylation/ inactivation, and nuclear exclusion. Overexpression of YAP or knockdown of MST1 prevented PA-induced inhibition of angiogenesis. When searching upstream signaling mechanisms, we found that PA dysregulated the Hippo-YAP pathway by inducing mitochondrial damage. PA treatment induced mitochondrial DNA (mtDNA) release to cytosol, and activated cytosolic DNA sensor cGAS-STING-IRF3 signaling. Activated IRF3 bound to the MST1 gene promoter and induced MST1 expression, leading to MST1 up-regulation, YAP inactivation, and angiogenesis inhibition. Thus, mitochondrial damage and cytosolic DNA sensor cGAS-STING-IRF3 signaling are critically involved in PA-induced Hippo-YAP dysregulation and angiogenesis suppression. This mechanism may have implication in impairment of angiogenesis and wound healing in diabetes.	[Yuan, Liangshuai; Mao, Yun; Mao, Yun; Luo, Wei; Wu, Weiwei; Xu, Hao; Wang, Xing Li] Shandong Univ, Qilu Hosp, Res Ctr Cell Therapy, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250012, Shandong, Peoples R China; [Mao, Yun; Mao, Yun; Wang, Xing Li; Shen, Ying H.] Shandong Univ, Qilu Hosp, Jinan 250012, Shandong, Peoples R China; [Mao, Yun; Mao, Yun; Wang, Xing Li; Shen, Ying H.] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA; [Mao, Yun; Mao, Yun; Wang, Xing Li; Shen, Ying H.] Texas Heart Inst, Dept Surg, Houston, TX 77030 USA	Shandong University; Shandong University; Baylor College of Medicine; Texas Heart Institute	Wang, XL (corresponding author), Qilu Hosp, 107 Wenhua West Rd, Jinan 250012, Shandong, Peoples R China.; Shen, YH (corresponding author), Baylor Coll Med, BM390,One Baylor Plaza, Houston, TX 77030 USA.	xingliwang@sdu.edu.cn; hyshen@bcm.edu	shen, ying/HHS-5635-2022		973 National Basic Research Program of China [2014CB542401]; National Institutes of Health [1R01HL131980-01]; American Heart Association [15GRNT23040007]; Shandong University National Qianren Scholar Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL143359, R01HL131980] Funding Source: NIH RePORTER	973 National Basic Research Program of China(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Shandong University National Qianren Scholar Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by 973 National Basic Research Program of China Grant 2014CB542401 (to X.L.W.), National Institutes of Health Grant 1R01HL131980-01 (to Y.H.S.), American Heart Association Grant 15GRNT23040007 (to Y.H.S.), and the Shandong University National Qianren Scholar Fund (to X.L.W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Bowie A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002919; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Choi HJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7943; D'Souza DR, 2009, J BIOL CHEM, V284, P17947, DOI 10.1074/jbc.M109.002378; Dobler D, 2006, DIABETES, V55, P1961, DOI 10.2337/db05-1634; Dunn LL, 2014, DIABETES, V63, P675, DOI 10.2337/db13-0417; Elbediwy A, 2016, BIOESSAYS, V38, P644, DOI 10.1002/bies.201600037; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Fan R, 2013, P NATL ACAD SCI USA, V110, P2569, DOI 10.1073/pnas.1216462110; Geng J, 2015, NAT IMMUNOL, V16, P1142, DOI 10.1038/ni.3268; Green DR, 2014, SCIENCE, V345, P1466, DOI 10.1126/science.1250256; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; He L, 2017, MED ONCOL, V34, DOI 10.1007/s12032-016-0882-1; Hesselink MKC, 2016, NAT REV ENDOCRINOL, V12, P633, DOI 10.1038/nrendo.2016.104; Holm CK, 2012, NAT IMMUNOL, V13, P737, DOI 10.1038/ni.2350; Hong AW, 2016, NAT REV GASTRO HEPAT, V13, P324, DOI 10.1038/nrgastro.2016.59; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jeremiah N, 2014, J CLIN INVEST, V124, P5516, DOI 10.1172/JCI79100; Kluge MA, 2013, CIRC RES, V112, P1171, DOI 10.1161/CIRCRESAHA.111.300233; Kurz ARM, 2016, J CLIN INVEST, V126, P4125, DOI 10.1172/JCI87043; Larger E, 2004, DIABETES, V53, P752, DOI 10.2337/diabetes.53.3.752; Li XN, 2009, DIABETES, V58, P2246, DOI 10.2337/db08-1512; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Mao Y, 2017, ARTERIOSCL THROM VAS, V37, P920, DOI [10.1161/atvbaha.117.309017, 10.1161/ATVBAHA.117.309017]; Margolis DJ, 2011, DIABETES CARE, V34, P2363, DOI 10.2337/dc11-0807; Marti P, 2015, HEPATOLOGY, V62, P1497, DOI 10.1002/hep.27992; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Matsuda T, 2016, CIRC RES, V119, P596, DOI 10.1161/CIRCRESAHA.116.308586; Mehra VC, 2014, AM J PATHOL, V184, P1562, DOI 10.1016/j.ajpath.2014.01.009; Meng FS, 2016, GENE DEV, V30, P1086, DOI 10.1101/gad.277533.116; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Moya IM, 2016, CURR OPIN CELL BIOL, V43, P62, DOI 10.1016/j.ceb.2016.08.004; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pi XC, 2014, ARTERIOSCL THROM VAS, V34, P2023, DOI 10.1161/ATVBAHA.114.303733; Prantner D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.382986; Qi WW, 2015, DIABETES, V64, P1407, DOI 10.2337/db14-1111; Sawada N, 2014, CELL METAB, V19, P246, DOI 10.1016/j.cmet.2013.12.014; Schrauwen P, 2004, DIABETES, V53, P1412, DOI 10.2337/diabetes.53.6.1412; Singh A, 2016, CELL REP, V15, P1384, DOI 10.1016/j.celrep.2016.04.027; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Vessby B, 2003, CURR OPIN LIPIDOL, V14, P15, DOI 10.1097/00041433-200302000-00004; Vono R, 2016, DIABETES, V65, P3691, DOI 10.2337/db16-0248; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Wu JQ, 2017, STEM CELL RES, V21, P74, DOI 10.1016/j.scr.2017.04.001; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Wu W., 2015, EURASIP J WIREL COMM, V2015, P1, DOI DOI 10.1371/J0URNAL.P0NE.0132499; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; You FP, 2013, NAT IMMUNOL, V14, P1237, DOI 10.1038/ni.2756; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zhang J, 2015, ARTERIOSCL THROM VAS, V35, P163, DOI 10.1161/ATVBAHA.114.304705; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhou Q, 2015, CIRC RES, V116, P1431, DOI 10.1161/CIRCRESAHA.116.303311	60	60	66	6	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15002	15015		10.1074/jbc.M117.804005	http://dx.doi.org/10.1074/jbc.M117.804005			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28698384	Green Published, hybrid			2022-12-26	WOS:000409902100023
J	Hayashi, Y; Yawata, S; Funabiki, K; Hikida, T				Hayashi, Yuichiro; Yawata, Satoshi; Funabiki, Kazuo; Hikida, Takatoshi			In vivo calcium imaging from dentate granule cells with wide-field fluorescence microscopy	PLOS ONE			English	Article							HIPPOCAMPAL PLACE CELLS; CELLULAR RESOLUTION; VIRTUAL NAVIGATION; UNIT-ACTIVITY; DYNAMICS; CORTEX; GYRUS; RAT; DECONVOLUTION; ENVIRONMENTS	A combination of genetically-encoded calcium indicators and micro-optics has enabled monitoring of large-scale dynamics of neuronal activity from behaving animals. In these studies, wide-field microscopy is often used to visualize neural activity. However, this method lacks optical sectioning capability, and therefore its axial resolution is generally poor. At present, it is unclear whether wide-field microscopy can visualize activity of densely packed small neurons at cellular resolution. To examine the applicability of wide-field microscopy for small-sized neurons, we recorded calcium activity of dentate granule cells having a small soma diameter of approximately 10 micrometers. Using a combination of high numerical aperture (0.8) objective lens and independent component analysis-based image segmentation technique, activity of putative single granule cell activity was separated from wide-field calcium imaging data. The result encourages wider application of wide-field microscopy in in vivo neurophysiology.	[Hayashi, Yuichiro; Yawata, Satoshi; Funabiki, Kazuo] Osaka Biosci Inst, Suita, Osaka, Japan; [Hayashi, Yuichiro; Hikida, Takatoshi] Kyoto Univ, Med Innovat Ctr, Grad Sch Med, Kyoto, Japan; [Hayashi, Yuichiro] Hokkaido Univ, Frontier Res Ctr Postgenome Sci & Technol, Sapporo, Hokkaido, Japan; [Hayashi, Yuichiro] Kansai Med Univ, Inst Biomed Sci, Hirakata, Osaka, Japan; [Yawata, Satoshi] Kyoto Univ, Grad Sch Med, Dept Physiol, Kyoto, Japan; [Funabiki, Kazuo] Fdn Biomed Res Innovat, IBRI Lab, Kobe, Hyogo, Japan; [Hikida, Takatoshi] Osaka Univ, Inst Prot Res, Osaka, Japan	Kyoto University; Hokkaido University; Kansai Medical University; Kyoto University; Institute for Biomedical Research & Innovation (IBRI); Osaka University	Hayashi, Y (corresponding author), Osaka Biosci Inst, Suita, Osaka, Japan.; Hayashi, Y (corresponding author), Kyoto Univ, Med Innovat Ctr, Grad Sch Med, Kyoto, Japan.; Hayashi, Y (corresponding author), Hokkaido Univ, Frontier Res Ctr Postgenome Sci & Technol, Sapporo, Hokkaido, Japan.; Hayashi, Y (corresponding author), Kansai Med Univ, Inst Biomed Sci, Hirakata, Osaka, Japan.	hayashiy16@gmail.com	Hikida, Takatoshi/J-5561-2017; Hayashi, Yuichiro/O-2163-2017	Hikida, Takatoshi/0000-0002-8653-311X; Hayashi, Yuichiro/0000-0001-9870-0053	PRESTO, Japan Science and Technology Agency; Japan Society for the promotion of science KAKENHI [24650223, 15H04275, 16K14579, 16H06568]; Takeda Science Foundation; Naito Foundation; Grants-in-Aid for Scientific Research [15H04275] Funding Source: KAKEN	PRESTO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the promotion of science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by PRESTO, Japan Science and Technology Agency, http://www.jst.go.jp/kisoken/presto/en/index.html (to YH); Japan Society for the promotion of science KAKENHI, https://www.jsps.go.jp/english/index.html, 24650223 (to YH), 15H04275, 16K14579, 16H06568 (to TH); the Takeda Science Foundation, http://www.takeda-sci.or.jp/ (to TH); and the Naito Foundation, https://www.naito-f.or.jp/en/ (to TH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alme CB, 2010, HIPPOCAMPUS, V20, P1109, DOI 10.1002/hipo.20810; Barretto Robert P J, 2012, Cold Spring Harb Protoc, V2012, P1029, DOI 10.1101/pdb.top071464; Barretto RPJ, 2009, NAT METHODS, V6, P511, DOI 10.1038/nmeth.1339; Betley JN, 2015, NATURE, V521, P180, DOI 10.1038/nature14416; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; CLAIBORNE BJ, 1990, J COMP NEUROL, V302, P206, DOI 10.1002/cne.903020203; Danielson NB, 2016, NEURON, V90, P101, DOI 10.1016/j.neuron.2016.02.019; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; EVARTS EV, 1966, J NEUROPHYSIOL, V29, P1011, DOI 10.1152/jn.1966.29.6.1011; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Goto A, 2015, P NATL ACAD SCI USA, V112, P6718, DOI 10.1073/pnas.1507121112; Hamel EJO, 2015, NEURON, V86, P140, DOI 10.1016/j.neuron.2015.03.055; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Holscher C, 2005, J EXP BIOL, V208, P561, DOI 10.1242/jeb.01371; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Inoue M, 2015, NAT METHODS, V12, P64, DOI [10.1038/NMETH.3185, 10.1038/nmeth.3185]; Jennings JH, 2015, CELL, V160, P516, DOI 10.1016/j.cell.2014.12.026; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Maruyama R, 2014, NEURAL NETWORKS, V55, P11, DOI 10.1016/j.neunet.2014.03.007; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Mohammed AI, 2016, SCI REP-UK, V6, DOI 10.1038/srep20986; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Murray TA, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.2.021106; Neunuebel JP, 2012, J NEUROSCI, V32, P3848, DOI 10.1523/JNEUROSCI.6038-11.2012; Niesner R, 2007, BIOPHYS J, V93, P2519, DOI 10.1529/biophysj.106.102459; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Oron D, 2005, OPT EXPRESS, V13, P1468, DOI 10.1364/OPEX.13.001468; Pilz GA, 2016, J NEUROSCI, V36, P7407, DOI 10.1523/JNEUROSCI.3065-15.2016; Pnevmatikakis EA, 2016, NEURON, V89, P285, DOI 10.1016/j.neuron.2015.11.037; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; Yamaguchi T, 2015, P NATL ACAD SCI USA, V112, P11383, DOI 10.1073/pnas.1514731112; Youngstrom IA, 2012, LEARN MEMORY, V19, P84, DOI 10.1101/lm.023523.111; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	38	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180452	10.1371/journal.pone.0180452	http://dx.doi.org/10.1371/journal.pone.0180452			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700611	gold, Green Published, Green Submitted			2022-12-26	WOS:000405649600031
J	Balhouse, BN; Patterson, L; Schmelz, EM; Slade, DJ; Verbridge, SS				Balhouse, Brittany N.; Patterson, Logan; Schmelz, Eva M.; Slade, Daniel J.; Verbridge, Scott S.			N-(3-oxododecanoyl)-L-homoserine lactone interactions in the breast tumor microenvironment: Implications for breast cancer viability and proliferation in vitro	PLOS ONE			English	Article							CELL-DEATH; HUMAN-MILK; MICROBIOME; HYPOXIA; CARCINOMA; APOPTOSIS; TISSUE; ENHANCEMENT; RESISTANCE; PATHWAYS	It is well documented that the tumor microenvironment profoundly impacts the etiology and progression of breast cancer, yet the contribution of the resident microbiome within breast tissue remains poorly understood. Tumor microenvironmental conditions, such as hypoxia and dense tumor stroma, predispose progressive phenotypes and therapy resistance, however the role of bacteria in this interplay remains uncharacterized. We hypothesized that the effect of individual bacterial secreted molecules on breast cancer viability and proliferation would be modulated by these tumor- relevant stressors differentially for cells at varying stages of progression. To test this, we incubated human breast adenocarcinoma cells (MDA-MB-231, MCF-DCIS. com) and non-malignant breast epithelial cells (MCF-10A) withN-(3-oxododecanoyl)-L-homoserine lactone (OdDHL), a quorum- sensing molecule from Pseudomonas aeruginosa that regulates bacterial stress responses. This molecule was selected because Pseudomonas was recently characterized as a significant fraction of the breast tissue microbiome and OdDHL is documented to impact mammalian cell viability. After OdDHL treatment, we demonstrated the greatest decrease in viability with the more malignant MDA-MB-231 cells and an intermediate MCF-DCIS. com (ductal carcinoma in situ) response. The responses were also culture condition (i.e. microenvironment) dependent. These results contrast the MCF-10A response, which demonstrated no change in viability in any culture condition. We further determined that the observed trends in breast cancer viability were due to modulation of proliferation for both cell types, as well as the induction of necrosis for MDA-MB-231 cells in all conditions. Our results provide evidence that bacterial quorum-sensing molecules interact with the host tissue environment to modulate breast cancer viability and proliferation, and that the effect of OdDHL is dependent on both cell type as well as microenvironment. Understanding the interactions between bacterial signaling molecules and the host tissue environment will allow for future studies that determine the contribution of bacteria to the onset, progression, and therapy response of breast cancer.	[Balhouse, Brittany N.; Verbridge, Scott S.] Virginia Tech Wake Forest Univ, Sch Biomed Engn & Sci, Blacksburg, VA USA; [Balhouse, Brittany N.; Verbridge, Scott S.] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA USA; [Patterson, Logan; Slade, Daniel J.] Virginia Tech, Dept Biochem, Blacksburg, VA USA; [Patterson, Logan] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Schmelz, Eva M.] Virginia Tech, Dept Human Nutr Foods & Exercise, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University of Virginia; Virginia Polytechnic Institute & State University	Verbridge, SS (corresponding author), Virginia Tech Wake Forest Univ, Sch Biomed Engn & Sci, Blacksburg, VA USA.; Verbridge, SS (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA USA.	sverb@vt.edu	Schmelz, Eva M/E-6579-2012; Slade, Daniel/E-1329-2015	Verbridge, Scott/0000-0002-4074-8799; Slade, Daniel/0000-0001-5634-7220; Patterson, Logan/0000-0002-4825-0565	National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health [R21EB019123]; Junior Faculty Award from the Virginia Tech Institute for Critical Technology and Applied Science; Virginia Tech's Open Access Subvention Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB019123] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Junior Faculty Award from the Virginia Tech Institute for Critical Technology and Applied Science; Virginia Tech's Open Access Subvention Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the R21 Award from the National Institute of Biomedical Imaging and Bioengineering (www.nibib.nih.gov) of the National Institutes of Health (R21EB019123 awarded to S.S.V.), and by the Junior Faculty Award (awarded to S.S.V.) from the Virginia Tech Institute for Critical Technology and Applied Science (www.ictas.vt.edu). The manuscript was published with financial support (awarded to S.S.V.) from Virginia Tech's Open Access Subvention Fund (http://www.lib.vt.edu/oafund/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Chan AA, 2016, SCI REP-UK, V6, DOI 10.1038/srep28061; Chavez Kathryn J, 2010, Breast Dis, V32, P35, DOI 10.3233/BD-2010-0307; Checka CM, 2012, AM J ROENTGENOL, V198, pW292, DOI 10.2214/AJR.10.6049; Cowell JK, 2005, CANCER GENET CYTOGEN, V163, P23, DOI 10.1016/j.cancergencyto.2005.04.019; Cross VL, 2010, BIOMATERIALS, V31, P8596, DOI 10.1016/j.biomaterials.2010.07.072; Cummins J, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-11; DelNero P, 2015, BIOMATERIALS, V55, P110, DOI 10.1016/j.biomaterials.2015.03.035; Dolnick R, 2005, CANCER RES, V65, P5917, DOI 10.1158/0008-5472.CAN-05-0431; Edmondson R, 2014, ASSAY DRUG DEV TECHN, V12, P207, DOI 10.1089/adt.2014.573; Eke I, 2015, SEMINARS CANC BIOL; Garcia-Contreras R, 2015, ISME J, V9, P115, DOI 10.1038/ismej.2014.98; Garrett WS, 2015, SCIENCE, V348, P80, DOI 10.1126/science.aaa4972; Gomez-Gallego C, 2016, SEMIN FETAL NEONAT M, V21, P400, DOI 10.1016/j.siny.2016.05.003; Hieken TJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep30751; Hoashi M, 2016, REPROD SCI, V23, P902, DOI 10.1177/1933719115623645; Infanger DW, 2013, ANNU REV BIOMED ENG, V15, P29, DOI 10.1146/annurev-bioeng-071811-150028; Jacobi CA, 2009, INT J MED MICROBIOL, V299, P509, DOI 10.1016/j.ijmm.2009.03.005; Jain RK, 2013, J CLIN ONCOL, V31, P2205, DOI 10.1200/JCO.2012.46.3653; Koumoutsakos P, 2013, ANNU REV FLUID MECH, V45, P325, DOI 10.1146/annurev-fluid-120710-101102; Kumar AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106480; Lazenby JJ, 2011, ROLE N 3 OXODODECANO; Li L, 2004, ONCOGENE, V23, P4894, DOI 10.1038/sj.onc.1207612; McGuire MK, 2017, CURR OPIN BIOTECH, V44, P63, DOI 10.1016/j.copbio.2016.11.013; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Nelson MT, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-825; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Reid G, 2016, FUTURE MED; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Schwarzer C, 2012, CELL MICROBIOL, V14, P698, DOI 10.1111/j.1462-5822.2012.01753.x; Seguin L, 2015, TRENDS CELL BIOL, V25, P234, DOI 10.1016/j.tcb.2014.12.006; Shieh AC, 2011, ANN BIOMED ENG, V39, P1379, DOI 10.1007/s10439-011-0252-2; Shiner EK, 2006, CELL MICROBIOL, V8, P1601, DOI 10.1111/j.1462-5822.2006.00734.x; So Jae Young, 2012, Mol Cell Pharmacol, V4, P31; Tao S, 2016, SCI REPORTS, P6; Tateda K, 2003, INFECT IMMUN, V71, P5785, DOI 10.1128/IAI.71.10.5785-5793.2003; Urbaniak C, 2016, APPL ENVIRON MICROB, V82, P5039, DOI 10.1128/AEM.01235-16; Urbaniak C, 2014, APPL ENVIRON MICROB, V80, P3007, DOI 10.1128/AEM.00242-14; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Ward C, 2013, CANCER TREAT REV, V39, P171, DOI 10.1016/j.ctrv.2012.08.004; Xuan CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083744; Yen TH, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0261-4; Zhao GP, 2016, ONCOTARGET, V7, P5924, DOI 10.18632/oncotarget.6827	46	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180372	10.1371/journal.pone.0180372	http://dx.doi.org/10.1371/journal.pone.0180372			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692660	gold, Green Published, Green Submitted			2022-12-26	WOS:000405544800037
J	Ellis, GA; Thomas, CS; Chanana, S; Adnani, N; Szachowicz, E; Braun, DR; Harper, MK; Wyche, TP; Bugni, TS				Ellis, Gregory A.; Thomas, Chris S.; Chanana, Shaurya; Adnani, Navid; Szachowicz, Emily; Braun, Doug R.; Harper, Mary Kay; Wyche, Thomas P.; Bugni, Tim S.			Brackish habitat dictates cultivable Actinobacterial diversity from marine sponges	PLOS ONE			English	Article							SELECTIVE ISOLATION; HALICHONDRIN-B; METABOANALYST; MICROORGANISMS; METABOLOMICS; EVOLUTION; SEDIMENTS; BACTERIA; ERIBULIN; TUBULIN	Bacterial communities associated with marine invertebrates such as sponges and ascidians have demonstrated potential as sources of bio-medically relevant small molecules. Metagenomic analysis has shown that many of these invertebrates harbor populations of Actinobacteria, many of which are cultivable. While some populations within invertebrates are transmitted vertically, others are obtained from the environment. We hypothesized that cultivable diversity from sponges living in brackish mangrove habitats have associations with Actinobacterial populations that differ from those found in clear tropical waters. In this study, we analyzed the cultivable Actinobacterial populations from sponges found in these two distinct habitats with the aim of understanding the secondary metabolite potential. Importantly, we wanted to broadly evaluate the potential differences among these groups to guide future Actinobacterial collection strategies for the purposes of drug discovery.	[Ellis, Gregory A.; Thomas, Chris S.; Chanana, Shaurya; Adnani, Navid; Szachowicz, Emily; Braun, Doug R.; Wyche, Thomas P.; Bugni, Tim S.] Univ Wisconsin, Sch Pharm, Pharmaceut Sci Div, 425 N Charter St, Madison, WI 53706 USA; [Harper, Mary Kay] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Ellis, Gregory A.] Naval Res Lab, Washington, DC 20375 USA; [Wyche, Thomas P.] Harvard Univ, Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of Wisconsin System; University of Wisconsin Madison; Utah System of Higher Education; University of Utah; United States Department of Defense; United States Navy; Naval Research Laboratory; Harvard University; Harvard Medical School	Bugni, TS (corresponding author), Univ Wisconsin, Sch Pharm, Pharmaceut Sci Div, 425 N Charter St, Madison, WI 53706 USA.	tim.bugni@wisc.edu	Chanana, Shaurya/GPK-7010-2022	Chanana, Shaurya/0000-0002-3021-2210; Ellis, Gregory/0000-0001-5559-3809	National Institutes of Health (NIH) through the National Institutes for General Medical Science (NIGMS) [R01-GM104192]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104192] Funding Source: NIH RePORTER	National Institutes of Health (NIH) through the National Institutes for General Medical Science (NIGMS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health (NIH) grant R01-GM104192 through the National Institutes for General Medical Science (NIGMS).	Alday PH, 2009, BIOCHEMISTRY-US, V48, P7927, DOI 10.1021/bi900776u; Bose U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091488; Cheng C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138528; Covington BC, 2016, NAT PROD REP; Dai HQ, 2010, INT J SYST EVOL MICR, V60, P1807, DOI 10.1099/ijs.0.017053-0; Duncan KR, 2015, J IND MICROBIOL BIOT, V42, P57, DOI 10.1007/s10295-014-1529-x; Freeman MF, 2012, SCIENCE, V338, P387, DOI 10.1126/science.1226121; Fuerst JA, 2014, APPL MICROBIOL BIOT, V98, P7331, DOI 10.1007/s00253-014-5861-x; GAUZE GF, 1957, PROBLEMS CLASSIFICAT; HAYAKAWA M, 1987, J FERMENT BIOENG, V65, P501, DOI 10.1016/0385-6380(87)90108-7; Hentschel U, 2003, MAR MOL BIOTECHNOL, P59; HIRATA Y, 1986, PURE APPL CHEM, V58, P701, DOI 10.1351/pac198658050701; Hodges TW, 2012, MAR BIOTECHNOL, V14, P270, DOI 10.1007/s10126-011-9410-7; Hou YP, 2012, ORG LETT, V14, P5050, DOI 10.1021/ol3022758; Hou Y, 2012, ANAL CHEM, V84, P4277, DOI 10.1021/ac202623g; Kim BY, 2011, SYST APPL MICROBIOL, V34, P606, DOI 10.1016/j.syapm.2011.03.008; Lee MY, 2015, J MICROBIOL BIOTECHN, V25, P1265, DOI 10.4014/jmb.1503.03005; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Magarvey NA, 2004, APPL ENVIRON MICROB, V70, P7520, DOI 10.1128/AEM.70.12.7520-7529.2004; Newman S, 2007, CURR OPIN INVEST DR, V8, P1057; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; Sipkema D, 2015, ENVIRON MICROBIOL, V17, P3807, DOI 10.1111/1462-2920.12827; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Steinert G, 2016, PEERJ, V4, DOI 10.7717/peerj.1936; Supong K, 2013, INT J SYST EVOL MICR, V63, P3970, DOI 10.1099/ijs.0.050906-0; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Thomas T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11870; Vicente J, 2013, MAR BIOTECHNOL, V15, P413, DOI 10.1007/s10126-013-9493-4; Wilson MC, 2014, NATURE, V506, P58, DOI 10.1038/nature12959; Xi LJ, 2012, INT J MOL SCI, V13, P5917, DOI 10.3390/ijms13055917; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356	36	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0176968	10.1371/journal.pone.0176968	http://dx.doi.org/10.1371/journal.pone.0176968			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692665	Green Published, Green Submitted, gold			2022-12-26	WOS:000405544800002
J	Khan, Z; Dreger, S; Shah, SMH; Pohlabeln, H; Khan, S; Ullah, Z; Rehman, B; Zeeb, H				Khan, Zohaib; Dreger, Steffen; Shah, Syed Majid Hussain; Pohlabeln, Hermann; Khan, Sheraz; Ullah, Zakir; Rehman, Basheer; Zeeb, Hajo			Oral cancer via the bargain bin: The risk of oral cancer associated with a smokeless tobacco product (Naswar)	PLOS ONE			English	Article							HARM REDUCTION; EPIDEMIOLOGY; SMOKING; EUROPE	In the wake of smokeless tobacco (SLT) being advocated as a mean of tobacco harm reduction, it is pertinent to establish individual health risks associated with each SLT product. This case-control study was aimed at assessing the risk of oral cancer associated with a smokeless tobacco product (Naswar). The study was conducted from September 2014 till May 2015 in Khyber Pakhtunkhwa, Pakistan. Exposure and covariate information was collected through a structured questionnaire. Conditional logistic regression was used to calculate odds ratios (OR) along with their 95% confidence intervals (CI). 84 oral cancer cases (62% males) and 174 age-and sex-matched controls were recruited. Ever users of Naswar had more than a 20-fold higher risk of oral cancer compared to never-users (OR 21.2, 95% CI 8.4-53.8). Females had a higher risk of oral cancer with the use of Naswar (OR 29.0, 95% CI 5.4-153.9) as compared to males (OR 21.0, 95% CI 6.1-72.1). Based on this result, 68% (men) and 38% (women) of the oral cancer burden in Pakistan is attributable to Naswar. The risk estimates observed in this study are comparable to risk estimates reported by previous studies on other forms of SLT use and the risk of oral cancer in Pakistan. The exposureresponse relationship also supports a strong role of Naswar in the etiology of oral cancer in Pakistan. Although still requiring further validation through independent studies, these findings may be used for smokeless tobacco control in countries where Naswar use is common.	[Khan, Zohaib; Dreger, Steffen; Pohlabeln, Hermann; Zeeb, Hajo] Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany; [Khan, Zohaib; Zeeb, Hajo] Univ Bremen, Hlth Sci Bremen, Bremen, Germany; [Shah, Syed Majid Hussain] Ayub Med Coll, Dent Sect, Abbottabad, Pakistan; [Khan, Zohaib; Khan, Sheraz] Khyber Med Univ, Peshawar, Pakistan; [Ullah, Zakir] Khyber Teaching Hosp, Peshawar, Pakistan; [Rehman, Basheer] Khyber Coll Dent, Peshawar, Pakistan	Leibniz Institute for Prevention Research & Epidemiology (BIPS); University of Bremen; Khyber Medical University	Khan, Z (corresponding author), Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany.; Khan, Z (corresponding author), Univ Bremen, Hlth Sci Bremen, Bremen, Germany.; Khan, Z (corresponding author), Khyber Med Univ, Peshawar, Pakistan.	khan@leibniz-bips.de	Zeeb, Hajo/I-2701-2019	Zeeb, Hajo/0000-0001-7509-242X; Khan, Sheraz/0000-0001-6679-9052	Leibniz Institute for Prevention Research and Epidemiology - BIPS GmbH, Bremen, Germany; Leibniz Association Open Access fund	Leibniz Institute for Prevention Research and Epidemiology - BIPS GmbH, Bremen, Germany; Leibniz Association Open Access fund	We received internal funding for this research study from our institute i.e. Leibniz Institute for Prevention Research and Epidemiology - BIPS GmbH, Bremen, Germany. The publication of this paper was also supported by the Leibniz Association Open Access fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayo-Yusuf OA, 2012, TOB CONTROL, V21, P245, DOI 10.1136/tobaccocontrol-2011-050367; Baig S, 2015, EUR J BIOTECHNOL BIO, V3, P39; Basharat S, 2012, J PUBLIC HEALTH-UK, V34, P60, DOI 10.1093/pubmed/fdr044; Bates C, 2003, TOB CONTROL, V12, P360, DOI 10.1136/tc.12.4.360; Begum N, 2009, JPMI, V23, P28; Cancela MD, 2012, ORAL ONCOL, V48, P484, DOI 10.1016/j.oraloncology.2011.12.013; Cogliano V, 2004, LANCET ONCOL, V5, P708, DOI 10.1016/S1470-2045(04)01633-X; Piemonte ED, 2010, J ORAL PATHOL MED, V39, P513, DOI 10.1111/j.1600-0714.2010.00901.x; DEAN AG, 1991, AM J PREV MED, V7, P178, DOI 10.1016/S0749-3797(18)30936-X; Eriksen M, 2013, TOBACCO ATLAS; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Foulds J, 2003, TOB CONTROL, V12, P349, DOI 10.1136/tc.12.4.349; Gilani SI, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-16; Guha N., 2013, INT J CANC; Gupta PC, 1996, CRIT REV TOXICOL, V26, P183, DOI 10.3109/10408449609017930; IARC, 2007, SMOK TOB SOM TOB SPE; Imam SZ, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-231; International Agency for Research on Cancer, 2007, IARC MONOGR EVAL CAR, V89; Jafarey N A, 1977, J Pak Med Assoc, V27, P340; Jayalekshmi PA, 2011, CANCER SCI, V102, P460, DOI 10.1111/j.1349-7006.2010.01785.x; Khan M, 2007, J PAK DENT ASS, V16; Khan Z, 2014, J CANCER EPIDEMIOL, V2014, DOI 10.1155/2014/394696; Lagiou P, 2009, EUR J CANCER PREV, V18, P76, DOI 10.1097/CEJ.0b013e32830c8dca; Lee PN, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-36; Mejia AB, 2010, TOB CONTROL, V19, P297, DOI 10.1136/tc.2009.031427; Merchant A, 2000, INT J CANCER, V86, P128, DOI 10.1002/(SICI)1097-0215(20000401)86:1&lt;128::AID-IJC20&gt;3.0.CO;2-M; Muwonge R, 2008, ORAL ONCOL, V44, P446, DOI 10.1016/j.oraloncology.2007.06.002; Naswar Khattak S., 2013, EXPRESS TRIBUNE; O'Connor RJ, 2012, TOB CONTROL, V21, P181, DOI 10.1136/tobaccocontrol-2011-050281; Pearce N, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i969; PTC, 2010, PAK TOB IND EC IMP 2; Rodu Brad, 2006, Harm Reduct J, V3, P37, DOI 10.1186/1477-7517-3-37; SAS Institute Inc, 2011, BAS SAS 9 3 PROC GUI; Schreiner M., 2010, J ASIAN AFR STUD, V45, P326; Shah SH, 1991, J POST GRADUATE MED, V5, P53; Siddiqi K, 2016, NICOTINE TOB RES, V18, P424, DOI 10.1093/ntr/ntv067; Stanfill SB, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.037465; Ullah N, 2011, INT J BCR, V1, P13; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Weitkunat R, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-334; Xue JP, 2014, CANCERS, V6, P1138, DOI 10.3390/cancers6021138; Zakiullah, 2012, TOB CONTROL, V21, P396, DOI 10.1136/tc.2010.042630	42	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180445	10.1371/journal.pone.0180445	http://dx.doi.org/10.1371/journal.pone.0180445			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692704	Green Published, Green Submitted, gold			2022-12-26	WOS:000405544800041
J	Asakawa, N; Uchida, K; Sakakibara, M; Omote, K; Noguchi, K; Tokuda, Y; Kamiya, K; Hatanaka, KC; Matsuno, Y; Yamada, S; Asakawa, K; Fukasawa, Y; Nagai, T; Anzai, T; Ikeda, Y; Ishibashi-Ueda, H; Hirota, M; Orii, M; Akasaka, T; Uto, K; Shingu, Y; Matsui, Y; Morimoto, SI; Tsutsui, H; Eishi, Y				Asakawa, Naoya; Uchida, Keisuke; Sakakibara, Mamoru; Omote, Kazunori; Noguchi, Keiji; Tokuda, Yusuke; Kamiya, Kiwamu; Hatanaka, Kanako C.; Matsuno, Yoshihiro; Yamada, Shiro; Asakawa, Kyoko; Fukasawa, Yuichiro; Nagai, Toshiyuki; Anzai, Toshihisa; Ikeda, Yoshihiko; Ishibashi-Ueda, Hatsue; Hirota, Masanori; Orii, Makoto; Akasaka, Takashi; Uto, Kenta; Shingu, Yasushige; Matsui, Yoshiro; Morimoto, Shin-Ichiro; Tsutsui, Hiroyuki; Eishi, Yoshinobu			Immunohistochemical identification of Propionibacterium acnes in granuloma and inflammatory cells of myocardial tissues obtained from cardiac sarcoidosis patients	PLOS ONE			English	Article							LYMPH-NODES; CORTICOSTEROID-THERAPY; DILATED CARDIOMYOPATHY; IMMUNE-RESPONSE; LOCALIZATION; TH1; DNA	Background Although rare, cardiac sarcoidosis (CS) is potentially fatal. Early diagnosis and intervention are essential, but histopathologic diagnosis is limited. We aimed to detect Propionibacterium acnes, a commonly implicated etiologic agent of sarcoidosis, in myocardial tissues obtained from CS patients. Methods and results We examined formalin-fixed paraffin-embedded myocardial tissues obtained by surgery or autopsy and endomyocardial biopsy from patients with CS (n = 26; CS-group), myocarditis (n = 15; M-group), or other cardiomyopathies (n = 39; CM-group) using immunohistochemistry (IHC) with a P. acnes-specific monoclonal antibody. We found granulomas in 16 (62%) CS-group samples. Massive (>= 14 inflammatory cells) and minimal (< 14 inflammatory cells) inflammatory foci, respectively, were detected in 16 (62%) and 11 (42%) of the CS-group samples, 10 (67%) and 10 (67%) of the M-group samples, and 1 (3%) and 18 (46%) of the CM-group samples. P. acnes-positive reactivity in granulomas, massive inflammatory foci, and minimal inflammatory foci were detected in 10 (63%), 10 (63%), and 8 (73%) of the CS-group samples, respectively, and in none of the M-group and CMgroup samples. Conclusions Frequent identification of P. acnes in sarcoid granulomas of originally aseptic myocardial tissues suggests that this indigenous bacterium causes granuloma in many CS patients. IHC detection of P. acnes in massive or minimal inflammatory foci of myocardial biopsy samples without granulomas may be useful for differentiating sarcoidosis from myocarditis or other cardiomyopathies.	[Asakawa, Naoya; Sakakibara, Mamoru; Omote, Kazunori; Noguchi, Keiji; Tokuda, Yusuke; Kamiya, Kiwamu] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan; [Uchida, Keisuke] Tokyo Med & Dent Univ Hosp, Div Surg Pathol, Tokyo, Japan; [Hatanaka, Kanako C.; Matsuno, Yoshihiro] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Hokkaido, Japan; [Yamada, Shiro] Otaru Kyokai Hosp, Dept Cardiovasc Med, Otaru, Hokkaido, Japan; [Asakawa, Kyoko] Sapporo City Gen Hosp, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan; [Fukasawa, Yuichiro] Sapporo City Gen Hosp, Dept Pathol, Sapporo, Hokkaido, Japan; [Nagai, Toshiyuki; Anzai, Toshihisa] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Osaka, Japan; [Ikeda, Yoshihiko; Ishibashi-Ueda, Hatsue] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Osaka, Japan; [Hirota, Masanori] Machida Municipal Hosp, Dept Cardiovasc Surg, Tokyo, Japan; [Orii, Makoto; Akasaka, Takashi] Wakayama Med Univ, Dept Cardiovasc Med, Wakayama, Japan; [Uto, Kenta] Tokyo Womens Med Univ, Dept Pathol, Tokyo, Japan; [Shingu, Yasushige; Matsui, Yoshiro] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc & Thorac Surg, Sapporo, Hokkaido, Japan; [Morimoto, Shin-Ichiro] Fujita Hlth Univ, Sch Med, Dept Cardiol, Aichi, Japan; [Tsutsui, Hiroyuki] Kyushu Univ, Dept Cardiovasc Med, Fukuoka, Japan; [Eishi, Yoshinobu] Tokyo Med & Dent Univ, Grad Sch, Dept Human Pathol, Tokyo, Japan; [Eishi, Yoshinobu] Tokyo Med & Dent Univ, Fac Med, Tokyo, Japan	Hokkaido University; Tokyo Medical & Dental University (TMDU); Hokkaido University; Sapporo City General Hospital; Sapporo City General Hospital; National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; Wakayama Medical University; Tokyo Women's Medical University; Hokkaido University; Fujita Health University; Kyushu University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Sakakibara, M (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan.	mike.s@ninus.ocn.ne.jp	Shingu, Yasushige/E-1939-2012	Shingu, Yasushige/0000-0001-8471-5166; Omote, Kazunori/0000-0002-8132-7173	Japan Ministry of Education, Culture, Sports, Science and Technology [23591024]	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Ministry of Education, Culture, Sports, Science and Technology (23591024, http://www.mext.go.jp/). M.S. received the funding.	ABE C, 1984, ZBL BAKT-INT J MED M, V256, P541, DOI 10.1016/S0174-3031(84)80032-3; Baughman RP, 2003, LANCET, V361, P1111, DOI 10.1016/S0140-6736(03)12888-7; Blauwet LA, 2013, HEART FAIL REV, V18, P733, DOI 10.1007/s10741-012-9358-3; CARR I, 1980, VIRCHOWS ARCH B, V32, P147, DOI 10.1007/BF02889023; Chiu CZ, 2005, AM J CARDIOL, V95, P143, DOI 10.1016/j.amjcard.2004.08.083; EISHI Y, 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/935289; Furusawa H, 2012, RESPIR INVESTIG, V50, P104, DOI 10.1016/j.resinv.2012.07.001; HOMMA JY, 1978, JPN J EXP MED, V48, P251; Iida Tu K, 2014, J MYCOBACT DIS, V4, P1, DOI [10.4172/2161-1068.1000142, DOI 10.4172/2161-1068.1000142]; Ishige I, 1999, LANCET, V354, P120, DOI 10.1016/S0140-6736(98)12310-3; IWAI K, 1993, ACTA PATHOL JAPON, V43, P372; Izumi T, 2011, CIRC J, V75, DOI 10.1253/circj.CJ-88-0008; Kandolin R, 2011, J INTERN MED, V270, P461, DOI 10.1111/j.1365-2796.2011.02396.x; Kanzaki Y, 2001, JPN CIRC J, V65, P797, DOI 10.1253/jcj.65.797; Maisch B, 2005, HERZ, V30, P535, DOI 10.1007/s00059-005-2730-5; Nagai T, 2015, CIRC J, V79, P1593, DOI 10.1253/circj.CJ-14-1275; Nakasuka Kosuke, 2014, J Cardiol Cases, V9, P35, DOI 10.1016/j.jccase.2013.09.004; Negi M, 2012, MODERN PATHOL, V25, P1284, DOI 10.1038/modpathol.2012.80; Okura Y, 2003, J AM COLL CARDIOL, V41, P322, DOI 10.1016/S0735-1097(02)02715-8; Padilla M, 2006, LUNG BIOL HLTH DIS S, V210, P515; Ponikowski P, 2016, EUR J HEART FAIL; Rosen Y, 2007, SEMIN RESP CRIT CARE, V28, P36, DOI 10.1055/s-2007-970332; Schupp JC, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0070-7; Sekhri V, 2011, ARCH MED SCI, V7, P546, DOI 10.5114/aoms.2011.24118; SILVERMAN KJ, 1978, CIRCULATION, V58, P1204, DOI 10.1161/01.CIR.58.6.1204; Tsuda T, 2006, JPN J SARCOIDOSIS OT, V27, P89; Uemura A, 1999, AM HEART J, V138, P299, DOI 10.1016/S0002-8703(99)70115-8; Yamada T, 2002, J PATHOL, V198, P541, DOI 10.1002/path.1243; Yorozu P, 2015, RESPIR INVESTIG, V53, P161, DOI 10.1016/j.resinv.2015.02.005; Zhou Y, 2015, CLIN EXP IMMUNOL, V181, P511, DOI 10.1111/cei.12650	30	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179980	10.1371/journal.pone.0179980	http://dx.doi.org/10.1371/journal.pone.0179980			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686683	Green Published, gold, Green Submitted			2022-12-26	WOS:000405464100029
J	Kooiman, K; van Rooij, T; Qin, B; Mastik, F; Vos, HJ; Versluis, M; Klibanov, AL; de Jong, N; Villanueva, FS; Chen, XC				Kooiman, Klazina; van Rooij, Tom; Qin, Bin; Mastik, Frits; Vos, Hendrik J.; Versluis, Michel; Klibanov, Alexander L.; de Jong, Nico; Villanueva, Flordeliza S.; Chen, Xucai			Focal areas of increased lipid concentration on the coating of microbubbles during short tone-burst ultrasound insonification	PLOS ONE			English	Article							CONTRAST AGENT MICROBUBBLES; COMPRESSION-ONLY BEHAVIOR; DRUG-DELIVERY; ENHANCED ULTRASOUND; COATED MICROBUBBLES; COLLAPSE TRANSITIONS; SINGLE MICROBUBBLES; NONLINEAR RESPONSE; MONOLAYERS; BUBBLES	Acoustic behavior of lipid-coated microbubbles has been widely studied, which has led to several numerical microbubble dynamics models that incorporate lipid coating behavior, such as buckling and rupture. In this study we investigated the relationship between microbubble acoustic and lipid coating behavior on a nanosecond scale by using fluorescently labeled lipids. It is hypothesized that a local increased concentration of lipids, appearing as a focal area of increased fluorescence intensity (hot spot) in the fluorescence image, is related to buckling and folding of the lipid layer thereby highly influencing the microbubble acoustic behavior. To test this hypothesis, the lipid microbubble coating was fluorescently labeled. The vibration of the microbubble (n = 177; 2.3-10.3 mu m in diameter) upon insonification at an ultrasound frequency of 0.5 or 1 MHz at 25 or 50 kPa acoustic pressure was recorded with the UPMC Cam, an ultra-high-speed fluorescence camera, operated at -4-5 million frames per second. During short tone-burst excitation, hot spots on the microbubble coating occurred at relative vibration amplitudes > 0.3 irrespective of frequency and acoustic pressure. Around resonance, the majority of the microbubbles formed hot spots. When the microbubble also deflated acoustically, hot spot formation was likely irreversible. Although compression-only behavior (defined as substantially more microbubble compression than expansion) and subharmonic responses were observed in those microbubbles that formed hot spots, both phenomena were also found in microbubbles that did not form hot spots during insonification. In conclusion, this study reveals hot spot formation of the lipid monolayer in the microbubble's compression phase. However, our experimental results show that there is no direct relationship between hot spot formation of the lipid coating and microbubble acoustic behaviors such as compression-only and the generation of a subharmonic response. Hence, our hypothesis that hot spots are related to acoustic buckling could not be verified.	[Kooiman, Klazina; Qin, Bin; Villanueva, Flordeliza S.; Chen, Xucai] Univ Pittsburgh, Med Ctr, Ctr Ultrasound Mol Imaging & Therapeut, Pittsburgh, PA 15260 USA; [Kooiman, Klazina] Netherlands Heart Inst, Utrecht, Netherlands; [Kooiman, Klazina; van Rooij, Tom; Mastik, Frits; Vos, Hendrik J.; de Jong, Nico] Erasmus MC, Thoraxctr, Dept Biomed Engn, Rotterdam, Netherlands; [Vos, Hendrik J.; de Jong, Nico] Delft Univ Technol, Fac Appl Sci, Lab Acoust Wavefield Imaging, Delft, Netherlands; [Versluis, Michel] Univ Twente, Phys Fluids Grp, MIRA Inst Biomed Technol & Tech Med, Enschede, Netherlands; [Versluis, Michel] Univ Twente, MESA Inst Nanotechnol, Enschede, Netherlands; [Klibanov, Alexander L.] Univ Virginia, Dept Med, Cardiovasc Div, Charlottesville, VA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Erasmus University Rotterdam; Erasmus MC; Delft University of Technology; University of Twente; University of Twente; University of Virginia	Kooiman, K (corresponding author), Univ Pittsburgh, Med Ctr, Ctr Ultrasound Mol Imaging & Therapeut, Pittsburgh, PA 15260 USA.; Kooiman, K (corresponding author), Netherlands Heart Inst, Utrecht, Netherlands.; Kooiman, K (corresponding author), Erasmus MC, Thoraxctr, Dept Biomed Engn, Rotterdam, Netherlands.	k.kooiman@erasmusmc.nl	Versluis, Michel/F-3541-2011; Mastik, Frits/F-1960-2011; De Jong, Nicolaas/F-1949-2011	Versluis, Michel/0000-0002-2296-1860; Mastik, Frits/0000-0001-9160-4077; De Jong, Nicolaas/0000-0001-8902-0099; Kooiman, Klazina/0000-0002-0607-4989	Netherlands Heart Institute; Center for Ultrasound Molecular Imaging and Therapeutics, University of Pittsburgh Medical Center; Center for Translational Molecular Medicine; Dutch Heart Foundation (PARISk)	Netherlands Heart Institute; Center for Ultrasound Molecular Imaging and Therapeutics, University of Pittsburgh Medical Center; Center for Translational Molecular Medicine; Dutch Heart Foundation (PARISk)	This research was financially supported by the Netherlands Heart Institute (fellowship to K.K.), the Center for Ultrasound Molecular Imaging and Therapeutics, University of Pittsburgh Medical Center, and the Center for Translational Molecular Medicine and the Dutch Heart Foundation (PARISk).	Alzaraa A, 2013, HEPATOL RES, V43, P809, DOI 10.1111/hepr.12044; Azmin M, 2012, CURR PHARM DESIGN, V18, P2118, DOI 10.2174/138161212800099955; Baoukina S, 2008, P NATL ACAD SCI USA, V105, P10803, DOI 10.1073/pnas.0711563105; Borden MA, 2006, LANGMUIR, V22, P4291, DOI 10.1021/la052841v; Borden MA, 2005, IEEE T ULTRASON FERR, V52, P1992, DOI 10.1109/TUFFC.2005.1561668; Cantisani V, 2015, EUR J RADIOL, V84, P1675, DOI 10.1016/j.ejrad.2015.05.008; Chen X., 2015, ULTRASOUND MED BIOL; Chen XC, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4809168; Chomas JE, 2001, J BIOMED OPT, V6, P141, DOI 10.1117/1.1352752; Correas JM, 1997, ACTA RADIOL, V38, P101; Daeichin V., 2015, INT J HYPERTHER, V31, P106; De Jong N, 2007, ULTRASOUND MED BIOL, V33, P653, DOI 10.1016/j.ultrasmedbio.2006.09.016; Denham SLW, 2016, ULTRASOUND Q, V32, P116, DOI 10.1097/RUQ.0000000000000182; Doinikov AA, 2009, ULTRASONICS, V49, P269, DOI 10.1016/j.ultras.2008.09.007; Eisenbrey JR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/640397; Emmer M, 2009, IEEE T ULTRASON FERR, V56, P2370, DOI 10.1109/TUFFC.2009.1325; Feinstein SB, 2010, J NUCL CARDIOL, V17, P106, DOI 10.1007/s12350-009-9165-y; Ferrara K, 2007, ANNU REV BIOMED ENG, V9, P415, DOI 10.1146/annurev.bioeng.8.061505.095852; Frinking PJA, 2010, IEEE T ULTRASON FERR, V57, P1762, DOI 10.1109/TUFFC.2010.1614; Gelderblom E. C., 2012, THESIS; Gong YJ, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4865805; Gopal A, 2001, J PHYS CHEM B, V105, P10348, DOI 10.1021/jp012532n; Helfield B, 2016, P NATL ACAD SCI USA, V113, P9983, DOI 10.1073/pnas.1606915113; Helfield BL, 2013, J ACOUST SOC AM, V133, P1158, DOI 10.1121/1.4774379; Hernot S, 2008, ADV DRUG DELIVER REV, V60, P1153, DOI 10.1016/j.addr.2008.03.005; Kim DH, 2003, LANGMUIR, V19, P8455, DOI 10.1021/la034779c; Klibanov AL, 2006, INVEST RADIOL, V41, P354, DOI 10.1097/01.rli.0000199292.88189.0f; Kooiman K, 2014, EUR J LIPID SCI TECH, V116, P1217, DOI 10.1002/ejlt.201300434; Kooiman K, 2014, ADV DRUG DELIVER REV, V72, P28, DOI 10.1016/j.addr.2014.03.003; Kwan JJ, 2012, ADV COLLOID INTERFAC, V183, P82, DOI 10.1016/j.cis.2012.08.005; Lee KYC, 2008, ANNU REV PHYS CHEM, V59, P771, DOI 10.1146/annurev.physchem.58.032806.104619; Lipp MM, 1998, PHYS REV LETT, V81, P1650, DOI 10.1103/PhysRevLett.81.1650; Lozano MM, 2009, SOFT MATTER, V5, P1822, DOI 10.1039/b820070j; Lozano MM, 2009, LANGMUIR, V25, P3705, DOI 10.1021/la803774q; Luan Y, 2014, ULTRASOUND MED BIOL, V40, P1834, DOI 10.1016/j.ultrasmedbio.2014.02.031; Marmottant P, 2005, J ACOUST SOC AM, V118, P3499, DOI 10.1121/1.2109427; Mortimer AJ, 1982, PHYS CHARACTERISITCS; O'Brien JP, 2011, J ACOUST SOC AM, V130, pEL180, DOI 10.1121/1.3630219; Overvelde M, 2010, ULTRASOUND MED BIOL, V36, P2080, DOI 10.1016/j.ultrasmedbio.2010.08.015; Owen J, 2015, ULTRASOUND MED BIOL, V41, P3253, DOI 10.1016/j.ultrasmedbio.2015.07.024; Paul S, 2010, J ACOUST SOC AM, V127, P3846, DOI 10.1121/1.3418685; PROSPERETTI A, 1974, J ACOUST SOC AM, V56, P878, DOI 10.1121/1.1903341; Pu G, 2006, LANGMUIR, V22, P2993, DOI 10.1021/la0530337; Renaud G, 2014, ULTRASOUND MED BIOL, V40, P1282, DOI 10.1016/j.ultrasmedbio.2013.12.018; Segers T, 2016, J ACOUST SOC AM, V140, P2506, DOI 10.1121/1.4964270; Segers T, 2016, LANGMUIR, V32, P3937, DOI 10.1021/acs.langmuir.6b00616; Shih R, 2016, LANGMUIR, V32, P1939, DOI 10.1021/acs.langmuir.5b03948; Sijl J, 2011, J ACOUST SOC AM, V130, P3271, DOI 10.1121/1.3626155; Sijl J, 2011, J ACOUST SOC AM, V129, P1729, DOI 10.1121/1.3505116; Sijl J, 2010, J ACOUST SOC AM, V128, P3239, DOI 10.1121/1.3493443; Sijl J, 2008, J ACOUST SOC AM, V124, P4091, DOI 10.1121/1.2997437; Sutton JT, 2013, EXPERT OPIN DRUG DEL, V10, P573, DOI 10.1517/17425247.2013.772578; Takamoto DY, 2001, BIOPHYS J, V81, P153, DOI 10.1016/S0006-3495(01)75688-3; Talu E, 2008, LANGMUIR, V24, P1745, DOI 10.1021/la703065v; van der Meer SM, 2007, J ACOUST SOC AM, V121, P648, DOI 10.1121/1.2390673; van Rooij T, 2013, IEEE ULTR S P; van Rooij T, 2016, J CONTROL RELEASE, V238, P197, DOI 10.1016/j.jconrel.2016.07.037; van Rooij T, 2015, ULTRASOUND MED BIOL, V41, P1432, DOI 10.1016/j.ultrasmedbio.2015.01.004; Vos HJ, 2008, ULTRASOUND MED BIOL, V34, P685, DOI 10.1016/j.ultrasmedbio.2007.10.001; Wang SY, 2016, INVEST RADIOL, V51, P758, DOI 10.1097/RLI.0000000000000310	60	12	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180747	10.1371/journal.pone.0180747	http://dx.doi.org/10.1371/journal.pone.0180747			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686673	Green Published, Green Submitted, gold			2022-12-26	WOS:000405464100098
J	Khafif, M; Balague, C; Huard-Chauveau, C; Roby, D				Khafif, Mehdi; Balague, Claudine; Huard-Chauveau, Carine; Roby, Dominique			An essential role for the VASt domain of the Arabidopsis VAD1 protein in the regulation of defense and cell death in response to pathogens	PLOS ONE			English	Article							PLANT IMMUNE-SYSTEM; GRAM DOMAIN; MOLECULAR CHARACTERIZATION; DISEASE RESISTANCE; ACTIVATION; CERAMIDE; GENE; TRANSFORMATION; INTERACTS; MEMBRANE	Several regulators of programmed cell death (PCD) have been identified in plants which encode proteins with putative lipid -binding domains. Among them, VAD1 (Vascular Associated Death) contains a novel protein domain called VASt (VAD1 analog StAR-related lipid transfer) still uncharacterized. The Arabidopsis mutant vadl-1 has been shown to exhibit a lesion mimic phenotype with light-conditional appearance of propagative hypersensitive response -like lesions along the vascular system, associated with defense gene expression and increased resistance to Pseudomonas strains. To test the potential of ectopic expression of VAD1 to influence HR cell death and to elucidate the role of the VASt domain in this function, we performed a structure -function analysis of VAD1 by transient over -expression in Nicotiana benthamiana and by complementation of the mutant vadl-1. We found that (i) overexpression of VAD1 controls negatively the HR cell death and defense expression either transiently in Nicotiana benthamania or in Arabidopsis plants in response to avirulent strains of Pseudomonas syringae, (ii) VAD1 is expressed in multiple subcellular compartments, including the nucleus, and (iii) while the GRAM domain does not modify neither the subcellular localization of VAD1 nor its immunorepressor activity, the domain VASt plays an essential role in both processes. In conclusion, VAD1 acts as a negative regulator of cell death associated with the plant immune response and the VASt domain of this unknown protein plays an essential role in this function, opening the way for the functional analysis of VASt-containing proteins and the characterization of novel mechanisms regulating PCD.	[Khafif, Mehdi; Balague, Claudine; Huard-Chauveau, Carine; Roby, Dominique] Univ Toulouse, CNRS, INRA, LIPM, Castanet Tolosan, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Roby, D (corresponding author), Univ Toulouse, CNRS, INRA, LIPM, Castanet Tolosan, France.	dominique.roby@toulouse.inra.fr			French Laboratory of Excellence project "TULIP' [ANR-10-LABX-41, ANR-11-IDEX-0002-02]	French Laboratory of Excellence project "TULIP'	This work was supported by the French Laboratory of Excellence project "TULIP' (ANR-10-LABX-41; ANR-11-IDEX-0002-02).	Aviv DH, 2002, PLANT J, V29, P381, DOI 10.1046/j.0960-7412.2001.01225.x; Babaeizad V, 2009, THEOR APPL GENET, V118, P455, DOI 10.1007/s00122-008-0912-2; Balague C, 2003, PLANT CELL, V15, P365, DOI 10.1105/tpc.006999; Berger P, 2003, P NATL ACAD SCI USA, V100, P12177, DOI 10.1073/pnas.2132732100; Bi FC, 2014, PLANT CELL, V26, P3449, DOI 10.1105/tpc.114.127050; Boevink P, 1998, PLANT J, V15, P441, DOI 10.1046/j.1365-313X.1998.00208.x; Bolduc N, 2003, PLANTA, V216, P377, DOI 10.1007/s00425-002-0879-1; Bouchez O, 2007, PLANT PHYSIOL, V145, P465, DOI 10.1104/pp.107.106302; Brodersen P, 2002, GENE DEV, V16, P490, DOI 10.1101/gad.218202; Bruggeman Q, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00024; BUELL CR, 1995, MOL PLANT MICROBE IN, V8, P435, DOI 10.1094/MPMI-8-0435; Canonne J, 2011, PLANT CELL, V23, P3498, DOI 10.1105/tpc.111.088815; Chisholm ST, 2005, P NATL ACAD SCI USA, V102, P2087, DOI 10.1073/pnas.0409468102; Chisholm ST, 2003, MOL MICROBIOL, V49, P1537; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; Gao X, 2008, J STAT PLAN INFER, V138, P3674, DOI 10.1016/j.jspi.2007.11.019; Gatta AT, 2015, ELIFE, V4, DOI 10.7554/eLife.07253; Hanada K, 2007, BBA-MOL CELL BIOL L, V1771, P644, DOI 10.1016/j.bbalip.2007.01.009; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Khafif M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-222; Kohler C, 1999, PLANT J, V20, P695; La Camera S, 2009, MOL PLANT MICROBE IN, V22, P469, DOI 10.1094/MPMI-22-4-0469; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lefebvre B, 2004, PLANT CELL, V16, P1772, DOI 10.1105/tpc.022277; Lefebvre B, 2010, P NATL ACAD SCI USA, V107, P2343, DOI 10.1073/pnas.0913320107; Li YR, 2016, PLANT CELL, V28, P233, DOI 10.1105/tpc.15.00626; Liang H, 2003, GENE DEV, V17, P2636, DOI 10.1101/gad.1140503; Liu DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046451; Lorrain S, 2004, PLANT CELL, V16, P2217, DOI 10.1105/tpc.104.022038; Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Macho AP, 2014, MOL CELL, V54, P263, DOI 10.1016/j.molcel.2014.03.028; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Marion J, 2008, PLANT J, V56, P169, DOI 10.1111/j.1365-313X.2008.03596.x; Matsumura H, 2003, PLANT J, V33, P425, DOI 10.1046/j.1365-313X.2003.01639.x; Mudgett MB, 1998, CURR OPIN MICROBIOL, V1, P109, DOI 10.1016/S1369-5274(98)80150-1; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Pontier D, 1998, MOL PLANT MICROBE IN, V11, P544, DOI 10.1094/MPMI.1998.11.6.544; Rodriguez E, 2016, FEBS J, V283, P1385, DOI 10.1111/febs.13613; RONALD PC, 1992, J BACTERIOL, V174, P1604, DOI 10.1128/jb.174.5.1604-1611.1992; Saito C, 2002, PLANT J, V29, P245, DOI 10.1046/j.0960-7412.2001.01189.x; Simanshu DK, 2014, CELL REP, V6, P388, DOI 10.1016/j.celrep.2013.12.023; Sokolov S, 2006, BBA-BIOENERGETICS, V1757, P1366, DOI 10.1016/j.bbabio.2006.07.005; Tang DZ, 2005, PLANT J, V44, P245, DOI 10.1111/j.1365-313X.2005.02523.x; Ternes P, 2011, NEW PHYTOL, V192, P841, DOI 10.1111/j.1469-8137.2011.03852.x; Tsujita K, 2004, J BIOL CHEM, V279, P13817, DOI 10.1074/jbc.M312294200; Vailleau F, 2002, P NATL ACAD SCI USA, V99, P10179, DOI 10.1073/pnas.152047199; Van Durme M, 2016, CURR OPIN PLANT BIOL, V29, P29, DOI 10.1016/j.pbi.2015.10.013; Vorwerk S, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-35; Watanabe N, 2009, INT J MOL SCI, V10, P3149, DOI 10.3390/ijms10073149; Williams B, 2008, MOL PLANT PATHOL, V9, P531, DOI [10.1111/j.1364-3703.2008.00473.x, 10.1111/J.1364-3703.2008.00473.X]; Yang HJ, 2007, PLANT PHYSIOL, V145, P135, DOI 10.1104/pp.107.100800	52	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0179782	10.1371/journal.pone.0179782	http://dx.doi.org/10.1371/journal.pone.0179782			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683084	Green Published, Green Submitted, gold			2022-12-26	WOS:000405335200015
J	Nagler, C; Hornig, MK; Haug, JT; Noever, C; Hoeg, JT; Glenner, H				Nagler, Christina; Hoernig, Marie K.; Haug, Joachim T.; Noever, Christoph; Hoeg, Jens T.; Glenner, Henrik			The bigger, the better? Volume measurements of parasites and hosts: Parasitic barnacles (Cirripedia, Rhizocephala) and their decapod hosts	PLOS ONE			English	Article							BRIAROSACCUS-CALLOSUS BOSCHMA; HERMIT-CRAB; LIFE-CYCLE; REPRODUCTIVE OUTPUT; BODY-SIZE; EGG SIZE; PELTOGASTRIDAE CRUSTACEA; COMPARATIVE MORPHOLOGY; R-SELECTION; KING CRAB	Rhizocephala, a group of parasitic castrators of other crustaceans, shows remarkable morphological adaptations to their lifestyle. The adult female parasite consists of a body that can be differentiated into two distinct regions: a sac-like structure containing the reproductive organs (the externa), and a trophic, root like system situated inside the hosts body (the interna). Parasitism results in the castration of their hosts, achieved by absorbing the entire reproductive energy of the host. Thus, the ratio of the host and parasite sizes is crucial for the understanding of the parasite's energetic cost. Using advanced imaging methods (micro-CT in conjunction with 3D modeling), we measured the volume of parasitic structures (externa, interna, egg mass, egg number, visceral mass) and the volume of the entire host. Our results show positive correlations between the volume of (1) entire rhizocephalan (externa + interna) and host body, (2) rhizocephalan externa and host body, (3) rhizocephalan visceral mass and rhizocephalan body, (4) egg mass and rhizocephalan externa, (5) rhizocephalan egg mass and their egg number. Comparing the rhizocephalan Sylon hippolytes, a parasite of caridean shrimps, and representatives of Peltogaster, parasites of hermit crabs, we could match their different traits on a reconstructed relationship. With this study we add new and significant information to our global understanding of the evolution of parasitic castrators, of interactions between a parasitic castrator and its host and of different parasitic strategies within parasitic castrators exemplified by rhizocephalans.	[Nagler, Christina; Haug, Joachim T.] Ludwig Maximilians Univ Munchen, Dept Biol 2, Planegg Martinsried, Germany; [Hoernig, Marie K.] Ernst Moritz Arndt Univ Greifswald, Cytol & Evolutionary Biol, Greifswald, Germany; [Haug, Joachim T.] Ludwig Maximilians Univ Munchen, GeoBioctr, Munich, Germany; [Noever, Christoph; Glenner, Henrik] Univ Bergen, Dept Marine Biol, Bergen, Norway; [Hoeg, Jens T.] Univ Copenhagen, Marine Biol Sect, Dept Biol, Copenhagen, Denmark	University of Munich; Ernst Moritz Arndt Universitat Greifswald; University of Munich; University of Bergen; University of Copenhagen	Nagler, C (corresponding author), Ludwig Maximilians Univ Munchen, Dept Biol 2, Planegg Martinsried, Germany.	christina.nagler@palaeo-evo-clevo.info	Hoeg, Jens Thorvald/D-5784-2015	Hoeg, Jens Thorvald/0000-0002-3596-1691; Noever, Christoph/0000-0002-1455-4966; Nagler, Christina/0000-0003-2876-6342; Hornig, Marie K./0000-0002-0401-2282	Studienstiftung des deutschen Volkes; German Research Foundation (DFG) [Ha 6300/3-1]; Carlsberg Foundation [2008_01_0491, 2013_01_0130]; Danish Agency for Science, Technology and Innovation [4070001486]; Norwegian Biodiversity Information Centre (NBIC); The University of Bergen (Norway); NBIC; The University of Greifswald (Germany); DFG [INST 292/119-1 FUGG, INST 292/120-1 FUGG]	Studienstiftung des deutschen Volkes; German Research Foundation (DFG)(German Research Foundation (DFG)); Carlsberg Foundation(Carlsberg Foundation); Danish Agency for Science, Technology and Innovation; Norwegian Biodiversity Information Centre (NBIC); The University of Bergen (Norway); NBIC; The University of Greifswald (Germany); DFG(German Research Foundation (DFG))	CN and MKH are grateful to be funded by the Studienstiftung des deutschen Volkes with a PhD fellowship. CN is furthermore grateful to be funded by the Studienstiftung des deutschen Volkes with a grant fora six month research stay in Bergen, Norway. JTH is kindly funded by the German Research Foundation (DFG) under Ha 6300/3-1. JT Hoeg is grateful to be funded by the Carlsberg Foundation under 2008_01_0491 and 2013_01_0130 and by the Danish Agency for Science, Technology and Innovation under 4070001486. C Noever and HG were financed by the Norwegian Biodiversity Information Centre (NBIC). HG was furthermore financed by the Carlsberg Foundation under 2008_01_0491. The University of Bergen (Norway) and the NBIC financed the sampling cruise. The University of Greifswald (Germany) financed the micro CT scans with a DFG grant under INST 292/119-1 FUGG and INST 292/120-1 FUGG.	ALLEN J. A., 1966, P45; Alvarez D, 2002, FUNCT ECOL, V16, P640, DOI 10.1046/j.1365-2435.2002.00658.x; Anger K, 1998, J CRUSTACEAN BIOL, V18, P823, DOI 10.2307/1549156; Barnes M., 1989, OCEANOGR MAR BIOL AN, P27; Battoni GM, 1948, I PUBBL STN ZOOL NAP, V21, P236; BAUDOIN M, 1975, EVOLUTION, V29, P335, DOI [10.2307/2407221, 10.1111/j.1558-5646.1975.tb00213.x]; BISHOP RK, 1979, J FISH DIS, V2, P131, DOI 10.1111/j.1365-2761.1979.tb00150.x; Bolte S, 2006, J MICROSC-OXFORD, V224, P13, DOI DOI 10.1111/J.1365-2818.2006.01706.X; Boschma H., 1962, Discovery Reports, V33, P55; BOSCHMA H., 1930, PROC U S NATION MUS, V76, P1; BOWER SM, 1990, PATHOLOGY IN MARINE SCIENCE, P267; Bresciani J, 2001, J MORPHOL, V249, P9, DOI 10.1002/jmor.1039; Bush SE, 2009, FUNCT ECOL, V23, P578, DOI 10.1111/j.1365-2435.2008.01535.x; Castillo-Neyra R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003433; Cavaleiro FI, 2014, INT J PARASITOL, V44, P173, DOI 10.1016/j.ijpara.2013.10.009; CEDHAGEN T, 1995, CRUSTACEANA, V68, P659, DOI 10.1163/156854095X00926; CLARKE A, 1991, FUNCT ECOL, V5, P724, DOI 10.2307/2389534; Costa S, 2013, CRUSTACEANA, V86, P34, DOI 10.1163/15685403-00003150; Fernando CH, 1970, PERCA FLUVIATILIS, V19, P1; GALIL BSA, 1995, J CRUSTACEAN BIOL, V15, P659, DOI 10.2307/1548815; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; GLENNER H, 1995, NATURE, V377, P147, DOI 10.1038/377147a0; Glenner H, 2000, MAR BIOL, V136, P249, DOI 10.1007/s002270050683; Glenner H, 2002, MODERN APPROACHES TO THE STUDY OF CRUSTACEA, P301; Glenner H, 2006, MOL PHYLOGENET EVOL, V41, P528, DOI 10.1016/j.ympev.2006.06.004; Glenner H, 2010, EXP PARASITOL, V125, P3, DOI 10.1016/j.exppara.2009.09.019; GOTTO R. V., 1960, ANN AND MAG NAT HIST, V3, P211; Guha Arun, 2013, Journal of Parasitic Diseases, V37', P118, DOI 10.1007/s12639-012-0144-x; Harrison L., 1915, Parasitology Cambridge, V8, DOI 10.1017/S0031182000010428; HARVEY PH, 1991, PHILOS T R SOC B, V332, P31, DOI 10.1098/rstb.1991.0030; Haug C, 2013, PALAEONTOL ELECTRON, V16; Haug Carolin, 2011, International Journal of Zoology, V2011, P1; Haug C, 2012, DEV GENES EVOL, V222, P253, DOI 10.1007/s00427-012-0407-7; HAWKES CR, 1985, P BIOL SOC WASH, V98, P935; Hoeg J. T., 1985, MARINE INVERTEBRATES, V6; HOEG JT, 1990, J CRUSTACEAN BIOL, V10, P37, DOI 10.2307/1548668; HOEG JT, 1985, J EXP MAR BIOL ECOL, V89, P221, DOI 10.1016/0022-0981(85)90128-5; HOEG JT, 1982, J EXP MAR BIOL ECOL, V58, P87, DOI 10.1016/0022-0981(82)90099-5; Hoeg JT, 1995, OCEANOGR MAR BIOL, V33, P427; HOEG JT, 1995, J MAR BIOL ASSOC UK, V75, P517, DOI 10.1017/S0025315400038996; HOEG JT, 1993, ZOOL SCR, V22, P363, DOI 10.1111/j.1463-6409.1993.tb00365.x; Hornig MK, 2016, PALAEONTOL ELECTRON, V19; Johnson KP, 2005, EVOLUTION, V59, P1744, DOI 10.1111/j.0014-3820.2005.tb01823.x; Kashenko SD, 2003, RUSS J MAR BIOL+, V29, P150; KIRK WDJ, 1991, ECOL ENTOMOL, V16, P351, DOI 10.1111/j.1365-2311.1991.tb00227.x; KURIS AM, 1974, Q REV BIOL, V49, P129, DOI 10.1086/408018; Kuris AM, 2000, DEV AN VET, V32, P9; Lafferty KD, 2002, TRENDS ECOL EVOL, V17, P507, DOI 10.1016/S0169-5347(02)02615-0; Lafferty KD, 2009, TRENDS PARASITOL, V25, P564, DOI 10.1016/j.pt.2009.09.003; Lajeunesse MJ, 2002, P ROY SOC B-BIOL SCI, V269, P703, DOI 10.1098/rspb.2001.1943; Llodra ER, 2000, J MAR BIOL ASSOC UK, V80, P473, DOI 10.1017/S0025315400002174; LUTZEN J, 1981, J EXP MAR BIOL ECOL, V50, P231, DOI 10.1016/0022-0981(81)90052-6; LUTZEN J, 1987, J CRUSTACEAN BIOL, V7, P493, DOI 10.2307/1548297; Lutzen J, 1996, ZOOL SCR, V25, P171, DOI 10.1111/j.1463-6409.1996.tb00157.x; Lutzen Jorgen, 1992, Bulletin of the National Science Museum Series A (Zoology), V18, P117; MAC ARTHUR ROBERT H., 1967; MACDIARMID AB, 1989, J EXP MAR BIOL ECOL, V127, P229, DOI 10.1016/0022-0981(89)90076-2; Martin J. W., 2009, DECAPOD CRUSTACEAN P, V18, P197; McDermott JJ, 2010, J EXP MAR BIOL ECOL, V394, P2, DOI 10.1016/j.jembe.2010.06.022; MCLAIN DK, 1991, OIKOS, V60, P263, DOI 10.2307/3544875; McMurrich J. P., 1917, T ROY SOC CAN SECT 3, V11, P47; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Morand S, 2000, BIOL J LINN SOC, V70, P239, DOI 10.1111/j.1095-8312.2000.tb00209.x; Nilsson-Cantell CA, 1921, ZOOL BIDR UPPS, V7, P75; Noever C, 2016, J SEA RES, V113, P58, DOI 10.1016/j.seares.2015.08.002; Noever C, 2016, ZOOL J LINN SOC-LOND, V176, P3, DOI 10.1111/zoj.12304; Oh CW, 1999, J CRUSTACEAN BIOL, V19, P252, DOI 10.2307/1549231; PARRY GD, 1981, OECOLOGIA, V48, P260, DOI 10.1007/BF00347974; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; PIKE R. B., 1960, JOUR LINN SOC LONDON ZOOL, V44, P239; Poulin R, 1997, ACTA OECOL, V18, P621, DOI 10.1016/S1146-609X(97)80047-1; Poulin R, 2011, ADV PARASIT, V74, P1, DOI 10.1016/B978-0-12-385897-9.00001-X; Reinhard Edward G., 1946, JOUR WASHINGTON ACAD SCI, V36, P127; Reinhard EG, 1942, J MORPHOL, V70, P69, DOI 10.1002/jmor.1050700105; Ritchie G., 1993, P153; ROSS DM, 1971, NATURE, V230, P401, DOI 10.1038/230401a0; ROTHLISBERG PC, 1976, FISH B-NOAA, V74, P994; Samuelsen TJ, 1970, BIOL 6 SPECIES ANOMU, V45, P25; Santos S, 1997, INTERCIENCIA, V22, P259; Sasal P, 1999, J ANIM ECOL, V68, P437, DOI 10.1046/j.1365-2656.1999.00313.x; SCHOLTZ G, 1995, ZOOL J LINN SOC-LOND, V113, P289, DOI 10.1006/zjls.1995.0011; Sibly R. M., 1986, PHYSL ECOLOGY ANIMAL; SLOAN NA, 1984, J EXP MAR BIOL ECOL, V84, P111, DOI 10.1016/0022-0981(84)90205-3; Sombke A, 2015, J COMP NEUROL, V523, P1281, DOI 10.1002/cne.23741; THESSALOULEGAKI M, 1992, ESTUAR COAST SHELF S, V35, P593, DOI 10.1016/S0272-7714(05)80041-1; Thompson S. N., 1993, P125; Timi JT, 2005, PARASITOL RES, V95, P1, DOI 10.1007/s00436-004-1242-1; VANDAMME PA, 1993, J FISH BIOL, V42, P395, DOI 10.1006/jfbi.1993.1042; VARADARAJAN S, 1982, MAR ECOL PROG SER, V8, P197, DOI 10.3354/meps008197; Walker G, 2001, J MORPHOL, V249, P1; WALKER SE, 1988, PALAEOGEOGR PALAEOCL, V63, P45, DOI 10.1016/0031-0182(88)90090-9; WENNER EL, 1979, CRUSTACEANA, V37, P293, DOI 10.1163/156854079X00618; Yoshida R, 2016, ZOOTAXA, V4139, P209, DOI 10.11646/zootaxa.4139.2.5; Yoshida R, 2014, J CRUSTACEAN BIOL, V34, P467, DOI 10.1163/1937240X-00002246; Yoshida R, 2011, ZOOL SCI, V28, P853, DOI 10.2108/zsj.28.853	95	12	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0179958	10.1371/journal.pone.0179958	http://dx.doi.org/10.1371/journal.pone.0179958			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678878	Green Published, gold, Green Submitted			2022-12-26	WOS:000405272200033
J	Pusceddu, M; Floris, I; Buffa, F; Salaris, E; Satta, A				Pusceddu, Michelins; Floris, Ignazio; Buffa, Franco; Salaris, Emanuele; Satta, Alberto			Agonistic interactions between the honeybee (Apis mellifera ligustica) and the European wasp (Vespula germanica) reveal context-dependent defense strategies	PLOS ONE			English	Article							COLONY DEFENSE; BEHAVIOR; BEES; HYMENOPTERA; PREDATOR; COMPETITION; AGGRESSION; VESPIDAE; VELUTINA; HORNETS	Predator-prey relationships between sympatric species allow the evolution of defense behaviors, such as honeybee colonies defending their nests against predatory wasps. We investigated the predator-prey relationship between the honeybee (Apis mellifera ligustica) and the European wasp (Vespula germanica) by evaluating the effectiveness of attack and defense behaviors, which have coevolved in these sympatric species, as well as the actual damage and disturbance caused to the colonies under attack. Attack and defense behaviors were recorded in front of the hive to observe attacks at the hive entrance (68 attacks in 279 h) and at ground level on isolated and weakened honeybees close to the hive (465 attacks in 32 h). We found that V. germanica attacked the hive entrance infrequently due to the low success rate of this strategy and instead preferred a specialized attack method targeting adult honeybees at ground level, demonstrating opportunistic scavenger behavior. Individual honeybees usually responded effectively to an attack by recruiting an average of two nestmates, causing the wasp to flee, whereas collective balling behavior was only observed on four occasions. V. germanica does not appear to disrupt the foraging activity of the colonies under attack. We found that agonistic events supported by other nestmates were typically the most intense ones, involving physical combat and prolonged attacks at the entrance to the hive. These observations support the hypothesis that A. mellifera ligustica can adapt its behavior to match the severity of the threat and the context of the attack.	[Pusceddu, Michelins; Floris, Ignazio; Buffa, Franco; Salaris, Emanuele; Satta, Alberto] Univ Sassari, Dipartimento Agr, Sez Patol Vegetate & Entomol, Sassari, Italy	University of Sassari	Satta, A (corresponding author), Univ Sassari, Dipartimento Agr, Sez Patol Vegetate & Entomol, Sassari, Italy.	albsatta@uniss.it	Satta, Alberto/K-8597-2015	Satta, Alberto/0000-0003-1296-3835	Italian Ministry of Education, University and Research (MIUR; Research Project PRIN); Social immunity in honeybee: behavioural, chemical and microbiological aspects [2012RCEZWH]; National Institute of Social providence (INPS, Italy)	Italian Ministry of Education, University and Research (MIUR; Research Project PRIN)(Ministry of Education, Universities and Research (MIUR)); Social immunity in honeybee: behavioural, chemical and microbiological aspects; National Institute of Social providence (INPS, Italy)	This study was financially supported by the Italian Ministry of Education, University and Research (MIUR; Research Project PRIN 2012), Social immunity in honeybee: behavioural, chemical and microbiological aspects. prot. 2012RCEZWH. The National Institute of Social providence (INPS, Italy) which provide the PhD scholarship granted to Michelina Pusceddu.	Abrol Dharam Pal, 2006, Journal of Apicultural Science, V50, P39; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Arca M, 2014, BEHAV PROCESS, V106, P122, DOI 10.1016/j.beproc.2014.05.002; Baracchi D, 2010, ETHOL ECOL EVOL, V22, P281, DOI 10.1080/03949370.2010.502323; BREED MD, 1978, INSECT SOC, V25, P351, DOI 10.1007/BF02224299; BREED MD, 1992, ANN ENTOMOL SOC AM, V85, P633, DOI 10.1093/aesa/85.5.633; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; BREED MD, 1990, BEHAV ECOL SOCIOBIOL, V27, P395, DOI 10.1007/BF00164065; COELHO JR, 1995, FUNCT ECOL, V9, P171, DOI 10.2307/2390561; COLLINS AM, 1982, SCIENCE, V218, P72, DOI 10.1126/science.218.4567.72; D'Adamo P, 2003, NEW ZEAL J ZOOL, V30, P171, DOI 10.1080/03014223.2003.9518336; De Wroey C, 1978, INSECTES SOC PARIS, V25; DeGrandi-Hoffman G, 1998, J INSECT BEHAV, V11, P37, DOI 10.1023/A:1020862432087; Denis D, 2008, ANIM BEHAV, V75, P791, DOI 10.1016/j.anbehav.2007.06.016; FREE JB, 1970, INSECT SOC, V17, P11, DOI 10.1007/BF02223769; Futuyama D. J., 1986, EVOLUTIONARY BIOL, P482; HELFMAN GS, 1989, BEHAV ECOL SOCIOBIOL, V24, P47, DOI 10.1007/BF00300117; Hermann H.R., 1984, P1; JOHNSON LK, 1974, ECOLOGY, V55, P120, DOI 10.2307/1934624; Kasper ML, 2008, INSECT SOC, V55, P288, DOI 10.1007/s00040-008-1004-7; Kastberger G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036736; Kastberger G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003141; Kastberger G, 2009, J INSECT BEHAV, V22, P65, DOI 10.1007/s10905-008-9155-y; Ken T, 2005, NATURWISSENSCHAFTEN, V92, P492, DOI 10.1007/s00114-005-0026-5; MARKWELL TJ, 1993, NEW ZEAL J ECOL, V17, P85; Matsuura M., 1991, P232; Matsuura M., 1973, HUSCAP J, V19, P125; Monceau K, 2014, J PEST SCI, V87, P1, DOI 10.1007/s10340-013-0537-3; Monceau K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066492; Nieh JC, 2005, INSECT SOC, V52, P147, DOI 10.1007/s00040-004-0785-6; ONO M, 1995, NATURE, V377, P334, DOI 10.1038/377334a0; Papachristoforou A, 2007, CURR BIOL, V17, pR795, DOI 10.1016/j.cub.2007.07.033; Papachristoforou A, 2011, BEHAV PROCESS, V86, P236, DOI 10.1016/j.beproc.2010.12.012; Pappas N., 1988, P85; Ruttner H., 1972, P PAAR SEL HON INT S, P112; SEELEY TD, 1982, ECOL MONOGR, V52, P43, DOI 10.2307/2937344; Shorter JR, 2012, INSECT SOC, V59, P1, DOI 10.1007/s00040-011-0210-x; Sokal R. R, 1981, BIOMETRY; Sugahara M, 2009, NATURWISSENSCHAFTEN, V96, P1133, DOI 10.1007/s00114-009-0575-0; SZATHMARY E, 1995, NATURE, V374, P227, DOI 10.1038/374227a0; Tan K, 2007, NATURWISSENSCHAFTEN, V94, P469, DOI 10.1007/s00114-006-0210-2; Tan K, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002423; Tan K, 2012, ANIM BEHAV, V83, P879, DOI 10.1016/j.anbehav.2011.12.031; Tan K, 2012, APIDOLOGIE, V43, P195, DOI 10.1007/s13592-011-0098-5; Turillazzi S., 2003, SOC VESPE, P55; WHITFORD WG, 1979, ECOLOGY, V60, P686, DOI 10.2307/1936605; Wilson E.O., 1975, P1; Wood MJ, 2004, APIDOLOGIE, V35, P461, DOI 10.1051/apido:2004040; Zakour MK, 2013, J APIC SCI, V57, P137, DOI 10.2478/JAS-2013-0024	49	8	8	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180278	10.1371/journal.pone.0180278	http://dx.doi.org/10.1371/journal.pone.0180278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678826	gold, Green Published, Green Submitted			2022-12-26	WOS:000405272200045
J	Sauter-Louis, C; Jones, BA; Henning, J; Stoll, A; Nielen, M; Van Schaik, G; Smolenaars, A; Schouten, M; den Uijl, I; Fourichon, C; Guatteo, R; Madouasse, A; Nusinovici, S; Deprez, P; De Vliegher, S; Laureyns, J; Booth, R; Cardwell, JM; Pfeiffer, DU				Sauter-Louis, Carole; Jones, Bryony A.; Henning, Jorg; Stoll, Alexander; Nielen, Mirjam; Van Schaik, Gerdien; Smolenaars, Anja; Schouten, Matthijs; den Uijl, Ingrid; Fourichon, Christine; Guatteo, Raphael; Madouasse, Aurelien; Nusinovici, Simon; Deprez, Piet; De Vliegher, Sarne; Laureyns, Jozef; Booth, Richard; Cardwell, Jacqueline M.; Pfeiffer, Dirk U.			Herd-level animal management factors associated with the occurrence of bovine neonatal pancytopenia in calves in a multi-country study	PLOS ONE			English	Article							HEMORRHAGIC DIATHESIS; CLASS-I; BNP; COLOSTRUM; ALLOANTIBODIES	Since 2007, mortality associated with a previously unreported haemorrhagic disease has been observed in young calves in several European countries. The syndrome, which has been named 'bovine neonatal pancytopenia' (BNP), is characterised by thrombocytopenia, leukocytopenia and a panmyelophthisis. A herd-level case-control study was conducted in four BNP affected countries (Belgium, France, Germany and the Netherlands) to identify herd management risk factors for BNP occurrence. Data were collected using structured face-to-face and telephone interviews of farm managers and their local veterinarians. In total, 363 case farms and 887 control farms were included in a matched multivariable conditional logistic regression analysis. Case-control status was strongly associated with the odds of herd level use of the vaccine PregSure r BVD (PregSure, Pfizer Animal Health) (matched adjusted odds ratio (OR) 107.2; 95% CI: 41.0-280.1). This was also the case for the practices of feeding calves colostrum from the calf's own dam (OR 2.0; 95% CI: 1.1-3.4) or feeding pooled colostrum (OR 4.1; 95% CI: 1.9-8.8). Given that the study had relatively high statistical power and represented a variety of cattle production and husbandry systems, it can be concluded with some confidence that no other herd level management factors are competent causes for a sufficient cause of BNP occurrence on herd level. It is suggested that genetic characteristics of the dams and BNP calves should be the focus of further investigations aimed at identifying the currently missing component causes that together with PregSure vaccination and colostrum feeding represent a sufficient cause for occurrence of BNP in calves.	[Sauter-Louis, Carole; Stoll, Alexander] Ludwig Maximilians Univ Munchen, Ctr Clin Vet Med, Clin Ruminants Ambulatory & Herd Hlth Serv, Oberschleissheim, Germany; [Sauter-Louis, Carole; Jones, Bryony A.; Cardwell, Jacqueline M.; Pfeiffer, Dirk U.] Royal Vet Coll, Vet Epidemiol Econ & Publ Hlth Grp, Hawkshead Lane, N Mymms, Herts, England; [Sauter-Louis, Carole] Friedrich Loeffler Inst, Inst Epidemiol, Suedufer 10, Greifswald, Germany; [Henning, Jorg] Univ Queensland, Sch Vet Sci, Gatton, Australia; [Nielen, Mirjam; Schouten, Matthijs] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Yalelaan 7, Utrecht, Netherlands; [Van Schaik, Gerdien; Smolenaars, Anja; den Uijl, Ingrid] GD Anim Hlth, Arnsbergstr 7, Deventer, Netherlands; [Fourichon, Christine; Guatteo, Raphael; Madouasse, Aurelien; Nusinovici, Simon] LUNAM Univ Oniris, Ecole Natl Vet Agroalimentaire & Alimentat Nantes, INRA, Biol Epidemiol & Risk Anal Anim Hlth UMR1300, Nantes, France; [Deprez, Piet] Univ Ghent, Fac Vet Med, Dept Internal Med & Clin Biol Large Anim, Salisburylaan 133, Merelbeke, Belgium; [De Vliegher, Sarne; Laureyns, Jozef] Univ Ghent, Fac Vet Med, Dept Reprod Obstet & Herd Hlth, Salisburylaan 133, Merelbeke, Belgium; [Booth, Richard] Royal Vet Coll, Dept Pathol & Infect Dis, Hawkshead Lane, N Mymms, Herts, England; [Pfeiffer, Dirk U.] City Univ Hong Kong, Sch Vet Med, Hong Kong, Hong Kong, Peoples R China	University of Munich; University of London; University of London Royal Veterinary College; Friedrich Loeffler Institute; University of Queensland; Utrecht University; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Ghent University; Ghent University; University of London; University of London Royal Veterinary College; City University of Hong Kong	Sauter-Louis, C (corresponding author), Ludwig Maximilians Univ Munchen, Ctr Clin Vet Med, Clin Ruminants Ambulatory & Herd Hlth Serv, Oberschleissheim, Germany.; Sauter-Louis, C (corresponding author), Royal Vet Coll, Vet Epidemiol Econ & Publ Hlth Grp, Hawkshead Lane, N Mymms, Herts, England.; Sauter-Louis, C (corresponding author), Friedrich Loeffler Inst, Inst Epidemiol, Suedufer 10, Greifswald, Germany.	carola@sauter-louis.de	Cardwell, Jacqueline Martina/I-3273-2014; De Vliegher, Sarne/J-9491-2012; Pfeiffer, Dirk U/C-5002-2009; van Schaik, Gerdien/AAD-7771-2020; Fourichon, Christine/B-1265-2010; De Vliegher, Sarne/N-7712-2019; Madouasse, Aurélien/AAC-2814-2019; Henning, Joerg/G-8662-2017	De Vliegher, Sarne/0000-0001-6330-9062; Pfeiffer, Dirk U/0000-0001-7000-0530; Fourichon, Christine/0000-0002-7079-0955; De Vliegher, Sarne/0000-0001-6330-9062; Madouasse, Aurélien/0000-0002-9254-5707; van Schaik, Gerdien/0000-0002-0460-2629; Jones, Bryony/0000-0003-4383-2504; Henning, Joerg/0000-0002-0282-1318	Zoetis (formerly Pfizer Animal Health)	Zoetis (formerly Pfizer Animal Health)	The study was funded by Zoetis (formerly Pfizer Animal Health) which produced the vaccine PregSure, one of the risk factors investigated here. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, Surveillance (Wellington), V39, P14; Armengol R, 2010, B ANEMBE, V85, P28; Assad A, 2012, VET IMMUNOL IMMUNOP, V147, P25, DOI 10.1016/j.vetimm.2012.04.012; BANKS KL, 1982, J AM VET MED ASSOC, V181, P1053; Bastian M, 2011, VACCINE, V29, P5267, DOI 10.1016/j.vaccine.2011.05.012; Bednarski M, 2011, MED WETER, V67, P283; Bell CR, 2013, VET IMMUNOL IMMUNOP, V151, P303, DOI 10.1016/j.vetimm.2012.12.002; Benedictus L, 2014, VET RES, V45, DOI 10.1186/s13567-014-0129-0; Bridger PS, 2011, VET IMMUNOL IMMUNOP, V141, P1, DOI 10.1016/j.vetimm.2011.01.001; Buck BC, 2011, BERL MUNCH TIERARZTL, V124, P329, DOI 10.2376/0005-9366-124-329; Carlin A, 2011, EPIDEMIOLOGISCHE UNT; Demasius W, 2014, RES VET SCI, V96, P537, DOI 10.1016/j.rvsc.2014.03.019; Deutskens F, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-97; DEVERYPOCIUS JE, 1983, J DAIRY SCI, V66, P221, DOI 10.3168/jds.S0022-0302(83)81780-9; Ellis-Iversen J, 2009, P SAT S HAEM DIAT CA; Euler KN, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-18; Foucras G, 2009, P SAT S HAEM DIATH C; Foucras G, 2011, J IMMUNOL, V187, P6564, DOI 10.4049/jimmunol.1102533; Friedrich A, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-10; Friedrich A, 2009, TIERAERZTL UMSCHAU, V64, P423; Gentile A, 2009, P SAT S HAEM DIATH C; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jones BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080619; Kappe EC, 2010, BERL MUNCH TIERARZTL, V123, P31, DOI 10.2376/0005-9366-123-31; Kasonta R, 2012, VACCINE, V30, P6649, DOI 10.1016/j.vaccine.2012.08.069; Lambton SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034183; Pardon B, 2010, TRANSBOUND EMERG DIS, V57, P135, DOI 10.1111/j.1865-1682.2010.01098.x; Pardon B, 2009, P  SAT S HAEM DIATH; Pardon B, 2011, VET IMMUNOL IMMUNOP, V141, P293, DOI 10.1016/j.vetimm.2011.02.017; Paul-Ehrlich-Institut, 2011, DTSCH TIERARZTEBLATT, V12, P1662; Paul-Ehrlich-Institut, 2013, FALL BOV NEON PANZ B; Reichmann F, 2012, FALL KONTROLL STUDIE; Sanchez-Miguel C, 2010, VET REC, V166, P664, DOI 10.1136/vr.c2690; Sauter-Louis C, 2012, PREV VET MED, V105, P49, DOI 10.1016/j.prevetmed.2012.02.008; Schroter P, 2012, BERL MUNCH TIERARZTL, V125, P476, DOI 10.2376/0005-9366-125-476; Schroter P, 2011, BERL MUNCH TIERARZTL, V124, P390, DOI 10.2376/0005-9366-124-390; Smolenaars AJG., 2009, P SAT S HAEM DIATH C; TODD AG, 1995, AUST VET J, V72, P415, DOI 10.1111/j.1751-0813.1995.tb06191.x; Wolf C., 2006, NUTZTIERPRAXIS AKTEL, P26	39	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e4179878	10.1371/journal.pone.0179878	http://dx.doi.org/10.1371/journal.pone.0179878			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678850	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000405272200030
J	Kong, E; Chun, KA; Cho, IH				Kong, Eunjung; Chun, Kyung Ah; Cho, Ihn Ho			Quantitative assessment of simultaneous F-18 FDG PET/MRI in patients with various types of hepatic tumors: Correlation between glucose metabolism and apparent diffusion coefficient	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CELL LUNG-CANCER; HEPATOCELLULAR-CARCINOMA; WEIGHTED MRI; LIVER; LESIONS; PET/CT; CHOLANGIOCARCINOMA; EXPRESSION; GRADE	Purpose Metabolism and water diffusion may have a relationship or an effect on each other in the same tumor. Knowledge of their relationship could expand the understanding of tumor biology and serve the field of oncologic imaging. This study aimed to evaluate the relationship between metabolism and water diffusivity in hepatic tumors using a simultaneous positron emission tomography/magnetic resonance imaging (PET/MRI) system with F-18 fluorodeoxyglucose (FDG) and to reveal the metabolic and diffusional characteristics of each type of hepatic tumor. Methods Forty-one patients (mean age 63 +/- 13 years, 31 male) with hepatic tumors (18 hepatocellular carcinoma [HCC], six cholangiocarcinoma [CCC], 10 metastatic tumors, one neuroendocrine malignancy, and six benign lesions) underwent FDG PET/MRI before treatment. Maximum standard uptake (SUVmax) values from FDG PET and the apparent diffusion coefficient (ADC) from the diffusion-weighted images were obtained for the tumor and their relationships were examined. We also investigated the difference in SUVmax and ADC for each type of tumor. Results SUVmax showed a negative correlation with ADC (r = -0.404, p = 0.009). The median of SUVmax was 3.22 in HCC, 6.99 in CCC, 6.30 in metastatic tumors, and 1.82 in benign lesions. The median of ADC was 1.039 x 10(-3) mm/s(2) in HCC, 1.148 x 10(-3) mm/s(2) in CCC, 0.876 x 10(-3) mm/s (2) in metastatic tumors, and 1.323 x 10(-3) mm/s (2) in benign lesions. SUVmax was higher in metastatic tumors than in benign lesions (p = 0.023). Metastatic tumors had a lower ADC than CCC (p = 0.039) and benign lesions (p = 0.004). HCC had a lower ADC than benign lesions, with a suggestive trend (p = 0.06). Conclusion Our results indicate that SUVmax is negatively correlated with ADC in hepatic tumors, and each group of tumors has different metabolic and water diffusivity characteristics. Evaluation of hepatic tumors by PET/MRI could be helpful in understanding tumor characteristics.	[Kong, Eunjung; Chun, Kyung Ah; Cho, Ihn Ho] Yeungnam Univ, Dept Nucl Med, Med Sch & Hosp, Daegu, South Korea	Yeungnam University	Kong, E (corresponding author), Yeungnam Univ, Dept Nucl Med, Med Sch & Hosp, Daegu, South Korea.	kongej@yu.ac.kr	Kong, Eunjung/J-9231-2018		Yeungnam University	Yeungnam University	This research was supported by a research grant from Yeungnam University (2014). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071571; Assy N, 2009, WORLD J GASTROENTERO, V15, P3217, DOI 10.3748/wjg.15.3217; Boussouar S, 2016, CANCER IMAGING, V16, DOI 10.1186/s40644-016-0062-8; Brandmaier P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141684; Conrad R, 2013, J GASTROINTEST ONCOL, V4, P53, DOI 10.3978/j.issn.2078-6891.2012.020; Czernin J, 2007, J NUCL MED, V48, p78S; Di Costanzo A, 2006, NEURORADIOLOGY, V48, P622, DOI 10.1007/s00234-006-0102-3; Folpe AL, 2000, CLIN CANCER RES, V6, P1279; Gambhir SS, 2001, J NUCL MED, V42, p1S; Gu J, 2011, MOL IMAGING BIOL, V13, P1020, DOI 10.1007/s11307-010-0433-7; Hamstra DA, 2005, P NATL ACAD SCI USA, V102, P16759, DOI 10.1073/pnas.0508347102; Hayashida Y, 2006, AM J NEURORADIOL, V27, P1419; HERHOLZ K, 1993, J NEUROSURG, V79, P853, DOI 10.3171/jns.1993.79.6.0853; Higashi K, 2000, J NUCL MED, V41, P85; Higashi T, 2002, J NUCL MED, V43, P173; Kong E, 2016, Q J NUCL ME IN PRESS; Kumar V A A, 2015, AJ ROBBINS COTRAN PA, P870; Lee JD, 2005, J NUCL MED, V46, P1753; Mannelli L, 2009, AM J ROENTGENOL, V193, P1044, DOI 10.2214/AJR.08.1461; Naganawa S, 2005, EUR RADIOL, V15, P71, DOI 10.1007/s00330-004-2529-4; Rakheja R, 2012, AM J ROENTGENOL, V198, P1409, DOI 10.2214/AJR.11.7560; Regier M, 2012, EUR J RADIOL, V81, P2913, DOI 10.1016/j.ejrad.2011.11.050; Roh MS, 2004, HEPATO-GASTROENTEROL, V51, P1315; Rubesova E, 2006, J MAGN RESON IMAGING, V24, P319, DOI 10.1002/jmri.20643; Schoder H, 2005, J CLIN ONCOL, V23, P4643, DOI 10.1200/JCO.2005.12.072; Schwenzer NF, 2014, J MAGN RESON IMAGING, V40, P1121, DOI 10.1002/jmri.24497; Wang JC, 2001, RADIOLOGY, V220, P621, DOI 10.1148/radiol.2202010063; Zimmerman RL, 2002, ONCOL REP, V9, P689	28	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180184	10.1371/journal.pone.0180184	http://dx.doi.org/10.1371/journal.pone.0180184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28672016	Green Submitted, Green Published, gold			2022-12-26	WOS:000405268500023
J	Tsai, CS; Chen, VCH; Yang, YH; Hung, TH; Lu, ML; Huang, KY; Gossop, M				Tsai, Ching-Shu; Chen, Vincent Chin-Hung; Yang, Yao-Hsu; Hung, Tai-Hsin; Lu, Mong-Liang; Huang, Kuo-You; Gossop, Michael			The association between Mycoplasma pneumoniae infection and speech and language impairment: A nationwide population-based study in Taiwan	PLOS ONE			English	Article							NERVOUS-SYSTEM COMPLICATIONS; OTITIS-MEDIA; RISK-FACTORS; CHILDREN; MANIFESTATIONS; DISORDERS; COMMUNITY; DISEASE; DELAY; EPIDEMIOLOGY	Manifestations of Mycoplasma pneumoniae infection can range from self- limiting upper respiratory symptoms to various neurological complications, including speech and language impairment. But an association between Mycoplasma pneumoniae infection and speech and language impairment has not been sufficiently explored. In this study, we aim to investigate the association between Mycoplasma pneumoniae infection and subsequent speech and language impairment in a nationwide population- based sample using Taiwan's National Health Insurance Research Database. We identified 5,406 children with Mycoplasma pneumoniae infection (International Classification of Disease, Revision 9, Clinical Modification code 4830) and compared to 21,624 age-, sex-, urban- and incomematched controls on subsequent speech and language impairment. The mean follow- up interval for all subjects was 6.44 years (standard deviation = 2.42 years); the mean latency period between the initial Mycoplasma pneumoniae infection and presence of speech and language impairment was 1.96 years (standard deviation = 1.64 years). The results showed that Mycoplasma pneumoniae infection was significantly associated with greater incidence of speech and language impairment [hazard ratio (HR) = 1.49, 95% CI: 1.23-1.80]. In addition, significantly increased hazard ratio of subsequent speech and language impairment in the groups younger than 6 years old and no significant difference in the groups over the age of 6 years were found (HR = 1.43, 95% CI: 1.09-1.88 for age 0-3 years group; HR = 1.67, 95% CI: 1.25-2.23 for age 4-5 years group; HR = 1.14, 95% CI: 0.54-2.39 for age 6-7 years group; and HR = 0.83, 95% CI: 0.23-2.92 for age 8-18 years group). In conclusion, Mycoplasma pneumoniae infection is temporally associated with incident speech and language impairment.	[Tsai, Ching-Shu; Chen, Vincent Chin-Hung; Hung, Tai-Hsin] Chang Gung Mem Hosp, Dept Psychiat, Chiayi, Taiwan; [Tsai, Ching-Shu; Chen, Vincent Chin-Hung; Hung, Tai-Hsin] Univ Chiayi, Chiayi, Taiwan; [Tsai, Ching-Shu; Chen, Vincent Chin-Hung; Hung, Tai-Hsin] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Tsai, Ching-Shu; Hung, Tai-Hsin] Chang Gung Inst Technol, Taoyuan, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Ctr Excellence Chang Gung Res Datalink, Chiayi, Taiwan; [Yang, Yao-Hsu] Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei, Taiwan; [Yang, Yao-Hsu] Chang Gung Univ, Sch Tradit Chinese Med, Coll Med, Taoyuan, Taiwan; [Lu, Mong-Liang] Taipei Med Univ, Dept Psychiat, Wan Fang Hosp, Taipei, Taiwan; [Lu, Mong-Liang] Taipei Med Univ, Coll Med, Sch Med, Taipei, Taiwan; [Huang, Kuo-You] Chung Shan Med Univ & Hosp, Dept Speech Language Pathol & Audiol, Taichung, Taiwan; [Gossop, Michael] Kings Coll London, Natl Addict Ctr, London, England	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Taiwan University; Chang Gung University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; University of London; King's College London	Huang, KY (corresponding author), Chung Shan Med Univ & Hosp, Dept Speech Language Pathol & Audiol, Taichung, Taiwan.	huangkuoyou@yahoo.com.tw	楊, 曜旭/A-3450-2019	楊, 曜旭/0000-0002-8080-0504; Lu, Mong-Liang/0000-0003-3184-6554	Chang Gung Memorial Hospital, Chiayi Branch [CMRPG6F0281]	Chang Gung Memorial Hospital, Chiayi Branch	The present study is supported by a grant from Chang Gung Memorial Hospital, Chiayi Branch (CMRPG6F0281). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashtekar CS, 2003, DEV MED CHILD NEUROL, V45, P634, DOI 10.1017/S0012162203001154; Bebear CM, 2008, ARCH PEDIATRIE, V15, P1253, DOI 10.1016/j.arcped.2008.02.010; BEHAN PO, 1986, ACTA NEUROL SCAND, V74, P314; BIBERFELD G, 1971, CLIN EXP IMMUNOL, V8, P319; Bitnun A, 2001, CLIN INFECT DIS, V32, P1674, DOI 10.1086/320748; Buschmann A, 2008, DEV MED CHILD NEUROL, V50, P223, DOI 10.1111/j.1469-8749.2008.02034.x; Chaudhry R, 2016, INDIAN J MED MICROBI, V34, P7, DOI 10.4103/0255-0857.174112; Chen CY, 2007, PEDIATRICS, V119, pE435, DOI 10.1542/peds.2006-1477; CIMOLAI N, 1994, ARCH DIS CHILD, V71, P281, DOI 10.1136/adc.71.3.281; Dollaghan CA, 1999, J SPEECH LANG HEAR R, V42, P1432, DOI 10.1044/jslhr.4206.1432; FERNALD GW, 1975, PEDIATRICS, V55, P327; FERNANDEZ CV, 1993, J CHILD NEUROL, V8, P27, DOI 10.1177/088307389300800104; Fox AV, 2002, INT J LANG COMM DIS, V37, P117, DOI 10.1080/13682820110116776; FOY HM, 1970, J AMER MED ASSOC, V214, P1666, DOI 10.1001/jama.214.9.1666; FOY HM, 1979, J INFECT DIS, V139, P681, DOI 10.1093/infdis/139.6.681; Fu M, 1998, J NEUROL SCI, V157, P113, DOI 10.1016/S0022-510X(98)00074-4; GOERTZEN SM, 1957, AM J MENT DEF, V62, P244; Guleria R, 2005, J LAB CLIN MED, V146, P55, DOI 10.1016/j.lab.2005.04.006; Gurgel LG, 2014, CODAS, V26, P350, DOI 10.1590/2317-1782/20142014070; Harrison LJ, 2010, J SPEECH LANG HEAR R, V53, P508, DOI 10.1044/1092-4388(2009/08-0086); Hauner KKY, 2005, J SPEECH LANG HEAR R, V48, P635, DOI 10.1044/1092-4388(2005/044); Horwitz SM, 2003, J AM ACAD CHILD PSY, V42, P932, DOI 10.1097/01.CHI.0000046889.27264.5E; Kammer J, 2016, NEUROPEDIATRICS, V47, P308, DOI 10.1055/s-0036-1584325; Korrel H, 2017, J CHILD PSYCHOL PSYC, V58, P640, DOI 10.1111/jcpp.12688; KOSKINIEMI M, 1993, CLIN INFECT DIS, V17, pS52, DOI 10.1093/clinids/17.Supplement_1.S52; Lin Wen-Chuan, 2002, Journal of Microbiology Immunology and Infection, V35, P173; LIND K, 1983, YALE J BIOL MED, V56, P461; LIND K, 1988, INFECT IMMUN, V56, P714, DOI 10.1128/IAI.56.3.714-715.1988; Ma YJ, 2015, J MICROBIOL IMMUNOL, V48, P632, DOI 10.1016/j.jmii.2014.08.003; MANSEL JK, 1989, CHEST, V95, P639, DOI 10.1378/chest.95.3.639; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; Mody M, 1999, J SPEECH LANG HEAR R, V42, P1069, DOI 10.1044/jslhr.4205.1069; MULDER LJMM, 1987, NEUROLOGY, V37, P1430, DOI 10.1212/WNL.37.8.1430; Nishimura M, 1996, J NEUROL SCI, V140, P91, DOI 10.1016/0022-510X(96)00106-2; Nordberg A, 2014, INT J SPEECH-LANG PA, V16, P386, DOI 10.3109/17549507.2014.917440; Paradise JL, 2000, PEDIATRICS, V105, P1119, DOI 10.1542/peds.105.5.1119; Prathanee B, 2007, CLIN PEDIATR, V46, P22, DOI 10.1177/0009922806297153; Reilly S, 2007, PEDIATRICS, V120, pE1441, DOI 10.1542/peds.2007-0045; Reilly S, 2006, J PAEDIATR CHILD H, V42, P764, DOI 10.1111/j.1440-1754.2006.00974.x; Rice ML, 1998, J SPEECH LANG HEAR R, V41, P419, DOI 10.1044/jslhr.4102.419; Roses-Noguer F, 2006, REV NEUROLOGIA, V42, P466, DOI 10.33588/rn.4208.2005429; Socan M, 2001, CLIN INFECT DIS, V32, pE31, DOI 10.1086/318446; Spitz RV, 1997, J SPEECH LANG HEAR R, V40, P990, DOI 10.1044/jslhr.4005.990; Stanton-Chapman TL, 2002, RES DEV DISABIL, V23, P390, DOI 10.1016/S0891-4222(02)00141-5; Tsai CJ, 2012, NEPHROLOGY, V17, P390, DOI 10.1111/j.1440-1797.2012.01571.x; Tsiodras S, 2005, J INFECTION, V51, P343, DOI 10.1016/j.jinf.2005.07.005; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Waites KB, 2003, PEDIATR PULM, V36, P267, DOI 10.1002/ppul.10346; Weindrich D, 2000, EUR CHILD ADOLES PSY, V9, P186, DOI 10.1007/s007870070042; Yeh JJ, 2015, J ALLERGY CLIN IMMUN; YEOH C, 1993, BRIT MED J, V306, P972, DOI 10.1136/bmj.306.6883.972; Yimenicioglu S, 2014, IRAN J PEDIATR, V24, P647; Zubrick SR, 2007, J SPEECH LANG HEAR R, V50, P1562, DOI 10.1044/1092-4388(2007/106)	53	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180402	10.1371/journal.pone.0180402	http://dx.doi.org/10.1371/journal.pone.0180402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA2JX	28672017	Green Published, Green Submitted, gold			2022-12-26	WOS:000405268500050
J	Arslan, AD; Sassano, A; Saleiro, D; Lisowski, P; Kosciuczuk, EM; Fischietti, M; Eckerdt, F; Fish, EN; Platanias, LC				Arslan, A. D.; Sassano, A.; Saleiro, D.; Lisowski, P.; Kosciuczuk, E. M.; Fischietti, M.; Eckerdt, F.; Fish, E. N.; Platanias, L. C.			Human SLFN5 is a transcriptional co-repressor of STAT1-mediated interferon responses and promotes the malignant phenotype in glioblastoma	ONCOGENE			English	Article							GLIOMA; CELLS; CANCER; EXPRESSION; INVASION; FAMILY; GROWTH; BETA; DIFFERENTIATION; MAINTENANCE	We provide evidence that the IFN-regulated member of the Schlafen (SLFN) family of proteins, SLFN5, promotes the malignant phenotype in glioblastoma multiforme (GBM). Our studies indicate that SLFN5 expression promotes motility and invasiveness of GBM cells, and that high levels of SLFN5 expression correlate with high-grade gliomas and shorter overall survival in patients suffering from GBM. In efforts to uncover the mechanism by which SLFN5 promotes GBM tumorigenesis, we found that this protein is a transcriptional co-repressor of STAT1. Type-I IFN treatment triggers the interaction of STAT1 with SLFN5, and the resulting complex negatively controls STAT1-mediated gene transcription via interferon stimulated response elements. Thus, SLFN5 is both an IFN-stimulated response gene and a repressor of IFN-gene transcription, suggesting the existence of a negative-feedback regulatory loop that may account for suppression of antitumor immune responses in glioblastoma.	[Arslan, A. D.; Sassano, A.; Saleiro, D.; Kosciuczuk, E. M.; Fischietti, M.; Eckerdt, F.; Platanias, L. C.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, 303 East Super, Chicago, IL 60611 USA; [Arslan, A. D.; Sassano, A.; Saleiro, D.; Kosciuczuk, E. M.; Fischietti, M.; Platanias, L. C.] Northwestern Univ, Div Hematol Oncol, Dept Med, Feinberg Sch Med, Chicago, IL USA; [Lisowski, P.] Med Univ Warsaw, Dept Med Genet, Ctr Preclin Res & Technol CePT, Warsaw, Poland; [Lisowski, P.] Helmholtz Assoc, iPS Cell Based Dis Modeling Grp, Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Kosciuczuk, E. M.; Platanias, L. C.] Jesse Brown Vet Affairs Med Ctr, Dept Med, Chicago, IL USA; [Fish, E. N.] Univ Hlth Network, Toronto Res Inst, Toronto, ON, Canada; [Fish, E. N.] Univ Toronto, Dept Immunol, Toronto, ON, Canada	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Medical University of Warsaw; Helmholtz Association; Max Delbruck Center for Molecular Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Platanias, LC (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, 303 East Super, Chicago, IL 60611 USA.	l-platanias@northwestern.edu	Fischietti, Mariafausta/Y-6449-2019; Kosciuczuk, Ewa Maria/AAD-2815-2022		NIH [CA161196, CA77816, CA155566, T32CA070085, T32CA080621]; Department of Veterans Affairs [5I01CX000916]; National Science Centre, Poland [2016/22/M/NZ2/00548]; NATIONAL CANCER INSTITUTE [R01CA155566, R01CA077816, T32CA070085, R01CA161796, T32CA080621] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000916] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); National Science Centre, Poland(National Science Centre, Poland); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	The work was supported in part by NIH grants CA161196, CA77816 and CA155566 and by grant 5I01CX000916 from the Department of Veterans Affairs. ADA was supported in part by NIH training grant T32CA070085, DS was supported in part by NIH training grant T32CA080621, and PL was supported in part by National Science Centre, Poland Grant 2016/22/M/NZ2/00548. We thank Dr John A. Kessler for providing the JK18 and JK46 GSC lines.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BRADLEY NJ, 1983, BRIT J CANCER, V48, P819, DOI 10.1038/bjc.1983.272; Bustos O, 2009, GENE, V447, P1, DOI 10.1016/j.gene.2009.07.006; Desjardins A, 2005, FRONT BIOSCI-LANDMRK, V10, P2645, DOI 10.2741/1727; Eckerdt F, 2016, BIOTECHNIQUES, V60, P43, DOI 10.2144/000114372; Feng HZ, 2014, J CLIN INVEST, V124, P3741, DOI 10.1172/JCI73093; Fish EN, 2014, MOL CANCER RES, V12, P1691, DOI 10.1158/1541-7786.MCR-14-0450; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Geserick P, 2004, INT IMMUNOL, V16, P1535, DOI 10.1093/intimm/dxh155; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Ji F, 2013, INT J ONCOL, V42, P1578, DOI 10.3892/ijo.2013.1878; Katsoulidis E, 2010, J BIOL CHEM, V285, P40333, DOI 10.1074/jbc.M110.151076; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; LEVY DE, 1988, GENE DEV, V2, P383, DOI 10.1101/gad.2.4.383; Li MQ, 2012, NATURE, V491, P125, DOI 10.1038/nature11433; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Mavrommatis E, 2013, J INTERF CYTOK RES, V33, P206, DOI 10.1089/jir.2012.0133; Motomura K, 2011, CANCER-AM CANCER SOC, V117, P1721, DOI 10.1002/cncr.25637; Nagato S, 2005, INT J CANCER, V117, P41, DOI 10.1002/ijc.21102; Napoles OC, 2017, J GASTROENTEROL, V52, P39, DOI 10.1007/s00535-016-1202-4; Natsume A, 2005, CANCER RES, V65, P7573, DOI 10.1158/0008-5472.CAN-05-0036; Neumann B, 2008, BIOCHEM BIOPH RES CO, V370, P62, DOI 10.1016/j.bbrc.2008.03.032; Parker BS, 2016, NAT REV CANCER, V16, P131, DOI 10.1038/nrc.2016.14; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Platanias LC, 2013, J INTERF CYTOK RES, V33, P143, DOI 10.1089/jir.2013.0019; Porritt RA, 2015, TRENDS IMMUNOL, V36, P150, DOI 10.1016/j.it.2015.02.002; REICH N, 1987, P NATL ACAD SCI USA, V84, P6394, DOI 10.1073/pnas.84.18.6394; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Ritchie KJ, 2004, SEMIN CELL DEV BIOL, V15, P237, DOI 10.1016/j.semcdb.2003.12.005; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Sassano A, 2015, MOL CELL BIOL, V35, P2684, DOI 10.1128/MCB.00019-15; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Srikanth M, 2013, NEURO-ONCOLOGY, V15, P319, DOI 10.1093/neuonc/nos316; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Wakabayashi T, 2000, J NEURO-ONCOL, V49, P57, DOI 10.1023/A:1006405512579; Wang Z, 2015, ONCOTARGET, V6, P14191, DOI 10.18632/oncotarget.3691; Yoon CH, 2012, ONCOGENE, V31, P4655, DOI 10.1038/onc.2011.634; Zhang ZF, 2013, GENOME MED, V5, DOI 10.1186/gm437; Zhu TZ, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0727-2; Zoppoli G, 2012, P NATL ACAD SCI USA, V109, P15030, DOI 10.1073/pnas.1205943109	46	35	35	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 26	2017	36	43					6006	6019		10.1038/onc.2017.205	http://dx.doi.org/10.1038/onc.2017.205			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FK9OT	28671669	Green Accepted			2022-12-26	WOS:000413841400009
J	Mahmoud, AM; Wilkinson, FL; McCarthy, EM; Moreno-Martinez, D; Langford-Smith, A; Romero, M; Duarte, J; Alexander, MY				Mahmoud, Ayman M.; Wilkinson, Fiona L.; McCarthy, Eoghan M.; Moreno-Martinez, Daniel; Langford-Smith, Alexander; Romero, Miguel; Duarte, Juan; Alexander, M. Yvonne			Endothelial microparticles prevent lipid-induced endothelial damage via Akt/eNOS signaling and reduced oxidative stress	FASEB JOURNAL			English	Article						extracellular microvesicles; endothelial dysfunction; Nrf2	NITRIC-OXIDE SYNTHASE; CIRCULATING MICROPARTICLES; NADPH OXIDASE; HEME OXYGENASE-1; ACTIVATION; CELLS; NRF2; DYSFUNCTION; INDUCTION; RECEPTOR	Endothelial microparticles (EMPs) are endothelium-derived submicron vesicles that are released in response to diverse stimuli and are elevated in cardiovascular disease, which is correlated with risk factors. This study investigates the effect of EMPs on endothelial cell function and dysfunction in a model of free fatty acid (FFA) palmitate-induced oxidative stress. EMPs were generated from TNF-alpha-stimulated HUVECs and quantified by using flow cytometry. HUVECs were treated with and without palmitate in the presence or absence of EMPs. EMPs were found to carry functional eNOS and to protect against oxidative stress by positively regulating eNOS/Akt signaling, which restored NO production, increased superoxide dismutase and catalase, and suppressed NADPH oxidase and reactive oxygen species (ROS) production, with the involvement of NF-erythroid 2-related factor 2 and heme oxygenase-1. Conversely, under normal conditions, EMPs reduced NO release and increased ROS and redox-sensitive marker expression. In addition, functional assays using EMP-treated mouse aortic rings that were performed under homeostatic conditions demonstrated a decline in endothelium-dependent vasodilatation, but restored the functional response under lipid-induced oxidative stress. These data indicate that EMPs harbor functional eNOS and potentially play a role in the feedback loop of damage and repair during homeostasis, but are also effective in protecting against FFA-induced oxidative stress; thus, EMP function is reflected by the microenvironment.Mahmoud, A. M., Wilkinson, F. L., McCarthy, E. M., Moreno-Martinez, D., Langford-Smith, A., Romero, M., Duarte, J., Alexander, M. Y. Endothelial microparticles prevent lipid-induced endothelial damage via Akt/eNOS signaling and reduced oxidative stress.	[Mahmoud, Ayman M.; Wilkinson, Fiona L.; McCarthy, Eoghan M.; Moreno-Martinez, Daniel; Langford-Smith, Alexander; Alexander, M. Yvonne] Manchester Metropolitan Univ, Healthcare Sci Res Ctr, Fac Sci & Engn, Manchester, Lancs, England; [Mahmoud, Ayman M.; Wilkinson, Fiona L.; McCarthy, Eoghan M.; Moreno-Martinez, Daniel; Langford-Smith, Alexander; Alexander, M. Yvonne] Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Mahmoud, Ayman M.] Beni Suef Univ, Div Physiol, Dept Zool, Fac Sci, Bani Suwayf, Egypt; [McCarthy, Eoghan M.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Inst Inflammat & Repair, Ctr Musculoskeletal Res, Manchester, Lancs, England; [McCarthy, Eoghan M.] Cent Manchester Univ Hosp NHS Fdn Trust, Natl Inst Hlth Res Manchester, Musculoskeletal Biomed Res Unit, Manchester, Lancs, England; [Romero, Miguel] Univ Granada, Sch Pharm, Dept Pharmacol, Granada, Spain; [Duarte, Juan] Inst Invest Biosanitaria Granada, Granada, Spain	Manchester Metropolitan University; University of Manchester; Egyptian Knowledge Bank (EKB); Beni Suef University; University of Manchester; University of Manchester; University of Granada; Instituto de Investigacion Biosanitaria IBS Granada	Alexander, MY (corresponding author), Manchester Metropolitan Univ, Healthcare Sci Res Ctr, John Dalton Bldg,Chester St, Manchester M1 5GD, Lancs, England.	y.alexander@mmu.ac.uk	Mahmoud, Ayman M./S-2613-2016; Duarte, Juan/AAH-1574-2020; perez, miguel/GXF-5077-2022; Langford-Smith, Alex/K-7624-2017; Romero, Miguel/K-6053-2014; Duarte, Juan/K-6472-2014	Mahmoud, Ayman M./0000-0003-0279-6500; Duarte, Juan/0000-0002-9153-5857; Langford-Smith, Alex/0000-0001-7006-0592; Romero, Miguel/0000-0003-0578-1099; Duarte, Juan/0000-0002-9153-5857; Wilkinson, Fiona/0000-0002-0358-3489; Moreno Martinez, Daniel/0000-0001-5633-0998	Science and Technology Development Fund	Science and Technology Development Fund(Science and Technology Development Fund (STDF))	The authors thank the Science and Technology Development Fund and the International Atherosclerosis Society for supporting the travel of A.M.M. The authors declare no conflicts of interest.	Addabbo F, 2009, HYPERTENSION, V53, P885, DOI 10.1161/HYPERTENSIONAHA.109.130054; Aharon A, 2008, THROMB HAEMOSTASIS, V100, P878, DOI 10.1160/TH07-11-0691; Alexander MY, 2000, CARDIOVASC RES, V47, P609, DOI 10.1016/S0008-6363(00)00079-1; Amabile N, 2014, EUR HEART J, V35, P2972, DOI 10.1093/eurheartj/ehu153; Boulanger CM, 2001, CIRCULATION, V104, P2649, DOI 10.1161/hc4701.100516; Brodsky SV, 2004, AM J PHYSIOL-HEART C, V286, pH1910, DOI 10.1152/ajpheart.01172.2003; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Burger D, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001842; Burger D, 2011, ARTERIOSCL THROM VAS, V31, P1898, DOI 10.1161/ATVBAHA.110.222703; Cade WT, 2008, PHYS THER, V88, P1322, DOI 10.2522/ptj.20080008; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Cheng XH, 2011, ANTIOXID REDOX SIGN, V14, P469, DOI 10.1089/ars.2010.3283; Chien SJ, 2014, TRANSL RES, V163, P43, DOI 10.1016/j.trsl.2013.09.008; Cho HY, 2010, TOXICOL APPL PHARM, V244, P43, DOI 10.1016/j.taap.2009.07.024; Combes V, 1999, J CLIN INVEST, V104, P93, DOI 10.1172/JCI4985; Datla SR, 2007, HYPERTENSION, V50, P636, DOI 10.1161/HYPERTENSIONAHA.107.092296; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Dimmeler S, 2000, FEBS LETT, V477, P258, DOI 10.1016/S0014-5793(00)01657-4; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; Fledderus JO, 2008, ARTERIOSCL THROM VAS, V28, P1339, DOI 10.1161/ATVBAHA.108.165811; Guo WX, 2008, ARCH MED RES, V39, P434, DOI 10.1016/j.arcmed.2008.02.001; Gyorgy B, 2011, BLOOD, V117, pE39, DOI 10.1182/blood-2010-09-307595; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Heathfield SK, 2013, CLIN EXP RHEUMATOL, V31, P225; Heiss EH, 2009, J BIOL CHEM, V284, P31579, DOI 10.1074/jbc.M109.009175; Hill AF, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.22859; Hirose A, 2010, FEBS LETT, V584, P61, DOI 10.1016/j.febslet.2009.11.082; Horn P, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.003764; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Italiano JE, 2010, CURR OPIN HEMATOL, V17, P578, DOI 10.1097/MOH.0b013e32833e77ee; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jansen F, 2012, ARTERIOSCL THROM VAS, V32, P1925, DOI 10.1161/ATVBAHA.112.253229; Jiang F, 2006, HYPERTENSION, V48, P950, DOI 10.1161/01.HYP.0000242336.58387.1f; Jung KA, 2010, MOLECULES, V15, P7266, DOI 10.3390/molecules15107266; Kim YM, 2011, ANTIOXID REDOX SIGN, V14, P137, DOI 10.1089/ars.2010.3153; Lacroix R, 2012, J THROMB HAEMOST, V10, P437, DOI 10.1111/j.1538-7836.2011.04610.x; Laughlin MH, 2008, J APPL PHYSIOL, V104, P588, DOI 10.1152/japplphysiol.01096.2007; Lee CH, 2014, INT J MOL SCI, V15, P10334, DOI 10.3390/ijms150610334; Leroyer AS, 2009, CIRCULATION, V119, P2808, DOI 10.1161/CIRCULATIONAHA.108.816710; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Li LR, 2014, CHEM-BIOL INTERACT, V209, P56, DOI 10.1016/j.cbi.2013.12.005; Liu TS, 2014, J ENDOCRINOL INVEST, V37, P645, DOI 10.1007/s40618-014-0086-5; LOTVALL J, 2014, J EXTRACELL VESICLES, V3; Luo ZM, 2015, HYPERTENSION, V65, P896, DOI 10.1161/HYPERTENSIONAHA.114.04760; Mahmoud AM, 2017, BBA-GEN SUBJECTS, V1861, P3311, DOI 10.1016/j.bbagen.2016.08.013; Mahmoud AM, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0491-1; Mann GE, 2007, CARDIOVASC RES, V75, P261, DOI 10.1016/j.cardiores.2007.04.004; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; McCarthy EM, 2016, VASC PHARMACOL, V86, P71, DOI 10.1016/j.vph.2016.05.016; Moreno-Martinez D, 2014, HEART, V100, DOI 10.1136/heartjnl-2014-306916.6; Mostefai HA, 2008, J IMMUNOL, V180, P5028, DOI 10.4049/jimmunol.180.7.5028; Mostefai HA, 2008, AM J RESP CRIT CARE, V178, P1148, DOI 10.1164/rccm.200712-1835OC; Parker B, 2014, ANN RHEUM DIS, V73, P1144, DOI 10.1136/annrheumdis-2012-203028; Perez-Casal M, 2009, HAEMATOL-HEMATOL J, V94, P387, DOI 10.3324/haematol.13547; Quintela AM, 2014, BRIT J PHARMACOL, V171, P3089, DOI 10.1111/bph.12646; Romero M, 2009, ATHEROSCLEROSIS, V202, P58, DOI 10.1016/j.atherosclerosis.2008.03.007; Schiro A, 2014, ATHEROSCLEROSIS, V234, P295, DOI 10.1016/j.atherosclerosis.2014.03.019; Schiro A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16658; Siow RCM, 1999, CARDIOVASC RES, V41, P385, DOI 10.1016/S0008-6363(98)00278-8; Toral M, 2015, CLIN SCI, V129, P823, DOI 10.1042/CS20150111; Wheatcroft SB, 2003, DIABETIC MED, V20, P255, DOI 10.1046/j.1464-5491.2003.00869.x; Xue MZ, 2008, DIABETES, V57, P2809, DOI 10.2337/db06-1003; Yuana Y, 2013, BLOOD REV, V27, P31, DOI 10.1016/j.blre.2012.12.002; Zhang HR, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0237-1	65	66	68	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4636	4648		10.1096/fj.201601244RR	http://dx.doi.org/10.1096/fj.201601244RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28687612	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000413397400038
J	Xue, JX; Jiang, W; Chen, YJ; Gong, FJ; Wang, MY; Zeng, P; Xia, C; Wang, Q; Huang, KH				Xue, Junxin; Jiang, Wei; Chen, Yongjun; Gong, Fengju; Wang, Minyan; Zeng, Peng; Xia, Can; Wang, Quan; Huang, Kehe			Thioredoxin reductase from Toxoplasma gondii: an essential virulence effector with antioxidant function	FASEB JOURNAL			English	Article						protein expression; enzyme activity; immune evasion; gene knockout	PROTOZOAN PARASITES; OXIDATIVE STRESS; REACTIVE OXYGEN; PLASMODIUM-FALCIPARUM; INNATE IMMUNITY; INFECTION; CATALASE; CELLS; MACROPHAGES; EXPRESSION	Thioredoxin reductase (TR) can help pathogens resist oxidative-burst injury from host immune cells by maintaining a thioredoxin-reduction state during NADPH consumption. TR is a necessary virulence factor that enables the persistent infection of some parasites. We performed bioinformatics analyses and biochemical assays to characterize the activity, subcellular localization, and genetic ablation of Toxoplasma gondii TR (TgTR), to shed light on its biologic function. We expressed the TgTR protein with an Escherichia coli expression system and analyzed its enzyme activity, reporting a K-m for the recombinant TgTR of 11.47-15.57 mu M, using NADPH as a substrate, and 130.48-151.09 mu M with dithio-bis-nitrobenzoic acid as a substrate. The TgTR sequence shared homology with that of TR, but lacked a selenocysteine residue in the C-terminal region and was thought to contain 2 flavin adenine dinucleotide (FAD) domains and 1 NADPH domain. In addition, immunoelectron microscopy results showed that TgTR was widely dispersed in the cytoplasm, and we observed that parasite antioxidant capacity, invasion efficiency, and proliferation were decreased in TR-knockout (TR-KO) strains in vitro, although this strain still stimulated the release of reactive oxygen species release in mouse macrophages while being more sensitive to H2O2 toxicity in vitro. Furthermore, our in vivo results revealed that the survival time of mice infected with the TR-KO strain was significantly prolonged relative to that of mice infected with the wild-type strain. These results suggest that TgTR plays an important role in resistance to oxidative damage and can be considered a virulence factor associated with T. gondii infection.-Xue, J., Jiang, W., Chen, Y., Gong, F., Wang, M., Zeng, P., Xia, C., Wang, Q., Huang, K. Thioredoxin reductase from Toxoplasma gondii: an essential virulence effector with antioxidant function.	[Xue, Junxin; Jiang, Wei; Chen, Yongjun; Wang, Minyan; Wang, Quan] Chinese Acad Agr Sci, Shanghai Vet Res Inst, 518 Ziyue Rd, Shanghai, Peoples R China; [Xue, Junxin; Gong, Fengju; Zeng, Peng; Xia, Can; Huang, Kehe] Nanjing Agr Univ, Coll Vet Med, 1 Weigang, Nanjing 210095, Jiangsu, Peoples R China; [Xue, Junxin] Shanghai Entry Exit Inspect & Quarantine Bur, Shanghai, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Nanjing Agricultural University	Wang, Q (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, 518 Ziyue Rd, Shanghai, Peoples R China.; Huang, KH (corresponding author), Nanjing Agr Univ, Coll Vet Med, 1 Weigang, Nanjing 210095, Jiangsu, Peoples R China.	wangquan@shvri.ac.cn; khhuang@njau.edu.cn			National Special Research Program for Nonprofit Trades (Agriculture) [201303045]; National Natural Science Foundation of China [31472253]; Shanghai Natural Science Foundation of China [17ZR1437300]; Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China [2013JB10]	National Special Research Program for Nonprofit Trades (Agriculture); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China	This work was supported by National Special Research Program for Nonprofit Trades (Agriculture) Grant 201303045 (to Q.W.), National Natural Science Foundation of China Grant 31472253 (to K.H.), Shanghai Natural Science Foundation of China Grand 17ZR1437300 (to Q.W.), and Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China Grant 2013JB10 (to W.J.). The authors declare no conflicts of interest.	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Akerman SE, 2005, J BIOL CHEM, V280, P564, DOI 10.1074/jbc.M406367200; Berens RL, 1998, J INFECT DIS, V177, P1128, DOI 10.1086/517411; Brantley EC, 2010, TRANSL ONCOL, V3, P380, DOI 10.1593/tlo.10208; Brizuela M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092411; Butcher BA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002236; Charvat RA, 2016, SCI REP-UK, V6, DOI 10.1038/srep22997; Chen XX, 2012, FREE RADICAL BIO MED, V53, P395, DOI 10.1016/j.freeradbiomed.2012.04.035; Correa G, 2010, MICROBES INFECT, V12, P497, DOI 10.1016/j.micinf.2010.03.004; Debierre-Grockiego F, 2010, GLYCOBIOLOGY, V20, P801, DOI 10.1093/glycob/cwq038; Engin AB, 2012, PARASITOL RES, V111, P1725, DOI 10.1007/s00436-012-3015-6; Fereig RM, 2016, PARASITOL INT, V65, P741, DOI 10.1016/j.parint.2016.09.008; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; Gan F, 2015, FREE RADICAL BIO MED, V80, P33, DOI 10.1016/j.freeradbiomed.2014.12.016; Gay G, 2016, J EXP MED, V213, P1779, DOI 10.1084/jem.20160340; Guillermo LVC, 2004, POULTRY SCI, V83, P776, DOI 10.1093/ps/83.5.776; Hunter CA, 2012, NAT REV MICROBIOL, V10, P766, DOI 10.1038/nrmicro2858; Kaasch AJ, 2000, J BIOL CHEM, V275, P1112, DOI 10.1074/jbc.275.2.1112; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; Kwok LY, 2004, MOL MICROBIOL, V51, P47, DOI 10.1046/j.1365-2958.2003.03823.x; Laliberte J, 2008, CELL MOL LIFE SCI, V65, P1900, DOI 10.1007/s00018-008-7556-x; Li ZH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003665; Lin HC, 2015, SCIENCE, V349, P91, DOI 10.1126/science.aab0515; Lingelbach K, 1998, J CELL SCI, V111, P1467; Lobanov AV, 2009, BBA-GEN SUBJECTS, V1790, P1424, DOI 10.1016/j.bbagen.2009.05.014; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Marshall ES, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-80; McCarty SE, 2015, MOLECULES, V20, P11459, DOI 10.3390/molecules200611459; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Moncada D, 2016, EXP PARASITOL, V164, P36, DOI 10.1016/j.exppara.2016.02.005; Naderer T, 2011, ESSAYS BIOCHEM, V51, P81, DOI [10.1042/BSE0510081, 10.1042/bse0510081]; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nebl T, 2005, PARASITOLOGY, V130, pS45, DOI 10.1017/S0031182005008152; Nischik N, 2001, MICROBES INFECT, V3, P689, DOI 10.1016/S1286-4579(01)01425-3; Novoselov SV, 2007, P NATL ACAD SCI USA, V104, P7857, DOI 10.1073/pnas.0610683104; Oliveira MP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158429; Pino P, 2007, PLOS PATHOG, V3, P1092, DOI 10.1371/journal.ppat.0030115; Portes JA, 2015, ANTIMICROB AGENTS CH, V59, P7374, DOI 10.1128/AAC.00057-15; Rahlfs S, 2002, CELL MOL LIFE SCI, V59, P1024, DOI 10.1007/s00018-002-8484-9; Ramakrishnan S, 2013, PROG LIPID RES, V52, P488, DOI 10.1016/j.plipres.2013.06.003; Roma EH, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1472-y; Rosowski EE, 2011, J EXP MED, V208, P195, DOI 10.1084/jem.20100717; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Schofield L, 2002, NATURE, V418, P785, DOI 10.1038/nature00937; Seabra SJ, 2002, EXP PARASITOL, V100, P62, DOI 10.1006/expr.2001.4675; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; SIBLEY LD, 1986, MOL BIOCHEM PARASIT, V19, P83, DOI 10.1016/0166-6851(86)90069-1; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Sun QA, 2001, P NATL ACAD SCI USA, V98, P3673, DOI 10.1073/pnas.051454398; Tawk L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001286; Tobin CM, 2012, INFECT IMMUN, V80, P55, DOI 10.1128/IAI.05543-11; Vonlaufen N, 2008, CELL MICROBIOL, V10, P2387, DOI 10.1111/j.1462-5822.2008.01210.x; Xue JX, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1643-x; Yan C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1432-6; Yarovinsky F, 2014, NAT REV IMMUNOL, V14, P109, DOI 10.1038/nri3598; Zheng J, 2015, INT J PARASITOL, V45, P141, DOI 10.1016/j.ijpara.2014.09.003; Zhou DH, 2014, ELECTROPHORESIS, V35, P533, DOI 10.1002/elps.201300044	57	20	24	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4447	4457		10.1096/fj.201700008R	http://dx.doi.org/10.1096/fj.201700008R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28687608				2022-12-26	WOS:000413397400022
J	Gerodimos, CA; Chang, HHY; Watanabe, G; Lieber, MR				Gerodimos, Christina A.; Chang, Howard H. Y.; Watanabe, Go; Lieber, Michael R.			Effects of DNA end configuration on XRCC4-DNA ligase IV and its stimulation of Artemis activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; DNA recombination; DNA repair; DNA-dependent serine; threonine protein kinase (DNA-PK); endonuclease; nucleic acid enzymology; NHEJ; V(D)J recombination; double strand DNA breaks; nonhomologous DNA end joining	DEPENDENT PROTEIN-KINASE; V(D)J RECOMBINATION; STRANDED-DNA; NUCLEASE ARTEMIS; JOINT FORMATION; DEFICIENT MICE; BREAK REPAIR; DAMAGE; PKCS; KU	In humans, nonhomologous DNA end-joining (NHEJ) is the major pathway by which DNA double-strand breaks are repaired. Recognition of each broken DNA end by the DNA repair protein Ku is the first step in NHEJ, followed by the iterative binding of nucleases, DNA polymerases, and the XRCC4-DNA ligase IV (X4-LIV) complex in an order influenced by the configuration of the two DNA ends at the break site. The endonuclease Artemis improves joining efficiency by functioning in a complex with DNA-dependent protein kinase, catalytic subunit (DNA-PKcs) that carries out endonucleolytic cleavage of 5 and 3 overhangs. Previously, we observed that X4-LIV alone can stimulate Artemis activity on 3 overhangs, but this DNA-PKcs-independent endonuclease activity of Artemis awaited confirmation. Here, using in vitro nuclease and ligation assays, we find that stimulation of Artemis nuclease activity by X4-LIV and the efficiency of blunt-end ligation are determined by structural configurations at the DNA end. Specifically, X4-LIV stimulated Artemis to cut near the end of 3 overhangs without the involvement of other NHEJ proteins. Of note, this ligase complex is not able to stimulate Artemis activity at hairpins or at 5 overhangs. We also found that X4-LIV and DNA-PKcs interfere with one another with respect to stimulating Artemis activity at 3 overhangs, favoring the view that these NHEJ proteins are sequentially rather than concurrently recruited to DNA ends. These data suggest specific functional and positional relationships among these components that explain genetic and molecular features of NHEJ and V(D)J recombination within cells.	[Lieber, Michael R.] Univ Southern Calif, Keck Sch Med, Dept Pathol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; Univ Southern Calif, Keck Sch Med, Dept Biochem & Mol Biol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biol Sci,Sect Mol & Computat Biol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Lieber, MR (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Pathol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA.	lieber@usc.edu		Lieber, Michael/0000-0003-3700-6345; Lieber, Michael/0000-0001-8809-0909	National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA196671, R01CA100504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health grants (to M. R. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ashour ME, 2015, NAT REV CANCER, V15, P137, DOI 10.1038/nrc3892; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chang HHY, 2016, J BIOL CHEM, V291, P24377, DOI 10.1074/jbc.M116.752329; Chang HHY, 2015, J BIOL CHEM, V290, P24036, DOI 10.1074/jbc.M115.680900; De Ioannes P, 2012, CELL REP, V2, P1505, DOI 10.1016/j.celrep.2012.11.004; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Gauss GH, 1996, MOL CELL BIOL, V16, P258; Goodarzi AA, 2004, DNA REPAIR, V3, P753, DOI 10.1016/j.dnarep.2004.03.041; GRIFFITH AJ, 1992, J BIOL CHEM, V267, P331; Gu JF, 2008, GENE DEV, V22, P411, DOI 10.1101/gad.1646608; Gu JF, 2010, DNA REPAIR, V9, P429, DOI 10.1016/j.dnarep.2010.01.001; Karanjawala ZE, 2002, DNA REPAIR, V1, P1017, DOI 10.1016/S1568-7864(02)00151-9; Kulesza P, 1998, NUCLEIC ACIDS RES, V26, P3944, DOI 10.1093/nar/26.17.3944; Li SC, 2014, J BIOL CHEM, V289, P7825, DOI 10.1074/jbc.M113.544874; Li SC, 2011, J BIOL CHEM, V286, P36368, DOI 10.1074/jbc.M111.287797; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; LIEBER MR, 1988, P NATL ACAD SCI USA, V85, P8588, DOI 10.1073/pnas.85.22.8588; Lieber MR, 2004, NAT REV MOL CELL BIO, V5, P69, DOI 10.1038/nrm1281; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; Ma YM, 2004, MOL CELL, V16, P701, DOI 10.1016/j.molcel.2004.11.017; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mahowald GK, 2008, CELL, V135, P1009, DOI 10.1016/j.cell.2008.11.024; Malu S, 2012, J EXP MED, V209, P955, DOI 10.1084/jem.20111437; MARTIN GM, 1985, ISRAEL J MED SCI, V21, P296; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; Niewolik D, 2006, J BIOL CHEM, V281, P33900, DOI 10.1074/jbc.M606023200; Niewolik D, 2017, J BIOL CHEM, V292, P3351, DOI 10.1074/jbc.M116.770461; Pannicke U, 2004, EMBO J, V23, P1987, DOI 10.1038/sj.emboj.7600206; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Reid DA, 2017, NUCLEIC ACIDS RES, V45, P1872, DOI 10.1093/nar/gkw1221; Renkawitz J, 2014, NAT REV MOL CELL BIO, V15, P369, DOI 10.1038/nrm3805; Rooney S, 2002, MOL CELL, V10, P1379, DOI 10.1016/S1097-2765(02)00755-4; Santivasi WL, 2014, ANTIOXID REDOX SIGN, V21, P251, DOI 10.1089/ars.2013.5668; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Touvrey C, 2008, MOL IMMUNOL, V45, P3383, DOI 10.1016/j.molimm.2008.04.004; West RB, 1998, MOL CELL BIOL, V18, P5908, DOI 10.1128/MCB.18.10.5908	36	21	23	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					13914	13924		10.1074/jbc.M117.798850	http://dx.doi.org/10.1074/jbc.M117.798850			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28696258	hybrid, Green Published			2022-12-26	WOS:000408439800002
J	Zhou, M; Wang, M; Xue, L; Lin, Z; He, QF; Shi, WW; Chen, YR; Jin, XF; Li, HY; Jiang, PP; Guan, MX				Zhou, Mi; Wang, Meng; Xue, Ling; Lin, Zhi; He, Qiufen; Shi, Wenwen; Chen, Yaru; Jin, Xiaofen; Li, Haiying; Jiang, Pingping; Guan, Min-Xin			A hypertension-associated mitochondrial DNA mutation alters the tertiary interaction and function of tRNA(Leu(UUR))	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hypertension; mitochondrial disease; mitochondrial DNA (mtDNA); mitochondrial membrane potential; mitochondrial metabolism; mitochondrial respiratory chain complex; mutant; pathogenesis; RNA structure; transfer RNA (tRNA)	TRANSFER-RNA MUTATIONS; MATERNALLY INHERITED HYPERTENSION; OXIDATIVE STRESS; BLOOD-PRESSURE; MTDNA; GENE; AMINOACYLATION; HEALTH; DEFICIENCY; METABOLISM	Several mitochondrial tRNA mutations have been associated with hypertension, but their pathophysiology remains poorly understood. In this report, we identified a novel homoplasmic 3253TC mutation in the mitochondrial tRNA(Leu(UUR)) gene in a Han Chinese family with maternally inherited hypertension. The m.3253TC mutation affected a highly conserved uridine at position 22 at the D-stem of tRNA(Leu(UUR)), introducing a G-C base pairing (G13-C22) at the D-stem and a tertiary base pairing (C22-G46) between the D-stem and the variable loop. We therefore hypothesized that the m.3253TC mutation altered both the structure and function of tRNA(Leu(UUR)). Using cytoplasmic hybrid (cybrid) cell lines derived from this Chinese family, we demonstrated that the m.3253TC mutation perturbed the conformation and stability of tRNA(Leu(UUR)), as suggested by faster electrophoretic mobility of mutated tRNA relative to the wild-type molecule. Northern blot analysis revealed an approximate to 45% decrease in the steady-state level of tRNA(Leu(UUR)) in the mutant cell lines carrying the m.3253TC mutation, as compared with control cell lines. Moreover, an approximate to 35% reduction in aminoacylation efficiency of tRNA(Leu(UUR)) was observed in the m.3253TC mutant cells. These alterations in tRNA(Leu(UUR)) metabolism impaired mitochondrial translation, especially for those polypeptides with a high proportion of Leu(UUR) codons, such as ND6. Furthermore, we demonstrated that the m.3253TC mutation decreased the activities of mitochondrial complexes I and V, markedly diminished mitochondrial ATP levels and membrane potential, and increased the production of reactive oxygen species in the cells. In conclusion, our findings may provide new insights into the pathophysiology of maternally inherited hypertension.	[Zhou, Mi; Wang, Meng; Jiang, Pingping; Guan, Min-Xin] Zhejiang Univ, Childrens Hosp, Div Med Genet & Genom, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Zhou, Mi; Wang, Meng; He, Qiufen; Jin, Xiaofen; Jiang, Pingping; Guan, Min-Xin] Zhejiang Univ, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China; [Guan, Min-Xin] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310058, Zhejiang, Peoples R China; [Xue, Ling; Lin, Zhi; Shi, Wenwen; Chen, Yaru] Wenzhou Med Univ, Attardi Inst Mitochondrial Biomed, Wenzhou 325600, Zhejiang, Peoples R China; [Li, Haiying] Wenzhou Med Univ, Affiliated Hosp 1, Dept Cardiol, Wenzhou 325600, Zhejiang, Peoples R China; [Guan, Min-Xin] Joint Inst Genet & Genom Med Zhejiang Univ & Univ, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Wenzhou Medical University; Wenzhou Medical University	Guan, MX (corresponding author), Zhejiang Univ, Inst Genet, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China.	gminxin88@zju.edu.cn		He, Qiufen/0000-0002-1175-1913; JIANG, PINGPING/0000-0002-4975-4861; Guan, Min-Xin/0000-0001-5067-6736	National Basic Research Priorities Program of China [2014CB541704]; National Natural Science Foundation of China [81600326, 31371270, 31401070, 81500611]; Postdoctoral Science Foundation of China [2016M591987]; Fundamental Research Funds for the Central Universities Grant [2017QNA7026]	National Basic Research Priorities Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities Grant(Fundamental Research Funds for the Central Universities)	This work was supported by National Basic Research Priorities Program of China Grant 2014CB541704 (to M. X. G.); National Natural Science Foundation of China Grants 81600326 (to M. Z.), 31371270 (to P. J.), 31401070 (to L. X.), and 81500611 (to M. W.); Postdoctoral Science Foundation of China Grant 2016M591987 (to M. Z.); and Fundamental Research Funds for the Central Universities Grant 2017QNA7026 (to M. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbott JA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00158; Addabbo F, 2009, HYPERTENSION, V53, P885, DOI 10.1161/HYPERTENSIONAHA.109.130054; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Chen C, 2015, PROTEIN CELL, V6, P862, DOI 10.1007/s13238-015-0175-z; Chen DN, 2016, INT J BIOCHEM CELL B, V77, P1, DOI 10.1016/j.biocel.2016.05.012; Chen YB, 2011, J CELL BIOL, V195, P263, DOI 10.1083/jcb.201108059; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199; De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Dromparis P, 2013, ANNU REV PHYSIOL, V75, P95, DOI 10.1146/annurev-physiol-030212-183804; Eirin A, 2015, HYPERTENSION, V65, P264, DOI 10.1161/HYPERTENSIONAHA.114.04598; Enriquez J A, 1996, Methods Enzymol, V264, P183, DOI 10.1016/S0076-6879(96)64019-1; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1; Giege R, 2012, WIRES RNA, V3, P37, DOI 10.1002/wrna.103; Gong SS, 2014, NUCLEIC ACIDS RES, V42, P8039, DOI 10.1093/nar/gku466; Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; Hao R, 2005, NUCLEIC ACIDS RES, V33, P3606, DOI 10.1093/nar/gki677; HAVLIK RJ, 1982, HYPERTENSION, V4, P121; Hayashi G, 2015, FREE RADICAL BIO MED, V88, P10, DOI 10.1016/j.freeradbiomed.2015.05.039; Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047; James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x; Jia ZD, 2013, HUM MOL GENET, V22, P4064, DOI 10.1093/hmg/ddt256; Jiang PP, 2016, MOL CELL BIOL, V36, P1920, DOI 10.1128/MCB.00199-16; Jiang PP, 2016, HUM MOL GENET, V25, P584, DOI 10.1093/hmg/ddv498; Joint National Committee on Prevention Detection evaluation and treatment of high blood pressure, 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005; King M P, 1996, Methods Enzymol, V264, P313, DOI 10.1016/S0076-6879(96)64030-0; KING MP, 1993, J BIOL CHEM, V268, P10228; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09; Li RH, 2009, HYPERTENSION, V54, P329, DOI 10.1161/HYPERTENSIONAHA.109.129270; Li Y, 1999, SCI CHINA SER C, V42, P185, DOI 10.1007/BF02880055; Li YF, 2007, J BIOL CHEM, V282, P17557, DOI 10.1074/jbc.M701056200; Li ZB, 2008, BIOCHEM BIOPH RES CO, V367, P906, DOI 10.1016/j.bbrc.2007.12.150; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Liu CY, 2012, HYPERTENSION, V60, P949, DOI 10.1161/HYPERTENSIONAHA.112.196519; Liu YJ, 2016, J CHEM-NY, V2016, DOI 10.1155/2016/6903524; Liu YQ, 2009, HYPERTENSION, V53, P1083, DOI 10.1161/HYPERTENSIONAHA.109.128702; Mahfouz R, 2009, FERTIL STERIL, V92, P819, DOI 10.1016/j.fertnstert.2008.05.087; Marian AJ, 2011, CIRC RES, V108, P784, DOI 10.1161/CIRCRESAHA.111.242768; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; Moser Marvin, 1999, J Clin Hypertens (Greenwich), V1, P48; Pallotti F, 2004, BIOCHEM J, V384, P287, DOI 10.1042/BJ20040561; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378; SAXENA SK, 1992, J BIOL CHEM, V267, P21982; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Szczepanowska J, 2012, BBA-BIOENERGETICS, V1817, P1740, DOI 10.1016/j.bbabio.2012.02.028; Thorburn DR, 2004, MITOCHONDRION, V4, P363, DOI 10.1016/j.mito.2004.07.003; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang M, 2016, NUCLEIC ACIDS RES, V44, P10974, DOI 10.1093/nar/gkw726; Wang M, 2016, J BIOL CHEM, V291, P21029, DOI 10.1074/jbc.M116.739482; Wang SW, 2011, CIRC RES, V108, P862, DOI 10.1161/CIRCRESAHA.110.231811; Watson B, 2001, AM J KIDNEY DIS, V38, P529, DOI 10.1053/ajkd.2001.26848; Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Xue L, 2016, MITOCHONDRION, V30, P208, DOI 10.1016/j.mito.2016.08.008; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Zhang JJ, 2014, MITOCHONDRION, V18, P18, DOI 10.1016/j.mito.2014.08.008; Zheng J, 2012, MITOCHONDRION, V12, P406, DOI 10.1016/j.mito.2012.04.001; ZINNER SH, 1971, NEW ENGL J MED, V284, P401, DOI 10.1056/NEJM197102252840801	69	20	22	0	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					13934	13946		10.1074/jbc.M117.787028	http://dx.doi.org/10.1074/jbc.M117.787028			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28679533	hybrid, Green Published			2022-12-26	WOS:000408439800004
J	Xie, Q; Wang, ZA				Xie, Qing; Wang, Zhu A.			Transcriptional regulation of the Nkx3.1 gene in prostate luminal stem cell specification and cancer initiation via its 3 ' genomic region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; ANDROGEN RECEPTOR; MOUSE PROSTATE; HOMEOBOX GENE; DNA-DAMAGE; PTEN LOSS; EXPRESSION; MODEL; CASTRATION; ADENOCARCINOMA	NK3 homeobox 1 (Nkx3.1), a transcription factor expressed in the prostate epithelium, is crucial for maintaining prostate cell fate and suppressing tumor initiation. Nkx3.1 isubiquitously expressed in luminal cells of hormonally intact prostate but, upon androgen deprivation, exclusively labels a type of luminal stem cells named castration-resistant Nkx3.1-expressing cells (CARNs). During prostate cancer initiation, Nkx3.1 expression is frequently lost in both humans and mouse models. Therefore, investigating how Nkx3.1 expression is regulated in vivo is important for understanding the mechanisms of prostate stem cell specification and cancer initiation. Here, using a transgenic mouse line with destabilized GFP, we identified an 11-kb genomic region 3' of the Nkx3.1 transcription start site to be responsible for alterations in Nkx3.1 expression patterns under various physiological conditions. We found that androgen cell-autonomously activates Nkx3.1 expression through androgen receptor (AR) binding to the 11-kb region in both normal luminal cells and CARNs and discovered new androgen response elements in the Nkx3.1 3' UTR. In contrast, we foundthat, in Pten(-/-) prostatetumors, loss of Nkx3.1 expression is mediated at the transcriptional level through the 11-kb region despite functional AR in the nucleus. Importantly, the GFP reporter specifically labeled CARNs in the regressed prostate only in the presence of cell-autonomous AR, supporting a facultative model for CARN specification.	[Xie, Qing; Wang, Zhu A.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, 1156 High St,Mailstop MCDB, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Wang, ZA (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, 1156 High St,Mailstop MCDB, Santa Cruz, CA 95064 USA.	zwang36@ucsc.edu		Wang, Zhu/0000-0002-8855-8951	UCSC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116872] Funding Source: NIH RePORTER	UCSC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank UCSC for a special research grant enabling generation of the Nkx3.1(11)-d2EGFP mice.	Abate-Shen C, 2003, CANCER RES, V63, P3886; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bethel CR, 2007, PROSTATE, V67, P1740, DOI 10.1002/pros.20579; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Bieberich CJ, 1996, J BIOL CHEM, V271, P31779, DOI 10.1074/jbc.271.50.31779; Bowen C, 2015, CANCER RES, V75, P2686, DOI 10.1158/0008-5472.CAN-14-3387; Bowen C, 2010, CANCER RES, V70, P3089, DOI 10.1158/0008-5472.CAN-09-3138; Cai BW, 2013, CELL REP, V4, P516, DOI 10.1016/j.celrep.2013.06.039; Chen H, 2005, DEV DYNAM, V234, P961, DOI 10.1002/dvdy.20596; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; Dutta A, 2016, SCIENCE, V352, P1576, DOI 10.1126/science.aad9512; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Francis JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003180; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Huang LW, 2005, DEV BIOL, V278, P396, DOI 10.1016/j.ydbio.2004.11.020; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P2884, DOI 10.1073/pnas.042688999; Kojima Chinatsu, 2010, Gene Expr, V15, P89; Kruithof-de Julio M, 2013, DEV DYNAM, V242, P1160, DOI 10.1002/dvdy.24008; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Nodouzi V, 2015, INT BRAZ J UROL, V41, P898, DOI 10.1590/S1677-5538.IBJU.2014.0036; Schneider A, 2000, MECH DEVELOP, V95, P163, DOI 10.1016/S0925-4773(00)00355-5; Sciavolino PJ, 1997, DEV DYNAM, V209, P127, DOI 10.1002/(SICI)1097-0177(199705)209:1<127::AID-AJA12>3.0.CO;2-Z; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Simons BW, 2012, DEV BIOL, V371, P246, DOI 10.1016/j.ydbio.2012.08.016; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tanaka M, 2000, DEV DYNAM, V219, P248, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1054>3.3.CO;2-5; Thomas MA, 2006, J CELL BIOCHEM, V99, P1409, DOI 10.1002/jcb.21020; Thomas MA, 2010, BIOCHEM J, V425, P575, DOI 10.1042/BJ20091109; Van Keymeulen A, 2009, J CELL BIOL, V187, P91, DOI 10.1083/jcb.200907080; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang XD, 2007, DIFFERENTIATION, V75, P219, DOI 10.1111/j.1432-0436.2006.00135.x; Wang ZA, 2013, NAT CELL BIOL, V15, P274, DOI 10.1038/ncb2697; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Xie Q, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14284; Yoo YA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12943; Yoon HG, 2006, MOL ENDOCRINOL, V20, P1048, DOI 10.1210/me.2005-0324; Zhang HL, 2016, PROSTATE, V76, P402, DOI 10.1002/pros.23131	43	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13521	13530		10.1074/jbc.M117.788315	http://dx.doi.org/10.1074/jbc.M117.788315			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28679531	Green Published, hybrid			2022-12-26	WOS:000407942400032
J	McLennan, MR; Hasegawa, H; Bardi, M; Huffman, MA				McLennan, Matthew R.; Hasegawa, Hideo; Bardi, Massimo; Huffman, Michael A.			Gastrointestinal parasite infections and self-medication in wild chimpanzees surviving in degraded forest fragments within an agricultural landscape mosaic in Uganda	PLOS ONE			English	Article							PAN-TROGLODYTES-SCHWEINFURTHII; MOUNTAINS NATIONAL-PARK; INTESTINAL PARASITES; MAHALE MOUNTAINS; GREAT APES; GIARDIA-DUODENALIS; GORILLA-BERINGEI; ECOSYSTEM HEALTH; RUBONDO ISLAND; WORM INFECTION	Monitoring health in wild great apes is integral to their conservation and is especially important where they share habitats with humans, given the potential for zoonotic pathogen exchange. We studied the intestinal parasites of wild chimpanzees (Pan troglodytes schweinfurthii) inhabiting degraded forest fragments amid farmland and villages in Bulindi, Uganda. We first identified protozoan and helminth parasites infecting this population. Sixteen taxa were demonstrated microscopically (9 protozoa, 5 nematodes, 1 cestode, and 1 trematode). DNA sequence analysis enabled more precise identification of larval nematodes (e.g. Oesophagostomum stephanostomum, O. bifurcum, Strongyloides fuelleborni, Necator sp. Type II) and tapeworm proglottids (genus Bertiella). To better understand the ecology of infections, we used multidimensional scaling analysis to reveal general patterns of association among parasites, climate, and whole leaf swallowing -a prevalent self-medicative behaviour at Bulindi linked to control of nodular worms (Oesophagostomum spp.). Prevalence of parasites varied with climate in diverse ways. For example, Oesophagostomum sp. was detected in faeces at higher frequencies with increasing rainfall but was most clearly associated with periods of low temperature. Certain parasites occurred together within chimpanzee hosts more or less frequently than expected by chance. For example, the commensal ciliate Troglodytella abrassarti was negatively associated with Balantidium coli and Oesophagostomum sp., possibly because the latter taxa make the large intestine less suitable for T. abrassarti. Whole leaves in faeces showed independent associations with the prevalence of Oesophagostomum sp., Strongyloides sp., and hookworm by microscopic examination, and with egestion of adult O. stephanostomum by macroscopic inspection. All parasites identified to species or genus have been reported in wild chimpanzees inhabiting less-disturbed environments than Bulindi. Nevertheless, several disease- causing taxa infecting these chimpanzees are potentially transmissible between apes and humans (e.g. rhabditoid and strongyle nematodes), underscoring the importance of identifying and reducing risks of pathogen exchange in shared landscapes.	[McLennan, Matthew R.] Oxford Brookes Univ, Anthropol Ctr Conservat Environm & Dev, Oxford, England; [McLennan, Matthew R.] Bulindi Chimpanzee & Community Project, Hoima, Uganda; [Hasegawa, Hideo] Oita Univ, Fac Med, Dept Infect Dis Control, Yufu, Oita, Japan; [Hasegawa, Hideo] Oita Univ, Fac Med, Dept Biol, Yufu, Oita, Japan; [Bardi, Massimo] Randolph Macon Coll, Dept Psychol & Behav Neurosci, Ashland, VA 23005 USA; [Huffman, Michael A.] Kyoto Univ, Primate Res Inst, Inuyama, Aichi, Japan	Oxford Brookes University; Oita University; Oita University; Kyoto University	McLennan, MR (corresponding author), Oxford Brookes Univ, Anthropol Ctr Conservat Environm & Dev, Oxford, England.; McLennan, MR (corresponding author), Bulindi Chimpanzee & Community Project, Hoima, Uganda.	mmclennan@brookes.ac.uk		McLennan, Matthew/0000-0002-5925-1483; Huffman, Michael A/0000-0002-6166-7795; Bardi, Massimo/0000-0001-9333-3493	Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/CS-ANT/121124/2010]; Leverhulme Trust, UK [ECF-2013-057]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Leverhulme Trust, UK(Leverhulme Trust)	M.M's fieldwork for this study was conducted in 2012-13. It was supported by a grant awarded to Dr Kimberley Hockings, (Lisbon University, hock@fcsh.unl.pt) from Fundacao para a Ciencia e a Tecnologia, Portugal, (ref: PTDC/CS-ANT/121124/2010). www.fct.pt/. During some of the preparation of this manuscript (between Jan and Aug 2016), M.M. was supported by a fellowship from the Leverhulme Trust, UK. (Ref: ECF-2013-057). https://www.leverhulme.ac.uk/. Coauthors did not receive any funding for this research, and did not contribute funds from any other source. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2010, ENCY RES DESIGN, V3, P1, DOI DOI 10.4135/9781412961288.N178; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ancrenaz M, 2015, ORYX, V49, P465, DOI 10.1017/S0030605313001270; Arcus Foundation, 2015, STAT AP IND AGR APE; Ashford RW, 2000, ANN TROP MED PARASIT, V94, P173, DOI 10.1080/00034980057518; ASHFORD RW, 1990, ANN TROP MED PARASIT, V84, P337, DOI 10.1080/00034983.1990.11812477; Bakuza JS, 2009, INT J PRIMATOL, V30, P43, DOI 10.1007/s10764-008-9329-7; Barelli C, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22610; Beaver PC, 1984, CLIN PARASITOLOGY, V9th; Box GE, 1976, TIME SERIES ANAL FOR, V2nd; Calvignac-Spencer S, 2012, CLIN MICROBIOL INFEC, V18, P521, DOI 10.1111/j.1469-0691.2012.03816.x; Chapman CA, 2005, EVOL ANTHROPOL, V14, P134, DOI 10.1002/evan.20068; Cibot M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004133; Garcia LMC, 2015, INTERCIENCIA, V40, P179; Dolezalova J, 2015, PARASITOLOGY, V142, P1278, DOI 10.1017/S003118201500058X; Drakulovski P, 2014, PARASITOL RES, V113, P2541, DOI 10.1007/s00436-014-3904-y; DURETTEDESSET MC, 1992, SYST PARASITOL, V23, P159, DOI 10.1007/BF00010868; Ebbert MA, 2015, PARASITOLOGY, V142, P958, DOI 10.1017/S0031182015000104; Estrada A, 2012, AM J PRIMATOL, V74, P696, DOI 10.1002/ajp.22033; Fowler A, 2007, PRIMATES, V48, P73, DOI 10.1007/s10329-006-0001-6; Fruth B, 2014, AM J PRIMATOL, V76, P146, DOI 10.1002/ajp.22217; Gaetano TJ, 2014, S AFR J WILDL RES, V44, P56, DOI 10.3957/056.044.0105; Garriga RM, 2017, ORYX; Ghai RR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002641; Gilardi KV, 2015, BEST PRACTICE GUIDE; Gillespie TR, 2010, AM J PHYS ANTHROPOL, V143, P534, DOI 10.1002/ajpa.21348; Gillespie TR, 2006, CONSERV BIOL, V20, P441, DOI 10.1111/j.1523-1739.2006.00290.x; Gillespie TR, 2005, J APPL ECOL, V42, P699, DOI 10.1111/j.1365-2664.2005.01049.x; Graczyk TK, 2002, J PARASITOL, V88, P905, DOI 10.1645/0022-3395(2002)088[0905:AGDGAA]2.0.CO;2; Hasegawa H, 2017, PARASITOL INT, V66, P12, DOI 10.1016/j.parint.2016.11.003; Hasegawa H, 2016, PARASITOL INT, V65, P367, DOI 10.1016/j.parint.2016.05.004; Hasegawa H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002715; Hasegawa H, 2009, CAM S BIO EVOL ANTHR, V57, P507; Hasegawa H, 2009, CAM S BIO EVOL ANTHR, V57, P29; Hill C.M., 2015, STATE OF THE APES, VII, P29; Hockings KJ, 2015, TRENDS ECOL EVOL, V30, P215, DOI 10.1016/j.tree.2015.02.002; Hockings KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033391; Hogan JN, 2014, J WILDLIFE DIS, V50, P21, DOI 10.7589/2012-09-229; Howells ME, 2011, AM J PRIMATOL, V73, P173, DOI 10.1002/ajp.20884; Huffman MA, 1997, PRIMATES, V38, P111, DOI 10.1007/BF02382002; Huffman MA, 2009, CAM S BIO EVOL ANTHR, V57, P1; HUFFMAN MA, 1989, PRIMATES, V30, P51, DOI 10.1007/BF02381210; Huffman MA, 1997, YEARB PHYS ANTHROPOL, V40, P171; Huffman MA, 2001, INT J PRIMATOL, V22, P329, DOI 10.1023/A:1010734310002; Huffman MA, 1996, INT J PRIMATOL, V17, P475, DOI 10.1007/BF02735188; Huffman Michael A., 1993, African Study Monographs, V14, P227; Huffman MA, 2009, CAM S BIO EVOL ANTHR, V57, P331; Hussain Shaik, 2013, PLoS One, V8, pe63685, DOI 10.1371/journal.pone.0063685; Jirku-Pomajbikova K, 2016, PARASITOLOGY, V143, P741, DOI 10.1017/S0031182016000263; Johnston AR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000683; Kalousova B, 2014, INT J PRIMATOL, V35, P463, DOI 10.1007/s10764-014-9753-9; Kaur T, 2009, CAM S BIO EVOL ANTHR, V57, P199; Keita MB, 2014, MICROB PATHOGENESIS, V77, P149, DOI 10.1016/j.micpath.2014.09.003; Kooriyama T, 2012, PRIMATES, V53, P365, DOI 10.1007/s10329-012-0311-9; Kouassi RYW, 2015, PARASITE, V22, DOI 10.1051/parasite/2015001; Kowalewski MM, 2011, AM J PRIMATOL, V73, P75, DOI 10.1002/ajp.20803; Krief S, 2005, INT J PRIMATOL, V26, P467, DOI 10.1007/s10764-005-2934-9; Krief S, 2008, J MED PRIMATOL, V37, P188, DOI 10.1111/j.1600-0684.2008.00285.x; Krief S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000630; Kruskal J, 1978, MULTIDIMENSIONAL SCA; Kuglerova L, 2016, ECOSYSTEMS, V19, P170, DOI 10.1007/s10021-015-9927-0; LANDSOUDSOUKATE J, 1995, ANN TROP MED PARASIT, V89, P73, DOI 10.1080/00034983.1995.11812931; Lello J, 2004, NATURE, V428, P840, DOI 10.1038/nature02490; Lilly AA, 2002, INT J PRIMATOL, V23, P555, DOI 10.1023/A:1014969617036; Makouloutou P, 2014, HELMINTHOLOGIA, V51, P83, DOI 10.2478/s11687-014-0214-y; Masi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049805; Mbora DNM, 2009, J ANIM ECOL, V78, P210, DOI 10.1111/j.1365-2656.2008.01481.x; McCarthy MS, 2017, INT J PRIMATOL, V38, P321, DOI 10.1007/s10764-016-9916-y; McCarthy MS, 2015, BMC ECOL, V15, DOI 10.1186/s12898-015-0052-x; MCGREW WC, 1989, AM J PRIMATOL, V17, P147, DOI 10.1002/ajp.1350170204; McKinney T, 2015, AM J PRIMATOL, V77, P715, DOI 10.1002/ajp.22395; McLennan MR, 2017, INT J PRIMATOL, V38, P105, DOI 10.1007/s10764-017-9962-0; McLennan MR, 2016, PRIMATES, V57, P377, DOI 10.1007/s10329-016-0528-0; McLennan MR, 2014, SCI REP-UK, V4, DOI 10.1038/srep05956; McLennan MR, 2013, INT J PRIMATOL, V34, P585, DOI 10.1007/s10764-013-9683-y; McLennan MR, 2012, ORYX, V46, P598, DOI 10.1017/S0030605312000592; McLennan MR, 2012, J NAT CONSERV, V20, P219, DOI 10.1016/j.jnc.2012.03.002; McLennan MR, 2012, AM J PRIMATOL, V74, P642, DOI 10.1002/ajp.22017; McLennan MR, 2012, TROP CONSERV SCI, V5, P79, DOI 10.1177/194008291200500108; McLennan Matthew R., 2008, Primate Conservation, V23, P45, DOI 10.1896/052.023.0105; Modry D, 2015, PARASITES AFRICAN GR; Muehlenbein MP, 2005, AM J PRIMATOL, V65, P167, DOI 10.1002/ajp.20106; Muriuki SMK, 1998, ACTA TROP, V71, P73, DOI 10.1016/S0001-706X(98)00040-0; Murray S, 2000, J ZOO WILDLIFE MED, V31, P176, DOI 10.1638/1042-7260(2000)031[0176:IPOBPC]2.0.CO;2; Narat V, 2015, ECOHEALTH, V12, P621, DOI 10.1007/s10393-015-1058-8; Newton-Fisher NE, 1999, AFR J ECOL, V37, P344, DOI 10.1046/j.1365-2028.1999.00186.x; Ota N, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150471; Parsons MB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003529; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; Petrasova J, 2011, INT J PARASITOL, V41, P1113, DOI 10.1016/j.ijpara.2011.06.010; Petrzelkova KJ, 2010, AM J PRIMATOL, V72, P307, DOI 10.1002/ajp.20783; Pomajbikova K, 2012, J EUKARYOT MICROBIOL, V59, P97, DOI 10.1111/j.1550-7408.2011.00586.x; Pomajbikova K, 2010, AM J PHYS ANTHROPOL, V142, P42, DOI 10.1002/ajpa.21191; Profousova I, 2011, FOLIA MICROBIOL, V56, P339, DOI 10.1007/s12223-011-0053-x; Sa RM, 2013, AM J PRIMATOL, V75, P1032, DOI 10.1002/ajp.22170; Sricharern W, 2016, INFECT GENET EVOL, V40, P310, DOI 10.1016/j.meegid.2016.02.004; STUNKARD HORACE W., 1940, AMER JOUR TROP MED, V20, P305; Su HH, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-22; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Terio KA, 2016, AM J PRIMATOL; UBOS, 2014, NATL POPULATION HOUS; Wenz-Mucke A, 2013, PARASITOLOGY, V140, P709, DOI 10.1017/S003118201200203X; WRANGHAM RW, 1995, AM J PRIMATOL, V37, P297, DOI 10.1002/ajp.1350370404; Young H, 2013, ECOL LETT, V16, P656, DOI 10.1111/ele.12094; Zommers Z, 2013, CONSERV LETT, V6, P264, DOI 10.1111/j.1755-263X.2012.00288.x	106	25	26	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180431	10.1371/journal.pone.0180431	http://dx.doi.org/10.1371/journal.pone.0180431			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692673	Green Published, Green Submitted, gold			2022-12-26	WOS:000405544800039
J	Acquadro, A; Barchi, L; Gramazio, P; Portis, E; Vilanova, S; Comino, C; Plazas, M; Prohens, J; Lanteri, S				Acquadro, Alberto; Barchi, Lorenzo; Gramazio, Pietro; Portis, Ezio; Vilanova, Santiago; Comino, Cinzia; Plazas, Mariola; Prohens, Jaime; Lanteri, Sergio			Coding SNPs analysis highlights genetic relationships and evolution pattern in eggplant complexes	PLOS ONE			English	Article							SOLANUM-MELONGENA L.; INTERSPECIFIC HYBRIDS; POPULATION-STRUCTURE; WILD RELATIVES; DIVERSITY; INTROGRESSION; HYBRIDIZATION; AETHIOPICUM; VESPERTILIO; MACROCARPON	Brinjal (Solanum melongena), scarlet (S. aethiopicum) and gboma (S. macrocarpon) eggplants are three Old World domesticates. The genomic DNA of a collection of accessions belonging to the three cultivated species, along with a representation of various wild relatives, was characterized for the presence of single nucleotide polymorphisms (SNPs) using a genotype-by-sequencing approach. A total of 210 million useful reads were produced and were successfully aligned to the reference eggplant genome sequence. Out of the 75,399 polymorphic sites identified among the 76 entries in study, 12,859 were associated with coding sequence. A genetic relationships analysis, supported by the output of the FastSTRUCTURE software, identified four major sub-groups as present in the germplasm panel. The first of these clustered S. aethiopicum with its wild ancestor S. anguivi; the second, S. melongena, its wild progenitor S. insanum, and its relatives S. incanum, S. lichtensteinii and S. linneanum; the third, S. macrocarpon and its wild ancestor S. dasyphyllum; and the fourth, the New World species S. sisymbriifolium, S. torvum and S. elaeagnifolium. By applying a hierarchical FastSTRUCTURE analysis on partitioned data, it was also possible to resolve the ambiguous membership of the accessions of S. campylacanthum, S. violaceum, S. lidii, S. vespertilio and S. tomentsum, as well as to genetically differentiate the three species of New World Origin. A principal coordinates analysis performed both on the entire germplasm panel and also separately on the entries belonging to sub-groups revealed a clear separation among species, although not between each of the domesticates and their respective wild ancestors. There was no clear differentiation between either distinct cultivar groups or different geographical provenance. Adopting various approaches to analyze SNP variation provided support for interpretation of results. The genotyping-by-sequencing approach showed to be highly efficient for both quantifying genetic diversity and establishing genetic relationships among and within cultivated eggplants and their wild relatives. The relevance of these results to the evolution of eggplants, as well as to their genetic improvement, is discussed.	[Acquadro, Alberto; Barchi, Lorenzo; Portis, Ezio; Comino, Cinzia; Lanteri, Sergio] Univ Turin, DISAFA Plant Genet & Breeding, Largo Braccini 2, Turin, Italy; [Gramazio, Pietro; Vilanova, Santiago; Prohens, Jaime] Univ Politecn Valencia, Inst Conservac & Mejora Agrodiversidad Valenciana, Camino Vera 14, Valencia, Spain; [Plazas, Mariola] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, CSIC, Camino Vera 14, Valencia, Spain	University of Turin; Universitat Politecnica de Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Lanteri, S (corresponding author), Univ Turin, DISAFA Plant Genet & Breeding, Largo Braccini 2, Turin, Italy.; Prohens, J (corresponding author), Univ Politecn Valencia, Inst Conservac & Mejora Agrodiversidad Valenciana, Camino Vera 14, Valencia, Spain.	jprohens@btc.upv.es; sergio.lanteri@unito.it	Gramazio, Pietro/O-3143-2017; De La O Plazas Ávila, Maria/AAA-8711-2019; vilanova, santiago/AAA-5743-2019; Prohens, Jaime/ABF-1229-2021; Prohens, Jaime/H-2228-2015; BARCHI, Lorenzo/ABC-4206-2020	Gramazio, Pietro/0000-0003-2226-7999; De La O Plazas Ávila, Maria/0000-0001-8090-7312; vilanova, santiago/0000-0003-4939-9713; Prohens, Jaime/0000-0003-1181-9065; Prohens, Jaime/0000-0003-1181-9065; BARCHI, Lorenzo/0000-0001-6414-4239; PORTIS, Ezio/0000-0002-1548-6096; ACQUADRO, Alberto/0000-0002-5322-9701	European Union's Horizon Research and Innovation Programme [677379]; Spanish Ministerio de Economia, Industria y Competitividad and Fondo Europeo de Desarrollo Regional [AGL2015-64755-R]; Adapting Agriculture to Climate Change: Collecting, Protecting and Preparing Crop Wild Relatives; Government of Norway; Spanish Ministerio de Economia, Industria y Competitividad for a post-doctoral grant within the Santiago Grisolia Programme [FCJI-2015-24835]	European Union's Horizon Research and Innovation Programme; Spanish Ministerio de Economia, Industria y Competitividad and Fondo Europeo de Desarrollo Regional; Adapting Agriculture to Climate Change: Collecting, Protecting and Preparing Crop Wild Relatives; Government of Norway; Spanish Ministerio de Economia, Industria y Competitividad for a post-doctoral grant within the Santiago Grisolia Programme	This work has been funded in part by European Unions Horizon 2020 Research and Innovation Programme under grant agreement No 677379 (G2P-SOL project: Linking genetic resources, genomes and phenotypes of Solanaceous crops) and by Spanish Ministerio de Economia, Industria y Competitividad and Fondo Europeo de Desarrollo Regional (grant AGL2015-64755-R from MINECO/FEDER). Funding has also been received from the initiative "Adapting Agriculture to Climate Change: Collecting, Protecting and Preparing Crop Wild Relatives", which is supported by the Government of Norway. This last project is managed by the Global Crop Diversity Trust with the Millennium Seed Bank of the Royal Botanic Gardens, Kew and implemented in partnership with national and international gene banks and plant breeding institutes around the world. For further information see the project website:http://www.cwrdiversity.org/. Pietro Gramazio is grateful to Universitat Politecnica de Valencia for a pre-doctoral (Programa FPI de la UPV-Subprograma 1/2013 call) contract. Mariola Plazas is grateful to Spanish Ministerio de Economia, Industria y Competitividad for a post-doctoral grant within the Santiago Grisolia Programme (FCJI-2015-24835). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquadro A, 2016, ACTA HORTIC, V1147, P1, DOI 10.17660/ActaHortic.2016.1147.1; Acquadro A, 2009, THEOR APPL GENET, V118, P1573, DOI 10.1007/s00122-009-1005-6; Anderson GJ, 2006, AN JARDIN BOT MADRID, V63, P159; Ano G., 2001, TROPICAL PLANT BREED, P200; Bajaj D, 2015, SCI REPORTS, V5, P357; Barchi L, 2016, 20 EUC GEN C ZUR; Bletsos FA, 1998, PLANT BREEDING, V117, P159, DOI 10.1111/j.1439-0523.1998.tb01471.x; BOYD JW, 1984, ECON BOT, V38, P210, DOI 10.1007/BF02858833; Bukenya Z. R., 1994, East African Agricultural and Forestry Journal, V59, P187; Cericola F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073702; Daunay M.-C., 2012, HDB VEGETABLES, P257, DOI DOI 10.1016/B978-0-08-040826-2.50028-X; Daunay MC., 1991, SOLANACEAE, P389; Davidar P, 2015, AM J BOT, V102, P129, DOI 10.3732/ajb.1400404; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Docimo T, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01233; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Emanuelli F, GENETIC DIVERSITY PO; Flint-Garcia SA, 2013, J AGR FOOD CHEM, V61, P8267, DOI 10.1021/jf305511d; Fowler C, 2003, INT TREATY PLANT GEN, VI; Frary A, 2006, GENOME MAPPING MOL B, VV; Frary A, 2014, EUPHYTICA, V197, P211, DOI 10.1007/s10681-013-1060-6; Furini A, 2004, THEOR APPL GENET, V108, P197, DOI 10.1007/s00122-003-1439-1; GLEDDIE S, 1986, THEOR APPL GENET, V71, P613, DOI 10.1007/BF00264265; Harlan JR, 1992, CROPS MAN, V2nd; Harper DAT, PAST PALAEONTOLOGICA; Isshiki S, 2008, SCI HORTIC-AMSTERDAM, V117, P186, DOI 10.1016/j.scienta.2008.04.003; Kaeppler SM, 2000, PLANT MOL BIOL, V43, P179, DOI 10.1023/A:1006423110134; Kashyap V, 2003, SCI HORTIC-AMSTERDAM, V97, P1, DOI 10.1016/S0304-4238(02)00140-1; Khan MMR, 2013, HORTSCIENCE, V48, P422; Knapp S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057039; Kouassi B, 2016, SCI HORTIC-AMSTERDAM, V213, P199, DOI 10.1016/j.scienta.2016.10.039; Kumchai J, 2013, GENET MOL RES, V12, P755, DOI 10.4238/2013.March.13.4; Kwon YI, 2008, BIORESOURCE TECHNOL, V99, P2981, DOI 10.1016/j.biortech.2007.06.035; Lanteri S, 2014, APPL VEGETABLE GENOM; Lester R. N., 1986, Solanaceae: biology and systematics, P433; Lester R. N., 1990, Plant Genetic Resources Newsletter, P17; Lester R. N., 2003, Schriften zu Genetischen Ressourcen, P137; Lester R.N., 2011, SOLANUM IN AFRICA; Lester R. N., 1991, SOLANACEAE, P369; LESTER RN, 1989, EUPHYTICA, V40, P67; Lester RN, 1998, ANN BOT-LONDON, V82, P445, DOI 10.1006/anbo.1998.0695; Levin RA, 2006, AM J BOT, V93, P157, DOI 10.3732/ajb.93.1.157; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu J, 2015, EUPHYTICA, V201, P463, DOI 10.1007/s10681-014-1234-x; Mace ES, 1999, THEOR APPL GENET, V99, P626, DOI 10.1007/s001220051277; Mammadov Jafar, 2012, Int J Plant Genomics, V2012, P728398, DOI 10.1155/2012/728398; Mennella G, 2010, J AGR FOOD CHEM, V58, P7597, DOI 10.1021/jf101004z; Meyer RS, 2012, MOL PHYLOGENET EVOL, V63, P685, DOI 10.1016/j.ympev.2012.02.006; Mutegi E, 2015, AM J BOT, V102, P140, DOI 10.3732/ajb.1400403; Patwardhan A., 2014, J PHYLOGENETICS EVOL, DOI [10.4172/2329-9002.1000131, DOI 10.4172/2329-9002.1000131]; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Plazas M, 2016, J AM SOC HORTIC SCI, V141, P34, DOI 10.21273/JASHS.141.1.34; Plazas M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00318; Plazas M, 2013, J AGR FOOD CHEM, V61, P8871, DOI 10.1021/jf402429k; Portis E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089499; Pritchard JK, 2000, GENETICS, V155, P945; Prohens J, 2007, GENET RESOUR CROP EV, V54, P451, DOI 10.1007/s10722-006-9174-5; Prohens J, 2012, EUPHYTICA, V186, P517, DOI 10.1007/s10681-012-0652-x; Raj A, 2014, GENETICS, P197; Ranil RHG, 2017, GENET RESOU IN PRESS; Rotino GL, 2014, ALIEN GENE TRANSFER, P381, DOI DOI 10.1007/978-1-4614-9572-7_; Sarkinen T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-214; SAKATA Y, 1991, EUPHYTICA, V55, P21, DOI 10.1007/BF00022555; Sakata Y, 1997, EUPHYTICA, V97, P295, DOI 10.1023/A:1003000612441; Salas P, 2011, EUPHYTICA, V182, P261, DOI 10.1007/s10681-011-0490-2; Schippers R. R., 2000, African indigenous vegetables: an overview of the cultivated species; SIHACHAKR D, 1988, PLANT SCI, V57, P215, DOI 10.1016/0168-9452(88)90127-6; Stern S, 2011, TAXON, V60, P1429, DOI 10.1002/tax.605018; Stommell JR, 2003, J AM SOC HORTIC SCI, V128, P704, DOI 10.21273/JASHS.128.5.0704; Sunseri F., 2010, African Journal of Plant Science, V4, P231; Syfert MM, 2016, AM J BOT, V103, P635, DOI 10.3732/ajb.1500539; Toppino L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00256; Varshney RK, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001883; Vorontsova MS, 2013, BOT J LINN SOC, V173, P176, DOI 10.1111/boj.12053; Weese TL, 2010, TAXON, V59, P49, DOI 10.1002/tax.591006; Zhang YJ, 2014, J AGR FOOD CHEM, V62, P2906, DOI 10.1021/jf404574c	76	29	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180774	10.1371/journal.pone.0180774	http://dx.doi.org/10.1371/journal.pone.0180774			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686642	gold, Green Published			2022-12-26	WOS:000405464100099
J	Harbertson, J; Hale, BR; Tran, BR; Thomas, AG; Grillo, MP; Jacobs, MB; McAnany, J; Shaffer, RA				Harbertson, Judith; Hale, Braden R.; Tran, Bonnie R.; Thomas, Anne G.; Grillo, Michael P.; Jacobs, Marni B.; McAnany, Jennifer; Shaffer, Richard A.			Self-reported HIV-positive status but subsequent HIV-negative test result using rapid diagnostic testing algorithms among seven sub-Saharan African military populations	PLOS ONE			English	Article							ADOLESCENTS; UGANDA	HIV rapid diagnostic tests (RDTs) combined in an algorithm are the current standard for HIV diagnosis in many sub-Saharan African countries, and extensive laboratory testing has confirmed HIV RDTs have excellent sensitivity and specificity. However, false-positive RDT algorithm results have been reported due to a variety of factors, such as suboptimal quality assurance procedures and inaccurate interpretation of results. We conducted HIV serosurveys in seven sub-Saharan African military populations and recorded the frequency of personnel self-reporting HIV positivity, but subsequently testing HIV-negative during the serosurvey. The frequency of individuals who reported they were HIV-positive but subsequently tested HIV-negative using RDT algorithms ranged from 3.3 to 91.1%, suggesting significant rates of prior false-positive HIV RDT algorithm results, which should be confirmed using biological testing across time in future studies. Simple measures could substantially reduce false-positive results, such as greater adherence to quality assurance guidelines and prevalence-specific HIV testing algorithms as described in the World Health Organization's HIV testing guidelines. Other measures to improve RDT algorithm specificity include classifying individuals with weakly positive test lines as HIV indeterminate and retesting. While expansion of HIV testing in resource-limited countries is critical to identifying HIV-infected individuals for appropriate care and treatment, careful attention to potential causes of false HIV-positive results are needed to prevent the significant medical, psychological, and fiscal costs resulting from individuals receiving a false-positive HIV diagnosis.	[Harbertson, Judith; Hale, Braden R.; Tran, Bonnie R.; Thomas, Anne G.; Grillo, Michael P.; Jacobs, Marni B.; McAnany, Jennifer; Shaffer, Richard A.] Naval Hlth Res Ctr, Dept Def HIV AIDS Prevent Program, San Diego, CA 92152 USA; [Harbertson, Judith] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA; [Harbertson, Judith; Tran, Bonnie R.; Thomas, Anne G.; Jacobs, Marni B.; McAnany, Jennifer] Leidos Inc, Reston, VA 20190 USA; [Hale, Braden R.] Univ Calif San Diego, La Jolla, CA 92093 USA	United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University of California System; University of California San Diego	Harbertson, J (corresponding author), Naval Hlth Res Ctr, Dept Def HIV AIDS Prevent Program, San Diego, CA 92152 USA.; Harbertson, J (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA.; Harbertson, J (corresponding author), Leidos Inc, Reston, VA 20190 USA.	judith.harbertson.ctr@mail.mil		Harbertson, Judith/0000-0003-2685-7750				Delaney KP, 2011, CLIN INFECT DIS, V52, P257, DOI 10.1093/cid/ciq068; Evangeli M, 2016, AIDS CARE, V28, P943, DOI 10.1080/09540121.2016.1139040; Everett DB, 2007, TROP MED INT HEALTH, V12, P1323, DOI 10.1111/j.1365-3156.2007.01933.x; Everett DB, 2010, J CLIN MICROBIOL, V48, P1570, DOI 10.1128/JCM.02264-09; Gray RH, 2007, BRIT MED J, V335, P188, DOI 10.1136/bmj.39210.582801.BE; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Johnson C, 2014, ARE WE DELIVERING WR; Kagulire SC, 2011, INT J STD AIDS, V22, P308, DOI 10.1258/ijsa.2009.009352; Klarkowski D, 2014, EXPERT REV ANTI-INFE, V12, P49, DOI 10.1586/14787210.2014.866516; Klarkowski DB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004351; Laforgerie E, 2010, J VIROL METHODS, V165, P105, DOI 10.1016/j.jviromet.2009.12.007; Lejon V, 2010, J CLIN MICROBIOL, V48, P2836, DOI 10.1128/JCM.00456-10; Merchant M, 2014, J CLIN VIROL, V59, P172, DOI 10.1016/j.jcv.2013.11.012; Mwangala SM, 2014, 16 ANN M INT C INF D; Organization WH Control CfD, 2001, GUID US HIV TEST TEC; Shanks L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0769-3; Shanks L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059906; WHO, 2015, CONSOLIDATED GUIDELI; World Health Organization, 2013, HIV ASS OP CHAR HIV; World Health Organization, 2002, GUID APPR EV HIV TES; World Health Organization, 2014, WHO REM NAT PROGR RE; World Health Organization, 2012, SERV DEL APPR HIV TE	22	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180796	10.1371/journal.pone.0180796	http://dx.doi.org/10.1371/journal.pone.0180796			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686678	Green Published, gold, Green Submitted			2022-12-26	WOS:000405464100107
J	Hegazi, NA; Sarhan, MS; Fayez, M; Patz, S; Murphy, BR; Ruppel, S				Hegazi, Nabil A.; Sarhan, Mohamed S.; Fayez, Mohamed; Patz, Sascha; Murphy, Brian R.; Ruppel, Silke			Plant-fed versus chemicals-fed rhizobacteria of Lucerne: Plant-only teabags culture media not only increase culturability of rhizobacteria but also recover a previously uncultured Lysobacter sp., Novosphingobium sp and Pedobacter sp	PLOS ONE			English	Article							GEL-ELECTROPHORESIS ANALYSIS; MEDICAGO-SATIVA; BACTERIAL COMMUNITIES; SOIL BACTERIA; GROWTH-MEDIUM; DIVERSITY; CULTIVATION; ACIDOBACTERIA; POPULATIONS; SIZE	In an effort to axenically culture the previously uncultivable populations of the rhizobacteria of Lucerne (Medicago sativa L.), we propose plant-only teabags culture media to mimic the nutritional matrix available in the rhizosphere. Here, we show that culture media prepared from Lucerne powder teabags substantially increased the cultivability of Lucerne rhizobacteria compared with a standard nutrient agar, where we found that the cultivable populations significantly increased by up to 60% of the total bacterial numbers as estimated by Quantitative Real-time Polymerase Chain Reaction (qRT-PCR). Cluster analysis of 16S rDNA Polymerase Chain Reaction-Denaturing Gradient Gel Electrophoresis (PCR-DGGE) of cultivable Colony-Forming Units (CFUs) revealed a more distinct composition and separation of bacterial populations recovered on the plant-only teabags culture media than those developed on a standard nutrient agar. Further, the new plant medium gave preference to the micro-symbiont Sinorhizobium meliloti, and succeeded in isolating a number of not-yet-cultured bacteria, most closely matched to Novosphingobium sp., Lysobacter sp. and Pedobacter sp. The present study may encourage other researchers to consider moving from the well-established standard culture media to the challenging new plant-only culture media. Such a move may reveal previously hidden members of rhizobacteria, and help to further explore their potential environmental impacts.	[Hegazi, Nabil A.; Sarhan, Mohamed S.; Fayez, Mohamed] Cairo Univ, Environm Studies & Res Unit, Dept Microbiol, Fac Agr, Giza, Egypt; [Patz, Sascha; Ruppel, Silke] Leibniz Inst Vegetable & Ornamental Crops Grossbe, Grossbeeren, Germany; [Murphy, Brian R.] Trinity Coll Dublin, Sch Nat Sci, Dept Bot, Dublin, Ireland	Egyptian Knowledge Bank (EKB); Cairo University; Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ); Trinity College Dublin	Hegazi, NA (corresponding author), Cairo Univ, Environm Studies & Res Unit, Dept Microbiol, Fac Agr, Giza, Egypt.	hegazinabil8@gmail.com	Sarhan, Mohamed/ABA-2586-2021; Sarhan, Mohamed S./AAI-6492-2020	Sarhan, Mohamed/0000-0003-0904-976X; Patz, Sascha/0000-0002-3385-8922; Murphy, Brian R./0000-0002-3771-5283	Cairo University; Alexandervon Humboldt Stiftung; Leibniz institut fur gemuse und zierpflanzenbau	Cairo University(Cairo University); Alexandervon Humboldt Stiftung(Alexander von Humboldt Foundation); Leibniz institut fur gemuse und zierpflanzenbau	This study was supported by Cairo University, Alexandervon Humboldt Stiftung, and Leibniz institut fur gemuse und zierpflanzenbau.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Annicchiarico P, 2015, CRIT REV PLANT SCI, V34, P327, DOI 10.1080/07352689.2014.898462; Atlas R. M., 2004, Handbook of microbiological media; Bai Y, 2015, NATURE, V528, P364, DOI 10.1038/nature16192; Carelli M, 2000, APPL ENV MICROBIOL, V66; Chi F, 2005, APPL ENVIRON MICROB, V71, P7271, DOI 10.1128/AEM.71.11.7271-7278.2005; Choi EJ, 2015, CHEM BIOL, V22, P1270, DOI 10.1016/j.chembiol.2015.07.014; Connon SA, 2002, APPL ENVIRON MICROB, V68, P3878, DOI 10.1128/AEM.68.8.3878-3885.2002; Davis KER, 2005, APPL ENVIRON MICROB, V71, P826, DOI 10.1128/AEM.71.2.826-834.2005; Dunbar J, 1999, APPL ENVIRON MICROB, V65, P1662; El Khalloufi F, 2016, SCI TOTAL ENVIRON, V539, P135, DOI 10.1016/j.scitotenv.2015.08.127; George IF, 2011, APPL ENVIRON MICROB, V77, P8184, DOI 10.1128/AEM.05956-11; Hegazi NA, 1998, DEV PLANT SOIL SCI, V79, P247; Janssen PH, 2002, APPL ENVIRON MICROB, V68, P2391, DOI 10.1128/AEM.68.5.2391-2396.2002; Joseph SJ, 2003, APPL ENVIRON MICROB, V69, P7210, DOI 10.1128/AEM.69.12.7210-7215.2003; Katsaveli K, 2012, EXTREMOPHILES, V16, P285, DOI 10.1007/s00792-012-0429-0; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; LEDERBERG J, 1952, J BACTERIOL, V63, P399, DOI 10.1128/JB.63.3.399-406.1952; Mielmann A, 2017, S AFR J BOT, V108, P8, DOI 10.1016/j.sajb.2016.09.006; Muhling M, 2008, ISME J, V2, P379, DOI 10.1038/ismej.2007.97; Muurholm S, 2007, INT J SYST EVOL MICR, V57, P2221, DOI 10.1099/ijs.0.65166-0; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nour EH, 2012, J ADV RES, V3, P35, DOI 10.1016/j.jare.2011.03.002; OLSEN RA, 1987, MICROB ECOL, V13, P59, DOI 10.1007/BF02014963; Ong M, 2016, PREP BIOCHEM BIOTECH, V46, P657, DOI 10.1080/10826068.2015.1135447; Peakall R, 2005, BIOINFORMATICS, V502, P1; Pham VHT, 2012, TRENDS BIOTECHNOL, V30, P475, DOI 10.1016/j.tibtech.2012.05.007; Pini F, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-78; Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56; Sarhan MS, 2016, PHYSIOL PLANTARUM, V157, P403, DOI 10.1111/ppl.12469; Schippers A, 2005, NATURE, V433, P861, DOI 10.1038/nature03302; Schoenborn L, 2004, APPL ENVIRON MICROB, V70, P4363, DOI 10.1128/AEM.70.7.4363-4366.2004; Schwieger F, 2000, APPL ENVIRON MICROB, V66, P3556, DOI 10.1128/AEM.66.8.3556-3565.2000; Sharma AR, 2003, CHARACTERIZATION ROO; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Nunez EV, 2012, APPL SOIL ECOL, V61, P113, DOI 10.1016/j.apsoil.2012.04.005; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watson RJ, 2001, APPL ENVIRON MICROB, V67, P3767, DOI 10.1128/AEM.67.8.3767-3770.2001; Yin H., 2010, THESIS; Youssef HH, 2016, J ADV RES, V7, P305, DOI 10.1016/j.jare.2015.07.005; Zengler K, 2002, P NATL ACAD SCI USA, V99, P15681, DOI 10.1073/pnas.252630999	42	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180424	10.1371/journal.pone.0180424	http://dx.doi.org/10.1371/journal.pone.0180424			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686606	gold, Green Published, Green Submitted			2022-12-26	WOS:000405464100063
J	Kubota, Y; Fujioka, K; Takekawa, M				Kubota, Yuji; Fujioka, Ko; Takekawa, Mutsuhiro			WGA-based lectin affinity gel electrophoresis: A novel method for the detection of OGlcNAc-modified proteins	PLOS ONE			English	Article							WHEAT-GERM-AGGLUTININ; LINKED N-ACETYLGLUCOSAMINE; O-GLCNACYLATION; CELLULAR COFACTOR; CRYSTAL-STRUCTURE; IDENTIFICATION; COMPLEX; PHOSPHORYLATION; GLYCOSYLATION; PEPTIDES	Post-translational modification with O-linked beta-N-acetylglucosamine (O-GlcNAc) occurs selectively on serine and/or threonine residues of cytoplasmic and nuclear proteins, and dynamically regulates their molecular functions. Since conventional strategies to evaluate the O-GlcNAcylation level of a specific protein require time-consuming steps, the development of a rapid and easy method for the detection and quantification of an O-GlcNAcylated protein has been a challenging issue. Here, we describe a novel method in which O-GlcNAcylated and non-O-GlcNAcylated forms of proteins are separated by lectin affinity gel electrophoresis using wheat germ agglutinin (WGA), which primarily binds to N-acetylglucosamine residues. Electrophoresis of cell lysates through a gel containing copoly-merized WGA selectively induced retardation of the mobility of O-GlcNAcylated proteins, thereby allowing the simultaneous visualization of both the O-GlcNAcylated and the unmodified forms of proteins. This method is therefore useful for the quantitative detection of O-GlcNAcylated proteins.	[Kubota, Yuji; Fujioka, Ko; Takekawa, Mutsuhiro] Univ Tokyo, Inst Med Sci, Div Cell Signaling & Mol Med, Tokyo, Japan; [Fujioka, Ko; Takekawa, Mutsuhiro] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Tokyo, Japan	University of Tokyo; University of Tokyo	Takekawa, M (corresponding author), Univ Tokyo, Inst Med Sci, Div Cell Signaling & Mol Med, Tokyo, Japan.; Takekawa, M (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Tokyo, Japan.	takekawa@ims.u-tokyo.ac.jp		Kubota, Yuji/0000-0002-8744-7176; Takekawa, Mutsuhiro/0000-0002-8027-3847	KAKENHI [15H04703]; Grants-in-Aid for Scientific Research [16K15212] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by KAKENHI Grant no. 15H04703 to MT, no. 16H06574 to MT, no. 15K19019 to YK, no. 17K08650 to YK from Japan Society for the Promotion of Science (JSPS) (https://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson NJ, 1997, J CHROMATOGR B, V699, P133, DOI 10.1016/S0378-4347(97)00202-8; AUB JC, 1965, P NATL ACAD SCI USA, V54, P400, DOI 10.1073/pnas.54.2.400; BARSOMIAN GD, 1990, J BIOL CHEM, V265, P6967; Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411; BOGERD HP, 1995, CELL, V82, P485, DOI 10.1016/0092-8674(95)90437-9; Chalkley RJ, 2001, J AM SOC MASS SPECTR, V12, P1106, DOI 10.1016/S1044-0305(01)00295-1; Chavelas E.A., 2004, REV SOC QUIM ME XICO, V48, P279; FRITZ CC, 1995, NATURE, V376, P530, DOI 10.1038/376530a0; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hu P, 2010, FEBS LETT, V584, P2526, DOI 10.1016/j.febslet.2010.04.044; KELLY WG, 1989, CELL, V57, P243, DOI 10.1016/0092-8674(89)90962-8; Khidekel N, 2004, P NATL ACAD SCI USA, V101, P13132, DOI 10.1073/pnas.0403471101; Kinoshita E, 2009, NAT PROTOC, V4, P1513, DOI 10.1038/nprot.2009.154; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; LUBAS WA, 1995, BIOCHEMISTRY-US, V34, P1686, DOI 10.1021/bi00005a025; Ma JF, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-8; Mizuguchi-Hata C, 2013, BBA-MOL CELL RES, V1833, P2682, DOI 10.1016/j.bbamcr.2013.06.008; MONSIGNY M, 1980, EUR J BIOCHEM, V104, P147, DOI 10.1111/j.1432-1033.1980.tb04410.x; Myers SA, 2011, P NATL ACAD SCI USA, V108, P9490, DOI 10.1073/pnas.1019289108; Pathak S, 2012, EMBO J, V31, P1394, DOI 10.1038/emboj.2012.8; Popov M, 2000, ANAL BIOCHEM, V279, P90, DOI 10.1006/abio.1999.4443; Rexach JE, 2010, NAT CHEM BIOL, V6, P645, DOI [10.1038/NCHEMBIO.412, 10.1038/nchembio.412]; RODRIGUEZROMERO A, 1989, BIOCHIM BIOPHYS ACTA, V998, P21, DOI 10.1016/0167-4838(89)90113-1; Ruan HB, 2013, TRENDS ENDOCRIN MET, V24, P301, DOI 10.1016/j.tem.2013.02.002; Sanchez-Velar N, 2004, GENE DEV, V18, P23, DOI 10.1101/gad.1149704; Sarge KD, 2009, METHODS MOL BIOL, V590, P265, DOI 10.1007/978-1-60327-378-7_17; Shen DL, 2012, J BIOL CHEM, V287, P15395, DOI 10.1074/jbc.M111.310664; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Teo CF, 2010, NAT CHEM BIOL, V6, P338, DOI 10.1038/nchembio.338; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; WRIGHT CS, 1987, J MOL BIOL, V194, P501, DOI 10.1016/0022-2836(87)90678-4; WRIGHT CS, 1992, J BIOL CHEM, V267, P14345; Zachara N. E., 2011, CURR PROTOC MOL BIOL, DOI [DOI 10.1002/0471142727.MB1706S95, 10.1002/0471142727.mb1706s95]	34	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180714	10.1371/journal.pone.0180714	http://dx.doi.org/10.1371/journal.pone.0180714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686627	gold, Green Published, Green Submitted			2022-12-26	WOS:000405464100095
J	Marshall, PWM; Schabrun, S; Knox, MF				Marshall, Paul W. M.; Schabrun, Siobhan; Knox, Michael F.			Physical activity and the mediating effect of fear, depression, anxiety, and catastrophizing on pain related disability in people with chronic low back pain	PLOS ONE			English	Article							AVOIDANCE BELIEFS QUESTIONNAIRE; RANDOMIZED CONTROLLED-TRIAL; ROUTINE-CLINICAL-PRACTICE; MUSCULOSKELETAL PAIN; PSYCHOLOGICAL DISTRESS; HOSPITAL ANXIETY; TAMPA SCALE; EXERCISES; MODEL; THERAPY	Background Chronic low back pain is a worldwide burden that is not being abated with our current knowledge and treatment of the condition. The fear-avoidance model is used to explain the relationship between pain and disability in patients with chronic low back pain. However there are gaps in empirical support for pathways proposed within this model, and no evidence exists as to whether physical activity moderates these pathways. Methods This was a cross-sectional study of 218 people with chronic low back pain. Multiple mediation analyses were conducted to determine the role of fear, catastrophizing, depression, and anxiety in the relationship between pain and disability. Separate analyses were performed with physical activity as the moderator. Individuals were classified as performing regular structured physical activity if they described on average once per week for > 30-minutes an activity classified at least moderate intensity (>= 4-6 METs), activity prescribed by an allied health professional for their back pain, leisure time sport or recreation, or self-directed physical activity such as resistance exercise. Results Fear, catastrophizing, and depression significantly mediated the relationship between pain and disability (p<0.001). However the mediating effect of catastrophizing was conditional upon weekly physical activity. That is, the indirect effect for catastrophizing mediating the relationship between pain and disability was only significant for individuals reporting weekly physical activity (B = 1.31, 95% CI 0.44 to 2.23), compared to individuals reporting no weekly physical activity (B = 0.21, 95% CI -0.50 to 0.97). Catastrophizing also mediated the relationship between pain and fear (B = 0.37, 95% CI 0.15 to 0.62), with higher scores explaining 53% of the total effect of pain on fear. Conclusions These results support previous findings about the importance of fear and depression as factors that should be targeted in low back pain patients to reduce back pain related disability. We have also extended understanding for the mediating effect of catastrophizing on back pain related disability. Back pain patients engaged with regular physical activity may require counselling with regards to negative pain perceptions.	[Marshall, Paul W. M.; Schabrun, Siobhan; Knox, Michael F.] Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia	Western Sydney University	Marshall, PWM (corresponding author), Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia.	p.marshall@westernsydney.edu.au		Knox, Michael/0000-0001-8728-4293; Schabrun, Siobhan/0000-0002-9083-3107				ACSM, 2013, GUID EX TEST PRESCR, V9th; Albaladejo C, 2010, SPINE, V35, P483, DOI 10.1097/BRS.0b013e3181b9c9a7; Balthazard P, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-162; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bergbom S, 2012, BEHAV RES THER, V50, P726, DOI 10.1016/j.brat.2012.08.008; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Cassidy EL, 2012, PAIN, V153, P644, DOI 10.1016/j.pain.2011.11.027; Cheung GW, 2008, ORGAN RES METHODS, V11, P296, DOI 10.1177/1094428107300343; Da Luz MA, 2014, PHYS THER, V94, P623, DOI 10.2522/ptj.20130277; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Fersum KV, 2013, EUR J PAIN, V17, P916, DOI 10.1002/j.1532-2149.2012.00252.x; Friedrich M, 1998, ARCH PHYS MED REHAB, V79, P475, DOI 10.1016/S0003-9993(98)90059-4; Fritz MS, 2007, PSYCHOL SCI, V18, P233, DOI 10.1111/j.1467-9280.2007.01882.x; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; Gay CW, 2015, EUR J PAIN, V19, P48, DOI 10.1002/ejp.519; GREENOUGH CG, 1993, ACTA ORTHOP SCAND, V64, P1, DOI 10.3109/17453679309153927; HARKAPAA K, 1991, PAIN, V46, P35, DOI 10.1016/0304-3959(91)90031-R; Henry SM, 2014, SPINE J, V14, P2799, DOI 10.1016/j.spinee.2014.03.024; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; Johnston M, 1997, PHYSIOTHER THEORY PR, V13, P67, DOI DOI 10.3109/09593989709036449; Kopec JA, 2000, SPINE, V25, P3110, DOI 10.1097/00007632-200012150-00005; Kovacs FM, 2012, SPINE J, V12, P545, DOI 10.1016/j.spinee.2012.06.002; Kovacs FM, 2011, SPINE, V36, P339, DOI 10.1097/BRS.0b013e3181cfba29; Lame IE, 2008, J HEALTH PSYCHOL, V13, P820, DOI 10.1177/1359105308093866; Lee H, 2015, PAIN, V156, P988, DOI 10.1097/j.pain.0000000000000146; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; LETHEM J, 1983, BEHAV RES THER, V21, P401, DOI 10.1016/0005-7967(83)90009-8; Lin CWC, 2011, PAIN, V152, P607, DOI 10.1016/j.pain.2010.11.034; Linden M, 2014, J BACK MUSCULOSKELET, V27, P563, DOI 10.3233/BMR-140518; Mannion AF, 2012, EUR SPINE J, V21, P1301, DOI 10.1007/s00586-012-2155-9; Mannion AF, 2001, SPINE, V26, P920, DOI 10.1097/00007632-200104150-00015; Marshall PW, 2008, ARCH PHYS MED REHAB, V89, P1305, DOI 10.1016/j.apmr.2007.11.051; Marshall PWM, 2013, SPINE, V38, pE952, DOI 10.1097/BRS.0b013e318297c1e5; Martin L.M., 2013, PROBLEM WORTH SOLVIN; Moix J, 2011, PAIN MED, V12, P1008, DOI 10.1111/j.1526-4637.2011.01155.x; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; O'Keeffe M, 2016, J PAIN, V17, P755, DOI 10.1016/j.jpain.2016.01.473; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Rasmussen-Barr E, 2009, SPINE, V34, P221, DOI 10.1097/BRS.0b013e318191e7cb; REVILL SI, 1976, ANAESTHESIA, V31, P1191, DOI 10.1111/j.1365-2044.1976.tb11971.x; Ross C, 2015, J PAIN, V16, P836, DOI 10.1016/j.jpain.2015.05.007; Smeets RJEM, 2006, J PAIN, V7, P261, DOI 10.1016/j.jpain.2005.10.011; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Summers S, 2001, J Perianesth Nurs, V16, P35; Swinkels-Meewisse EJCM, 2003, MANUAL THER, V8, P29, DOI 10.1054/math.2002.0484; Tabachnick B. G., 2013, USING MULTIVARIATE S; Unsgaard-Tondel M, 2010, PHYS THER, V90, P1426, DOI 10.2522/ptj.20090421; Van Damme S, 2002, PAIN, V96, P319, DOI 10.1016/S0304-3959(01)00463-8; van Middelkoop M, 2011, EUR SPINE J, V20, P19, DOI 10.1007/s00586-010-1518-3; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; WADDELL G, 1992, BAILLIERE CLIN RHEUM, V6, P523, DOI 10.1016/S0950-3579(05)80126-8; Walker B F, 2003, Asia Pac J Public Health, V15, P79, DOI 10.1177/101053950301500202; Wertli MM, 2014, SPINE, V39, P263, DOI 10.1097/BRS.0000000000000110; Wideman TH, 2013, PAIN, V154, P2262, DOI 10.1016/j.pain.2013.06.005; Wideman TH, 2009, PAIN, V145, P45, DOI 10.1016/j.pain.2009.04.022; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	60	103	109	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180788	10.1371/journal.pone.0180788	http://dx.doi.org/10.1371/journal.pone.0180788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686644	Green Submitted, Green Published, gold			2022-12-26	WOS:000405464100106
J	Mellink, E; Riojas-Lopez, ME; Cardenas-Garcia, M				Mellink, Eric; Riojas-Lopez, Monica E.; Cardenas-Garcia, Melinda			Biodiversity conservation in an anthropized landscape: Trees, not patch size drive, bird community composition in a low-input agro-ecosystem	PLOS ONE			English	Article							HABITAT HETEROGENEITY; RODENT ASSEMBLAGES; DIVERSITY; PLATEAU; ALPHA	One of the most typical agro-ecosystems in the Llanos de Ojuelos, a semi-arid region of central Mexico, is that of fruit-production orchards of nopales (prickly pear cacti). This perennial habitat with complex vertical structure provides refuge and food for at least 112 species of birds throughout the year. Nopal orchards vary in their internal structure, size and shrub/tree composition, yet these factors have unknown effects on the animals that use them. To further understand the conservation potential of this agro-ecosystem, we evaluated the effects of patch-size and the presence of trees on bird community composition, as well as several habitat variables, through an information-theoretical modelling approach. Community composition was obtained through a year of census transects in 12 orchards. The presence of trees in the orchards was the major driver of bird communities followed by seasonality; bird communities are independent of patch size, except for small orchard patches that benefit black-chin sparrows, which are considered a sensitive species. At least 55 species of six trophic guilds (insectivores, granivores, carnivores, nectivores, omnivores, and frugivores) used the orchards. Orchards provide adequate habitat and food resources for several sensitive species of resident and migratory sparrows. The attributes that make orchards important for birds: trees, shrubs, herb seeds, and open patches can be managed to maintain native biodiversity in highly anthropized regions with an urgent need to find convergence between production and biological conservation.	[Mellink, Eric; Cardenas-Garcia, Melinda] Ctr Invest Cient & Educ Super Ensenada, Dept Biol Conservac, Ensenada, Baja California, Mexico; [Riojas-Lopez, Monica E.] Univ Guadalajara, Ctr Univ Ciencias Biol & Agr, Dept Ecol, Zapopan, Jalisco, Mexico; [Cardenas-Garcia, Melinda] Tulipanes 1128 Fraccionamiento Jardines de Fatima, Los Mochis, Sinaloa, Mexico	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Universidad de Guadalajara	Riojas-Lopez, ME (corresponding author), Univ Guadalajara, Ctr Univ Ciencias Biol & Agr, Dept Ecol, Zapopan, Jalisco, Mexico.	monica.riojas@academicos.udg.mx		Riojas-Lopez, Monica E./0000-0003-2246-3519	Consejo Nacionalde Cienciay Tecnologoia and Secretaroia de Educacioin Pubiica, Mexico [Ciencia Basica-2010-01 / 157186]; Consejo Nacional de Ciencia y Tecnologoia, Mexico	Consejo Nacionalde Cienciay Tecnologoia and Secretaroia de Educacioin Pubiica, Mexico; Consejo Nacional de Ciencia y Tecnologoia, Mexico	This project was supported by funds from Consejo Nacionalde Cienciay Tecnologoia and Secretaroia de Educacioin Pubiica, Mexico to MERL (Ciencia Basica-2010-01 / 157186). MCG held a master in science scholarship from Consejo Nacional de Ciencia y Tecnologoia, Mexico. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri M. A., 1983, AGROECOLOGY SCI BASI; [Anonymous], 2010, R LANG ENV STAT COMP; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Farina A, 1997, LANDSCAPE ECOL, V12, P365, DOI 10.1023/A:1007934518160; Fischer J, 2002, BIOL CONSERV, V106, P129, DOI 10.1016/S0006-3207(01)00241-5; Fischer J, 2010, BIOL CONSERV, V143, P1564, DOI 10.1016/j.biocon.2010.03.030; Gonthier DJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1358; Harris D. R., 1978, Hawkes, J. G. : Conservation and agriculture., P61; Harvey CA, 2006, ECOL APPL, V16, P1986, DOI 10.1890/1051-0761(2006)016[1986:POADID]2.0.CO;2; Haslem A, 2008, ECOL APPL, V18, P185, DOI 10.1890/07-0692.1; Hays RL, 1981, ESTIMATING WILDLIFE; Helzer CJ, 1999, ECOL APPL, V9, P1448; Inglese P, 2002, CACTI BIOL USES, P163, DOI [10.1525/california/9780520231573.003.0010, DOI 10.1525/CALIFORNIA/9780520231573.003.0010]; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jost L, 2010, ECOLOGY, V91, P1969, DOI 10.1890/09-0368.1; LeHouerou HN, 1996, J ARID ENVIRON, V33, P135, DOI 10.1006/jare.1996.0053; Loumou A, 2003, AGRIC HUMAN VALUES, V20, P87, DOI 10.1023/A:1022444005336; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; Martinez JA, 2004, ARDEOLA, V51, P215; MELLINK E, 1991, AGR ECOSYST ENVIRON, V36, P37, DOI 10.1016/0167-8809(91)90034-U; Mellink E., 2002, CACTI BIOL USES, P109; Mellink E, 2016, J ARID ENVIRON, V124, P1, DOI 10.1016/j.jaridenv.2015.07.005; Millenium Ecosystem Assessment, 2005, EC HUM WELL BEING BI, V1; Moguel P, 1999, CONSERV BIOL, V13, P11, DOI 10.1046/j.1523-1739.1999.97153.x; Nabhan GP, 1982, J ETHNOBIOL, V2, P124; Perfecto I, 2008, ANN NY ACAD SCI, V1134, P173, DOI 10.1196/annals.1439.011; Rey PJ, 2011, J APPL ECOL, V48, P228, DOI 10.1111/j.1365-2664.2010.01902.x; Riojas-Lopez ME, 2012, J ARID ENVIRON, V85, P27, DOI 10.1016/j.jaridenv.2012.04.004; Riojas-Lopez ME, 2005, BIODIVERS CONSERV, V14, P2251, DOI 10.1007/s10531-004-5289-1; Riojas-Lopez ME, 2014, JALISCO MUNDO CONT A, VIII, P323; Riojas-Lopez ME, 2011, DIVERS DISTRIB, V17, P739, DOI 10.1111/j.1472-4642.2011.00764.x; Riojas-López Mónica E., 2006, Acta Zool. Mex, V22, P85; Rosenberg K. V., 2016, PARTNERS FLIGHT LAND; Scherr SJ, 2008, PHILOS T R SOC B, V363, P477, DOI 10.1098/rstb.2007.2165; Servicio de Informacion Agroalimentaria y Pesquera, PROD ANN 2013; Shake CS, 2012, CONDOR, V114, P268, DOI 10.1525/cond.2012.110107; Southwood TRE, 2000, ECOLOGICAL METHODS; Telleria JL, 2008, ARDEOLA, V55, P203; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Wright HL, 2012, CONSERV LETT, V5, P11, DOI 10.1111/j.1755-263X.2011.00208.x	44	8	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179438	10.1371/journal.pone.0179438	http://dx.doi.org/10.1371/journal.pone.0179438			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686608	Green Published, Green Submitted, gold			2022-12-26	WOS:000405464100017
J	Lebani, K; Jones, ML; Watterson, D; Ranzoni, A; Traves, RJ; Young, PR; Mahler, SM				Lebani, Kebaneilwe; Jones, Martina L.; Watterson, Daniel; Ranzoni, Andrea; Traves, Renee J.; Young, Paul R.; Mahler, Stephen M.			Isolation of serotype-specific antibodies against dengue virus non-structural protein 1 using phage display and application in a multiplexed serotyping assay	PLOS ONE			English	Article							ANTIGEN CAPTURE IMMUNOASSAY; MONOCLONAL-ANTIBODIES; NS1; DIAGNOSIS; SENSITIVITY; LIBRARY; TESTS; BLOOD; SERUM	The multidimensional nature of dengue virus (DENV) infections, which can be caused by four distinct serotypes of the virus, complicates the sensitivity of assays designed for the diagnosis of infection. Different viral markers can be optimally detected at different stages of infection. Of particular clinical importance is the early identification of infection, which is pivotal for disease management and the development of blood screening assays. Nonstructural protein 1 ( NS1) is an early surrogate marker of infection and its detection in serum coincides with detectable viraemia. The aim of this work was to isolate and characterise serotype-specific monoclonal antibodies that bind to NS1 for each of the four DENV serotypes. This was achieved using phage display and a subtractive biopanning strategy to direct the antibody selection towards serotype-specific epitopes. This antibody isolation strategy has advantages over immunisation techniques where it is difficult to avoid antibody responses to cross-reactive, immunodominant epitopes. Serotype specificity to recombinant antigen for each of the antibodies was confirmed by Enzyme Linked Immunosorbent Assay ( ELISA) and Surface Plasmon Resonance. Confirmation of binding to native DENV NS1 was achieved using ELISA and immunofluorescence assay on DENV infected Vero cells. No cross-reactivity with Zika or Kunjin viruses was observed. A previously isolated pan-reactive antibody that binds to an immunodominant epitope was able to pair with each of the serotype-specific antibodies in a sandwich ELISA, indicating that the serotype specific antibodies bind to epitopes which are all spatially distinct from the immunodominant epitope. These antibodies were suitable for use in a multiplexed assay for simultaneous detection and serotyping of DENV NS1 in human serum. This work demonstrates that phage display coupled with novel biopanning strategies is a valuable in vitro methodology for isolation of binders that can discern amongst antigens with high homology for diagnostic applicability.	[Lebani, Kebaneilwe; Jones, Martina L.; Mahler, Stephen M.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia; [Jones, Martina L.; Young, Paul R.; Mahler, Stephen M.] Univ Queensland, ARC Training Ctr Biopharmaceut Innovat, Brisbane, Qld, Australia; [Watterson, Daniel; Traves, Renee J.; Young, Paul R.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Watterson, Daniel; Young, Paul R.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Ranzoni, Andrea] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Lebani, Kebaneilwe] Botswana Int Univ Sci & Technol, Dept Biol & Biotechnol Sci, Palapye, Botswana	University of Queensland; University of Queensland; University of Queensland; University of Queensland; University of Queensland	Jones, ML (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia.; Jones, ML (corresponding author), Univ Queensland, ARC Training Ctr Biopharmaceut Innovat, Brisbane, Qld, Australia.	martina.jones@uq.edu.au	Young, Paul R/A-6176-2010	Young, Paul R/0000-0002-2040-5190; mahler, stephen/0000-0003-2403-1437; Jones, Martina/0000-0002-5154-6017; Traves, Renee Joycelyn/0000-0003-4291-8699; Watterson, Daniel/0000-0001-5957-2853; Lebani, Kebaneilwe/0000-0001-8927-091X	Australian Research Council Linkage Grant; Australian Red Cross Blood Service	Australian Research Council Linkage Grant(Australian Research Council); Australian Red Cross Blood Service	This work was supported by an Australian Research Council Linkage Grant with project partner Australian Red Cross Blood Service. The Blood Service. The funders had no role in study design, data colloction and analysis,decision to publish, or preparation of the manuscript.	Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749; Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002; Andries AC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001993; Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183; Bessoff K, 2010, CLIN VACCINE IMMUNOL, V17, P949, DOI 10.1128/CVI.00041-10; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11; Bock G., 2006, NEW TREATMENT STRATE; Cabezas S, 2008, J VIROL METHODS, V147, P235, DOI 10.1016/j.jviromet.2007.09.001; Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Codamo J, 2011, J CHEM TECHNOL BIOT, V86, P923, DOI 10.1002/jctb.2572; Das S, 2008, J CLIN MICROBIOL, V46, P3276, DOI 10.1128/JCM.00163-08; de Haard HJ, 1999, J BIOL CHEM, V274, P18218, DOI 10.1074/jbc.274.26.18218; Ding XX, 2011, CLIN VACCINE IMMUNOL, V18, P430, DOI 10.1128/CVI.00462-10; FALCONAR AKI, 1991, J GEN VIROL, V72, P961, DOI 10.1099/0022-1317-72-4-961; Guzman MG, 2004, INT J INFECT DIS, V8, P69, DOI 10.1016/j.ijid.2003.03.003; Halstead S. B, 2008, DENGUE; Hang VT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000360; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Jones ML, 2017, MOLECULES, V22, DOI 10.3390/molecules22040607; Jones ML, 2010, J IMMUNOL METHODS, V354, P85, DOI 10.1016/j.jim.2010.02.001; Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863; Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Poulsen TR, 2011, J IMMUNOL, V187, P4229, DOI 10.4049/jimmunol.1000928; PRYOR MJ, 1994, J GEN VIROL, V75, P1183, DOI 10.1099/0022-1317-75-5-1183; Qiu LW, 2009, CLIN VACCINE IMMUNOL, V16, P88, DOI 10.1128/CVI.00212-08; Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738; Ranzoni A, 2015, ANAL CHEM, V87, P6150, DOI 10.1021/acs.analchem.5b00762; Rathakrishnan Anusyah, 2013, Expert Opin Med Diagn, V7, P99, DOI 10.1517/17530059.2012.718759; Sanjaya KC, 2015, BIOSENS BIOELECTRON, V67, P769, DOI 10.1016/j.bios.2014.09.048; Sheets MD, 1998, P NATL ACAD SCI USA, V95, P6157, DOI 10.1073/pnas.95.11.6157; Teles FRR, 2005, REV MED VIROL, V15, P287, DOI 10.1002/rmv.461; Tezuka K, 2016, TRANSFUSION, V56, P3094, DOI 10.1111/trf.13875; Xu H, 2006, J CLIN MICROBIOL, V44, P2872, DOI 10.1128/JCM.00777-06; Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000	37	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2017	12	7							e0180669	10.1371/journal.pone.0180669	http://dx.doi.org/10.1371/journal.pone.0180669			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3HX	28683141	Green Published, Green Submitted, gold			2022-12-26	WOS:000405335200059
J	Gupta, P; Martin, R; Knolker, HJ; Nihalani, D; Sinha, DK				Gupta, Prabuddha; Martin, Rene; Knoelker, Hans-Joachim; Nihalani, Deepak; Sinha, Deepak Kumar			Myosin-1 inhibition by PClP affects membrane shape, cortical actin distribution and lipid droplet dynamics in early Zebrafish embryos	PLOS ONE			English	Article							BLEBBISTATIN INHIBITION; XENOPUS-LAEVIS; CELL; CYTOSKELETON; CYTOKINESIS; PENTACHLOROPSEUDILIN; LOCALIZATION; TRAFFICKING; SPECIFICITY; EXOCYTOSIS	Myosin-1 (Myo1) represents a mechanical link between the membrane and actin-cytoskeleton in animal cells. We have studied the effect of Myo1 inhibitor PClP in 1-8 cell Zebrafish embryos. Our results indicate a unique involvement of Myo1 in early development of Zebrafish embryos. Inhibition of Myo1 (by PClP) and Myo2 (by Blebbistatin) lead to arrest in cell division. While Myo1 isoforms appears to be important for both the formation and the maintenance of cleavage furrows, Myo2 is required only for the formation of furrows. We found that the blastodisc of the embryo, which contains a thick actin cortex (similar to 13 mu m), is loaded with cortical Myo1. Myo1 appears to be crucial for maintaining the blastodisc morphology and the actin cortex thickness. In addition to cell division and furrow formation, inhibition of Myo1 has a drastic effect on the dynamics and distribution of lipid droplets (LDs) in the blastodisc near the cleavage furrow. All these results above are effects of Myo1 inhibition exclusively; Myo2 inhibition by blebbistatin does not show such phenotypes. Therefore, our results demonstrate a potential role for Myo1 in the maintenance and formation of furrow, blastodisc morphology, cell-division and LD organization within the blastodisc during early embryogenesis.	[Gupta, Prabuddha; Sinha, Deepak Kumar] IACS, Dept Biol Chem, Kolkata, India; [Martin, Rene; Knoelker, Hans-Joachim] Tech Univ Dresden, Dept Chem, Dresden, Germany; [Nihalani, Deepak] Med Univ South Carolina, Dept Med, Charleston, SC USA; [Gupta, Prabuddha] Amity Univ Kolkata, Kolkata, India	Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur; Technische Universitat Dresden; Medical University of South Carolina	Sinha, DK (corresponding author), IACS, Dept Biol Chem, Kolkata, India.	bcdks@iacs.res.in	Knölker, Hans-Joachim/I-4954-2019; nihalani, deepak/AAK-9453-2020	Knölker, Hans-Joachim/0000-0002-9631-5239; Gupta, Prabuddha/0000-0003-1009-2781	CSIR poolship [13 (8655-A)/2013-pool]; Department of Science and Technology, India [SB/S0/BB-101/2013]; Ramanujan fellowship [SR/S2/RJN-114/2011]; Department of Biotechnology, India [BT/PR6995/BRB/10/1140/2012]; Wellcome Trust-DBT of Dr B Sinha, IISER Kolkata [IA/I/13/1/500885]; National Institutes of Health, NIDDK [RO1 2R01DK087956-06A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087956] Funding Source: NIH RePORTER	CSIR poolship; Department of Science and Technology, India(Department of Science & Technology (India)); Ramanujan fellowship(Department of Science & Technology (India)); Department of Biotechnology, India(Department of Biotechnology (DBT) India); Wellcome Trust-DBT of Dr B Sinha, IISER Kolkata; National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	PG Acknowledge CSIR poolship 13 (8655-A)/2013-pool, also Drs Probhatand Pradip Kr Mallick memorial. DKS acknowledge Grant No SB/S0/BB-101/2013 (Department of Science and Technology, India), SR/S2/RJN-114/2011 (Ramanujan fellowship), BT/PR6995/BRB/10/1140/2012 (Department of Biotechnology, India). TIRF microscopy is funded by Grant no-IA/I/13/1/500885 (Wellcome Trust-DBT) of Dr B Sinha, IISER Kolkata. National Institutes of Health, NIDDK, grants RO1 2R01DK087956-06A1 to D.N. is duly acknowledged.	Alberts B, 2008, MOL BIOL CELL; Allingham JS, 2005, NAT STRUCT MOL BIOL, V12, P378, DOI 10.1038/nsmb908; Arif E, 2013, KIDNEY INT, V84, P1154, DOI 10.1038/ki.2013.201; BLUEMINK JG, 1973, J CELL BIOL, V59, P89, DOI 10.1083/jcb.59.1.89; Brandstaetter H, 2014, AUTOPHAGY, V10, P2310, DOI 10.4161/15548627.2014.984272; Brandstaetter H, 2012, J CELL SCI, V125, P1991, DOI 10.1242/jcs.097212; Cheng J, 2012, MOL BIOL CELL, V23, P2891, DOI 10.1091/mbc.E11-04-0383; Chinthalapudi K, 2011, J BIOL CHEM, V286, P29700, DOI 10.1074/jbc.M111.239210; Coudrier Evelyne, 2011, Bioarchitecture, V1, P230; Danilchik MV, 2003, J CELL SCI, V116, P273, DOI 10.1242/jcs.00217; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Dutta A, 2015, SCI REPORTS, V5; Dzijak R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030529; Eliyahu E, 2005, REPRODUCTION, V129, P161, DOI 10.1530/rep.1.00424; Field CM, 2011, J CELL SCI, V124, P2086, DOI 10.1242/jcs.082263; Fleming A, 2007, ZEBRAFISH ALTERNATIV; Gomez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031658; Greenberg MJ, 2015, P NATL ACAD SCI USA, V112, pE3337, DOI 10.1073/pnas.1506633112; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Gupta Prabuddha, 2013, Biol Open, V2, P1288, DOI 10.1242/bio.20135827; Hart NH, 1995, CURR TOP DEV BIOL, V31, P343; Harvey SA, 2013, DEVELOPMENT, V140, P2703, DOI 10.1242/dev.095091; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Ikegami R, 1999, DEV BIOL, V209, P409, DOI 10.1006/dbio.1999.9243; Joensuu M, 2014, MOL BIOL CELL, V25, P1111, DOI 10.1091/mbc.E13-12-0712; Kane DA, 2009, ESSENTIAL ZEBRAFISH, P11; Kittelberger N, 2016, J CELL SCI, V129, P1685, DOI 10.1242/jcs.181313; Kolega J, 2006, MOL BIOL CELL, V17, P4435, DOI 10.1091/mbc.E06-05-0431; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Langley AR, 2014, DEVELOPMENT, V141, P3834, DOI 10.1242/dev.102368; Lee KW, 2003, INT J DEV BIOL, V47, P411; Li WM, 2008, DEV BIOL, V316, P228, DOI 10.1016/j.ydbio.2008.01.027; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Logue JS, 2015, ELIFE, V4, DOI 10.7554/eLife.08314; Marlow F., 2010, MAT CONTROL DEV VERT; Martin R, 2009, ANGEW CHEM INT EDIT, V48, P8042, DOI 10.1002/anie.200903743; McConnell RE, 2010, TRENDS CELL BIOL, V20, P418, DOI 10.1016/j.tcb.2010.04.004; McIntosh BB, 2016, J CELL SCI, V129, P2689, DOI 10.1242/jcs.186403; Mehta IS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r5; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Nair S, 2013, DEV DYNAM, V242, P44, DOI 10.1002/dvdy.23894; Patino-Lopez G, 2010, J BIOL CHEM, V285, P8675, DOI 10.1074/jbc.M109.086959; Pestic-Dragovich L, 2000, SCIENCE, V290, P337, DOI 10.1126/science.290.5490.337; Peterson Samuel M, 2009, J Vis Exp, DOI 10.3791/1470; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; Pol A, 2014, J CELL BIOL, V204, P635, DOI 10.1083/jcb.201311051; POLLARD TD, 1973, J BIOL CHEM, V248, P4682; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Prosperi MT, 2015, J CELL BIOL, V210, P347, DOI 10.1083/jcb.201501018; Rozbicki E, 2015, NAT CELL BIOL, V17, P397, DOI 10.1038/ncb3138; RUPPERT C, 1995, J CELL SCI, V108, P3775; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; SINGAL PK, 1974, CELL TISSUE RES, V154, P189; Sittaramane V, 2008, GENE EXPR PATTERNS, V8, P161, DOI 10.1016/j.gep.2007.10.010; Sokac AM, 2006, DEV CELL, V11, P629, DOI 10.1016/j.devcel.2006.09.002; Sukardi H, 2011, EXPERT OPIN DRUG MET, V7, P579, DOI 10.1517/17425255.2011.562197; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Topczewski J, 2009, ESSENTIAL ZEBRAFIS A, P133; Urven LE, 2006, J CELL SCI, V119, P4342, DOI 10.1242/jcs.03197; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wuhr M, 2011, METHOD CELL BIOL, V101, P1, DOI 10.1016/B978-0-12-387036-0.00001-3; Yip MF, 2008, CELL METAB, V8, P384, DOI 10.1016/j.cmet.2008.09.011	63	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180301	10.1371/journal.pone.0180301	http://dx.doi.org/10.1371/journal.pone.0180301			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678859	Green Published, gold, Green Submitted			2022-12-26	WOS:000405272200049
J	Jiang, ZH; Hu, Y; Jiang, HY; Tong, JH				Jiang, Zhuohua; Hu, Yang; Jiang, Huanyu; Tong, Junhua			Design and force analysis of end-effector for plug seedling transplanter	PLOS ONE			English	Article								Automatic transplanters have been very important in greenhouses since the popularization of seedling nurseries. End-effector development is a key technology for transplanting plug seedlings. Most existing end-effectors have problems with holding root plugs or releasing plugs. An efficient end-effector driven by a linear pneumatic cylinder was designed in this study, which could hold root plugs firmly and release plugs easily. This end-effector with four needles could clamp the plug simultaneously while the needles penetrate into the substrate. The depth and verticality of the needles could be adjusted conveniently for different seedling trays. The effectiveness of this end-effector was tested by a combinational trial examining three seedling nursery factors (the moisture content of the substrate, substrate bulk density and the volume proportion of substrate ingredients). Results showed that the total transplanting success rate for the end-effector was 100%, and the root plug harm rate was below 17%. A force measure system with tension and pressure transducers was installed on the designed end-effector. The adhesive force FL between the root plug and the cell of seedling trays and the extrusion force FK on the root plug were measured and analyzed. The results showed that all three variable factors and their interactions had significant effects on the extrusion force. Each factor had a significant effect on adhesive force. Additionally, it was found that the end-effector did not perform very well when the value of FK/FL was beyond the range of 5.99 similar to 8.67. This could provide a scientific basis for end-effector application in transplanting.	[Jiang, Zhuohua; Hu, Yang; Jiang, Huanyu] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou, Zhejiang, Peoples R China; [Jiang, Huanyu] Minist Agr, Key Lab Equipment & Informatizat Environm Control, Hangzhou, Zhejiang, Peoples R China; [Tong, Junhua] Zhejiang Sci Tech Univ, Fac Mech Engn & Automat, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Ministry of Agriculture & Rural Affairs; Zhejiang Sci-Tech University	Jiang, HY (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou, Zhejiang, Peoples R China.; Jiang, HY (corresponding author), Minist Agr, Key Lab Equipment & Informatizat Environm Control, Hangzhou, Zhejiang, Peoples R China.	hyjiang@zju.edu.cn			National Nature Science Foundation of China [51275475]; Ministry of Agriculture of Chinas Introduction of Advanced International Agricultural Science and Technology [2011-G32]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of Chinas Introduction of Advanced International Agricultural Science and Technology	This work was supported by National Nature Science Foundation of China (51275475), URL: http://www.nsfc.gov.cn/, and The Ministry of Agriculture of Chinas Introduction of Advanced International Agricultural Science and Technology Project (2011-G32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beam SM, 1991, ASAE ANN INT M ST JO; Boudreault S, 2014, VADOSE ZONE J, P1; Chen J, 2004, ADV HORTICULTURE, V6, P410; Choi JM, 2012, HORTICULTURE ENV BIO, V53; Feng QingChun, 2013, Transactions of the Chinese Society of Agricultural Engineering, V29, P21; Gao GuoHua, 2015, Transactions of the Chinese Society of Agricultural Engineering, V31, P16; Han LuHua, 2013, Transactions of the Chinese Society of Agricultural Engineering, V29, P24; Hu MinJuan, 2011, Acta Agriculturae Zhejiangensis, V23, P154; Idris M, 2004, FOREST ECOL MANAG, V195, P399, DOI 10.1016/j.foreco.2004.03.005; Jiang HuanYu, 2009, Transactions of the Chinese Society of Agricultural Engineering, V25, P127; Jiang ZH, 2015, COMPUT ELECTRON AGR, V113, P225, DOI 10.1016/j.compag.2015.02.011; Kim K.D., 1995, P ARBIP, V95, P157; KUTZ LJ, 1987, T ASAE, V30, P586; Ryu KH, 2001, J AGR ENG RES, V78, P141, DOI 10.1006/jaer.2000.0656; SIMONTON W, 1991, T ASAE, V34, P2615, DOI 10.13031/2013.31914; Sun GuoXiang, 2010, Nongye Jixie Xuebao = Transactions of the Chinese Society for Agricultural Machinery, V41, P48; TAI YW, 1994, T ASAE, V37, P661, DOI 10.13031/2013.28127; TING KC, 1990, T ASAE, V33, P1013, DOI 10.13031/2013.31431; TING KC, 1992, IN VITRO CELL DEV-PL, V28P, P5; Tong JunHua, 2014, Transactions of the Chinese Society of Agricultural Engineering, V30, P8; Wang Qiao, 2013, Transactions of the Chinese Society of Agricultural Engineering, V29, P32; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; [周婷 ZHOU Ting], 2009, [机械设计与研究, Machine Design and Research], V25, P121	23	11	15	6	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180229	10.1371/journal.pone.0180229	http://dx.doi.org/10.1371/journal.pone.0180229			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678858	gold, Green Submitted, Green Published			2022-12-26	WOS:000405272200041
J	Negi, S; Singh, H; Mukhopadhyay, A				Negi, Sapna; Singh, Harpreet; Mukhopadhyay, Anirban			Gut bacterial peptides with autoimmunity potential as environmental trigger for late onset complex diseases: In-silico study	PLOS ONE			English	Article							IGM ANTIBODIES; MICROBIOTA; PREDICTION; BARRIER	Recent evidences suggest that human gut microbiota with major component as bacteria can induce immunity. It is also known that gut lining depletes with ageing and that there is increased risk of autoimmune and inflammatory disorders with ageing. It is therefore likely that both may be correlated as depletion of gut lining exposes the gut bacterial antigens to host immune mechanisms, which may induce immunity to certain bacterial proteins, but at the same time such immunity may also be auto-immunogenic to host. This autoimmunity may make a protein molecule nonfunctional and thereby may be involved in late onset metabolic, autoimmune and inflammatory disorders such as, Diabetes, Rheumatoid Arthritis, Hyperlipidemias and Cancer. In this in-silico study we found a large number of peptides identical between human and gut bacteria which were binding to HLA-II alleles, and hence, likely to be auto-immunogenic. Further we observed that such autoimmune candidates were enriched in bacterial species belonging to Firmicutes and Proteobacteria phyla, which lead us to conclude that these phyla may have higher disease impact in genetically predisposed individuals. Functional annotation of human proteins homologous to candidate gut-bacterial peptides showed significant enrichment in metabolic processes and pathways. Cognitive trait, Ageing, Alzheimer, Type 2 diabetes, Chronic Kidney Failure (CKF), Chronic Obstructive Pulmonary Disease (COPD) and various Cancers were the major diseases represented in the dataset. This dataset provides us with gut bacterial autoimmune candidates which can be studied for their clinical significance in late onset diseases.	[Negi, Sapna] Natl Inst Pathol ICMR, Safdarjung Hosp Campus, New Delhi, India; [Singh, Harpreet] Indian Council Med Res ICMR Headquarter, Biomed Informat Ctr, New Delhi, India; [Mukhopadhyay, Anirban] Univ Delhi, Dept Genet, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Pathology (IOP); University of Delhi	Negi, S (corresponding author), Natl Inst Pathol ICMR, Safdarjung Hosp Campus, New Delhi, India.; Singh, H (corresponding author), Indian Council Med Res ICMR Headquarter, Biomed Informat Ctr, New Delhi, India.	negisapna@yahoo.com; hsingh@bmi.icmr.org.in	Negi, Sapna/HGA-5265-2022; Mukhopadhyay, Anirban/H-3220-2012	Singh, Harpreet/0000-0002-5838-1884				Bar F, 2013, CLIN EXP IMMUNOL, V172, P280, DOI 10.1111/cei.12047; Bhasin M, 2005, BIOINFORMATICS, V21, P2522, DOI 10.1093/bioinformatics/bti309; Bonder MJ, 2016, NAT GENET, V48, P1407, DOI 10.1038/ng.3663; Chen J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0299-7; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; D'Souza AL, 2007, POSTGRAD MED J, V83, P44, DOI 10.1136/pgmj.2006.049361; Dambroise E, 2016, SCI REP-UK, V6, DOI 10.1038/srep23523; Frulloni L, 2009, NEW ENGL J MED, V361, P2135, DOI 10.1056/NEJMoa0903068; Graessler J, 2013, PHARMACOGENOMICS J, V13, P514, DOI 10.1038/tpj.2012.43; Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0; Harmsen HJM, 2012, CLIN VACCINE IMMUNOL, V19, P515, DOI 10.1128/CVI.05517-11; Kohm AP, 2003, TRENDS MICROBIOL, V11, P101, DOI 10.1016/S0966-842X(03)00006-4; Tran L, 2013, J GERONTOL A-BIOL, V68, P1045, DOI 10.1093/gerona/glt106; Lopez P, 2016, SCI REP-UK, V6, DOI 10.1038/srep24072; Mallegol J, 2007, GASTROENTEROLOGY, V132, P1866, DOI 10.1053/j.gastro.2007.02.043; Man AL, 2014, CELL IMMUNOL, V289, P112, DOI 10.1016/j.cellimm.2014.04.001; Merchant HA, 2016, INT J PHARMACEUT, V512, P382, DOI 10.1016/j.ijpharm.2016.04.024; Morohoshi K, 2012, EXP MOL PATHOL, V92, P64, DOI 10.1016/j.yexmp.2011.09.017; Mrozinska S, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/3876764; Newkirk MM, 2005, RHEUMATOLOGY, V44, P1433, DOI 10.1093/rheumatology/kei036; Packard TA, 2013, IMMUNOL RES, V55, P48, DOI 10.1007/s12026-012-8347-x; Paschke A, 2013, POL ARCH MED WEWN, V123, P401, DOI 10.20452/pamw.1831; Percival RS, 1996, FEMS IMMUNOL MED MIC, V15, P35, DOI 10.1111/j.1574-695X.1996.tb00356.x; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; Rigoni R, 2016, GUT MICROBES, V7, P503, DOI 10.1080/19490976.2016.1228517; Rogier R, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/527696; Saraswat A, J VACCINES VACCIN, V3, P141; Shamriz O, 2016, AUTOIMMUN REV, V15, P859, DOI 10.1016/j.autrev.2016.07.012; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Shiota S, 2010, FUTURE MICROBIOL, V5, P1885, DOI 10.2217/FMB.10.135; Singh H, 2003, BIOINFORMATICS, V19, P1009, DOI 10.1093/bioinformatics/btg108; Somers K, 2011, J AUTOIMMUN, V36, P33, DOI 10.1016/j.jaut.2010.10.003; Van Niel G, 2003, GUT, V52, P1690, DOI 10.1136/gut.52.12.1690; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Wu HJ, 2012, GUT MICROBES, V3, P4, DOI 10.4161/gmic.19320; Wu XH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030431; Zhang X, 2015, NAT MED, V21, P895, DOI 10.1038/nm.3914	38	24	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2017	12	7							e0180518	10.1371/journal.pone.0180518	http://dx.doi.org/10.1371/journal.pone.0180518			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2LF	28678867	Green Published, Green Submitted, gold			2022-12-26	WOS:000405272200069
J	Chen, S; Zhu, YQ; Wayland, R				Chen, Si; Zhu, Yiqing; Wayland, Ratree			Effects of stimulus duration and vowel quality in cross-linguistic categorical perception of pitch directions	PLOS ONE			English	Article							SPEECH-PERCEPTION; LANGUAGE EXPERIENCE; LEXICAL TONES; ONSET TIME; DISCRIMINATION; IDENTIFICATION; MANDARIN; INTONATION; CONSONANTS; FREQUENCY	We investigated categorical perception of rising and falling pitch contours by tonal and nontonal listeners. Specifically, we determined minimum durations needed to perceive both contours and compared to those of production, how stimuli duration affects their perception, whether there is an intrinsic F0 effect, and how first language background, duration, directions of pitch and vowel quality interact with each other. Continua of fundamental frequency on different vowels with 9 duration values were created for identification and discrimination tasks. Less time is generally needed to effectively perceive a pitch direction than to produce it. Overall, tonal listeners' perception is more categorical than non-tonal listeners. Stimuli duration plays a critical role for both groups, but tonal listeners showed a stronger duration effect, and may benefit more from the extra time in longer stimuli for context-coding, consistent with the multistore model of categorical perception. Within a certain range of semitones, tonal listeners also required shorter stimulus duration to perceive pitch direction changes than non-tonal listeners. Finally, vowel quality plays a limited role and only interacts with duration in perceiving falling pitch directions. These findings further our understanding on models of categorical perception, the relationship between speech perception and production, and the interaction between the perception of tones and vowel quality.	[Chen, Si] Hong Kong Polytech Univ, Dept Chinese & Bilingual Studies, Hong Kong, Hong Kong, Peoples R China; [Zhu, Yiqing; Wayland, Ratree] Univ Florida, Dept Linguist, Gainesville, FL USA	Hong Kong Polytechnic University; State University System of Florida; University of Florida	Chen, S (corresponding author), Hong Kong Polytech Univ, Dept Chinese & Bilingual Studies, Hong Kong, Hong Kong, Peoples R China.	sarah.chen@polyu.edu.hk	Chen, Si/B-8601-2015	Chen, Si/0000-0003-3581-9561	Research Grants Council of the Hong Kong Special Administrative Region; Early Career Scheme [25602816]; Fund for ECS Project Rated 3.5 CRG Grant of Faculty of Humanities [G-YBGK]; Hong Kong Polytechnic University [1-ZVHJ]	Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council); Early Career Scheme; Fund for ECS Project Rated 3.5 CRG Grant of Faculty of Humanities; Hong Kong Polytechnic University(Hong Kong Polytechnic University)	This work was supported by the Research Grants Council of the Hong Kong Special Administrative Region; Funding scheme: Early Career Scheme (grant number: 25602816) (http:// www.ugc.edu.hk/eng/rgc/about/term/rgc.htm) and Fund for ECS Project Rated 3.5 CRG (grant number: G-YBGK) Grant of Faculty of Humanities, the Hong Kong Polytechnic University (grant number: 1-ZVHJ) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON AS, 1977, J ACOUST SOC AM, V61, pS66, DOI 10.1121/1.2015837; AINSWORTH WA, 1981, J PHONETICS, V9, P333, DOI 10.1016/S0095-4470(19)30976-3; Altmann CF, 2014, NEUROPSYCHOLOGIA, V64, P13, DOI 10.1016/j.neuropsychologia.2014.09.006; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bidelman GM, 2015, NEUROIMAGE, V120, P191, DOI 10.1016/j.neuroimage.2015.06.087; Burnham D, 2002, P 9 INT C SPEECH SCI; Casserly ED, 2010, WIRES COGN SCI, V1, P629, DOI 10.1002/wcs.63; DiCanio CT, 2012, J PHONETICS, V40, P672, DOI 10.1016/j.wocn.2012.05.003; Diehl RL, 2004, ANNU REV PSYCHOL, V55, P149, DOI 10.1146/annurev.psych.55.090902.142028; DURLACH NI, 1969, J ACOUST SOC AM, V46, P372, DOI 10.1121/1.1911699; Eerola O, 2012, J PHONETICS, V40, P315, DOI 10.1016/j.wocn.2011.12.003; EIMAS PD, 1963, LANG SPEECH, V6, P206, DOI 10.1177/002383096300600403; Feldman NH, 2009, PSYCHOL REV, V116, P752, DOI 10.1037/a0017196; Francis AL, 2003, PERCEPT PSYCHOPHYS, V65, P1029, DOI 10.3758/BF03194832; Francis AL, 2008, J PHONETICS, V36, P268, DOI 10.1016/j.wocn.2007.06.005; FRY DB, 1962, LANG SPEECH, V5, P171, DOI 10.1177/002383096200500401; Fujisaki H., 1970, Annual Report of the Engineering Research Institute, Faculty of Engineering, University of Tokyo, V29, P207; Fujisaki H., 1971, Annual Report of the Engineering Research Institute, Faculty of Engineering, University of Tokyo, V30, P59; Fujisaki H., 1969, Annual Report of the Engineering Research Institute, Faculty of Engineering, University of Tokyo, V28, P67; GANDOUR J, 1977, PHONETICA, V34, P54, DOI 10.1159/000259869; GANDOUR J, 1983, J PHONETICS, V11, P149, DOI 10.1016/S0095-4470(19)30813-7; Gandour J, 2000, J COGNITIVE NEUROSCI, V12, P207, DOI 10.1162/089892900561841; Gandour JT., 1984, THESIS; Halle A P, 2004, J PHONETICS, V32, P395; Hao YC, 2012, J PHONETICS, V40, P269, DOI 10.1016/j.wocn.2011.11.001; HOWARD D, 1992, MUSIC PERCEPT, V10, P205; Janse E, 2003, PRODUCTION PERCEPTIO; Jongman A, 2016, J ACOUST SOC AM, V140, P3225, DOI DOI 10.1121/1.4970184; Kaan E, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-53; Krishnan A, 2004, HEARING RES, V189, P1, DOI 10.1016/S0378-5955(03)00402-7; Kronrod Y, 2012, P 34 ANN C COGN SCI, P629; KUHL PK, 1975, SCIENCE, V190, P69, DOI 10.1126/science.1166301; Kutner M., 2005, APPL LINEAR STAT MOD; Lehiste L., 1976, J PHONETICS, V4, P113, DOI DOI 10.1016/S0095-4470(19)31231-8; Lehnert-LeHouillier H., 2013, ORIGINS SOUND CHANGE, P98, DOI [10.1093/acprof:oso/9780199573745.003.0004, DOI 10.1093/ACPROF:OSO/9780199573745.003.0004]; LIBERMAN AM, 1957, J EXP PSYCHOL, V54, P358, DOI 10.1037/h0044417; LIBERMAN AM, 1996, SPEECH SPECIAL CODE; LISKER L, 1964, WORD, V20, P384, DOI 10.1080/00437956.1964.11659830; Liu L, 2017, LANGUAGE LINGUISTICS, V18; Macmillan NA, 2005, DETECTION THEORY USE; McMurray B, 2002, COGNITION, V86, pB33, DOI 10.1016/S0010-0277(02)00157-9; Meister E, 2009, LINGUIST URAL, V45, P161, DOI 10.3176/lu.2009.3.01; MOULINES E, 1995, SPEECH COMMUN, V16, P175, DOI 10.1016/0167-6393(94)00054-E; Niebuhr O., 2004, P INT C SPEECH PROS; Ohman S., 1979, FRONTIERS SPEECH COM, P127; Ortega-Llebaria M, 2017, BILING-LANG COGN, V20, P367, DOI 10.1017/S1366728915000723; Peng G, 2010, J PHONETICS, V38, P616, DOI 10.1016/j.wocn.2010.09.003; PISONI DB, 1973, PERCEPT PSYCHOPHYS, V13, P253, DOI 10.3758/BF03214136; PISONI DB, 1975, MEM COGNITION, V3, P7, DOI 10.3758/BF03198202; PISONI DB, 1977, J ACOUST SOC AM, V61, P1352, DOI 10.1121/1.381409; PISONI DB, 1976, J ACOUST SOC AM, V59, pS39, DOI 10.1121/1.2002669; Pisoni DB, 1971, THESIS; POLLACK I, 1971, PSYCHON SCI, V24, P299; Prom-on S, 2009, J ACOUST SOC AM, V125, P405, DOI 10.1121/1.3037222; Reetz H., 2009, PHONETICS TRANSCRIPT; Repp B., 1984, SPEECH LANGUAGE ADV, V10, P243, DOI [10.1016/B978-0-12-608610-2.50012-1, DOI 10.1016/B978-0-12-608610-2.50012-1]; REPP BH, 1979, J EXP PSYCHOL HUMAN, V5, P129, DOI 10.1037/0096-1523.5.1.129; SCHOUTEN MEH, 1992, J ACOUST SOC AM, V92, P1841, DOI 10.1121/1.403841; Sharma A, 1999, J ACOUST SOC AM, V106, P1078, DOI 10.1121/1.428048; So CK, 2010, LANG SPEECH, V53, P273, DOI 10.1177/0023830909357156; STAGRAY JR, 1993, J CHINESE LINGUIST, V21, P143; Stevens K.N., 1981, ADV PSYCHOL, DOI [10.1016/S0166-4115(08)60179-X, DOI 10.1016/S0166-4115(08)60179-X]; STOLL G, 1984, SPEECH COMMUN, V3, P137, DOI 10.1016/0167-6393(84)90035-9; STUDDERTKENNEDY M, 1970, PSYCHOL REV, V77, P234, DOI 10.1037/h0029078; TANNER WP, 1964, J ACOUST SOC AM, V36, P1465, DOI 10.1121/1.1919226; TREISMAN M, 1995, Q J EXP PSYCHOL-A, V48, P334, DOI 10.1080/14640749508401394; van Hessen AJ, 1999, PHONETICA, V56, P56, DOI 10.1159/000028441; Venables WN., 2002, MODERN APPL STAT S, V4; WANG WSY, 1976, ANN NY ACAD SCI, V280, P61, DOI 10.1111/j.1749-6632.1976.tb25472.x; WANG WSY, 1976, J ACOUST SOC AM, V60, pS92, DOI 10.1121/1.2003607; Wayland R, 2015, SCOTTISH CONSORTIUM; Wayland RP, 2004, LANG LEARN, V54, P681, DOI 10.1111/j.1467-9922.2004.00283.x; WERKER JF, 1985, PERCEPT PSYCHOPHYS, V37, P35, DOI 10.3758/BF03207136; WHALEN DH, 1995, J PHONETICS, V23, P349, DOI 10.1016/S0095-4470(95)80165-0; Wu H, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00436; Xu Y, 2002, J ACOUST SOC AM, V111, P1399, DOI 10.1121/1.1445789; Xu Y, 2009, LINGUA, V119, P906, DOI 10.1016/j.lingua.2007.09.015; Xu YS, 2006, J ACOUST SOC AM, V120, P1063, DOI 10.1121/1.2213572; Yu A. C. L., 2010, LABORABORY PHONOLOGY, V10, P151, DOI DOI 10.1515/9783110224917.2.151; Yu AC, 2014, 4 INT S TON ASP LANG; Zhang C., 2013, EASTWARD FLOWS GREAT, P256, DOI DOI 10.1007/S10831-007-9016-2; Zhang CC, 2015, J NEUROLINGUIST, V33, P149, DOI 10.1016/j.jneuroling.2014.07.002	82	8	8	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180656	10.1371/journal.pone.0180656	http://dx.doi.org/10.1371/journal.pone.0180656			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FA2JX	28671991	Green Published, Green Submitted, gold			2022-12-26	WOS:000405268500076
J	Guisier, F; Bohn, P; Patout, M; Piton, N; Farah, I; Vera, P; Thiberville, L; Salaun, M				Guisier, Florian; Bohn, Pierre; Patout, Maxime; Piton, Nicolas; Farah, Insaf; Vera, Pierre; Thiberville, Luc; Salaun, Mathieu			In-and ex-vivo molecular imaging of apoptosis to assess sensitivity of non-small cell lung cancer to EGFR inhibitors using probe-based confocal laser endomicroscopy	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; TYROSINE KINASE INHIBITORS; FLUORESCENCE MICROSCOPY; PULMONARY ASPERGILLOSIS; 1ST-LINE TREATMENT; OPEN-LABEL; ADENOCARCINOMA; CHEMOTHERAPY; ERLOTINIB; MUTATION	Background Prediction of treatment outcome of non-small cell lung cancer (NSCLC) with EGFR inhibitors on the basis of the genetic analysis of the tumor can be incorrect in case of rare or complex mutations, bypass molecular activation pathways, or pharmacodynamic variations. The aim of this study was to develop an ex vivo and in vivo real-time quantitative imaging test for EGFR inhibitors sensitivity assessment. Methods Erlotinib resistant (A549, H460, H1975), insensitive (H1650) and hypersensitive (HCC827) cell lines were injected subcutaneously in Nude mice. Tumor xenografts from mice treated with Erlotinib were imaged ex vivo and in vivo using probe-based confocal laser endomicroscopy (pCLE) and NucView 488 Caspase 3 substrate, a fluorescent probe specific for the activated caspase 3. Results Assessment of apoptosis at 24h post treatment, both ex vivo in explanted tumor xenografts and in vivo, showed a significant difference between resistant cell lines (A549, H460 and H1975) and insensitive (H1650) or hypersensitive (HCC827) ones (p< 0.05 for ex vivo imaging, p <= 0.02 for in vivo imaging). There was also a significant difference between insensitive and hypersensitive cell lines, both ex vivo (p< 0.05) and in vivo (p = 0.01). Conclusion Real-time in vivo and ex vivo assessment of apoptosis using pCLE differentiates resistant from sensitive NSCLC xenografts to Erlotinib.	[Guisier, Florian; Thiberville, Luc; Salaun, Mathieu] Rouen Univ Hosp, Dept Pulmonol Thorac Oncol & Resp Intens Care, Rouen, France; [Guisier, Florian; Thiberville, Luc; Salaun, Mathieu] Rouen Univ Hosp, CIC INSERM U1404, Rouen, France; [Guisier, Florian; Bohn, Pierre; Patout, Maxime; Farah, Insaf; Vera, Pierre; Thiberville, Luc; Salaun, Mathieu] Normandie Univ, UNIROUEN, LITIS, Quant IF EA 4108, Rouen, France; [Bohn, Pierre; Vera, Pierre] Henri Becquerel Canc Ctr, Nucl Med Dept, Rouen, France; [Bohn, Pierre; Vera, Pierre] Rouen Univ Hosp, Rouen, France; [Piton, Nicolas] Rouen Univ Hosp, Cytol & Pathol Dept, Rouen, France	CHU de Rouen; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Henri Becquerel; CHU de Rouen; CHU de Rouen	Salaun, M (corresponding author), Rouen Univ Hosp, Dept Pulmonol Thorac Oncol & Resp Intens Care, Rouen, France.; Salaun, M (corresponding author), Rouen Univ Hosp, CIC INSERM U1404, Rouen, France.; Salaun, M (corresponding author), Normandie Univ, UNIROUEN, LITIS, Quant IF EA 4108, Rouen, France.	mathieu.salaun@univ-rouen.fr	Patout, Maxime/AAH-9001-2019; Bohn, Pierre/AAO-8549-2020; SALAUN, Mathieu/M-3914-2019	Patout, Maxime/0000-0002-1366-8726; Bohn, Pierre/0000-0001-8972-9022; SALAUN, Mathieu/0000-0003-1430-6396; Piton, Nicolas/0000-0001-8779-586X; Guisier, Florian/0000-0002-8166-7303	ADIR Association and LaLigue Contrele Cancer	ADIR Association and LaLigue Contrele Cancer	This study was funded by ADIR Association and LaLigue Contrele Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AM, 2012, EUR J NUCL MED MOL I, V39, P1400, DOI 10.1007/s00259-012-2150-8; Aukema TS, 2010, J NUCL MED, V51, P1344, DOI 10.2967/jnumed.110.076224; Barlesi F, 2016, LANCET, V387, P1415, DOI 10.1016/S0140-6736(16)00004-0; Becker S, 2015, NUCL MED BIOL, V42, P923, DOI 10.1016/j.nucmedbio.2015.08.002; Besse B, 2014, ANN ONCOL, V25, P1475, DOI 10.1093/annonc/mdu123; Blankenberg FG, 2012, J NUCL MED, V53, P1659, DOI 10.2967/jnumed.112.108944; Challapalli A, 2013, J NUCL MED, V54, P1551, DOI 10.2967/jnumed.112.118760; Gainor JF, 2013, J CLIN ONCOL, V31, P3987, DOI 10.1200/JCO.2012.45.2029; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Lee JK, 2014, JAMA-J AM MED ASSOC, V311, P1430, DOI 10.1001/jama.2014.3314; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mohapatra PR, 2012, EUR RESPIR J, V39, P1550, DOI 10.1183/09031936.00022112; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Morisse H, 2013, MED MYCOL, V51, P352, DOI 10.3109/13693786.2012.729138; Morisse H, 2012, MED MYCOL, V50, P386, DOI 10.3109/13693786.2011.617788; National Comprehensive Cancer Network (NCCN), 2015, NCCN CLIN PRACT GUID; Obstoy B, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0020-4; Pal A, 2006, MOL IMAGING BIOL, V8, P262, DOI 10.1007/s11307-006-0049-0; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Salaun M, 2010, EUR RESPIR J, V36, P451, DOI 10.1183/09031936.00194509; Salaun M, 2013, EUR RESPIR J, V42, P1646, DOI 10.1183/09031936.00191911; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Sohn HJ, 2008, CLIN CANCER RES, V14, P7423, DOI 10.1158/1078-0432.CCR-08-0312; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Thiberville L, 2009, EUR RESPIR J, V33, P974, DOI 10.1183/09031936.00083708; Thiberville L, 2010, EUR RESPIR J, V36, P451; Thiberville L, 2007, AM J RESP CRIT CARE, V175, P22, DOI 10.1164/rccm.200605-684OC; Thiberville Luc, 2009, Proc Am Thorac Soc, V6, P444, DOI 10.1513/pats.200902-009AW; Wu YL, 2013, J CLIN ONCOL, V31; Wu YL, 2015, ANN ONCOL; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Yeh HH, 2011, P NATL ACAD SCI USA, V108, P1603, DOI 10.1073/pnas.1010744108; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Zhu CQ, 2008, J CLIN ONCOL, V26, P4268, DOI 10.1200/JCO.2007.14.8924	35	4	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180576	10.1371/journal.pone.0180576	http://dx.doi.org/10.1371/journal.pone.0180576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671975	gold, Green Published, Green Submitted			2022-12-26	WOS:000405268500071
J	Yaya, S; Bishwajit, G; Ekholuenetale, M; Shah, V; Kadio, B; Udenigwe, O				Yaya, Sanni; Bishwajit, Ghose; Ekholuenetale, Michael; Shah, Vaibhav; Kadio, Bernard; Udenigwe, Ogochukwu			Knowledge of prevention, cause, symptom and practices of malaria among women in Burkina Faso	PLOS ONE			English	Article							HOUSEHOLDS; BARRIERS; BEHAVIOR; CHILDREN; NETS	Background Malaria remains a major public health issue in most southern African countries as the disease remains hyper endemic. Burkina Faso continues to face challenges in the treatment of malaria, as the utilization of preventive measures remains low on a national scale. While it has been acknowledged that understanding women's health-seeking behaviours, perception of malaria and its preventive measures will aid in the control of malaria, there is paucity of information on Knowledge, Attitudes and Practices among women in the reproductive age of 15-49 years in Burkina Faso. This study investigated women's knowledge of malaria, attitudes towards malaria, and practices of malaria control in order to create a synergy between community efforts and governmental/non-governmental malaria control interventions in Burkina Faso. Methods The analysis used data from the 2014 Burkina Faso Malaria Indicator Survey (MIS). In total 8111 women aged between 15-49 years were included in the present study. We assessed women's knowledge about 1) preventive measures, 2) causes and 3) symptoms of malaria, as well as malaria prevention practices for their children and during pregnancy. The socio-demographic characteristics were considered for Age, Religion, Education, Wealth index, Number of household members, Sex of household head, Household possession of radio, TV and Received antenatal care. Data were analyzed using STATA, version 14. Associations between variables were tested using a Chi-square and logistic regression, with the level of statistical significance set at 95%. Results A preponderant proportion of respondents were aged 15-29 years (mean age was 28.63 +/- 9.41). About three-quarters of the respondents had no formal education. An estimated two-third of the participants were of Islamic faith, while access to media and behavioural communication were generally poor. The level of knowledge was 53% for rural women and 68.2% for urban dwellers. In sum, there was 56.1% level of accurate knowledge of malaria among women in Burkina Faso. In the multivariable logistic regression, women in rural location had 40% reduction in the odds of having accurate knowledge of malaria when compared to urban women (aOR = 0.60; 95%CI: 0.52-0.68). The educational level was a key factor in the knowledge of malaria. The odds of having accurate knowledge of malaria increased as the educational level increased, hence, women with secondary and higher education had 29% and 93% increase in the odds of having accurate knowledge of malaria when compared to the women without formal education. Results indicate that antenatal care (ANC) services were major sources of information on malaria. Women who reportedly received ANC were 3.9 times more likely to have accurate knowledge of malaria when compared to those who did not utilize skilled ANC services (aOR = 3.90; 95%CI = 3.34-4.56). Conclusion The overall knowledge of malaria prevention practices among a large proportion of women was found to be low, which implies that the knowledge about the prevention of malaria should be improved upon by both urban and rural dwellers. There is need for concerted behavioural communication intervention to improve the knowledge of malaria especially for rural dwellers regarding malaria prevention measures, causes and symptoms. Consistent efforts at providing relevant information by health organizations are needed to reduce and control incidences of malaria in the general public.	[Yaya, Sanni; Udenigwe, Ogochukwu] Univ Ottawa, Sch Int Dev & Global Studies, Fac Social Sci, Ottawa, ON, Canada; [Bishwajit, Ghose] Huazhong Univ Sci & Technol, Sch Med & Hlth Management, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Ekholuenetale, Michael] Womens Hlth & Act Res Ctr, Benin, Nigeria; [Shah, Vaibhav; Kadio, Bernard] Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada	University of Ottawa; Huazhong University of Science & Technology; University of Ottawa	Yaya, S (corresponding author), Univ Ottawa, Sch Int Dev & Global Studies, Fac Social Sci, Ottawa, ON, Canada.	sanni.yaya@uOttawa.ca	Yaya, Sanni/C-1079-2019; Ekholuenetale, Michael/AAL-3655-2021	Yaya, Sanni/0000-0002-4876-6043; Ekholuenetale, Michael/0000-0002-2372-3020; Udenigwe, Ogochukwu/0000-0001-6844-8854				Astatkie A., 2011, ETHIOPIAN J HLTH SCI, V20; Beiersmann C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-106; Bocoum FY, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0108-0; Borgella S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080624; Chuma J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-137; Deressa W, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-259; Dhawan G, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-303; Diboulo E, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1282-x; Diiro GM, 2016, MALARIA J, V15, DOI 10.1186/s12936-015-1039-y; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Forero DA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-165; Garley A, 2012, AM J TROP MED HYG, V87, P117; Hien AS, 2017, J TROP MED-US, V2017, P1, DOI 10.1155/2017/1507829; Institut National de la Statistique et de la De A mographie, 2014, ENQ IND PAL EIPBF; Jagannathan P, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-435; Jenkins R, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0781-5; Kidima WB., 2015, SYNCYTIOTROPHOBLAST, V2015; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330; Louis VR, 2015, B WORLD HEALTH ORGAN, V93, P750, DOI 10.2471/BLT.14.147702; Maslove DM, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-26; Maternal and Child Health Integrated Program, 2013, DOC MAL PROGR IMPL B, V54; Mathania MM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1332-4; Mutegeki E, 2016, ACTA TROP ELSEVIER B; Obasy E, 2010, MALARIA RES TREATMEN, V2010, P1; Okiro EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062214; Okwundu C, 2013, COCHRANE DATABASE SY; Pell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022452; Singh Rupashree, 2014, J Family Med Prim Care, V3, P39, DOI 10.4103/2249-4863.130271; Tipke M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-95; Tusting LS, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002234; WHO, 2016, WORLD MALARIA REPORT; WHO WHO, 2015, MAL IS NO LONG LEAD; World Health Organization, 2007, HLTH POLICY, V52, P267; Yamamoto SS, 2010, J TROP PEDIATRICS, V56, P414, DOI 10.1093/tropej/fmq016; Zhou G, 2011, PLOS ONE, V6	35	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0180508	10.1371/journal.pone.0180508	http://dx.doi.org/10.1371/journal.pone.0180508			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671987	Green Submitted, Green Published, gold			2022-12-26	WOS:000405268500060
J	Zhou, X; Zhou, SQ; Feng, XB				Zhou, Xiao; Zhou, Shaoqi; Feng, Xinbin			Optimization of the photoelectrocatalytic oxidation of landfill leachate using copper and nitrate co-doped TiO2 (Ti) by response surface methodology	PLOS ONE			English	Article							PHOTOCATALYTIC DEGRADATION; RSM; DECOLORIZATION; WASTEWATERS; DESIGN	In this paper, a statistically-based experimental design with response surface methodology (RSM) was employed to examine the effects of functional conditions on the photoelectrocatalytic oxidation of landfill leachate using a Cu/N co-doped TiO2 (Ti) electrode. The experimental design method was applied to response surface modeling and the optimization of the operational parameters of the photoelectro-catalytic degradation of landfill leachate using TiO2 as a photo-anode. The variables considered were the initial chemical oxygen demand (COD) concentration, pH and the potential bias. Two dependent parameters were either directly measured or calculated as responses: chemical oxygen demand (COD) removal and total organic carbon (TOC) removal. The results of this investigation reveal that the optimum conditions are an initial pH of 10.0, 4377.98mgL(-1) initial COD concentration and 25.0 V of potential bias. The model predictions and the test data were in satisfactory agreement. COD and TOC removals of 67% and 82.5%, respectively, were demonstrated. Under the optimal conditions, GC/MS showed 73 organic micro-pollutants in the raw landfill leachate which included hydrocarbons, aromatic compounds and esters. After the landfill leachate treatment processes, 38 organic micro-pollutants disappeared completely in the photoelectrocatalytic process.	[Zhou, Xiao] Guangdong Univ Technol, Guangzhou Higher Educ Mega Ctr, Coll Environm Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Zhou, Xiao; Zhou, Shaoqi] Guizhou Acad Sci, Inst Biol, Guiyang, Peoples R China; [Zhou, Xiao; Zhou, Shaoqi] South China Univ Technol, State Key Lab Subtrop Bldg Sci, Guangzhou, Guangdong, Peoples R China; [Zhou, Xiao; Feng, Xinbin] Chinese Acad Sci, Inst Geochem, Guiyang, Peoples R China; [Zhou, Shaoqi] South China Univ Technol, Coll Environm & Energy, Guangzhou Higher Educ Mega Ctr, Guangzhou, Guangdong, Peoples R China; [Zhou, Shaoqi] South China Univ Technol, Key Lab Environm Protect & Ecoremediat, Guangzhou Higher Educ Mega Ctr, Guangdong Regular Higher Educ Inst, Guangzhou, Guangdong, Peoples R China	Guangdong University of Technology; South China University of Technology; Chinese Academy of Sciences; Guiyang Institute of Geochemistry, CAS; South China University of Technology; South China University of Technology	Zhou, SQ (corresponding author), Guizhou Acad Sci, Inst Biol, Guiyang, Peoples R China.; Zhou, SQ (corresponding author), South China Univ Technol, State Key Lab Subtrop Bldg Sci, Guangzhou, Guangdong, Peoples R China.; Zhou, SQ (corresponding author), South China Univ Technol, Coll Environm & Energy, Guangzhou Higher Educ Mega Ctr, Guangzhou, Guangdong, Peoples R China.; Zhou, SQ (corresponding author), South China Univ Technol, Key Lab Environm Protect & Ecoremediat, Guangzhou Higher Educ Mega Ctr, Guangdong Regular Higher Educ Inst, Guangzhou, Guangdong, Peoples R China.	fesqzhou@scut.edu.cn	Feng, Xinbin/F-4512-2011	Feng, Xinbin/0000-0002-7462-8998; ZHOU, XIAO/0000-0002-7229-9473	National Key Research and Development Plan [2016YFC0400702, 2016YFC0400705]; Department of Guangdong Education and Science and Technology Bureau; State Key Laboratory of Subtropical Building Science [2013ZC03, 2014ZB04, 2016ZB24]; Environmental Protection Bureau [201203]; Guizhou Province Scientific Technology Foundation [20152056]; Guizhou Academy of Sciences Foundation for Young Scientists [019]; Guizhou province major science and technology projects [J[2015]2001]	National Key Research and Development Plan; Department of Guangdong Education and Science and Technology Bureau; State Key Laboratory of Subtropical Building Science; Environmental Protection Bureau; Guizhou Province Scientific Technology Foundation; Guizhou Academy of Sciences Foundation for Young Scientists; Guizhou province major science and technology projects	Funded by National Key Research and Development Plan (2016YFC0400702, 2016YFC0400705), the Department of Guangdong Education and Science and Technology Bureau (2010), the State Key Laboratory of Subtropical Building Science (2013ZC03,2014ZB04, 2016ZB24),the Environmental Protection Bureau (201203), the Guizhou Province Scientific Technology Foundation (20152056), the Guizhou Academy of Sciences Foundation for Young Scientists (019) and the Guizhou province major science and technology projects (J[2015]2001)	Anderson-Cook C.M., 2016, RESPONSE SURFACE MET; Arslan-Alaton I, 2010, APPL CATAL B-ENVIRON, V96, P208, DOI 10.1016/j.apcatb.2010.02.023; Beg QK, 2003, PROCESS BIOCHEM, V39, P203, DOI 10.1016/S0032-9592(03)00064-5; Benatti CT, 2006, J ENVIRON MANAGE, V80, P66, DOI 10.1016/j.jenvman.2005.08.014; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Castillo M, 2001, ANAL CHIM ACTA, V426, P253, DOI 10.1016/S0003-2670(00)00828-X; Cho IH, 2007, DYES PIGMENTS, V75, P533, DOI 10.1016/j.dyepig.2006.06.041; Fang CR, 2009, BIORESOURCE TECHNOL, V100, P5664, DOI 10.1016/j.biortech.2009.06.039; Fromme H, 2002, WATER RES, V36, P1429, DOI 10.1016/S0043-1354(01)00367-0; Ghafari S, 2009, J HAZARD MATER, V163, P650, DOI 10.1016/j.jhazmat.2008.07.090; Gunst RF., 2002, TECHNOMETRICS, V38, P284; Haaland PD, 1989, EXPT DESIGN BIOTECHN; JOGLEKAR AM, 1987, CEREAL FOOD WORLD, V32, P857; Korbahti BK, 2009, J HAZARD MATER, V161, P281, DOI 10.1016/j.jhazmat.2008.03.118; Li MC, 2006, J SOLID STATE ELECTR, V10, P980, DOI 10.1007/s10008-005-0043-5; Liu HL, 2005, CHEM ENG J, V112, P173, DOI 10.1016/j.cej.2005.07.012; Mason R.L., 2003, STAT DESIGN ANAL EXP; Moraes PB, 2005, CHEMOSPHERE, V58, P41, DOI 10.1016/j.chemosphere.2004.09.026; Olmez-Hanci T, 2011, J HAZARD MATER, V185, P193, DOI 10.1016/j.jhazmat.2010.09.018; Palominos RA, 2009, CATAL TODAY, V144, P100, DOI 10.1016/j.cattod.2008.12.031; Parilti NB, 2011, J PHOTOCH PHOTOBIO A, V225, P26, DOI 10.1016/j.jphotochem.2011.09.021; Ray S, 2009, CHEM ENG J, V150, P15, DOI 10.1016/j.cej.2008.11.039; Sakkas VA, 2010, J HAZARD MATER, V175, P33, DOI 10.1016/j.jhazmat.2009.10.050; Secula MS, 2008, CHEM ENG J, V141, P18, DOI 10.1016/j.cej.2007.10.003; Tatsi AA, 2003, CHEMOSPHERE, V53, P737, DOI 10.1016/S0045-6535(03)00513-7; Tauchert E, 2006, CHEMOSPHERE, V64, P1458, DOI 10.1016/j.chemosphere.2005.12.064; WANG XIAOJUN, 2009, FENTON OXIDATION BIO, V29, P1354, DOI DOI 10.1016/J.WASMAN.2008.10.006; Wang ZP, 2002, J HAZARD MATER, V95, P153, DOI 10.1016/S0304-3894(02)00116-4; WARD MD, 1982, J PHYS CHEM-US, V86, P3599, DOI 10.1021/j100215a021; Wu JJ, 2004, CHEMOSPHERE, V54, P997, DOI 10.1016/j.chemosphere.2003.10.006; Xu YL, 2013, CHEM ENG J, V225, P138, DOI 10.1016/j.cej.2013.03.085; Zhang JW, 2010, J ENVIRON SCI, V22, P1281, DOI 10.1016/S1001-0742(09)60251-5	32	13	13	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2017	12	7							e0171234	10.1371/journal.pone.0171234	http://dx.doi.org/10.1371/journal.pone.0171234			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA2JX	28671943	Green Published, Green Submitted, gold			2022-12-26	WOS:000405268500001
J	De Palma, GD; Colavita, I; Zambrano, G; Giglio, MC; Maione, F; Luglio, G; Sarnelli, G; Rispo, A; Schettino, P; D'Armiento, FP; De Palma, FDE; D'Argenio, V; Salvatore, F				De Palma, Giovanni Domenico; Colavita, Irene; Zambrano, Gerardo; Giglio, Mariano Cesare; Maione, Francesco; Luglio, Gaetano; Sarnelli, Giovanni; Rispo, Antonio; Schettino, Pietro; D'Armiento, Francesco Paolo; De Palma, Fatima Domenica Elisa; D'Argenio, Valeria; Salvatore, Francesco			Detection of colonic dysplasia in patients with ulcerative colitis using a targeted fluorescent peptide and confocal laser endomicroscopy: A pilot study	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GROWTH-FACTOR RECEPTOR; COLORECTAL-CANCER; INTRAEPITHELIAL NEOPLASIA; INSTABILITY PATHWAY; DIAGNOSTIC YIELD; SURVEILLANCE; MANAGEMENT; CHROMOENDOSCOPY; CONSENSUS	Aim Targeted molecular probes have been used to detect sporadic colonic dysplasia during confocal laser endomicroscopy (CLE) with promising results. This is a feasibility pilot study aiming to assess the potential role of CLE combined with a fluorescent-labeled peptide to stain and detect dysplasia associated with Ulcerative Colitis. Method A phage-derived heptapeptide with predicted high binding affinity for dysplastic tissue, was synthesized and labeled with fluorescein. Eleven lesions with suspected dysplasia at endoscopy were excised from nine patients with long-standing ulcerative colitis. Specimens were sprayed with the peptide and examined by CLE. The CLE images were then compared to the corresponding histological sections. Results At definitive histology, 4 lesions were diagnosed as inflammatory polyps, 6 as dysplastic lesions and one as invasive cancer. In inflammatory polyps, the fluorescence signal came from peri-cryptal spaces and crypt lumen due to passive accumulation of the peptide in these areas. Dysplasia was associated with active binding of the peptide to dysplastic colonocytes. Conclusion Ex vivo staining of ulcerative colitis-associated dysplasia using a fluorescent labeled molecular probe and CLE is feasible. In vivo studies on larger populations are required to evaluate the safety and the effective contribution of molecular probes in cancer surveillance of ulcerative colitis.	[De Palma, Giovanni Domenico; Giglio, Mariano Cesare; Maione, Francesco; Luglio, Gaetano; Sarnelli, Giovanni; Rispo, Antonio; Schettino, Pietro] Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy; [Colavita, Irene; Zambrano, Gerardo; De Palma, Fatima Domenica Elisa; D'Argenio, Valeria; Salvatore, Francesco] CEINGE Biotecnol Avanzate, Naples, Italy; [Zambrano, Gerardo; De Palma, Fatima Domenica Elisa; D'Argenio, Valeria; Salvatore, Francesco] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [D'Armiento, Francesco Paolo] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy	University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Naples Federico II; University of Naples Federico II	De Palma, GD (corresponding author), Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy.	giovanni.depalma@unina.it	D'Argenio, Valeria/K-9345-2016; De Palma, Giovanni D/G-6895-2012; Sarnelli, Giovanni/AAB-4050-2019; Giglio, Mariano Cesare/L-6550-2017	D'Argenio, Valeria/0000-0001-9273-3698; Sarnelli, Giovanni/0000-0002-1467-1134; Giglio, Mariano Cesare/0000-0002-9222-5885; Maione, Francesco/0000-0001-7043-9295; De Palma, Fatima/0000-0002-6109-2768; Zambrano, Gerardo/0000-0002-4284-2172; De Palma, Giovanni Domenico/0000-0001-7474-7180; Luglio, Gaetano/0000-0002-5931-9599; Rispo, Antonio/0000-0002-1454-2412	(Campania - Bioscience) from the Italian Ministry of University and Research [PON03PE_00060_2, PON03PE_00060_7]	(Campania - Bioscience) from the Italian Ministry of University and Research	This study was supported by grant PON03PE_00060_2 and PON03PE_00060_7 (Campania - Bioscience) from the Italian Ministry of University and Research (to Francesco Salvatore). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROSTROM O, 1986, GUT, V27, P1408, DOI 10.1136/gut.27.12.1408; De Palma GD, 2010, DIGEST LIVER DIS, V42, P791, DOI 10.1016/j.dld.2010.03.009; Dlugosz A, 2016, ENDOSC INT OPEN, V4, pE901, DOI 10.1055/s-0042-111203; Dunican DS, 2002, ONCOGENE, V21, P3253, DOI 10.1038/sj.onc.1205431; Farraye FA, 2010, GASTROENTEROLOGY, V138, P746, DOI [10.1053/j.gastro.2009.12.035, 10.1053/j.gastro.2009.12.037]; Fujiwara I, 2008, DIS COLON RECTUM, V51, P1387, DOI 10.1007/s10350-008-9212-9; Goetz M, 2013, ENDOSCOPY, V45, P469, DOI 10.1055/s-0032-1326361; Goetz M, 2010, GASTROENTEROLOGY, V138, P435, DOI 10.1053/j.gastro.2009.10.032; GruionuLG A, 2012, PLOS ONE, V7; Hsiung PL, 2008, NAT MED, V14, P454, DOI 10.1038/nm1692; Hurlstone DP, 2006, ENDOSCOPY, V38, P1213, DOI 10.1055/s-2006-944732; Karstensen JG, 2014, WORLD J GASTROENTERO, V20, P7794, DOI 10.3748/wjg.v20.i24.7794; Kiesslich R, 2003, GASTROENTEROLOGY, V124, P880, DOI 10.1053/gast.2003.50146; Kiesslich R, 2007, GASTROENTEROLOGY, V132, P874, DOI 10.1053/j.gastro.2007.01.048; Laine L, 2015, GASTROINTEST ENDOSC, V81, P489, DOI 10.1016/j.gie.2014.12.009; Liu J, 2013, CANCER LETT, V330, P200, DOI 10.1016/j.canlet.2012.11.044; Munkholm P, 2003, ALIMENT PHARM THER, V18, P1, DOI 10.1046/j.1365-2036.18.s2.2.x; Paramsothy S, 2010, NAT REV GASTRO HEPAT, V7, P366, DOI 10.1038/nrgastro.2010.83; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Rispo A, 2012, WORLD J GASTRO ENDOS, V4, P414, DOI 10.4253/wjge.v4.i9.414; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Shergill AK, 2015, GASTROINTEST ENDOSC, V81, P1101, DOI 10.1016/j.gie.2014.10.030; Sturm MB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004733; Thorlacius H, 2007, INFLAMM BOWEL DIS, V13, P911, DOI 10.1002/ibd.20118; Van Assche G, 2013, J CROHNS COLITIS, V7, P1, DOI 10.1016/j.crohns.2012.09.005; Wallace MB, 2010, ALIMENT PHARM THER, V31, P548, DOI 10.1111/j.1365-2036.2009.04207.x; Wanders LK, 2016, GASTROINTEST ENDOSC, V83, P966, DOI 10.1016/j.gie.2015.09.001	27	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180509	10.1371/journal.pone.0180509	http://dx.doi.org/10.1371/journal.pone.0180509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666016	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608700013
